Citrus Sinensis ID: 013249

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------
Protein Sequence
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV
Secondary Structure (PSIPRED)
ccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccccccccccHHHHHHccccccHHccccccccccccccEEEEEEcccccEEEEEEEEcccccccccEEEEEEccccHHHcccHHHHHHHHHHHHHHcccccEEcccccccccccEEEEEEcccccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEccccccccccccccccccccccccccHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHHHccccccccccccccccccccccccHHHHHcccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccc
Secondary Structure Prediction (SSPRO)
cccHccccHHHHHHHHccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHcHcEEEEEEccccccHEEEEEEccccccccccEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHcccHHHccccccccHHHHHccccHHHccHHHHHHcccccccccccccHcccHcccHHHccccccccccccHHHHHHccccEEcccHHHHccc
Coil and Loop (DISEMBL)
mvstsqknLHSLLTTKLkkltitppsasspdfdftevfgpltpcrhnnqspastsaslgdpqvihnrshsfvgpspryalssslplqIQELEHENDaeleaeserkigpgdfeIFRVVGQGAFGKVFQVKkkgvddgdsdgIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYrqgifredqaRFYTAEIVSAVSHLHkcgivhrdlkpenilmdsdghvmltdfglakeidessrsnsmcgtteymapeillskghnkdadwWSVGILLYEmltgqppfthaNRQKLQQRIINekvklppfltseAHSLLKGVSFLTQLlhkdpskrlgsgpggvdaikhhkwFRSINWKTLearemqpkfkpdvsgkdcianfdkcwttmpaddspaptptagehfkgytyvapnpwlssv
Flexible Loop (DISEMBL)
mvstsqknLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKvfqvkkkgvddgdsdgiyamkvmrkdtiikknHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKdpskrlgsgpggvdaikhhkWFRSINWKTLEAREMqpkfkpdvsgkDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTyvapnpwlssv
Low Complexity Region (SEG)
MVSTSQKNLHSllttklkkltITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFgkvfqvkkkgvddgdsdgIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWttmpaddspaptptaGEHFKGYTYVAPNPWLSSV
Disordered region (IsUnstruct)
************************************VF***********************************************************************GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK***********CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLH***********GGVDAIKHHKWFRSINWKTLEAREM***FKPDVSGKDCIANFDKCWTTM***************FKGYTYVAP*******
Disordered Region (DISOPRED)
**************************************************************************************************************DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD**********EHFKGYTYVAPNPWL***
Disordered Region (DISEMBL)
*********HSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNN**********GDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI*********CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV
Disordered Region (DISPRO)
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTE*********************************************************************KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNP*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	447	2.2.26 [Sep-21-2011]
Q39030	471	Serine/threonine-protein	yes	no	0.901	0.855	0.583	1e-146
P42818	465	Serine/threonine-protein	no	no	0.908	0.873	0.552	1e-137
Q6TJY3	527	Ribosomal protein S6 kina	no	no	0.733	0.622	0.498	9e-93
Q9UBS0	482	Ribosomal protein S6 kina	yes	no	0.774	0.717	0.476	1e-92
Q8BSK8	525	Ribosomal protein S6 kina	yes	no	0.733	0.624	0.495	3e-92
P67998	525	Ribosomal protein S6 kina	yes	no	0.733	0.624	0.495	3e-92
P23443	525	Ribosomal protein S6 kina	no	no	0.733	0.624	0.495	3e-92
P67999	525	Ribosomal protein S6 kina	yes	no	0.733	0.624	0.495	3e-92
P28178	479	Protein kinase 2 OS=Dicty	yes	no	0.706	0.659	0.492	5e-92
Q9Z1M4	485	Ribosomal protein S6 kina	no	no	0.774	0.713	0.473	3e-91

>sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2

 Score =  519 bits (1337), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 265/454 (58%), Positives = 326/454 (71%), Gaps = 51/454 (11%)

Query: 20  LTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSP 76
           L+I+PP +   D     F++VFGP+        S  +   +  +P V+++RSHS VGPS 
Sbjct: 24  LSISPPKSVLGDNLELQFSDVFGPMPEA----NSEEACDVAYDEPAVVYSRSHSLVGPS- 78

Query: 77  RYALSSSLP---LQIQELE--------------HEND---AELEAESERK-------IGP 109
              +S SL    L ++E E               END      + +SE+        +G 
Sbjct: 79  -LVVSHSLKMNKLTLRETEDSVDLVECVEGESIKENDEFSGNDDTDSEKSPEEVSGVVGI 137

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE+ +VVGQGAFGKV+QV+KK     D+  IYAMKVMRKD I++KNH +YMKAERDIL
Sbjct: 138 EDFEVLKVVGQGAFGKVYQVRKK-----DTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 192

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           TK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+FRED AR YTAEIVSAVS
Sbjct: 193 TKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIVSAVS 252

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           HLH+ GI+HRDLKPENILMD DGHVMLTDFGLAKE +E++RSNSMCGTTEYMAPEI+  K
Sbjct: 253 HLHEKGIMHRDLKPENILMDVDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEIVRGK 312

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS 349
           GH+K ADWWSVGILLYEMLTG+PPF   ++ K+QQ+I+ +K+KLP FL++EAH+LLKG  
Sbjct: 313 GHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQKIVKDKIKLPQFLSNEAHALLKG-- 369

Query: 350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 409
               LL K+P +RLGSGP G + IK HKWF++INWK LEARE+QP FKP VSG+ CIANF
Sbjct: 370 ----LLQKEPERRLGSGPSGAEEIKKHKWFKAINWKKLEAREVQPSFKPAVSGRQCIANF 425

Query: 410 DKCWTTMPADDSPAPTPTA---GEHFKGYTYVAP 440
           DKCWT M   DSPA +P +      F  +TYV P
Sbjct: 426 DKCWTDMSVLDSPASSPNSDAKANPFTNFTYVRP 459

Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P42818|KPK1_ARATH Serine/threonine-protein kinase AtPK1/AtPK6 OS=Arabidopsis thaliana GN=ATPK1 PE=1 SV=1

 Score =  488 bits (1255), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 256/463 (55%), Positives = 323/463 (69%), Gaps = 57/463 (12%)

Query: 16  KLKKLTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
           K + L+I+P ++   D    +F++VFGPL P   N+        +  +P V+++RSHS V
Sbjct: 14  KQQYLSISPSNSVLKDDVELEFSDVFGPL-PEEAND-------IAYDEPAVVYSRSHSLV 65

Query: 73  GPSPRYALS------------SSLPLQIQELEHE---------------NDAELEAESER 105
           GP    + S             S+ L ++ LE E               N+  LE +  +
Sbjct: 66  GPCSLDSHSLKLTKLTLLETEDSIDL-VECLEGESLKENDDFSGNDDSDNEKALEGDLVK 124

Query: 106 K---IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G  DFE+ +VVG+GAFGKV+QV+KK     ++  IYAMKVMRKD I++KNH +YM
Sbjct: 125 VSGVVGIDDFEVMKVVGKGAFGKVYQVRKK-----ETSEIYAMKVMRKDHIMEKNHAEYM 179

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           KAERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+FRED AR YTA
Sbjct: 180 KAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTA 239

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           EIVSAVSHLH+ GI+HRDLKPENILMD+DGHVMLTDFGLAKE +E++RSNSMCGTTEYMA
Sbjct: 240 EIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMA 299

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PEI+  KGH+K ADWWSVGILLYEMLTG+PPF   ++ K+QQ+I+ +K+KLP FL++EAH
Sbjct: 300 PEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQKIVKDKIKLPQFLSNEAH 358

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG 402
           ++LKG      LL K+P +RLGSG  G + IK HKWF+ INWK LEARE+ P FKP+VSG
Sbjct: 359 AILKG------LLQKEPERRLGSGLSGAEEIKQHKWFKGINWKKLEAREVMPSFKPEVSG 412

Query: 403 KDCIANFDKCWTTMPA---DDSPAPTPTAGEHFKGYTYVAPNP 442
           + CIANFDKCWT M       S   +      F  +TYV P P
Sbjct: 413 RQCIANFDKCWTDMSVLDSPASSPSSDPKANPFTNFTYVRPPP 455

Downstream effector of TOR signaling pathway involved in osmotic stress response. Could be involved in the control of plant growth and development. Phosphorylates the ribosomal proteins P14, P16 and S6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6TJY3|KS6B1_BOVIN Ribosomal protein S6 kinase beta-1 OS=Bos taurus GN=RPS6KB1 PE=2 SV=1

 Score =  340 bits (873), Expect = 9e-93,   Method: Compositional matrix adjust.
 Identities = 170/341 (49%), Positives = 236/341 (69%), Gaps = 13/341 (3%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LLK      +LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  +
Sbjct: 323 LLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 376

Query: 404 DCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 441
           + ++ FD  +T     DSP   A + +A + F G+TYVAP+
Sbjct: 377 EDVSQFDSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9UBS0|KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2

 Score =  340 bits (871), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 173/363 (47%), Positives = 239/363 (65%), Gaps = 17/363 (4%)

Query: 88  IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY 143
           ++ + H  + EL   S      +IGP  FE+ RV+G+G +GKVFQV+K  V   +   IY
Sbjct: 39  LEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVFQVRK--VQGTNLGKIY 96

Query: 144 AMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           AMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  KLYLIL+ ++GG L
Sbjct: 97  AMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGEL 156

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++ S GH+ LTDFGL 
Sbjct: 157 FTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIMLSSQGHIKLTDFGLC 216

Query: 263 KE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 321
           KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K
Sbjct: 217 KESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDMLTGSPPFTAENRKK 276

Query: 322 LQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
              +II  K+ LPP+LT +A  L+K      + L ++PS+R+G GPG    ++ H +FR 
Sbjct: 277 TMDKIIRGKLALPPYLTPDARDLVK------KFLKRNPSQRIGGGPGDAADVQRHPFFRH 330

Query: 382 INWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYV 438
           +NW  L A  + P F+P +  ++ ++ FD  +T     DSP   A + +A + F G+TYV
Sbjct: 331 MNWDDLLAWRVDPPFRPCLQSEEDVSQFDTRFTRQTPVDSPDDTALSESANQAFLGFTYV 390

Query: 439 APN 441
           AP+
Sbjct: 391 APS 393

Phosphorylates specifically ribosomal protein S6.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8BSK8|KS6B1_MOUSE Ribosomal protein S6 kinase beta-1 OS=Mus musculus GN=Rps6kb1 PE=1 SV=2

 Score =  339 bits (869), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 169/341 (49%), Positives = 235/341 (68%), Gaps = 13/341 (3%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LLK      +LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  +
Sbjct: 323 LLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 376

Query: 404 DCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 441
           + ++ FD  +T     DSP     + +A + F G+TYVAP+
Sbjct: 377 EDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67998|KS6B1_RABIT Ribosomal protein S6 kinase beta-1 OS=Oryctolagus cuniculus GN=RPS6KB1 PE=2 SV=1

 Score =  339 bits (869), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 169/341 (49%), Positives = 235/341 (68%), Gaps = 13/341 (3%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LLK      +LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  +
Sbjct: 323 LLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 376

Query: 404 DCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 441
           + ++ FD  +T     DSP     + +A + F G+TYVAP+
Sbjct: 377 EDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P23443|KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2

 Score =  339 bits (869), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 169/341 (49%), Positives = 235/341 (68%), Gaps = 13/341 (3%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LLK      +LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  +
Sbjct: 323 LLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 376

Query: 404 DCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 441
           + ++ FD  +T     DSP     + +A + F G+TYVAP+
Sbjct: 377 EDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67999|KS6B1_RAT Ribosomal protein S6 kinase beta-1 OS=Rattus norvegicus GN=Rps6kb1 PE=1 SV=1

 Score =  338 bits (868), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 169/341 (49%), Positives = 235/341 (68%), Gaps = 13/341 (3%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LLK      +LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  +
Sbjct: 323 LLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 376

Query: 404 DCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 441
           + ++ FD  +T     DSP     + +A + F G+TYVAP+
Sbjct: 377 EDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28178|PK2_DICDI Protein kinase 2 OS=Dictyostelium discoideum GN=pkgB PE=1 SV=2

 Score =  338 bits (867), Expect = 5e-92,   Method: Compositional matrix adjust.
 Identities = 165/335 (49%), Positives = 228/335 (68%), Gaps = 19/335 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+  V+G+G+FGKV QVKKKG      D I+AMKV+RKD II +  V++ K+E+ IL 
Sbjct: 152 DFELLNVIGKGSFGKVMQVKKKG-----EDKIFAMKVLRKDAIIARKQVNHTKSEKTILQ 206

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            ++HPFIV L Y+FQT+ KLY++LDF+NGG LFFHL R+G F E + + Y AEIVSA+ H
Sbjct: 207 CISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIVSALDH 266

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LHK  IV+RDLKPENIL+DS+GH+ +TDFGL+K+I+ +  + + CGT EY+APE+L   G
Sbjct: 267 LHKQDIVYRDLKPENILLDSEGHICITDFGLSKKIETTDGTFTFCGTPEYLAPEVLNGHG 326

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           H    DWWS+G LLYEMLTG PPF   N   + Q+I+N ++K+P +++ EA SLL+G   
Sbjct: 327 HGCAVDWWSLGTLLYEMLTGLPPFYSQNVSTMYQKILNGELKIPTYISPEAKSLLEG--- 383

Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
              LL ++  KRLG+  GG   +K H WF++I+W+ L+ +E++  FKP V     I+  D
Sbjct: 384 ---LLTREVDKRLGTKGGG--EVKQHPWFKNIDWEKLDRKEVEVHFKPKVKSGTDISQID 438

Query: 411 KCWTTMPADDSPAPTPTAGE------HFKGYTYVA 439
             +T     DS   T   G+       F+G+TYVA
Sbjct: 439 PVFTQERPMDSLVETSALGDAMGKDTSFEGFTYVA 473

Required for morphogenesis during multicellular development. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Z1M4|KS6B2_MOUSE Ribosomal protein S6 kinase beta-2 OS=Mus musculus GN=Rps6kb2 PE=1 SV=1

 Score =  336 bits (861), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 172/363 (47%), Positives = 236/363 (65%), Gaps = 17/363 (4%)

Query: 88  IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY 143
           ++ + H  + EL   S      +IGP  FE+  V+G+G +GKVFQV+K  V   +   IY
Sbjct: 39  LETVGHYEEVELTESSVNLGPERIGPHCFELLSVLGKGGYGKVFQVRK--VQGTNLGKIY 96

Query: 144 AMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           AMKV+RK  I+       + +AER+IL  V HPFIV+L Y+FQT  KLYLIL+ ++GG L
Sbjct: 97  AMKVLRKAKIVCSAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGEL 156

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++ S GH+ LTDFGL 
Sbjct: 157 FTHLEREGIFLEDTACFYLAEITLALGHLHSHGIIYRDLKPENIMLSSQGHIKLTDFGLC 216

Query: 263 KE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 321
           KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K
Sbjct: 217 KESIHEGAITHTFCGTIEYMAPEILVRTGHNRAVDWWSLGALMYDMLTGSPPFTAENRKK 276

Query: 322 LQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
              +II  K+ LPP+LT +A  L K      + L ++P++R+G G G    ++ H +FR 
Sbjct: 277 TMDKIIKGKLVLPPYLTPDARDLAK------KFLKRNPTQRIGGGLGDAADVQRHPFFRH 330

Query: 382 INWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYV 438
           INW  L AR + P F+P +  ++ ++ FD  +T     DSP   A + +A + F G+TYV
Sbjct: 331 INWDDLLARRVDPPFRPSLQSEEDVSQFDARFTRQTPVDSPDDTALSESANQAFLGFTYV 390

Query: 439 APN 441
           AP+
Sbjct: 391 APS 393

Phosphorylates specifically ribosomal protein S6.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	447
225457176	452	PREDICTED: serine/threonine-protein kina	0.966	0.955	0.751	0.0
147817142	463	hypothetical protein VITISV_040765 [Viti	0.979	0.946	0.742	0.0
224119194	470	predicted protein [Populus trichocarpa]	0.973	0.925	0.734	0.0
449440730	483	PREDICTED: serine/threonine-protein kina	0.961	0.890	0.686	0.0
449527582	486	PREDICTED: serine/threonine-protein kina	0.961	0.884	0.682	0.0
62183960	466	putative ribosomal-protein S6 kinase-lik	0.966	0.927	0.687	1e-177
358248554	415	uncharacterized protein LOC100798259 [Gl	0.845	0.910	0.786	1e-172
297733856	296	unnamed protein product [Vitis vinifera]	0.662	1.0	0.864	1e-155
167999486	452	predicted protein [Physcomitrella patens	0.906	0.896	0.606	1e-153
255540831	297	ribosomal protein S6 kinase, putative [R	0.662	0.996	0.844	1e-153

>gi|225457176|ref|XP_002280523.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Vitis vinifera]

 Score =  682 bits (1761), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/454 (75%), Positives = 379/454 (83%), Gaps = 22/454 (4%)

Query: 6   QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
           +K LHS+L +KLK   +T PS SSPD  DF++VFGPLTP  H       + S +S   +L
Sbjct: 8   KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
           GDPQVIHNRSHS +GPSPR+A+++ L P +   +     ++ E      E ++GPGDFEI
Sbjct: 65  GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124

Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            RVVG+GAFGKVFQV+KKG  +  GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            HPFIV LR SFQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCSFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           K GIVHRDLKPENILMD+DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN
Sbjct: 245 KSGIVHRDLKPENILMDADGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 304

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLT 352
           KDADWWS+GILLYEMLTGQPPFTHANRQKLQQRII EKVKLP +L+SEAHSLLKG     
Sbjct: 305 KDADWWSIGILLYEMLTGQPPFTHANRQKLQQRIIKEKVKLPSYLSSEAHSLLKG----- 359

Query: 353 QLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC 412
            LL K+PS+RLGSGP G D I++HKWFRSINWK LEARE+QPKFKPDVSGKDC ANFD+C
Sbjct: 360 -LLQKEPSRRLGSGPTGGDEIQNHKWFRSINWKKLEARELQPKFKPDVSGKDCTANFDQC 418

Query: 413 WTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 446
           WT MP DDSPAPTPTAG HF+GYTYVAPNPWLSS
Sbjct: 419 WTAMPLDDSPAPTPTAGGHFQGYTYVAPNPWLSS 452

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147817142|emb|CAN77683.1| hypothetical protein VITISV_040765 [Vitis vinifera]

 Score =  679 bits (1752), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/459 (74%), Positives = 381/459 (83%), Gaps = 21/459 (4%)

Query: 6   QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
           +K LHS+L +KLK   +T PS SSPD  DF++VFGPLTP  H       + S +S   +L
Sbjct: 8   KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
           GDPQVIHNRSHS +GPSPR+A+++ L P +   +     ++ E      E ++GPGDFEI
Sbjct: 65  GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124

Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            RVVG+GAFGKVFQV+KKG  +  GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            HPFIV LR  FQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCFFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           K GIVHRDLKPENILMD+DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN
Sbjct: 245 KSGIVHRDLKPENILMDADGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 304

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV---S 349
           KDADWWS+GILLYEMLTGQPPFTHANRQKLQQRII EKVKLP +L+SEAHSLLKG+    
Sbjct: 305 KDADWWSIGILLYEMLTGQPPFTHANRQKLQQRIIKEKVKLPSYLSSEAHSLLKGLLTRK 364

Query: 350 FLT--QLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA 407
            L+  QLL K+PS+RLGSGP G D I++HKWFRSINWK LE RE+QPKFKPDVSGKDC A
Sbjct: 365 LLSHCQLLQKEPSRRLGSGPTGGDEIQNHKWFRSINWKKLEXRELQPKFKPDVSGKDCTA 424

Query: 408 NFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 446
           NFD+CWT MP DDSPAPTPTAG HF+GYTYVAPNPWLSS
Sbjct: 425 NFDQCWTAMPLDDSPAPTPTAGGHFQGYTYVAPNPWLSS 463

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119194|ref|XP_002318010.1| predicted protein [Populus trichocarpa] gi|222858683|gb|EEE96230.1| predicted protein [Populus trichocarpa]

 Score =  671 bits (1730), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/475 (73%), Positives = 385/475 (81%), Gaps = 40/475 (8%)

Query: 1   MVSTSQK-NLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPL-TPCRHNNQSPASTSASL 58
           +VSTSQK  L SLL+  LKKLTITPP+    D +F++VFGP  TP   N+    STS+S+
Sbjct: 6   LVSTSQKKTLLSLLSINLKKLTITPPN----DLEFSDVFGPSSTPHDPNHSHSPSTSSSV 61

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAES--------------- 103
            DP VIHNRSHSFVGPSPRY L SS PL    ++ +++A +E ES               
Sbjct: 62  LDPPVIHNRSHSFVGPSPRYPLPSS-PLPFHHIQEDDEAVIENESCDNEKGKSEDDEGQV 120

Query: 104 -----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKD 151
                  KIGP DFEI RVVG+GAFGKVFQV+KK  D  +  G       IYAMKVMRKD
Sbjct: 121 GSCGNNNKIGPADFEILRVVGKGAFGKVFQVRKKTGDGKEKGGGGGSGDGIYAMKVMRKD 180

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           TIIKK HVDYMKAERDILTKV HPFIVQLRYSFQT+SKLYLILDF+NGGHLFFHLYRQGI
Sbjct: 181 TIIKKKHVDYMKAERDILTKVVHPFIVQLRYSFQTKSKLYLILDFMNGGHLFFHLYRQGI 240

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F EDQARFYTAEIVSAV+HLHKCGIVHRDLKPENIL+D+DGHV+LTDFGLAKEIDESSRS
Sbjct: 241 FSEDQARFYTAEIVSAVAHLHKCGIVHRDLKPENILLDADGHVLLTDFGLAKEIDESSRS 300

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
           NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH+NR+KLQ+RII E+V
Sbjct: 301 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHSNRKKLQERIIKERV 360

Query: 332 KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 391
           KLPP+L+SEAHSLLKG      LL K+PS+RLGSG  G D IK HKW R INWK LEARE
Sbjct: 361 KLPPYLSSEAHSLLKG------LLQKEPSRRLGSGLDGGDEIKGHKWLRPINWKKLEARE 414

Query: 392 MQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 446
           +QPK+ PDVSGKDC ANFD+CWTTMP DDSPAPTPTAGEHF+GYTYVAPNPWLSS
Sbjct: 415 LQPKYIPDVSGKDCTANFDQCWTTMPLDDSPAPTPTAGEHFQGYTYVAPNPWLSS 469

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440730|ref|XP_004138137.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus]

 Score =  650 bits (1676), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/497 (68%), Positives = 376/497 (75%), Gaps = 67/497 (13%)

Query: 1   MVSTS-QKNLHSLLTTKLKKLTITPPSASSP---------DFDFTEVFGPLTPCRHNNQS 50
           MVS S QKN+HSLL   L KLTI   S+SS          DFDF +VFGP  P       
Sbjct: 1   MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAVHDFDFNDVFGPTNP------- 53

Query: 51  PASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE-------- 94
             S S+  GDPQ        VIHNRSHSFVGPSPR    +SLP   +E++ +        
Sbjct: 54  --SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEEEEE 110

Query: 95  --NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQVKKK 132
             ND E+      + E +R              KIG GDF+I RVVG+GAFGKVF V+KK
Sbjct: 111 EENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLVRKK 170

Query: 133 GVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
           G   G   D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT+SK
Sbjct: 171 GNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQTKSK 230

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           LYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENILMD
Sbjct: 231 LYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENILMD 290

Query: 250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +DGHV+LTDFGLAKEIDESSRSNS+CGTTEYMAPEILLS+GHNKDADWWSVGILLYEML+
Sbjct: 291 ADGHVVLTDFGLAKEIDESSRSNSLCGTTEYMAPEILLSRGHNKDADWWSVGILLYEMLS 350

Query: 310 GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGG 369
           GQPPFTH NR+KLQ+RII EKVKLPP+L++EAHSLL+G      LL K+PSKRLGSGP G
Sbjct: 351 GQPPFTHTNRKKLQERIIKEKVKLPPYLSTEAHSLLRG------LLEKEPSKRLGSGPKG 404

Query: 370 VDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAG 429
            D IK+HKWFR +NWK LE RE+QPKFKPDVSG DC ANFD CWT MP DDSPAPTPT G
Sbjct: 405 GDEIKNHKWFRPVNWKKLECRELQPKFKPDVSGNDCTANFDHCWTAMPPDDSPAPTPTDG 464

Query: 430 EHFKGYTYVAPNPWLSS 446
            HF+GY+YVAPN WLSS
Sbjct: 465 GHFQGYSYVAPNLWLSS 481

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449527582|ref|XP_004170789.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus]

 Score =  649 bits (1673), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/500 (68%), Positives = 376/500 (75%), Gaps = 70/500 (14%)

Query: 1   MVSTS-QKNLHSLLTTKLKKLTITPPSASSP------------DFDFTEVFGPLTPCRHN 47
           MVS S QKN+HSLL   L KLTI   S+SS             DFDF +VFGP  P    
Sbjct: 1   MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAAAAVHDFDFNDVFGPTNP---- 56

Query: 48  NQSPASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE----- 94
                S S+  GDPQ        VIHNRSHSFVGPSPR    +SLP   +E++ +     
Sbjct: 57  -----SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEE 110

Query: 95  -----NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQV 129
                ND E+      + E +R              KIG GDF+I RVVG+GAFGKVF V
Sbjct: 111 EEEEENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLV 170

Query: 130 KKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
           +KKG   G   D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT
Sbjct: 171 RKKGNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQT 230

Query: 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
           +SKLYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENI
Sbjct: 231 KSKLYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENI 290

Query: 247 LMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
           LMD+DGHV+LTDFGLAKEIDESSRSNS+CGTTEYMAPEILLS+GHNKDADWWSVGILLYE
Sbjct: 291 LMDADGHVVLTDFGLAKEIDESSRSNSLCGTTEYMAPEILLSRGHNKDADWWSVGILLYE 350

Query: 307 MLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSG 366
           ML+GQPPFTH NR+KLQ+RII EKVKLPP+L++EAHSLL+G      LL K+PSKRLGSG
Sbjct: 351 MLSGQPPFTHTNRKKLQERIIKEKVKLPPYLSTEAHSLLRG------LLQKEPSKRLGSG 404

Query: 367 PGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP 426
           P G D IK+HKWFR +NWK LE RE+QPKFKPDVSG DC ANFD CWT MP DDSPAPTP
Sbjct: 405 PKGGDEIKNHKWFRPVNWKKLECRELQPKFKPDVSGNDCTANFDHCWTAMPPDDSPAPTP 464

Query: 427 TAGEHFKGYTYVAPNPWLSS 446
           T G HF+GY+YVAPN WLSS
Sbjct: 465 TDGGHFQGYSYVAPNLWLSS 484

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|62183960|gb|AAX73301.1| putative ribosomal-protein S6 kinase-like protein [Solanum lycopersicum]

 Score =  628 bits (1619), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 328/477 (68%), Positives = 369/477 (77%), Gaps = 45/477 (9%)

Query: 1   MVSTSQKNLHSLLTTKLKKLTITPPSASSPD------FDFTEVFGPLTPCRHNNQSPAST 54
             +  +K +HS+L  KL  L I   S+SS        FDF++VFG  T       SP+S+
Sbjct: 3   FAAQQKKAIHSMLANKLTHLKIPDSSSSSSPPPTDPDFDFSDVFGAPT-------SPSSS 55

Query: 55  SASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAEL--------------- 99
           S+ L DPQ+IH+RSHSFVGPSPR  LS  LP   QE++ E +++                
Sbjct: 56  SSFLTDPQIIHSRSHSFVGPSPRITLSKPLPFH-QEVDSEGESDSDKVNTHVGTHQTECS 114

Query: 100 ---------EAESERKIGPGDFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMR 149
                    E  +  K GPGDFEI R++G+G+FGKVFQVK K    +G+ DGI AMKVMR
Sbjct: 115 DGIEEISGDEGSAVTKFGPGDFEILRMIGKGSFGKVFQVKMKGYGGEGEGDGILAMKVMR 174

Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ 209
           KDT+IK NHVDYM+AERDILTKV HPFIVQLRYSFQT+SKLYLILDFINGGHLF+HLYRQ
Sbjct: 175 KDTVIKNNHVDYMRAERDILTKVEHPFIVQLRYSFQTKSKLYLILDFINGGHLFYHLYRQ 234

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
           GIF EDQAR Y AEIVSAVSHLH+ GIVHRDLKPENILMD DGHVMLTDFGLAKEIDESS
Sbjct: 235 GIFSEDQARIYAAEIVSAVSHLHQRGIVHRDLKPENILMDGDGHVMLTDFGLAKEIDESS 294

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           RSNSMCGT EYMAPEI+ SKGHNKDADWWSVG+LLYEMLTGQPPFTHANR+KLQ++II+E
Sbjct: 295 RSNSMCGTMEYMAPEIIQSKGHNKDADWWSVGVLLYEMLTGQPPFTHANRKKLQEKIISE 354

Query: 330 KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA 389
           K+KL P LT EAHSLLKG      LL KDPSKRLGSGP G D IK HKWFR+INWK L+A
Sbjct: 355 KLKLLPRLTGEAHSLLKG------LLQKDPSKRLGSGPRGGDEIKSHKWFRTINWKKLDA 408

Query: 390 REMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 446
           RE+QPKFKPDV G+DC ANFDKCWTTMP DDSPA TPT GEHF+GYTYVAPNPWLSS
Sbjct: 409 RELQPKFKPDVIGRDCTANFDKCWTTMPPDDSPASTPTTGEHFQGYTYVAPNPWLSS 465

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248554|ref|NP_001239901.1| uncharacterized protein LOC100798259 [Glycine max] gi|255634893|gb|ACU17805.1| unknown [Glycine max]

 Score =  612 bits (1578), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 305/388 (78%), Positives = 330/388 (85%), Gaps = 10/388 (2%)

Query: 62  QVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE---AESERKIGPGDFEIFRVV 118
            VI +RSHSFVGPSPR+ + SS PL   E E E + E E        KIGP DF I RVV
Sbjct: 31  HVIFSRSHSFVGPSPRF-VPSSTPLFFLEEEEEEEEEEELPFGPDPPKIGPSDFHILRVV 89

Query: 119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV 178
           GQGAFGKVF V+KKG    D+DG++AMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIV
Sbjct: 90  GQGAFGKVFLVRKKGDCFDDADGVFAMKVMRKDTIIKKNHVDYMKAERDILTKVLHPFIV 149

Query: 179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVH 238
           QLRYSFQT+SKLYL+LDFINGGHLFF LYRQGIF EDQAR YTAEIVSAVSHLHK GIVH
Sbjct: 150 QLRYSFQTKSKLYLVLDFINGGHLFFQLYRQGIFSEDQARLYTAEIVSAVSHLHKNGIVH 209

Query: 239 RDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           RDLKPENILMD+DGHVMLTDFGL+KEI+E  RSNS CGT EYMAPEILL+KGHNKDADWW
Sbjct: 210 RDLKPENILMDADGHVMLTDFGLSKEINELGRSNSFCGTVEYMAPEILLAKGHNKDADWW 269

Query: 299 SVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKD 358
           SVGILLYEMLTG+ PFTH NR+KLQ++II EKVKLPPFLTSEAHSLLKG      LL KD
Sbjct: 270 SVGILLYEMLTGKAPFTHNNRKKLQEKIIKEKVKLPPFLTSEAHSLLKG------LLQKD 323

Query: 359 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA 418
           PS RLG+GP G   IK HKWFRSINWK LEARE++PKFKPDVS KDC +NFD+CWT MPA
Sbjct: 324 PSTRLGNGPNGDGHIKSHKWFRSINWKKLEARELEPKFKPDVSAKDCTSNFDQCWTAMPA 383

Query: 419 DDSPAPTPTAGEHFKGYTYVAPNPWLSS 446
           DDSPAPTPTAG+HF+GYTYVAPNPWLSS
Sbjct: 384 DDSPAPTPTAGDHFQGYTYVAPNPWLSS 411

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297733856|emb|CBI15103.3| unnamed protein product [Vitis vinifera]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 261/302 (86%), Positives = 275/302 (91%), Gaps = 6/302 (1%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           MKVMRKDTII KNH+DYMKAERDIL KV HPFIV LR SFQT SKLYLI+DF+NGGHLFF
Sbjct: 1   MKVMRKDTIISKNHMDYMKAERDILIKVEHPFIVSLRCSFQTNSKLYLIMDFVNGGHLFF 60

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           HLYRQGIF EDQAR Y AEIVSAVSHLHK GIVHRDLKPENILMD+DGHVMLTDFGLAKE
Sbjct: 61  HLYRQGIFSEDQARVYIAEIVSAVSHLHKSGIVHRDLKPENILMDADGHVMLTDFGLAKE 120

Query: 265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
           IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWS+GILLYEMLTGQPPFTHANRQKLQQ
Sbjct: 121 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSIGILLYEMLTGQPPFTHANRQKLQQ 180

Query: 325 RIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
           RII EKVKLP +L+SEAHSLLKG      LL K+PS+RLGSGP G D I++HKWFRSINW
Sbjct: 181 RIIKEKVKLPSYLSSEAHSLLKG------LLQKEPSRRLGSGPTGGDEIQNHKWFRSINW 234

Query: 385 KTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWL 444
           K LEARE+QPKFKPDVSGKDC ANFD+CWT MP DDSPAPTPTAG HF+GYTYVAPNPWL
Sbjct: 235 KKLEARELQPKFKPDVSGKDCTANFDQCWTAMPLDDSPAPTPTAGGHFQGYTYVAPNPWL 294

Query: 445 SS 446
           SS
Sbjct: 295 SS 296

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|167999486|ref|XP_001752448.1| predicted protein [Physcomitrella patens subsp. patens] gi|162696348|gb|EDQ82687.1| predicted protein [Physcomitrella patens subsp. patens]

 Score =  548 bits (1412), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 278/458 (60%), Positives = 334/458 (72%), Gaps = 53/458 (11%)

Query: 25  PSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLG-----------DPQVIHNRSHSFVG 73
           P   + +FDF++VFGP+ P   +  SP    A  G           DP V+++RSHS VG
Sbjct: 8   PDQCNEEFDFSDVFGPVPP---HPTSPLPAVAEDGETIDWSLELRQDPVVVYSRSHSLVG 64

Query: 74  PSPRYALSSSLPLQIQELEHENDA-----------------ELEAE------SERKIGPG 110
           PSP+ +L+    LQ + +  E D+                 EL ++         K+GP 
Sbjct: 65  PSPKPSLTR---LQSKPVWDEQDSLSLVRVASDSPTVHEVGELTSKDFVNGIGTEKLGPQ 121

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+ RVVGQGAFGKVFQV+KKG  +     IYAMKVMRK+ II++NH DYMKAERDILT
Sbjct: 122 DFELLRVVGQGAFGKVFQVQKKGTSE-----IYAMKVMRKEKIIERNHGDYMKAERDILT 176

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           KV HPFIVQL+YSFQT+SKLYL+LDFINGGHLFF LYRQG F ED AR YTAEIV AV+H
Sbjct: 177 KVVHPFIVQLQYSFQTQSKLYLVLDFINGGHLFFQLYRQGTFNEDLARMYTAEIVLAVAH 236

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LHK GI+HRDLKPENIL+D DG+VMLTDFGLAKE+ E S SNS+CGT EYMAPEI+LSKG
Sbjct: 237 LHKNGIIHRDLKPENILLDGDGYVMLTDFGLAKEVKEDSHSNSLCGTMEYMAPEIILSKG 296

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           H K ADWWSVGILLYEMLTGQPPF H N+QKLQQ+II +K+KLP +LT++A++LLKG   
Sbjct: 297 HGKPADWWSVGILLYEMLTGQPPFAHKNKQKLQQKIIKDKIKLPTYLTADANNLLKG--- 353

Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
              LL KDPSKRLG+GP G + IK +KWF+ INW+ LEAR++ PKF P V+GK C ANFD
Sbjct: 354 ---LLQKDPSKRLGNGPTGSEDIKQNKWFKGINWRKLEARQVTPKFLPAVNGKQCTANFD 410

Query: 411 KCWTTMPADDSPAPTPTAGEH--FKGYTYVAPNPWLSS 446
           + WTT+P DDSP  TP +G+   F+GYTYVAPN WL S
Sbjct: 411 EAWTTLPLDDSPVGTPKSGDRDFFRGYTYVAPNVWLKS 448

Source: Physcomitrella patens subsp. patens

Species: Physcomitrella patens

Genus: Physcomitrella

Family: Funariaceae

Order: Funariales

Class: Bryopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255540831|ref|XP_002511480.1| ribosomal protein S6 kinase, putative [Ricinus communis] gi|223550595|gb|EEF52082.1| ribosomal protein S6 kinase, putative [Ricinus communis]

 Score =  547 bits (1409), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 255/302 (84%), Positives = 275/302 (91%), Gaps = 6/302 (1%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           MKVMRKD IIKKNHVDYMKAERDILTKV HPF+VQLRYSFQT+SKLYLI+DF+NGGHLFF
Sbjct: 1   MKVMRKDIIIKKNHVDYMKAERDILTKVVHPFVVQLRYSFQTKSKLYLIMDFMNGGHLFF 60

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           HLYRQG+F EDQAR YTAEIVSAVSHLHKCGIVHRDLKPENI++DSDGHVMLTDFGLAKE
Sbjct: 61  HLYRQGLFSEDQARVYTAEIVSAVSHLHKCGIVHRDLKPENIILDSDGHVMLTDFGLAKE 120

Query: 265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
           IDESSRSNSMCGTTEYMAPEIL SKGHNKDADWWS+GILLYEMLTGQPPF H +R+KLQ+
Sbjct: 121 IDESSRSNSMCGTTEYMAPEILQSKGHNKDADWWSIGILLYEMLTGQPPFEHKDRKKLQE 180

Query: 325 RIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
           RII EK+KLP FL+SEAHSLLKG      LL K+PS+RLGSGP G D +K HKWFRSINW
Sbjct: 181 RIIKEKIKLPSFLSSEAHSLLKG------LLQKEPSRRLGSGPSGGDEVKSHKWFRSINW 234

Query: 385 KTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWL 444
           K LEARE+ PKFKPDVSGK C  NFD+CWTTMP DDSPA TPTAGEHF+GYTY+APNPWL
Sbjct: 235 KKLEARELIPKFKPDVSGKYCTENFDRCWTTMPPDDSPACTPTAGEHFQGYTYIAPNPWL 294

Query: 445 SS 446
           SS
Sbjct: 295 SS 296

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	447
TAIR|locus:2077873	465	PK1 "protein-serine kinase 1"	0.758	0.729	0.610	3.2e-121
TAIR|locus:2077843	471	S6K2 "serine/threonine protein	0.890	0.845	0.555	1.6e-116
UNIPROTKB|J9NU84	482	RPS6KB2 "Uncharacterized prote	0.827	0.767	0.436	2e-79
UNIPROTKB|E1BLQ5	485	RPS6KB2 "Uncharacterized prote	0.809	0.746	0.422	1.8e-78
UNIPROTKB|E2R7K9	482	RPS6KB2 "Uncharacterized prote	0.805	0.746	0.437	1.8e-78
UNIPROTKB|F1RUZ0	485	RPS6KB2 "Uncharacterized prote	0.805	0.742	0.427	1e-77
UNIPROTKB|Q9UBS0	482	RPS6KB2 "Ribosomal protein S6	0.809	0.751	0.424	1.6e-77
UNIPROTKB|F1MNP4	525	RPS6KB1 "Ribosomal protein S6	0.778	0.662	0.445	5.5e-77
UNIPROTKB|Q6TJY3	527	RPS6KB1 "Ribosomal protein S6	0.778	0.660	0.445	5.5e-77
UNIPROTKB|E2RMD8	525	RPS6KB1 "Uncharacterized prote	0.778	0.662	0.445	5.5e-77

TAIR|locus:2077873 PK1 "protein-serine kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1135 (404.6 bits), Expect = 3.2e-121, Sum P(2) = 3.2e-121
 Identities = 218/357 (61%), Positives = 264/357 (73%)

Query:    92 EHENDAELEAESERK---IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM 148
             + +N+  LE +  +    +G  DFE+ +VVG+GAF                  IYAMKVM
Sbjct:   111 DSDNEKALEGDLVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSE-----IYAMKVM 165

Query:   149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
             RKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY 
Sbjct:   166 RKDHIMEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH 225

Query:   209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
             QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD+DGHVMLTDFGLAKE +E+
Sbjct:   226 QGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEEN 285

Query:   269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
             +RSNSMCGTTEYMAPEI+  KGH+K ADWWSVGILLYEMLTG+PPF   ++ K+QQ+I+ 
Sbjct:   286 TRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQKIVK 344

Query:   329 EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 388
             +K+KLP FL++EAH++LKG      LL K+P +RLGSG  G + IK HKWF+ INWK LE
Sbjct:   345 DKIKLPQFLSNEAHAILKG------LLQKEPERRLGSGLSGAEEIKQHKWFKGINWKKLE 398

Query:   389 AREMQPKFKPDVSGKDCIANFDKCWXXXXXXXXXXXXXXX---GEHFKGYTYVAPNP 442
             ARE+ P FKP+VSG+ CIANFDKCW                     F  +TYV P P
Sbjct:   399 AREVMPSFKPEVSGRQCIANFDKCWTDMSVLDSPASSPSSDPKANPFTNFTYVRPPP 455

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IMP;IDA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

TAIR|locus:2077843 S6K2 "serine/threonine protein kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1148 (409.2 bits), Expect = 1.6e-116, P = 1.6e-116
 Identities = 241/434 (55%), Positives = 292/434 (67%)

Query:    31 DFDFTEVFGPLTP------CRHNNQSPA---STSASLGDPQVIHNRSHSFVGPSPRYALS 81
             +  F++VFGP+        C      PA   S S SL  P ++ + S      + R    
Sbjct:    38 ELQFSDVFGPMPEANSEEACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETED 97

Query:    82 SSLPLQIQELEH--END---AELEAESERK-------IGPGDFEIFRVVGQGAFXXXXXX 129
             S   ++  E E   END      + +SE+        +G  DFE+ +VVGQGAF      
Sbjct:    98 SVDLVECVEGESIKENDEFSGNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQV 157

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
                         IYAMKVMRKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +
Sbjct:   158 RKKDTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYR 212

Query:   190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
             LYL+LDFINGGHLFF LY QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD
Sbjct:   213 LYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMD 272

Query:   250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
              DGHVMLTDFGLAKE +E++RSNSMCGTTEYMAPEI+  KGH+K ADWWSVGILLYEMLT
Sbjct:   273 VDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLT 332

Query:   310 GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGG 369
             G+PPF   ++ K+QQ+I+ +K+KLP FL++EAH+LLKG      LL K+P +RLGSGP G
Sbjct:   333 GKPPFL-GSKGKIQQKIVKDKIKLPQFLSNEAHALLKG------LLQKEPERRLGSGPSG 385

Query:   370 VDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXXXXXX---X 426
              + IK HKWF++INWK LEARE+QP FKP VSG+ CIANFDKCW                
Sbjct:   386 AEEIKKHKWFKAINWKKLEAREVQPSFKPAVSGRQCIANFDKCWTDMSVLDSPASSPNSD 445

Query:   427 XXGEHFKGYTYVAP 440
                  F  +TYV P
Sbjct:   446 AKANPFTNFTYVRP 459

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009408 "response to heat" evidence=IEP

UNIPROTKB|J9NU84 RPS6KB2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
 Identities = 171/392 (43%), Positives = 235/392 (59%)

Query:    57 SLGDPQVIHNRSHSFVGPSPRYALSSSLPL-QIQELE-HENDAELEAESERKIGPGDFEI 114
             S G+P+     S S  GP P      + P+   +E+E  E    L  E   +IGP  FE+
Sbjct:    15 SEGEPEF----SPSVSGPPPPLTSCINRPVGHCEEVELTETSVNLGPE---RIGPHCFEL 67

Query:   115 FRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVT 173
              RV+G+G +                  IYAMKV+RK  I++      + +AER+IL  V 
Sbjct:    68 LRVLGKGGYGKVFQVRKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVK 125

Query:   174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
             HPFIV+L Y+FQT  KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH 
Sbjct:   126 HPFIVELAYAFQTGGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHS 185

Query:   234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHN 292
              GI++RDLKPENI+++S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN
Sbjct:   186 QGIIYRDLKPENIMLNSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHN 245

Query:   293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLT 352
             +  DWWS+G L+Y+MLTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K      
Sbjct:   246 RAVDWWSLGALMYDMLTGSPPFTAENRKKTMDKIIKGKLTLPPYLTPDARDLVK------ 299

Query:   353 QLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC 412
             + L ++PS+R+G GPG    ++ H +FR INW  L AR + P F+P +  ++ ++ FD  
Sbjct:   300 KFLKRNPSQRIGGGPGDSADVQRHPFFRHINWDDLLARRIDPPFRPCLQSEEDVSQFDTH 359

Query:   413 WXXXXXXXX---XXXXXXXGEHFKGYTYVAPN 441
             +                   + F G+TYVAP+
Sbjct:   360 FTRQTPVDSPDDTALSESANQAFLGFTYVAPS 391

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

UNIPROTKB|E1BLQ5 RPS6KB2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 789 (282.8 bits), Expect = 1.8e-78, P = 1.8e-78
 Identities = 160/379 (42%), Positives = 228/379 (60%)

Query:    72 VGPSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXX 127
             + P+    L+      ++ + H  + EL   S      +IGP  FE+ RV+G+G +    
Sbjct:    23 LSPADACPLAELRAAGLEPVGHYEEVELTESSVNPGPERIGPHCFELLRVLGKGNYGKVF 82

Query:   128 XXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
                           IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT
Sbjct:    83 QVRKVQGSNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQT 140

Query:   187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
               KLYLIL+ ++GG LF HL R+GIF ED A FY +EI  A+ HLH  GI++RDLKPENI
Sbjct:   141 GGKLYLILECLSGGELFTHLEREGIFLEDTACFYLSEITLALGHLHSQGIIYRDLKPENI 200

Query:   247 LMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY 305
             ++ S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y
Sbjct:   201 MLSSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMY 260

Query:   306 EMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
             +MLTG PPFT  NR+K   +II  K++LPP+LT +A  L+K      + L ++P++R+G 
Sbjct:   261 DMLTGSPPFTAENRKKTMDKIIRGKLELPPYLTPDARDLVK------KFLKRNPNQRIGG 314

Query:   366 GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---X 422
             GPG    ++ H +FR +NW  L AR + P F+P +  ++ ++ FD  +            
Sbjct:   315 GPGDAADVQRHPFFRHVNWDDLLARRVDPPFRPSLQSEEDVSQFDSHFTKQTPVDSPDDT 374

Query:   423 XXXXXXGEHFKGYTYVAPN 441
                    + F G+TYVAP+
Sbjct:   375 TLSESANQAFLGFTYVAPS 393

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2R7K9 RPS6KB2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 789 (282.8 bits), Expect = 1.8e-78, P = 1.8e-78
 Identities = 165/377 (43%), Positives = 227/377 (60%)

Query:    74 PSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXX 129
             PS    L+ S     + + H  + EL   S      +IGP  FE+ RV+G+G +      
Sbjct:    23 PSDVCPLAESRAAGPEPVGHCEEVELTETSVNLGPERIGPHCFELLRVLGKGGYGKVFQV 82

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188
                         IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  
Sbjct:    83 RKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGG 140

Query:   189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
             KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++
Sbjct:   141 KLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIML 200

Query:   249 DSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
             +S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+M
Sbjct:   201 NSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDM 260

Query:   308 LTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP 367
             LTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K      + L ++PS+R+G GP
Sbjct:   261 LTGSPPFTAENRKKTMDKIIKGKLTLPPYLTPDARDLVK------KFLKRNPSQRIGGGP 314

Query:   368 GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXX 424
             G    ++ H +FR INW  L AR + P F+P +  ++ ++ FD  +              
Sbjct:   315 GDSADVQRHPFFRHINWDDLLARRIDPPFRPCLQSEEDVSQFDTHFTRQTPVDSPDDTAL 374

Query:   425 XXXXGEHFKGYTYVAPN 441
                  + F G+TYVAP+
Sbjct:   375 SESANQAFLGFTYVAPS 391

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1RUZ0 RPS6KB2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 782 (280.3 bits), Expect = 1.0e-77, P = 1.0e-77
 Identities = 161/377 (42%), Positives = 227/377 (60%)

Query:    74 PSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXX 129
             P+    L+ S    ++ + H  + EL   S      +IGP  FE+ RV+G+G +      
Sbjct:    25 PADACPLAESRAAGLEPVGHYEEVELTETSVNPGPERIGPHCFELLRVLGKGNYGKVFQV 84

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188
                         IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  
Sbjct:    85 RKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGG 142

Query:   189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
             KLYLIL+ ++GG LF  L R+GIF ED A FY +EI  A+ HLH  GI++RDLKPEN+++
Sbjct:   143 KLYLILECLSGGELFTRLEREGIFLEDTACFYLSEITLALGHLHSQGIIYRDLKPENVML 202

Query:   249 DSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
              S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+M
Sbjct:   203 SSQGHIKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDM 262

Query:   308 LTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP 367
             LTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K      + L ++PS+R+G GP
Sbjct:   263 LTGSPPFTAENRKKTMDKIIRGKLVLPPYLTPDARDLVK------KFLKRNPSQRIGGGP 316

Query:   368 GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXX 424
             G    ++ H +FR INW+ L AR + P F+P +  ++ ++ FD  +              
Sbjct:   317 GDAADVQKHPFFRHINWEDLLARRVDPPFRPCLQSEEDVSQFDTHFTRQTPVDSPDDTAL 376

Query:   425 XXXXGEHFKGYTYVAPN 441
                  + F G+TYVAP+
Sbjct:   377 SESANQAFLGFTYVAPS 393

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q9UBS0 RPS6KB2 "Ribosomal protein S6 kinase beta-2" [Homo sapiens (taxid:9606)]

 Score = 780 (279.6 bits), Expect = 1.6e-77, P = 1.6e-77
 Identities = 161/379 (42%), Positives = 226/379 (59%)

Query:    72 VGPSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXX 127
             + P+    L+      ++ + H  + EL   S      +IGP  FE+ RV+G+G +    
Sbjct:    23 LSPADACPLAELRAAGLEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVF 82

Query:   128 XXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
                           IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT
Sbjct:    83 QVRKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQT 140

Query:   187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
               KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI
Sbjct:   141 GGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENI 200

Query:   247 LMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY 305
             ++ S GH+ LTDFGL KE I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y
Sbjct:   201 MLSSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMY 260

Query:   306 EMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
             +MLTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K      + L ++PS+R+G 
Sbjct:   261 DMLTGSPPFTAENRKKTMDKIIRGKLALPPYLTPDARDLVK------KFLKRNPSQRIGG 314

Query:   366 GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---X 422
             GPG    ++ H +FR +NW  L A  + P F+P +  ++ ++ FD  +            
Sbjct:   315 GPGDAADVQRHPFFRHMNWDDLLAWRVDPPFRPCLQSEEDVSQFDTRFTRQTPVDSPDDT 374

Query:   423 XXXXXXGEHFKGYTYVAPN 441
                    + F G+TYVAP+
Sbjct:   375 ALSESANQAFLGFTYVAPS 393

GO:0004711 "ribosomal protein S6 kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0042277 "peptide binding" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IMP

GO:0004672 "protein kinase activity" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0006412 "translation" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

UNIPROTKB|F1MNP4 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 775 (277.9 bits), Expect = 5.5e-77, P = 5.5e-77
 Identities = 163/366 (44%), Positives = 226/366 (61%)

Query:    91 LEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMK 146
             +EH    E+   S      KI P  FE+ RV+G+G +                  I+AMK
Sbjct:    66 MEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMK 123

Query:   147 VMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
             V++K  I++      + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  
Sbjct:   124 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 183

Query:   206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE- 264
             L R+GIF ED A FY AEI  A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE 
Sbjct:   184 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 243

Query:   265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
             I + + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   
Sbjct:   244 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 303

Query:   325 RIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
             +I+  K+ LPP+LT EA  LLK      +LL ++ + RLG+GPG    ++ H +FR INW
Sbjct:   304 KILKCKLNLPPYLTQEARDLLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 357

Query:   385 KTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGEHFKGYTYVAPN 441
             + L AR+++P FKP +  ++ ++ FD  +                   + F G+TYVAP+
Sbjct:   358 EELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPS 417

Query:   442 PWLSSV 447
               L SV
Sbjct:   418 V-LESV 422

GO:0071363 "cellular response to growth factor stimulus" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q6TJY3 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 775 (277.9 bits), Expect = 5.5e-77, P = 5.5e-77
 Identities = 163/366 (44%), Positives = 226/366 (61%)

Query:    91 LEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMK 146
             +EH    E+   S      KI P  FE+ RV+G+G +                  I+AMK
Sbjct:    66 MEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMK 123

Query:   147 VMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
             V++K  I++      + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  
Sbjct:   124 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 183

Query:   206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE- 264
             L R+GIF ED A FY AEI  A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE 
Sbjct:   184 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 243

Query:   265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
             I + + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   
Sbjct:   244 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 303

Query:   325 RIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
             +I+  K+ LPP+LT EA  LLK      +LL ++ + RLG+GPG    ++ H +FR INW
Sbjct:   304 KILKCKLNLPPYLTQEARDLLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 357

Query:   385 KTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGEHFKGYTYVAPN 441
             + L AR+++P FKP +  ++ ++ FD  +                   + F G+TYVAP+
Sbjct:   358 EELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPS 417

Query:   442 PWLSSV 447
               L SV
Sbjct:   418 V-LESV 422

GO:0004672 "protein kinase activity" evidence=ISS

GO:0005739 "mitochondrion" evidence=ISS

GO:0071363 "cellular response to growth factor stimulus" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0043005 "neuron projection" evidence=IEA

GO:0005741 "mitochondrial outer membrane" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0045202 "synapse" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2RMD8 RPS6KB1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 775 (277.9 bits), Expect = 5.5e-77, P = 5.5e-77
 Identities = 163/366 (44%), Positives = 226/366 (61%)

Query:    91 LEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMK 146
             +EH    E+   S      KI P  FE+ RV+G+G +                  I+AMK
Sbjct:    66 MEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMK 123

Query:   147 VMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
             V++K  I++      + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  
Sbjct:   124 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 183

Query:   206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE- 264
             L R+GIF ED A FY AEI  A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE 
Sbjct:   184 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 243

Query:   265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
             I + + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   
Sbjct:   244 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 303

Query:   325 RIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
             +I+  K+ LPP+LT EA  LLK      +LL ++ + RLG+GPG    ++ H +FR INW
Sbjct:   304 KILKCKLNLPPYLTQEARDLLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 357

Query:   385 KTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGEHFKGYTYVAPN 441
             + L AR+++P FKP +  ++ ++ FD  +                   + F G+TYVAP+
Sbjct:   358 EELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Query:   442 PWLSSV 447
               L SV
Sbjct:   418 V-LESV 422

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39030	KPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.5837	0.9015	0.8556	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	447
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-144
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-131
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-130
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-119
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-112
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-111
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-108
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-108
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-106
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-105
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-102
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-101
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-98
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-98
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-97
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-96
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-94
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-94
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-94
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-94
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-93
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-93
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-93
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-91
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-90
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-90
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-90
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-90
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-89
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-89
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-88
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-88
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-88
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-88
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-87
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-86
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-84
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-84
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-83
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-82
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-79
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-77
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-76
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-75
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-74
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-74
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-72
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-71
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-71
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-70
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-70
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-69
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-69
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-68
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-68
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-67
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-67
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-67
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-65
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-64
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-63
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-62
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-60
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-58
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-58
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-58
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-58
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-58
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-57
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-55
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-50
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-47
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-47
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-44
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-44
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-43
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-42
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-42
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-40
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-39
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-39
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-38
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-38
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-38
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-38
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-38
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-38
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-37
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-37
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-36
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-36
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-36
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-35
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-35
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-35
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-34
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-34
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-33
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-33
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-33
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-33
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-32
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-31
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-31
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-31
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-30
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-30
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-30
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-29
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-29
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-29
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-28
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-28
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-28
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-28
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-27
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-27
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-27
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-27
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-27
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-26
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-26
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-26
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-26
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-26
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-26
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-26
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-25
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-25
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-24
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-24
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-24
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-24
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-24
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-24
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-23
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-23
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-23
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-23
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-23
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-22
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-22
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-22
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-21
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-21
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-20
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-20
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-19
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-19
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-19
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-19
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-18
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-18
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-18
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-18
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-17
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-17
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-16
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-16
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
smart00133	64	smart00133, S_TK_X, Extension to Ser/Thr-type prot	3e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-07
PRK09188	365	PRK09188, PRK09188, serine/threonine protein kinas	5e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-06
pfam00433	47	pfam00433, Pkinase_C, Protein kinase C terminal do	3e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	5e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	7e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	9e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	5e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	6e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05151	170	cd05151, ChoK, Choline Kinase (ChoK)	0.001
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.002
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.002
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	0.002
cd05119	187	cd05119, RIO, RIO kinase family, catalytic domain	0.002
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  409 bits (1055), Expect = e-144
 Identities = 140/263 (53%), Positives = 194/263 (73%), Gaps = 14/263 (5%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGKV  V+KK     D+  +YAMKV++K  IIK+  V++   ER+IL+++ HPFI
Sbjct: 1   LGKGSFGKVLLVRKK-----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L Y+FQT  KLYL+L++  GG LF HL ++G F E++ARFY AEIV A+ +LH  GI+
Sbjct: 56  VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           +RDLKPENIL+D+DGH+ LTDFGLAKE   E SR+N+ CGT EY+APE+LL KG+ K  D
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVD 175

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLH 356
           WWS+G+LLYEMLTG+PPF   +R+++ ++I+ + ++ P FL+ EA  L+ G      LL 
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISG------LLQ 229

Query: 357 KDPSKRLGSGPGGVDAIKHHKWF 379
           KDP+KRLGSG    + IK H +F
Sbjct: 230 KDPTKRLGSGG--AEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  379 bits (975), Expect = e-131
 Identities = 133/301 (44%), Positives = 193/301 (64%), Gaps = 13/301 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  + +G G+FG+V  V+ K      S   YA+K++ K  I+K   V+++  E+ IL 
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HPF+V L  SFQ  S LYL+++++ GG LF HL + G F E  ARFY A++V A+ +
Sbjct: 57  SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   IV+RDLKPEN+L+DSDG++ +TDFG AK +    R+ ++CGT EY+APEI+LSKG
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--RTYTLCGTPEYLAPEIILSKG 174

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           + K  DWW++GIL+YEML G PPF   N  ++ ++I+  KV+ P F + +A  L++    
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIR---- 230

Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
              LL  D +KRLG+   GV+ IK+H WF  I+W  L  R+++  F P V G    +NFD
Sbjct: 231 --NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFD 288

Query: 411 K 411
            
Sbjct: 289 D 289

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  379 bits (974), Expect = e-130
 Identities = 171/331 (51%), Positives = 231/331 (69%), Gaps = 15/331 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDILTKVT 173
           +V+G+G +GKVFQV+K  V   D+  I+AMKV++K TI++ N  D  + KAER+IL  V 
Sbjct: 2   KVLGKGGYGKVFQVRK--VTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVK 58

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HPFIV L Y+FQT  KLYLIL++++GG LF HL R+GIF ED A FY +EI  A+ HLH+
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHN 292
            GI++RDLKPENIL+D+ GHV LTDFGL KE I E + +++ CGT EYMAPEIL+  GH 
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHG 178

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLT 352
           K  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  LLK      
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLK------ 232

Query: 353 QLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC 412
           +LL ++PS RLG+GPG    ++ H +FR +NW  L AR+++P FKP +  ++ ++ FD  
Sbjct: 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSK 292

Query: 413 WTTMPADDSPAPT---PTAGEHFKGYTYVAP 440
           +T     DSP  +    +A + F G+TYVAP
Sbjct: 293 FTRQTPVDSPDDSTLSESANQIFLGFTYVAP 323

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  351 bits (901), Expect = e-119
 Identities = 157/326 (48%), Positives = 220/326 (67%), Gaps = 12/326 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +V+GQG+FGKVF V+K  +   D+  +YAMKV++K T+  ++ V   K ERDIL +V HP
Sbjct: 2   KVLGQGSFGKVFLVRK--ITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHP 58

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           FIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY AE+  A+ HLH  G
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           I++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EYMAPE++  +GH + 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ EA SLL+       L
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR------AL 232

Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 414
             ++P+ RLG+GP GV+ IK H +F +I+W  L  RE++P FKP V   D    FD  +T
Sbjct: 233 FKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFT 292

Query: 415 TMPADDSPAPTPTAGEH--FKGYTYV 438
           +    DSP   P+A  H  F+G+++V
Sbjct: 293 SRTPKDSPGIPPSANAHQLFRGFSFV 318

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  333 bits (856), Expect = e-112
 Identities = 148/335 (44%), Positives = 210/335 (62%), Gaps = 24/335 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   K K          YA+KV++K  I+KK    ++ AER++L K V H
Sbjct: 1   KVIGKGSFGKVLLAKHK-----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L YSFQT  KLY +LD++NGG LFFHL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            I++RDLKPENIL+DS GHV+LTDFGL KE I+ S  +++ CGT EY+APE+L  + +++
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWW +G +LYEML G PPF   +  ++   I+N+ ++L P ++  A  LL+G      
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEG------ 229

Query: 354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW 413
           LL KD +KRLG+       IK+H +F SINW  L  +++ P F P+VSG   + +FD  +
Sbjct: 230 LLQKDRTKRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEF 288

Query: 414 TTMPADDSPAPTPT----------AGEHFKGYTYV 438
           T  P  +S   +P           A + F G++Y 
Sbjct: 289 TEEPVPNSVGKSPDSVLVSASVKEADDAFLGFSYA 323

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  331 bits (849), Expect = e-111
 Identities = 159/340 (46%), Positives = 228/340 (67%), Gaps = 18/340 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
           +FE+ +V+G GA+GKVF V+K  V   D+  +YAMKV++K  +++K   V++ + ER++L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRK--VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             V   PF+V L Y+FQT +KL+LILD+++GG +F HLY++  F ED+ RFY+ EI+ A+
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEIL 286
            HLHK GIV+RD+K ENIL+DS+GHV+LTDFGL+KE   +E  R+ S CGT EYMAPEI+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 287 LSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ----QRIINEKVKLPPFLTSEA 341
             K GH K  DWWS+GIL++E+LTG  PFT    +  Q    +RI+      P F+  EA
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238

Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 401
             LL       +LL KDP KRLG+GP G   IK H +F+ ++W+ L  R++ P F+P + 
Sbjct: 239 QDLLH------KLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIR 292

Query: 402 GKDCIANFDKCWTTMPADDSPAPTPTAGEH-FKGYTYVAP 440
            +  + NF + +T +    SPA TP +G   F+GY++VAP
Sbjct: 293 NELDVGNFAEEFTNLEPVYSPAGTPPSGARVFQGYSFVAP 332

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  323 bits (830), Expect = e-108
 Identities = 137/329 (41%), Positives = 210/329 (63%), Gaps = 17/329 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           +V+G+G+FGKV   + KG D+     +YA+KV++KD I++ + V+    E+ +L     H
Sbjct: 1   KVLGKGSFGKVLLAELKGTDE-----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+ QL   FQT+ +L+ +++++NGG L FH+ R G F E +ARFY AEIV  +  LH+ 
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+DS+GH+ + DFG+ KE I     +++ CGT +Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWW++G+LLYEML GQ PF   +  +L Q I+ ++V+ P +L+ EA S+LK  SFLT 
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILK--SFLT- 232

Query: 354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW 413
              K+P KRLG  P G   IK H +FR I+W  LE +E++P FKP + G+  ++NFD  +
Sbjct: 233 ---KNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEF 289

Query: 414 TTMPADDSPAPTPTAG----EHFKGYTYV 438
           T      +P           E F+G++Y+
Sbjct: 290 TKEKPVLTPPDEAIIRNIDQEEFRGFSYI 318

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  320 bits (821), Expect = e-108
 Identities = 143/298 (47%), Positives = 200/298 (67%), Gaps = 20/298 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV-DYMKAERDIL 169
           +FE+ RV+G GA+GKVF V+K G    D+  +YAMKV++K TI++K    ++ + ER +L
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVG--GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             V   PF+V L Y+FQT +KL+LILD++NGG LF HLY++  F E + R Y AEIV A+
Sbjct: 59  EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEIL 286
            HLH+ GI++RD+K ENIL+DS+GHV+LTDFGL+KE   +E  R+ S CGT EYMAPE++
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 287 LSK--GHNKDADWWSVGILLYEMLTGQPPFT---HANRQK-LQQRIINEKVKLPPFLTSE 340
                GH+K  DWWS+G+L +E+LTG  PFT     N Q  + +RI+  K   P  +++E
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
           A        F+ +LL KDP KRLG+   G D IK+H +F+ I+W  L A+ +   FKP
Sbjct: 239 AR------DFIQKLLEKDPKKRLGA--NGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  316 bits (811), Expect = e-106
 Identities = 115/272 (42%), Positives = 165/272 (60%), Gaps = 22/272 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI   +G+G+FGKV+  + K      +  + A+KV++K  I K    + +  E  IL K
Sbjct: 1   YEILEKLGEGSFGKVYLARDK-----KTGKLVAIKVIKKKKIKKD--RERILREIKILKK 53

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L   F+   KLYL++++  GG LF  L ++G   ED+ARFY  +I+SA+ +L
Sbjct: 54  LKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H  GIVHRDLKPENIL+D DGHV L DFGLA+++D   +  +  GT EYMAPE+LL KG+
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 292 NKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPPF---LTSEAHSLLKG 347
            K  D WS+G++LYE+LTG+PPF       +L ++I   K   PP    ++ EA  L++ 
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR- 232

Query: 348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
                +LL KDP KRL       +    H +F
Sbjct: 233 -----KLLVKDPEKRL-----TAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  314 bits (807), Expect = e-105
 Identities = 146/325 (44%), Positives = 210/325 (64%), Gaps = 18/325 (5%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGKV QV+K+     D+  IYA+K +RK  I+ ++ V +  AER +L +V  PFI
Sbjct: 1   IGKGSFGKVMQVRKR-----DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V L++SFQ+  KLYL+L FINGG LF HL R+G F   +ARFYTAE++ A+ +LHK  ++
Sbjct: 56  VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           +RDLKPENIL+D  GH+ L DFGL K  + +  ++N+ CGT EY+APE+LL  G+ K  D
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLH 356
           WW++G+LLYEMLTG PPF   N  ++ ++I+ E ++ P     +A  LL G      LL 
Sbjct: 176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIG------LLS 229

Query: 357 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT- 415
           +DP++RLG    G   IK+H +F  ++WK L  + +QP FKP VS     +NFD+ +T  
Sbjct: 230 RDPTRRLGY--NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTRE 287

Query: 416 MPAD---DSPAPTPTAGEHFKGYTY 437
            P D   D    + T  + F G++Y
Sbjct: 288 KPIDSVVDDSHLSETVQQQFGGWSY 312

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  307 bits (789), Expect = e-102
 Identities = 139/367 (37%), Positives = 206/367 (56%), Gaps = 57/367 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE+ +V+G+GAFG+V+ V+ K     D+  +YAMKV+RK  +IK+N + +++AERDIL
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDK-----DTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                P+IV+L YSFQ    LYL+++++ GG L   L R+ +F E+ ARFY AE+V A+ 
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------------- 269
            +HK G +HRD+KP+NIL+D+DGH+ L DFGL K+++++                     
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 270 ----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
                     R+NS  GT +Y+APE+L    +  + DWWS+G++LYEML G PPF     
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 320 QKLQQRIINEKVKL--PPF--LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           Q+   +IIN K  L  PP   ++ EA  L+     L      DP  RLGS     + IK 
Sbjct: 236 QETYNKIINWKESLRFPPDPPVSPEAIDLI--CRLLC-----DPEDRLGS----FEEIKS 284

Query: 376 HKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC-WTTMPADDSPAPTPTAGEH--- 431
           H +F+ I+W+ L  RE +P F P++S     +NFD        +D     +    +    
Sbjct: 285 HPFFKGIDWENL--RETKPPFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQL 342

Query: 432 -FKGYTY 437
            F G+TY
Sbjct: 343 AFVGFTY 349

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  301 bits (773), Expect = e-101
 Identities = 120/278 (43%), Positives = 176/278 (63%), Gaps = 24/278 (8%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           + +GA+G+VF  KKK   D     IYA+KV++K  +I+KN VD +  ERDIL++   P++
Sbjct: 1   ISKGAYGRVFLAKKKSTGD-----IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L YSFQ +  LYL+++++ GG L   L   G   ED AR Y AEIV A+ +LH  GI+
Sbjct: 56  VKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKE---------IDESSRSNSMCGTTEYMAPEILLS 288
           HRDLKP+NIL+DS+GH+ LTDFGL+K           D+      + GT +Y+APE++L 
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--PFLTSEAHSLLK 346
           +GH+K  DWWS+G +LYE L G PPF     +++ Q I+N K++ P    ++ EA  L+ 
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS 235

Query: 347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
                 +LL  DP KRLG+    ++ IK+H +F+ I+W
Sbjct: 236 ------KLLVPDPEKRLGA--KSIEEIKNHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  297 bits (763), Expect = 1e-98
 Identities = 138/338 (40%), Positives = 203/338 (60%), Gaps = 25/338 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG     +D +YA+K+++KD II+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLA 55

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 56  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LH  GI++RDLK +N+++D++GH+ + DFG+ KE I     + + CGT +Y+APEI+  
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           + + K  DWW+ G+LLYEML GQPPF   +  +L Q I+   V  P  L+ EA S+ KG 
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG- 234

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN 408
                LL K P+KRLG GP G   I+ H +FR I+W+ LE RE+QP FKP V G+    N
Sbjct: 235 -----LLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAEN 289

Query: 409 FDKCWTTMPADDSPAPTPT--------AGEHFKGYTYV 438
           FDK +T  P    P  TP             F+G+++V
Sbjct: 290 FDKFFTREP----PVLTPPDKLVIANIDQSEFQGFSFV 323

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  297 bits (763), Expect = 2e-98
 Identities = 131/313 (41%), Positives = 200/313 (63%), Gaps = 13/313 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      +   YAMK+++K+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH C 
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE+L    + + 
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
            DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L+ EA SLL G      L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAG------L 229

Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 414
           L KDP +RLG GP     I  H++F SINW+ +  ++++P FKP V+ +     FD+ +T
Sbjct: 230 LKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFT 289

Query: 415 TMPADDSPAPTPT 427
                 +P P   
Sbjct: 290 AQSITITP-PDRY 301

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  294 bits (754), Expect = 4e-97
 Identities = 130/325 (40%), Positives = 193/325 (59%), Gaps = 14/325 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+   +G G+FG+V   K KG  +      YA+K ++K  I+K   V ++  E+ IL 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGE-----YYAIKCLKKREILKMKQVQHVAQEKSILM 73

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +++HPFIV +  SFQ  +++Y +L+F+ GG LF HL + G F  D A+FY AE+V A  +
Sbjct: 74  ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   I++RDLKPEN+L+D+ GHV +TDFG AK++ +  R+ ++CGT EY+APE++ SKG
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKG 191

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           H K  DWW++G+LLYE + G PPF      ++ ++I+  ++K P +    A  L+KG   
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG--- 248

Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
              LL  D +KRLG+  GGV  +K+H +F   NW  L AR         V      +NF+
Sbjct: 249 ---LLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFE 305

Query: 411 KCWTTMPADDSPAPTPTAGEHFKGY 435
           K +   P D  P  T      F G+
Sbjct: 306 K-YPDSPVDRLPPLTAAQQAEFAGF 329

Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  291 bits (746), Expect = 6e-96
 Identities = 140/341 (41%), Positives = 213/341 (62%), Gaps = 32/341 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--- 174
           +G+G FG+V+QV+KK     D+  IYAMKV+ K  I+ K  V +   ER+IL +      
Sbjct: 1   IGKGTFGQVYQVRKK-----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PFIV L++SFQT S LYL+ D+++GG LF+HL ++G F ED+A+FY AE+V A+ HLHK 
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTTEYMAPEILL-SKGHN 292
            IV+RDLKPENIL+D+ GH+ L DFGL+K  + ++  +N+ CGTTEY+APE+LL  KG+ 
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLT 352
           K  D+WS+G+L++EM  G  PF   + Q++ + I   KV+ P  + S      +G  F+ 
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLS-----DEGRQFVK 230

Query: 353 QLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC 412
            LL+++P  RLG+    V+ +K H +F  I+W  L  +++ P FKP V   + ++NFD  
Sbjct: 231 GLLNRNPQHRLGAHRDAVE-LKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPE 289

Query: 413 WTT----------------MPADDSPAPTPTAGEHFKGYTY 437
           +T                 +P  +S   + +  E+F+G+T+
Sbjct: 290 FTNSSLLNAGIVPWEDVPGLPGANSTPLSSSVQENFRGFTF 330

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  286 bits (734), Expect = 1e-94
 Identities = 143/294 (48%), Positives = 197/294 (67%), Gaps = 10/294 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKAERDIL 169
           +FE+ +V+G GA+GKVF V+K  V   DS  +YAMKV++K TI++K    ++ + ER +L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRK--VSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             +   PF+V L Y+FQT +KL+LILD+INGG LF HL ++  F+E + + Y+ EIV A+
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEIL 286
            HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+KE   DE  R+ S CGT EYMAP+I+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 287 L--SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
                GH+K  DWWS+G+L+YE+LTG  PFT    +  Q  I    +K  P    E  +L
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238

Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
            K +  + +LL KDP KRLG GP   D IK H +F+ INW  L A+++   FKP
Sbjct: 239 AKDI--IQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  288 bits (737), Expect = 1e-94
 Identities = 145/334 (43%), Positives = 211/334 (63%), Gaps = 23/334 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTK-VT 173
           +V+G+G+FGKV   K+K      SDG  YA+KV++K TI+KK   +++ AER++L K + 
Sbjct: 1   KVIGKGSFGKVLLAKRK------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK 54

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HPF+V L YSFQT  KLY +LD++NGG LFFHL R+  F E +ARFY AE+ SA+ +LH 
Sbjct: 55  HPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHN 292
             I++RDLKPENIL+DS GHV+LTDFGL KE ++    +++ CGT EY+APE+L  + ++
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLT 352
           +  DWW +G +LYEML G PPF   +  ++   I+++ ++LP   T  A  LL G     
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVG----- 229

Query: 353 QLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC 412
            LLHKD  +RLG+    ++ IK+H +F  INW  L  + + P + P+V+G   + +FD  
Sbjct: 230 -LLHKDQRRRLGAKADFLE-IKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPE 287

Query: 413 WTTMPADDSPAPTP-------TAGEHFKGYTYVA 439
           +T      S   TP       +A   F G++Y  
Sbjct: 288 FTQEAVSSSVGQTPDLTASSSSASSAFLGFSYAP 321

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  286 bits (734), Expect = 3e-94
 Identities = 147/337 (43%), Positives = 215/337 (63%), Gaps = 24/337 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   + K       +  YA+KV++K  I+KK    ++ +ER++L K V H
Sbjct: 1   KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L +SFQT  KLY +LD+INGG LF+HL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            IV+RDLKPENIL+DS GH++LTDFGL KE I+ +  +++ CGT EY+APE+L  + +++
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWW +G +LYEML G PPF   N  ++   I+N+ ++L P +T+ A  LL+G      
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG------ 229

Query: 354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW 413
           LL KD +KRLG+    ++ IK+H +F  INW  L  +++ P F P+VSG + + +FD  +
Sbjct: 230 LLQKDRTKRLGAKDDFME-IKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEF 288

Query: 414 TTMPADDSPAPTP----------TAGEHFKGYTYVAP 440
           T  P  +S   +P           A E F G++Y  P
Sbjct: 289 TEEPVPNSIGQSPDSILVTASVKEAAEAFLGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  285 bits (731), Expect = 8e-94
 Identities = 133/335 (39%), Positives = 205/335 (61%), Gaps = 27/335 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTH 174
           +V+G+G+FGKV   + KG D+     +YA+KV++KD I++ + VD    E+ IL     H
Sbjct: 1   KVLGKGSFGKVMLAELKGTDE-----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L   FQT+ +L+ +++++NGG L F + R   F E ++RFY AE+  A+  LH+ 
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           G+++RDLK +NIL+D++GH  L DFG+ KE I     + + CGT +Y+APEIL    +  
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWW++G+L+YEM+ GQPPF   N   L + I+++ V  P +L+ EA S+LK   F+T 
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA--FMT- 232

Query: 354 LLHKDPSKRLGSGP--GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 411
              K+P+KRLG     GG DAIK H +F+ I+W  LE R+++P FKP +  K  + NFD+
Sbjct: 233 ---KNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQ 289

Query: 412 CWTTMPADDSPAPTPTAG--------EHFKGYTYV 438
            +T     + P  TP           E F+G+++ 
Sbjct: 290 DFTK----EEPVLTPVDPAVIKQINQEEFRGFSFF 320

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  283 bits (725), Expect = 3e-93
 Identities = 121/300 (40%), Positives = 187/300 (62%), Gaps = 13/300 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E  + VG G FG+V  V+ +      S+  YA+KVM    +I+     ++  E+ +L 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +V+HPFI++L ++   +  LY++++++ GG LF +L   G F      FY +EIV A+ +
Sbjct: 57  EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   IV+RDLKPENIL+D +GH+ LTDFG AK++    R+ ++CGT EY+APE++ SKG
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RDRTWTLCGTPEYLAPEVIQSKG 174

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           HNK  DWW++GIL+YEML G PPF   N   + ++I+  K++ P  L   A  L+K    
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIK---- 230

Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
             +LL  D ++RLG+   G D +K+H+WF+S++W  +  R+++P   P VS     +NFD
Sbjct: 231 --KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFD 288

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  281 bits (721), Expect = 4e-93
 Identities = 109/271 (40%), Positives = 175/271 (64%), Gaps = 15/271 (5%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FG+V  VK K       +  +A+K ++K  I++    +++ +E++IL +  HPFI
Sbjct: 1   LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L  +F+ +  +Y+++++  GG L+  L  +G+F E  ARFY A +V A  +LH  GI+
Sbjct: 56  VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADW 297
           +RDLKPEN+L+DS+G+V L DFG AK++    ++ + CGT EY+APEI+L+KG++   D+
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175

Query: 298 WSVGILLYEMLTGQPPFTHANR--QKLQQRII--NEKVKLPPFLTSEAHSLLKGVSFLTQ 353
           WS+GILLYE+LTG+PPF   +    ++   I+  N K++ P ++   A  L+K      Q
Sbjct: 176 WSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK------Q 229

Query: 354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
           LL ++P +RLG+  GG+  IK HKWF   +W
Sbjct: 230 LLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  281 bits (722), Expect = 7e-93
 Identities = 106/291 (36%), Positives = 164/291 (56%), Gaps = 34/291 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F  V   K+K     +++  YA+K++ K  +IK+  V Y+K E+++LT
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEK-----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++  HP I++L Y+FQ    LY +L++   G L  ++ + G   E   RFY AEI+ A+ 
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------------- 269
           +LH  GI+HRDLKPENIL+D D H+ +TDFG AK +D +S                    
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
            R  S  GT EY++PE+L  K   K +D W++G ++Y+MLTG+PPF  +N     Q+I+ 
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236

Query: 329 EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
            +   PP    +A         + +LL  DP  RLG    G D +K H +F
Sbjct: 237 LEYSFPPNFPPDA------KDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  275 bits (706), Expect = 7e-91
 Identities = 104/268 (38%), Positives = 163/268 (60%), Gaps = 11/268 (4%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE+ RV+G+GAFGKV  V+K+     D+  ++AMK M K   ++K  V  +  ER IL +
Sbjct: 2   FELLRVIGKGAFGKVCIVQKR-----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HPF+V L YSFQ    +YL++D + GG L +HL ++  F E+Q +F+  EIV A+ +L
Sbjct: 57  LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H  GI+HRD+KP+NIL+D  GHV +TDF +A ++   + + S  GT  YMAPE+L  +G+
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176

Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL 351
           +   DWWS+G+  YE L G+ P+   + + ++ +I  ++      L     S  + +  +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRAKQETADV-LYPATWS-TEAIDAI 233

Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
            +LL +DP KRLG        +K+H +F
Sbjct: 234 NKLLERDPQKRLGDNL---KDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  276 bits (708), Expect = 3e-90
 Identities = 145/337 (43%), Positives = 210/337 (62%), Gaps = 24/337 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   K+K   DG     YA+KV++K  ++ +    ++ AER++L K V H
Sbjct: 1   KVIGKGSFGKVLLAKRK--LDGK---CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L YSFQT  KLY +LDF+NGG LFFHL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            IV+RDLKPENIL+DS GHV+LTDFGL KE I +S  + + CGT EY+APE++  + ++ 
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWW +G +LYEML G PPF   +  ++   I+++ + L P  +  A S+L+      +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE------E 229

Query: 354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW 413
           LL KD  +RLG+       I+ H +F S++W  LE +++ P F P+V G D I+NFD  +
Sbjct: 230 LLEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVF 288

Query: 414 T--TMPADDSPAPTPT--------AGEHFKGYTYVAP 440
           T  T+P     +   +        A + F G++Y  P
Sbjct: 289 TEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  278 bits (712), Expect = 3e-90
 Identities = 129/375 (34%), Positives = 201/375 (53%), Gaps = 64/375 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  IYAMK +RK  +++K  V +++AERDIL 
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKK-----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +  +P++V+L YSFQ  + LYLI++++ GG +   L ++  F E++ RFY AE + A+  
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +HK G +HRD+KP+N+L+D+ GH+ L+DFGL   + +S R+                   
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 273 ---------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
                                S  GT +Y+APE+ L  G+NK+ DWWS+G+++YEML G 
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236

Query: 312 PPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP 367
           PPF   N Q+  ++IIN  E ++ P    L+ EA  L+K           +  +RLG+  
Sbjct: 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIK--RLCC-----EAERRLGN-- 287

Query: 368 GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPT 427
            GV+ IK H +F+ ++W+ +  RE      P++      +NFD          +    P 
Sbjct: 288 NGVNEIKSHPFFKGVDWEHI--RERPAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPPR 345

Query: 428 AGEH-----FKGYTY 437
                    F GYTY
Sbjct: 346 GKIKSKDLAFIGYTY 360

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  275 bits (705), Expect = 8e-90
 Identities = 129/333 (38%), Positives = 202/333 (60%), Gaps = 20/333 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIVSA+ +LH   
Sbjct: 56  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE+L    + + 
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
            DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SLL G      L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG------L 229

Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 414
           L KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD  +T
Sbjct: 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFT 289

Query: 415 TMPADDSP--------APTPTAGEHFKGYTYVA 439
                 +P                HF  ++Y A
Sbjct: 290 AQSITITPPDRYDSLGLLELDQRTHFPQFSYSA 322

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  275 bits (704), Expect = 9e-90
 Identities = 127/332 (38%), Positives = 202/332 (60%), Gaps = 20/332 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           RV+G+G+FGKV   + K     +S  +YA+KV++KD I++ + V+    E+ IL+    H
Sbjct: 1   RVLGKGSFGKVMLARLK-----ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+ QL   FQT  +L+ +++F+NGG L FH+ +   F E +ARFY AEI SA+  LH  
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D +GH  L DFG+ KE I     +++ CGT +Y+APEIL    +  
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWW++G+LLYEML G  PF   N   L + I+N++V  P +L+ +A  +LK       
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKA------ 229

Query: 354 LLHKDPSKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC 412
            + K+P+ RLGS   GG +AI  H +F+ ++W+ L  R+++P F+P +  ++ ++NFD  
Sbjct: 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPD 289

Query: 413 WTT-----MPADDSPAPTPTAGEHFKGYTYVA 439
           +        P ++S  P     + F+ ++Y A
Sbjct: 290 FIKEDPVLTPIEESLLP-MINQDEFRNFSYTA 320

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  274 bits (702), Expect = 3e-89
 Identities = 118/336 (35%), Positives = 196/336 (58%), Gaps = 21/336 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-- 169
           F    V+G+G FGKV   + K      +  +YA+K ++K  II ++ V+ +  E+ I   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFET 55

Query: 170 -TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
                HPF+V L   FQT   +  ++++  GG L  H++   +F E +A FY A +V  +
Sbjct: 56  ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILL 287
            +LH+  IV+RDLK +N+L+D++G V + DFGL KE +    R+++ CGT E++APE+L 
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
              + +  DWW +G+L+YEML G+ PF   + +++   I+N++V+ P FL+ EA      
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREA------ 228

Query: 348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA 407
           +S + +LL ++P +RLGSG    + +K   +FR INW  L AR+++P F P + G + ++
Sbjct: 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVS 288

Query: 408 NFDKCWTTMPADDSPAPTPTA-----GEHFKGYTYV 438
           NFD+ +T+     +P   P        E F+G+ YV
Sbjct: 289 NFDEEFTSEAPVLTPPREPRLLTEEEQELFRGFDYV 324

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  273 bits (699), Expect = 5e-89
 Identities = 128/333 (38%), Positives = 201/333 (60%), Gaps = 25/333 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           +V+G+G+FGKV   + KG ++      +A+K ++KD +++ + V+    ER +L     H
Sbjct: 1   KVLGKGSFGKVMLAELKGTNE-----FFAIKALKKDVVLEDDDVECTMVERRVLALAWEH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++++NGG L FH+   G F E +ARFY AEI+  +  LHK 
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D DGH+ + DFG+ KE ++   ++++ CGT +Y+APEIL  + +N+
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWWS G+LLYEML GQ PF   +  +L   I+N++   P +++ EA   L       +
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLS------K 229

Query: 354 LLHKDPSKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANFDK 411
           L  +DP+KRLG  G      I+ H +FR I+W+ LE RE+ P FKP V S  D  +NFD+
Sbjct: 230 LFERDPTKRLGVDGD-----IRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDA-SNFDR 283

Query: 412 CWTTMPADDSPAPTPTAG----EHFKGYTYVAP 440
            +T      SP           E F+G+++  P
Sbjct: 284 EFTNEKVRLSPVDKKLLASMDQEQFRGFSFTNP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  271 bits (695), Expect = 2e-88
 Identities = 139/334 (41%), Positives = 204/334 (61%), Gaps = 18/334 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG D+     +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E QA FY AEI   + 
Sbjct: 56  LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LH+ GI++RDLK +N+++DS+GH+ + DFG+ KE + +   + + CGT +Y+APEI+  
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           + + K  DWW+ G+LLYEML GQPPF   +  +L Q I+   V  P  L+ EA S+ KG 
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG- 234

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN 408
                L+ K PSKRLG GP G   I+ H +FR I+W  LE RE+QP FKP V GK    N
Sbjct: 235 -----LMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGKGA-EN 288

Query: 409 FDKCWT-TMPADDSPAPTPTAG---EHFKGYTYV 438
           FDK +T   P    P     A      F+G++YV
Sbjct: 289 FDKFFTRGQPVLTPPDQLVIANIDQADFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  271 bits (695), Expect = 2e-88
 Identities = 128/328 (39%), Positives = 180/328 (54%), Gaps = 48/328 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F+  +++G+G  G+VF V+ KG     +  ++A+KV+ K  +IK+N V  +  E++IL 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAV 228
            + HPF+  L  SFQT + L L++D+  GG LF  L RQ      E+ ARFY AE++ A+
Sbjct: 57  TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE--------------------- 267
            +LH  GIV+RDLKPENIL+   GH+ML+DF L+K+ D                      
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 268 ---------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
                    S RSNS  GT EY+APE++   GH    DWW++GILLYEML G  PF  +N
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 319 RQKLQQRIINEKVKLP--PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH 376
           R +    I+ ++V  P  P ++S A  L++       LL KDPSKRLGS  G  + IK H
Sbjct: 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRK------LLVKDPSKRLGSKRGAAE-IKQH 289

Query: 377 KWFRSINWKTLEAREMQPKFKPDVSGKD 404
            +FR +NW  +  R   P   P      
Sbjct: 290 PFFRGVNWALI--RHTTPPIIPRPDDGI 315

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  268 bits (688), Expect = 4e-88
 Identities = 104/273 (38%), Positives = 157/273 (57%), Gaps = 18/273 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +E+ R +G G+FG V++ K KG        I A+K+++K +   K      + E  IL +
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGK-----IVAVKILKKRSEKSKKDQ-TARREIRILRR 54

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           ++HP IV+L  +F+ +  LYL++++  GG LF +L R G   ED+A+    +I+  + +L
Sbjct: 55  LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILL-SK 289
           H  GI+HRDLKPENIL+D +G V + DFGLAK++ +SS S  +  GT  YMAPE+LL   
Sbjct: 115 HSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ---RIINEKVKLPPFLTSEAHSLLK 346
           G+    D WS+G++LYE+LTG+PPF+  N     Q   RI+   ++      S      K
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234

Query: 347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + + L+KDPSKR        + I  H WF
Sbjct: 235 --DLIKKCLNKDPSKRP-----TAEEILQHPWF 260

Length = 260

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  271 bits (693), Expect = 4e-88
 Identities = 129/308 (41%), Positives = 198/308 (64%), Gaps = 12/308 (3%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      S   YAMK+++K+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+YSFQT+ +L  +++++NGG LFFHL R+ +F ED+ RFY AEIVSA+ +LH   
Sbjct: 56  FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
           IV+RDLK EN+++D DGH+ +TDFGL KE I +++   + CGT EY+APE+L    + + 
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
            DWW +G+++YEM+ G+ PF + + +KL + I+ E +K P  L+++A SLL G      L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSG------L 229

Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 414
           L KDP+KRLG GP     I  H +F  +NW+ +  +++ P FKP V+ +     FD+ +T
Sbjct: 230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFT 289

Query: 415 TMPADDSP 422
                 +P
Sbjct: 290 AQTITITP 297

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  268 bits (685), Expect = 8e-87
 Identities = 134/335 (40%), Positives = 204/335 (60%), Gaps = 21/335 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  VK+K      +   YAMK+++K+ I+ K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KC 234
           F+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH + 
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
            +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE+L    + +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L+ EA SLL G      
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSG------ 229

Query: 354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW 413
           LL KDP +RLG GP     I  HK+F  I W+ +  +++ P FKP V+ +     FD+ +
Sbjct: 230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEF 289

Query: 414 T----TMPADDSPAPTPTAGE----HFKGYTYVAP 440
           T    T+   D      T       HF  ++Y A 
Sbjct: 290 TAQMITITPPDQDDSMETVDNERRPHFPQFSYSAS 324

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  266 bits (682), Expect = 2e-86
 Identities = 133/338 (39%), Positives = 202/338 (59%), Gaps = 26/338 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG D+     +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                PF+ QL   FQT  +LY +++++NGG L + + + G F+E  A FY AEI   + 
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LH  GI++RDLK +N+++DS+GH+ + DFG+ KE + +   + + CGT +Y+APEI+  
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ EA ++ KG 
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG- 234

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN 408
                L+ K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP   G+D   N
Sbjct: 235 -----LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDA-EN 288

Query: 409 FDKCWTTMPADDSPAPTPTAGE--------HFKGYTYV 438
           FDK +T  P    P  TP   E         F+G++YV
Sbjct: 289 FDKFFTRHP----PVLTPPDQEVIMNLDQSEFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  261 bits (670), Expect = 2e-84
 Identities = 120/303 (39%), Positives = 180/303 (59%), Gaps = 16/303 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DF+I   VGQG +G+VF  KKK     D+  I A+K M+K  + K N V ++  ERDIL
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKK-----DTGEIVALKRMKKSLLFKLNEVRHVLTERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           T     ++V+L Y+FQ    LYL ++++ GG     L   G+  ED ARFY AE+  AV 
Sbjct: 56  TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
            LH+ G +HRDLKPEN L+D+ GH+ LTDFGL+K I   + +NS+ G+ +YMAPE+L  K
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI--VTYANSVVGSPDYMAPEVLRGK 173

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLKG 347
           G++   D+WS+G +LYE L G PPF+ +   +  + +   K  L  P +     +   + 
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233

Query: 348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA 407
              +T+L+  DPS+R GS    ++ IK+H +F+ ++W  L  RE++P F P++  +    
Sbjct: 234 WDLITKLI-NDPSRRFGS----LEDIKNHPFFKEVDWNEL--RELKPPFVPELESEIDTG 286

Query: 408 NFD 410
            FD
Sbjct: 287 YFD 289

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  258 bits (661), Expect = 7e-84
 Identities = 107/288 (37%), Positives = 164/288 (56%), Gaps = 17/288 (5%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+V   + K      +  +YA K + K  + K+        E+ IL KV+  FI
Sbjct: 1   LGKGGFGEVCACQVK-----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG 235
           V L Y+F+T+  L L++  +NGG L +H+Y  G   F E +A FY A+I+  + HLH+  
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDA 295
           IV+RDLKPEN+L+D  G+V ++D GLA E+    +     GT  YMAPE+L  + ++   
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 296 DWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL 351
           DW+++G  LYEM+ G+ PF        +++L++R +   V+ P   + EA  L +     
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA---- 231

Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
             LL KDP KRLG   G  D ++ H  F+ +NW+ LEA  ++P F PD
Sbjct: 232 --LLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  261 bits (669), Expect = 1e-83
 Identities = 129/362 (35%), Positives = 189/362 (52%), Gaps = 60/362 (16%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V  V+K      D++ +YAMK +RK  ++ +N   ++KAERDIL +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKV-----DTNALYAMKTLRKADVLMRNQAAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R GIF ED ARFY AE+  A+  +
Sbjct: 58  ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLA--------------------------KEI 265
           HK G +HRD+KP+NIL+D DGH+ LTDFGL                           +E 
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 266 DESSR------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
            E  R                  ++S+ GT  Y+APE+LL  G+ +  DWWSVG++LYEM
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 308 LTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP 367
           L GQPPF      + Q ++IN +  L   + S+A  L +  S L   L      RLG   
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTL--HIPSQA-KLSREASDLILRLCCGAEDRLGK-- 292

Query: 368 GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD-----KCWTTMPADDSP 422
            G D IK H +F+ I++ +L  R  +  + P ++     +NFD     K  +    + SP
Sbjct: 293 NGADEIKAHPFFKGIDFASL-IRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSP 351

Query: 423 AP 424
             
Sbjct: 352 DR 353

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  257 bits (657), Expect = 1e-82
 Identities = 124/339 (36%), Positives = 203/339 (59%), Gaps = 27/339 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTH 174
           RV+G+G++ KV  V+ K      +  IYAMKV++K+ +     +D+++ E+ +  T   H
Sbjct: 1   RVIGRGSYAKVLLVELK-----KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+ +++F++GG L FH+ RQ    E+ ARFY+AEI  A++ LH+ 
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D++GH+ LTD+G+ KE I     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQK---------LQQRIINEKVKLPPFLTSEAHSL 344
             DWW++G+L++EM+ G+ PF                L Q I+ +++++P  L+ +A S+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV 235

Query: 345 LKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LKG       L+KDP +RLG  P  G   IK H +FR+I+W  LE +++ P +KP++   
Sbjct: 236 LKG------FLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESD 289

Query: 404 DCIANFDKCWTTMPADDSPAPTPTAGE----HFKGYTYV 438
             + NFD  +T  P   +P             F+G+ Y+
Sbjct: 290 RDLDNFDPQFTDEPVQLTPDDPDVIARIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  249 bits (636), Expect = 2e-79
 Identities = 127/337 (37%), Positives = 205/337 (60%), Gaps = 25/337 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           RV+G+G++ KV  V+ K      +D IYAMKV++K+ +     +D+++ E+ +  +  ++
Sbjct: 1   RVIGRGSYAKVLLVRLK-----KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSN 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+L+++++NGG L FH+ RQ    E+ ARFY AEI  A++ LH+ 
Sbjct: 56  PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+D+DGH+ LTD+G+ KE +     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175

Query: 294 DADWWSVGILLYEMLTGQPPF-------THANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
             DWW++G+L++EM+ G+ PF              L Q I+ + +++P FL+ +A  +LK
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK 235

Query: 347 GVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC 405
           G       L+KDP +RLG  P  G   IK H +FRSI+W  LE +++ P FKP ++    
Sbjct: 236 G------FLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYG 289

Query: 406 IANFDKCWTTMPA----DDSPAPTPTAGEHFKGYTYV 438
           + NFD  +T+ P     DD           F+G+ Y+
Sbjct: 290 LENFDTQFTSEPVQLTPDDEDVIKRIDQSEFEGFEYI 326

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  243 bits (620), Expect = 5e-77
 Identities = 122/339 (35%), Positives = 208/339 (61%), Gaps = 27/339 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           RV+G+G++ KV  V+ K      ++ IYAMKV++K+ +     +D+++ E+ +  + + H
Sbjct: 1   RVIGRGSYAKVLLVRLK-----KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI  A+++LH+ 
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 294 DADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPPFLTSEAHSL 344
             DWW++G+L++EM+ G+ PF                L Q I+ +++++P  L+ +A S+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235

Query: 345 LKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LK        L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++SG+
Sbjct: 236 LK------SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGE 289

Query: 404 DCIANFDKCWTT----MPADDSPAPTPTAGEHFKGYTYV 438
             + NFD  +T     +  DD           F+G+ Y+
Sbjct: 290 FGLDNFDAQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  240 bits (613), Expect = 1e-76
 Identities = 116/297 (39%), Positives = 170/297 (57%), Gaps = 23/297 (7%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-ERDI 168
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I KK   + M   E+ I
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRI-KKRKGEAMALNEKQI 53

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVS 226
           L KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E++A FY AEI  
Sbjct: 54  LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
            +  LH+  IV+RDLKPENIL+D  GH+ ++D GLA EI E        GT  YMAPE++
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV 173

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAH 342
            ++ +    DWW +G L+YEM+ G+ PF        R+++++R+  ++ +     +  A 
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
           S+ +      QLL KDP  RLG    G + +K H +FR+ N+K LEA  ++P F PD
Sbjct: 234 SICR------QLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  239 bits (610), Expect = 1e-75
 Identities = 117/298 (39%), Positives = 183/298 (61%), Gaps = 17/298 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +++G+G+FGKVF  + KG     ++  +A+K ++KD ++  + V+    E+ +L+    H
Sbjct: 1   KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++++NGG L FH+     F   +A FY AEI+  +  LH  
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GIV+RDLK +NIL+D+DGH+ + DFG+ KE +   +++ + CGT +Y+APEILL + +N 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWWS G+LLYEML GQ PF   + ++L Q I  +    P +LT EA  +      L +
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDI------LVK 229

Query: 354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 411
           L  ++P +RLG        I+ H +FR I+W  LE RE++P FKP V   +  +NFDK
Sbjct: 230 LFVREPERRLGVK----GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDK 283

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  237 bits (606), Expect = 2e-74
 Identities = 121/340 (35%), Positives = 184/340 (54%), Gaps = 28/340 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++ +V+G+GAFG+V  V+ K      S  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHK-----SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
                +IVQL Y+FQ    LY++++++ GG L   +    I  E  ARFYTAE+V A+  
Sbjct: 99  HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++D +   R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 289 KGHN----KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G +    ++ DWWSVG+ LYEML G  PF   +      +I++ K  L       ++ +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 400
           A  L+    FLT     D   RLG    GVD IK H +F++  W     RE      P++
Sbjct: 278 AKDLICA--FLT-----DREVRLGR--NGVDEIKSHPFFKNDQWTFDNIRETVAPVVPEL 328

Query: 401 SGKDCIANFDKCWT-TMPADDSPAPTPTAGEH--FKGYTY 437
           S     +NFD         +  P P   AG    F G+TY
Sbjct: 329 SSDIDTSNFDDIEDDDKNEETFPLPKAFAGNQLPFIGFTY 368

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  234 bits (599), Expect = 9e-74
 Identities = 124/318 (38%), Positives = 183/318 (57%), Gaps = 12/318 (3%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           ++D+  E + + K+   DF   R +G G+FG+V     K   + D   + A+K   K  I
Sbjct: 14  DSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYK---NEDFPPV-AIKRFEKSKI 69

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
           IK+  VD++ +ER IL  + HPF V L  SF+  S LYL+L+F+ GG  F  L R   F 
Sbjct: 70  IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP 129

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
            D   FY A+IV    +L    IV+RDLKPEN+L+D DG + +TDFG AK +D  +R+ +
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--TRTYT 187

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
           +CGT EY+APEILL+ GH K ADWW++GI +YE+L G PPF       + Q+I+   +  
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247

Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 393
           P FL +    L+K      +LL  D +KR G+   G   +K H WF +I+W +L  + ++
Sbjct: 248 PKFLDNNCKHLMK------KLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVE 301

Query: 394 PKFKPDVSGKDCIANFDK 411
             +KP        +NF++
Sbjct: 302 VPYKPKYKNVFDSSNFER 319

Length = 340

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  229 bits (585), Expect = 1e-72
 Identities = 110/273 (40%), Positives = 164/273 (60%), Gaps = 23/273 (8%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPF 176
           + +GAFG V+  KK+   D      +A+KV++K  +I KN V  +KAER I+  +   P+
Sbjct: 4   ISKGAFGSVYLAKKRSTGD-----YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
           + +L YSFQ++  LYL+++++NGG     +   G   ED A+ Y AE+V  V  LH+ GI
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           +HRD+KPEN+L+D  GH+ LTDFGL++   E+ +     GT +Y+APE +L  G +K +D
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPETILGVGDDKMSD 175

Query: 297 WWSVGILLYEMLTGQPPFTHANR-----QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL 351
           WWS+G +++E L G PPF HA         +  R IN   ++  F + EA  L      +
Sbjct: 176 WWSLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL------I 228

Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
            +LL  DP+KRLG+   G   IK H +F+SINW
Sbjct: 229 NRLLCMDPAKRLGA--NGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  228 bits (582), Expect = 1e-71
 Identities = 113/298 (37%), Positives = 180/298 (60%), Gaps = 17/298 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +V+G+G+FGKV   + KG  +      +A+K ++KD ++  + V+    E+ +L     +
Sbjct: 1   KVLGKGSFGKVLLAELKGKGE-----YFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++F+NGG L FH+  +G F   +A FY AEIV  +  LH  
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNK 293
           GI++RDLK +N+++D DGH+ + DFG+ KE +   +R+++ CGT +Y+APEIL    +  
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
             DWWS G+LLYEML GQ PF   +  +L + I  +    P ++T E+  +L+      +
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILE------K 229

Query: 354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 411
           L  +DP++RLG     V  I+ H +F++INW  LE RE+ P FKP V      +NFD+
Sbjct: 230 LFERDPTRRLGV----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDR 283

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  228 bits (583), Expect = 2e-71
 Identities = 119/337 (35%), Positives = 181/337 (53%), Gaps = 32/337 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++  +VG+G FG+V  V++K   D     IYAMKVM+K  ++ +  V + + ERDIL+
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGD-----IYAMKVMKKSVLLAQETVSFFEEERDILS 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
               P+I QL+Y+FQ +  LYL++++  GG L   L R +  F ED A+FY AE+V A+ 
Sbjct: 57  ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM--CGTTEYMAPEILL 287
            +H+ G VHRD+KPEN+L+D  GH+ L DFG A  +  +   NS    GT +Y+APE+L 
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 288 -----SKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP--PFL 337
                 KG +  + DWWS+G++ YEM+ G+ PF      K    I+N +  +K P  P +
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236

Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
           +S+   L++  S L         +RL     G + +  H +F  I+W  +  R   P F 
Sbjct: 237 SSDFLDLIQ--SLLC-----GQKERL-----GYEGLCCHPFFSKIDWNNI--RNSLPPFV 282

Query: 398 PDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKG 434
           P +   D  +NFD+           + T      F G
Sbjct: 283 PTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSG 319

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  227 bits (580), Expect = 2e-70
 Identities = 127/388 (32%), Positives = 186/388 (47%), Gaps = 77/388 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF   +V+G+GAFG+V  V+KK  D G    IYAMK + K  + KK+ + ++KAERD+L 
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKK--DTGK---IYAMKTLLKSEMFKKDQLAHVKAERDVLA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P++V L YSFQ    LYLI++F+ GG L   L +   F ED  RFY AE V A+  
Sbjct: 57  ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEA 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +HK G +HRD+KP+NIL+D  GH+ L+DFGL+    +   S                   
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 273 ------------------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGI 302
                                         S  GT +Y+APEI L +G+ ++ DWWS+G 
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236

Query: 303 LLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGVSFLTQLLHKD 358
           +++E L G PPF   N  +  ++IIN  E +  P    L+ EA  L++    +T     +
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIR--RLIT-----N 289

Query: 359 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG---------KDCIANF 409
              RLG   GG   IK H +FR ++W T+  R+++  F P +            +     
Sbjct: 290 AENRLGR--GGAHEIKSHPFFRGVDWDTI--RQIRAPFIPQLKSITDTSYFPTDELEQVP 345

Query: 410 DKCWTTMPADDSPAPTPTAGEHFKGYTY 437
           +       A      +      F GYTY
Sbjct: 346 EAPALKQAAPAQQEESVELDLAFIGYTY 373

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  224 bits (573), Expect = 3e-70
 Identities = 112/320 (35%), Positives = 183/320 (57%), Gaps = 34/320 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE  +++  GA+G V+ V+ K     ++   +AMK + K  +I +N +  +  ERDIL
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHK-----ETRQRFAMKKINKQNLILRNQIQQVFVERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           T   +PF+V +  SF+T+  L ++++++ GG     L   G    D AR Y AE V A+ 
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-------------EIDESSRS---NS 273
           +LH  GIVHRDLKP+N+L+ S GH+ LTDFGL+K              I++ +R      
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
           +CGT EY+APE++L +G+ K  DWW++GI+LYE L G  PF     ++L  ++I++ ++ 
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Query: 334 P---PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 390
           P     L ++A  L      +++LL ++P +RLG+  GG   +K H++F  ++W  L   
Sbjct: 236 PEGDEALPADAQDL------ISRLLRQNPLERLGT--GGAFEVKQHRFFLGLDWNGL--L 285

Query: 391 EMQPKFKPDVSGKDCIANFD 410
             + +F P +  +D  + FD
Sbjct: 286 RQKAEFIPQLESEDDTSYFD 305

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  223 bits (569), Expect = 2e-69
 Identities = 122/345 (35%), Positives = 184/345 (53%), Gaps = 34/345 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K         +YAMK++ K  ++K+      + ERD+L 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQ-----VYAMKILNKWEMLKRAETACFREERDVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEYMAPEILL 287
            +H+ G VHRD+KP+N+L+D +GH+ L DFG  L    D + +SN   GT +Y++PEIL 
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 288 S----KGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLT-- 338
           +    KG    + DWWS+G+ +YEML G+ PF   +  +   +I+N  E  + PP +T  
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236

Query: 339 -SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
             EA  L++      +L+   P  RLG    G+   K H +F  I+W  +  R     + 
Sbjct: 237 SEEAKDLIR------RLICS-PETRLGR--NGLQDFKDHPFFEGIDWDNI--RNSTAPYV 285

Query: 398 PDVSGKDCIANFD---KCWTTMPADDSPAPTPTAGEH--FKGYTY 437
           P+VS     +NFD          +    +    +G H  F G+TY
Sbjct: 286 PEVSSPTDTSNFDVDDDDLRNTESLPPSSHGAFSGNHLPFVGFTY 330

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  220 bits (561), Expect = 6e-69
 Identities = 114/296 (38%), Positives = 166/296 (56%), Gaps = 21/296 (7%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATG-------KMYACKRLEKKRIKKRKGESMALNEKQIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E++A FY AEI+  
Sbjct: 55  EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +  LH+   V+RDLKPENIL+D  GH+ ++D GLA +I E        GT  YMAPE+L 
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHS 343
           ++ +    D+W +G L+YEM+ GQ PF        R+++ +R++  +       + EA S
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
           + K       LL KDP +RLG    G   +K H +FR++N+K LEA  + P F PD
Sbjct: 235 ICK------MLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  219 bits (560), Expect = 1e-68
 Identities = 118/292 (40%), Positives = 164/292 (56%), Gaps = 13/292 (4%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGESMALNEKQIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   
Sbjct: 55  EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +  LH+  IV+RDLKPENIL+D  GH+ ++D GLA  + E        GT  YMAPE++ 
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
           ++ +    DWW++G LLYEM+ GQ PF    ++K+++  +   VK      SE  S    
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYSEKFS-PDA 232

Query: 348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
            S    LL KDP +RLG   GG   +K H  F+ IN+K LEA  ++P FKPD
Sbjct: 233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  217 bits (555), Expect = 3e-68
 Identities = 84/259 (32%), Positives = 147/259 (56%), Gaps = 20/259 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +EI + +G+G+FGKV+ V++K      SDG +Y +K +    + +K   D +  E  IL
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRK------SDGKLYVLKEIDLSNMSEKEREDALN-EVKIL 53

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI----FREDQARFYTAEIV 225
            K+ HP I++   SF+ + KL +++++ +GG L   + +Q      F E+Q   +  ++ 
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPE 284
            A+ +LH   I+HRD+KP+NI + S+G V L DFG++K +  +     ++ GT  Y++PE
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHS 343
           +  +K +N  +D WS+G +LYE+ T + PF   N  +L  +I+  +   +P   +SE  +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRN 233

Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L+        LL KDP +R
Sbjct: 234 LVS------SLLQKDPEER 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  216 bits (552), Expect = 2e-67
 Identities = 110/296 (37%), Positives = 165/296 (55%), Gaps = 21/296 (7%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGEAMALNEKRIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AE+   
Sbjct: 55  EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +  L +  IV+RDLKPENIL+D  GH+ ++D GLA +I E        GT  YMAPE++ 
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHS 343
           ++ +    DWW +G L+YEM+ GQ PF        R+++ +R+  ++ +     + +A S
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
           + +       LL K+P +RLG    G   +K H  F++IN+K LEA  ++P F PD
Sbjct: 235 ICR------MLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  218 bits (557), Expect = 5e-67
 Identities = 126/351 (35%), Positives = 186/351 (52%), Gaps = 67/351 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V   +K      D+  +YAMK +RK  ++ +N V ++KAERDIL +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKV-----DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R GIF ED ARFY AE+  AV  +
Sbjct: 58  ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGL--------------------------AKEI 265
           HK G +HRD+KP+NIL+D DGH+ LTDFGL                          + E 
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 266 DESSR----------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
            + +                       ++S+ GT  Y+APE+LL  G+ +  DWWSVG++
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 304 LYEMLTGQPPFTHANRQKLQQRIINEKVKL--PP--FLTSEAHSLLKGVSFLTQLLHKDP 359
           LYEML GQPPF      + Q ++IN +  L  PP   L+ EA  L+         L + P
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-------LCRGP 290

Query: 360 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
             RLG    G D IK H +F++I++ + + R+    + P ++     +NFD
Sbjct: 291 EDRLGK--NGADEIKAHPFFKTIDFSS-DLRQQSAPYIPKITHPTDTSNFD 338

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  217 bits (553), Expect = 8e-67
 Identities = 125/375 (33%), Positives = 197/375 (52%), Gaps = 68/375 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  IYAMK++RK  +++K  V +++AERDIL 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKK-----DTGHIYAMKILRKADMLEKEQVAHIRAERDILV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +    ++V++ YSFQ +  LYLI++F+ GG +   L ++    E+  +FY AE V A+  
Sbjct: 57  EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +H+ G +HRD+KP+N+L+D+ GHV L+DFGL   + ++ R+                   
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 273 ------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
                             S  GT +Y+APE+ +  G+NK  DWWS+G+++YEML G PPF
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 315 THANRQKLQQRIIN--EKVKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGV 370
                Q+  ++++N  E +  PP   ++ +A  L+  + F T     D   R+GS   GV
Sbjct: 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLI--LRFCT-----DSENRIGS--NGV 287

Query: 371 DAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGE 430
           + IK H +F  ++W  +  RE       ++   D  +NFD+     P  D   P     E
Sbjct: 288 EEIKSHPFFEGVDWGHI--RERPAAIPIEIKSIDDTSNFDE----FPESDILQPAENTIE 341

Query: 431 H--------FKGYTY 437
                    F  YTY
Sbjct: 342 PDYKSKDWVFLNYTY 356

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  211 bits (539), Expect = 1e-65
 Identities = 109/291 (37%), Positives = 170/291 (58%), Gaps = 20/291 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+V   + +      +  +YA K + K  + K+   +    E+ IL KV   FI
Sbjct: 1   LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHK 233
           V L Y+FQT++ L L++  +NGG L +H+Y        F E +A FYTA+I+S + HLH+
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHN 292
             I++RDLKPEN+L+D+DG+V ++D GLA E+ D  S++    GT  +MAPE+L  + ++
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 293 KDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
              D++++G+ LYEM+  + PF         ++L+QRI+N+ V  P   +  + S  +  
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEA- 234

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
                LL KDP KRLG   G  D ++ H  FR +NW+ LEA  + P F PD
Sbjct: 235 -----LLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  209 bits (533), Expect = 9e-64
 Identities = 122/378 (32%), Positives = 198/378 (52%), Gaps = 71/378 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  +YAMK++RK  +++K  V +++AERDIL 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKK-----DTGHVYAMKILRKADMLEKEQVGHIRAERDILV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +    ++V++ YSFQ +  LYLI++F+ GG +   L ++    E++ +FY AE V A+  
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN------------------ 272
           +H+ G +HRD+KP+N+L+DS GHV L+DFGL   + ++ R+                   
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 273 ------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
                             S  GT +Y+APE+ +  G+NK  DWWS+G+++YEML G PPF
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 315 THANRQKLQQRIIN--EKVKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGV 370
                Q+  ++++N  E +  PP   ++ +A  L+  + F  +  H+        G  GV
Sbjct: 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLI--LRFCCEWEHR-------IGAPGV 287

Query: 371 DAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGE 430
           + IK + +F  ++W+ +  RE       ++   D  +NFD+     P  D   PT     
Sbjct: 288 EEIKTNPFFEGVDWEHI--RERPAAIPIEIKSIDDTSNFDE----FPDSDILKPTVATSN 341

Query: 431 H-----------FKGYTY 437
           H           F  YTY
Sbjct: 342 HPETDYKNKDWVFINYTY 359

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  208 bits (531), Expect = 4e-63
 Identities = 126/383 (32%), Positives = 193/383 (50%), Gaps = 74/383 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V    K      D+  +YAMK +RK  ++ +N V ++KAERDIL +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKV-----DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R  +F E  ARFY AE+  A+  +
Sbjct: 58  ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGL------------------------------ 261
           HK G +HRD+KP+NIL+D DGH+ LTDFGL                              
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 262 ------------------AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
                             A +  +   ++S+ GT  Y+APE+LL KG+ +  DWWSVG++
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237

Query: 304 LYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGVSFLTQLLHKDP 359
           L+EML GQPPF      + Q ++IN    + +PP   L+ EA      V  +T+L     
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEA------VDLITKLCCS-A 290

Query: 360 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD 419
            +RLG    G D IK H +F  +++ + + R     + P +S     +NFD      P +
Sbjct: 291 EERLGR--NGADDIKAHPFFSEVDFSS-DIRTQPAPYVPKISHPMDTSNFD------PVE 341

Query: 420 DSPAPTPTAGEHFKGY-TYVAPN 441
           +       +G+  + + T  +PN
Sbjct: 342 EESPWNDASGDSTRTWDTLCSPN 364

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  200 bits (512), Expect = 8e-62
 Identities = 84/255 (32%), Positives = 138/255 (54%), Gaps = 20/255 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
            ++G+G+FG V+      +D  D+  + A+K +      ++  ++ ++ E  IL+ + HP
Sbjct: 6   ELLGRGSFGSVYL----ALDK-DTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHP 59

Query: 176 FIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            IV+   S +   K  L + L++++GG L   L + G   E   R YT +I+  +++LH 
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE---SSRSNSMCGTTEYMAPEILLSKG 290
            GIVHRD+K  NIL+DSDG V L DFG AK + +      + S+ GT  +MAPE++  + 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVK--LPPFLTSEAHSLLKG 347
           + + AD WS+G  + EM TG+PP++   N      +I +      +P  L+ EA      
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK----- 234

Query: 348 VSFLTQLLHKDPSKR 362
             FL + L +DP KR
Sbjct: 235 -DFLRKCLRRDPKKR 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  196 bits (500), Expect = 7e-60
 Identities = 110/290 (37%), Positives = 167/290 (57%), Gaps = 21/290 (7%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
           ++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+ V+   
Sbjct: 1   IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E + RFY AEI+  + H+H 
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--H 291
             +V+RDLKP NIL+D  GHV ++D GLA +  +     S+ GT  YMAPE+ L KG  +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV-LQKGVAY 173

Query: 292 NKDADWWSVGILLYEMLTGQPPF-THANRQKLQ--QRIINEKVKLPPFLTSEAHSLLKGV 348
           +  ADW+S+G +L+++L G  PF  H  + K +  +  +   V+LP   + E  SLL+G 
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG- 232

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
                LL +D ++RLG    G   +K H +FRS++W+ +  ++  P   P
Sbjct: 233 -----LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  193 bits (491), Expect = 1e-58
 Identities = 107/290 (36%), Positives = 166/290 (57%), Gaps = 21/290 (7%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
           ++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+ V+   
Sbjct: 1   IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E + RFY  EI+  + H+H 
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--H 291
             +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L KG  +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-LQKGTAY 173

Query: 292 NKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           +  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  SLL+G 
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG- 232

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
                LL +D SKRLG    G   +K H +F+ I+W+ +  ++  P   P
Sbjct: 233 -----LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  193 bits (491), Expect = 1e-58
 Identities = 104/291 (35%), Positives = 160/291 (54%), Gaps = 23/291 (7%)

Query: 118 VGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +G+G FG+V   QVK  G        +YA K + K  + KK+       E++IL KV  P
Sbjct: 1   LGKGGFGEVCAVQVKNTG-------KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP 53

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR--FYTAEIVSAVSHLHK 233
           FIV L Y+F++++ L L++  +NGG L +H+Y  G    +  R   Y+A+I   + HLH 
Sbjct: 54  FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNK 293
             IV+RD+KPEN+L+D  G+  L+D GLA E+ +        GT  YMAPEIL  + ++ 
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 294 DADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP-PFLTSEAHSLLKGV 348
             DW+++G  +YEM+ G+ PF        +++L++R + ++VK      T E+  + +  
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICR-- 231

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
                 L K P  RLGS     D  KH  +F++IN+  LEA  + P F PD
Sbjct: 232 ----LFLAKKPEDRLGSREKNDDPRKHE-FFKTINFPRLEAGLIPPPFVPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  196 bits (498), Expect = 2e-58
 Identities = 119/340 (35%), Positives = 188/340 (55%), Gaps = 28/340 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAFG+V  V+ K      +  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217

Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 400
           A +L+   +FLT     D   RLG    GV+ IK H +F++  W     R+      PD+
Sbjct: 278 AKNLI--CAFLT-----DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 328

Query: 401 SGKDCIANFDKCWTTMPADDS-PAPTPTAGEH--FKGYTY 437
           S     +NFD        +++ P P    G    F G+TY
Sbjct: 329 SSDIDTSNFDDIEEDKGEEETFPIPKAFVGNQLPFVGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  194 bits (494), Expect = 3e-58
 Identities = 120/342 (35%), Positives = 187/342 (54%), Gaps = 28/342 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K      ++ IYAMK++ K  ++K+      + ER++L 
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMK-----HTERIYAMKILNKWEMLKRAETACFREERNVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEYMAPEIL- 286
            +H+   VHRD+KP+N+L+D +GH+ L DFG  L    D + +S+   GT +Y++PEIL 
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 287 -LSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLTSE 340
            +  G  K   + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + P  +T  
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 400
           +         L Q L     +RLG    G++  K H +F  I+W+ +  R ++  + PDV
Sbjct: 237 SEE----AKDLIQRLICSRERRLGQ--NGIEDFKKHAFFEGIDWENI--RNLEAPYIPDV 288

Query: 401 SGKDCIANFDKCWTTMPADDSPAP---TPTAGEH--FKGYTY 437
           S     +NFD     +   +   P   T  +G H  F G+TY
Sbjct: 289 SSPSDTSNFDVDDDVLRNPEIAPPSSHTGFSGLHLPFVGFTY 330

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  194 bits (493), Expect = 3e-58
 Identities = 121/345 (35%), Positives = 191/345 (55%), Gaps = 30/345 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K     ++D ++AMK++ K  ++K+      + ERD+L 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
              + +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEILL 287
            +H+   VHRD+KP+NILMD +GH+ L DFG   ++  D + +S+   GT +Y++PEIL 
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 288 S----KG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           +    KG +  + DWWS+G+ +YEML G+ PF   +  +   +I+N K +      ++  
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--FPAQVT 234

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG 402
            + +    L + L      RLG    G++  K H +F  I+W  +  R  +  + P+VS 
Sbjct: 235 DVSEDAKDLIRRLICSREHRLGQ--NGIEDFKQHPFFTGIDWDNI--RNCEAPYIPEVSS 290

Query: 403 KDCIANFD------KCWTTMPADDSPAPTPTAGEH--FKGYTYVA 439
               +NFD      K   TMP    P+ T  +G H  F G+TY +
Sbjct: 291 PTDTSNFDVDDDCLKNSETMP---PPSHTAFSGHHLPFVGFTYTS 332

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  192 bits (490), Expect = 3e-57
 Identities = 116/338 (34%), Positives = 184/338 (54%), Gaps = 24/338 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ +V+G+GAFG+V  V+ K      S  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL  +FQ    LY++++++ GG L  +L       E  A+FYTAE+V A+  
Sbjct: 99  FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G++HRD+KP+N+L+D  GH+ L DFG   ++DE+   R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217

Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAH 342
           +G    + ++ DWWSVG+ L+EML G  PF   +      +I++ K  L  P  +    H
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG 402
           +     +FLT     D   RLG    GV+ IK H +F++  W     RE      P++S 
Sbjct: 278 AKNLICAFLT-----DREVRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSS 330

Query: 403 KDCIANFDKCWTTM-PADDSPAPTPTAGEH--FKGYTY 437
               +NFD         +  P P    G    F G+TY
Sbjct: 331 DIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  187 bits (478), Expect = 8e-57
 Identities = 84/260 (32%), Positives = 134/260 (51%), Gaps = 26/260 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            FEI   +G+G FG+V++ + K        G   A+KV++ ++  KK  +     E  IL
Sbjct: 1   LFEILEKIGKGGFGEVYKARHK------RTGKEVAIKVIKLESKEKKEKI---INEIQIL 51

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAE 223
            K  HP IV+   S+  + +L+++++F +GG L     +           E Q  +   E
Sbjct: 52  KKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL-----KDLLKSTNQTLTESQIAYVCKE 106

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  + +LH  GI+HRD+K  NIL+ SDG V L DFGL+ ++ ++   N+M GT  +MAP
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  K ++  AD WS+GI   E+  G+PP++     K   +I       P     E  S
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP--PGLRNPEKWS 224

Query: 344 L-LKGVSFLTQLLHKDPSKR 362
              K   FL + L K+P KR
Sbjct: 225 DEFK--DFLKKCLQKNPEKR 242

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  182 bits (465), Expect = 2e-55
 Identities = 81/249 (32%), Positives = 128/249 (51%), Gaps = 48/249 (19%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG V+  +     D  +    A+K+++K+     + ++ +  E +IL K+ HP I
Sbjct: 1   LGEGGFGTVYLAR-----DKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNI 53

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGI 236
           V+L   F+  + LYL++++  GG L   L    G   ED+      +I+  + +LH  GI
Sbjct: 54  VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGI 113

Query: 237 VHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLSKGH-NK 293
           +HRDLKPENIL+DSD G V L DFGL+K +        ++ GT  YMAPE+LL KG+ ++
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ 353
            +D WS+G++LYE+                                E   L++      +
Sbjct: 174 KSDIWSLGVILYEL-------------------------------PELKDLIR------K 196

Query: 354 LLHKDPSKR 362
           +L KDP KR
Sbjct: 197 MLQKDPEKR 205

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  175 bits (444), Expect = 1e-50
 Identities = 98/299 (32%), Positives = 145/299 (48%), Gaps = 30/299 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            + I R +G+G+FG+V+  + +         + A+KV+ K    K   V+    E  IL 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK--------LVALKVLAKKLESKSKEVERFLREIQILA 52

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVS 226
            + HP  IV+L   FQ    LYL++++++GG    L   + R+G   E +A F  A+I+S
Sbjct: 53  SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGH-VMLTDFGLAKEIDESS-------RSNSMCGTT 278
           A+ +LH  GI+HRD+KPENIL+D DG  V L DFGLAK + +           ++  GT 
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 279 EYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKV 331
            YMAPE+LL       +  +D WS+GI LYE+LTG PPF      +   +  + I+    
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 332 KLPPFLTSE---AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 387
                  S              L +LL KDP  RL S       +  H   +  +   L
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291

Length = 384

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  164 bits (416), Expect = 1e-47
 Identities = 84/250 (33%), Positives = 134/250 (53%), Gaps = 12/250 (4%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
            ++G G+FG V++    G++  D    +A+K +    D    +  V  ++ E  +L+K+ 
Sbjct: 6   ELLGSGSFGSVYE----GLN-LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HP IVQ   + +    LY+ L+ + GG L   L + G F E   R YT +I+  + +LH 
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HN 292
              VHRD+K  NIL+D++G V L DFG+AK++ E S + S  G+  +MAPE++  +G + 
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLT 352
             AD WS+G  + EM TG+PP++         +I   K  LPP      H   +   F+ 
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-LPPI---PDHLSDEAKDFIL 236

Query: 353 QLLHKDPSKR 362
           + L +DPS R
Sbjct: 237 KCLQRDPSLR 246

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  163 bits (414), Expect = 2e-47
 Identities = 85/270 (31%), Positives = 142/270 (52%), Gaps = 17/270 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++  ++G+GAFG V+    KG++  ++    A+K +  + I ++     M  E D+L 
Sbjct: 1   NYQLGDLIGRGAFGVVY----KGLN-LETGDFVAIKQISLEKIKEEALKSIM-QEIDLLK 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+   S +T   LY+IL++   G L   + + G F E     Y  +++  +++
Sbjct: 55  NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLSK 289
           LH+ G++HRD+K  NIL   DG V L DFG+A ++++ S+   S+ GT  +MAPE++   
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS 349
           G +  +D WS+G  + E+LTG PP+   N      RI+ +    PP L       LK   
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--DHPP-LPEGISPELK--D 229

Query: 350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
           FL Q   KDP+ R  +       +  H W 
Sbjct: 230 FLMQCFQKDPNLRPTA-----KQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  155 bits (394), Expect = 2e-44
 Identities = 81/266 (30%), Positives = 140/266 (52%), Gaps = 27/266 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+E+   +G+G+FG V +V++K      SDG I   K +    + +K     + +E +IL
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRK------SDGKILVWKEIDYGNMTEKEK-QQLVSEVNIL 53

Query: 170 TKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHL--FFHLYRQ--GIFREDQARFYTAE 223
            ++ HP IV+   R   ++   LY+++++  GG L       ++      E+       +
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNSMCGT 277
           ++ A+   H        ++HRDLKP NI +D++ +V L DFGLAK +   SS + +  GT
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF 336
             YM+PE L    +++ +D WS+G L+YE+    PPFT  N+ +L  +I   K  ++P  
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYR 233

Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKR 362
            +SE + ++K       +L+ DP KR
Sbjct: 234 YSSELNEVIK------SMLNVDPDKR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  155 bits (393), Expect = 4e-44
 Identities = 78/257 (30%), Positives = 133/257 (51%), Gaps = 16/257 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E  +V+GQG+ G V++V+ K    G    IYA+K +  D   +      +  E   L 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKP--TGK---IYALKKIHVDGDEEFRKQ--LLRELKTLR 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++V+   +F    ++ ++L++++GG L   L + G   E    +   +I+  + +
Sbjct: 55  SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 231 LHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNSMCGTTEYMAPEILLS 288
           LH    I+HRD+KP N+L++S G V + DFG++K ++ +  + N+  GT  YM+PE +  
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQK---LQQRIINEKVKLPPFLTSEAHSLL 345
           + ++  AD WS+G+ L E   G+ PF    +     L Q I +     PP L +E  S  
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP---PPSLPAEEFS-P 230

Query: 346 KGVSFLTQLLHKDPSKR 362
           +   F++  L KDP KR
Sbjct: 231 EFRDFISACLQKDPKKR 247

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  151 bits (383), Expect = 9e-43
 Identities = 84/257 (32%), Positives = 129/257 (50%), Gaps = 24/257 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FGKV+        + D+  + A+K +R      K     +  E  +L  + HP +
Sbjct: 8   IGGGTFGKVYTAV-----NLDTGELMAVKEIRIQDNDPKTI-KEIADEMKVLELLKHPNL 61

Query: 178 VQLRYSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
           V+  Y  +  R K+Y+ +++ +GG L   L    I  E   R YT +++  +++LH  GI
Sbjct: 62  VKY-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEILL---S 288
           VHRD+KP NI +D +G + L DFG A ++  ++ +      S+ GT  YMAPE++     
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---PPFLTSEAHSLL 345
           KGH + AD WS+G ++ EM TG+ P+      + Q   I   V     PP   S   S  
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPW-SELDNEFQ---IMFHVGAGHKPPIPDSLQLSPE 236

Query: 346 KGVSFLTQLLHKDPSKR 362
            G  FL + L  DP KR
Sbjct: 237 -GKDFLDRCLESDPKKR 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  150 bits (382), Expect = 2e-42
 Identities = 79/273 (28%), Positives = 143/273 (52%), Gaps = 20/273 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F +   +G+G+FG+V+    K +D   +  + A+KV+  +    ++ ++ ++ E   L++
Sbjct: 3   FTLLECIGKGSFGEVY----KAIDKRTNQ-VVAIKVIDLEE--AEDEIEDIQQEIQFLSQ 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P+I +   SF   SKL++I+++  GG     L + G   E    F   E++  + +L
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEYL 114

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKG 290
           H+ G +HRD+K  NIL+  +G V L DFG++ ++    S+ N+  GT  +MAPE++   G
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-LLKGVS 349
           +++ AD WS+GI   E+  G+PP +  +  ++   I       PP L     S   K   
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKD-- 229

Query: 350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
           F++  L+KDP +R    P   + +K HK+ +  
Sbjct: 230 FVSLCLNKDPKER----PSAKELLK-HKFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  150 bits (382), Expect = 3e-42
 Identities = 82/274 (29%), Positives = 139/274 (50%), Gaps = 20/274 (7%)

Query: 96  DAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
           + EL+A  +  +  GD    ++    +G+GA G+V++   +    G      A+K MR  
Sbjct: 1   EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRA--TGKE---VAIKKMR-- 53

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QG 210
             ++K + + +  E  I+    HP IV    S+    +L++++++++GG L   + +   
Sbjct: 54  --LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV 111

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESS 269
              E Q  +   E++  + +LH   ++HRD+K +NIL+  DG V L DFG A ++  E S
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           + NS+ GT  +MAPE++  K +    D WS+GI+  EM  G+PP+      +    I  +
Sbjct: 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231

Query: 330 KVKLPPFLTSEAHS-LLKGVSFLTQLLHKDPSKR 362
            +  PP    E  S   K   FL + L KDP KR
Sbjct: 232 GI--PPLKNPEKWSPEFK--DFLNKCLVKDPEKR 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  151 bits (384), Expect = 5e-40
 Identities = 66/155 (42%), Positives = 105/155 (67%), Gaps = 9/155 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F I + + +GAFGKV+  +KK     ++  +YA+KV++K  +I KN V  ++AERD L 
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKK-----NNSKLYAVKVVKKADMINKNMVHQVQAERDALA 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
               PFIV L YS Q+ + +YL+++++ GG +    H+Y  G F E+ A  Y +E+  A+
Sbjct: 60  LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALAL 117

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            +LH+ GI+HRDLKP+N+L+ ++GH+ LTDFGL+K
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  142 bits (360), Expect = 2e-39
 Identities = 83/265 (31%), Positives = 134/265 (50%), Gaps = 23/265 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK-------VMRKDTIIKKNHVDYMKA 164
           + +   +G GAFG V++V+KK     +   + A+K          KD   +   +  + +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS 57

Query: 165 ERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARF 219
           E  I+ + + HP IV+   +F    +LY+++D I G  L  H      ++  F E++   
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 220 YTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
              ++V A+ +LHK   IVHRDL P NI++  D  V +TDFGLAK+    S+  S+ GT 
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFL 337
            Y  PEI+ ++ + + AD W+ G +LY+M T QPPF   N   L  +I+    + LP  +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKR 362
            SE  + +     +T  L  D   R
Sbjct: 238 YSEDVTDV-----ITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  142 bits (361), Expect = 2e-39
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 41/296 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           ++    +G+G +G V++ +     D  +  I A+K ++      ++      A R+I  L
Sbjct: 1   YQKLGKIGEGTYGVVYKAR-----DKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            ++ HP I++L   F+ +  LYL+ +F++         RQ    E   + Y  +++  ++
Sbjct: 53  KELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILL- 287
             H  GI+HRDLKPEN+L++++G + L DFGLA+      R       T  Y APE+LL 
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANR-------------------QKLQQRIIN 328
            KG++   D WSVG +  E+L+ +P F   +                     K      N
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232

Query: 329 EKVKLPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
            K   P         L      + +  L+Q+LH DP KR+       +    H +F
Sbjct: 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI-----TAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  140 bits (354), Expect = 1e-38
 Identities = 82/256 (32%), Positives = 136/256 (53%), Gaps = 18/256 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   RV+G+GAFG+    ++      + D +   K +    + +K   D +  E  IL+ 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRT-----EDDSLVVWKEVNLTRLSEKERRDALN-EIVILSL 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
           + HP I+     F   + L + +++ NGG L+  + RQ   +F E+   +Y  +IVSAVS
Sbjct: 56  LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLS 288
           ++HK GI+HRD+K  NI +   G + L DFG++K +  E S + ++ GT  YM+PE+   
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII--NEKVKLPPFLTSEAHSLLK 346
             +N  +D W++G +LYE+LT +  F   N   L  +I+  N    +  + +SE  SL  
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY-SSELISL-- 232

Query: 347 GVSFLTQLLHKDPSKR 362
               +  LL +DP KR
Sbjct: 233 ----VHSLLQQDPEKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  139 bits (352), Expect = 2e-38
 Identities = 80/259 (30%), Positives = 141/259 (54%), Gaps = 22/259 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
           DFEI   +G+G+FG VF+V +K   D     +YAMK   + + +   ++  +D    E  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRK--ADKR---VYAMKQIDLSKMNRREREEAID----EAR 51

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQA-RFYTAEI 224
           +L K+   +I++   SF  + KL +++++   G  H    + R     EDQ  RF+  +I
Sbjct: 52  VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QI 110

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAP 283
           +  ++HLH   I+HRD+K  N+ +D+  +V + D G+AK + +++  +N++ GT  Y++P
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E+   K +N+ +D W++G++LYE  TG+ PF   N+  L  +II  +   PP     +  
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII--RGVFPPVSQMYSQQ 228

Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      + Q L KD  +R
Sbjct: 229 L---AQLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  139 bits (352), Expect = 3e-38
 Identities = 79/265 (29%), Positives = 129/265 (48%), Gaps = 29/265 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAER 166
            D E    +G G  G V +V  +      +  I A+K +R    + I K+     +  E 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEINEAIQKQ-----ILREL 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
           DIL K   P+IV    +F     + + +++++GG L       +  I  E         +
Sbjct: 51  DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRI-PERILGKIAVAV 109

Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMA 282
           +  +++LH K  I+HRD+KP NIL++S G + L DFG++ + ++  S + +  GT+ YMA
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN--SLAKTFVGTSSYMA 167

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----KLQQRIINEKVKLPPFL 337
           PE +    ++  +D WS+G+ L E+ TG+ P+   N       +L Q I+NE    PP L
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRL 224

Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKR 362
            S   S      F+   L KDP +R
Sbjct: 225 PSGKFS-PDFQDFVNLCLIKDPRER 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  138 bits (351), Expect = 3e-38
 Identities = 69/267 (25%), Positives = 136/267 (50%), Gaps = 19/267 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F+I   +G+G++G V++   K     ++  + A+KV+  +  +++     +  E  IL 
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHK-----ETGQVVAIKVVPVEEDLQE-----IIKEISILK 53

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVS 229
           +   P+IV+   S+   + L++++++   G +   +        E++      + +  + 
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLS 288
           +LH    +HRD+K  NIL++ +G   L DFG++ ++ D  ++ N++ GT  +MAPE++  
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            G+N  AD WS+GI   EM  G+PP++  +  +    I N   K PP L+       +  
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPTLSDPEKWSPEFN 230

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKH 375
            F+ + L KDP +R    P  +  ++H
Sbjct: 231 DFVKKCLVKDPEER----PSAIQLLQH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  138 bits (349), Expect = 3e-38
 Identities = 76/237 (32%), Positives = 122/237 (51%), Gaps = 14/237 (5%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHL 202
           M    + T I K      +  R+ LT + H  P +V L     +   ++L+L    GG L
Sbjct: 13  MDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           + H+ +     E+  + + AE+V A+  LH+ GIV RDL P NIL+D  GH+ LT F   
Sbjct: 73  WSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRW 132

Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
            E+++S    ++     Y APE+       +  DWWS+G +L+E+LTG+      +   +
Sbjct: 133 SEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLTGK-TLVECHPSGI 189

Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
                +  + +P +++ EA SL      L QLL  +P++RLG+G  GV+ IK H +F
Sbjct: 190 NT---HTTLNIPEWVSEEARSL------LQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  138 bits (349), Expect = 5e-38
 Identities = 78/248 (31%), Positives = 135/248 (54%), Gaps = 14/248 (5%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGK   VK K  +DG    I  + + +    +     +  + E  +L+ + HP I
Sbjct: 8   IGEGSFGKAILVKSK--EDGKQYVIKEINISK----MSPKEREESRKEVAVLSNMKHPNI 61

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GI-FREDQARFYTAEIVSAVSHLHKCG 235
           VQ + SF+    LY+++D+  GG L+  +  Q G+ F EDQ   +  +I  A+ H+H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC-GTTEYMAPEILLSKGHNKD 294
           I+HRD+K +NI +  DG + L DFG+A+ ++ +      C GT  Y++PEI  ++ +N  
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181

Query: 295 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           +D W++G +LYEM T +  F   N + L  +II  +   PP  +  ++ L    + ++QL
Sbjct: 182 SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII--RGSYPPVSSHYSYDLR---NLVSQL 236

Query: 355 LHKDPSKR 362
             ++P  R
Sbjct: 237 FKRNPRDR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 2e-37
 Identities = 79/274 (28%), Positives = 131/274 (47%), Gaps = 19/274 (6%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P ++   +++GQGAFG+V+      VD G    +  +         K   V+ ++ E  +
Sbjct: 1   PTNWRRGKLLGQGAFGRVYLCYD--VDTGRELAVKQVPFDPDSPETK-KEVNALECEIQL 57

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L  + H  IVQ     +    L + ++++ GG +   L   G   E   R YT +I+  V
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID----ESSRSNSMCGTTEYMAPE 284
            +LH   IVHRD+K  NIL DS G+V L DFG +K +       +   S+ GT  +M+PE
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII--NEKVKLPPFLTSEAH 342
           ++  +G+ + AD WSVG  + EMLT +PP+          +I       +LP  ++ +A 
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA- 236

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH 376
                 +FL +   ++  KR    P   + ++H 
Sbjct: 237 -----RNFLRRTFVENAKKR----PSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 8e-37
 Identities = 79/286 (27%), Positives = 128/286 (44%), Gaps = 45/286 (15%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E+  VVG+GA+G V + + K    G+   I   K    D  +KK       A R++  L
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNK--ATGEIVAIKKFKESEDDEDVKK------TALREVKVL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVS 226
            ++ H  IV L+ +F+ + +LYL+ +++        L      G+   D  R Y  +++ 
Sbjct: 55  RQLRHENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGL-PPDAVRSYIWQLLQ 111

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--SMCGTTEYMAPE 284
           A+++ H   I+HRD+KPENIL+   G + L DFG A+ +     S       T  Y APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 285 ILLSKG-HNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII------------- 327
           +L+    + K  D W++G ++ E+L G+P F   +  ++  L Q+ +             
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231

Query: 328 ---NEKVKLPPFLTSE--AHSLLKGVS-----FLTQLLHKDPSKRL 363
                 V  P     E         VS     FL   L  DP +RL
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  134 bits (339), Expect = 2e-36
 Identities = 72/259 (27%), Positives = 133/259 (51%), Gaps = 18/259 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           DF++ + +G+G++G V++VK+       SD   YA+K +   ++ +K   D +   R IL
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKR------LSDNQFYALKEVDLGSMSQKEREDAVNEIR-IL 53

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             V HP I+  + +F   +KL +++++   G L   + ++     +  E +      +++
Sbjct: 54  ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
             +  LH+  I+HRDLK  NIL+ ++  V + D G++K + + + + +  GT  YMAPE+
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAKTQIGTPHYMAPEV 172

Query: 286 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL 345
              + ++  +D WS+G LLYEM T  PPF   + Q L+ ++   + K PP     +  L 
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--RGKYPPIPPIYSQDLQ 230

Query: 346 KGVSFLTQLLHKDPSKRLG 364
             +     +L   P  R  
Sbjct: 231 NFIRS---MLQVKPKLRPN 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  134 bits (338), Expect = 3e-36
 Identities = 81/277 (29%), Positives = 148/277 (53%), Gaps = 24/277 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++   ++G+GA+G V+  + K V  G    + A+K++  DT    + V  ++ E  +L++
Sbjct: 3   YQRLELIGRGAYGAVY--RGKHVPTGR---VVALKIINLDT--PDDDVSDIQREVALLSQ 55

Query: 172 VTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           +     P I +   S+    +L++I+++  GG +   L + G   E        E++ A+
Sbjct: 56  LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVAL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAPEILL 287
            ++HK G++HRD+K  NIL+ + G+V L DFG+A  ++++S   S   GT  +MAPE++ 
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174

Query: 288 S-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-LL 345
             K ++  AD WS+GI +YEM TG PP++  +  +    I   K   PP L    +S LL
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSKLL 231

Query: 346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
           +   F+   L ++P +RL +     + +   KW ++ 
Sbjct: 232 R--EFVAACLDEEPKERLSA-----EELLKSKWIKAH 261

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  133 bits (335), Expect = 5e-36
 Identities = 79/256 (30%), Positives = 134/256 (52%), Gaps = 17/256 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI + +G+G+FGK++  K K     DS+     ++      +K+      K E  +L K
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKS----DSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAK 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
           + HP IV    SFQ   +L++++++ +GG L   + RQ   +F EDQ   +  +I   + 
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMC-GTTEYMAPEILL 287
           H+H   I+HRD+K +NI +  +G V  L DFG+A+++++S      C GT  Y++PEI  
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLK 346
           ++ +N   D WS+G +LYE+ T + PF   N  +L  +I       + P  + +  SL  
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL-- 233

Query: 347 GVSFLTQLLHKDPSKR 362
               ++QL    P  R
Sbjct: 234 ----ISQLFKVSPRDR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 1e-35
 Identities = 73/314 (23%), Positives = 139/314 (44%), Gaps = 73/314 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
           +E    +G+G +G+V++ + K   +     + A+K +R +             E++    
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGE-----LVALKKIRMEN------------EKEGFPI 43

Query: 168 -------ILTKVTHPFIVQLR--YSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFRE 214
                  +L K+ HP IV+L+   + + +  +Y++ +++     G         +  F E
Sbjct: 44  TAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTE 99

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---S 271
            Q + Y  +++  + +LH  GI+HRD+K  NIL+++DG + L DFGLA+   + +    +
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-- 328
           N +  T  Y  PE+LL +  +  + D WSVG +L E+  G+P F  +   +  ++I    
Sbjct: 160 NRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218

Query: 329 --------EKVKLPPF-----LTSEAHSLLK----------GVSFLTQLLHKDPSKRLGS 365
                     V   P+             L+           +  L +LL  DP KR+ +
Sbjct: 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278

Query: 366 GPGGVDAIKHHKWF 379
                 A+  H++F
Sbjct: 279 D----QAL-QHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 1e-35
 Identities = 84/312 (26%), Positives = 140/312 (44%), Gaps = 74/312 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           +E    +G+G +G V++ + K      +  I A+K +R D        T ++        
Sbjct: 1   YEKLEKLGEGTYGVVYKARDK-----KTGEIVALKKIRLDNEEEGIPSTALR-------- 47

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQAR 218
            E  +L ++ HP IV+L     T  KLYL+ ++ +       L      R G    +  +
Sbjct: 48  -EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIK 101

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
               +++  +++ H   I+HRDLKP+NIL++ DG + L DFGLA+             T 
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF----GIPLRTYTH 157

Query: 279 E-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RI---- 326
           E     Y APEILL SK ++   D WSVG +  EM+TG+P F      ++ Q  +I    
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF--PGDSEIDQLFKIFQIL 215

Query: 327 --------------INEKVKLPPFLTSEAHSLLK-----GVSFLTQLLHKDPSKRLGSGP 367
                          + K   P F   +   +L      G+  L+++L  +P+KR+ +  
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK- 274

Query: 368 GGVDAIKHHKWF 379
              +A+K H +F
Sbjct: 275 ---EALK-HPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 2e-35
 Identities = 74/260 (28%), Positives = 133/260 (51%), Gaps = 20/260 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ + +G G +G V++ +     D  +  + A+KV++ +     +  + ++ E  +L 
Sbjct: 4   DYELIQRIGSGTYGDVYKAR-----DIATGELVAIKVIKLE---PGDDFEIIQQEISMLK 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
           +  HP IV    S+  R KL++++++  GG L   + + R G   E Q  +   E +  +
Sbjct: 56  ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILL 287
           ++LH+ G +HRD+K  NIL+  DG V L DFG++ ++  + ++  S  GT  +MAPE+  
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 288 SK---GHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFLTSEAH 342
            +   G++   D W++GI   E+   QPP    H  R      +I++    PP L  +  
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LISKSNFPPPKLKDKEK 231

Query: 343 SLLKGVSFLTQLLHKDPSKR 362
                  F+ + L KDP KR
Sbjct: 232 WSPVFHDFIKKCLTKDPKKR 251

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  129 bits (326), Expect = 1e-34
 Identities = 80/257 (31%), Positives = 136/257 (52%), Gaps = 19/257 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
            + + RVVG+G+FG+   V+       +SD  YAMK +R   + K +  V+  + E  +L
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHV-----NSDQKYAMKEIR---LPKSSSAVEDSRKEAVLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARFYTAEIVSA 227
            K+ HP IV  + SF+    LY+++++ +GG L     L R  +F ED    +  ++   
Sbjct: 53  AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           V H+H+  ++HRD+K +NI +  +G V L DFG A+ +    + + +  GT  Y+ PEI 
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLL 345
            +  +N  +D WS+G +LYE+ T + PF   + + L  ++     K LP   + E  SL+
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLI 232

Query: 346 KGVSFLTQLLHKDPSKR 362
           K      Q+  ++P  R
Sbjct: 233 K------QMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  127 bits (322), Expect = 5e-34
 Identities = 76/272 (27%), Positives = 123/272 (45%), Gaps = 38/272 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDIL 169
           D+E+  V+G GA   V+                A+ +   + + IK+  ++  +   D L
Sbjct: 2   DYELIEVIGVGATAVVYA---------------AICLPNNEKVAIKRIDLEKCQTSVDEL 46

Query: 170 TK-------VTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARF 219
            K         HP +V+   SF    +L+L++ +++GG    +    Y +G   E     
Sbjct: 47  RKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT 106

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG----LAKEIDESSRS-NSM 274
              E++  + +LH  G +HRD+K  NIL+  DG V + DFG    LA   D + +   + 
Sbjct: 107 VLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166

Query: 275 CGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
            GT  +MAPE++    G++  AD WS GI   E+ TG  P++     K+    +      
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---ND 223

Query: 334 PPFLTSEAHSLLKGVSF---LTQLLHKDPSKR 362
           PP L + A       SF   ++  L KDPSKR
Sbjct: 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKR 255

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  127 bits (320), Expect = 1e-33
 Identities = 89/282 (31%), Positives = 144/282 (51%), Gaps = 27/282 (9%)

Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            R + P + +EI   +G GAFGKV++ K K     ++  + A KV+  +T  ++   DYM
Sbjct: 5   RRDLDPNEVWEIIGELGDGAFGKVYKAKNK-----ETGALAAAKVI--ETKSEEELEDYM 57

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARF 219
             E +IL    HP+IV+L  +F    KL+++++F  GG    +   L R     E Q + 
Sbjct: 58  -VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQV 114

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTT 278
              +++ A+ +LH   I+HRDLK  N+L+  DG + L DFG+ AK +    R +S  GT 
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174

Query: 279 EYMAPEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
            +MAPE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I   +   
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--- 231

Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           PP L+  +   ++   FL   L K P  R    P     ++H
Sbjct: 232 PPTLSQPSKWSMEFRDFLKTALDKHPETR----PSAAQLLEH 269

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 3e-33
 Identities = 79/298 (26%), Positives = 136/298 (45%), Gaps = 52/298 (17%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +++ + +G G FG V+  + K     ++  + A+K M+K      +  + M   R++  L
Sbjct: 1   YKVIKQLGDGTFGSVYLARNK-----ETGELVAIKKMKKKF---YSWEECMN-LREVKSL 51

Query: 170 TKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIV 225
            K+  HP IV+L+  F+   +LY + +++ G    + L +      F E   R    +I+
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
             ++H+HK G  HRDLKPEN+L+     V + DFGLA+EI           T  Y APEI
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 286 LL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANR----------------------QKL 322
           LL S  ++   D W++G ++ E+ T +P F  ++                        KL
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229

Query: 323 QQRIINEKVKLPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
             ++     + P F  +  H L+     + +  +  +L  DP KR    P    A++H
Sbjct: 230 ASKL---GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKR----PTASQALQH 280

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  126 bits (317), Expect = 4e-33
 Identities = 86/275 (31%), Positives = 138/275 (50%), Gaps = 23/275 (8%)

Query: 109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           P D  EI   +G GAFGKV++ + K     ++    A K++      ++   D+M  E D
Sbjct: 3   PNDIWEIIGELGDGAFGKVYKAQHK-----ETGLFAAAKII--QIESEEELEDFM-VEID 54

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVS 226
           IL++  HP IV L  ++   +KL+++++F +GG L    L  +    E Q R+   +++ 
Sbjct: 55  ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYMAPEI 285
           A++ LH   ++HRDLK  NIL+  DG V L DFG+ AK      + ++  GT  +MAPE+
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174

Query: 286 LL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           +         ++  AD WS+GI L E+   +PP    N  ++  +I+  +   PP L   
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQP 231

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           +        FL   L KDP  R    P   + +KH
Sbjct: 232 SKWSSSFNDFLKSCLVKDPDDR----PTAAELLKH 262

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  124 bits (313), Expect = 7e-33
 Identities = 78/262 (29%), Positives = 138/262 (52%), Gaps = 30/262 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM-KAER---- 166
           +E  RVVG+GAFG V   ++K   D            +K  IIK+  V+ M K ER    
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRK--AD------------QKLVIIKQIPVEQMTKDERLAAQ 47

Query: 167 ---DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
               +L  ++HP I++   +F     L +++++  GG L  ++ ++   +  ED    + 
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEY 280
            +I+ A+ H+H   I+HRDLK +NIL+D    V+ + DFG++K +   S++ ++ GT  Y
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCY 167

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           ++PE+   K +N+ +D W++G +LYE+ + +  F  AN   L  +I++      P     
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG--TFAPISDRY 225

Query: 341 AHSLLKGVSFLTQLLHKDPSKR 362
           +  L +    +  +L+ DPSKR
Sbjct: 226 SPDLRQ---LILSMLNLDPSKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 2e-32
 Identities = 78/274 (28%), Positives = 137/274 (50%), Gaps = 35/274 (12%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            G FE+  V+G+G +GKV++ + K      +  + A+K+M     I ++  + +K E +I
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHK-----KTGQLVAIKIMD----IIEDEEEEIKEEYNI 55

Query: 169 LTKVT-HPFIVQLRYSFQTRS------KLYLILDFINGG---HLFFHLYRQG-IFREDQA 217
           L K + HP I     +F  ++      +L+L+++   GG    L   L ++G   +E+  
Sbjct: 56  LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCG 276
            +   E +  +++LH+  ++HRD+K +NIL+  +  V L DFG++ ++D    R N+  G
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175

Query: 277 TTEYMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPFT--HANRQKLQQRIIN 328
           T  +MAPE++       DA      D WS+GI   E+  G+PP    H  R   +  I  
Sbjct: 176 TPYWMAPEVIACD-EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK--IPR 232

Query: 329 EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
                PP L S  +   K   F+++ L K+  +R
Sbjct: 233 NP---PPTLKSPENWSKKFNDFISECLIKNYEQR 263

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  121 bits (306), Expect = 1e-31
 Identities = 84/273 (30%), Positives = 125/273 (45%), Gaps = 55/273 (20%)

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN------HV-DYMKAERDILTKVT 173
           G FGKV  +K K             K+  +  I  KN       V   MK          
Sbjct: 27  GKFGKVSVLKHKPTQ----------KLFVQKIIKAKNFNAIEPMVHQLMK---------D 67

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P  ++L YS  T     LI+D+I  G LF  L ++G   E + +    ++V A++ LHK
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 234 CGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
             I+H D+K EN+L D +   + L D+GL K I   S      GT +Y +PE +  KGHN
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKI--KGHN 182

Query: 293 KDA--DWWSVGILLYEMLTGQPPF--------THANRQKLQQRIINEKVKLPPFLTSEAH 342
            D   DWW+VG+L YE+LTG+ PF           +  K QQ+    K+     ++  A+
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKNVSKNAN 238

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
                  F+  +L  + + RL +     + IKH
Sbjct: 239 ------DFVQSMLKYNINYRLTN---YNEIIKH 262

Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  120 bits (302), Expect = 5e-31
 Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 21/259 (8%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
               + F  +G+G+ G V     K      +    A+K M    + K+   + +  E  I
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDK-----STGRQVAVKKM---DLRKQQRRELLFNEVVI 69

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           +    HP IV++  S+    +L+++++F+ GG L   +       E+Q       ++ A+
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCLAVLKAL 128

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILL 287
           S LH  G++HRD+K ++IL+ SDG V L+DFG   ++  E  R  S+ GT  +MAPE++ 
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ--QRIINEKVKLPPFL--TSEAHS 343
              +  + D WS+GI++ EM+ G+PP+   N   LQ  +RI +     PP L    +   
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYF--NEPPLQAMKRIRDNL---PPKLKNLHKVSP 243

Query: 344 LLKGVSFLTQLLHKDPSKR 362
            L+  SFL ++L +DP++R
Sbjct: 244 RLR--SFLDRMLVRDPAQR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  119 bits (301), Expect = 6e-31
 Identities = 70/257 (27%), Positives = 136/257 (52%), Gaps = 15/257 (5%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR----KDTIIKKNHVDYMKAERDILTKV 172
           ++G+G +G+V+      V  G+   +  +++      +    +K+ V  +++E + L  +
Sbjct: 8   LIGKGTYGRVYLALN--VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            H  IVQ      T   L + L+++ GG +   L   G F E   RF+T +++  +++LH
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE---SSRSNSMCGTTEYMAPEILLS- 288
             GI+HRDLK +N+L+D+DG   ++DFG++K+ D+   + ++ SM G+  +MAPE++ S 
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 289 -KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK- 346
            +G++   D WS+G ++ EM  G+ P++         ++ N++   PP +  +    L  
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-SAPP-IPPDVSMNLSP 243

Query: 347 -GVSFLTQLLHKDPSKR 362
             + FL      +P  R
Sbjct: 244 VALDFLNACFTINPDNR 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  118 bits (299), Expect = 1e-30
 Identities = 86/310 (27%), Positives = 137/310 (44%), Gaps = 66/310 (21%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
            ++I   +G+GA G VF+ K +      +    A+K   + R +  I    +  +KA   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRLEGGIPNQALREIKA--- 52

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQARFYTA 222
            L    HP++V+L   F   S   L+++++        L       +    E Q + Y  
Sbjct: 53  -LQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMR 106

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS-MCGTTEY 280
            ++  V+++H  GI+HRDLKP N+L+ +DG + + DFGLA+    E  R  S    T  Y
Sbjct: 107 MLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166

Query: 281 MAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV-- 331
            APE+L  ++ ++   D W+VG +  E+L G P F   N  +    +       NE+   
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226

Query: 332 ---KLP-------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGG 369
               LP                   P  + EA  LLKG      LL  DPSKRL +    
Sbjct: 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKG------LLVYDPSKRLSAA--- 277

Query: 370 VDAIKHHKWF 379
            +A++ H +F
Sbjct: 278 -EALR-HPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  118 bits (297), Expect = 2e-30
 Identities = 88/266 (33%), Positives = 136/266 (51%), Gaps = 23/266 (8%)

Query: 107 IGPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           + P +F EI   +G GAFGKV++ + K     ++  + A KV+  DT  ++   DYM  E
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQNK-----ETGVLAAAKVI--DTKSEEELEDYM-VE 52

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQGIFREDQARFYTA 222
            DIL    HP IV+L  +F   + L+++++F  GG +      L R     E Q R    
Sbjct: 53  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCK 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH+  I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170

Query: 282 APEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           APE+++      + ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPT 227

Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKR 362
           L   +    +   FL + L K+   R
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDAR 253

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  118 bits (296), Expect = 3e-30
 Identities = 81/260 (31%), Positives = 138/260 (53%), Gaps = 20/260 (7%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FG+VF    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++   P++
Sbjct: 12  IGKGSFGEVF----KGIDN-RTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
            +   S+   +KL++I++++ GG     L R G F E Q      EI+  + +LH    +
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAPE++    ++  AD
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PPFLTSEAHSLLKGVSFLTQLL 355
            WS+GI   E+  G+PP    N      R++    K  PP LT E     K   F+   L
Sbjct: 184 IWSLGITAIELAKGEPP----NSDMHPMRVLFLIPKNNPPTLTGEFSKPFK--EFIDACL 237

Query: 356 HKDPSKRLGSGPGGVDAIKH 375
           +KDPS R    P   + +KH
Sbjct: 238 NKDPSFR----PTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  117 bits (294), Expect = 4e-30
 Identities = 80/279 (28%), Positives = 139/279 (49%), Gaps = 41/279 (14%)

Query: 117 VVGQGAFGKVF-----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++G G+FG V+            VK+  +    +          KD   K++ +D +  E
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASS--------KDR--KRSMLDALARE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L ++ H  IVQ   S      L + L+++ GG +   L   G F E   R +  +I+
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN-------SMCGTT 278
             +++LH  GI+HRD+K  NIL+D+ G + ++DFG++K+++ +S S        S+ G+ 
Sbjct: 117 KGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LPPF 336
            +MAPE++    + + AD WS+G L+ EMLTG+ PF    + +   + I E     +P  
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-IGENASPEIPSN 235

Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           ++SEA      + FL +    D +KR    P   + +KH
Sbjct: 236 ISSEA------IDFLEKTFEIDHNKR----PTAAELLKH 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  116 bits (291), Expect = 1e-29
 Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 37/276 (13%)

Query: 117 VVGQGAFGKVF----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           V+G+GA+G V+           VK+  +D  +     A K   K           ++ E 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA--AEKEYEK-----------LQEEV 53

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
           D+L  + H  IVQ   +    + + + ++F+ GG +   L R G   E     YT +I+ 
Sbjct: 54  DLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD 113

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-------DESSRSNSMCGTTE 279
            V++LH   +VHRD+K  N+++  +G + L DFG A+ +         S+   SM GT  
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           +MAPE++   G+ + +D WS+G  ++EM TG+PP    +R      I   +  +P    S
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS 233

Query: 340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
            + +    + F+T  L +D  +R    P  +  ++H
Sbjct: 234 FSAA---AIDFVTSCLTRDQHER----PSALQLLRH 262

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  115 bits (291), Expect = 1e-29
 Identities = 78/263 (29%), Positives = 140/263 (53%), Gaps = 20/263 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK-DTIIKKNHVDYMKAERDI 168
           G+F+I + +G+G F  V++             + A+K ++  + +  K   D +K E D+
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICL-----LDGRVVALKKVQIFEMMDAKARQDCLK-EIDL 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQG-IFREDQARFYTAEI 224
           L ++ HP +++   SF   ++L ++L+  + G    +  H  +Q  +  E     Y  ++
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
            SA+ H+H   I+HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+P
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFLTSEA 341
           E +   G+N  +D WS+G LLYEM   Q PF     N   L ++I  EK   PP L ++ 
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EKCDYPP-LPADH 232

Query: 342 HSL-LKGVSFLTQLLHKDPSKRL 363
           +S  L+ +  +++ ++ DP KR 
Sbjct: 233 YSEELRDL--VSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  114 bits (287), Expect = 5e-29
 Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 33/262 (12%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+GAFG+V++   KG  +G  +   A+K +++    ++   ++++ E  I+ K++HP
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGT-ETKVAVKTLKEGAS-EEEREEFLE-EASIMKKLSHP 61

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKC 234
            IV+L         LY++ +++ GG L   L + G             +I   + +L   
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE---YMAPEILLSKGH 291
             VHRDL   N L+  +  V ++DFGL+++I E        G      +MAPE L     
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 292 NKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL----------PPFLTSE 340
              +D WS G+LL+E+ T G+ P+           + NE+V            P     E
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPY---------PGMSNEEVLELLEDGYRLPRPENCPDE 232

Query: 341 AHSLLKGVSFLTQLLHKDPSKR 362
            + L+       Q    DP  R
Sbjct: 233 LYELML------QCWAYDPEDR 248

Length = 258

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  115 bits (291), Expect = 5e-29
 Identities = 70/223 (31%), Positives = 113/223 (50%), Gaps = 36/223 (16%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK------NHVDYMKAE 165
           +EI + +G+GA+G V+    K +D          +  ++   +KK      N  D  +  
Sbjct: 9   YEILQKLGKGAYGIVW----KAID----------RRTKEVVALKKIFDAFRNATDAQRTF 54

Query: 166 RDI--LTKVT-HPFIVQLR--YSFQTRSKLYLILDFINGGHLFFH-LYRQGIFREDQARF 219
           R+I  L ++  HP IV+L      +    +YL+ +++       H + R  I  +   R+
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD---LHAVIRANILEDVHKRY 111

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +++ A+ ++H   ++HRDLKP NIL++SD  V L DFGLA+ + E   +      T+
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 280 YMA------PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFT 315
           Y+A      PEILL S  + K  D WSVG +L EML G+P F 
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  114 bits (286), Expect = 5e-29
 Identities = 79/257 (30%), Positives = 128/257 (49%), Gaps = 17/257 (6%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAER 166
           P ++ + +++GQGAFG+V+        D D+    A+K ++   ++      V+ ++ E 
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCY-----DADTGRELAVKQVQFDPESPETSKEVNALECEI 55

Query: 167 DILTKVTHPFIVQLRYSF---QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            +L  + H  IVQ  Y          L + ++ + GG +   L   G   E+  R YT +
Sbjct: 56  QLLKNLLHERIVQY-YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ 114

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN----SMCGTTE 279
           I+  VS+LH   IVHRD+K  NIL DS G+V L DFG +K +     S     S+ GT  
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--KLPPFL 337
           +M+PE++  +G+ + AD WSVG  + EMLT +PP+          +I  +     LPP +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHV 234

Query: 338 TSEAHSLLKGVSFLTQL 354
           +      LK +    +L
Sbjct: 235 SDHCRDFLKRIFVEAKL 251

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 6e-29
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 21/214 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+GAFG+V++ K KG D   ++   A+K +++D   ++   D++K E  ++ K+ HP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEV--AVKTLKEDASEEE-RKDFLK-EARVMKKLGHP 56

Query: 176 FIVQLR-YSFQTRSKLYLILDFINGGHL----------FFHLYRQGIFREDQARFYTAEI 224
            +V+L          LYL+L+++ GG L          F    +  +  +D   F   +I
Sbjct: 57  NVVRLLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQI 114

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE---YM 281
              + +L     VHRDL   N L+  D  V ++DFGL++++ +        G      +M
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           APE L        +D WS G+LL+E+ T G  P+
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  114 bits (286), Expect = 7e-29
 Identities = 82/287 (28%), Positives = 144/287 (50%), Gaps = 19/287 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F     +G+G+FG+VF    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++
Sbjct: 6   FTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQ 58

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P++ +   S+   +KL++I++++ GG     L   G   E Q      EI+  + +L
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYL 117

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKG 290
           H    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAPE++    
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L       LK   F
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLK--EF 232

Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
           +   L+K+PS R    P   + +KH    R    KT    E+  ++K
Sbjct: 233 VEACLNKEPSFR----PTAKELLKHKFIVRFAK-KTSYLTELIDRYK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (284), Expect = 1e-28
 Identities = 62/256 (24%), Positives = 113/256 (44%), Gaps = 21/256 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           + +G+GAFG+V+    KG   G  DG     A+K +++D   +   ++    E  I+ K+
Sbjct: 5   KKLGEGAFGEVY----KGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSH 230
            HP IV+L         L ++++++ GG L  +    R           +  +I   + +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--TTEYMAPEILLS 288
           L     +HRDL   N L+  +  V ++DFGL++++ +        G     +MAPE L  
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 289 KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTSEA-HSLLK 346
                 +D WS G+LL+E+ T G+ P+   +  ++ + +        P       + L+ 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLML 238

Query: 347 GVSFLTQLLHKDPSKR 362
                 Q   +DP  R
Sbjct: 239 ------QCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 2e-28
 Identities = 78/250 (31%), Positives = 127/250 (50%), Gaps = 15/250 (6%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAER 166
           P ++ + +++G+GAFG+V+        D D+    A+K +  D   ++    V+ ++ E 
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCY-----DADTGRELAVKQVPFDPDSQETSKEVNALECEI 55

Query: 167 DILTKVTHPFIVQLRYSFQ--TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
            +L  + H  IVQ     +     KL + ++++ GG +   L   G   E+  R YT +I
Sbjct: 56  QLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI 115

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----NSMCGTTEY 280
           +  VS+LH   IVHRD+K  NIL DS G+V L DFG +K I     S     S+ GT  +
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LPPFLT 338
           M+PE++  +G+ + AD WSV   + EMLT +PP+          +I  +  K  LP  ++
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235

Query: 339 SEAHSLLKGV 348
                 LK +
Sbjct: 236 DACRDFLKQI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  112 bits (281), Expect = 4e-28
 Identities = 68/205 (33%), Positives = 108/205 (52%), Gaps = 8/205 (3%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE+  VVG+GA+G V + + K     ++  I A+K   KD+   +   +    E  +L  
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHK-----ETKEIVAIKKF-KDSEENEEVKETTLRELKMLRT 56

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           +    IV+L+ +F+ R KLYL+ +++    L            ++ R Y  +++ A+   
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--SMCGTTEYMAPEILLSK 289
           HK  IVHRD+KPEN+L+  +  + L DFG A+ + E S +N      T  Y +PE+LL  
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 290 GHNKDADWWSVGILLYEMLTGQPPF 314
            + K  D WSVG +L E+  GQP F
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  112 bits (280), Expect = 7e-28
 Identities = 79/274 (28%), Positives = 140/274 (51%), Gaps = 25/274 (9%)

Query: 98  ELEAESERKIGPGD----FEIFRVVGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKD 151
           +  A  +  + PGD     + F  +G+G+ G V    VK  G           +  ++K 
Sbjct: 4   QFRAALQMVVDPGDPRTYLDNFIKIGEGSTGIVCIATVKSSG----------KLVAVKKM 53

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
            + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   +     
Sbjct: 54  DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIVTHTR 112

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
             E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  E  R
Sbjct: 113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
             S+ GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I   +
Sbjct: 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R 229

Query: 331 VKLPPFLTS--EAHSLLKGVSFLTQLLHKDPSKR 362
             LPP L +  +    LKG  FL +LL +DP++R
Sbjct: 230 DNLPPKLKNLHKVSPSLKG--FLDRLLVRDPAQR 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  110 bits (275), Expect = 2e-27
 Identities = 73/259 (28%), Positives = 134/259 (51%), Gaps = 18/259 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FG+V+    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++   P+I
Sbjct: 12  IGKGSFGEVY----KGIDN-RTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
            +   S+   +KL++I++++ GG     L + G   E        EI+  + +LH    +
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKI 123

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDAD 296
           HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAPE++    ++  AD
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLH 356
            WS+GI   E+  G+PP +  +  ++   I       PP L  +     K   F+   L+
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFK--EFVEACLN 238

Query: 357 KDPSKRLGSGPGGVDAIKH 375
           KDP  R    P   + +KH
Sbjct: 239 KDPRFR----PTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  113 bits (285), Expect = 3e-27
 Identities = 93/296 (31%), Positives = 142/296 (47%), Gaps = 51/296 (17%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
           D     E  +K     + I RV+G GA G V   K+  V DG+    +A+KV+  + +  
Sbjct: 23  DEATAKEQAKK-----YWISRVLGSGATGTVLCAKR--VSDGEP---FAVKVVDMEGM-- 70

Query: 156 KNHVDYMKA--ERDILTKVTHPFIVQLRYSFQTR--------SKLYLILDFINGGHLFFH 205
            +  D  +A  E   L       IV+    F  +          + L+LD+ N G L   
Sbjct: 71  -SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL--- 126

Query: 206 LYRQGI---------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
             RQ I         FRE +A     +++ AV H+H   ++HRD+K  NIL+ S+G V L
Sbjct: 127 --RQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 257 TDFGLAKEI-----DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
            DFG +K       D+  R+   CGT  Y+APEI   K ++K AD +S+G+LLYE+LT +
Sbjct: 185 GDFGFSKMYAATVSDDVGRT--FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242

Query: 312 PPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSG 366
            PF   N +++  + +  +   LPP ++ E   +      +T LL  DP +R  S 
Sbjct: 243 RPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEI------VTALLSSDPKRRPSSS 292

Length = 496

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  109 bits (274), Expect = 5e-27
 Identities = 76/264 (28%), Positives = 141/264 (53%), Gaps = 23/264 (8%)

Query: 107 IGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           + PGD     + F  +G+G+ G V    +K      +    A+K M    + K+   + +
Sbjct: 15  VSPGDPREYLDSFIKIGEGSTGIVCIATEK-----HTGKQVAVKKM---DLRKQQRRELL 66

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E  I+    H  +V +  S+    +L+++++F+ GG L   +       E+Q      
Sbjct: 67  FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCL 125

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYM 281
            ++ A+S+LH  G++HRD+K ++IL+ SDG + L+DFG   ++  E  +  S+ GT  +M
Sbjct: 126 SVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE++    +  + D WS+GI++ EM+ G+PP+ +    +  +RI   +  LPP +  ++
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNLPPRV-KDS 241

Query: 342 H---SLLKGVSFLTQLLHKDPSKR 362
           H   S+L+G  FL  +L ++PS+R
Sbjct: 242 HKVSSVLRG--FLDLMLVREPSQR 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  108 bits (273), Expect = 5e-27
 Identities = 61/255 (23%), Positives = 115/255 (45%), Gaps = 20/255 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           + +G+GAFG+V+    KG   G         A+K +++D   +   ++    E  I+ K+
Sbjct: 5   KKLGEGAFGEVY----KGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHL 231
            HP +V+L         LY++++++ GG L  +L   +          +  +I   + +L
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLSK 289
                +HRDL   N L+  +  V ++DFGL++++ +    R         +MAPE L   
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 290 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTSEA-HSLLKG 347
                +D WS G+LL+E+ T G+ P+   + +++ + + N      P       + L+  
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLML- 237

Query: 348 VSFLTQLLHKDPSKR 362
                Q   +DP  R
Sbjct: 238 -----QCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  109 bits (273), Expect = 6e-27
 Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      V  G    I  M +    +K+ II  N +  M+  +     
Sbjct: 24  FEKIGQGASGTVYTAID--VATGQEVAIKQMNLQQQPKKELII--NEILVMRENK----- 74

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             HP IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 75  --HPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKG 290
           H   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  108 bits (270), Expect = 7e-27
 Identities = 75/253 (29%), Positives = 135/253 (53%), Gaps = 19/253 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--ILTKVT 173
           RVVG+G++G+V  V+ +      +DG     V++K  +   +  +   AE++  +L+++ 
Sbjct: 6   RVVGKGSYGEVSLVRHR------TDG--KQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57

Query: 174 HPFIVQLRYSFQTRS-KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSH 230
           HP IV  R S++     LY+++ F  GG L+  L  Q   +  E+Q   +  +I  A+ +
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSK 289
           LH+  I+HRDLK +N+ +     + + D G+A+ ++ +   ++++ GT  YM+PE+  +K
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS 349
            +N  +D W++G  +YEM T +  F   +   L  RII  + KLPP     +  L     
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII--EGKLPPMPKDYSPEL---GE 232

Query: 350 FLTQLLHKDPSKR 362
            +  +L K P KR
Sbjct: 233 LIATMLSKRPEKR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  109 bits (276), Expect = 7e-27
 Identities = 79/329 (24%), Positives = 137/329 (41%), Gaps = 62/329 (18%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E+ + +G GA+G V         D  +    A+K +     +  + +D  +  R+I  L
Sbjct: 2   YELLKPIGSGAYGVVCSAV-----DKRTGRKVAIKKISN---VFDDLIDAKRILREIKLL 53

Query: 170 TKVTHPFIVQLRYSFQTRSK-----LYLILDFINGGHLFFH--LYRQGIFREDQARFYTA 222
             + H  I+ L    +  S      +Y++ + +       H  +       +D  +++  
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM---ETDLHKVIKSPQPLTDDHIQYFLY 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM- 281
           +I+  + +LH   ++HRDLKP NIL++S+  + + DFGLA+ +D           TEY+ 
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF--LTEYVV 168

Query: 282 -----APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQ----------- 323
                APE+LLS   + K  D WSVG +  E+LT +P F       +L            
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228

Query: 324 ---QRIINEKVK-----LPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKRLGSGPGGV 370
              + I +EK +     LP         L  G S      L ++L  DP KR+ +     
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD---- 284

Query: 371 DAIKHHKWFRSINWKTLEAREMQPKFKPD 399
           +A+  H +   ++       E   K   D
Sbjct: 285 EALA-HPYLAQLH---DPEDEPVAKPPFD 309

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  108 bits (271), Expect = 8e-27
 Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 21/270 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G GAF   +Q +   V  G    +  +  +R  +  ++  V+ ++ E  ++ ++ HP
Sbjct: 6   QQLGTGAFSSCYQARD--VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I+++  +    S   L ++++ GG +   L + G F+E     YT +++  +S+LH+  
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123

Query: 236 IVHRDLKPENILMDSDGH-VMLTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSK 289
           I+HRD+K  N+L+DS G  + + DFG A  +             + GT  +MAPE+L  +
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183

Query: 290 GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
            + +  D WSVG ++ EM T +PP+    H+N   L  +I +      P +      L  
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT--APSIPE---HLSP 238

Query: 347 GV-SFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           G+     + L   P  R    P   + +KH
Sbjct: 239 GLRDVTLRCLELQPEDR----PPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  107 bits (267), Expect = 2e-26
 Identities = 76/258 (29%), Positives = 127/258 (49%), Gaps = 17/258 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+ + +G G +G V+  K + V+ G+   + A+KV++ +          ++ E  ++ 
Sbjct: 10  DFELIQRIGSGTYGDVY--KARNVNTGE---LAAIKVIKLE---PGEDFAVVQQEIIMMK 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
              H  IV    S+  R KL++ ++F  GG L    +  G   E Q  + + E +  + +
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILLSK 289
           LH  G +HRD+K  NIL+  +GHV L DFG++ +I  + ++  S  GT  +MAPE+   +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 290 ---GHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFLTSEAHSL 344
              G+N+  D W+VGI   E+   QPP    H  R      ++ +    PP L  +    
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQPPKLKDKMKWS 238

Query: 345 LKGVSFLTQLLHKDPSKR 362
                F+   L K+P KR
Sbjct: 239 NSFHHFVKMALTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  107 bits (267), Expect = 2e-26
 Identities = 75/260 (28%), Positives = 133/260 (51%), Gaps = 16/260 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +F I + +G+G F +V+  +   + DG    +  +++   D +  K   D +K E D+L
Sbjct: 2   ANFRIEKKIGRGQFSEVY--RATCLLDGVPVALKKVQIF--DLMDAKARADCIK-EIDLL 56

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIV 225
            ++ HP +++   SF   ++L ++L+  + G L     H  +Q  +  E     Y  ++ 
Sbjct: 57  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPE 284
           SA+ H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFLTSEAH 342
            +   G+N  +D WS+G LLYEM   Q PF     N   L ++I  E+   PP  +    
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSDHYS 234

Query: 343 SLLKGVSFLTQLLHKDPSKR 362
             L+    +   ++ DP KR
Sbjct: 235 EELR--QLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  106 bits (266), Expect = 3e-26
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 13/207 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           +++GQGAFG+V+        D D+    A K ++   ++      V  ++ E  +L  + 
Sbjct: 8   KLLGQGAFGRVYLCY-----DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 174 HPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           H  IVQ     + R++  L + ++++ GG +   L   G   E   R YT +I+  +S+L
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN----SMCGTTEYMAPEILL 287
           H   IVHRD+K  NIL DS G+V L DFG +K +     S     S+ GT  +M+PE++ 
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF 314
            +G+ + AD WS+G  + EMLT +PP+
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  106 bits (266), Expect = 4e-26
 Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 16/259 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+I + +G+G F +V+    +     D   +   KV   + +  K   D +K E D+L 
Sbjct: 3   NFQIEKKIGRGQFSEVY----RATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLK 57

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIVS 226
           ++ HP +++   SF   ++L ++L+  + G L     +  +Q  +  E     Y  ++ S
Sbjct: 58  QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEI 285
           AV H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+PE 
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 286 LLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFLTSEAHS 343
           +   G+N  +D WS+G LLYEM   Q PF     N   L Q+I  E+   PP  T   H 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI--EQCDYPPLPTE--HY 233

Query: 344 LLKGVSFLTQLLHKDPSKR 362
             K    ++  ++ DP +R
Sbjct: 234 SEKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 4e-26
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +E    +G+GA+G V++ +          KK       +GI  +  +R+  ++K+     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI-PLSTLREIALLKQ----- 54

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRS-----KLYLILDFINGG-HLFFHLYRQGIFRED 215
                  L    HP IV+L             KL L+ + ++     +     +     +
Sbjct: 55  -------LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE 107

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
             +    +++  V  LH   IVHRDLKP+NIL+ SDG V + DFGLA+         S+ 
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV 167

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
            T  Y APE+LL   +    D WSVG +  E+   +P F
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  107 bits (267), Expect = 5e-26
 Identities = 71/262 (27%), Positives = 136/262 (51%), Gaps = 19/262 (7%)

Query: 107 IGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +  GD     E +  +G+G+ G V   ++K      S    A+K+M    + K+   + +
Sbjct: 14  VDQGDPRSLLENYIKIGEGSTGIVCIAREK-----HSGRQVAVKMM---DLRKQQRRELL 65

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E  I+    H  +V++  S+    +L+++++F+ GG L   +  Q    E+Q      
Sbjct: 66  FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQTRLNEEQIATVCE 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYM 281
            ++ A+ +LH  G++HRD+K ++IL+  DG V L+DFG   +I +   +  S+ GT  +M
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 184

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE++    +  + D WS+GI++ EM+ G+PP+   +  +  +R+ +     PP     A
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PPPKLKNA 240

Query: 342 HSLLKGV-SFLTQLLHKDPSKR 362
           H +   +  FL ++L ++P +R
Sbjct: 241 HKISPVLRDFLERMLTREPQER 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  106 bits (266), Expect = 5e-26
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      V  G    I  M +    +K+ II  N +  M+  ++    
Sbjct: 25  FEKIGQGASGTVYTAMD--VATGQEVAIRQMNLQQQPKKELII--NEILVMRENKN---- 76

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 77  ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKG 290
           H   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  105 bits (263), Expect = 7e-26
 Identities = 71/265 (26%), Positives = 131/265 (49%), Gaps = 24/265 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHP 175
           +G+G+FG V+ VK K     +      +KV+++  +  +  N       E  +L+K+ HP
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEER-----LKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQG--IFREDQARFYTAEIVSAVSHL 231
            IV+   SF  R    +I ++  G  L   L   +       E+Q   +  +++  V ++
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILLSKG 290
           H+  I+HRDLK +NI + ++  + + DFG+++ +  S   + +  GT  YM+PE L  +G
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGVS 349
           ++  +D WS+G +LYEM      F   N   +  RI+      LP   + + +S+++   
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ--- 238

Query: 350 FLTQLLHKDPSKRLGSGPGGVDAIK 374
               +L+KDPS R    P   + ++
Sbjct: 239 ---SMLNKDPSLR----PSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  105 bits (264), Expect = 9e-26
 Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 16/208 (7%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      +  G    I  M +    +K+ II  N +  M+  ++    
Sbjct: 24  FEKIGQGASGTVYTAID--IATGQEVAIKQMNLQQQPKKELII--NEILVMRENKN---- 75

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 76  ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALDFL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKG 290
           H   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 42/291 (14%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-- 164
           +   D E    +G G  G V +VK           I    VM K  +    H+    +  
Sbjct: 2   LRNEDLETISDLGAGNGGSVSKVKH----------IPTGTVMAKKVV----HIGAKSSVR 47

Query: 165 -----ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
                E  I+ +   P+IV    +F   + + + ++F++ G L     + G    +    
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK 107

Query: 220 YTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
               +V  +++L+    I+HRD+KP NIL++S G + L DFG++ E+  +S +++  GT+
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFVGTS 166

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK-----------LQQRII 327
            YM+PE +    +   +D WS+GI + E+  G+ PF  +N              L Q+I+
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226

Query: 328 NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
            E    PP L S          F+   L KDP++R    P          +
Sbjct: 227 QEP---PPRLPSSDFPEDL-RDFVDACLLKDPTER----PTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  103 bits (257), Expect = 8e-25
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 12/206 (5%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDS-DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           +  +GQGA G VF           +   I   K  +K+ II  N +  MK       ++ 
Sbjct: 24  YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII--NEILVMK-------ELK 74

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P IV    SF    +L+++++++ GG L   +  +    E Q      E + A+  LH 
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLT-DVVTETCMDEAQIAAVCRECLQALEFLHA 133

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHN 292
             ++HRD+K +N+L+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K + 
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 293 KDADWWSVGILLYEMLTGQPPFTHAN 318
              D WS+GI+  EM+ G+PP+ + N
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  103 bits (257), Expect = 8e-25
 Identities = 68/221 (30%), Positives = 115/221 (52%), Gaps = 26/221 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  VVG G +G+V+  K + V  G    + A+KVM     + ++  + +K E ++L
Sbjct: 16  GIFELVEVVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTEDEEEEIKLEINML 66

Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  +S      +L+L+++F   G +       +    +ED   + 
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  ++HLH   ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186

Query: 280 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPF 314
           +MAPE++     N DA      D WS+GI   EM  G PP 
Sbjct: 187 WMAPEVIACD-ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  102 bits (255), Expect = 2e-24
 Identities = 80/299 (26%), Positives = 134/299 (44%), Gaps = 46/299 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ER 166
                   +G+GA G V + + K      +  I+A+K     TI    + D  K    E 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALK-----TITTDPNPDLQKQILREL 50

Query: 167 DILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
           +I      P+IV+   +F  ++ S + + +++  GG L   +Y++   ++   R    E 
Sbjct: 51  EINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKK--VKKRGGR--IGEK 105

Query: 224 --------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
                   ++  +S+LH   I+HRD+KP NIL+   G V L DFG++ E+  S    +  
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG-TFT 164

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----KLQQRIINEK 330
           GT+ YMAPE +  K ++  +D WS+G+ L E+   + PF           +L   I+N  
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224

Query: 331 VKLPPFLTSEAHSLLKGV----SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 385
               P L  E  + +K       F+ Q L KDP++R    P   D ++H      +  K
Sbjct: 225 ---NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR----PTPWDMLEHPWIKAQMKKK 276

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  104 bits (260), Expect = 3e-24
 Identities = 81/261 (31%), Positives = 127/261 (48%), Gaps = 35/261 (13%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +VG+      F V  +G D    + + A  VM  D    +    Y ++E   L    H  
Sbjct: 74  LVGRNPTTAAF-VATRGSDP--KEKVVAKFVMLND----ERQAAYARSELHCLAACDHFG 126

Query: 177 IVQLRYSFQTRSKLYLILDFINGG------------HLFFHLYRQGIFREDQARFYTAEI 224
           IV+    F++  KL LI+++ +GG            HL F  Y  G+       FY  +I
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL------FY--QI 178

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYM 281
           V A+  +H   ++HRDLK  NI +   G + L DFG +K+  +S     ++S CGT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE+   K ++K AD WS+G++LYE+LT   PF   +++++ Q+++  K    P   S  
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSG 298

Query: 342 HSLLKGVSFLTQLLHKDPSKR 362
              L     L  LL K+P+ R
Sbjct: 299 MKAL-----LDPLLSKNPALR 314

Length = 478

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  101 bits (254), Expect = 4e-24
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E  + +G+G +  V++ +     D ++  I A+K ++     +        A R+I  L
Sbjct: 2   YEKGKKLGEGTYAVVYKAR-----DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLL 56

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS--- 226
            ++ HP I+ L   F  +S + L+ +F+    L      + + ++       A+I S   
Sbjct: 57  QELKHPNIIGLLDVFGHKSNINLVFEFM-ETDL------EKVIKDKSIVLTPADIKSYML 109

Query: 227 ----AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
                + +LH   I+HRDLKP N+L+ SDG + L DFGLA+     + +      T  Y 
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 282 APEILL-SKGHNKDADWWSVGILLYEMLTGQP 312
           APE+L  ++ +    D WSVG +  E+L   P
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  101 bits (252), Expect = 4e-24
 Identities = 73/266 (27%), Positives = 132/266 (49%), Gaps = 28/266 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + E+   +G+G +G V++V  +      +    AMK +R +  + ++  + +  E DIL 
Sbjct: 2   EIEVLDELGKGNYGSVYKVLHR-----PTGVTMAMKEIRLE--LDESKFNQIIMELDILH 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
           K   P+IV    +F     +Y+ +++++ G    L+          ED  R  T  +V  
Sbjct: 55  KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114

Query: 228 VSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
           +  L  +  I+HRD+KP N+L++ +G V L DFG++  +  +S + +  G   YMAPE +
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERI 173

Query: 287 LSKGHNK------DADWWSVGILLYEMLTGQ---PPFTHAN-RQKLQQRIINEKVKLPPF 336
            S G N+       +D WS+G+ + EM  G+   PP T+AN   +L   +  +   LP  
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233

Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKR 362
            + +A        F+ + L+K P++R
Sbjct: 234 YSDDAQ------DFVAKCLNKIPNRR 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  101 bits (252), Expect = 5e-24
 Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 32/278 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F+    +G+G +G V++ + K      +  + A+K +R DT  +      ++ E  +L +
Sbjct: 2   FQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           + HP IV+L     T +KLYL+ +F++     F              + Y  +++  ++ 
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILL-S 288
            H   ++HRDLKP+N+L++++G + L DFGLA+      R+ +    T  Y APEILL  
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV-----KLPPFL 337
           K ++   D WS+G +  EM+T +  F   +      RI       +E V      LP + 
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235

Query: 338 TS----EAHSLLK--------GVSFLTQLLHKDPSKRL 363
            S          K        G   L+Q+LH DP+KR+
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI 273

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  105 bits (263), Expect = 5e-24
 Identities = 67/237 (28%), Positives = 116/237 (48%), Gaps = 18/237 (7%)

Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-SKLYLILDFINGGHL 202
           A+K++R D   +++     + E  +  ++ HP IV L  S +     L+ + +++ G  L
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDF 259
              L   G     +      +++ A++  H  GIVHRDLKP+NI++   G   H  + DF
Sbjct: 67  REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126

Query: 260 GL------AKEIDES--SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           G+       ++ D +  +R+  + GT  Y APE L  +    ++D ++ G++  E LTGQ
Sbjct: 127 GIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

Query: 312 PPFTHANRQK-LQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP 367
                A+  + L Q++    V LPP++    H L      L + L+KDP +R  S P
Sbjct: 187 RVVQGASVAEILYQQLSPVDVSLPPWI--AGHPL---GQVLRKALNKDPRQRAASAP 238

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  100 bits (251), Expect = 8e-24
 Identities = 81/268 (30%), Positives = 130/268 (48%), Gaps = 23/268 (8%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
                 D E    +G G  G+V++++ K      +  + A+K MR+    ++N    M  
Sbjct: 10  YPADLNDLENLGEIGSGTCGQVYKMRFK-----KTGHVMAVKQMRRTGNKEENKRILM-- 62

Query: 165 ERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFY 220
           + D++ K +H  P+IV+    F T S +++ ++ +        L +  QG   ED     
Sbjct: 63  DLDVVLK-SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKM 119

Query: 221 TAEIVSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           T  IV A+ +L  K G++HRD+KP NIL+D+ G+V L DFG++  + +S       G   
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 280 YMAPEILLSKGHNKD----ADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP 334
           YMAPE +     N      AD WS+GI L E+ TGQ P+ +   + ++  +I+ E+   P
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE---P 236

Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P L           SF+   L KD  KR
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKR 264

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 75/298 (25%), Positives = 137/298 (45%), Gaps = 57/298 (19%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  V++ + +   +     I A+K +  D       T I+         E  ++ 
Sbjct: 8   LGEGTYATVYKGRNRTTGE-----IVALKEIHLDAEEGTPSTAIR---------EISLMK 53

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ H  IV+L     T +KL L+ ++++     ++  H  R G    +  + +T +++  
Sbjct: 54  ELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVR-GALDPNTVKSFTYQLLKG 112

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE--IDESSRSNSMCGTTEYMAPEI 285
           ++  H+  ++HRDLKP+N+L++  G + L DFGLA+   I  ++ SN +  T  Y AP++
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171

Query: 286 LL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN---------------- 328
           LL S+ ++   D WSVG ++ EM+TG+P F   N +    +I                  
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231

Query: 329 --EKVKLPPFLTSEAHSLLK-----GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
              K   P +   +   L       G+  L +LL  +P  R+       DA+  H WF
Sbjct: 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI----SAHDAL-QHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  100 bits (251), Expect = 2e-23
 Identities = 77/293 (26%), Positives = 126/293 (43%), Gaps = 54/293 (18%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRK--DTIIKKNHVDYMKAE 165
           P  ++    VG GA+G+V              G   A+K + +   + I   H      E
Sbjct: 14  PDRYQNLSPVGSGAYGQVCSAFDTKT------GRKVAIKKLSRPFQSAI---HAKRTYRE 64

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQGIFREDQARF 219
             +L  + H  ++ L   F   S L      YL+   +  G    ++ +     +D  +F
Sbjct: 65  LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQF 122

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--- 276
              +I+  + ++H  GI+HRDLKP NI ++ D  + + DFGLA+  D+      M G   
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-----EMTGYVA 177

Query: 277 TTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---------------THANRQ 320
           T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F                    +
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 321 KLQQRIINEKVK-----LPPFLTSEAHSLLKG-----VSFLTQLLHKDPSKRL 363
           +L Q+I +E  +     LP     +   +  G     +  L ++L  DP KR+
Sbjct: 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI 290

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 86/301 (28%), Positives = 130/301 (43%), Gaps = 50/301 (16%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI 168
           +E   +VG+G++G V + K K     ++  I A+K       D ++KK       A R+I
Sbjct: 3   YENLGLVGEGSYGMVMKCKHK-----ETGQIVAIKKFLESEDDKMVKK------IAMREI 51

Query: 169 --LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIV 225
             L ++ H  +V L   F+ + +LYL+ +F++   L     Y  G+  E + R Y  +I+
Sbjct: 52  RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQIL 110

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPE 284
             +   H   I+HRD+KPENIL+   G V L DFG A+ +            T  Y APE
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170

Query: 285 ILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-----------NEKVK 332
           +L+    + +  D W+VG L+ EMLTG+P F   +       II               K
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230

Query: 333 LPPFL------TSEAHSLLK--------GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
            P F         E   L K         +    Q L  DP  R  S       + HH++
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS-----QLLHHEF 285

Query: 379 F 379
           F
Sbjct: 286 F 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 73/267 (27%), Positives = 129/267 (48%), Gaps = 17/267 (6%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +  R+    D+E+ + VG G +G V++ +   +  G+   +  +K+   D          
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARN--LHTGELAAVKIIKLEPGDDF------SL 52

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E  ++ +  H  IV    S+ +R KL++ +++  GG L    +  G   E Q  +  
Sbjct: 53  IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEY 280
            E +  +++LH  G +HRD+K  NIL+  +G V L DFG+A +I  + ++  S  GT  +
Sbjct: 113 RETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172

Query: 281 MAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPP 335
           MAPE+   +   G+N+  D W+VGI   E+   QPP    H  R      ++++    PP
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQPP 229

Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            L  +        +F+   L K+P KR
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 63/301 (20%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDY- 161
           +GP  ++    +G+GA+G V                  +KV      IKK     H  + 
Sbjct: 3   VGP-RYQNLSYIGEGAYGMVCSAT---------HKPTGVKVA-----IKKISPFEHQTFC 47

Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
            +  R+I  L +  H  I+ +       SF++ + +Y++ + +      + L +      
Sbjct: 48  QRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKTQHLSN 105

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
           D  +++  +I+  + ++H   ++HRDLKP N+L++++  + + DFGLA+  D        
Sbjct: 106 DHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 275 CGTTEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQ-- 323
              TEY+      APEI+L SKG+ K  D WSVG +L EML+ +P F       Q     
Sbjct: 166 --LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL 223

Query: 324 -----------QRIINEKVK-----LP-----PFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
                        II+ + +     LP     P+     ++  K +  L ++L  +P KR
Sbjct: 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283

Query: 363 L 363
           +
Sbjct: 284 I 284

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 97.3 bits (242), Expect = 7e-23
 Identities = 70/229 (30%), Positives = 120/229 (52%), Gaps = 18/229 (7%)

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I A+KV+  D  ++      + +E +IL K   P+I+    +F   +++ +  +F++GG 
Sbjct: 28  ILAVKVIPLDITVELQK--QIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L   +YR+ I      R   A +V  +++L    I+HRD+KP N+L+++ G V L DFG+
Sbjct: 86  L--DVYRK-IPEHVLGRIAVA-VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGV 141

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-----TH 316
           + ++  +S + +  GT  YMAPE +  + +   +D WS+GI   E+  G+ P+       
Sbjct: 142 STQL-VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200

Query: 317 ANRQKLQ--QRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            +   LQ  Q I++E    PP L     S  K V F+TQ + K P +R 
Sbjct: 201 GSLMPLQLLQCIVDED---PPVLPVGQFS-EKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 35/213 (16%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMKAERDIL 169
           +G+G +G V++ + K   +     I A+K +R +        T I+         E  +L
Sbjct: 7   IGEGTYGVVYKARDKLTGE-----IVALKKIRLETEDEGVPSTAIR---------EISLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSA 227
            ++ HP IV+L     + +KLYL+ +F++             G+      + Y  +++  
Sbjct: 53  KELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQG 111

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMA 282
           +++ H   ++HRDLKP+N+L+D +G + L DFGLA+      R+     T E     Y A
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY----THEVVTLWYRA 167

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           PEILL S+ ++   D WS+G +  EM+  +P F
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 66/221 (29%), Positives = 115/221 (52%), Gaps = 26/221 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +G+V+  K + V  G    + A+KVM     +  +  + +K E ++L
Sbjct: 6   GIFELVELVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTGDEEEEIKQEINML 56

Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  ++      +L+L+++F   G +       +    +E+   + 
Sbjct: 57  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  +SHLH+  ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176

Query: 280 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPF 314
           +MAPE++     N DA      D WS+GI   EM  G PP 
Sbjct: 177 WMAPEVIACD-ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 61/285 (21%)

Query: 119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVT-HP 175
           G+G F +V   K +    G     YA+K M+K        ++ +   R+I  L +++ HP
Sbjct: 8   GEGTFSEVL--KAQSRKTGKY---YAIKCMKK----HFKSLEQVNNLREIQALRRLSPHP 58

Query: 176 FIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGI----------FREDQARFYTAEI 224
            I++L         + ++ D   G   L F L    +            E + + Y  ++
Sbjct: 59  NILRL---------IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL 109

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           + ++ H+H+ GI HRD+KPENIL+  D  + L DFG  + I           T  Y APE
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168

Query: 285 ILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHAN--------------------RQKLQ 323
            LL+ G +    D W+VG + +E+L+  P F   N                    ++  +
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228

Query: 324 QRIINEKVKLPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRL 363
            R +N     P    +    LL     +G+  L +LL  DP +R+
Sbjct: 229 SRHMN--YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI 271

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 66/308 (21%), Positives = 123/308 (39%), Gaps = 64/308 (20%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK---DTIIKKNHVDYMKAERDI 168
           ++    +G GA+G V       +D      +   K+       T+ K+        E  I
Sbjct: 7   YKPIENIGSGAYGVVC----SAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-----RELKI 57

Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           L    H  I+ +R   +         Y+++D +    L   ++      E+  R++  ++
Sbjct: 58  LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-----CGTTE 279
           +  + ++H   ++HRDLKP N+L++ D  + + DFG+A+ +  S   +         T  
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 280 YMAPEILLS-KGHNKDADWWSVGILLYEML---------------------TGQPPFTHA 317
           Y APE+LLS   +    D WSVG +  EML                      G P     
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS---- 232

Query: 318 NRQKLQQRIINEKVK-----LPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGP 367
             +++  RI +++V+     LP         +      + +  L+Q+L  DP +R+    
Sbjct: 233 --EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV-- 288

Query: 368 GGVDAIKH 375
               A++H
Sbjct: 289 --EQALQH 294

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 82/299 (27%), Positives = 136/299 (45%), Gaps = 65/299 (21%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           F+I   +G+G +G+V++ +     D D+  + A+K +R D        T I+        
Sbjct: 9   FDIIGQIGEGTYGQVYKAR-----DKDTGELVALKKVRLDNEKEGFPITAIR-------- 55

Query: 164 AERDILTKVTHPFIVQLR---------YSFQTRSK-LYLILDFINGGHLFFHLYRQGI-- 211
            E  IL ++ H  IV L+           F+      YL+ ++++  H    L   G+  
Sbjct: 56  -EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--HDLMGLLESGLVH 112

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESS 269
           F ED  + +  +++  +++ HK   +HRD+K  NIL+++ G + L DFGLA+    +ES 
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
              +   T  Y  PE+LL +     A D WS G +L E+ T +P F  AN++  Q  +I+
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF-QANQELAQLELIS 231

Query: 329 ------------EKVKLPPFLT-----------SEAHSLL--KGVSFLTQLLHKDPSKR 362
                       + +KLP F T            E  S +    +  L  +L  DPSKR
Sbjct: 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 82/288 (28%), Positives = 129/288 (44%), Gaps = 39/288 (13%)

Query: 48  NQSPASTSASLGDPQVIHNRSH-----SFVGPSPRYALSSSLPLQIQELEHENDAELEAE 102
            Q P              +R       +   P    +L+  LPL        + +   A 
Sbjct: 4   IQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSAS 63

Query: 103 SERKIGPGDF-EIFRV--VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
                      E+ RV  +G GA G V++V  +      +  +YA+KV      I  NH 
Sbjct: 64  GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKV------IYGNHE 112

Query: 160 DYMK----AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           D ++     E +IL  V HP +V+    F    ++ ++L+F++GG L         F  D
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD 172

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG----LAKEIDESSRS 271
            AR    +I+S +++LH+  IVHRD+KP N+L++S  +V + DFG    LA+ +D     
Sbjct: 173 VAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---C 225

Query: 272 NSMCGTTEYMAPEIL---LSKGHNKD--ADWWSVGILLYEMLTGQPPF 314
           NS  GT  YM+PE +   L+ G       D WS+G+ + E   G+ PF
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 65/311 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
           +FE    +G+G +G V++ +     D  S  I A+K +R            M  ERD   
Sbjct: 8   EFEKLNRIGEGTYGIVYRAR-----DTTSGEIVALKKVR------------MDNERDGIP 50

Query: 168 --------ILTKVTHPFIVQLRYSFQTRS--KLYLILDFING--GHLFFHLYRQGIFRED 215
                   +L  + HP IV+L+     +    ++L++++       L  ++     F E 
Sbjct: 51  ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSES 108

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
           Q +    +++  + +LH+  I+HRDLK  N+L+   G + + DFGLA+     ++  +  
Sbjct: 109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168

Query: 276 GTT-EYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------ 327
             T  Y APE+LL    +    D W+VG +L E+L  +P     +  +    II      
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228

Query: 328 NEKV-----KLPPF----LTSEAHSLLK---------GVSFLTQLLHKDPSKRLGSGPGG 369
           NE +      LP      L  + ++ LK         G+  L  LL  DP KR  +    
Sbjct: 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE--- 285

Query: 370 VDAIKHHKWFR 380
            +A++   +F+
Sbjct: 286 -EALE-SSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 85/330 (25%), Positives = 144/330 (43%), Gaps = 77/330 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDI- 168
           +EI   +G+G +G+V++ K+K   +G     YA+K  + D    K         A R+I 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRK---NGKDGKEYAIKKFKGD----KEQYTGISQSACREIA 54

Query: 169 -LTKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHL---YRQGIFREDQARFY-- 220
            L ++ H  +V L   F   +   +YL+ D+    H  + +   +RQ             
Sbjct: 55  LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----VMLTDFGLAKEIDESSRS---- 271
              +I++ V +LH   ++HRDLKP NIL+  +G     V + D GLA+  +   +     
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ------- 323
           + +  T  Y APE+LL ++ + K  D W++G +  E+LT +P F      K++       
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF-KGREAKIKKSNPFQR 231

Query: 324 ---QRIIN------EK-----VKLP---------PFLTSEAHSLLK-----------GVS 349
              +RI        EK      K+P            T  ++SL K           G  
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291

Query: 350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
            L +LL  DP+KR+ +     +A++ H +F
Sbjct: 292 LLRKLLEYDPTKRITAE----EALE-HPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 83/272 (30%), Positives = 130/272 (47%), Gaps = 34/272 (12%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +EI   +G+G +GKV++V  K   DG    + A+K++  D I   +  + ++AE +IL
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNK--KDGS---LAAVKIL--DPI--SDVDEEIEAEYNIL 72

Query: 170 TKVT-HPFIVQLRYSFQTRSK-----LYLILDFINGG---HLFFHLYRQGIFREDQAR-- 218
             +  HP +V+    F    K     L+L+L+  NGG    L   L   G  R D+A   
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMIS 131

Query: 219 --FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNSMC 275
              Y A +   + HLH   I+HRD+K  NIL+ ++G V L DFG++ ++  +  R N+  
Sbjct: 132 YILYGALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 276 GTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           GT  +MAPE++  +      ++   D WS+GI   E+  G PP    +  K   +I    
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249

Query: 331 VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
              PP L            F++Q L KD   R
Sbjct: 250 ---PPTLLHPEKWCRSFNHFISQCLIKDFEAR 278

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 38/272 (13%)

Query: 116 RVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
             +G GAFG+V++     +   G      A+K +RK    ++   +++K E  +++   H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNH 58

Query: 175 PFIV-QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA----------- 222
           P IV  L          Y+I++ + GG L  +L    +      RF              
Sbjct: 59  PNIVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARV-----ERFGPPLLTLKELLDIC 112

Query: 223 -EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKEI---DESSRSNS 273
            ++     +L +   +HRDL   N L+   G+     V + DFGLA++I   D   +   
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KV 331
                 +MAPE LL       +D WS G+L++E+LT GQ P+   N Q++ Q +    ++
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232

Query: 332 KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
           + P     + + L      +T    +DPS+R 
Sbjct: 233 QKPENCPDKIYQL------MTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.1 bits (221), Expect = 4e-20
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 32/221 (14%)

Query: 107 IGPGDFEIFRVVGQGAFGKV--------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
           I P +    + +G G FG V         +V  K +++G          M ++  I+   
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG---------AMSEEDFIE--- 48

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
                 E  ++ K++HP +VQL Y   T+ K LY++ +F+  G L  +L  RQG   +D 
Sbjct: 49  ------EAKVMMKLSHPKLVQL-YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM 101

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSM 274
                 ++   + +L +   +HRDL   N L+ S G V ++DFG+ + +  DE + S+  
Sbjct: 102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161

Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
               ++  PE+     ++  +D WS G+L++E+ T G+ PF
Sbjct: 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 89.7 bits (222), Expect = 4e-20
 Identities = 79/287 (27%), Positives = 135/287 (47%), Gaps = 39/287 (13%)

Query: 109 PGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           P D +EI   +G+G +GKVF+V  K   +G      A+K++     I +     ++AE +
Sbjct: 16  PSDTWEIIETIGKGTYGKVFKVLNK--KNGSKA---AVKILDPIHDIDEE----IEAEYN 66

Query: 168 ILTKVT-HPFIVQL-----RYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQA 217
           IL  ++ HP +V+      +   +   +L+L+L+  NGG +       L R     E   
Sbjct: 67  ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNSMCG 276
            +   E +  + HLH    +HRD+K  NIL+ ++G V L DFG++ ++  +  R N+  G
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186

Query: 277 TTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-- 329
           T  +MAPE++     L   ++   D WS+GI   E+  G PP    +  +   +I     
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246

Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
             +  P   ++E +       F+ + L KD  KR    P   D ++H
Sbjct: 247 PTLHQPELWSNEFN------DFIRKCLTKDYEKR----PTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 90.1 bits (223), Expect = 7e-20
 Identities = 65/215 (30%), Positives = 113/215 (52%), Gaps = 9/215 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G VF+V  K      S  I A K++  +  IK    + +  E  +L 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  ++  +++
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 118

Query: 231 L-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+PE L   
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT 177

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
            ++  +D WS+G+ L EM  G+ P    + ++L+ 
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 62/267 (23%), Positives = 128/267 (47%), Gaps = 33/267 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G  D       A+K++++ ++ +   ++    E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSEDEFIE----EA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
            ++ K++H  +VQL      +  +Y++ ++++ G L  +L      RE   RF  ++++ 
Sbjct: 51  KVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL------REHGKRFQPSQLLE 104

Query: 227 -------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-- 277
                   +++L     +HRDL   N L+D  G V ++DFGL++ + +   ++S+ G+  
Sbjct: 105 MCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKF 163

Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
              +  PE+LL    +  +D W+ G+L++E+ + G+ P+   N  +  +++        P
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP 223

Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            L SE     K  + +    H+   +R
Sbjct: 224 HLASE-----KVYAIMYSCWHEKAEER 245

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 28/217 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-----AMKVMRKDTIIKKNHVDY 161
           I   + ++   +G+G FG V              G Y     A+K ++ D+         
Sbjct: 3   INSKELKLGATIGKGEFGDVML------------GDYRGQKVAVKCLKDDS----TAAQA 46

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY---RQGIFREDQAR 218
             AE  ++T + HP +VQL       + LY++ +++  G L  +L    R  I    Q  
Sbjct: 47  FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG 106

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           F   ++   + +L +   VHRDL   N+L+  D    ++DFGLAKE  +   S  +    
Sbjct: 107 F-ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--PV 163

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           ++ APE L  K  +  +D WS GILL+E+ + G+ P+
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 79/312 (25%), Positives = 135/312 (43%), Gaps = 71/312 (22%)

Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +E    +G+G +GKV++ +          KK   + D +GI         T ++      
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGI-------PPTALR------ 49

Query: 162 MKAERDILTKVTH-PFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFR- 213
              E  +L  ++   +IV+L        K     LYL+ ++++     F     +G  R 
Sbjct: 50  ---EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP 106

Query: 214 --EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAK--EIDES 268
                 + +  +++  V+H HK G++HRDLKP+N+L+D    ++ + D GL +   I   
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQ--- 324
           S ++ +  T  Y APE+LL   H     D WSVG +  EM   QP F      +LQQ   
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF--PGDSELQQLLH 223

Query: 325 --RII---NEKV--------------KLPPFLTSEAHSLL--KGVSFLTQLLHKDPSKRL 363
             +++    E+V              +  P   S A   L  +G+  L ++L  DP+KR+
Sbjct: 224 IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI 283

Query: 364 GSGPGGVDAIKH 375
            +      A+ H
Sbjct: 284 SA----KAALTH 291

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 8/166 (4%)

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGL 261
           + +   + +  E+         V A+++L +   I+HRD+KP NIL+D +G++ L DFG+
Sbjct: 95  YVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           + ++ +S       G   YMAPE +      G++  +D WS+GI LYE+ TG+ P+   N
Sbjct: 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214

Query: 319 R--QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
               +L Q +  +   L    + E       V+F+   L KD SKR
Sbjct: 215 SVFDQLTQVVKGDPPILSN--SEEREFSPSFVNFINLCLIKDESKR 258

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 79/313 (25%), Positives = 131/313 (41%), Gaps = 60/313 (19%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-----------ER 166
           +G+G +GKV +       D  +  I A+K ++   I      D               E 
Sbjct: 17  LGEGTYGKVEKAY-----DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
            I+ ++ H  I+ L   +     + L++D +    L   + R+    E Q +    +I++
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILN 130

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE------IDESSRSNSMCGTTE- 279
            ++ LHK   +HRDL P NI ++S G   + DFGLA+        D  S+  +M    E 
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 280 --------YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-- 328
                   Y APE+L+ ++ ++   D WSVG +  E+LTG+P F   N      RI    
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250

Query: 329 ---------EKVKLP---PFLTSEAHSL---LKGVS-----FLTQLLHKDPSKRLGSGPG 368
                    +  KLP    F   +   L       S      L  LL  +P +R+ +   
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK-- 308

Query: 369 GVDAIKHHKWFRS 381
             +A+K H++F+S
Sbjct: 309 --EALK-HEYFKS 318

Length = 335

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 70/263 (26%), Positives = 128/263 (48%), Gaps = 23/263 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E+   +G+GA+G V +++        +  I A+K +R     ++     M  + DI  
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHV-----PTGTIMAVKRIRATVNSQEQKRLLM--DLDISM 54

Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIF-REDQARFYTAEIVS 226
           +    P+ V    +      +++ ++ ++      +  +Y +G+   ED        IV 
Sbjct: 55  RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114

Query: 227 AVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE- 284
           A+ +LH K  ++HRD+KP N+L++ +G V L DFG++  + +S       G   YMAPE 
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER 174

Query: 285 ---ILLSKGHNKDADWWSVGILLYEMLTGQPPFT--HANRQKLQQRIINEKVKLPPFLTS 339
               L  KG++  +D WS+GI + E+ TG+ P+       Q+L+Q ++ E     P L +
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-VVEEP---SPQLPA 230

Query: 340 EAHSLLKGVSFLTQLLHKDPSKR 362
           E  S  +   F+ + L K+  +R
Sbjct: 231 EKFS-PEFQDFVNKCLKKNYKER 252

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 80/306 (26%), Positives = 141/306 (46%), Gaps = 55/306 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++E    + +G +G V++ + K      +  I A+K ++ +   +   +  ++ E +IL 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDK-----KTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59

Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI---- 224
           K+ HP IV ++         K+Y++++++       H  +  +    Q  F  +E+    
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVE------HDLKSLMETMKQ-PFLQSEVKCLM 112

Query: 225 ---VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEY 280
              +S V+HLH   I+HRDLK  N+L+++ G + + DFGLA+E     +    +  T  Y
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWY 172

Query: 281 MAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV-- 331
            APE+LL       A D WSVG +  E+LT +P F   +      +I        EK+  
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232

Query: 332 ---KLP----PFLTSEAHSLLK-----------GVSFLTQLLHKDPSKRLGSGPGGVDAI 373
              +LP       T   ++ L+           G   L +LL  DP+KR+ +     DA+
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE----DAL 288

Query: 374 KHHKWF 379
           K H +F
Sbjct: 289 K-HPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 46/226 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYM 162
           D+     +G+G +G V++ + K      +  I AMK +R +        T I+       
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNK-----KTGQIVAMKKIRLESEEEGVPSTAIR------- 48

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN------------GGHLFFHLYRQG 210
             E  +L ++ HP IV L+      S+LYLI +F++            G ++   L +  
Sbjct: 49  --EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS- 105

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
                    Y  +I+  +   H   ++HRDLKP+N+L+D+ G + L DFGLA+      R
Sbjct: 106 ---------YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156

Query: 271 SNSM-CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
             +    T  Y APE+LL S  ++   D WS+G +  EM T +P F
Sbjct: 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 68/300 (22%)

Query: 115 FRVVGQGAFGKVFQ-----------VKKKGVDDGDS--DGIYAMKVMRK---DTIIKKNH 158
            R +G G+ G VF            VKK  + D  S    +  +K++R+   D I+K   
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69

Query: 159 VDYMKAERD-----ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
           V              LT++   +IVQ           Y+  D  N       +  QG   
Sbjct: 70  VLGPSGSDLTEDVGSLTELNSVYIVQE----------YMETDLAN-------VLEQGPLS 112

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEID-ESSRS 271
           E+ AR +  +++  + ++H   ++HRDLKP N+ ++++  V+ + DFGLA+ +D   S  
Sbjct: 113 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172

Query: 272 N--SMCGTTE-YMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
              S    T+ Y +P +LLS  +  K  D W+ G +  EMLTG+P F  A+  +  Q I+
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232

Query: 328 -----------NEKVKLPPFLTSEAHS--------LLKGVS-----FLTQLLHKDPSKRL 363
                      NE + + P                LL GV+     FL Q+L  +P  RL
Sbjct: 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 76/317 (23%), Positives = 127/317 (40%), Gaps = 79/317 (24%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +E+ + +GQGA+G V   +     + ++  I      +K T +             IL K
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAI------KKITNVFSK---------KILAK 46

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYR---QGIFREDQA---- 217
                +  LR+ F+    +  + D         N  +L+  L       I R  Q     
Sbjct: 47  RALRELKLLRH-FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105

Query: 218 --RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-- 273
             + +  +I+  + ++H   ++HRDLKP N+L+++D  + + DFGLA+   E+   N+  
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 274 ---MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--------------- 314
                 T  Y APEI+LS + + K  D WSVG +L E+L  +P F               
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225

Query: 315 ---------THANRQKLQQRIIN----EKVKLP---PFLTSEAHSLLKGVSFLTQLLHKD 358
                    +     K Q  I +     K       P     A  LL+      +LL  D
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE------KLLAFD 279

Query: 359 PSKRLGSGPGGVDAIKH 375
           P+KR+       +A++H
Sbjct: 280 PTKRISVE----EALEH 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 7e-19
 Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 38/229 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
              + R +GQG+FG V++   KGV  G+ +   A+K + ++  +++      +A   ++ 
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA--SVMK 64

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY---------- 220
           +     +V+L     T     ++++ +  G L  +L R      +               
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQ 123

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
             AEI   +++L     VHRDL   N ++  D  V + DFG+ ++I E          T+
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----------TD 173

Query: 280 Y-------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           Y             MAPE L        +D WS G++L+EM T  + P+
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 11/205 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G V +V  +      S  I A K++  +  IK    + +  E  +L 
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHR-----PSGLIMARKLIHLE--IKPAIRNQIIRELKVLH 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E+     +  ++  +++
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114

Query: 231 LH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
           L  K  I+HRD+KP NIL++S G + L DFG++ + ID  S +NS  GT  YM+PE L  
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG 172

Query: 289 KGHNKDADWWSVGILLYEMLTGQPP 313
             +   +D WS+G+ L EM  G+ P
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 41/106 (38%), Positives = 66/106 (62%), Gaps = 4/106 (3%)

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDE-SSR 270
            E    FYT +I+  + +LH   IVHRD+K +N+L+++  G V ++DFG +K +   +  
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165

Query: 271 SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF 314
           + +  GT +YMAPE++    +G+   AD WS+G  + EM TG+PPF
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 87.4 bits (216), Expect = 1e-18
 Identities = 85/348 (24%), Positives = 147/348 (42%), Gaps = 71/348 (20%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFR-------- 116
           H  +    G        +   L  +E  H N+A  + + E+ I   D +I R        
Sbjct: 18  HKANKGGSGKFEM----NDKKLDEEERSHNNNAGEDEDEEKMI---DNDINRSPNKSYKL 70

Query: 117 --VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
             ++G G+FG V++     +    S+ +   KV++           Y   E  I+  + H
Sbjct: 71  GNIIGNGSFGVVYE----AICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNH 118

Query: 175 PFIVQLRYSFQTRSK--------LYLILDFINGGHLFFHLYRQGIFREDQA------RFY 220
             I+ L+  + T           L ++++FI       H Y +   R + A      + Y
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT---VHKYMKHYARNNHALPLFLVKLY 175

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTE 279
           + ++  A++++H   I HRDLKP+N+L+D + H + L DFG AK +    RS S   +  
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235

Query: 280 YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN---------- 328
           Y APE++L +  +    D WS+G ++ EM+ G P F+  +      RII           
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295

Query: 329 -------EKVKLPPFLTSEAHSLL-KG-----VSFLTQLLHKDPSKRL 363
                    +K P     +   +  KG     ++F++Q L  +P KRL
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343

Length = 440

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 69/251 (27%), Positives = 124/251 (49%), Gaps = 28/251 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAER 166
            + E  +V+G GAFG V+    KGV   +G+   I  A+KV+R++T   K + + +  E 
Sbjct: 7   TELEKIKVLGSGAFGTVY----KGVWIPEGEKVKIPVAIKVLREETS-PKANKEILD-EA 60

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF------- 219
            ++  V HP +V+L       S++ LI   +  G L  ++      R  +          
Sbjct: 61  YVMASVDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYV------RNHKDNIGSQYLLN 113

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--- 276
           +  +I   +S+L +  +VHRDL   N+L+ +  HV +TDFGLAK +D   +     G   
Sbjct: 114 WCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLP 334
             ++MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  P
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP 233

Query: 335 PFLTSEAHSLL 345
           P  T + + +L
Sbjct: 234 PICTIDVYMVL 244

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 75/283 (26%), Positives = 130/283 (45%), Gaps = 34/283 (12%)

Query: 109 PGDFEIFRVVGQGAFGKV---------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           P  ++    VG GA+G V          +V  K +       I+A +  R+  ++K    
Sbjct: 16  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK---- 71

Query: 160 DYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
            +MK E  I L  V  P       S +  + +YL+   +  G    ++ +     +D  +
Sbjct: 72  -HMKHENVIGLLDVFTP-----ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ 123

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+         T 
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATR 181

Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINEKVKLP 334
            Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++       
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP---G 238

Query: 335 PFLTSE--AHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
             L  +  + S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 281

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 30/203 (14%)

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
            YL++ F+  G     L +     ED+ +F   +++  + ++H  GI+HRDLKP N+ ++
Sbjct: 95  FYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152

Query: 250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEML 308
            D  + + DFGLA++ D  S       T  Y APE++L+  H  +  D WSVG ++ EML
Sbjct: 153 EDCELKILDFGLARQTD--SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Query: 309 TGQPPFT---HANR----------------QKLQQRIINEKVK-LPPFLTSEAHSLLK-- 346
           TG+P F    H ++                QKLQ       VK LP F   +  SLL   
Sbjct: 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNA 270

Query: 347 ---GVSFLTQLLHKDPSKRLGSG 366
               V+ L ++L  D   R+ + 
Sbjct: 271 NPLAVNVLEKMLVLDAESRITAA 293

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 74/318 (23%), Positives = 122/318 (38%), Gaps = 83/318 (26%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+VF+ + K         I A+K +  +   +   +  ++ E  IL  + H  +
Sbjct: 20  IGQGTFGEVFKARHKKTKQ-----IVALKKVLMENEKEGFPITALR-EIKILQLLKHENV 73

Query: 178 VQL------------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI- 224
           V L            RY    +   YL+ +F    H        G+      +F  +EI 
Sbjct: 74  VNLIEICRTKATPYNRY----KGSFYLVFEFCE--HDL-----AGLLSNKNVKFTLSEIK 122

Query: 225 ------VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
                 ++ + ++H+  I+HRD+K  NIL+  DG + L DFGLA+    S  S     T 
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 279 E-----YMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN---- 328
                 Y  PE+LL  + +    D W  G ++ EM T  P       Q     I      
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242

Query: 329 ---------------EKVKLP------------PFLTSEAHSLLKGVSFLTQLLHKDPSK 361
                          +K++LP            P++          +  + +LL  DP+K
Sbjct: 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPH-----ALDLIDKLLVLDPAK 297

Query: 362 RLGSGPGGVDAIKHHKWF 379
           R+ +     D   +H +F
Sbjct: 298 RIDA-----DTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 24/205 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI--LTKV 172
           +G+G++G VF+ + +     ++  I A+K       D +IKK       A R+I  L ++
Sbjct: 9   IGEGSYGVVFKCRNR-----ETGQIVAIKKFVESEDDPVIKK------IALREIRMLKQL 57

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVS 229
            HP +V L   F+ + KL+L+ ++ +  H   +      +G+  E   +    + + AV+
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCD--HTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-YMAPEILLS 288
             HK   +HRD+KPENIL+   G + L DFG A+ +       +    T  Y APE+L+ 
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 289 K-GHNKDADWWSVGILLYEMLTGQP 312
              +    D W++G +  E+LTGQP
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 87.9 bits (218), Expect = 2e-18
 Identities = 81/325 (24%), Positives = 144/325 (44%), Gaps = 62/325 (19%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDI 168
             ++I R++G+G  G+V+       D   S  + A+K +R+D          +++ E  I
Sbjct: 2   QRYDIIRLIGKGGMGEVYL----AYDPVCSRRV-ALKKIREDLSENPLLKKRFLR-EAKI 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKL-YLILDFING---GHLFFHLYRQGIFREDQAR------ 218
              + HP IV + YS  +     Y  + +I G     L   ++++    ++ A       
Sbjct: 56  AADLIHPGIVPV-YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114

Query: 219 ----FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--------EID 266
               F+   I + + ++H  G++HRDLKP+NIL+   G V++ D+G A          +D
Sbjct: 115 FLSIFHK--ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 267 ESSRSNSMC-----------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
                 ++C           GT +YMAPE LL    ++  D +++G++LY+MLT   P+ 
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY- 231

Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHK----DPSKRLGSGPGGVD 371
              R+K  ++I    V L P    E     +   FL+Q+  K    DP++R  S      
Sbjct: 232 ---RRKKGRKISYRDVILSP---IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285

Query: 372 AIKHH-----KWFRSINWKTLEARE 391
            ++ H     +W       TL  ++
Sbjct: 286 DLEPHLQGSPEWTVKA---TLMTKK 307

Length = 932

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 29/272 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDI 168
           F   R +G G+FG V+  +     D  ++ + A+K M    K +  K    D +K E   
Sbjct: 17  FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQ--DIIK-EVRF 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           L ++ HP  ++ +  +      +L++++ +        ++++ + +E +        +  
Sbjct: 69  LQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPL-QEVEIAAICHGALQG 127

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +++LH    +HRD+K  NIL+   G V L DFG A  +     +NS  GT  +MAPE++L
Sbjct: 128 LAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVIL 184

Query: 288 S--KGHNKD-ADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-NEKVKLPPFLTSEAHS 343
           +  +G      D WS+GI   E+   +PP  + N       I  N+     P L+S   S
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND----SPTLSSNDWS 240

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
                +F+   L K P  R    P   + +KH
Sbjct: 241 -DYFRNFVDSCLQKIPQDR----PSSEELLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 80/321 (24%), Positives = 135/321 (42%), Gaps = 68/321 (21%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM--KAERD 167
            D+EI   +G+G FG+V++ ++       +  + A+K      I+  N  D     A R+
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQI-----KTGRVVALK-----KILMHNEKDGFPITALRE 57

Query: 168 I--LTKVTHPFIVQL------RYSFQTRSK--LYLILDFINGGH-LFFHLYRQGI-FRED 215
           I  L K+ HP +V L      R     R +  +Y++  +++  H L   L    +   E 
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPSVKLTES 115

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--- 272
           Q + Y  +++  +++LH+  I+HRD+K  NIL+D+ G + + DFGLA+  D    +    
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 273 ---------SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF-------- 314
                    ++  T  Y  PE+LL  + +    D W +G +  EM T +P          
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235

Query: 315 --------------THANRQKLQ-QRIINEKVKLPPFLTSEAHSLLK-GVSFLTQLLHKD 358
                         T    + L     ++     P  L      L   G+  L++LL  D
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295

Query: 359 PSKRLGSGPGGVDAIKHHKWF 379
           P KRL +     DA   H +F
Sbjct: 296 PYKRLTA----SDA-LEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 55/213 (25%), Positives = 110/213 (51%), Gaps = 16/213 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V   K +G  D       A+K++R+  +   +  D+++ E 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKID------VAIKMIREGAM---SEDDFIE-EA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEI 224
            ++ K++HP +VQL Y   T+ + ++++ +++  G L  +L  + G    +      +++
Sbjct: 51  KVMMKLSHPNLVQL-YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV 109

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMA 282
             A+ +L   G +HRDL   N L+  D  V ++DFGLA+ +  D+ + S       ++  
Sbjct: 110 CEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAP 169

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           PE+      +  +D WS G+L++E+ + G+ P+
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 28/255 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G FGKV   +   + D   + + A+K +      ++ H    + E +IL  + H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQV-AVKSLNHSG--EEQHRSDFEREIEILRTLDHE 66

Query: 176 FIVQLRY--SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
            IV+ +          L LI++++  G L  +L R    + +  R   ++++I   + +L
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYL 125

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT-TEYMAPEILL 287
                +HRDL   NIL++S+  V ++DFGLAK + E            +   + APE L 
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTH-----------ANRQKLQQRIIN-----EKV 331
           +   +  +D WS G+ LYE+ T   P              A  Q +  R++      E++
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Query: 332 KLPPFLTSEAHSLLK 346
             PP    E + L+K
Sbjct: 246 PRPPSCPDEVYDLMK 260

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 86.3 bits (213), Expect = 6e-18
 Identities = 64/240 (26%), Positives = 121/240 (50%), Gaps = 38/240 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++E+ + +G G FG+VF VK K   +      +  K +    + K+     +  E +++ 
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQE-----FFCWKAISYRGL-KEREKSQLVIEVNVMR 67

Query: 171 KVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHL---YRQ-GIFREDQARFYTAEI 224
           ++ H  IV+   R+  +   KLY++++F + G L  ++   Y+  G   E      T ++
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 225 VSAVSHLHKCG-------IVHRDLKPENILMDSD----GHVM-------------LTDFG 260
           + A+++ H          ++HRDLKP+NI + +     G +              + DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           L+K I   S ++S  GT  Y +PE+LL  +K ++  +D W++G ++YE+ +G+ PF  AN
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247

Length = 1021

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 67/243 (27%), Positives = 125/243 (51%), Gaps = 24/243 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +V+G GAFG V+  K   + DG++  I  A+KV+R++T  K N    +  E  ++  V  
Sbjct: 13  KVLGSGAFGTVY--KGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGS 68

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------YTAEIVSA 227
           P++ +L       S + L+   +  G L  ++      RE++ R        +  +I   
Sbjct: 69  PYVCRL-LGICLTSTVQLVTQLMPYGCLLDYV------RENKDRIGSQDLLNWCVQIAKG 121

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESS-RSNSMCGTTEYMAPE 284
           +S+L +  +VHRDL   N+L+ S  HV +TDFGLA+  +IDE+   ++      ++MA E
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAH 342
            +L +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  T + +
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241

Query: 343 SLL 345
            ++
Sbjct: 242 MIM 244

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 33/190 (17%)

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSN 272
           D  + +  +I+  + +LH  GI+HRD+KP N+L++S+  + + DFGLA+  E DES    
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 273 SMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--- 328
               T  Y APEIL+   H   A D WSVG +  E+L  +  F   +  +    I +   
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222

Query: 329 -------------------EKVKLPPFLTS----EAHSLLKGVSFLTQLLHKDPSKRLGS 365
                                   PP L       + +  + V  L ++L  DP KR+  
Sbjct: 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI-- 280

Query: 366 GPGGVDAIKH 375
                DA+ H
Sbjct: 281 --SAADALAH 288

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +G+GAFGKVF  +   ++  +   + A+K + K+T       D+ + E ++LT   H 
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER-EAELLTNFQHE 68

Query: 176 FIVQLRYSFQTR-SKLYLILDFINGGHLFFHLYRQG-----IFREDQARF---------Y 220
            IV+  Y   T      ++ +++  G L   L   G     +   D              
Sbjct: 69  NIVKF-YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT-- 278
             +I S + +L     VHRDL   N L+  D  V + DFG+++++  ++    + G T  
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-YTTDYYRVGGHTML 186

Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 318
              +M PE ++ +    ++D WS G++L+E+ T   QP +  +N
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 83.4 bits (206), Expect = 4e-17
 Identities = 46/133 (34%), Positives = 70/133 (52%), Gaps = 18/133 (13%)

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP- 334
           GT +Y+APE+LL K H    DWW++G+ L+E LTG PPF     Q++ Q I+N  +  P 
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601

Query: 335 --PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM 392
               L+  A + ++       LL  DP+KR      G+  +K H  F  ++W+ L+ + M
Sbjct: 602 GEEKLSVNAQNAIE------ILLTMDPTKR-----AGLKELKQHPLFHGVDWENLQNQTM 650

Query: 393 ----QPKFKPDVS 401
               QP  + D S
Sbjct: 651 PFIPQPDDETDTS 663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 44/217 (20%)

Query: 118 VGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           VG GA+G V          +V  K +       I+A +  R+ T++K    + +    D+
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYRQGIFREDQARFYT 221
            T            S       YL++ +       I G              ED+ ++  
Sbjct: 83  FTSAV---------SGDEFQDFYLVMPYMQTDLQKIMGHP----------LSEDKVQYLV 123

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TT 278
            +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA+  D       M G   T 
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTR 178

Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
            Y APE++L+  H N+  D WSVG ++ EMLTG+  F
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 71/292 (24%), Positives = 127/292 (43%), Gaps = 52/292 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           +G+G +G VF+ K +     ++  I A+K +R D     +      A R+I  L ++ H 
Sbjct: 8   IGEGTYGTVFKAKNR-----ETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKHK 59

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            IV+L     +  KL L+ ++ +     +     G    +  + +  +++  ++  H   
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILL-SKGHNK 293
           ++HRDLKP+N+L++ +G + L DFGLA+      R  S    T  Y  P++L  +K ++ 
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179

Query: 294 DADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII------NEK-----VKLP------- 334
             D WS G +  E+   G+P F   +     +RI        E+      KLP       
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239

Query: 335 -----------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
                      P L S    LL+       LL  +P +R+ +     +A++H
Sbjct: 240 YPATTSLVNVVPKLNSTGRDLLQ------NLLVCNPVQRISAE----EALQH 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 80.5 bits (198), Expect = 4e-17
 Identities = 68/251 (27%), Positives = 120/251 (47%), Gaps = 23/251 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+V+     G  +G +    A+K ++  T+  +  +     E  ++ K+ H  +
Sbjct: 14  LGQGCFGEVW----MGTWNGTTR--VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 63

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCG 235
           VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A+I S ++++ +  
Sbjct: 64  VQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNK 293
            VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L      
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 294 DADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL 351
            +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP      H L      +
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL------M 236

Query: 352 TQLLHKDPSKR 362
            Q   K+P +R
Sbjct: 237 CQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 48/151 (31%), Positives = 78/151 (51%), Gaps = 11/151 (7%)

Query: 214 EDQ-ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
           E Q  +++  +I+  + ++H  G+VHRDLKP NIL++ +  + + DFGLA+  D   +  
Sbjct: 106 EKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--PQMT 163

Query: 273 SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIIN 328
               T  Y APEI+L+ + ++ + D WS G +  EML G+P F    H N    Q  II 
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN----QFSIIT 219

Query: 329 EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDP 359
           + +  PP            + F+  L  ++P
Sbjct: 220 DLLGTPPDDVINTICSENTLRFVQSLPKREP 250

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 62/214 (28%), Positives = 112/214 (52%), Gaps = 9/214 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G V +V+ K      S  I A K++  +  IK    + +  E  +L 
Sbjct: 6   DFERISELGAGNGGVVTKVQHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L       E+     +  ++  +++
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAY 118

Query: 231 L-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+PE L   
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT 177

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
            ++  +D WS+G+ L E+  G+ P    + ++L+
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 79.3 bits (195), Expect = 9e-17
 Identities = 64/257 (24%), Positives = 119/257 (46%), Gaps = 25/257 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + ++ + +G+G FG V     +G          A+K ++ D   +        AE  ++T
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA-----FLAEASVMT 54

Query: 171 KVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSA 227
           ++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    ++ ++  A
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + +L     VHRDL   N+L+  D    ++DFGL KE   SS  ++     ++ APE L 
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALR 172

Query: 288 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLL 345
            K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P       + ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232

Query: 346 KGVSFLTQLLHKDPSKR 362
           K      Q  H D + R
Sbjct: 233 K------QCWHLDAATR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 80.5 bits (198), Expect = 9e-17
 Identities = 65/267 (24%), Positives = 115/267 (43%), Gaps = 19/267 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +     D  ++ + A+K M             +  E   L +
Sbjct: 27  FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  ++ +  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG- 290
           H   ++HRD+K  NIL+   G V L DFG A      S +NS  GT  +MAPE++L+   
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMDE 198

Query: 291 --HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
             ++   D WS+GI   E+   +PP  + N       I   +   P   ++E     +  
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PTLQSNEWSDYFR-- 254

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           +F+   L K P  R    P   + +KH
Sbjct: 255 NFVDSCLQKIPQDR----PTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 81.1 bits (200), Expect = 1e-16
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 14/197 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + + + +  G+ G+VF   K G  D        +K+ +K T +          E  +L  
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDP-----VVLKIGQKGTTL---------IEAMLLQN 113

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V HP +++++ +  + +   ++L   +     +   R      DQA     +I+  + +L
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   I+HRD+K ENI ++    V + D G A+    +     + GT E  APE+L    +
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKY 233

Query: 292 NKDADWWSVGILLYEML 308
           N  AD WS GI+L+EML
Sbjct: 234 NSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  VF+ + K  ++     + A+K +R +       T I+         E  +L 
Sbjct: 13  LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV L     T   L L+ ++++     +      +      + +  +++  +S+
Sbjct: 59  NLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL- 287
            HK  I+HRDLKP+N+L++  G + L DFGL  AK +   + SN +  T  Y  P++LL 
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF 314
           S  ++   D W VG +LYEM TG+P F
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 15/156 (9%)

Query: 168 ILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE-DQAR-- 218
           ++  V H  I+ L      + S +    +YL+++ ++          Q I  + D  R  
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD------ANLCQVIQMDLDHERMS 121

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T 
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
            Y APE++L  G+ ++ D WSVG ++ EM+ G   F
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 27/227 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F + R +G G FG+V++   K           A+K+++ D        D+ K E   L 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVR------VAIKILKSDD--LLKQQDFQK-EVQALK 57

Query: 171 KVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT-------- 221
           ++ H  ++ L ++  +  + +Y+I + +  G L   L      R  + +           
Sbjct: 58  RLRHKHLISL-FAVCSVGEPVYIITELMEKGSLLAFL------RSPEGQVLPVASLIDMA 110

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-TEY 280
            ++   +++L +   +HRDL   NIL+  D    + DFGLA+ I E    +S      ++
Sbjct: 111 CQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW 170

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
            APE       +  +D WS GILLYEM T GQ P+   N  ++  +I
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 36/260 (13%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +G G FG+V+     G  +G +    A+K ++  T+  +    +++ E  I+ K+ H 
Sbjct: 12  RKLGAGQFGEVW----MGTWNGTTK--VAVKTLKPGTMSPE---AFLQ-EAQIMKKLRHD 61

Query: 176 FIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARF--------YTAEIVS 226
            +VQL Y+  +  + +Y++ ++++ G L   L      +  + +           A+I  
Sbjct: 62  KLVQL-YAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAE 114

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPE 284
            +++L     +HRDL   NIL+  +    + DFGLA+  E DE +         ++ APE
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPPFLTSEAH 342
                     +D WS GILL E++T G+ P+    NR+ L+Q     ++  PP    E +
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234

Query: 343 SLLKGVSFLTQLLHKDPSKR 362
            L+       Q   KDP +R
Sbjct: 235 DLML------QCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 33/221 (14%)

Query: 109 PGDFEIFRVVGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           P  ++    VG GA+G V          +V  K +       I+A +  R+  ++K    
Sbjct: 14  PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK---- 69

Query: 160 DYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
            +MK E      D+ T  T         S +  +++YL+ + +  G    ++ +     +
Sbjct: 70  -HMKHENVIGLLDVFTPAT---------SIENFNEVYLVTNLM--GADLNNIVKCQKLSD 117

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
           +  +F   +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA++ D+       
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--EMTGY 175

Query: 275 CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
             T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 80.0 bits (197), Expect = 3e-16
 Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 39/235 (16%)

Query: 92  EHENDAE----LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           E E+DA+    L AE+   I    F I      GA G  F                    
Sbjct: 70  EDESDADASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDNKT------------- 116

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
             +  +IK         E  IL  + HP I+QL+ +F       LIL            Y
Sbjct: 117 -CEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP----------RY 165

Query: 208 RQGIF--REDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTD 258
           +  ++     +      +I++       A+ +LH+  I+HRD+K ENI ++  G V L D
Sbjct: 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGD 225

Query: 259 FGLA-KEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           FG A   +D  +++     GT    APE+L    +    D WS GI+L+EM T  
Sbjct: 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 37/92 (40%), Positives = 55/92 (59%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           PE++L  G+ ++ D WSVG ++ EM+ G   F
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 55/293 (18%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  V++ + K  D+     + A+K +R +       T I+         E  +L 
Sbjct: 14  LGEGTYATVYKGRSKLTDN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
            + H  IV L     T   L L+ ++++   L  +L   G        + +  +++  ++
Sbjct: 60  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+  ++HRDLKP+N+L++  G + L DFGL  AK I   + SN +  T  Y  P+ILL
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILL 177

Query: 288 -SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII----------------NEK 330
            S  ++   D W VG + YEM TG+P F  +  ++    I                 NE+
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237

Query: 331 VKLPPFLTSEAHSLLK--------GVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
            K   +    A  L          G   L++LL  +  KR+ +     +A+KH
Sbjct: 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE----EAMKH 286

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 73/302 (24%), Positives = 134/302 (44%), Gaps = 54/302 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  VF+ + K  ++     + A+K +R +       T I+         E  +L 
Sbjct: 14  LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV L     T   L L+ ++++     +      I      + +  +I+  +++
Sbjct: 60  DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL- 287
            H+  ++HRDLKP+N+L++  G + L DFGL  AK +   + SN +  T  Y  P++LL 
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINE--------------- 329
           S  ++   D W VG + +EM +G+P F   T  +   L  R++                 
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238

Query: 330 ------KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 383
                 K K  P +        +G+  LT+ L  +  KR+ +     +A+K H +FRS+ 
Sbjct: 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAE----EAMK-HAYFRSLG 293

Query: 384 WK 385
            +
Sbjct: 294 TR 295

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 57/233 (24%), Positives = 112/233 (48%), Gaps = 18/233 (7%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--DYMKAERDILTKVTH 174
            +G+G FG+VF  K KG+++   + +  +K ++K    K  ++  ++ + E D+  K++H
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRR-ELDMFRKLSH 67

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV---- 228
             +V+L    +     Y+IL++ + G L  F    +    +       T + V+      
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 229 ---SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAP 283
               HL     VHRDL   N L+ S   V ++   L+K++   E  +  +      ++AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
           E +     +  +D WS G+L++E+ T G+ PF   + +++  R+   K++LP 
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 10/200 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G FGKV        +DG  + + A+K ++++    + +    K E +IL  + H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGE-MVAVKTLKREC--GQQNTSGWKKEINILKTLYHE 66

Query: 176 FIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            IV+ +   S Q    L LI++++  G L  +L +  +    Q   +  +I   +++LH 
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL-NLAQLLLFAQQICEGMAYLHS 125

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSK 289
              +HRDL   N+L+D+D  V + DFGLAK + E      +    +    + A E L   
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185

Query: 290 GHNKDADWWSVGILLYEMLT 309
             +  +D WS G+ LYE+LT
Sbjct: 186 KFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 68/258 (26%), Positives = 123/258 (47%), Gaps = 26/258 (10%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           ++ R +G G FG+V++    G+ +  +    A+K ++  T+  K+ +    AE  I+ K+
Sbjct: 9   QLLRKLGAGQFGEVWE----GLWNNTTP--VAVKTLKPGTMDPKDFL----AEAQIMKKL 58

Query: 173 THPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
            HP ++QL Y+  T  + +Y++ + +  G L  +L        +  Q     A++ S ++
Sbjct: 59  RHPKLIQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEYMAPEIL 286
           +L     +HRDL   N+L+  +    + DFGLA+ I E     +  G     ++ APE  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAA 176

Query: 287 LSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           L    +  +D WS GILL E++T G+ P+    N + LQQ     ++  PP    E + +
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDI 236

Query: 345 LKGVSFLTQLLHKDPSKR 362
                 +     +DP  R
Sbjct: 237 ------MLDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 6/154 (3%)

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E DIL  ++H  I+ L ++++ +S + +++       LF ++ R G    +QA      +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRL 194

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC----GTTEY 280
           + A+++LH  GI+HRD+K ENI +D   + +L DFG A ++D    +   C    GT E 
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT-PQCYGWSGTLET 253

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
            +PE+L    +    D WS G++L+EM       
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 13/168 (7%)

Query: 156 KNHVDYMKAERDI--LTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHL-FFHL 206
           +N     +A R++  L  V H  I+ L      + S +    +YL+++ ++       H+
Sbjct: 59  QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM 118

Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
                   ++  +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+   
Sbjct: 119 E----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174

Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
            +        T  Y APE++L  G+ ++ D WSVG ++ E++ G   F
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 62/250 (24%), Positives = 119/250 (47%), Gaps = 28/250 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI---YAMKVMRKDTIIKKNHVDYMKAERD 167
           +F+  +V+G GAFG V+    KG+   + + +    A+K +R+ T  K N    +  E  
Sbjct: 8   EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAY 61

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
           ++  V +P + +L       S + LI   +  G L  ++      RE +          +
Sbjct: 62  VMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYV------REHKDNIGSQYLLNW 114

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---T 277
             +I   +++L +  +VHRDL   N+L+ +  HV +TDFGLAK +    +     G    
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPP 335
            ++MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234

Query: 336 FLTSEAHSLL 345
             T + + ++
Sbjct: 235 ICTIDVYMIM 244

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 17/176 (9%)

Query: 147 VMRKDTIIKK------NHVDYMKAERD-ILTK-VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+ +L K V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99

Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 65/258 (25%), Positives = 125/258 (48%), Gaps = 25/258 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
            ++ + +G G FG+V+     G  +G++    A+K ++  T+  ++ ++    E  I+ K
Sbjct: 8   LQLIKKLGNGQFGEVWM----GTWNGNTK--VAVKTLKPGTMSPESFLE----EAQIMKK 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAV 228
           + H  +VQL Y+  +   +Y++ ++++ G L   L + G  R           A++ + +
Sbjct: 58  LRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGM 115

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEIL 286
           +++ +   +HRDL+  NIL+       + DFGLA+ I+++  +         ++ APE  
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 287 LSKGHNKDADWWSVGILLYEMLT-GQPPFTHA-NRQKLQQRIINEKVKLPPFLTSEAHSL 344
           L       +D WS GILL E++T G+ P+    NR+ L+Q     ++  P       H L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235

Query: 345 LKGVSFLTQLLHKDPSKR 362
                 + Q   KDP +R
Sbjct: 236 ------MLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 15/208 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--IL 169
           +E    +G+G++  V++ K K      +  + A+KV+R    +++       A R+  +L
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIR----LQEEEGTPFTAIREASLL 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  IV L     T+  L L+ ++++     +     G    +  + +  +++  +S
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL 287
           ++H+  I+HRDLKP+N+L+   G + L DFGL  AK +   + SN +  T  Y  P++LL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176

Query: 288 -SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S  ++   D W VG +  EM+ G   F
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 40/231 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  D  YA+K +    I        M A R+I  L ++ HP
Sbjct: 9   VGRGTYGHVYKAKRK---DGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHP 58

Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
            ++ L+  F + +  K++L+ D+    H  +H+ +    R  +A            +   
Sbjct: 59  NVISLQKVFLSHADRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPVQLPRGMVKSLL 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKEIDESSRS----NS 273
            +I+  + +LH   ++HRDLKP NIL+  +    G V + D G A+  +   +     + 
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           +  T  Y APE+LL   H  K  D W++G +  E+LT +P F H  ++ ++
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQEDIK 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 11/210 (5%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +     D  +  + A+K M             +  E   L K
Sbjct: 17  FSDLREIGHGSFGAVYFAR-----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG- 290
           H   ++HRD+K  NIL+   G V L DFG A  +   + +N   GT  +MAPE++L+   
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDE 188

Query: 291 --HNKDADWWSVGILLYEMLTGQPPFTHAN 318
             ++   D WS+GI   E+   +PP  + N
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 4/153 (2%)

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L  + H  IV L     T+  L  + ++++     + +   G       R +  ++
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA--KEIDESSRSNSMCGTTEYMA 282
           +  ++++H   I+HRDLKP+N+L+   G + L DFGLA  K I   + S+ +  T  Y  
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRP 171

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           P++LL +  ++   D W  G +  EML GQP F
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 56/296 (18%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDIL 169
            +G+G++  V++ + K         + A+K +R +       T I+         E  +L
Sbjct: 12  KLGEGSYATVYKGRSKLTGQ-----LVALKEIRLEHEEGAPFTAIR---------EASLL 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  IV L     T+  L L+ ++++     +     G       R +  +++  ++
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+  ++HRDLKP+N+L+   G + L DFGL  AK +   + SN +  T  Y  P++LL
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLL 176

Query: 288 -SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------NEKV--KLPPFL 337
            S  ++   D W VG + YEM TG+P F  +   + Q   I        E+    +    
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236

Query: 338 TSEAHSLLK------------------GVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
             + +S                     G     + L  +P KR+       +A+KH
Sbjct: 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI----SAAEAMKH 288

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 28/216 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           +E    +G+G +G V++ + +  ++       A+K +R +        T I+        
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIR-------- 50

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ--ARFYT 221
            E  +L ++ H  IV+L+    +  +LYL+ ++++   L  H+     F ++    + Y 
Sbjct: 51  -EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYL 108

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSM-CGTTE 279
            +I+  +++ H   ++HRDLKP+N+L+D     + L DFGLA+      R+ +    T  
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW 168

Query: 280 YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           Y APEILL S+ ++   D WSVG +  EM+  +P F
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204

Length = 294

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 66/269 (24%), Positives = 128/269 (47%), Gaps = 28/269 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F + R++G+G FG V + + K  +DG    + A+K+++ D     +  ++++ E   + +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLK-SEDGSFQKV-AVKMLKADIFSSSDIEEFLR-EAACMKE 57

Query: 172 VTHPFIVQL-RYSFQTRSKLYL-----ILDFINGG--HLFFHLYRQG-----IFREDQAR 218
             HP +++L   S ++R+K  L     IL F+  G  H F  + R G     +  +   R
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT- 277
           F   +I S + +L     +HRDL   N +++ +  V + DFGL+K+I         C + 
Sbjct: 118 FMI-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKL 333
              +++A E L    +   +D W+ G+ ++E++T GQ P+      ++   +I   ++K 
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236

Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           PP    + + L      + Q    +P  R
Sbjct: 237 PPDCLEDVYEL------MCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 18/201 (8%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++G+G FG V Q +  G          A+K ++ D   +         E  ++TK+ H  
Sbjct: 13  IIGEGEFGAVLQGEYTGQK-------VAVKNIKCDVTAQA-----FLEETAVMTKLHHKN 60

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKC 234
           +V+L       + LY++++ ++ G+L   L  +G       +   ++ ++   + +L   
Sbjct: 61  LVRL-LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKD 294
            +VHRDL   NIL+  DG   ++DFGLA+    S   ++     ++ APE L  K  +  
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKWTAPEALKHKKFSSK 177

Query: 295 ADWWSVGILLYEMLT-GQPPF 314
           +D WS G+LL+E+ + G+ P+
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 40/231 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  +  YA+K +    I        M A R+I  L ++ HP
Sbjct: 9   VGRGTYGHVYKAKRK---DGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHP 58

Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
            ++ L+  F + S  K++L+ D+    H  +H+ +    R  +A            +   
Sbjct: 59  NVIALQKVFLSHSDRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPMQLPRSMVKSLL 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKEIDESSRS----NS 273
            +I+  + +LH   ++HRDLKP NIL+  +    G V + D G A+  +   +     + 
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           +  T  Y APE+LL   H  K  D W++G +  E+LT +P F H  ++ ++
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQEDIK 224

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDIL 169
           +E    +G+GA+GKVF+ +    D  +     A+K +R  T  +   +  ++  A    L
Sbjct: 3   YECVAEIGEGAYGKVFKAR----DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 170 TKVTHPFIVQL----RYSFQTR-SKLYLILDFINGGHLFFHLYR---QGIFREDQARFYT 221
               HP +V+L      S   R +KL L+ + ++   L  +L +    G+  E   +   
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE-TIKDMM 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM 281
            +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y 
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 176

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           APE+LL   +    D WSVG +  EM   +P F
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 63/263 (23%), Positives = 119/263 (45%), Gaps = 23/263 (8%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           +G G+FG V+        +  ++ + A+K M      K+ +  +    +++  L ++ HP
Sbjct: 29  IGHGSFGAVYFAT-----NSHTNEVVAVKKMSYSG--KQTNEKWQDIIKEVKFLQQLKHP 81

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
             ++ +  +      +L++++  G         +   +E +    T   +  +++LH   
Sbjct: 82  NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG---HN 292
           ++HRD+K  NIL+   G V L DFG A    +SS +NS  GT  +MAPE++L+     ++
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS---KSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLT 352
              D WS+GI   E+   +PP  + N       I       P   ++E     +G  F+ 
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDSFRG--FVD 254

Query: 353 QLLHKDPSKRLGSGPGGVDAIKH 375
             L K P +R    P   + ++H
Sbjct: 255 YCLQKIPQER----PASAELLRH 273

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 45/113 (39%), Positives = 58/113 (51%), Gaps = 1/113 (0%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 58/235 (24%), Positives = 109/235 (46%), Gaps = 21/235 (8%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++      + R +G GAFG+V++   +G D    +   A+K + +    +++  D++  E
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLM-E 59

Query: 166 RDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR---- 218
             I++K  H  IV+L   SF+   + +++L+ + GG L  F    R    R         
Sbjct: 60  ALIMSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 219 -FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS--RSN 272
            F   ++     +L +   +HRD+   N L+   G      + DFG+A++I  +S  R  
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 273 --SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT-HANRQKLQ 323
             +M    ++M PE  L        D WS G+LL+E+ + G  P+    N++ ++
Sbjct: 179 GRAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 74.7 bits (184), Expect = 9e-15
 Identities = 51/184 (27%), Positives = 91/184 (49%), Gaps = 41/184 (22%)

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +++  +++  + ++H   ++HRDLKP N+L++++  + + DFGLA+    S + + 
Sbjct: 107 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDF 164

Query: 274 MCGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ 323
           M   TEY+      APE+LL+   +    D WSVG +  E+L  +P F    + ++ KL 
Sbjct: 165 M---TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI 221

Query: 324 QRII------------NEKVK-----LPPF-------LTSEAHSLLKGVSFLTQLLHKDP 359
             ++            NEK +     LP         L   A+ L   +  L ++L  DP
Sbjct: 222 TELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPL--AIDLLEKMLVFDP 279

Query: 360 SKRL 363
           SKR+
Sbjct: 280 SKRI 283

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 12/202 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           R +G+G FGKV   +     +GD+ G   A+K ++ ++    NH+  +K E +IL  + H
Sbjct: 10  RDLGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYH 65

Query: 175 PFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHL 231
             IV+ +   +    + + LI++F+  G L  +L R +      Q   Y  +I   + +L
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGTTEYMAPEILL 287
                VHRDL   N+L++S+  V + DFGL K I+         + +     + APE L+
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 288 SKGHNKDADWWSVGILLYEMLT 309
                  +D WS G+ LYE+LT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 64/242 (26%), Positives = 117/242 (48%), Gaps = 25/242 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     +I +V+G G FG+V   + K    G  +   A+K + K    +K   D++ +E 
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLK--LPGKREIPVAIKTL-KAGYTEKQRRDFL-SEA 56

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            I+ +  HP I+ L     T+SK + ++ +++  G L          R+   +F   ++V
Sbjct: 57  SIMGQFDHPNIIHLE-GVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLV 109

Query: 226 -------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCG 276
                  S + +L   G VHRDL   NIL++S+    ++DFGL++  E D  +   +  G
Sbjct: 110 GMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169

Query: 277 T--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
                + APE +  +     +D WS GI+++E+++ G+ P+   + Q +  + I E  +L
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEGYRL 228

Query: 334 PP 335
           P 
Sbjct: 229 PA 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 65/243 (26%), Positives = 123/243 (50%), Gaps = 28/243 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           I P    I +V+G G FG+V +  +K  G  + D     A+K   K     K  +D++  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEID----VAIK-TLKAGSSDKQRLDFL-T 54

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E  I+ +  HP I++L     T+S+ + +I +++  G L   L      RE+  +F   +
Sbjct: 55  EASIMGQFDHPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFL------RENDGKFTVGQ 107

Query: 224 IV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMC 275
           +V       S + +L +   VHRDL   NIL++S+    ++DFGL++ +++S  +  +  
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167

Query: 276 GTT--EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK 332
           G     + APE +  +     +D WS GI+++E+++ G+ P+   + Q + +  + +  +
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA-VEDGYR 226

Query: 333 LPP 335
           LPP
Sbjct: 227 LPP 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 39/244 (15%)

Query: 106 KIGPGDFEIFRVVGQGAF----GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           K+G G F    VV +G +    GKV  V              A+K ++ D +      D+
Sbjct: 2   KLGDGSF---GVVRRGEWSTSGGKVIPV--------------AVKCLKSDKL-SDIMDDF 43

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARF 219
           +K E  I+  + H  +++L Y       L ++ +    G L         G F       
Sbjct: 44  LK-EAAIMHSLDHENLIRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           Y  +I + + +L     +HRDL   NIL+ SD  V + DFGL + + +    N      E
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ----NEDHYVME 157

Query: 280 --------YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK 330
                   + APE L ++  +  +D W  G+ L+EM T G+ P+   +  ++ ++I  E 
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG 217

Query: 331 VKLP 334
            +L 
Sbjct: 218 ERLE 221

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 67/252 (26%), Positives = 121/252 (48%), Gaps = 25/252 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+V+     G  +G +    A+K ++  T++ +  +     E  I+ K+ H  +
Sbjct: 14  LGQGCFGEVWM----GTWNGTTK--VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKL 63

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKC 234
           V L Y+  +   +Y++ +F+  G L   L ++G     +  Q     A+I   ++++ + 
Sbjct: 64  VPL-YAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHN 292
             +HRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L     
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 293 KDADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
             +D WS GILL E++T G+ P+    NR+ L+Q     ++  P       H L+K    
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK---- 237

Query: 351 LTQLLHKDPSKR 362
                 KDP +R
Sbjct: 238 --LCWKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases

 Score = 67.0 bits (164), Expect = 3e-14
 Identities = 21/64 (32%), Positives = 34/64 (53%), Gaps = 4/64 (6%)

Query: 380 RSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAG----EHFKGY 435
           R I+W  LE +E++P F P +      +NFD  +T      +P  +P +G    E F+G+
Sbjct: 1   RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEPFRGF 60

Query: 436 TYVA 439
           +YV 
Sbjct: 61  SYVF 64

Length = 64

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 60/237 (25%), Positives = 111/237 (46%), Gaps = 29/237 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
           D +   V+G+G FG+V + + K       DG+    A+K M K+   K +H D+   E +
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIK------KDGLRMDAAIKRM-KEYASKDDHRDF-AGELE 59

Query: 168 ILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----------- 215
           +L K+  HP I+ L  + + R  LYL +++   G+L   L +  +   D           
Sbjct: 60  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119

Query: 216 -----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
                Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 179

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
                    +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 23/221 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA----ERDILTK 171
             +G+G FG V++   KG      +   A+K  R            +K     E +IL +
Sbjct: 1   EKIGKGNFGDVYKGVLKG------NTEVAVKTCRSTL------PPDLKRKFLQEAEILKQ 48

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSH 230
             HP IV+L      +  +Y++++ + GG L   L ++       +    + +  + + +
Sbjct: 49  YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEIL 286
           L     +HRDL   N L+  +  + ++DFG+++E +    + S  G  +    + APE L
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQIPIKWTAPEAL 167

Query: 287 LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
               +  ++D WS GILL+E  + G  P+   + Q+ ++RI
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 61/245 (24%), Positives = 120/245 (48%), Gaps = 31/245 (12%)

Query: 118 VGQGAFG----KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           +G G FG     V++++KK +D        A+KV++ +   +K+  D M  E +I+ ++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQID-------VAIKVLKNEN--EKSVRDEMMREAEIMHQLD 53

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSAVS-- 229
           +P+IV++    +  + L L+++  +GG  + F    +  I   +       E++  VS  
Sbjct: 54  NPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSN-----VVELMHQVSMG 107

Query: 230 --HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT--TEYMAP 283
             +L     VHRDL   N+L+ +  +  ++DFGL+K +  D+S       G    ++ AP
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEA 341
           E +  +  +  +D WS GI ++E  + GQ P+      ++   I   +++  P     E 
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEM 227

Query: 342 HSLLK 346
           ++L+K
Sbjct: 228 YALMK 232

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 49/217 (22%), Positives = 104/217 (47%), Gaps = 28/217 (12%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++ +G FG++F         G  + ++   V    + I+   V  +  E  +L  ++H  
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ---VTLLLQESCLLYGLSHQN 69

Query: 177 IVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA--------EIVSA 227
           I+  L    +     +++  ++N G+L   L +  +   +  +  +         +I   
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---------DESSRSNSMCGTT 278
           +S+LHK G++H+D+   N ++D +  V +TD  L++++         D  +R        
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP------V 183

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           ++MA E L++K ++  +D WS G+LL+E++T GQ P+
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 63/238 (26%), Positives = 121/238 (50%), Gaps = 14/238 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +V+G GAFG V+  K   V +G++  I  A+K++ + T  K N V++M  E  I+  + H
Sbjct: 13  KVLGSGAFGTVY--KGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMD-EALIMASMDH 68

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           P +V+L         + L+   +  G L  + H ++  I  +     +  +I   + +L 
Sbjct: 69  PHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMYLE 126

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEYMAPEILLSK 289
           +  +VHRDL   N+L+ S  HV +TDFGLA+ ++   +  +  G     ++MA E +  +
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 290 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHSLL 345
                +D WS G+ ++E++T G  P+     +++   +   E++  PP  T + + ++
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVM 244

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)

Query: 118 VGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V   +  G+D D   + +     M KD   +K+  D + +E +++  +  H 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 81

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFR--EDQARFY---- 220
            I+ L  +      LY+I+++ + G+L  +L         Y   I R  ++Q  F     
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE---IDESSRSNSMCG 276
            T ++   + +L     +HRDL   N+L+  +  + + DFGLA++   ID   ++ +   
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
             ++MAPE L  + +   +D WS G+L++E+ T G  P+
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 53/214 (24%), Positives = 110/214 (51%), Gaps = 12/214 (5%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++G+G FG+VF   K  + D       A+K  ++D + ++  + ++   R IL +  HP 
Sbjct: 2   LLGKGNFGEVF---KGTLKDKTP---VAVKTCKED-LPQELKIKFLSEAR-ILKQYDHPN 53

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCG 235
           IV+L      R  +Y++++ + GG     L ++    +  Q   +  +  + +++L    
Sbjct: 54  IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNK 293
            +HRDL   N L+  +  + ++DFG++++ D+   S+S       ++ APE L    ++ 
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 294 DADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
           ++D WS GILL+E  + G  P+     Q+ ++++
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 29/238 (12%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            + E  R +GQGAFG+VFQ +  G+   +   + A+K M K+        D+ + E  ++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALM 62

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYT- 221
            +  HP IV+L         + L+ +++  G L   L                 AR    
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 222 --------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-- 265
                          ++ + +++L +   VHRDL   N L+  +  V + DFGL++ I  
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 266 -DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG--QPPFTHANRQ 320
            D    S +      +M PE +    +  ++D W+ G++L+E+ +   QP +  A+ +
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 60/235 (25%), Positives = 114/235 (48%), Gaps = 11/235 (4%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P      +V+G G FG+VF+   K    G  +   A+K + K    +K   D++ +E
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILK--MPGRKEVAVAIKTL-KPGYTEKQRQDFL-SE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEI 224
             I+ + +H  I++L           +I +++  G L  +L    G F   Q       I
Sbjct: 57  ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCG---TTEY 280
            + + +L     VHRDL   NIL++S+    ++DFGL++ + D+   + +  G      +
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
            APE +  +     +D WS GI+++E+++ G+ P+   +  ++  + IN+  +LP
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-MKAINDGFRLP 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 57/230 (24%), Positives = 110/230 (47%), Gaps = 27/230 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+VF  + +       +   A+K  R +T+       +++  R IL + +HP I
Sbjct: 3   IGRGNFGEVFSGRLRA-----DNTPVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSHPNI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV-------SAVSH 230
           V+L      +  +Y++++ + GG            R +  R    E++       + + +
Sbjct: 56  VRLIGVCTQKQPIYIVMELVQGGDF------LTFLRTEGPRLKVKELIQMVENAAAGMEY 109

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEIL 286
           L     +HRDL   N L+     + ++DFG+++E +E     S  G  +    + APE L
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEAL 168

Query: 287 LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
               ++ ++D WS GILL+E  + G  P+ + + Q+ ++  I + V+LP 
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-AIEQGVRLPC 217

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 52/216 (24%), Positives = 107/216 (49%), Gaps = 22/216 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVF----QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           I P +  + + +G G FG V+      K+K           A+K +R+  + +++     
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRK----------VAIKTIREGAMSEED----F 46

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYT 221
             E  ++ K++HP +VQL      RS + L+ +F+  G L  +L  Q G F ++      
Sbjct: 47  IEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTE 279
            ++   +++L    ++HRDL   N L+  +  V ++DFG+ + +  D+ + S       +
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           + +PE+     ++  +D WS G+L++E+ + G+ P+
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 74/320 (23%), Positives = 131/320 (40%), Gaps = 48/320 (15%)

Query: 18  KKLTITPPSASSPDFDFTEV-----FGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
           +K++I  P  + P      +      G L   R N    AS        +        F 
Sbjct: 64  EKVSIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHLDFD 123

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVG---QGAFGKVF-- 127
              P  A    +PL   +L+H+++                  FRV+     GAFGK+F  
Sbjct: 124 EAPPDAA--GPVPLAQAKLKHDDEF--------------LAHFRVIDDLPAGAFGKIFIC 167

Query: 128 --------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
                      ++GV+  +       +++ K           ++ E   L ++ H  I++
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227

Query: 180 LRYSFQTRSKLYLI---LDFINGGHLFFHLYRQGIFRED-----QARFYTAEIVSAVSHL 231
           +    ++ +  Y+I    DF     L+  +Y +    +D     Q R    +++ AV ++
Sbjct: 228 IEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI 283

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPEILLSK 289
           H   ++HRD+K ENI ++ DG ++L DFG A   E +  +      GT    +PEIL   
Sbjct: 284 HDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD 343

Query: 290 GHNKDADWWSVGILLYEMLT 309
           G+ +  D WS G++L +ML+
Sbjct: 344 GYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 57/233 (24%), Positives = 105/233 (45%), Gaps = 42/233 (18%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIKKNHVDYMK--AERDILTK 171
           + +G+G FGKV  VK          G    A+K+++++     +  +     +E ++L +
Sbjct: 6   KTLGEGEFGKV--VKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQ 59

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQ--------GIFREDQARF-- 219
           V HP +++L  +      L LI+++   G L  F    R+           R        
Sbjct: 60  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 220 ------------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEID 266
                       +  +I   + +L +  +VHRDL   N+L+ ++G  M ++DFGL++++ 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVY 178

Query: 267 ES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           E      RS       ++MA E L    +   +D WS G+LL+E++T G  P+
Sbjct: 179 EEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 23/214 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +G+G FG V   +   +   D+ G + A+K ++  T     H+   + E +IL  + H  
Sbjct: 12  LGKGNFGSVELCRYDPL--QDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDN 66

Query: 177 IVQLR---YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
           IV+ +   YS   R  L L+++++  G L  +L +    R D  +   Y ++I   + +L
Sbjct: 67  IVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL 124

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YMAPEILL 287
                VHRDL   NIL++S+  V + DFGL K + +      +    E    + APE L 
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 321
               +  +D WS G++LYE+      FT++++  
Sbjct: 185 ESKFSVASDVWSFGVVLYEL------FTYSDKSC 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 66/275 (24%), Positives = 124/275 (45%), Gaps = 32/275 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D  + R +G+GAFGKVF  +   +       + A+K ++  T+  +   D+ + E ++LT
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQR-EAELLT 62

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE--- 223
            + H  IV+          L ++ +++  G L   L   G    I  + Q R    E   
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 224 ---------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
                    I S + +L     VHRDL   N L+ ++  V + DFG+++++  S+    +
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRV 181

Query: 275 CGTT----EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIIN 328
            G T     +M PE ++ +    ++D WS G++L+E+ T   QP F  +N + ++     
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241

Query: 329 EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
             ++ P     E + ++ G         ++P +RL
Sbjct: 242 RVLERPRVCPKEVYDIMLGC------WQREPQQRL 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 61/238 (25%), Positives = 121/238 (50%), Gaps = 27/238 (11%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           +I  V+G G FG+V + + K    G  +   A+K + K    +K   D++ +E  I+ + 
Sbjct: 7   KIEEVIGAGEFGEVCRGRLKLP--GKREIFVAIKTL-KSGYTEKQRRDFL-SEASIMGQF 62

Query: 173 THPFIVQLRYSFQTRSKLYLIL-DFINGGHLFFHLYRQGIFREDQARFYTAEIV------ 225
            HP I+ L     T+S+  +I+ +F+  G L          R++  +F   ++V      
Sbjct: 63  DHPNIIHLE-GVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGI 115

Query: 226 -SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGT--T 278
            + + +L +   VHRDL   NIL++S+    ++DFGL++ +++ +     ++S+ G    
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
            + APE +  +     +D WS GI+++E+++ G+ P+   + Q +    I +  +LPP
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN-AIEQDYRLPP 232

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 68/259 (26%), Positives = 124/259 (47%), Gaps = 20/259 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D  + R +G+G FG V+Q V     ++  +  +   K     ++ +K        E  I+
Sbjct: 7   DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-----FLQEAYIM 61

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSA 227
            +  HP IV+L     T + ++++++    G L  +L +   +  D A    Y+ ++ +A
Sbjct: 62  RQFDHPHIVKL-IGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTA 119

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEI 285
           +++L     VHRD+   N+L+ S   V L DFGL++ +++ S   +  G    ++MAPE 
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179

Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239

Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +T+    DPSKR
Sbjct: 240 L------MTKCWAYDPSKR 252

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.1 bits (169), Expect = 5e-13
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 17/210 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV 172
           + +G GAFGKV +    G+   D+     MKV   M K T    +  + + +E  I++ +
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDA----VMKVAVKMLKPTA-HSSEREALMSELKIMSHL 95

Query: 173 -THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVS 229
             H  IV L  +      + +I ++   G L  F    R+     +    ++ ++   ++
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGT---TEYMAPEI 285
            L     +HRDL   N+L+ + G ++ + DFGLA++I   S            ++MAPE 
Sbjct: 156 FLASKNCIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           + +  +  ++D WS GILL+E+ + G  P+
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 70/299 (23%), Positives = 137/299 (45%), Gaps = 38/299 (12%)

Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           + E E   D   E   +R +      + + +G+G FG+V   +  G+D    + +  + V
Sbjct: 2   VSEYELPEDPRWEVPRDRLV------LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV 55

Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 56  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 114

Query: 206 L-----------YRQGIFREDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           L           Y      E+Q  F        ++   + +L     +HRDL   N+L+ 
Sbjct: 115 LRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174

Query: 250 SDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 306
            D  + + DFGLA++I   D   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234

Query: 307 MLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           + T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 235 IFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.0 bits (166), Expect = 8e-13
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 118 VGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +G G +G+V++ V KK           A+K +++DT+     V+    E  ++ ++ HP 
Sbjct: 14  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPN 63

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYTA-EIVSAVSHLH 232
           +VQL          Y+I +F+  G+L  +L      R++       Y A +I SA+ +L 
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLE 121

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---EYMAPEILLSK 289
           K   +HRDL   N L+  +  V + DFGL++ +   + + +  G     ++ APE L   
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN 180

Query: 290 GHNKDADWWSVGILLYEMLT-GQPPF 314
             +  +D W+ G+LL+E+ T G  P+
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 67/269 (24%), Positives = 126/269 (46%), Gaps = 32/269 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKV-MRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V + +  G+D    D    + V M KD    K+  D + +E +++  +  H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI-SEMELMKLIGKHK 78

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS 226
            I+ L         LY+I+++   G+L   L         Y   I +  + +    ++VS
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 227 AV-------SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSMCG 276
                     +L     +HRDL   N+L+  D  + + DFGLA+   +ID   ++++   
Sbjct: 139 CAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE L  + +   +D WS GIL++E+ T G  P+     ++L  +++ E  ++  
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-FKLLREGHRMDK 257

Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P   T E + L++      +  H  P++R
Sbjct: 258 PSNCTHELYMLMR------ECWHAVPTQR 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 34/214 (15%)

Query: 118 VGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +G G FG V     KGV     G    + A+K ++++ I           E  ++ ++ H
Sbjct: 3   LGHGNFGSV----VKGVYLMKSGKEVEV-AVKTLKQEHI--AAGKKEFLREASVMAQLDH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           P IV+L    +    L L+++    G L  +L ++        +    ++   +++L   
Sbjct: 56  PCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114

Query: 235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MA 282
             VHRDL   N+L+ +     ++DFG+++ +          G+  Y             A
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALG--------AGSDYYRATTAGRWPLKWYA 166

Query: 283 PE-ILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           PE I   K  +K +D WS G+ L+E  + G  P+
Sbjct: 167 PECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 53/230 (23%), Positives = 104/230 (45%), Gaps = 24/230 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAFGKV++ +  G ++  S    A+K ++++   K       + E ++++ + HP I
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR----------------QGIFREDQARFYT 221
           V L           ++ +++  G L   L R                +            
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGT 277
            +I + + +L     VHRDL   N L+     V ++DFGL+++I  +     +S S+   
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-P 189

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
             +M PE +L      ++D WS G++L+E+ + G  P+   + Q++ + I
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS--- 271
           +  +F+  +++ A+ ++H   + HRDLKP+NIL ++D  + + DFGLA+     + +   
Sbjct: 103 EHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162

Query: 272 -NSMCGTTEYMAPEI---LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
                 T  Y APE+     SK +    D WS+G +  E+LTG+P F   N    Q  +I
Sbjct: 163 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLI 220

Query: 328 NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDP 359
            + +  P   T       K   +L+ +  K P
Sbjct: 221 TDLLGTPSPETISRVRNEKARRYLSSMRKKQP 252

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 24/235 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FGKV   +      G S     +K +R  +      + +++ E     ++ HP +
Sbjct: 3   IGNGWFGKVLLGE---AHRGMSKARVVVKELR-ASATPDEQLLFLQ-EVQPYRELNHPNV 57

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFRED-----QARFYTAEIVSAVSHL 231
           +Q            L+L+F   G L  +L   +G+  +        R    E+ S +  L
Sbjct: 58  LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVASGLLWL 116

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEI--- 285
           H+   +H DL   N  + +D  V + D+GLA E    D     +       ++APE+   
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 286 ----LLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLP 334
               LL K   K ++ WS+G+ ++E+ T   QP    ++ Q L+Q +  + +KLP
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 34/269 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPF 176
           +G+GAFG+V + +  G+D+ +     A+K M KD   +K+  D + +E +++  +  H  
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLV-SEMEMMKMIGKHKN 77

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS- 226
           I+ L         LY+++++   G+L   L               R  +      ++VS 
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 227 ------AVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDE----SSRSNSMC 275
                  +  L     +HRDL   N+L+ ++ HVM + DFGLA++I         +N   
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKL 333
              ++MAPE L  + +   +D WS G+LL+E+ T G  P+     ++L + +    +++ 
Sbjct: 197 -PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEK 255

Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P   T E + L++         H+ PS+R
Sbjct: 256 PQNCTQELYHLMR------DCWHEVPSQR 278

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 60/252 (23%), Positives = 118/252 (46%), Gaps = 27/252 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAFGKVF  +   +       + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTVLQHQHI 69

Query: 178 VQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQG----IFREDQAR-----------FYT 221
           V+  Y   T  + L ++ +++  G L   L   G    I    +                
Sbjct: 70  VRF-YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT--- 278
           ++I S + +L     VHRDL   N L+     V + DFG++++I  S+    + G T   
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLP 187

Query: 279 -EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPP 335
             +M PE +L +    ++D WS G++L+E+ T   QP +  +N + ++      +++ P 
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR 247

Query: 336 FLTSEAHSLLKG 347
               E +++++G
Sbjct: 248 TCPPEVYAIMQG 259

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 29/231 (12%)

Query: 117 VVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           V+G+G FG+V +  +KK G+       + A     K+   K +H D+   E ++L K+ H
Sbjct: 2   VIGEGNFGQVLKARIKKDGLR------MDAAIKRMKEYASKDDHRDF-AGELEVLCKLGH 54

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA---------------- 217
            P I+ L  + + R  LYL +++   G+L   L +  +   D A                
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 218 -RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
             F  A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +      
Sbjct: 115 LHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
              +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 58/257 (22%), Positives = 118/257 (45%), Gaps = 28/257 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           D +   V+G+G FG+V +  +KK      D   + A   M K+   + +H D+   E ++
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKK------DGLKMNAAIKMLKEFASENDHRDF-AGELEV 55

Query: 169 LTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED------------ 215
           L K+  HP I+ L  + + R  LY+ +++   G+L   L +  +   D            
Sbjct: 56  LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 216 ----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
               Q   + +++ + + +L +   +HRDL   N+L+  +    + DFGL++  +   + 
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE- 329
                   +MA E L    +   +D WS G+LL+E+++ G  P+      +L +++    
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235

Query: 330 KVKLPPFLTSEAHSLLK 346
           +++ P     E + L++
Sbjct: 236 RMEKPRNCDDEVYELMR 252

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 19/221 (8%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNH--V 159
           R +   +    +++G G FG V     KG+   +GDS  I  A+K ++  +  +      
Sbjct: 2   RILKETELRKLKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEIT 57

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQAR 218
           D+M A    +  + H +IV+L       + L L+      G L  H+   +      +  
Sbjct: 58  DHMLA----MGSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMC 275
            +  +I   + +L +  +VHR+L   NIL+ SD  V + DFG+A  +   D+    +   
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT 315
              ++MA E +L   +   +D WS G+ ++EM++ G  P+ 
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 55/219 (25%), Positives = 105/219 (47%), Gaps = 23/219 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKV-MRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V   +  G+D    +    + V M KD    K+  D + +E +++  +  H 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LVSEMEMMKMIGKHK 78

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS 226
            I+ L  +      LY+++++ + G+L  +L         Y     +  + +    ++VS
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 227 -------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE---IDESSRSNSMCG 276
                   + +L     +HRDL   N+L+  D  + + DFGLA++   ID   ++ +   
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
             ++MAPE L  + +   +D WS G+LL+E+ T G  P+
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 62/270 (22%), Positives = 120/270 (44%), Gaps = 37/270 (13%)

Query: 118 VGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +G+ AFGK+++  +   G+D      + A+K ++   I         + E  ++ ++ HP
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQ---LVAIKTLKD--INNPQQWGEFQQEASLMAELHHP 67

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ------------GIFRE--DQARFY 220
            IV L         + ++ +++N G L  F + R             G  +   D   F 
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 221 --TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSM 274
               +I + + +L     VH+DL   NIL+    HV ++D GL++EI  +     +  S+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG--QPPFTHANRQKLQQRIINEKVK 332
                +M PE ++    + D+D WS G++L+E+ +   QP +  +N++      + E V+
Sbjct: 188 L-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------VIEMVR 240

Query: 333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
               L        +  S +T+   + PS+R
Sbjct: 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 82/351 (23%), Positives = 142/351 (40%), Gaps = 52/351 (14%)

Query: 2   VSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDP 61
              S K  +S  T +    +      S    D        +    +++  A+T  +   P
Sbjct: 28  SGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTP 87

Query: 62  QVIHNRSHSFVGPSP-RYALSSSLPLQIQELEHEN---DAELEAESERKIGPGDFEIFRV 117
                 ++  V P P +  ++ +LP Q +E  H       +++  ++R      F+I  +
Sbjct: 88  T-----TNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQR------FKILSL 136

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDILTKVTH 174
           +G+G FGKV +       D       A+K++R   K T   K  + +M+  R        
Sbjct: 137 LGEGTFGKVVEAW-----DRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRF 191

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV----SAVSH 230
           P +   RY FQ  +    I+    G  L   + + G F       + A+I+     A+ +
Sbjct: 192 PLMKIQRY-FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHR----HLAQIIFQTGVALDY 246

Query: 231 LH-KCGIVHRDLKPENILMDSDG----------------HVMLTDFGLAKEIDESSRSNS 273
            H +  ++H DLKPENILM++                   V + D G     DE     +
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTA 304

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQ 323
           +  T  Y +PE++L  G     D WS+G ++YE+ TG+  + TH N + L 
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355

Length = 467

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 51/204 (25%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G G FG+V+          +     A+K M+  ++     V+   AE +++  + H 
Sbjct: 12  KKLGAGQFGEVWMATY------NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHD 61

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHK 233
            +V+L ++  T+  +Y+I +F+  G L   L      ++   +   ++A+I   ++ + +
Sbjct: 62  KLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPEILLSKGH 291
              +HRDL+  NIL+ +     + DFGLA+  E +E +         ++ APE +     
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 292 NKDADWWSVGILLYEMLT-GQPPF 314
              +D WS GILL E++T G+ P+
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 24/249 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FG V + +    DDG S    A+K M+ D        +++  E   +    HP
Sbjct: 5   KILGEGEFGSVMEGQLSQ-DDG-SQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFDHP 61

Query: 176 FIVQL-RYSFQTRS-----KLYLILDFINGGHLFFHLYRQGIFREDQARFYT-------- 221
            +++L    F+  S     K  +IL F+  G L   L    +                  
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL--GGLPEKLPLQTLLKFM 119

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---T 278
            +I   + +L     +HRDL   N ++  D  V + DFGL+K+I                
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPF 336
           +++A E L  + +   +D W+ G+ ++E+ T GQ P+      ++   + +  ++K P  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239

Query: 337 LTSEAHSLL 345
              E + L+
Sbjct: 240 CLDELYDLM 248

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 60/253 (23%), Positives = 113/253 (44%), Gaps = 27/253 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           R +G+GAFGKVF  +   +       + A+K ++   D   K  H      E ++LT + 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-----REAELLTNLQ 65

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-------------FREDQARFY 220
           H  IV+          L ++ +++  G L   L   G                + Q    
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT-- 278
             +I + + +L     VHRDL   N L+  +  V + DFG+++++  S+    + G T  
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTML 184

Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLP 334
              +M PE ++ +    ++D WS+G++L+E+ T G+ P+   +  ++ + I   +V + P
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244

Query: 335 PFLTSEAHSLLKG 347
                E + L+ G
Sbjct: 245 RTCPKEVYDLMLG 257

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 54/207 (26%), Positives = 107/207 (51%), Gaps = 16/207 (7%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           ++ + +G G FG+V+     G  +G +    A+K +++ ++      +   AE +++ ++
Sbjct: 9   KLVKKLGAGQFGEVWM----GYYNGHTK--VAIKSLKQGSM----SPEAFLAEANLMKQL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFI-NGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSH 230
            HP +V+L Y+  T+  +Y+I +++ NG  + F    +GI    ++     A+I   ++ 
Sbjct: 59  QHPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTTEYMAPEILLS 288
           + +   +HRDL+  NIL+       + DFGLA+  E +E +         ++ APE +  
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177

Query: 289 KGHNKDADWWSVGILLYEMLT-GQPPF 314
                 +D WS GILL E++T G+ P+
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 44/184 (23%), Positives = 88/184 (47%), Gaps = 16/184 (8%)

Query: 147 VMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTRSKLYLILDFINGGH--- 201
            ++K  +   +  D    +++I+T  ++ HP I+    SF   S+LY++   +  G    
Sbjct: 29  AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L    + +G   E    F   ++++A+ ++H  G +HR +K  +IL+  DG V+L+    
Sbjct: 89  LLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147

Query: 262 AKEIDESS-RSNSMCGTTEY-------MAPEILLS--KGHNKDADWWSVGILLYEMLTGQ 311
           +  + +   R   +    +        ++PE+L    +G+N+ +D +SVGI   E+  G 
Sbjct: 148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207

Query: 312 PPFT 315
            PF 
Sbjct: 208 VPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 61/243 (25%), Positives = 111/243 (45%), Gaps = 27/243 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHV------DYMKAERDIL 169
           +G G FG V    KKG+        Y MK   K   +K  KN        D +  E +++
Sbjct: 3   LGSGNFGTV----KKGM--------YKMKKSEKTVAVKILKNDNNDPALKDELLREANVM 50

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            ++ +P+IV++    +  S   L+++    G L   L +     E        ++   + 
Sbjct: 51  QQLDNPYIVRMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMK 109

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT--TEYMAPEI 285
           +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G    ++ APE 
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +     +  +D WS G+L++E  + GQ P+      ++ Q I + E+++ P     E + 
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYD 229

Query: 344 LLK 346
           L+K
Sbjct: 230 LMK 232

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 52/214 (24%), Positives = 102/214 (47%), Gaps = 29/214 (13%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY------AMKVMRKDTIIKKNHVDYMKAER 166
           ++ + +G G FG+V+             G Y      A+K ++  T+     V     E 
Sbjct: 9   KLVKKLGAGQFGEVWM------------GYYNNSTKVAVKTLKPGTM----SVQAFLEEA 52

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARF--YTAE 223
           +++  + H  +V+L Y+  T+ + +Y+I +++  G L   L      +    +   ++A+
Sbjct: 53  NLMKTLQHDKLVRL-YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 111

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYM 281
           I   ++++ +   +HRDL+  N+L+       + DFGLA+ I  +E +         ++ 
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           APE +        +D WS GILLYE++T G+ P+
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 67/267 (25%), Positives = 105/267 (39%), Gaps = 70/267 (26%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +V+G GAFGKV +    G+D   S    A+K M K+      H   M +E  IL  +  H
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVK-MLKEGATASEHKALM-SELKILIHIGNH 70

Query: 175 PFIVQLRYS-FQTRSKLYLILDFINGGHL---------FFHLYRQ--------------- 209
             +V L  +  +    L +I++F   G+L         FF  YR+               
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 210 ---------GIFREDQARF-----------------------------YTAEIVSAVSHL 231
                    G      +RF                             Y+ ++   +  L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLS 288
                +HRDL   NIL+  +  V + DFGLA++I    +  R  S     ++MAPE +  
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250

Query: 289 KGHNKDADWWSVGILLYEMLT-GQPPF 314
           K +   +D WS G+LL+E+ + G  P+
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 53/225 (23%), Positives = 103/225 (45%), Gaps = 21/225 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +GQG+FG V++   KGV   + +   A+K + +   +++  ++++  E  ++ +    
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-RIEFLN-EASVMKEFNCH 69

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA------------E 223
            +V+L           +I++ +  G L  +L  + +  E +     A            E
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEY 280
           I   +++L+    VHRDL   N ++  D  V + DFG+ ++I E+    +         +
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQ 323
           M+PE L        +D WS G++L+E+  L  QP    +N Q L+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 5/88 (5%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN----SMCGTT 278
           +++SA+ ++H  GI+HRD+K EN+L++    + L DFG A      S S      + GT 
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWSTPFHYGIAGTV 326

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYE 306
           +  APE+L    +    D WS G++++E
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 12/149 (8%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+  +  V + DFGLA++I    +  R      
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF--THANRQKLQQRIINEKVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+     + +  ++     +++ 
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303

Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 304 PDYTTPEMYQT------MLDCWHGEPSQR 326

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 14/136 (10%)

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSK 289
           KC  +HRDL   NIL+  +  V + DFGLA++I +     R        ++MAPE +  K
Sbjct: 193 KC--IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 290 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLK 346
            +   +D WS G+LL+E+ + G  P+      +   R + E  ++  P + T E +S++ 
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML 310

Query: 347 GVSFLTQLLHKDPSKR 362
                    H +P  R
Sbjct: 311 DC------WHNNPEDR 320

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 18/178 (10%)

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----QARFYTAEIVSAVS 229
           HP I+Q            L+ ++   G L  +L ++   R +      +    EI + V+
Sbjct: 54  HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA----KEIDESSRSNSMCGTTEYMAPEI 285
           H+HK   +H DL   N  + SD  V + D+G+     KE D     +  C    ++APE+
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPEL 172

Query: 286 -------LLSKGHNKDADWWSVGILLYEML-TGQPPFTH-ANRQKLQQRIINEKVKLP 334
                  L++    K ++ W++G+ L+E+      P++H ++R+ L   I +++VKL 
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 26/216 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           +G+G FG+V   + +G+ +              + A+K++R D + K    D++K E  I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLK-EIKI 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE------------DQ 216
           ++++ +P I++L     +   L +I +++  G L   L ++ I                 
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNS 273
             +   +I S + +L     VHRDL   N L+ +   + + DFG+++ +   D       
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
                 +MA E +L       +D W+ G+ L+EM T
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 30/88 (34%), Positives = 44/88 (50%), Gaps = 6/88 (6%)

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           VHRDL   N ++D    V + DFGLA     KE              ++MA E L ++  
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179

Query: 292 NKDADWWSVGILLYEMLT-GQPPFTHAN 318
              +D WS G+LL+E++T G PP+   +
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVD 207

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 35/244 (14%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G FG V + +   ++  DS    A+K M K  I  ++ ++   +E   + +  HP
Sbjct: 5   KTLGEGEFGSVMEGQ---LNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 176 FIVQL-RYSFQ-TRSKLY----LILDFINGG--HLFFHLYRQGIFREDQARF-------- 219
            +++L     Q   S+ Y    +IL F+  G  H F    R G    D  ++        
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVK 116

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           +  +I S + +L     +HRDL   N +++ + +V + DFGL+K+I   D   +      
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK----LQQRIINEKV 331
             +++A E L  + +   +D WS G+ ++E+ T GQ P+      +    L+Q     ++
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ---GNRL 233

Query: 332 KLPP 335
           K PP
Sbjct: 234 KQPP 237

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 37/125 (29%), Positives = 63/125 (50%), Gaps = 14/125 (11%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA----KEIDESSRSNSMCGTT 278
           EI   + HLHK   +H DL   N L+ +D  V + D+GL+    KE D     + +    
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE-DYYVTPDQLWVPL 166

Query: 279 EYMAPEI-------LLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQQRIINE 329
            ++APE+       LL     K+++ WS+G+ ++E+  L  QP    ++ Q L   +  +
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ 226

Query: 330 KVKLP 334
           ++KLP
Sbjct: 227 QLKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 53/228 (23%), Positives = 104/228 (45%), Gaps = 23/228 (10%)

Query: 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           + R +GQG+FG V++   + +  G+++   A+K + +   +++  ++++  E  ++   T
Sbjct: 10  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-RIEFLN-EASVMKGFT 67

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----QARF---------Y 220
              +V+L           ++++ +  G L  +L      R +      R           
Sbjct: 68  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS---LRPEAENNPGRPPPTLQEMIQM 124

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT 277
            AEI   +++L+    VHRDL   N ++  D  V + DFG+ ++I E+    +       
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQ 323
             +MAPE L        +D WS G++L+E+  L  QP    +N Q L+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 56/238 (23%), Positives = 105/238 (44%), Gaps = 22/238 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+  FGKV++    G   G+     A+K ++          +  K E  + +++ HP I
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFKHEAMMRSRLQHPNI 70

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ-----GIFREDQ--------ARFY--T 221
           V L         L +I  + +   L  F + R      G   +D+        A F    
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---T 278
            +I + +  L    +VH+DL   N+L+    +V ++D GL +E+  +     M  +    
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
            +M+PE ++    + D+D WS G++L+E+ + G  P+   + Q + + I N +V   P
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 33/228 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G+G FG+V   + +G++            G+   + A+K++R+D   K    D++K E 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLK-EI 70

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA--------- 217
            I++++  P I++L     T   L +I +++  G L   L R    +E            
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE-PQEAAEKADVVTISY 129

Query: 218 ---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRS 271
               F   +I S + +L     VHRDL   N L+  +  + + DFG+++ +   D     
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 272 NSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT--GQPPFTH 316
                   +M+ E ILL K     +D W+ G+ L+E+LT   + P++ 
Sbjct: 190 GRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ 236

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 53.4 bits (128), Expect = 8e-08
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 18/176 (10%)

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           HP I+     F T S L++I  F+  G    L    + +G+  E          +  +++
Sbjct: 58  HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFGALRGLNY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFG-LAKEIDESSRS-------NSMCGTTEYMA 282
           LH+ G +HR++K  +IL+  DG V L+    L   +    ++               +++
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176

Query: 283 PEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           PE+L     G+N  +D +SVGI   E+ TG+ PF    R ++    + +K+K PP+
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM----LLQKLKGPPY 228

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 4/99 (4%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-- 277
           ++ ++ + +  L     VHRDL   N+L+     V + DFGLA++I   S   S   T  
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
             ++MAPE + +  +   +D WS GILL+E+ T G  P+
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 3/93 (3%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-- 277
           +T ++   +  L     VHRDL   N+L+     V + DFGLA++I   S   S   T  
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
             ++MAPE +    +   +D WS GILL+E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.7 bits (129), Expect = 9e-08
 Identities = 34/107 (31%), Positives = 60/107 (56%), Gaps = 9/107 (8%)

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESS--- 269
           +D  RF ++++   +  L     +HRD+   N+L+ +DG V  + DFGLA++I   S   
Sbjct: 212 DDLLRF-SSQVAQGMDFLASKNCIHRDVAARNVLL-TDGRVAKICDFGLARDIMNDSNYV 269

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            + N+     ++MAPE +    +   +D WS GILL+E+ + G+ P+
Sbjct: 270 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 26/67 (38%), Positives = 41/67 (61%), Gaps = 2/67 (2%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE--Y 280
           ++++ +  LH+ GIVHRD+KPEN+L+  DG V + DFG A ++      N + G  +  Y
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376

Query: 281 MAPEILL 287
             PE L+
Sbjct: 377 SPPEELV 383

Length = 507

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 54/254 (21%), Positives = 107/254 (42%), Gaps = 40/254 (15%)

Query: 134 VDDGDSDGIYAMKVMRKDTIIK------KNH---VDYMKAERDILTKVTHPFIVQLRYSF 184
           + + D + IY      K+ II+      K H   +D  + E   L ++    I+++ Y F
Sbjct: 28  IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI-YGF 86

Query: 185 -----QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-----EIVSAVSHLHK- 233
                    +L LIL++   G+L     R+ + +E    F T      +    + +L+K 
Sbjct: 87  IIDIVDDLPRLSLILEYCTRGYL-----REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY 141

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILL---S 288
               +++L   + L+  +  + +   GL K +        N M     Y + ++L    S
Sbjct: 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFS 197

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           + +    D +S+G++L+E+ TG+ PF +   +++   IIN+   L   L  +    +K +
Sbjct: 198 E-YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--LPLDCPLEIKCI 254

Query: 349 SFLTQLLHKDPSKR 362
             +      D  KR
Sbjct: 255 --VEACTSHDSIKR 266

Length = 283

>gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 29/80 (36%), Positives = 36/80 (45%), Gaps = 8/80 (10%)

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDS 250
           L+  +  G  L  HL R      D A F +A    A+  LH+ GI H DL KP+N LM  
Sbjct: 95  LVRGWTEGVPL--HLARP---HGDPAWFRSAH--RALRDLHRAGITHNDLAKPQNWLMGP 147

Query: 251 DGHVMLTDFGLAKEIDESSR 270
           DG   + DF LA        
Sbjct: 148 DGEAAVIDFQLASVFRRRGA 167

Length = 365

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.7 bits (121), Expect = 7e-07
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 8/134 (5%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMC 275
           ++ ++   +S L     +HRDL   NIL+       + DFGLA++I   S    + N+  
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL- 333
              ++MAPE + +  +  ++D WS GILL+E+ + G  P+          ++I E  ++ 
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337

Query: 334 -PPFLTSEAHSLLK 346
            P    SE + ++K
Sbjct: 338 SPECAPSEMYDIMK 351

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 37/277 (13%)

Query: 98  ELEAES---ERKIGPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           EL+ +S   ER +G G F E+ R   +    +   V    +  G SD             
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD------------- 47

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIF 212
             K    ++ AE   L +  H  IV+L       + + ++ ++++ G L   L + +G  
Sbjct: 48  --KQRRGFL-AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQL 104

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
              Q       + S + +L + G VH+ L    +L++SD    ++ F   +E    +   
Sbjct: 105 VAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT 164

Query: 273 SMCGTTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE 329
           +M G +   + APE +     +  +D WS GI+++E+++ G+ P+   + Q +  + + +
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-IKAVED 223

Query: 330 KVKLPPFLTSEAHSLLKGVSFLTQLL----HKDPSKR 362
             +LP                L QL+     K+  +R
Sbjct: 224 GFRLPAPRNCPNL--------LHQLMLDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain

 Score = 43.8 bits (104), Expect = 3e-06
 Identities = 13/46 (28%), Positives = 20/46 (43%), Gaps = 4/46 (8%)

Query: 400 VSGKDCIANFDKCWTTMPADDSPAPTPTAG----EHFKGYTYVAPN 441
           V      +NFD  +T+ P   SP  +          F+G++YV P 
Sbjct: 2   VKSPTDTSNFDPEFTSEPPKLSPPDSEVLSSIDQLEFRGFSYVNPE 47

Length = 47

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 43/187 (22%), Positives = 77/187 (41%), Gaps = 24/187 (12%)

Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++R D   K    D++K E  IL+++  P I++L         L +I +++  G L 
Sbjct: 50  AVKILRPDAN-KNARNDFLK-EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 204 FHLYR------------------QGIFREDQARFYTA-EIVSAVSHLHKCGIVHRDLKPE 244
             L                            +  + A +I S + +L     VHRDL   
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 245 NILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVG 301
           N L+  +  + + DFG+++ +   D             +MA E +L       +D W+ G
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227

Query: 302 ILLYEML 308
           + L+E+L
Sbjct: 228 VTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 14/169 (8%)

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFRED 215
           V +++ E  +     HP IV  R +F   ++L+++  F+  G    L    +  G+  E 
Sbjct: 43  VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-SEL 101

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF-GLAKEIDESSRSNSM 274
              +    ++ A+ ++H  G VHR +K  +IL+  DG V L+        I+   R   +
Sbjct: 102 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161

Query: 275 CGTTEY-------MAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF 314
               +Y       ++PE+L    +G++  +D +SVGI   E+  G  PF
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 35/146 (23%), Positives = 60/146 (41%), Gaps = 14/146 (9%)

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
           +  + +  E++     A  +  +  L +    HR  K  NIL+  DG + L      K  
Sbjct: 9   VRGRPL-NEEEI---WAVCLQCLGALREL---HRQAKSGNILLTWDGLLKLDGSVAFKT- 60

Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-Q 324
            E SR +       +MAPE++  + + + AD +S+GI LYE L  + P+          +
Sbjct: 61  PEQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE 115

Query: 325 RIINEKVKLPPFLTSEAHSLLKGVSF 350
            ++N      P   S    +    SF
Sbjct: 116 ILLNGMPADDPRDRSNLEGVSAARSF 141

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 18/41 (43%), Positives = 25/41 (60%), Gaps = 1/41 (2%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLA 262
           +I+ A+  LH  GIVHRD+KP+NI+     G   + D G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 17/41 (41%), Positives = 22/41 (53%), Gaps = 1/41 (2%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
           E+   V  LHK GIVH DL   NI++     +   DFGL +
Sbjct: 100 EVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139

Length = 204

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 16/33 (48%), Positives = 22/33 (66%), Gaps = 1/33 (3%)

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
           LH  GI+H DL   N+++ S G + L DFGLA+
Sbjct: 111 LHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE 142

Length = 211

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 31/141 (21%), Positives = 61/141 (43%), Gaps = 16/141 (11%)

Query: 131 KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY----MKAERDILTKV-THPFIV-QLRYSF 184
            K +  G ++ +Y +    +D ++K N         + E  IL  +      V ++  S 
Sbjct: 3   IKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG 62

Query: 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---GIVHRDL 241
           ++    YL++++I G  L      +   +ED A     ++   ++ LH+     + H DL
Sbjct: 63  ESDGWSYLLMEWIEGETLDEVSEEE---KEDIAE----QLAELLAKLHQLPLLVLCHGDL 115

Query: 242 KPENILMDSDGHVMLTDFGLA 262
            P NIL+D    + + D+  A
Sbjct: 116 HPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 14/150 (9%)

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           + K+ HP IV+L    ++    YLI ++I G +L   L  + +  E + +     I  A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RNLSWERRRKIAIG-IAKAL 793

Query: 229 SHLH-KCG--IVHRDLKPENILMD--SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
             LH +C   +V  +L PE I++D   + H+ L+  GL    D     +S      Y+AP
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLC-TDTKCFISS-----AYVAP 847

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPP 313
           E   +K   + +D +  G++L E+LTG+ P
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 35/228 (15%)

Query: 119 GQGAFGKV----------FQVKK-KGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           G+G FG+V          F  K     D+ D+  + A+KV+R D        D++K E  
Sbjct: 14  GEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLK-EVK 71

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT------ 221
           IL++++ P I +L         L +I++++  G L   L +  +         +      
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH-VAETSGLACNSKSLSFS 130

Query: 222 ------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RS 271
                  +I S + +L     VHRDL   N L+  +  + + DFG+++ +  S     + 
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190

Query: 272 NSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT--GQPPFTH 316
            +      +MA E +LL K     +D W+ G+ L+E+LT   + P+ H
Sbjct: 191 RAPL-PIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 19/37 (51%), Positives = 22/37 (59%), Gaps = 1/37 (2%)

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            V  LHK GIVH DL   NI++  D  + L DFGL K
Sbjct: 102 LVGKLHKAGIVHGDLTTSNIIVRDDK-LYLIDFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 6e-04
 Identities = 21/52 (40%), Positives = 25/52 (48%), Gaps = 5/52 (9%)

Query: 220 YTAEIVSAVSH----LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
              E+V  V      LHK GIVH DL   N ++  D  + L DFGL K  D 
Sbjct: 429 GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDRLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 14/42 (33%), Positives = 29/42 (69%)

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
             ++++ + ++H+ GI H D+KPENI++D +    + D+G+A
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK)

 Score = 39.2 bits (92), Expect = 0.001
 Identities = 26/119 (21%), Positives = 40/119 (33%), Gaps = 18/119 (15%)

Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLILDFINGGHLFFH 205
           V+R      +  ++  + E +         I  +L Y         LI +FI G  L   
Sbjct: 25  VVRIPGNGTELLIN-RENEAENSKLAAEAGIGPKLYYFDPETG--VLITEFIEGSELLTE 81

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIV-----HRDLKPENILMDSDGHVMLTDF 259
            +      E        +I   +  LH   +      H DL P N L   DG + L D+
Sbjct: 82  DFSDPENLE--------KIAKLLKKLHSSPLPDLVPCHNDLLPGNFL-LDDGRLWLIDW 131

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 44/227 (19%), Positives = 96/227 (42%), Gaps = 32/227 (14%)

Query: 119 GQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DILTKVTH 174
           GQG F  +++  ++ +   D    G     V++   ++  +H D +       ++++++H
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLK---VLGSDHRDSLAFFETASLMSQLSH 60

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSHLHK 233
             +V+L Y    R +  ++ +++  G L   L+R+        +   A ++ SA+ +L  
Sbjct: 61  KHLVKL-YGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 234 CGIVHRDLKPENILMDSDGH-------VMLTDFG-----LAKEIDESSRSNSMCGTTEYM 281
             +VH ++  +NIL+   G        + L+D G     L++E               ++
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER--------IPWI 171

Query: 282 APEIL--LSKGHNKDADWWSVGILLYEMLTGQP-PFTHANRQKLQQR 325
           APE +          AD WS G  L E+ +    P +  +  + ++ 
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 47/226 (20%), Positives = 103/226 (45%), Gaps = 32/226 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDILTKVTH 174
           +GQG F K+F+  ++ V  GD   ++  +V+ K  ++ K+H +Y ++      ++++++H
Sbjct: 3   LGQGTFTKIFKGIRREV--GDYGELHKTEVLLK--VLDKSHRNYSESFFEAASMMSQLSH 58

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSHLHK 233
             +V          +  ++ +++  G L  +L +         +   A ++  A+  L  
Sbjct: 59  KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118

Query: 234 CGIVHRDLKPENILMDSDGH--------VMLTDFG-----LAKEIDESSRSNSMCGTTEY 280
            G+ H ++  +N+L+  +          + L+D G     L KEI        +     +
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--------LLERIPW 170

Query: 281 MAPEILL-SKGHNKDADWWSVGILLYEMLTG--QPPFTHANRQKLQ 323
           + PE +   +  +  AD WS G  L+E+ +G  +P     +++KLQ
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 39.0 bits (92), Expect = 0.002
 Identities = 14/37 (37%), Positives = 22/37 (59%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
           EI+  +   +K GI+H DL   NIL+D D  + + D+
Sbjct: 133 EILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain

 Score = 38.6 bits (91), Expect = 0.002
 Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 3/76 (3%)

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDS 250
           L+++FI G  +     +     ED    Y  +I+  +  L  + G+VH DL   NIL+D 
Sbjct: 92  LVMEFIGGDGIPAPRLKDVRLLEDPEELY-DQILELMRKLYREAGLVHGDLSEYNILVD- 149

Query: 251 DGHVMLTDFGLAKEID 266
           DG V + D   A EID
Sbjct: 150 DGKVYIIDVPQAVEID 165

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 63/268 (23%), Positives = 118/268 (44%), Gaps = 40/268 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGI---YAMKVMRKDTIIKKNHVDYMKA---ERDILTK 171
           +G+G   +++       DD + DG      +KV+ K  ++  +H D   A      ++ +
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILK--VLDPSHRDISLAFFETASMMRQ 60

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSH 230
           V+H  IV L        +  ++ +F+  G L   ++R+        +F  A ++ SA+S+
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 231 LHKCGIVHRDLKPENILMDSDG-------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           L    +VH ++  +NIL+  +G        + L+D G+   I   SR   +     ++AP
Sbjct: 121 LEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECV-ERIPWIAP 177

Query: 284 EILL-SKGHNKDADWWSVGILLYEM-LTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           E +  SK  +  AD WS G  L+E+   G+ P        L+ + + EK +       E 
Sbjct: 178 ECVEDSKNLSIAADKWSFGTTLWEICYNGEIP--------LKDKTLAEKERF-----YEG 224

Query: 342 HSLLKGVS------FLTQLLHKDPSKRL 363
             +L   S       +T  ++ DP++R 
Sbjct: 225 QCMLVTPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	447
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.87
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
smart00090	237	RIO RIO-like kinase.	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.17
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.12
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.93
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.91
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.91
COG4248	637	Uncharacterized protein with protein kinase and he	98.86
PRK09902	216	hypothetical protein; Provisional	98.8
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.79
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.78
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.55
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.54
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.51
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.48
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.48
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.26
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.2
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.16
smart00133	64	S_TK_X Extension to Ser/Thr-type protein kinases.	98.14
PLN02876	822	acyl-CoA dehydrogenase	98.08
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.04
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.89
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.86
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.8
PRK10593	297	hypothetical protein; Provisional	97.72
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.69
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.65
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.6
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.58
PRK05231	319	homoserine kinase; Provisional	97.53
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.52
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.5
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.44
KOG2270	520	consensus Serine/threonine protein kinase involved	97.41
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.21
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.09
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.98
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.9
PLN02236	344	choline kinase	96.87
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.81
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.75
PLN02756	418	S-methyl-5-thioribose kinase	96.72
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.57
PF00433	48	Pkinase_C: Protein kinase C terminal domain; Inter	96.38
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.3
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.26
PRK11768	325	serine/threonine protein kinase; Provisional	96.03
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.92
PTZ00384	383	choline kinase; Provisional	95.9
PRK12396	409	5-methylribose kinase; Reviewed	95.87
PRK06148	1013	hypothetical protein; Provisional	95.49
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.46
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.12

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-77  Score=559.28  Aligned_cols=322  Identities=55%  Similarity=0.997  Sum_probs=297.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+++++||+|+||+||+++.+.     +++.||+|+++|..+.....++.+..|..||.+++||+||+++..|++
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~d-----t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt   96 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKD-----TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT   96 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcc-----cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence            556799999999999999999999885     899999999999999988889999999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc-
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~-  265 (447)
                      .+++|+|+||+.||+|+.+|.+++.|+|+.+++|+++|+.||.|||++|||||||||+|||||.+|+++|+|||+|+.. 
T Consensus        97 ~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen   97 EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999999964 


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSL  344 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~l  344 (447)
                      ..+..+.++|||+.|||||++.+.+|+..+|||||||++|||++|.+||.+.+..+++++|..++. ..|..++.+++++
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardl  256 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDL  256 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHH
Confidence            455567789999999999999999999999999999999999999999999999999999999994 4555599999888


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP  424 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (447)
                      ++.      +|.+||++|+| +..++++|++||||.+++|+.+.++++.|||+|...+..|+.+||..|+.+....++..
T Consensus       257 l~~------LL~rdp~~RLg-~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~  329 (357)
T KOG0598|consen  257 LKK------LLKRDPRQRLG-GPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVD  329 (357)
T ss_pred             HHH------HhccCHHHhcC-CCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhccccCCccc
Confidence            776      99999999998 45689999999999999999999999999999999999999999999988855444432


Q ss_pred             C-----------CCCCCCccCeeeeCC
Q 013249          425 T-----------PTAGEHFKGYTYVAP  440 (447)
Q Consensus       425 ~-----------~~~~~~f~~~~~~~~  440 (447)
                      .           ......|.||+|+++
T Consensus       330 ~~~~~~~~~~~~~~~~~~f~gft~~~~  356 (357)
T KOG0598|consen  330 SSPDMSAFTAFSRTYNKIFPGFTYVAS  356 (357)
T ss_pred             cCcccccccccccccccccCCccccCC
Confidence            1           135667999999876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-73  Score=563.50  Aligned_cols=325  Identities=38%  Similarity=0.804  Sum_probs=303.8

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  183 (447)
                      ..+..++|.++++||+|+||+|+++..++     +++.||||+++|+.+...+.++..+.|.+|+...+ ||++++|+.+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~-----~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKG-----TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcC-----CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence            45778899999999999999999999998     88899999999999999999999999999999886 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      |++.+++|+||||+.||++ .++...+.|++..+++|+++|+.||+|||++||||||||.+|||||.+|++||+|||+++
T Consensus       438 fQT~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             cccCCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999999999994 444455789999999999999999999999999999999999999999999999999999


Q ss_pred             cc-cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHH
Q 013249          264 EI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (447)
Q Consensus       264 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  342 (447)
                      .. ..+..+.++|||+.|||||++.+..|+.++|||||||+|||||.|+.||.+.++++++..|+.....+|.+++.++.
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~  596 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI  596 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence            74 36667889999999999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP  422 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  422 (447)
                      .++++      +|.+||++|+|+++.++++|++||||++|+|+.+++++++|||+|.+.+..+.+|||..||.+++..++
T Consensus       597 ~il~~------ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~  670 (694)
T KOG0694|consen  597 AIMRR------LLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTP  670 (694)
T ss_pred             HHHHH------HhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCC
Confidence            77666      999999999999988999999999999999999999999999999999999999999999999887775


Q ss_pred             CCC----CCCCCCccCeeeeCCC
Q 013249          423 APT----PTAGEHFKGYTYVAPN  441 (447)
Q Consensus       423 ~~~----~~~~~~f~~~~~~~~~  441 (447)
                      ...    ..++++|.||+|+++.
T Consensus       671 ~~~~~l~~~~q~~F~~Fs~~~~~  693 (694)
T KOG0694|consen  671 SDPRPLTEEEQEAFRDFSFVAEW  693 (694)
T ss_pred             CCccccchhhHHHhcCccccCCC
Confidence            321    2578999999999874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-72  Score=510.34  Aligned_cols=293  Identities=44%  Similarity=0.863  Sum_probs=282.8

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ...++|++++.||.|+||+|.+++.+.     ++..||+|++.+..+.+..+++...+|..+|+.+.||++++|++.|.+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~-----~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKH-----SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEcc-----CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            667899999999999999999999987     899999999999999999999999999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .+++|+||||++||.|+.++++.++|++..+++|++||+.||+|||.++|++|||||||||||.+|++||+|||+|+.+.
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhh
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  346 (447)
                      ..  +.+.|||+.|+|||++..++|+.++|||||||++|||+.|.+||...++..++++|+.++..||..++.++++|++
T Consensus       196 ~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~  273 (355)
T KOG0616|consen  196 GR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLK  273 (355)
T ss_pred             Cc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHH
Confidence            64  7789999999999999999999999999999999999999999999999999999999999999999999998877


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCC-CCCCCccCCCcccc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP-DVSGKDCIANFDKC  412 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~  412 (447)
                      .      +|+.|-.+|.|...++.++|+.||||++++|..+..++++|||+| .+....+++||+..
T Consensus       274 ~------LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y  334 (355)
T KOG0616|consen  274 K------LLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDY  334 (355)
T ss_pred             H------HHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCccccccccc
Confidence            6      999999999999888999999999999999999999999999998 88889999999965

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-69  Score=526.41  Aligned_cols=321  Identities=41%  Similarity=0.802  Sum_probs=279.4

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      ...+..++|+++++||+|+||.||+|+.+.     +|.+||+|+++|......++++.++.|.++|...++|+||+||..
T Consensus       135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~-----Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs  209 (550)
T KOG0605|consen  135 RTRLSLDDFELLKVIGKGAFGEVRLARKKD-----TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS  209 (550)
T ss_pred             cccCCcccchhheeeccccceeEEEEEEcc-----CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence            345788999999999999999999999987     999999999999999999999999999999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      |++..++||||||++||++..+|.+.+.++++.+++|+.+++.|++-||+.|+|||||||+|+|||..||+||+|||+|.
T Consensus       210 FQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  210 FQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             ecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999986


Q ss_pred             cccC-------------------------C-----------------------CCCCccccCCcccccccccCCCCCCcc
Q 013249          264 EIDE-------------------------S-----------------------SRSNSMCGTTEYMAPEILLSKGHNKDA  295 (447)
Q Consensus       264 ~~~~-------------------------~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~  295 (447)
                      .+..                         .                       ....+.+|||.|||||++.+++|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            4311                         0                       011345799999999999999999999


Q ss_pred             ceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCCC--CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChh
Q 013249          296 DWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVD  371 (447)
Q Consensus       296 DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p~~--~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~  371 (447)
                      |||||||||||||.|.+||.+.++.+++.+|.+.+  +.+|..  .+.+++      |||.+||+ ||.+|+|+  .+++
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~------DLI~rll~-d~~~RLG~--~G~~  440 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAK------DLITRLLC-DPENRLGS--KGAE  440 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHH------HHHHHHhc-CHHHhcCc--ccHH
Confidence            99999999999999999999999999999999877  556654  444544      55666999 99999985  4899


Q ss_pred             hhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCC-CCCC--------------CCCCCCccCee
Q 013249          372 AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDS-PAPT--------------PTAGEHFKGYT  436 (447)
Q Consensus       372 ~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------------~~~~~~f~~~~  436 (447)
                      ||++||||++++|+.+.  +..|||+|.+.+..++.+|++ |++...... ....              ...+..|.||+
T Consensus       441 EIK~HPfF~~v~W~~l~--~~~apfvP~v~~~~DT~yFdd-F~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfT  517 (550)
T KOG0605|consen  441 EIKKHPFFKGVDWDHLR--EMPAPFVPQVNSELDTQYFDD-FPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFT  517 (550)
T ss_pred             HHhcCCccccCCcchhh--cCCCCCCCCCCCccccccccc-CcccccCcccccccccchhhhhcccccCCccccccccee
Confidence            99999999999999994  556999999999999999994 333221111 0000              02345699999


Q ss_pred             eeCCC
Q 013249          437 YVAPN  441 (447)
Q Consensus       437 ~~~~~  441 (447)
                      |.+.+
T Consensus       518 yk~~~  522 (550)
T KOG0605|consen  518 YKNFD  522 (550)
T ss_pred             eeccc
Confidence            98765

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-69  Score=495.34  Aligned_cols=327  Identities=42%  Similarity=0.819  Sum_probs=308.0

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      ..++..++|..+++||+|.||+|.+|+.+.     +++.||+|+++|+.+..++.+..-..|-++|+.++||++..|...
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKa-----t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs  236 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKA-----TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS  236 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecc-----cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence            345678899999999999999999999987     899999999999999999999999999999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      |+..+++|+||||+.||.|+.+|.+...|+|+.++++..+|+.||.|||+++||+||||.+|+|+|++|++||+|||+|+
T Consensus       237 FQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  237 FQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             hccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             c-ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHH
Q 013249          264 E-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (447)
Q Consensus       264 ~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  342 (447)
                      . +.......++|||+.|+|||++....|+.++|||.+||+||||++|+.||...+.+.++.-|+.+.++||..++++++
T Consensus       317 E~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAk  396 (516)
T KOG0690|consen  317 EEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAK  396 (516)
T ss_pred             hcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHH
Confidence            7 455666789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP  422 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  422 (447)
                      .++.+      +|.+||.+|+|.++..+.||.+|+||.+++|+.+-.+++.|||+|.+.++.++..||+.||..+....|
T Consensus       397 tLLsG------LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTP  470 (516)
T KOG0690|consen  397 TLLSG------LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTP  470 (516)
T ss_pred             HHHHH------HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcceeEecC
Confidence            99888      999999999999999999999999999999999999999999999999999999999999998766555


Q ss_pred             CCCC--------CCCCCccCeeeeCCC
Q 013249          423 APTP--------TAGEHFKGYTYVAPN  441 (447)
Q Consensus       423 ~~~~--------~~~~~f~~~~~~~~~  441 (447)
                      +...        ..+..|..|+|.+..
T Consensus       471 P~r~~~~~~~~~e~~~~FpQFsy~~~~  497 (516)
T KOG0690|consen  471 PDRYGSTVDEDEERRPHFPQFSYSASM  497 (516)
T ss_pred             CCCCCcccchhhhhccCCcceeeecch
Confidence            5321        357789999998865

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-65  Score=482.57  Aligned_cols=324  Identities=43%  Similarity=0.837  Sum_probs=301.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  185 (447)
                      +...+|.++.+||+|+||+|.++..++     +.+.||||+++++.+...+.++--..|.++|.... -|++++|+.+|+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkg-----tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ  420 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ  420 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccC-----cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence            445689999999999999999999988     78899999999999888888887788999988774 689999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc-
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-  264 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~-  264 (447)
                      +-+.+|+||||+.||+|..++++-++|.|..+.+|+.+|+-||-+||++|||+||||.+|||||.+|++||+|||+++. 
T Consensus       421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999999986 


Q ss_pred             ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhh
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      +-....+.++|||+.|+|||++..++|+.++||||+||+||||+.|++||++.+..++++.|......+|..++.++.++
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i  580 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI  580 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence            34445667899999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP  424 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (447)
                      .++      +|.+.|.+|+|+++.+-++|..||||+.+||+.++.++++|||+|.+.-..+..|||+.||..+.+..|+-
T Consensus       581 ckg------~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD  654 (683)
T KOG0696|consen  581 CKG------LLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPD  654 (683)
T ss_pred             HHH------HhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCch
Confidence            888      99999999999999999999999999999999999999999999999888889999999999887776553


Q ss_pred             C----CCCCCCccCeeeeCCC
Q 013249          425 T----PTAGEHFKGYTYVAPN  441 (447)
Q Consensus       425 ~----~~~~~~f~~~~~~~~~  441 (447)
                      .    --++..|.||+|++|.
T Consensus       655 ~~v~~nldq~eF~gFsfvNpe  675 (683)
T KOG0696|consen  655 KLVMMNLDQSEFEGFSFVNPE  675 (683)
T ss_pred             HHHHhcCchhhcCceeeeChh
Confidence            2    2589999999999984

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-62  Score=478.92  Aligned_cols=267  Identities=41%  Similarity=0.746  Sum_probs=252.0

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      .-...||.+++.||.|+|++|++|+.+.     +++.||||++.|..+.++..++++..|..+|.+| .||.|++|+..|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~-----t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKA-----TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecC-----CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            3456799999999999999999999987     8999999999999999999999999999999999 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ++...+|+|+||+++|+|.++|++.|.|++..+++|++||+.||+|||++|||||||||||||||+||++||+|||.|+.
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC--------------CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc
Q 013249          265 IDESSR--------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK  330 (447)
Q Consensus       265 ~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~  330 (447)
                      +.....              ..+++||..|.+||++.....+..+|+|+||||||.|+.|++||.+.++-.++++|+...
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~  303 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD  303 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence            743211              145899999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHH
Q 013249          331 VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  388 (447)
Q Consensus       331 ~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~  388 (447)
                      +.||+.+++.+.+|++.      +|..||.+|+     ++++|++||||.+++|+.+-
T Consensus       304 y~fp~~fp~~a~dLv~K------LLv~dp~~Rl-----t~~qIk~HpFF~~Vdw~nlw  350 (604)
T KOG0592|consen  304 YEFPEGFPEDARDLIKK------LLVRDPSDRL-----TSQQIKAHPFFEGVDWENLW  350 (604)
T ss_pred             ccCCCCCCHHHHHHHHH------HHccCccccc-----cHHHHhhCcccccCChhhhh
Confidence            99999999998888776      9999999999     78999999999999999964

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-63  Score=473.36  Aligned_cols=328  Identities=39%  Similarity=0.717  Sum_probs=296.8

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..+.|...++||+|+||.||-|+.+.     +|+.||+|.+.|..+..+.......+|..||.+++.++||.|-.+|+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvra-----TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe  255 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRA-----TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE  255 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEec-----chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence            4667889999999999999999999886     99999999999988877777777889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +.+.+|+||..|+||+|..+|...+  .|++..+++|+++|++||++||+.+||+|||||+|||+|+.|+++|+|+|+|.
T Consensus       256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEE
Confidence            9999999999999999999998876  79999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC----CHHHHHHHHHhcccCCCCCCch
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~----~~~~~~~~i~~~~~~~p~~~~~  339 (447)
                      .+.+.......+||.+|||||++.+..|+...|||||||+||||+.|+.||...    ..+++.++++.....++..+++
T Consensus       336 ei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~  415 (591)
T KOG0986|consen  336 EIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE  415 (591)
T ss_pred             ecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence            998888777889999999999999999999999999999999999999999643    4457888888889999999999


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccc-cCCCCC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC-WTTMPA  418 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~~~~~~  418 (447)
                      +++++.+.      +|++||.+|+||...+++++++||||++++|..+++.++.|||+|+....++.+-+|-. |.+.. 
T Consensus       416 eakslc~~------LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~VK-  488 (591)
T KOG0986|consen  416 EAKSLCEG------LLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTVK-  488 (591)
T ss_pred             HHHHHHHH------HHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhccccc-
Confidence            99999887      99999999999998999999999999999999999999999999999888776666522 22221 


Q ss_pred             CCCCCCCCCCCCCccCeee-eCCCccccCC
Q 013249          419 DDSPAPTPTAGEHFKGYTY-VAPNPWLSSV  447 (447)
Q Consensus       419 ~~~~~~~~~~~~~f~~~~~-~~~~~~~~~~  447 (447)
                        .-...+.+++.|+.|.- ..+.+||+|+
T Consensus       489 --GV~ld~~D~~fy~~F~tg~vsipWQnE~  516 (591)
T KOG0986|consen  489 --GVKLDDTDTDFYKNFATGSVSIPWQNEM  516 (591)
T ss_pred             --ceecccccHHHHHhccCCcccchHHHHH
Confidence              11223468889999999 8888999985

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-61  Score=446.00  Aligned_cols=329  Identities=38%  Similarity=0.810  Sum_probs=301.0

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  181 (447)
                      ..+.++..+|.++++||+|+|++|.+++.+.     +.++||+|++++....+.+.+++++.|..+..+. +||++|.|+
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~-----t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh  317 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH  317 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcc-----cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence            3456788899999999999999999999987     8899999999999888888899999999999876 699999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      .+|++...+++|.||++||+|..+++++.+++|+.++++..+|+.||.|||++|||+||||.+|+|||..|++||+|+|+
T Consensus       318 scfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  318 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             hhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccc-ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCC--------CCHHHHHHHHHhcccC
Q 013249          262 AKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--------ANRQKLQQRIINEKVK  332 (447)
Q Consensus       262 a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~--------~~~~~~~~~i~~~~~~  332 (447)
                      ++. +.....+.++|||+.|+|||++.+..|+..+|||+|||+|+||+.|+.||.-        ....-+++.|+...++
T Consensus       398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir  477 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR  477 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence            997 4666678899999999999999999999999999999999999999999952        2334577888889999


Q ss_pred             CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCC-CChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCccc
Q 013249          333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  411 (447)
Q Consensus       333 ~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~-~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  411 (447)
                      +|..++-.+...++.      .|++||.+|+||.. .++.+++.|+||++++|+.++++++.|||.|.+.+...+.|||.
T Consensus       478 iprslsvkas~vlkg------flnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~  551 (593)
T KOG0695|consen  478 IPRSLSVKASHVLKG------FLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDT  551 (593)
T ss_pred             ccceeehhhHHHHHH------hhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCcccccc
Confidence            999998888888777      99999999999976 46999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCC----CCCCCccCeeeeCCCc
Q 013249          412 CWTTMPADDSPAPTP----TAGEHFKGYTYVAPNP  442 (447)
Q Consensus       412 ~~~~~~~~~~~~~~~----~~~~~f~~~~~~~~~~  442 (447)
                      .||.++...+|....    .++..|.||+|++|--
T Consensus       552 qft~e~~qltpdd~d~i~ridqsefegfeyinpl~  586 (593)
T KOG0695|consen  552 QFTSEPVQLTPDDEDAIKRIDQSEFEGFEYINPLL  586 (593)
T ss_pred             ccccCCcccCCCCHHHHHhcchhhcCcceecchhh
Confidence            999987766655432    5789999999999853

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-60  Score=451.05  Aligned_cols=287  Identities=40%  Similarity=0.728  Sum_probs=257.0

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++++.||.|.-|+||+|+.++     ++..+|+|++.+..+..+..+.+++.|.+||+.++||++..||..|
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~-----t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f  146 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRG-----TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF  146 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecC-----CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence            45667789999999999999999999987     7789999999999988888889999999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      +.....|+|||||.||+|..+++++  +.|++..+++|+++++.||+|||..|||+||||||||||-++|+|.|+||.++
T Consensus       147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccc
Confidence            9999999999999999999988876  57999999999999999999999999999999999999999999999999987


Q ss_pred             ccccC-----------------------------------C----------------------CCCCccccCCccccccc
Q 013249          263 KEIDE-----------------------------------S----------------------SRSNSMCGTTEYMAPEI  285 (447)
Q Consensus       263 ~~~~~-----------------------------------~----------------------~~~~~~~gt~~y~aPE~  285 (447)
                      .....                                   .                      ....+++||-+|+|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            53210                                   0                      11245689999999999


Q ss_pred             ccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC--CchhHHhhhhhhhHHhhhccCCCCCCC
Q 013249          286 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRL  363 (447)
Q Consensus       286 ~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~~~l~~~L~~dP~~R~  363 (447)
                      +.|.+++.++|||+|||++||||.|..||.+.+..+.+.+|+.....||..  ++..+++||      +++|.+||++|+
T Consensus       307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLI------r~LLvKdP~kRl  380 (459)
T KOG0610|consen  307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLI------RKLLVKDPSKRL  380 (459)
T ss_pred             eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHH------HHHhccChhhhh
Confidence            999999999999999999999999999999999999999999999999864  455555555      459999999999


Q ss_pred             CCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCcc
Q 013249          364 GSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC  405 (447)
Q Consensus       364 ~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~  405 (447)
                      |+. .++.||++||||++++|..+  +-..||++|...+..+
T Consensus       381 g~~-rGA~eIK~HpFF~gVnWaLi--r~~~PP~iP~~~d~~~  419 (459)
T KOG0610|consen  381 GSK-RGAAEIKRHPFFEGVNWALI--RCARPPEIPKPVDGGL  419 (459)
T ss_pred             ccc-cchHHhhcCccccCCChhhe--eccCCCcCCCccccCc
Confidence            874 37899999999999999944  7789999998766544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-61  Score=454.08  Aligned_cols=262  Identities=34%  Similarity=0.615  Sum_probs=232.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch----hHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      .+.|.+.+.||+|+||.|-+|..+.     +++.||||++.++.....    .....+.+|++||++++|||||+++++|
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~-----tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f  245 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKK-----TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF  245 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcc-----cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence            4578999999999999999999987     899999999998766542    2334477999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC---CcEEEeecCC
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGL  261 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~~kL~DFG~  261 (447)
                      +..+..|+||||++||+|++.+-.++.+.+...+.+++|++.||.|||++||+||||||+|||+..+   ..+||+|||+
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999999999999999999999999999999999999999999999999999766   7899999999


Q ss_pred             cccccCCCCCCccccCCcccccccccCCCC---CCccceeehhHhHHHHhhCCCCCCCCCHHH-HHHHHHhcccCCCCC-
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTHANRQK-LQQRIINEKVKLPPF-  336 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~ell~G~~pf~~~~~~~-~~~~i~~~~~~~p~~-  336 (447)
                      |+..++.....+.|||+.|.|||++.++++   ..++|+||+||+||-+|+|.+||....... +.++|..+++.+-+. 
T Consensus       326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~  405 (475)
T KOG0615|consen  326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ  405 (475)
T ss_pred             hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence            999998888999999999999999997654   457899999999999999999998766555 888999998877543 


Q ss_pred             ---CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          337 ---LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       337 ---~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                         ++.++.      +||.+||..||++|+     +++|+++||||+.+....
T Consensus       406 w~~Iseea~------dlI~~mL~VdP~~R~-----s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  406 WDRISEEAL------DLINWMLVVDPENRP-----SADEALNHPWFKDAPCLS  447 (475)
T ss_pred             hhhhhHHHH------HHHHHhhEeCcccCc-----CHHHHhcChhhhcccccc
Confidence               444544      455569999999999     889999999999776444

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-60  Score=470.12  Aligned_cols=255  Identities=31%  Similarity=0.625  Sum_probs=245.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ..|+..++||+|||++||.+++..     +|+.||+|++.+..+.+....+.+.+|++|.+.|+|||||+++++|++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~-----tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD-----TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC-----CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence            469999999999999999999875     899999999999988888899999999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      +|||+|+|..++|..++.+++.++|.++++|+.||+.||.|||+++|||||||..|+||+++.+|||+|||+|..+... 
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999998743 


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  348 (447)
                      .+..+.|||+.|+|||++...+++..+||||+|||||-||.|++||...+..+++.+|....+.+|..++.++++||.. 
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~-  251 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK-  251 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHH-
Confidence            6788999999999999999999999999999999999999999999999999999999999999999999999888776 


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                           ||++||.+||     ++++|+.|+||.
T Consensus       252 -----lL~~~P~~Rp-----sl~~vL~h~Ff~  273 (592)
T KOG0575|consen  252 -----LLRPNPSERP-----SLDEVLDHPFFK  273 (592)
T ss_pred             -----HhcCCcccCC-----CHHHHhcCHhhh
Confidence                 9999999999     899999999994

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-59  Score=438.26  Aligned_cols=257  Identities=30%  Similarity=0.518  Sum_probs=234.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++.+.++.||+|..|+||+|+++.     +++.||+|++...  .+....+++.+|+++++.++|||||.+|++|..
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~-----t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKP-----TGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcC-----CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            555688999999999999999999997     8999999999543  456667789999999999999999999999999


Q ss_pred             CC-EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RS-KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~-~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ++ .++|+||||+||+|...+...++++|..+..++.++++||.|||+ ++||||||||+||||+..|.|||||||.++.
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence            99 599999999999999999988999999999999999999999995 9999999999999999999999999999999


Q ss_pred             ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC-----CHHHHHHHHHhc-ccCCCCC-C
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----NRQKLQQRIINE-KVKLPPF-L  337 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~-----~~~~~~~~i~~~-~~~~p~~-~  337 (447)
                      +.+. ...+++||..|||||.+.+..|+.++||||||++++||.+|+.||...     +..+++..|..+ .+.+|.. +
T Consensus       229 lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  229 LVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF  307 (364)
T ss_pred             hhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence            8776 678899999999999999999999999999999999999999999764     777888888884 4567776 8


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      ++++++++..      ||++||.+|+     +++++++|||++..
T Consensus       308 S~ef~~FV~~------CL~Kdp~~R~-----s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  308 SPEFRSFVSC------CLRKDPSERP-----SAKQLLQHPFIKKF  341 (364)
T ss_pred             CHHHHHHHHH------HhcCCcccCC-----CHHHHhcCHHHhhc
Confidence            8888777665      9999999999     88999999999854

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-60  Score=491.58  Aligned_cols=322  Identities=38%  Similarity=0.701  Sum_probs=283.4

Q ss_pred             hhhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeee
Q 013249          102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR  181 (447)
Q Consensus       102 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~  181 (447)
                      .....+..+||+++++||+|+||.|.+++++.     ++++||+|++.|-...+......|..|..+|...+.+-|++|+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~-----t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKS-----TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeec-----cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            34456778899999999999999999999997     8899999999998777777788899999999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      .+|+++.++|+|||||+||+|..++.+.++++++.+++|+++|+.||+-||+.|+|||||||+|||||..||+||+|||.
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC--CCccccCCcccccccccC-----CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccC
Q 013249          262 AKEIDESSR--SNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVK  332 (447)
Q Consensus       262 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~--~~~  332 (447)
                      |-.+.....  ....+|||.|++||++..     +.|+..+||||+||++|||+.|..||...+..+.+.+|.+.  .+.
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS  301 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence            988764333  456789999999999962     46899999999999999999999999999999999999976  677


Q ss_pred             CC--CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcc
Q 013249          333 LP--PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  410 (447)
Q Consensus       333 ~p--~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  410 (447)
                      ||  ..++.+++++|++       |--+|..|+|-  +++++++.||||.+++|+.+  |...|||+|.+++..+++|||
T Consensus       302 FP~~~~VSeeakdLI~~-------ll~~~e~RLgr--ngiedik~HpFF~g~~W~~i--R~~~pP~vPevssd~DTsnFd  370 (1317)
T KOG0612|consen  302 FPDETDVSEEAKDLIEA-------LLCDREVRLGR--NGIEDIKNHPFFEGIDWDNI--RESVPPVVPEVSSDDDTSNFD  370 (1317)
T ss_pred             CCcccccCHHHHHHHHH-------HhcChhhhccc--ccHHHHHhCccccCCChhhh--hhcCCCCCCcCCCCCcccccc
Confidence            88  5689999999885       66799999953  47999999999999999888  788999999999999999996


Q ss_pred             cccCCCCCCCCCC-----CCCCCCCCccCeeeeC
Q 013249          411 KCWTTMPADDSPA-----PTPTAGEHFKGYTYVA  439 (447)
Q Consensus       411 ~~~~~~~~~~~~~-----~~~~~~~~f~~~~~~~  439 (447)
                      ..-......+..+     ...+..-.|.||+|..
T Consensus       371 ~~~dd~~~~e~~p~~~~~~f~Gn~LPFIGfTy~~  404 (1317)
T KOG0612|consen  371 VDEDDLRDAETFPPRIPKAFSGNHLPFIGFTYTH  404 (1317)
T ss_pred             ccccccchhhccCCCCCCCCcCCcCCeeeeeecc
Confidence            5433322222211     1224566799999985

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-57  Score=446.38  Aligned_cols=314  Identities=42%  Similarity=0.832  Sum_probs=275.4

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      ++||+|+||.||+|+++.     +++.||||++++...........+.+|+.+|++++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence            469999999999999876     788999999987655555556677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCcc
Q 013249          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSM  274 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~~  274 (447)
                      |+.||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            99999999999998999999999999999999999999999999999999999999999999999998642 22334457


Q ss_pred             ccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhh
Q 013249          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL  354 (447)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~  354 (447)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||...+...+...+......+|..++.++.++++.      |
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~------~  229 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAG------L  229 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------H
Confidence            8999999999999999999999999999999999999999999888888888888888898888888776655      9


Q ss_pred             ccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC--------C
Q 013249          355 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT--------P  426 (447)
Q Consensus       355 L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~  426 (447)
                      |++||++||+....+++++++||||.+++|..+..+.+.|++.|......+...|+..++.......++..        .
T Consensus       230 L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  309 (323)
T cd05571         230 LKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQL  309 (323)
T ss_pred             ccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCcccccccccc
Confidence            99999999987666899999999999999999999999999999998888888888777665433333221        1


Q ss_pred             CCCCCccCeeeeCC
Q 013249          427 TAGEHFKGYTYVAP  440 (447)
Q Consensus       427 ~~~~~f~~~~~~~~  440 (447)
                      .....|.+|+|.+.
T Consensus       310 ~~~~~~~~~~~~~~  323 (323)
T cd05571         310 EERPHFPQFSYSAS  323 (323)
T ss_pred             cccccCCCCeeeCC
Confidence            24667999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.1e-57  Score=443.15  Aligned_cols=315  Identities=41%  Similarity=0.783  Sum_probs=275.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ...++|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+|++++||||+++++++.+
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   89 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKG-----TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD   89 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence            445789999999999999999999886     788999999987665555566778899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .+.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhh
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  346 (447)
                      ..  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..+...+|..++.+++++++
T Consensus       170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  247 (329)
T PTZ00263        170 DR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVK  247 (329)
T ss_pred             CC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHH
Confidence            42  3356899999999999999999999999999999999999999999988888999998888888888887776655


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP  426 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (447)
                      .      ||+.||.+|+++...++++++.||||.+.+|..+..+.+.+|+.+......+..+|.+. ..-+....++...
T Consensus       248 ~------~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~~~~~~  320 (329)
T PTZ00263        248 G------LLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKY-PDSPVDRLPPLTA  320 (329)
T ss_pred             H------HhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcccchhccCC-cccccccCCCCch
Confidence            5      99999999998766789999999999999999999888888888887777777888643 2222222233344


Q ss_pred             CCCCCccCe
Q 013249          427 TAGEHFKGY  435 (447)
Q Consensus       427 ~~~~~f~~~  435 (447)
                      ..+..|.||
T Consensus       321 ~~~~~~~~~  329 (329)
T PTZ00263        321 AQQAEFAGF  329 (329)
T ss_pred             hhhhhcCCC
Confidence            567778776

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.9e-56  Score=436.74  Aligned_cols=317  Identities=41%  Similarity=0.819  Sum_probs=273.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  189 (447)
                      +|++++.||+|+||.||+|+++.     +++.||+|++.+.........+.+..|..++..+ +|++|+++++++...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence            58999999999999999999886     7889999999876544455556677788888877 58999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~  268 (447)
                      +|+||||+.+|+|..++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999998643 22


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  348 (447)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+......+|...+.++.+++.. 
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~-  234 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG-  234 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH-
Confidence            2344568999999999999999999999999999999999999999999999999999988888888888887666554 


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC---
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT---  425 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  425 (447)
                           ||++||.+|+++.....+++++|+||..++|..+..+.++||+.|.... .+..+|+..+...+....+...   
T Consensus       235 -----~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  308 (323)
T cd05616         235 -----LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG-RDAENFDKFFTRHPPVLTPPDQEVI  308 (323)
T ss_pred             -----HcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC-chhhhcCchhccCCccCCCCCcccc
Confidence                 9999999999877667899999999999999999999999999998764 5667777666544333222221   


Q ss_pred             -CCCCCCccCeeeeC
Q 013249          426 -PTAGEHFKGYTYVA  439 (447)
Q Consensus       426 -~~~~~~f~~~~~~~  439 (447)
                       ...+..|+||+|++
T Consensus       309 ~~~~~~~~~~~~~~~  323 (323)
T cd05616         309 MNLDQSEFEGFSYVN  323 (323)
T ss_pred             ccccccccCCCcccC
Confidence             23467899999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-59  Score=446.51  Aligned_cols=297  Identities=37%  Similarity=0.740  Sum_probs=281.9

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+...+++++..||-|+||+|-+++.+.     ....+|+|+++|..+.+..+.+.+..|.+||..++.|+||+||-.|
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~-----~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf  489 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNS-----QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF  489 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEecc-----cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence            44667789999999999999999998875     4446999999999999999999999999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .+..++|++||-|-||.|...++.++.|.+..+++|+..++.|++|||++|||+|||||+|+|++.+|.+||.|||+|+.
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCchhHH
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAH  342 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~  342 (447)
                      +..+..+-++|||+.|.|||++.+++++.++|.||||+++|||++|.+||.+.++...++.|+.+  .+.+|..+...+.
T Consensus       570 i~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~  649 (732)
T KOG0614|consen  570 IGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTAT  649 (732)
T ss_pred             hccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHH
Confidence            99999999999999999999999999999999999999999999999999999999999999986  5678999998888


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccc
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  412 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  412 (447)
                      ++++.      +...+|.+|+|...+++.+|++|.||.+.||+.+..+.+.|||+|.+.+..+++|||..
T Consensus       650 ~Lik~------LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~  713 (732)
T KOG0614|consen  650 DLIKK------LCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNF  713 (732)
T ss_pred             HHHHH------HHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCC
Confidence            77665      89999999999888899999999999999999999999999999999999999999965

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.1e-56  Score=435.45  Aligned_cols=315  Identities=42%  Similarity=0.814  Sum_probs=274.5

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      +.||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence            469999999999999876     788999999987655555566778889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCcc
Q 013249          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSM  274 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~~  274 (447)
                      |+.+|+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            99999999999888899999999999999999999999999999999999999999999999999988642 22233456


Q ss_pred             ccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhh
Q 013249          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL  354 (447)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~  354 (447)
                      +||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+|..++.++.++++.      |
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~------~  229 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSG------L  229 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHH------H
Confidence            8999999999999999999999999999999999999999988888888888888888888888887766555      9


Q ss_pred             ccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC----------
Q 013249          355 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----------  424 (447)
Q Consensus       355 L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------  424 (447)
                      |++||++|++..+.+++++++|+||.+++|..+....+.|++.|......+...|+..++.......++.          
T Consensus       230 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (328)
T cd05593         230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCM  309 (328)
T ss_pred             cCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcccccCCcccCCcccccccccccc
Confidence            9999999998777799999999999999999999999999999999888888888877655432222211          


Q ss_pred             CCCCCCCccCeeeeCCC
Q 013249          425 TPTAGEHFKGYTYVAPN  441 (447)
Q Consensus       425 ~~~~~~~f~~~~~~~~~  441 (447)
                      .......|.+|+|.++.
T Consensus       310 ~~~~~~~~~~~~~~~~~  326 (328)
T cd05593         310 DNERRPHFPQFSYSASG  326 (328)
T ss_pred             ccccccccCCceeeCCC
Confidence            11346789999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.9e-56  Score=434.08  Aligned_cols=318  Identities=42%  Similarity=0.836  Sum_probs=276.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeCCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~  189 (447)
                      +|++++.||+|+||.||+|+++.     +++.||||++.+.........+.+..|..++..+.| ++|+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence            58999999999999999999876     778999999987655455556678889999999976 568889999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~  268 (447)
                      +|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999987532 22


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  348 (447)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+|..++.++.++++  
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~--  233 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK--  233 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence            233456799999999999999999999999999999999999999999999999999988888888888887766555  


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC---
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT---  425 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  425 (447)
                          +||.+||.+|+++.....+++++||||..++|..+..+.+.+++.|.........+|+..++.......+...   
T Consensus       234 ----~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (324)
T cd05587         234 ----GLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKLVI  309 (324)
T ss_pred             ----HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcCcccccCccccCCCCcccc
Confidence                5999999999987666679999999999999999999999999999998888889999877665433332211   


Q ss_pred             -CCCCCCccCeeeeC
Q 013249          426 -PTAGEHFKGYTYVA  439 (447)
Q Consensus       426 -~~~~~~f~~~~~~~  439 (447)
                       ...+..|.+|+|++
T Consensus       310 ~~~~~~~~~~~~~~~  324 (324)
T cd05587         310 ANIDQSEFQGFSFVN  324 (324)
T ss_pred             ccccccccCCCcccC
Confidence             24577899999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.7e-56  Score=435.27  Aligned_cols=315  Identities=37%  Similarity=0.765  Sum_probs=274.0

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHH---hcCCCCceeeeEEEEeCC
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT---KVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~  188 (447)
                      |++++.||+|+||.||+|.++.     +++.||||++++.........+.+..|++++.   .++||||+++++++...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence            7889999999999999999876     78899999998765444555667777777664   567999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-C
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-E  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~  267 (447)
                      .+|+||||+.|++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            99999999999999888754 579999999999999999999999999999999999999999999999999987542 2


Q ss_pred             CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  347 (447)
                      .......+|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+|..++.++.+++. 
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~-  233 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR-  233 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Confidence            2234457899999999999999999999999999999999999999999998888888988888888888877766555 


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC---
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP---  424 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  424 (447)
                           +||+.||.+||++...+++++++||||++++|..+..+.+.|++.|.+....+..+|+..++.......+..   
T Consensus       234 -----~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~  308 (324)
T cd05589         234 -----RLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPPREPR  308 (324)
T ss_pred             -----HHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhhcCccccccccccCCCcccc
Confidence                 599999999998877789999999999999999999999999999999888888999877766544333332   


Q ss_pred             --CCCCCCCccCeeee
Q 013249          425 --TPTAGEHFKGYTYV  438 (447)
Q Consensus       425 --~~~~~~~f~~~~~~  438 (447)
                        .++.++.|.+|+|+
T Consensus       309 ~~~~~~~~~~~~~~~~  324 (324)
T cd05589         309 LLTEEEQELFRGFDYV  324 (324)
T ss_pred             ccchhhhcccCCcccC
Confidence              23679999999985

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6e-56  Score=434.89  Aligned_cols=313  Identities=40%  Similarity=0.791  Sum_probs=271.4

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||.||+|+++.     +++.||||++.+.........+.+..|..++..+ +||||+++++++...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE-----SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence            469999999999999876     7889999999876554555566777888888876 6999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987642 2233445


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+......+|..++.++.++++.      
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~------  229 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKA------  229 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH------
Confidence            68999999999999999999999999999999999999999999999999999988888888888887666555      


Q ss_pred             hccCCCCCCCCCCC-CChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC----CCCCC
Q 013249          354 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----PTPTA  428 (447)
Q Consensus       354 ~L~~dP~~R~~~~~-~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  428 (447)
                      ||++||.+|+++.. .+.+++++||||.+++|..+..+.+.|||.|......+..+|+..+.......++.    .....
T Consensus       230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (320)
T cd05590         230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLLPMIN  309 (320)
T ss_pred             HcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCccCCCCccccccccc
Confidence            99999999996522 23489999999999999999999999999999999989999987665554333321    23356


Q ss_pred             CCCccCeeeeC
Q 013249          429 GEHFKGYTYVA  439 (447)
Q Consensus       429 ~~~f~~~~~~~  439 (447)
                      ++.|++|+|.+
T Consensus       310 ~~~~~~~~~~~  320 (320)
T cd05590         310 QDEFRNFSYTA  320 (320)
T ss_pred             ccCcCCCcccC
Confidence            78999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.4e-56  Score=437.21  Aligned_cols=294  Identities=41%  Similarity=0.744  Sum_probs=264.4

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.+.||+|+||.||+|.++.    ..+..||+|++.+.........+.+.+|+.+++.++||||+++++++.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKN----EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEEC----CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            3556789999999999999999998764    134689999998766555556677889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      +.+.+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999999999999999999999899999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.....+.+..+...+|..++.++.+++
T Consensus       182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  259 (340)
T PTZ00426        182 DT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM  259 (340)
T ss_pred             CC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            43  2345689999999999999999999999999999999999999999999888899999888888988888877665


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCccc
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  411 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  411 (447)
                      +.      ||+.||.+|++....+++++++||||.+++|..+..+.+.+|++|......+..+|..
T Consensus       260 ~~------~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  319 (340)
T PTZ00426        260 KK------LLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFER  319 (340)
T ss_pred             HH------HcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCcchhhcCC
Confidence            55      9999999999776678999999999999999999999999999999887777777754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-56  Score=424.59  Aligned_cols=257  Identities=33%  Similarity=0.627  Sum_probs=230.5

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||.|+||+||+|+++.     ++..||||.+.+..+ .+..++.+..|+.+|+.++|||||.|++++...+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~-----~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK-----SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc-----CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            4689999999999999999999997     778999999988765 5566778899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC------CcEEEeecCCc
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------GHVMLTDFGLA  262 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~------~~~kL~DFG~a  262 (447)
                      .+|||||||+||+|.+++++++.++|..++.++.||+.||++||+++||||||||+||||+.+      -.+||+|||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999999999999999999999999999999999999999999999999999765      45899999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---CCCCch
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---PPFLTS  339 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~---p~~~~~  339 (447)
                      +.+.......+.||++.|||||++..+.|+.|+|+||+|+|+|+|++|+.||...+..++...+..+....   +...+.
T Consensus       163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN  242 (429)
T ss_pred             hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence            99999888899999999999999999999999999999999999999999999999999998887765433   334455


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +..++      +..+|+.+|..|.     +..+-..|++...-
T Consensus       243 ~~~~L------l~~ll~~~~~~~~-----~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  243 PLREL------LISLLQRNPKDRI-----SFEDFFDHPFLAAN  274 (429)
T ss_pred             chhhh------hhHHHhcCccccC-----chHHhhhhhhcccC
Confidence            54444      4448999999998     66788888887643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-56  Score=430.38  Aligned_cols=290  Identities=41%  Similarity=0.801  Sum_probs=263.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||+|+||.||+|+++.     +++.||+|++...........+.+.+|+.+|+.++||||+++++++.+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence            479999999999999999999876     788999999986554444456678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999999876442 


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~  349 (447)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..+.+......+|...+..++++++.  
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~--  231 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK--  231 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHH--
Confidence             33567999999999999999999999999999999999999999999999999999998888888888777666555  


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccc
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  412 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  412 (447)
                          ||+.||.+|+++...+++++++||||..++|..+..++..|++.|.+...+++.+|+.+
T Consensus       232 ----~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  290 (291)
T cd05612         232 ----LLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDDY  290 (291)
T ss_pred             ----HcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccccCC
Confidence                99999999998766789999999999999999999999999999999988888888753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-55  Score=429.32  Aligned_cols=307  Identities=47%  Similarity=0.868  Sum_probs=268.5

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (447)
                      ||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+|++++||||+++++++...+.+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRD-----TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence            7999999999999876     78899999998765545556677888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC-CCCCCcccc
Q 013249          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNSMCG  276 (447)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~-~~~~~~~~g  276 (447)
                      .||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+|
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            9999999999888999999999999999999999999999999999999999999999999999986432 223445689


Q ss_pred             CCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhcc
Q 013249          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLH  356 (447)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~  356 (447)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+|..++.++.+++..      ||.
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~------~L~  229 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIG------LLS  229 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH------HcC
Confidence            99999999999999999999999999999999999999999988999999988888888888887766555      999


Q ss_pred             CCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC----CCCCCCCCc
Q 013249          357 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----PTPTAGEHF  432 (447)
Q Consensus       357 ~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~f  432 (447)
                      .||.+|++..  ++.+++.||||...+|..+..+.+++++.|......+.++|+..++......+..    .....+..|
T Consensus       230 ~dp~~R~~~~--~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (312)
T cd05585         230 RDPTRRLGYN--GAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSHLSETVQQQF  307 (312)
T ss_pred             CCHHHcCCCC--CHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccccccccCCCccccccchhcccc
Confidence            9999999653  6899999999999999999999999999999888888888987766543222211    122458888


Q ss_pred             cCeee
Q 013249          433 KGYTY  437 (447)
Q Consensus       433 ~~~~~  437 (447)
                      .+|+|
T Consensus       308 ~~~~~  312 (312)
T cd05585         308 GGWSY  312 (312)
T ss_pred             CCCCC
Confidence            88887

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-55  Score=431.62  Aligned_cols=314  Identities=41%  Similarity=0.807  Sum_probs=273.5

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      +.||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||++++++|...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence            469999999999999876     788999999987655455556677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCcc
Q 013249          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSM  274 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~~  274 (447)
                      |+.+|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            99999999999888899999999999999999999999999999999999999999999999999987642 22233456


Q ss_pred             ccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhh
Q 013249          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL  354 (447)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~  354 (447)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+......+|..++.++.++++.      |
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~------~  229 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG------L  229 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH------H
Confidence            7999999999999999999999999999999999999999998888888888888888888888888776665      9


Q ss_pred             ccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC--------C
Q 013249          355 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT--------P  426 (447)
Q Consensus       355 L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~  426 (447)
                      |+.||++|++....++.++++|+||.+++|..+..+.+.|++.|..........|+..++.......++..        .
T Consensus       230 L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (323)
T cd05595         230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLEL  309 (323)
T ss_pred             ccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccccCCccCCCCccccccccccc
Confidence            99999999987777899999999999999999999999999999999888888888777664332222111        1


Q ss_pred             CCCCCccCeeeeCC
Q 013249          427 TAGEHFKGYTYVAP  440 (447)
Q Consensus       427 ~~~~~f~~~~~~~~  440 (447)
                      ..-..|.+|+|..+
T Consensus       310 ~~~~~~~~~~~~~~  323 (323)
T cd05595         310 DQRTHFPQFSYSAS  323 (323)
T ss_pred             ccccccCCCcccCC
Confidence            24556999998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.7e-55  Score=428.77  Aligned_cols=312  Identities=41%  Similarity=0.821  Sum_probs=269.1

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||.||+|+++.     +++.||||++.+.........+.+..|..++..+ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG-----TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence            469999999999999876     7889999999876555555666677899999866 7999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999987642 2223445


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......+|..++.++.++++.      
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~------  229 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA------  229 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------
Confidence            67999999999999999999999999999999999999999999999999999988888888888877666555      


Q ss_pred             hccCCCCCCCCCCCC--ChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC----CC
Q 013249          354 LLHKDPSKRLGSGPG--GVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----PT  427 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~--~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~  427 (447)
                      ||++||++|+++...  +++++++||||.+++|..+..+++.++|.|......+..+|+..++.......+..+    ..
T Consensus       230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (321)
T cd05591         230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPAVIKQI  309 (321)
T ss_pred             HhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCccccCccccCCCCccccccc
Confidence            999999999976543  789999999999999999999999999999988777777887665544322222211    23


Q ss_pred             CCCCccCeeee
Q 013249          428 AGEHFKGYTYV  438 (447)
Q Consensus       428 ~~~~f~~~~~~  438 (447)
                      .++.|.||+|.
T Consensus       310 ~~~~~~~~~~~  320 (321)
T cd05591         310 NQEEFRGFSFF  320 (321)
T ss_pred             cccccCCCccc
Confidence            56779999885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.9e-55  Score=427.95  Aligned_cols=317  Identities=43%  Similarity=0.830  Sum_probs=272.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (447)
                      +|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+..|..+++.+. |++|+++++++.+.+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence            48899999999999999999886     78899999998765444555666778999998886 5788899999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      +|+||||++||+|..++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999998864322 


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  348 (447)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|...+.++.+++.  
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~--  233 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK--  233 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH--
Confidence            223456799999999999999999999999999999999999999999999989999998888888888877766554  


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC----C
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----P  424 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~  424 (447)
                          +||++||.+|+++.....+++++||||..++|..+..+.+++||+|..... ...+|++.++......+++    .
T Consensus       234 ----~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  308 (323)
T cd05615         234 ----GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKFFTRGQPVLTPPDQLVI  308 (323)
T ss_pred             ----HHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC-chhhcCccccccCCCCCCCccccc
Confidence                599999999998766678999999999999999999999999999976664 3778887765543332221    2


Q ss_pred             CCCCCCCccCeeeeC
Q 013249          425 TPTAGEHFKGYTYVA  439 (447)
Q Consensus       425 ~~~~~~~f~~~~~~~  439 (447)
                      ...+...|.+|+|++
T Consensus       309 ~~~~~~~~~~~~~~~  323 (323)
T cd05615         309 ANIDQADFEGFSYVN  323 (323)
T ss_pred             ccccccccCCCcccC
Confidence            234567899999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4e-55  Score=428.66  Aligned_cols=312  Identities=43%  Similarity=0.850  Sum_probs=270.4

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||+||+|+++.     +++.||||++++...........+..|..+++.+ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG-----TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            479999999999999876     7889999999887655555666777899999888 6999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||+.||+|..++.+.+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999987532 2223345


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..++.++.++++      +
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~------~  229 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILK------S  229 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHH------H
Confidence            6799999999999999999999999999999999999999999988888888888888888888877766655      4


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC----CCCCC
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAG  429 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  429 (447)
                      ||+.||++||++......++++||||++++|.....+.+.|+++|......+..+|+..+...+...++..    ....+
T Consensus       230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (318)
T cd05570         230 FLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQ  309 (318)
T ss_pred             HccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhccCcccCCCCcccccccccc
Confidence            99999999995544445999999999999999999999999999999988888899877654443333222    23568


Q ss_pred             CCccCeeee
Q 013249          430 EHFKGYTYV  438 (447)
Q Consensus       430 ~~f~~~~~~  438 (447)
                      +.|.||+|+
T Consensus       310 ~~~~~~~~~  318 (318)
T cd05570         310 EEFRGFSYI  318 (318)
T ss_pred             cccCCCCCC
Confidence            899999995

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.5e-55  Score=427.29  Aligned_cols=317  Identities=53%  Similarity=0.949  Sum_probs=273.1

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||.||+|++....  ..++.||+|++++.... .......+..|+.+|+.++||||++++++|..++.+|+||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGA--DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccC--CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence            67999999999999875321  26789999999875432 2233456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||+.|++|..++.+.+.+.+..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... .......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            999999999999998999999999999999999999999999999999999999999999999999987543 2223445


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+......+|..++.++.++++.      
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~------  233 (323)
T cd05584         160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKK------  233 (323)
T ss_pred             cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------
Confidence            68999999999999999999999999999999999999999999888888888888888888888877766554      


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC---CCCCCCC
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA---PTPTAGE  430 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  430 (447)
                      ||++||++|+++...+++++++||||...+|..+..+...+++.+......+...|+..++......++.   .......
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQ  313 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCchhcccccccCcccccccccccc
Confidence            9999999999887888999999999999999999999999999998888888888887766554333332   2224578


Q ss_pred             CccCeeeeCC
Q 013249          431 HFKGYTYVAP  440 (447)
Q Consensus       431 ~f~~~~~~~~  440 (447)
                      .|.||+|+++
T Consensus       314 ~~~~~~~~~~  323 (323)
T cd05584         314 IFLGFTYVAP  323 (323)
T ss_pred             CcCCCeecCC
Confidence            8999999875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.9e-55  Score=427.11  Aligned_cols=310  Identities=40%  Similarity=0.836  Sum_probs=269.7

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||.||+|+++.     +++.||||++++.........+.+..|..++..+ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG-----TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            469999999999999876     7889999999876544444555566677777654 8999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC-CCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~-~~~~~~  273 (447)
                      ||+.||+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9999999999998888999999999999999999999999999999999999999999999999999986432 233445


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.++++.      
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~------  229 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSK------  229 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------
Confidence            68999999999999999999999999999999999999999999988888888888777888888877766554      


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC----CCCCC
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAG  429 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  429 (447)
                      ||+.||.+|++.    .+++++||||..++|..+..+.+.|+|.|......+..+|+..++......++..    ...++
T Consensus       230 ~l~~~P~~R~~~----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (316)
T cd05592         230 LFERDPTKRLGV----DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDKKLLASMDQ  305 (316)
T ss_pred             HccCCHHHcCCC----hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccccccCCCccccccccccc
Confidence            999999999942    4689999999999999999999999999999888888999988877665555443    23578


Q ss_pred             CCccCeeeeCC
Q 013249          430 EHFKGYTYVAP  440 (447)
Q Consensus       430 ~~f~~~~~~~~  440 (447)
                      ..|.+|.|++|
T Consensus       306 ~~~~~~~~~~~  316 (316)
T cd05592         306 EQFRGFSFTNP  316 (316)
T ss_pred             cccCCCcccCc
Confidence            99999999885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.8e-55  Score=428.67  Aligned_cols=313  Identities=39%  Similarity=0.811  Sum_probs=266.6

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||.||+|+++.     +++.||+|++++.........+.+..|..+++.+ +||||++++++|.+...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK-----TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence            479999999999999886     7889999999886655555667788999999988 7999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc-cCCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~-~~~~~~~~  273 (447)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ........
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999998753 23333456


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC---------CHHHHHHHHHhcccCCCCCCchhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---------NRQKLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~---------~~~~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...         ......+.+......+|..++.++.++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l  235 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV  235 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            78999999999999999999999999999999999999999531         223355667777778888888777666


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCC-CChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA  423 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~-~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  423 (447)
                      ++.      ||+.||.+|+++.. .+++++++||||.+++|..+...+..|++.|.........+|+..+...+....+.
T Consensus       236 i~~------~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~  309 (329)
T cd05588         236 LKG------FLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPD  309 (329)
T ss_pred             HHH------HhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcchhhhcCCccccCccccCCC
Confidence            554      99999999997532 35899999999999999999999999999999988888888987776654333332


Q ss_pred             C----CCCCCCCccCeeeeC
Q 013249          424 P----TPTAGEHFKGYTYVA  439 (447)
Q Consensus       424 ~----~~~~~~~f~~~~~~~  439 (447)
                      .    ...++..|.||.|++
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~  329 (329)
T cd05588         310 DPDVIARIDQSEFEGFEYIN  329 (329)
T ss_pred             CccccccccccccCCCcccC
Confidence            2    224578999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-54  Score=426.12  Aligned_cols=322  Identities=48%  Similarity=0.912  Sum_probs=271.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (447)
                      +|+++++||+|+||.||+|++...  ..+++.||+|++.+..... ....+.+..|+.+|+.+ +||||+++++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEccc--CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence            589999999999999999987532  2368899999998654322 33445678899999999 5899999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+.||+|..++..++.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999865332


Q ss_pred             --CCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCC----CHHHHHHHHHhcccCCCCCCchhH
Q 013249          269 --SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLTSEA  341 (447)
Q Consensus       269 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~----~~~~~~~~i~~~~~~~p~~~~~~~  341 (447)
                        ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...    ....+...+......+|..++..+
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA  238 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence              223356899999999999875 4789999999999999999999999642    344555666666667777777777


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDS  421 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  421 (447)
                      .+++.      +||+.||++|+++...+++++++||||++++|..+...++.++|.|......+..+|...+..+.+..+
T Consensus       239 ~~li~------~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (332)
T cd05614         239 QDLLH------KLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYS  312 (332)
T ss_pred             HHHHH------HHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccC
Confidence            66655      499999999998877789999999999999999999999999999998887777788776666544444


Q ss_pred             CCC-CCCCCCCccCeeeeCC
Q 013249          422 PAP-TPTAGEHFKGYTYVAP  440 (447)
Q Consensus       422 ~~~-~~~~~~~f~~~~~~~~  440 (447)
                      +.. ++.....|.||+|+.+
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~  332 (332)
T cd05614         313 PAGTPPSGARVFQGYSFVAP  332 (332)
T ss_pred             CCCCCcccccccCCceecCC
Confidence            443 4566788999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-54  Score=425.76  Aligned_cols=313  Identities=40%  Similarity=0.823  Sum_probs=265.8

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||.||+|+++.     +++.||+|++.+.........+.+..|+.++.++ +||||+++++++.....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK-----NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence            479999999999999876     7889999999887655556677788999999888 6999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc-cCCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~-~~~~~~~~  273 (447)
                      ||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.. ........
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            99999999999988889999999999999999999999999999999999999999999999999999753 22333456


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCC-------CCHHHHHHHHHhcccCCCCCCchhHHhhhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-------ANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~-------~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  346 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||..       .......+.+......+|..++..+.++++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~  235 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK  235 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            7899999999999999999999999999999999999999953       223445566666677788888877766655


Q ss_pred             hhhHHhhhccCCCCCCCCCCC-CChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT  425 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~-~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (447)
                            +||++||++|+++.. .++++++.||||.+++|+.+..+++.++|+|......+..+|+..+...+...++...
T Consensus       236 ------~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (327)
T cd05617         236 ------GFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQLTPDDE  309 (327)
T ss_pred             ------HHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhcCCccccCcccCCCCCc
Confidence                  499999999997532 3578999999999999999999999999999998888889998766554433332211


Q ss_pred             ----CCCCCCccCeeeeC
Q 013249          426 ----PTAGEHFKGYTYVA  439 (447)
Q Consensus       426 ----~~~~~~f~~~~~~~  439 (447)
                          ..+...|.||+|++
T Consensus       310 ~~~~~~~~~~~~~~~~~~  327 (327)
T cd05617         310 DVIKRIDQSEFEGFEYIN  327 (327)
T ss_pred             cccccccccccCCCcCCC
Confidence                13677899999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.8e-54  Score=423.68  Aligned_cols=309  Identities=39%  Similarity=0.787  Sum_probs=266.4

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      +.||+|+||.||+|+++.     +++.||||++++..............|..++..+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence            469999999999999886     7889999999876543334445566788888764 8999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||++||+|..++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            999999999999888889999999999999999999999999999999999999999999999999987532 2223345


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||..|+|||++.+..++.++|||||||++|||++|+.||...+..++.+.+......+|..++.++.+++.      +
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~------~  229 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILV------K  229 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH------H
Confidence            6799999999999999999999999999999999999999999888888888887777777777777766555      5


Q ss_pred             hccCCCCCCCCCCCCCh-hhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC----CCCCC
Q 013249          354 LLHKDPSKRLGSGPGGV-DAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----PTPTA  428 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~-~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  428 (447)
                      ||+.||++|+     ++ +++++||||..++|..+..+.+.+++.|......+..+|+..+.......+..    ....+
T Consensus       230 ~l~~~P~~R~-----~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (316)
T cd05619         230 LFVREPERRL-----GVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRMLINSMD  304 (316)
T ss_pred             HhccCHhhcC-----CChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcCCcccCCCccccccccc
Confidence            9999999999     55 48999999999999999999999999999999999999998877654433322    12357


Q ss_pred             CCCccCeeeeCC
Q 013249          429 GEHFKGYTYVAP  440 (447)
Q Consensus       429 ~~~f~~~~~~~~  440 (447)
                      ++.|++|+|.++
T Consensus       305 ~~~~~~~~~~~~  316 (316)
T cd05619         305 QNMFENFSFINP  316 (316)
T ss_pred             ccccCCCcccCc
Confidence            899999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-55  Score=431.45  Aligned_cols=259  Identities=39%  Similarity=0.714  Sum_probs=238.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch--hHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK--NHVDYMKAERDILTKVT-HPFIVQLRYS  183 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~  183 (447)
                      ...+.|++.+.||+|+||+|++|.+..     ++..||+|++.+......  ...+.+.+|+.+++.++ ||||++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~-----t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev   88 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL-----TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV   88 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc-----CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence            345689999999999999999999886     779999998877533211  34566789999999999 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC-CcEEEeecCCc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLA  262 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~~kL~DFG~a  262 (447)
                      +.....+|+||||+.||+|++++...+++.|.+++++++||+.|++|||++||+||||||||||++.+ +++||+|||++
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999 99999999999


Q ss_pred             ccc-cCCCCCCccccCCcccccccccCCC-CC-CccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC-c
Q 013249          263 KEI-DESSRSNSMCGTTEYMAPEILLSKG-HN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL-T  338 (447)
Q Consensus       263 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~-~  338 (447)
                      ... .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...++.+|..+.+.+|.++ +
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S  248 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLS  248 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCC
Confidence            988 5666788999999999999999988 85 789999999999999999999999999999999999999999999 9


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      .+++.+++.      ||..||.+|+     ++++|+.||||+.
T Consensus       249 ~~~~~Li~~------mL~~~P~~R~-----t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  249 PEARSLIEK------MLVPDPSTRI-----TLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHH------HcCCCcccCC-----CHHHHhhChhhcc
Confidence            988887666      9999999999     8999999999986

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.9e-54  Score=423.53  Aligned_cols=311  Identities=46%  Similarity=0.838  Sum_probs=265.6

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH-HHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||+||+|+++.     +++.||+|++.+...........+..|.. +++.++||||+++++.+...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA-----DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence            479999999999999876     78899999998765444444444555555 567899999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987642 2233445


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+......+++..+.++.++++      +
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~------~  229 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLE------G  229 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH------H
Confidence            6899999999999999999999999999999999999999999998899899988888888777777766655      4


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC--------
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT--------  425 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  425 (447)
                      ||+.||.+|+++. ..+++++.||||.+++|..+..+.+.+|+.|..........|+..++..+...+....        
T Consensus       230 ~l~~~p~~R~~~~-~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (323)
T cd05575         230 LLQKDRTKRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSA  308 (323)
T ss_pred             HhhcCHHhCCCCC-CCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccccccccccCCCcccccccc
Confidence            9999999999663 3568999999999999999999999999999988888888888777655443332221        


Q ss_pred             --CCCCCCccCeeee
Q 013249          426 --PTAGEHFKGYTYV  438 (447)
Q Consensus       426 --~~~~~~f~~~~~~  438 (447)
                        ......|.||+|.
T Consensus       309 ~~~~~~~~~~~~~~~  323 (323)
T cd05575         309 SVKEADDAFLGFSYA  323 (323)
T ss_pred             cccccccccCCCccC
Confidence              2467889999983

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-54  Score=422.93  Aligned_cols=310  Identities=38%  Similarity=0.769  Sum_probs=266.6

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||.||+|+++.     +++.||+|++++.........+.+..|..++... +||||+++++++.+.+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG-----KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence            479999999999999886     7889999999876543344455667788888754 8999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||+.||+|..++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            999999999999888899999999999999999999999999999999999999999999999999987532 2223445


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+......+|..++.+++++++.      
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~------  229 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEK------  229 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------
Confidence            78999999999999999999999999999999999999999998888888888888878888888887766555      


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC----CCCCC
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAG  429 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  429 (447)
                      ||+.||++|++.    .+++++||||++++|..+..+.+.+++.|......+..+|+..+.......+...    ...++
T Consensus       230 ~l~~dP~~R~~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (316)
T cd05620         230 LFERDPTRRLGV----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKNLIDSMDQ  305 (316)
T ss_pred             HccCCHHHcCCC----hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccccCcccCCCcccccccccc
Confidence            999999999932    3689999999999999999999999999999888888889877665443333221    12467


Q ss_pred             CCccCeeeeCC
Q 013249          430 EHFKGYTYVAP  440 (447)
Q Consensus       430 ~~f~~~~~~~~  440 (447)
                      ..|.||+|.+|
T Consensus       306 ~~~~~~~~~~~  316 (316)
T cd05620         306 SAFAGFSFINP  316 (316)
T ss_pred             cCcCCCcccCC
Confidence            89999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.6e-54  Score=423.15  Aligned_cols=313  Identities=39%  Similarity=0.807  Sum_probs=262.7

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      +.||+|+||.||+|+++.     +++.||+|++++...........+..|+.++.++ +||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK-----TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence            479999999999999886     7889999999886555555667788899998877 7999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||+.+|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999997642 2223445


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCC---------CCHHHHHHHHHhcccCCCCCCchhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---------ANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~---------~~~~~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      .+||..|+|||++.+..++.++|||||||++|||++|+.||..         .....+.+.+......+|...+.++.++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  235 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV  235 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence            7899999999999999999999999999999999999999952         1223455667777778888888777666


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCC-CChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA  423 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~-~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  423 (447)
                      ++      +||+.||++|+++.. .+++++++||||.+++|..+..+++.|+++|.........+|+..++..+....+.
T Consensus       236 l~------~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (329)
T cd05618         236 LK------SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPD  309 (329)
T ss_pred             HH------HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcccchhcCcccccCCccCCCC
Confidence            55      499999999997522 24789999999999999999999999999999988777777876555443322221


Q ss_pred             ----CCCCCCCCccCeeeeC
Q 013249          424 ----PTPTAGEHFKGYTYVA  439 (447)
Q Consensus       424 ----~~~~~~~~f~~~~~~~  439 (447)
                          ........|.||.|++
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~  329 (329)
T cd05618         310 DDDIVRKIDQSEFEGFEYIN  329 (329)
T ss_pred             cccccccccccccCCCcccC
Confidence                1224578899998874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-54  Score=423.94  Aligned_cols=314  Identities=42%  Similarity=0.805  Sum_probs=269.4

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      +.||+|+||.||+|+++.     +++.||+|++.+...........+..|+++++.++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence            469999999999999876     788999999987655555556677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      |+.||+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++... .......
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            99999999999888899999999999999999999997 799999999999999999999999999987642 2223345


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+......+|..++.++.++++.      
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~------  229 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSG------  229 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH------
Confidence            67999999999999999999999999999999999999999999888888888888888898888887776655      


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC--------
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT--------  425 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  425 (447)
                      ||++||++|++....+++++++|+||.++.|..+..+.+.|++.|......+...|+..++.......+...        
T Consensus       230 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (325)
T cd05594         230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVD  309 (325)
T ss_pred             HhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhhcCccccCCCcccccccccc
Confidence            999999999987777899999999999999999999999999999888877778887665443221111111        


Q ss_pred             CCCCCCccCeeeeCC
Q 013249          426 PTAGEHFKGYTYVAP  440 (447)
Q Consensus       426 ~~~~~~f~~~~~~~~  440 (447)
                      ......|..++|.++
T Consensus       310 ~~~~~~~~~~~~~~~  324 (325)
T cd05594         310 NERRPHFPQFSYSAS  324 (325)
T ss_pred             cccccccCCceecCC
Confidence            123566777777653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.7e-54  Score=428.18  Aligned_cols=315  Identities=36%  Similarity=0.719  Sum_probs=255.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+...........+..|+.++..++|+||+++++.+.+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD-----TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence            479999999999999999999876     788999999987665555666778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||++||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.+....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999987643211


Q ss_pred             ------------------------------------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCC
Q 013249          270 ------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  313 (447)
Q Consensus       270 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~p  313 (447)
                                                          .....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                                01245899999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhc--ccCCCCC--CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHh
Q 013249          314 FTHANRQKLQQRIINE--KVKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  389 (447)
Q Consensus       314 f~~~~~~~~~~~i~~~--~~~~p~~--~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~  389 (447)
                      |.+.+..+...++...  ...+|+.  ++.++++++.      +|+. +|.+|++.  .++++|++||||++++|+.+..
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~------~l~~-~~~~r~~r--~~~~ei~~hp~f~~~~~~~~~~  306 (363)
T cd05628         236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLIL------RFCC-EWEHRIGA--PGVEEIKTNPFFEGVDWEHIRE  306 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHH------HHcC-ChhhcCCC--CCHHHHhCCCCCCCCCHHHHHh
Confidence            9998888888888763  3445543  4566666554      4664 66766532  2799999999999999999987


Q ss_pred             hhcCCCCCCCCCCCccCCCcccccCCC---CCCCCC-CCC---CCCCCCccCeeeeCC
Q 013249          390 REMQPKFKPDVSGKDCIANFDKCWTTM---PADDSP-APT---PTAGEHFKGYTYVAP  440 (447)
Q Consensus       390 ~~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~-~~~---~~~~~~f~~~~~~~~  440 (447)
                      +...+|+  ......+..+|+......   +...+. .+.   ......|.||+|...
T Consensus       307 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (363)
T cd05628         307 RPAAIPI--EIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYTYKRF  362 (363)
T ss_pred             CCCCCCc--cCCCcchhhccCCCCccccccccccccCCcccccCcCCcccCCceeecC
Confidence            6655554  344566677777432111   000110 000   134566999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-55  Score=435.57  Aligned_cols=260  Identities=30%  Similarity=0.557  Sum_probs=245.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .+-|++++.||.|+-|.|-+|++..     +|+..|||++.+...........+.+|+.||+.+.|||+++||+++++..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~-----TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAE-----TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhccc-----ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            3469999999999999999999886     99999999998875455556677999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      ++|+|.||++||.|++++.++|++++.++.++++||+.|+.|||..+|+||||||+|+|||..+++||+|||+|..-.++
T Consensus        86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988888


Q ss_pred             CCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  347 (447)
                      ....+.||++.|.|||++.|..| +.++||||.|||||.||+|+.||++.|...++.++..+.+++|..++.++++|+.+
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR  245 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence            88889999999999999999988 57899999999999999999999999999999999999999999999999998776


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                            ||..||.+|+     +.++|++|||+.+..-
T Consensus       246 ------ml~VDp~~Ri-----T~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  246 ------MLDVDPSTRI-----TTEEILKHPFLSGYTS  271 (786)
T ss_pred             ------HhccCccccc-----cHHHHhhCchhhcCCC
Confidence                  9999999999     8999999999987643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.7e-56  Score=405.25  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=220.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      +.|+.+.++|+|+||+||+|+++.     +|++||||++.... .++...+-..+|+++|++++|+|+|.|+++|.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~-----TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD-----TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC-----cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            579999999999999999999997     99999999997643 234444556799999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~  268 (447)
                      ++||+|||+..-|..+-.....++.+.++.|+.|++.|+.|+|++++||||||||||||+.+|.+||||||+|+.+. .+
T Consensus        76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99999999876554444444568999999999999999999999999999999999999999999999999999987 56


Q ss_pred             CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC---------------
Q 013249          269 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---------------  332 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~---------------  332 (447)
                      ...+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+.++.+....|......               
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            66778899999999999998 78999999999999999999999999999988887777643222               


Q ss_pred             ----CCCCCch-hH-Hhhh----hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          333 ----LPPFLTS-EA-HSLL----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       333 ----~p~~~~~-~~-~~li----~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                          +|.--.. .+ +...    -.+||+.+||..||.+|+     +.++++.|+||.+.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~-----sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL-----SCEQLLHHPYFDGF  290 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc-----cHHHHhcChHHHHH
Confidence                2211000 00 0000    136889999999999999     56999999999653

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.2e-54  Score=422.74  Aligned_cols=313  Identities=45%  Similarity=0.806  Sum_probs=265.3

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH-HHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||+||+|+++.     +++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL-----DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence            469999999999999876     78899999998765444444445555655 567899999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||+.||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... .......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987642 2233445


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+......+++..+.++.++      |.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------l~~  229 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI------LEE  229 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHH------HHH
Confidence            68999999999999999999999999999999999999999999888888888887777777777666555      555


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC---------
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP---------  424 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------  424 (447)
                      ||++||.+||+.. ..+++++.||||.+++|..+..+.+.+++.|......+..+|+..+.+.....+...         
T Consensus       230 ll~~~p~~R~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (325)
T cd05604         230 LLEKDRQRRLGAK-EDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNA  308 (325)
T ss_pred             HhccCHHhcCCCC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCccccCCcccCcccccccccccc
Confidence            9999999999753 357899999999999999999999999999998888888889877665543233211         


Q ss_pred             -CCCCCCCccCeeeeCC
Q 013249          425 -TPTAGEHFKGYTYVAP  440 (447)
Q Consensus       425 -~~~~~~~f~~~~~~~~  440 (447)
                       ......+|.||+|.+|
T Consensus       309 ~~~~~~~~~~~~~~~~~  325 (325)
T cd05604         309 SVLEADDAFVGFSYAPP  325 (325)
T ss_pred             cccccccccCCCEecCC
Confidence             1135778999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-54  Score=416.46  Aligned_cols=278  Identities=38%  Similarity=0.715  Sum_probs=241.5

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|++.+.||+|+||.||+|.++.     +++.||+|++.+...........+.+|+.++++++|+||+++++++.+.+.+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEec-----CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence            38899999999999999999886     7889999999876544444445677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      |+||||+.+|+|..++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999999998887643  36899999999999999999999999999999999999999999999999999876554


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH----HHHHHHHhcccCCCCCCchhHHhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~----~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||...+..    .+...+......++..++.++.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI  235 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence            4445668999999999999999999999999999999999999999875442    333334444455666777777665


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  399 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~  399 (447)
                      ++      +||+.||.+|+++...+++++++||||.+++|+.+.++.+.|||+|+
T Consensus       236 i~------~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05631         236 CR------MLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD  284 (285)
T ss_pred             HH------HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence            55      59999999999876668999999999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-54  Score=421.48  Aligned_cols=314  Identities=49%  Similarity=0.905  Sum_probs=267.1

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      +.||+|+||.||++++...  ..+++.||+|++.+.... ......+..|+.+|++++||||+++++++.+.+.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITG--PDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEecc--CCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            6799999999999986421  126889999999875432 2233456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-CCCCcc
Q 013249          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSM  274 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~~  274 (447)
                      |+.+|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            9999999999988888999999999999999999999999999999999999999999999999999875443 234457


Q ss_pred             ccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhh
Q 013249          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL  354 (447)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~  354 (447)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......+|..++.++.++++.      |
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~------~  232 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRA------L  232 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------H
Confidence            8999999999999999999999999999999999999999999888888888888888888888887766555      9


Q ss_pred             ccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC--CCCCCCCCc
Q 013249          355 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA--PTPTAGEHF  432 (447)
Q Consensus       355 L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~f  432 (447)
                      |+.||++||++....+++++.|+||..++|..+..+++.|++.|......+...++..+........+.  ..+.....|
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~  312 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANAHQLF  312 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCcccccCccccCCCCcccccccccc
Confidence            999999999876556899999999999999999999999999998877776767766554332222222  223467789


Q ss_pred             cCeeee
Q 013249          433 KGYTYV  438 (447)
Q Consensus       433 ~~~~~~  438 (447)
                      .||+|+
T Consensus       313 ~~~~~~  318 (318)
T cd05582         313 RGFSFV  318 (318)
T ss_pred             CCCEeC
Confidence            999985

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-53  Score=427.37  Aligned_cols=312  Identities=39%  Similarity=0.693  Sum_probs=256.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|++++.||+|+||+||+|+++.     +++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD-----THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence            69999999999999999999876     7889999999887665666677899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC--
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES--  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~--  268 (447)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.+...  
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999999999998889999999999999999999999999999999999999999999999999997643110  


Q ss_pred             ----------------------------------------------CCCCccccCCcccccccccCCCCCCccceeehhH
Q 013249          269 ----------------------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI  302 (447)
Q Consensus       269 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv  302 (447)
                                                                    ......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0112457999999999999999999999999999


Q ss_pred             hHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCC--CCchhHHhhhhhhhHHhhhcc--CCCCCCCCCCCCChhhhhcC
Q 013249          303 LLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPP--FLTSEAHSLLKGVSFLTQLLH--KDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       303 il~ell~G~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~~~l~~~L~--~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ++|||++|+.||...+..+....+...  ...+|.  .++.++.+++..      ||.  .++..|+     +++++++|
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~------ll~~~~~~~~R~-----~~~~~l~h  305 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITK------LCCSAEERLGRN-----GADDIKAH  305 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHH------HccCcccccCCC-----CHHHHhcC
Confidence            999999999999888877766666542  334443  356676666554      554  4455588     88999999


Q ss_pred             CccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCC----CCC------CC--CCCCCCCccCeeeeC
Q 013249          377 KWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD----DSP------AP--TPTAGEHFKGYTYVA  439 (447)
Q Consensus       377 ~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~------~~--~~~~~~~f~~~~~~~  439 (447)
                      |||.+++|.... +...+|+.|......+..+|+......+..    ++.      ..  .......|.||+|..
T Consensus       306 p~f~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (381)
T cd05626         306 PFFSEVDFSSDI-RTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRR  379 (381)
T ss_pred             cccCCCChhHHh-hcCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeec
Confidence            999999998865 456778999998888888887654332211    000      01  112368899999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-54  Score=424.56  Aligned_cols=310  Identities=44%  Similarity=0.827  Sum_probs=263.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||||++.+...........+..|+.++..++||||+++++++.+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD-----TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC-----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence            479999999999999999999876     788999999988765555667778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||+.|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999998764432


Q ss_pred             ------------------------------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH
Q 013249          270 ------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR  319 (447)
Q Consensus       270 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~  319 (447)
                                                    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                          23346799999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHh--cccCCCCCC--chhHHhhhhhhhHHhhhccCCCCCCCCCCCCC-hhhhhcCCccCCCChhHHHhhhcCC
Q 013249          320 QKLQQRIIN--EKVKLPPFL--TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGG-VDAIKHHKWFRSINWKTLEAREMQP  394 (447)
Q Consensus       320 ~~~~~~i~~--~~~~~p~~~--~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~-~~~l~~h~~f~~~~~~~~~~~~~~~  394 (447)
                      .....++..  ....+|...  +.++.+++.      +||. ||.+|+     + ++++++||||.+++|....  ...+
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~------~ll~-dp~~R~-----~s~~~ll~hp~~~~~~~~~~~--~~~~  301 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLIC------RLLC-DPEDRL-----GSFEEIKSHPFFKGIDWENLR--ETKP  301 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHH------HHcc-ChhhcC-----CCHHHHhcCCCcCCCCHHHHh--hCCC
Confidence            888888776  444555443  666665554      5997 999999     5 8999999999999999886  6678


Q ss_pred             CCCCCCCCCccCCCcccccCCCCCCCC-----CCCCCCCCCCccCeeee
Q 013249          395 KFKPDVSGKDCIANFDKCWTTMPADDS-----PAPTPTAGEHFKGYTYV  438 (447)
Q Consensus       395 ~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~f~~~~~~  438 (447)
                      +++|......+..+|+..-...+....     .......+..|.||+|.
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (350)
T cd05573         302 PFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGFTYK  350 (350)
T ss_pred             CcCCCCCCchhhhhcCCCCcccccccccccccccccccccCccCCCccC
Confidence            899998888888888765333321110     11122478889999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-55  Score=429.90  Aligned_cols=290  Identities=42%  Similarity=0.786  Sum_probs=259.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ....-|..++.||-|+||.|.+++...     +...||+|.++|..+..++++..++.|..||...+.+-||+||..|++
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvD-----T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVD-----TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecc-----hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            456679999999999999999998775     788999999999988899999999999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .+.+|+||||++||++..+|-+.+.|.|+.+++|++++.+|+++.|+.|+|||||||+|||||.+|+|||+|||+|.-+.
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999997541


Q ss_pred             ---------CC----------------------------------CCCCccccCCcccccccccCCCCCCccceeehhHh
Q 013249          267 ---------ES----------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL  303 (447)
Q Consensus       267 ---------~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi  303 (447)
                               ++                                  ......+||+.|+|||++...+|+..+||||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence                     00                                  01234579999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCC--CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          304 LYEMLTGQPPFTHANRQKLQQRIINEK--VKLP--PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       304 l~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p--~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ||||+.|++||....+.+...+|++-.  +.+|  ..++.++.++|..       |+.+++.|+|.  .++++|+.||||
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~k-------Lc~sad~RLGk--ng~d~vKaHpfF  931 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQK-------LCCSADSRLGK--NGADQVKAHPFF  931 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHH-------HhcChhhhhcc--cchhhhhcCccc
Confidence            999999999999888888777776532  3343  4688899888875       77899999976  378889999999


Q ss_pred             CCCChhHHHhhhcCCCCCCCCCCCccCCCcccc
Q 013249          380 RSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  412 (447)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  412 (447)
                      ++|||..+  ++.+++|+|.+.-..+++|||..
T Consensus       932 kgIDfssl--Rkq~ApYIP~ItHptDTSNFdpv  962 (1034)
T KOG0608|consen  932 KGIDFSSL--RKQRAPYIPRITHPTDTSNFDPV  962 (1034)
T ss_pred             cccchHhh--hhccCCcCccccCCCccccCCcC
Confidence            99999995  67778899999999999999854

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-53  Score=423.31  Aligned_cols=314  Identities=40%  Similarity=0.777  Sum_probs=258.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||++++++|.+...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD-----TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence            479999999999999999999886     788999999987655555566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987542211


Q ss_pred             ---------------------------------------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhC
Q 013249          270 ---------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG  310 (447)
Q Consensus       270 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  310 (447)
                                                             .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence                                                   11235799999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhccc--CCCC--CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          311 QPPFTHANRQKLQQRIINEKV--KLPP--FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       311 ~~pf~~~~~~~~~~~i~~~~~--~~p~--~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      ..||...+..+....+.....  .+|.  .++.++.++      |.+||. +|.+|++.  .+++++++||||++++|+.
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l------i~~ll~-~p~~R~~~--~~~~~ll~h~~~~~~~~~~  306 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDL------IKRLCC-EAERRLGN--NGVNEIKSHPFFKGVDWEH  306 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHH------HHHHcc-CHhhcCCC--CCHHHHhcCCCcCCCCHHH
Confidence            999999888887777765432  3333  245555555      555886 99999953  2599999999999999998


Q ss_pred             HHhhhcCCCCCCCCCCCccCCCcccccCCCCC--CCC----CCCCCCCCCCccCeeeeCC
Q 013249          387 LEAREMQPKFKPDVSGKDCIANFDKCWTTMPA--DDS----PAPTPTAGEHFKGYTYVAP  440 (447)
Q Consensus       387 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~f~~~~~~~~  440 (447)
                      +.  ...+++.|......+..+|+.. .+.+.  ..+    .......+..|.||+|.+.
T Consensus       307 ~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (364)
T cd05599         307 IR--ERPAPIIPELKSITDTSNFDDF-EEIDLDVPTSPGPPRGKIKSKDLAFIGYTYKRF  363 (364)
T ss_pred             Hh--hcCCCCCCCCCCchhhhhcccc-ccccccccCCCccccccccccCCCCCCCeeeCC
Confidence            75  4567888888777777788643 22211  111    1112246778999998753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-53  Score=424.82  Aligned_cols=315  Identities=39%  Similarity=0.728  Sum_probs=256.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||.||+|+++.     +++.||||++.+.........+.+.+|+++++.++||||++++++|.+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD-----TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence            479999999999999999999886     788999999987655555667788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999986431100


Q ss_pred             ------------------------------------------------CCCccccCCcccccccccCCCCCCccceeehh
Q 013249          270 ------------------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVG  301 (447)
Q Consensus       270 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG  301 (447)
                                                                      .....+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence                                                            00135799999999999999999999999999


Q ss_pred             HhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCC--CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCC
Q 013249          302 ILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPP--FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHK  377 (447)
Q Consensus       302 vil~ell~G~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~  377 (447)
                      |++|||++|..||.+.+..+.+..+...  ...+|.  .++.++.++      |.+||+ +|.+|++.  .++++++.||
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dl------i~~lL~-~~~~r~~r--~~~~~~l~hp  306 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDL------IRRLIT-NAENRLGR--GGAHEIKSHP  306 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHH------HHHHhc-CHhhcCCC--CCHHHHhcCC
Confidence            9999999999999988887777777653  334444  245555554      555997 88888643  2899999999


Q ss_pred             ccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCC----CCCC-----CCCCCCCCCCccCeeeeCC
Q 013249          378 WFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP----ADDS-----PAPTPTAGEHFKGYTYVAP  440 (447)
Q Consensus       378 ~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~-----~~~~~~~~~~f~~~~~~~~  440 (447)
                      ||.+++|+.+  +.+.+|+.|......+...|........    ....     +...+.....|.||+|...
T Consensus       307 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (377)
T cd05629         307 FFRGVDWDTI--RQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRF  376 (377)
T ss_pred             CcCCCCHHHH--ccCCCCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCC
Confidence            9999999988  5778889998777666666653322111    0000     0111245777999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-53  Score=423.51  Aligned_cols=313  Identities=37%  Similarity=0.736  Sum_probs=257.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||+|++.+...........+..|+.++..++||||+++++.+.+.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD-----TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            479999999999999999999886     788999999987655556667788899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.+....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987542210


Q ss_pred             ------------------------------------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCC
Q 013249          270 ------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  313 (447)
Q Consensus       270 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~p  313 (447)
                                                          .....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence                                                11245799999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhc--ccCCCCC--CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHh
Q 013249          314 FTHANRQKLQQRIINE--KVKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  389 (447)
Q Consensus       314 f~~~~~~~~~~~i~~~--~~~~p~~--~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~  389 (447)
                      |...+.......+...  ...+|+.  ++.++++++.      +|+ .||.+|++.  .+++++++||||.+++|..+..
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~------~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~~~~~~  306 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLIL------RFC-TDSENRIGS--NGVEEIKSHPFFEGVDWGHIRE  306 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHH------Hhc-cChhhcCCC--CCHHHHhcCCCCCCCCHHHHhc
Confidence            9998888888877753  3344543  4566655544      466 599999965  3689999999999999999987


Q ss_pred             hhcCCCCCCCCCCCccCCCcccccCCCC-----CCCCCCCCCCCCCCccCeeeeC
Q 013249          390 REMQPKFKPDVSGKDCIANFDKCWTTMP-----ADDSPAPTPTAGEHFKGYTYVA  439 (447)
Q Consensus       390 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~f~~~~~~~  439 (447)
                      +...+|+  .+....+..+|+.. ....     .....+........|.+|+|..
T Consensus       307 ~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (360)
T cd05627         307 RPAAIPI--EIKSIDDTSNFDEF-PESDILQPAENTIEPDYKSKDWVFLNYTYKR  358 (360)
T ss_pred             CCCCCCc--cCCCcchhhhcCCC-CcccccCCCccccccccCcCCcccCCceeec
Confidence            7665554  34556667777632 1111     1111112224677799999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.6e-53  Score=417.15  Aligned_cols=313  Identities=46%  Similarity=0.848  Sum_probs=264.4

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHH-HHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER-DILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      +.||+|+||+||+|+++.     +++.||+|++.+...........+..|. .+++.++||||+++++++...+.+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence            469999999999999876     7789999999876543333333444444 4578899999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||+.||+|..++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999997643 2233446


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......+++.++.++.++++.      
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~------  229 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG------  229 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHH------
Confidence            78999999999999999999999999999999999999999999988888888888777777788777766555      


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC--------
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT--------  425 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  425 (447)
                      ||++||.+|+++. ..+.++++|+||..++|+.+...+..+++.|......+...|+..++..+...+....        
T Consensus       230 ~l~~~p~~R~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (325)
T cd05602         230 LLQKDRTKRLGAK-DDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTA  308 (325)
T ss_pred             HcccCHHHCCCCC-CCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCccccCCcccccCCCchhhhhcc
Confidence            9999999999763 3567999999999999999999999999999998888888888776655443332211        


Q ss_pred             --CCCCCCccCeeeeCC
Q 013249          426 --PTAGEHFKGYTYVAP  440 (447)
Q Consensus       426 --~~~~~~f~~~~~~~~  440 (447)
                        ......|.||+|-.|
T Consensus       309 ~~~~~~~~~~g~~~~~~  325 (325)
T cd05602         309 SVKEAAEAFLGFSYAPP  325 (325)
T ss_pred             cccccccccCCCccCCC
Confidence              135666899998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6e-53  Score=421.49  Aligned_cols=319  Identities=34%  Similarity=0.666  Sum_probs=260.9

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      ....+..++|++.++||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC  110 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3455667899999999999999999999886     78899999998755444455566889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      ++.++..+|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         111 AFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999999999999988654 6899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC--CCCccccCCcccccccccCCC----CCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCC
Q 013249          263 KEIDESS--RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP  334 (447)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p  334 (447)
                      .......  .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+.......|....  ..+|
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  269 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP  269 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC
Confidence            8764332  234568999999999997643    7889999999999999999999999988888888887643  3444


Q ss_pred             C--CCchhHHhhhhhhhHHhhhccCCCCC--CCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcc
Q 013249          335 P--FLTSEAHSLLKGVSFLTQLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  410 (447)
Q Consensus       335 ~--~~~~~~~~li~~~~~l~~~L~~dP~~--R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  410 (447)
                      .  .++..+++++.      +||..++.+  |+     +++++++||||++..|.....+...+|+.|......+..+|+
T Consensus       270 ~~~~~s~~~~~li~------~~L~~~~~r~~R~-----~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  338 (370)
T cd05621         270 EDVEISKHAKNLIC------AFLTDREVRLGRN-----GVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFD  338 (370)
T ss_pred             CcccCCHHHHHHHH------HHccCchhccCCC-----CHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhcC
Confidence            4  34566665554      488754433  65     899999999999988877777788899999998888888887


Q ss_pred             cccCCCCCCCC-CCCC--CCCCCCccCeeee
Q 013249          411 KCWTTMPADDS-PAPT--PTAGEHFKGYTYV  438 (447)
Q Consensus       411 ~~~~~~~~~~~-~~~~--~~~~~~f~~~~~~  438 (447)
                      ..-......+. +.+.  ...+..|.||+|.
T Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (370)
T cd05621         339 DIEDDKGDVETFPIPKAFVGNQLPFIGFTYY  369 (370)
T ss_pred             CccccccccccCCCCccccccccccCCCEec
Confidence            54322211111 1121  1347889999996

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.7e-53  Score=423.35  Aligned_cols=287  Identities=43%  Similarity=0.799  Sum_probs=246.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|+++++||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+++++.|.+.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD-----TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC-----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence            69999999999999999999876     7889999999876655566677889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC---
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE---  267 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~---  267 (447)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+..   
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999753210   


Q ss_pred             ---------------------------------------------CCCCCccccCCcccccccccCCCCCCccceeehhH
Q 013249          268 ---------------------------------------------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI  302 (447)
Q Consensus       268 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv  302 (447)
                                                                   .......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00112357999999999999999999999999999


Q ss_pred             hHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCC--CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCc
Q 013249          303 LLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP--FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW  378 (447)
Q Consensus       303 il~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p~--~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~  378 (447)
                      ++|||++|+.||...+..+....+....  ..+|.  .+++++.+++.      +|+ .||.+|++.  .+++++++|||
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~------~l~-~~p~~R~~~--~~~~ei~~hp~  307 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLII------KLC-RGPEDRLGK--NGADEIKAHPF  307 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHH------HHc-cCHhHcCCC--CCHHHHhcCCC
Confidence            9999999999999888877777766533  23332  45666665554      465 599999953  25899999999


Q ss_pred             cCCCChhHHHhhhcCCCCCCCCCCCccCCCcccc
Q 013249          379 FRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  412 (447)
Q Consensus       379 f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  412 (447)
                      |++++|.... .+..+|+.|.+....+..+|+..
T Consensus       308 f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
T cd05625         308 FKTIDFSSDL-RQQSAPYIPKITHPTDTSNFDPV  340 (382)
T ss_pred             cCCcChHHHH-hcCCCCccCcCCCcchhhhcCCC
Confidence            9999998865 46678999999988888888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.9e-53  Score=420.11  Aligned_cols=318  Identities=35%  Similarity=0.667  Sum_probs=263.6

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      ...+..++|++.++||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~  111 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKS-----SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA  111 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            445667899999999999999999999886     788999999987654444555667889999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +.+...+|+||||++||+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         112 FQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999999999998865 468999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC--CCCccccCCcccccccccCC----CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCC
Q 013249          264 EIDESS--RSNSMCGTTEYMAPEILLSK----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP  335 (447)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p~  335 (447)
                      ......  .....+||+.|+|||++.+.    .++.++|||||||++|||++|+.||.+.+....+..+....  ..+|.
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  270 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD  270 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence            764332  23456899999999998754    37899999999999999999999999988888888887643  34454


Q ss_pred             --CCchhHHhhhhhhhHHhhhccCCCCC--CCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCccc
Q 013249          336 --FLTSEAHSLLKGVSFLTQLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  411 (447)
Q Consensus       336 --~~~~~~~~li~~~~~l~~~L~~dP~~--R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  411 (447)
                        .++.++.++++      +||+.+|.+  |+     +++++++||||++.+|.....+...+++.|......+..+|+.
T Consensus       271 ~~~~s~~~~~li~------~~L~~~p~r~~R~-----s~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  339 (370)
T cd05596         271 DIEISKQAKDLIC------AFLTDREVRLGRN-----GVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDD  339 (370)
T ss_pred             cCCCCHHHHHHHH------HHccChhhccCCC-----CHHHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhcCC
Confidence              34666665554      599999987  88     8999999999999999988888888999999888888888875


Q ss_pred             ccCCCCCCCC---CCCCCCCCCCccCeeee
Q 013249          412 CWTTMPADDS---PAPTPTAGEHFKGYTYV  438 (447)
Q Consensus       412 ~~~~~~~~~~---~~~~~~~~~~f~~~~~~  438 (447)
                      ..........   +.........|.||+|.
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (370)
T cd05596         340 IEDDDKNEETFPLPKAFAGNQLPFIGFTYS  369 (370)
T ss_pred             ccccccccccCCCccccccccCccCCCeec
Confidence            5433211111   11122345569999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.5e-53  Score=413.52  Aligned_cols=311  Identities=44%  Similarity=0.822  Sum_probs=261.6

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH-HHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ++||+|+||.||+|+++.     +++.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS-----DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence            479999999999999876     78899999998765444444444555554 678899999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc-cCCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~-~~~~~~~~  273 (447)
                      ||++|++|..++.....+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.. ........
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998763 22233445


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...+...+......+|...+.++.+++.      +
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~------~  229 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLV------G  229 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH------H
Confidence            6899999999999999999999999999999999999999999988888888888887888777777666555      4


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC-------CC
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP-------TP  426 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~  426 (447)
                      ||++||.+|+++. .++.++++|+||..++|..+..+.+.+++.|..........|+..++......+...       .+
T Consensus       230 ~l~~~p~~R~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (321)
T cd05603         230 LLHKDQRRRLGAK-ADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSS  308 (321)
T ss_pred             HccCCHhhcCCCC-CCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccccccccccCCCCccccccc
Confidence            9999999999753 257799999999999999999889999999988887777788766654433222221       12


Q ss_pred             CCCCCccCeeee
Q 013249          427 TAGEHFKGYTYV  438 (447)
Q Consensus       427 ~~~~~f~~~~~~  438 (447)
                      .....|.||+|.
T Consensus       309 ~~~~~~~~~~~~  320 (321)
T cd05603         309 SASSAFLGFSYA  320 (321)
T ss_pred             ccccccCCCccC
Confidence            356678999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-54  Score=384.41  Aligned_cols=259  Identities=34%  Similarity=0.635  Sum_probs=244.1

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++++.||+|-||.||+|+.+.     ++.++|+|++.|..+.......++.+|++|-..++||||+++|++|.
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekk-----s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh   92 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKK-----SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH   92 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeecc-----CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence            4567799999999999999999999987     88999999999988877777788999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          186 TRSKLYLILDFINGGHLFFHLY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +...+||++||..+|+|+..|.  +..++++..+..|+.|++.||.|+|.++||||||||+|+|++..|.+||+|||.+.
T Consensus        93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            9999999999999999999999  66789999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHh
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  343 (447)
                      .-. .....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..+.+++|...++.+|..++.++++
T Consensus       173 ~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d  251 (281)
T KOG0580|consen  173 HAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD  251 (281)
T ss_pred             ecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence            654 4567789999999999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +|..      ||.++|.+|+     ...+++.|||...
T Consensus       252 lI~~------ll~~~p~~r~-----~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  252 LISR------LLVKNPIERL-----ALTEVMDHPWIVA  278 (281)
T ss_pred             HHHH------HhccCccccc-----cHHHHhhhHHHHh
Confidence            8766      9999999999     8999999999853

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-53  Score=415.33  Aligned_cols=285  Identities=46%  Similarity=0.854  Sum_probs=246.0

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEEeCCEEEEEE
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      ||+|+||+||+|+++.     +++.||||++.+..............|..++..+   +||||+++++++.....+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKD-----TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECC-----CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence            7999999999999876     7889999999876554444445556677777765   6999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-CCCCCCc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNS  273 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-~~~~~~~  273 (447)
                      ||+.+|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            999999999999988999999999999999999999999999999999999999999999999999987642 2233446


Q ss_pred             cccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC-CchhHHhhhhhhhHH
Q 013249          274 MCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF-LTSEAHSLLKGVSFL  351 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~-~~~~~~~li~~~~~l  351 (447)
                      .+||..|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+..+...+|.. ++.++.++      |
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l------i  229 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQF------V  229 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH------H
Confidence            7899999999998764 58999999999999999999999999998888888888877777653 56666555      5


Q ss_pred             hhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccC
Q 013249          352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT  414 (447)
Q Consensus       352 ~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  414 (447)
                      .+||+.||++||++. .+++++++||||.+.+|..+..+.+++++.|.........+|+..++
T Consensus       230 ~~~L~~~P~~R~~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (330)
T cd05586         230 KGLLNRNPQHRLGAH-RDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFT  291 (330)
T ss_pred             HHHcCCCHHHCCCCC-CCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCcccc
Confidence            559999999999763 37899999999999999999999999999998887777777776543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6e-52  Score=414.54  Aligned_cols=324  Identities=35%  Similarity=0.680  Sum_probs=262.8

Q ss_pred             HhhhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceee
Q 013249          101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL  180 (447)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l  180 (447)
                      ......+..++|++.+.||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+++
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~  108 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  108 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            344456677899999999999999999999886     788999999987554444555667889999999999999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecC
Q 013249          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                      ++++.+...+|+||||++||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999999999998865 468999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC--CCCccccCCcccccccccCCC----CCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cC
Q 013249          261 LAKEIDESS--RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VK  332 (447)
Q Consensus       261 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~  332 (447)
                      +++......  .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+.+....+..|....  ..
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  267 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  267 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence            998764332  234568999999999997643    7899999999999999999999999998888888887644  33


Q ss_pred             CCC--CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcc
Q 013249          333 LPP--FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  410 (447)
Q Consensus       333 ~p~--~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  410 (447)
                      +|.  .++.++++++.      +||. +|.+|++.  .+++++++|+||++..|.....++..+|++|.........+|+
T Consensus       268 ~~~~~~~s~~~~~li~------~~L~-~~~~r~~r--~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (371)
T cd05622         268 FPDDNDISKEAKNLIC------AFLT-DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD  338 (371)
T ss_pred             CCCcCCCCHHHHHHHH------HHcC-ChhhhcCC--CCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchhhhcC
Confidence            443  45666666555      4998 66665532  2899999999999988877777888889999888777777777


Q ss_pred             cccCCCCCCCC-CCCC--CCCCCCccCeeeeC
Q 013249          411 KCWTTMPADDS-PAPT--PTAGEHFKGYTYVA  439 (447)
Q Consensus       411 ~~~~~~~~~~~-~~~~--~~~~~~f~~~~~~~  439 (447)
                      +.-.+...... +.+.  ......|.||+|.+
T Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T cd05622         339 DIEEDKGEEETFPIPKAFVGNQLPFVGFTYYS  370 (371)
T ss_pred             CCcccccccccCCCCccccccccccCCCeecC
Confidence            54333221111 1111  12357899999974

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-54  Score=421.30  Aligned_cols=254  Identities=33%  Similarity=0.631  Sum_probs=237.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|.+.+.||+|+||+||+++.|.     +.+.||+|.+.|... .+..++.+.+|++|++.++|||||.++++|++..+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~-----t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY-----TIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc-----ceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            579999999999999999999987     889999999988764 34456779999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+|.||+.| +|+.++...+.++|++++.++.+++.||.|||+++|+|||+||.|||++.+|++|+||||+|+.+....
T Consensus        76 ~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9999999987 999999999999999999999999999999999999999999999999999999999999999876543


Q ss_pred             -CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhh
Q 013249          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  348 (447)
                       ....+.||+.|||||++.++.|+..+|+||||||+|||++|++||.......+...|..+....|...+..+..++++ 
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~g-  233 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQG-  233 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHH-
Confidence             345678999999999999999999999999999999999999999999999999999999999999999888888777 


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                           +|.+||.+|+     ++.+++.|||.++
T Consensus       234 -----LL~kdP~~Rl-----tW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  234 -----LLIKDPAQRL-----TWTDLLGHPFWKG  256 (808)
T ss_pred             -----HhhcChhhcc-----cHHHHhcChHHhh
Confidence                 9999999999     8999999999875

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.2e-52  Score=416.02  Aligned_cols=288  Identities=42%  Similarity=0.785  Sum_probs=244.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++.|.+++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVD-----TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence            379999999999999999999886     788999999987655445556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+... 
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999997532100 


Q ss_pred             -------------------------------------------CCCCccccCCcccccccccCCCCCCccceeehhHhHH
Q 013249          269 -------------------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY  305 (447)
Q Consensus       269 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~  305 (447)
                                                                 ......+||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                       0112357999999999999999999999999999999


Q ss_pred             HHhhCCCCCCCCCHHHHHHHHHhccc--CCCC--CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          306 EMLTGQPPFTHANRQKLQQRIINEKV--KLPP--FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       306 ell~G~~pf~~~~~~~~~~~i~~~~~--~~p~--~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ||++|+.||.+.+..+....+.....  .+|.  .++.++.++      |.+|+ .+|.+|++.  .+++++++||||++
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l------i~~l~-~~p~~R~~~--~t~~ell~h~~~~~  306 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDL------ILRLC-CGAEDRLGK--NGADEIKAHPFFKG  306 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHH------HHHHh-cCHhhcCCC--CCHHHHhCCCCcCC
Confidence            99999999998888777666654332  2232  345555554      44465 599999954  27899999999999


Q ss_pred             CChhHHHhhhcCCCCCCCCCCCccCCCcccc
Q 013249          382 INWKTLEAREMQPKFKPDVSGKDCIANFDKC  412 (447)
Q Consensus       382 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  412 (447)
                      ++|..+. +...+++.|......+.++|+..
T Consensus       307 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  336 (376)
T cd05598         307 IDFASLI-RRQKAPYIPKITHPTDTSNFDPV  336 (376)
T ss_pred             CCHHHHh-hcCCCCCCCcCCCcchhhhcCCC
Confidence            9999987 66778889988877777777644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-51  Score=407.09  Aligned_cols=281  Identities=41%  Similarity=0.740  Sum_probs=244.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||||++.+...........+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD-----TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence            479999999999999999999876     788999999987655445556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999987644  


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc--CCCCC------CchhH
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--KLPPF------LTSEA  341 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~--~~p~~------~~~~~  341 (447)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.....  ..|..      ++.++
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence            34556899999999999999999999999999999999999999999888887777665332  22222      24444


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  410 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  410 (447)
                      .      +||.+||..+|.+|+     +++++++||||.+++|..+.  ...|++.|......+...|+
T Consensus       234 ~------~li~~~l~~~~~rr~-----s~~~ll~h~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  289 (333)
T cd05600         234 W------DLITKLINDPSRRFG-----SLEDIKNHPFFKEVDWNELR--ELKPPFVPELESEIDTGYFD  289 (333)
T ss_pred             H------HHHHHHhhChhhhcC-----CHHHHHhCcccCCCCHHHHh--hCCCCCCCCCCCcchhhhcc
Confidence            4      456669999999999     89999999999999999886  78888999877665555554

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-54  Score=412.50  Aligned_cols=261  Identities=29%  Similarity=0.506  Sum_probs=227.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~  187 (447)
                      .++|.++++||.|+||.||+|+.+.     +++.||||.|++.... -++.- -.+|+..|++++ |||||+|.+++.+.
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~-----~~~~VAIK~MK~Kf~s-~ee~~-nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKE-----TGELVAIKKMKKKFYS-WEECM-NLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecC-----CCceeeHHHHHhhhcc-HHHHH-HHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            4589999999999999999999886     8889999999876533 22222 347999999999 99999999999988


Q ss_pred             C-EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          188 S-KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       188 ~-~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      + .+|+|||||+. +|++++..+ ..|++..++.|+.||++||+|+|++|++|||+||||||+..+..+||+|||+||.+
T Consensus        82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence            8 99999999975 788888755 57999999999999999999999999999999999999998899999999999999


Q ss_pred             cCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc---------------
Q 013249          266 DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---------------  329 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~---------------  329 (447)
                      ......+..+.|.+|+|||++.. ..|+.++||||+|||++|+.+-++.|.+.++.+...+|..-               
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            88888888999999999999885 56899999999999999999999999999998888888642               


Q ss_pred             ----ccCCCCCCchhHHhhh-----hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          330 ----KVKLPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       330 ----~~~~p~~~~~~~~~li-----~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                          .+.+|......+.+++     .++++|.+||.+||.+||     +++++++||||+..
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp-----TA~~al~~pffq~~  297 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP-----TASQALQHPFFQVG  297 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc-----cHHHHhcCcccccc
Confidence                2345555555555554     246788899999999999     88999999999854

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-51  Score=397.85  Aligned_cols=278  Identities=39%  Similarity=0.715  Sum_probs=239.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|++.++||+|+||.||++.+..     +++.||||++.+...........+.+|+.+++.++||||+++++.+.+++.+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC-----CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence            48999999999999999999875     7889999999875544444445677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      |+||||+.||+|..++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999999999888654  46899999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHH----HHHHHhcccCCCCCCchhHHhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL----QQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      ......+|+..|+|||++.+..++.++||||+||++|||++|+.||.+.+....    ...+......++..++..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI  235 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence            444456899999999999998999999999999999999999999987655433    3333344445555666666655


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  399 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~  399 (447)
                      +      .+||..||.+||++...+++++++|+||...+|+.+.+++++|||+|+
T Consensus       236 i------~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05605         236 C------RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD  284 (285)
T ss_pred             H------HHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence            4      559999999999887778999999999999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-51  Score=405.34  Aligned_cols=310  Identities=36%  Similarity=0.700  Sum_probs=255.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|++++.........+.+.+|+.+++.++|+||+++++++.+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA-----TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence            479999999999999999999886     788999999987665455566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+...
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999999999876 68999999999999999999999999999999999999999999999999999876443


Q ss_pred             CC--CCccccCCccccccccc------CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCC--C
Q 013249          269 SR--SNSMCGTTEYMAPEILL------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP--F  336 (447)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p~--~  336 (447)
                      ..  .....||+.|+|||++.      ...++.++|||||||++|||++|+.||...+....+.++....  ..+|.  .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence            22  23357999999999987      4567899999999999999999999999888877777776543  23333  3


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCC
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  416 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  416 (447)
                      ++.++.++      |.+||+ ||.+|+     +++++++||||..++|..+.  ...|++.|......+..+|+......
T Consensus       236 ~~~~~~~l------i~~ll~-~p~~R~-----t~~~l~~h~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (330)
T cd05601         236 VSSDFLDL------IQSLLC-GQKERL-----GYEGLCCHPFFSKIDWNNIR--NSLPPFVPTLKSDDDTSNFDEPEKNS  301 (330)
T ss_pred             CCHHHHHH------HHHHcc-ChhhCC-----CHHHHhCCCCcCCCCHHHHh--hCCCCccCcCCCcchhhhcCCCcccc
Confidence            45565555      445997 999999     88999999999999999886  35678888888888888886543332


Q ss_pred             CCCCCCC-------CCCCCCCCccCeeee
Q 013249          417 PADDSPA-------PTPTAGEHFKGYTYV  438 (447)
Q Consensus       417 ~~~~~~~-------~~~~~~~~f~~~~~~  438 (447)
                      +......       ........|.||+|+
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (330)
T cd05601         302 TRRSQSSTTQLKPNGFSGKDLPFVGFSFI  330 (330)
T ss_pred             ccccccccccCCCcCCCCCCCCccCceeC
Confidence            2111111       112356778888874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-54  Score=389.38  Aligned_cols=243  Identities=29%  Similarity=0.515  Sum_probs=216.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE-EEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY-SFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~  188 (447)
                      .+|+++++||+|+||.||++++..     ++..+|.|.+....+ +....+.+..|+.+|++++|||||++++ .|..+.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~-----~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLL-----DGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeecc-----Ccchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            479999999999999999999987     889999999986554 4555677889999999999999999998 565555


Q ss_pred             E-EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCCcccCCCCcEEEeec
Q 013249          189 K-LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK--CG--IVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       189 ~-~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~--~~--iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                      . ++||||||.+|+|...++.    +..++|..++.++.|++.||.+||.  ..  |+||||||.||+|+.+|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            5 9999999999999988863    3569999999999999999999998  44  999999999999999999999999


Q ss_pred             CCcccccCCCC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-CC-CC
Q 013249          260 GLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LP-PF  336 (447)
Q Consensus       260 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-~p-~~  336 (447)
                      |+++.+..... ..+.+|||.||+||++...+|+.++||||+||++|||+.-++||.+.+..++..+|.++.+. +| ..
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence            99999865433 56789999999999999999999999999999999999999999999999999999999764 56 56


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCC
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLG  364 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~  364 (447)
                      ++.++..++..      |+..||..||+
T Consensus       253 YS~~l~~li~~------ci~vd~~~RP~  274 (375)
T KOG0591|consen  253 YSTDLRELINM------CIAVDPEQRPD  274 (375)
T ss_pred             hhhHHHHHHHH------HccCCcccCCC
Confidence            78888777666      99999999994

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-54  Score=382.93  Aligned_cols=257  Identities=33%  Similarity=0.598  Sum_probs=234.6

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.++||+|.|+.||+|.++.     +|+.||+|++.-..+... ..+.+.+|++|.+.++|||||+|.+.+...+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~-----tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhcc-----chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            3578999999999999999999876     899999999987665444 5567999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEEeecCCcccc
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEI  265 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL~DFG~a~~~  265 (447)
                      ..|+|+|+|.|++|..-+-.+..++|-.+-.+++||+.+|.|+|.+||||||+||+|+|+-.   .--+||+|||+|..+
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999999999988888888999999999999999999999999999999999999953   345999999999999


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhH
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  341 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  341 (447)
                      +.......++||+.|||||++....|+..+|||+.||+||-||.|.+||.+.+...+++.|..+.+.+|.    .+++++
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            8777788899999999999999999999999999999999999999999999999999999999998875    466777


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +++++      +||..||.+|+     ++.|.++|||+.+-
T Consensus       244 k~Lvr------rML~~dP~kRI-----ta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  244 KSLIR------RMLTVNPKKRI-----TADEALKHPWICNR  273 (355)
T ss_pred             HHHHH------HHhccChhhhc-----cHHHHhCCchhcch
Confidence            66655      59999999999     88999999999863

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-52  Score=401.31  Aligned_cols=259  Identities=31%  Similarity=0.591  Sum_probs=222.9

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-----------hhHHHHHHHHHHHHHhcCC
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------KNHVDYMKAERDILTKVTH  174 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~h  174 (447)
                      ....++|++++.||+|.||.|-+|++..     +++.||||++.+.....           ...++.+.+|+.||++|+|
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~-----~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H  167 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEV-----DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH  167 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecC-----CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence            3456799999999999999999999876     88999999998765432           1234678999999999999


Q ss_pred             CCceeeeEEEEe--CCEEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC
Q 013249          175 PFIVQLRYSFQT--RSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (447)
Q Consensus       175 pnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~  251 (447)
                      ||||+|+++..+  .+++|||+|||..|.+... ...+. +++.+++.|+++++.||+|||.+|||||||||+|+||+.+
T Consensus       168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             cCeeEEEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence            999999999976  4689999999999977332 23344 8999999999999999999999999999999999999999


Q ss_pred             CcEEEeecCCcccccCC------CCCCccccCCcccccccccCCC----CCCccceeehhHhHHHHhhCCCCCCCCCHHH
Q 013249          252 GHVMLTDFGLAKEIDES------SRSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQK  321 (447)
Q Consensus       252 ~~~kL~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~ell~G~~pf~~~~~~~  321 (447)
                      |++||+|||.+......      ......+||+.|+|||...+..    -+.+.||||+||+||.|+.|+.||.+....+
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence            99999999998865221      1123478999999999998632    2678999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCC--CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          322 LQQRIINEKVKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       322 ~~~~i~~~~~~~p~~--~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++.+|.+..+.+|..  ...+++++|.+      ||++||++|+     ++.+|+.|||...
T Consensus       327 l~~KIvn~pL~fP~~pe~~e~~kDli~~------lL~KdP~~Ri-----~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  327 LFDKIVNDPLEFPENPEINEDLKDLIKR------LLEKDPEQRI-----TLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHhcCcccCCCcccccHHHHHHHHH------HhhcChhhee-----ehhhheecceecc
Confidence            999999999999976  57777777665      9999999999     8999999999853

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-50  Score=398.84  Aligned_cols=287  Identities=37%  Similarity=0.741  Sum_probs=240.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+++++.     +++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH-----TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            479999999999999999999876     788999999987554445555668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||+.||+|..++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999999999987 468999999999999999999999999999999999999999999999999999876433


Q ss_pred             CC--CCccccCCcccccccccC-----CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCCC---
Q 013249          269 SR--SNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF---  336 (447)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p~~---  336 (447)
                      ..  ....+||+.|+|||++.+     ..++.++|||||||++|||++|+.||...+..+....+....  ..+|..   
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD  235 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence            22  234579999999999875     457889999999999999999999999888888777777643  334433   


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  412 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  412 (447)
                      ++.++++      ||.+||+.++ +|++.  .+++++++|+||.+++|..+  +...+++.|.........+|+..
T Consensus       236 ~~~~~~~------li~~ll~~~~-~~~~~--~~~~~~~~h~~f~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~  300 (331)
T cd05624         236 VSEEAKD------LIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGIDWENI--RNLEAPYIPDVSSPSDTSNFDVD  300 (331)
T ss_pred             CCHHHHH------HHHHHccCch-hhcCC--CCHHHHhcCCCcCCCCHHHH--hhCCCCccCCCCCcchhhhcCCc
Confidence            3445544      4556998665 44422  37999999999999999988  46778899988777777777643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-52  Score=403.81  Aligned_cols=261  Identities=28%  Similarity=0.465  Sum_probs=221.3

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..+.|+.+++||+|+||.||+|++..     ++++||+|.++.+.. +.+....+.+|+.||++|+||||++|.+...+.
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~-----tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLE-----TGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSK  188 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecc-----cCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence            34579999999999999999999886     899999999988753 455566778999999999999999999998776


Q ss_pred             --CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          188 --SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                        +.+|||+|||+. ||.-++... -.|++.+++.|++||+.||+|||.+||+|||||.+|||||.+|.+||+|||+|+.
T Consensus       189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceee
Confidence              789999999976 676676654 3799999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCC--CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc----------
Q 013249          265 IDESS--RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------  331 (447)
Q Consensus       265 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~----------  331 (447)
                      +....  ..+..+-|.+|+|||+++| ..|+.++|+||.||||.||+.|++.|.+.++.+...+|.....          
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            65443  4567788999999999997 5799999999999999999999999999999999998875321          


Q ss_pred             CCCC------------CCchhHHhhh-hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          332 KLPP------------FLTSEAHSLL-KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       332 ~~p~------------~~~~~~~~li-~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      .+|.            .+.+..+.+- ..++|+..||..||.+|.     ++.++++|+||.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~-----tA~~aL~seyF~  404 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG-----TASSALQSEYFT  404 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc-----cHHHHhcCcccc
Confidence            1221            0111111111 246889999999999999     889999999994

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-50  Score=397.43  Aligned_cols=314  Identities=36%  Similarity=0.685  Sum_probs=249.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||+|+||.||+++++.     +++.||+|++.+...........+..|+.++..++|+||+++++++.+...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence            479999999999999999999876     778999999987554455555668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||+.||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999999999987 467999999999999999999999999999999999999999999999999999765332


Q ss_pred             CC--CCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc--CCCC---C
Q 013249          269 SR--SNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--KLPP---F  336 (447)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~--~~p~---~  336 (447)
                      ..  ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+...++.....  .+|.   .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence            22  23457999999999986     34688999999999999999999999999888888888876543  3333   3


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCC
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  416 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  416 (447)
                      ++.++.++      |.+||+.++++ ++  ..+++++++||||.+++|+.+.  ...+++.|.........+++..-..+
T Consensus       236 ~s~~~~~l------i~~ll~~~~~r-~~--r~~~~~~~~h~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (332)
T cd05623         236 VSEDAKDL------IRRLICSREHR-LG--QNGIEDFKQHPFFTGIDWDNIR--NCEAPYIPEVSSPTDTSNFDVDDDCL  304 (332)
T ss_pred             CCHHHHHH------HHHHccChhhh-cC--CCCHHHHhCCCCcCCCCHHHHh--hCCCCccCCCCCCcccccCCCCcccc
Confidence            45565555      45588765544 22  1289999999999999999985  45667888777666666554211111


Q ss_pred             --CCCCCC---CCCCCCCCCccCeeeeC
Q 013249          417 --PADDSP---APTPTAGEHFKGYTYVA  439 (447)
Q Consensus       417 --~~~~~~---~~~~~~~~~f~~~~~~~  439 (447)
                        .....+   +........|.+|+|.+
T Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (332)
T cd05623         305 KNSETMPPPSHTAFSGHHLPFVGFTYTS  332 (332)
T ss_pred             cccCCCCCCCccccccCCCCcCCeeecC
Confidence              111111   11123577788999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-53  Score=395.69  Aligned_cols=254  Identities=30%  Similarity=0.584  Sum_probs=237.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      .+|++.+.||+|+||+|-+|+.+.     .++.||||.++++.+.++..+-.+++|++||..++||||+++|.+|+..+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~-----sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHK-----SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhcc-----CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence            379999999999999999998865     899999999999999998888899999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +.|||||..+|+|++++.+++.++|.+++.+++||+.|+.|||.++|+|||||.+|||+|.++++||+|||++-.+....
T Consensus       128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998888


Q ss_pred             CCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  348 (447)
                      ...++||++-|.+||++.+..| +..+|-|||||+||-|+.|..||++.+...+..+|..+.+.-|..-+ .+..     
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PS-dA~g-----  281 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPS-DASG-----  281 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCc-hHHH-----
Confidence            8899999999999999999998 57899999999999999999999999999999999999887766543 3444     


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                       ||+.||..||.+|.     ++++|..|-|.+
T Consensus       282 -LIRwmLmVNP~RRA-----TieDiAsHWWvN  307 (668)
T KOG0611|consen  282 -LIRWMLMVNPERRA-----TIEDIASHWWVN  307 (668)
T ss_pred             -HHHHHHhcCcccch-----hHHHHhhhheee
Confidence             45569999999998     999999998873

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-50  Score=396.18  Aligned_cols=287  Identities=38%  Similarity=0.736  Sum_probs=237.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||.||+++++.     +++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.+.++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN-----TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence            479999999999999999999886     788999999987655555566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||+.||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999999999976 467999999999999999999999999999999999999999999999999998775433


Q ss_pred             CC--CCccccCCcccccccccC-----CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCC---C
Q 013249          269 SR--SNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP---F  336 (447)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p~---~  336 (447)
                      ..  ....+||+.|+|||++..     ..++.++|||||||++|||++|+.||...+..+....+....  ..++.   .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence            22  223579999999999973     457889999999999999999999999888887777776543  23333   2


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  412 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  412 (447)
                      ++.++++++      .+||+.+ .+|++-  .+++++++||||.+++|..+..  ..+++.|......+..+|+..
T Consensus       236 ~~~~~~~li------~~ll~~~-~~r~~r--~~~~~~l~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  300 (331)
T cd05597         236 VSEEAKDLI------RRLICSP-ETRLGR--NGLQDFKDHPFFEGIDWDNIRN--STAPYVPEVSSPTDTSNFDVD  300 (331)
T ss_pred             CCHHHHHHH------HHHccCc-ccccCC--CCHHHHhcCCCCCCCCHHHHhh--CCCCccCcCCCcchhhhcCCc
Confidence            455555554      4588754 443321  1899999999999999999864  466788887776666666543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.6e-50  Score=389.20  Aligned_cols=289  Identities=46%  Similarity=0.877  Sum_probs=261.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||++.++.     +++.+|+|++.+.........+.+.+|++++++++||||+++++++.....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG-----SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence            479999999999999999999876     778999999987665555566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||+.+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++...... 
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999999999999999899999999999999999999999999999999999999999999999999999876543 


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~  349 (447)
                       ....+|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.....+.+..+...+|...+..+++++.   
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---  230 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIR---  230 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHH---
Confidence             3455789999999999988899999999999999999999999988888888888888888888888777766655   


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCccc
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  411 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  411 (447)
                         +||..||.+|+++...+++++++||||..++|..+....+.+|+.|......+.+.|++
T Consensus       231 ---~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (290)
T cd05580         231 ---NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD  289 (290)
T ss_pred             ---HHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccccC
Confidence               49999999999887789999999999999999999999999999998887777777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.1e-51  Score=391.82  Aligned_cols=271  Identities=39%  Similarity=0.745  Sum_probs=232.8

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (447)
                      ||+|+||+||+|.++.     +++.||+|++.+.........+.+..|+.+++.++|+||+++++++.....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEcc-----CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence            6999999999999886     78899999998765544445566788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-CCC
Q 013249          198 NGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSN  272 (447)
Q Consensus       198 ~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~  272 (447)
                      +||+|..++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ...
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            99999887753    3468999999999999999999999999999999999999999999999999998764332 233


Q ss_pred             ccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH----HHHHHHHHhcccCCCCCCchhHHhhhhhh
Q 013249          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~li~~~  348 (447)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....    ......+......++..++.++.+++.  
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~--  233 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE--  233 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHH--
Confidence            46799999999999999999999999999999999999999976432    333444444555566667777766555  


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCC
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  399 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~  399 (447)
                          +||+.||++|++....+++++++||||++++|..++...+.+||.|.
T Consensus       234 ----~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~  280 (280)
T cd05608         234 ----ALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD  280 (280)
T ss_pred             ----HHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCCC
Confidence                49999999999887778999999999999999999999999999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-51  Score=390.41  Aligned_cols=254  Identities=32%  Similarity=0.569  Sum_probs=215.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      .++...+.||+|+||.||++.++.     ++..+|||.+.....   ...+.+.+|+.+|++++|||||++++...... 
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~-----~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKK-----TGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             chhhhhccccCccceEEEEEEecC-----CCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            368888999999999999999886     688999999876521   12667899999999999999999999755544 


Q ss_pred             -EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-CCcEEEeecCCcccc
Q 013249          189 -KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI  265 (447)
Q Consensus       189 -~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~~kL~DFG~a~~~  265 (447)
                       .+++.|||+.||+|.+++.+.+ .++|..++.+++||++||.|||++|||||||||+||||+. ++.+||+|||+++..
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence             6999999999999999999887 8999999999999999999999999999999999999999 799999999999876


Q ss_pred             cC----CCCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCC-CCHHHHHHHHHhcc--cCCCCCC
Q 013249          266 DE----SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEK--VKLPPFL  337 (447)
Q Consensus       266 ~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~-~~~~~~~~~i~~~~--~~~p~~~  337 (447)
                      ..    ........||+.|||||++... ....++|||||||++.||+||+.||.. .........|....  +.+|..+
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~l  248 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSL  248 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCccc
Confidence            63    1224467899999999999962 334599999999999999999999987 44444444554443  4677788


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +.++++++.      +||.+||++||     ++++++.|||..+.
T Consensus       249 s~~a~~Fl~------~C~~~~p~~Rp-----ta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  249 SDEAKDFLR------KCFKRDPEKRP-----TAEELLEHPFLKQN  282 (313)
T ss_pred             CHHHHHHHH------HHhhcCcccCc-----CHHHHhhChhhhcc
Confidence            887776655      49999999999     88999999999764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.4e-51  Score=367.93  Aligned_cols=261  Identities=25%  Similarity=0.460  Sum_probs=218.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      .+|..+++||+|.||.||+|++..     +++.||||.++.....+. .-....+|+.+|+.++|+||+.|+++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~-----t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE-----TGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC-----CCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            468889999999999999999886     899999999987654332 23346689999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +.||+|||+. +|...++.. -.++..+++.|+.++++||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.+...
T Consensus        76 l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   76 LSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9999999964 888888755 46899999999999999999999999999999999999999999999999999987644


Q ss_pred             CC-CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-----------CCC
Q 013249          269 SR-SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----------LPP  335 (447)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-----------~p~  335 (447)
                      .. ....+-|.+|+|||.+.| +.|+..+||||.|||+.||+-|.+-|.+.++.+....|......           +|.
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            33 233478999999999986 67999999999999999999999999999999988888753221           111


Q ss_pred             C-----Cchh-HHhhh-----hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          336 F-----LTSE-AHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       336 ~-----~~~~-~~~li-----~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +     .+.. ...++     ..+||+.+||.+||.+|+     ++.++++|+||.+.
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri-----ta~qaL~~~yf~~~  287 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI-----TASQALKHPYFKSL  287 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc-----cHHHHhcchhhhcC
Confidence            0     0000 00011     236889999999999999     78999999999753

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=404.63  Aligned_cols=253  Identities=30%  Similarity=0.519  Sum_probs=225.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ...|....+||+|+.|.||.|+...     +++.||||.+......   ..+.+.+|+.+|+..+|+|||++++.|...+
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~-----~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKIS-----TKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhhcchhhhccccccceeeeeecc-----CCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            3468899999999999999999887     7888999999876533   3456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|.|||||+||+|.+.+.. ..++|.++..|+++++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+...
T Consensus       344 eLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            99999999999999888755 45999999999999999999999999999999999999999999999999999987655


Q ss_pred             C-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc---ccCCCCCCchhHHhh
Q 013249          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~l  344 (447)
                      . ...+.+||++|||||++..+.|+.++||||||++++||+-|++||-..++....+.|...   .+..|..++.+++++
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence            4 667899999999999999999999999999999999999999999988888777777654   334567788887766


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +.      +||+.|+.+|+     ++.|||+||||+-
T Consensus       503 L~------~cL~~dv~~Ra-----sA~eLL~HpFl~~  528 (550)
T KOG0578|consen  503 LD------RCLVVDVEQRA-----SAKELLEHPFLKM  528 (550)
T ss_pred             HH------HHhhcchhcCC-----CHHHHhcChhhhh
Confidence            55      59999999999     8899999999953

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-50  Score=383.78  Aligned_cols=269  Identities=29%  Similarity=0.468  Sum_probs=227.7

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++..+||.|..++||+|+.+.     .+..||||++..+...  ..++.+++|+..|+.++||||++++..|
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p-----~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sF   93 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIP-----TNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSF   93 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecc-----cCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence            44566799999999999999999999987     7789999999887653  3478899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      ..+..+|+||.||.+|++.+.+...  ..+.|..+..|++++++||.|||.+|-||||||+.||||+.+|.|||+|||.+
T Consensus        94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence            9999999999999999999999765  45999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCC----C-CccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 013249          263 KEIDESSR----S-NSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP  335 (447)
Q Consensus       263 ~~~~~~~~----~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~  335 (447)
                      ..+.....    . .+++||++|||||+++.  .+|+.|+||||||++..||.+|..||....+.+++...+++.+..+.
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            76533221    1 56789999999999653  68999999999999999999999999988888877777777655333


Q ss_pred             CC--chh-HHhh-hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          336 FL--TSE-AHSL-LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       336 ~~--~~~-~~~l-i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      ..  +.+ .+.+ ....+++..||++||.+||     +++++++|+||+...-.
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp-----tAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRP-----TASKLLKHAFFKKAKSK  302 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCC-----CHHHHhccHHHhhccch
Confidence            11  111 0000 1224567779999999999     88999999999976433

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.1e-50  Score=384.69  Aligned_cols=278  Identities=40%  Similarity=0.731  Sum_probs=234.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|++.++||+|+||.||++.++.     +++.||+|.+.+...........+..|+.++++++|+||+.+++.+.+.+.+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcC-----CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence            37889999999999999999986     7889999999876544444455677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      |+||||+.|++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999999999888654  35899999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH---HHHHHH-HhcccCCCCCCchhHHhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---KLQQRI-INEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---~~~~~i-~~~~~~~p~~~~~~~~~l  344 (447)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|+.||......   +....+ ......++..++.++.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence            4444567999999999999999999999999999999999999999764321   111222 112223455566665555


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  399 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~  399 (447)
                            +.+||+.||.+|+++...+++++++||||+.++|..+...++.|+|+|.
T Consensus       236 ------i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05630         236 ------CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD  284 (285)
T ss_pred             ------HHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence                  5559999999999754445899999999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5e-50  Score=395.95  Aligned_cols=260  Identities=35%  Similarity=0.615  Sum_probs=233.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (447)
                      ..|++.+.||+|.||.||+|+.+.     +++.+|+|++.+.........+.+.+|+.+|+++. |||||.++++|++..
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~-----tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKS-----TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecC-----CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            479999999999999999999987     78999999999987766656678999999999998 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC----CCcEEEeecCCccc
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKE  264 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~----~~~~kL~DFG~a~~  264 (447)
                      .+|+|||+|.||+|++.+... .++|..+..++.|++.++.|||+.||+||||||+|+|+..    ++.+|++|||++..
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999999887 4999999999999999999999999999999999999954    35799999999999


Q ss_pred             ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhh
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      ..........|||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+.......|..+.+.++....+.... 
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~-  267 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE-  267 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH-
Confidence            8876678889999999999999999999999999999999999999999999999999999999988776543322211 


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                       .+.+||++||..||.+|+     ++.++++|||+.+.
T Consensus       268 -~akd~i~~ll~~dp~~R~-----ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  268 -SAKDFIRKLLEFDPRKRL-----TAAQALQHPWIKSI  299 (382)
T ss_pred             -HHHHHHHHhcccCcccCC-----CHHHHhcCccccCC
Confidence             123456669999999999     89999999999865

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.7e-51  Score=374.64  Aligned_cols=263  Identities=27%  Similarity=0.456  Sum_probs=219.9

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (447)
                      ..++|+.+..|++|+||.||+|+++.     ++++||+|.++.+.. ....--.-.+|+.+|.+++|||||.+-.+... 
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~-----t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~  147 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKK-----TDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGS  147 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCC-----cceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence            44689999999999999999999987     889999999987652 22222234579999999999999999888764 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 -RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                       -+.+|+|||||+. +|..++...+ +|...+++.++.|+++||+|||.+.|+|||||++|+|++..|.+||+|||+|+.
T Consensus       148 ~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  148 NMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             ccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence             4579999999976 7888887765 899999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc------------
Q 013249          265 IDESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK------------  330 (447)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~------------  330 (447)
                      ++... ..+..+-|.+|+|||++.+ ..|+.++|+||+|||+.||+++++.|.+....+..++|....            
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            87653 3556788999999999987 579999999999999999999999999999999888887532            


Q ss_pred             -------cCCCCCCchhHHhh-------hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          331 -------VKLPPFLTSEAHSL-------LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       331 -------~~~p~~~~~~~~~l-------i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                             ..++..-...++.-       -.+.+|+..+|.+||.+|.     ++++.++|.||...
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~-----tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI-----TAEDGLKHEYFRET  367 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc-----cHHHhhcccccccC
Confidence                   11221111111111       1235788899999999999     88999999999864

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.7e-49  Score=380.39  Aligned_cols=278  Identities=38%  Similarity=0.705  Sum_probs=237.9

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|+..++||+|+||+||++.+..     +++.||+|.+.+...........+.+|+++|+.++|+||+.+++.+..++.+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECC-----CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            37888999999999999999876     7889999999876554444455677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      |+||||+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            9999999999998888654  36999999999999999999999999999999999999999999999999999776443


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHH----HhcccCCCCCCchhHHhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI----INEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i----~~~~~~~p~~~~~~~~~l  344 (447)
                      .......|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+    ......++..++.++.++
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            3344567999999999999999999999999999999999999999876654433333    333334455566655554


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  399 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~  399 (447)
                            +.+||+.||++||++....+++++.|+||..++|+.++.+++.|+|.|.
T Consensus       236 ------i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05632         236 ------CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD  284 (285)
T ss_pred             ------HHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence                  5559999999999876666999999999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.6e-49  Score=379.82  Aligned_cols=270  Identities=37%  Similarity=0.697  Sum_probs=224.5

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (447)
                      ||+|+||.||+++.+.     +++.||+|.+.+...........+..|++++++++||||+++++.+.....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKN-----TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEcc-----CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence            6999999999999886     78899999997655443334445667999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccc
Q 013249          198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC  275 (447)
Q Consensus       198 ~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~  275 (447)
                      .|++|..++...+  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            9999988886543  58899999999999999999999999999999999999999999999999998765544444567


Q ss_pred             cCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH----HHHHHHHHhcccCCC-CCCchhHHhhhhhhhH
Q 013249          276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLP-PFLTSEAHSLLKGVSF  350 (447)
Q Consensus       276 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~----~~~~~~i~~~~~~~p-~~~~~~~~~li~~~~~  350 (447)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||.....    .++...+......++ ..++.++.+      +
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------l  229 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKD------I  229 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHH------H
Confidence            99999999999988899999999999999999999999975432    333344443333332 234555544      5


Q ss_pred             HhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCC
Q 013249          351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  399 (447)
Q Consensus       351 l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~  399 (447)
                      |.+||++||++||++.. -.++++.|+||++++|..++.+...|||.|+
T Consensus       230 i~~~L~~~P~~R~~~~~-~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd05607         230 CRLFLAKKPEDRLGSRE-KNDDPRKHEFFKTINFPRLEAGLIPPPFVPD  277 (277)
T ss_pred             HHHHhccCHhhCCCCcc-chhhhhcChhhcCCCHHHHhcCcCCCCCCCC
Confidence            55699999999995421 2378899999999999999999999998774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-50  Score=374.79  Aligned_cols=261  Identities=26%  Similarity=0.450  Sum_probs=218.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (447)
                      ..|..++.||+|+||.|+.+.++.     +++.||||.+... .......++..+|+.+|+.++|+||+.+++.+..   
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~-----t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKR-----TGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcC-----CCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            356668999999999999999987     7899999998642 2345556678899999999999999999999865   


Q ss_pred             --CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                        -..+|+|+|+| +.+|...++.+..++++.++.+++||++||.|+|+.+|+||||||.|+|++.+..+||||||+|+.
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence              35799999999 568999998888899999999999999999999999999999999999999999999999999998


Q ss_pred             ccC---CCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-----
Q 013249          265 IDE---SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP-----  335 (447)
Q Consensus       265 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~-----  335 (447)
                      ...   ....+..+.|.+|+|||++.. ..|+.++||||+|||+.||++|++.|.+.+..+..+.|..-....++     
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            853   344567789999999999874 78999999999999999999999999999888877777643222110     


Q ss_pred             CCchhHHhhh--------------------hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          336 FLTSEAHSLL--------------------KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       336 ~~~~~~~~li--------------------~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      -.+..++..+                    .++|||.+||..||.+|+     +++|+++||||...
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi-----ta~eAL~hPYl~~~  316 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI-----TAEEALAHPYLAPY  316 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC-----CHHHHhcChhhhhh
Confidence            0111111111                    246888899999999999     89999999999753

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-49  Score=386.04  Aligned_cols=251  Identities=29%  Similarity=0.492  Sum_probs=216.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +...+..+.+.||.|+||+||++.+++      ...+|+|++......... .+.+.+|+.+|.+++|||||+++|++.+
T Consensus        38 i~~~~l~~~~~iG~G~~g~V~~~~~~g------~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   38 IDPDELPIEEVLGSGSFGTVYKGKWRG------TDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             cChHHhhhhhhcccCCceeEEEEEeCC------ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            444566677779999999999999974      223999999876544444 7789999999999999999999999998


Q ss_pred             CC-EEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCcccCCCC-cEEEeecCC
Q 013249          187 RS-KLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPENILMDSDG-HVMLTDFGL  261 (447)
Q Consensus       187 ~~-~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-iiHrDikp~NILl~~~~-~~kL~DFG~  261 (447)
                      .. .+++||||+++|+|..++.+  ...++...+..++.||++||+|||+++ ||||||||+||||+.++ ++||||||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            87 79999999999999999988  578999999999999999999999999 99999999999999998 999999999


Q ss_pred             cccccCC-CCCCccccCCccccccccc--CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCCC
Q 013249          262 AKEIDES-SRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPF  336 (447)
Q Consensus       262 a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~--~~~~p~~  336 (447)
                      ++..... .......||+.|||||++.  ...|+.++|||||||++|||+||+.||.+.....+...+...  +..+|..
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~  270 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE  270 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            9987654 3344478999999999999  669999999999999999999999999998887777776544  3445666


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ....+..+++.      ||..||.+||     ++.+|..
T Consensus       271 ~~~~l~~l~~~------CW~~dp~~RP-----~f~ei~~  298 (362)
T KOG0192|consen  271 CPPHLSSLMER------CWLVDPSRRP-----SFLEIVS  298 (362)
T ss_pred             CCHHHHHHHHH------hCCCCCCcCC-----CHHHHHH
Confidence            77777666555      9999999999     6667664

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-50  Score=364.35  Aligned_cols=256  Identities=29%  Similarity=0.562  Sum_probs=227.5

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      .|+-.+.||+|..++|.+|.++.     +++.+|+|++......     .....+.-.+|+.||+++ .||+|+++.++|
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~-----t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKE-----TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcc-----cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            57777899999999999998886     8889999998653211     123345566899999988 599999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +++..+++|+|.|+.|.|+++|...-.++|...+.|++|++.|++|||.++||||||||+|||++++.++||+|||+|+.
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence            99999999999999999999999988999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCccccCCcccccccccC------CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC---
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP---  335 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~---  335 (447)
                      +..+......|||++|+|||.+..      .+|+..+|+|++|||||.|+.|.+||.+....-+...|..+++.|..   
T Consensus       173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence            999888999999999999999863      47899999999999999999999999999888899999999988743   


Q ss_pred             -CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          336 -FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       336 -~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                       .++.+.+      |||++||+.||.+|+     +++|+++||||..+
T Consensus       253 adis~~~K------dLIsrlLqVdp~~Ri-----take~LaHpff~q~  289 (411)
T KOG0599|consen  253 ADISATVK------DLISRLLQVDPTKRI-----TAKEALAHPFFIQI  289 (411)
T ss_pred             hhccccHH------HHHHHHHeeCchhcc-----cHHHHhcChHHHHH
Confidence             2344444      456669999999999     88999999999643

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=384.26  Aligned_cols=258  Identities=34%  Similarity=0.590  Sum_probs=238.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      +=|.+.+.||+|.|++|-+|++.-     +|+.||||++.|.++..- ....+..|++.|+.++|||||+||++..++..
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVF-----TGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhc-----ccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            358888999999999999999875     899999999999876443 34457789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc-CCCCcEEEeecCCcccccC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl-~~~~~~kL~DFG~a~~~~~  267 (447)
                      +|||+|+=++|+|+++|.++ ..+.|+.+++|++||+.|+.|||+..||||||||+||.+ .+-|-|||+|||++-.+..
T Consensus        92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999999999877 469999999999999999999999999999999999877 5678999999999999999


Q ss_pred             CCCCCccccCCcccccccccCCCCC-CccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  346 (447)
                      +....+.||+..|-|||++.+..|+ +++||||||||||.|++|++||...++.+.+..|+..++..|..++.+++++|.
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ  251 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence            8899999999999999999999996 579999999999999999999999999999999999999999999999999877


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      .      ||+.||++|.     ++++|..|+|++.+|-
T Consensus       252 s------MLvRdPkkRA-----slEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  252 S------MLVRDPKKRA-----SLEEIVSTSWLQAGDR  278 (864)
T ss_pred             H------HHhcCchhhc-----cHHHHhccccccCCCC
Confidence            6      9999999998     8999999999998763

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.3e-48  Score=372.77  Aligned_cols=253  Identities=29%  Similarity=0.487  Sum_probs=211.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE-----TKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC-----CCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            479999999999999999999886     788999999976532 23345667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99999999998776665555679999999999999999999999999999999999999999999999999998764322


Q ss_pred             --CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC---------------
Q 013249          270 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---------------  332 (447)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~---------------  332 (447)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......               
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence              223457899999999999989999999999999999999999999887665544433321111               


Q ss_pred             ----CCC-------------CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          333 ----LPP-------------FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       333 ----~p~-------------~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                          +|.             .++.+      ..+||.+||++||++||     +++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~------~~dll~~~L~~~P~~R~-----s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGV------LLDLMKNLLKLNPTDRY-----LTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHH------HHHHHHHHccCCcccCC-----CHHHHhcCCCC
Confidence                111             01222      35677889999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-48  Score=365.52  Aligned_cols=262  Identities=28%  Similarity=0.481  Sum_probs=219.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~  188 (447)
                      ..|+.+++||+|+||+||+|+.+.     +|+.||+|+++-.... +..-....+|+.+|+.++|+| ||.|++++.+..
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~-----~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~   84 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKR-----TGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN   84 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEec-----CCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence            457888899999999999999987     8899999999865421 223344678999999999999 999999998877


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEee
Q 013249          189 ------KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (447)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~D  258 (447)
                            .+++|+||++ -+|..++....    .++...++.++.||+.||+|||+++|+||||||+||||+++|.+||+|
T Consensus        85 ~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   85 NHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             cccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence                  8999999995 48989988765    477889999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCC-CCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc------
Q 013249          259 FGLAKEIDES-SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK------  330 (447)
Q Consensus       259 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~------  330 (447)
                      ||+|+...-. ......++|.+|+|||++.+. .|+..+||||+|||++||++++..|.+.++.+....|..-.      
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            9999987633 335667899999999999986 79999999999999999999999999999988888887421      


Q ss_pred             ------------cCCCCCC-chhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          331 ------------VKLPPFL-TSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       331 ------------~~~p~~~-~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                                  ..++.+. ...+...     ..+.+++.+||+.+|.+|.     +++.++.||||..+.
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~-----Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI-----SAKGALTHPYFSELP  309 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc-----CHHHHhcChhhcccc
Confidence                        1122221 1111111     2457899999999999999     789999999998774

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-47  Score=394.43  Aligned_cols=258  Identities=23%  Similarity=0.399  Sum_probs=206.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC------CCceee
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PFIVQL  180 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l  180 (447)
                      +..++|+++++||+|+||+||+|.++.     +++.||||+++...    ........|+.+++.++|      .+|+++
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i  196 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRK-----RKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKI  196 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcC-----CCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence            445789999999999999999999876     78899999996432    122345567777777754      458889


Q ss_pred             eEEEEeC-CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCC------
Q 013249          181 RYSFQTR-SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDG------  252 (447)
Q Consensus       181 ~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~------  252 (447)
                      +++|... .++|+|||++ |++|.+++.+.+.+++..++.|+.||+.||+|||. .|||||||||+|||++.++      
T Consensus       197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence            8888764 5799999998 77899999888899999999999999999999997 5999999999999998765      


Q ss_pred             ----------cEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHH
Q 013249          253 ----------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL  322 (447)
Q Consensus       253 ----------~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~  322 (447)
                                .+||+|||.+.....  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                      499999998865332  34467899999999999999999999999999999999999999988877665


Q ss_pred             HHHHHhcccCCCCCC------------------------chhH---------Hhh---hhhhhHHhhhccCCCCCCCCCC
Q 013249          323 QQRIINEKVKLPPFL------------------------TSEA---------HSL---LKGVSFLTQLLHKDPSKRLGSG  366 (447)
Q Consensus       323 ~~~i~~~~~~~p~~~------------------------~~~~---------~~l---i~~~~~l~~~L~~dP~~R~~~~  366 (447)
                      ...+......+|..+                        ....         ...   -..+|||.+||++||.+||   
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~---  430 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL---  430 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC---
Confidence            555443322222110                        0000         000   1135899999999999999   


Q ss_pred             CCChhhhhcCCccCC
Q 013249          367 PGGVDAIKHHKWFRS  381 (447)
Q Consensus       367 ~~~~~~l~~h~~f~~  381 (447)
                        +++|+++||||..
T Consensus       431 --ta~e~L~Hp~~~~  443 (467)
T PTZ00284        431 --NARQMTTHPYVLK  443 (467)
T ss_pred             --CHHHHhcCccccc
Confidence              8899999999974

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.8e-48  Score=369.33  Aligned_cols=271  Identities=39%  Similarity=0.750  Sum_probs=232.7

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (447)
                      ||+|+||+||+|.++.     +++.||+|++.+...........+..|+.+|+.++||||+++++.+...+.+|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKA-----TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcC-----CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence            6899999999999876     78899999998755444444556678999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccc
Q 013249          198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC  275 (447)
Q Consensus       198 ~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~  275 (447)
                      ++++|.+++.+.+  .+++..++.++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.............
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            9999999998766  79999999999999999999999999999999999999999999999999998765443444556


Q ss_pred             cCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH----HHHHHHHHhcccCCCCCCchhHHhhhhhhhHH
Q 013249          276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL  351 (447)
Q Consensus       276 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l  351 (447)
                      ++..|+|||++.+..++.++|||||||++|+|++|+.||.....    ..+...+......++...+.++.++      |
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------i  229 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDL------C  229 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHH------H
Confidence            88899999999888899999999999999999999999976543    3333444444445566666666555      4


Q ss_pred             hhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCC
Q 013249          352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  399 (447)
Q Consensus       352 ~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~  399 (447)
                      .+||+.||.+||+....++++++.||||..++|..+.....+|||.|+
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD  277 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCCC
Confidence            559999999999887778999999999999999999999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8e-48  Score=371.64  Aligned_cols=258  Identities=26%  Similarity=0.443  Sum_probs=209.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.++||.|+||.||+|+++.     +++.||+|+++....  ......+.+|+.++++++||||+++++++.+.+
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTER   76 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECC-----CCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            4689999999999999999999876     788999999875431  222345678999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+.+ +|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          77 CLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99999999975 8888887654 579999999999999999999999999999999999999999999999999986533


Q ss_pred             CC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-------------
Q 013249          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-------------  332 (447)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-------------  332 (447)
                      .. ......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+......             
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            22 2334578999999999875 56899999999999999999999999988777666555432111             


Q ss_pred             ------CCCCCchhHHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          333 ------LPPFLTSEAHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       333 ------~p~~~~~~~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                            +|.........     --..++||.+||++||.+|+     +++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~-----t~~~~l~hp~f  288 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI-----SAEAALRHSYF  288 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC-----CHHHHhcCCCC
Confidence                  11100000000     01235788889999999999     89999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-47  Score=373.19  Aligned_cols=264  Identities=25%  Similarity=0.422  Sum_probs=208.5

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++.....  ......+.+|+.+++.++||||+++++++.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC-----CCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence            3689999999999999999999876     788999999875432  222334678999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          77 TLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             eEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            9999999996 5777777654 5789999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCH-HHHHHHHHhccc-----------CC
Q 013249          268 S-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKV-----------KL  333 (447)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~~-----------~~  333 (447)
                      . ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .+....+.....           ..
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence            2 22345678999999999875 4588999999999999999999999986533 222222221100           00


Q ss_pred             CC--------CCchhHHhh-------hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          334 PP--------FLTSEAHSL-------LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       334 p~--------~~~~~~~~l-------i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      +.        .........       -...+||.+||++||++|+     +++++++||||+++.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~-----s~~~~l~h~~f~~~~~~  297 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL-----SAQAALSHEYFSDLPPR  297 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc-----CHHHHhcCcccccCChh
Confidence            00        000011100       1234788889999999999     88999999999988653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-48  Score=365.70  Aligned_cols=254  Identities=31%  Similarity=0.518  Sum_probs=211.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  188 (447)
                      .|+..+++|.|+||.||+|....     +++.+|||.+..+...       -.+|+++|+.++|||||+|..+|...  .
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e-----~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE-----TEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC-----CCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence            58889999999999999999886     6789999998765421       23699999999999999999888643  2


Q ss_pred             ---EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC-CcEEEeecC
Q 013249          189 ---KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFG  260 (447)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~~kL~DFG  260 (447)
                         ...+|||||+. +|...++.    +..++.-.++.++.||++||.|||+.||+||||||.|||+|.+ |.+||||||
T Consensus        93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence               45689999964 78888874    5679999999999999999999999999999999999999976 899999999


Q ss_pred             CcccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc---------
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------  330 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~---------  330 (447)
                      .|+.+..+....+...|..|+|||.+.+ ..|+.+.||||.|||+.||+.|++.|.+.+..+....|...-         
T Consensus       172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            9999988877888889999999999987 679999999999999999999999999998887777666421         


Q ss_pred             --------cCCCCCCchhHHh------hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          331 --------VKLPPFLTSEAHS------LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       331 --------~~~p~~~~~~~~~------li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                              ..+|.........      -.+.++|+.++|+++|.+|.     ++.+++.||||+.+
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~-----~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL-----SALEALAHPFFDEL  312 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC-----CHHHHhcchhhHHh
Confidence                    1122111111000      01346788889999999999     78999999999754

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-50  Score=382.11  Aligned_cols=255  Identities=25%  Similarity=0.488  Sum_probs=222.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ..|..+++||+|+||.||+|.+..     +++.||+|++..+.  .+..++.+++|+.+|.+++++||.++|+.|..+..
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~-----t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNK-----TKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK   85 (467)
T ss_pred             cccccchhccccccceeeeeeecc-----ccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence            368888999999999999999886     88999999998764  45667889999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      ++++||||.||++.+.+.....+.|..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus        86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999999999999999888888999999999999999999999999999999999999999999999999998875543


Q ss_pred             C-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhhhh
Q 013249          270 R-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLKG  347 (447)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~  347 (447)
                      . ..+++||+.|||||++.+.+|+.++||||||++.+||++|.+||....+......|-+..+ .+...+++.+++    
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kE----  241 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKE----  241 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHH----
Confidence            3 4789999999999999999999999999999999999999999988776444333333221 122234555555    


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                        |+..||++||+.||     ++.+|++|+|.+..
T Consensus       242 --FV~~CL~k~P~~Rp-----sA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  242 --FVEACLDKNPEFRP-----SAKELLKHKFIKRA  269 (467)
T ss_pred             --HHHHHhhcCcccCc-----CHHHHhhhHHHHhc
Confidence              45559999999999     88999999999874

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-46  Score=363.90  Aligned_cols=284  Identities=38%  Similarity=0.729  Sum_probs=238.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||++.++.     +++.||+|.+.+.........+.+.+|+++++.++||||+++++.+..++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE-----TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC-----CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence            379999999999999999999886     788999999987654444555678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      +|+||||++|++|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999999999988888999999999999999999999999999999999999999999999999998642100 


Q ss_pred             ---------------CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC
Q 013249          269 ---------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL  333 (447)
Q Consensus       269 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~  333 (447)
                                     .......|+..|+|||.+.+..++.++|+|||||++|||++|..||.+.+..++...+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                           01113467889999999998889999999999999999999999999888888888777665544


Q ss_pred             CC---CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCC
Q 013249          334 PP---FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN  408 (447)
Q Consensus       334 p~---~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  408 (447)
                      |.   ..+.++.+      ||.+||+.||++||++.  ++.++++||||.+.+|......  ...+.|.....++...
T Consensus       236 ~~~~~~~~~~~~~------li~~~l~~~P~~R~~~~--~~~~ll~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  303 (305)
T cd05609         236 PEGDEALPADAQD------LISRLLRQNPLERLGTG--GAFEVKQHRFFLGLDWNGLLRQ--KAEFIPQLESEDDTSY  303 (305)
T ss_pred             CCccccCCHHHHH------HHHHHhccChhhccCcc--CHHHHHhCccccCCCHHHHhhc--CCCCCCCCCCcccccc
Confidence            43   34455544      55569999999999763  6899999999999999997644  3366776655444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.2e-48  Score=376.53  Aligned_cols=255  Identities=33%  Similarity=0.558  Sum_probs=234.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+.++++|+|+||.+++++++.     .+..|++|.+.......+. .+....|+.+++++.|||||.+.+.|..++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~-----~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~   76 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKS-----DDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDG   76 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhcc-----CCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence            3589999999999999999999987     6779999999877654443 346778999999999999999999999888


Q ss_pred             E-EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          189 K-LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       189 ~-~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      . +||||+||+||+|.+.+.+.+  .|+|+.+..++.|++.|+.|||++.|+|||||+.||+++.++.|||+|||+|+.+
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            7 999999999999999997654  6999999999999999999999999999999999999999999999999999998


Q ss_pred             cCCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhHHh
Q 013249          266 DESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHS  343 (447)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~  343 (447)
                      .... ...+.+||+.||.||++.+..|+.++|||||||++|||++-+++|...+...+..+|.... ..+|...+.+++.
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~  236 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRS  236 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHH
Confidence            7766 6778999999999999999999999999999999999999999999999999999999887 5678889999988


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      +++.      ||..+|..||     ++.+|+.+|...
T Consensus       237 lv~~------~l~~~P~~RP-----sa~~LL~~P~l~  262 (426)
T KOG0589|consen  237 LVKS------MLRKNPEHRP-----SALELLRRPHLL  262 (426)
T ss_pred             HHHH------HhhcCCccCC-----CHHHHhhChhhh
Confidence            8877      9999999999     889999998776

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-46  Score=371.18  Aligned_cols=260  Identities=27%  Similarity=0.447  Sum_probs=217.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++++.||+|+||.||+++++.     ++..+|+|++....  .....+.+.+|+++|++++||||+++++++..
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKP-----SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECC-----CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            345789999999999999999999886     78899999987542  23345678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+.+++||||++|++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            999999999999999999999888899999999999999999999986 6999999999999999999999999999876


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc--------------
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------------  331 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~--------------  331 (447)
                      ... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+..++...+.....              
T Consensus       155 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         155 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence            443 23456799999999999999999999999999999999999999987665554332211000              


Q ss_pred             ---------------------------------CCC-CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCC
Q 013249          332 ---------------------------------KLP-PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHK  377 (447)
Q Consensus       332 ---------------------------------~~p-~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~  377 (447)
                                                       ..+ ..++.+      ..+||.+||++||++||     ++++|++||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------l~~li~~~L~~~P~~Rp-----t~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD------FQEFVNKCLIKNPAERA-----DLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHH------HHHHHHHHccCCcccCC-----CHHHHhcCh
Confidence                                             000 011222      24677789999999999     899999999


Q ss_pred             ccCCCChh
Q 013249          378 WFRSINWK  385 (447)
Q Consensus       378 ~f~~~~~~  385 (447)
                      ||+.....
T Consensus       303 ~~~~~~~~  310 (331)
T cd06649         303 FIKRSEVE  310 (331)
T ss_pred             HHhhcccc
Confidence            99865543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.2e-47  Score=386.22  Aligned_cols=260  Identities=26%  Similarity=0.420  Sum_probs=207.6

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ...++|+++++||+|+||.||+|.++.     +++.||||++....       ....+|+.+|+.++||||++++++|..
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~  130 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICID-----TSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYT  130 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence            345689999999999999999999876     78899999886432       124579999999999999999888753


Q ss_pred             C--------CEEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-c
Q 013249          187 R--------SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-H  253 (447)
Q Consensus       187 ~--------~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~  253 (447)
                      .        ..+++||||+.+ +|..++.    ....+++..++.++.||+.||.|||++||+||||||+||||+.++ .
T Consensus       131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~  209 (440)
T PTZ00036        131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT  209 (440)
T ss_pred             cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCc
Confidence            2        257899999975 5655553    346799999999999999999999999999999999999999665 6


Q ss_pred             EEEeecCCcccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--
Q 013249          254 VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--  330 (447)
Q Consensus       254 ~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--  330 (447)
                      +||+|||+|+.+.........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+....  
T Consensus       210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999999998765555556789999999999876 468999999999999999999999999887766555554321  


Q ss_pred             ---------------cCCCCCCchhHHhh------hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          331 ---------------VKLPPFLTSEAHSL------LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       331 ---------------~~~p~~~~~~~~~l------i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                                     ..+|......+...      ...++||.+||++||.+|+     ++.++++||||..+..
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~-----ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL-----NPIEALADPFFDDLRD  359 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc-----CHHHHhCChhHHhhhc
Confidence                           12222111122111      1245677889999999999     8899999999987643

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.8e-46  Score=371.44  Aligned_cols=252  Identities=27%  Similarity=0.471  Sum_probs=205.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||.||+|+++.     +++.||||++....  .......+.+|+.+|+.++|+||+++++++...+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECC-----CCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            3578889999999999999999876     78899999986542  2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+++++|...    ....+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus       146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999999999998542    34578888999999999999999999999999999999999999999999999876433


Q ss_pred             C-CCCccccCCcccccccccC-----CCCCCccceeehhHhHHHHhhCCCCCCCCCHHH---HHHHHH-hcccCCCCCCc
Q 013249          269 S-RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQK---LQQRII-NEKVKLPPFLT  338 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~---~~~~i~-~~~~~~p~~~~  338 (447)
                      . .....+||..|+|||++..     ...+.++|||||||++|||++|+.||......+   ....+. ......+...+
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence            2 2345679999999999853     234568999999999999999999997433222   222222 22233455566


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .++.+++      .+||..||++||     +++++++||||.+.
T Consensus       302 ~~l~~li------~~~l~~~P~~Rp-----t~~ell~hp~~~~~  334 (353)
T PLN00034        302 REFRHFI------SCCLQREPAKRW-----SAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHH------HHHccCChhhCc-----CHHHHhcCcccccC
Confidence            6665554      559999999999     88999999999863

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-46  Score=371.63  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=207.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR---  187 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---  187 (447)
                      +|++.++||+|+||.||+|+++.     +++.||||++.... ........+.+|+.+++.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            58999999999999999999876     78899999987532 1223344678899999999999999999988543   


Q ss_pred             --CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                        ..+|+||||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          75 EFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence              35899999995 689999988888999999999999999999999999999999999999999999999999999864


Q ss_pred             cCCC----CCCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-------
Q 013249          266 DESS----RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-------  332 (447)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-------  332 (447)
                      ....    .....+||..|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.......+......       
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            3221    1234579999999999876  67899999999999999999999999876654433322211000       


Q ss_pred             -----------------CCC-------CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          333 -----------------LPP-------FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       333 -----------------~p~-------~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                                       .+.       ..+.+      ..+||.+||+.||++||     +++++++||||+++..
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~~l~~~P~~Rp-----t~~e~l~hp~f~~~~~  298 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPL------ALRLLERLLAFDPKDRP-----TAEEALADPYFKGLAK  298 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChH------HHHHHHHHcCcCcccCC-----CHHHHhcCchhhhcCc
Confidence                             000       11222      24677789999999999     8899999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.1e-47  Score=377.42  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=215.5

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-C-----CCceeeeEEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H-----PFIVQLRYSF  184 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~  184 (447)
                      +|+++++||+|+||.|.+|.+++     +++.||||+++.+    +....+...|+.||..++ |     -|+|+++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~-----T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHK-----TGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             EEEEEEEecccccceeEEEEecC-----CCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            57899999999999999999987     8999999999865    344556778999999997 4     3899999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC--cEEEeecC
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--HVMLTDFG  260 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~--~~kL~DFG  260 (447)
                      ...+++|||+|.+ .-+|+++++.+.  .|+...++.|+.||+.||.+||++||||+|||||||||..-+  .|||+|||
T Consensus       258 ~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  258 YFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence            9999999999999 568999998773  589999999999999999999999999999999999997543  69999999


Q ss_pred             CcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC--------
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--------  332 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~--------  332 (447)
                      .|+......  .+.+.+..|+|||++.|..|+.+.||||||||++||++|.+.|.+.+..+....|..-...        
T Consensus       337 SSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  337 SSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            999876543  3778999999999999999999999999999999999999999999999888887642110        


Q ss_pred             -------------CCCC------------------------------CchhHHhhh------hhhhHHhhhccCCCCCCC
Q 013249          333 -------------LPPF------------------------------LTSEAHSLL------KGVSFLTQLLHKDPSKRL  363 (447)
Q Consensus       333 -------------~p~~------------------------------~~~~~~~li------~~~~~l~~~L~~dP~~R~  363 (447)
                                   ++..                              ........+      ..+|||.+||.+||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                         0100                              000000111      126899999999999999


Q ss_pred             CCCCCChhhhhcCCccCCC
Q 013249          364 GSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       364 ~~~~~~~~~l~~h~~f~~~  382 (447)
                           +..++++||||.+.
T Consensus       495 -----tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  495 -----TPAQALNHPFLTGT  508 (586)
T ss_pred             -----CHHHHhcCcccccc
Confidence                 78999999999854

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-46  Score=360.20  Aligned_cols=270  Identities=38%  Similarity=0.740  Sum_probs=219.6

Q ss_pred             eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHH---hcCCCCceeeeEEEEeCCEEEEE
Q 013249          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT---KVTHPFIVQLRYSFQTRSKLYLI  193 (447)
Q Consensus       117 ~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~~~~lv  193 (447)
                      +||+|+||.||++.++.     +++.+|+|.+.+.............+|..+++   ..+||||+.+++.+...+..|+|
T Consensus         1 ~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECC-----CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence            48999999999999875     78899999997654433322233344544444   34799999999999999999999


Q ss_pred             EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCc
Q 013249          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS  273 (447)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~  273 (447)
                      |||+.|++|..++..++.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~  154 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA  154 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccC
Confidence            999999999999988889999999999999999999999999999999999999999999999999998765432 2234


Q ss_pred             cccCCccccccccc-CCCCCCccceeehhHhHHHHhhCCCCCCCC---CHHHHHHHHHhcccCCCCCCchhHHhhhhhhh
Q 013249          274 MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       274 ~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~pf~~~---~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~  349 (447)
                      ..|+..|+|||++. +..++.++||||+||++|+|++|..||...   ....+..........+|..++.++.++++   
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---  231 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE---  231 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHH---
Confidence            57899999999986 466899999999999999999999999643   22333333333344556666666666554   


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCC
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  398 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p  398 (447)
                         +||..||++|+++...+++++++||||++++|..+...+..+|.+|
T Consensus       232 ---~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~  277 (279)
T cd05633         232 ---GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP  277 (279)
T ss_pred             ---HHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCCCCC
Confidence               5999999999987666899999999999999999876666666555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-46  Score=365.51  Aligned_cols=277  Identities=45%  Similarity=0.811  Sum_probs=234.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+|.+..     +++.||+|.+.+.........+.+..|+++++.++|+||+++++.+.....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC-----CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence            379999999999999999999876     788999999987655444566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .|+||||+.|++|.+++.+.  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999999998764  5789999999999999999999999999999999999999999999999999875432


Q ss_pred             CC------------------------------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC
Q 013249          268 SS------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA  317 (447)
Q Consensus       268 ~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~  317 (447)
                      ..                              ......||..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            11                              112346899999999999988999999999999999999999999988


Q ss_pred             CHHHHHHHHHhcccCCCCC--CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCC
Q 013249          318 NRQKLQQRIINEKVKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK  395 (447)
Q Consensus       318 ~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~  395 (447)
                      +.......+......++..  .+.++.++      |.+||+.||++||++. ..+++++.||||++.+|..+..  ..||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------i~~~l~~~p~~R~s~~-~~~~~ll~~~~~~~~~~~~~~~--~~~~  306 (316)
T cd05574         236 NRDETFSNILKKEVTFPGSPPVSSSARDL------IRKLLVKDPSKRLGSK-RGAAEIKQHPFFRGVNWALIRH--TTPP  306 (316)
T ss_pred             chHHHHHHHhcCCccCCCccccCHHHHHH------HHHHccCCHhHCCCch-hhHHHHHcCchhhcCChhhccc--CCCC
Confidence            8887777777666666554  35555555      5559999999999321 1289999999999999998865  3444


Q ss_pred             CCCCC
Q 013249          396 FKPDV  400 (447)
Q Consensus       396 ~~p~~  400 (447)
                      -.|..
T Consensus       307 ~~~~~  311 (316)
T cd05574         307 IIPRP  311 (316)
T ss_pred             CCCCc
Confidence            44433

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-46  Score=377.16  Aligned_cols=257  Identities=25%  Similarity=0.327  Sum_probs=206.8

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|+++++||+|+||.||+|.++.     +++.||+|....         ..+.+|+++|++++||||++++++|.
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~-----~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~  153 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNK-----TCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFT  153 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECC-----CCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence            3556789999999999999999999886     788999997542         23568999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .....|+|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       154 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        154 YNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             ECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            9999999999995 689899888888999999999999999999999999999999999999999999999999999754


Q ss_pred             cCC--CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC-------HHHHHHHHHhcccCCCCC
Q 013249          266 DES--SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-------RQKLQQRIINEKVKLPPF  336 (447)
Q Consensus       266 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-------~~~~~~~i~~~~~~~p~~  336 (447)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......+.......|..
T Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            321  22345689999999999999999999999999999999999998874321       112222222211111110


Q ss_pred             Cc----------------------------hhHHh-hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          337 LT----------------------------SEAHS-LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       337 ~~----------------------------~~~~~-li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      ..                            ..... -....+||.+||++||.+||     +++++++||||..+
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~  382 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRP-----SAEALLDFAAFQDI  382 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCC-----CHHHHhcChhhccC
Confidence            00                            00000 11235688899999999999     88999999999753

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-47  Score=375.50  Aligned_cols=260  Identities=32%  Similarity=0.578  Sum_probs=242.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ...+.|.+.+.||+|.|++|.++++..     ++..||||++.+....... .+.+.+|+++|+.++|||||+|+.+.+.
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~-----t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t  126 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHIL-----TGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIET  126 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecC-----CCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence            345689999999999999999999886     7889999999987754443 3448899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ...+|+||||+.+|.+++++.+++++.+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++..+.
T Consensus       127 ~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  127 EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      ......++||++.|.|||++.+..| +..+|+||+|+++|-|+.|..||++.+..++..+.+.+++.+|..++.++.++|
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lL  286 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLL  286 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHH
Confidence            8888999999999999999999887 578999999999999999999999999999999999999999999999998887


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      +.      +|.++|.+|+     +.+++++|.|.....
T Consensus       287 rk------~lvl~Pskr~-----~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  287 RK------FLVLNPSKRG-----PCDQIMKDRWRNDLL  313 (596)
T ss_pred             HH------hhccCccccC-----CHHHhhhhcccchhh
Confidence            76      9999999999     789999999997543

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-46  Score=373.80  Aligned_cols=259  Identities=25%  Similarity=0.421  Sum_probs=210.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|++.+.||+|+||.||+|.++.     .++.||||++.+.. ........+.+|+.+++.++||||+++++++... 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~   96 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   96 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECC-----CCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence            3589999999999999999999876     77889999987543 2233445677899999999999999999987643 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                           ..+|+||||+.+ +|...+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875          97 SLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence                 368999999975 67666643  4889999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--------  334 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p--------  334 (447)
                      +............||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......+        
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            876655445567899999999999999999999999999999999999999998887766665543211100        


Q ss_pred             -----------CCCc---------------hhHH--hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 -----------PFLT---------------SEAH--SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 -----------~~~~---------------~~~~--~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                                 ....               .+..  ..-...+||.+||+.||.+||     +++++++||||..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~-----t~~e~L~hp~~~~  323 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI-----SVDEALQHPYINV  323 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC-----CHHHHhcCccccc
Confidence                       0000               0000  001235788889999999999     8899999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.4e-46  Score=360.13  Aligned_cols=258  Identities=27%  Similarity=0.394  Sum_probs=206.7

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEE--
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ--  185 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~--  185 (447)
                      +|++++.||+|+||.||+|++..    .+++.||+|+++..... ......+.+|+.+++.+   +||||+++++++.  
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~   76 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   76 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcC----CCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence            79999999999999999998753    14678999998764322 22223455677777765   6999999999885  


Q ss_pred             ---eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecC
Q 013249          186 ---TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       186 ---~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                         ....+++||||+. ++|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence               3457999999996 5888888754  458999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-CCCCCch
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTS  339 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-~p~~~~~  339 (447)
                      +++............||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+...... .+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            998766554455678999999999999889999999999999999999999999988887777776543210 0100000


Q ss_pred             ---------------hHHhhh-----hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          340 ---------------EAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       340 ---------------~~~~li-----~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                                     ....+.     ...+|+.+||+.||++||     ++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC-----CHHHHhcCCCC
Confidence                           000110     124678889999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.2e-46  Score=370.94  Aligned_cols=259  Identities=25%  Similarity=0.425  Sum_probs=206.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|++.+.. ........+.+|+.+++.++||||+++++++....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   93 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTV-----LGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK   93 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcC-----CCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            3589999999999999999999876     78899999997543 23334456778999999999999999999986543


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                            .+|+||||+.+ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          94 SLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             CccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence                  57999999976 4656553  35889999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc-------------
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  329 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~-------------  329 (447)
                      +............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...             
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            8765544455668999999999999999999999999999999999999999877654433332211             


Q ss_pred             ---------ccCCCCCCchhH-Hh-------------hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          330 ---------KVKLPPFLTSEA-HS-------------LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       330 ---------~~~~p~~~~~~~-~~-------------li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                               ...++.....+. .+             .-...+||.+||+.||++||     +++++++||||..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~  320 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI-----SVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC-----CHHHHhcCchhhh
Confidence                     111110000000 00             01235678889999999999     8899999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.4e-46  Score=355.37  Aligned_cols=270  Identities=37%  Similarity=0.738  Sum_probs=222.9

Q ss_pred             eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHH---HHHHhcCCCCceeeeEEEEeCCEEEEE
Q 013249          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---DILTKVTHPFIVQLRYSFQTRSKLYLI  193 (447)
Q Consensus       117 ~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~~~~~~~~~~lv  193 (447)
                      +||+|+||.||+|++..     +++.||+|++.+..............|.   .+++...||||+.+++++...+.+|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEec-----CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence            48999999999999875     7889999999875433222222233343   344556799999999999999999999


Q ss_pred             EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCc
Q 013249          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS  273 (447)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~  273 (447)
                      |||+.|++|..++...+.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..+... ....
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~  154 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA  154 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcC
Confidence            999999999999988888999999999999999999999999999999999999999999999999998765432 2334


Q ss_pred             cccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCC---CHHHHHHHHHhcccCCCCCCchhHHhhhhhhh
Q 013249          274 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~---~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~  349 (447)
                      .+|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...   ........+......+|...+.++.+++.   
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~---  231 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE---  231 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHH---
Confidence            579999999999975 46899999999999999999999999765   44444444554555666666777666655   


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCC
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  398 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p  398 (447)
                         +||..||.+|+.+...+++++++||||+.++|..+..++..++.+|
T Consensus       232 ---~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~  277 (278)
T cd05606         232 ---GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP  277 (278)
T ss_pred             ---HHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcccCCCCCC
Confidence               4999999999987667899999999999999999987776665554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.2e-46  Score=352.83  Aligned_cols=257  Identities=42%  Similarity=0.837  Sum_probs=224.8

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (447)
                      ||.|+||.||+|+++.     +++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|+||||+
T Consensus         1 lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECC-----CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence            6999999999999875     68899999998765544555677999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccccC
Q 013249          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT  277 (447)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt  277 (447)
                      ++++|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.............|+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            99999999998888999999999999999999999999999999999999999999999999999887654444456789


Q ss_pred             CcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC--HHHHHHHHH--hcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRII--NEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~--~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      ..|++||.+.+..++.++|+||||+++|+|++|..||....  ..+....+.  .....+|...+.++.++      |.+
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------i~~  229 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL------IKQ  229 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH------HHH
Confidence            99999999988889999999999999999999999998766  666666666  34555666666666555      555


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      ||+.||++|+++....++++++||||++.+|+
T Consensus       230 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         230 LLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             HccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            99999999997555569999999999999986

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-45  Score=355.60  Aligned_cols=280  Identities=49%  Similarity=0.920  Sum_probs=233.4

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-chhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (447)
                      +|++.+.||.|+||.||+|++....  .+++.||+|++...... .....+.+.+|+++|+++ +|+||+++++.+..+.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH--DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC--CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence            4899999999999999999875321  26788999999764332 223345678899999999 5899999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999876432


Q ss_pred             C--CCCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCCC----HHHHHHHHHhcccCCCCCCchh
Q 013249          269 S--RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPPFLTSE  340 (447)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~----~~~~~~~i~~~~~~~p~~~~~~  340 (447)
                      .  ......|+..|+|||.+.+  ..++.++||||||+++|+|++|..||...+    ..++...+......+|...+..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL  238 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHH
Confidence            2  2234578999999999875  347889999999999999999999996432    3344444444455556566665


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  398 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p  398 (447)
                      +.++      +.+||+.||++|++++..++++++.||||..++|+.+..+..++||.|
T Consensus       239 ~~~l------l~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  290 (290)
T cd05613         239 AKDI------IQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP  290 (290)
T ss_pred             HHHH------HHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhccCCCCCCC
Confidence            5555      555999999999988888999999999999999999988888877765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-45  Score=363.77  Aligned_cols=257  Identities=29%  Similarity=0.475  Sum_probs=213.6

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.++||+|+||.||++.++.     ++..+|+|++....  .......+.+|+++|+.++||||++++++|.+
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKP-----SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECC-----CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            345789999999999999999999876     77889999987542  23345668899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+.+|+||||+.+++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            999999999999999999999888899999999999999999999975 7999999999999999999999999999865


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHh-----------------
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----------------  328 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~-----------------  328 (447)
                      ... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......+...+..                 
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         155 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             hhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence            432 23445799999999999998899999999999999999999999976654433221110                 


Q ss_pred             ---------------------------cc-cCCCC-CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          329 ---------------------------EK-VKLPP-FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       329 ---------------------------~~-~~~p~-~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                                                 .. ..++. ..+.++      .+||.+||++||++||     ++++++.|+||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~~P~~Rp-----t~~ell~h~~~  302 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEF------QDFVNKCLIKNPAERA-----DLKQLMVHAFI  302 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHH------HHHHHHhccCCcccCc-----CHHHHhhCHHH
Confidence                                       00 00000 012222      4677889999999999     89999999999


Q ss_pred             CCC
Q 013249          380 RSI  382 (447)
Q Consensus       380 ~~~  382 (447)
                      +..
T Consensus       303 ~~~  305 (333)
T cd06650         303 KRS  305 (333)
T ss_pred             hcC
Confidence            764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=336.31  Aligned_cols=260  Identities=29%  Similarity=0.472  Sum_probs=216.7

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY  182 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~  182 (447)
                      ......++.+.+..||.|+.|.|++++.+.     ++.+.|||.+.+..  ..+..+++...++++...+ +|+||+++|
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs-----~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~G  158 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRS-----TGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFG  158 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcc-----cceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence            344556778889999999999999999997     88999999998764  4556677888888877665 899999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecC
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                      +|..+..+++.||.|.- -+..++.+ .++++|..+-++...+++||.||-+ +||||||+||+|||+|+.|++||||||
T Consensus       159 yFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  159 YFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             EEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccc
Confidence            99999999999999843 34444433 4789999999999999999999985 589999999999999999999999999


Q ss_pred             CcccccCCCCCCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCCC-CHHHHHHHHHhcccC-CCC
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIINEKVK-LPP  335 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~i~~~~~~-~p~  335 (447)
                      ++.++.+....+...|.+.|||||.+.-   ..|+.++||||||++++||.||+.||.+. .+.++..+|+++... +|.
T Consensus       238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~  317 (391)
T KOG0983|consen  238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG  317 (391)
T ss_pred             ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc
Confidence            9999888777777889999999999974   46899999999999999999999999874 455677777765432 221


Q ss_pred             --CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          336 --FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       336 --~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                        .+++...      +|+..||++|+.+||     ...+|++|||...-
T Consensus       318 ~~gFSp~F~------~fv~~CL~kd~r~RP-----~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  318 HMGFSPDFQ------SFVKDCLTKDHRKRP-----KYNKLLEHPFIKRY  355 (391)
T ss_pred             ccCcCHHHH------HHHHHHhhcCcccCc-----chHHHhcCcceeec
Confidence              2444444      455569999999999     78999999999743

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=367.33  Aligned_cols=242  Identities=27%  Similarity=0.450  Sum_probs=211.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..+.+.+++.||+|-||.||+|.+++      ...||+|.++......    +.+.+|+++|++|+|+|||+|++++..
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~------~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNG------STKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcC------CCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            444456778899999999999999984      3458999987654322    356789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ++.+|||||||..|+|.++|+.  .+.+...+...++.||++|++||+++++|||||-..||||++++.+||+|||+|+.
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence            8899999999999999999987  46799999999999999999999999999999999999999999999999999996


Q ss_pred             ccCCCCCCc--cccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchh
Q 013249          265 IDESSRSNS--MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~  340 (447)
                      ..++.....  ..-...|.|||.+....++.++|||||||+||||+| |+.||.+.+..++.+.+..+ +..-|..++++
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~  432 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE  432 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence            554433222  223567999999999999999999999999999999 99999999999999988876 45567889999


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLG  364 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~  364 (447)
                      +.+++..      ||..+|++||+
T Consensus       433 vY~lM~~------CW~~~P~~RPt  450 (468)
T KOG0197|consen  433 VYELMKS------CWHEDPEDRPT  450 (468)
T ss_pred             HHHHHHH------HhhCCcccCCC
Confidence            9887766      99999999993

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-45  Score=354.71  Aligned_cols=257  Identities=28%  Similarity=0.414  Sum_probs=204.7

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEEe-
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQT-  186 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-  186 (447)
                      +|++.+.||+|+||.||+|+++.     +++.||+|.++..... ......+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            58999999999999999999886     7889999998764321 22223345677777655   79999999998864 


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecC
Q 013249          187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                          ...+++||||+.+ +|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          75 RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             cCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence                3468999999975 788888764  348999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-----CCCC
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----KLPP  335 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-----~~p~  335 (447)
                      +++............||..|+|||++.+..++.++|||||||++|+|++|++||...+..+...++.....     .++.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            99877654444556789999999999999999999999999999999999999988777666655543210     0110


Q ss_pred             -----------CCchhHHhhh-----hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          336 -----------FLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       336 -----------~~~~~~~~li-----~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                                 ........+.     ...+||.+||++||++||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~l~hp~f  288 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI-----SAFRALQHPFF  288 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC-----CHHHHhcCCCC
Confidence                       0000001110     124678889999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-45  Score=370.04  Aligned_cols=256  Identities=26%  Similarity=0.370  Sum_probs=211.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  188 (447)
                      +|++.++||+|+||.||+|.+..     +++.||||++.... ......+.+.+|+.+|+.++||||+++++++....  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR-----DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC-----CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            58899999999999999999875     78899999986532 22333456788999999999999999999998776  


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                         .+|+||||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence               8999999996 578888888888999999999999999999999999999999999999999999999999999865


Q ss_pred             cCC--CCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-----------
Q 013249          266 DES--SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----------  331 (447)
Q Consensus       266 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-----------  331 (447)
                      ...  .......++..|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.....           
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            332  223345689999999999874 579999999999999999999999988877665555432110           


Q ss_pred             ------------CCC---------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          332 ------------KLP---------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       332 ------------~~p---------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                                  ..+         ...+.+      ..+||.+||+.||++||     +++++++||||.+..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~~~~  296 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHE------AVHLLCRMLVFDPDKRI-----SAADALAHPYLDEGRL  296 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHH------HHHHHHHhCCCChhhCc-----CHHHHhcCHhhCCCcc
Confidence                        001         111222      34677889999999999     8899999999998654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-45  Score=379.35  Aligned_cols=254  Identities=28%  Similarity=0.482  Sum_probs=218.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|.+.+.||+|+||.||+|.+...    .++.+|+|.+...   .......+.+|+.+|+.++|||||++++++...+.+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~----~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~  140 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSD----PKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL  140 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCC----CCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence            599999999999999999987651    2677888876543   233445678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          191 YLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ||||||++||+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            999999999999887753    3568999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHH
Q 013249          267 ESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAH  342 (447)
Q Consensus       267 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~  342 (447)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+..+.. .+|..++.++.
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  300 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK  300 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence            432   23456799999999999999999999999999999999999999999888888888776554 34556666666


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +++      .+||..||++||     ++++++.|+|++.+
T Consensus       301 ~li------~~~L~~dP~~Rp-----s~~~~l~~~~~~~~  329 (478)
T PTZ00267        301 ALL------DPLLSKNPALRP-----TTQQLLHTEFLKYV  329 (478)
T ss_pred             HHH------HHHhccChhhCc-----CHHHHHhCHHHHHH
Confidence            554      459999999999     78999999998643

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-47  Score=346.24  Aligned_cols=251  Identities=32%  Similarity=0.548  Sum_probs=215.5

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      +.||+|+|+.|--|....     ++..||||++.|..   .....++.+|++++.+++ |+||++|+++|+++..+||||
T Consensus        84 e~LGeGAyasVqtcv~i~-----t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQ-----TGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHhcCccceeeeeeeeec-----cchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            479999999999998776     88899999998863   334567889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC---cEEEeecCCcccccCC---
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEIDES---  268 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~~kL~DFG~a~~~~~~---  268 (447)
                      |-|.||.|..+|.++..|+|.++..++++|+.||+|||.+||.||||||+|||-....   -||||||.+.......   
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            9999999999999999999999999999999999999999999999999999997654   4899999987654221   


Q ss_pred             -----CCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCC---------------CHHHHH
Q 013249          269 -----SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHA---------------NRQKLQ  323 (447)
Q Consensus       269 -----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~---------------~~~~~~  323 (447)
                           ....+.+|+..|||||+..     ...|+.++|.||||||+|-||+|.+||.+.               -...++
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                 1234578999999999975     246899999999999999999999999653               135688


Q ss_pred             HHHHhcccCCCCC----CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          324 QRIINEKVKLPPF----LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       324 ~~i~~~~~~~p~~----~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      ..|..++++||..    ++.++++++      +.+|.+|+.+|+     ++.++++|||++.+.-+
T Consensus       316 esIQEGkYeFPdkdWahIS~eakdli------snLlvrda~~rl-----sa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  316 ESIQEGKYEFPDKDWAHISSEAKDLI------SNLLVRDAKQRL-----SAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHhccCCcCChhhhHHhhHHHHHHH------HHHHhccHHhhh-----hhhhccCCccccccchh
Confidence            8999999999974    555655554      459999999999     77999999999876543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=371.15  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=211.2

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      .++.+..+++.++..||+|.||+||+|+|.+        .||||++..+.. ..++.+.|++|+.+|++-+|.||+-+.|
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--------ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            5577888899999999999999999999876        499999988764 4558899999999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      ++..... .||+-+|+|.+|+.+++.. .+|.....+.|++||++|+.|||.++|||||||..||++.+++.|||+|||+
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence            9998877 9999999999999999855 5799999999999999999999999999999999999999999999999999


Q ss_pred             cccc---cCCCCCCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--
Q 013249          262 AKEI---DESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--  333 (447)
Q Consensus       262 a~~~---~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~--  333 (447)
                      +..-   ..........|...|||||++..   ..|+..+||||||||+|||++|..||...+.+.+...+-.+....  
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL  614 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence            8753   23333445568899999999974   468999999999999999999999999777666555544442211  


Q ss_pred             ---CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          334 ---PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       334 ---p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                         -.....+++.      |+..||.+++++||     .+.+|+.
T Consensus       615 s~~~s~~pk~mk~------Ll~~C~~~~~~eRP-----~F~~il~  648 (678)
T KOG0193|consen  615 SKIRSNCPKAMKR------LLSDCWKFDREERP-----LFPQLLS  648 (678)
T ss_pred             hhhhccCHHHHHH------HHHHHHhcCcccCc-----cHHHHHH
Confidence               1122334444      45559999999999     6677764

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-45  Score=367.65  Aligned_cols=259  Identities=25%  Similarity=0.436  Sum_probs=207.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|++++.||+|+||.||+|.+..     +++.||||++.... ........+.+|+.+++.++||||+++++++... 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   89 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecC-----CCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence            3589999999999999999999875     77889999987543 2333445677899999999999999999998643 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                           ..+|+||||+++ +|...+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          90 SLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence                 357999999976 56666543  5889999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-----------
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----------  331 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-----------  331 (447)
                      +............||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....           
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            876655455567899999999999999999999999999999999999999988776554443322110           


Q ss_pred             ----------------CCCCCCchhH-------H--hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          332 ----------------KLPPFLTSEA-------H--SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       332 ----------------~~p~~~~~~~-------~--~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                                      .++.......       .  ..-...+||.+||+.||++||     +++++++||||..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp-----s~~ell~hp~~~~  316 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDEALQHPYINV  316 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC-----CHHHHhcCcchhc
Confidence                            0010000000       0  001235788889999999999     8899999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2e-45  Score=379.71  Aligned_cols=258  Identities=31%  Similarity=0.501  Sum_probs=221.4

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.++||+|+||+||+|+++.     +++.||||++..... .......+.+|+.+|..++|+||++++..+...
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVS-----DGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcC-----CCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            34689999999999999999999876     788999999976543 334456678899999999999999998877543


Q ss_pred             C--------EEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEE
Q 013249          188 S--------KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       188 ~--------~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~k  255 (447)
                      .        .+++||||+.+|+|.+++...    ..+++..+..++.|++.||.|||++||+||||||+||||+.++.+|
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence            2        478999999999999988653    4689999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCC---CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-
Q 013249          256 LTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-  331 (447)
Q Consensus       256 L~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-  331 (447)
                      |+|||+++.+...   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+..+.. 
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~  263 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD  263 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            9999999875432   223456899999999999999999999999999999999999999999888888877776544 


Q ss_pred             CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          332 KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       332 ~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .+|..++.++.+++.      +||+.||.+||     ++.++++|||++..
T Consensus       264 ~~~~~~~~~l~~li~------~~L~~dP~~RP-----s~~ell~~p~~~~~  303 (496)
T PTZ00283        264 PLPPSISPEMQEIVT------ALLSSDPKRRP-----SSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCHHHHHHHH------HHcccChhhCc-----CHHHHHhCHHHHHh
Confidence            356677777766655      49999999999     88999999998764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-45  Score=364.08  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=206.8

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      +.+..++|++.++||+|+||.||+|.+.+..+..+++.||||+++...  .......+.+|+.+|+.+ +||||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            345667999999999999999999987655544567789999987532  233445688999999999 89999999998


Q ss_pred             EEeC-CEEEEEEeccCCCChHHHHHHc-----------------------------------------------------
Q 013249          184 FQTR-SKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (447)
Q Consensus       184 ~~~~-~~~~lv~E~~~gg~L~~~l~~~-----------------------------------------------------  209 (447)
                      +... ..+|+||||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            8764 4689999999999999998753                                                     


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC---CCCccccC
Q 013249          210 ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGT  277 (447)
Q Consensus       210 ---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt  277 (447)
                               ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ......++
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                     237788899999999999999999999999999999999999999999999998653221   12233467


Q ss_pred             CcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH-HHHHHHhc-ccCCCCCCchhHHhhhhhhhHHhhh
Q 013249          278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK-LQQRIINE-KVKLPPFLTSEAHSLLKGVSFLTQL  354 (447)
Q Consensus       278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~-~~~~i~~~-~~~~p~~~~~~~~~li~~~~~l~~~  354 (447)
                      ..|+|||++.+..++.++|||||||++|||++ |..||.+....+ ....+..+ ....|...+.++.+      ++.+|
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~------li~~c  313 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYR------IMLAC  313 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHH------HHHHH
Confidence            88999999999999999999999999999997 999998755433 33333332 23344555555554      45569


Q ss_pred             ccCCCCCCCCCCCCChhhhhc
Q 013249          355 LHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       355 L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      |+.||.+||     ++.+|++
T Consensus       314 l~~dp~~RP-----s~~el~~  329 (338)
T cd05102         314 WQGDPKERP-----TFSALVE  329 (338)
T ss_pred             ccCChhhCc-----CHHHHHH
Confidence            999999999     7788875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-45  Score=365.43  Aligned_cols=263  Identities=24%  Similarity=0.345  Sum_probs=211.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ..+|++++.||+|+||.||+|..++.   ..++.||+|.+....        ...+|+.+|+.++||||+++++++....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~---~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGD---EQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCC---ccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            45799999999999999999986542   256789999886532        2457999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+|||++. ++|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9999999995 688888877788999999999999999999999999999999999999999999999999999876433


Q ss_pred             CC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH---HHHHHHHHhc----ccCCCCCCc
Q 013249          269 SR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR---QKLQQRIINE----KVKLPPFLT  338 (447)
Q Consensus       269 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~---~~~~~~i~~~----~~~~p~~~~  338 (447)
                      ..   .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...   ......+...    ...++....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            22   2346799999999999999999999999999999999999999965432   1222222211    111121110


Q ss_pred             hh---------------------HH---hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHH
Q 013249          339 SE---------------------AH---SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  388 (447)
Q Consensus       339 ~~---------------------~~---~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~  388 (447)
                      ..                     ..   .-....+||.+||+.||++||     ++.+++.||||....|..+.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp-----sa~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP-----SAQDILSLPLFTKEPINLLN  387 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC-----CHHHHhhCchhhccchhhhc
Confidence            00                     00   001234678889999999999     88999999999988887763

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-45  Score=345.88  Aligned_cols=254  Identities=30%  Similarity=0.496  Sum_probs=216.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc--chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ++|++.+.||+|++|.||+|.+..     +++.+|+|.+......  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD-----TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC-----CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence            479999999999999999998775     7789999998754322  223456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..+|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||+|+||+++.++.+||+|||+++....
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCC----CccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCchhH
Q 013249          268 SSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTSEA  341 (447)
Q Consensus       268 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~  341 (447)
                      ....    ....|+..|+|||++.+..++.++||||||+++|||++|+.||...+.......+...  ...+|...+.++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence            2111    3456888999999999998999999999999999999999999876665554444433  234555566666


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      .++      |.+||..||.+||     +++++++|+||
T Consensus       237 ~~l------i~~~l~~~p~~Rp-----t~~~ll~~~~~  263 (263)
T cd06625         237 RNF------LRRTFVENAKKRP-----SAEELLRHFFV  263 (263)
T ss_pred             HHH------HHHHhhcCcccCC-----CHHHHhhCCCC
Confidence            555      4559999999999     89999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.1e-45  Score=351.14  Aligned_cols=278  Identities=49%  Similarity=0.917  Sum_probs=232.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (447)
                      +|++.+.||+|+||.||++++....  ..+..||||++++..... ....+.+.+|+.+++++ +||||+++++.+..+.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence            4899999999999999999875422  256789999997643322 33445678899999999 5999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+.+++|..++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+...
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998875432


Q ss_pred             CC--CCccccCCcccccccccCCC--CCCccceeehhHhHHHHhhCCCCCCCCC----HHHHHHHHHhcccCCCCCCchh
Q 013249          269 SR--SNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPPFLTSE  340 (447)
Q Consensus       269 ~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~ell~G~~pf~~~~----~~~~~~~i~~~~~~~p~~~~~~  340 (447)
                      ..  .....|+..|+|||.+.+..  ++.++||||||+++|||++|..||...+    ..++.+.+.......|..++.+
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE  238 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHH
Confidence            21  23456899999999987654  7889999999999999999999996432    2344445555555566666666


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  398 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p  398 (447)
                      +.++      |.+||+.||++||++.  +++++++||||++++|+.+.++.+.|+|.|
T Consensus       239 l~~l------i~~~l~~~p~~R~t~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  288 (288)
T cd05583         239 ARDF------IQKLLEKDPKKRLGAN--GADEIKNHPFFQGIDWDDLAAKRIPAPFKP  288 (288)
T ss_pred             HHHH------HHHHhcCCHhhccCcc--hHHHHhcCcccccCCHHHHhhhccCCCCCC
Confidence            6555      5559999999999653  688999999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.1e-45  Score=356.25  Aligned_cols=261  Identities=24%  Similarity=0.441  Sum_probs=209.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|.+.++||+|+||.||+|+++.     +++.||+|.++....  ......+.+|+.++++++||||+++++++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK   77 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecC-----CCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence            4679999999999999999999876     778899999875432  222334668999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          78 SLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             eEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99999999975 787777654 4589999999999999999999999999999999999999999999999999976533


Q ss_pred             CC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc---------------
Q 013249          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------------  330 (447)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~---------------  330 (447)
                      .. ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            22 2234568999999999875 468999999999999999999999998877665554443211               


Q ss_pred             ----cCCCCCCchhHHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          331 ----VKLPPFLTSEAHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       331 ----~~~p~~~~~~~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                          ..++.........     -....+||.+||+.||.+|+     +++++++||||+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~~  292 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI-----SAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC-----CHHHHhcChhhhhc
Confidence                1111111000000     01234677889999999999     88999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-45  Score=347.13  Aligned_cols=254  Identities=41%  Similarity=0.806  Sum_probs=215.3

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHH-HhcCCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      +.||.|+||.||+|.++.     +++.||+|++.+...........+..|..++ ...+|+||+++++++..++.+|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS-----TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecC-----CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence            569999999999999876     7789999999765443333334445565554 4558999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCcc
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM  274 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~  274 (447)
                      ||+.|++|..++...+.+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||+++....   ....
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~  153 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF  153 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence            9999999999998888899999999999999999999999999999999999999999999999999876543   3345


Q ss_pred             ccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHHhhhhhhhH
Q 013249          275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHSLLKGVSF  350 (447)
Q Consensus       275 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~~~  350 (447)
                      .|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......++.    .++.++.      ++
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  227 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAV------DL  227 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHH------HH
Confidence            6889999999999888999999999999999999999999988888877777666554443    2344444      45


Q ss_pred             HhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       351 l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      +.+||+.||++||++.  ++++++.||||.+++|+
T Consensus       228 i~~~l~~~p~~R~~~~--~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         228 INRLLCMDPAKRLGAN--GYQEIKSHPFFKSINWD  260 (260)
T ss_pred             HHHHccCCHHHccCCC--cHHHHHcChHhhcCCCC
Confidence            6669999999999763  67999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.9e-45  Score=345.88  Aligned_cols=255  Identities=41%  Similarity=0.789  Sum_probs=221.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||.|+||.||+|+++.     +++.||+|++.+.........+.+.+|++++++++||||+++++.+.+...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD-----TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc-----CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence            58999999999999999999875     7888999999876655555677889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      |+||||+.|++|..++.....+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++........
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999987655444


Q ss_pred             CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC---HHHHHHHHHhcccCCCCCCchhHHhhhhh
Q 013249          271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (447)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~li~~  347 (447)
                      .....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+   ...+..........+|...+.++.++   
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  232 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA---  232 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHH---
Confidence            455678999999999998889999999999999999999999998766   34444443334455666666555554   


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         |.+||..||.+|+++.   +++++.||||
T Consensus       233 ---i~~~l~~~p~~R~~~~---~~~l~~~~~~  258 (258)
T cd05578         233 ---INKLLERDPQKRLGDN---LKDLKNHPYF  258 (258)
T ss_pred             ---HHHHccCChhHcCCcc---HHHHhcCCCC
Confidence               5569999999999321   3999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-45  Score=347.99  Aligned_cols=251  Identities=34%  Similarity=0.635  Sum_probs=210.4

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |++++.||+|+||+||+++++.     +++.||+|++......... .....+|+.++++++||||+++++++.....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK-----NGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT-----TTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECC-----CCeEEEEEEeccccccccc-cchhhhhhhcccccccccccccccccccccccc
Confidence            7899999999999999999986     7789999999887543332 233455999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc-cCCCC
Q 013249          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSR  270 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~-~~~~~  270 (447)
                      +||||+.+++|.+++...+.+++..+..++.||+.||.+||++||+|+||||+|||++.++.++|+|||.+... .....
T Consensus        75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999863 23334


Q ss_pred             CCccccCCccccccccc-CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHH---HHHHHHhcccCCCCC----CchhHH
Q 013249          271 SNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK---LQQRIINEKVKLPPF----LTSEAH  342 (447)
Q Consensus       271 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~---~~~~i~~~~~~~p~~----~~~~~~  342 (447)
                      .....++..|+|||++. +..++.++||||||+++|+|++|..||...+...   ...............    ...++ 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-  233 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL-  233 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH-
Confidence            45677899999999998 8889999999999999999999999998773333   333333222211111    12333 


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                           .++|.+||+.||++||     +++++++||||
T Consensus       234 -----~~li~~~l~~~p~~R~-----~~~~l~~~~~~  260 (260)
T PF00069_consen  234 -----RDLIKKMLSKDPEQRP-----SAEELLKHPWF  260 (260)
T ss_dssp             -----HHHHHHHSSSSGGGST-----THHHHHTSGGG
T ss_pred             -----HHHHHHHccCChhHCc-----CHHHHhcCCCC
Confidence                 3456669999999999     89999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-46  Score=337.65  Aligned_cols=249  Identities=33%  Similarity=0.594  Sum_probs=215.3

Q ss_pred             CCCcEEE-eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe
Q 013249          109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (447)
Q Consensus       109 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  186 (447)
                      .++|.+- ++||-|-.|.|..|.++.     +++.+|+|++....        ..++|+++--.. .|||||+++++|++
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~-----T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKR-----TQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEecc-----chhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            4577764 589999999999999997     88899999986431        356788775544 59999999999864


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEEe
Q 013249          187 ----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLT  257 (447)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL~  257 (447)
                          ...+.+|||.|+||+|+..+..++.  |+|.++..|+.||..|+.|||+.+|.||||||+|+|...   |..+||+
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence                4568899999999999999998865  999999999999999999999999999999999999964   4579999


Q ss_pred             ecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC----HHHHHHHHHhcccCC
Q 013249          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKL  333 (447)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~----~~~~~~~i~~~~~~~  333 (447)
                      |||+|+.........+.|-|+.|.|||++....|+..+|+||+||++|-||+|.+||....    ...+..+|..+.+.|
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            9999998876667788899999999999999999999999999999999999999996543    345778999999999


Q ss_pred             CCC----CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          334 PPF----LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       334 p~~----~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      |..    ++..++++      |+++|..+|.+|+     ++++++.|||...
T Consensus       287 P~pEWs~VSe~aKdl------IR~LLkt~PteRl-----TI~~~m~hpwi~~  327 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDL------IRKLLKTEPTERL-----TIEEVMDHPWINQ  327 (400)
T ss_pred             CChhHhHHHHHHHHH------HHHHhcCCchhhe-----eHHHhhcCchhcc
Confidence            864    45555555      4559999999999     9999999999975

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-45  Score=361.41  Aligned_cols=259  Identities=25%  Similarity=0.443  Sum_probs=208.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|++++.||+|+||+||+|.+..     +++.||||++.+... .....+.+.+|+.+|+.++||||+++++++... 
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTR-----LRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-----CCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            3689999999999999999999876     788999999876432 223345577899999999999999999888643 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                           ..+|++||++ +++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                 4579999998 778877664 467999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--------
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--------  333 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~--------  333 (447)
                      +.....  ....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......        
T Consensus       166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            876542  345679999999999977 568999999999999999999999998877665555543321110        


Q ss_pred             ------------CCCCchhHHhhh-----hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          334 ------------PPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       334 ------------p~~~~~~~~~li-----~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                  +.........++     ...+||.+||+.||.+||     ++++++.||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~-----s~~ell~hp~~~~~  304 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI-----SASEALAHPYFSQY  304 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCcchhcc
Confidence                        000001111111     124788889999999999     88999999999754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-45  Score=361.28  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=200.3

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ...+|++++.||+|+||.||+|+++.     +++.||+|+..+..         ...|+.++++++||||+++++++...
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~  129 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPG-----QPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSG  129 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECC-----CCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeC
Confidence            34579999999999999999999876     67889999865432         34589999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ...|+|||++. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       130 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        130 AITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             CeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            99999999995 577777765 4679999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCC-CCCCCCH---------HHHHHHHHhcc----cC
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP-PFTHANR---------QKLQQRIINEK----VK  332 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~-pf~~~~~---------~~~~~~i~~~~----~~  332 (447)
                      .........||..|+|||++.+..++.++|||||||++|||+++.. +|.....         ......+....    ..
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  288 (357)
T PHA03209        209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE  288 (357)
T ss_pred             cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence            4334455679999999999999999999999999999999998544 4443211         01111111111    11


Q ss_pred             CCCCC-chhHHh-----------------------hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          333 LPPFL-TSEAHS-----------------------LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       333 ~p~~~-~~~~~~-----------------------li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      ++... ......                       .....+||.+||+.||.+||     +++++++||||+++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp-----ta~e~l~hp~f~~~  357 (357)
T PHA03209        289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP-----SAEEILNYPMFAQL  357 (357)
T ss_pred             cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc-----CHHHHhcCchhccC
Confidence            12100 000000                       11224588899999999999     88999999999864

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4e-44  Score=382.21  Aligned_cols=150  Identities=43%  Similarity=0.765  Sum_probs=139.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|.++++||+|+||.||+|.+..     +++.||||++++...........+..|+.+++.++||||+++++++....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKN-----NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            4689999999999999999999876     78899999998766555666678889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      ++|+||||+.|++|..++...+.+++..++.|+.||+.||+|||.+|||||||||+||||+.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999999888889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.4e-44  Score=349.71  Aligned_cols=254  Identities=27%  Similarity=0.454  Sum_probs=212.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+++++.     ++..+|+|.+....  .......+.+|++++++++||||+++++.+..++.
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP-----SGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE   73 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC-----CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence            379999999999999999999876     77889999986542  23345568889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||++|++|.+++.+.+.+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999999999999988899999999999999999999997 69999999999999999999999999998765432


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---------------
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---------------  333 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~---------------  333 (447)
                       .....+|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......               
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence             2345678999999999988889999999999999999999999997665444332222111000               


Q ss_pred             ----------------------CC-CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          334 ----------------------PP-FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       334 ----------------------p~-~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                            |. .++.+      ..+|+.+||..||++||     +++++++||||.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~~l~~~P~~Rp-----t~~~ll~~~~~~~~  293 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDE------FQDFVDKCLKKNPKERA-----DLKELTKHPFIKRA  293 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHH------HHHHHHHHccCChhhCc-----CHHHHhcChhhhhc
Confidence                                  00 01222      24677789999999999     88999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.6e-44  Score=345.99  Aligned_cols=266  Identities=20%  Similarity=0.333  Sum_probs=217.6

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.++||+|+||.||+|..+....+..+..||+|.+....  .......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            45567899999999999999999987654444456789999886543  2223345778999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEE
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~k  255 (447)
                      +....|+||||+.+|+|.+++...+          .++...+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999997532          346678899999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-
Q 013249          256 LTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-  330 (447)
Q Consensus       256 L~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-  330 (447)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.... 
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999886532211   122345678999999998889999999999999999998 899998888777776665442 


Q ss_pred             cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc------CCccCCCCh
Q 013249          331 VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH------HKWFRSINW  384 (447)
Q Consensus       331 ~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~------h~~f~~~~~  384 (447)
                      ...+...+.++.++      +.+||+.||++||     ++.++++      ||||.+++|
T Consensus       240 ~~~~~~~~~~~~~l------i~~~l~~~p~~Rp-----s~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         240 LDQPDNCPERVTDL------MRMCWQFNPKMRP-----TFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCCCCCCCHHHHHH------HHHHcCCChhHCc-----CHHHHHHHHHhhcCCCCCCCCC
Confidence            33444555555555      5559999999999     6777765      999999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-46  Score=357.94  Aligned_cols=268  Identities=33%  Similarity=0.573  Sum_probs=228.9

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      ++||.|.||+||-++++.     +|+.||||++.|.....+. ...+++|+.||++++||.||.|-..|++.+.++.|||
T Consensus       570 evLGSGQFG~VYgg~hRk-----tGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRK-----TGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             hhccCCcceeeecceecc-----cCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            689999999999999987     8999999999988765544 4779999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC---CcEEEeecCCcccccCCCCC
Q 013249          196 FINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRS  271 (447)
Q Consensus       196 ~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~~kL~DFG~a~~~~~~~~~  271 (447)
                      -+.|.-|.-.|. ..+++++...++++.||+.||.|||-++|+|.||||+|||+...   -++||||||+|+.+++....
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            997655544444 34789999999999999999999999999999999999999654   36999999999999998888


Q ss_pred             CccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHH
Q 013249          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL  351 (447)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l  351 (447)
                      .+.+||+.|+|||++.+++|++..|+||+|||+|--|+|..||...  +++-.+|.+..+.+|+.-..++..  .++|||
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~--~AidlI  799 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISP--EAIDLI  799 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCH--HHHHHH
Confidence            8999999999999999999999999999999999999999999643  566778888888888654333322  245667


Q ss_pred             hhhccCCCCCCCCCCCCChhhhhcCCccCCC-ChhHHHh--hhcCCCCCC
Q 013249          352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI-NWKTLEA--REMQPKFKP  398 (447)
Q Consensus       352 ~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~-~~~~~~~--~~~~~~~~p  398 (447)
                      ..+|+..-.+|.     +++..+.|||+++- -|..+..  .++-+.|+-
T Consensus       800 n~LLqVkm~kRy-----svdk~lsh~Wlq~yq~w~DLRelE~~igeRyiT  844 (888)
T KOG4236|consen  800 NNLLQVKMRKRY-----SVDKSLSHPWLQDYQTWLDLRELEVRIGERYIT  844 (888)
T ss_pred             HHHHHHHHHHhc-----chHhhccchhhhcchHHHHHHHHHHhhCcceec
Confidence            779999999999     89999999999874 4666542  233444544

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-44  Score=353.14  Aligned_cols=250  Identities=28%  Similarity=0.460  Sum_probs=191.2

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEEEE
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSKLYL  192 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l  192 (447)
                      .++||+|+||+||+|+++..   .+++.||+|.+.....     ...+.+|+.+|++++||||+++++++..  ...+|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~---~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG---KDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   77 (317)
T ss_pred             ccccccCCCeEEEEEEEccC---CCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence            46899999999999997632   2567899999865432     2346789999999999999999999854  567999


Q ss_pred             EEeccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc----CCCCcEEEeec
Q 013249          193 ILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDF  259 (447)
Q Consensus       193 v~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~~kL~DF  259 (447)
                      ||||+. ++|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          78 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            999995 4787776532         258999999999999999999999999999999999999    46689999999


Q ss_pred             CCcccccCCC----CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCH---------HHHHHH
Q 013249          260 GLAKEIDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR---------QKLQQR  325 (447)
Q Consensus       260 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~---------~~~~~~  325 (447)
                      |+++......    .....+||+.|+|||++.+ ..++.++||||+||++|||++|++||.....         ......
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            9998764321    2335678999999999987 4589999999999999999999999964332         111222


Q ss_pred             HHhccc-----------CCCCCCchhHH----------------------hhhhhhhHHhhhccCCCCCCCCCCCCChhh
Q 013249          326 IINEKV-----------KLPPFLTSEAH----------------------SLLKGVSFLTQLLHKDPSKRLGSGPGGVDA  372 (447)
Q Consensus       326 i~~~~~-----------~~p~~~~~~~~----------------------~li~~~~~l~~~L~~dP~~R~~~~~~~~~~  372 (447)
                      +.....           .++.. .....                      .-...++||.+||++||.+|+     ++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~-----t~~e  310 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEH-STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI-----TSEQ  310 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccch-hhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCC-----CHHH
Confidence            221100           00000 00000                      001245788899999999999     8999


Q ss_pred             hhcCCcc
Q 013249          373 IKHHKWF  379 (447)
Q Consensus       373 l~~h~~f  379 (447)
                      +++||||
T Consensus       311 ~l~hp~f  317 (317)
T cd07868         311 AMQDPYF  317 (317)
T ss_pred             HhcCCCC
Confidence            9999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-44  Score=342.00  Aligned_cols=254  Identities=46%  Similarity=0.866  Sum_probs=221.5

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (447)
                      ||.|+||.||+|.+..     +++.+++|++...........+.+.+|++++++++||||+++++.+.....+|+||||+
T Consensus         1 lg~g~~~~vy~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKS-----TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECC-----CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence            6899999999999875     68899999998765544566677889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC--------
Q 013249          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--------  269 (447)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~--------  269 (447)
                      .+++|..++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.......        
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            999999999888889999999999999999999999999999999999999999999999999987643321        


Q ss_pred             -CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC--chhHHhhhh
Q 013249          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL--TSEAHSLLK  346 (447)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~--~~~~~~li~  346 (447)
                       ......++..|+|||++....++.++||||||+++|+|++|..||......+....+..+...+|...  +..+.+   
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  232 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAID---  232 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHH---
Confidence             22345688899999999988899999999999999999999999998888888888877666666554  555544   


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                         |+.+||+.+|.+||++.  .+.++++||||++++|
T Consensus       233 ---~i~~~l~~~p~~Rpt~~--~~~~~l~~~~~~~~~~  265 (265)
T cd05579         233 ---LISKLLVPDPEKRLGAK--SIEEIKNHPFFKGIDW  265 (265)
T ss_pred             ---HHHHHhcCCHhhcCCCc--cHHHHhcCccccCCCC
Confidence               45569999999999442  4599999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=368.05  Aligned_cols=257  Identities=29%  Similarity=0.514  Sum_probs=221.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      +.|+|+..||.|+||.||+|..+.     ++-..|-|++.-.   ..+.++.+.-|+.||..|+||+||+|++.|...+.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nke-----t~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKE-----TKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK  103 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhccc-----chhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence            357899999999999999999885     6777888888643   45667778889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc-cC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DE  267 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~-~~  267 (447)
                      ++|+.|||.||-....+-.- ..+.++++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+... ..
T Consensus       104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence            99999999999887766544 57999999999999999999999999999999999999999999999999987543 33


Q ss_pred             CCCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC---CCCCCch
Q 013249          268 SSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTS  339 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~---~p~~~~~  339 (447)
                      .....++.||++|||||++.     ..+|+.++||||||++|.||..+.+|....++..+.-+|....++   -|..++.
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence            34567899999999999986     468999999999999999999999999999998888888765432   2445555


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      ...++      |.+||.+||..||     ++.+|++||||.+++-.
T Consensus       264 ~F~Df------Lk~cL~Knp~~Rp-----~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  264 SFSDF------LKRCLVKNPRNRP-----PAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             HHHHH------HHHHHhcCCccCC-----CHHHHhhCcccccCCcc
Confidence            55554      5559999999999     78999999999987644

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-43  Score=336.24  Aligned_cols=252  Identities=29%  Similarity=0.530  Sum_probs=214.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-CCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~  189 (447)
                      +|++++.||+|++|.||++.++.     +++.||+|.+..... .....+.+.+|+.++++++|+||+++++.+.. ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT-----DGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC-----CCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            48999999999999999999875     678899999876432 23345567889999999999999999988864 457


Q ss_pred             EEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      +|+||||+++++|.+++...  ..+++.+++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            89999999999999998763  4689999999999999999999999999999999999999999999999999987643


Q ss_pred             C-CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhh
Q 013249          268 S-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  345 (447)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li  345 (447)
                      . .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..+.. ..+...+.++.+  
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  232 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE--  232 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHH--
Confidence            2 223345789999999999999999999999999999999999999988877776666665543 334445555554  


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                          |+.+||+.||++||     ++.++++||||
T Consensus       233 ----li~~~l~~~p~~Rp-----~~~~~l~~~~~  257 (257)
T cd08223         233 ----LIATMLSKRPEKRP-----SVKSILRQPYI  257 (257)
T ss_pred             ----HHHHHhccCcccCC-----CHHHHhcCCCC
Confidence                45569999999999     88999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-44  Score=345.99  Aligned_cols=240  Identities=18%  Similarity=0.220  Sum_probs=206.0

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----CCEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----RSKLY  191 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~  191 (447)
                      ..||+|++|.||+|..       +++.||||.+++.........+.+.+|+.+|++++||||+++++++.+    ...++
T Consensus        26 ~~i~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~   98 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS   98 (283)
T ss_pred             eEEeeCCceEEEEEEE-------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence            6799999999999987       467899999987654444446778899999999999999999999877    45789


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      +||||+.||+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+...  
T Consensus        99 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--  176 (283)
T PHA02988         99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--  176 (283)
T ss_pred             EEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence            999999999999999988889999999999999999999998 49999999999999999999999999999875432  


Q ss_pred             CCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCCCCchhHHhhhh
Q 013249          271 SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPFLTSEAHSLLK  346 (447)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~  346 (447)
                      .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..++...+....  ..+|...+.+++++  
T Consensus       177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l--  254 (283)
T PHA02988        177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCI--  254 (283)
T ss_pred             cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHH--
Confidence            234578999999999976  679999999999999999999999999988888887776543  33444566666555  


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                          +.+||+.||++||     +++++++
T Consensus       255 ----i~~cl~~dp~~Rp-----s~~ell~  274 (283)
T PHA02988        255 ----VEACTSHDSIKRP-----NIKEILY  274 (283)
T ss_pred             ----HHHHhcCCcccCc-----CHHHHHH
Confidence                5559999999999     7788875

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.1e-44  Score=344.11  Aligned_cols=261  Identities=30%  Similarity=0.505  Sum_probs=217.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .+.|+++++||.|+||.||+|+++.     +++.+++|++...   .....+.+.+|+.+++.++||||+++++.+..++
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKE-----TGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECC-----CCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            3569999999999999999999876     7789999998754   2344566888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+|+||||+.|++|..++.+ ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999999999887754 45789999999999999999999999999999999999999999999999999876433


Q ss_pred             C-CCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCc
Q 013249          268 S-SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLT  338 (447)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~  338 (447)
                      . .......++..|+|||++.     ...++.++|||||||++|||++|..||...+......++.....   ..+..++
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS  242 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence            2 2233456889999999985     34568899999999999999999999987766655555543322   1223344


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHH
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  388 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~  388 (447)
                      .++.      +||.+||..||++||     +++++++||||..++|....
T Consensus       243 ~~~~------~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~~~~~  281 (292)
T cd06644         243 MEFR------DFLKTALDKHPETRP-----SAAQLLEHPFVSSVTSNRPL  281 (292)
T ss_pred             HHHH------HHHHHHhcCCcccCc-----CHHHHhcCccccccccchhH
Confidence            4444      456669999999999     88999999999999988743

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.2e-44  Score=382.91  Aligned_cols=260  Identities=26%  Similarity=0.475  Sum_probs=213.2

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ...++|+++++||+|+||+||+|+++.     +++.||+|++..... .......+..|+.+|+.++|||||+++++|..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~-----tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKR-----TQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECC-----CCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            445689999999999999999999886     788999999976543 33445668889999999999999999999864


Q ss_pred             --CCEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCCcccCC---
Q 013249          187 --RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKC-------GIVHRDLKPENILMDS---  250 (447)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-------~iiHrDikp~NILl~~---  250 (447)
                        ...+||||||+.+|+|..+|...    +.+++..++.|+.||+.||.|||+.       +||||||||+||||+.   
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence              45799999999999999988652    5799999999999999999999985       4999999999999964   


Q ss_pred             --------------CCcEEEeecCCcccccCCCCCCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCC
Q 013249          251 --------------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF  314 (447)
Q Consensus       251 --------------~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf  314 (447)
                                    .+.+||+|||++..+.........+||+.|+|||++.+  ..++.++||||||||||||++|+.||
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                          23599999999987765545556789999999999864  45889999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcccCCC-CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          315 THANRQKLQQRIINEKVKLP-PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       315 ~~~~~~~~~~~i~~~~~~~p-~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      ...+.......++.....+| ...+.++.+      ||.+||..+|.+||     ++.+++.|+||..+.
T Consensus       244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~d------LI~~~L~~dPeeRP-----Sa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        244 HKANNFSQLISELKRGPDLPIKGKSKELNI------LIKNLLNLSAKERP-----SALQCLGYQIIKNVG  302 (1021)
T ss_pred             CcCCcHHHHHHHHhcCCCCCcCCCCHHHHH------HHHHHhcCChhHCc-----CHHHHhccHHHhhcC
Confidence            76654443333333333333 234555554      45569999999999     889999999998664

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.3e-44  Score=339.01  Aligned_cols=253  Identities=29%  Similarity=0.503  Sum_probs=213.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc------hhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +|.+.+.||+|+||.||+|.+..     +++.+|+|.+.......      ....+.+.+|+.++++++||||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS-----SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC-----CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            36788899999999999999875     67889999886543221      23346788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ......++||||+++++|..++...+.+++..++.++.|++.||+|||++|++||||+|+|||++.++.+||+|||+++.
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC-------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc-ccCCCCC
Q 013249          265 IDESS-------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF  336 (447)
Q Consensus       265 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~-~~~~p~~  336 (447)
                      .....       ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+... ...+|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN  235 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcc
Confidence            64211       112346889999999999888999999999999999999999999876655544444332 3345555


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      .+.++.++      |.+||+.||.+||     +++++++||||
T Consensus       236 ~~~~~~~l------i~~~l~~~p~~Rp-----~~~~il~~~~~  267 (267)
T cd06628         236 ISSEAIDF------LEKTFEIDHNKRP-----TAAELLKHPFL  267 (267)
T ss_pred             cCHHHHHH------HHHHccCCchhCc-----CHHHHhhCCCC
Confidence            66666555      4559999999999     88999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.5e-44  Score=338.71  Aligned_cols=252  Identities=29%  Similarity=0.481  Sum_probs=212.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh---cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI---IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      +|++.+.||+|+||.||+|...      +++.+|+|.+.....   ........+.+|+.+|+.++|+||+++++++.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence            4788999999999999999753      677899999875421   1234456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      +.+|+||||+.|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999876421


Q ss_pred             -------CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc---cCCCCCC
Q 013249          268 -------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFL  337 (447)
Q Consensus       268 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~---~~~p~~~  337 (447)
                             ........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+....   ..++..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF  234 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence                   111234568999999999999889999999999999999999999998766555444443331   2344455


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      +.++.+      ||.+||..||.+||     +++++++||||
T Consensus       235 ~~~~~~------~i~~~l~~~p~~Rp-----~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAID------FVTSCLTRDQHERP-----SALQLLRHDFL  265 (265)
T ss_pred             CHHHHH------HHHHHhcCCcccCC-----CHHHHhcCCCC
Confidence            555544      45569999999999     88999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.8e-44  Score=346.26  Aligned_cols=256  Identities=25%  Similarity=0.442  Sum_probs=209.3

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.++||.|+||.||+|+++.     +++.||+|.+.....  ......+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~   77 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKL-----TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK   77 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcC-----CCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence            4689999999999999999999875     778999999875432  222345678999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        78 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          78 SLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             eEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            9999999997 5888877654 5689999999999999999999999999999999999999999999999999976533


Q ss_pred             CC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc--------------
Q 013249          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------------  331 (447)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~--------------  331 (447)
                      .. ......++..|+|||++.+ ..++.++|||||||++|||++|++||...+..+....+.....              
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            22 2234567899999999875 4578899999999999999999999988776655544432111              


Q ss_pred             -----CCCC-----------CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          332 -----KLPP-----------FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       332 -----~~p~-----------~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                           .+|.           .++.+      ..+||.+||+.||.+||     +++++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~ml~~dp~~R~-----t~~eil~h~~f~~~~  293 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSD------GAELLSKLLQFEGRKRI-----SAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHH------HHHHHHHHhcCCcccCc-----CHHHHhcCccccccc
Confidence                 1111           11222      24677889999999999     889999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-44  Score=359.66  Aligned_cols=257  Identities=22%  Similarity=0.387  Sum_probs=209.6

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      .+..++|++.+.||+|+||.||+|++....+..+...||||+++...  .....+.+.+|+.+++.+ +|+||+++++++
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            44556899999999999999999998765555566789999997643  233456788999999999 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-------------------------------------------------------
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-------------------------------------------------------  209 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-------------------------------------------------------  209 (447)
                      ...+.+|+||||+.+|+|.+++...                                                       
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            9999999999999999999988642                                                       


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC---C
Q 013249          210 ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---S  271 (447)
Q Consensus       210 ---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~---~  271 (447)
                                     .++++.+++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.......   .
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                           2478889999999999999999999999999999999999999999999999987543221   1


Q ss_pred             CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc--cCCCCCCchhHHhhhhhh
Q 013249          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK--VKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~  348 (447)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.||...........+....  ...|...+.++.+++   
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li---  348 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM---  348 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH---
Confidence            12335678999999999999999999999999999997 999998765544443443332  234455566666554   


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                         .+||+.||++||     +++++.+
T Consensus       349 ---~~cl~~dp~~RP-----s~~~l~~  367 (374)
T cd05106         349 ---KMCWNLEPTERP-----TFSQISQ  367 (374)
T ss_pred             ---HHHcCCChhhCc-----CHHHHHH
Confidence               459999999999     7788765

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.1e-44  Score=352.06  Aligned_cols=253  Identities=21%  Similarity=0.390  Sum_probs=204.0

Q ss_pred             EEeeEeec--CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          114 IFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       114 ~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      ++++||+|  +||+||+++++.     +++.||+|.+..... .....+.+.+|+.+++.++||||++++++|..++.+|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP-----TGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecc-----cCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            56789999  789999999886     889999999976542 2344567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          192 LILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +||||+++|+|.+++..+  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+.......
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            999999999999998653  458999999999999999999999999999999999999999999999998654432111


Q ss_pred             --------CCCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC------
Q 013249          270 --------RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL------  333 (447)
Q Consensus       270 --------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~------  333 (447)
                              ......++..|+|||++.+  ..++.++|||||||++|||++|+.||...................      
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence                    1122356788999999976  468999999999999999999999998765544433333221110      


Q ss_pred             -C---------------------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhh
Q 013249          334 -P---------------------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAI  373 (447)
Q Consensus       334 -p---------------------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l  373 (447)
                       +                                       ..+++      ...+||.+||+.||++||     +++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~li~~~l~~dP~~Rp-----t~~el  304 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSP------HFHHFVEQCLQRNPDARP-----SASTL  304 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCH------HHHHHHHHHHhhCchhcC-----CHHHH
Confidence             0                                       00111      124678889999999999     88999


Q ss_pred             hcCCccCCCC
Q 013249          374 KHHKWFRSIN  383 (447)
Q Consensus       374 ~~h~~f~~~~  383 (447)
                      ++||||+.+.
T Consensus       305 l~~p~f~~~~  314 (327)
T cd08227         305 LNHSFFKQIK  314 (327)
T ss_pred             hcChhhhhcc
Confidence            9999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.1e-43  Score=333.80  Aligned_cols=252  Identities=29%  Similarity=0.523  Sum_probs=216.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||+|+||.||+|.++.     +++.|++|.+...... ......+.+|+.+++.++||||+++++++...+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA-----DKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC-----CCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            58899999999999999999876     7889999998765433 34456688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      |+||||+.|++|.+++...  ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++.+...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999999999774  57899999999999999999999999999999999999999999999999998876443


Q ss_pred             CC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-CCCCCchhHHhhhh
Q 013249          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLK  346 (447)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~li~  346 (447)
                      .. .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+...... ++..++.++.+   
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQ---  231 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHH---
Confidence            22 23457889999999999999999999999999999999999999988877777766655432 33344455444   


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         ++.+||+.+|++||     ++.++++|||+
T Consensus       232 ---~i~~~l~~~p~~Rp-----~~~~ll~~~~~  256 (256)
T cd08529         232 ---LIDQCLTKDYRQRP-----DTFQLLRNPSL  256 (256)
T ss_pred             ---HHHHHccCCcccCc-----CHHHHhhCCCC
Confidence               55669999999999     78999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-43  Score=340.65  Aligned_cols=259  Identities=27%  Similarity=0.415  Sum_probs=209.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||+|+||.||+|+++.     +++.||+|++..... .....+.+.+|+.++++++|+||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE-----TGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC-----CCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            479999999999999999999875     788999999875432 22233457789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99999999999888887777789999999999999999999999999999999999999999999999999998765433


Q ss_pred             -CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc----------------
Q 013249          270 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------------  331 (447)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~----------------  331 (447)
                       ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....                
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             2334568899999999876 5578999999999999999999999987766554444332110                


Q ss_pred             ---CCCCCCc-hhHHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 ---KLPPFLT-SEAHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ---~~p~~~~-~~~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         ..|.... .....     .....+|+.+||+.||++||     ++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~eil~~~~f  286 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL-----SCEELLEHPYF  286 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC-----CHHHHhcCCCC
Confidence               0111000 00000     11234678889999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-43  Score=340.25  Aligned_cols=252  Identities=27%  Similarity=0.459  Sum_probs=207.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||+|+||.||+|.+..     +++.||+|++....  .......+.+|+.++++++||||+++++.+.....
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLL-----TRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcC-----CCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence            368999999999999999999876     78899999987542  23344568889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      .++||||+++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...... 
T Consensus        74 ~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          74 ISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             EEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999999999988544    35789999999999999999999999999999999999999999999999999876443 


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH-------HHHHHHHHhcc-cCCC-CCCchh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-------QKLQQRIINEK-VKLP-PFLTSE  340 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-------~~~~~~i~~~~-~~~p-~~~~~~  340 (447)
                      .....+||..|+|||++.+..++.++|||||||++|+|++|+.||.....       ......+.... ...+ ...+.+
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK  228 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence            23456899999999999999999999999999999999999999964321       12222222221 1111 123444


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      +.      +|+.+||+.||++||     +++++++||||...+-
T Consensus       229 ~~------~li~~~l~~~P~~Rp-----~~~eil~~~~~~~~~~  261 (279)
T cd06619         229 FV------HFITQCMRKQPKERP-----APENLMDHPFIVQYND  261 (279)
T ss_pred             HH------HHHHHHhhCChhhCC-----CHHHHhcCcccccccC
Confidence            44      456669999999999     8899999999986653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.8e-43  Score=336.88  Aligned_cols=254  Identities=29%  Similarity=0.472  Sum_probs=211.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (447)
                      .+|++.+.||+|+||.||+|.+..     ++..||+|++.....  ........+.+|+.+++.++||||+++++++.. 
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD-----TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR   76 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC-----CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence            479999999999999999999876     788999999875432  123345678899999999999999999999875 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                       ...++++|||+.+++|.+++...+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus        77 ~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          77 AEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence             4678999999999999999988888999999999999999999999999999999999999999999999999998865


Q ss_pred             cCCC----CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCch
Q 013249          266 DESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTS  339 (447)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~  339 (447)
                      ....    ......++..|+|||++.+..++.++|||||||++|||++|+.||...+.......+...  ...+|...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE  236 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence            3311    122356889999999999988999999999999999999999999876554444433322  2334555566


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      .+++++       +||..+|++||     ++++|++||||+
T Consensus       237 ~~~~li-------~~~~~~p~~Rp-----~~~eil~hp~~~  265 (266)
T cd06651         237 HARDFL-------GCIFVEARHRP-----SAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHH-------HHhcCChhhCc-----CHHHHhcCcccc
Confidence            665555       37778999999     899999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=359.15  Aligned_cols=245  Identities=27%  Similarity=0.423  Sum_probs=216.9

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      .|.+..+...-++-||.|+-|.||+++.+       ++.||||+++.-          -..+++-|++|+||||+.+.++
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-------netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGV  180 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-------NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGV  180 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeecc-------CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeee
Confidence            35566666666788999999999999874       578999987532          1247788999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      |.....+|||||||..|-|+..|+....+.......+..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++
T Consensus       181 CtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  181 CTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             ecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCCCCchhH
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPFLTSEA  341 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~  341 (447)
                      .+.+......++||..|||||++.+...+.|+|||||||||||||||..||.+.+...+..-+-.+.  +..|...++.+
T Consensus       261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf  340 (904)
T KOG4721|consen  261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF  340 (904)
T ss_pred             hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence            9988777889999999999999999999999999999999999999999998876554444333333  34677888888


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +-|++.      ||+-.|.+||     ++.+|+.|
T Consensus       341 klL~Kq------cw~sKpRNRP-----SFrqil~H  364 (904)
T KOG4721|consen  341 KLLLKQ------CWNSKPRNRP-----SFRQILLH  364 (904)
T ss_pred             HHHHHH------HHhcCCCCCc-----cHHHHHHH
Confidence            888776      9999999999     78999988

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-44  Score=341.31  Aligned_cols=255  Identities=29%  Similarity=0.518  Sum_probs=215.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||.|+||.||++.++.     ++..+|+|++...   .....+.+..|+.++++++||||+++++.+.....
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE-----TGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK   76 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC-----CCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence            579999999999999999999875     6788999998653   23445668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||+++++|..++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999999999998764 57999999999999999999999999999999999999999999999999998765332


Q ss_pred             -CCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCch
Q 013249          269 -SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTS  339 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~  339 (447)
                       .......|+..|+|||++.     ...++.++|||||||++|+|++|+.||...+.......+.....   ..+..++.
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS  236 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence             2233457899999999985     34567899999999999999999999988877766666655432   22344555


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      ++.++      |.+||+.||.+||     +++++++|+||.+..
T Consensus       237 ~~~~l------i~~~l~~~p~~Rp-----s~~~il~~~~~~~~~  269 (280)
T cd06611         237 SFNDF------LKSCLVKDPDDRP-----TAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHH------HHHHhccChhhCc-----CHHHHhcChhhcccc
Confidence            55554      5569999999999     889999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-43  Score=361.49  Aligned_cols=253  Identities=23%  Similarity=0.295  Sum_probs=202.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ...|.+.+.||+|+||.||+|.+..     .++.||||....         ..+.+|+++|++++|+|||++++++...+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-----~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~  233 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD-----YPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGG  233 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC-----CCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence            4579999999999999999999876     678899996432         12467999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+|||++. ++|..++... ..+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..
T Consensus       234 ~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        234 LTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            9999999995 6888887654 5699999999999999999999999999999999999999999999999999987543


Q ss_pred             CCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC--------CHHHHHHHHHhccc---CC
Q 013249          268 SSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA--------NRQKLQQRIINEKV---KL  333 (447)
Q Consensus       268 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~--------~~~~~~~~i~~~~~---~~  333 (447)
                      ...   ....+||..|+|||++.+..++.++|||||||++|||++|..++...        ....+.+.+.....   .+
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            221   23467999999999999999999999999999999999987654221        12333333333222   12


Q ss_pred             CCCCchhH---------------------H----hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          334 PPFLTSEA---------------------H----SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       334 p~~~~~~~---------------------~----~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +......+                     .    .-....+||.+||+.||.+||     +++|+++||||++
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP-----sa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP-----SAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCc-----CHHHHhhCcccCC
Confidence            21111000                     0    001235688889999999999     8899999999974

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-43  Score=335.32  Aligned_cols=252  Identities=28%  Similarity=0.488  Sum_probs=212.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||.|+||+||+|....     ++..+|+|++.......  ..+.+.+|+.+|+.++|+||+++++.+.....
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP-----NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE   73 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC-----CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence            479999999999999999999875     67889999987644322  55678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .|+|||++.+++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++..+.
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            99999999999999999764   458999999999999999999999999999999999999999999999999988764


Q ss_pred             CCCC-----CCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-CCC----
Q 013249          267 ESSR-----SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPP----  335 (447)
Q Consensus       267 ~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-~p~----  335 (447)
                      ....     .....|+..|+|||++... .++.++|+|||||++|+|++|+.||...+..+....+...... ++.    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY  233 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccc
Confidence            3322     2345689999999998876 7899999999999999999999999877766655555544221 111    


Q ss_pred             -CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          336 -FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       336 -~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                       .++.++      .+|+.+||+.||++||     ++++|+.||||
T Consensus       234 ~~~~~~~------~~li~~~l~~~p~~Rp-----~~~~ll~~p~~  267 (267)
T cd06610         234 KKYSKSF------RKMISLCLQKDPSKRP-----TAEELLKHKFF  267 (267)
T ss_pred             ccccHHH------HHHHHHHcCCChhhCc-----CHHHHhhCCCC
Confidence             222333      3567779999999999     89999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=332.54  Aligned_cols=255  Identities=27%  Similarity=0.499  Sum_probs=213.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||.|+||.||+|.++.     +++.+++|++....   ....+.+.+|+.++++++||||+++++++.....
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA-----TGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDK   74 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC-----CCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCE
Confidence            589999999999999999999875     67789999997643   2245678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|++|||+.+++|.+++... ..+++.++..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            99999999999999998876 78999999999999999999999999999999999999999999999999999876443


Q ss_pred             C-CCCccccCCcccccccccCC---CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhh
Q 013249          269 S-RSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      . ......++..|+|||++.+.   .++.++|||||||++|+|++|+.||...+.......+.......+. ........
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  233 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK-LKDKEKWS  233 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-ccchhhhh
Confidence            2 23345788999999999876   7899999999999999999999999887766555554444222211 11111111


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCc
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW  378 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~  378 (447)
                      ....+|+.+||..||.+||     ++++++.|+|
T Consensus       234 ~~~~~li~~~l~~~p~~Rp-----t~~~il~~~~  262 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRP-----TATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHHcCCChhhCC-----CHHHHhcCCC
Confidence            2234677779999999999     8899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.6e-43  Score=334.54  Aligned_cols=254  Identities=30%  Similarity=0.505  Sum_probs=209.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      .+|++.++||+|+||.||++.++.     +++.||||.+.....  ......+.+.+|+.++++++||||+++++++.+.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   76 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD-----TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP   76 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC-----CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence            589999999999999999999875     788999999864321  1234456788999999999999999999998763


Q ss_pred             --CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                        ..+|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||+++..
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          77 MERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             CCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence              578999999999999999988888999999999999999999999999999999999999999999999999998865


Q ss_pred             cCC----CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCCCCch
Q 013249          266 DES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPFLTS  339 (447)
Q Consensus       266 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~  339 (447)
                      ...    .......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+....  ...|...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD  236 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence            321    11234568999999999998889999999999999999999999998765554444433221  123333444


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      .+.      ++|++||. +|++||     +++++++|||++
T Consensus       237 ~~~------~~i~~~l~-~p~~Rp-----~~~~il~~~~~~  265 (265)
T cd06652         237 HCR------DFLKRIFV-EAKLRP-----SADELLRHTFVH  265 (265)
T ss_pred             HHH------HHHHHHhc-ChhhCC-----CHHHHhcCcccC
Confidence            444      45556884 999999     889999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.2e-44  Score=338.88  Aligned_cols=251  Identities=28%  Similarity=0.488  Sum_probs=208.6

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.++||+|+||.||+|++..     +++.||+|+++...   ......+.+|+.+++.++||||+++++.+...+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVN-----TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcC-----CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            3478999999999999999999876     78899999987542   223345778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+.+++|.+++...+.+++.+++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998765432


Q ss_pred             C-CCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-----CCch
Q 013249          269 S-RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP-----FLTS  339 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~-----~~~~  339 (447)
                      . ......|+..|+|||++.   ...++.++|||||||++|+|++|..||...........+.......+.     .++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence            2 223457899999999985   456889999999999999999999999765544433333333222221     1223


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW  378 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~  378 (447)
                      .+      .+|+.+||..||++||     ++++|++|||
T Consensus       240 ~~------~~li~~~l~~~P~~R~-----~~~~ll~~~~  267 (267)
T cd06645         240 SF------HHFVKMALTKNPKKRP-----TAEKLLQHPF  267 (267)
T ss_pred             HH------HHHHHHHccCCchhCc-----CHHHHhcCCC
Confidence            33      3567779999999999     8899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=338.41  Aligned_cols=255  Identities=28%  Similarity=0.547  Sum_probs=217.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||.|+||.||+++++.     +++.||+|++....  .......+.+|+++++.++|+||+++++++.++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR-----TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK   73 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC-----CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence            368999999999999999999876     78899999987543  23345567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      +|+|+||+.+++|.+++... .+++..++.++.|++.||.|||+++|+||||+|+||+++.++.++|+|||+++..... 
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            99999999999999998765 8899999999999999999999999999999999999999999999999999887543 


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCC-CchhHHhhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF-LTSEAHSLLK  346 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~-~~~~~~~li~  346 (447)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++.. ++.++.    
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  228 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFK----  228 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHH----
Confidence            233456788999999999988899999999999999999999999987776665555554422 22222 444444    


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                        +++.+||..||++||     +++++++|+||.+..
T Consensus       229 --~~l~~~l~~~p~~Rp-----t~~~il~~~~~~~~~  258 (274)
T cd06609         229 --DFVSLCLNKDPKERP-----SAKELLKHKFIKKAK  258 (274)
T ss_pred             --HHHHHHhhCChhhCc-----CHHHHhhChhhcCCC
Confidence              456669999999999     889999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-43  Score=364.41  Aligned_cols=274  Identities=22%  Similarity=0.319  Sum_probs=199.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCC----------CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDG----------DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV  178 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~----------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv  178 (447)
                      .++|+++++||+|+||+||+|..+.....          ..+...+.|.+.+...........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            45899999999999999999986541110          00111111112221112233445688999999999999999


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc
Q 013249          179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (447)
Q Consensus       179 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~  253 (447)
                      ++++++...+..|+|+|++. ++|..++...     ......+++.++.||+.||.|||++|||||||||+||||+.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            99999999999999999995 5676666432     23446778899999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCC-CCCC--CHHHHHHHHHh
Q 013249          254 VMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP-FTHA--NRQKLQQRIIN  328 (447)
Q Consensus       254 ~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~p-f~~~--~~~~~~~~i~~  328 (447)
                      +||+|||+++.+....  .....+||..|+|||++.+..++.++|||||||++|||++|..+ |...  +.......+..
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            9999999998765432  23356899999999999999999999999999999999998754 4322  22222222222


Q ss_pred             cc----cCCCCC---------------CchhHHhhh-------hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          329 EK----VKLPPF---------------LTSEAHSLL-------KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       329 ~~----~~~p~~---------------~~~~~~~li-------~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      ..    ..+|..               .......++       ...++|.+||++||++||     +++|++.||||.+.
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp-----sa~elL~hp~f~~~  460 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP-----GAAELLALPLFSAE  460 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc-----CHHHHhhChhhhcC
Confidence            11    111110               000111111       123568889999999999     88999999999988


Q ss_pred             ChhHHH
Q 013249          383 NWKTLE  388 (447)
Q Consensus       383 ~~~~~~  388 (447)
                      ..+.+.
T Consensus       461 ~~~~~~  466 (501)
T PHA03210        461 EEEEIL  466 (501)
T ss_pred             CchHHH
Confidence            766653

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-43  Score=337.47  Aligned_cols=251  Identities=27%  Similarity=0.464  Sum_probs=208.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++....   ......+.+|+.++++++||||+++++++....
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLH-----TGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECC-----CCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            4579999999999999999999876     77899999987542   233456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+.+++|.+++...+.+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+...
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-----CCch
Q 013249          269 S-RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP-----FLTS  339 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~-----~~~~  339 (447)
                      . ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||...+..+....+.......+.     .++.
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence            2 233457899999999985   345788999999999999999999999765544333333222222221     1233


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW  378 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~  378 (447)
                      ++      .+||.+||+.||++||     ++++|++|+|
T Consensus       240 ~~------~~li~~~l~~~P~~Rp-----~~~~il~~l~  267 (267)
T cd06646         240 TF------HNFVKISLTKNPKKRP-----TAERLLTHLF  267 (267)
T ss_pred             HH------HHHHHHHhhCChhhCc-----CHHHHhcCCC
Confidence            33      4567779999999999     8899999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.3e-43  Score=338.01  Aligned_cols=252  Identities=31%  Similarity=0.521  Sum_probs=211.4

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |++.+.||+|+||.||++.++.     ++..+++|.+....   ....+.+.+|+.+++.++||||+++++.+......|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   78 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE-----TGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   78 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC-----CCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence            6888999999999999999876     67889999986532   334556788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-C
Q 013249          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-S  269 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-~  269 (447)
                      +||||+.+++|..++.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... .
T Consensus        79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            99999999999888765 467999999999999999999999999999999999999999999999999998765332 2


Q ss_pred             CCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCchhH
Q 013249          270 RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEA  341 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~  341 (447)
                      ......|+..|+|||++.     +..++.++|||||||++|||++|+.||...+..+....+.....   ..|..++.++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence            234467899999999984     34578899999999999999999999988777666655554322   2233455555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .+      ||.+||+.||.+||     +++++++||||...
T Consensus       239 ~~------li~~~l~~~p~~Rp-----~~~~il~~~~~~~~  268 (282)
T cd06643         239 KD------FLKKCLEKNVDARW-----TTTQLLQHPFVTVN  268 (282)
T ss_pred             HH------HHHHHccCChhhCc-----CHHHHhcCCCEecc
Confidence            54      45569999999999     88999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-43  Score=355.15  Aligned_cols=257  Identities=24%  Similarity=0.372  Sum_probs=206.4

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      .+..++|++.++||+|+||.||+|++.+.....++..||||+++...  .....+.+.+|+.+|+.+ +||||+++++++
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            34456899999999999999999987554444467789999987543  223345688899999999 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC------------------------------------------------------
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQG------------------------------------------------------  210 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~------------------------------------------------------  210 (447)
                      ...+..|+||||++||+|.+++....                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            99999999999999999999886532                                                      


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          211 ---------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       211 ---------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                                           .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                                 46788899999999999999999999999999999999999999999999998764322


Q ss_pred             C---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH-HHHHHHhcc-cCCCCCCchhHHh
Q 013249          270 R---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK-LQQRIINEK-VKLPPFLTSEAHS  343 (447)
Q Consensus       270 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~-~~~~i~~~~-~~~p~~~~~~~~~  343 (447)
                      .   .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..+.+..+. ...|...+.++.+
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  348 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD  348 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence            1   112345678999999999999999999999999999998 999997765443 333333321 2234445555554


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                            |+.+||+.||++||     ++.+|++
T Consensus       349 ------li~~cl~~dP~~RP-----s~~eil~  369 (375)
T cd05104         349 ------IMKSCWDADPLKRP-----TFKQIVQ  369 (375)
T ss_pred             ------HHHHHccCChhHCc-----CHHHHHH
Confidence                  45569999999999     7788875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3e-43  Score=338.36  Aligned_cols=251  Identities=29%  Similarity=0.485  Sum_probs=204.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||.|+||.||+|+++.     +++.||+|++..... .......+.+|+.+++.++||||+++++++..+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK-----TGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC-----CCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            58999999999999999999875     788999999875432 233345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      |+||||+. ++|..++...   ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            99999997 5787877543   4689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc--------------
Q 013249          268 SSR-SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------------  331 (447)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~--------------  331 (447)
                      ... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....              
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence            221 233467899999999875 4578899999999999999999999987765444333322110              


Q ss_pred             ----CCC-----------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 ----KLP-----------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ----~~p-----------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                          .++           ..++.++      .+||.+||+.||.+||     ++++|+.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~l~~dP~~Rp-----t~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDG------LDLLEKMLIYDPAKRI-----SAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHH------HHHHHHHhcCChhhCC-----CHHHHhcCCCC
Confidence                001           1122222      3677789999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.4e-43  Score=330.46  Aligned_cols=252  Identities=28%  Similarity=0.499  Sum_probs=218.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||+|+||.||+|.++.     +++.+|+|.+..... .......+.+|+.+|++++||||+++++.+...+.+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA-----DQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC-----CCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            58999999999999999999876     788999999976543 234456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-cEEEeecCCcccccC
Q 013249          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDE  267 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~~kL~DFG~a~~~~~  267 (447)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||++.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999999999999764  3589999999999999999999999999999999999998654 589999999988765


Q ss_pred             CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhhh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  346 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~  346 (447)
                      ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..... .++...+.++.+++ 
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li-  233 (256)
T cd08220         155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLI-  233 (256)
T ss_pred             CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHH-
Confidence            5555556789999999999988899999999999999999999999988877776666655432 34555666666554 


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                           .+||..||.+||     +++++++||||
T Consensus       234 -----~~~l~~~p~~Rp-----t~~~ll~~p~~  256 (256)
T cd08220         234 -----LSMLNLDPSKRP-----QLSQIMAQPIC  256 (256)
T ss_pred             -----HHHccCChhhCC-----CHHHHhhCCCC
Confidence                 459999999999     88999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-43  Score=339.55  Aligned_cols=256  Identities=21%  Similarity=0.382  Sum_probs=215.9

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++++.||+|+||.||+|.............+|+|.+....  .......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            345899999999999999999998764433455789999987542  233456688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~  251 (447)
                      ...|++|||+++++|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999999765                457889999999999999999999999999999999999999


Q ss_pred             CcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHH
Q 013249          252 GHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  327 (447)
Q Consensus       252 ~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~  327 (447)
                      +.+||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999998653221   1234457889999999998889999999999999999998 999999888888877776


Q ss_pred             hccc-CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          328 NEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       328 ~~~~-~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .... ..|..++.++.+++..      ||+.||.+||     ++++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~l~~~------c~~~~p~~Rp-----~~~~i~~~  279 (283)
T cd05048         241 SRQLLPCPEDCPARVYALMIE------CWNEIPARRP-----RFKDIHTR  279 (283)
T ss_pred             cCCcCCCcccCCHHHHHHHHH------HccCChhhCc-----CHHHHHHH
Confidence            5543 3455667777666554      9999999999     78888864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-43  Score=339.65  Aligned_cols=254  Identities=26%  Similarity=0.492  Sum_probs=210.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||+|.+....  .......+.+|+.++++++|+||+++++.+...+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP-----TGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA   73 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC-----CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence            379999999999999999999876     78899999887532  23344668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      +|+||||++|++|..++...   ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..+
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999999999998888763   379999999999999999999996 59999999999999999999999999999876


Q ss_pred             cCCCCCCccccCCcccccccccCC------CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHH---Hhc-ccCCCC
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI---INE-KVKLPP  335 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i---~~~-~~~~p~  335 (447)
                      ... ......|+..|+|||++.+.      .++.++|||||||++|+|++|+.||...........+   ... ...++.
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd06622         154 VAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS  232 (286)
T ss_pred             cCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc
Confidence            432 23345688999999998643      3588999999999999999999999765554443332   222 233455


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .++.++.++      |.+||+.||++||     ++++++.||||...
T Consensus       233 ~~~~~~~~l------i~~~l~~~p~~Rp-----~~~~l~~~~~~~~~  268 (286)
T cd06622         233 GYSDDAQDF------VAKCLNKIPNRRP-----TYAQLLEHPWLVKY  268 (286)
T ss_pred             ccCHHHHHH------HHHHcccCcccCC-----CHHHHhcChhhhhc
Confidence            566666555      5559999999999     88999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.1e-43  Score=338.05  Aligned_cols=254  Identities=42%  Similarity=0.783  Sum_probs=225.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (447)
                      ++|++.+.||+|+||.||++..+.     +++.||+|++.+.........+.+.+|..++++++ ||||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE-----TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC-----CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence            479999999999999999999876     78899999998765544555567889999999998 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+.+++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998865432


Q ss_pred             C---------------------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHH
Q 013249          269 S---------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII  327 (447)
Q Consensus       269 ~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~  327 (447)
                      .                     ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.....+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            2                     1223467899999999998889999999999999999999999999888777777777


Q ss_pred             hcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCCh----hhhhcCCcc
Q 013249          328 NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGV----DAIKHHKWF  379 (447)
Q Consensus       328 ~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~----~~l~~h~~f  379 (447)
                      .....+|..++..+.+++.      +||+.||.+||     ++    +++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~li~------~~l~~~p~~R~-----~~~~~~~~ll~~~~~  280 (280)
T cd05581         236 KLEYSFPPNFPPDAKDLIE------KLLVLDPQDRL-----GVNEGYDELKAHPFF  280 (280)
T ss_pred             hcCCCCCCccCHHHHHHHH------HHhcCCHhhCC-----CcccCHHHHhcCCCC
Confidence            7777788777777766555      49999999999     77    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=342.62  Aligned_cols=252  Identities=25%  Similarity=0.465  Sum_probs=215.5

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |.++.+||+|+||.||+|.++.     +|+++|+|.+..+     ..++.+..|+.|+++++.|++|++|+.|.....++
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~E-----sG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW  104 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRE-----SGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW  104 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhc-----cCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence            7788899999999999999987     8999999988643     34566888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-C
Q 013249          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-S  269 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-~  269 (447)
                      +|||||..|++.+.++. ++.++|.++..+++..++||+|||...-||||||..|||++-+|+.||+|||.|..+.+. .
T Consensus       105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            99999999999999874 478999999999999999999999999999999999999999999999999999876543 3


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCchhHHhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSLLK  346 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~  346 (447)
                      ..++..||+.|||||++..-+|+.++||||||++..||..|++||.+..+......|-....   +-|..++.+..    
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~----  260 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFN----  260 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHH----
Confidence            45678999999999999999999999999999999999999999987655433322222211   11233444444    


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                        ||+++||.+.|++|-     ++-++++|+|.++..-
T Consensus       261 --DFi~~CLiK~PE~R~-----TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  261 --DFIRSCLIKKPEERK-----TALRLCEHTFIKNAPG  291 (502)
T ss_pred             --HHHHHHhcCCHHHHH-----HHHHHhhhhhhcCCCc
Confidence              456669999999998     8899999999997543

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.7e-43  Score=349.94  Aligned_cols=258  Identities=25%  Similarity=0.432  Sum_probs=208.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++.+.. ........+.+|+.++++++||||++++++|... 
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTV-----TGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK   88 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECC-----CCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence            3579999999999999999999876     78899999986532 2233445577899999999999999999998643 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                           ...|+||||+.+ +|...+...  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          89 SLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence                 357999999964 787777654  899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-------
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP-------  335 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~-------  335 (447)
                      +............|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......+.       
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            8776544445567899999999999999999999999999999999999999877765555444321111000       


Q ss_pred             ------------C----CchhH--------------HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          336 ------------F----LTSEA--------------HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       336 ------------~----~~~~~--------------~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                                  .    +....              ...-...+||.+||+.||++||     ++++++.||||+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~eiL~~~~~~  315 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI-----SVDDALQHPYIN  315 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc-----CHHHHhcChhHh
Confidence                        0    00000              0000135788889999999999     899999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.1e-43  Score=330.10  Aligned_cols=252  Identities=30%  Similarity=0.566  Sum_probs=216.7

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||+|+||.||+++.+.     +++.||+|.+...... ......+.+|+.++++++||||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE-----DGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC-----CCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            58999999999999999999875     7789999998765432 33445688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      |+||||+.+++|.+++....  .+++.++..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            99999999999999987643  5799999999999999999999999999999999999999999999999999876443


Q ss_pred             CC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhhh
Q 013249          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  346 (447)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~  346 (447)
                      .. .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+..+.. ..+...+.++.+++.
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence            22 2234688899999999988899999999999999999999999988888777777665543 244555666655554


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                            +||+.+|.+||     +++++++||||
T Consensus       235 ------~~l~~~p~~Rp-----~~~~vl~~~~~  256 (256)
T cd08218         235 ------QLFKRNPRDRP-----SVNSILEKNFI  256 (256)
T ss_pred             ------HHhhCChhhCc-----CHHHHhhCcCC
Confidence                  59999999999     89999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.2e-43  Score=339.99  Aligned_cols=255  Identities=21%  Similarity=0.328  Sum_probs=203.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCC-----------CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP  175 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp  175 (447)
                      +..++|.+.++||+|+||.||+|.++...+           ..++..||+|++....  .......+.+|+.+|.+++||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence            345689999999999999999998653211           1244579999987642  233456688999999999999


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013249          176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------IFREDQARFYTAEIVSAVSHLHKCGI  236 (447)
Q Consensus       176 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~i  236 (447)
                      ||+++++++.+.+..|+||||+.+|+|.+++....                   .+++..+..++.||+.||.|||++||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999886532                   36778899999999999999999999


Q ss_pred             eeccCCCCCcccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh--CC
Q 013249          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQ  311 (447)
Q Consensus       237 iHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--G~  311 (447)
                      +||||||+|||++.++.+||+|||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999986543221   223456789999999998889999999999999999986  67


Q ss_pred             CCCCCCCHHHHHHHHHhc--------ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhh
Q 013249          312 PPFTHANRQKLQQRIINE--------KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIK  374 (447)
Q Consensus       312 ~pf~~~~~~~~~~~i~~~--------~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~  374 (447)
                      .||...+..+....+...        ....|+..+..+.+      |+.+||..||++||     ++++|.
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------li~~cl~~~p~~RP-----s~~~i~  299 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYE------LMLQCWSRDCRERP-----SFSDIH  299 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHH------HHHHHccCCchhCc-----CHHHHH
Confidence            888877666554443221        11123344455444      55669999999999     778884

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-43  Score=340.83  Aligned_cols=251  Identities=25%  Similarity=0.450  Sum_probs=202.7

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.++||+|+||.||+|+++.     +++.||+|.+..... .......+.+|+.++++++||||+++++++.+...+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~-----~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC-----CCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            48999999999999999999886     788999999876432 223334577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      |+|+||+.+ +|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        75 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          75 TLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            999999975 67777654 5679999999999999999999999999999999999999999999999999998654322


Q ss_pred             C-CCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCC-CCCCHHHHHHHHHhccc--------------C
Q 013249          270 R-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKV--------------K  332 (447)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf-~~~~~~~~~~~i~~~~~--------------~  332 (447)
                      . .....++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+....+.....              .
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            2 2345678999999998764 4789999999999999999988885 44444444444332110              0


Q ss_pred             ---CC------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          333 ---LP------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       333 ---~p------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         ++            +.++.++      .+||.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~l~~~P~~R~-----t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTG------RDLLQNLLVCNPVQRI-----SAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHH------HHHHHHHhcCChhhcC-----CHHHHhcCCCC
Confidence               00            1122222      4677779999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.8e-43  Score=337.57  Aligned_cols=254  Identities=27%  Similarity=0.477  Sum_probs=214.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ..+|++.+.||.|+||.||++.+..     +++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+....
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVA-----TGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcC-----CCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            3579999999999999999998875     78899999987543   233456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+.+++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999999999999988865 46899999999999999999999999999999999999999999999999998865433


Q ss_pred             CC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc---cCCCCCCchhHHhh
Q 013249          269 SR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~l  344 (447)
                      .. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+....   ...+..++..+.+ 
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  247 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD-  247 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH-
Confidence            22 234578999999999998889999999999999999999999998877665544444322   1233345555544 


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                           ||.+||..||++||     ++++++.||||+..
T Consensus       248 -----li~~~l~~dp~~Rp-----t~~~il~~~~~~~~  275 (296)
T cd06655         248 -----FLNRCLEMDVEKRG-----SAKELLQHPFLKLA  275 (296)
T ss_pred             -----HHHHHhhcChhhCC-----CHHHHhhChHhhhc
Confidence                 45569999999999     88999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-42  Score=328.90  Aligned_cols=252  Identities=31%  Similarity=0.514  Sum_probs=217.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|+++++||.|+||.||.++...     +++.+++|.+..... .......+.+|++++++++|+||+++++++.+.+.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE-----DDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC-----CCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            58999999999999999999875     788899999876543 234455678999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      ++||||+++++|.+++.+.  ..+++.++..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999999999999775  46899999999999999999999999999999999999999999999999999876443


Q ss_pred             C-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-CCCCchhHHhhhh
Q 013249          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PPFLTSEAHSLLK  346 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~-p~~~~~~~~~li~  346 (447)
                      . ......|+..|+|||++.+..++.++||||||+++|||++|..||...+..+....+..+.... +...+.++.+   
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELIS---  231 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHH---
Confidence            3 2345678999999999998889999999999999999999999999888888777776654332 2334455444   


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         |+.+||..||.+||     +++++++|+|+
T Consensus       232 ---~i~~~l~~~p~~R~-----s~~~ll~~~~l  256 (256)
T cd08221         232 ---LVHSLLQQDPEKRP-----TADEVLDQPLL  256 (256)
T ss_pred             ---HHHHHcccCcccCC-----CHHHHhhCcCC
Confidence               55569999999999     88999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.5e-43  Score=334.44  Aligned_cols=254  Identities=20%  Similarity=0.295  Sum_probs=209.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +...+|++.+.||+|+||.||++.++...  ..+..||+|.++...  .......+.+|+.++++++||||+++++++..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~--~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   77 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPS--KRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR   77 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCC--CceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence            34568999999999999999999875321  256789999987642  23334568889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      ++..|+||||+.+|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||.+...
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999999999998774 57899999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCCC--CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhH
Q 013249          266 DESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEA  341 (447)
Q Consensus       266 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~  341 (447)
                      ......  ....++..|+|||++.+..++.++|||||||++|||++ |..||...+..++...+.... ...|...+..+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL  237 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            322111  12345678999999999999999999999999999775 999999888887777765542 23344455555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++      +.+||+.+|.+||     ++++|++
T Consensus       238 ~~l------i~~c~~~~p~~RP-----~~~~i~~  260 (266)
T cd05064         238 HQL------MLDCWQKERGERP-----RFSQIHS  260 (266)
T ss_pred             HHH------HHHHcCCCchhCC-----CHHHHHH
Confidence            544      5559999999999     7788765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.4e-43  Score=334.78  Aligned_cols=254  Identities=26%  Similarity=0.467  Sum_probs=210.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc---chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      +|+..+.||+|+||.||++.++.     +++.||+|++......   .....+.+.+|+.++++++|+||+++++++.+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK-----TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC-----CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence            47888999999999999998865     7889999998754321   123456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-cEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~~kL~DFG~a~~~~  266 (447)
                      +.+++||||+.|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||.+....
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999999998888899999999999999999999999999999999999998776 59999999988764


Q ss_pred             CCC-----CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHh-----cccCCCCC
Q 013249          267 ESS-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----EKVKLPPF  336 (447)
Q Consensus       267 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~-----~~~~~p~~  336 (447)
                      ...     ......|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+..     ....+|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            321     12235688999999999988899999999999999999999999965443222222221     12234444


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      .+.++.+      |+.+||..||.+||     ++.++++||||.
T Consensus       236 ~~~~~~~------~i~~~l~~~p~~R~-----~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRD------VTLRCLELQPEDRP-----PSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHH------HHHHHcCCCcccCc-----CHHHHhcCcccC
Confidence            5555554      45569999999999     889999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.7e-43  Score=329.71  Aligned_cols=253  Identities=32%  Similarity=0.526  Sum_probs=214.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      +|+..+.||+|+||.||+|..+.     +++.|++|.+.....  ..+...+.+.+|+.+++.++|+||+++++++....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD-----DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC-----CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence            47778999999999999999875     678899999875432  22345567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCccccCCcccccccccCCC-CCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHh--cccCCCCCCchhHHhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li  345 (447)
                      .......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||...........+..  ....++..++.++.++ 
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-  234 (258)
T cd06632         156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF-  234 (258)
T ss_pred             ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHH-
Confidence            4345567899999999998776 89999999999999999999999977665444444433  2223445555665554 


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                           +.+||+.+|.+||     ++++++.|||+
T Consensus       235 -----i~~~l~~~p~~Rp-----~~~~~l~~~~~  258 (258)
T cd06632         235 -----ILKCLQRDPSLRP-----TAAELLEHPFV  258 (258)
T ss_pred             -----HHHHhhcCcccCc-----CHHHHhcCCCC
Confidence                 5559999999999     88999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.5e-43  Score=337.94  Aligned_cols=254  Identities=27%  Similarity=0.472  Sum_probs=211.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ..+|++.+.||+|+||.||++.++.     +++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++.+....
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECC-----CCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            4589999999999999999999875     778999999876432   22356788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      ..|+||||+.|++|..++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999999999998864 46899999999999999999999999999999999999999999999999998865432


Q ss_pred             C-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCchhHHhh
Q 013249          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~l  344 (447)
                      . ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.....   ..+..++..+.  
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--  247 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR--  247 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH--
Confidence            2 22345789999999999988899999999999999999999999987765443333332211   12233334433  


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                          +|+.+||..||++||     +++++++|+||...
T Consensus       248 ----~li~~~l~~~p~~Rp-----t~~eil~~~~~~~~  276 (296)
T cd06654         248 ----DFLNRCLDMDVEKRG-----SAKELLQHQFLKIA  276 (296)
T ss_pred             ----HHHHHHCcCCcccCc-----CHHHHhhChhhhcc
Confidence                456679999999999     88999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-42  Score=333.73  Aligned_cols=258  Identities=25%  Similarity=0.435  Sum_probs=204.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHH-HHhcCCCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~  188 (447)
                      ++|++.+.||+|+||.||+++++.     +++.||+|.++.... ..... .+..|+.+ ++..+||||+++++++...+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~   73 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP-----TGTIMAVKRIRATVN-SQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREG   73 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC-----CCcEEEEEEEecCCC-cHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence            479999999999999999999886     789999999876532 22222 34445554 66778999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .+|+||||++ |+|..++..    ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            9999999996 577666653    24689999999999999999999997 99999999999999999999999999998


Q ss_pred             cccCCCCCCccccCCcccccccccC----CCCCCccceeehhHhHHHHhhCCCCCCCC-CHHHHHHHHHh-cccCCCC-C
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLS----KGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIIN-EKVKLPP-F  336 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~i~~-~~~~~p~-~  336 (447)
                      ............|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||... ...+....+.. ....+|. .
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd06617         153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK  232 (283)
T ss_pred             ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence            7654433344678999999999865    45788999999999999999999999643 22222223222 2223332 3


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      ++.++.+      ||.+||..+|.+||     +++++++||||.......
T Consensus       233 ~~~~l~~------li~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~~~  271 (283)
T cd06617         233 FSPEFQD------FVNKCLKKNYKERP-----NYPELLQHPFFELHLSKN  271 (283)
T ss_pred             cCHHHHH------HHHHHccCChhhCc-----CHHHHhcCchhhhccccc
Confidence            4555544      55569999999999     889999999999876553

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8e-43  Score=335.78  Aligned_cols=253  Identities=29%  Similarity=0.520  Sum_probs=211.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|+++... ......+.+.+|++++++++|+||+++++.+...+.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA-----TGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC-----CCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            379999999999999999999876     67899999987543 233445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||+.++.+..+..+...+++.++..++.||+.||.|||++||+||||+|+||++++++.+||+|||++.......
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99999999988777777666779999999999999999999999999999999999999999999999999998765433


Q ss_pred             --CCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---------------
Q 013249          270 --RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------------  331 (447)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---------------  331 (447)
                        ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+.....               
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence              33456788999999999887 889999999999999999999999987665544433322110               


Q ss_pred             ----C-------------CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 ----K-------------LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ----~-------------~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                          .             ++..++.++      .+||.+||..||++||     +++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~l~~~p~~Rp-----s~~~il~~~~f  288 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPA------LDFLKACLRMDPKERL-----TCDELLQHPYF  288 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHH------HHHHHHHhccCchhcc-----cHHHHhcCCCC
Confidence                1             111122233      4567779999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.3e-43  Score=337.48  Aligned_cols=253  Identities=30%  Similarity=0.482  Sum_probs=209.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||+|+||.||+|.++.     +++.||+|.+.+... .....+.+.+|+++++.++||||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE-----TGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC-----CCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            479999999999999999999875     678999999876432 22344567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      .|+||||++++.|..+......+++.+++.++.||+.||.|||+.||+|+||+|+||++++++.+||+|||++..+....
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99999999999998877776779999999999999999999999999999999999999999999999999988754322


Q ss_pred             -CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--------------
Q 013249          270 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--------------  333 (447)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~--------------  333 (447)
                       ......++..|+|||++.+ ..++.++|||||||++|||++|++||...+..+....+......+              
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence             2334568899999999875 457889999999999999999999998766555444433211111              


Q ss_pred             -----C------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          334 -----P------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       334 -----p------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                           +            +.++..      ..+|+.+||+.||++||     +++++++|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~~l~~~P~~Rp-----~~~~il~~~~~  286 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGL------VLDLAKQCLRIDPDDRP-----SSSQLLHHEFF  286 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHH------HHHHHHHHhcCCcccch-----hHHHHhcCCCC
Confidence                 1            011222      34677789999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=346.40  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=198.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      ++|.-..+||+|+||.||+|...      .+..||||.+.......   ...|.+|+.+|.+++|||+|+|+|+|.+.+ 
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~------~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~  145 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLS------DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGE  145 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEEC------CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence            68888899999999999999876      44889999776543211   334999999999999999999999999988 


Q ss_pred             EEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          189 KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +.+||+|||.+|+|.++|+...  .++|.+...|+.++++||+|||+..   |||||||++|||||+++++||+|||+|+
T Consensus       146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~  225 (361)
T KOG1187|consen  146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK  225 (361)
T ss_pred             eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence            5999999999999999998765  8999999999999999999999854   9999999999999999999999999997


Q ss_pred             cccC-CCCCCcc-ccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC------HHHHHHHHHhcccCCCC
Q 013249          264 EIDE-SSRSNSM-CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN------RQKLQQRIINEKVKLPP  335 (447)
Q Consensus       264 ~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~------~~~~~~~i~~~~~~~p~  335 (447)
                      .... ....... .||.+|+|||++.....+.++|||||||+|+||++|+.+.+...      ..+......... .+..
T Consensus       226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~e  304 (361)
T KOG1187|consen  226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLRE  304 (361)
T ss_pred             cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhh
Confidence            6554 3333333 89999999999999889999999999999999999998886432      122222222221 1111


Q ss_pred             CCchh--------HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhh
Q 013249          336 FLTSE--------AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAI  373 (447)
Q Consensus       336 ~~~~~--------~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l  373 (447)
                      .+++.        ...+.+...+..+|++.+|.+||     +..++
T Consensus       305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP-----~m~~V  345 (361)
T KOG1187|consen  305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERP-----TMSQV  345 (361)
T ss_pred             eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCc-----CHHHH
Confidence            11111        12333445678899999999999     55554

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.2e-43  Score=331.04  Aligned_cols=249  Identities=26%  Similarity=0.491  Sum_probs=211.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||.|+||.||+|+++.     +++.+++|.+.....     .+.+.+|++++++++|+||+++++.+.....
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   72 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE-----TGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTD   72 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC-----CCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc
Confidence            579999999999999999999875     678999999875431     5678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+++||+.+++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999999999876 457899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCchhHHhh
Q 013249          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~l  344 (447)
                      . ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....   ..+..++.++.  
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  230 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFN--  230 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHH--
Confidence            3 23345688999999999999999999999999999999999999987665544433322211   12223334443  


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                          +||.+||+.||++||     ++++++.||||
T Consensus       231 ----~~i~~~l~~~P~~Rp-----s~~~il~~~~~  256 (256)
T cd06612         231 ----DFVKKCLVKDPEERP-----SAIQLLQHPFI  256 (256)
T ss_pred             ----HHHHHHHhcChhhCc-----CHHHHhcCCCC
Confidence                456669999999999     88999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.8e-43  Score=333.62  Aligned_cols=250  Identities=27%  Similarity=0.504  Sum_probs=205.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR-  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-  187 (447)
                      +.|++.+.||+|+||.||+|.++.     +++.||+|++....    .....+..|+.+++++ +|+||+++++++... 
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcC-----CCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            468899999999999999999876     78899999987542    2234577899999998 699999999998753 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecC
Q 013249          188 -----SKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                           ..+|+||||+.+++|..++...  ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCC
Confidence                 4689999999999999998864  468999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCC-CCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC--
Q 013249          261 LAKEIDES-SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--  332 (447)
Q Consensus       261 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~--  332 (447)
                      ++...... .......|+..|+|||++.     +..++.++|||||||++|||++|+.||...........+......  
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL  236 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence            99875432 2234567899999999986     345888999999999999999999999766655444443332211  


Q ss_pred             CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       333 ~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      .+...+.++.      +|+.+||..||.+||     ++++++.||||
T Consensus       237 ~~~~~~~~~~------~li~~~l~~~p~~Rp-----t~~~il~~~~~  272 (272)
T cd06637         237 KSKKWSKKFQ------SFIESCLVKNHSQRP-----TTEQLMKHPFI  272 (272)
T ss_pred             CCCCcCHHHH------HHHHHHcCCChhhCC-----CHHHHhhCCCC
Confidence            1122344443      556679999999999     88999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.9e-43  Score=338.85  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=210.7

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc--chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      +|++.+.||+|+||.||+|.++.     +++.||+|.+......  .......+..|+.++++++|+||+++++++.+..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE-----TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC-----CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence            48899999999999999999876     6789999999865432  1223345678999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+|+||||+ +++|..++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++....
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            999999999 899999998776 799999999999999999999999999999999999999999999999999987654


Q ss_pred             CC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-----C------
Q 013249          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-----P------  334 (447)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~-----p------  334 (447)
                      .. ......++..|+|||.+.+ ..++.++|||||||++|||++|.++|.+.+..+...++.......     +      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            32 2233457889999999865 467899999999999999999999998777666555554321000     0      


Q ss_pred             CC------CchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 PF------LTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 ~~------~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      ..      ........     -...+||.+||.+||++||     ++++++.|+||.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~e~l~~~~~~~~  288 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI-----TARQALEHPYFSND  288 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc-----CHHHHhhCccccCC
Confidence            00      00000000     1234678889999999999     88999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-42  Score=329.08  Aligned_cols=252  Identities=29%  Similarity=0.542  Sum_probs=215.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~  188 (447)
                      +|++++.||.|+||.||+|.+..     +++.+|+|++..... .....+.+..|+.+++.++||||+++++.+..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS-----DGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC-----CCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            58999999999999999999876     778899999876543 34445678889999999999999999998753  45


Q ss_pred             EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCCcccCCCCcEEEeec
Q 013249          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLH-----KCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-----~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                      .+|++|||+++++|..++..    ...+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.+||+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            78999999999999998865    367899999999999999999999     899999999999999999999999999


Q ss_pred             CCcccccCCCC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCC
Q 013249          260 GLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFL  337 (447)
Q Consensus       260 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~  337 (447)
                      |++........ .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+...+.+.+..... .++...
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd08217         155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY  234 (265)
T ss_pred             cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcccc
Confidence            99987654433 3456789999999999988899999999999999999999999998887777777665543 344455


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      +.++.++      +.+||+.+|++||     ++++|++|||+
T Consensus       235 ~~~~~~l------~~~~l~~~p~~Rp-----~~~~il~~~~~  265 (265)
T cd08217         235 SSELNEV------IKSMLNVDPDKRP-----STEELLQLPLI  265 (265)
T ss_pred             CHHHHHH------HHHHccCCcccCC-----CHHHHhhCCCC
Confidence            5555554      5559999999999     89999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-42  Score=333.71  Aligned_cols=258  Identities=28%  Similarity=0.466  Sum_probs=210.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||.|+||.||+|+++.     +++.||+|++..... .......+.+|+.++++++||||+++++++.....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC-----CCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            58999999999999999999876     688999999876542 233445688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      |+||||+ +++|.+++... ..+++.+++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9999999 99999988653 568999999999999999999999999999999999999999999999999998765432


Q ss_pred             --CCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---------------
Q 013249          270 --RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------------  331 (447)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---------------  331 (447)
                        ......|+..|+|||++.+. .++.++||||+||++|||++|.++|.+.+.......+.....               
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence              13345789999999998754 468999999999999999999999987776665555443211               


Q ss_pred             ----CCCCCCchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          332 ----KLPPFLTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       332 ----~~p~~~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                          .++.........+     -...+||.+||+.||++||     +++++++||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----~~~~~l~h~~~~  286 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL-----SAAEALRHPYFT  286 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC-----CHHHHhhCcCcC
Confidence                1111111011111     1235678889999999999     889999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-42  Score=332.00  Aligned_cols=253  Identities=28%  Similarity=0.510  Sum_probs=208.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-------chhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------KKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      +|.+.+.||.|+||.||+|..+.     +++.+|+|.++.....       .....+.+..|+.+++.++||||++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   76 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT-----TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF   76 (272)
T ss_pred             ceeecceecccCceEEEEEeecC-----CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            58889999999999999999775     6789999988642211       12234568889999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +.....+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||+++
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          77 ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             eccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC---CCCccccCCcccccccccCCC--CCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCCC
Q 013249          264 EIDESS---RSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPF  336 (447)
Q Consensus       264 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~--~~~~p~~  336 (447)
                      ......   ......|+..|+|||++....  ++.++|+||||+++|+|++|..||...+.......+...  ...++..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD  236 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence            653221   123456889999999988654  889999999999999999999999765554433333222  1222322


Q ss_pred             ----CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          337 ----LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       337 ----~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                          ++.++      .+||.+||..||++||     +++++++||||
T Consensus       237 ~~~~~~~~~------~~li~~~l~~~p~~Rp-----s~~~il~~~~~  272 (272)
T cd06629         237 VSMNLSPVA------LDFLNACFTINPDNRP-----TARELLQHPFI  272 (272)
T ss_pred             ccccCCHHH------HHHHHHHhcCChhhCC-----CHHHHhhCCCC
Confidence                23333      3456679999999999     78999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=8e-43  Score=339.25  Aligned_cols=252  Identities=24%  Similarity=0.387  Sum_probs=205.0

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCc--EEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      +..++|++.+.||+|+||.||+|.++.     ++.  .+|+|.+...  ........+.+|+.++.++ +|+||++++++
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~-----~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~   76 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGA   76 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEcc-----CCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            455789999999999999999999865     333  4577766532  2344456788899999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NIL  247 (447)
                      +...+.+|+||||+++++|.+++.+.+                .+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nil  156 (303)
T cd05088          77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  156 (303)
T ss_pred             ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEE
Confidence            999999999999999999999997543                4789999999999999999999999999999999999


Q ss_pred             cCCCCcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHH
Q 013249          248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  326 (447)
Q Consensus       248 l~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i  326 (447)
                      ++.++.+||+|||++.............++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  236 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  236 (303)
T ss_pred             ecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            99999999999999875322111222234667999999988889999999999999999998 99999888777766665


Q ss_pred             Hhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          327 INE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       327 ~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ... ....+...+.++.      +|+.+||+.||++||     ++++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~------~li~~~l~~~p~~Rp-----~~~~il~~  276 (303)
T cd05088         237 PQGYRLEKPLNCDDEVY------DLMRQCWREKPYERP-----SFAQILVS  276 (303)
T ss_pred             hcCCcCCCCCCCCHHHH------HHHHHHcCCChhhCc-----CHHHHHHH
Confidence            443 2223444455544      456669999999999     77888875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-42  Score=333.37  Aligned_cols=258  Identities=20%  Similarity=0.302  Sum_probs=210.7

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.+.||+|+||.||++.+++......+..||+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34567899999999999999999998754433456789999986532  2223455788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEE
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~k  255 (447)
                      .....++||||+.+++|.+++....          .+++..+..++.|++.||.|||++|++||||||+|||+++++.+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            9999999999999999999987532          356788999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc
Q 013249          256 LTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV  331 (447)
Q Consensus       256 L~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~  331 (447)
                      |+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            999999876533221   122345788999999998889999999999999999999 7999988887777766655432


Q ss_pred             -CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          332 -KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       332 -~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                       ..+...+..+.+      ++.+||+.||++||     ++.+++++
T Consensus       240 ~~~~~~~~~~~~~------li~~~l~~~p~~Rp-----s~~e~l~~  274 (277)
T cd05062         240 LDKPDNCPDMLFE------LMRMCWQYNPKMRP-----SFLEIISS  274 (277)
T ss_pred             CCCCCCCCHHHHH------HHHHHcCCChhhCc-----CHHHHHHH
Confidence             344445554444      56669999999999     77888763

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-42  Score=326.94  Aligned_cols=247  Identities=31%  Similarity=0.584  Sum_probs=211.7

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.++||+|+||.||+++++.     +++.||+|.++...  .....+.+.+|+.+++.++|+||+++++.+.+.+.+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN-----SDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC-----CCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            58999999999999999999876     78889999987543  233456778899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      |+||||+++++|..++...  ..+++..++.++.||+.||.|||++||+|+||||+|||+++++.++|+|||++......
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            9999999999999988653  45899999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-CCCCCchhHHhhhh
Q 013249          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLK  346 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~li~  346 (447)
                      . ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..+... ++..++..+.+   
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  230 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRS---  230 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHH---
Confidence            2 233467899999999999988999999999999999999999999988877777776655433 44555555544   


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                         ||.+||+.||++||     ++++|+.
T Consensus       231 ---li~~~l~~~P~~Rp-----~~~~il~  251 (255)
T cd08219         231 ---LIKQMFKRNPRSRP-----SATTILS  251 (255)
T ss_pred             ---HHHHHHhCCcccCC-----CHHHHhh
Confidence               45569999999999     7888876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=334.76  Aligned_cols=258  Identities=24%  Similarity=0.433  Sum_probs=203.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||.|+||.||+|.++.     +++.||+|.+.....  ......+.+|+.+++.++|+||+++++++.+..
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKL-----TGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKK   76 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcC-----CCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence            3689999999999999999999875     678999999875432  122234567999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+.+ +|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          77 TLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             eEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            99999999975 898888764 4689999999999999999999999999999999999999999999999999876432


Q ss_pred             CC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHHHHHhccc-------------
Q 013249          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINEKV-------------  331 (447)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~~~-------------  331 (447)
                      .. ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||.... ..+....+.....             
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence            11 1223457889999999875 558899999999999999999999997654 2222222221100             


Q ss_pred             ------CCCCCCchhH-------HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 ------KLPPFLTSEA-------HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ------~~p~~~~~~~-------~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                            .++......+       .......+++.+||+.||++||     ++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp-----s~~e~l~~~~f  291 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI-----SAAEAMKHPYF  291 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc-----CHHHHhcCCCC
Confidence                  0000000111       0012235788889999999999     88999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-43  Score=336.97  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=212.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++++.||+|+||+||++.++.     +++.||+|++....  .....+.+.+|+++++.++||||+++++.+...
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIP-----TGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcC-----CCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            44689999999999999999999875     67899999987542  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ..+|+||||+++++|..++.+.+.+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            9999999999999999999888889999999999999999999997 699999999999999999999999999987653


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH-----------HHHHHHHhcc-cCCC
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----------KLQQRIINEK-VKLP  334 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-----------~~~~~i~~~~-~~~p  334 (447)
                      .. .....+|+..|+|||++.+..++.++|||||||++|+|++|+.||......           +....+.... ..++
T Consensus       156 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd06620         156 NS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP  234 (284)
T ss_pred             hh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence            32 233567999999999998888999999999999999999999999765432           2222332221 1122


Q ss_pred             CC-CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 PF-LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 ~~-~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      .. ++.++      .+|+.+||+.||.+||     +++++++|+||..
T Consensus       235 ~~~~~~~~------~~li~~~l~~dp~~Rp-----t~~e~~~~~~~~~  271 (284)
T cd06620         235 SSDFPEDL------RDFVDACLLKDPTERP-----TPQQLCAMPPFIQ  271 (284)
T ss_pred             chhcCHHH------HHHHHHHhcCCcccCc-----CHHHHhcCccccc
Confidence            21 33333      3566779999999999     8899999999953

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=354.75  Aligned_cols=248  Identities=27%  Similarity=0.494  Sum_probs=211.7

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      -+||+|+||+||.|+++.     +....|||.+..+   ....++-+..|+.+-++++|.|||+++|.+..++++-|.||
T Consensus       581 vVLGKGTYG~VYA~RD~~-----tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME  652 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMD-----TQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME  652 (1226)
T ss_pred             EEeecCceeEEEeecccc-----ceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence            379999999999999986     7778999998754   24456678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC-CCCcEEEeecCCcccccC-CCC
Q 013249          196 FINGGHLFFHLYRQ-GIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDE-SSR  270 (447)
Q Consensus       196 ~~~gg~L~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~~kL~DFG~a~~~~~-~~~  270 (447)
                      -++||+|..+++.. |++  .|..+-+|.+||++||.|||++.|||||||-+||||+ -.|.+||+|||.++++.. ...
T Consensus       653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            99999999999866 677  8899999999999999999999999999999999996 578999999999998743 345


Q ss_pred             CCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCC-CHHHHHHH--HHhcccCCCCCCchhHHhhh
Q 013249          271 SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQR--IINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~--i~~~~~~~p~~~~~~~~~li  345 (447)
                      +.++.||..|||||++..  .+|+.++|||||||++.||.||++||... ++.....+  +.+..+.+|..++.+++.+|
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi  812 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI  812 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence            668899999999999985  57999999999999999999999999533 22222222  22334566777777776654


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                            .+|+.+||..||     ++.+++..||++.-
T Consensus       813 ------lrcFepd~~~R~-----sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  813 ------LRCFEPDPCDRP-----SAKDLLQDPFLQHN  838 (1226)
T ss_pred             ------HHHcCCCcccCc-----cHHHhccCcccccC
Confidence                  459999999999     78999999999754

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.3e-42  Score=332.61  Aligned_cols=252  Identities=28%  Similarity=0.485  Sum_probs=206.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (447)
                      .++|++.+.||+|+||.||+|..+.     +++.+|+|++....    .....+.+|+.+++++ +||||+++++++...
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~-----~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKK-----DGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            5689999999999999999999875     78899999986532    1234567899999998 799999999998753


Q ss_pred             -----CEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEee
Q 013249          188 -----SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (447)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~D  258 (447)
                           +.+|+||||+.|++|.+++..    ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence                 468999999999999988753    35789999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCC-CCCccccCCcccccccccCC-----CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-
Q 013249          259 FGLAKEIDESS-RSNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-  331 (447)
Q Consensus       259 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-  331 (447)
                      ||++....... ......|+..|+|||++...     .++.++|||||||++|||++|+.||...+.......+..... 
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  251 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP  251 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence            99988754322 23345789999999998643     368899999999999999999999987766555544443321 


Q ss_pred             --CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          332 --KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       332 --~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                        ..+.....++      .+||.+||+.||++||     ++.+|++||||+
T Consensus       252 ~~~~~~~~~~~l------~~li~~~l~~~p~~Rp-----s~~~il~~~~~~  291 (291)
T cd06639         252 TLLHPEKWCRSF------NHFISQCLIKDFEARP-----SVTHLLEHPFIK  291 (291)
T ss_pred             CCCcccccCHHH------HHHHHHHhhcChhhCc-----CHHHHhcCcccC
Confidence              1122233333      4567779999999999     889999999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.4e-43  Score=334.09  Aligned_cols=255  Identities=22%  Similarity=0.396  Sum_probs=213.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|.+.+.||+|+||.||+|.+........++.||+|++....  .....+.+.+|+++|+.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            345799999999999999999988654333457889999987542  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG--------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~  253 (447)
                      ...|+||||+++++|.+++...+              .+++.++..++.||+.||.|||++|++||||||+|||++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997643              4788999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 013249          254 VMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE  329 (447)
Q Consensus       254 ~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~  329 (447)
                      +||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            9999999997643221   1223456788999999999999999999999999999998 99999888888877777765


Q ss_pred             ccCC-CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          330 KVKL-PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       330 ~~~~-p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .... +...+.++.++      +.+||+.||++||     +++++++
T Consensus       241 ~~~~~~~~~~~~~~~l------i~~~l~~~p~~Rp-----~~~eil~  276 (280)
T cd05049         241 RLLQRPRTCPSEVYDI------MLGCWKRDPQQRI-----NIKDIHE  276 (280)
T ss_pred             CcCCCCCCCCHHHHHH------HHHHcCCCcccCC-----CHHHHHH
Confidence            5433 34455555554      5559999999999     7788875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=350.69  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=213.7

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |.-++.||.|+||.||-|++..     +.++||||.+....-...+..+.+..|+.+|++++|||+|.+.++|......|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~-----n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccC-----ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence            6667899999999999999886     88999999998665445555677899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      ||||||-| +-.+++.-. +++.+.++..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|.....   
T Consensus       103 LVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  103 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            99999965 555666543 6799999999999999999999999999999999999999999999999999977543   


Q ss_pred             CCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc-cCCCC-CCchhHHhhh
Q 013249          271 SNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPP-FLTSEAHSLL  345 (447)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~-~~~p~-~~~~~~~~li  345 (447)
                      .++++||+.|||||++..   +.|+-++||||||++..||.-.++|+-..|-...+.-|..+. +.++. .++..+    
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F----  254 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF----  254 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHH----
Confidence            678999999999999873   679999999999999999999999998888777666666553 33332 233333    


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                        +.|+..||++-|.+||     +.+++++|+|...
T Consensus       255 --~~Fvd~CLqKipqeRp-----tse~ll~H~fv~R  283 (948)
T KOG0577|consen  255 --RNFVDSCLQKIPQERP-----TSEELLKHRFVLR  283 (948)
T ss_pred             --HHHHHHHHhhCcccCC-----cHHHHhhcchhcc
Confidence              3466779999999999     7799999999864

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.7e-43  Score=338.04  Aligned_cols=253  Identities=27%  Similarity=0.469  Sum_probs=210.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      .+|++++.||+|+||.||++.++.     +++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++.+...+.
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIA-----TGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECC-----CCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            589999999999999999999875     788999999875432   233567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||+++++|..++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999999999998865 468999999999999999999999999999999999999999999999999988654332


Q ss_pred             C-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc---cCCCCCCchhHHhhh
Q 013249          270 R-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHSLL  345 (447)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li  345 (447)
                      . .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+....   ...|...+..+.   
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  246 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR---  246 (297)
T ss_pred             cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHH---
Confidence            2 234578999999999999889999999999999999999999997765543322222211   112233344443   


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                         +|+.+||..||++||     +++++++||||...
T Consensus       247 ---~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (297)
T cd06656         247 ---DFLNRCLEMDVDRRG-----SAKELLQHPFLKLA  275 (297)
T ss_pred             ---HHHHHHccCChhhCc-----CHHHHhcCchhccc
Confidence               456679999999999     88999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.4e-42  Score=339.09  Aligned_cols=251  Identities=27%  Similarity=0.444  Sum_probs=189.1

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEEEE
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSKLYL  192 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l  192 (447)
                      ..+||+|+||.||+|+++..   .++..||+|.+.....     ...+.+|+.+|+.++||||+++++++..  +..+|+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~---~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG---KDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC---CccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            36899999999999997642   2567899998865422     2346789999999999999999999853  567899


Q ss_pred             EEeccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc----CCCCcEEEeec
Q 013249          193 ILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDF  259 (447)
Q Consensus       193 v~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~~kL~DF  259 (447)
                      ||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9999865 677766421         248899999999999999999999999999999999999    56789999999


Q ss_pred             CCcccccCCC----CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHH---------HHHHH
Q 013249          260 GLAKEIDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------KLQQR  325 (447)
Q Consensus       260 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---------~~~~~  325 (447)
                      |+++......    ......||..|+|||++.+ ..++.++|||||||++|||++|++||......         .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            9998764322    2234578999999999976 45899999999999999999999999654321         11111


Q ss_pred             HHhcc--------------cCCCCCC---------chhHHh---------hhhhhhHHhhhccCCCCCCCCCCCCChhhh
Q 013249          326 IINEK--------------VKLPPFL---------TSEAHS---------LLKGVSFLTQLLHKDPSKRLGSGPGGVDAI  373 (447)
Q Consensus       326 i~~~~--------------~~~p~~~---------~~~~~~---------li~~~~~l~~~L~~dP~~R~~~~~~~~~~l  373 (447)
                      +....              ..++...         ......         -....++|.+||+.||.+||     +++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-----t~~e~  311 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI-----TSEQA  311 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc-----CHHHH
Confidence            11100              0000000         000000         01134678889999999999     88999


Q ss_pred             hcCCcc
Q 013249          374 KHHKWF  379 (447)
Q Consensus       374 ~~h~~f  379 (447)
                      ++||||
T Consensus       312 l~hp~f  317 (317)
T cd07867         312 LQDPYF  317 (317)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=325.93  Aligned_cols=249  Identities=55%  Similarity=1.025  Sum_probs=220.2

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (447)
                      ||.|+||.||++.++.     .++.+|+|++.+...........+..|+.++++++|+||+++++.+..+..+|+||||+
T Consensus         1 lg~G~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKD-----TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECC-----CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence            6999999999999875     67899999998876655556778899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-CCCCcccc
Q 013249          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCG  276 (447)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~~~g  276 (447)
                      .+++|.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            99999999988888999999999999999999999999999999999999999999999999999876443 23345678


Q ss_pred             CCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhcc
Q 013249          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLH  356 (447)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~  356 (447)
                      +..|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+......+|...+.++.++++      +||.
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~------~~l~  229 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLIS------GLLQ  229 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH------HHhc
Confidence            9999999999988889999999999999999999999988887777888877777788777777766555      5999


Q ss_pred             CCCCCCCCCCCCChhhhhcCCcc
Q 013249          357 KDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       357 ~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      .||++||++..  +++++.||||
T Consensus       230 ~~p~~R~~~~~--~~~l~~~~~f  250 (250)
T cd05123         230 KDPTKRLGSGG--AEEIKAHPFF  250 (250)
T ss_pred             CCHhhCCCccc--HHHHHhCCCC
Confidence            99999994321  3999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.5e-42  Score=333.17  Aligned_cols=254  Identities=22%  Similarity=0.413  Sum_probs=211.4

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ...+|.+.+.||+|+||.||++.........++..+|+|.+....   ....+.+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            446899999999999999999987543333356779999886532   33455688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcE
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG-------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~  254 (447)
                      +.+|+||||+.+++|.+++...+             .+++..++.++.||+.||+|||++||+||||||+|||+++++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999997554             48999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc
Q 013249          255 MLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK  330 (447)
Q Consensus       255 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~  330 (447)
                      ||+|||+++......   ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+..+.
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999998653321   1223345778999999999999999999999999999998 999998888877777777654


Q ss_pred             c-CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          331 V-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       331 ~-~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      . ..+...+.++.+      |+.+||+.||.+||     +++++++
T Consensus       240 ~~~~~~~~~~~l~~------li~~~l~~~p~~Rp-----t~~~v~~  274 (288)
T cd05093         240 VLQRPRTCPKEVYD------LMLGCWQREPHMRL-----NIKEIHS  274 (288)
T ss_pred             cCCCCCCCCHHHHH------HHHHHccCChhhCC-----CHHHHHH
Confidence            3 334445555544      55569999999999     7788754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2e-42  Score=327.76  Aligned_cols=246  Identities=22%  Similarity=0.404  Sum_probs=206.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+++++      .+..+|+|.+......    .+.+.+|+.+|++++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~------~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR------AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec------cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            457999999999999999999876      3457999988654321    245778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+|+||||+++|+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++....
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            999999999999999998754 5689999999999999999999999999999999999999999999999999886533


Q ss_pred             CCCC--CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHh
Q 013249          268 SSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHS  343 (447)
Q Consensus       268 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~  343 (447)
                      ....  ....++..|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+..+.. ..|...+.++. 
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  231 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVY-  231 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH-
Confidence            2221  22335668999999998899999999999999999999 9999998888887777766532 23444444443 


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                           +++.+||+.||++||     +++++++
T Consensus       232 -----~li~~c~~~~p~~Rp-----s~~~l~~  253 (256)
T cd05114         232 -----EVMYSCWHEKPEGRP-----TFAELLR  253 (256)
T ss_pred             -----HHHHHHccCCcccCc-----CHHHHHH
Confidence                 456669999999999     7788865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.2e-42  Score=326.33  Aligned_cols=252  Identities=30%  Similarity=0.549  Sum_probs=211.7

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||+|+||.||++.+..     +++.||+|++..... .....+.+..|+.+++.++|+||+++++.+...+.+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD-----TGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC-----CCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            58899999999999999998875     678999999976543 245677899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      ++|+||+.+++|.+++...+.+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999999999998887899999999999999999999999999999999999999999999999999987643322


Q ss_pred             C-----CccccCCcccccccccCCC---CCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHHHHHhc-ccCCCCCC--c
Q 013249          271 S-----NSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINE-KVKLPPFL--T  338 (447)
Q Consensus       271 ~-----~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~-~~~~p~~~--~  338 (447)
                      .     ....++..|+|||++.+..   ++.++||||||+++|+|++|+.||...+ .......+... ...+|...  +
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS  234 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence            1     2356789999999998766   8899999999999999999999997653 33333333322 22334332  4


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ..+.      +||.+||+.||.+||     ++++++.|||+
T Consensus       235 ~~~~------~li~~~l~~~p~~R~-----~~~~i~~~~~~  264 (264)
T cd06626         235 PEGK------DFLDRCLESDPKKRP-----TASELLQHPFV  264 (264)
T ss_pred             HHHH------HHHHHHccCCcccCC-----CHHHHhcCCCC
Confidence            4444      456669999999999     88999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.6e-44  Score=327.08  Aligned_cols=264  Identities=27%  Similarity=0.450  Sum_probs=207.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-CC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  188 (447)
                      ..|++++.||+|+||.||+|..+.+++. ..+.||+|.++.... .........+|+.+++.++||||+.|..+|.. +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k-r~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK-RTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcc-cchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3699999999999999999976654432 245799999876532 22233456789999999999999999999987 78


Q ss_pred             EEEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC----CcEEEeec
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDF  259 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~----~~~kL~DF  259 (447)
                      .+++++||.+. +|...++-+     ..++...++.|+.||+.|+.|||++-|+||||||.||||..+    |.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999976 777777533     458899999999999999999999999999999999999877    89999999


Q ss_pred             CCcccccCCC----CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCH---------HHHHHH
Q 013249          260 GLAKEIDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR---------QKLQQR  325 (447)
Q Consensus       260 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~---------~~~~~~  325 (447)
                      |+++.+...-    .....+-|.+|+|||.+.| ..|+.++|||++|||+.||++-++.|.+...         .+...+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999875432    2446778999999999997 5799999999999999999999999965321         234445


Q ss_pred             HHhccc-----------CCCCCCchhHHh-------------hh--------hhhhHHhhhccCCCCCCCCCCCCChhhh
Q 013249          326 IINEKV-----------KLPPFLTSEAHS-------------LL--------KGVSFLTQLLHKDPSKRLGSGPGGVDAI  373 (447)
Q Consensus       326 i~~~~~-----------~~p~~~~~~~~~-------------li--------~~~~~l~~~L~~dP~~R~~~~~~~~~~l  373 (447)
                      |.+-..           .+|.+ ...+.+             ..        .+.+||.+||++||-+|+     ++++.
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~-q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI-----ta~qA  334 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEY-QTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI-----TAEQA  334 (438)
T ss_pred             HHHHcCCCccccchhhhhCcch-HHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc-----cHHHH
Confidence            543211           12211 001111             11        146899999999999999     78999


Q ss_pred             hcCCccCCC
Q 013249          374 KHHKWFRSI  382 (447)
Q Consensus       374 ~~h~~f~~~  382 (447)
                      ++|+||..-
T Consensus       335 leh~yF~~d  343 (438)
T KOG0666|consen  335 LEHPYFTED  343 (438)
T ss_pred             hcccccccC
Confidence            999999754

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-42  Score=331.25  Aligned_cols=245  Identities=29%  Similarity=0.533  Sum_probs=199.4

Q ss_pred             CcEEEeeE--eecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013249          111 DFEIFRVV--GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (447)
Q Consensus       111 ~y~~~~~l--G~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (447)
                      +|++.+.+  |.|+||.||++..+.     +++.+|+|++.......        .|+.+...+ +||||+++++.|...
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKP-----TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcC-----CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            56666665  999999999999876     78889999987643211        122222222 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-cEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~~kL~DFG~a~~~~  266 (447)
                      +.+|+||||+++++|.+++..++.+++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            99999999999999999998888999999999999999999999999999999999999999998 99999999988654


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHH----HHHHhcccCCCCCCchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ----QRIINEKVKLPPFLTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~----~~i~~~~~~~p~~~~~~~~  342 (447)
                      ..   ....|+..|+|||++.+..++.++|||||||++|+|++|+.||.........    ..........+...+..+.
T Consensus       162 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T PHA03390        162 TP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN  238 (267)
T ss_pred             CC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence            32   2346899999999999989999999999999999999999999755433221    1111233344445566665


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++      |.+||+.||.+|++    +++++++||||++
T Consensus       239 ~l------i~~~l~~~p~~R~~----~~~~~l~h~~~~~  267 (267)
T PHA03390        239 DF------VQSMLKYNINYRLT----NYNEIIKHPFLKI  267 (267)
T ss_pred             HH------HHHHhccChhhCCc----hHHHHhcCCcccC
Confidence            55      45599999999993    3699999999974

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.2e-43  Score=344.27  Aligned_cols=259  Identities=24%  Similarity=0.410  Sum_probs=207.3

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      |.+..++|++.++||+|+||.||+|.+.+..+..+++.||+|+++...  .....+.+..|+.+++++ +|+||++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            345567899999999999999999987766555577899999987532  233445677899999999 89999999998


Q ss_pred             EEe-CCEEEEEEeccCCCChHHHHHHc-----------------------------------------------------
Q 013249          184 FQT-RSKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (447)
Q Consensus       184 ~~~-~~~~~lv~E~~~gg~L~~~l~~~-----------------------------------------------------  209 (447)
                      +.. +..++++|||+.+++|.+++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            865 45789999999999999888642                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC---CCCccccCC
Q 013249          210 --------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTT  278 (447)
Q Consensus       210 --------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~  278 (447)
                              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....   ......++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    257899999999999999999999999999999999999999999999999998763322   122345677


Q ss_pred             cccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc--cCCCCCCchhHHhhhhhhhHHhhhc
Q 013249          279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK--VKLPPFLTSEAHSLLKGVSFLTQLL  355 (447)
Q Consensus       279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~~~l~~~L  355 (447)
                      .|+|||++.+..++.++|||||||++|||++ |..||.+....+.........  ...|...+.++.      +++.+||
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~l~~~cl  313 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIY------SIMLDCW  313 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHH------HHHHHHc
Confidence            8999999999999999999999999999998 999997754433333333221  223344444444      4566699


Q ss_pred             cCCCCCCCCCCCCChhhhhcC
Q 013249          356 HKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       356 ~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.+|++||     ++++|++|
T Consensus       314 ~~~p~~RP-----s~~ell~~  329 (337)
T cd05054         314 HNNPEDRP-----TFSELVEI  329 (337)
T ss_pred             cCChhhCc-----CHHHHHHH
Confidence            99999999     78898875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-42  Score=337.41  Aligned_cols=262  Identities=26%  Similarity=0.403  Sum_probs=209.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.+.||+|+||.||+|.++.     +++.||+|+++..... ......+.+|+.++++++|+||+++++++...
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTT-----SGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGK   78 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECC-----CCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence            45689999999999999999999876     7889999998754322 22223456799999999999999999998765


Q ss_pred             --CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          188 --SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                        +.+|+||||+.+ +|..++... ..+++.+++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          79 HLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             CCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence              579999999965 787777653 6789999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-----------
Q 013249          265 IDESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----------  331 (447)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-----------  331 (447)
                      ..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+.....           
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            65432 2223346788999999875 5678999999999999999999999998888777766654211           


Q ss_pred             --------CCCCCCchhHH-----hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          332 --------KLPPFLTSEAH-----SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       332 --------~~p~~~~~~~~-----~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                              .++........     ..-...+||.+||+.||++||     +++++++||||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~-----t~~~il~h~~f~~  295 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA-----TAEEALESSYFKE  295 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc-----CHHHHhcChhhcc
Confidence                    01100000000     011234678889999999999     8899999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.3e-42  Score=326.88  Aligned_cols=256  Identities=29%  Similarity=0.533  Sum_probs=218.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||.|++|.||+|+++.     +++.|++|++.....  ......+.+|+.++++++|+||+++++++.....
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP-----TGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE   73 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence            379999999999999999999886     788999999876532  1445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++......
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          74 ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            99999999999999999888889999999999999999999999 99999999999999999999999999999876543


Q ss_pred             CCC-CccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC---CHHHHHHHHHhcc-cCCCCC-CchhHH
Q 013249          269 SRS-NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEK-VKLPPF-LTSEAH  342 (447)
Q Consensus       269 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~---~~~~~~~~i~~~~-~~~p~~-~~~~~~  342 (447)
                      ... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...   ...+....+.... ...+.. ++..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  233 (264)
T cd06623         154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR  233 (264)
T ss_pred             CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence            332 2557889999999999999999999999999999999999999766   3444444444332 223333 455555


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      ++      |.+||..+|++||     +++++++||||+..+
T Consensus       234 ~l------i~~~l~~~p~~R~-----~~~~ll~~~~~~~~~  263 (264)
T cd06623         234 DF------ISACLQKDPKKRP-----SAAELLQHPFIKKAD  263 (264)
T ss_pred             HH------HHHHccCChhhCC-----CHHHHHhCHHHHhcc
Confidence            55      5559999999999     889999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.1e-43  Score=332.48  Aligned_cols=253  Identities=29%  Similarity=0.494  Sum_probs=212.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||.|+||.||+|.++.     +++.+|+|.+.....  ......+.+|++++++++||||+++++.+.....
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD   73 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcC-----CCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence            368889999999999999999876     788999999876532  2445668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      +|+|+||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||.+.....
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999999999999876 789999999999999999999999 9999999999999999999999999999876543


Q ss_pred             CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC-----CHHHHHHHHHhcc-cCCCCC-Cchh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----NRQKLQQRIINEK-VKLPPF-LTSE  340 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~-----~~~~~~~~i~~~~-~~~p~~-~~~~  340 (447)
                      .... ...++..|+|||++.+..++.++||||||+++|+|++|..||...     ...+..+.+.... ...+.. ++.+
T Consensus       154 ~~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd06605         154 SLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD  232 (265)
T ss_pred             HHhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            2222 267899999999999999999999999999999999999999654     2233333333322 222322 4455


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +.+      ||.+||..||++||     ++.+++.||||+.
T Consensus       233 ~~~------li~~~l~~~p~~Rp-----t~~~ll~~~~~~~  262 (265)
T cd06605         233 FQD------FVNLCLIKDPRERP-----SYKELLEHPFIKK  262 (265)
T ss_pred             HHH------HHHHHcCCCchhCc-----CHHHHhhCchhhc
Confidence            544      45569999999999     8999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-42  Score=329.38  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=213.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.+.||+|+||.||++.++....+..+..||+|.+....  .......+.+|+.+|+.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4567899999999999999999998875544567889999986543  22334567789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEE
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL  256 (447)
                      ....|+||||+.+|+|.+++....          .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999986532          3678899999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-cc
Q 013249          257 TDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KV  331 (447)
Q Consensus       257 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~  331 (447)
                      +|||+++.+....   ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+..+.+... ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            9999998654322   1233456789999999998889999999999999999998 99999888887777766643 23


Q ss_pred             CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          332 KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       332 ~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+|...+.++.++      +.+||+.+|++||     ++.+++.
T Consensus       241 ~~~~~~~~~~~~l------i~~~l~~~p~~Rp-----t~~~l~~  273 (277)
T cd05032         241 DLPENCPDKLLEL------MRMCWQYNPKMRP-----TFLEIVS  273 (277)
T ss_pred             CCCCCCCHHHHHH------HHHHcCCChhhCC-----CHHHHHH
Confidence            4555666655554      5559999999999     7788875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-42  Score=347.92  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=207.4

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY  182 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~  182 (447)
                      .+.+..++|+++++||+|+||.||+|.+.+......+..||||++....  .....+.+.+|+.+|+++. ||||+++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            3455677899999999999999999998765444456679999997542  2334567889999999996 999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc-----------------------------------------------------
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-----------------------------------------------------  209 (447)
                      ++...+.+|+|||||++|+|.+++.++                                                     
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            999999999999999999999888653                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCc
Q 013249          210 -------------------------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (447)
Q Consensus       210 -------------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NI  246 (447)
                                                                 ..+++.++..++.||+.||.|||+++|+||||||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                       2367888899999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHH
Q 013249          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~  322 (447)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999999999986533221   223456788999999999999999999999999999997 9999987544333


Q ss_pred             -HHHHHhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          323 -QQRIINE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       323 -~~~i~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                       ...+... ....+...+.++.+      ++.+||+.||++||     ++.+|.+
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~l~~------li~~cl~~dP~~RP-----t~~~l~~  392 (400)
T cd05105         349 FYNKIKSGYRMAKPDHATQEVYD------IMVKCWNSEPEKRP-----SFLHLSD  392 (400)
T ss_pred             HHHHHhcCCCCCCCccCCHHHHH------HHHHHCccCHhHCc-----CHHHHHH
Confidence             3333332 22334445555544      55669999999999     6666654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.1e-42  Score=330.63  Aligned_cols=254  Identities=27%  Similarity=0.481  Sum_probs=202.8

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeC--C
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR--S  188 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~  188 (447)
                      |++.++||+|+||.||+|.++.     +++.||+|++++... ..... ...+|+.+++++. |+||+++++++.+.  +
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   73 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK-----TGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTG   73 (282)
T ss_pred             CceEeeccccccceEEEEEEcC-----CCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence            6789999999999999999875     778999999876432 22222 2346888888885 99999999999987  8


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+++||||+.+ +|.+.+... +.+++.+++.++.||+.||.|||++||+||||||+||+++. +.+||+|||+++....
T Consensus        74 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          74 RLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            99999999975 777777653 57899999999999999999999999999999999999999 9999999999987755


Q ss_pred             CCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc----------------
Q 013249          268 SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------------  330 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~----------------  330 (447)
                      ........++..|+|||++.. ..++.++|||||||++|||++|..||.+.+..+....+....                
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444445678999999998754 557889999999999999999999998877666555443211                


Q ss_pred             --cCCCCCCchhHHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          331 --VKLPPFLTSEAHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       331 --~~~p~~~~~~~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                        ..+|.........     ....++||.+||.+||++||     +++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI-----TAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc-----CHHHHhhCCCC
Confidence              1122211111111     11235678889999999999     88999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.8e-42  Score=332.22  Aligned_cols=255  Identities=27%  Similarity=0.498  Sum_probs=214.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|+.+++||.|+||.||+|.++.     ++..+|+|++....  .......+.+|+.+++.++||||+++++.+.++..+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc-----CCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            58888999999999999999875     67889999987543  234456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      |+||||+.|++|.+++.. +++++.++..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... 
T Consensus        78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999999999998864 578999999999999999999999999999999999999999999999999997754322 


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhHHhhhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~  348 (447)
                      ......++..|+|||++.+..++.++|+|||||++|||++|..||...+.......+.... ..++...+.++.      
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  230 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK------  230 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHH------
Confidence            2234568889999999998889999999999999999999999998777666555443322 122223333333      


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      +++.+||+.||++||     +++++++|+||.....
T Consensus       231 ~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~  261 (277)
T cd06640         231 EFIDACLNKDPSFRP-----TAKELLKHKFIVKNAK  261 (277)
T ss_pred             HHHHHHcccCcccCc-----CHHHHHhChHhhhcch
Confidence            456679999999999     8899999999976544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.8e-42  Score=331.63  Aligned_cols=257  Identities=28%  Similarity=0.479  Sum_probs=205.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||.|+||.||+|+++.     +++.||||.+..... .......+.+|++++++++||||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC-----CCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            58999999999999999999876     788999999875432 233335678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      |+||||+. ++|..++...  ..+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++......
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999996 5788888653  56899999999999999999999999999999999999999999999999998865432


Q ss_pred             C-CCCccccCCcccccccccCCC-CCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---------------
Q 013249          269 S-RSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------------  331 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---------------  331 (447)
                      . ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+......++.....               
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            2 223345788999999987644 68899999999999999999999987766554444332110               


Q ss_pred             ---CCCCCCchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 ---KLPPFLTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ---~~p~~~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         .++.........+     ....++|.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI-----SAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC-----CHHHHhcCCCC
Confidence               1111111111111     1124678889999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5e-42  Score=329.97  Aligned_cols=255  Identities=21%  Similarity=0.361  Sum_probs=209.3

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ...+|++.+.||+|+||+||+|.+...+ ...+..+|+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPG-MDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCC-CCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            3468999999999999999999864322 1256789999987532  234456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG-----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~  250 (447)
                      ...|+||||+.+++|.+++..+.                 .+++.++..++.|++.||.|||++||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            99999999999999999986432                 3788899999999999999999999999999999999999


Q ss_pred             CCcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHH
Q 013249          251 DGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  326 (447)
Q Consensus       251 ~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i  326 (447)
                      ++.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+...+.+.+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998753321   1233456778999999998889999999999999999998 99999887777766666


Q ss_pred             Hhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          327 INEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       327 ~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .... ...+..++.++.++      +.+||+.||.+||     ++.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l------i~~cl~~~p~~Rp-----~~~~i~~~  279 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSL------MTECWQEGPSRRP-----RFKDIHTR  279 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHH------HHHHcccCcccCc-----CHHHHHHH
Confidence            5443 23445556655554      5559999999999     77888764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.8e-42  Score=330.32  Aligned_cols=252  Identities=28%  Similarity=0.497  Sum_probs=203.5

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEE-
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ-  185 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-  185 (447)
                      ..++|++.+.||+|+||.||+|.++.     +++.+|+|++....    .....+.+|+.+++.+ +||||+++++++. 
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKK-----NGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECC-----CCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            45689999999999999999999876     77889999876432    1224577899999999 6999999999874 


Q ss_pred             ----eCCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEe
Q 013249          186 ----TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       186 ----~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~  257 (447)
                          .+..+|+||||++|++|.+++..    ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence                45679999999999999887753    3568999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCC-CCCccccCCcccccccccC-----CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc-
Q 013249          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-  330 (447)
Q Consensus       258 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~-  330 (447)
                      |||+++...... ......|+..|+|||++..     ..++.++|||||||++|||++|+.||...+.......+.... 
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  246 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP  246 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence            999998754322 2334578999999999853     457889999999999999999999998765544333332221 


Q ss_pred             --cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          331 --VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       331 --~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                        ...|...+.++.      +||.+||+.||++||     +++++++|+||
T Consensus       247 ~~~~~~~~~~~~~~------~li~~~l~~~p~~Rp-----s~~ell~~~~~  286 (286)
T cd06638         247 PTLHQPELWSNEFN------DFIRKCLTKDYEKRP-----TVSDLLQHVFI  286 (286)
T ss_pred             CcccCCCCcCHHHH------HHHHHHccCCcccCC-----CHHHHhhcccC
Confidence              112223334443      456669999999999     88999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=330.71  Aligned_cols=260  Identities=27%  Similarity=0.490  Sum_probs=210.6

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC--C----Ccee
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--P----FIVQ  179 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p----nIv~  179 (447)
                      .+..++|++++.+|+|+||.|..|.++.     ++..||||+++.-    ..+.+..+-|+++|+++.+  |    -+|+
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~-----~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~  155 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRE-----TKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQ  155 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecC-----CCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence            3446789999999999999999999886     6789999999743    3344566779999999943  3    3788


Q ss_pred             eeEEEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-------
Q 013249          180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------  250 (447)
Q Consensus       180 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-------  250 (447)
                      +.++|.-.+++|||+|.+ |-++++++..++  +|+..+++.+++||+.++.|||+++++|-||||||||+-.       
T Consensus       156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence            889999999999999999 779999998764  6899999999999999999999999999999999999932       


Q ss_pred             -------------CCcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC
Q 013249          251 -------------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA  317 (447)
Q Consensus       251 -------------~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~  317 (447)
                                   +..|||+|||.|+...+.  ..+.+.|..|+|||++++-+++.++||||+||||+|+.+|...|...
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                         336999999999876553  36778999999999999999999999999999999999999999766


Q ss_pred             CHHH---HHHHHHh------------------cccCCCCCCchh--------H-----------HhhhhhhhHHhhhccC
Q 013249          318 NRQK---LQQRIIN------------------EKVKLPPFLTSE--------A-----------HSLLKGVSFLTQLLHK  357 (447)
Q Consensus       318 ~~~~---~~~~i~~------------------~~~~~p~~~~~~--------~-----------~~li~~~~~l~~~L~~  357 (447)
                      +..+   +.++|+.                  +.+..|...+..        +           ..-....|||.+||.+
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            5444   4444442                  111112111111        0           0111236899999999


Q ss_pred             CCCCCCCCCCCChhhhhcCCccCCC
Q 013249          358 DPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       358 dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      ||.+|+     ++.|++.||||+..
T Consensus       393 DP~~Ri-----Tl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  393 DPARRI-----TLREALSHPFFARL  412 (415)
T ss_pred             Cccccc-----cHHHHhcCHHhhcC
Confidence            999999     89999999999754

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-42  Score=334.93  Aligned_cols=261  Identities=26%  Similarity=0.443  Sum_probs=206.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (447)
                      ++|+..++||+|+||.||++.++.     +++.+|+|.+.....  ......+.+|+.++.++. |+||+++++++....
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~   76 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKP-----SGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG   76 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECC-----CCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence            467778899999999999999886     788999999876432  234456788999999996 999999999999999


Q ss_pred             EEEEEEeccCCCChHH---HHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          189 KLYLILDFINGGHLFF---HLY--RQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~---~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      ..+++|||+.+ +|..   .+.  ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          77 DCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             cEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            99999999864 4433   222  236799999999999999999999974 9999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCC---CCCCccceeehhHhHHHHhhCCCCCCCCCH-HHHHHHHHhcc-cCCCC--
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEK-VKLPP--  335 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~-~~~p~--  335 (447)
                      +.+..........|+..|+|||++.+.   .++.++|||||||++|+|++|+.||..... .+....+.... ..++.  
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence            876544444455789999999999866   689999999999999999999999976542 11112222111 11211  


Q ss_pred             --CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHh
Q 013249          336 --FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  389 (447)
Q Consensus       336 --~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~  389 (447)
                        .++.++      .+|+.+||++||++||     ++++|++||||+...|.....
T Consensus       236 ~~~~~~~l------~~li~~~l~~~p~~Rp-----t~~~i~~~~~~~~~~~~~~~~  280 (288)
T cd06616         236 EREFSPSF------VNFINLCLIKDESKRP-----KYKELLEHPFIKDYEERNVDV  280 (288)
T ss_pred             CCccCHHH------HHHHHHHccCChhhCc-----CHHHHhcChhhhchhhcchhH
Confidence              133333      4566679999999999     889999999999877766543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7e-42  Score=330.31  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=201.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|.+.+.||+|+||.||+|.++.     +++.||+|++.....  ......+.+|+.+++.++|+||+++++++....
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   76 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI-----NGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC-----CCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence            3589999999999999999999876     678999999875432  222234668999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+. ++|...+.. ...+.+.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          77 TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9999999996 566666554 35688999999999999999999999999999999999999999999999999876432


Q ss_pred             CC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHH-HHHHHHHhccc-----------CC
Q 013249          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKV-----------KL  333 (447)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~~-----------~~  333 (447)
                      .. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.. +....+.....           .+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence            21 2234567899999999876 45788999999999999999999999765432 22222211000           00


Q ss_pred             CC--------CCchhHH-------hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          334 PP--------FLTSEAH-------SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       334 p~--------~~~~~~~-------~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      |.        .......       ......+++.+||+.||.+||     ++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~-----t~~~~l~h~~~  291 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI-----SAQDALLHPYF  291 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc-----CHHHHhcCCCC
Confidence            00        0000000       011234678889999999999     88999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5e-42  Score=326.44  Aligned_cols=249  Identities=23%  Similarity=0.378  Sum_probs=210.6

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +...+|++.+.||+|+||.||+|.++.     .++.+|+|++....    .....+.+|+++++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   73 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEec-----CCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence            455689999999999999999999876     67889999987542    224567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .+.+++||||+.+++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+|||+++++.+||+|||++..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            99999999999999999998764  3589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCC--CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchh
Q 013249          265 IDESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~  340 (447)
                      .......  ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ....+...+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (263)
T cd05052         154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK  233 (263)
T ss_pred             cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            6543221  12234568999999999999999999999999999998 99999988887777776653 34455666666


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.+++.      +||+.||++||     ++.++++
T Consensus       234 ~~~li~------~cl~~~p~~Rp-----~~~~l~~  257 (263)
T cd05052         234 VYELMR------ACWQWNPSDRP-----SFAEIHQ  257 (263)
T ss_pred             HHHHHH------HHccCCcccCC-----CHHHHHH
Confidence            666554      59999999999     7788765

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.8e-42  Score=333.42  Aligned_cols=252  Identities=28%  Similarity=0.495  Sum_probs=207.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (447)
                      ++|++.+.||.|+||.||+|.++.     +++.+|+|.++..... ......+.+|+.++++++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK-----TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC-----CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            479999999999999999999875     6788999999765432 23334567899999999999999999999877  


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ...|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus        79 ~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          79 DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             CcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            899999999975 888888765 458999999999999999999999999999999999999999999999999998765


Q ss_pred             CC-CCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-------------
Q 013249          267 ES-SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-------------  331 (447)
Q Consensus       267 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-------------  331 (447)
                      .. .......++..|+|||++.+. .++.++||||||+++|+|++|..||...+......++.....             
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            43 223345678899999998764 468899999999999999999999988776665555432211             


Q ss_pred             ------------------CCCCC-CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 ------------------KLPPF-LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ------------------~~p~~-~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                                        .++.. ++..+      .+||.+||+.||++||     ++++++.|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~l~~~p~~R~-----t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNG------FDLLNRLLTYDPAKRI-----SAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHH------HHHHHHHhccCccccC-----CHHHHhcCCCC
Confidence                              01111 12222      3567779999999999     88999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=299.35  Aligned_cols=260  Identities=26%  Similarity=0.475  Sum_probs=215.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|...++||+|.||+||+++++.     ++++||+|.++.+.. ++..-....+|+-+|+.++|.|||+++++...+..+
T Consensus         3 ~ydkmekigegtygtvfkarn~~-----t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC-----ccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            56667899999999999999886     889999999987653 334445677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      -+|+|||+. +|..+... ++.++.+.++.++.|+++||.|+|+++++||||||.|+||+.+|.+||+|||+++.++-..
T Consensus        77 tlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   77 TLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             EEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            999999964 67666653 5789999999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccC-----------CCC
Q 013249          270 R-SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK-----------LPP  335 (447)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~-----------~p~  335 (447)
                      . ....+-|.+|++|.++.+ +-|+...|+||-||++.|+.. |++.|.+.+..+...+|......           +|.
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            2 334567999999999987 458999999999999999998 99999999999888888753211           111


Q ss_pred             CC-----------chhHHhh-hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          336 FL-----------TSEAHSL-LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       336 ~~-----------~~~~~~l-i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +.           +.-...+ ..+.|++.++|.-+|.+|+     ++++.++||||.+.
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qri-----saeaalqhpyf~d~  289 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI-----SAEAALQHPYFSDF  289 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCccccc-----CHHHHhcCcccccc
Confidence            10           0001111 1346899999999999999     78999999999753

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=345.32  Aligned_cols=259  Identities=24%  Similarity=0.386  Sum_probs=216.5

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      |.+..++-.+.++||+|+||.||+|+.+..... ....||+|..+......+..+..+.+|.++|++++|||||++||+.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCc-eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            445556667789999999999999998753211 1122899998865545677788899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .....+|+|||+|.||+|.++|.+.+ .++..+...++.+.++||+|||++++|||||-.+|+|++.++.+||+|||+++
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            99999999999999999999999987 49999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCCCC-ccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccC--CCCCCch
Q 013249          264 EIDESSRSN-SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK--LPPFLTS  339 (447)
Q Consensus       264 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~  339 (447)
                      ......... ...-...|+|||.+...-|+.++|||||||++||+++ |..||.+....++..+|....++  .|...+.
T Consensus       311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~  390 (474)
T KOG0194|consen  311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPK  390 (474)
T ss_pred             CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence            754222222 1124678999999999999999999999999999999 89999999999999999665444  3444555


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +...+++      +|+..||+.|+     +..++.+
T Consensus       391 ~~~~~~~------~c~~~~p~~R~-----tm~~i~~  415 (474)
T KOG0194|consen  391 ELAKVMK------QCWKKDPEDRP-----TMSTIKK  415 (474)
T ss_pred             HHHHHHH------HhccCChhhcc-----CHHHHHH
Confidence            5555444      59999999999     5566654

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.4e-42  Score=330.51  Aligned_cols=259  Identities=26%  Similarity=0.461  Sum_probs=203.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (447)
                      ++|++.+.||+|+||.||+|.++.     +++.||||++.... ........+.+|+.+++.+. ||||+++++++....
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN-----TGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC-----CCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            479999999999999999999876     78899999986543 22233456778999999995 699999999998766


Q ss_pred             E-----EEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-CCcEEEe
Q 013249          189 K-----LYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLT  257 (447)
Q Consensus       189 ~-----~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~~kL~  257 (447)
                      .     +|+||||+.+ +|..++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence            5     8999999986 788877643     35799999999999999999999999999999999999998 8999999


Q ss_pred             ecCCcccccCC-CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC---
Q 013249          258 DFGLAKEIDES-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---  332 (447)
Q Consensus       258 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~---  332 (447)
                      |||+++.+... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......   
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99998865332 12233457889999998865 45789999999999999999999999887766655544432100   


Q ss_pred             --------------CCCCCchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          333 --------------LPPFLTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       333 --------------~p~~~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                                    ++..........     ....+||.+||..||.+||     ++++++.||||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~-----~~~eil~~~~~~  295 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI-----SAKAALTHPYFD  295 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC-----CHHHHhcCCCcC
Confidence                          111111111111     1124677789999999999     889999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.7e-42  Score=329.28  Aligned_cols=251  Identities=27%  Similarity=0.490  Sum_probs=203.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT-  186 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-  186 (447)
                      .+.|++.+.||.|+||.||+|+++.     +++.+|+|++....    .....+..|+.+++++ +|+||+++++++.. 
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcC-----CCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            3579999999999999999999876     77899999986532    2334577899999998 69999999999853 


Q ss_pred             -----CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          187 -----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                           ...+|++|||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence                 46899999999999999988753  45889999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCC-CCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-C
Q 013249          260 GLAKEIDES-SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-K  332 (447)
Q Consensus       260 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~  332 (447)
                      |++...... .......|+..|+|||++.     ...++.++|||||||++|||++|..||...........+..... .
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  245 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  245 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence            998865432 2234567899999999986     34678899999999999999999999976655443333332211 1


Q ss_pred             C-CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          333 L-PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       333 ~-p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      . +..++.++.      +||.+||..||.+||     ++.+|++||||
T Consensus       246 ~~~~~~~~~~~------~li~~cl~~~p~~Rp-----~~~ell~~~~~  282 (282)
T cd06636         246 LKSKKWSKKFI------DFIEGCLVKNYLSRP-----STEQLLKHPFI  282 (282)
T ss_pred             CcccccCHHHH------HHHHHHhCCChhhCc-----CHHHHhcCCCC
Confidence            1 112344443      456669999999999     88999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-42  Score=335.51  Aligned_cols=251  Identities=26%  Similarity=0.491  Sum_probs=208.6

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |.....||+|+||.||++.+..     ++..||||.+....   ....+.+.+|+.+++.++|+||+++++.+...+..|
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKH-----TGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECC-----CCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            4556779999999999998875     67899999986532   334456889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-C
Q 013249          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-R  270 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-~  270 (447)
                      +||||+++++|.+++.. +.+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus        96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658          96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            99999999999888754 568999999999999999999999999999999999999999999999999987653322 2


Q ss_pred             CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---CCCCchhHHhhhhh
Q 013249          271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---PPFLTSEAHSLLKG  347 (447)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~---p~~~~~~~~~li~~  347 (447)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||...+.......+.......   ....+..+.     
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  249 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR-----  249 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHH-----
Confidence            334578999999999998889999999999999999999999998877666555544322111   112333343     


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                       +|+.+||..||.+||     +++++++||||...
T Consensus       250 -~li~~~l~~~P~~Rp-----t~~~il~~~~~~~~  278 (292)
T cd06658         250 -GFLDLMLVREPSQRA-----TAQELLQHPFLKLA  278 (292)
T ss_pred             -HHHHHHccCChhHCc-----CHHHHhhChhhhcc
Confidence             456669999999999     88999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-41  Score=325.15  Aligned_cols=251  Identities=27%  Similarity=0.469  Sum_probs=204.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      +++.....||+|+||.||+++++.     ++..||+|.+....   ....+.+.+|+.+++.++|+||+++++++..++.
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLS-----TQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF   79 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecC-----CCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence            345555789999999999999875     67889999886542   2344578899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-CCcEEEeecCCcccc
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI  265 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~~kL~DFG~a~~~  265 (447)
                      +|+||||+.+++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999999999999765 455  88899999999999999999999999999999999976 679999999998765


Q ss_pred             cCCC-CCCccccCCcccccccccCC--CCCCccceeehhHhHHHHhhCCCCCCCCCHHH--HHHH-HHhcccCCCCCCch
Q 013249          266 DESS-RSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQK--LQQR-IINEKVKLPPFLTS  339 (447)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~--~~~~-i~~~~~~~p~~~~~  339 (447)
                      .... ......|+..|+|||++.+.  .++.++||||||+++|+|++|+.||.......  .... .......+|...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06624         160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA  239 (268)
T ss_pred             ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence            4322 23345688999999998754  47899999999999999999999996543221  1111 12223345556666


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ++.++      +.+||+.+|.+||     ++++++.||||
T Consensus       240 ~~~~l------i~~~l~~~p~~Rp-----t~~~ll~~~~~  268 (268)
T cd06624         240 EAKNF------ILRCFEPDPDKRA-----SAHDLLQDPFL  268 (268)
T ss_pred             HHHHH------HHHHcCCCchhCC-----CHHHHHhCCCC
Confidence            66555      5559999999999     88999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.3e-42  Score=326.07  Aligned_cols=248  Identities=27%  Similarity=0.473  Sum_probs=205.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||+|+||.||+|+++.     +++.||||.+.............+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL-----DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC-----CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence            589999999999999999999876     778999998876444445555678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .++||||+++++|..++..    ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            9999999999999888753    345899999999999999999999999999999999999999999999999998876


Q ss_pred             cCCCC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC--HHHHHHHHHhcccCCCC----CCc
Q 013249          266 DESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRIINEKVKLPP----FLT  338 (447)
Q Consensus       266 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~--~~~~~~~i~~~~~~~p~----~~~  338 (447)
                      ..... .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....  .......+...  .+|+    ..+
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  234 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEHYS  234 (267)
T ss_pred             cchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhhcC
Confidence            43221 234568899999999998889999999999999999999999996543  23444444332  2222    223


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..+      .+++.+||+.+|++||     +++++++
T Consensus       235 ~~~------~~li~~cl~~~p~~Rp-----~~~~vl~  260 (267)
T cd08228         235 EKL------RELVSMCIYPDPDQRP-----DIGYVHQ  260 (267)
T ss_pred             HHH------HHHHHHHCCCCcccCc-----CHHHHHH
Confidence            333      3566679999999999     7888886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=350.21  Aligned_cols=243  Identities=37%  Similarity=0.624  Sum_probs=211.3

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (447)
                      .++|++...+|.|+|+.|-.|.++.     +++.+++|++.+...       ...+|+.++... +||||+++++.+.++
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~-----t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~  388 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSP-----TDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDG  388 (612)
T ss_pred             chhhccccccCCCCccceeeeeccc-----cccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCC
Confidence            4678899999999999999999886     788899999987622       133566555554 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc-CCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl-~~~~~~kL~DFG~a~~~~  266 (447)
                      .+.|+|||++.|+.|.+.+.....+. .++..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++...
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            99999999999999999998877666 8888999999999999999999999999999999 699999999999999876


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH-HHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      ..  ..+.|-|..|.|||++...+|+.++||||||++||+||+|+.||..... .++..+|.....  ...+|.++++++
T Consensus       468 ~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~--s~~vS~~AKdLl  543 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF--SECVSDEAKDLL  543 (612)
T ss_pred             hh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc--ccccCHHHHHHH
Confidence            65  4455778999999999999999999999999999999999999975544 466666655433  378899988887


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      +.      ||+.||.+|+     ++.+++.||||
T Consensus       544 ~~------LL~~dP~~Rl-----~~~~i~~h~w~  566 (612)
T KOG0603|consen  544 QQ------LLQVDPALRL-----GADEIGAHPWF  566 (612)
T ss_pred             HH------hccCChhhCc-----ChhhhccCcch
Confidence            76      9999999999     78999999999

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-41  Score=331.53  Aligned_cols=254  Identities=24%  Similarity=0.373  Sum_probs=209.6

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ...|++.+.||+|+||.||++.++.     +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~   88 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH   88 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence            3469999999999999999999875     77899999987554344455567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+.| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus        89 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          89 TAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             eEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99999999975 56666543 46799999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc-cCCC-CCCchhHH
Q 013249          268 SSRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLP-PFLTSEAH  342 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~-~~~p-~~~~~~~~  342 (447)
                      .   ....|+..|+|||++.   ...++.++||||||+++|||++|+.||...+.......+.... ..++ ..++.++ 
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  243 (307)
T cd06607         168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF-  243 (307)
T ss_pred             C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH-
Confidence            2   3456888999999985   3568889999999999999999999998877666555444332 1111 1233333 


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                           .++|.+||..||++||     ++.+|+.|+||...
T Consensus       244 -----~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~  273 (307)
T cd06607         244 -----RNFVDSCLQKIPQDRP-----SSEELLKHRFVLRE  273 (307)
T ss_pred             -----HHHHHHHhcCChhhCc-----CHHHHhcChhhccc
Confidence                 4556679999999999     88999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.1e-42  Score=329.72  Aligned_cols=259  Identities=22%  Similarity=0.417  Sum_probs=213.4

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      ..+..++|++.+.||+|+||.||++.++..........+|+|.+....  .......+.+|+.+++++ +|+||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            445667899999999999999999998764433456789999987643  223345688899999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NIL  247 (447)
                      +...+.+|+||||+.+|+|..++...                +.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            99999999999999999999998643                45889999999999999999999999999999999999


Q ss_pred             cCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHH
Q 013249          248 MDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQ  323 (447)
Q Consensus       248 l~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~  323 (447)
                      ++.++.+||+|||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999987643221   122235678999999999999999999999999999998 99999988877777


Q ss_pred             HHHHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          324 QRIINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       324 ~~i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ..+.... ...+...+.++.+      |+.+||..||++||     ++++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~------li~~~l~~~p~~Rp-----s~~eil~~  287 (293)
T cd05053         245 KLLKEGYRMEKPQNCTQELYH------LMRDCWHEVPSQRP-----TFKQLVED  287 (293)
T ss_pred             HHHHcCCcCCCCCCCCHHHHH------HHHHHcccCcccCc-----CHHHHHHH
Confidence            7665543 2334444555444      56669999999999     78888864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-41  Score=328.02  Aligned_cols=261  Identities=27%  Similarity=0.408  Sum_probs=208.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  187 (447)
                      ++|+..+.||.|++|.||+|.++.     +++.+|+|.+....  .......+.+|++++++++||||++++++|..  .
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   73 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS   73 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC-----CCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence            479999999999999999999876     78899999987543  22345668889999999999999999998865  4


Q ss_pred             CEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +.+|+||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            479999999999999887653    3468999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC-----CHHHHHHHHHhcc-cCCCCCC
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----NRQKLQQRIINEK-VKLPPFL  337 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~-----~~~~~~~~i~~~~-~~~p~~~  337 (447)
                      ...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...     ...+....+.... ..++...
T Consensus       154 ~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd06621         154 ELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP  232 (287)
T ss_pred             cccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence            654322 22456788999999999999999999999999999999999999755     2233333333311 1111111


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      .....-.-...+||.+||..||.+||     ++.+++.|+||.+..
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~eil~~~~~~~~~  273 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRP-----TPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCC-----CHHHHHhCccccccc
Confidence            10000001124677789999999999     889999999997654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-42  Score=326.55  Aligned_cols=251  Identities=27%  Similarity=0.503  Sum_probs=205.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (447)
                      .++|++.+.||.|+||.||+|.++.     +++.+++|++.....    ..+.+.+|+.+++++ +|+||+++++++...
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKK-----TGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKK   75 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECC-----CCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence            4689999999999999999999875     678899999875432    335688999999999 699999999999764


Q ss_pred             C------EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEe
Q 013249          188 S------KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       188 ~------~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~  257 (447)
                      .      .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEEC
Confidence            4      58999999999999988865    3578999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCC-CCCccccCCcccccccccC-----CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc
Q 013249          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV  331 (447)
Q Consensus       258 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~  331 (447)
                      |||++....... ......|+..|+|||++..     ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            999987653322 2334568999999999864     3467889999999999999999999987665555555444322


Q ss_pred             C---CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 K---LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ~---~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      .   .+..++.++.      +||.+||..||++||     +++++++|||+
T Consensus       236 ~~~~~~~~~~~~~~------~li~~~l~~dp~~Rp-----t~~~ll~~~~~  275 (275)
T cd06608         236 PTLKSPENWSKKFN------DFISECLIKNYEQRP-----FMEELLEHPFI  275 (275)
T ss_pred             CCCCchhhcCHHHH------HHHHHHhhcChhhCc-----CHHHHhcCCCC
Confidence            1   1111333333      566679999999999     88999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=324.63  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=209.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++...  .+...||+|+++...  .......+.+|+.++++++||||+++++.+...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPG--KKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCC--CCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            468999999999999999999986421  135679999987543  2334456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+.+++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999999998764 5789999999999999999999999999999999999999999999999999987642


Q ss_pred             CCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhHH
Q 013249          268 SSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAH  342 (447)
Q Consensus       268 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~  342 (447)
                      ...   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.... ...+...+..+.
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  238 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY  238 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            111   112334678999999998899999999999999999998 999998877777777666542 233444555554


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                            +++.+||+.||++||     ++++++++
T Consensus       239 ------~li~~cl~~~p~~Rp-----~~~ei~~~  261 (266)
T cd05033         239 ------QLMLDCWQKDRNERP-----TFSQIVST  261 (266)
T ss_pred             ------HHHHHHcCCCcccCc-----CHHHHHHH
Confidence                  455669999999999     78888764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=359.29  Aligned_cols=248  Identities=26%  Similarity=0.435  Sum_probs=208.0

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  183 (447)
                      ..++..+++|.+.|.+|||+.||+|+...     .+..||+|.+-..   ++..++.+++|+++|++|. |+|||.+++.
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~-----~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yids  103 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVK-----GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDS  103 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecC-----CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence            44666689999999999999999999875     4588999998653   5777888999999999997 9999999994


Q ss_pred             EE-e------CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccCCCC
Q 013249          184 FQ-T------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDG  252 (447)
Q Consensus       184 ~~-~------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~  252 (447)
                      .. .      .-.++|.||||.||.|.+++..+  ..|+|.++++|++|+++|+.+||...  |||||||-|||||+.+|
T Consensus       104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence            32 1      13588999999999999999844  56999999999999999999999998  99999999999999999


Q ss_pred             cEEEeecCCcccccCCCCC----------CccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCH
Q 013249          253 HVMLTDFGLAKEIDESSRS----------NSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANR  319 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~~----------~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~  319 (447)
                      +.||||||.|.........          -...-|+.|+|||++.   +.+.+.|+|||+|||+||-|+....||+....
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            9999999998753222111          1123589999999985   67889999999999999999999999986532


Q ss_pred             HHHHHHHHhcccCCCC--CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          320 QKLQQRIINEKVKLPP--FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       320 ~~~~~~i~~~~~~~p~--~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                          ..|+++.+.+|+  .++..+++||+.      ||+.||.+||     ++-+++.
T Consensus       264 ----laIlng~Y~~P~~p~ys~~l~~LI~~------mL~~nP~~RP-----nI~Qv~~  306 (738)
T KOG1989|consen  264 ----LAILNGNYSFPPFPNYSDRLKDLIRT------MLQPNPDERP-----NIYQVLE  306 (738)
T ss_pred             ----eeEEeccccCCCCccHHHHHHHHHHH------HhccCcccCC-----CHHHHHH
Confidence                467888999987  467777776665      9999999999     6777665

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9e-42  Score=324.04  Aligned_cols=249  Identities=21%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|+++++||+|+||.||+|...      .+..||+|.+.....    ..+.+.+|+.+++.++|+||+++++.+.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN------NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVT   71 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec------CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            456678999999999999999999865      456799998765322    2456888999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      ..+..|+||||+.+++|.+++...  ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence            999999999999999999998754  568899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCch
Q 013249          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~  339 (447)
                      .......  .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.... ...+...+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPD  231 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            7644321  122345678999999998889999999999999999998 999998887777776665442 122233444


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.      +++.+||..||++||     +++++.+
T Consensus       232 ~~~------~li~~~l~~~p~~Rp-----~~~~i~~  256 (261)
T cd05072         232 ELY------DIMKTCWKEKAEERP-----TFDYLQS  256 (261)
T ss_pred             HHH------HHHHHHccCCcccCc-----CHHHHHH
Confidence            444      456669999999999     6777764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1e-41  Score=329.40  Aligned_cols=254  Identities=23%  Similarity=0.410  Sum_probs=210.3

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ...+|.+.+.||+|+||.||+|++.......++..+++|.+....   ....+.+.+|+.++++++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            345799999999999999999987654444456779999886532   23345688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~  251 (447)
                      ...++||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997643                37899999999999999999999999999999999999999


Q ss_pred             CcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHH
Q 013249          252 GHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  327 (447)
Q Consensus       252 ~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~  327 (447)
                      +.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            999999999997653321   1233456789999999999999999999999999999998 999998887777776665


Q ss_pred             hcccC-CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          328 NEKVK-LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       328 ~~~~~-~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..... .+...+.++.      +++.+||+.||++||     +++++++
T Consensus       240 ~~~~~~~~~~~~~~~~------~li~~~l~~~P~~Rp-----t~~~v~~  277 (291)
T cd05094         240 QGRVLERPRVCPKEVY------DIMLGCWQREPQQRL-----NIKEIYK  277 (291)
T ss_pred             CCCCCCCCccCCHHHH------HHHHHHcccChhhCc-----CHHHHHH
Confidence            54432 2334444444      456669999999999     7788765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=322.69  Aligned_cols=253  Identities=30%  Similarity=0.482  Sum_probs=212.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechh--hcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      .+|++.+.||+|+||.||++.++.     ++..||+|++....  .........+.+|+.++++++|+||+++++++.+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   76 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD-----TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP   76 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC-----CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence            479999999999999999999875     78899999875432  12234556788999999999999999999998764


Q ss_pred             --CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                        ..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++..
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          77 EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence              568999999999999999988888999999999999999999999999999999999999999999999999999865


Q ss_pred             cCC----CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCch
Q 013249          266 DES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTS  339 (447)
Q Consensus       266 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~  339 (447)
                      ...    .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+...  ...+|..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence            321    1123456899999999999988999999999999999999999999876655544444432  2345666777


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ++.+++..      ||+ +|.+||     ++.+++.|||.
T Consensus       237 ~~~~~i~~------~l~-~~~~r~-----~~~~~~~~~~~  264 (264)
T cd06653         237 ACRDFLKQ------IFV-EEKRRP-----TAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHH------Hhc-CcccCc-----cHHHHhcCCCC
Confidence            76666554      998 579999     88999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.9e-42  Score=334.61  Aligned_cols=255  Identities=22%  Similarity=0.341  Sum_probs=205.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +...+|++.+.||+|+||.||+|+++.... .....||+|+++...  .....+.+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCC-ccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            345689999999999999999999765221 123458999986432  23345668889999999999999999999876


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      . ..++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence            4 578999999999999999875 46889999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCC---CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchh
Q 013249          266 DESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (447)
Q Consensus       266 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~  340 (447)
                      ......   ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+... ....+...+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  239 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            543222   22334678999999999999999999999999999998 99999887776655443332 12233444444


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.      +++.+||..||.+||     ++.+++.+
T Consensus       240 ~~------~li~~cl~~~p~~Rp-----s~~~l~~~  264 (316)
T cd05108         240 VY------MIMVKCWMIDADSRP-----KFRELIIE  264 (316)
T ss_pred             HH------HHHHHHccCChhhCc-----CHHHHHHH
Confidence            44      456669999999999     77888875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.9e-42  Score=332.35  Aligned_cols=259  Identities=26%  Similarity=0.392  Sum_probs=203.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.++||+|+||.||+|+++.     +++.||||++..... .......+.+|+.++++++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKK-----TKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECC-----CCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            3579999999999999999999876     788999999865432 2222334567999999999999999999886543


Q ss_pred             --------EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          189 --------KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       189 --------~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                              ..|+||||+.+ +|...+... ..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence                    56999999965 777777654 37899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCC-----CCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC
Q 013249          260 GLAKEIDESSR-----SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL  333 (447)
Q Consensus       260 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~  333 (447)
                      |++........     .....++..|+|||++.+. .++.++||||||+++|||++|+.||.+.+.......+......+
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99986543221     1234678899999998764 47889999999999999999999998877655444333321111


Q ss_pred             C-------------------CCCchhHHh-------hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          334 P-------------------PFLTSEAHS-------LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       334 p-------------------~~~~~~~~~-------li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      +                   .........       .....+||.+||..||.+||     +++++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~-----t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI-----DADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc-----CHHHHhcCCCC
Confidence            1                   111000000       01234788899999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.3e-42  Score=327.53  Aligned_cols=256  Identities=22%  Similarity=0.387  Sum_probs=209.0

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|.+.+.||+|+||.||+|.++..........||+|.+....  .......+..|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            446799999999999999999998753322356789999886432  223335578899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC---cEEEe
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLT  257 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~~kL~  257 (447)
                      ...|+||||+.|++|.+++...+       .+++..+..++.||+.||.|||+++++||||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999997653       489999999999999999999999999999999999998765   59999


Q ss_pred             ecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccC
Q 013249          258 DFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVK  332 (447)
Q Consensus       258 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~  332 (447)
                      |||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999987633211   112234568999999998889999999999999999997 99999988777766665443 334


Q ss_pred             CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       333 ~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +|..++.++.+      |+.+||+.||++||     ++.++++|
T Consensus       242 ~~~~~~~~~~~------~i~~cl~~~p~~Rp-----s~~~vl~~  274 (277)
T cd05036         242 PPKGCPGPVYR------IMTDCWQHTPEDRP-----NFATILER  274 (277)
T ss_pred             CCCCCCHHHHH------HHHHHcCCCcccCc-----CHHHHHHH
Confidence            45556655554      45569999999999     78999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.7e-42  Score=364.19  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=201.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||+|+||.||+|+++.     +++.||+|++...........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~-----tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV-----CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC-----CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence            589999999999999999999876     788999999976543334445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEee
Q 013249          190 LYLILDFINGGHLFFHLYRQ-----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~D  258 (447)
                      .|+||||++||+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence            99999999999999988642           2345677889999999999999999999999999999999999999999


Q ss_pred             cCCcccccCC-------------------CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH
Q 013249          259 FGLAKEIDES-------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR  319 (447)
Q Consensus       259 FG~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~  319 (447)
                      ||+++.....                   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            9999865210                   011235799999999999999999999999999999999999999987654


Q ss_pred             HHHHHHHHh-cccCCC--CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          320 QKLQQRIIN-EKVKLP--PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       320 ~~~~~~i~~-~~~~~p--~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..+...... ......  ..++..+.      +++.+||..||++|++    +++++++
T Consensus       237 ~ki~~~~~i~~P~~~~p~~~iP~~L~------~LI~rcL~~DP~kR~s----s~eeLl~  285 (932)
T PRK13184        237 RKISYRDVILSPIEVAPYREIPPFLS------QIAMKALAVDPAERYS----SVQELKQ  285 (932)
T ss_pred             hhhhhhhhccChhhccccccCCHHHH------HHHHHHccCChhhCcC----HHHHHHH
Confidence            433322111 111111  12334443      4566799999999985    3455543

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.1e-42  Score=331.33  Aligned_cols=255  Identities=22%  Similarity=0.351  Sum_probs=212.3

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ...+|++.++||+|+||.||+|.+........++.||+|++....  .....+.+.+|+.++..++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            345688899999999999999998764444456789999997542  233446688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~  251 (447)
                      ...++++||+.+++|..++...                ..+++..+..++.|++.||.|||++||+||||||+|||++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999988532                347888899999999999999999999999999999999999


Q ss_pred             CcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHH
Q 013249          252 GHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  327 (447)
Q Consensus       252 ~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~  327 (447)
                      +.+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999886543221   223456789999999988889999999999999999998 999999888888887777


Q ss_pred             hccc-CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          328 NEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       328 ~~~~-~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .... ..+...+..+.++      +.+||+.||.+||     ++++|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~l------i~~cl~~~p~~RP-----~~~~i~~  278 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTL------MLECWNEFPSRRP-----RFKDIHS  278 (283)
T ss_pred             cCCcCCCCCCCCHHHHHH------HHHHhCCCcccCC-----CHHHHHH
Confidence            6553 3355566665554      5559999999999     7888876

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-41  Score=330.35  Aligned_cols=251  Identities=23%  Similarity=0.365  Sum_probs=204.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (447)
                      ++|++.++||+|+||.||+|..+...   ....+++|.++..  ......+.+.+|+.++.++ +||||+++++++...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG---LKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC---CcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence            58999999999999999999886521   1234788877632  2233345678899999999 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  252 (447)
                      .+|+||||+++++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence            9999999999999999997642                478899999999999999999999999999999999999999


Q ss_pred             cEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-
Q 013249          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-  330 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-  330 (447)
                      .+||+|||++..............+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.... 
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            999999999875332212222233567999999998889999999999999999997 999999888887777766542 


Q ss_pred             cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          331 VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       331 ~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ...|..++.++.++      +.+||+.||.+||     +++++++.
T Consensus       237 ~~~~~~~~~~~~~l------i~~~l~~~p~~Rp-----~~~~i~~~  271 (297)
T cd05089         237 MEKPRNCDDEVYEL------MRQCWRDRPYERP-----PFAQISVQ  271 (297)
T ss_pred             CCCCCCCCHHHHHH------HHHHcCCChhhCc-----CHHHHHHH
Confidence            23445566665554      5559999999999     77888753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.9e-42  Score=328.36  Aligned_cols=256  Identities=26%  Similarity=0.511  Sum_probs=207.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.++||.|++|.||+|+++.     +++.||||++.....  ......+.+|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT-----TGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKL   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC-----CCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence            58999999999999999999875     788999999976532  22335567899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      |+||||+.+ +|.+++...   ..+++..+..++.||+.||.|||++|++||||||+||++++++.+||+|||++.....
T Consensus        74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            999999985 788877654   3589999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc---------------
Q 013249          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------------  330 (447)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~---------------  330 (447)
                      .. ......++..|++||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            22 2234567889999999866 457889999999999999999999998877666555544321               


Q ss_pred             ---cCCCCCCchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          331 ---VKLPPFLTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       331 ---~~~p~~~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         ..+|.........+     -...+++.+||+.||.+||     +++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~-----~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI-----SAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC-----CHHHHhcCCCC
Confidence               01111111111111     1234678889999999999     88999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-41  Score=326.79  Aligned_cols=253  Identities=26%  Similarity=0.507  Sum_probs=213.4

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      -|+++++||.|+||.||+|.++.     +++.+|+|++....  .......+.+|+.++++++||||+++++++..+..+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~-----~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   77 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   77 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECC-----CCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence            37788999999999999998875     67899999986543  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      |+||||+.+++|..++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.... 
T Consensus        78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            999999999999988864 568999999999999999999999999999999999999999999999999987654322 


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~  348 (447)
                      ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..... .++...+.++.+     
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  231 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE-----  231 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHH-----
Confidence            22345688999999999888889999999999999999999999987776666655543322 233444555554     


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                       ++.+||+.+|.+||     +++++++||||...
T Consensus       232 -~i~~~l~~~p~~Rp-----~~~~~l~~~~~~~~  259 (277)
T cd06641         232 -FVEACLNKEPSFRP-----TAKELLKHKFIVRF  259 (277)
T ss_pred             -HHHHHccCChhhCc-----CHHHHHhCHHHhhh
Confidence             45569999999999     88999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.3e-43  Score=357.40  Aligned_cols=255  Identities=25%  Similarity=0.441  Sum_probs=222.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +...+.+..+.||+|+||+||+|+.-+.........||||.++...  +......|++|+++|..++|||||+|+|+|..
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            4556788899999999999999998877666678899999998754  34466789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG--------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  252 (447)
                      ++.+|+|+|||..|||.++|..+.              +++..+...|+.||+.|++||-++.+|||||-..|+||.++.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence            999999999999999999997542              278899999999999999999999999999999999999999


Q ss_pred             cEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHh
Q 013249          253 HVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN  328 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~  328 (447)
                      .|||+|||+++..-....   .....-.+.|||||.|+...++.++||||+||+|||+++ |+.||.+...+++.+.|..
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            999999999997532221   112344688999999999999999999999999999999 9999999999999999988


Q ss_pred             ccc-CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhh
Q 013249          329 EKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIK  374 (447)
Q Consensus       329 ~~~-~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~  374 (447)
                      +.. .-|...+.++..++..      ||+.+|++||     ++.||-
T Consensus       721 g~lL~~Pe~CP~~vY~LM~~------CW~~~P~~RP-----sF~eI~  756 (774)
T KOG1026|consen  721 GQLLSCPENCPTEVYSLMLE------CWNENPKRRP-----SFKEIH  756 (774)
T ss_pred             CCcccCCCCCCHHHHHHHHH------HhhcCcccCC-----CHHHHH
Confidence            765 5578888888877665      9999999999     556664

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.1e-41  Score=319.56  Aligned_cols=252  Identities=32%  Similarity=0.593  Sum_probs=217.9

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||.|+||.||++.+..     ++..||+|++..... .......+.+|+++++.++|+|++++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS-----DGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC-----CCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            58999999999999999999875     678999999876542 234556688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          191 YLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ++|+||+++++|.+++...    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            9999999999999998764    679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhh
Q 013249          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSL  344 (447)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~l  344 (447)
                      ... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+...+...+..... .+|...+.++.++
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T cd08215         155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL  234 (258)
T ss_pred             cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence            433 23345789999999999988899999999999999999999999988877777766655432 3444555565555


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                            +.+||..+|++||     ++++++.||||
T Consensus       235 ------i~~~l~~~p~~Rp-----~~~~ll~~~~~  258 (258)
T cd08215         235 ------VSSLLQKDPEERP-----SIAQILQSPFI  258 (258)
T ss_pred             ------HHHHcCCChhhCc-----CHHHHhcCCCC
Confidence                  5559999999999     88999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-41  Score=319.23  Aligned_cols=252  Identities=33%  Similarity=0.554  Sum_probs=216.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  188 (447)
                      +|.+.+.||+|++|.||+|.++.     +++.+++|++..... .....+.+.+|+.++++++|+||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD-----TGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC-----CCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            48889999999999999999875     788999999876542 245567889999999999999999999999988  8


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+++||||+.+++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+......
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999887654


Q ss_pred             CC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHHHHHh--cccCCCCCCchhHH
Q 013249          269 SR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIIN--EKVKLPPFLTSEAH  342 (447)
Q Consensus       269 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~--~~~~~p~~~~~~~~  342 (447)
                      ..   .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+ .......+..  ....+|...+.++.
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence            43   445678999999999998889999999999999999999999997765 3333333332  23344555555555


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ++      +.+||+.||++||     ++.+++.||||
T Consensus       235 ~~------i~~~l~~~p~~Rp-----~~~~ll~~~~~  260 (260)
T cd06606         235 DF------LRKCLRRDPKKRP-----TADELLQHPFL  260 (260)
T ss_pred             HH------HHHhCcCChhhCC-----CHHHHhhCCCC
Confidence            54      5559999999999     88999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-43  Score=339.71  Aligned_cols=257  Identities=29%  Similarity=0.486  Sum_probs=207.1

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~  184 (447)
                      .+....|+++++||+||.+.||++..-      ..+.||+|.+.... .+...+..+..|+.+|.+++ |.+||+||++-
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s------~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE  429 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNS------DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE  429 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecC------CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence            355668999999999999999999854      45678888775543 35666788999999999995 89999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      ..++.+|+||||= .-+|...|.+.+. ++...+++|..|++.|+.++|+.||||.||||.|+|+ -.|.+||+|||+|.
T Consensus       430 v~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~  507 (677)
T KOG0596|consen  430 VTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN  507 (677)
T ss_pred             ccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence            9999999999985 3489899987754 3335899999999999999999999999999999998 46799999999999


Q ss_pred             cccCCCC---CCccccCCcccccccccCCC-----------CCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHHHHHh
Q 013249          264 EIDESSR---SNSMCGTTEYMAPEILLSKG-----------HNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIIN  328 (447)
Q Consensus       264 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~  328 (447)
                      .+.....   ..+.+||+.||+||.+....           .++++||||||||||+|+.|++||.... ...-+..|..
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~  587 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD  587 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence            8765433   34678999999999997433           3578999999999999999999996532 2222333332


Q ss_pred             c--ccCCCCCCchh-HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          329 E--KVKLPPFLTSE-AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       329 ~--~~~~p~~~~~~-~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      -  .++||..-... +.      +++..||.+||++|+     ++.+||+|||+..+
T Consensus       588 P~~~Iefp~~~~~~~li------~~mK~CL~rdPkkR~-----si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELI------DVMKCCLARDPKKRW-----SIPELLQHPFLQIQ  633 (677)
T ss_pred             CCccccccCCCCchHHH------HHHHHHHhcCcccCC-----CcHHHhcCcccccc
Confidence            2  34666544433 44      445559999999999     88999999999864

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-41  Score=322.18  Aligned_cols=252  Identities=30%  Similarity=0.573  Sum_probs=212.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||+|+||.||++.++.     ++..+|+|.+..... .....+.+.+|+.+++.++|+||+++++.+.....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS-----DSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC-----CCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            58999999999999999999876     778899999876543 223445678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc-EEEeecCCcccccC
Q 013249          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-VMLTDFGLAKEIDE  267 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~-~kL~DFG~a~~~~~  267 (447)
                      |+|+||+.+++|.+++.+..  .+++..+..++.|++.||.|||+++|+|+||||+||++++++. +||+|||.+.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            99999999999999987653  4799999999999999999999999999999999999998864 69999999987654


Q ss_pred             CCC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhh
Q 013249          268 SSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  345 (447)
Q Consensus       268 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li  345 (447)
                      ... .....|+..|+|||++.+..++.++|+|||||++|||++|..||...+..+....+..... ..++..+.++.   
T Consensus       155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLR---  231 (257)
T ss_pred             CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHH---
Confidence            322 2234688999999999888899999999999999999999999988777666655554432 22333444444   


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         ++|.+||..+|++||     +++++++||||
T Consensus       232 ---~~i~~~l~~~p~~Rp-----t~~~ll~~~~~  257 (257)
T cd08225         232 ---SLISQLFKVSPRDRP-----SITSILKRPFL  257 (257)
T ss_pred             ---HHHHHHhccChhhCc-----CHHHHhhCCCC
Confidence               456669999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-41  Score=328.88  Aligned_cols=262  Identities=26%  Similarity=0.453  Sum_probs=206.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|++|.||+|.++.     +++.||+|.+..... .....+.+.+|++++++++||||+++++++.....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV-----TNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC-----CCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            579999999999999999999876     788999999865432 22334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-CCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~~kL~DFG~a~~~~  266 (447)
                      +|+||||+. ++|..++....  .+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++....
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            999999996 57877776544  3578899999999999999999999999999999999985 5679999999997654


Q ss_pred             CCC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-------------
Q 013249          267 ESS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-------------  331 (447)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-------------  331 (447)
                      ... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...++.....             
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            322 2234467899999999876 4578999999999999999999999987766555544432110             


Q ss_pred             -----CCCCCCchhHHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          332 -----KLPPFLTSEAHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       332 -----~~p~~~~~~~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                           .++.........     .....+|+.+||+.||++||     ++++++.||||.+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----s~~~~l~~~~~~~~~  291 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI-----TARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc-----CHHHHhcCchHhHHh
Confidence                 001000000000     01234678889999999999     889999999998654

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-42  Score=333.44  Aligned_cols=257  Identities=26%  Similarity=0.486  Sum_probs=213.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|+..+.||+|+||.||+|.+..     +++.||+|.+....  .....+.+.+|+.++++++||||+++++.+..+..+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR-----TKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC-----CCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence            47777889999999999998875     67889999987543  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      |+||||+.+++|..++.. +.+++..++.++.||+.||.|||++|++|+||+|+||++++++.+||+|||++..+.... 
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            999999999999988854 578999999999999999999999999999999999999999999999999998764332 


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhHHhhhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~  348 (447)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+.... ..++...+.++.      
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  230 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFK------  230 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHH------
Confidence            2233568899999999999899999999999999999999999998766555444433222 122223344444      


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      +++.+||+.+|.+||     ++.++++|+||....+..
T Consensus       231 ~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~~~  263 (277)
T cd06642         231 EFVEACLNKDPRFRP-----TAKELLKHKFITRYTKKT  263 (277)
T ss_pred             HHHHHHccCCcccCc-----CHHHHHHhHHHHHHhhhH
Confidence            456669999999999     889999999997655443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.6e-42  Score=338.50  Aligned_cols=255  Identities=26%  Similarity=0.449  Sum_probs=207.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (447)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|++.... ........+.+|+.+|+.++||||+++++++..   
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTR-----SGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            589999999999999999999886     78899999987643 223345667789999999999999999988763   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                       ...+|+||||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence             457899999995 589999888888999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCC-----CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-------
Q 013249          266 DESSR-----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-------  332 (447)
Q Consensus       266 ~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-------  332 (447)
                      .....     .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+......       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     234578999999999865 46899999999999999999999999877655443333221110       


Q ss_pred             -------------CC-----------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          333 -------------LP-----------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       333 -------------~p-----------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                   ++           +..+.++      .+||.+||+.||.+||     ++++++.||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~l~~~P~~Rp-----t~~~~l~~~~~~~~  300 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEA------LDLLSQMLQFDPEERI-----TVEQALQHPFLAQY  300 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHH------HHHHHHHccCChhhCc-----CHHHHHhChhhhhc
Confidence                         11           1122222      4567779999999999     88999999999743

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=318.01  Aligned_cols=252  Identities=32%  Similarity=0.589  Sum_probs=217.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||+|++|.||++.++.     .++.|++|.+..... .....+.+.+|++++++++|+|++++++++.+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE-----TGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC-----CCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            58899999999999999999875     678899999987643 234567789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      |+||||+.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999987654332


Q ss_pred             -CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHH-hcccCCCCCCchhHHhhhhhh
Q 013249          271 -SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-NEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       271 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~li~~~  348 (447)
                       .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+.......+. .....++..++.++.++    
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  230 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDF----  230 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHH----
Confidence             234578999999999988889999999999999999999999998766554444443 33334455566666554    


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                        +.+||..+|++||     +++++++|+||
T Consensus       231 --i~~~l~~~p~~R~-----~~~~~l~~~~~  254 (254)
T cd06627         231 --LMQCFQKDPNLRP-----TAKQLLKHPWI  254 (254)
T ss_pred             --HHHHHhCChhhCc-----CHHHHhcCCCC
Confidence              5559999999999     88999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-41  Score=326.31  Aligned_cols=254  Identities=22%  Similarity=0.399  Sum_probs=209.9

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ...+|.+.++||+|+||.||++.........++..+|+|.+...   .....+.+.+|+++++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            44589999999999999999998654333345678999987653   234456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG---------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  252 (447)
                      ...|+||||+.+++|.+++...+               .+++..++.++.||+.||.|||++||+||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999997653               478999999999999999999999999999999999999999


Q ss_pred             cEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHh
Q 013249          253 HVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN  328 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~  328 (447)
                      .+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|||++ |.+||......+....+..
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            999999999876532211   122345778999999999999999999999999999998 9999988777776666655


Q ss_pred             cc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          329 EK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       329 ~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .. ...+..++.++.+++      .+||+.||.+||     ++++|++
T Consensus       240 ~~~~~~~~~~~~~~~~li------~~cl~~~P~~Rp-----~~~~l~~  276 (280)
T cd05092         240 GRELERPRTCPPEVYAIM------QGCWQREPQQRM-----VIKDIHS  276 (280)
T ss_pred             CccCCCCCCCCHHHHHHH------HHHccCChhhCC-----CHHHHHH
Confidence            43 334555666665554      459999999999     7788764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.3e-41  Score=331.34  Aligned_cols=258  Identities=22%  Similarity=0.389  Sum_probs=210.3

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (447)
                      .+..++|.+.+.||+|+||.||++++.+....  .....+|+|.+....  .......+..|+.+++.+ +||||+++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG   91 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            34456899999999999999999987653221  234579999987642  233345677899999999 7999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCc
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NI  246 (447)
                      ++...+.+|+||||+.+|+|.+++....                .+++.++..++.||+.||+|||++|++||||||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  171 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  171 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence            9999999999999999999999997642                478899999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHH
Q 013249          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~  322 (447)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..++
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            999999999999999886543211   112234568999999999889999999999999999998 9999988887777


Q ss_pred             HHHHHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          323 QQRIINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       323 ~~~i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ...+.... ...|...+.++.++      +.+||..+|.+||     ++++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~l------i~~~l~~~p~~Rp-----s~~evl~~  295 (307)
T cd05098         252 FKLLKEGHRMDKPSNCTNELYMM------MRDCWHAVPSQRP-----TFKQLVED  295 (307)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHH------HHHHcccChhhCc-----CHHHHHHH
Confidence            77665543 24455556666555      5559999999999     77888763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.5e-41  Score=325.85  Aligned_cols=252  Identities=28%  Similarity=0.500  Sum_probs=212.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|...+.||+|++|.||++.++.     +++.+++|.+....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~   91 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS-----TGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL   91 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC-----CCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence            45667899999999999999875     67889999886432   23345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      |+|+||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....... 
T Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            999999999999999877 678999999999999999999999999999999999999999999999999887654322 


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC---CCCchhHHhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---PFLTSEAHSLLK  346 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p---~~~~~~~~~li~  346 (447)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+........   ...+..+     
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-----  245 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRL-----  245 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHH-----
Confidence            22345689999999999988899999999999999999999999988877776666665432211   1133344     


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                       .+|+.+||+.||++||     +++++++|+||.+.
T Consensus       246 -~~li~~~l~~~p~~Rp-----t~~~il~~~~~~~~  275 (285)
T cd06648         246 -RSFLDRMLVRDPAQRA-----TAAELLNHPFLAKA  275 (285)
T ss_pred             -HHHHHHHcccChhhCc-----CHHHHccCcccccC
Confidence             3556669999999999     78999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=321.65  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=206.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.+.||+|+||.||+|.+.      .++.||+|.++....    ..+.+.+|+.++++++||||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN------NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTL   72 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec------CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence            45568999999999999999999865      346799999875432    23457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .+.+|+||||+.+++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            999999999999999999997654  689999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCC--CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchh
Q 013249          265 IDESSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  340 (447)
                      .......  ....++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+.......+.... ...+...+..
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05068         153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE  232 (261)
T ss_pred             ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            6532211  11223457999999999899999999999999999999 999999888777776665442 2234444555


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.+      ++.+||+.||.+||     ++++|.+
T Consensus       233 ~~~------li~~~l~~~P~~Rp-----~~~~l~~  256 (261)
T cd05068         233 LYD------IMLDCWKEDPDDRP-----TFETLQW  256 (261)
T ss_pred             HHH------HHHHHhhcCcccCC-----CHHHHHH
Confidence            444      55669999999999     7777764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-41  Score=323.12  Aligned_cols=248  Identities=22%  Similarity=0.402  Sum_probs=206.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++++.||+|+||.||++++++      +..+|+|.+.....    ..+.+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ   71 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC------CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            34579999999999999999998753      34599998875432    124578899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ..+|+||||+.+|+|.+++... ..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++...
T Consensus        72 ~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecC
Confidence            9999999999999999999764 468999999999999999999999999999999999999999999999999988654


Q ss_pred             CCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccC-CCCCCchhHH
Q 013249          267 ESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAH  342 (447)
Q Consensus       267 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~  342 (447)
                      ....  .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+...... .+...+..+.
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY  231 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            3221  112335678999999998889999999999999999998 99999888877777777665432 2334444444


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +      ++.+||+.||.+||     ++.+|+.+
T Consensus       232 ~------li~~cl~~~p~~Rp-----~~~~ll~~  254 (256)
T cd05113         232 A------IMYSCWHEKAEERP-----TFQQLLSS  254 (256)
T ss_pred             H------HHHHHcCCCcccCC-----CHHHHHHh
Confidence            4      56669999999999     78888753

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-41  Score=322.00  Aligned_cols=243  Identities=22%  Similarity=0.356  Sum_probs=202.1

Q ss_pred             eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 013249          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (447)
Q Consensus       117 ~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (447)
                      +||+|+||.||+|.++...   ++..+|+|+++... ......+.+..|+.+++.++||||+++++++. ....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~---~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKK---SEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCC---CceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            6899999999999765322   56789999987543 23445567889999999999999999999875 4567999999


Q ss_pred             cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC----CC
Q 013249          197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SN  272 (447)
Q Consensus       197 ~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~----~~  272 (447)
                      +.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||+++.+.....    ..
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            99999999998888899999999999999999999999999999999999999999999999999987643321    12


Q ss_pred             ccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhHHhhhhhhhH
Q 013249          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKGVSF  350 (447)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~~~  350 (447)
                      ...++..|+|||++....++.++|||||||++|||++ |+.||...+..++...+..+. ...|...+.++.+++.    
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~----  232 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMK----  232 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH----
Confidence            2234678999999988889999999999999999998 999999888877777776543 3456667777666554    


Q ss_pred             HhhhccCCCCCCCCCCCCChhhhhc
Q 013249          351 LTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       351 l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                        +||+.||++||     ++++|..
T Consensus       233 --~~~~~~p~~Rp-----~~~~i~~  250 (257)
T cd05116         233 --LCWTYGVDERP-----GFAVVEL  250 (257)
T ss_pred             --HHhccCchhCc-----CHHHHHH
Confidence              59999999999     6666643

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-41  Score=321.19  Aligned_cols=242  Identities=22%  Similarity=0.421  Sum_probs=199.7

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      +.||+|+||.||+|+++.     +++.+|+|.+....  ..+....+.+|+++++.++||||+++++++.....+|+|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   73 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA-----DNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME   73 (252)
T ss_pred             CccCcccCccEEEEEEec-----CCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence            369999999999999876     77899999886432  23445668899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCC--
Q 013249          196 FINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN--  272 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~--  272 (447)
                      |+.+++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........  
T Consensus        74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            999999999997654 68999999999999999999999999999999999999999999999999988654322111  


Q ss_pred             -ccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHHhhhhhhh
Q 013249          273 -SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       273 -~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~~  349 (447)
                       ...++..|+|||.+.+..++.++|||||||++|||++ |..||...........+... ....+...+..+.+      
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  227 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYR------  227 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHH------
Confidence             1123457999999998889999999999999999998 99999877766655555443 23344455555544      


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      |+.+||+.||++||     +++++++
T Consensus       228 li~~~l~~~p~~Rp-----s~~~~~~  248 (252)
T cd05084         228 LMERCWEYDPGQRP-----SFSTVHQ  248 (252)
T ss_pred             HHHHHcCCChhhCc-----CHHHHHH
Confidence            45569999999999     7788764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-44  Score=376.38  Aligned_cols=254  Identities=31%  Similarity=0.538  Sum_probs=219.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +++...+||.|.||.||-|.+..     +|+..|+|.++..... ......+.+|..+|..++|||+|++|++-...+.+
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~-----tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLD-----TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCC-----ccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            45667899999999999999876     8899999999876544 55566788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      +|.||||+||+|.+.+...+..+|...+.+..|++.|+.|||+.|||||||||+||||+.+|.+|++|||.|..+.... 
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999999875542 


Q ss_pred             ----CCCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHHHHHh-cccCCCCCCchh
Q 013249          270 ----RSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIIN-EKVKLPPFLTSE  340 (447)
Q Consensus       270 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~-~~~~~p~~~~~~  340 (447)
                          ......||+.|||||++.+   ++...+.||||||||+.||+||+.||...+ ...+...+.. ..+.+|..++.+
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence                1235789999999999985   567889999999999999999999996543 3344444443 456788888877


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      .+++++      +||+.||++|.     ++.+|+.|.|-+.
T Consensus      1470 g~dFle------~Cl~~dP~~Rw-----~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLE------HCLEQDPKMRW-----TASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHHH------HHHhcCchhhh-----HHHHHHHhhcccc
Confidence            766555      59999999999     7889999988754

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=323.94  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=207.8

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEEeCC
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRS  188 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~  188 (447)
                      |++.+.||+|+||.||+|+++.     +++.||+|+++.... .......+.+|+.+++++   +|+||+++++++....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN-----TGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC-----CCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            6889999999999999999875     678999999975432 222234466788777766   5999999999998877


Q ss_pred             E-----EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          189 K-----LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       189 ~-----~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      .     ++++|||+.+ +|.+++....  .+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||+
T Consensus        75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence            6     9999999975 7888887643  589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-----C----
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----K----  332 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-----~----  332 (447)
                      +.............++..|+|||++.+..++.++|||||||++|+|++|.+||...+..+...++.....     .    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            9887554444455688999999999998899999999999999999999999998887776666653210     0    


Q ss_pred             -------CCCCCchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          333 -------LPPFLTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       333 -------~p~~~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                             ++..........     ....+||.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~il~~~~~  287 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI-----SAFEALQHPYF  287 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC-----CHHHHhcCcCC
Confidence                   111111111111     1234788889999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.7e-42  Score=336.65  Aligned_cols=255  Identities=23%  Similarity=0.425  Sum_probs=207.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (447)
                      .+|.+.+.||+|+||+||+|+++.     +++.||||.+..... .......+.+|+.+++.++|+||+++++++...  
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   78 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSE-----TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR   78 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecC-----CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence            479999999999999999999875     788999999875432 233345567899999999999999999988654  


Q ss_pred             ---CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                         ..+|+||||+. ++|..++...+.+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||+++.
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          79 EAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence               35899999995 68989988888999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCC-CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC----------
Q 013249          265 IDES-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----------  332 (447)
Q Consensus       265 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~----------  332 (447)
                      .... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......          
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            6443 22334568899999999875 46899999999999999999999999876654433333211000          


Q ss_pred             ---------------------CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          333 ---------------------LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       333 ---------------------~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                           ..+..+.+      ..+||.+||+.||++||     +++++++||||..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~~l~~~P~~Rp-----s~~ell~h~~~~~~  297 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFARLFPHANPL------AIDLLEKMLVFDPSKRI-----TVEEALAHPYLASL  297 (337)
T ss_pred             chhhhHHHHhcCcccccCHHHHcccCCHH------HHHHHHHHhcCChhhcc-----CHHHHHcCcchhhh
Confidence                                 00112222      24677789999999999     88999999999765

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=335.23  Aligned_cols=259  Identities=25%  Similarity=0.424  Sum_probs=202.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (447)
                      ++|++.++||+|+||.||+|.++.     +++.||+|++....  .......+.+|+.+++.++|+||+++++++...  
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKP-----TGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcC-----CCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            589999999999999999999876     78899999986422  233445577899999999999999999887644  


Q ss_pred             ---CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                         ..+|+||||+.+ +|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        78 ~~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          78 ESFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             cccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence               368999999964 7877764 45799999999999999999999999999999999999999999999999999886


Q ss_pred             ccCCCC----CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-------
Q 013249          265 IDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-------  332 (447)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-------  332 (447)
                      ......    .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            533221    223578999999998764 56899999999999999999999999876654433322211000       


Q ss_pred             -------------CCCCCchhHHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          333 -------------LPPFLTSEAHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       333 -------------~p~~~~~~~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                   .+.........     .-...+||.+||+.||.+||     ++.++++||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~e~l~hp~~~~~  298 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI-----TVEEALAHPYLEQY  298 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc-----CHHHHhcCcccccc
Confidence                         00000000000     11234678889999999999     88999999999854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=325.72  Aligned_cols=254  Identities=28%  Similarity=0.558  Sum_probs=209.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeeeEEEEeC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTR  187 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~  187 (447)
                      .|++.+.||.|+||.||+|.++.     +++.||+|.+....  .......+.+|+.+++.++   ||||+++++++...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP-----TGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC-----CCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence            58888999999999999999875     78899999987542  2334556888999999996   99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ...|+||||+.|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          75 PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999999999998865 4789999999999999999999999999999999999999999999999999987644


Q ss_pred             CC-CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc-cCCCCC-CchhHHh
Q 013249          268 SS-RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPF-LTSEAHS  343 (447)
Q Consensus       268 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~-~~~p~~-~~~~~~~  343 (447)
                      .. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.... ..++.. .+.++  
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  231 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLL--  231 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHH--
Confidence            32 2334578999999999875 457899999999999999999999998776554443332221 111111 33333  


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                          .+|+.+||+.||++||     ++++++.|+||+...
T Consensus       232 ----~~~i~~~l~~~p~~R~-----~~~~il~~~~~~~~~  262 (277)
T cd06917         232 ----REFVAACLDEEPKERL-----SAEELLKSKWIKAHS  262 (277)
T ss_pred             ----HHHHHHHcCCCcccCc-----CHHHHhhChHhhccc
Confidence                3566779999999999     889999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-43  Score=346.18  Aligned_cols=254  Identities=23%  Similarity=0.397  Sum_probs=214.9

Q ss_pred             CCc-EEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          110 GDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ++| +...+||+|+|-+||+|.+..     +|..||--.++...+ .....++++..|+.+|+.|+|||||++|+++.+.
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~-----~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEE-----EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT  113 (632)
T ss_pred             Cceeehhhhcccccceeeeeccccc-----cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence            344 345689999999999998754     666666555443333 2355668899999999999999999999999876


Q ss_pred             CE--EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccCC-CCcEEEeecCCc
Q 013249          188 SK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFGLA  262 (447)
Q Consensus       188 ~~--~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~~-~~~~kL~DFG~a  262 (447)
                      ..  +.+|+|++.+|+|..|+.+.++++...++.|++||++||.|||++.  |||||||-+||+|+. .|.|||+|+|+|
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence            54  8899999999999999999999999999999999999999999885  999999999999975 589999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCC-CCCHHHHHHHHHhcccC--CCCCCch
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVK--LPPFLTS  339 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~-~~~~~~~~~~i~~~~~~--~p~~~~~  339 (447)
                      +....... ...+|||.|||||++. ..|+..+||||||++|+||+|+.+||. ..+...+++++..+..+  |-.--.+
T Consensus       194 tl~r~s~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP  271 (632)
T KOG0584|consen  194 TLLRKSHA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP  271 (632)
T ss_pred             HHhhcccc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence            98766543 4489999999999998 779999999999999999999999994 67899999999987642  2233356


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +++.+|.      +||.. .+.|+     ++.|||.|+||..-
T Consensus       272 evr~fIe------kCl~~-~~~R~-----sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  272 EVREFIE------KCLAT-KSERL-----SAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHH------HHhcC-chhcc-----CHHHHhhChhhccc
Confidence            6666555      59999 99999     88999999999753

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=322.65  Aligned_cols=246  Identities=22%  Similarity=0.428  Sum_probs=205.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ..+|++.+.||+|+||.||+++++      .+..+|+|++.+....    ...+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR------GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR   72 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec------CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            347899999999999999999875      4557999998654321    234677999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            999999999999999999764 5689999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCC--CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHHh
Q 013249          268 SSRS--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  343 (447)
Q Consensus       268 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~  343 (447)
                      ....  ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... ....|...+.++.+
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYT  232 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            2211  11223457999999999999999999999999999999 89999887777777666544 23445556666655


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +      +.+||..+|++||     +++++++
T Consensus       233 l------i~~cl~~~p~~Rp-----t~~~~l~  253 (256)
T cd05059         233 I------MYSCWHEKPEDRP-----AFKKLLS  253 (256)
T ss_pred             H------HHHHhcCChhhCc-----CHHHHHH
Confidence            5      4559999999999     7888876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.2e-42  Score=331.27  Aligned_cols=252  Identities=25%  Similarity=0.481  Sum_probs=209.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|+....||+|+||.||++.++.     +++.||+|++.....   ...+.+.+|+.+++.++||||+++++.+..++..
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKH-----SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcC-----CCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            45556689999999999999875     678999999865432   2345578899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      |+||||+++++|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999999999887654 568999999999999999999999999999999999999999999999999987654322 


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---CCCCchhHHhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---PPFLTSEAHSLLK  346 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~---p~~~~~~~~~li~  346 (447)
                      .....+|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.......   +...+..+.    
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~----  248 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLR----  248 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHH----
Confidence            2334678999999999998889999999999999999999999998777666655554332211   122333333    


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                        +||.+||+.||.+||     +++++++|+||.+.
T Consensus       249 --~~i~~~l~~~P~~Rp-----s~~~ll~~~~~~~~  277 (297)
T cd06659         249 --DFLERMLTREPQERA-----TAQELLDHPFLLQT  277 (297)
T ss_pred             --HHHHHHhcCCcccCc-----CHHHHhhChhhccC
Confidence              456679999999999     88999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-41  Score=335.49  Aligned_cols=259  Identities=27%  Similarity=0.454  Sum_probs=207.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++++.||+|+||.||++.++.     ++..||||++.+.. ........+.+|+.+|+.++||||+++++++....
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRR-----TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECC-----CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            4689999999999999999999876     78899999986532 22333456778999999999999999999987653


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                            .+|+||||+ |++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence                  469999999 778887775 467999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-------
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-------  334 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p-------  334 (447)
                      ......  .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.......+       
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            875432  334567899999999876 4588999999999999999999999988776655555443222111       


Q ss_pred             -------------CCCchhHHhhh-----hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 -------------PFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 -------------~~~~~~~~~li-----~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                   .........+.     ...++|.+||+.||++||     ++.+++.||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~-----t~~~~l~~~~~~~~  304 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI-----TAAEALAHPYFEEF  304 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC-----CHHHHhcCccHhhh
Confidence                         11001111110     134678889999999999     88999999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=320.12  Aligned_cols=246  Identities=26%  Similarity=0.457  Sum_probs=210.3

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      +.||+|+||.||+|.+....  ..+..||+|++.....  ....+.+.+|+.+++.++|+||+++++++.....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCC--CCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            46999999999999987521  1378899999976542  2246778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          196 FINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       196 ~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      |+++++|.+++...         ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999999875         789999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhH
Q 013249          267 ESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (447)
Q Consensus       267 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~  341 (447)
                      ...   ......++..|+|||.+....++.++|||||||++|+|++ |..||......++.+.+... ....|..++.++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL  236 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHH
Confidence            432   2334567889999999998889999999999999999999 69999988888877777643 334556666666


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .+++      .+||+.||++||     ++++++++
T Consensus       237 ~~li------~~~l~~~p~~Rp-----s~~~l~~~  260 (262)
T cd00192         237 YELM------LSCWQLDPEDRP-----TFSELVER  260 (262)
T ss_pred             HHHH------HHHccCCcccCc-----CHHHHHHh
Confidence            5554      459999999999     78898864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-41  Score=328.51  Aligned_cols=257  Identities=23%  Similarity=0.391  Sum_probs=209.0

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      .+..++|++.+.||+|+||.||++.+........+..+|+|.++...  .....+.+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            34556899999999999999999987543333456789999987542  233456788999999999 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      ...+.+|+||||+.+|+|..++....  .+++.++..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999999997643  3899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc--CCCCC
Q 013249          263 KEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV--KLPPF  336 (447)
Q Consensus       263 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~--~~p~~  336 (447)
                      +.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||.................  ..+..
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH  268 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence            86543221   122346788999999999889999999999999999998 9999987766554444443322  22334


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+.++.+      |+.+||.++|++||     +++++++
T Consensus       269 ~~~~~~~------li~~cl~~~p~~Rp-----t~~ell~  296 (302)
T cd05055         269 APAEIYD------IMKTCWDADPLKRP-----TFKQIVQ  296 (302)
T ss_pred             CCHHHHH------HHHHHcCCCchhCc-----CHHHHHH
Confidence            4555544      45569999999999     7788875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.7e-42  Score=336.08  Aligned_cols=260  Identities=25%  Similarity=0.410  Sum_probs=214.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  188 (447)
                      +|++.+.||.|+||.||+|++..     +++.||+|.+.... ......+.+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR-----TGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC-----CCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            58999999999999999999875     68899999987642 22344567888999999999999999999998775  


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                         .+|+||||+. ++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence               8999999997 489899888789999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCC----CCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC----
Q 013249          266 DESS----RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF----  336 (447)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~----  336 (447)
                      ....    ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+.......+..    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            5432    23445688999999999887 88999999999999999999999999888777666665432111100    


Q ss_pred             -Cchh---------------HHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          337 -LTSE---------------AHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       337 -~~~~---------------~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                       ....               ...     .-...+||.+||++||.+||     ++++++.||||+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~~~~~~~  295 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI-----TADEALAHPYLAQL  295 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC-----CHHHHHhCccHHhh
Confidence             0000               000     01124678889999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.1e-41  Score=326.37  Aligned_cols=255  Identities=23%  Similarity=0.387  Sum_probs=207.9

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCC-----------CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF  176 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn  176 (447)
                      ..++|++++.||+|+||.||+|.+.....           ...+..||+|.+....  .....+.+.+|++++++++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence            34689999999999999999998765321           1134678999987653  2345567889999999999999


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                      |+++++++..++..++||||+.+++|..++.+..           .+++..++.++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999998765           68999999999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh--CCCCCCCCCHH
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ  320 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--G~~pf~~~~~~  320 (447)
                      ||++.++.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            999999999999999998653322   1233456788999999998889999999999999999998  78899877766


Q ss_pred             HHHHHHHhc------c--cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          321 KLQQRIINE------K--VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       321 ~~~~~i~~~------~--~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +....+...      .  ...+...+.++.      +++.+||+.||.+||     ++.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~------~li~~cl~~~p~~Rp-----t~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIY------ELMLECWRRDEEDRP-----TFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHH------HHHHHHhccChhcCC-----CHHHHHH
Confidence            665555432      1  112233344444      456669999999999     7788854

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=325.44  Aligned_cols=256  Identities=28%  Similarity=0.507  Sum_probs=208.2

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--SK  189 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  189 (447)
                      |++.+.||.|+||.||+|.++.     +++.+|+|.+.... ........+.+|+.+++.++|+||+++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK-----TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC-----CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            7889999999999999999876     67899999998754 2334445677899999999999999999999988  89


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++|++|+||||+|||+++++.+||+|||++......
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          75 IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             EEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9999999975 888888665 57999999999999999999999999999999999999999999999999999876543


Q ss_pred             C--CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-----CC-----
Q 013249          269 S--RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-----PP-----  335 (447)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~-----p~-----  335 (447)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.......     +.     
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            2  1234467889999998765 457899999999999999999999998887766655554321110     00     


Q ss_pred             ---------CCchhHHhh------hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          336 ---------FLTSEAHSL------LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       336 ---------~~~~~~~~l------i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                               .......+.      -..++++.+||..||.+||     ++++++.|+||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~~l~~~~~  287 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI-----SADQALQHEYF  287 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc-----CHHHHhhCcCC
Confidence                     000011111      1235788889999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-41  Score=331.15  Aligned_cols=259  Identities=27%  Similarity=0.427  Sum_probs=203.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|++.++||.|+||.||+|.++.     +++.+|+|++...... ......+.+|+++++.++||||+++++++... 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK-----TGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            4689999999999999999999876     7788999998764322 22223467899999999999999999887543 


Q ss_pred             -------CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          188 -------SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       188 -------~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                             ..+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+||
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcC
Confidence                   357999999965 56666654 457999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCC------------CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHH
Q 013249          260 GLAKEIDESSR------------SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI  326 (447)
Q Consensus       260 G~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i  326 (447)
                      |+++.......            .....|+..|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99986533221            123457888999998865 45889999999999999999999999888776665555


Q ss_pred             HhcccCCC-----------C--------CCchhHHh----h-hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          327 INEKVKLP-----------P--------FLTSEAHS----L-LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       327 ~~~~~~~p-----------~--------~~~~~~~~----l-i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      .......+           .        ........    + -...+||.+||+.||.+||     ++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~-----t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL-----TASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc-----CHHHHhcCCCC
Confidence            43211100           0        00000000    0 1235788899999999999     88999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-41  Score=323.28  Aligned_cols=250  Identities=27%  Similarity=0.466  Sum_probs=205.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+++++.     +++.+|||.+.............+.+|+.+++.++|+||+++++++...+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL-----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC-----CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence            478999999999999999999876     778999998876544445555678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+++|||+.+++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            9999999999999988864    356899999999999999999999999999999999999999999999999998876


Q ss_pred             cCCCC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH--HHHHHHHHhccc-CCC-CCCchh
Q 013249          266 DESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR--QKLQQRIINEKV-KLP-PFLTSE  340 (447)
Q Consensus       266 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~--~~~~~~i~~~~~-~~p-~~~~~~  340 (447)
                      ..... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.+...  ......+..... ..+ ...+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            43322 2345789999999999998899999999999999999999999975433  233333332221 111 224444


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.+      |+.+||..||++||     ++++|.+
T Consensus       237 ~~~------li~~~l~~~p~~Rp-----t~~~i~~  260 (267)
T cd08229         237 LRQ------LVNMCINPDPEKRP-----DITYVYD  260 (267)
T ss_pred             HHH------HHHHhcCCCcccCC-----CHHHHHH
Confidence            444      55569999999999     7776653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=324.92  Aligned_cols=256  Identities=28%  Similarity=0.483  Sum_probs=205.4

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |++.++||.|++|.||+|.++.     ++..||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL-----TGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC-----CCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            6788999999999999999876     788999999876532 2333355778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          192 LILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +||||+. ++|..++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.++.+||+|||++.......
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            9999995 68999887765  78999999999999999999999999999999999999999999999999997654322


Q ss_pred             C-CCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc----------------
Q 013249          270 R-SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------------  331 (447)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~----------------  331 (447)
                      . .....++..|+|||++.+. .++.++|||||||++|+|++|+.||...+......++.....                
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            1 2334578899999988764 578899999999999999999999987776554444433210                


Q ss_pred             --CCCCCCchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 --KLPPFLTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 --~~p~~~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                        .++..........     ....++|.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI-----SAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc-----CHHHHhcCCCC
Confidence              0111100000000     1234678889999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.2e-41  Score=328.79  Aligned_cols=257  Identities=21%  Similarity=0.390  Sum_probs=209.7

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (447)
                      .+..++|.+.++||+|+||.||+|++.+...  ......+|+|.++...  .......+..|+.+++.+ +||||+++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            3445689999999999999999998754322  1245679999987542  233456688899999999 6999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCc
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NI  246 (447)
                      ++...+.+|+||||+.+|+|.+++...                ..+++.++..++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            999999999999999999999999763                3478899999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHH
Q 013249          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~  322 (447)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987543211   112234567999999999899999999999999999999 9999998888887


Q ss_pred             HHHHHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          323 QQRIINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       323 ~~~i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ...+.... ...+...+.++.+      ++.+||..||++||     +++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~------li~~cl~~~p~~Rp-----s~~~ll~  288 (314)
T cd05099         246 FKLLREGHRMDKPSNCTHELYM------LMRECWHAVPTQRP-----TFKQLVE  288 (314)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHH------HHHHHcCCCcccCc-----CHHHHHH
Confidence            77766543 2344455555554      45569999999999     7788875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.8e-41  Score=326.00  Aligned_cols=252  Identities=22%  Similarity=0.396  Sum_probs=207.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||+|+||.||+|.............+|+|.+....  .....+.+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            588899999999999999988654443455679999887543  233446688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCc
Q 013249          191 YLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NI  246 (447)
                      |+||||+.+++|.+++...                        ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2478899999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHH
Q 013249          247 LMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~  322 (447)
                      |+++++.+||+|||+++......   ......++..|+|||++.+..++.++||||||+++|||++ |..||.+....++
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999998653221   1223456778999999998889999999999999999998 9999998888777


Q ss_pred             HHHHHhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          323 QQRIINE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       323 ~~~i~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+.+... ....+...+.++.+      |+.+||+.||++||     +++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~------~i~~cl~~~P~~Rp-----~~~~i~~  281 (290)
T cd05045         239 FNLLKTGYRMERPENCSEEMYN------LMLTCWKQEPDKRP-----TFADISK  281 (290)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHH------HHHHHccCCcccCC-----CHHHHHH
Confidence            6665543 22334445555544      55669999999999     7788764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=321.23  Aligned_cols=251  Identities=21%  Similarity=0.340  Sum_probs=204.6

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE--
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK--  189 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--  189 (447)
                      |.+++.||+|+||.||+|..+..  ...+..||+|.++.... .....+.+.+|+.+++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~--~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD--DGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC--CCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            56789999999999999987641  12457899999876432 33445678899999999999999999998865543  


Q ss_pred             ----EEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          190 ----LYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       190 ----~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                          .++||||+.+|+|..++...      ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                89999999999999888543      35899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCC
Q 013249          260 GLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP  334 (447)
Q Consensus       260 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p  334 (447)
                      |+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ....|
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP  237 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99987543221   112335678999999998899999999999999999999 99999888877777766654 23345


Q ss_pred             CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       335 ~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ...+.++.+      ++.+||+.||++||     ++.+++++
T Consensus       238 ~~~~~~~~~------li~~~l~~~p~~Rp-----~~~e~~~~  268 (273)
T cd05035         238 EDCLDELYD------LMYSCWRADPKDRP-----TFTKLREV  268 (273)
T ss_pred             cCCCHHHHH------HHHHHcCCChhhCc-----CHHHHHHH
Confidence            555555544      45569999999999     78888763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.9e-41  Score=327.95  Aligned_cols=254  Identities=28%  Similarity=0.488  Sum_probs=209.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||++.++.     +++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+.....
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA-----TGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC-----CCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            589999999999999999998765     67789999986432   2234567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      .|+|+||+++++|..++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999999999998865 457899999999999999999999999999999999999999999999999987654322


Q ss_pred             -CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc-ccCC--CCCCchhHHhhh
Q 013249          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKL--PPFLTSEAHSLL  345 (447)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~-~~~~--p~~~~~~~~~li  345 (447)
                       ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+... ...+  +..++..+.   
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---  246 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR---  246 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH---
Confidence             223456889999999999888999999999999999999999999876654433322211 1111  122333444   


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                         +|+.+||..||++||     ++++++.|+||+...
T Consensus       247 ---~li~~~l~~~p~~Rp-----~~~~il~h~~~~~~~  276 (293)
T cd06647         247 ---DFLNRCLEMDVEKRG-----SAKELLQHPFLKIAK  276 (293)
T ss_pred             ---HHHHHHccCChhhCc-----CHHHHhcCHHHhcCc
Confidence               456669999999999     889999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-41  Score=340.78  Aligned_cols=258  Identities=23%  Similarity=0.372  Sum_probs=209.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  183 (447)
                      +.+..++|.+.++||+|+||.||+|++++......+..||||+++...  .....+.+.+|+.+|.++. ||||++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            445556899999999999999999998764444466789999997542  2333456889999999997 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC-----------------------------------------------------
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQG-----------------------------------------------------  210 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------------  210 (447)
                      +...+.+|+||||+.+|+|.+++.+.+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999997542                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          211 ---------------------------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       211 ---------------------------------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                                                                   .+++..+..++.||+.||.|||+++|+||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         35677788999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~  321 (447)
                      ||++.++.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            999999999999999998653221   1223457889999999998889999999999999999998 899997765554


Q ss_pred             HHHHHHhcc--cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          322 LQQRIINEK--VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       322 ~~~~i~~~~--~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .........  ...|...+.++.+++.      +||..||.+||     ++++|++
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~------~cl~~~P~~RP-----s~~ell~  394 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQ------KCWEEKFEIRP-----DFSQLVH  394 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHH------HHcCCChhHCc-----CHHHHHH
Confidence            443333322  3345556666655544      59999999999     7788876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.4e-41  Score=322.57  Aligned_cols=255  Identities=24%  Similarity=0.419  Sum_probs=213.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++++.||+|+||.||+|+.+........+.+++|.+....  .....+.+.+|++++++++|+||+++++++.+.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            46899999999999999999998765554567789999886532  2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          189 KLYLILDFINGGHLFFHLYRQG---------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                      ..|+||||+++|+|.+++....         .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998765         6899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccCC--C
Q 013249          260 GLAKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--P  334 (447)
Q Consensus       260 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~~--p  334 (447)
                      |++.......  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+......+  +
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            9987543211  2233456788999999988888999999999999999998 899998877777777766554433  3


Q ss_pred             CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       335 ~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ...+..+.+      ++.+||+.||++||     ++.+++.+
T Consensus       242 ~~~~~~l~~------~i~~~l~~~p~~Rp-----~~~~~l~~  272 (275)
T cd05046         242 EGCPSRLYK------LMTRCWAVNPKDRP-----SFSELVSA  272 (275)
T ss_pred             CCCCHHHHH------HHHHHcCCCcccCC-----CHHHHHHH
Confidence            344555544      45569999999999     78888763

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=317.81  Aligned_cols=245  Identities=25%  Similarity=0.427  Sum_probs=208.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.+.||.|+||.||+|..       .++.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~-------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDY-------RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQ   71 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEe-------cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence            4556899999999999999999986       457799999875432    45678889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ....|+||||+.+++|.+++....  .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++.
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence            999999999999999999998765  789999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHH
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  342 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~  342 (447)
                      ......  ...++..|+|||++.+..++.++||||||+++|||++ |..||...+..++...+... ....+...+.++.
T Consensus       152 ~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05039         152 ASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVY  229 (256)
T ss_pred             cccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHH
Confidence            643222  3345678999999988889999999999999999997 99999888877776665543 2234445555555


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +      +|.+||..+|++||     ++++++.
T Consensus       230 ~------li~~~l~~~p~~Rp-----~~~~l~~  251 (256)
T cd05039         230 K------VMKDCWELDPAKRP-----TFKQLRE  251 (256)
T ss_pred             H------HHHHHhccChhhCc-----CHHHHHH
Confidence            5      45569999999999     7788775

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.1e-41  Score=314.14  Aligned_cols=249  Identities=33%  Similarity=0.572  Sum_probs=211.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.+.||+|++|.||++.++.     +++.+++|++.....   .....+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   72 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR-----TGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL   72 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC-----CCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            58899999999999999999875     678899999976532   3456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      ++++||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||.+.......
T Consensus        73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            9999999999999998876 689999999999999999999999999999999999999999999999999998775543


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc-ccCCCCC--CchhHHhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAHSLLK  346 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~-~~~~p~~--~~~~~~~li~  346 (447)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+... ....+..  ++.++.    
T Consensus       153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  228 (253)
T cd05122         153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK----  228 (253)
T ss_pred             cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHH----
Confidence            344567899999999999888999999999999999999999999877554444333322 1122222  144444    


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW  378 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~  378 (447)
                        +||.+||+.||++||     ++++++.|||
T Consensus       229 --~~i~~~l~~~p~~R~-----t~~~~l~~~~  253 (253)
T cd05122         229 --DFLKKCLQKNPEKRP-----TAEQLLKHPF  253 (253)
T ss_pred             --HHHHHHccCChhhCC-----CHHHHhcCCC
Confidence              455669999999999     8899999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-41  Score=334.86  Aligned_cols=258  Identities=24%  Similarity=0.438  Sum_probs=205.3

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      .+..++|++.++||+|+||.||+|.+.+..+..+++.||||+++...  .......+.+|+.+|.++ +||||+++++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            45567899999999999999999998766555578899999997543  233455688899999999 689999999987


Q ss_pred             Ee-CCEEEEEEeccCCCChHHHHHHc------------------------------------------------------
Q 013249          185 QT-RSKLYLILDFINGGHLFFHLYRQ------------------------------------------------------  209 (447)
Q Consensus       185 ~~-~~~~~lv~E~~~gg~L~~~l~~~------------------------------------------------------  209 (447)
                      .. +..+++||||+++|+|.+++...                                                      
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            65 45689999999999999988643                                                      


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC---CCCc
Q 013249          210 -------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNS  273 (447)
Q Consensus       210 -------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~---~~~~  273 (447)
                                   ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         236778889999999999999999999999999999999999999999999998653221   1122


Q ss_pred             cccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHH-HHHHHHHhc-ccCCCCCCchhHHhhhhhhhH
Q 013249          274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ-KLQQRIINE-KVKLPPFLTSEAHSLLKGVSF  350 (447)
Q Consensus       274 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~-~~~~~i~~~-~~~~p~~~~~~~~~li~~~~~  350 (447)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+..+ ....|...+.++.      ++
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  314 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY------QT  314 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHH------HH
Confidence            345678999999999999999999999999999997 99999765433 233333222 2233444555444      45


Q ss_pred             HhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          351 LTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       351 l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.+||+.||++||     ++.+|++|
T Consensus       315 ~~~cl~~~p~~Rp-----s~~eil~~  335 (343)
T cd05103         315 MLDCWHGEPSQRP-----TFSELVEH  335 (343)
T ss_pred             HHHHccCChhhCc-----CHHHHHHH
Confidence            6669999999999     88999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.1e-41  Score=322.30  Aligned_cols=254  Identities=23%  Similarity=0.366  Sum_probs=204.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +...+|+++++||+|+||+||+|+++..... ....||+|+++...  .......+.+|+.+++.++||||+++++++..
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGEN-VKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCc-cceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            3456899999999999999999997652211 12358999987542  23344568889999999999999999998875


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                       ...+++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence             4578999999999999999764 56999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCC---CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchh
Q 013249          266 DESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (447)
Q Consensus       266 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  340 (447)
                      ......   ....++..|+|||.+.+..++.++|||||||++|||++ |..||.......+...+.... ...+...+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence            432221   12234678999999999999999999999999999998 999998877766665554432 2334445555


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.+      ++.+||+.||++||     ++.+++.
T Consensus       240 ~~~------li~~~l~~dp~~Rp-----~~~~l~~  263 (279)
T cd05109         240 VYM------IMVKCWMIDSECRP-----RFRELVD  263 (279)
T ss_pred             HHH------HHHHHcCCChhhCc-----CHHHHHH
Confidence            444      55569999999999     7788875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.3e-41  Score=322.38  Aligned_cols=258  Identities=28%  Similarity=0.506  Sum_probs=217.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..+.|++.+.||+|+||.||++.+..     +++.|++|++.....    ..+.+.+|+.+++.++|+||+++++.+...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   87 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA-----TGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVG   87 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc-----CCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence            34579999999999999999999875     678899999975432    345678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ...|+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999999999998876 89999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CC--CCCCchhHH
Q 013249          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KL--PPFLTSEAH  342 (447)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~--p~~~~~~~~  342 (447)
                      ... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..... ..  +..++.++.
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence            321 22344678899999999988899999999999999999999999988776665555543322 11  112444444


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      +      ||.+||+.+|.+||     ++++++.|+||....|.
T Consensus       248 ~------li~~~l~~~p~~Rp-----t~~~il~~~~~~~~~~~  279 (286)
T cd06614         248 D------FLNKCLVKDPEKRP-----SAEELLQHPFLKKACPK  279 (286)
T ss_pred             H------HHHHHhccChhhCc-----CHHHHhhChHhhccCch
Confidence            4      55669999999999     88999999999985543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.7e-41  Score=316.45  Aligned_cols=251  Identities=28%  Similarity=0.522  Sum_probs=215.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|++.++||+|+||.||+++++.     +++.+|+|.+...... ......+.+|+.+++.++|+||+++++++......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS-----DNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC-----CCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            58999999999999999998876     7789999999765432 33445677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          191 YLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      |+||||+++++|..++.+    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+++...
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            999999999999998876    3568999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhh
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  345 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li  345 (447)
                      .. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..... ..+...+.++.+  
T Consensus       155 ~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  231 (256)
T cd08530         155 KN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQN--  231 (256)
T ss_pred             cC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHH--
Confidence            54 33345688999999999998899999999999999999999999998887777666655443 233334444444  


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                          ++.+||..+|++||     +++++++||+.
T Consensus       232 ----li~~~l~~~p~~Rp-----~~~~~l~~p~~  256 (256)
T cd08530         232 ----FIRSMLQVKPKLRP-----NCDKILASPAV  256 (256)
T ss_pred             ----HHHHHcCCCcccCC-----CHHHHhcCCCC
Confidence                55669999999999     88999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=352.58  Aligned_cols=308  Identities=47%  Similarity=0.816  Sum_probs=275.8

Q ss_pred             eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEEEEEEe
Q 013249          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       117 ~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      ++|+|+||.|++++..+-.  ..+..||+|+.++......... .-..|..++..++ ||++|+++..|+.....+++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~--da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGA--DAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccc--cccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            4799999999998765433  3778899999988765444333 5567899999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccc
Q 013249          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC  275 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~  275 (447)
                      +..||+|+..+.....+.+...+.+...++.+++++|+.||+|||+|++||+++.+|++|+.|||+++........   |
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---c  154 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---C  154 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---c
Confidence            9999999999999999999999999999999999999999999999999999999999999999999986554333   9


Q ss_pred             cCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhc
Q 013249          276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLL  355 (447)
Q Consensus       276 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L  355 (447)
                      ||..|||||++.  ++..++|+||||++++||++|..||..    ++..+|...+..+|...+.++++++..      ++
T Consensus       155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~------l~  222 (612)
T KOG0603|consen  155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQ------LF  222 (612)
T ss_pred             cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHH------HH
Confidence            999999999998  788899999999999999999999987    788889998999999999998888776      99


Q ss_pred             cCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCCC--CCCCCcc
Q 013249          356 HKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP--TAGEHFK  433 (447)
Q Consensus       356 ~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~f~  433 (447)
                      .++|.+|+++++..+.++++|+||..++|..+..++.+|+|+|.+..+.+..+|+..|+...+.+++...+  .+...|.
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~  302 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFS  302 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhc
Confidence            99999999998889999999999999999999999999999999999999999999999987777766443  4457899


Q ss_pred             CeeeeCCCc
Q 013249          434 GYTYVAPNP  442 (447)
Q Consensus       434 ~~~~~~~~~  442 (447)
                      ||+|+++..
T Consensus       303 g~sfva~~i  311 (612)
T KOG0603|consen  303 GPSFVAPGV  311 (612)
T ss_pred             CCCccChHH
Confidence            999998863

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-40  Score=317.06  Aligned_cols=250  Identities=28%  Similarity=0.485  Sum_probs=206.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|.++..........+.+.+|+.++++++|+||+++++.+...+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL-----DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC-----CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            589999999999999999999875     778999999876544445556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .++||||+++++|..++..    ...+++.+++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            9999999999999988864    245899999999999999999999999999999999999999999999999998875


Q ss_pred             cCCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC--HHHHHHHHHhccc-CCCC-CCchh
Q 013249          266 DESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRIINEKV-KLPP-FLTSE  340 (447)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~--~~~~~~~i~~~~~-~~p~-~~~~~  340 (447)
                      .... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....  ..+....+..+.. ..|. ..+.+
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             cCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            4332 2334578999999999999899999999999999999999999996543  2334444433322 2222 33444


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.      ++|.+||..+|++||     ++.+|++
T Consensus       237 ~~------~~i~~cl~~~p~~Rp-----~~~~il~  260 (267)
T cd08224         237 LR------DLVSRCINPDPEKRP-----DISYVLQ  260 (267)
T ss_pred             HH------HHHHHHcCCCcccCC-----CHHHHHH
Confidence            44      456669999999999     7777764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-41  Score=329.08  Aligned_cols=260  Identities=27%  Similarity=0.443  Sum_probs=201.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  188 (447)
                      .|++.++||+|+||.||+|.++..   ..++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.  .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence            488999999999999999998642   15789999999874433334445677899999999999999999999988  8


Q ss_pred             EEEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC----CCcEEEeec
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----DGHVMLTDF  259 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~----~~~~kL~DF  259 (447)
                      .+|+||||+.+ +|...+...     ..+++..++.++.||+.||.|||+++|+||||||+|||++.    ++.+||+||
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            89999999975 566655422     36899999999999999999999999999999999999999    999999999


Q ss_pred             CCcccccCCCC----CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHH---------HHHH
Q 013249          260 GLAKEIDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQK---------LQQR  325 (447)
Q Consensus       260 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~---------~~~~  325 (447)
                      |+++.......    ....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+...         ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987543222    234578899999998876 458899999999999999999999997554321         1111


Q ss_pred             HHhcc-----------cCCCC-----------CCc-hhHHh--------hhhhhhHHhhhccCCCCCCCCCCCCChhhhh
Q 013249          326 IINEK-----------VKLPP-----------FLT-SEAHS--------LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIK  374 (447)
Q Consensus       326 i~~~~-----------~~~p~-----------~~~-~~~~~--------li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~  374 (447)
                      +...-           ...+.           ..+ .....        .....+++.+||+.||++||     ++++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----s~~eil  311 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI-----TAEEAL  311 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc-----CHHHHh
Confidence            11100           00000           000 11111        11235788889999999999     889999


Q ss_pred             cCCcc
Q 013249          375 HHKWF  379 (447)
Q Consensus       375 ~h~~f  379 (447)
                      .||||
T Consensus       312 ~~~~f  316 (316)
T cd07842         312 EHPYF  316 (316)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-41  Score=334.15  Aligned_cols=256  Identities=21%  Similarity=0.318  Sum_probs=200.2

Q ss_pred             eeEeec--CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 013249          116 RVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (447)
Q Consensus       116 ~~lG~G--~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  193 (447)
                      ..||+|  +||+||+++++.     +++.||+|++..... .....+.+.+|+.+++.++||||++++++|..++.+|+|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP-----TGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC-----CCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            346666  999999999876     789999999876542 234557889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC-
Q 013249          194 LDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-  270 (447)
Q Consensus       194 ~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~-  270 (447)
                      |||+.+++|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+........ 
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            9999999999988765  3589999999999999999999999999999999999999999999999986543221111 


Q ss_pred             -------CCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC-----
Q 013249          271 -------SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF-----  336 (447)
Q Consensus       271 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~-----  336 (447)
                             .....++..|+|||++.+  ..++.++|||||||++|||++|+.||...........+.......|..     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence                   111234667999999976  357899999999999999999999998766554444333322111100     


Q ss_pred             ----------------------------------Cch--hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          337 ----------------------------------LTS--EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       337 ----------------------------------~~~--~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                                                        ...  .........+||++||+.||++||     +++++++|+||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----ta~e~l~~~~~~  312 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP-----SASSLLSHAFFK  312 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC-----CHHHHhhCHHHH
Confidence                                              000  000011235788889999999999     899999999997


Q ss_pred             CC
Q 013249          381 SI  382 (447)
Q Consensus       381 ~~  382 (447)
                      ++
T Consensus       313 ~~  314 (328)
T cd08226         313 QV  314 (328)
T ss_pred             HH
Confidence            54

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-41  Score=321.42  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=207.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ..+|+++++||.|+||.||+|.++      .++.+|+|++....   ....+.+..|+.+++.++|+||+++++++....
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~------~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   75 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWK------NRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE   75 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEec------CCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence            457999999999999999999986      46779999987643   223456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .+|+||||+++++|.+++...  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            999999999999999999763  468999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHHh
Q 013249          267 ESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  343 (447)
Q Consensus       267 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~  343 (447)
                      .... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+... ....+...+.++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYK  235 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHH
Confidence            3221 223345678999999998889999999999999999998 89999888877777776644 22344455555554


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                            ++.+||+.||.+||     ++++|++
T Consensus       236 ------~i~~~l~~~p~~Rp-----t~~~l~~  256 (261)
T cd05148         236 ------IMLECWAAEPEDRP-----SFKALRE  256 (261)
T ss_pred             ------HHHHHcCCCchhCc-----CHHHHHH
Confidence                  45569999999999     7777764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-41  Score=326.03  Aligned_cols=258  Identities=21%  Similarity=0.388  Sum_probs=211.2

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (447)
                      .+..++|.+.+.||+|+||.||+|++.....  ...+..+|+|.+....  .......+.+|+.+++.+ +||||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            4556789999999999999999998654221  1245679999987542  233456688999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCc
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NI  246 (447)
                      ++.....+|+||||+.+|+|..++.+.                ..++...+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            999999999999999999999999764                2467788999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHH
Q 013249          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~  322 (447)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999999987643221   223345678999999998889999999999999999998 8999998888888


Q ss_pred             HHHHHhccc-CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          323 QQRIINEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       323 ~~~i~~~~~-~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ...+..... ..+...+.++.++      +.+||..+|.+||     ++.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~l------i~~cl~~~p~~Rp-----s~~e~l~~  292 (304)
T cd05101         249 FKLLKEGHRMDKPANCTNELYMM------MRDCWHAIPSHRP-----TFKQLVED  292 (304)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHH------HHHHcccChhhCC-----CHHHHHHH
Confidence            777765432 2344455555554      5559999999999     77888763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.8e-41  Score=323.41  Aligned_cols=255  Identities=22%  Similarity=0.386  Sum_probs=209.9

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.+.||+|+||.||+|.+++...+.++..||+|++....  .......+.+|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            346899999999999999999998754444467889999987542  233445688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                      ...|+||||+.+|+|.+++....                      .+++.++..++.||+.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                      36788899999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~  321 (447)
                      ||++.++.+||+|||++........   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876532211   122344677999999998899999999999999999998 889998888887


Q ss_pred             HHHHHHhccc-CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          322 LQQRIINEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       322 ~~~~i~~~~~-~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ....+..... ..+...+.++.+      |+.+||+.||.+||     +++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~------li~~~l~~~p~~Rp-----t~~el~~  284 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYN------LMRLCWSKLPSDRP-----SFASINR  284 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHH------HHHHHcccCcccCC-----CHHHHHH
Confidence            7777665543 234445555544      55669999999999     6777764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.6e-41  Score=318.77  Aligned_cols=247  Identities=25%  Similarity=0.408  Sum_probs=201.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.++||+|+||.||+|++.+      ...+|+|++.+...    ..+.+.+|+++++.++||||+++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   72 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE   72 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecC------CceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC
Confidence            445689999999999999999998753      34599999875432    12457889999999999999999988754


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                       ...|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||.++.
T Consensus        73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~  151 (262)
T cd05071          73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  151 (262)
T ss_pred             -CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence             5689999999999999999764  3579999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchh
Q 013249          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  340 (447)
                      +.....  .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.... ...+...+..
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd05071         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  231 (262)
T ss_pred             ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHH
Confidence            643322  123346778999999998889999999999999999999 899998887777766665432 2223334444


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.      +++.+||++||++||     ++++++.
T Consensus       232 l~------~li~~~l~~~p~~Rp-----~~~~~~~  255 (262)
T cd05071         232 LH------DLMCQCWRKEPEERP-----TFEYLQA  255 (262)
T ss_pred             HH------HHHHHHccCCcccCC-----CHHHHHH
Confidence            43      456679999999999     6677664

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.9e-40  Score=324.15  Aligned_cols=256  Identities=24%  Similarity=0.381  Sum_probs=210.2

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |...++||+|+||+||+|++..     +++.|++|++.............+.+|+.+++.++|||++++++++.+....|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH-----TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC-----CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            6777889999999999999865     78899999997654444455567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      +||||+.+ +|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....   
T Consensus        98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633          98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            99999964 67666654 45789999999999999999999999999999999999999999999999999865322   


Q ss_pred             CCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-CC-CCCchhHHhhh
Q 013249          271 SNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LP-PFLTSEAHSLL  345 (447)
Q Consensus       271 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-~p-~~~~~~~~~li  345 (447)
                      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...+.......+...... .+ ..++..+    
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l----  249 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF----  249 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH----
Confidence            33567899999999985   356788999999999999999999999887766555555443221 11 1223333    


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHH
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  387 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~  387 (447)
                        .+|+.+||+++|.+||     ++.++++||||...+-..+
T Consensus       250 --~~li~~~l~~~P~~Rp-----~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         250 --RGFVDYCLQKIPQERP-----ASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             --HHHHHHHccCChhhCc-----CHHHHhcCcccCCCchhHH
Confidence              3567779999999999     8899999999987664443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.9e-41  Score=330.12  Aligned_cols=259  Identities=21%  Similarity=0.392  Sum_probs=210.8

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  181 (447)
                      +.+...+|++++.||+|+||.||+|++.+....  .....+|+|++....  .....+.+.+|+.+++++ +||||++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            345556899999999999999999987653322  123468999887532  233456788999999999 799999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                      +++...+.+|+||||+.+|+|.+++.+..                .++..++..++.||+.||.|||++||+||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            99999999999999999999999987642                36778899999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~  321 (447)
                      ||++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999987543221   122234567999999999999999999999999999998 899999888888


Q ss_pred             HHHHHHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          322 LQQRIINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       322 ~~~~i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ....+.... ...+...+.++.++      +.+||+.+|.+||     ++++++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~l------i~~cl~~~p~~Rp-----s~~ell~~  289 (334)
T cd05100         245 LFKLLKEGHRMDKPANCTHELYMI------MRECWHAVPSQRP-----TFKQLVED  289 (334)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHH------HHHHcccChhhCc-----CHHHHHHH
Confidence            777766543 23444455555444      5559999999999     78898875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.7e-41  Score=320.94  Aligned_cols=250  Identities=21%  Similarity=0.345  Sum_probs=201.0

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC----
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR----  187 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----  187 (447)
                      |.+.++||+|+||.||+|++....   ....+|+|.++... ......+.+.+|+.+++.++|+||+++++.+...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~---~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD---SILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC---CeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            356789999999999999986511   12368999887643 2344566788899999999999999999977432    


Q ss_pred             --CEEEEEEeccCCCChHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          188 --SKLYLILDFINGGHLFFHLYR------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                        ...++||||+.+|+|..++..      ...+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+||
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence              257899999999999887742      134889999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCC
Q 013249          260 GLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLP  334 (447)
Q Consensus       260 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p  334 (447)
                      |+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |+.||......++...+..+.. ..+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP  236 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99987643221   122346778999999999999999999999999999999 8999988877777777665432 344


Q ss_pred             CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       335 ~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ...+..+.+      +|.+||+.||++||     ++++|+++
T Consensus       237 ~~~~~~~~~------li~~~l~~~p~~Rp-----s~~~l~~~  267 (272)
T cd05075         237 PDCLDGLYS------LMSSCWLLNPKDRP-----SFETLRCE  267 (272)
T ss_pred             CCCCHHHHH------HHHHHcCCCcccCc-----CHHHHHHH
Confidence            455555544      55569999999999     78888763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.5e-41  Score=318.68  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=205.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++...  ..+..+|+|.++...  .....+.+.+|+.++++++||||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPG--KREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCC--CCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            458999999999999999999876421  134579999986542  2334567888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+++++|.+++.+. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..+..
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999999999775 4689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhH
Q 013249          268 SSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEA  341 (447)
Q Consensus       268 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~  341 (447)
                      ...    .....++..|+|||++.+..++.++|+|||||++|||++ |..||...+..+....+.... ...+...+..+
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL  238 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHH
Confidence            221    111223568999999998889999999999999999887 999998877776666665442 12223344444


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .      +++.+||+++|.+||     ++.++++
T Consensus       239 ~------~li~~~l~~~p~~Rp-----~~~~i~~  261 (267)
T cd05066         239 H------QLMLDCWQKDRNERP-----KFEQIVS  261 (267)
T ss_pred             H------HHHHHHcccCchhCC-----CHHHHHH
Confidence            4      456669999999999     6777764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-41  Score=332.07  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=204.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|++.+.||+|+||.||++.++.     +++.||+|++.+... .....+.+.+|+.++++++||||+++++++... 
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcC-----CCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            4689999999999999999998875     788999999875421 223345677899999999999999999988643 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                           ..+|++++++ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence                 3478899887 7788777754 46899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC----C
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF----L  337 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~----~  337 (447)
                      +....  ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.......++.    +
T Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            86543  2334578999999999876 568899999999999999999999998776655544443321111000    0


Q ss_pred             c-hhH---------------H-----hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          338 T-SEA---------------H-----SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       338 ~-~~~---------------~-----~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      . ...               .     ..-...+||.+||+.||.+|+     ++.+++.||||..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~f~~  305 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQ  305 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC-----CHHHHhcChhhhh
Confidence            0 000               0     001224678889999999999     8899999999974

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.6e-41  Score=316.90  Aligned_cols=244  Identities=25%  Similarity=0.445  Sum_probs=202.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE-
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  185 (447)
                      +...+|++.+.||+|+||.||++..+       +..+|+|.++...     ..+.+.+|+.++++++|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE   70 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEc-------CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence            44568999999999999999999763       5678999886432     2346788999999999999999998764 


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      ....+|+||||+++++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence            5567999999999999999987654  48899999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhH
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~  341 (447)
                      ......  ....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+..+ ....+...+..+
T Consensus       151 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05082         151 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV  228 (256)
T ss_pred             eccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            654322  23345678999999998899999999999999999997 99999888777777666544 223344555555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++      +.+||+.||++||     +++++++
T Consensus       229 ~~l------i~~~l~~~p~~Rp-----t~~~l~~  251 (256)
T cd05082         229 YDV------MKQCWHLDAATRP-----SFLQLRE  251 (256)
T ss_pred             HHH------HHHHhcCChhhCc-----CHHHHHH
Confidence            554      5569999999999     7788764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-41  Score=317.50  Aligned_cols=234  Identities=33%  Similarity=0.575  Sum_probs=195.9

Q ss_pred             cCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCC
Q 013249          121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG  200 (447)
Q Consensus       121 G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg  200 (447)
                      |.||.||+|+++.     +++.||+|.+.+...        ...|...+....||||+++++++.....+|+||||+.||
T Consensus         4 g~~~~v~~~~~~~-----~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   70 (237)
T cd05576           4 GVIDKVLLVMDTR-----TQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG   70 (237)
T ss_pred             cccceEEEEEEcc-----CCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence            8999999999886     788999999976431        234555555667999999999999999999999999999


Q ss_pred             ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccccCCcc
Q 013249          201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY  280 (447)
Q Consensus       201 ~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y  280 (447)
                      +|.+++.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+......  .....++..|
T Consensus        71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y  148 (237)
T cd05576          71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMY  148 (237)
T ss_pred             CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccc
Confidence            99999988888999999999999999999999999999999999999999999999999988765442  2344567889


Q ss_pred             cccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCC
Q 013249          281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS  360 (447)
Q Consensus       281 ~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~  360 (447)
                      +|||.+.+..++.++||||+||++|||++|+.||...... ..   ......+|..++..+.++      |.+||+.||+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~l------i~~~l~~dp~  218 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN---THTTLNIPEWVSEEARSL------LQQLLQFNPT  218 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc---cccccCCcccCCHHHHHH------HHHHccCCHH
Confidence            9999998888999999999999999999999988643211 00   012234566666666555      4459999999


Q ss_pred             CCCCCCCCChhhhhcCCcc
Q 013249          361 KRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       361 ~R~~~~~~~~~~l~~h~~f  379 (447)
                      +|++++..+++++++||||
T Consensus       219 ~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         219 ERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HhcCCCccchHHHHcCCCC
Confidence            9998877788999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-40  Score=317.80  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=206.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|.++....  .+..||||++....  .......+..|+.+++.++||||+++++++.++.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGK--REIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCC--CceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            3579999999999999999999875221  34579999987542  3444567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+++||||+.+++|.+++... +.+++.+++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999999998764 5689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCCc----cc--cCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCch
Q 013249          268 SSRSNS----MC--GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (447)
Q Consensus       268 ~~~~~~----~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~  339 (447)
                      ......    ..  .+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ....+...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT  238 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence            221111    11  2457999999999999999999999999999886 99999888877777766433 1223334444


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+.      +++.+||..+|++||     ++++|+.
T Consensus       239 ~~~------~li~~~l~~~p~~Rp-----~~~~i~~  263 (269)
T cd05065         239 ALH------QLMLDCWQKDRNARP-----KFGQIVS  263 (269)
T ss_pred             HHH------HHHHHHcCCChhhCc-----CHHHHHH
Confidence            444      456669999999999     7788875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.7e-41  Score=318.48  Aligned_cols=246  Identities=23%  Similarity=0.414  Sum_probs=202.6

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.++||+|+||.||+|.+.      .+..+|+|.+.....    ..+.+.+|+.++++++|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~------~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-   71 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN------GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-   71 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec------CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-
Confidence            44568999999999999999999865      455699999876432    1245788999999999999999998875 


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ....|+||||+.+++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||++..
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~  151 (260)
T cd05070          72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARL  151 (260)
T ss_pred             CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeee
Confidence            45689999999999999998764  4589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchh
Q 013249          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~  340 (447)
                      +.....  .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+... ....+...+..
T Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd05070         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS  231 (260)
T ss_pred             ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            643221  122345678999999988889999999999999999999 99999888877777766543 22334444555


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhh
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIK  374 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~  374 (447)
                      +.+      |+.+||.+||++||     +++++.
T Consensus       232 ~~~------li~~~l~~~p~~Rp-----t~~~l~  254 (260)
T cd05070         232 LHE------LMLQCWKKDPEERP-----TFEYLQ  254 (260)
T ss_pred             HHH------HHHHHcccCcccCc-----CHHHHH
Confidence            444      55669999999999     667765

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.6e-41  Score=317.27  Aligned_cols=247  Identities=21%  Similarity=0.380  Sum_probs=204.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+++++||+|+||.||+|..+      .++.||+|.+.....    ....+.+|+.++++++|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC------CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            45678999999999999999999865      457799999875432    2345788999999999999999998864 


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .+.+|+||||+.+++|.+++...  ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  151 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL  151 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence            56789999999999999998754  4689999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchh
Q 013249          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  340 (447)
                      ......  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+....+.... ...+...+.+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd05067         152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE  231 (260)
T ss_pred             cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHH
Confidence            653221  123346778999999998889999999999999999999 999998887777666654432 2334445555


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.+      ++.+||..||++||     ++++++.
T Consensus       232 ~~~------li~~~l~~~p~~Rp-----~~~~l~~  255 (260)
T cd05067         232 LYE------LMRLCWKEKPEERP-----TFEYLRS  255 (260)
T ss_pred             HHH------HHHHHccCChhhCC-----CHHHHHH
Confidence            544      45569999999999     7787764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.3e-41  Score=332.12  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=202.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (447)
                      ++|++.+.||.|+||.||+|.++.     +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~-----~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSD-----CDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECC-----CCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            589999999999999999999876     78899999986543   23446678899999999999999999776543  


Q ss_pred             ------------CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC-CCCcE
Q 013249          188 ------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHV  254 (447)
Q Consensus       188 ------------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~~  254 (447)
                                  ..+|+||||+. ++|...+. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence                        36899999997 58877775 45789999999999999999999999999999999999997 45678


Q ss_pred             EEeecCCcccccCCCC----CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 013249          255 MLTDFGLAKEIDESSR----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE  329 (447)
Q Consensus       255 kL~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~  329 (447)
                      ||+|||+++.+.....    .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999986533211    123467889999998754 56889999999999999999999999877766555544432


Q ss_pred             ccCC------------------------------CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          330 KVKL------------------------------PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       330 ~~~~------------------------------p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ....                              .+.++.      ...+||.+||+.||.+||     +++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~li~~~L~~dP~~R~-----t~~ell~h~~~  303 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP------EALDFLEQILTFNPMDRL-----TAEEALMHPYM  303 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCH------HHHHHHHHHhCCCchhcc-----CHHHHhCCCcc
Confidence            1100                              001112      234678889999999999     88999999999


Q ss_pred             CCC
Q 013249          380 RSI  382 (447)
Q Consensus       380 ~~~  382 (447)
                      +..
T Consensus       304 ~~~  306 (342)
T cd07854         304 SCY  306 (342)
T ss_pred             ccc
Confidence            754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=320.30  Aligned_cols=255  Identities=30%  Similarity=0.534  Sum_probs=206.3

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  190 (447)
                      |++.+.||+|+||.||+|..+.     +++.||||.+......  .......+|+..+++++ |+||+++++++..++..
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   73 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE-----TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL   73 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC-----CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence            6788999999999999999875     6788999998754321  11223456899999999 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      |+||||+ +|+|.+++....  .+++.++..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            9999999 789998887765  7899999999999999999999999999999999999999999999999999877654


Q ss_pred             CCCCccccCCccccccccc-CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc----------------
Q 013249          269 SRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------------  331 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~----------------  331 (447)
                      .......++..|+|||++. ...++.++|+||||+++|||++|+.||...+..+....+.....                
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            4445567899999999885 45578999999999999999999999987766555544432111                


Q ss_pred             ---CCCCCCchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 ---KLPPFLTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ---~~p~~~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         .++.........+     -...+||++||+.||++||     ++++++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP-----TASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC-----CHHHHhhCCCC
Confidence               1111111111111     1235778889999999999     88999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.2e-40  Score=324.22  Aligned_cols=252  Identities=24%  Similarity=0.389  Sum_probs=209.5

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|+..+.||+|+||.||++++..     ++..+|+|++.............+.+|+++++.++|||++++++++.+....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcC-----CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence            48888999999999999999875     7789999998765433444556788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      |+||||+.| +|.+.+.. ...+++.++..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....  
T Consensus       101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            999999975 66666644 46789999999999999999999999999999999999999999999999999876443  


Q ss_pred             CCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-C-CCCCchhHHhh
Q 013249          270 RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-L-PPFLTSEAHSL  344 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-~-p~~~~~~~~~l  344 (447)
                       .....|+..|+|||++.   ...++.++|||||||++|||++|+.||...+.......+...... . +...+..+.  
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--  254 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR--  254 (317)
T ss_pred             -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHH--
Confidence             23457889999999984   456889999999999999999999999887766666665554322 1 123344444  


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                          +|+.+||+.+|.+||     +++++++|+|+...
T Consensus       255 ----~li~~~l~~~p~~Rp-----t~~~il~~~~~~~~  283 (317)
T cd06635         255 ----NFVDSCLQKIPQDRP-----TSEELLKHMFVLRE  283 (317)
T ss_pred             ----HHHHHHccCCcccCc-----CHHHHHhChhhhcc
Confidence                456669999999999     88999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=316.57  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=207.0

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.++||.|+||.||+|.++      .++.+|||.+.....    ..+.+.+|+.++++++|+||+++++++..
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~------~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN------GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSE   72 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc------CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence            55679999999999999999999865      346799999875432    23457889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ....++||||+++++|.+++....  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..
T Consensus        73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcccccee
Confidence            899999999999999999997653  689999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchh
Q 013249          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  340 (447)
                      +.....  .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+.......+.... ...+...+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05034         153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE  232 (261)
T ss_pred             ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            643211  112234578999999998889999999999999999998 999998888777777765542 2334444555


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.+      ++.+||+.||++||     +++++.+
T Consensus       233 ~~~------~i~~~l~~~p~~Rp-----~~~~l~~  256 (261)
T cd05034         233 LYD------LMLQCWDKDPEERP-----TFEYLQS  256 (261)
T ss_pred             HHH------HHHHHcccCcccCC-----CHHHHHH
Confidence            544      55669999999999     6777763

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-41  Score=320.50  Aligned_cols=249  Identities=32%  Similarity=0.526  Sum_probs=203.9

Q ss_pred             EEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 013249          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL  192 (447)
Q Consensus       113 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  192 (447)
                      ++.+.||.|.||.||+|.++. .....+..|+||+++..  ......+.+.+|++++++++||||+++++++...+.+++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccc
Confidence            467899999999999999984 22336788999999543  234446778899999999999999999999998888999


Q ss_pred             EEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          193 ILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       193 v~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      ||||+.+|+|.+++...  ..+++.++..++.||+.||.|||+++|+|+||+++|||++.++.+||+|||++........
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999987  6799999999999999999999999999999999999999999999999999987632211


Q ss_pred             ---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhh
Q 013249          271 ---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  345 (447)
Q Consensus       271 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li  345 (447)
                         .....+...|+|||.+....++.++||||||+++|||++ |+.||...+..++...+..... ..+..++..+.+++
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence               223456788999999998889999999999999999999 7899998888888877755433 34556677776665


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..      ||..||++||     ++++|++
T Consensus       239 ~~------C~~~~p~~RP-----s~~~i~~  257 (259)
T PF07714_consen  239 QQ------CWSHDPEKRP-----SFQEILQ  257 (259)
T ss_dssp             HH------HT-SSGGGS-------HHHHHH
T ss_pred             HH------HcCCChhhCc-----CHHHHHh
Confidence            54      9999999999     7788764

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.7e-41  Score=324.92  Aligned_cols=254  Identities=27%  Similarity=0.466  Sum_probs=204.3

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.+.||+|+||.||+|.++.     +++.||+|+++.... .......+.+|+.++++++||||+++++++.+.
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~   78 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKD-----TGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDK   78 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECC-----CCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence            34689999999999999999999875     678999999876432 222334567899999999999999999998765


Q ss_pred             C----------EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEE
Q 013249          188 S----------KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (447)
Q Consensus       188 ~----------~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL  256 (447)
                      .          .+|+||||+++ +|...+... ..+++.+++.++.||+.||.|||++||+||||||+||++++++.+||
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEe
Confidence            4          89999999986 666666543 46899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCC--CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-
Q 013249          257 TDFGLAKEIDESSR--SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-  332 (447)
Q Consensus       257 ~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-  332 (447)
                      +|||++........  .....++..|+|||++.+ ..++.++|||||||++|||++|++||...+..+....+...... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999987644321  223356788999998865 45788999999999999999999999877666555554432111 


Q ss_pred             ----CC-------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          333 ----LP-------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       333 ----~p-------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                          +|                         ..++..      ..++|.+||+.||.+||     ++++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~~l~~~P~~Rp-----~~~~il~~~~~  302 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTP------ALDLLDHMLTLDPSKRC-----TAEEALNSPWL  302 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHH------HHHHHHHHccCChhhCC-----CHHHHhcCCCC
Confidence                00                         011222      34677789999999999     88999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=315.27  Aligned_cols=244  Identities=19%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      ++||+|+||.||+|.+.....  ....+|+|.+......  ...+.+.+|+.+++.++|+||+++++++. ...+++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~--~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCC--CcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            479999999999998765221  3478999998865432  34456888999999999999999999876 456899999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCC----
Q 013249          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----  271 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~----  271 (447)
                      |+.+++|.+++...+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++........    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            9999999999998888999999999999999999999999999999999999999999999999999876433221    


Q ss_pred             CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhHHhhhhhhh
Q 013249          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~~  349 (447)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.... ...|...+..+.+      
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~------  229 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS------  229 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHH------
Confidence            11123467999999998899999999999999999998 999998887777666665443 2344455555544      


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.+||..||++||     ++.++++
T Consensus       230 li~~cl~~~p~~Rp-----~~~~l~~  250 (257)
T cd05060         230 IMLSCWKYRPEDRP-----TFSELES  250 (257)
T ss_pred             HHHHHhcCChhhCc-----CHHHHHH
Confidence            45569999999999     7777764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.4e-41  Score=330.65  Aligned_cols=261  Identities=26%  Similarity=0.436  Sum_probs=205.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (447)
                      ++|.+.+.||+|+||.||+|.++.     +++.||||++.+... .......+.+|+.+++.++||||+++++++...  
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKR-----TGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCC-----CCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            589999999999999999999875     788999999876432 223345577899999999999999999998754  


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                          ..+|+||||+.+ +|..++  ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          89 GDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             CCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence                357999999964 666554  3468999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC----------
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----------  332 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~----------  332 (447)
                      ....  ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+......          
T Consensus       166 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         166 HADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            6533  2334578899999999876 46889999999999999999999999887765555444331100          


Q ss_pred             ----------CCCCCchhHHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          333 ----------LPPFLTSEAHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       333 ----------~p~~~~~~~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                                .+.........     .-..++||.+||+.||.+||     ++++++.||||+.+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~-----~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL-----TATEALEHPYFDSFRDAD  307 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc-----CHHHHhcCcchhhccccc
Confidence                      00000000000     01234678889999999999     889999999998876433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-41  Score=331.81  Aligned_cols=258  Identities=27%  Similarity=0.440  Sum_probs=208.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTK-----TGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS   87 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECC-----CCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence            4689999999999999999999876     77899999986542 22334456778999999999999999998887655


Q ss_pred             E------EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          189 K------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       189 ~------~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      .      +|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        88 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          88 SLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence            4      99999999 6789888765 57999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC-----
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF-----  336 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~-----  336 (447)
                      ......  .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.......++.     
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            876443  334578899999999865 467899999999999999999999998877766665554432111100     


Q ss_pred             Cch---------------hHH-----hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          337 LTS---------------EAH-----SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       337 ~~~---------------~~~-----~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ...               ...     ......+||.+||+.||++||     ++++|++||||..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp-----t~~ell~h~~~~~  303 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI-----TAAEALAHPYLAE  303 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC-----CHHHHhcCCCccc
Confidence            000               000     011234678889999999999     8899999999984

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-40  Score=322.78  Aligned_cols=259  Identities=31%  Similarity=0.499  Sum_probs=206.0

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      ..+..++|++.+.||+|+||.||+|.++.     +++.||||.+.+...  ......+..|+.++.+. .||||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~   82 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKK-----TGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGY   82 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECC-----CCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence            34566789999999999999999999875     688999999976432  22334455677766666 49999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      +.+...+|+||||+. ++|...+.. .+.+++..+..++.||+.||.|||+ +||+||||+|+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          83 FITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             eecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence            999999999999985 466666554 4678999999999999999999997 6999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccccccccCCC----CCCccceeehhHhHHHHhhCCCCCCCCCH-HHHHHHHHhccc-CCCC
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKV-KLPP  335 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~~-~~p~  335 (447)
                      +..+..........++..|+|||++.+..    ++.++||||||+++|+|++|+.||..... .+....+..... .++.
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T cd06618         162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP  241 (296)
T ss_pred             chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence            98765444444456888999999997653    78899999999999999999999976432 334444443322 2222


Q ss_pred             --CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          336 --FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       336 --~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                        .++.++      .+|+.+||..||++||     ++++++.|+||...
T Consensus       242 ~~~~~~~l------~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~  279 (296)
T cd06618         242 NEGFSPDF------CSFVDLCLTKDHRKRP-----KYRELLQHPFIRRY  279 (296)
T ss_pred             CCCCCHHH------HHHHHHHccCChhhCC-----CHHHHhcChhhhcc
Confidence              134444      4456679999999999     88999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-41  Score=321.97  Aligned_cols=256  Identities=27%  Similarity=0.497  Sum_probs=207.8

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |++.+.||.|++|.||+|.+..     +++.+++|.+..... .......+.+|+.+|++++|+||+++++++..+..+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL-----TGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC-----CCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            6778899999999999999865     788899999876532 2234456788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      +||||+.+ +|...+... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....... 
T Consensus        75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            99999975 787777663 689999999999999999999999999999999999999999999999999998765433 


Q ss_pred             CCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC----------------
Q 013249          270 RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----------------  332 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~----------------  332 (447)
                      ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+......                
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            22334678899999999876 7899999999999999999999999887776655554432111                


Q ss_pred             ---CCCCCchhHHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          333 ---LPPFLTSEAHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       333 ---~p~~~~~~~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         ++.........     ....++||.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI-----TAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc-----CHHHHhhCCCC
Confidence               11111111010     11235778889999999999     88999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-41  Score=320.60  Aligned_cols=256  Identities=30%  Similarity=0.511  Sum_probs=209.1

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |++.+.||+|+||.||+|+...     +++.||+|++.... ......+.+..|+.+++.++|+||+++++++...+.+|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK-----TGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecC-----CCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            6778899999999999999876     68899999998654 22333456778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      +||||+. ++|.+++.+. ..+++..++.++.|++.||.|||++||+||||+|+||++++++.+||+|||+++...... 
T Consensus        75 ~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             EEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            9999997 5899999876 579999999999999999999999999999999999999999999999999998764432 


Q ss_pred             CCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc------------------c
Q 013249          270 RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE------------------K  330 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~------------------~  330 (447)
                      ......++..|+|||++.+. .++.++|||||||++|||++|+.||...+..+...++...                  .
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            22334567889999998776 7899999999999999999999999887766655554431                  1


Q ss_pred             cCCCCCCchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          331 VKLPPFLTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       331 ~~~p~~~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ..++..........     -...+||.+||..||++||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI-----SAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCC-----CHHHHhhCcCC
Confidence            11111111111111     1235678889999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.9e-41  Score=329.75  Aligned_cols=262  Identities=26%  Similarity=0.372  Sum_probs=208.2

Q ss_pred             CCcE-EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchh-----------HHHHHHHHHHHHHhcCCCCc
Q 013249          110 GDFE-IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------HVDYMKAERDILTKVTHPFI  177 (447)
Q Consensus       110 ~~y~-~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~-----------~~~~~~~E~~il~~l~hpnI  177 (447)
                      ++|. +.+.||.|+||+||+|.++.     .++.||||++.........           ....+.+|+.+++.++|+||
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   82 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTL-----TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI   82 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECC-----CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence            3565 45779999999999999875     7889999998764322210           01246789999999999999


Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEe
Q 013249          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       178 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~  257 (447)
                      +++++++...+..|+||||+. |+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus        83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             eeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence            999999999999999999996 5899999888889999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCC---------------CCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHH
Q 013249          258 DFGLAKEIDES---------------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQK  321 (447)
Q Consensus       258 DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~  321 (447)
                      |||++......               .......++..|+|||++.+. .++.++|||||||++|+|++|+.||...+..+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999865411               112234568899999998764 46899999999999999999999999888776


Q ss_pred             HHHHHHhcccC-----CC------------CCCchhHHh-----hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          322 LQQRIINEKVK-----LP------------PFLTSEAHS-----LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       322 ~~~~i~~~~~~-----~p------------~~~~~~~~~-----li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ....+......     ++            .........     .....+||.+||+.||++||     ++++++.||||
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~~~l~~~~~  316 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI-----SAKEALKHEYF  316 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc-----CHHHHhcCccc
Confidence            66655432111     00            000111111     11235778889999999999     88999999999


Q ss_pred             CCC
Q 013249          380 RSI  382 (447)
Q Consensus       380 ~~~  382 (447)
                      ++-
T Consensus       317 ~~~  319 (335)
T PTZ00024        317 KSD  319 (335)
T ss_pred             CCC
Confidence            753

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=322.64  Aligned_cols=254  Identities=20%  Similarity=0.373  Sum_probs=202.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCC---------CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCcee
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ  179 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~  179 (447)
                      ..+|++.++||+|+||.||+|++.+...         ......||+|.+....  .....+.+.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            4589999999999999999998754211         1123469999987542  2344566889999999999999999


Q ss_pred             eeEEEEeCCEEEEEEeccCCCChHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcc
Q 013249          180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (447)
Q Consensus       180 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NIL  247 (447)
                      +++++......|+||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+|||
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999986542            3688899999999999999999999999999999999


Q ss_pred             cCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh--CCCCCCCCCHHHH
Q 013249          248 MDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKL  322 (447)
Q Consensus       248 l~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--G~~pf~~~~~~~~  322 (447)
                      ++.++.+||+|||++..+.....   .....++..|+|||++.+..++.++|||||||++|+|++  |..||...+..+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999976533221   122345778999999998889999999999999999988  7789987766665


Q ss_pred             HHHHHhc-----c---cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          323 QQRIINE-----K---VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       323 ~~~i~~~-----~---~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ...+...     .   ...++..+..+.      +|+.+||+.||++||     ++++|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~------~li~~~l~~~p~~RP-----s~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVF------KLMMRCWSRDIKDRP-----TFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHH------HHHHHHcCCCchhCc-----CHHHHHH
Confidence            5444221     1   112333444444      456669999999999     7788764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=314.61  Aligned_cols=264  Identities=27%  Similarity=0.420  Sum_probs=209.9

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHH-hcCCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~  183 (447)
                      ..+..++.+-+..||.|+||+|++..++.     +++..|||.++....  .....++..|.+... .-++||||++||+
T Consensus        59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~-----sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKP-----SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHHHHHhcCCcchhhhhhhcCc-----cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            44555677778899999999999999987     899999999987654  333455666776654 4579999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHH---H--HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCcccCCCCcEEEe
Q 013249          184 FQTRSKLYLILDFINGGHLFFH---L--YRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~---l--~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDikp~NILl~~~~~~kL~  257 (447)
                      ...++.+|+.||+|+- +|..+   +  .++..++|..+-.|....+.||+||- +..||||||||+||||+..|.+|||
T Consensus       132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeee
Confidence            9999999999999964 44222   2  13467999999999999999999998 4589999999999999999999999


Q ss_pred             ecCCcccccCCCCCCccccCCccccccccc--CCCCCCccceeehhHhHHHHhhCCCCCCCCCH-HHHHHHHHhcccCCC
Q 013249          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKLP  334 (447)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~~~~p  334 (447)
                      |||.+..+.++-..+.-.|...|||||.+.  +.+|+.++||||||++|||+.||+.||..-+. .+....+..+..+.-
T Consensus       211 DFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  211 DFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL  290 (361)
T ss_pred             cccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee
Confidence            999999887766666778999999999997  45799999999999999999999999976544 233333444433221


Q ss_pred             CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 ~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ..-.....-....++||.-||.+|-+.||     ...+++++||++.
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rp-----ky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRP-----KYDDLKKFPFYRM  332 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCc-----chhhhhcCchhhh
Confidence            11112223334556788889999999999     7899999999964

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.7e-40  Score=314.14  Aligned_cols=247  Identities=21%  Similarity=0.402  Sum_probs=206.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ..+|++.+.||+|+||.||++.+.      .+..+|+|.+......    ...+.+|++++++++||||+++++++....
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~------~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL------EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe------CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            458999999999999999999875      3567999998754322    235778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+.+++|.+++... +.++++.++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            999999999999999998764 5689999999999999999999999999999999999999999999999999886543


Q ss_pred             CCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHh
Q 013249          268 SSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHS  343 (447)
Q Consensus       268 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~  343 (447)
                      ...  .....++..|+|||++.+..++.++|||||||++|||++ |..||.......+...+..+.. ..|...+.++.+
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYE  232 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence            221  122335678999999998889999999999999999998 9999988887777777665422 234445555554


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                            |+.+||+.+|++||     ++++++++
T Consensus       233 ------l~~~~l~~~p~~Rp-----~~~~~l~~  254 (256)
T cd05112         233 ------LMQHCWKERPEDRP-----SFSLLLHQ  254 (256)
T ss_pred             ------HHHHHcccChhhCC-----CHHHHHHh
Confidence                  45569999999999     78888763

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-40  Score=321.22  Aligned_cols=254  Identities=21%  Similarity=0.386  Sum_probs=201.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCC-----------CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI  177 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI  177 (447)
                      .++|++.++||+|+||.||+|+++...           ...+...+|+|++....  .....+.+.+|+.+|+.++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            457999999999999999998765321           11234579999987542  23445678899999999999999


Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCc
Q 013249          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (447)
Q Consensus       178 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NI  246 (447)
                      +++++++...+..|+||||+.+++|..++....           .+++..+..++.||+.||+|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999987643           366788999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh--CCCCCCCCCHHH
Q 013249          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQK  321 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--G~~pf~~~~~~~  321 (447)
                      |++.++.+||+|||+++.+.....   .....++..|+|||+..+..++.++|||||||++|||++  |..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986533221   122344678999999888889999999999999999998  789998766655


Q ss_pred             HHHHHHh--------cccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          322 LQQRIIN--------EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       322 ~~~~i~~--------~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .......        .....+...+..+.      +|+.+||+.||.+||     ++++|.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~li~~cl~~~p~~Rp-----~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLY------KLMLSCWRRNAKERP-----SFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHH------HHHHHHcCCCcccCC-----CHHHHHH
Confidence            4443321        01122333444444      456669999999999     6677754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-40  Score=318.92  Aligned_cols=254  Identities=19%  Similarity=0.308  Sum_probs=201.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++++.||+|+||.||+|.+...... ....+++|.+...  ........+..|+.++++++||||+++++++. 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-   79 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDS-IKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-   79 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCc-eeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence            3456899999999999999999998652110 1124777777532  12333456778888999999999999999875 


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      ....++++||+.+|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            45678999999999999999764 57899999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCchh
Q 013249          266 DESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSE  340 (447)
Q Consensus       266 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~  340 (447)
                      .....   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.......+.+..+.. ..+.....+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence            43221   223456788999999998889999999999999999998 9999988777666555544332 223333333


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .      .+++.+||..||++||     +++++++
T Consensus       240 ~------~~li~~c~~~~p~~Rp-----s~~el~~  263 (279)
T cd05111         240 V------YMVMVKCWMIDENVRP-----TFKELAN  263 (279)
T ss_pred             H------HHHHHHHcCCCcccCc-----CHHHHHH
Confidence            3      3456679999999999     7788865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=317.72  Aligned_cols=242  Identities=24%  Similarity=0.403  Sum_probs=195.9

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCC--cEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCCEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSD--GIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYL  192 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  192 (447)
                      +.||+|+||.||+|+++.     ++  ..+++|.+....  .....+.+..|+.+++++ +||||+++++++...+.+|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-----~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcC-----CCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            368999999999999875     33  346888876432  234445688899999999 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEE
Q 013249          193 ILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (447)
Q Consensus       193 v~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL  256 (447)
                      ||||+.+|+|.+++....                .+++.+++.++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEE
Confidence            999999999999997643                4788999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCC
Q 013249          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP  334 (447)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p  334 (447)
                      +|||++..............+..|+|||++....++.++|||||||++|||++ |..||.+.+..+....+... ....+
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP  233 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC
Confidence            99999864322111222234567999999998889999999999999999997 99999888777766666543 22334


Q ss_pred             CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       335 ~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ...+.++.      +++.+||..||.+||     ++++++.
T Consensus       234 ~~~~~~~~------~li~~~l~~~p~~Rp-----s~~~il~  263 (270)
T cd05047         234 LNCDDEVY------DLMRQCWREKPYERP-----SFAQILV  263 (270)
T ss_pred             CcCCHHHH------HHHHHHcccChhhCC-----CHHHHHH
Confidence            44444444      456669999999999     7788765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-40  Score=314.45  Aligned_cols=242  Identities=22%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 013249          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (447)
Q Consensus       117 ~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (447)
                      .||+|+||.||+|.++...   .+..+|+|++....  .....+.+.+|+.++++++||||+++++++. ....++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~---~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK---KQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCC---CceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence            3899999999999876421   45579999987542  3344566889999999999999999999876 4578999999


Q ss_pred             cCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC----C
Q 013249          197 INGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----S  271 (447)
Q Consensus       197 ~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~----~  271 (447)
                      +.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........    .
T Consensus        76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999999999875 45789999999999999999999999999999999999999999999999999986543221    1


Q ss_pred             CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhHHhhhhhhh
Q 013249          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~~  349 (447)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||......+....+..+. ...|...+.++.+++    
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li----  231 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALM----  231 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH----
Confidence            11223578999999998889999999999999999996 999998888777766665543 345566666666554    


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                        .+||..||++||     ++.+|.+
T Consensus       232 --~~c~~~~~~~Rp-----~~~~i~~  250 (257)
T cd05115         232 --KDCWIYKWEDRP-----NFAKVEE  250 (257)
T ss_pred             --HHHcCCChhhCc-----CHHHHHH
Confidence              459999999999     6666654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-40  Score=326.40  Aligned_cols=255  Identities=26%  Similarity=0.406  Sum_probs=203.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe---
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT---  186 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---  186 (447)
                      +|++.+.||+|+||.||+++++...   .+..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+..   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~---~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS---EEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC---cCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            4889999999999999999987521   27789999986532 2233345677899999999 59999999987543   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                       ...+|+++||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence             246889999985 689999988888999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC-----CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-----
Q 013249          266 DESS-----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-----  334 (447)
Q Consensus       266 ~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p-----  334 (447)
                      ....     ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.......+     
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4321     1234578999999998765 5689999999999999999999999987765554444332211000     


Q ss_pred             --------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 --------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 --------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                                                +..+.      ...+|+.+||+.||++||     ++++++.||||..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~li~~~l~~~P~~R~-----t~~~ll~~~~~~~  297 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANP------LALDLLEKLLAFDPTKRI-----SVEEALEHPYLAI  297 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCH------HHHHHHHHHccCCcccCC-----CHHHHhcChhhhh
Confidence                                      00111      234678889999999999     8899999999953

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.1e-40  Score=314.74  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=206.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+..+.||+|+||.||+|+.+...  .....+|+|.+....  .....+.+..|+.++++++|+||+++++++..
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPG--RKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCC--CCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            34568999999999999999999986521  134579999986542  23334568889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+..|+||||+.+++|..++... +.+++.++..++.|++.||+|||++|++||||||+|||++.++.+||+|||++...
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999999999998764 57899999999999999999999999999999999999999999999999999866


Q ss_pred             cCCCCC----CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCch
Q 013249          266 DESSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTS  339 (447)
Q Consensus       266 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~  339 (447)
                      ......    .....+..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+..... ..+...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  237 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPS  237 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCH
Confidence            432211    11223457999999998889999999999999999997 9999988877777777654321 12223344


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++      .+++.+||+.||++||     +++++++
T Consensus       238 ~~------~~li~~c~~~~p~~Rp-----~~~~i~~  262 (268)
T cd05063         238 AV------YQLMLQCWQQDRARRP-----RFVDIVN  262 (268)
T ss_pred             HH------HHHHHHHcCCCcccCc-----CHHHHHH
Confidence            44      3556679999999999     7788764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-40  Score=314.17  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=200.6

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.+.||+|+||.||+|.+..      +..+|+|.+.....    ..+.+.+|+.+++.++|+||+++++++. .
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   72 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNG------TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-E   72 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcC------CceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence            34579999999999999999998763      34589998765432    2345778999999999999999998875 4


Q ss_pred             CEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      ...|+||||+.+++|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||+++..
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            5689999999999999999764  34789999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhH
Q 013249          266 DESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEA  341 (447)
Q Consensus       266 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~  341 (447)
                      .....  .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.... ...+...+..+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T cd05069         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL  232 (260)
T ss_pred             cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence            43221  122345678999999998889999999999999999999 999998887777666665432 22344445555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+      |+.+||.+||++||     +++++++
T Consensus       233 ~~------li~~~l~~~p~~Rp-----~~~~i~~  255 (260)
T cd05069         233 HE------LMKLCWKKDPDERP-----TFEYIQS  255 (260)
T ss_pred             HH------HHHHHccCCcccCc-----CHHHHHH
Confidence            44      45569999999999     6777764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.2e-40  Score=322.34  Aligned_cols=249  Identities=27%  Similarity=0.484  Sum_probs=206.9

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  193 (447)
                      ...+||+|+||.||++..+.     +++.+|+|++....   ......+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKS-----SGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcC-----CCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence            34679999999999999876     78899999875432   23345688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-CCC
Q 013249          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSN  272 (447)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~  272 (447)
                      |||+++++|.+++. .+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus        96 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~  174 (292)
T cd06657          96 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  174 (292)
T ss_pred             EecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence            99999999988764 4578999999999999999999999999999999999999999999999999987654322 223


Q ss_pred             ccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC---CCCCCchhHHhhhhhhh
Q 013249          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~li~~~~  349 (447)
                      ...|+..|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+......   .....+.++.      +
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~------~  248 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK------G  248 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHH------H
Confidence            456899999999998888899999999999999999999999887766655554432211   1122344444      4


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      ++.+||+.||.+||     ++.+++.||||...
T Consensus       249 li~~~l~~~P~~R~-----~~~~ll~~~~~~~~  276 (292)
T cd06657         249 FLDRLLVRDPAQRA-----TAAELLKHPFLAKA  276 (292)
T ss_pred             HHHHHHhCCcccCc-----CHHHHhcChHHhcc
Confidence            56669999999999     88999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-40  Score=316.42  Aligned_cols=250  Identities=23%  Similarity=0.357  Sum_probs=194.8

Q ss_pred             Cc-EEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013249          111 DF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (447)
Q Consensus       111 ~y-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  187 (447)
                      +| ++++.||+|+||+||++..+... ...++.||+|+++...  .......+.+|+++|+.++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            45 99999999999999988754322 2367789999987542  22334567789999999999999999998865  3


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..+|+||||+.+++|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999998764 589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH--HHH------------HHHHhc
Q 013249          268 SSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ--KLQ------------QRIINE  329 (447)
Q Consensus       268 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~--~~~------------~~i~~~  329 (447)
                      ...    .....++..|+|||++.+..++.++|||||||++|||++|..||......  +..            ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            221    12234567799999999888999999999999999999999998643211  000            000000


Q ss_pred             --ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          330 --KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       330 --~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                        ....+...+.++.+      ++.+||+.||++||     +++++++
T Consensus       240 ~~~~~~~~~~~~~~~~------li~~cl~~~p~~Rp-----s~~~i~~  276 (283)
T cd05080         240 GMRLPCPKNCPQEVYI------LMKNCWETEAKFRP-----TFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCCHHHHH------HHHHHhccChhhCC-----CHHHHHH
Confidence              11123334445444      45569999999999     7788774

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.7e-40  Score=311.75  Aligned_cols=248  Identities=22%  Similarity=0.378  Sum_probs=202.9

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.++||+|+||.||++.+.      .+..+|+|.+....    ...+.+.+|+.+++.++|+||+++++.+.
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT   71 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec------CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence            355678999999999999999999864      34569999887532    23456788999999999999999999988


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      . ...|++|||+.+++|.+++.+.  ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus        72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence            7 7789999999999999999764  457888999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCch
Q 013249          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~  339 (447)
                      .+.....  .....++..|+|||++....++.++|+|||||++|+|++ |..||...+.......+..... ..+...+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd05073         151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE  230 (260)
T ss_pred             eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCH
Confidence            6543221  122345678999999998889999999999999999998 9999998877776666554321 22333444


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.      +++.+||+.||++||     +++++++
T Consensus       231 ~~~------~~i~~~l~~~p~~Rp-----~~~~l~~  255 (260)
T cd05073         231 ELY------NIMMRCWKNRPEERP-----TFEYIQS  255 (260)
T ss_pred             HHH------HHHHHHcccCcccCc-----CHHHHHH
Confidence            444      456669999999999     6676653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.8e-40  Score=322.15  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=207.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|+..+.||+|+||.||+++++.     ++..+|+|.+.............+.+|+.+++.++|+|++++++++......
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcC-----CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            47788899999999999999875     6788999998754333344455677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      |+||||+. |+|.+.+.. ...+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++.....  
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--  167 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence            99999996 577776654 45689999999999999999999999999999999999999999999999999876543  


Q ss_pred             CCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-C-CCCCchhHHhh
Q 013249          270 RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-L-PPFLTSEAHSL  344 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-~-p~~~~~~~~~l  344 (447)
                       .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...+.......+...... . +...+..+.+ 
T Consensus       168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  245 (308)
T cd06634         168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN-  245 (308)
T ss_pred             -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH-
Confidence             23456889999999985   345788999999999999999999999876655555444433221 1 1234444444 


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                           ||.+||..+|++||     +++++++|+|+...
T Consensus       246 -----li~~cl~~~P~~Rp-----~~~~ll~~~~~~~~  273 (308)
T cd06634         246 -----FVDSCLQKIPQDRP-----TSEVLLKHRFVLRE  273 (308)
T ss_pred             -----HHHHHhhCCcccCC-----CHHHHhhCcccccc
Confidence                 56669999999999     88999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-40  Score=324.95  Aligned_cols=251  Identities=22%  Similarity=0.364  Sum_probs=195.3

Q ss_pred             CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 013249          122 AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH  201 (447)
Q Consensus       122 ~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~  201 (447)
                      ++|.||.++.+.     +++.||||++..... .....+.+.+|+.+++.++|+||+++++++......|++|||+.+++
T Consensus        12 ~~~~v~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216          12 DLMIVHLAKHKP-----TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             CCceEEEEEecC-----CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            445556666554     788999999986532 34456779999999999999999999999999999999999999999


Q ss_pred             hHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC--------CC
Q 013249          202 LFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--------RS  271 (447)
Q Consensus       202 L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~--------~~  271 (447)
                      |.+++...  ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+.......        ..
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence            99998764  468999999999999999999999999999999999999999999999999887543211        12


Q ss_pred             CccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-------CCCC---C--
Q 013249          272 NSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-------LPPF---L--  337 (447)
Q Consensus       272 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-------~p~~---~--  337 (447)
                      ....++..|+|||++.+  ..++.++|||||||++|||++|+.||..............+...       .+..   .  
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
T cd08216         166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ  245 (314)
T ss_pred             ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence            23457788999999876  46889999999999999999999999876544332221111100       0000   0  


Q ss_pred             --------------chhHHh--hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          338 --------------TSEAHS--LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       338 --------------~~~~~~--li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                                    ......  .....+|+.+||+.||++||     +++++++||||+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~p~~~~~~  302 (314)
T cd08216         246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP-----SASQLLNHSFFKQCK  302 (314)
T ss_pred             ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc-----CHHHHhcCchHhhhc
Confidence                          000000  01235688889999999999     889999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=304.29  Aligned_cols=253  Identities=26%  Similarity=0.408  Sum_probs=203.4

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..++.++|.+.+.||+|||+-||+++...     +++.||+|.+....   .+..+...+|++..++++||||++++++.
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s-----~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLS-----TGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccC-----cccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            34667899999999999999999999765     88899999987543   45567788999999999999999998776


Q ss_pred             EeC-----CEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccCCCCc
Q 013249          185 QTR-----SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH  253 (447)
Q Consensus       185 ~~~-----~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~  253 (447)
                      ..+     ...||+++|...|+|.+.+.+.    .-++|.++..|+.+|++||++||+..  ++||||||.|||+.+.+.
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence            433     3599999999999999988754    36999999999999999999999998  999999999999999999


Q ss_pred             EEEeecCCcccccCCCC----------CCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCCCCH-
Q 013249          254 VMLTDFGLAKEIDESSR----------SNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANR-  319 (447)
Q Consensus       254 ~kL~DFG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-  319 (447)
                      ++|.|||.++...-.-.          ......|..|+|||.+.-   ...+.++|||||||+||+|+.|..||+..-. 
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            99999999876421110          112346889999999874   4568899999999999999999999953211 


Q ss_pred             -HHHHHHHHhcccCCCCC--CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          320 -QKLQQRIINEKVKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       320 -~~~~~~i~~~~~~~p~~--~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                       ..+...+.+..+.+|..  ++..+..+++      .||+.||.+||     ++.+++.+
T Consensus       248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik------~mlqvdP~qRP-----~i~~ll~~  296 (302)
T KOG2345|consen  248 GGSLALAVQNAQISIPNSSRYSEALHQLIK------SMLQVDPNQRP-----TIPELLSK  296 (302)
T ss_pred             CCeEEEeeeccccccCCCCCccHHHHHHHH------HHhcCCcccCC-----CHHHHHHH
Confidence             11223344555666643  5555555554      59999999999     78888764

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-40  Score=328.70  Aligned_cols=255  Identities=29%  Similarity=0.498  Sum_probs=205.3

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (447)
                      .++|++.+.||+|+||.||+|.++.     +++.+|+|.+.+... .......+.+|+.+++++ +||||+++++++...
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~   79 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRR-----TKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE   79 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcC-----CCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence            3579999999999999999999875     678899998865322 222334567899999999 999999999998643


Q ss_pred             --CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                        ..+|+||||+. ++|..++... .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          80 NDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             CCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence              46899999997 5898888765 7899999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC------CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----
Q 013249          266 DESS------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----  334 (447)
Q Consensus       266 ~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----  334 (447)
                      ....      ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+...++.......+    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            3321      2234568999999998865 5578899999999999999999999987766554444433211100    


Q ss_pred             ---------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 ---------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 ---------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                                 +..+.+      ..+||.+||+.||++||     ++.++++||||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------l~~li~~~l~~~P~~Rp-----s~~~il~~~~~~~~  301 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDD------ALDLLKKLLVFNPNKRL-----TAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHH------HHHHHHHhccCCccccc-----CHHHHhhChhhhhh
Confidence                                       011222      24677789999999999     88999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=353.21  Aligned_cols=256  Identities=23%  Similarity=0.401  Sum_probs=218.6

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +.....++.+.||+|.||.||.|...+.........||||.+++.  .+.+.+..|.+|..+|++++|||||+++|++.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            446678899999999999999999887543222455899988764  456777889999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                      ....+|++|||+||+|..+|++.       ..++..+...++.||++|++||+++++|||||..+|+||+....+||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999876       34889999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCC-CCc--cccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHH-HHHhcccCCC
Q 013249          260 GLAKEIDESSR-SNS--MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQ-RIINEKVKLP  334 (447)
Q Consensus       260 G~a~~~~~~~~-~~~--~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~-~i~~~~~~~p  334 (447)
                      |+|+.+-.... ...  ..-...|||||.+....++.++|||||||++||+++ |..||.+.+..++.. -...+++..|
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            99995432221 111  123468999999999999999999999999999999 999999998888877 4445677788


Q ss_pred             CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       335 ~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..++..+.+++..      ||+.+|++||     ++..|++
T Consensus       927 ~~CP~~ly~lM~~------CW~~~pe~RP-----~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQ------CWKHDPEDRP-----SFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHH------HccCChhhCc-----cHHHHHh
Confidence            8998888766555      9999999999     6677776

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.4e-40  Score=312.37  Aligned_cols=244  Identities=23%  Similarity=0.386  Sum_probs=202.6

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      ++||+|+||.||+|.+...  ......+|||.+......  ...+.+.+|+.++++++||||+++++.+.. ..+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~--~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS--GGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecC--CCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            4689999999999998642  113446999999876532  556778899999999999999999999988 89999999


Q ss_pred             ccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC---
Q 013249          196 FINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---  270 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~---  270 (447)
                      |+++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+.....   
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999999998764  689999999999999999999999999999999999999999999999999987643211   


Q ss_pred             -CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccC--CCCCCchhHHhhhh
Q 013249          271 -SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK--LPPFLTSEAHSLLK  346 (447)
Q Consensus       271 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~  346 (447)
                       .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+......  .+...+..+.+   
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  232 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYN---  232 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHH---
Confidence             123457789999999999899999999999999999998 99999888877777766643222  23344445444   


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                         ++.+||+.+|++||     +++++++
T Consensus       233 ---li~~~l~~~p~~Rp-----s~~~~~~  253 (257)
T cd05040         233 ---VMLQCWAHNPADRP-----TFAALRE  253 (257)
T ss_pred             ---HHHHHCCCCcccCC-----CHHHHHH
Confidence               45569999999999     7788765

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.1e-40  Score=323.22  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=203.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (447)
                      ..++|++.+.||.|+||.||+|.++.     +++.||+|++.+.. ......+.+..|+.+++.++||||++++++|.. 
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   81 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQL-----TGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISP   81 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECC-----CCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence            35689999999999999999999876     78899999886543 223344567789999999999999999999875 


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ...+|+||||+ +++|..++. ...+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++....
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            56799999999 568877765 4568999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc--------------
Q 013249          267 ESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------------  331 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~--------------  331 (447)
                      .  ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.....              
T Consensus       160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence            3  2234567889999999865 6789999999999999999999999987665433222221100              


Q ss_pred             ------------CCC-----CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          332 ------------KLP-----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       332 ------------~~p-----~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                                  ..|     +..+.+      ..++|.+||+.||++||     ++++++.|+||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~~l~~~P~~R~-----t~~ell~~~~~~  292 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPS------AIDLLEKMLVFDPQKRI-----SAAEALAHPYLA  292 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHH------HHHHHHHHcCCChhhCC-----CHHHHhcCCccc
Confidence                        000     112222      34567779999999999     889999999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-40  Score=315.11  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=207.4

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.+.||+|+||.||+|.++.... .....+|+|.+.+...  ......+.+|+.++++++||||+++++++.. 
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGE-KVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCC-CcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            34689999999999999999999875321 1234699998876532  3445668889999999999999999999887 


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ...++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999999875 568999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCC---ccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhH
Q 013249          267 ESSRSN---SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEA  341 (447)
Q Consensus       267 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~  341 (447)
                      ......   ...++..|+|||.+....++.++|||||||++|||++ |+.||......++.+.+.... ...|...+.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            332211   1223568999999988889999999999999999998 999999888888777776543 23344455554


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+      ++.+||..||++||     ++.++++
T Consensus       241 ~~------~~~~~l~~~p~~Rp-----~~~~l~~  263 (279)
T cd05057         241 YM------VLVKCWMIDAESRP-----TFKELIN  263 (279)
T ss_pred             HH------HHHHHcCCChhhCC-----CHHHHHH
Confidence            44      45569999999999     6677754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-40  Score=314.67  Aligned_cols=252  Identities=28%  Similarity=0.485  Sum_probs=205.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      +|.+.++||+|+||.||++++..     .+..+++|+++....  ........+..|+.+++.++||||+++++++.+..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK-----AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC-----CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence            48899999999999999998875     444466666543221  12223345667999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ..++||||+.+++|..++..    ...+++.+++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||+++.
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence            99999999999999888764    356899999999999999999999999999999999999975 5799999999887


Q ss_pred             ccCCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHH
Q 013249          265 IDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAH  342 (447)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~  342 (447)
                      ..... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..... .++...+.++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd08222         155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN  234 (260)
T ss_pred             cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHH
Confidence            54322 23345688999999999888899999999999999999999999987776666666554322 23334444444


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                            ++|.+||..||++||     +++++++||||
T Consensus       235 ------~li~~~l~~~p~~Rp-----~~~~il~~~~~  260 (260)
T cd08222         235 ------SIMQSMLNKDPSLRP-----SAAEILRNPFI  260 (260)
T ss_pred             ------HHHHHHhcCChhhCc-----CHHHHhhCCCC
Confidence                  456669999999999     88999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.2e-40  Score=309.26  Aligned_cols=241  Identities=22%  Similarity=0.414  Sum_probs=198.9

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      ++||+|+||.||++...      .+..+|+|++....  .......+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~ig~g~~g~vy~~~~~------~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   72 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK------DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME   72 (250)
T ss_pred             CccCCCCCceEEEEEec------CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence            36899999999999854      56789999987542  23334467889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCC--C
Q 013249          196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS--N  272 (447)
Q Consensus       196 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~--~  272 (447)
                      |+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........  .
T Consensus        73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            99999999988754 46899999999999999999999999999999999999999999999999998764332211  1


Q ss_pred             ccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHHhhhhhhhH
Q 013249          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGVSF  350 (447)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~~~  350 (447)
                      ...++..|+|||++.+..++.++|||||||++|+|++ |..||...........+... ....+...+..+.++      
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------  226 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKV------  226 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH------
Confidence            2234677999999998889999999999999999998 99999888777766666543 223444555555554      


Q ss_pred             HhhhccCCCCCCCCCCCCChhhhhc
Q 013249          351 LTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       351 l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.+||..+|++||     +++++.+
T Consensus       227 i~~~l~~~p~~Rp-----~~~~l~~  246 (250)
T cd05085         227 MQRCWDYKPENRP-----KFSELQK  246 (250)
T ss_pred             HHHHcccCcccCC-----CHHHHHH
Confidence            5559999999999     7788765

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8e-40  Score=314.05  Aligned_cols=255  Identities=20%  Similarity=0.338  Sum_probs=207.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.++||+|+||.||+|.++... ...+..+++|.+...  ......+.+.+|+.++++++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            45678999999999999999999987422 123678999988643  234456778899999999999999999998765


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEe
Q 013249          187 -RSKLYLILDFINGGHLFFHLYRQ--------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~  257 (447)
                       +...++++||+.+++|..++...        ..+++.++..++.||+.||.|||+++++||||||+|||++.++.+||+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             56789999999999999998764        358899999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cC
Q 013249          258 DFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VK  332 (447)
Q Consensus       258 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~  332 (447)
                      |||+++.+.....   .....++..|+|||++.+..++.++|||||||++||+++ |+.||...+..++...+..+. ..
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            9999986533221   123346778999999998899999999999999999999 999998887777666555432 12


Q ss_pred             CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       333 ~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+...+.++.+      ++.+||..||++||     ++.++++
T Consensus       240 ~~~~~~~~~~~------li~~~l~~~p~~Rp-----s~~~~~~  271 (280)
T cd05043         240 QPINCPDELFA------VMACCWALDPEERP-----SFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHH------HHHHHcCCChhhCC-----CHHHHHH
Confidence            23334455544      56669999999999     7788774

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.6e-40  Score=309.01  Aligned_cols=250  Identities=24%  Similarity=0.428  Sum_probs=208.1

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      +++.+.||.|+||.||++++..... ..+..+|+|++....  .....+.+..|+.+++.++|+||+++++.+.+.+..|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            4577899999999999999875221 234889999996543  2225567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          192 LILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      ++|||+.+++|.+++.....  +++.++..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999999976554  8999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCC--ccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhh
Q 013249          270 RSN--SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  345 (447)
Q Consensus       270 ~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li  345 (447)
                      ...  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.....+.+..... ..+...+.++.++ 
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  236 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL-  236 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH-
Confidence            211  1236789999999988889999999999999999998 8999988888777777765443 2344455555554 


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                           +.+||..||++||     ++.++++
T Consensus       237 -----i~~~l~~~p~~Rp-----t~~~ll~  256 (258)
T smart00219      237 -----MLQCWAEDPEDRP-----TFSELVE  256 (258)
T ss_pred             -----HHHHCcCChhhCc-----CHHHHHh
Confidence                 5559999999999     7888875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.3e-39  Score=310.82  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=206.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +...+|.+.++||+|+||.||+|.+....  .....+|+|......  .....+.+.+|+.++++++||||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            34567999999999999999999876421  134568999886542  23445678899999999999999999998875


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                       ...|+||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence             45789999999999999997754 5899999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhH
Q 013249          266 DESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  341 (447)
Q Consensus       266 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~  341 (447)
                      .....  .....++..|+|||.+....++.++|||||||++|||++ |..||...+..+....+... ....+...+.++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  237 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence            43321  112234568999999998889999999999999999996 99999888777666665543 334455566665


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++      +.+||..+|.+||     ++.+++.
T Consensus       238 ~~l------i~~~l~~~P~~Rp-----t~~~~~~  260 (270)
T cd05056         238 YSL------MTKCWAYDPSKRP-----RFTELKA  260 (270)
T ss_pred             HHH------HHHHcCCChhhCc-----CHHHHHH
Confidence            555      5559999999999     7778775

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-40  Score=314.11  Aligned_cols=242  Identities=19%  Similarity=0.317  Sum_probs=194.2

Q ss_pred             eeEeecCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  193 (447)
                      +.||.|+||.||+|.++...+.  .....+|+|.+....   ....+.+.+|..+++.++||||+++++++......++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            3699999999999988653221  123458888875432   33445678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc--------EEEeecCCccc
Q 013249          194 LDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------VMLTDFGLAKE  264 (447)
Q Consensus       194 ~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--------~kL~DFG~a~~  264 (447)
                      |||+.+|+|..++..++ .+++..+..++.||+.||.|||++||+||||||+|||++.++.        +||+|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 5899999999999999999999999999999999999987765        69999999876


Q ss_pred             ccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhC-CCCCCCCCHHHHHHHHHhcccCCCCCCchhHH
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  342 (447)
                      ...   .....++..|+|||++.+ ..++.++|||||||++|||++| ..||...+..... .+......+|...+.++.
T Consensus       158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (258)
T cd05078         158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTELA  233 (258)
T ss_pred             cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHHH
Confidence            533   234568889999999986 4579999999999999999998 5677665554433 233445556665555554


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +      ++.+||+.||++||     ++++|++
T Consensus       234 ~------li~~~l~~~p~~Rp-----s~~~il~  255 (258)
T cd05078         234 N------LINQCMDYEPDFRP-----SFRAIIR  255 (258)
T ss_pred             H------HHHHHhccChhhCC-----CHHHHHH
Confidence            4      45569999999999     7888876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-39  Score=311.06  Aligned_cols=243  Identities=21%  Similarity=0.341  Sum_probs=189.2

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      +.||+|+||.||+|....   +.++..+|+|.++...  .......+.+|+.++++++||||+++++++.+...+|+|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS---GYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcC---CCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence            368999999999998753   1255679999887543  12233467889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          196 FINGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      |+++|+|.+++....     ..++..++.++.|++.||.|||++|++||||||+||+++.++++||+|||+++...... 
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            999999999987532     35677888999999999999999999999999999999999999999999987543321 


Q ss_pred             --CCCccccCCcccccccccCC-------CCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHH-hcccCCCC---
Q 013249          270 --RSNSMCGTTEYMAPEILLSK-------GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPP---  335 (447)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~-~~~~~~p~---  335 (447)
                        ......|+..|+|||++.+.       .++.++|||||||++|||++ |+.||......+...... .....++.   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL  235 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence              12234678899999998642       35789999999999999996 999998766555443332 22222221   


Q ss_pred             --CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          336 --FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       336 --~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                        ..+....      +++.+|+ .+|++||     ++++|.+
T Consensus       236 ~~~~~~~~~------~l~~~c~-~~P~~Rp-----t~~~l~~  265 (269)
T cd05087         236 KLPLSDRWY------EVMQFCW-LQPEQRP-----SAEEVHL  265 (269)
T ss_pred             CCCCChHHH------HHHHHHh-cCcccCC-----CHHHHHH
Confidence              2233333      3555688 6899999     7788764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=307.35  Aligned_cols=241  Identities=24%  Similarity=0.407  Sum_probs=200.1

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      ++||+|+||.||+|.+.      .++.||+|++.....  ......+.+|++++++++|+||+++++++......|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~------~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   72 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK------GNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME   72 (251)
T ss_pred             CccccCCCceEEEEEEe------CCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence            46999999999999875      367899999876532  2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCC---
Q 013249          196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---  271 (447)
Q Consensus       196 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~---  271 (447)
                      |+.|++|.+++... ..+++..+..++.+++.||.|||+++++||||||+|||++.++.+||+|||++.........   
T Consensus        73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            99999999998764 56899999999999999999999999999999999999999999999999999865422111   


Q ss_pred             CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHHhhhhhhh
Q 013249          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~~  349 (447)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||...........+... ....|...+.++.+      
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  226 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYR------  226 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHH------
Confidence            12234567999999998889999999999999999999 89999888777666666543 22334455555554      


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.+||+.+|++||     +++++++
T Consensus       227 li~~~l~~~p~~Rp-----~~~ell~  247 (251)
T cd05041         227 LMLQCWAYDPENRP-----SFSEIYN  247 (251)
T ss_pred             HHHHHhccChhhCc-----CHHHHHH
Confidence            45569999999999     7888875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-39  Score=307.89  Aligned_cols=242  Identities=24%  Similarity=0.424  Sum_probs=199.3

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.+.||+|+||.||++..       .++.||+|.+....     ..+.+.+|+.++++++||||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-------~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY-------TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN   71 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc-------CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            346799999999999999998763       56679999986532     234678899999999999999999998765


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                       ..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus        72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence             4799999999999999997653  5789999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhHHh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHS  343 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~  343 (447)
                      ...  ......+..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+.... ...+...+.++. 
T Consensus       151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  227 (254)
T cd05083         151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY-  227 (254)
T ss_pred             ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHH-
Confidence            332  222344678999999998889999999999999999998 999998888777766665442 122333444444 


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                           +|+.+||+.+|++||     ++++++.
T Consensus       228 -----~li~~~l~~~p~~Rp-----~~~~l~~  249 (254)
T cd05083         228 -----VLMTSCWETEPKKRP-----SFHKLRE  249 (254)
T ss_pred             -----HHHHHHcCCChhhCc-----CHHHHHH
Confidence                 456669999999999     6777764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=336.56  Aligned_cols=244  Identities=34%  Similarity=0.526  Sum_probs=198.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  188 (447)
                      -+..-+.||+|+||.||+++++.     +|+.||||.+++..  ....++...+|+++|++++|+|||+++++-++..  
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnke-----tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKE-----TGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG   86 (732)
T ss_pred             ceeehhhhcCCccceeeeecccc-----cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence            45667889999999999999887     89999999998754  3444566778999999999999999988866543  


Q ss_pred             ----EEEEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC--CCC--cEEEe
Q 013249          189 ----KLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDG--HVMLT  257 (447)
Q Consensus       189 ----~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~--~~~--~~kL~  257 (447)
                          .-.+|||||.||+|+..+.+.   ..++|.+.+.++.++..||.|||++|||||||||.||++-  .+|  ..||+
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence                568999999999999999754   3599999999999999999999999999999999999993  334  47999


Q ss_pred             ecCCcccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCC----CHHHHHHHHHhc---
Q 013249          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINE---  329 (447)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~----~~~~~~~~i~~~---  329 (447)
                      |||.|+.++++....+.+||..|.+||++.. +.|+..+|.|||||++|+++||..||...    +..++...+...   
T Consensus       167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence            9999999999888899999999999999995 88999999999999999999999999532    122233333321   


Q ss_pred             ------------------ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCC
Q 013249          330 ------------------KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL  363 (447)
Q Consensus       330 ------------------~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~  363 (447)
                                        .+++|...+......+.  ..|..+|..+|++|.
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~--kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLT--KWLASMLEWNPRKRG  296 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhh--HHHHHHHhhhHHHhC
Confidence                              11223333333333322  356679999999997

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-39  Score=308.22  Aligned_cols=245  Identities=22%  Similarity=0.357  Sum_probs=195.6

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE-eCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lv~  194 (447)
                      +.||+|+||.||+|.+....  .....+|+|.+...  ......+.+.+|+.+++.++||||+++++++. .++..|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCC--CceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            46899999999999875421  24567999987542  22344567788999999999999999999775 456689999


Q ss_pred             eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC----
Q 013249          195 DFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----  269 (447)
Q Consensus       195 E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~----  269 (447)
                      ||+.+|+|.+++.+. ....+..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......    
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999999764 456788889999999999999999999999999999999999999999999998653221    


Q ss_pred             -CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhhh
Q 013249          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  346 (447)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~  346 (447)
                       ......++..|+|||++.+..++.++|||||||++|||++ |.+||...+..++...+..... ..+...+..+.+   
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  233 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYE---  233 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH---
Confidence             1123345778999999998899999999999999999999 5778887777776666654432 233444555544   


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                         ++.+||..+|++||     ++.++++
T Consensus       234 ---li~~cl~~~p~~Rp-----~~~~il~  254 (262)
T cd05058         234 ---VMLSCWHPKPEMRP-----TFSELVS  254 (262)
T ss_pred             ---HHHHHcCCChhhCC-----CHHHHHH
Confidence               45569999999999     7788875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-39  Score=311.82  Aligned_cols=251  Identities=26%  Similarity=0.386  Sum_probs=197.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  188 (447)
                      -|+++++||+|+||.||+|+..... ..++..||+|.++...  .......+.+|+.+++.++||||+++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCC-CCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            4789999999999999999864311 1367889999986542  234456788999999999999999999998875  5


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+++||||++|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            789999999999999998765 3589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC---------------HHHHHHHHHh
Q 013249          268 SSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---------------RQKLQQRIIN  328 (447)
Q Consensus       268 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~---------------~~~~~~~i~~  328 (447)
                      ...    .....++..|+|||++.+..++.++|||||||++|||++++.|+....               .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            221    223456778999999998889999999999999999999877653211               0111111111


Q ss_pred             c-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          329 E-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       329 ~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      . ....+..++..+.      +|+.+||+.||++||     +++++++
T Consensus       242 ~~~~~~~~~~~~~~~------~li~~~l~~~p~~Rp-----t~~~il~  278 (284)
T cd05079         242 GKRLPRPPNCPEEVY------QLMRKCWEFQPSKRT-----TFQNLIE  278 (284)
T ss_pred             CccCCCCCCCCHHHH------HHHHHHccCCcccCc-----CHHHHHH
Confidence            1 1122333444444      456669999999999     7888876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.7e-39  Score=309.91  Aligned_cols=243  Identities=22%  Similarity=0.353  Sum_probs=188.3

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      ++||+|+||.||+|.....   .....+|+|.+....  .......+.+|+.+++.++|+||+++++.+.....+|+|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG---MSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecC---CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEE
Confidence            3699999999999975432   245678888876432  23334567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          196 FINGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      |+.+|+|.+++....     .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            999999999997643     24678889999999999999999999999999999999999999999999987542221 


Q ss_pred             --CCCccccCCcccccccccC-------CCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCC---
Q 013249          270 --RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPP---  335 (447)
Q Consensus       270 --~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~---  335 (447)
                        ......++..|+|||++..       ..++.++|||||||++|||++ |..||......+....+... ...++.   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL  235 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence              1223346778999999753       456889999999999999999 88999877666555544333 223322   


Q ss_pred             --CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          336 --FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       336 --~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                        ..+.....      ++..|+ .||++||     ++++|++
T Consensus       236 ~~~~~~~~~~------~~~~~~-~dp~~Rp-----t~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYE------VMQFCW-LDPETRP-----TAEEVHE  265 (269)
T ss_pred             cccCCHHHHH------HHHHHh-cCccccc-----CHHHHHH
Confidence              33334433      444577 5999999     6677764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-42  Score=307.25  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=208.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (447)
                      +.|+-+.+||+|.||.||+|+.+.     +++.||+|++-.+. .+...-....+|+.+|..+.|+|++.+++.|..   
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n-----~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKN-----TGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcC-----ccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            468888899999999999999886     77889998765432 123333445689999999999999999887753   


Q ss_pred             -----CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecC
Q 013249          187 -----RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                           ...+|+||++|+. +|.-.+... -+|+..+++.++.+++.||.|+|++.|+|||+|++|+||+.+|.+||+|||
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence                 3459999999975 787777655 579999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC-----CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC--
Q 013249          261 LAKEIDESS-----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--  332 (447)
Q Consensus       261 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~--  332 (447)
                      +++.+....     ..+..+-|.+|++||.+.+ ..|+.+.|||.-|||+.||++|.+.|.+.+.......|..-...  
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            998764322     2344567999999999987 67999999999999999999999999988877766666432111  


Q ss_pred             --------------------CCCCCchhHHhhh-------hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          333 --------------------LPPFLTSEAHSLL-------KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       333 --------------------~p~~~~~~~~~li-------~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                                          +|...-..+.+.+       .++||+.+||..||.+|+     ++++++.|.||..
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~-----~ad~alnh~~F~k  320 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI-----DADQALNHDFFWK  320 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc-----chHhhhchhhhhc
Confidence                                1111111112222       247889999999999999     7899999999975

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-39  Score=311.52  Aligned_cols=242  Identities=19%  Similarity=0.295  Sum_probs=190.8

Q ss_pred             eEeecCCeEEEEEEEcCCC-------------------CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc
Q 013249          117 VVGQGAFGKVFQVKKKGVD-------------------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI  177 (447)
Q Consensus       117 ~lG~G~fg~V~~~~~~~~~-------------------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI  177 (447)
                      .||+|+||.||++......                   +......+|+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            6999999999999754211                   11123458889886542   2333557788999999999999


Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC----
Q 013249          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----  252 (447)
Q Consensus       178 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----  252 (447)
                      +++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999988875 46789999999999999999999999999999999999997654    


Q ss_pred             ---cEEEeecCCcccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHh-hCCCCCCCCCHHHHHHHHH
Q 013249          253 ---HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRII  327 (447)
Q Consensus       253 ---~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-~G~~pf~~~~~~~~~~~i~  327 (447)
                         .+||+|||++......   ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+... ..
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~  234 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FY  234 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HH
Confidence               4899999988654321   23457888999999875 56899999999999999985 6999998776555433 23


Q ss_pred             hcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          328 NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       328 ~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .....+|.....++.      ++|.+||+.+|++||     ++++|+++
T Consensus       235 ~~~~~~~~~~~~~~~------~li~~cl~~~p~~Rp-----s~~~il~~  272 (274)
T cd05076         235 EKKHRLPEPSCKELA------TLISQCLTYEPTQRP-----SFRTILRD  272 (274)
T ss_pred             HhccCCCCCCChHHH------HHHHHHcccChhhCc-----CHHHHHHh
Confidence            333445544444444      456669999999999     78888864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-39  Score=308.46  Aligned_cols=243  Identities=21%  Similarity=0.289  Sum_probs=190.3

Q ss_pred             eeEeecCCeEEEEEEEcCCCC-------CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          116 RVVGQGAFGKVFQVKKKGVDD-------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~-------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      +.||+|+||.||++.......       ......+++|++....   ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            368999999999998643111       0123358888876532   333456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc-------EEEeecC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------VMLTDFG  260 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~-------~kL~DFG  260 (447)
                      ..++||||+++|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.       +|++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888754 56999999999999999999999999999999999999987664       8999999


Q ss_pred             CcccccCCCCCCccccCCccccccccc-CCCCCCccceeehhHhHHHHh-hCCCCCCCCCHHHHHHHHHhcccCCCCCCc
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRIINEKVKLPPFLT  338 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~  338 (447)
                      ++.....   .....++..|+|||++. +..++.++|||||||++|||+ .|..||......+... .............
T Consensus       158 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~  233 (262)
T cd05077         158 IPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPSC  233 (262)
T ss_pred             CCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCCCh
Confidence            9876532   22346788999999987 567899999999999999998 5999997765444322 2223222222233


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .++      .+||.+||+.||.+||     ++++|+++
T Consensus       234 ~~~------~~li~~cl~~dp~~Rp-----~~~~il~~  260 (262)
T cd05077         234 KEL------ADLMTHCMNYDPNQRP-----FFRAIMRD  260 (262)
T ss_pred             HHH------HHHHHHHcCCChhhCc-----CHHHHHHh
Confidence            333      3456679999999999     78898864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.5e-41  Score=350.94  Aligned_cols=254  Identities=29%  Similarity=0.480  Sum_probs=204.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (447)
                      .+|+.++.||+||||.||+|+++-     +|+.||||.|....  .......+.+|+.+|.+|+|||||++|..+.+   
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKl-----DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKL-----DGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecc-----cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            478999999999999999999986     89999999998765  44555678899999999999999986531100   


Q ss_pred             --------------------------------------------------------------------------------
Q 013249          187 --------------------------------------------------------------------------------  186 (447)
Q Consensus       187 --------------------------------------------------------------------------------  186 (447)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------C--------CEEEEEEeccCCCChHHHHHHcCCC-CHHHHHHHHHHHHHHHH
Q 013249          187 ----------------------------R--------SKLYLILDFINGGHLFFHLYRQGIF-REDQARFYTAEIVSAVS  229 (447)
Q Consensus       187 ----------------------------~--------~~~~lv~E~~~gg~L~~~l~~~~~~-~~~~~~~i~~qi~~aL~  229 (447)
                                                  .        ..+||-||||+...|.+.+.++... ....++++++||++||.
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence                                        0        1368999999988887777776554 57889999999999999


Q ss_pred             HHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc-------------------CCCCCCccccCCcccccccccCCC
Q 013249          230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-------------------ESSRSNSMCGTTEYMAPEILLSKG  290 (447)
Q Consensus       230 ~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~  290 (447)
                      |+|++|||||||||.||++++++.|||+|||+|+...                   .....++.+||.-|+|||++.+..
T Consensus       712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999999999999999999998721                   112345678999999999998754


Q ss_pred             ---CCCccceeehhHhHHHHhhCCCCCC-CCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCC
Q 013249          291 ---HNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSG  366 (447)
Q Consensus       291 ---~~~~~DvwSlGvil~ell~G~~pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~  366 (447)
                         |+.|+|+||||||++||+.   ||. ......+...+..+.++.|..+.  .........+|++||+.||.+||   
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~--~~~~~~e~slI~~Ll~hdP~kRP---  863 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFF--DPEHPEEASLIRWLLSHDPSKRP---  863 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccc--cccchHHHHHHHHHhcCCCccCC---
Confidence               9999999999999999996   574 34555566666655555542211  12223345678889999999999   


Q ss_pred             CCChhhhhcCCccC
Q 013249          367 PGGVDAIKHHKWFR  380 (447)
Q Consensus       367 ~~~~~~l~~h~~f~  380 (447)
                        ++.++|++.||-
T Consensus       864 --tA~eLL~s~llp  875 (1351)
T KOG1035|consen  864 --TATELLNSELLP  875 (1351)
T ss_pred             --CHHHHhhccCCC
Confidence              889999999998

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3e-39  Score=314.06  Aligned_cols=255  Identities=21%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.+.||+|+||.||+|.++..... ....+|+|.+....  .......+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGET-VKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCc-ceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            3456899999999999999999998752211 12357888886542  22333457889999999999999999999875


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      . ..++++||+.+|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence            4 4789999999999999987654 6899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchh
Q 013249          266 DESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (447)
Q Consensus       266 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  340 (447)
                      .....   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+.... ...+...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID  239 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            43222   223345778999999999999999999999999999997 999998776665554443322 1222233333


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +      .+++.+||..||++||     +++++++.
T Consensus       240 ~------~~li~~c~~~~p~~Rp-----~~~~l~~~  264 (303)
T cd05110         240 V------YMVMVKCWMIDADSRP-----KFKELAAE  264 (303)
T ss_pred             H------HHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            3      4566679999999999     77888763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.7e-39  Score=308.26  Aligned_cols=251  Identities=23%  Similarity=0.388  Sum_probs=195.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  187 (447)
                      .+|++.+.||+|+||.||+|..+.... .+++.||+|.+...   .....+.+.+|++++++++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcC-CCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            479999999999999999998654322 26788999998654   23445678899999999999999999998754  3


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ..+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            4689999999999999999764 568999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCC----CccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHH---------------HHHHH
Q 013249          267 ESSRS----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL---------------QQRII  327 (447)
Q Consensus       267 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~---------------~~~i~  327 (447)
                      .....    ....++..|+|||++.+..++.++|||||||++|||++|..++........               ...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            32211    112234569999999988899999999999999999998877643221100               01111


Q ss_pred             hccc--CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          328 NEKV--KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       328 ~~~~--~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ....  ..+...+.++.      +|+.+||..+|++||     ++++|++
T Consensus       240 ~~~~~~~~~~~~~~~~~------~li~~cl~~~p~~Rp-----t~~ei~~  278 (284)
T cd05081         240 KNNGRLPAPPGCPAEIY------AIMKECWNNDPSQRP-----SFSELAL  278 (284)
T ss_pred             hcCCcCCCCCCCCHHHH------HHHHHHccCChhhCC-----CHHHHHH
Confidence            1111  22233444444      456669999999999     7888875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.3e-39  Score=308.75  Aligned_cols=247  Identities=27%  Similarity=0.455  Sum_probs=200.0

Q ss_pred             eeEeecCCeEEEEEEEcCCCC-CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDD-GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (447)
                      +.||+|+||.||+|+++.... ...++.+|+|.+.+..  .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            368999999999998865331 2234679999886542  2233456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-----cEEEeecCCc
Q 013249          195 DFINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----HVMLTDFGLA  262 (447)
Q Consensus       195 E~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-----~~kL~DFG~a  262 (447)
                      ||+++++|.+++...       ..+++.++..++.||+.||.|||+++++|+||||+|||++.++     .+||+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998753       3478899999999999999999999999999999999999887     8999999999


Q ss_pred             ccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCC
Q 013249          263 KEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (447)
Q Consensus       263 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (447)
                      +.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ....+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC  238 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence            76533211   123345788999999998889999999999999999998 99999887777766665543 23445555


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +..+.+      |+.+||..+|.+||     +++++++
T Consensus       239 ~~~~~~------li~~~l~~~p~~Rp-----~~~~i~~  265 (269)
T cd05044         239 PDKIYQ------LMTNCWAQDPSERP-----TFDRIQE  265 (269)
T ss_pred             hHHHHH------HHHHHcCCCcccCC-----CHHHHHH
Confidence            555544      55669999999999     7788764

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=315.77  Aligned_cols=257  Identities=29%  Similarity=0.507  Sum_probs=210.6

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh----cchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI----IKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      .++|-++.+||+|||+.||+|.+..     ..++||||+-..++.    .+.++.+...+|.+|-+.|+||.||++|++|
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~-----EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLT-----EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccc-----hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            3568889999999999999999875     788999998654322    2345566788999999999999999999999


Q ss_pred             E-eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCcccC---CCCcEEEee
Q 013249          185 Q-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--GIVHRDLKPENILMD---SDGHVMLTD  258 (447)
Q Consensus       185 ~-~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~iiHrDikp~NILl~---~~~~~kL~D  258 (447)
                      . +.+.+|-|+|||+|.+|..+|..++.++|.+++.|+.||+.||.||.+.  .|||.||||.||||-   ..|.+||+|
T Consensus       537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            6 5667999999999999999999999999999999999999999999977  499999999999994   457899999


Q ss_pred             cCCcccccCCCC--------CCccccCCcccccccccCC----CCCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHH-
Q 013249          259 FGLAKEIDESSR--------SNSMCGTTEYMAPEILLSK----GHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQ-  324 (447)
Q Consensus       259 FG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~-  324 (447)
                      ||+++.++....        +....||.+|++||.+.-.    ..+.++||||+|||+|.++.|+.||.+.- ..++++ 
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            999998765432        3456799999999998632    35889999999999999999999996542 222222 


Q ss_pred             -HHH-hcccCCCC--CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          325 -RII-NEKVKLPP--FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       325 -~i~-~~~~~~p~--~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                       .|+ .....||.  .++.+++++      |++||++.-+.|.     .+.+|..||||.-
T Consensus       697 NTIlkAtEVqFP~KPvVsseAkaF------IRRCLaYRKeDR~-----DV~qLA~dpyllP  746 (775)
T KOG1151|consen  697 NTILKATEVQFPPKPVVSSEAKAF------IRRCLAYRKEDRI-----DVQQLACDPYLLP  746 (775)
T ss_pred             hchhcceeccCCCCCccCHHHHHH------HHHHHHhhhhhhh-----hHHHHccCccccc
Confidence             122 22345654  467777665      5559999999999     8999999999853

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-39  Score=305.65  Aligned_cols=240  Identities=20%  Similarity=0.288  Sum_probs=190.2

Q ss_pred             eeEeecCCeEEEEEEEcCCCC-----CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDD-----GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +.||+|+||.||++.++....     ......+++|++.....    ....+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            469999999999999875321     11124577787654321    14567889999999999999999999988 778


Q ss_pred             EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-------cEEEeecCCc
Q 013249          191 YLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------HVMLTDFGLA  262 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-------~~kL~DFG~a  262 (447)
                      ++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 789999999999999999999999999999999999999888       7999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCC--CCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCch
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTS  339 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~  339 (447)
                      .....   .....++..|+|||++.+.  .++.++|||||||++|||++ |..||...+......... .....+.....
T Consensus       156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (259)
T cd05037         156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCA  231 (259)
T ss_pred             ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCch
Confidence            87544   2234577889999999876  78999999999999999999 688887665443333222 22222222223


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+      .+|+.+||..||.+||     ++.++++
T Consensus       232 ~~------~~li~~~l~~~p~~Rp-----t~~~il~  256 (259)
T cd05037         232 EL------ANLINQCWTYDPTKRP-----SFRAILR  256 (259)
T ss_pred             HH------HHHHHHHhccChhhCC-----CHHHHHH
Confidence            33      4567779999999999     7788775

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.4e-39  Score=310.51  Aligned_cols=254  Identities=16%  Similarity=0.186  Sum_probs=186.3

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHH--------HHHHHHHHHHHhcCCCCce
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--------DYMKAERDILTKVTHPFIV  178 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~--------~~~~~E~~il~~l~hpnIv  178 (447)
                      +..++|++.++||+|+||+||+|.+....  ..+..+|+|+............        .....+...+..+.|++|+
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDH--CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCc--ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            44568999999999999999999987521  1256677776443221100000        0111233445567899999


Q ss_pred             eeeEEEEeCC----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcE
Q 013249          179 QLRYSFQTRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (447)
Q Consensus       179 ~l~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~  254 (447)
                      ++++++....    ..++++|++. .++.+.+.....+++..++.++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            9998765543    4578888874 4666666666667899999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC--------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH-HH----
Q 013249          255 MLTDFGLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-QK----  321 (447)
Q Consensus       255 kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~----  321 (447)
                      ||+|||+|+.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..    
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            999999998763211        12235699999999999999999999999999999999999999976632 21    


Q ss_pred             ----HHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          322 ----LQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       322 ----~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                          ...++......++ ..+.++.+      ++..|+..+|++||     ++++|++
T Consensus       246 ~~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~rp-----~~~~l~~  291 (294)
T PHA02882        246 AKCDFIKRLHEGKIKIK-NANKFIYD------FIECVTKLSYEEKP-----DYDALIK  291 (294)
T ss_pred             hHHHHHHHhhhhhhccC-CCCHHHHH------HHHHHHhCCCCCCC-----CHHHHHH
Confidence                2233333333222 33444444      55569999999999     7788764

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.3e-39  Score=306.37  Aligned_cols=250  Identities=22%  Similarity=0.377  Sum_probs=200.6

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC---
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS---  188 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  188 (447)
                      |.+.++||+|+||.||+|.++..  ..+++.+|||++..+. ......+.+.+|+++++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE--DGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc--CCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            66788999999999999987642  1257889999987643 23344566888999999999999999999886532   


Q ss_pred             ---EEEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          189 ---KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                         ..++++||+.+|+|..++...      ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               347899999999998877532      24788999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCC
Q 013249          260 GLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLP  334 (447)
Q Consensus       260 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p  334 (447)
                      |+++......   ......++..|++||.+.+..++.++|||||||++|+|++ |+.||...+..+....+.... ...+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP  237 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            9998754322   1223345678999999998889999999999999999999 999998887777766665432 2333


Q ss_pred             CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       335 ~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ...+..+.      +++.+||..+|++||     ++.++++
T Consensus       238 ~~~~~~~~------~l~~~~l~~~p~~Rp-----s~~~~~~  267 (273)
T cd05074         238 PDCLEDVY------ELMCQCWSPEPKCRP-----SFQHLRD  267 (273)
T ss_pred             CCCCHHHH------HHHHHHcCCChhhCc-----CHHHHHH
Confidence            34444444      456669999999999     7788875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.7e-39  Score=305.70  Aligned_cols=250  Identities=31%  Similarity=0.545  Sum_probs=204.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-------cchhHHHHHHHHHHHHHh-cCCCCceeeeE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------IKKNHVDYMKAERDILTK-VTHPFIVQLRY  182 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~~E~~il~~-l~hpnIv~l~~  182 (447)
                      +|++.+.||+|+||.||++.++.    ..++.+|+|.+.....       ........+..|+.++.+ ++||||+++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~----~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   76 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK   76 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC----CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence            48889999999999999999864    2467899998864321       123344556778888865 79999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEe
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~  257 (447)
                      ++..++..|+||||+.|++|.+++..    ...+++..++.++.|++.||.|||+ .||+|+||||+|||++.++.+||+
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence            99999999999999999999888743    3568999999999999999999996 789999999999999999999999


Q ss_pred             ecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-CC-
Q 013249          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP-  335 (447)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~-p~-  335 (447)
                      |||++.............|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+....... +. 
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence            9999987655444455678999999999998889999999999999999999999998877776666665544321 11 


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..+.++.+      |+.+||+.||++||     ++.++..
T Consensus       237 ~~~~~l~~------li~~cl~~~p~~Rp-----~~~e~~~  265 (269)
T cd08528         237 MYSEDVTD------VITSCLTPDAEARP-----DIIQVSA  265 (269)
T ss_pred             cCCHHHHH------HHHHHCCCCCccCC-----CHHHHHH
Confidence            34445444      55669999999999     6777765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-38  Score=304.01  Aligned_cols=242  Identities=21%  Similarity=0.340  Sum_probs=188.2

Q ss_pred             eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 013249          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (447)
Q Consensus       117 ~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (447)
                      .||+|+||.||++.....   .....+++|.+....  .....+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD---TGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcC---CCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence            699999999999976431   134456777765432  223456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC---C
Q 013249          197 INGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES---S  269 (447)
Q Consensus       197 ~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~---~  269 (447)
                      +.+|+|..++.+.    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......   .
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            9999999999764    34667788899999999999999999999999999999999999999999998643211   1


Q ss_pred             CCCccccCCcccccccccC-------CCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cC-----CCC
Q 013249          270 RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VK-----LPP  335 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~-----~p~  335 (447)
                      .....+|+..|+|||++..       ..++.++|||||||++|||++ |..||...+..+....+..+. ..     ++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence            2234578899999999853       245788999999999999997 688998777766666554432 22     122


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++....+      ++.+|| .+|++||     ++++|++
T Consensus       237 ~~~~~~~~------l~~~c~-~~P~~Rp-----~~~~i~~  264 (268)
T cd05086         237 PYSERWYE------VLQFCW-LSPEKRA-----TAEEVHR  264 (268)
T ss_pred             CCcHHHHH------HHHHHh-hCcccCC-----CHHHHHH
Confidence            33444433      455588 6899999     7788764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=305.81  Aligned_cols=258  Identities=25%  Similarity=0.411  Sum_probs=196.8

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----C---CCcee
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----H---PFIVQ  179 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---pnIv~  179 (447)
                      ..++|.+.++||+|.|++||+|.+..     ..+.||+|+.+..    +.+.+....|+.+|++++     |   .+||+
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq-----~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQ-----NKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeecc-----CCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence            34899999999999999999999886     8899999999854    344556778999999984     3   37999


Q ss_pred             eeEEEEe----CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCcccCCC-
Q 013249          180 LRYSFQT----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSD-  251 (447)
Q Consensus       180 l~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDikp~NILl~~~-  251 (447)
                      |++.|..    +.++|+|+|++ |.+|..+|.+.  ..++...++.|++||+.||.||| ++||||.||||+|||+..+ 
T Consensus       147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence            9999974    56999999999 77888888765  45899999999999999999999 5699999999999999300 


Q ss_pred             --------------------------------------------------------------------------------
Q 013249          252 --------------------------------------------------------------------------------  251 (447)
Q Consensus       252 --------------------------------------------------------------------------------  251 (447)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 013249          252 --------------------------------------------------------------------------------  251 (447)
Q Consensus       252 --------------------------------------------------------------------------------  251 (447)
                                                                                                      
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                                                                            


Q ss_pred             -----CcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC-------CH
Q 013249          252 -----GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-------NR  319 (447)
Q Consensus       252 -----~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~-------~~  319 (447)
                           -.+||+|||-|+....  ..+.-..|..|+|||++.+.+|+..+||||++|++|||+||...|...       +.
T Consensus       386 ~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             CCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence                 0245666666655432  122335688999999999999999999999999999999999999532       22


Q ss_pred             HHHHHHHHhcccCCCCC-------------------------CchhHHhh-----------hhhhhHHhhhccCCCCCCC
Q 013249          320 QKLQQRIINEKVKLPPF-------------------------LTSEAHSL-----------LKGVSFLTQLLHKDPSKRL  363 (447)
Q Consensus       320 ~~~~~~i~~~~~~~p~~-------------------------~~~~~~~l-----------i~~~~~l~~~L~~dP~~R~  363 (447)
                      ..+. .|+.-...+|..                         ..+-..-|           .+..+||.-||+.+|++|+
T Consensus       464 DHiA-~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~  542 (590)
T KOG1290|consen  464 DHIA-LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP  542 (590)
T ss_pred             HHHH-HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence            2222 222211112210                         00000111           1125799999999999999


Q ss_pred             CCCCCChhhhhcCCccCCCC
Q 013249          364 GSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       364 ~~~~~~~~~l~~h~~f~~~~  383 (447)
                           ++.++++|||++.+-
T Consensus       543 -----tA~~cl~hPwLn~~~  557 (590)
T KOG1290|consen  543 -----TAAQCLKHPWLNPVA  557 (590)
T ss_pred             -----cHHHHhcCccccCCC
Confidence                 889999999998753

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=7.7e-40  Score=316.75  Aligned_cols=263  Identities=26%  Similarity=0.418  Sum_probs=215.3

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC------CC
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PF  176 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h------pn  176 (447)
                      ....+.-+.|.+....|+|-|++|..|++..     .+..||||+|+.+.+.-+    .=+.|++||++|+.      -|
T Consensus       425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~-----r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQA-----RGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             ehhhhhcceeEEEeccccceeeeeeeccccC-----CCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhH
Confidence            3344555789999999999999999999876     677999999987654322    33569999999963      38


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-
Q 013249          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-  252 (447)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-  252 (447)
                      +++|+-.|....++|||+|.+ ..+|.+.|.+-|   .+....++.|+.|++.||..|-.+||+|.||||+||||++.. 
T Consensus       496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN  574 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc
Confidence            999999999999999999998 458999998765   377889999999999999999999999999999999999764 


Q ss_pred             cEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 013249          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK  332 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~  332 (447)
                      .+||||||.|....+... +.+.-+..|+|||++.|..|+...|+||+||+||||.||+..|.+.+...++.-.+..+..
T Consensus       575 iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             eeeeccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence            589999999988766543 3445678899999999999999999999999999999999999998888777665544444


Q ss_pred             CCC-----------------------------------------------------CCc-hhHHhhhhhhhHHhhhccCC
Q 013249          333 LPP-----------------------------------------------------FLT-SEAHSLLKGVSFLTQLLHKD  358 (447)
Q Consensus       333 ~p~-----------------------------------------------------~~~-~~~~~li~~~~~l~~~L~~d  358 (447)
                      ||.                                                     .++ ...+.+....+||.+||..|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence            431                                                     001 11111112358999999999


Q ss_pred             CCCCCCCCCCChhhhhcCCccCC
Q 013249          359 PSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       359 P~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      |++|+     ++.++|+||||..
T Consensus       734 P~KRi-----t~nqAL~HpFi~~  751 (752)
T KOG0670|consen  734 PEKRI-----TVNQALKHPFITE  751 (752)
T ss_pred             hhhcC-----CHHHHhcCCcccC
Confidence            99999     8899999999964

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-38  Score=305.14  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=200.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  187 (447)
                      .+|++.+.||+|+||.||++.+.... ..++..+|||++......  ...+.+.+|+.+++.+.|+||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            47888999999999999999875432 225788999999765422  345678999999999999999999999877  5


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ...++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            68999999999999999997754 68999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHH--------------HHHHHHh
Q 013249          267 ESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK--------------LQQRIIN  328 (447)
Q Consensus       267 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~--------------~~~~i~~  328 (447)
                      ....    .....++..|+|||.+.+..++.++||||||+++|||++|..||.......              ....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            3221    112344567999999998889999999999999999999999986532211              1111222


Q ss_pred             cccCC--CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          329 EKVKL--PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       329 ~~~~~--p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .....  +...+.++      .+++.+||+.||++||     ++.+|++
T Consensus       241 ~~~~~~~~~~~~~~~------~~li~~cl~~~p~~Rp-----t~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEV------YDLMKLCWEAEPQDRP-----SFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHH------HHHHHHHhccChhhCC-----CHHHHHH
Confidence            22222  22333333      3466679999999999     7788875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=311.33  Aligned_cols=250  Identities=20%  Similarity=0.347  Sum_probs=207.0

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..+...+.++||+|-||.|.+|...      ....||||+++...  .......|.+|+++|.+|+|||||.|+++|..
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeve------g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVE------GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEec------CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            44556788999999999999999864      35789999998764  34556789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ++.+|+|+|||++|+|.+++.++.  .........|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence            999999999999999999998874  334566777999999999999999999999999999999999999999999996


Q ss_pred             ccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh--CCCCCCCCCHHHHHHHHHhc--------cc
Q 013249          265 IDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINE--------KV  331 (447)
Q Consensus       265 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--G~~pf~~~~~~~~~~~i~~~--------~~  331 (447)
                      +-....   ....+-...|||+|.+....++.++|||+||+++||+++  ...||.....+++.++....        .+
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence            533222   223456789999999999999999999999999999865  88999888777766654432        12


Q ss_pred             CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          332 KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       332 ~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..|.-++.++.      ++|.+|+..|-++||     ++++|-.
T Consensus       767 ~~P~~cp~~ly------elml~Cw~~es~~RP-----sFe~lh~  799 (807)
T KOG1094|consen  767 SRPPACPQGLY------ELMLRCWRRESEQRP-----SFEQLHL  799 (807)
T ss_pred             cCCCcCcHHHH------HHHHHHhchhhhcCC-----CHHHHHH
Confidence            23444555543      456779999999999     6787754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=298.91  Aligned_cols=256  Identities=25%  Similarity=0.443  Sum_probs=208.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (447)
                      .+|.-++.+|.|.- .|..+.+.-     .++.||+|.+... .......++..+|..++..++|+||++++.+|.-.  
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v-----~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQV-----LGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT   89 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhh-----ccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence            47888899999988 666665543     7888999988765 33345556678899999999999999999999654  


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                          ..+|+|||+|.. +|...+.  -.++.+.+.++..|+++|++|||+.||+||||||+||++..++.+||+|||+|+
T Consensus        90 l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   90 LEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence                368999999954 7877776  347889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-----------
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----------  332 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-----------  332 (447)
                      .-+..-..+..+.|..|+|||++.+.+|...+||||+||++.||++|...|.+.+..+.+.++......           
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            876665667788999999999999999999999999999999999999999998877766666532111           


Q ss_pred             --------------------CCC-----CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          333 --------------------LPP-----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       333 --------------------~p~-----~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                                          +|.     ....+-.+.-.+.+++.+||..||++|.     +++++|+||||+
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri-----sv~daL~HPY~~  314 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI-----SVDDALRHPYIK  314 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc-----cHHHHhcCCeee
Confidence                                111     0000101111235789999999999999     899999999998

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=321.75  Aligned_cols=258  Identities=27%  Similarity=0.498  Sum_probs=214.1

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  186 (447)
                      ..+-|++..+||.|.+|.||+++.+.     +++..|+|++....    +.-+.+..|.++|+.. +|||++.+|++|..
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~-----~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVK-----TGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeee-----cCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            34579999999999999999999987     78899999987653    2234577899999977 69999999999964


Q ss_pred             -----CCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          187 -----RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                           ++.+|||||||.||+.-+++..  ..++.|+.+..|++.++.||.+||++.+||||||=.|||++.+|.|||+||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence                 5789999999999999888864  367999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCC-CCCCccccCCcccccccccC-----CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC
Q 013249          260 GLAKEIDES-SRSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL  333 (447)
Q Consensus       260 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~  333 (447)
                      |++..+... ....+.+||+.|||||++..     ..|+..+|+||||++..||.-|.+|+-+..+...+..|..+.   
T Consensus       168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP---  244 (953)
T KOG0587|consen  168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---  244 (953)
T ss_pred             eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC---
Confidence            999887543 34667899999999999974     347889999999999999999999998887776655554432   


Q ss_pred             CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       334 p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      |+.+-..-+-.-+..+||..||.+|-.+||     ...++++|||....
T Consensus       245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP-----~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRP-----STEELLKHPFITEQ  288 (953)
T ss_pred             CccccchhhHHHHHHHHHHHHHhhccccCc-----chhhhccCCccccc
Confidence            222221111122235678889999999999     78999999999843

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.8e-38  Score=328.82  Aligned_cols=267  Identities=19%  Similarity=0.302  Sum_probs=182.8

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE-
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS-  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~-  183 (447)
                      ..+..++|++.++||+|+||.||+|++..... ..+..||+|.+.....     .+....|  .++...+.+++.++.. 
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~  198 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF  198 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence            44567899999999999999999999876211 1278899998764321     1111111  1122222222222221 


Q ss_pred             -----EEeCCEEEEEEeccCCCChHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013249          184 -----FQTRSKLYLILDFINGGHLFFHLYRQGI--------------------FREDQARFYTAEIVSAVSHLHKCGIVH  238 (447)
Q Consensus       184 -----~~~~~~~~lv~E~~~gg~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~aL~~LH~~~iiH  238 (447)
                           ......+++||||+.+++|.+++.....                    ..+..+..++.||+.||.|||++||+|
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH  278 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH  278 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence                 2456689999999999999998865421                    123456789999999999999999999


Q ss_pred             ccCCCCCcccCC-CCcEEEeecCCcccccCC--CCCCccccCCcccccccccCC----------------------CCCC
Q 013249          239 RDLKPENILMDS-DGHVMLTDFGLAKEIDES--SRSNSMCGTTEYMAPEILLSK----------------------GHNK  293 (447)
Q Consensus       239 rDikp~NILl~~-~~~~kL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~----------------------~~~~  293 (447)
                      |||||+|||++. ++.+||+|||+|+.+...  ......+|++.|+|||.+...                      .++.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            999999999986 689999999999865332  223467899999999976432                      2345


Q ss_pred             ccceeehhHhHHHHhhCCCCCCCCCHHHHHHH-HHhcccC-------CCCCCchhHHhhhh--------hhhHHhhhccC
Q 013249          294 DADWWSVGILLYEMLTGQPPFTHANRQKLQQR-IINEKVK-------LPPFLTSEAHSLLK--------GVSFLTQLLHK  357 (447)
Q Consensus       294 ~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~-i~~~~~~-------~p~~~~~~~~~li~--------~~~~l~~~L~~  357 (447)
                      ++|||||||+||||+++..++..  ....+.. +......       .+...+.+.....+        ..+||.+||++
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            67999999999999997766532  2222222 2111111       11112222111111        23689999999


Q ss_pred             CCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          358 DPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       358 dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      ||++||     +++++++||||.+..+..
T Consensus       437 dP~kR~-----ta~e~L~Hpff~~~~~~~  460 (566)
T PLN03225        437 KGRQRI-----SAKAALAHPYFDREGLLG  460 (566)
T ss_pred             CcccCC-----CHHHHhCCcCcCCCCccc
Confidence            999999     889999999999887764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=320.26  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=220.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+......|.++||.|-||.||+++.+.-.  .....||||.++...  .+.+...|..|..||-+++||||++|.|+.
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pg--kre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVV  699 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPG--KREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVV  699 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCC--CcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence            3466667889999999999999999988633  255779999998653  455566788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .....+.||.|||++|+|..+|+.+ +.|...++.-+++.|+.|++||-+.|+|||||-..||||+.+..+|++|||+++
T Consensus       700 Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  700 TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence            9999999999999999999999876 689999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-CCC-cccc--CCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCC
Q 013249          264 EIDESS-RSN-SMCG--TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (447)
Q Consensus       264 ~~~~~~-~~~-~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (447)
                      .+.+.. ... +..|  ...|.|||.+....++.++||||+||+|||.++ |..||...+..++.+.|..+ +++.|..+
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDC  859 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDC  859 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCC
Confidence            875544 222 2223  468999999999999999999999999999888 99999999999988888765 33445567


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +..+..|+-.      ||++|-.+||     .+.+|..
T Consensus       860 P~aL~qLMld------CWqkdR~~RP-----~F~qiV~  886 (996)
T KOG0196|consen  860 PAALYQLMLD------CWQKDRNRRP-----KFAQIVS  886 (996)
T ss_pred             cHHHHHHHHH------HHHHHhhcCC-----CHHHHHH
Confidence            7777666554      9999999999     7788876

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=312.80  Aligned_cols=244  Identities=24%  Similarity=0.414  Sum_probs=207.0

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      ..+.++||.|-||.||.+......++ ..-.||||..+.+.  ..+..+.|..|..+|++++|||||+|+|+|.+. ..+
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kg-e~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKG-ERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccC-cceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            34457899999999999988654321 33459999988754  334467789999999999999999999999765 589


Q ss_pred             EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      ||||+++-|.|..+|+.+ ..++......|+.||+.||.|||++..|||||-..|||+....-|||+|||+++.+.+...
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            999999999999999877 4689999999999999999999999999999999999999999999999999999877655


Q ss_pred             CCccc--cCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHHhhhh
Q 013249          271 SNSMC--GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       271 ~~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~  346 (447)
                      .....  -...|||||-+.-..++.++|||.|||++||++. |..||.+....++.-.|.++ +++.|+.+++.+..++.
T Consensus       547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslms  626 (974)
T KOG4257|consen  547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMS  626 (974)
T ss_pred             hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHH
Confidence            44333  3577999999999999999999999999999988 99999987766665555554 56788899988876654


Q ss_pred             hhhHHhhhccCCCCCCCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGS  365 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~  365 (447)
                            +||.+||.+||..
T Consensus       627 ------kcWayeP~kRPrf  639 (974)
T KOG4257|consen  627 ------KCWAYEPSKRPRF  639 (974)
T ss_pred             ------HHhccCcccCCcH
Confidence                  5999999999943

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=315.54  Aligned_cols=252  Identities=23%  Similarity=0.402  Sum_probs=216.5

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      |..++..++++||+|.||.|+++.|+.-  ..+...||||+++.+...  .....|.+|+.+|.+|+|||+++|||+..+
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~p--sgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQP--SGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCC--CCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            4445677788999999999999999862  124456999999876543  266789999999999999999999999988


Q ss_pred             CCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                       ..+.+|||++.+|+|.+.|++  ...|....+..|+.||+.|+.||..++.|||||-..||||-....|||||||+.+.
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence             678999999999999999987  35688899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCccc----cCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          265 IDESSRSNSMC----GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       265 ~~~~~~~~~~~----gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      +......+.+.    -...|+|||.+....++.++|||++||+||||++ |+.||.+.....++++|-.+ .+.-|+.++
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cs  341 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCS  341 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCCh
Confidence            87665544332    3567999999999999999999999999999999 99999999999999988743 445678889


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhh
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIK  374 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~  374 (447)
                      .++.++++.      ||..+|+.||     ++..|.
T Consensus       342 edIY~imk~------cWah~paDRp-----tFsair  366 (1039)
T KOG0199|consen  342 EDIYQIMKN------CWAHNPADRP-----TFSAIR  366 (1039)
T ss_pred             HHHHHHHHH------hccCCccccc-----cHHHHH
Confidence            888887776      9999999999     555554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.8e-37  Score=285.31  Aligned_cols=240  Identities=46%  Similarity=0.805  Sum_probs=205.4

Q ss_pred             CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 013249          122 AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH  201 (447)
Q Consensus       122 ~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~  201 (447)
                      +||.||+|.+.+     +++.+|+|++........  .+.+.+|++++++++|+||+++++.+......+++|||+.+++
T Consensus         1 ~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKK-----TGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECC-----CCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence            589999999875     678999999876543221  5678899999999999999999999999999999999999999


Q ss_pred             hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccccCCccc
Q 013249          202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM  281 (447)
Q Consensus       202 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~  281 (447)
                      |..++.....+++..+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||.+.............++..|+
T Consensus        74 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  153 (244)
T smart00220       74 LFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM  153 (244)
T ss_pred             HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence            99999877768999999999999999999999999999999999999999999999999999876654455667899999


Q ss_pred             ccccccCCCCCCccceeehhHhHHHHhhCCCCCCC-CCHHHHHHHHHhcccCCCCC---CchhHHhhhhhhhHHhhhccC
Q 013249          282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVKLPPF---LTSEAHSLLKGVSFLTQLLHK  357 (447)
Q Consensus       282 aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~-~~~~~~~~~i~~~~~~~p~~---~~~~~~~li~~~~~l~~~L~~  357 (447)
                      +||.+.+..++.++||||||+++|+|++|..||.. .+...+.+.+..........   ++.++.+      ++.+||..
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~i~~~l~~  227 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKD------LIRKLLVK  227 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHH------HHHHHccC
Confidence            99999988899999999999999999999999987 55555555555444433222   4444444      56669999


Q ss_pred             CCCCCCCCCCCChhhhhcCCcc
Q 013249          358 DPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       358 dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ||++||     ++.++++||||
T Consensus       228 ~p~~Rp-----~~~~~~~~~~~  244 (244)
T smart00220      228 DPEKRL-----TAEEALQHPFF  244 (244)
T ss_pred             Cchhcc-----CHHHHhhCCCC
Confidence            999999     88999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=307.14  Aligned_cols=244  Identities=23%  Similarity=0.362  Sum_probs=210.2

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +...+.....+||-|.||.||.+.|++     -.-.||||.++.+.    -.++.|..|..+|+.++|||+|+|+++|..
T Consensus       264 meRtdItMkhKLGGGQYGeVYeGvWKk-----yslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  264 MERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             ccchheeeeeccCCCcccceeeeeeec-----cceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            334456677899999999999999997     55679999998654    356778899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +..+|||+|||..|+|.++|++..  .++.-.+..++.||..|++||..+++|||||-..|+|+.++..||++|||+++.
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999999998653  467778889999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCC--ccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchh
Q 013249          265 IDESSRSN--SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~  340 (447)
                      +.....+.  ...-.+.|.|||-+....++.++|||+|||+|||+.| |-.||.+.+...++..+.++ +..-|..+++.
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpk  494 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPK  494 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHH
Confidence            86544322  1223578999999999999999999999999999999 99999999988887766554 33558888888


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGS  365 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~  365 (447)
                      +..++.+      ||++.|..||++
T Consensus       495 VYeLMra------CW~WsPsDRPsF  513 (1157)
T KOG4278|consen  495 VYELMRA------CWNWSPSDRPSF  513 (1157)
T ss_pred             HHHHHHH------HhcCCcccCccH
Confidence            8777666      999999999943

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.2e-38  Score=280.39  Aligned_cols=256  Identities=26%  Similarity=0.473  Sum_probs=205.7

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  186 (447)
                      ..++|++.+++|+|-|+.||.+.+..     +++.++||+++.-+      .+.+.+|+.||+.+. ||||++|++...+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~-----~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINIT-----NNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccC-----CCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            35689999999999999999998765     77789999987532      245889999999997 9999999999876


Q ss_pred             C--CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC-CcEEEeecCCcc
Q 013249          187 R--SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAK  263 (447)
Q Consensus       187 ~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~~kL~DFG~a~  263 (447)
                      .  ....||+||+++.+...+.   ..++...++.++.|+++||.|||++||+|||+||.|++||.. -.++|+|+|+|.
T Consensus       105 p~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             ccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence            4  4578999999887765444   457889999999999999999999999999999999999864 469999999999


Q ss_pred             cccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCC-CCCHHHHHHHHHh-------------
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIIN-------------  328 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~-~~~~~~~~~~i~~-------------  328 (447)
                      ........+-.+.+..|--||.+.. +.|+...|+|||||++..|+..+.||- +.+..+..-+|..             
T Consensus       182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            9877776777788999999999875 678999999999999999999999983 3333333333321             


Q ss_pred             cccCCCC----------------CCchhHHhhh--hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          329 EKVKLPP----------------FLTSEAHSLL--KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       329 ~~~~~p~----------------~~~~~~~~li--~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      -.+.+++                ++..+.+.+.  +++|||.++|.+|-++|+     |++|++.||||..+
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl-----TakEam~HpyF~~~  328 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL-----TAKEAMAHPYFAPV  328 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc-----chHHHhcCchHHHH
Confidence            1222222                1122222222  357889999999999999     88999999999754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=310.29  Aligned_cols=265  Identities=22%  Similarity=0.293  Sum_probs=186.5

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCC-----------CCCCCcEEEEEEeechhhcch-----------hHHHHHH
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKK-----------NHVDYMK  163 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----------~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~  163 (447)
                      .+..++|++.++||+|+||+||++......           +...++.||||.+........           ...+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            456789999999999999999999753221           123456799999864321100           0112233


Q ss_pred             HHHHHHHhcCCCCc-----eeeeEEEEe--------CCEEEEEEeccCCCChHHHHHHc---------------------
Q 013249          164 AERDILTKVTHPFI-----VQLRYSFQT--------RSKLYLILDFINGGHLFFHLYRQ---------------------  209 (447)
Q Consensus       164 ~E~~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~---------------------  209 (447)
                      .|+.++.+++|.++     ++++++|..        .+..+|||||+.+++|.++++..                     
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46777777766544     566676643        35689999999999999988642                     


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCc--cccCCcccccc
Q 013249          210 ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS--MCGTTEYMAPE  284 (447)
Q Consensus       210 ---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~--~~gt~~y~aPE  284 (447)
                         ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..........  ..+|+.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence               1235677889999999999999999999999999999999999999999999976543322222  23478999999


Q ss_pred             cccCCC--------------------CC--CccceeehhHhHHHHhhCCC-CCCCCCHHH-----------HHHHHHhcc
Q 013249          285 ILLSKG--------------------HN--KDADWWSVGILLYEMLTGQP-PFTHANRQK-----------LQQRIINEK  330 (447)
Q Consensus       285 ~~~~~~--------------------~~--~~~DvwSlGvil~ell~G~~-pf~~~~~~~-----------~~~~i~~~~  330 (447)
                      ++....                    |+  .+.||||+||++|+|++|.. ||.......           ....+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            986432                    22  34799999999999999875 775321111           111112222


Q ss_pred             cCCC--CCCchhHHhhhhhhhHHhhhccCCC---CCCCCCCCCChhhhhcCCccCC
Q 013249          331 VKLP--PFLTSEAHSLLKGVSFLTQLLHKDP---SKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       331 ~~~p--~~~~~~~~~li~~~~~l~~~L~~dP---~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ..++  ...+...+      ||+.+||.++|   .+|+     +++|+++||||..
T Consensus       461 ~~~~~~d~~s~~~~------dLi~~LL~~~~~~~~~Rl-----Sa~eaL~Hp~f~~  505 (507)
T PLN03224        461 YDFSLLDRNKEAGW------DLACKLITKRDQANRGRL-----SVGQALSHRFFLP  505 (507)
T ss_pred             CCcccccccChHHH------HHHHHHhccCCCCcccCC-----CHHHHhCCCCcCC
Confidence            3332  23344444      45566999876   6899     8899999999964

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-39  Score=287.53  Aligned_cols=261  Identities=27%  Similarity=0.420  Sum_probs=206.8

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC---
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS---  188 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  188 (447)
                      .+--+.||.|+||.||.+.+-.     +++.+|+|++..-. ..-...+.+.+|+.+|..++|.|++..++..+...   
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPR-----dgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df  128 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPR-----SGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF  128 (449)
T ss_pred             CCCCCcccccceeEEEeccCCC-----CccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence            3334689999999999988765     88999999886421 22233456778999999999999999988876543   


Q ss_pred             --EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          189 --KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       189 --~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                        .+|.|+|+|. .+|...+-....++.+.++-+++||++||+|||+.+|+||||||.|+|++.|..+||||||+++...
T Consensus       129 FqEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  129 FQELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence              4788999995 4788888777889999999999999999999999999999999999999999999999999999764


Q ss_pred             CC--CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc-------------
Q 013249          267 ES--SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-------------  330 (447)
Q Consensus       267 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~-------------  330 (447)
                      ..  ...+..+-|.+|+|||+++| ..|+.++||||+|||+.||+..+..|...++.+..+.|..-.             
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            33  33445677899999999997 578999999999999999999999999888877776665311             


Q ss_pred             ----------cCCCCC-----CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          331 ----------VKLPPF-----LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       331 ----------~~~p~~-----~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                                .+-|..     ++.....--..++++.++|..||++|+     +.++.+.|++......
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri-----s~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI-----SVEEALQHRYLEEGRL  351 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc-----cHhhhcccccccccce
Confidence                      111110     111111111235678889999999999     7899999999876543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=267.96  Aligned_cols=215  Identities=27%  Similarity=0.452  Sum_probs=179.0

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  186 (447)
                      ..++...+..||+|+||.|-+.++..     +|...|+|.++...  ......++.+|+++..+. .+|++|.+|+.+..
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~-----sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQ-----SGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeecc-----CCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            33456667789999999999999886     89999999997653  233445567788877655 69999999999999


Q ss_pred             CCEEEEEEeccCCCChHH----HHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEEeecCC
Q 013249          187 RSKLYLILDFINGGHLFF----HLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~----~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      .+.+++.||.|+- +|..    .+.+.+.++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|++|+||||.
T Consensus       117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence            9999999999964 4532    334567899999999999999999999965 899999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccccccccC----CCCCCccceeehhHhHHHHhhCCCCCCC-CCHHHHHHHHHhcc
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLS----KGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEK  330 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~ell~G~~pf~~-~~~~~~~~~i~~~~  330 (447)
                      +..+.++-..+-..|...|||||.+..    .+|+.++||||||+++.||.+++.||.. .++.+.+.++..+.
T Consensus       196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            998876555554678999999999863    4899999999999999999999999964 45666666666543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=312.80  Aligned_cols=246  Identities=27%  Similarity=0.435  Sum_probs=195.0

Q ss_pred             cEEEeeEeecCCeE-EEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013249          112 FEIFRVVGQGAFGK-VFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (447)
Q Consensus       112 y~~~~~lG~G~fg~-V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (447)
                      |.-.+++|.|+-|+ ||++..       .++.||||.+-..      ......+|+..|+..+ |||||++|+.-.+...
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-------e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF  577 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-------EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF  577 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-------CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence            33446789999986 788876       5678999987543      3456789999999984 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---C--CcEEEeecC
Q 013249          190 LYLILDFINGGHLFFHLYRQGI----FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---D--GHVMLTDFG  260 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~--~~~kL~DFG  260 (447)
                      +||..|.|.. +|.+++...+.    ......+.++.|++.||++||+.+||||||||.||||+.   +  ..++|+|||
T Consensus       578 ~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  578 LYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            9999999965 89999977411    111456788999999999999999999999999999976   3  468999999


Q ss_pred             CcccccCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCC
Q 013249          261 LAKEIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP  335 (447)
Q Consensus       261 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~~p~  335 (447)
                      +++.+..+..    ..+..||-+|+|||++....-+.++||||+||++|+.++ |..||...  .+...+|+.+...+-.
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~  734 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVH  734 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceee
Confidence            9998754432    345679999999999998888889999999999999999 59999643  3344566666554432


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ..+.. ..  .+.|||.+||.+||..||     ++.+++.||+|.+
T Consensus       735 L~~~~-d~--eA~dLI~~ml~~dP~~RP-----sa~~VL~HPlFW~  772 (903)
T KOG1027|consen  735 LEPLP-DC--EAKDLISRMLNPDPQLRP-----SATDVLNHPLFWD  772 (903)
T ss_pred             eccCc-hH--HHHHHHHHhcCCCcccCC-----CHHHHhCCCccCC
Confidence            21111 00  345666679999999999     8899999999975

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=296.43  Aligned_cols=202  Identities=32%  Similarity=0.521  Sum_probs=181.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHH-----HHHHHHHHHHHhcC---CCCceee
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV-----DYMKAERDILTKVT---HPFIVQL  180 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~-----~~~~~E~~il~~l~---hpnIv~l  180 (447)
                      ..+|..++.+|.|+||.|++|.++.     ....|+||.+.|.++.....+     -.+..|++||..++   |+||+++
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~-----n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKE-----NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             cccceeeeeccccccceEEEeeecc-----cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            3579999999999999999999997     678899999998776443332     34667999999997   9999999


Q ss_pred             eEEEEeCCEEEEEEecc-CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          181 RYSFQTRSKLYLILDFI-NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       181 ~~~~~~~~~~~lv~E~~-~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                      +++|++++++||+||-- +|-+|++++..+..++|.+++.|++|++.|+++||+.||||||||-+|+.++.+|-+||+||
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence            99999999999999985 45699999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCC
Q 013249          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTH  316 (447)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~  316 (447)
                      |.|..... .....++||..|.|||++.|..| +..-|||+||++||.++....||..
T Consensus       715 gsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  715 GSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99876544 35667899999999999999887 6779999999999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.8e-35  Score=327.72  Aligned_cols=241  Identities=20%  Similarity=0.286  Sum_probs=187.9

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|...++||+|+||.||+|+++.     ++..||||.+.....       ....|++++++++|||||++++++.+....
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIK-----NGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECC-----CCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            45667899999999999999875     778999998864321       113468889999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH---KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      |+||||+++|+|.+++.   .+++.++..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.......
T Consensus       759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            99999999999999985   3789999999999999999999   6699999999999999999988876 666544322


Q ss_pred             CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC-----HHHHHHHHHhc-------ccCCCC
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-----RQKLQQRIINE-------KVKLPP  335 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-----~~~~~~~i~~~-------~~~~p~  335 (447)
                         .....||..|+|||++.+..++.++|||||||++|||++|+.||....     ..+........       ......
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence               223468899999999999999999999999999999999999995321     11111111100       001111


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .............+++.+||+.||++||     +++++++
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~  946 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARP-----CANDVLK  946 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCc-----CHHHHHH
Confidence            1122223344456788899999999999     7788875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=305.57  Aligned_cols=259  Identities=24%  Similarity=0.430  Sum_probs=215.6

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCC--CCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceee
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGD--SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQL  180 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l  180 (447)
                      .+.+..++.++.+.||.|.||.|+++..++.....  ....||||.++....  ....+.+..|+++|+.+ .|+||+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence            34555566777889999999999999877544321  256799999876543  35667889999999998 59999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 013249          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE  244 (447)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~  244 (447)
                      ++++...+.+++|+||+..|+|..+++..+                .++..+...++.||+.|++||++..+|||||-..
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999999999999999999999998765                3888999999999999999999999999999999


Q ss_pred             CcccCCCCcEEEeecCCcccccCCCCCC--cccc--CCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCC-
Q 013249          245 NILMDSDGHVMLTDFGLAKEIDESSRSN--SMCG--TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN-  318 (447)
Q Consensus       245 NILl~~~~~~kL~DFG~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~-  318 (447)
                      |||+.++..+||+|||+|+.........  ...|  ...|||||.+....|+.++|||||||+|||+++ |..||.+.. 
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            9999999999999999999654332221  1222  345999999999999999999999999999999 999999865 


Q ss_pred             HHHHHHHHHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          319 RQKLQQRIINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       319 ~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..++.+.+..+. ...|...+.+..++++.      ||+.+|++||     ++.++..
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~------CW~~~p~~RP-----~F~~~~~  574 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKS------CWNADPEDRP-----TFSECVE  574 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHH------HhCCCcccCC-----CHHHHHH
Confidence            666666666653 46788888888877666      9999999999     6677664

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=299.03  Aligned_cols=255  Identities=29%  Similarity=0.496  Sum_probs=218.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++.++|.|+||.||+++++.     +++..|+|+++...   .+...-++.|+-+++.++|||||.+++.+...+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~-----s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~d   85 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKR-----SGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD   85 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccc-----cCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhc
Confidence            4689999999999999999999987     88899999998653   344556788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .++++||||.||+|.+.-+--++++|.++.+++++.++||+|||+.|=+|||||-.|||+++.|.+||+|||.+..+...
T Consensus        86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999998776432


Q ss_pred             -CCCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-----CCCch
Q 013249          269 -SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-----PFLTS  339 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p-----~~~~~  339 (447)
                       .+...+.||+.|||||+-.   ..+|...+|||++|++..|+---++|-....+...........+.-|     ...++
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~  245 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE  245 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence             3456789999999999964   56899999999999999999999988766655554444444433333     23455


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .+.++++.      +|.++|++||     +++-++.|||...-
T Consensus       246 ~fh~fvK~------altknpKkRp-----taeklL~h~fvs~~  277 (829)
T KOG0576|consen  246 FFHNFVKG------ALTKNPKKRP-----TAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHH------HhcCCCccCC-----Chhhheeceeeccc
Confidence            66666665      9999999999     77899999998754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=278.38  Aligned_cols=243  Identities=23%  Similarity=0.425  Sum_probs=190.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh--cCCCCceeeeEEEE
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQ  185 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~  185 (447)
                      .....+++++||+|.||.||+|+.       .++.||||++...      ..+.+++|.+|.+.  +.|+||++++++-.
T Consensus       208 ~l~pl~l~eli~~Grfg~V~KaqL-------~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek  274 (534)
T KOG3653|consen  208 ELDPLQLLELIGRGRFGCVWKAQL-------DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEK  274 (534)
T ss_pred             cCCchhhHHHhhcCccceeehhhc-------cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence            345677889999999999999987       4589999998643      34568889998875  57999999998876


Q ss_pred             eCC----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCcccCCCC
Q 013249          186 TRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENILMDSDG  252 (447)
Q Consensus       186 ~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------~iiHrDikp~NILl~~~~  252 (447)
                      ...    .++||+||.+.|+|.++|..+ .+++....+++.-+++||+|||+-         .|+|||||..||||..|+
T Consensus       275 r~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  275 RGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             cCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence            555    799999999999999999765 679999999999999999999952         499999999999999999


Q ss_pred             cEEEeecCCcccccCCC---CCCccccCCcccccccccCCC-CC-----CccceeehhHhHHHHhhCCC-----------
Q 013249          253 HVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKG-HN-----KDADWWSVGILLYEMLTGQP-----------  312 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlGvil~ell~G~~-----------  312 (447)
                      +..|+|||+|..+....   .....+||..|||||++.+.- ..     .+.||||+|.|||||++.-.           
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq  433 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ  433 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence            99999999999875432   234578999999999998642 22     46899999999999998532           


Q ss_pred             -CCC-----CCCHHHHHHHHHhcc--cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCC
Q 013249          313 -PFT-----HANRQKLQQRIINEK--VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGS  365 (447)
Q Consensus       313 -pf~-----~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~  365 (447)
                       ||.     +...+++...+...+  +.+|..+... ..+-..++.+..||..||+.|+++
T Consensus       434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA  493 (534)
T KOG3653|consen  434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTA  493 (534)
T ss_pred             CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhh
Confidence             342     234455555555443  3444433222 122223567888999999999954

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=292.06  Aligned_cols=244  Identities=23%  Similarity=0.317  Sum_probs=205.0

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      ....++||.|+||+||++.+-...+ .-+-.||+|++.....  ......+..|.-+|.+++|||+++|++++.... +-
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege-~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGE-NVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCc-eecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            4456799999999999999865321 2345699999876543  333456888999999999999999999998776 88


Q ss_pred             EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      ||++||++|.|.++++.+ +.+--.....|+.||++||.|||+++++||||-..||||..-.++||+|||+++.+.....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999865 5788899999999999999999999999999999999999999999999999998765544


Q ss_pred             CCc---cccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHHhhh
Q 013249          271 SNS---MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLL  345 (447)
Q Consensus       271 ~~~---~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li  345 (447)
                      ...   ..-.+.|||-|.+....|+.++|||||||++||++| |..||.+....++-..+..+ ++.-|+..+.++..++
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            332   223578999999999999999999999999999999 99999999888877666543 4556777777776654


Q ss_pred             hhhhHHhhhccCCCCCCCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGS  365 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~  365 (447)
                      -      +||..|+..||++
T Consensus       934 v------kCwmid~~~rp~f  947 (1177)
T KOG1025|consen  934 V------KCWMIDADSRPTF  947 (1177)
T ss_pred             H------HHhccCcccCccH
Confidence            4      5999999999943

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=268.21  Aligned_cols=239  Identities=26%  Similarity=0.429  Sum_probs=185.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh--cCCCCceeeeEEEEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~  187 (447)
                      .+..+.+.||+|.||.||+++++       |+.||||++....     + +...+|.+|++.  |+|+||+.+++.-..+
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-------Ge~VAVKiF~srd-----E-~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-------GEDVAVKIFSSRD-----E-RSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             heeEEEEEecCccccceeecccc-------CCceEEEEecccc-----h-hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            47889999999999999999996       4679999996432     1 235578888875  4999999998876543


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCcccCCCCcEE
Q 013249          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~iiHrDikp~NILl~~~~~~k  255 (447)
                          ..+|||.+|-+.|+|+++|.+ ..++.+...+++..++.||.|||..        .|.|||||..||||.++|..-
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence                369999999999999999988 6789999999999999999999952        399999999999999999999


Q ss_pred             EeecCCcccccCCC-----CCCccccCCcccccccccCCC----C--CCccceeehhHhHHHHhhC----------CCCC
Q 013249          256 LTDFGLAKEIDESS-----RSNSMCGTTEYMAPEILLSKG----H--NKDADWWSVGILLYEMLTG----------QPPF  314 (447)
Q Consensus       256 L~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvil~ell~G----------~~pf  314 (447)
                      |+|+|+|.......     ..+..+||..|||||++...-    +  -..+||||||.|+||++..          ++||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            99999998764432     245679999999999997431    1  1358999999999998752          5688


Q ss_pred             CC-----CCHHHHHHHHHhccc--CCCCC-CchhHHhhhhhhhHHhhhccCCCCCCCC
Q 013249          315 TH-----ANRQKLQQRIINEKV--KLPPF-LTSEAHSLLKGVSFLTQLLHKDPSKRLG  364 (447)
Q Consensus       315 ~~-----~~~~~~~~~i~~~~~--~~p~~-~~~~~~~li~~~~~l~~~L~~dP~~R~~  364 (447)
                      .+     .+.+++.+-+...++  .+|.. .+.++  +-....+++.||..||.-|++
T Consensus       437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~--l~~m~klMkeCW~~Np~aRlt  492 (513)
T KOG2052|consen  437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPA--LRVMAKLMKECWYANPAARLT  492 (513)
T ss_pred             ccCCCCCCCHHHHhcceeecccCCCCCcccccCHH--HHHHHHHHHHhhcCCchhhhH
Confidence            43     344555554443333  33332 22222  222235788999999999993

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=262.89  Aligned_cols=260  Identities=18%  Similarity=0.294  Sum_probs=218.1

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      .+..+...+++...++-+|.||+||.+.++..++-...+.+.+|.++..  ..+-++..+..|.-+|..+.|||+.++.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            3344566778999999999999999999987655556677888887655  35677888999999999999999999998


Q ss_pred             EEEe-CCEEEEEEeccCCCChHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc
Q 013249          183 SFQT-RSKLYLILDFINGGHLFFHLYRQ--------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (447)
Q Consensus       183 ~~~~-~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~  253 (447)
                      ++.. ....+.++.++.-|+|..++...        ..++..++..++.|++.|++|||++||||.||-..|++||+..+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence            8765 45678889999999999888722        23677889999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCC---CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 013249          254 VMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE  329 (447)
Q Consensus       254 ~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~  329 (447)
                      +||+|=.+++.+-..   +.....-....||+||.+....|+.++|||||||+||||+| |+.||...++.++...+..+
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            999999999976332   22333345678999999999999999999999999999999 99999999999999888776


Q ss_pred             -ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       330 -~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                       ++.-|-.+++++...+-.      ||..+|++||     +.+++..
T Consensus       515 yRlaQP~NCPDeLf~vMac------CWallpeeRP-----sf~Qlv~  550 (563)
T KOG1024|consen  515 YRLAQPFNCPDELFTVMAC------CWALLPEERP-----SFSQLVI  550 (563)
T ss_pred             ceecCCCCCcHHHHHHHHH------HHhcCcccCC-----CHHHHHH
Confidence             345577889998887766      9999999999     5666653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=3.8e-32  Score=250.98  Aligned_cols=214  Identities=40%  Similarity=0.663  Sum_probs=186.5

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |.+.+.||.|++|.||++....     +++.+|+|.+......  ...+.+.+|+..+++++|+|++++++.+......+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG-----TGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC-----CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence            5678999999999999999875     6788999999865322  24567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          192 LILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      +++|++.+++|..++..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||.+....... 
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            99999999999999988766 8999999999999999999999999999999999999999999999999998875543 


Q ss_pred             -CCCccccCCcccccccc-cCCCCCCccceeehhHhHHHHhhCCCCCCC--CCHHHHHHHHHhcccC
Q 013249          270 -RSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLTGQPPFTH--ANRQKLQQRIINEKVK  332 (447)
Q Consensus       270 -~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ell~G~~pf~~--~~~~~~~~~i~~~~~~  332 (447)
                       ......++..|++||.+ ....++.++|||+||+++|+|++|+.||..  .+...+.+.|..+...
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence             33456788899999999 667788899999999999999999999977  4444677777766543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=4.2e-33  Score=265.44  Aligned_cols=260  Identities=24%  Similarity=0.464  Sum_probs=197.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~  187 (447)
                      .+.|.++++||.|+|++||++.+...  ....+.||+|.+....     ...++.+|+++|..+. +.||+++.+++..+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            45799999999999999999987642  2367889999886543     3346889999999995 89999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-CCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~~kL~DFG~a~~~~  266 (447)
                      +.+++||||++..+..++...   ++-.+++.+++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|....
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999998877776643   568899999999999999999999999999999999985 5678999999987211


Q ss_pred             C--------C-------------------------------------CCCCccccCCcccccccccCC-CCCCccceeeh
Q 013249          267 E--------S-------------------------------------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSV  300 (447)
Q Consensus       267 ~--------~-------------------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSl  300 (447)
                      .        .                                     .......||++|+|||++... ..+.++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            0        0                                     000123599999999999864 46889999999


Q ss_pred             hHhHHHHhhCCCCCCC-CCHHHHHHHHH--------------hcc--c----CCC---C------CC-------------
Q 013249          301 GILLYEMLTGQPPFTH-ANRQKLQQRII--------------NEK--V----KLP---P------FL-------------  337 (447)
Q Consensus       301 Gvil~ell~G~~pf~~-~~~~~~~~~i~--------------~~~--~----~~p---~------~~-------------  337 (447)
                      |||++-+++++.||-. .++.+....|.              .+.  +    .+|   .      .+             
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            9999999999999842 22111111111              011  0    000   0      00             


Q ss_pred             -chhHHhhh--hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          338 -TSEAHSLL--KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       338 -~~~~~~li--~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                       .....+..  .+.||+.+||..||.+|+     +++++|+||||...+
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRi-----tAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRI-----TAEDALKHPFFDEAD  388 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcc-----cHHHHhcCcCCcchh
Confidence             00111111  246899999999999999     889999999998543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1e-30  Score=237.52  Aligned_cols=211  Identities=38%  Similarity=0.668  Sum_probs=182.6

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (447)
                      ||.|++|.||++....     +++.+++|++.......  ..+.+.+|+.+++.+.|++|+++++++......+++||++
T Consensus         1 l~~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKK-----TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecC-----CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence            6899999999999864     67899999987653211  3466889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-CCcEEEeecCCcccccCCC-CCCcc
Q 013249          198 NGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESS-RSNSM  274 (447)
Q Consensus       198 ~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~~kL~DFG~a~~~~~~~-~~~~~  274 (447)
                      .|++|..++... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+....... .....
T Consensus        74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            999999998876 57899999999999999999999999999999999999999 8999999999998765432 12335


Q ss_pred             ccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhh
Q 013249          275 CGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQ  353 (447)
Q Consensus       275 ~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~  353 (447)
                      .+...|++||.+... .++.+.|+|++|+++++|                               ..+      .+++.+
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~------~~~l~~  196 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PEL------KDLIRK  196 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHH------HHHHHH
Confidence            678899999999877 888999999999999999                               222      345666


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCC
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHK  377 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~  377 (447)
                      ||..||++||     +++++++|+
T Consensus       197 ~l~~~p~~R~-----~~~~l~~~~  215 (215)
T cd00180         197 MLQKDPEKRP-----SAKEILEHL  215 (215)
T ss_pred             HhhCCcccCc-----CHHHHhhCC
Confidence            9999999999     789998874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.97  E-value=3e-32  Score=283.83  Aligned_cols=248  Identities=40%  Similarity=0.751  Sum_probs=203.5

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ..+|+.++.|..|+||.||+++++.     +.+.+|+|+ .++.+.       +++   +|.....|++|          
T Consensus        82 e~df~~IklisngAygavylvrh~~-----trqrfa~ki-Nkq~li-------lRn---ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKE-----TRQRFAMKI-NKQNLI-------LRN---ILTFAGNPFVV----------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccc-----cccchhhcc-cccchh-------hhc---cccccCCccee----------
Confidence            4689999999999999999999986     778899954 443321       111   45555666666          


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                                 |+-...+..-+.++.+.        +.+++|||+.||+|||+||+|+||..-|++|++|||+++.....
T Consensus       136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                       44445555556655433        88999999999999999999999999999999999998753110


Q ss_pred             ----------------CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 013249          269 ----------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK  332 (447)
Q Consensus       269 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~  332 (447)
                                      -.....|||+.|+|||++..++|+..+|||++|+|+||++.|..||.+..+++++...+...+.
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence                            1124569999999999999999999999999999999999999999999999999999999988


Q ss_pred             CCCC---CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCc
Q 013249          333 LPPF---LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF  409 (447)
Q Consensus       333 ~p~~---~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  409 (447)
                      +|+.   +..|+++++.      ++|+.+|..|++.+  ++-++++|+||..+||..|..++  ..|+|-...++++..|
T Consensus       277 wpE~dea~p~Ea~dli~------~LL~qnp~~Rlgt~--ga~evk~h~ff~~LDw~~llRqk--aefvpql~~eddtsyf  346 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIE------QLLRQNPLCRLGTG--GALEVKQHGFFQLLDWKSLLRQK--AEFVPQLESEDDTSYF  346 (1205)
T ss_pred             ccccCcCCCHHHHHHHH------HHHHhChHhhcccc--hhhhhhhccceeecccchhhhhh--ccccccccccccchhh
Confidence            8865   4456665555      59999999999875  78899999999999999987665  4599999999999999


Q ss_pred             cc
Q 013249          410 DK  411 (447)
Q Consensus       410 ~~  411 (447)
                      +.
T Consensus       347 dT  348 (1205)
T KOG0606|consen  347 DT  348 (1205)
T ss_pred             cc
Confidence            84

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-32  Score=242.32  Aligned_cols=235  Identities=26%  Similarity=0.383  Sum_probs=176.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE-EEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS-FQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~-~~~~  187 (447)
                      +.|.+.+.||+|.||.+.+|++++     ++..+++|.+.+...    .+..|.+|...--.| .|.||+.-|++ |++.
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~-----s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQ-----SKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccC-----CceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            469999999999999999999998     888999999876432    334566777654444 48999987754 7888


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC--CCCcEEEeecCCcccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAKEI  265 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~--~~~~~kL~DFG~a~~~  265 (447)
                      +.+.++|||++.|+|..-+...| +-|...+.++.|++.||.|||++++||||||.+||||-  +.-+|||||||+.+..
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            89999999999999988876644 68889999999999999999999999999999999993  2347999999998765


Q ss_pred             cCCCCCCccccCCcccccccccCC-----CCCCccceeehhHhHHHHhhCCCCCCCCC-----HHHHHHHHHhcccCCCC
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHAN-----RQKLQQRIINEKVKLPP  335 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~ell~G~~pf~~~~-----~~~~~~~i~~~~~~~p~  335 (447)
                      +..  ....--+..|.+||+....     ...+.+|+|.||+++|.+++|.+||....     ..+..+-........|.
T Consensus       174 g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  174 GTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             Cce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence            432  1122335679999987632     23678999999999999999999996321     11221211222223443


Q ss_pred             C---CchhHHhhhhhhhHHhhhccCCCCCC
Q 013249          336 F---LTSEAHSLLKGVSFLTQLLHKDPSKR  362 (447)
Q Consensus       336 ~---~~~~~~~li~~~~~l~~~L~~dP~~R  362 (447)
                      .   +++.+..+      ..+-|..++++|
T Consensus       252 ~F~~fs~~a~r~------Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  252 KFNPFSEKALRL------FKKSLTPRFKDR  275 (378)
T ss_pred             hhcccCHHHHHH------HHHhcCCccccc
Confidence            3   34444333      445899999998

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.8e-31  Score=291.34  Aligned_cols=197  Identities=20%  Similarity=0.247  Sum_probs=145.5

Q ss_pred             cCC-CCceeeeEEE-------EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013249          172 VTH-PFIVQLRYSF-------QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK  242 (447)
Q Consensus       172 l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDik  242 (447)
                      ++| +||++++++|       .....++++|||+ +++|.+++... ..+++.+++.++.||+.||.|||++||||||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            344 5777788877       2334678889988 66999999754 569999999999999999999999999999999


Q ss_pred             CCCcccCCC-------------------CcEEEeecCCcccccCCC-----------------CCCccccCCcccccccc
Q 013249          243 PENILMDSD-------------------GHVMLTDFGLAKEIDESS-----------------RSNSMCGTTEYMAPEIL  286 (447)
Q Consensus       243 p~NILl~~~-------------------~~~kL~DFG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~  286 (447)
                      |+||||+..                   +.+||+|||+++......                 .....+||+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   455666666665321100                 01124689999999999


Q ss_pred             cCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCC
Q 013249          287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSG  366 (447)
Q Consensus       287 ~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~  366 (447)
                      .+..|+.++|||||||+||||++|..|+....  .....+....  +|+...   .......+++.+||++||.+||   
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~L~~~P~~Rp---  257 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQIL---LNWPKEASFCLWLLHPEPSCRP---  257 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhhh---hcCHHHHHHHHHhCCCChhhCc---
Confidence            99999999999999999999999999875432  1222222111  222111   1122334667789999999999   


Q ss_pred             CCChhhhhcCCccCC
Q 013249          367 PGGVDAIKHHKWFRS  381 (447)
Q Consensus       367 ~~~~~~l~~h~~f~~  381 (447)
                        ++.++++||||..
T Consensus       258 --s~~eil~h~~~~~  270 (793)
T PLN00181        258 --SMSELLQSEFINE  270 (793)
T ss_pred             --ChHHHhhchhhhh
Confidence              8899999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=6.5e-29  Score=221.73  Aligned_cols=164  Identities=22%  Similarity=0.230  Sum_probs=128.6

Q ss_pred             CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccccCC
Q 013249          200 GHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT  278 (447)
Q Consensus       200 g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~  278 (447)
                      |+|.+++..+ ..+++.+++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            6899999874 56999999999999999999999999      999999999999999  99998764422    26899


Q ss_pred             cccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCCCCCchhHHhhh---hhhhHHhhh
Q 013249          279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLPPFLTSEAHSLL---KGVSFLTQL  354 (447)
Q Consensus       279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~li---~~~~~l~~~  354 (447)
                      .|||||++.+..++.++|||||||++|||++|+.||...... .....+...................   ...+|+.+|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            999999999999999999999999999999999999765432 2333333322221111001111111   346788889


Q ss_pred             ccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          355 LHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       355 L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      |..||.+||     ++.+++.|+|+.
T Consensus       149 l~~~p~~Rp-----~~~~ll~~~~~~  169 (176)
T smart00750      149 ASRLPQRRE-----AANHYLAHCRAL  169 (176)
T ss_pred             Hhccccccc-----CHHHHHHHHHHH
Confidence            999999999     889999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=8.6e-30  Score=265.57  Aligned_cols=264  Identities=25%  Similarity=0.388  Sum_probs=196.5

Q ss_pred             EEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeec---hhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK---DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       113 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ....++|.|++|.|+.+....     ....++.|..+.   ...........+..|.-+-..+.|+|++..+..+.+...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~-----~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRS-----DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG  395 (601)
T ss_pred             CccceeeecccCceEEEEecC-----CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence            356789999999888877665     333344444331   111122222226677878888999999888777777666


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      .+-+||||++ +|+..+...+.+...++..++.||+.|++|||..||.|||||++|+++..+|.+||+|||.+..+... 
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            6666999999 99999998889999999999999999999999999999999999999999999999999999876322 


Q ss_pred             ----CCCCccccCCcccccccccCCCCCC-ccceeehhHhHHHHhhCCCCCCCCCHHHHH-HHHH-hcccCCCCCCchhH
Q 013249          269 ----SRSNSMCGTTEYMAPEILLSKGHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRII-NEKVKLPPFLTSEA  341 (447)
Q Consensus       269 ----~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~ell~G~~pf~~~~~~~~~-~~i~-~~~~~~p~~~~~~~  341 (447)
                          ......+|+..|+|||++.+..|+. .+||||.|++++.|++|+.||......+.. .... ............-.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL  554 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence                3345788999999999999999975 589999999999999999999654333221 1111 11111111111111


Q ss_pred             Hhhh-hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHH
Q 013249          342 HSLL-KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  387 (447)
Q Consensus       342 ~~li-~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~  387 (447)
                      ..+- ....+|.+||+.||.+|.     ++++|++.+||+.++-..+
T Consensus       555 ~~lp~~~~~~~~~~l~~~P~~R~-----ti~~i~~d~W~~~i~~c~v  596 (601)
T KOG0590|consen  555 SLLPRETRIIIYRMLQLDPTKRI-----TIEQILNDEWIRSIECCHV  596 (601)
T ss_pred             HhchhhHHHHHHHHccCChhhee-----cHHHHhhChHhhhcceEEe
Confidence            1111 113567789999999999     8999999999998764443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=9.1e-27  Score=225.07  Aligned_cols=256  Identities=38%  Similarity=0.626  Sum_probs=204.2

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC-CceeeeEEEEeCCEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP-FIVQLRYSFQTRSKL  190 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~  190 (447)
                      |.+.+.||.|+||.||++.+.        ..+++|.+.............+.+|..++..+.|+ +|+++++.+......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence            788999999999999999875        57899999876544433567788999999999988 799999999888889


Q ss_pred             EEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-cEEEeecCCccccc
Q 013249          191 YLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEID  266 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~~kL~DFG~a~~~~  266 (447)
                      +++++++.++++...+....   .+.+..+..++.|++.++.|+|+.+++||||||+|||++..+ .++++|||.++.+.
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999999999997777664   799999999999999999999999999999999999999998 79999999998654


Q ss_pred             CCC-------CCCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCCCCH----HHHHHHHHhcccC
Q 013249          267 ESS-------RSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVK  332 (447)
Q Consensus       267 ~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~~----~~~~~~i~~~~~~  332 (447)
                      ...       .....+||..|+|||.+.+   ..++...|+||+|++++++++|..||.....    ......+......
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            432       2456789999999999987   5788999999999999999999999877653    4444545444433


Q ss_pred             -CCCCCchhHH--hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          333 -LPPFLTSEAH--SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       333 -~p~~~~~~~~--~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                       ..........  ......+++.+++..+|..|.     +..+...++|..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~-----~~~~~~~~~~~~  279 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRL-----SSSSDLSHDLLA  279 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcC-----CHHHHhhchHhh
Confidence             2222221110  001223567779999999999     455555554443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.7e-27  Score=233.69  Aligned_cols=184  Identities=22%  Similarity=0.255  Sum_probs=138.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      ..++|.+.++||+|+||+||+|+++.    .+++.+|||++.....  ......+.+.+|+++|++++|+||+..+..  
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--   89 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAG----DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--   89 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcC----CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence            34689999999999999999998764    1456789998753311  123345668999999999999999853322  


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCcccCCCCcEEEeecCCccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDi-kp~NILl~~~~~~kL~DFG~a~~  264 (447)
                       .+..|+||||++|++|.. +.   ...   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus        90 -~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             -cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence             246899999999999963 21   111   1467889999999999999999999 99999999999999999999997


Q ss_pred             ccCCCC---------CCccccCCcccccccccCCC------CCCcccee-ehhHhHH
Q 013249          265 IDESSR---------SNSMCGTTEYMAPEILLSKG------HNKDADWW-SVGILLY  305 (447)
Q Consensus       265 ~~~~~~---------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw-SlGvil~  305 (447)
                      +.....         ....+++..|+|||.+....      .+...|-| .-|=+.+
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDlg~  218 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKKVY  218 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCEEE
Confidence            643321         13457888999999997432      22335555 5555444

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=8.1e-26  Score=221.53  Aligned_cols=200  Identities=26%  Similarity=0.405  Sum_probs=166.7

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC----CCceeeeEEE-E
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH----PFIVQLRYSF-Q  185 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h----pnIv~l~~~~-~  185 (447)
                      +|.+.++||+|+||.||+|.+....    ...+|+|+.........   ..+..|+.+|..+..    .++..+++.+ .
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~   91 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS   91 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence            7999999999999999999987521    45789998765422111   147779999988863    5889999998 5


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC-----CcEEEee
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----GHVMLTD  258 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-----~~~kL~D  258 (447)
                      .....|+||+.+ |.+|.++....  +.|+...+..++.|++.+|++||+.|+|||||||+|+++...     ..+.|.|
T Consensus        92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            788899999998 88999887554  579999999999999999999999999999999999999865     3699999


Q ss_pred             cCCcc--cccCCC------C---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC
Q 013249          259 FGLAK--EIDESS------R---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN  318 (447)
Q Consensus       259 FG~a~--~~~~~~------~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~  318 (447)
                      ||+++  .+....      .   ...+.||..|+++....+...+++.|+||++.++.||+.|..||.+..
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            99999  321111      1   123559999999999999999999999999999999999999997654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-25  Score=199.20  Aligned_cols=228  Identities=22%  Similarity=0.333  Sum_probs=183.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeEEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~  185 (447)
                      +..++|.++++||.|+||.+|++....     .|..||||+-....-.     .++.-|..+.+.+++ ..|..+..++.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~-----~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISIT-----SGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeecc-----CCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcc
Confidence            456789999999999999999999886     8899999987654321     235678889988875 56666777778


Q ss_pred             eCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC---CcEEEeecCC
Q 013249          186 TRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGL  261 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~~kL~DFG~  261 (447)
                      +..+-.+|||++ |-+|.+++.- ...|+...+.-++-|++.-++|+|.+++|||||||+|+|..-+   ..+.|+|||+
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence            888899999998 8899888763 4679999999999999999999999999999999999999643   4689999999


Q ss_pred             cccccCCC--------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC---CHHHHHHHHHhcc
Q 013249          262 AKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEK  330 (447)
Q Consensus       262 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~---~~~~~~~~i~~~~  330 (447)
                      |+.+.+..        ......||..|.+--...+...+..-|+-|+|.+|.++..|..||.+.   +...-+++|...+
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK  240 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK  240 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence            99864321        123567999999998888888899999999999999999999999765   3445566777766


Q ss_pred             cCCC-----CCCchhHHhhh
Q 013249          331 VKLP-----PFLTSEAHSLL  345 (447)
Q Consensus       331 ~~~p-----~~~~~~~~~li  345 (447)
                      ...|     ..++.|....+
T Consensus       241 ~s~~ie~LC~G~P~EF~myl  260 (341)
T KOG1163|consen  241 MSTPIEVLCKGFPAEFAMYL  260 (341)
T ss_pred             cCCCHHHHhCCCcHHHHHHH
Confidence            6544     34455554444

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.9e-25  Score=204.24  Aligned_cols=210  Identities=21%  Similarity=0.356  Sum_probs=177.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (447)
                      +|.++++||+|+||.++++.+.-     +++.||||.-....     ..-+++.|.+..+.|. .+.|.+.|.+.+.+-+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~-----nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~   98 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLY-----NNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY   98 (449)
T ss_pred             cceeccccccCcceeeecccccc-----cCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence            79999999999999999998775     78999999764332     2235788999999885 6899999988888889


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-----cEEEeecCCcc
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----HVMLTDFGLAK  263 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-----~~kL~DFG~a~  263 (447)
                      -.||||++ |-+|.+++.-. ..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+     .|.|+|||+|+
T Consensus        99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            99999998 78898887644 5799999999999999999999999999999999999997544     58999999999


Q ss_pred             cccCCCC--------CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCC---CCHHHHHHHHHhccc
Q 013249          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKV  331 (447)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~---~~~~~~~~~i~~~~~  331 (447)
                      .+.+...        ..+..||..||+-.-..+...++.-|+-|||-+++++|.|..||.+   .+..+-+++|-..+.
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr  256 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR  256 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence            8743321        2356799999999999999999999999999999999999999965   455566666655443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=5.2e-25  Score=201.73  Aligned_cols=175  Identities=15%  Similarity=0.170  Sum_probs=136.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHH------HHHHHHHHHhcCCCCceee
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY------MKAERDILTKVTHPFIVQL  180 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~E~~il~~l~hpnIv~l  180 (447)
                      +-.++|.++++||.|+||.||++..       +++.+|||+++......+.....      +.+|+..+.++.|++|..+
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~  100 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL  100 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence            4467999999999999999998643       24469999997654434433333      6789999999999999999


Q ss_pred             eEEEEeC--------CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC
Q 013249          181 RYSFQTR--------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       181 ~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  252 (447)
                      .+++...        +..+|||||++|.+|.+..    .+++    ....+++.+|..||+.|++||||||+||+++.+|
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC
Confidence            8886643        3589999999999997763    2333    2456999999999999999999999999999999


Q ss_pred             cEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHh
Q 013249          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML  308 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  308 (447)
                       ++|+|||............           .++....|+.++|+|+||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence             9999999887653322111           1444556778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=1.3e-24  Score=196.32  Aligned_cols=143  Identities=19%  Similarity=0.291  Sum_probs=112.0

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchh-----------------------HHHHHHHHHHHHHh
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------------------HVDYMKAERDILTK  171 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~-----------------------~~~~~~~E~~il~~  171 (447)
                      ...||+|+||.||+|.+.      +|+.||||+++........                       .......|..+|.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05147           2 NGCISTGKEANVYHATTA------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR   75 (190)
T ss_pred             CCccccccceEEEEEECC------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            467999999999999874      5789999999865321111                       01234469999999


Q ss_pred             cCCCCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCcccCC
Q 013249          172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDS  250 (447)
Q Consensus       172 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~iiHrDikp~NILl~~  250 (447)
                      +.++++........ . ..+|||||+.|+++.......+.+++..+..++.|++.+|.|| |+.||+||||||+|||++ 
T Consensus        76 l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          76 LVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             HHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence            98877644333222 2 2389999999987766555567899999999999999999999 799999999999999998 


Q ss_pred             CCcEEEeecCCccccc
Q 013249          251 DGHVMLTDFGLAKEID  266 (447)
Q Consensus       251 ~~~~kL~DFG~a~~~~  266 (447)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            5789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=9.7e-24  Score=189.47  Aligned_cols=187  Identities=18%  Similarity=0.238  Sum_probs=139.1

Q ss_pred             EEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch-hHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEE
Q 013249          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       113 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  190 (447)
                      .+...|++|+||+||++..       .+..++.+.+........ -....+.+|+++|+++. |++|.+++++    ...
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec-------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence            4567899999999997653       455666666654332111 11235789999999995 5789998876    347


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDi-kp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      |++|||+.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.......
T Consensus        74 ~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             EEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999999999998654321      1 2357789999999999999999999 7999999999999999999998655433


Q ss_pred             CC--------------CccccCCcccccccccCC-CCC-CccceeehhHhHHHHhhCCCCCCCC
Q 013249          270 RS--------------NSMCGTTEYMAPEILLSK-GHN-KDADWWSVGILLYEMLTGQPPFTHA  317 (447)
Q Consensus       270 ~~--------------~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~ell~G~~pf~~~  317 (447)
                      ..              .-...++.|++|+...-. ..+ ...+|++.|+-+|.++|+..++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            21              011257788888765422 233 5679999999999999999887554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=1.9e-23  Score=189.03  Aligned_cols=144  Identities=20%  Similarity=0.263  Sum_probs=113.7

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch-----------------------hHHHHHHHHHHHHHh
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----------------------NHVDYMKAERDILTK  171 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-----------------------~~~~~~~~E~~il~~  171 (447)
                      .+.||+|+||.||+|.+.      +++.||||+++.......                       .....+..|...+.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05145           2 NGCISTGKEANVYHARTG------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR   75 (190)
T ss_pred             CceeecCCCcEEEEEEcC------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999999864      578999999986521100                       012234679999999


Q ss_pred             cCCCCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCC
Q 013249          172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDS  250 (447)
Q Consensus       172 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~  250 (447)
                      +.|++|.....+....  .|+||||++|+++.........++..++..++.|++.+|.+||. +||+||||||+|||++ 
T Consensus        76 l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-  152 (190)
T cd05145          76 LYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             HHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence            9999875444333322  48999999988654443345678889999999999999999999 9999999999999999 


Q ss_pred             CCcEEEeecCCcccccC
Q 013249          251 DGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       251 ~~~~kL~DFG~a~~~~~  267 (447)
                      ++.++|+|||+++....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            89999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=2.4e-24  Score=225.42  Aligned_cols=235  Identities=25%  Similarity=0.399  Sum_probs=176.9

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechh--hcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      +|...+.||.+.|=+|.+|+++       ...|+||++-+..  +.-....+++ .|++ ...+++||++.+.-+...+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-------eG~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-------EGLVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-------CceEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhH
Confidence            7888999999999999999875       3459999987653  1122333333 3444 66778999999988877888


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc--c
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--D  266 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~--~  266 (447)
                      ..|||-+|+.. +|++.+..+.-+..-+.+.|+.||++||.-+|+.||+|+|||.|||||+.-+-+.|+||..-+..  .
T Consensus        95 AAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen   95 AAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence            88999999854 79999988877888999999999999999999999999999999999999989999999876642  1


Q ss_pred             CCCC--CC----ccccCCcccccccccCCC-----------CCCccceeehhHhHHHHhh-CCCCCCCC-----------
Q 013249          267 ESSR--SN----SMCGTTEYMAPEILLSKG-----------HNKDADWWSVGILLYEMLT-GQPPFTHA-----------  317 (447)
Q Consensus       267 ~~~~--~~----~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~ell~-G~~pf~~~-----------  317 (447)
                      +...  ..    +...-.+|+|||.+....           .+++.||||+||+++||++ |++||.-.           
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~  253 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD  253 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence            1111  11    111234799999986422           4678999999999999999 89999521           


Q ss_pred             CHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          318 NRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       318 ~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.+...++|.          +...+      .+|..|++.||.+|+     ++++.|+.
T Consensus       254 ~~e~~Le~Ie----------d~~~R------nlil~Mi~rdPs~Rl-----SAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKIE----------DVSLR------NLILSMIQRDPSKRL-----SAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhCc----------CccHH------HHHHHHHccCchhcc-----CHHHHHHh
Confidence            1111111111          11223      456669999999999     77998875

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=3.2e-23  Score=195.47  Aligned_cols=234  Identities=25%  Similarity=0.358  Sum_probs=149.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC---C-------Cceee
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---P-------FIVQL  180 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h---p-------nIv~l  180 (447)
                      .+...+.||.|+++.||.+.+..     +++.+|||+............+.+++|.-....+.+   |       .++-.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~-----t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVE-----TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEEccccccCCceEEEEEEEcc-----CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            36678899999999999999986     899999999876654555667777777655444322   1       12222


Q ss_pred             eEEEE---------eC---C-----EEEEEEeccCCCChHHHHH---HcCCC---CHHHH-HHHHHHHHHHHHHHHHCCc
Q 013249          181 RYSFQ---------TR---S-----KLYLILDFINGGHLFFHLY---RQGIF---REDQA-RFYTAEIVSAVSHLHKCGI  236 (447)
Q Consensus       181 ~~~~~---------~~---~-----~~~lv~E~~~gg~L~~~l~---~~~~~---~~~~~-~~i~~qi~~aL~~LH~~~i  236 (447)
                      ++...         ..   .     +.+++|+-+. ++|.+.+.   .....   ....+ ..+..|+++.+++||..||
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl  166 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL  166 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence            22221         11   1     2477888874 47766643   33222   11223 3455899999999999999


Q ss_pred             eeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccccCCcccccccccC--------CCCCCccceeehhHhHHHHh
Q 013249          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--------KGHNKDADWWSVGILLYEML  308 (447)
Q Consensus       237 iHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ell  308 (447)
                      +|+||||+|+|++.+|.++|+||+.....+.....  ...+..|.+||....        -.++.+.|.|+||+++|.|.
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999999987765543222  344578999998753        24688899999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCC
Q 013249          309 TGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR  362 (447)
Q Consensus       309 ~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R  362 (447)
                      +|..||...........    .+..-..+++..+.+|+.      +|++||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~------lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRG------LLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHH------HT-SSGGGS
T ss_pred             HccCCCCCCCccccccc----cchhcCCcCHHHHHHHHH------HccCCcccC
Confidence            99999975533221111    122222555666666555      999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=9.5e-23  Score=193.09  Aligned_cols=261  Identities=28%  Similarity=0.415  Sum_probs=179.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCC------------------------------CCCCcEEEEEEeechhhc
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD------------------------------GDSDGIYAMKVMRKDTII  154 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~------------------------------~~~~~~~avK~~~~~~~~  154 (447)
                      .++..++|+++..||+|....||.++......                              ....-..|||.+-.-...
T Consensus       152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~  231 (598)
T KOG4158|consen  152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD  231 (598)
T ss_pred             cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence            34677899999999999999999987654111                              001123566765432211


Q ss_pred             --chhHHHHHHHHHH------HH--------Hh--------cCCCCceeeeEEEEe------------------------
Q 013249          155 --KKNHVDYMKAERD------IL--------TK--------VTHPFIVQLRYSFQT------------------------  186 (447)
Q Consensus       155 --~~~~~~~~~~E~~------il--------~~--------l~hpnIv~l~~~~~~------------------------  186 (447)
                        ....++.+-+|.-      .+        +.        -+|||||++..+|.+                        
T Consensus       232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g  311 (598)
T KOG4158|consen  232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG  311 (598)
T ss_pred             CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence              1122223333321      11        11        259999999877753                        


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC--CCC--cEEEeec
Q 013249          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDG--HVMLTDF  259 (447)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~--~~~--~~kL~DF  259 (447)
                         ...+|+||...+. +|..++..+. .+....+-++.|+++|+.|||++||.|||+|.+||||.  +|+  .+.|+||
T Consensus       312 ~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  312 AGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             cCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence               1358999998854 7888887765 46677888999999999999999999999999999993  444  5789999


Q ss_pred             CCcccccC-------CCCCCccccCCcccccccccCCC------CCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHH-
Q 013249          260 GLAKEIDE-------SSRSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR-  325 (447)
Q Consensus       260 G~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~-  325 (447)
                      |+|-..+.       ....-...|....||||+.....      .-.++|.|+.|.+.||++....||.......+..+ 
T Consensus       390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~  469 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT  469 (598)
T ss_pred             ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence            98754222       11223345788899999986432      12469999999999999999999976433222111 


Q ss_pred             -HHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          326 -IINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       326 -i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                       -......+|..+++.+++++..      +|+.||++|++..  -+..+++
T Consensus       470 Yqe~qLPalp~~vpp~~rqlV~~------lL~r~pskRvsp~--iAANvl~  512 (598)
T KOG4158|consen  470 YQESQLPALPSRVPPVARQLVFD------LLKRDPSKRVSPN--IAANVLN  512 (598)
T ss_pred             hhhhhCCCCcccCChHHHHHHHH------HhcCCccccCCcc--HHHhHHH
Confidence             1223445677888888877666      9999999999652  3455555

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.87  E-value=3.3e-23  Score=216.73  Aligned_cols=295  Identities=33%  Similarity=0.574  Sum_probs=244.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ...+.+.+.+-+-.|+++.++.+.-.+     ++...+.|+..+.........+.+..+..++-..++|.++.....+..
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~-----sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~  875 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAG-----SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC  875 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccc-----cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence            355678888999999999999887665     566677777666554455555666677777776778888877766777


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ....+||++|+.|++|...++.-+..+++-++.++..+..+++|||...+.|||++|.|+|+..+|+.+++|||......
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence            88899999999999999999999989999999999999999999999999999999999999999999999998433211


Q ss_pred             C--------------------------------CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCC
Q 013249          267 E--------------------------------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF  314 (447)
Q Consensus       267 ~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf  314 (447)
                      .                                ........||+.|.+||.+.+......+|||++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0                                01123457999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcccCCCC---CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhh
Q 013249          315 THANRQKLQQRIINEKVKLPP---FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE  391 (447)
Q Consensus       315 ~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~  391 (447)
                      .......+++.|.......|.   ..+.++++++..      +|..+|.+|.++.  .+.++..|+||+.++|+.+....
T Consensus      1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~------ll~~~~~qr~~a~--~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINR------LLTEEPTQRLGAK--GAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred             CCcchhhhhhccccCCCCCCCCccccChhhhhhhhh------hhccCchhccCcc--cccccccCCccCCCCcccccccc
Confidence            999999999999998887664   456677766554      9999999999763  56689999999999999997554


Q ss_pred             cCCCCCCCCCCCccCCCcccccCCC
Q 013249          392 MQPKFKPDVSGKDCIANFDKCWTTM  416 (447)
Q Consensus       392 ~~~~~~p~~~~~~~~~~~~~~~~~~  416 (447)
                        ..|+|......+...|...|...
T Consensus      1108 --~~~~p~~~s~~dtS~~~~r~~~~ 1130 (1205)
T KOG0606|consen 1108 --AEFVPQPESTQDTSYFESRFSEE 1130 (1205)
T ss_pred             --CccCCCCCCCCccchhhcccccc
Confidence              35788888888888888776643

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.2e-21  Score=178.71  Aligned_cols=134  Identities=18%  Similarity=0.156  Sum_probs=105.4

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-----CCCCceeeeEEEEeCC-
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THPFIVQLRYSFQTRS-  188 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~-  188 (447)
                      .+.||+|+||.||.  +..     +.. .+||++....   ....+.+.+|+.+++.+     .||||++++++++++. 
T Consensus         7 ~~~LG~G~~~~Vy~--hp~-----~~~-k~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPE-----DAQ-RCIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             cceecCCCceEEEE--CCC-----CcC-eEEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            46899999999995  442     333 4799887642   22345688999999999     5799999999999873 


Q ss_pred             --EEE-EEEec--cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCCcccCCC----CcEEEee
Q 013249          189 --KLY-LILDF--INGGHLFFHLYRQGIFREDQARFYTAEIVSAV-SHLHKCGIVHRDLKPENILMDSD----GHVMLTD  258 (447)
Q Consensus       189 --~~~-lv~E~--~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL-~~LH~~~iiHrDikp~NILl~~~----~~~kL~D  258 (447)
                        .++ +||||  +.+++|.+++.+ +.+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+|
T Consensus        76 ~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         76 TGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             CeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence              444 78999  557999999965 456666  35678888888 99999999999999999999743    3799999


Q ss_pred             cCCc
Q 013249          259 FGLA  262 (447)
Q Consensus       259 FG~a  262 (447)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5533

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-22  Score=183.51  Aligned_cols=237  Identities=22%  Similarity=0.355  Sum_probs=189.3

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++..++.+|.+...|..|++++.+       .-+++|++....... ...+.|..|.-.|+-+.||||+.+++.|..
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqg-------ndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacns  258 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQG-------NDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNS  258 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccC-------cchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccC
Confidence            344456677789999999999999864       346678776655432 233457788888999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccCCCCcEEEe--ecC
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLT--DFG  260 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~~kL~--DFG  260 (447)
                      ..++.++..||+.|+|+..++....  .+..++.+++.++++|+.|||+..  |.---|....++||++.+.+|.  |--
T Consensus       259 ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  259 PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence            9999999999999999999987753  677899999999999999999875  4445788999999999877663  332


Q ss_pred             CcccccCCCCCCccccCCcccccccccCCCCC---CccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCC
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHN---KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPP  335 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~--~~~~p~  335 (447)
                      ++..  +    ....-.+.||+||.+..++-+   .++|+|||++++|||.|...||..-.+.+.--+|.-+  +..+|+
T Consensus       339 fsfq--e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp  412 (448)
T KOG0195|consen  339 FSFQ--E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP  412 (448)
T ss_pred             eeee--c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC
Confidence            2221  1    112336789999999876654   5799999999999999999999988887776666544  456899


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCC
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRL  363 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~  363 (447)
                      ..+.....+++.      |+..||.+||
T Consensus       413 gis~hm~klm~i------cmnedpgkrp  434 (448)
T KOG0195|consen  413 GISRHMNKLMNI------CMNEDPGKRP  434 (448)
T ss_pred             CccHHHHHHHHH------HhcCCCCcCC
Confidence            999988888776      9999999999

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=1.1e-21  Score=209.13  Aligned_cols=197  Identities=20%  Similarity=0.379  Sum_probs=160.6

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceee
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQL  180 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l  180 (447)
                      ...+..+.|.|-+.||+|+||.||+|...      .++.||||+-+.....+-..      =.+++.+|+   -+-|+.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~------~~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~  759 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHS------NGKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHI  759 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecC------CCcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHH
Confidence            34466678999999999999999999875      48899999976543322111      122333333   2446666


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-------CCc
Q 013249          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------DGH  253 (447)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-------~~~  253 (447)
                      ..++.-.+..+||+||.+.|+|.+++...+.+++..+.+++.|++..+++||..+|||+||||+|+||..       .--
T Consensus       760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  760 SSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             HHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence            6666777788999999999999999998889999999999999999999999999999999999999942       235


Q ss_pred             EEEeecCCcccc---cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCC
Q 013249          254 VMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP  312 (447)
Q Consensus       254 ~kL~DFG~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  312 (447)
                      ++|+|||.+..+   .+...-...++|-.+--+|+..|+.++..+|.|.|+.+++-||.|+.
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999999998764   33334556788999999999999999999999999999999999864

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=3.3e-21  Score=179.95  Aligned_cols=149  Identities=25%  Similarity=0.269  Sum_probs=114.8

Q ss_pred             CcEEEeeEeecCCeEEEEEE-EcCCCCCCCCcEEEEEEeechhhcc---------------------hhHHHHHHHHHHH
Q 013249          111 DFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMRKDTIIK---------------------KNHVDYMKAERDI  168 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~-~~~~~~~~~~~~~avK~~~~~~~~~---------------------~~~~~~~~~E~~i  168 (447)
                      .|.+.+.||+|+||.||+|. +..     +++.||||+++......                     ......+..|..+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDG-----SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCC-----CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            58899999999999999998 433     78899999997542110                     0012346789999


Q ss_pred             HHhcCCCCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCcc
Q 013249          169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPENIL  247 (447)
Q Consensus       169 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-iiHrDikp~NIL  247 (447)
                      ++++.+.. +.+...+... ..++||||+.|++|.........+...++..++.||+.+|.+||++| |+||||||+||+
T Consensus       104 L~~L~~~~-i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      104 LQRLYEAG-VPVPKPIAWR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             HHHHHhcC-CCCCeeeEec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence            99997532 2222222222 35899999999888666544556677778899999999999999999 999999999999


Q ss_pred             cCCCCcEEEeecCCcccccC
Q 013249          248 MDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       248 l~~~~~~kL~DFG~a~~~~~  267 (447)
                      ++ ++.++|+|||.+.....
T Consensus       182 i~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EE-CCCEEEEEChhhhccCC
Confidence            99 88999999999876443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.1e-19  Score=167.05  Aligned_cols=137  Identities=20%  Similarity=0.326  Sum_probs=113.5

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +.||+|++|.||+|++       .+..+++|+.......     .......+.+|+.++..+.|++|.....++......
T Consensus         2 ~~l~~G~~~~vy~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF   74 (211)
T ss_pred             cccccCceEEEEEEee-------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence            5799999999999986       3456888976543211     112234577899999999999988777777777889


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ++||||++|++|.+.+.....    ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999998865432    7889999999999999999999999999999999 78999999998865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=7e-22  Score=206.34  Aligned_cols=255  Identities=28%  Similarity=0.498  Sum_probs=200.9

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (447)
                      .|.+.+.||+|+|+.|-++....    .....+|+|.+.... ......+.+..|..+-+.+. |.|++.+++.......
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~----~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSR----DPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcC----CCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            57777889999999998876543    245567777765443 23444556677888888887 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCcccCCCC-cEEEeecCCcccc
Q 013249          190 LYLILDFINGGHLFFHL-YRQG-IFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEI  265 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l-~~~~-~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDikp~NILl~~~~-~~kL~DFG~a~~~  265 (447)
                      .+++++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+|++|||+|..+
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999999999988 5554 6788899999999999999999 99999999999999999999 9999999999886


Q ss_pred             cC-CC---CCCcccc-CCcccccccccCCC-CCCccceeehhHhHHHHhhCCCCCCCCCHHHHH-HHHHhcc----cCCC
Q 013249          266 DE-SS---RSNSMCG-TTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRIINEK----VKLP  334 (447)
Q Consensus       266 ~~-~~---~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~-~~i~~~~----~~~p  334 (447)
                      .. ..   .....+| ++.|+|||...+.. .....|+||.|+++.-+++|..||......... .......    ....
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            55 22   2345678 99999999999854 467899999999999999999999755433321 1111111    1122


Q ss_pred             CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 ~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ..++....+      ++.++|..+|.+|.     +.+++..++|+..
T Consensus       256 ~~~~~~~~~------~l~k~l~~~~~~r~-----s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHD------LLHKILKENPSNRL-----SIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhh------cccccccCCchhcc-----ccccccccccccc
Confidence            234444444      45559999999999     8899999999987

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2e-19  Score=163.81  Aligned_cols=133  Identities=22%  Similarity=0.251  Sum_probs=107.1

Q ss_pred             eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       117 ~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      .||+|+||.||++.+       .+..+++|........     .......+.+|+++++.+.|+++.....++......+
T Consensus         1 ~ig~G~~~~vy~~~~-------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec-------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence            489999999999985       4467899986543211     1122356778999999999887665555556667789


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +||||++|++|.+.+.....       .++.+++.+|.+||+.|++|+|++|+|||++ ++.++|+|||+++.
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999999888755321       7899999999999999999999999999999 88999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1e-20  Score=186.15  Aligned_cols=176  Identities=26%  Similarity=0.382  Sum_probs=135.4

Q ss_pred             CEEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .++||.|++|.-++|.+++.++.   ..+....+.++.|++.|++|   +|.+|||+||.||++..+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            36899999999999999997553   35667888999999999999   9999999999999999999999999999887


Q ss_pred             ccCCC-------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCC
Q 013249          265 IDESS-------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPF  336 (447)
Q Consensus       265 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~~p~~  336 (447)
                      .....       ..+..+||..||+||.+.++.|+.++||||||++|+||+. -...|..   ......+..+.  +|+.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~--ip~~  480 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGI--IPPE  480 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCC--CChH
Confidence            65544       4556789999999999999999999999999999999998 3333321   12222233332  3321


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         .+.+--....|+.+||...|.+||     .+.+.-.|.|.
T Consensus       481 ---~~~d~p~e~~ll~~lls~~p~~RP-----~~~~~~~~~~~  515 (516)
T KOG1033|consen  481 ---FLQDYPEEYTLLQQLLSPSPEERP-----SAIEVALHEFL  515 (516)
T ss_pred             ---HhhcCcHHHHHHHHhcCCCcccCc-----hHHHHhhhhhc
Confidence               111222335677789999999999     44555556553

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=1.6e-19  Score=164.51  Aligned_cols=140  Identities=19%  Similarity=0.200  Sum_probs=108.8

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch-------------------hHHHHHHHHHHHHHhc
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-------------------NHVDYMKAERDILTKV  172 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-------------------~~~~~~~~E~~il~~l  172 (447)
                      |.+.+.||+|+||.||++...      +++.+|||++........                   ........|..++..+
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   90 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL   90 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence            788899999999999999864      678899999765321000                   0112356789999999


Q ss_pred             CCCC--ceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC
Q 013249          173 THPF--IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (447)
Q Consensus       173 ~hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~  250 (447)
                      .|++  +...++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||||+||++++
T Consensus        91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             HHcCCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence            8774  444433    245689999999998865432      1456778899999999999999999999999999999


Q ss_pred             CCcEEEeecCCcccccC
Q 013249          251 DGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       251 ~~~~kL~DFG~a~~~~~  267 (447)
                      ++.++|+|||++..+..
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            99999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=4.6e-19  Score=185.28  Aligned_cols=139  Identities=22%  Similarity=0.247  Sum_probs=111.4

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechh-----hcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-----IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .|...++||+|+||+||++.+.+       ..+++|+.....     .......+.+.+|+++++.++|++|+....++.
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~-------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  406 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG-------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV  406 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC-------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence            34567899999999999988743       223444322211     111223456889999999999999988877777


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .....++||||++|++|.+++.        ....++.|++.+|.|||++||+||||||+|||+ .++.++|+|||+++..
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            7777899999999999988875        457789999999999999999999999999999 6789999999998763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=2.4e-18  Score=155.03  Aligned_cols=140  Identities=24%  Similarity=0.305  Sum_probs=99.3

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHH---------------------HHHHHHHHHhcC
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY---------------------MKAERDILTKVT  173 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~---------------------~~~E~~il~~l~  173 (447)
                      .+.||+|+||+||+|.+.      +++.||||+++............                     ...|...+..+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   75 (187)
T cd05119           2 GGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY   75 (187)
T ss_pred             CcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence            467999999999999864      56789999987643211111111                     135666666665


Q ss_pred             CCC--ceeeeEEEEeCCEEEEEEeccCCCChHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccC
Q 013249          174 HPF--IVQLRYSFQTRSKLYLILDFINGGHLFF-HLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD  249 (447)
Q Consensus       174 hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~-~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~  249 (447)
                      +..  +.++++.    ...++||||+.|+.+.. .+... .. ..+++.++.+++.++.++|. +||+||||||+||+++
T Consensus        76 ~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          76 EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             HcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            432  3334332    24689999999954321 11111 11 16788999999999999999 9999999999999999


Q ss_pred             CCCcEEEeecCCcccccC
Q 013249          250 SDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       250 ~~~~~kL~DFG~a~~~~~  267 (447)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             89999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=3.4e-18  Score=171.40  Aligned_cols=199  Identities=22%  Similarity=0.324  Sum_probs=152.0

Q ss_pred             HHhcCCCCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCCc
Q 013249          169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGI-VHRDLKPENI  246 (447)
Q Consensus       169 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i-iHrDikp~NI  246 (447)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... -.+++.-...++++|+.||.|||.-.| .|+.+++.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45688999999999999999999999999999999999874 457777788899999999999998766 9999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCC---CCCCccccCCcccccccccCCC-------CCCccceeehhHhHHHHhhCCCCCCC
Q 013249          247 LMDSDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKG-------HNKDADWWSVGILLYEMLTGQPPFTH  316 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvil~ell~G~~pf~~  316 (447)
                      ++|....+||+|||+.......   .......-..-|.|||.+.+..       .+.+.||||+|++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998765321   1111222345699999998631       36679999999999999999999964


Q ss_pred             C----CHHHHHHHHHh-cccCCCCCCc-h-hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhh
Q 013249          317 A----NRQKLQQRIIN-EKVKLPPFLT-S-EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIK  374 (447)
Q Consensus       317 ~----~~~~~~~~i~~-~~~~~p~~~~-~-~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~  374 (447)
                      .    +..++...+.. +...+-+.+. . +...  ..+.++.+||..+|.+||     +++.+.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~--~l~~l~~~cw~e~P~~rP-----s~~~i~  218 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPP--ELLLLVARCWEEIPEKRP-----SIEQIR  218 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcch--HHHHHHHHhcccChhhCc-----cHHHHH
Confidence            2    33455555555 2222222222 1 1111  235668889999999999     555554

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=2.4e-17  Score=154.27  Aligned_cols=137  Identities=23%  Similarity=0.316  Sum_probs=103.4

Q ss_pred             eeEe-ecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh----c------chhHHHHHHHHHHHHHhcCCCCc--eeeeE
Q 013249          116 RVVG-QGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI----I------KKNHVDYMKAERDILTKVTHPFI--VQLRY  182 (447)
Q Consensus       116 ~~lG-~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~----~------~~~~~~~~~~E~~il~~l~hpnI--v~l~~  182 (447)
                      ..|| .|+.|+||.+..       .+..++||.+.....    .      .......+.+|+.++..+.|++|  +..++
T Consensus        37 ~~lg~~~g~gtv~~v~~-------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~  109 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA  109 (239)
T ss_pred             ceeecCCCCccEEEEEe-------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence            3576 788888888765       356799998864321    1      11223567889999999998775  56666


Q ss_pred             EEEeC-CE---EEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEe
Q 013249          183 SFQTR-SK---LYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       183 ~~~~~-~~---~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~  257 (447)
                      +.... ..   .++|||+++| .+|.+++.. ..+++..    +.+|+.+|.+||++||+||||||+|||++.++.++|+
T Consensus       110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        110 ARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             eeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence            64432 22   3599999997 688887754 4556543    5689999999999999999999999999999999999


Q ss_pred             ecCCccc
Q 013249          258 DFGLAKE  264 (447)
Q Consensus       258 DFG~a~~  264 (447)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998765

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=6.4e-17  Score=139.40  Aligned_cols=132  Identities=21%  Similarity=0.290  Sum_probs=111.3

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC--CCceeeeEEEEeCCEEE
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~  191 (447)
                      +++.||.|.++.||++...       +..+++|.......     ...+..|..+++.+.|  .++.+++.++...+..+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-------~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~   69 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-------DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSY   69 (155)
T ss_pred             cceecccccccceEEEEec-------CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccE
Confidence            4578999999999999864       25799999865432     3457889999999976  58899988888888999


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ++|||+.|+.+..+       +......++.+++.+|.+||..   +++|+||+|+|||+++++.++|+|||.++.
T Consensus        70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99999998877543       5567778899999999999985   799999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=8e-16  Score=154.48  Aligned_cols=254  Identities=24%  Similarity=0.256  Sum_probs=186.0

Q ss_pred             CcEEEeeEee--cCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeC
Q 013249          111 DFEIFRVVGQ--GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (447)
Q Consensus       111 ~y~~~~~lG~--G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~  187 (447)
                      .|.+.+.+|.  |.+|.||.++...   ..+...+|+|.-+...- .......=.+|....++++ |+|.++.+..++..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccC
Confidence            4677888999  9999999987721   12677899987433211 1111111234666666664 89999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCCcccCCC-CcEEEeecCC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVS----AVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGL  261 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~----aL~~LH~~~iiHrDikp~NILl~~~-~~~kL~DFG~  261 (447)
                      +..|+-+|++. .+|..+...... +++..++.+..+...    ||.++|..+++|-|+||.||++..+ ...+++|||+
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            99999999994 778777776655 889999999999999    9999999999999999999999999 8899999999


Q ss_pred             cccccCCCCC------CccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHh--cccCC
Q 013249          262 AKEIDESSRS------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKL  333 (447)
Q Consensus       262 a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~--~~~~~  333 (447)
                      ...+......      ....|...|++||...+. ++...|++++|.++.+..+|..++......... .+..  ...++
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-~~r~~~ip~e~  347 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-QLRQGYIPLEF  347 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcc-ccccccCchhh
Confidence            9887654422      223578889999998755 788899999999999999988776433111100 0111  11112


Q ss_pred             CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       334 p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      -...+.++..      .+..|++.+|..|+     +.+.++.|++....
T Consensus       348 ~~~~s~~l~~------~~~~~~d~~~~~~~-----~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  348 CEGGSSSLRS------VTSQMLDEDPRLRL-----TAQILTALNVIHSK  385 (524)
T ss_pred             hcCcchhhhh------HHHHhcCcchhhhh-----HHHHHhccccccch
Confidence            2223333333      35559999999999     77999999988743

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=1.9e-14  Score=146.12  Aligned_cols=142  Identities=18%  Similarity=0.301  Sum_probs=96.7

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-------------------------------hhHHH----
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHVD----  160 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-------------------------------~~~~~----  160 (447)
                      +.||.|++|.||+|+.+      +|+.||||+.+......                               .+...    
T Consensus       123 ~plasaSigQVh~A~l~------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             cceeeeehhheEEEEec------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            57999999999999976      67899999986531100                               00001    


Q ss_pred             --HHHHHHHHHHhc----C-CCCceeeeEEE-EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHH-HHHH
Q 013249          161 --YMKAERDILTKV----T-HPFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVS-AVSH  230 (447)
Q Consensus       161 --~~~~E~~il~~l----~-hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~-aL~~  230 (447)
                        .+.+|...+.++    . +++|. +-.++ ...+..+|||||++|++|.+..... ...   ....++.+++. .+..
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQ  272 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHH
Confidence              123344444444    2 33332 22222 2234579999999999998776432 122   23445666665 4788


Q ss_pred             HHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       231 LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      +|..|++|+|+||.||+++.+|.++|+|||++..+..
T Consensus       273 l~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       273 VLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.56  E-value=2.9e-15  Score=153.89  Aligned_cols=144  Identities=18%  Similarity=0.344  Sum_probs=96.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-------------------------------chhHH
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------------------------------KKNHV  159 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-------------------------------~~~~~  159 (447)
                      +|+. +.||.|++|.||+|+.+.     +|+.||||++++....                               -.+..
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~-----~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~  194 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKD-----NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE  194 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECC-----CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence            5666 789999999999999875     5889999999754210                               00122


Q ss_pred             HHHHHHHHHHHhc----------CCCCceeeeEEEEe-CCEEEEEEeccCCCChHHH--HHHcC----CCCHHHHHHHHH
Q 013249          160 DYMKAERDILTKV----------THPFIVQLRYSFQT-RSKLYLILDFINGGHLFFH--LYRQG----IFREDQARFYTA  222 (447)
Q Consensus       160 ~~~~~E~~il~~l----------~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--l~~~~----~~~~~~~~~i~~  222 (447)
                      +.+.+|+++.+..          .+...+.+-.++.+ ....+|||||++|+.+.+.  +...+    .+.+..+..++.
T Consensus       195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            3344455544433          12222222222221 3456799999999999764  33333    244444555555


Q ss_pred             HHHHHHHHHHHCCceeccCCCCCcccCCCC----cEEEeecCCcccccC
Q 013249          223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLAKEIDE  267 (447)
Q Consensus       223 qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~~kL~DFG~a~~~~~  267 (447)
                      |+       ...|++|+|+||.||+++.+|    .++++|||++..+..
T Consensus       275 Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            55       469999999999999999988    999999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=1e-14  Score=146.63  Aligned_cols=251  Identities=26%  Similarity=0.320  Sum_probs=183.9

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEe
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  186 (447)
                      ...+|..+..||.|.|+.|+.+..+.    .++..|++|.+.+........+..+ .|+.+...+ .|.+++.++..+..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~----~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRP----EGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecC----CCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCccc
Confidence            34578999999999999999887442    2677899998876554443333333 466666655 48899998888888


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC-CcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~~kL~DFG~a~~~  265 (447)
                      ..+.|+=-|||+++++...+.....+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||+...+
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence            88889999999999887777555668899999999999999999999999999999999999886 78899999998753


Q ss_pred             cCCCCCCccc-cCCcc-cccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHh
Q 013249          266 DESSRSNSMC-GTTEY-MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (447)
Q Consensus       266 ~~~~~~~~~~-gt~~y-~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  343 (447)
                      .-..  .... ++..| .+++......+..++|++|||..+.+.++|...=....   ....|..+.....+....+.+.
T Consensus       418 ~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  418 AFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNLPGLKLQLQV  492 (524)
T ss_pred             ceec--ccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecccccCCCchHHhhhh
Confidence            2211  1112 23334 35555556788899999999999999999865432211   1233444544444444455666


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      +.+.      +...|+..|+     .+.++..|.=|
T Consensus       493 ~~kv------~~~~~~~~~~-----l~~~l~~~~~~  517 (524)
T KOG0601|consen  493 LLKV------MINPDRKRRP-----SAVELSLHSEF  517 (524)
T ss_pred             hhhh------hcCCccccch-----hhhhhcccchh
Confidence            5554      8889999998     56676666544

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.49  E-value=3.6e-13  Score=136.81  Aligned_cols=162  Identities=20%  Similarity=0.344  Sum_probs=125.5

Q ss_pred             CCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHH
Q 013249          139 SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR  218 (447)
Q Consensus       139 ~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~  218 (447)
                      .+..+.|.+.+...   ....+.+.+-+.-|+.++||||+++++.++..+.+|||+|-+.  -|..++.+.+   ...+.
T Consensus        36 ~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHH
Confidence            56677777765432   2445667788889999999999999999999999999999985  4666676544   67788


Q ss_pred             HHHHHHHHHHHHHH-HCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC-CCccccCCcccccccccCCCCCCccc
Q 013249          219 FYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDAD  296 (447)
Q Consensus       219 ~i~~qi~~aL~~LH-~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~D  296 (447)
                      .-+.||+.||.||| +++++|++|.-..|+|+..|..||++|-++........ .....--..|..|+.+....  -..|
T Consensus       108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence            88999999999998 67899999999999999999999999988765433221 11111223466676654333  3479


Q ss_pred             eeehhHhHHHHhhC
Q 013249          297 WWSVGILLYEMLTG  310 (447)
Q Consensus       297 vwSlGvil~ell~G  310 (447)
                      .|-|||+++|++.|
T Consensus       186 ~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  186 SWGLGCLIEELFNG  199 (690)
T ss_pred             hhhHHHHHHHHhCc
Confidence            99999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.5e-13  Score=121.61  Aligned_cols=128  Identities=23%  Similarity=0.299  Sum_probs=94.7

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCCEEEEE
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLI  193 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lv  193 (447)
                      ++.|+.|.++.||+++.       .++.|++|+......    ....+..|..+++.+.+.+++ +++...  ....++|
T Consensus         3 ~~~l~~G~~~~vy~~~~-------~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv   69 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-------ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI   69 (170)
T ss_pred             eeecCCcccCceEEEEE-------CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence            46788999999999885       356799998764321    112356789999988665544 344433  2335799


Q ss_pred             EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI-----VHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i-----iHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      |||++|.++...        ......++.+++.+|..||..++     +|+|++|.||+++ ++.++|+|||.+..
T Consensus        70 ~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          70 TEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999999877543        11123456799999999999985     9999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=9.1e-14  Score=129.67  Aligned_cols=205  Identities=18%  Similarity=0.285  Sum_probs=147.7

Q ss_pred             HHHhcCCCCceeeeEEEEeC-----CEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q 013249          168 ILTKVTHPFIVQLRYSFQTR-----SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG--I  236 (447)
Q Consensus       168 il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--i  236 (447)
                      -|-.+.|.|||+++.++.+.     ....++.|||..|+|..+|++-    ..+.....++++.||+.||.|||+..  |
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            34456799999999888653     4588999999999999988754    45888899999999999999999885  9


Q ss_pred             eeccCCCCCcccCCCCcEEEeecCCccc-----ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCC
Q 013249          237 VHRDLKPENILMDSDGHVMLTDFGLAKE-----IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ  311 (447)
Q Consensus       237 iHrDikp~NILl~~~~~~kL~DFG~a~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  311 (447)
                      +|+++..+-|++..+|-+|+.--.-...     ...........+-++|.+||.=.....+.++|||+||+...||..|.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            9999999999999999998853221110     00001112234678899999877777788999999999999999876


Q ss_pred             CC-CCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          312 PP-FTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       312 ~p-f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      .- -.+....+....|.+-.+.+....         ..+++++||+..|+.||     ++.+++.||-+-++-...
T Consensus       280 iq~tnseS~~~~ee~ia~~i~~len~l---------qr~~i~kcl~~eP~~rp-----~ar~llfHpllfeVhslk  341 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVIIGLENGL---------QRGSITKCLEGEPNGRP-----DARLLLFHPLLFEVHSLK  341 (458)
T ss_pred             eccCCCcceeehhhhhhhheeeccCcc---------ccCcCcccccCCCCCCc-----chhhhhcCceeeecchHH
Confidence            54 222222222223322222111111         24567779999999999     789999999887765444

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=7.2e-13  Score=119.07  Aligned_cols=147  Identities=19%  Similarity=0.249  Sum_probs=102.5

Q ss_pred             EeeEeecCCeEEEEEEEcCCC-CCCCCcEEEEEEeechhh--------c-----------chhHHHH----HHHHHHHHH
Q 013249          115 FRVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTI--------I-----------KKNHVDY----MKAERDILT  170 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~-~~~~~~~~avK~~~~~~~--------~-----------~~~~~~~----~~~E~~il~  170 (447)
                      ...||.|--+.||.|...... ....+..+|||+.+-...        .           .......    .++|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            357999999999999743200 000246899998764211        0           0111222    338999999


Q ss_pred             hcCC--CCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCcc
Q 013249          171 KVTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENIL  247 (447)
Q Consensus       171 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~iiHrDikp~NIL  247 (447)
                      ++..  -++.+++++    ..-+|||||+.++.+....-+...+++.++..+..+++.+|..| |+.||||+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8853  344455543    45689999997754533222334566677788889999999999 8999999999999999


Q ss_pred             cCCCCcEEEeecCCccccc
Q 013249          248 MDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       248 l~~~~~~kL~DFG~a~~~~  266 (447)
                      ++ ++.+.|+|||.+....
T Consensus       158 ~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE-CCcEEEEECCCceeCC
Confidence            96 5789999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=1.3e-11  Score=107.51  Aligned_cols=134  Identities=24%  Similarity=0.264  Sum_probs=97.2

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeec-----hhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK-----DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~-----~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      ..+++|+-+.||.+.+.+       ..+++|.=.+     ..+..+-..++..+|..+|.++.--.|.--+-++.+...-
T Consensus         2 ~~i~~GAEa~i~~~~~~g-------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeeccC-------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            357899999999886643       2355554322     2223333345677899999988654444444455566777


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .|+|||++|..|.+.+...   .    ..++..+-.-+.-||..||||+||.++||++..++ +.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            8999999999888888765   1    34555666667779999999999999999997665 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.32  E-value=2.6e-11  Score=105.20  Aligned_cols=144  Identities=25%  Similarity=0.277  Sum_probs=105.9

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEe-----echhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM-----RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~-----~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .+..|-+|+-++|+++.+       .|+.+.||.-     +...+..+-...+.++|.++|.++.--.|.--.-+|.+..
T Consensus        11 ~l~likQGAEArv~~~~~-------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeecc-------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence            567889999999999987       4566666653     2333334444567888999999886444444444566666


Q ss_pred             EEEEEEeccCC-CChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC---cEEEeecCCc
Q 013249          189 KLYLILDFING-GHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLA  262 (447)
Q Consensus       189 ~~~lv~E~~~g-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~~kL~DFG~a  262 (447)
                      .-.|+|||++| .++.+++....  .........++.+|-..+.-||.++|||+||..+||+|..+|   .+.|+|||++
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence            67899999988 36777776542  222333368888999999999999999999999999997665   3589999987


Q ss_pred             cc
Q 013249          263 KE  264 (447)
Q Consensus       263 ~~  264 (447)
                      ..
T Consensus       164 ~~  165 (229)
T KOG3087|consen  164 SV  165 (229)
T ss_pred             hc
Confidence            53

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=2.5e-11  Score=112.00  Aligned_cols=140  Identities=15%  Similarity=0.239  Sum_probs=104.3

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC--CceeeeEEEEeC---CEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQTR---SKL  190 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~---~~~  190 (447)
                      +.||.|..+.||++...      .++.+++|+.......  .....+..|..+++.+.+.  .+.+++.+....   +..
T Consensus         4 ~~l~~G~~n~~~~v~~~------~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~   75 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG------GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP   75 (223)
T ss_pred             eecCCCccceEEEEEec------CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence            56899999999999763      2467999997654321  1234578899999999753  456666666553   367


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-------------------------------------  233 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-------------------------------------  233 (447)
                      ++||||++|.++...+.. ..+++.+...++.+++.+|.+||+                                     
T Consensus        76 ~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (223)
T cd05154          76 FYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP  154 (223)
T ss_pred             eEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence            899999999887665432 356777777778888888877773                                     


Q ss_pred             -------------------CCceeccCCCCCcccCC--CCcEEEeecCCccc
Q 013249          234 -------------------CGIVHRDLKPENILMDS--DGHVMLTDFGLAKE  264 (447)
Q Consensus       234 -------------------~~iiHrDikp~NILl~~--~~~~kL~DFG~a~~  264 (447)
                                         ..++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               23699999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=3.9e-11  Score=122.66  Aligned_cols=154  Identities=22%  Similarity=0.372  Sum_probs=115.8

Q ss_pred             HHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEEeecCCcccccCCCC----------CCccccCCcccccccccCCCC
Q 013249          223 EIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----------SNSMCGTTEYMAPEILLSKGH  291 (447)
Q Consensus       223 qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~  291 (447)
                      +++.||.|+|+. ++||+.|.|++|.++.+|.+||+.|+++........          ..-..-...|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            455999999964 899999999999999999999999998765433111          001123567999999999888


Q ss_pred             CCccceeehhHhHHHHh-hCCCCCCCCCHHHHHHHHH----hcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCC
Q 013249          292 NKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRII----NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSG  366 (447)
Q Consensus       292 ~~~~DvwSlGvil~ell-~G~~pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~  366 (447)
                      +.++|+||+||++|.+. .|+..+...+....+..-.    .....+...++.++++.+.+      +|..++..||   
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k------~l~~~~~~rp---  257 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKK------LLNGDSAVRP---  257 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHH------HhcCCcccCc---
Confidence            99999999999999999 5777665543322222111    12233456677888887776      9999999999   


Q ss_pred             CCChhhhhcCCccCCCChhHH
Q 013249          367 PGGVDAIKHHKWFRSINWKTL  387 (447)
Q Consensus       367 ~~~~~~l~~h~~f~~~~~~~~  387 (447)
                        ++.+++..+||.+.-...+
T Consensus       258 --~~~~l~~~~ff~D~~~~aL  276 (700)
T KOG2137|consen  258 --TLDLLLSIPFFSDPGLKAL  276 (700)
T ss_pred             --chhhhhcccccCCchhhhh
Confidence              7899999999998655554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.12  E-value=1.3e-09  Score=103.27  Aligned_cols=126  Identities=16%  Similarity=0.059  Sum_probs=89.0

Q ss_pred             CCcEEEEEEeechhhc---ch-----hHHHHHHHHHHHHHhcCCCC--ceeeeEEEEe-----CCEEEEEEeccCCC-Ch
Q 013249          139 SDGIYAMKVMRKDTII---KK-----NHVDYMKAERDILTKVTHPF--IVQLRYSFQT-----RSKLYLILDFINGG-HL  202 (447)
Q Consensus       139 ~~~~~avK~~~~~~~~---~~-----~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~-----~~~~~lv~E~~~gg-~L  202 (447)
                      .|+.|.||........   ..     .-...+.+|...+.+|..-+  ...++++++.     ...-+||||++++. +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            4567888865432210   00     01113668888888774322  2233444433     23578999999886 78


Q ss_pred             HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-------CCcEEEeecCCccc
Q 013249          203 FFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------DGHVMLTDFGLAKE  264 (447)
Q Consensus       203 ~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-------~~~~kL~DFG~a~~  264 (447)
                      .+++..  ...........++.+++..+.-||.+||+|+|+++.|||++.       ++.+.|+||+.+..
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            888753  345667788899999999999999999999999999999975       46799999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=1.3e-09  Score=97.53  Aligned_cols=129  Identities=23%  Similarity=0.303  Sum_probs=82.4

Q ss_pred             EEEEEEEcCCCCCCCCcEEEEEEeechhh-----------------------cchhHHHHHHHHHHHHHhcCCC--Ccee
Q 013249          125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----------------------IKKNHVDYMKAERDILTKVTHP--FIVQ  179 (447)
Q Consensus       125 ~V~~~~~~~~~~~~~~~~~avK~~~~~~~-----------------------~~~~~~~~~~~E~~il~~l~hp--nIv~  179 (447)
                      .||.|...      .+..+|||+.+....                       .........++|.+.|.++..-  ++.+
T Consensus         1 ~Vy~~~~~------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~   74 (188)
T PF01163_consen    1 DVYHAIDP------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPK   74 (188)
T ss_dssp             EEEEEEEC------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--
T ss_pred             CEEEEECC------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCc
Confidence            37888764      567899998764211                       0111234577899999999765  4455


Q ss_pred             eeEEEEeCCEEEEEEeccC--CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCCcccCCCCcEEE
Q 013249          180 LRYSFQTRSKLYLILDFIN--GGHLFFHLYRQGIFREDQARFYTAEIVSAVSH-LHKCGIVHRDLKPENILMDSDGHVML  256 (447)
Q Consensus       180 l~~~~~~~~~~~lv~E~~~--gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~-LH~~~iiHrDikp~NILl~~~~~~kL  256 (447)
                      ++++.    .-+|||||+.  |..+..+. .. .++.+....++.+++..+.. +|..||+|+||.+.|||++++ .+.|
T Consensus        75 p~~~~----~~~ivME~I~~~G~~~~~l~-~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   75 PYDYN----RNVIVMEYIGEDGVPLPRLK-DV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             EEEEE----TTEEEEE--EETTEEGGCHH-HC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE
T ss_pred             EEEEe----CCEEEEEecCCCccchhhHH-hc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEE
Confidence            54332    2479999998  55553332 22 12245567778888886555 579999999999999999887 8999


Q ss_pred             eecCCccccc
Q 013249          257 TDFGLAKEID  266 (447)
Q Consensus       257 ~DFG~a~~~~  266 (447)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.93  E-value=1.4e-08  Score=100.80  Aligned_cols=217  Identities=17%  Similarity=0.276  Sum_probs=148.9

Q ss_pred             CeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----CCEEEEEEeccC
Q 013249          123 FGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----RSKLYLILDFIN  198 (447)
Q Consensus       123 fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~~~  198 (447)
                      -.+.|+|....     +|..|++|.+...+....+   ....-+++++++.|+|||++.++|..    +..+++|++|.+
T Consensus       289 ~~Ttyk~~s~~-----DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  289 SITTYKATSNV-----DGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             cceeEeeeecc-----CCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence            45678888765     7889999998443322211   12345778999999999999999873    457999999988


Q ss_pred             CC-ChHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          199 GG-HLFFHLYRQ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       199 gg-~L~~~l~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      +. +|.++-...               ...+|..+|.|+.||..||.++|+.|+..+-|.+.+||++.+.+++|...|..
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence            64 676654322               24678999999999999999999999999999999999999888999887777


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCC-CCCCCHHHH-HHHHHhcccCCCCCCchh
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP-FTHANRQKL-QQRIINEKVKLPPFLTSE  340 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~p-f~~~~~~~~-~~~i~~~~~~~p~~~~~~  340 (447)
                      ..+.....             |-+.+   -.+-|.=.||.+++.|.+|..- +........ ...       +-..++.+
T Consensus       441 Dvl~~d~~-------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I~~~yS~D  497 (655)
T KOG3741|consen  441 DVLQEDPT-------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------ITTTYSTD  497 (655)
T ss_pred             eeecCCCC-------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------hhhhhhHH
Confidence            66544320             11111   1346778899999999998542 222222211 111       22345566


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC---CccCCC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH---KWFRSI  382 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h---~~f~~~  382 (447)
                      +++++.-      +...+++++      ++++++.|   .||..+
T Consensus       498 ~rn~v~y------l~s~~~~~k------sI~~llp~~~~~ff~vm  530 (655)
T KOG3741|consen  498 LRNVVEY------LESLNFREK------SIQDLLPMIGSRFFTVM  530 (655)
T ss_pred             HHHHHHH------HHhcCcccc------cHHHHHHHHHHHHHHHH
Confidence            6655543      666666643      56777764   455443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=3.2e-08  Score=90.54  Aligned_cols=105  Identities=26%  Similarity=0.300  Sum_probs=83.1

Q ss_pred             HHHHHHHHHHHhcCCC--CceeeeEEEEeC----CEEEEEEeccCCC-ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 013249          160 DYMKAERDILTKVTHP--FIVQLRYSFQTR----SKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH  232 (447)
Q Consensus       160 ~~~~~E~~il~~l~hp--nIv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH  232 (447)
                      ....+|...+..+..-  .+.+.+++.+..    ...+||+|+++|. +|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            3466788877777432  233444444432    2468999999885 79888887555778888999999999999999


Q ss_pred             HCCceeccCCCCCcccCCCC---cEEEeecCCccc
Q 013249          233 KCGIVHRDLKPENILMDSDG---HVMLTDFGLAKE  264 (447)
Q Consensus       233 ~~~iiHrDikp~NILl~~~~---~~kL~DFG~a~~  264 (447)
                      ++||+|+|+++.|||++.++   .+.|+||+.++.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999887   899999997765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.91  E-value=1.3e-10  Score=117.72  Aligned_cols=246  Identities=20%  Similarity=0.220  Sum_probs=170.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~  189 (447)
                      .++...-+++|+++++++.+...      .+....+.+...        ....-++++|.+++||| .+..++.++.+..
T Consensus       243 ws~~fh~fvK~altknpKkRpta------eklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~  308 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTA------EKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY  308 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCCh------hhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence            46667778999999999766432      122224444322        23456899999999999 7777777788889


Q ss_pred             EEEEEeccCCC-ChHHH-HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          190 LYLILDFINGG-HLFFH-LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       190 ~~lv~E~~~gg-~L~~~-l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+++|+++.++ +-... -...-.+.+-+...+.+.-+++|++||+.-=+|||    |||..+ +..|+.||+....+..
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc
Confidence            99999999887 22111 11111244445556677778899999988778999    887765 6799999999988877


Q ss_pred             CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  347 (447)
                      .....+..+|+.++|||+.....+....|+|++|+-..+|.-|.+|-...  ......+-.+ ..-|...+..+......
T Consensus       384 ~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~-p~s~~L~~~~aw~~~~~  460 (829)
T KOG0576|consen  384 TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNG-PNSPMLTDKSAWSPVFH  460 (829)
T ss_pred             ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCC-CCccccchhhhcCcccc
Confidence            66677788999999999999999999999999999888888887775431  0000000000 00111122233333333


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      .+|...|+..-|..|+     .....+-|.+|++..
T Consensus       461 ~~~~~~~~~g~P~~pk-----v~mgacfsKvfngCp  491 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPK-----VHMGACFSKVFNGCP  491 (829)
T ss_pred             cCCcccccCCCCCCCc-----chhhHHHHHHhccCc
Confidence            3566679999999998     667888889998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.86  E-value=1.4e-08  Score=98.49  Aligned_cols=189  Identities=17%  Similarity=0.233  Sum_probs=128.6

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE------Ee
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF------QT  186 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~------~~  186 (447)
                      ..+.||+|+-+.+|-.-.        -+-.+-|+..+....-.   .   ..+..|... .||-+-.-+.+=      -+
T Consensus        15 ~gr~LgqGgea~ly~l~e--------~~d~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~   80 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--------VRDQVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGR   80 (637)
T ss_pred             CCccccCCccceeeecch--------hhchhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence            346799999999995432        12234577665322111   1   122233333 465433211111      12


Q ss_pred             -CCEEEEEEeccCCCChHHHHH----Hc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEee
Q 013249          187 -RSKLYLILDFINGGHLFFHLY----RQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (447)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~----~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~D  258 (447)
                       +..+-++|..+.|..--..+.    ++   ....++-+.+.++.|+.+...||+.|.+-+|+.++|+|+.+++.|.|.|
T Consensus        81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence             223778899888763222221    22   2467888999999999999999999999999999999999999999998


Q ss_pred             cCCcccccCCCCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhC-CCCCCC
Q 013249          259 FGLAKEIDESSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTG-QPPFTH  316 (447)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G-~~pf~~  316 (447)
                      -.......++......+|...|.+||...     +.+-+...|.|.|||++++++.| +.||.+
T Consensus       161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            65444334444444568999999999865     34456789999999999999995 999975

>PRK09902 hypothetical protein; Provisional

Probab=98.80  E-value=8.7e-08  Score=86.58  Aligned_cols=138  Identities=9%  Similarity=0.111  Sum_probs=98.9

Q ss_pred             eecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc---hhHHHHHHHHHHHHHhcCCC--CceeeeEEEE-e----CC
Q 013249          119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHP--FIVQLRYSFQ-T----RS  188 (447)
Q Consensus       119 G~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~-~----~~  188 (447)
                      |+||-+.|+.....       |+.|-+|.-.......   ..-...+.+|...|+++..-  .+.+.. ++. .    .-
T Consensus        27 ~rgG~SgV~r~~~~-------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~   98 (216)
T PRK09902         27 RRNGMSGVQCVERN-------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEW   98 (216)
T ss_pred             CCCCcceEEEEEeC-------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCce
Confidence            57888889987753       3367788654211100   22335688899999988532  244443 222 1    12


Q ss_pred             EEEEEEeccCC-CChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc--EEEeecCCcc
Q 013249          189 KLYLILDFING-GHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAK  263 (447)
Q Consensus       189 ~~~lv~E~~~g-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--~kL~DFG~a~  263 (447)
                      .-+||+|-+.| -+|.+++...  .+.+......++.+++..|.-||+.|+.|+|+.+.|||++.+|.  ++++||--++
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            47899998765 4888887653  34577778899999999999999999999999999999987777  9999998665


Q ss_pred             c
Q 013249          264 E  264 (447)
Q Consensus       264 ~  264 (447)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.79  E-value=4.2e-08  Score=90.80  Aligned_cols=139  Identities=20%  Similarity=0.221  Sum_probs=100.5

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc------------c-------hhHHHHHHHHHHHHHhc
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------------K-------KNHVDYMKAERDILTKV  172 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~------------~-------~~~~~~~~~E~~il~~l  172 (447)
                      +.+...||-|--+.||.|...      .+..+|||.=+.....            .       .-.....++|.++|.++
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L  166 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL  166 (304)
T ss_pred             HhhccccccCccceEEEEECC------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence            346689999999999999865      5788999964321100            0       01122356788899988


Q ss_pred             CCC--CceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC
Q 013249          173 THP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (447)
Q Consensus       173 ~hp--nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~  250 (447)
                      ...  .+.+.++    .+...+||||++|-.|...     ++..+.+..++..|++-+.-+-..||||+|+.+=|||+++
T Consensus       167 ~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         167 YPEGVKVPKPIA----WNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             hhcCCCCCCccc----cccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence            644  4544433    3567899999999766332     1235556667777777777777999999999999999999


Q ss_pred             CCcEEEeecCCcccc
Q 013249          251 DGHVMLTDFGLAKEI  265 (447)
Q Consensus       251 ~~~~kL~DFG~a~~~  265 (447)
                      +|.+.++||-.+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.78  E-value=1.3e-07  Score=85.87  Aligned_cols=143  Identities=20%  Similarity=0.243  Sum_probs=94.4

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHH------HHHHHHHHHhcC---CCC
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY------MKAERDILTKVT---HPF  176 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~E~~il~~l~---hpn  176 (447)
                      .+..++|.+.+++-......|.+..-       .++.+.+|..+......+.....      ..+++..+.++.   .-.
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei-------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~   99 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI-------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE   99 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE-------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence            35567899999999988888887764       56789999887543222211111      122333333332   223


Q ss_pred             ceeeeEEEEe-----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC
Q 013249          177 IVQLRYSFQT-----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (447)
Q Consensus       177 Iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~  251 (447)
                      ++.++.+.+.     ....++||||++|..|.+...    +.+    .+...|..++.-||+.|++|+|..|.|++++++
T Consensus       100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             cccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC
Confidence            3333333322     235678999999988755432    232    244567788999999999999999999999865


Q ss_pred             CcEEEeecCCccc
Q 013249          252 GHVMLTDFGLAKE  264 (447)
Q Consensus       252 ~~~kL~DFG~a~~  264 (447)
                      + ++++||+..+.
T Consensus       172 ~-i~iID~~~k~~  183 (229)
T PF06176_consen  172 G-IRIIDTQGKRM  183 (229)
T ss_pred             c-EEEEECccccc
Confidence            5 99999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.55  E-value=3.5e-07  Score=98.92  Aligned_cols=204  Identities=21%  Similarity=0.256  Sum_probs=149.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE----EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 013249          158 HVDYMKAERDILTKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK  233 (447)
Q Consensus       158 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  233 (447)
                      .+.....|+..+.++.|+|++.++.+-.....    ..+..|++...++...+..-+..+...++.+..++++||.|+|+
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            34445567788889999999999887654322    33456788888999999888999999999999999999999999


Q ss_pred             CCceeccCCCC---CcccCCCCcEEEe--ecCCcccccCCCCCCccccCCcccccccccCCCCCCc--cceeehhHhHHH
Q 013249          234 CGIVHRDLKPE---NILMDSDGHVMLT--DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKD--ADWWSVGILLYE  306 (447)
Q Consensus       234 ~~iiHrDikp~---NILl~~~~~~kL~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwSlGvil~e  306 (447)
                      ....|.-+...   +-..+..+.+.++  ||+..+.+..........-+..+.++|......+..+  .|+|.+|..+..
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            97766666555   5555667777777  9999988777666656666778889999887766554  799999999999


Q ss_pred             HhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          307 MLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       307 ll~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +..|..+-...   .....++      +.....+      ..+++.+|+.-++++|+     .+.+++.|+|.+-
T Consensus       385 ~~~~~~i~~~~---~~~~~~l------~~~~~~~------~~d~~~~~~~~~~~~Rl-----~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  385 LSQGEDISEKS---AVPVSLL------DVLSTSE------LLDALPKCLDEDSEERL-----SALELLTHPFLRF  439 (1351)
T ss_pred             hhhcCcccccc---cchhhhh------ccccchh------hhhhhhhhcchhhhhcc-----chhhhhhchhccc
Confidence            99876542111   0000000      1111112      23456669999999999     6799999999863

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.54  E-value=1.1e-06  Score=80.74  Aligned_cols=140  Identities=23%  Similarity=0.253  Sum_probs=94.3

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchh---------------------HHHHHHHHHHHHHhcC
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---------------------HVDYMKAERDILTKVT  173 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~---------------------~~~~~~~E~~il~~l~  173 (447)
                      ...|..|--+.||+|...      .+..+|+|+++......+.                     ...+..+|..-|+++.
T Consensus        53 ~g~istGKEA~Vy~a~~~------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~  126 (268)
T COG1718          53 VGCISTGKEANVYLAETG------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAY  126 (268)
T ss_pred             EeeecCCcceEEEeeccC------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            457788888999998753      5788999998754322111                     1123455666666663


Q ss_pred             --CCCceeeeEEEEeCCEEEEEEeccCCCCh-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccC
Q 013249          174 --HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD  249 (447)
Q Consensus       174 --hpnIv~l~~~~~~~~~~~lv~E~~~gg~L-~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~  249 (447)
                        +-.+.+-+.+.    +-.|||||+....+ .-.|. .-.+..+++..+..++++.+.-|-. .|+||+||..=|||+.
T Consensus       127 eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         127 EAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             HcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence              22233333332    34799999854311 11111 1123334788888999999988876 8999999999999999


Q ss_pred             CCCcEEEeecCCccccc
Q 013249          250 SDGHVMLTDFGLAKEID  266 (447)
Q Consensus       250 ~~~~~kL~DFG~a~~~~  266 (447)
                       ++.+.|+|||-|....
T Consensus       202 -~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 -DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CCeEEEEECccccccC
Confidence             8899999999887654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=3.1e-07  Score=94.34  Aligned_cols=142  Identities=21%  Similarity=0.302  Sum_probs=91.1

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc---------------------------c----hhHHHHHHH
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---------------------------K----KNHVDYMKA  164 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~---------------------------~----~~~~~~~~~  164 (447)
                      .-|+.++-|.||+|+.+      +|+.||||+.+..-..                           -    .+..+.+..
T Consensus       131 ~PiAsASIaQVH~A~L~------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         131 EPIASASIAQVHRAVLK------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             CchhhhhHhhheeEEec------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            57899999999999987      6899999998753210                           0    011112222


Q ss_pred             ------HHHHHHhcC-----CCCceeeeEEEEeCCEEEEEEeccCCCChHHHH--HHcCCCCHHHHHHHHHHHHHH-HHH
Q 013249          165 ------ERDILTKVT-----HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQGIFREDQARFYTAEIVSA-VSH  230 (447)
Q Consensus       165 ------E~~il~~l~-----hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l--~~~~~~~~~~~~~i~~qi~~a-L~~  230 (447)
                            |..-+.+++     .+++.--.-+++-.+.-.|+|||++|-.+.+..  .. ..++.   +.++..++.+ +..
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~---k~ia~~~~~~f~~q  280 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDR---KELAELLVRAFLRQ  280 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCH---HHHHHHHHHHHHHH
Confidence                  222233321     233322222333345678999999998877663  33 33442   2333333332 334


Q ss_pred             HHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       231 LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      +-..|++|.|.+|.||+++.+|++.+.|||+...+.+
T Consensus       281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            4468999999999999999999999999999887654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.51  E-value=1.5e-06  Score=80.69  Aligned_cols=134  Identities=17%  Similarity=0.157  Sum_probs=82.0

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC--ceeeeEEEEeCCEEEEE
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLI  193 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lv  193 (447)
                      ..||+|..+.||+.         .+..+++|......     ....+.+|.++++.+..-.  +.+.+++....+...+|
T Consensus         7 ~~i~~G~t~~~y~~---------~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv   72 (226)
T TIGR02172         7 TQTGEGGNGESYTH---------KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI   72 (226)
T ss_pred             eeecCCCCcceeEe---------cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence            57899999999973         23347888876422     1234678999998886433  35566777777788999


Q ss_pred             EeccCCCC-hH--------------HH-------HHHc--CCCCHHH-HHHHHHH----------HHH-HHHHHHH----
Q 013249          194 LDFINGGH-LF--------------FH-------LYRQ--GIFREDQ-ARFYTAE----------IVS-AVSHLHK----  233 (447)
Q Consensus       194 ~E~~~gg~-L~--------------~~-------l~~~--~~~~~~~-~~~i~~q----------i~~-aL~~LH~----  233 (447)
                      ||+++|.. +.              ..       ++..  ....... ...+..+          +.. ...+|..    
T Consensus        73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence            99999963 11              11       1110  0011000 0111100          111 1222221    


Q ss_pred             CCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       234 ~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ..++|+|+.|.||++++++ +.|+||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            2478999999999999988 99999997753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.48  E-value=2.3e-06  Score=79.24  Aligned_cols=138  Identities=25%  Similarity=0.365  Sum_probs=81.3

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC--ceeeeEEE---EeCCE
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSF---QTRSK  189 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~---~~~~~  189 (447)
                      ++.|+.|..+.||++...       ++.+++|.....     .....+..|..+++.+....  +.+++...   .....
T Consensus         2 i~~l~~G~~n~~~~v~~~-------~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~   69 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD-------DGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF   69 (239)
T ss_dssp             EEEEEESSSSEEEEEEET-------TSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred             CccCCCCCeeeEEEEEEC-------CcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence            568999999999999864       258999987643     23445778888888875332  44555533   23446


Q ss_pred             EEEEEeccCCCChHH----------------HH---HHc----CCCCHHH------HHHH---------------HHHHH
Q 013249          190 LYLILDFINGGHLFF----------------HL---YRQ----GIFREDQ------ARFY---------------TAEIV  225 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~----------------~l---~~~----~~~~~~~------~~~i---------------~~qi~  225 (447)
                      .+++|++++|..+..                .+   +..    ..+....      ....               ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            899999999987766                11   111    0111100      0000               11122


Q ss_pred             H-HHHHHHH-------CCceeccCCCCCcccC-CCCcEEEeecCCccc
Q 013249          226 S-AVSHLHK-------CGIVHRDLKPENILMD-SDGHVMLTDFGLAKE  264 (447)
Q Consensus       226 ~-aL~~LH~-------~~iiHrDikp~NILl~-~~~~~kL~DFG~a~~  264 (447)
                      . .+..+++       ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2 2333332       3599999999999999 667778999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.48  E-value=2.3e-06  Score=76.86  Aligned_cols=128  Identities=25%  Similarity=0.374  Sum_probs=91.0

Q ss_pred             CCcEEEeeEeecCC-eEEEEEEEcCCCCCCCCcEEEEEEeechhhcc----------h--------hHHHHHHHHHHHHH
Q 013249          110 GDFEIFRVVGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------K--------NHVDYMKAERDILT  170 (447)
Q Consensus       110 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~----------~--------~~~~~~~~E~~il~  170 (447)
                      .+++.++.||.|.- |.||+++.       .++.||||+++.-....          .        .+..-|..|.+...
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg  109 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG  109 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence            58999999999999 99999987       56799999943211100          0        22344667777766


Q ss_pred             hc---CCCCc--eeeeEEEEeC------------------CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHH
Q 013249          171 KV---THPFI--VQLRYSFQTR------------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA  227 (447)
Q Consensus       171 ~l---~hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~a  227 (447)
                      ++   .+.++  |+++|+..-.                  ....||.||+....         .+...+    +.+|++-
T Consensus       110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~d  176 (207)
T PF13095_consen  110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRD  176 (207)
T ss_pred             HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHH
Confidence            66   45566  8999987321                  13568888887653         223333    4467777


Q ss_pred             HHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       228 L~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      |..+|..||+-+|+++.|..     .-||+|||.+
T Consensus       177 l~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  177 LKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            88899999999999999986     3489999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.26  E-value=7.6e-06  Score=76.84  Aligned_cols=133  Identities=14%  Similarity=0.097  Sum_probs=79.5

Q ss_pred             EeecCC-eEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEEEEEEe
Q 013249          118 VGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       118 lG~G~f-g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      |-.|.. ..||++...       +..+.||+.....      ...+.+|+++++.+. +--+.+++++....+..++|||
T Consensus         6 ~~~g~~~~~v~~~~~~-------~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   72 (244)
T cd05150           6 VTEGQSGATVYRLDGK-------NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTS   72 (244)
T ss_pred             cCCCCCcCeEEEEcCC-------CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEE
Confidence            444555 788987542       2468888875432      223567888888874 3334566777766677899999


Q ss_pred             ccCCCChHHHH-------------------HHcC----CCCHH---HHHH---HHH----------------HHHHHHHH
Q 013249          196 FINGGHLFFHL-------------------YRQG----IFRED---QARF---YTA----------------EIVSAVSH  230 (447)
Q Consensus       196 ~~~gg~L~~~l-------------------~~~~----~~~~~---~~~~---i~~----------------qi~~aL~~  230 (447)
                      +++|..|....                   +...    .+...   ....   .+.                .+...+..
T Consensus        73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T cd05150          73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE  152 (244)
T ss_pred             eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence            99997765331                   1000    11100   0000   000                01111222


Q ss_pred             HH-------HCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          231 LH-------KCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       231 LH-------~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      |-       ...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            21       1248999999999999998878999998765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.20  E-value=8.3e-06  Score=71.05  Aligned_cols=130  Identities=19%  Similarity=0.280  Sum_probs=89.3

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCcee-eeEEEEeCCEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ-LRYSFQTRSKL  190 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~~~~  190 (447)
                      .++.+.||+|.+|.||++.++       +..+|+|+-+.+.     ....+..|.++|..+.-.++.. +|.+..    .
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-------~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~   87 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-------GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----D   87 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-------CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----h
Confidence            345678999999999999985       4578999876543     2345888999999988766654 333322    3


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCCcccCCCCcEEEeecCCccc
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK-PENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDik-p~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ++.|||+.|-.|.......   ...+    +..++..---|-..||-|..|. |..++|-.++.+.|+||..|+.
T Consensus        88 ~i~me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          88 FIRMEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            4559999998886654321   2222    3345555555778899999886 4444444555899999998874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.16  E-value=3.5e-05  Score=69.67  Aligned_cols=130  Identities=25%  Similarity=0.266  Sum_probs=91.8

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-------------cchhHHHHHHHHHHHHHhcC------CCC
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------------IKKNHVDYMKAERDILTKVT------HPF  176 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~~~~E~~il~~l~------hpn  176 (447)
                      ..||+|+.-.||.--        .+...+||++.....             ..........+|+.....+.      +.+
T Consensus         7 ~~i~~G~~R~cy~HP--------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~   78 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP--------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH   78 (199)
T ss_pred             cccccCCCceEEECC--------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence            579999999999532        344588999877650             01122345566776666555      778


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCC------CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC
Q 013249          177 IVQLRYSFQTRSKLYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (447)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~g------g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~  250 (447)
                      |.+++|+.+++-..-+|+|.+..      -+|.+++.. +.+++ ....   .+-.-.+||-+++|+.+||+|.||++..
T Consensus        79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence            99999999999999999998653      257777744 44665 3333   3444456889999999999999999954


Q ss_pred             CC----cEEEee
Q 013249          251 DG----HVMLTD  258 (447)
Q Consensus       251 ~~----~~kL~D  258 (447)
                      +.    .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            32    577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>smart00133 S_TK_X Extension to Ser/Thr-type protein kinases

Probab=98.14  E-value=2.5e-06  Score=62.25  Aligned_cols=59  Identities=34%  Similarity=0.727  Sum_probs=47.7

Q ss_pred             CCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCCCC----CCCCccCeeee
Q 013249          380 RSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPT----AGEHFKGYTYV  438 (447)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~f~~~~~~  438 (447)
                      ++++|+.|..++++|||+|.+.+..++.+|+..|+......++.....    .+..|.||+|.
T Consensus         1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s~~~~~~~~~~~~~~F~gfsy~   63 (64)
T smart00133        1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLTPVDSPASGGSQQEPFRGFSYV   63 (64)
T ss_pred             CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCCCCCccccccccccccCCCccc
Confidence            478999999999999999999999999999988888765555443221    14789999996

>PLN02876 acyl-CoA dehydrogenase

Probab=98.08  E-value=3.7e-05  Score=84.83  Aligned_cols=83  Identities=13%  Similarity=0.278  Sum_probs=56.1

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCc--eeeeEEEEeC---
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFI--VQLRYSFQTR---  187 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~---  187 (447)
                      .++.|+.|.++.+|++....   +.....+++|+........  ....+.+|.++|+.+. |.+|  .+++.++.+.   
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~---~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~  116 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGN---GGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI  116 (822)
T ss_pred             eEEEeCCCCcCceEEEEECC---CCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence            36778999999999987642   1112457777754332111  1235778999999995 6654  6677776654   


Q ss_pred             CEEEEEEeccCCCC
Q 013249          188 SKLYLILDFINGGH  201 (447)
Q Consensus       188 ~~~~lv~E~~~gg~  201 (447)
                      +..|+||||++|..
T Consensus       117 G~~flVME~v~G~~  130 (822)
T PLN02876        117 GTAFYIMEYLEGRI  130 (822)
T ss_pred             CCceEEEEecCCcc
Confidence            46789999999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.04  E-value=2.6e-05  Score=80.16  Aligned_cols=140  Identities=19%  Similarity=0.305  Sum_probs=86.3

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc----------------------------chhHHHHHHHHHH
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII----------------------------KKNHVDYMKAERD  167 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~----------------------------~~~~~~~~~~E~~  167 (447)
                      +.||..+.|.||+|+.+      .|+.||||+-+..-..                            -.+..+.+..|++
T Consensus       167 ~piaaASlaQVhrA~L~------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             chhhhcchhheEEEEec------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            57999999999999987      5889999987652110                            0011112222333


Q ss_pred             HHH----------hcCCCC------ceeeeEEEEeCCEEEEEEeccCCCChH--HHHHHcCCCCHHHHHHHHHHHHHHH-
Q 013249          168 ILT----------KVTHPF------IVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARFYTAEIVSAV-  228 (447)
Q Consensus       168 il~----------~l~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~--~~l~~~~~~~~~~~~~i~~qi~~aL-  228 (447)
                      .++          .+.|-+      |-++|.  .-.....|+||||+|.-+.  +.+.+.+ ++...+   +..+.++. 
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i---~~~l~~~~~  314 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDI---LNKLVEAYL  314 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-CCHHHH---HHHHHHHHH
Confidence            222          222333      222221  2234678999999998554  4455544 344333   33333332 


Q ss_pred             HHHHHCCceeccCCCCCcccCC----CCcEEEeecCCcccccC
Q 013249          229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       229 ~~LH~~~iiHrDikp~NILl~~----~~~~kL~DFG~a~~~~~  267 (447)
                      +-+=..|++|.|-.|.||++..    ++.+.+-|||+...+..
T Consensus       315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2233578999999999999984    67899999999887654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.89  E-value=3.3e-05  Score=69.44  Aligned_cols=98  Identities=16%  Similarity=0.157  Sum_probs=78.5

Q ss_pred             HHHHHHHhcCC-CCceeeeEEEEeCCEEEEEEeccCCCChHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCc
Q 013249          164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVSHLHK---CGI  236 (447)
Q Consensus       164 ~E~~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~---l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i  236 (447)
                      .|.-+|+.+.+ +++.+++|+|-    .++|.||...+++...   +..-...++..+..|+.+++..+++|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47888888876 69999999983    3678999987765321   1122345899999999999999999997   347


Q ss_pred             eeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          237 VHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       237 iHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .-.|++++|+-++++|++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            77999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.86  E-value=9.1e-05  Score=69.16  Aligned_cols=30  Identities=30%  Similarity=0.423  Sum_probs=25.4

Q ss_pred             CceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       235 ~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +++|+|+.+.|||++.++..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            489999999999998766567999997653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.80  E-value=0.00028  Score=65.64  Aligned_cols=76  Identities=25%  Similarity=0.273  Sum_probs=46.5

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCCEEEEE
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSKLYLI  193 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lv  193 (447)
                      ++.|..|-...+|++....    ..++.|++|+......   . .-...+|..+++.+.... ..++++.+. .   .+|
T Consensus         3 i~~l~gG~tN~~~~v~~~~----~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKE----DNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCC----CCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEE
Confidence            4567788888999986431    0145788997654311   1 112346888888885433 344444332 2   379


Q ss_pred             EeccCCCCh
Q 013249          194 LDFINGGHL  202 (447)
Q Consensus       194 ~E~~~gg~L  202 (447)
                      |||++|..+
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.72  E-value=0.00047  Score=66.76  Aligned_cols=79  Identities=9%  Similarity=0.080  Sum_probs=54.4

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC---CCceeeeEEEEe--
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQT--  186 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~--  186 (447)
                      -.-.+.||.|..+.||.....       +..+.+|..+..     .....+..|...|+.+..   -.+.++++++..  
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~-------~~~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~   83 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS-------QGNPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ   83 (297)
T ss_pred             hheeeecCCccceeEEEEEcC-------CCCEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence            444678999999999987542       234677774321     012357889999988853   356677776654  


Q ss_pred             -CCEEEEEEeccCCCCh
Q 013249          187 -RSKLYLILDFINGGHL  202 (447)
Q Consensus       187 -~~~~~lv~E~~~gg~L  202 (447)
                       .+..+||||+++|+.+
T Consensus        84 ~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         84 SPGPDVLLLERLRGVSV  100 (297)
T ss_pred             cCCCeEEEEeccCCEec
Confidence             3668999999998754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.69  E-value=1.7e-06  Score=95.79  Aligned_cols=200  Identities=15%  Similarity=0.061  Sum_probs=135.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ..++++.--+|-|.+++   +++.+.    .-..+.+|+.+.-..  ..+-..+....|++.++...|+++...+.-...
T Consensus      1228 ~e~~EV~l~i~~~~~~R---~k~Lr~----kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~p 1300 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFR---NKWLRS----KIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPP 1300 (2724)
T ss_pred             hhhhheeeecccceeec---cchHhh----hhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCC
Confidence            34566665566665543   333221    112245555443211  112233445567777777889988776554433


Q ss_pred             --CCEEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCcccCCCCcEE
Q 013249          187 --RSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----iiHrDikp~NILl~~~~~~k  255 (447)
                        ....|.+++|+.+|.++..+-+.-    .+.+.-+.....+.+.+..-+|...     .+|+++|+-|.+|..+-++|
T Consensus      1301 s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~ 1380 (2724)
T KOG1826|consen 1301 SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVK 1380 (2724)
T ss_pred             CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccc
Confidence              345789999999999999987652    2333334444444466666666432     78999999999999999999


Q ss_pred             EeecCCcccc-cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCC
Q 013249          256 LTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT  315 (447)
Q Consensus       256 L~DFG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~  315 (447)
                      ++++|+.+.. .........++++.|++|++...-.++.++|+|..|+.+|+...|..+|.
T Consensus      1381 ~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1381 LGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             ccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence            9999999832 22223345678889999999988889989999999999999999988874

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.65  E-value=0.0019  Score=64.84  Aligned_cols=80  Identities=13%  Similarity=0.149  Sum_probs=52.8

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-c-c--hhHHHHHHHHHHHHHhcC---CCCceeeeEEEEe
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-I-K--KNHVDYMKAERDILTKVT---HPFIVQLRYSFQT  186 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~-~-~--~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~  186 (447)
                      -.+.||.|.+..||++....     .++.++||.-..... . .  ....++...|.+.|+.+.   ..++.+++.+  +
T Consensus        30 ~~~elggGn~N~VyrV~~~~-----g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D  102 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTE-----GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D  102 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCC-----CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C
Confidence            35789999999999998752     235799997532110 0 0  123456677888888763   2355666555  4


Q ss_pred             CCEEEEEEeccCCC
Q 013249          187 RSKLYLILDFINGG  200 (447)
Q Consensus       187 ~~~~~lv~E~~~gg  200 (447)
                      .+..++||||+++.
T Consensus       103 ~~~~~lVME~L~~~  116 (401)
T PRK09550        103 EELAVTVMEDLSDH  116 (401)
T ss_pred             CCCCEEEEecCCCc
Confidence            45678999999864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.60  E-value=4.9e-05  Score=72.40  Aligned_cols=138  Identities=14%  Similarity=0.230  Sum_probs=93.7

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc------ch-----------hHHH--HHHHHHHHHHhc
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------KK-----------NHVD--YMKAERDILTKV  172 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~-----------~~~~--~~~~E~~il~~l  172 (447)
                      +.++..||-|--+.||.+-+.      .|+..++|+-+.....      ..           -++.  ...+|...|+.+
T Consensus        94 ~svGnqIGVGKESDIY~v~d~------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL  167 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKAL  167 (465)
T ss_pred             hhhccccccccccceEEEecC------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHH
Confidence            567889999999999998865      5778888864321110      00           0111  234678888877


Q ss_pred             C-CCCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC
Q 013249          173 T-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (447)
Q Consensus       173 ~-hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~  251 (447)
                      . |.+=|+-   -.+.+..|+|||++.|-.|...-+-      ..+..+...+..-+.-|-++|+||+|..-=||+|+++
T Consensus       168 ~e~gfpVPk---piD~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  168 YERGFPVPK---PIDHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD  238 (465)
T ss_pred             HHcCCCCCC---cccccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence            4 4332221   1234567899999998776443211      2233445556666777899999999999999999999


Q ss_pred             CcEEEeecCCccc
Q 013249          252 GHVMLTDFGLAKE  264 (447)
Q Consensus       252 ~~~kL~DFG~a~~  264 (447)
                      +.++++||--+..
T Consensus       239 ~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  239 DKIVVIDFPQMVS  251 (465)
T ss_pred             CCEEEeechHhhc
Confidence            9999999976543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.58  E-value=0.00029  Score=66.64  Aligned_cols=132  Identities=14%  Similarity=0.210  Sum_probs=74.3

Q ss_pred             EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCCEEEEEEec
Q 013249          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLILDF  196 (447)
Q Consensus       118 lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lv~E~  196 (447)
                      +..|-.+.+|++..       .++.+++|.......  .-.. ...+|..+++.+..-.++ +++...  .  -++||||
T Consensus         4 ~~~G~tn~~y~~~~-------~~~~~vlR~~~~~~~--~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~   69 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-------PGISFVWRPQSPVCK--ALGV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEW   69 (256)
T ss_pred             CCCcCcCCeEEEEe-------CCccEEEeeCCcccc--cccC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEe
Confidence            45677788998762       455688887543211  1001 245788888888643332 333332  2  2689999


Q ss_pred             cCCCChHH--------------H---HHHcC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------CCce
Q 013249          197 INGGHLFF--------------H---LYRQG----IFRE-DQARFYTAEI---------VSAVSHLHK--------CGIV  237 (447)
Q Consensus       197 ~~gg~L~~--------------~---l~~~~----~~~~-~~~~~i~~qi---------~~aL~~LH~--------~~ii  237 (447)
                      ++|..+..              .   ++...    +++. ..+..+..++         ...+..+-.        ..++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            99865421              1   11111    1111 1222222121         111222222        2489


Q ss_pred             eccCCCCCcccCCCCcEEEeecCCccc
Q 013249          238 HRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       238 HrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      |+|+.|.|||+++++ +.|+||..|..
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            999999999999877 78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.53  E-value=0.0021  Score=62.89  Aligned_cols=30  Identities=33%  Similarity=0.521  Sum_probs=25.8

Q ss_pred             CCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       234 ~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .++||+|+.+.|||++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999866556899999775

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.52  E-value=0.0012  Score=63.87  Aligned_cols=140  Identities=19%  Similarity=0.226  Sum_probs=83.3

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC--ceeeeE------
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRY------  182 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~------  182 (447)
                      +..-++.|..|....+|++..       .+..+++|+....      ....+..|..++..+.+..  +.+++.      
T Consensus        15 ~~~~i~~i~~G~~n~~y~v~~-------~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~   81 (296)
T cd05153          15 ELLSFEGISAGIENTNYFVTT-------DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEY   81 (296)
T ss_pred             chhheecccCccccceEEEEe-------CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcE
Confidence            344466788888889998864       2346899987541      1234666888887774322  333332      


Q ss_pred             EEEeCCEEEEEEeccCCCChHH--------------HHHHc-CCC----------CHHH--HH--------HHHHHHHHH
Q 013249          183 SFQTRSKLYLILDFINGGHLFF--------------HLYRQ-GIF----------REDQ--AR--------FYTAEIVSA  227 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~--------------~l~~~-~~~----------~~~~--~~--------~i~~qi~~a  227 (447)
                      +....+..++|++|++|..+..              .++.. ..+          .+..  ..        .....+..+
T Consensus        82 ~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  161 (296)
T cd05153          82 LSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADE  161 (296)
T ss_pred             eeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHH
Confidence            1233456789999999876421              01110 000          0000  00        011123334


Q ss_pred             HHHHHH-------CCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          228 VSHLHK-------CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       228 L~~LH~-------~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +.++.+       .+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         162 LARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             HHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            455543       469999999999999998778899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.50  E-value=0.0017  Score=63.26  Aligned_cols=142  Identities=20%  Similarity=0.290  Sum_probs=82.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC--ceeeeEE----
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYS----  183 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~----  183 (447)
                      +....++.++.|.-..+|++..       .+..+++|+.....  .   .+.+..|.+++..+....  +.+++..    
T Consensus        22 ~~~~~i~~~~~G~~n~~y~v~t-------~~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~   89 (307)
T TIGR00938        22 GELLSLKGIAEGVENSNYLLTT-------DVGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGR   89 (307)
T ss_pred             CCceeccccCCccccceEEEEe-------CCCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCC
Confidence            3455677888888889998863       23358889875421  1   123455677777664211  3333321    


Q ss_pred             --EEeCCEEEEEEeccCCCChH----H----------HHHHc-CCC--------CHHH-----HH----------HHHHH
Q 013249          184 --FQTRSKLYLILDFINGGHLF----F----------HLYRQ-GIF--------REDQ-----AR----------FYTAE  223 (447)
Q Consensus       184 --~~~~~~~~lv~E~~~gg~L~----~----------~l~~~-~~~--------~~~~-----~~----------~i~~q  223 (447)
                        ....+..+++|||++|..+.    .          .++.. ..+        ....     ..          .....
T Consensus        90 ~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~  169 (307)
T TIGR00938        90 QLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAE  169 (307)
T ss_pred             eehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHH
Confidence              12246789999999985431    0          11110 001        0000     00          01112


Q ss_pred             HHHHHHHHHH-------CCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          224 IVSAVSHLHK-------CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       224 i~~aL~~LH~-------~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +...++++..       .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       170 l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       170 LDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3344555542       579999999999999998877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.44  E-value=0.001  Score=64.43  Aligned_cols=80  Identities=16%  Similarity=0.159  Sum_probs=47.0

Q ss_pred             EeeEeecCCeEEEEEEEcCCC-CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCCEEEE
Q 013249          115 FRVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYL  192 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~-~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~l  192 (447)
                      ++.|..|-...||++...... ....++.|++|+.....    .......+|..+++.+....+. ++++.+. +   .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            345666777789988743200 01125679999975432    1112356788888887533333 4444443 2   35


Q ss_pred             EEeccCCCCh
Q 013249          193 ILDFINGGHL  202 (447)
Q Consensus       193 v~E~~~gg~L  202 (447)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999988765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.41  E-value=0.0016  Score=63.27  Aligned_cols=145  Identities=20%  Similarity=0.324  Sum_probs=97.4

Q ss_pred             EEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----------------------chhHHHHHHHHHHHH
Q 013249          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----------------------KKNHVDYMKAERDIL  169 (447)
Q Consensus       113 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----------------------~~~~~~~~~~E~~il  169 (447)
                      ++-..|..|--+.||.|...      .|..+|||+++-.-+.                       .+-..-+...|++-|
T Consensus       147 ~inGCiSTGKEANVYHat~~------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL  220 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL  220 (520)
T ss_pred             ecccccccCccceeEeeecC------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence            45578889999999998754      6777999987642111                       111123456678878


Q ss_pred             HhcCCCCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCccc
Q 013249          170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILM  248 (447)
Q Consensus       170 ~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~iiHrDikp~NILl  248 (447)
                      ++++...|..- ....- ....|||+++.+.....-.-+.-.++...+..+-.|++.-+.-| |.+++||.||.-=|+|+
T Consensus       221 kRl~~aGIP~P-ePIlL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  221 KRLNNAGIPCP-EPILL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY  298 (520)
T ss_pred             HHHHhcCCCCC-Cceee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence            88764332211 11111 23578999996443322223445677888888888888888777 57799999999999999


Q ss_pred             CCCCcEEEeecCCccccc
Q 013249          249 DSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       249 ~~~~~~kL~DFG~a~~~~  266 (447)
                      . +|.+.|+|-+-+...+
T Consensus       299 h-dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  299 H-DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             E-CCEEEEEEccccccCC
Confidence            4 6789999998776543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.21  E-value=0.00081  Score=67.88  Aligned_cols=164  Identities=16%  Similarity=0.237  Sum_probs=101.5

Q ss_pred             HHHHHHHHHhcCCCCceeeeEEEEeC-CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 013249          162 MKAERDILTKVTHPFIVQLRYSFQTR-SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (447)
Q Consensus       162 ~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (447)
                      +.-...+++.+.|+|+.+.+++-... ....+|||++ +.+|++.+..+. +......              .+|+.|- 
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~~-   91 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLHL-   91 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccccee-
Confidence            44567789999999999988777643 4588999999 668888887654 2221111              2233322 


Q ss_pred             CCCCCcccCCCCcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH
Q 013249          241 LKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ  320 (447)
Q Consensus       241 ikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~  320 (447)
                          |       .++.+| .++   ..   .....|                +++|||++|.++.++.-|...+......
T Consensus        92 ----~-------~~~~td-~~~---t~---~~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~~~~s  137 (725)
T KOG1093|consen   92 ----N-------IIYITD-HFL---TK---YPSPIG----------------PKSDVWSLGFIILELYLGISLEAELTES  137 (725)
T ss_pred             ----h-------hhhccc-ccc---cc---CCCCCC----------------cchhhhhHHHHHHHHHHhhHHHHHHHHH
Confidence                1       233333 111   00   011111                4899999999999999999888766655


Q ss_pred             HHHHHHHhcccCCCC-CCchhHHhhh------hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          321 KLQQRIINEKVKLPP-FLTSEAHSLL------KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       321 ~~~~~i~~~~~~~p~-~~~~~~~~li------~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +....|..-. ..+. ...-....++      ..+.++.+|+-..|..||     ...++++|+-|..+
T Consensus       138 ~~l~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~-----l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  138 EYLEILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP-----LPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc-----chhHHhcCccHHHH
Confidence            5555544321 1111 1111111111      125678889999999999     67899999998765

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.09  E-value=0.0042  Score=59.45  Aligned_cols=30  Identities=43%  Similarity=0.605  Sum_probs=25.3

Q ss_pred             CceeccCCCCCcccCCCCc-EEEeecCCccc
Q 013249          235 GIVHRDLKPENILMDSDGH-VMLTDFGLAKE  264 (447)
Q Consensus       235 ~iiHrDikp~NILl~~~~~-~kL~DFG~a~~  264 (447)
                      .++|+|+++.|||+++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3899999999999997565 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.98  E-value=0.011  Score=57.50  Aligned_cols=29  Identities=31%  Similarity=0.549  Sum_probs=25.5

Q ss_pred             CCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       234 ~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.90  E-value=0.0093  Score=58.72  Aligned_cols=77  Identities=16%  Similarity=0.145  Sum_probs=47.8

Q ss_pred             eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh----cchhHHHHHHHHHHHHHhcC--CCC-ceeeeEEEEeCCE
Q 013249          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI----IKKNHVDYMKAERDILTKVT--HPF-IVQLRYSFQTRSK  189 (447)
Q Consensus       117 ~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~E~~il~~l~--hpn-Iv~l~~~~~~~~~  189 (447)
                      .||.|....||++....     .++.++||.-.....    .-+-..++..-|...|+...  .|. +.++|  +.+...
T Consensus         2 EigdGnlN~VfrV~~~~-----g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE-----GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCC-----CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEcccc
Confidence            57999999999998532     335788886432111    11233455667888887764  353 44443  345556


Q ss_pred             EEEEEeccCCC
Q 013249          190 LYLILDFINGG  200 (447)
Q Consensus       190 ~~lv~E~~~gg  200 (447)
                      ..+|||+++..
T Consensus        75 ~~~vMEdL~~~   85 (370)
T TIGR01767        75 AVTVMEDLSHH   85 (370)
T ss_pred             ceehHhhCccc
Confidence            67999998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=96.87  E-value=0.0079  Score=59.51  Aligned_cols=143  Identities=17%  Similarity=0.237  Sum_probs=81.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~  189 (447)
                      ...+ ..|-.|-...+|++...... ...++.|++|+.....   ...++ -.+|..+++.+..-++. ++++.+.. + 
T Consensus        38 ~~~i-~~l~gGlTN~~y~v~~~~~~-~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g-  109 (344)
T PLN02236         38 ALQV-IPLKGAMTNEVFQIKWPTKE-GNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G-  109 (344)
T ss_pred             cEEE-EEcCCcccceeEEEEeCCCC-CCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c-
Confidence            4444 45555888899998753211 1134678999876532   22222 25688888888643333 45555533 2 


Q ss_pred             EEEEEeccCCCChHHH-----------------HHHcC------CCCHHHHHHHHHHH-----------------HHHHH
Q 013249          190 LYLILDFINGGHLFFH-----------------LYRQG------IFREDQARFYTAEI-----------------VSAVS  229 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~-----------------l~~~~------~~~~~~~~~i~~qi-----------------~~aL~  229 (447)
                        .|+||++|.+|...                 ++...      .....++..+..++                 ...+.
T Consensus       110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~  187 (344)
T PLN02236        110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN  187 (344)
T ss_pred             --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence              57999987665311                 11111      01122333333221                 11111


Q ss_pred             HH----H----HCCceeccCCCCCcccCC-CCcEEEeecCCcc
Q 013249          230 HL----H----KCGIVHRDLKPENILMDS-DGHVMLTDFGLAK  263 (447)
Q Consensus       230 ~L----H----~~~iiHrDikp~NILl~~-~~~~kL~DFG~a~  263 (447)
                      .|    .    ...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus       188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            22    1    225899999999999986 4789999998765

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.81  E-value=0.014  Score=56.55  Aligned_cols=148  Identities=15%  Similarity=0.203  Sum_probs=82.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC--CceeeeEEEEeCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~~  188 (447)
                      ...+++.+-.|..-.+|....       +++.++|. ... ............+|..+++.+.--  -+-..++.|.++.
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~-------~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~   96 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGD-------TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY   96 (321)
T ss_pred             CCceeeeccCCcccceEEEec-------CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC
Confidence            445555554444444454432       35678777 321 112233445567888888877531  1223445555544


Q ss_pred             --EEEEEEeccCCCChHHH----------HH--------Hc-----------C---CCCHHHHHHHHHHH----------
Q 013249          189 --KLYLILDFINGGHLFFH----------LY--------RQ-----------G---IFREDQARFYTAEI----------  224 (447)
Q Consensus       189 --~~~lv~E~~~gg~L~~~----------l~--------~~-----------~---~~~~~~~~~i~~qi----------  224 (447)
                        ..|.||+|++|..+...          ..        .-           +   .+...++..+..+.          
T Consensus        97 ~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~  176 (321)
T COG3173          97 LGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR  176 (321)
T ss_pred             CCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence              67999999998432111          11        00           0   01111122222221          


Q ss_pred             ----HHHHHHHHHC--------CceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          225 ----VSAVSHLHKC--------GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       225 ----~~aL~~LH~~--------~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                          ..-..+|+.+        .++|+|+.+.||+|+.++-+=|.||+++..-+.
T Consensus       177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                2224455433        379999999999999998899999999876443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.75  E-value=0.014  Score=57.45  Aligned_cols=143  Identities=18%  Similarity=0.266  Sum_probs=79.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~  188 (447)
                      ++.++..+.| |--..+|++...+..  .....|++|+.....   ...++ -.+|..+++.+..-++. ++++++. ++
T Consensus        15 ~~i~i~~l~g-GlTN~~~~v~~~~~~--~~~~~~v~Ri~g~~t---~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G   86 (330)
T PLN02421         15 SDFSVERISG-GITNLLLKVSVKEEN--GNEVSVTVRLFGPNT---DYVID-RERELQAIKYLSAAGFGAKLLGVFG-NG   86 (330)
T ss_pred             CceEEEEeCC-cccceEEEEEecCCC--CCCceEEEEEecCCc---CeEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc
Confidence            3555554444 777889988754311  123478899875432   11122 24688888888654443 4555553 33


Q ss_pred             EEEEEEeccCCCChHH--------------H---HHHcC-C----C-CHHHHHHHHHHH---------------------
Q 013249          189 KLYLILDFINGGHLFF--------------H---LYRQG-I----F-REDQARFYTAEI---------------------  224 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~--------------~---l~~~~-~----~-~~~~~~~i~~qi---------------------  224 (447)
                         +|.+|++|..|..              .   ++... +    + ....+..+..++                     
T Consensus        87 ---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~  163 (330)
T PLN02421         87 ---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEE  163 (330)
T ss_pred             ---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHH
Confidence               5899998765521              1   11111 0    1 122333333222                     


Q ss_pred             -HHHHHHHH----HCC----ceeccCCCCCcccCC-CCcEEEeecCCcc
Q 013249          225 -VSAVSHLH----KCG----IVHRDLKPENILMDS-DGHVMLTDFGLAK  263 (447)
Q Consensus       225 -~~aL~~LH----~~~----iiHrDikp~NILl~~-~~~~kL~DFG~a~  263 (447)
                       ..-+..+.    ..+    ++|.|+.+.|||+++ ++.++|+||..|.
T Consensus       164 l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        164 LRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence             11122221    112    799999999999975 5789999998764

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.72  E-value=0.015  Score=58.31  Aligned_cols=77  Identities=13%  Similarity=0.131  Sum_probs=49.4

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-cch---hHHHHHHHHHHHHHhcC---CCCceeeeEEEEe
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKK---NHVDYMKAERDILTKVT---HPFIVQLRYSFQT  186 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~---~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~  186 (447)
                      ..+.||.|....||++...       ++.++||.-..... ...   ....+...|...|+.+.   ..++.+++.++. 
T Consensus        36 ~~~eiggGn~N~VyrV~~~-------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            4678899999999998752       23588887542211 111   12334455677776654   246677777666 


Q ss_pred             CCEEEEEEeccCC
Q 013249          187 RSKLYLILDFING  199 (447)
Q Consensus       187 ~~~~~lv~E~~~g  199 (447)
                       +..+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             446788999977

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.57  E-value=0.035  Score=54.01  Aligned_cols=30  Identities=23%  Similarity=0.243  Sum_probs=27.4

Q ss_pred             CceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       235 ~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +++|+|+.+.|||++.++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=96.38  E-value=0.0014  Score=44.71  Aligned_cols=41  Identities=37%  Similarity=0.686  Sum_probs=27.6

Q ss_pred             CCCCccCCCcccccCCCCCCCCCC-C----CCCCCCCccCeeeeCC
Q 013249          400 VSGKDCIANFDKCWTTMPADDSPA-P----TPTAGEHFKGYTYVAP  440 (447)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~f~~~~~~~~  440 (447)
                      +.+..+++|||..|+.++...++. .    ....++.|.||+|+++
T Consensus         2 v~~~~DtsnFD~eFt~~~~~~t~~~~~~~~~~~~~~~F~GFTy~~~   47 (48)
T PF00433_consen    2 VKSETDTSNFDPEFTEEPPVDTPPSDPSPLSSSMQENFQGFTYVNP   47 (48)
T ss_dssp             -SSTT-GTTSCHHHHTSSSSS--S--HHHHCTSSGGGGTT-CEETC
T ss_pred             CCchhhhhhcCcccccCCCCCCCcccCCcccccccCcCCCCeecCC
Confidence            456788999999999998777764 1    2245566999999986

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.30  E-value=0.037  Score=53.16  Aligned_cols=76  Identities=17%  Similarity=0.287  Sum_probs=46.9

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeeeEEEEeCC
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRS  188 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~  188 (447)
                      .+-.+.|+-|....+|++.  .     .++.+.||+-....      ...+..|..-|+.|.   --.+.+.+.+....+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~-----~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~   85 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--T-----DGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD   85 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--T-----TS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred             eeeeEecCCCChhheEEEE--C-----CCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence            4456788989999999876  2     67789999876321      235677888888873   335667888887777


Q ss_pred             EEEEEEeccCCC
Q 013249          189 KLYLILDFINGG  200 (447)
Q Consensus       189 ~~~lv~E~~~gg  200 (447)
                      .-||||||++.+
T Consensus        86 ~~fLlle~l~~~   97 (288)
T PF03881_consen   86 DAFLLLEFLEMG   97 (288)
T ss_dssp             CCEEEEE-----
T ss_pred             CceEEEEeecCC
Confidence            779999998876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.26  E-value=0.013  Score=57.10  Aligned_cols=84  Identities=27%  Similarity=0.355  Sum_probs=60.0

Q ss_pred             CCceeeeEEE-EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCC
Q 013249          175 PFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDG  252 (447)
Q Consensus       175 pnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~  252 (447)
                      ++..+++-+- .+..+.|++|++- |+.|..    ...-...++..|+.+.+..++-+..+ ..-|||+...||||+ +|
T Consensus       285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G  358 (488)
T COG5072         285 VFLETLKVVSLDETLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG  358 (488)
T ss_pred             hhhhcceEEecCCceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence            4444443333 3344677888875 544421    12235678888888888877777754 689999999999999 99


Q ss_pred             cEEEeecCCccc
Q 013249          253 HVMLTDFGLAKE  264 (447)
Q Consensus       253 ~~kL~DFG~a~~  264 (447)
                      +|.|+||-+++.
T Consensus       359 nvtLIDfklsRl  370 (488)
T COG5072         359 NVTLIDFKLSRL  370 (488)
T ss_pred             ceEEEEeeeeec
Confidence            999999999984

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.03  E-value=0.22  Score=48.79  Aligned_cols=71  Identities=10%  Similarity=0.058  Sum_probs=41.8

Q ss_pred             cCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC--Cceeee---E--EEEeCCEEEEE
Q 013249          121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLR---Y--SFQTRSKLYLI  193 (447)
Q Consensus       121 G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~---~--~~~~~~~~~lv  193 (447)
                      +.-..||++...      .+..+++|+.+....    ....+..|.+++..+...  .++...   +  ....++..+.|
T Consensus        36 s~eN~vy~v~~~------~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l  105 (325)
T PRK11768         36 SYENRVYQFGDE------DGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFAL  105 (325)
T ss_pred             cccceEEEEecC------CCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEE
Confidence            455678988643      456799998764321    223466677777766321  122211   1  12335678889


Q ss_pred             EeccCCCC
Q 013249          194 LDFINGGH  201 (447)
Q Consensus       194 ~E~~~gg~  201 (447)
                      +++++|..
T Consensus       106 ~~~~~G~~  113 (325)
T PRK11768        106 FPRRGGRA  113 (325)
T ss_pred             EeeeCCCC
Confidence            99998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.92  E-value=0.013  Score=53.55  Aligned_cols=30  Identities=47%  Similarity=0.706  Sum_probs=21.4

Q ss_pred             CceeccCCCCCccc-CCCCcEEEeecCCccc
Q 013249          235 GIVHRDLKPENILM-DSDGHVMLTDFGLAKE  264 (447)
Q Consensus       235 ~iiHrDikp~NILl-~~~~~~kL~DFG~a~~  264 (447)
                      -++|.|+.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999988754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=95.90  E-value=0.052  Score=54.45  Aligned_cols=84  Identities=13%  Similarity=0.111  Sum_probs=45.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCC-CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc-eeeeEEEEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDD-GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~  187 (447)
                      ++.++. .|..|--..+|++....... ....+.|.+++....   ....+ .-.+|..+++.+...++ .++++.+.. 
T Consensus        51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~-  124 (383)
T PTZ00384         51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD-  124 (383)
T ss_pred             ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence            344444 55558889999987542110 000122444432111   11111 12468899998865444 445555542 


Q ss_pred             CEEEEEEeccCCCCh
Q 013249          188 SKLYLILDFINGGHL  202 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L  202 (447)
                         ++|+||++|..|
T Consensus       125 ---g~l~efIeGr~l  136 (383)
T PTZ00384        125 ---FTIQEWVEGNTM  136 (383)
T ss_pred             ---EEEEEEeccccC
Confidence               589999998765

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.87  E-value=0.06  Score=53.77  Aligned_cols=78  Identities=15%  Similarity=0.193  Sum_probs=50.7

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc---chhHHHHHHHHHHHHHhcC--CCC-ceeeeEEEEeCC
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---KKNHVDYMKAERDILTKVT--HPF-IVQLRYSFQTRS  188 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~--hpn-Iv~l~~~~~~~~  188 (447)
                      .+.||.|.-..||++.+..     .++.++||.-......   -.-..++..-|..+|+...  .|. +.++|  +.+..
T Consensus        34 ~~eigdGnlN~VfrV~~~~-----~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ-----KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC-----CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcH
Confidence            7789999999999998742     2456888864321111   1334556677888888764  354 44443  34555


Q ss_pred             EEEEEEeccCC
Q 013249          189 KLYLILDFING  199 (447)
Q Consensus       189 ~~~lv~E~~~g  199 (447)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            67889999854

>PRK06148 hypothetical protein; Provisional

Probab=95.49  E-value=0.29  Score=55.53  Aligned_cols=31  Identities=39%  Similarity=0.624  Sum_probs=26.4

Q ss_pred             CCceeccCCCCCcccCCCC--cEE-EeecCCccc
Q 013249          234 CGIVHRDLKPENILMDSDG--HVM-LTDFGLAKE  264 (447)
Q Consensus       234 ~~iiHrDikp~NILl~~~~--~~k-L~DFG~a~~  264 (447)
                      .++||.|+.+.|||++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999875  565 999997753

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.46  E-value=0.14  Score=47.00  Aligned_cols=75  Identities=17%  Similarity=0.317  Sum_probs=50.6

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeeeEEEEeCCEEE
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~  191 (447)
                      .+.+.-|.--..|.+.+       ....|.||+-.      ......+..|+.=|+.|.   .-.+.+++.+....++.|
T Consensus        21 r~~v~gG~inea~~v~d-------g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sy   87 (286)
T COG3001          21 REEVSGGDINEAWRLRD-------GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSY   87 (286)
T ss_pred             ccccCCccccceeEeec-------CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeE
Confidence            34454555555566553       44568888743      344556777877666664   345677888888999999


Q ss_pred             EEEeccCCCCh
Q 013249          192 LILDFINGGHL  202 (447)
Q Consensus       192 lv~E~~~gg~L  202 (447)
                      +||||++-+.+
T Consensus        88 lVle~L~~~~~   98 (286)
T COG3001          88 LVLEYLPTGPL   98 (286)
T ss_pred             EEEeeccCCCC
Confidence            99999987554

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.12  E-value=0.085  Score=50.78  Aligned_cols=80  Identities=11%  Similarity=0.137  Sum_probs=46.5

Q ss_pred             eecCCeEEEEEEEcC--C-CCCCCCcEEEEEEeechhhcc--hhHHHHHHHHHHHHHhcC---------C----CCceee
Q 013249          119 GQGAFGKVFQVKKKG--V-DDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVT---------H----PFIVQL  180 (447)
Q Consensus       119 G~G~fg~V~~~~~~~--~-~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~---------h----pnIv~l  180 (447)
                      |.|-.|.+|++....  . ........+.||.........  -.....+.+|+.+.+.+-         .    ....++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            677788899887644  1 112234558889876322111  122356778888776551         1    233455


Q ss_pred             eEEEEeCCEEEEEEeccC
Q 013249          181 RYSFQTRSKLYLILDFIN  198 (447)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~  198 (447)
                      +....+....+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            555545556889998763

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	447
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-82
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-82
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-78
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-78
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-78
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-77
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-72
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-70
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-69
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-69
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-69
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-69
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-68
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-68
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-68
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-66
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-66
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-66
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-65
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-65
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-65
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-63
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-63
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-63
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-63
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-63
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-63
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-63
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-63
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-63
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-63
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-63
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-63
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-63
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-63
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-63
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-63
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-63
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-63
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-63
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-63
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-63
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-63
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-63
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-63
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-63
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-63
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-63
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-63
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-63
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-63
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-63
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-63
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-63
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-63
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-63
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-62
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-62
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-62
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-62
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-62
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-62
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-62
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-62
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-62
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-62
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-62
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-62
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-62
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-62
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-62
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-62
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-62
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-62
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-62
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-62
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-62
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-61
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-61
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-61
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-61
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-55
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-55
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-53
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-53
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-53
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-53
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-53
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-53
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-52
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-52
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-52
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-52
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-52
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-52
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-52
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-52
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-52
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-52
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-52
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-52
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-52
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-52
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-51
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-49
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-49
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-48
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-48
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-47
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-47
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-46
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-46
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-46
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-45
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-45
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-45
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-45
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-45
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-45
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-45
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-44
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-43
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-43
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-38
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-38
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-38
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-37
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-37
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-37
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-37
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-36
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-36
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-36
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-36
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-36
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-36
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-36
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-36
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-35
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-35
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-35
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-35
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-35
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-35
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-35
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-35
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-35
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-35
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-35
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-35
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-35
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-35
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-35
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-35
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-35
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-35
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-35
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-35
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-35
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-35
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-35
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-35
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-35
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-35
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-35
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-34
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-34
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-34
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-34
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-34
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-34
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-34
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-34
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-33
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-33
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-33
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-33
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-33
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-33
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-33
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-32
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-32
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-32
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-32
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-32
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-32
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-31
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-30
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-30
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-30
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-30
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-30
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-30
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-30
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-30
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-30
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-29
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-29
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-29
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-29
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-29
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-29
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-29
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-29
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-29
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-29
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-29
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-29
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-29
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-29
3soa_A	444	Full-Length Human Camkii Length = 444		3e-29
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-29
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-29
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-29
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-29
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-29
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-29
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-29
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-29
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-29
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-28
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-28
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-28
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-28
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-28
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-28
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-28
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-28
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-28
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-28
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-28
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-28
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-28
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-27
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-27
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-27
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-27
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-27
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-27
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-27
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-27
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-26
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-26
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-26
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-26
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-26
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-26
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-26
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-26
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-26
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-26
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-26
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-26
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-26
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-26
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-26
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-26
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-26
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-26
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-26
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-26
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-26
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-26
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-25
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-25
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-25
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-25
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-25
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-24
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-24
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-24
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-24
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-24
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-24
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-24
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-24
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-23
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-23
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-23
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-23
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-23
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-23
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-22
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-22
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-22
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-22
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-22
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-22
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-22
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-22
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-22
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-22
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-22
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-22
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-22
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-22
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-22
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-22
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-22
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-22
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-22
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-22
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-22
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-22
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-21
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-21
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-21
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-21
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-21
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-21
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-21
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-21
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-21
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-21
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-21
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-21
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-21
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-21
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-21
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-21
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-21
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-20
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-20
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-20
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-20
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-20
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-20
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-20
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-20
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-20
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-20
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-20
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-19
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-19
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-19
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-19
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-19
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-19
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-19
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-18
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-18
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-18
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-18
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-18
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-18
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-18
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-18
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-18
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-18
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-18
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-18
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-18
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-18
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-18
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-18
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-18
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-18
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-18
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-18
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-18
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-18
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-18
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-18
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-18
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-18
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-18
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-18
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-18
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-17
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-17
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-17
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-17
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-17
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-16
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-16
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-16
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-16
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-16
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-16
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-16
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-16
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-16
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-15
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-15
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-15
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-14
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-14
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-13
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-13
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-13
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-13
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-12
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-12
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-12
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-12
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-12
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-12
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-12
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		9e-12
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		9e-12
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-12
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		9e-12
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		9e-12
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-12
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-12
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		9e-12
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		9e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-11
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-11
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-11
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		8e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		8e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		9e-10
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		9e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		9e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		9e-10
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		9e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-09
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		8e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-08

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  301 bits (772), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 149/307 (48%), Positives = 206/307 (67%), Gaps = 10/307 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +                  I+AMKV++K  I++      + KA
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT EYMAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LLK      +LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  +
Sbjct: 251 LLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 304
Query: 404 DCIANFD 410
           + ++ FD
Sbjct: 305 EDVSQFD 311

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  301 bits (770), Expect = 7e-82,   Method: Compositional matrix adjust.
 Identities = 149/307 (48%), Positives = 205/307 (66%), Gaps = 10/307 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +                  I+AMKV++K  I++      + KA
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
             A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + ++  CGT EYMAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LLK      +LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  +
Sbjct: 251 LLK------KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 304
Query: 404 DCIANFD 410
           + ++ FD
Sbjct: 305 EDVSQFD 311

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  289 bits (740), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 143/310 (46%), Positives = 197/310 (63%), Gaps = 10/310 (3%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 72
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           MAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ E
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 400
           A SLL+       L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P FKP  
Sbjct: 253 AQSLLR------MLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPAT 306
Query: 401 SGKDCIANFD 410
              +    FD
Sbjct: 307 GRPEDTFYFD 316

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  288 bits (738), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 141/298 (47%), Positives = 194/298 (65%), Gaps = 10/298 (3%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 72
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           MAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ E
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
           A SLL+       L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P FKP
Sbjct: 253 AQSLLR------MLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  288 bits (738), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 141/298 (47%), Positives = 194/298 (65%), Gaps = 10/298 (3%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 17  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 73
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 74  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 133
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT EY
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 193
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           MAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ E
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 253
Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
           A SLL+       L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P FKP
Sbjct: 254 AQSLLR------MLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 305

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  286 bits (731), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 144/313 (46%), Positives = 202/313 (64%), Gaps = 11/313 (3%)
Query: 99  LEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNH 158
           ++A SE K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ 
Sbjct: 18  VKAGSE-KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGH--LYAMKVLKKATLKVRDR 74
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           V   K ERDIL  V HPF+V+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +
Sbjct: 75  VR-TKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 133
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGT 277
           FY AE+   + HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID   ++ S CGT
Sbjct: 134 FYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGT 193
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
            EYMAPE++  +GH+  ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFL 253
Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
           ++EA SLL+       L  ++P+ RLGSGP G + IK H ++ +I+W  L  RE++P FK
Sbjct: 254 STEAQSLLRA------LFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPPFK 307
Query: 398 PDVSGKDCIANFD 410
           P V+  D    FD
Sbjct: 308 PAVAQPDDTFYFD 320

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  269 bits (687), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 137/304 (45%), Positives = 197/304 (64%), Gaps = 14/304 (4%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P DF   +V+G+G+F                   YA+KV++K  I+KK    ++ +ER++
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEV-----FYAVKVLQKKAILKKKEEKHIMSERNV 91
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           L K V HPF+V L +SFQT  KLY +LD+INGG LF+HL R+  F E +ARFY AEI SA
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 151
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEIL 286
           + +LH   IV+RDLKPENIL+DS GH++LTDFGL KE I+ +S +++ CGT EY+APE+L
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
             + +++  DWW +G +LYEML G PPF   N  ++   I+N+ ++L P +T+ A  LL+
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 271
Query: 347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 406
           G      LL KD +KRLG+    ++ IK H +F  INW  L  +++ P F P+VSG + +
Sbjct: 272 G------LLQKDRTKRLGAKDDFME-IKSHVFFSLINWDDLINKKITPPFNPNVSGPNDL 324
Query: 407 ANFD 410
            +FD
Sbjct: 325 RHFD 328

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  261 bits (667), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 143/330 (43%), Positives = 203/330 (61%), Gaps = 12/330 (3%)
Query: 87  QIQELEHE-NDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAM 145
           Q+  ++HE   A L   +E K+G  +FE+ +V+G GA+                  +YAM
Sbjct: 31  QLLTVKHELRTANLTGHAE-KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK--LYAM 87
Query: 146 KVMRKDTIIKK-NHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           KV++K TI++K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 88  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 147
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+K
Sbjct: 148 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207
Query: 264 EI--DESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           E   DE+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG  PFT    
Sbjct: 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267
Query: 320 QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
           +  Q  I    +K  P    E  +L K    + +LL KDP KRLG GP   D IK H +F
Sbjct: 268 KNSQAEISRRILKSEPPYPQEMSALAK--DLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
Query: 380 RSINWKTLEAREMQPKFKPDVSGKDCIANF 409
           + INW  L A+++   FKP +  +  ++NF
Sbjct: 326 QKINWDDLAAKKVPAPFKPVIRDELDVSNF 355

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  258 bits (660), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 121/306 (39%), Positives = 189/306 (61%), Gaps = 12/306 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 58
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 59  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 118
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 119 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
           L G      LL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ + 
Sbjct: 239 LAG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 292
Query: 405 CIANFD 410
               FD
Sbjct: 293 DTRYFD 298

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  258 bits (659), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 121/306 (39%), Positives = 189/306 (61%), Gaps = 12/306 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
           L G      LL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ + 
Sbjct: 236 LAG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289
Query: 405 CIANFD 410
               FD
Sbjct: 290 DTRYFD 295

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  258 bits (658), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 121/306 (39%), Positives = 189/306 (61%), Gaps = 12/306 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
           L G      LL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ + 
Sbjct: 236 LAG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289
Query: 405 CIANFD 410
               FD
Sbjct: 290 DTRYFD 295

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  257 bits (656), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 121/306 (39%), Positives = 188/306 (61%), Gaps = 12/306 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
           L G      LL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ + 
Sbjct: 236 LAG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289
Query: 405 CIANFD 410
               FD
Sbjct: 290 DTRYFD 295

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  257 bits (656), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 121/306 (39%), Positives = 188/306 (61%), Gaps = 12/306 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
           L G      LL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ + 
Sbjct: 236 LAG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289
Query: 405 CIANFD 410
               FD
Sbjct: 290 DTRYFD 295

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  256 bits (655), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 121/306 (39%), Positives = 188/306 (61%), Gaps = 12/306 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
           L G      LL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ + 
Sbjct: 236 LAG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289
Query: 405 CIANFD 410
               FD
Sbjct: 290 DTRYFD 295

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  256 bits (655), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 121/306 (39%), Positives = 188/306 (61%), Gaps = 12/306 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 61  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 120
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +     CGT EY+APE
Sbjct: 121 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 240
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
           L G      LL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ + 
Sbjct: 241 LAG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 294
Query: 405 CIANFD 410
               FD
Sbjct: 295 DTRYFD 300

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  248 bits (634), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 124/303 (40%), Positives = 184/303 (60%), Gaps = 14/303 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            +  P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E QA FY AEI   + 
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLF 134
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            LHK GI++RDLK +N+++DS+GH+ + DFG+ KE + +   +   CGT +Y+APEI+  
Sbjct: 135 FLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY 194
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           + + K  DWW+ G+LLYEML GQPPF   +  +L Q I+   V  P  L+ EA S+ KG 
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG- 253
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN 408
                L+ K P+KRLG GP G   ++ H +FR I+W+ LE RE+QP FKP V GK    N
Sbjct: 254 -----LMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGA-EN 307
Query: 409 FDK 411
           FDK
Sbjct: 308 FDK 310

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  248 bits (633), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 121/313 (38%), Positives = 190/313 (60%), Gaps = 13/313 (4%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A+ + ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V 
Sbjct: 142 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVA 196
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY
Sbjct: 197 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 256
Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTT 278
            AEIVSA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT 
Sbjct: 257 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           EY+APE+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L 
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 376
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
            EA SLL G      LL KDP +RLG G      I  H++F  I W+ +  +++ P FKP
Sbjct: 377 PEAKSLLSG------LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKP 430
Query: 399 DVSGKDCIANFDK 411
            V+ +     FD+
Sbjct: 431 QVTSETDTRYFDE 443

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  248 bits (633), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 121/313 (38%), Positives = 190/313 (60%), Gaps = 13/313 (4%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A+ + ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V 
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVA 193
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTT 278
            AEIVSA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +   + CGT 
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           EY+APE+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L 
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 373
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
            EA SLL G      LL KDP +RLG G      I  H++F  I W+ +  +++ P FKP
Sbjct: 374 PEAKSLLSG------LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKP 427
Query: 399 DVSGKDCIANFDK 411
            V+ +     FD+
Sbjct: 428 QVTSETDTRYFDE 440

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  247 bits (630), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 120/308 (38%), Positives = 186/308 (60%), Gaps = 13/308 (4%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 58
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 59  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 118
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           SA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +     CGT EY+AP
Sbjct: 119 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L  EA S
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 238
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LL G      LL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ +
Sbjct: 239 LLSG------LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSE 292
Query: 404 DCIANFDK 411
                FD+
Sbjct: 293 TDTRYFDE 300

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  247 bits (630), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 120/308 (38%), Positives = 186/308 (60%), Gaps = 13/308 (4%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 59
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 60  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 119
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           SA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +     CGT EY+AP
Sbjct: 120 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 179
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L  EA S
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 239
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LL G      LL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ +
Sbjct: 240 LLSG------LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSE 293
Query: 404 DCIANFDK 411
                FD+
Sbjct: 294 TDTRYFDE 301

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  247 bits (630), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 120/308 (38%), Positives = 186/308 (60%), Gaps = 13/308 (4%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 61  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 120
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           SA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I + +     CGT EY+AP
Sbjct: 121 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L  EA S
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 240
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LL G      LL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ +
Sbjct: 241 LLSG------LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSE 294
Query: 404 DCIANFDK 411
                FD+
Sbjct: 295 TDTRYFDE 302

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  239 bits (611), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 171/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+ ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  239 bits (611), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  239 bits (611), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 150 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 210 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 267
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 268 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 321
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 322 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 349

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 124/311 (39%), Positives = 189/311 (60%), Gaps = 14/311 (4%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S  ++G  +FE  RV+G+G+F                  +YA+KV++KD I++ + V+  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGD-----LYAVKVLKKDVILQDDDVECT 70
Query: 163 KAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ IL+    HPF+ QL   FQT  +L+ +++F+NGG L FH+ +   F E +ARFY 
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI+SA+  LH  GI++RDLK +N+L+D +GH  L DFG+ KE I     + + CGT +Y
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           +APEIL    +    DWW++G+LLYEML G  PF   N   L + I+N++V  P +L  +
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250
Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
           A  +LK  SF+T    K+P+ RLGS   GG  AI  H +F+ I+W  L  R+++P F+P 
Sbjct: 251 ATGILK--SFMT----KNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPR 304
Query: 400 VSGKDCIANFD 410
           +  ++ ++NFD
Sbjct: 305 IKSREDVSNFD 315

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 64  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 123
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 124 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 183
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 184 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 241
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 242 YEKIVSGKVRFPSHFSSDLKDLLRN------LLQVDLTKRFGNLKNGVNDIKNHKWFATT 295
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 296 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 323

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+ P GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLPNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +N D
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNAD 328

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  239 bits (610), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 56  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 116 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFA 175
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 176 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 233
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 234 YEKIVSGKVRFPSHFSSDLKDLLRN------LLQVDLTKRFGNLKNGVNDIKNHKWFATT 287
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 288 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 315

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 171/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 55  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 114
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 115 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 174
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+ ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 175 KRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 232
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 233 YEKIVSGKVRFPSHFSSDLKDLLRN------LLQVDLTKRFGNLKDGVNDIKNHKWFATT 286
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 287 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 314

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 62  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 121
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 122 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 182 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 239
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 240 YEKIVSGKVRFPSHFSSDLKDLLRN------LLQVDLTKRFGNLKNGVNDIKNHKWFATT 293
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 294 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 321

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 150 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 210 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 267
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 268 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 321
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 322 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 349

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKDGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  238 bits (608), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  238 bits (608), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  238 bits (608), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 62  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 121
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 122 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 182 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 239
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 240 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 293
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 294 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 321

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  238 bits (608), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKDGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  238 bits (608), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKDGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  238 bits (608), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKDGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  238 bits (607), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+Y+M  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  238 bits (606), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 108/268 (40%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI++SKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  238 bits (606), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 171/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 150 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +  ++   ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 210 KRVKGATW--TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 267
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 268 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 321
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 322 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 349

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  237 bits (605), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFGLA
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  237 bits (604), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 170/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFGLA
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  237 bits (604), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+AP I+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  237 bits (604), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ I +HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIXNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  236 bits (603), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 114/299 (38%), Positives = 177/299 (59%), Gaps = 13/299 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL 351
           NK  DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+     
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR----- 270
Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
             LL  D +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 271 -NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  236 bits (603), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +K  G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKAFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  236 bits (602), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  236 bits (602), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  236 bits (602), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  + GT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  235 bits (600), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 114/299 (38%), Positives = 177/299 (59%), Gaps = 13/299 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL 351
           NK  DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+     
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR----- 270
Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
             LL  D +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 271 -NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  235 bits (600), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 114/299 (38%), Positives = 177/299 (59%), Gaps = 13/299 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL 351
           NK  DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+     
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR----- 270
Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
             LL  D +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 271 -NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  235 bits (599), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  + GT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 189 KRV--KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  235 bits (599), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 113/302 (37%), Positives = 186/302 (61%), Gaps = 14/302 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+I R +G G+F                   YAMKV++K+ +++   V++   ER +L+
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRY-----YAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+  A+ +
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   I++RDLKPENIL+D +GH+ +TDFG AK + + +    +CGT +Y+APE++ +K 
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--XLCGTPDYIAPEVVSTKP 179
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           +NK  DWWS GIL+YEML G  PF  +N  K  ++I+N +++ PPF   +   L      
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL------ 233
Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANF 409
           L++L+ +D S+RLG+   G + +K+H WF+ + W+ L +R ++  ++P +  G+   + F
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQF 293
Query: 410 DK 411
           DK
Sbjct: 294 DK 295

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  234 bits (598), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 119/335 (35%), Positives = 204/335 (60%), Gaps = 26/335 (7%)
Query: 91  LEHENDAELEAESER---KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           +E E +A    ES +    +G  DF++ RV+G+G++                  IYAM+V
Sbjct: 30  IEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMRV 84
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           ++K+ +     +D+++ E+ +  + + HPF+V L   FQT S+L+ +++++NGG L FH+
Sbjct: 85  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 144
Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-I 265
            RQ    E+ ARFY+AEI  A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +
Sbjct: 145 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204
Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF---------TH 316
                +++ CGT  Y+APEIL  + +    DWW++G+L++EM+ G+ PF           
Sbjct: 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
Query: 317 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKH 375
                L Q I+ +++++P  L+ +A S+LK        L+KDP +RLG  P  G   I+ 
Sbjct: 265 NTEDYLFQVILEKQIRIPRSLSVKAASVLKS------FLNKDPKERLGCHPQTGFADIQG 318
Query: 376 HKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
           H +FR+++W  +E +++ P FKP++SG+  + NFD
Sbjct: 319 HPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFD 353

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  234 bits (597), Expect = 7e-62,   Method: Compositional matrix adjust.
 Identities = 108/268 (40%), Positives = 168/268 (62%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  234 bits (597), Expect = 7e-62,   Method: Compositional matrix adjust.
 Identities = 108/268 (40%), Positives = 168/268 (62%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  234 bits (597), Expect = 7e-62,   Method: Compositional matrix adjust.
 Identities = 108/268 (40%), Positives = 168/268 (62%), Gaps = 8/268 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G++ +TDFG A
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
           K +    R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++
Sbjct: 190 KRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF + 
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 301
Query: 383 NWKTLEAREMQPKFKPDVSGKDCIANFD 410
           +W  +  R+++  F P   G    +NFD
Sbjct: 302 DWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  234 bits (596), Expect = 9e-62,   Method: Compositional matrix adjust.
 Identities = 115/299 (38%), Positives = 175/299 (58%), Gaps = 13/299 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  R +G G+F                   YAMK++ K  ++K   +++   E+ I   
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++L++  GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH 291
           H   +++RDLKPEN+L+D  G++ + DFG AK +    R+  +CGT EY+APEI+LSKG+
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGY 216
Query: 292 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL 351
           NK  DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+     
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR----- 271
Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 410
             LL  D +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 272 -NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  234 bits (596), Expect = 9e-62,   Method: Compositional matrix adjust.
 Identities = 117/303 (38%), Positives = 179/303 (59%), Gaps = 14/303 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            L   GI++RDLK +N+++DS+GH+ + DFG+ KE I +   +   CGT +Y+APEI+  
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ EA ++ KG 
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG- 575
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN 408
                L+ K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP  SG++   N
Sbjct: 576 -----LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGRNA-EN 629
Query: 409 FDK 411
           FD+
Sbjct: 630 FDR 632

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  233 bits (594), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 195/316 (61%), Gaps = 23/316 (7%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 56
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 57  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 116
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
            A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     ++  CGT  Y+APE
Sbjct: 117 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 176
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPP 335
           IL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++++P 
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 236
Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQP 394
            L+ +A S+LK        L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P
Sbjct: 237 SLSVKAASVLKS------FLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 290
Query: 395 KFKPDVSGKDCIANFD 410
            FKP++SG+  + NFD
Sbjct: 291 PFKPNISGEFGLDNFD 306

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  232 bits (592), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 114/316 (36%), Positives = 195/316 (61%), Gaps = 23/316 (7%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 71
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
            A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     ++  CGT  Y+APE
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 191
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPP 335
           IL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++++P 
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 251
Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQP 394
            ++ +A S+LK        L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P
Sbjct: 252 SMSVKAASVLKS------FLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVP 305
Query: 395 KFKPDVSGKDCIANFD 410
            FKP++SG+  + NFD
Sbjct: 306 PFKPNISGEFGLDNFD 321

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  232 bits (592), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 195/316 (61%), Gaps = 23/316 (7%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 61  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
            A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     ++  CGT  Y+APE
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 180
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPP 335
           IL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++++P 
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240
Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQP 394
            L+ +A S+LK        L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P
Sbjct: 241 SLSVKAASVLKS------FLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 294
Query: 395 KFKPDVSGKDCIANFD 410
            FKP++SG+  + NFD
Sbjct: 295 PFKPNISGEFGLDNFD 310

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  232 bits (592), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 116/303 (38%), Positives = 178/303 (58%), Gaps = 14/303 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLS 288
            L   GI++RDLK +N+++DS+GH+ + DFG+ KE I +   +   CGT +Y+APEI+  
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 195
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ EA ++ KG 
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG- 254
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN 408
                L+ K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP   G++   N
Sbjct: 255 -----LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGRNA-EN 308
Query: 409 FDK 411
           FD+
Sbjct: 309 FDR 311

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  214 bits (544), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 113/308 (36%), Positives = 175/308 (56%), Gaps = 17/308 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DFE+ +++G+G+F                   +A+K ++KD ++  + V+    E
Sbjct: 14  KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVE 68
Query: 166 RDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           + +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           +  +  LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE +   +++N  CGT +Y+AP
Sbjct: 129 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAP 188
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EILL + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  EA  
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 248
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           L      L +L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V   
Sbjct: 249 L------LVKLFVREPEKRLGVRGD----IRQHPLFREINWEELERKEIDPPFRPKVKSP 298
Query: 404 DCIANFDK 411
              +NFDK
Sbjct: 299 FDCSNFDK 306

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  211 bits (536), Expect = 9e-55,   Method: Compositional matrix adjust.
 Identities = 112/308 (36%), Positives = 174/308 (56%), Gaps = 17/308 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF + +++G+G+F                   +A+K ++KD ++  + V+    E
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVE 67
Query: 166 RDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           + +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAP 283
           +  +  LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE +   +++N  CGT +Y+AP
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EILL + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  EA  
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           L      L +L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V   
Sbjct: 248 L------LVKLFVREPEKRLGVRGD----IRQHPLFREINWEELERKEIDPPFRPKVKSP 297
Query: 404 DCIANFDK 411
              +NFDK
Sbjct: 298 FDCSNFDK 305

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  206 bits (525), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 109/287 (37%), Positives = 165/287 (57%), Gaps = 15/287 (5%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 5   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 59
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 120 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 239
Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
             L++      +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 240 RDLVE------KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 280

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  206 bits (525), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 109/287 (37%), Positives = 165/287 (57%), Gaps = 15/287 (5%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 4   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 58
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 119 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 238
Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
             L++      +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 239 RDLVE------KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 279

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  206 bits (525), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 109/287 (37%), Positives = 165/287 (57%), Gaps = 15/287 (5%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 2   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 56
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 117 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 236
Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
             L++      +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 237 RDLVE------KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 277

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 109/287 (37%), Positives = 165/287 (57%), Gaps = 15/287 (5%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 57
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237
Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
             L++      +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 238 RDLVE------KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  204 bits (520), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 164/281 (58%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+NS  GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K  +K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 266
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 267 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  204 bits (520), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 163/281 (58%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+NS  GT +Y++PE+L 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 267
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  204 bits (518), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 164/281 (58%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+NS  GT +Y++PE+L 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 263
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 264 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  204 bits (518), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 163/281 (58%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N+  GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 264
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 265 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 162/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 90
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 91  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVE- 269
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 270 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 305

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  203 bits (516), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 162/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 266
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 267 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  203 bits (516), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 162/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 266
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 267 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 162/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 267
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 162/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 264
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 265 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 162/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 266
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 267 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 162/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 264
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 265 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  202 bits (515), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 162/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 264
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 265 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 92
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L + FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 93  RLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 152
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 271
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 272 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 307

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 105/281 (37%), Positives = 163/281 (58%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 69
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 129
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+N   GT +Y++PE+L 
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 248
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 249 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 284

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 105/281 (37%), Positives = 163/281 (58%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+N   GT +Y++PE+L 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE- 263
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 264 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  201 bits (510), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 105/281 (37%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   +  +II  +   P     +A  L++ 
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVE- 266
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 267 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 105/281 (37%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILL 287
           LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K   K +D W++G ++Y+++ G PPF   N   +  +II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVE- 266
Query: 348 VSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 387
                +LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 267 -----KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 114/301 (37%), Positives = 162/301 (53%), Gaps = 9/301 (2%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  +RV+G+G F                  +YA K + K  I K+        E+ IL K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
           V   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   + 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
            LH+  IV+RDLKPENIL+D  GH+ ++D GLA  + E        GT  YMAPE++ ++
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS 349
            +    DWW++G LLYEM+ GQ PF    ++K+++  +   VK  P   SE  S  +  S
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFS-PQARS 418
Query: 350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 409
             +QLL KDP++RLG   G    +K H  F+ +N+K L A  ++P FKPD     C    
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVL 478
Query: 410 D 410
           D
Sbjct: 479 D 479

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 114/301 (37%), Positives = 162/301 (53%), Gaps = 9/301 (2%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  +RV+G+G F                  +YA K + K  I K+        E+ IL K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
           V   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   + 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
            LH+  IV+RDLKPENIL+D  GH+ ++D GLA  + E        GT  YMAPE++ ++
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS 349
            +    DWW++G LLYEM+ GQ PF    ++K+++  +   VK  P   SE  S  +  S
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFS-PQARS 418
Query: 350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 409
             +QLL KDP++RLG   G    +K H  F+ +N+K L A  ++P FKPD     C    
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVL 478
Query: 410 D 410
           D
Sbjct: 479 D 479

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  187 bits (476), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 107/297 (36%), Positives = 165/297 (55%), Gaps = 20/297 (6%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 342
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
                  F   LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 ------DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 107/297 (36%), Positives = 165/297 (55%), Gaps = 20/297 (6%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 342
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
                  F   LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 ------DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 107/297 (36%), Positives = 165/297 (55%), Gaps = 20/297 (6%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 342
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
                  F   LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 ------DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 107/297 (36%), Positives = 165/297 (55%), Gaps = 20/297 (6%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEIL 286
           + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 342
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
                  F   LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 ------DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 108/310 (34%), Positives = 170/310 (54%), Gaps = 25/310 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 308
Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 400
           A +L+   +FLT     D   RLG    GV+ IK H +F++  W     R+      PD+
Sbjct: 309 AKNLI--CAFLT-----DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 359
Query: 401 SGKDCIANFD 410
           S     +NFD
Sbjct: 360 SSDIDTSNFD 369

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 108/310 (34%), Positives = 170/310 (54%), Gaps = 25/310 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303
Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 400
           A +L+   +FLT     D   RLG    GV+ IK H +F++  W     R+      PD+
Sbjct: 304 AKNLI--CAFLT-----DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 354
Query: 401 SGKDCIANFD 410
           S     +NFD
Sbjct: 355 SSDIDTSNFD 364

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 108/310 (34%), Positives = 170/310 (54%), Gaps = 25/310 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y++PE+L S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 308
Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 400
           A +L+   +FLT     D   RLG    GV+ IK H +F++  W     R+      PD+
Sbjct: 309 AKNLI--CAFLT-----DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 359
Query: 401 SGKDCIANFD 410
           S     +NFD
Sbjct: 360 SSDIDTSNFD 369

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 108/317 (34%), Positives = 169/317 (53%), Gaps = 23/317 (7%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E ++   DFEI +V+G+GAF                  IYAMK++ K  ++K+      +
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTER-----IYAMKILNKWEMLKRAETACFR 138
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTA 222
            ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY  
Sbjct: 139 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 198
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEY 280
           E+V A+  +H+   VHRD+KP+N+L+D +GH+ L DFG  L    D + +S+   GT +Y
Sbjct: 199 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 281 MAPEIL--LSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKL 333
           ++PEIL  +  G  K   + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + 
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 318
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 393
           P  +T  +         L Q L     +RLG    G++  K H +F  +NW+ +  R ++
Sbjct: 319 PSHVTDVSEE----AKDLIQRLICSRERRLGQ--NGIEDFKKHAFFEGLNWENI--RNLE 370
Query: 394 PKFKPDVSGKDCIANFD 410
             + PDVS     +NFD
Sbjct: 371 APYIPDVSSPSDTSNFD 387

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 108/317 (34%), Positives = 169/317 (53%), Gaps = 23/317 (7%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E ++   DFEI +V+G+GAF                  IYAMK++ K  ++K+      +
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTER-----IYAMKILNKWEMLKRAETACFR 122
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTA 222
            ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY  
Sbjct: 123 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 182
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEY 280
           E+V A+  +H+   VHRD+KP+N+L+D +GH+ L DFG  L    D + +S+   GT +Y
Sbjct: 183 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 281 MAPEIL--LSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKL 333
           ++PEIL  +  G  K   + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + 
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 302
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 393
           P  +T  +         L Q L     +RLG    G++  K H +F  +NW+ +  R ++
Sbjct: 303 PSHVTDVSEE----AKDLIQRLICSRERRLGQ--NGIEDFKKHAFFEGLNWENI--RNLE 354
Query: 394 PKFKPDVSGKDCIANFD 410
             + PDVS     +NFD
Sbjct: 355 APYIPDVSSPSDTSNFD 371

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 110/314 (35%), Positives = 171/314 (54%), Gaps = 26/314 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 243
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 304 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 361
Query: 288 SKG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAH 342
            KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 421
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---D 399
           SLL+G      LL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +
Sbjct: 422 SLLEG------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 475
Query: 400 VSGKDC--IANFDK 411
           V+  D   I +FD+
Sbjct: 476 VNAADAFDIGSFDE 489

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 110/314 (35%), Positives = 171/314 (54%), Gaps = 26/314 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 362
Query: 288 SKG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAH 342
            KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---D 399
           SLL+G      LL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +
Sbjct: 423 SLLEG------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 476
Query: 400 VSGKDC--IANFDK 411
           V+  D   I +FD+
Sbjct: 477 VNAADAFDIGSFDE 490

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 110/314 (35%), Positives = 171/314 (54%), Gaps = 26/314 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 362
Query: 288 SKG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAH 342
            KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---D 399
           SLL+G      LL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +
Sbjct: 423 SLLEG------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 476
Query: 400 VSGKDC--IANFDK 411
           V+  D   I +FD+
Sbjct: 477 VNAADAFDIGSFDE 490

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 110/314 (35%), Positives = 171/314 (54%), Gaps = 26/314 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+ L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEV-L 362
Query: 288 SKG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAH 342
            KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---D 399
           SLL+G      LL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +
Sbjct: 423 SLLEG------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 476
Query: 400 VSGKDC--IANFDK 411
           V+  D   I +FD+
Sbjct: 477 VNAADAFDIGSFDE 490

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 111/317 (35%), Positives = 163/317 (51%), Gaps = 21/317 (6%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E ++   DFEI +V+G+GAF                  +YAMK+M K  ++K+  V   +
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ-----VYAMKIMNKWDMLKRGEVSCFR 109
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTA 222
            ERD+L      +I QL ++FQ  + LYL++++  GG L   L + G     + ARFY A
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG--LAKEIDESSRSNSMCGTTEY 280
           EIV A+  +H+ G VHRD+KP+NIL+D  GH+ L DFG  L    D + RS    GT +Y
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 281 MAPEILLS-------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
           ++PEIL +         +  + DWW++G+  YEM  GQ PF   +  +   +I++ K  L
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 393
              L  E     +   F+ +LL   P  RLG   GG    + H +F  ++W  L  R+  
Sbjct: 290 SLPLVDEGVP-EEARDFIQRLLCP-PETRLGR--GGAGDFRTHPFFFGLDWDGL--RDSV 343
Query: 394 PKFKPDVSGKDCIANFD 410
           P F PD  G     NFD
Sbjct: 344 PPFTPDFEGATDTCNFD 360

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 166/308 (53%), Gaps = 21/308 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL  +FQ    LY++++++ GG L  +L       E  A+FYTAE+V A+  
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILLS 288
           +H  G++HRD+KP+N+L+D  GH+ L DFG   ++DE+     ++  GT +Y++PE+L S
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 289 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAH 342
           +G    + ++ DWWSVG+ L+EML G  PF   +      +I++ K  L  P       H
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKH 309
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG 402
           +     +FLT     D   RLG    GV+ IK H +F++  W     RE      P++S 
Sbjct: 310 AKNLICAFLT-----DREVRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSS 362
Query: 403 KDCIANFD 410
               +NFD
Sbjct: 363 DIDSSNFD 370

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 109/342 (31%), Positives = 174/342 (50%), Gaps = 24/342 (7%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAF                  ++AMK++ K  ++K+      + ERD+L 
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADK-----VFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    E+ ARFY AE+V A+ 
Sbjct: 130 NGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAPEILL 287
            +H+   VHRD+KP+NILMD +GH+ L DFG   ++  D + +S+   GT +Y++PEIL 
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 288 S----KG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           +    KG +  + DWWS+G+ +YEML G+ PF   +  +   +I+N K +      ++  
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--FPTQVT 307
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG 402
            + +    L + L      RLG    G++  K H +F  I+W  +  R  +  + P+VS 
Sbjct: 308 DVSENAKDLIRRLICSREHRLGQ--NGIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSS 363
Query: 403 KDCIANF---DKCWXXXXXXXXXXXXXXXGEH--FKGYTYVA 439
               +NF   D C                G H  F G+TY +
Sbjct: 364 PTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTS 405

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  172 bits (436), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 159/305 (52%), Gaps = 21/305 (6%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FEI R +G+G+F                  +YAMK M K   +++N V  +  E  I+  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKK-----MYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HPF+V L YSFQ    +++++D + GG L +HL +   F+E+  + +  E+V A+ +L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-- 289
               I+HRD+KP+NIL+D  GHV +TDF +A  +   ++  +M GT  YMAPE+  S+  
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 290 -GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPPFLTSEAHSLL 345
            G++   DWWS+G+  YE+L G+ P+   +  + +++        V  P   + E  SLL
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL 251
Query: 346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC 405
           K      +LL  +P +R       +  +++  +   INW  +  + + P F P+    +C
Sbjct: 252 K------KLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNC 301
Query: 406 IANFD 410
              F+
Sbjct: 302 DPTFE 306

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 147/284 (51%), Gaps = 17/284 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +RK    DF+I R +G+G F                  I A+KV+ K  + K+     ++
Sbjct: 8   KRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKF-----IMALKVLFKSQLEKEGVEHQLR 62
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++  +  E
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  A+ + H+  ++HRD+KPEN+LM   G + + DFG +     S R   MCGT +Y+ P
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRXMCGTLDYLPP 181
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  K H++  D W  G+L YE L G PPF   +  +  +RI+N  +K PPFL+  +  
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 387
           L      +++LL   P +RL      +  +  H W ++ + + L
Sbjct: 242 L------ISKLLRYHPPQRL-----PLKGVMEHPWVKANSRRVL 274

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 147/284 (51%), Gaps = 17/284 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +RK    DF+I R +G+G F                  I A+KV+ K  + K+     ++
Sbjct: 9   KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKF-----IMALKVLFKSQLEKEGVEHQLR 63
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++  +  E
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 123
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  A+ + H+  ++HRD+KPEN+LM   G + + DFG +     S R   MCGT +Y+ P
Sbjct: 124 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRXMCGTLDYLPP 182
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  K H++  D W  G+L YE L G PPF   +  +  +RI+N  +K PPFL+  +  
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 242
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 387
           L      +++LL   P +RL      +  +  H W ++ + + L
Sbjct: 243 L------ISKLLRYHPPQRL-----PLKGVMEHPWVKANSRRVL 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 142/268 (52%), Gaps = 18/268 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
           +    + S      F+  L+ KDP KR 
Sbjct: 241 YWDDISDS---AKDFIRHLMEKDPEKRF 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 142/268 (52%), Gaps = 18/268 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
           +    + S      F+  L+ KDP KR 
Sbjct: 241 YWDDISDS---AKDFIRHLMEKDPEKRF 265

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 142/268 (52%), Gaps = 18/268 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
           +    + S      F+  L+ KDP KR 
Sbjct: 241 YWDDISDS---AKDFIRHLMEKDPEKRF 265

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 141/268 (52%), Gaps = 18/268 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K  +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKKALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
           +    + S      F+  L+ KDP KR 
Sbjct: 241 YWDDISDS---AKDFIRHLMEKDPEKRF 265

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 87/296 (29%), Positives = 161/296 (54%), Gaps = 22/296 (7%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK-- 245
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
               + L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 246 ----KFLILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 149/290 (51%), Gaps = 16/290 (5%)
Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXX 132
           GP P      S P    E E  +  + E   +R+    DFEI R +G+G F         
Sbjct: 1   GPQP----LPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK 56
Query: 133 XXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                    I A+KV+ K  + K      ++ E +I + + HP I++L   F   +++YL
Sbjct: 57  QSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           IL++   G ++  L +   F E +   Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 171
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFG +     SSR  ++CGT +Y+ PE++  + H++  D WS+G+L YE L G+P
Sbjct: 172 ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230
Query: 313 PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           PF     Q+  +RI   +   P F+T  A  L      +++LL  +PS+R
Sbjct: 231 PFEANTYQETYKRISRVEFTFPDFVTEGARDL------ISRLLKHNPSQR 274

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 160/296 (54%), Gaps = 22/296 (7%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGREV-----AIKIIDK-TQLNPTSLQKLFREVRIM 65
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 66  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E     + ++ CG+  Y APE+   K
Sbjct: 126 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK-- 243
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
               + L  +P KR     G ++ I   +W  + +    E  E++P  +P++   D
Sbjct: 244 ----RFLVLNPIKR-----GTLEQIMKDRWINAGH----EEDELKPFVEPELDISD 286

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 149/290 (51%), Gaps = 16/290 (5%)
Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXX 132
           GP P      S P    E E  +  + E   +R+    DFEI R +G+G F         
Sbjct: 1   GPQP----LPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK 56
Query: 133 XXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                    I A+KV+ K  + K      ++ E +I + + HP I++L   F   +++YL
Sbjct: 57  QSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           IL++   G ++  L +   F E +   Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 171
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFG +     SSR + +CGT +Y+ PE++  + H++  D WS+G+L YE L G+P
Sbjct: 172 ELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230
Query: 313 PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           PF     Q+  +RI   +   P F+T  A  L      +++LL  +PS+R
Sbjct: 231 PFEANTYQETYKRISRVEFTFPDFVTEGARDL------ISRLLKHNPSQR 274

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 87/296 (29%), Positives = 160/296 (54%), Gaps = 22/296 (7%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG   Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK-- 245
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
               + L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 246 ----KFLILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 151/271 (55%), Gaps = 18/271 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK-- 245
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L  +PSKR     G ++ I   +W 
Sbjct: 246 ----KFLILNPSKR-----GTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 87/296 (29%), Positives = 161/296 (54%), Gaps = 22/296 (7%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 7   GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 60
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 180
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK-- 238
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
               + L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 239 ----KFLILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 281

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 159/296 (53%), Gaps = 22/296 (7%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREV-----AIKIIDK-TQLNPTSLQKLFREVRIM 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E     + ++ CG   Y APE+   K
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK-- 246
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
               + L  +P KR     G ++ I   +W  + +    E  E++P  +P++   D
Sbjct: 247 ----RFLVLNPIKR-----GTLEQIMKDRWINAGH----EEDELKPFVEPELDISD 289

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 161/296 (54%), Gaps = 22/296 (7%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A++++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVRIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK-- 245
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
               + L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 246 ----KFLILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 142/267 (53%), Gaps = 18/267 (6%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  +KI    FE    +G GAF                  ++A+K + K  +  K   
Sbjct: 16  QAEDIKKI----FEFKETLGTGAFSEVVLAEEKATGK-----LFAVKCIPKKAL--KGKE 64
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E  +L K+ H  IV L   +++ + LYL++  ++GG LF  +  +G + E  A  
Sbjct: 65  SSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST 124
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              +++ AV +LH+ GIVHRDLKPEN+L    D +  +M++DFGL+K   +    ++ CG
Sbjct: 125 LIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG 184
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 335
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSP 244
Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +    + S      F+  L+ KDP+KR
Sbjct: 245 YWDDISDS---AKDFIRNLMEKDPNKR 268

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 140/263 (53%), Gaps = 12/263 (4%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           E   +R+    DFEI R +G+G F                  I A+KV+ K  + K    
Sbjct: 15  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVE 69
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   
Sbjct: 70  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 129
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +
Sbjct: 130 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLD 188
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           Y+ PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T 
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 248
Query: 340 EAHSLLKGVSFLTQLLHKDPSKR 362
            A  L      +++LL  +PS+R
Sbjct: 249 GARDL------ISRLLKHNPSQR 265

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 160/296 (54%), Gaps = 22/296 (7%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A++++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVRIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ +  CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK-- 245
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
               + L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 246 ----KFLILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 140/260 (53%), Gaps = 12/260 (4%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLP 178
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A 
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 238
Query: 343 SLLKGVSFLTQLLHKDPSKR 362
            L      +++LL  +PS+R
Sbjct: 239 DL------ISRLLKHNPSQR 252

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 139/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 241 L------ISRLLKHNPSQR 253

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 140/259 (54%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR +++CGT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDTLCGTLDYLPP 176
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 237 L------ISRLLKHNPSQR 249

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 82/252 (32%), Positives = 136/252 (53%), Gaps = 12/252 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ PE++  + 
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 182
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L      
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL------ 236
Query: 351 LTQLLHKDPSKR 362
           +++LL  +PS+R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 139/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 241 L------ISRLLKHNPSQR 253

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 139/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 239 L------ISRLLKHNPSQR 251

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 139/262 (53%), Gaps = 12/262 (4%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A   R+    DFEI R +G+G F                  I A+KV+ K  + K     
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEH 56
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            ++ E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALCGTLDY 175
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           + PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 235
Query: 341 AHSLLKGVSFLTQLLHKDPSKR 362
           A  L      +++LL  +PS+R
Sbjct: 236 ARDL------ISRLLKHNPSQR 251

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E +  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 241 L------ISRLLKHNPSQR 253

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 82/252 (32%), Positives = 135/252 (53%), Gaps = 12/252 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ PE++  + 
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTELCGTLDYLPPEMIEGRM 182
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L      
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL------ 236
Query: 351 LTQLLHKDPSKR 362
           +++LL  +PS+R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 140/260 (53%), Gaps = 12/260 (4%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           ++R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALCGTLDYLP 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A 
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 343 SLLKGVSFLTQLLHKDPSKR 362
            L      +++LL  +PS+R
Sbjct: 235 DL------ISRLLKHNPSQR 248

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 82/252 (32%), Positives = 136/252 (53%), Gaps = 12/252 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR + +CGT +Y+ PE++  + 
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRM 185
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L      
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL------ 239
Query: 351 LTQLLHKDPSKR 362
           +++LL  +PS+R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 139/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 55
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 115
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 116 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 174
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 234
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 235 L------ISRLLKHNPSQR 247

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 139/260 (53%), Gaps = 12/260 (4%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           ++R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 116 ELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALCGTLDYLP 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G+PPF     Q   +RI   +   P F+T  A 
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGAR 234
Query: 343 SLLKGVSFLTQLLHKDPSKR 362
            L      +++LL  +PS+R
Sbjct: 235 DL------ISRLLKHNPSQR 248

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 176
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 237 L------ISRLLKHNPSQR 249

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 241 L------ISRLLKHNPSQR 253

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 139/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ P
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 239 L------ISRLLKHNPSQR 251

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 175
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 236 L------ISRLLKHNPSQR 248

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 175
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 236 L------ISRLLKHNPSQR 248

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 138/255 (54%), Gaps = 16/255 (6%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F    V+G GAF                  ++A+K ++K    + +    ++ E  +L K
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGK-----LFALKCIKKSPAFRDSS---LENEIAVLKK 62
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + H  IV L   +++ +  YL++  ++GG LF  +  +G++ E  A     +++SAV +L
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 232 HKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           H+ GIVHRDLKPEN+L    + +  +M+TDFGL+K ++++   ++ CGT  Y+APE+L  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PPFLTSEAHSLLKG 347
           K ++K  D WS+G++ Y +L G PPF      KL ++I     +   PF    + S    
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES---A 238
Query: 348 VSFLTQLLHKDPSKR 362
             F+  LL KDP++R
Sbjct: 239 KDFICHLLEKDPNER 253

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 58
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLPP 177
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 238 L------ISRLLKHNPSQR 250

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 82/252 (32%), Positives = 136/252 (53%), Gaps = 12/252 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ PE++  + 
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 179
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L      
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL------ 233
Query: 351 LTQLLHKDPSKR 362
           +++LL  +PS+R
Sbjct: 234 ISRLLKHNPSQR 245

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTXLCGTLDYLPP 175
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 236 L------ISRLLKHNPSQR 248

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 139/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 58
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + +FG +     SSR  ++CGT +Y+ P
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP-SSRRTTLCGTLDYLPP 177
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 238 L------ISRLLKHNPSQR 250

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 147/270 (54%), Gaps = 18/270 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIX 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL+ ++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D+D ++ + DFG + E    ++ ++ CG   Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P + +++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLK-- 245
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
               + L  +PSKR     G ++ I   +W
Sbjct: 246 ----KFLILNPSKR-----GTLEQIXKDRW 266

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 147/279 (52%), Gaps = 17/279 (6%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DF+I R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKF-----ILALKVLFKTQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S+G + + DFG +     SSR +++CGT +Y+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP-SSRRDTLCGTLDYLP 178
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G PPF     Q+  +RI   +   P F+T  A 
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
            L      +++LL  + S+RL      +  +  H W ++
Sbjct: 239 DL------ISRLLKHNASQRL-----TLAEVLEHPWIKA 266

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLPP 175
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 236 L------ISRLLKHNPSQR 248

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 139/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + +FG +     SSR  ++CGT +Y+ P
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP-SSRRTTLCGTLDYLPP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 239 L------ISRLLKHNPSQR 251

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 146/279 (52%), Gaps = 17/279 (6%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DF+I R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKF-----ILALKVLFKTQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           E+ +A+S+ H   ++HRD+KPEN+L+ S+G + + DFG +     SSR  ++CGT +Y+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP-SSRRTTLCGTLDYLP 178
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++  + H++  D WS+G+L YE L G PPF     Q+  +RI   +   P F+T  A 
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
            L      +++LL  + S+RL      +  +  H W ++
Sbjct: 239 DL------ISRLLKHNASQRL-----TLAEVLEHPWIKA 266

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLPP 178
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 239 L------ISRLLKHNPSQR 251

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 138/259 (53%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++ GT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP-SSRRTTLSGTLDYLPP 176
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 237 L------ISRLLKHNPSQR 249

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 137/259 (52%), Gaps = 12/259 (4%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   + GT +Y+ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLXGTLDYLPP 180
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +++LL  +PS+R
Sbjct: 241 L------ISRLLKHNPSQR 253

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 144/283 (50%), Gaps = 17/283 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  I K+     ++ E +I  
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHF-----IVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F  R ++YLIL++   G L+  L +   F E +      E+  A+ +
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+   G + + DFG +     S R  +MCGT +Y+ PE++  + 
Sbjct: 139 CHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAP-SLRRKTMCGTLDYLPPEMIEGRM 197
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           HN+  D W +G+L YE+L G PPF  A+  +  +RI+   +K P  + + A  L      
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDL------ 251
Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 393
           +++LL  +PS+RL      +  +  H W R+ + + L    +Q
Sbjct: 252 ISKLLRHNPSERL-----PLAQVSAHPWVRANSRRVLPPSALQ 289

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 69/170 (40%), Positives = 103/170 (60%), Gaps = 8/170 (4%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +  S+CGT  Y+AP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAP 192
Query: 284 EILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           EI+         G+ K+ D WS G+++Y +L G PPF H  +Q L  R+I
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 241

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 137/250 (54%), Gaps = 19/250 (7%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT----LEAR 390
           P + +E     K +  + +LL  DP  R  +     +    H W +  + K     L + 
Sbjct: 241 PEVWAEVSE--KALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMKRKFQDLLSE 293
Query: 391 EMQPKFKPDV 400
           E +   KP V
Sbjct: 294 ENESTAKPQV 303

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 130/231 (56%), Gaps = 15/231 (6%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 246
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 385
           P + +E     K +  + +LL  DP  R  +     +    H W +  + K
Sbjct: 247 PEVWAEVSE--KALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 290

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 130/231 (56%), Gaps = 15/231 (6%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 385
           P + +E     K +  + +LL  DP  R  +     +    H W +  + K
Sbjct: 241 PEVWAEVSE--KALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 284

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 130/231 (56%), Gaps = 15/231 (6%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 385
           P + +E     K +  + +LL  DP  R  +     +    H W +  + K
Sbjct: 241 PEVWAEVSE--KALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 284

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 130/231 (56%), Gaps = 15/231 (6%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 239
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 385
           P + +E     K +  + +LL  DP  R  +     +    H W +  + K
Sbjct: 240 PEVWAEVSE--KALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 283

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 68/170 (40%), Positives = 102/170 (60%), Gaps = 8/170 (4%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+AP
Sbjct: 120 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 179
Query: 284 EILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           EI+         G+ K+ D WS G+++Y +L G PPF H  +Q L  R+I
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 228

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 68/170 (40%), Positives = 102/170 (60%), Gaps = 8/170 (4%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+AP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 284 EILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           EI+         G+ K+ D WS G+++Y +L G PPF H  +Q L  R+I
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 241

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/247 (32%), Positives = 137/247 (55%), Gaps = 23/247 (9%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 260 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 379
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 394
           P + +E     K +  + +LL  DP  R  +     +    H W        L+  +M+ 
Sbjct: 380 PEVWAEVSE--KALDLVKKLLVVDPKARFTT-----EEALRHPW--------LQDEDMKR 424
Query: 395 KFKPDVS 401
           KF+  +S
Sbjct: 425 KFQDLLS 431

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/247 (32%), Positives = 137/247 (55%), Gaps = 23/247 (9%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT 
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 279 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 334
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 394
           P + +E     K +  + +LL  DP  R  +     +    H W        L+  +M+ 
Sbjct: 366 PEVWAEVSE--KALDLVKKLLVVDPKARFTT-----EEALRHPW--------LQDEDMKR 410
Query: 395 KFKPDVS 401
           KF+  +S
Sbjct: 411 KFQDLLS 417

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/228 (35%), Positives = 132/228 (57%), Gaps = 13/228 (5%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV++K T+ KK     ++ E  +L +++HP I++L+  F+T +++ L+L+ + GG L
Sbjct: 81  YALKVLKK-TVDKK----IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  +  +G + E  A     +I+ AV++LH+ GIVHRDLKPEN+L  +   D  + + DF
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THAN 318
           GL+K ++      ++CGT  Y APEIL    +  + D WSVGI+ Y +L G  PF     
Sbjct: 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255
Query: 319 RQKLQQRIIN-EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
            Q + +RI+N E   + P+    +   L     + +L+  DP KRL +
Sbjct: 256 DQFMFRRILNCEYYFISPWWDEVS---LNAKDLVRKLIVLDPKKRLTT 300

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 157/291 (53%), Gaps = 22/291 (7%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREV-----AVKIIDK-TQLNPTSLQKLFREVRIM 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 128
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLK EN+L+D D ++ + DFG + E    ++ ++ CG+  Y APE+   K
Sbjct: 129 YCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGK 188
Query: 290 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +L    
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL---- 244
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
             L +LL  +P KR     G ++ I   +W    +    E  E++P  +PD
Sbjct: 245 --LKKLLVLNPIKR-----GSLEQIMKDRWMNVGH----EEEELKPYTEPD 284

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 136/255 (53%), Gaps = 13/255 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++  ++G+G+F                    A+K++ K  + K   V  ++ E  I  
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEV-----AIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVS 229
           ++ HP I++L   F+  + +YL+L+  + G +  +L  R   F E++AR +  +I++ + 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-SSRSNSMCGTTEYMAPEILLS 288
           +LH  GI+HRDL   N+L+  + ++ + DFGLA ++     +  ++CGT  Y++PEI   
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
             H  ++D WS+G + Y +L G+PPF     +    +++    ++P FL+ EA  L+   
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH-- 244
Query: 349 SFLTQLLHKDPSKRL 363
               QLL ++P+ RL
Sbjct: 245 ----QLLRRNPADRL 255

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 24/272 (8%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +++F  +G+GAF                   YA K++    +  ++H   ++ E  I   
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQE-----YAAKIINTKKLSARDH-QKLEREARICRL 77
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 232 HKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILL 287
           H+ G+VHRDLKPEN+L+ S      V L DFGLA E++ E        GT  Y++PE+L 
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHS 343
              + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA  
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 257
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           L      + ++L  +PSKR+ +     +A+KH
Sbjct: 258 L------INKMLTINPSKRITAA----EALKH 279

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 126/238 (52%), Gaps = 12/238 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  +K E   L    HP I++L     T +  ++++++++GG LF
Sbjct: 40  AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            ++ + G   E +AR    +I+SAV + H+  +VHRDLKPEN+L+D+  +  + DFGL+ 
Sbjct: 100 DYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159
Query: 264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
            + +     + CG+  Y APE++  + +   + D WS G++LY +L G  PF   +   L
Sbjct: 160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            ++I      +P +L     +L      L  +L  DP KR       +  I+ H+WF+
Sbjct: 220 FKKIRGGVFYIPEYLNRSVATL------LMHMLQVDPLKR-----ATIKDIREHEWFK 266

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 117/211 (55%), Gaps = 11/211 (5%)
Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           + E  IL +V  HP I+ L  S+++ S ++L+ D +  G LF +L  +    E + R   
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM 281
             ++ AVS LH   IVHRDLKPENIL+D +  + L+DFG +  ++   +   +CGT  Y+
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 282 APEILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLP 334
           APEIL         G+ K+ D W+ G++L+ +L G PPF H  RQ L  R+I E + +  
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFS 325
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
                +  S +K +  +++LL  DP  RL +
Sbjct: 326 SPEWDDRSSTVKDL--ISRLLQVDPEARLTA 354

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 126/238 (52%), Gaps = 12/238 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  ++ E   L    HP I++L     T S +++++++++GG LF
Sbjct: 45  AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELF 104
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            ++ + G   E ++R    +I+S V + H+  +VHRDLKPEN+L+D+  +  + DFGL+ 
Sbjct: 105 DYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164
Query: 264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
            + +       CG+  Y APE++  + +   + D WS G++LY +L G  PF   +   L
Sbjct: 165 MMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            ++I +     P +L     SLLK       +L  DP KR       +  I+ H+WF+
Sbjct: 225 FKKICDGIFYTPQYLNPSVISLLK------HMLQVDPMKR-----ATIKDIREHEWFK 271

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 121/222 (54%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +I+ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 189 ATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A +L++      ++LH DP+ R
Sbjct: 249 ETYIRIKKNEYSVPRHINPVASALIR------RMLHADPTLR 284

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 125/238 (52%), Gaps = 12/238 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  +K E   L    HP I++L     T +  ++++++++GG LF
Sbjct: 40  AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            ++ + G   E +AR    +I+SAV + H+  +VHRDLKPEN+L+D+  +  + DFGL+ 
Sbjct: 100 DYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159
Query: 264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
            + +       CG+  Y APE++  + +   + D WS G++LY +L G  PF   +   L
Sbjct: 160 MMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
Query: 323 QQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            ++I      +P +L     +L      L  +L  DP KR       +  I+ H+WF+
Sbjct: 220 FKKIRGGVFYIPEYLNRSVATL------LMHMLQVDPLKR-----ATIKDIREHEWFK 266

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 120/222 (54%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 189 ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A +L++      ++LH DP+ R
Sbjct: 249 ETYIRIKKNEYSVPRHINPVASALIR------RMLHADPTLR 284

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 120/222 (54%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 189 ATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A +L++      ++LH DP+ R
Sbjct: 249 ETYIRIKKNEYSVPRHINPVASALIR------RMLHADPTLR 284

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 116/215 (53%), Gaps = 15/215 (6%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227
Query: 335 P----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
                 +T EA SL+        +L  +P KR+ +
Sbjct: 228 SPEWDTVTPEAKSLIDS------MLTVNPKKRITA 256

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 120/222 (54%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 48  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 107
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 108 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 167
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 168 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 227
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A SL++      ++L  DP+ R
Sbjct: 228 ETYLRIKKNEYSIPKHINPVAASLIQ------KMLQTDPTAR 263

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 120/222 (54%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 53  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 112
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 113 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 172
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 173 ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 232
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A +L++      ++LH DP+ R
Sbjct: 233 ETYIRIKKNEYSVPRHINPVASALIR------RMLHADPTLR 268

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 125/229 (54%), Gaps = 14/229 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K+++K ++   ++   +  E  +L ++ HP I++L   F+ +   YL+++   GG LF
Sbjct: 50  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 109
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S  ++LHK  IVHRDLKPEN+L++S   D  + + DFG
Sbjct: 110 DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 169
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           L+   +   +     GT  Y+APE+ L K +++  D WS G++LY +L G PPF     Q
Sbjct: 170 LSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ 228
Query: 321 KLQQRIINEKVKLPP----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
           ++ +R+   K    P     ++ EA  L+K       +L  +PSKR+ +
Sbjct: 229 EILKRVEKGKFSFDPPDWTQVSDEAKQLVK------LMLTYEPSKRISA 271

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 116/215 (53%), Gaps = 15/215 (6%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 47  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 106
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 107 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 166
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 226
Query: 335 P----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
                 +T EA SL+        +L  +P KR+ +
Sbjct: 227 SPEWDTVTPEAKSLIDS------MLTVNPKKRITA 255

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 116/215 (53%), Gaps = 15/215 (6%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227
Query: 335 P----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
                 +T EA SL+        +L  +P KR+ +
Sbjct: 228 SPEWDTVTPEAKSLIDS------MLTVNPKKRITA 256

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/213 (35%), Positives = 115/213 (53%), Gaps = 15/213 (7%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 130
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM 274
                +I+ ++++ H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +  
Sbjct: 131 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 250
Query: 335 P----FLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
                 +T EA SL+        +L  +P KR+
Sbjct: 251 SPEWDTVTPEAKSLIDS------MLTVNPKKRI 277

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 120/222 (54%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 164 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 223
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A SL++      ++L  DP+ R
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQ------KMLQTDPTAR 259

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 120/222 (54%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 164 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 223
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A SL++      ++L  DP+ R
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQ------KMLQTDPTAR 259

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 134/273 (49%), Gaps = 24/273 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQE-----YAAKIINTKKLSARDH-QKLEREARICR 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 86  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNH 145
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +H+  IVHRDLKPEN+L+ S      V L DFGLA E+  E        GT  Y++PE+L
Sbjct: 146 IHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL 205
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ KL Q+I       P      +T EA 
Sbjct: 206 RKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 265
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           +L      + Q+L  +P+KR+ +      A+KH
Sbjct: 266 NL------INQMLTINPAKRITAD----QALKH 288

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 125/229 (54%), Gaps = 14/229 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K+++K ++   ++   +  E  +L ++ HP I++L   F+ +   YL+++   GG LF
Sbjct: 33  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 92
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S  ++LHK  IVHRDLKPEN+L++S   D  + + DFG
Sbjct: 93  DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 152
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           L+   +   +     GT  Y+APE+ L K +++  D WS G++LY +L G PPF     Q
Sbjct: 153 LSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ 211
Query: 321 KLQQRIINEKVKLPP----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
           ++ +R+   K    P     ++ EA  L+K       +L  +PSKR+ +
Sbjct: 212 EILKRVEKGKFSFDPPDWTQVSDEAKQLVK------LMLTYEPSKRISA 254

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 140/277 (50%), Gaps = 29/277 (10%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 68
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 128
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAH 342
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P ++    H
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV----H 244
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
              +    ++++   DP+KR+      +  I++H+WF
Sbjct: 245 ISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 276

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 119/222 (53%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A SL++      ++L  DP+ R
Sbjct: 248 ETYLRIKKNEYSIPKHINPVAASLIQ------KMLQTDPTAR 283

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 139/277 (50%), Gaps = 29/277 (10%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I  N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIAAN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAH 342
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P ++    H
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV----H 245
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
              +    ++++   DP+KR+      +  I++H+WF
Sbjct: 246 ISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 133/273 (48%), Gaps = 24/273 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA  ++    +  ++H   ++ E  I  
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQE-----YAAMIINTKKLSARDH-QKLEREARICR 65
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
            H+ G+VHR+LKPEN+L+ S      V L DFGLA E++ E        GT  Y++PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
            L      + ++L  +PSKR+ +     +A+KH
Sbjct: 246 DL------INKMLTINPSKRITAA----EALKH 268

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 146/282 (51%), Gaps = 24/282 (8%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A S+R IGP  + I   +G+G+F                    + ++++K  +       
Sbjct: 2   AISKRHIGP--YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM------- 52
Query: 161 YMKAERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           +M+ ER+I  L  + HP I++L     T + + +++++  GG LF ++  +    ED+ R
Sbjct: 53  HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR 111
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +  +I+ A+ + H+  IVHRDLKPEN+L+D + +V + DFGL+  + + +   + CG+ 
Sbjct: 112 RFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSP 171
Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
            Y APE++  K +   + D WS GI+LY ML G+ PF       L +++ +    +P FL
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231
Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
           +  A SL++      +++  DP +R+      +  I+   WF
Sbjct: 232 SPGAQSLIR------RMIVADPMQRI-----TIQEIRRDPWF 262

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 119/222 (53%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 66  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 125
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 126 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 185
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 186 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 245
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A SL++      ++L  DP+ R
Sbjct: 246 ETYLRIKKNEYSIPKHINPVAASLIQ------KMLQTDPTAR 281

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 140/277 (50%), Gaps = 29/277 (10%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 130 YAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAH 342
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P ++    H
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV----H 245
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
              +    ++++   DP+KR+      +  I++H+WF
Sbjct: 246 ISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 135/273 (49%), Gaps = 24/273 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +++++  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEIL 286
            H+ G+VHRDLKPEN+L+ S      V L DFGLA E+    ++     GT  Y++PE+L
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
             + + K  D W+ G++LY +L G PPF   ++ KL Q+I       P      +T EA 
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           +L      + Q+L  +P+KR+ +     +A+KH
Sbjct: 239 NL------INQMLTINPAKRITAH----EALKH 261

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 119/222 (53%), Gaps = 7/222 (3%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 42  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D  V + DFGL
Sbjct: 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 262 AKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +   RI   +  +P  +   A SL++      ++L  DP+ R
Sbjct: 222 ETYLRIKKNEYSIPKHINPVAASLIQ------KMLQTDPTAR 257

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 24/273 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEIL 286
            H  GIVHRDLKPEN+L+ S      V L DFGLA E+    ++     GT  Y++PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
            L      + ++L  +P+KR+ +     +A+KH
Sbjct: 239 DL------INKMLTINPAKRITAS----EALKH 261

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 24/273 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 231 LHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEIL 286
            H  GIVHRDLKPEN+L+ S      V L DFGLA E+    ++     GT  Y++PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
            L      + ++L  +P+KR+ +     +A+KH
Sbjct: 239 DL------INKMLTINPAKRITAS----EALKH 261

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 113/203 (55%), Gaps = 8/203 (3%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           + E  +L  + HP IVQ R SF+    LY+++D+  GG LF  +  Q   +F+EDQ   +
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC-GTTE 279
             +I  A+ H+H   I+HRD+K +NI +  DG V L DFG+A+ ++ +      C GT  
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           Y++PEI  +K +N  +D W++G +LYE+ T +  F   + + L  +II+     PP    
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--SFPPVSLH 248
Query: 340 EAHSLLKGVSFLTQLLHKDPSKR 362
            ++ L    S ++QL  ++P  R
Sbjct: 249 YSYDLR---SLVSQLFKRNPRDR 268

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 122/222 (54%), Gaps = 26/222 (11%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HP IV+L   F  +   +L+++ +NGG LF  + ++  F E +A +   ++VSAVSH+H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 234 CGIVHRDLKPENILMDSDG---HVMLTDFGLAK-EIDESSRSNSMCGTTEYMAPEILLSK 289
            G+VHRDLKPEN+L   +     + + DFG A+ +  ++    + C T  Y APE+L   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPF---------LT 338
           G+++  D WS+G++LY ML+GQ PF   +R       +   +K+K   F         ++
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            EA  L++G      LL  DP+KRL      +  +++++W +
Sbjct: 245 QEAKDLIQG------LLTVDPNKRL-----KMSGLRYNEWLQ 275

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 139/277 (50%), Gaps = 29/277 (10%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + +  FG +K     S+  S  GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAH 342
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P ++    H
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV----H 245
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
              +    ++++   DP+KR+      +  I++H+WF
Sbjct: 246 ISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 140/272 (51%), Gaps = 18/272 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 62
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 181
Query: 290 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K  
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK-- 239
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
               ++L  +P  R+      +  I    WF+
Sbjct: 240 ----RMLIVNPLNRI-----SIHEIMQDDWFK 262

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 140/272 (51%), Gaps = 18/272 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 186
Query: 290 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K  
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK-- 244
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
               ++L  +P  R+      +  I    WF+
Sbjct: 245 ----RMLIVNPLNRI-----SIHEIMQDDWFK 267

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 140/272 (51%), Gaps = 18/272 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 187
Query: 290 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K  
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK-- 245
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
               ++L  +P  R+      +  I    WF+
Sbjct: 246 ----RMLIVNPLNRI-----SIHEIMQDDWFK 268

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 140/272 (51%), Gaps = 18/272 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 58
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           + H+  IVHRDLKPEN+L+D   +V + DFGL+  + + +   + CG+  Y APE++  K
Sbjct: 118 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 177
Query: 290 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K  
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK-- 235
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
               ++L  +P  R+      +  I    WF+
Sbjct: 236 ----RMLIVNPLNRI-----SIHEIMQDDWFK 258

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 122/228 (53%), Gaps = 19/228 (8%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           VD  K E +I+  + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A 
Sbjct: 50  VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA 109
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILM--DS-DGHVMLTDFGLAKEIDESSRSNSMC 275
               +++SAV++ HK  + HRDLKPEN L   DS D  + L DFGLA          +  
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           GT  Y++P++ L   +  + D WS G+++Y +L G PPF+     ++  +I       P 
Sbjct: 170 GTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 228
Query: 336 ----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
                ++ +A SL++      +LL K P +R+ S    + A++ H+WF
Sbjct: 229 KDWLNVSPQAESLIR------RLLTKSPKQRITS----LQALE-HEWF 265

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 122/228 (53%), Gaps = 19/228 (8%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           VD  K E +I+  + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A 
Sbjct: 67  VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA 126
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILM--DS-DGHVMLTDFGLAKEIDESSRSNSMC 275
               +++SAV++ HK  + HRDLKPEN L   DS D  + L DFGLA          +  
Sbjct: 127 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 186
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           GT  Y++P++ L   +  + D WS G+++Y +L G PPF+     ++  +I       P 
Sbjct: 187 GTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 245
Query: 336 ----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
                ++ +A SL++      +LL K P +R+ S    + A++ H+WF
Sbjct: 246 KDWLNVSPQAESLIR------RLLTKSPKQRITS----LQALE-HEWF 282

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 138/277 (49%), Gaps = 29/277 (10%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   + HRDLK EN L+D      + +  FG +K     S+     GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAH 342
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P ++    H
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV----H 245
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
              +    ++++   DP+KR+      +  I++H+WF
Sbjct: 246 ISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 143/273 (52%), Gaps = 24/273 (8%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 56  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 229
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGV 348
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++  
Sbjct: 230 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR-- 287
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
               ++L   PS R+ +     DA+  H+W ++
Sbjct: 288 ----KMLTYVPSMRISA----RDAL-DHEWIQT 311

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 143/273 (52%), Gaps = 24/273 (8%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 38  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 211
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGV 348
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++  
Sbjct: 212 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR-- 269
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
               ++L   PS R+ +     DA+  H+W ++
Sbjct: 270 ----KMLTYVPSMRISAR----DAL-DHEWIQT 293

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 143/273 (52%), Gaps = 24/273 (8%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 55  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 228
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGV 348
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++  
Sbjct: 229 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR-- 286
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
               ++L   PS R+ +     DA+  H+W ++
Sbjct: 287 ----KMLTYVPSMRISA----RDAL-DHEWIQT 310

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 143/273 (52%), Gaps = 24/273 (8%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 32  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 205
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGV 348
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++  
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR-- 263
Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
               ++L   PS R+ +     DA+  H+W ++
Sbjct: 264 ----KMLTYVPSMRISAR----DAL-DHEWIQT 287

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 78/247 (31%), Positives = 128/247 (51%), Gaps = 24/247 (9%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTRSKLYLILDFING 199
           + A+K + +   I +N       +R+I+    + HP IV+ +    T + L +I+++ +G
Sbjct: 47  LVAVKYIERGAAIDEN------VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLT 257
           G L+  +   G F ED+ARF+  +++S VS+ H   I HRDLK EN L+D      + + 
Sbjct: 101 GELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC 160
Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTH 316
           DFG +K     S+  S  GT  Y+APE+LL + ++ K AD WS G+ LY ML G  PF  
Sbjct: 161 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
Query: 317 A----NRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDA 372
                + +K  QRI++ K  +P     +     +    ++++   DP+ R+      +  
Sbjct: 221 PEEPRDYRKTIQRILSVKYSIP----DDIRISPECCHLISRIFVADPATRI-----SIPE 271
Query: 373 IKHHKWF 379
           IK H WF
Sbjct: 272 IKTHSWF 278

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 128/226 (56%), Gaps = 9/226 (3%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++RK ++   ++   ++ E  +L  + HP I++L   F+ +   YL+++   GG LF
Sbjct: 66  AIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFG 260
             +  +  F E  A     +++S V++LHK  IVHRDLKPEN+L++S   D  + + DFG
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           L+   +   +     GT  Y+APE+ L K +++  D WS+G++L+ +L G PPF     Q
Sbjct: 185 LSAVFENQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGV-SFLTQLLHKDPSKRLGS 365
           ++ +++  EK K   F + E  ++ +G    + Q+L  D  +R+ +
Sbjct: 244 EILRKV--EKGKY-TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 115/206 (55%), Gaps = 6/206 (2%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E  IL +V HP I+ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  + 
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVMLTDFGLAKEIDESSRSNSMCGT 277
            +I+  V++LH   I H DLKPENI L+D +    H+ L DFGLA EI++     ++ GT
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    I           
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRL 363
            S+   L K   F+ +LL K+  KRL
Sbjct: 242 FSQTSELAK--DFIRKLLVKETRKRL 265

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 114/214 (53%), Gaps = 9/214 (4%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 32  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I +L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S +++ HK  
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 236 IVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
           IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+L    ++
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YD 205
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           +  D WS G++LY +L+G PPF  AN   + +++
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 149/318 (46%), Gaps = 30/318 (9%)
Query: 81  SSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXX 140
           SS + L  + L  ++  E   E   ++G G F I R   Q                    
Sbjct: 8   SSGVDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKE-------------- 53
Query: 141 XIYAMKVMRKDTIIK-KNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197
             YA K ++K  +   +  V   + ER+  IL ++ HP I+ L   F+ ++ + LIL+ +
Sbjct: 54  --YAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 111
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---H 253
           +GG LF  L  +    ED+A  +  +I+  V +LH   I H DLKPENI L+D +     
Sbjct: 112 SGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 171
Query: 254 VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP 313
           + L DFG+A +I+  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  P
Sbjct: 172 IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231
Query: 314 FTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAI 373
           F    +Q+    I            S    L K   F+ +LL KDP +R+      +   
Sbjct: 232 FLGETKQETLTNISAVNYDFDEEYFSNTSELAK--DFIRRLLVKDPKRRM-----XIAQS 284
Query: 374 KHHKWFRSINWKTLEARE 391
             H W ++I  + +   +
Sbjct: 285 LEHSWIKAIRRRNVRGED 302

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 108/187 (57%), Gaps = 5/187 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DF
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           GL+    ++++     GT  Y+APE+L    +++  D WS G++LY +L+G PPF   N 
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 320 QKLQQRI 326
             + +R+
Sbjct: 228 YDILKRV 234

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 108/187 (57%), Gaps = 5/187 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DF
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           GL+    ++++     GT  Y+APE+L    +++  D WS G++LY +L+G PPF   N 
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 320 QKLQQRI 326
             + +R+
Sbjct: 228 YDILKRV 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 108/187 (57%), Gaps = 5/187 (2%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF 259
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DF
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           GL+    ++++     GT  Y+APE+L    +++  D WS G++LY +L+G PPF   N 
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 320 QKLQQRI 326
             + +R+
Sbjct: 228 YDILKRV 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 122/234 (52%), Gaps = 11/234 (4%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  + 
Sbjct: 55  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVMLTDFGLAKEIDESSRSNSMCGT 277
            +I+  V +LH   I H DLKPENI L+D +     + L DFG+A +I+  +   ++ GT
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    I           
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234
Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 391
            S    L K   F+ +LL KDP +R+      +     H W ++I  + +   +
Sbjct: 235 FSNTSELAK--DFIRRLLVKDPKRRM-----TIAQSLEHSWIKAIRRRNVRGED 281

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 17/254 (6%)
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           II K+  D  +    +L    HP I+ L+  +     +Y++ + + GG L   + RQ  F
Sbjct: 54  IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF 113
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTDFGLAKEI-DE 267
            E +A      I   V +LH  G+VHRDLKP NIL +D  G+   + + DFG AK++  E
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQ 324
           +    + C T  ++APE+L  +G++   D WS+G+LLY MLTG  PF +      +++  
Sbjct: 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233
Query: 325 RIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
           RI + K  L     +      K    ++++LH DP +RL +       +  H W   ++W
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAK--DLVSKMLHVDPHQRLTAA-----LVLRHPWI--VHW 284
Query: 385 KTLEAREMQPKFKP 398
             L   ++  +  P
Sbjct: 285 DQLPQYQLNRQDAP 298

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 124/228 (54%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    I            S+   L K   F+ +LL K+  KRL
Sbjct: 220 GDTKQETLANITAVSYDFDEEFFSQTSELAK--DFIRKLLVKETRKRL 265

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 124/228 (54%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    I +          S    L K   F+ +LL K+  KRL
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAK--DFIRKLLVKETRKRL 265

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 124/228 (54%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    I            S+   L K   F+ +LL K+  KRL
Sbjct: 220 GDTKQETLANITAVSYDFDEEFFSQTSELAK--DFIRKLLVKETRKRL 265

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 38  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 97
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 98  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 263

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 113/206 (54%), Gaps = 6/206 (2%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  + 
Sbjct: 62  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 121
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVMLTDFGLAKEIDESSRSNSMCGT 277
            +I+  V +LH   I H DLKPENI L+D +     + L DFG+A +I+  +   ++ GT
Sbjct: 122 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 181
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    I           
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 241
Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRL 363
            S    L K   F+ +LL KDP +R+
Sbjct: 242 FSNTSELAK--DFIRRLLVKDPKRRM 265

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 124/228 (54%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    I +          S    L K   F+ +LL K+  KRL
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAK--DFIRKLLVKETRKRL 265

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 124/228 (54%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD---GHVM 255
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +    H+ 
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           L DFGLA EI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    I +          S    L K   F+ +LL K+  KRL
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAK--DFIRKLLVKETRKRL 265

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 38  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 97
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 98  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 263

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 119/238 (50%), Gaps = 20/238 (8%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           + E KIG   F++ R +G GA+                    A+KV++K    K  + D 
Sbjct: 29  KKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEK-----AIKVIKKSQFDKGRYSDD 82
Query: 162 MKA----------ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
            K           E  +L  + HP I++L   F+ +   YL+ +F  GG LF  +  +  
Sbjct: 83  NKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK 142
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEIDES 268
           F E  A     +I+S + +LHK  IVHRD+KPENIL+++     ++ + DFGL+    + 
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
            +     GT  Y+APE+ L K +N+  D WS G+++Y +L G PPF   N Q + +++
Sbjct: 203 YKLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 77/229 (33%), Positives = 119/229 (51%), Gaps = 16/229 (6%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV      I K+  D  +    +L    HP I+ L+  +     +YL+ + + GG L
Sbjct: 55  YAVKV------IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTD 258
              + RQ  F E +A F    I   V +LH  G+VHRDLKP NIL +D  G+   + + D
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICD 168
Query: 259 FGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA 317
           FG AK++  E+    + C T  ++APE+L  +G+++  D WS+GILLY ML G  PF + 
Sbjct: 169 FGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG 228
Query: 318 ---NRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
                +++  RI + K  L     +      K    ++++LH DP +RL
Sbjct: 229 PSDTPEEILTRIGSGKFTLSGGNWNTVSETAK--DLVSKMLHVDPHQRL 275

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/229 (33%), Positives = 119/229 (51%), Gaps = 16/229 (6%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV      I K+  D  +    +L    HP I+ L+  +     +YL+ + + GG L
Sbjct: 55  YAVKV------IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTD 258
              + RQ  F E +A F    I   V +LH  G+VHRDLKP NIL +D  G+   + + D
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICD 168
Query: 259 FGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA 317
           FG AK++  E+    + C T  ++APE+L  +G+++  D WS+GILLY ML G  PF + 
Sbjct: 169 FGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG 228
Query: 318 ---NRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
                +++  RI + K  L     +      K    ++++LH DP +RL
Sbjct: 229 PSDTPEEILTRIGSGKFTLSGGNWNTVSETAK--DLVSKMLHVDPHQRL 275

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 135/262 (51%), Gaps = 18/262 (6%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM--RKDTIIKKNHVDYMKAERDIL 169
           +E+  V+G+GAF                   +A+K++   K T       + +K E  I 
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQ-----FAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A  Y  +I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSR-SNSMCGTTEYM 281
            A+ + H   I+HRD+KPEN+L+ S  +   V L DFG+A ++ ES   +    GT  +M
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+ P     +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKMNP--RQWS 257
Query: 342 HSLLKGVSFLTQLLHKDPSKRL 363
           H        + ++L  DP++R+
Sbjct: 258 HISESAKDLVRRMLMLDPAERI 279

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 124/233 (53%), Gaps = 24/233 (10%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           ++ ++AE ++L  + HP I+++   F+    +Y++++   GG L   +       +  + 
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 219 FYTAEIV----SAVSHLHKCGIVHRDLKPENILM-DSDGH--VMLTDFGLAKEIDESSRS 271
            Y AE++    +A+++ H   +VH+DLKPENIL  D+  H  + + DFGLA+       S
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII---- 327
            +  GT  YMAPE+   +      D WS G+++Y +LTG  PFT  + +++QQ+      
Sbjct: 184 TNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242
Query: 328 NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
           N  V+  P LT +A  LLK      Q+L KDP +R    P     + HH+WF+
Sbjct: 243 NYAVECRP-LTPQAVDLLK------QMLTKDPERR----PSAAQVL-HHEWFK 283

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 122/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT  ++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 122/228 (53%), Gaps = 9/228 (3%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LI + + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSDG---HVM 255
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +     + 
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           + DFGLA +ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +Q+    +     +      S   +L K   F+ +LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRM 264

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 123/254 (48%), Gaps = 17/254 (6%)
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           II K+  D  +    +L    HP I+ L+  +     +Y++ +   GG L   + RQ  F
Sbjct: 54  IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFF 113
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH---VMLTDFGLAKEI-DE 267
            E +A      I   V +LH  G+VHRDLKP NIL +D  G+   + + DFG AK++  E
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQ 324
           +    + C T  ++APE+L  +G++   D WS+G+LLY  LTG  PF +      +++  
Sbjct: 174 NGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILA 233
Query: 325 RIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
           RI + K  L     +      K    +++ LH DP +RL +       +  H W   ++W
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAK--DLVSKXLHVDPHQRLTAA-----LVLRHPWI--VHW 284
Query: 385 KTLEAREMQPKFKP 398
             L   ++  +  P
Sbjct: 285 DQLPQYQLNRQDAP 298

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 119/218 (54%), Gaps = 9/218 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 181 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 239
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 240 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 300 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359
Query: 327 INEKVKLPPFLTS--EAHSLLKGVSFLTQLLHKDPSKR 362
              +  LPP L +  +    LKG  FL +LL +DP++R
Sbjct: 360 ---RDNLPPRLKNLHKVSPSLKG--FLDRLLVRDPAQR 392

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 126/266 (47%), Gaps = 19/266 (7%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH   I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWM 202
Query: 282 APEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           APE+++      + ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT 259
Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKR 362
           L   +        FL + L K+   R
Sbjct: 260 LAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 126/266 (47%), Gaps = 19/266 (7%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH   I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 202
Query: 282 APEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           APE+++      + ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT 259
Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKR 362
           L   +        FL + L K+   R
Sbjct: 260 LAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 119/218 (54%), Gaps = 9/218 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 104 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 162
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 163 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 223 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282
Query: 327 INEKVKLPPFLTS--EAHSLLKGVSFLTQLLHKDPSKR 362
              +  LPP L +  +    LKG  FL +LL +DP++R
Sbjct: 283 ---RDNLPPRLKNLHKVSPSLKG--FLDRLLVRDPAQR 315

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 119/218 (54%), Gaps = 9/218 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 119
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 120 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 179
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 180 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 239
Query: 327 INEKVKLPPFLTS--EAHSLLKGVSFLTQLLHKDPSKR 362
              +  LPP L +  +    LKG  FL +LL +DP++R
Sbjct: 240 ---RDNLPPRLKNLHKVSPSLKG--FLDRLLVRDPAQR 272

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 119/218 (54%), Gaps = 9/218 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 59  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 117
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 118 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 177
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 178 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 237
Query: 327 INEKVKLPPFLTS--EAHSLLKGVSFLTQLLHKDPSKR 362
              +  LPP L +  +    LKG  FL +LL +DP++R
Sbjct: 238 ---RDNLPPRLKNLHKVSPSLKG--FLDRLLVRDPAQR 270

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 121/218 (55%), Gaps = 9/218 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V +  S+    +L+++++F+ GG L   + 
Sbjct: 75  VKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT-DIV 133
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S+LH  G++HRD+K ++IL+ SDG + L+DFG   ++  
Sbjct: 134 THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 193
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  +   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    +  +RI
Sbjct: 194 EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 253
Query: 327 INEKVKLPPFLTS--EAHSLLKGVSFLTQLLHKDPSKR 362
              +  LPP +    +  S+L+G  FL  +L ++PS+R
Sbjct: 254 ---RDSLPPRVKDLHKVSSVLRG--FLDLMLVREPSQR 286

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 119/218 (54%), Gaps = 9/218 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 50  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 108
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 109 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 169 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
Query: 327 INEKVKLPPFLTS--EAHSLLKGVSFLTQLLHKDPSKR 362
              +  LPP L +  +    LKG  FL +LL +DP++R
Sbjct: 229 ---RDNLPPRLKNLHKVSPSLKG--FLDRLLVRDPAQR 261

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 119/218 (54%), Gaps = 9/218 (4%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 54  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 112
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG V L+DFG   ++  
Sbjct: 113 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 172
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 173 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 232
Query: 327 INEKVKLPPFLTS--EAHSLLKGVSFLTQLLHKDPSKR 362
              +  LPP L +  +    LKG  FL +LL +DP++R
Sbjct: 233 ---RDNLPPRLKNLHKVSPSLKG--FLDRLLVRDPAQR 265

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 125/266 (46%), Gaps = 19/266 (7%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTEYM 281
           + + A+++LH   I+HRDLK  NIL   DG + L DFG+ AK      R +   GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWM 202
Query: 282 APEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 336
           APE+++      + ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT 259
Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKR 362
           L   +        FL + L K+   R
Sbjct: 260 LAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 126/268 (47%), Gaps = 45/268 (16%)
Query: 143 YAMKVMRKDTIIK-----------------------KNHVDYMKAERDILTKVTHPFIVQ 179
           YAMKV+ K  +I+                       +  ++ +  E  IL K+ HP +V+
Sbjct: 41  YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVK 100
Query: 180 LRYSFQ--TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           L           LY++ + +N G +   +       EDQARFY  +++  + +LH   I+
Sbjct: 101 LVEVLDDPNEDHLYMVFELVNQGPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKII 159
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--SNSMCGTTEYMAPEILLSKGH---N 292
           HRD+KP N+L+  DGH+ + DFG++ E   S    SN++ GT  +MAPE L         
Sbjct: 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSG 218
Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--PFLTSEAHSLLKGVSF 350
           K  D W++G+ LY  + GQ PF       L  +I ++ ++ P  P +  +   L      
Sbjct: 219 KALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDL------ 272
Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
           +T++L K+P  R+      V  IK H W
Sbjct: 273 ITRMLDKNPESRI-----VVPEIKLHPW 295

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 90/147 (61%), Gaps = 2/147 (1%)
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++++H  IV +    +     YL++++I G  L  ++   G    D A  +T +I+  + 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILL 287
           H H   IVHRD+KP+NIL+DS+  + + DFG+AK + E+S  ++N + GT +Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPF 314
            +  ++  D +S+GI+LYEML G+PPF
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 117/234 (50%), Gaps = 12/234 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++    ++ +   S+   SKL++I++++ GG     L R G F E Q      EI
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEI 129
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
           +  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAP
Sbjct: 130 LKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 189
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++    ++  AD WS+GI   E+  G+PP +  +  ++   I       PP L  +   
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLVGDFTK 246
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
             K   F+   L+KDPS R    P   + +K HK+    + KT    E+  +FK
Sbjct: 247 SFK--EFIDACLNKDPSFR----PTAKELLK-HKFIVKNSKKTSYLTELIDRFK 293

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQA 217
           +K E  I   + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSR-SNS 273
             Y  +I+ A+ + H   I+HRD+KP  +L+ S  +   V L  FG+A ++ ES   +  
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
             GT  +MAPE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKM 253
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            P   S      K    + ++L  DP++R+
Sbjct: 254 NPRQWSHISESAK--DLVRRMLMLDPAERI 281

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQA 217
           +K E  I   + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSR-SNS 273
             Y  +I+ A+ + H   I+HRD+KP  +L+ S  +   V L  FG+A ++ ES   +  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
             GT  +MAPE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKM 251
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            P     +H        + ++L  DP++R+
Sbjct: 252 NP--RQWSHISESAKDLVRRMLMLDPAERI 279

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 87/152 (57%), Gaps = 2/152 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             K +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 86/152 (56%), Gaps = 2/152 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ + M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             K +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 86/152 (56%), Gaps = 2/152 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ + M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             K +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 86/152 (56%), Gaps = 2/152 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 129
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
           +  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S+ + M GT  +MAPE++
Sbjct: 130 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189
Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             K +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 221

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 240 ----ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 240 ----ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 240 ----ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 240 ----ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 16/260 (6%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +F I + +G+G F                  +   KV   D +  K   D +K E D+L
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVP----VALKKVQIFDLMDAKARADCIK-EIDLL 86
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIV 225
            ++ HP +++   SF   ++L ++L+  + G L     H  +Q  +  E     Y  ++ 
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPE 284
           SA+ H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFLTSEAH 342
            +   G+N  +D WS+G LLYEM   Q PF     N   L ++I  E+   PP  +    
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSDHYS 264
Query: 343 SLLKGVSFLTQLLHKDPSKR 362
             L+    +   ++ DP KR
Sbjct: 265 EELR--QLVNMCINPDPEKR 282

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINA 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 240 ----ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 11/220 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILR 131
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
           EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +M
Sbjct: 132 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L    
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNY 248
Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
              LK   F+   L+K+PS R    P   + +KH    R+
Sbjct: 249 SKPLK--EFVEACLNKEPSFR----PTAKELLKHKFILRN 282

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 2/146 (1%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  LH 
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHS 135
Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHN 292
             ++HR++K +NIL+  DG V LTDFG   +I  E S+ ++M GT  +MAPE++  K + 
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 195
Query: 293 KDADWWSVGILLYEMLTGQPPFTHAN 318
              D WS+GI+  EM+ G+PP+ + N
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNEN 221

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 114/210 (54%), Gaps = 7/210 (3%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   +  Q    E
Sbjct: 82  KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNE 140
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-RSNS 273
           +Q       ++ A+++LH  G++HRD+K ++IL+  DG V L+DFG   +I +   +   
Sbjct: 141 EQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX 200
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 333
           + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+   +  +  +R+ +     
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---- 256
Query: 334 PPFLTSEAHSLLKGV-SFLTQLLHKDPSKR 362
           PP     +H +   +  FL ++L +DP +R
Sbjct: 257 PPPKLKNSHKVSPVLRDFLERMLVRDPQER 286

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 238 ----ALLHKILVENPSARI-----TIPDIKKDRWY 263

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 12/234 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      EI
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREI 113
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
           +  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N+  GT  +MAP
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 173
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L      
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSK 230
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
            LK   F+   L+K+PS R    P   + +KH    R+   KT    E+  ++K
Sbjct: 231 PLK--EFVEACLNKEPSFR----PTAKELLKHKFILRNAK-KTSYLTELIDRYK 277

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 135/281 (48%), Gaps = 27/281 (9%)
Query: 105 RKIGPGD-FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P + +EI   +G GAF                  + A KV+  +T  ++   DY+ 
Sbjct: 13  RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVI--ETKSEEELEDYI- 64
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARFY 220
            E +IL    HP+IV+L  ++    KL+++++F  GG    +   L R     E Q +  
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVV 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTE 279
             +++ A++ LH   I+HRDLK  N+LM  +G + L DFG+ AK +    + +S  GT  
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182
Query: 280 YMAPEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
           +MAPE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I       P
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---P 239
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           P L + +   ++   FL   L K+P  R    P     ++H
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETR----PSAAQLLEH 276

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 135/281 (48%), Gaps = 27/281 (9%)
Query: 105 RKIGPGD-FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P + +EI   +G GAF                  + A KV+  +T  ++   DY+ 
Sbjct: 5   RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVI--ETKSEEELEDYI- 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARFY 220
            E +IL    HP+IV+L  ++    KL+++++F  GG    +   L R     E Q +  
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVV 114
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL-AKEIDESSRSNSMCGTTE 279
             +++ A++ LH   I+HRDLK  N+LM  +G + L DFG+ AK +    + +S  GT  
Sbjct: 115 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 174
Query: 280 YMAPEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
           +MAPE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I       P
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---P 231
Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           P L + +   ++   FL   L K+P  R    P     ++H
Sbjct: 232 PTLLTPSKWSVEFRDFLKIALDKNPETR----PSAAQLLEH 268

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 12/234 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      EI
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREI 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
           +  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N   GT  +MAP
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 188
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L      
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSK 245
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
            LK   F+   L+K+PS R    P   + +KH    R+   KT    E+  ++K
Sbjct: 246 PLK--EFVEACLNKEPSFR----PTAKELLKHKFILRNAK-KTSYLTELIDRYK 292

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 240 ----ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 240 ----ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 12/234 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      EI
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREI 113
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAP 283
           +  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N   GT  +MAP
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 173
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L      
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSK 230
Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
            LK   F+   L+K+PS R    P   + +KH    R+   KT    E+  ++K
Sbjct: 231 PLK--EFVEACLNKEPSFR----PTAKELLKHKFILRNAK-KTSYLTELIDRYK 277

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 138/312 (44%), Gaps = 58/312 (18%)
Query: 109 PGDFEIF-----RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           PG FE        ++G+GA+                   YA+K++ K     ++ V   +
Sbjct: 7   PGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKE-----YAVKIIEKQAGHSRSRV--FR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
               +     +  I++L   F+  ++ YL+ + + GG +  H+ +Q  F E +A     +
Sbjct: 60  EVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRD 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSM------ 274
           + +A+  LH  GI HRDLKPENIL +S      V + DF L   +  ++    +      
Sbjct: 120 VAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 275 --CGTTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQPPFT------------ 315
             CG+ EYMAPE++      +  ++K  D WS+G++LY ML+G PPF             
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRG 239
Query: 316 ---HANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPG 368
                 + KL + I   K + P      ++SEA  L      +++LL +D  +RL +   
Sbjct: 240 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDL------ISKLLVRDAKQRLSAA-- 291
Query: 369 GVDAIKHHKWFR 380
               +  H W +
Sbjct: 292 ---QVLQHPWVQ 300

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 117/224 (52%), Gaps = 16/224 (7%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           +K E  I   + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGT 277
             ++++ V +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT
Sbjct: 111 H-QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 278 TEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPP 335
             Y+APE+L  +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 229
Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
           +   ++  L    + L ++L ++PS R+      +  IK  +W+
Sbjct: 230 WKKIDSAPL----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 5/205 (2%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           ++ E   ++ + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             ++   + H+H+   VH DLKPENI+  +     + L DFGL   +D         GT 
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 320
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           E+ APE+   K      D WSVG+L Y +L+G  PF   N  +  + + +    +     
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRL 363
           S       G  F+ +LL  DP+ R+
Sbjct: 381 SGISE--DGKDFIRKLLLADPNTRM 403

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 98  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 157
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 158 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 217
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 218 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 275
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 276 LKTEPTQRM-----TITEFMNHPWI 295

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 90  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 149
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 150 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 209
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 210 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 267
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 268 LKTEPTQRM-----TITEFMNHPWI 287

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 202 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 259
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 260 LKTEPTQRM-----TITEFMNHPWI 279

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 89  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 148
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 149 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 208
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 209 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 266
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 267 LKTEPTQRM-----TITEFMNHPWI 286

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 88  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 147
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 148 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 207
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 208 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 265
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 266 LKTEPTQRM-----TITEFMNHPWI 285

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 83  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 142
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 143 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 202
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 203 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 260
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 261 LKTEPTQRM-----TITEFMNHPWI 280

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 204 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 261
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 262 LKTEPTQRM-----TITEFMNHPWI 281

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 204 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 261
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 262 LKTEPTQRM-----TITEFMNHPWI 281

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 5/205 (2%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           ++ E   ++ + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y
Sbjct: 95  VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 154
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             ++   + H+H+   VH DLKPENI+  +     + L DFGL   +D         GT 
Sbjct: 155 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 214
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           E+ APE+   K      D WSVG+L Y +L+G  PF   N  +  + + +    +     
Sbjct: 215 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 274
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRL 363
           S       G  F+ +LL  DP+ R+
Sbjct: 275 SGISE--DGKDFIRKLLLADPNTRM 297

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 247
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 305
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 306 LKTEPTQRM-----TITEFMNHPWI 325

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 134 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 193
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 194 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 253
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 254 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 311
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 312 LKTEPTQRM-----TITEFMNHPWI 331

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +     C T  Y+APE+L  + ++K  D W
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 202 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 259
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWF 379
           L  +P++R+      +    +H W 
Sbjct: 260 LKTEPTQRM-----TITEFMNHPWI 279

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 126/232 (54%), Gaps = 20/232 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NIL+ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVV 158
Query: 258 DFGLAKEIDESSRS----NSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S  S     ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVXQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL-LKGVSFLTQLLHKDPSKR 362
           PPFT  +   +  + + E   +PP    E  S  L  V  + + L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAV--VLKALAKNPENR 265

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 128/232 (55%), Gaps = 20/232 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL-LKGVSFLTQLLHKDPSKR 362
           PPFT  +   +  + + E   +PP    E  S  L  V  + + L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAV--VLKALAKNPENR 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 128/232 (55%), Gaps = 20/232 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL-LKGVSFLTQLLHKDPSKR 362
           PPFT  +   +  + + E   +PP    E  S  L  V  + + L K+P  R
Sbjct: 217 PPFTGDSPDSVAYQHVRED-PIPPSARHEGLSADLDAV--VLKALAKNPENR 265

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 128/232 (55%), Gaps = 20/232 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL-LKGVSFLTQLLHKDPSKR 362
           PPFT  +   +  + + E   +PP    E  S  L  V  + + L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAV--VLKALAKNPENR 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 128/232 (55%), Gaps = 20/232 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 312 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL-LKGVSFLTQLLHKDPSKR 362
           PPFT  +   +  + + E   +PP    E  S  L  V  + + L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAV--VLKALAKNPENR 265

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/183 (34%), Positives = 97/183 (53%), Gaps = 12/183 (6%)
Query: 190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           L +I++ + GG LF  +  +G   F E +A     +I +A+  LH   I HRD+KPEN+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 248 MDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILL 304
             S   D  + LTDFG AKE  +++     C T  Y+APE+L  + ++K  D WS+G+++
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 305 YEMLTGQPPFTHANRQK----LQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           Y +L G PPF     Q     +++RI   +   P    SE     K    +  LL  DP+
Sbjct: 220 YILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK--QLIRLLLKTDPT 277
Query: 361 KRL 363
           +RL
Sbjct: 278 ERL 280

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 240 ----ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 12/218 (5%)
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH 232
           P ++ L   ++  S++ LIL++  GG +F     +   +  E+       +I+  V +LH
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 233 KCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           +  IVH DLKP+NIL+ S    G + + DFG++++I  +     + GT EY+APEIL   
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS 349
                 D W++GI+ Y +LT   PF   + Q+    I    V       S    L     
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL--ATD 266
Query: 350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 387
           F+  LL K+P KR    P   +    H W +  +++ L
Sbjct: 267 FIQSLLVKNPEKR----PTA-EICLSHSWLQQWDFENL 299

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/183 (34%), Positives = 97/183 (53%), Gaps = 12/183 (6%)
Query: 190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           L +I++ + GG LF  +  +G   F E +A     +I +A+  LH   I HRD+KPEN+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 248 MDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILL 304
             S   D  + LTDFG AKE  +++     C T  Y+APE+L  + ++K  D WS+G+++
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 305 YEMLTGQPPFTHANRQK----LQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           Y +L G PPF     Q     +++RI   +   P    SE     K    +  LL  DP+
Sbjct: 201 YILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK--QLIRLLLKTDPT 258
Query: 361 KRL 363
           +RL
Sbjct: 259 ERL 261

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 5/205 (2%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFY 220
           +K E  I+ ++ HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 154
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTT 278
             +    + H+H+  IVH D+KPENI+ ++     V + DFGLA +++          T 
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 214
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           E+ APEI+  +      D W++G+L Y +L+G  PF   +  +  Q +     +      
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 274
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRL 363
           S      K   F+  LL K+P KRL
Sbjct: 275 SSVSPEAK--DFIKNLLQKEPRKRL 297

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 121/235 (51%), Gaps = 12/235 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A K+++   +  K  V   K E  ++ ++ H  ++QL  +F++++ + L++++++GG LF
Sbjct: 118 AAKIIKTRGMKDKEEV---KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 204 FHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDG-HVMLTDFG 260
             +  +     E     +  +I   + H+H+  I+H DLKPENIL ++ D   + + DFG
Sbjct: 175 DRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG 234
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           LA+      +     GT E++APE++     +   D WSVG++ Y +L+G  PF   N  
Sbjct: 235 LARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           +    I+  +  L      +     K   F+++LL K+ S R+ +     +A+KH
Sbjct: 295 ETLNNILACRWDLEDEEFQDISEEAK--EFISKLLIKEKSWRISAS----EALKH 343

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 128/232 (55%), Gaps = 20/232 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 58  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 115
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT 257
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +   V + 
Sbjct: 116 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 175
Query: 258 DFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 311
           DFG+A+ I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 176 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 233
Query: 312 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL-LKGVSFLTQLLHKDPSKR 362
           PPFT  +   +  + + E   +PP    E  S  L  V  + + L K+P  R
Sbjct: 234 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAV--VLKALAKNPENR 282

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 138/306 (45%), Gaps = 36/306 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I   D+E+  V+G GA                      + + R +    +  +D +  E 
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEK-------VAIKRINLEKCQTSMDELLKEI 64
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--------YRQGIFREDQAR 218
             +++  HP IV    SF  + +L+L++  ++GG +   +        ++ G+  E    
Sbjct: 65  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK------EIDESSRSN 272
               E++  + +LHK G +HRD+K  NIL+  DG V + DFG++       +I  +    
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 273 SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
           +  GT  +MAPE++   +G++  AD WS GI   E+ TG  P+      K+    +    
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243
Query: 332 KLPPFLTS--EAHSLLK--GVSF---LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
             PP L +  +   +LK  G SF   ++  L KDP KR    P   + ++H  + ++ N 
Sbjct: 244 --PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR----PTAAELLRHKFFQKAKNK 297
Query: 385 KTLEAR 390
           + L+ +
Sbjct: 298 EFLQEK 303

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 23/275 (8%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL 344
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+   ++  L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
               + L ++L ++PS R+      +  IK  +W+
Sbjct: 239 ----ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 38/223 (17%)
Query: 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
           + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  GI HRDLKPENIL 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 249 DSDGH---VMLTDFGLAKEIDESSRSNSM--------CGTTEYMAPEILLSKG-----HN 292
           +       V + DFGL   I  +   + +        CG+ EYMAPE++ +       ++
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 293 KDADWWSVGILLYEMLTGQPPFTH---------------ANRQKLQQRIINEKVKLPPFL 337
           K  D WS+G++LY +L+G PPF                 A +  L + I   K + P   
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD-- 262
Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
              AH        +++LL +D  +RL +       +  H W +
Sbjct: 263 KDWAHISCAAKDLISKLLVRDAKQRLSAA-----QVLQHPWVQ 300

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 50/136 (36%), Positives = 76/136 (55%), Gaps = 5/136 (3%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++ + ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 128 YAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDV 187
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE    +   + C T  Y+APE+L  + ++K  D W
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXW 247
Query: 299 SVGILLYEMLTGQPPF 314
           S+G++ Y +L G PPF
Sbjct: 248 SLGVIXYILLCGYPPF 263

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 37/296 (12%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I   D+E+  V+G GA                      + + R +    +  +D +  E 
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEK-------VAIKRINLEKCQTSMDELLKEI 59
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--------YRQGIFREDQAR 218
             +++  HP IV    SF  + +L+L++  ++GG +   +        ++ G+  E    
Sbjct: 60  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 119
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK------EIDESSRSN 272
               E++  + +LHK G +HRD+K  NIL+  DG V + DFG++       +I  +    
Sbjct: 120 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 179
Query: 273 SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
           +  GT  +MAPE++   +G++  AD WS GI   E+ TG  P+      K+    +    
Sbjct: 180 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 238
Query: 332 KLPPFLTS--EAHSLLK--GVSF---LTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
             PP L +  +   +LK  G SF   ++  L KDP KR    P   + ++ HK+F+
Sbjct: 239 --PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR----PTAAELLR-HKFFQ 287

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 11/214 (5%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P+I +   S+   +KL++I++++ GG     L + G   E        
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILR 123
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYM 281
           EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ D   + N   GT  +M
Sbjct: 124 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWM 183
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           APE++    ++  AD WS+GI   E+  G+PP +  +  ++   I       PP L  + 
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQH 240
Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
               K   F+   L+KDP  R    P   + +KH
Sbjct: 241 SKPFK--EFVEACLNKDPRFR----PTAKELLKH 268

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 106/190 (55%), Gaps = 14/190 (7%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
            R  T ++  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S 
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           + +  GT  YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K
Sbjct: 173 AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 331 VKLPPFLTSE 340
            +  P+  S+
Sbjct: 233 FRRIPYRYSD 242

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 106/190 (55%), Gaps = 14/190 (7%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
            R  T ++  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S 
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           + +  GT  YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 331 VKLPPFLTSE 340
            +  P+  S+
Sbjct: 233 FRRIPYRYSD 242

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 38/223 (17%)
Query: 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
           + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  GI HRDLKPENIL 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 249 DSDGH---VMLTDFGLAKEIDESSRSNSM--------CGTTEYMAPEILLSKG-----HN 292
           +       V + DF L   I  +   + +        CG+ EYMAPE++ +       ++
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 293 KDADWWSVGILLYEMLTGQPPFTH---------------ANRQKLQQRIINEKVKLPPFL 337
           K  D WS+G++LY +L+G PPF                 A +  L + I   K + P   
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD-- 262
Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
              AH        +++LL +D  +RL +       +  H W +
Sbjct: 263 KDWAHISCAAKDLISKLLVRDAKQRLSAA-----QVLQHPWVQ 300

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 8/200 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMA 282
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ + IDE   +N   GT  YM+
Sbjct: 117 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE--MANEFVGTRSYMS 174
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE L    ++  +D WS+G+ L EM  G+ P       +L   I+NE    PP L S   
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEP---PPKLPSAVF 231
Query: 343 SLLKGVSFLTQLLHKDPSKR 362
           S L+   F+ + L K+P++R
Sbjct: 232 S-LEFQDFVNKCLIKNPAER 250

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 84/153 (54%), Gaps = 2/153 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+ +   P +V+   S+   + L++++++   G +   +  R     ED+       
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMA 282
            +  + +LH    +HRD+K  NIL++++GH  L DFG+A ++ D  ++ N + GT  +MA
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           PE++   G+N  AD WS+GI   EM  G+PP+ 
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 109/203 (53%), Gaps = 10/203 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 191
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQRIINEKVKLPPFLTS 339
           E L    ++  +D WS+G+ L EM  G+ P    +      +L   I+NE    PP L S
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEP---PPKLPS 248
Query: 340 EAHSLLKGVSFLTQLLHKDPSKR 362
              S L+   F+ + L K+P++R
Sbjct: 249 GVFS-LEFQDFVNKCLIKNPAER 270

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 45/286 (15%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVMLLA 57
Query: 171 KVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RED 215
            + H ++V+       R +F       + +S L++ +++   G L+  ++ + +   R++
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------- 268
             R +  +I+ A+S++H  GI+HRDLKP NI +D   +V + DFGLAK +  S       
Sbjct: 118 YWRLFR-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 269 ------SRSN--SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANR 319
                 S  N  S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+   P  T   R
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMER 234
Query: 320 QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
             + +++ +  ++ PP        + K +  L  L+  DP+KR G+
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL--LIDHDPNKRPGA 278

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 110/209 (52%), Gaps = 16/209 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----------KLQQRIINEKVKL 333
           E L    ++  +D WS+G+ L EM  G+ P    + +          +L   I+NE    
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEP--- 229
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           PP L S   S L+   F+ + L K+P++R
Sbjct: 230 PPKLPSGVFS-LEFQDFVNKCLIKNPAER 257

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+ +     LF  +  +G  +E+ AR +  ++
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQV 123
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 182
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 236
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 237 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 265

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 103/190 (54%), Gaps = 14/190 (7%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSR 270
            R  T ++  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ +   
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF 172
Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           +    GT  YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K
Sbjct: 173 AKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 331 VKLPPFLTSE 340
            +  P+  S+
Sbjct: 233 FRRIPYRYSD 242

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQAR--FYTAEIVSAV 228
           + H  IVQ   SF     + + ++ + GG L   L  + G  ++++    FYT +I+  +
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 229 SHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDE-SSRSNSMCGTTEYMAPEIL 286
            +LH   IVHRD+K +N+L+++  G + ++DFG +K +   +  + +  GT +YMAPEI+
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195
Query: 287 LS--KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKV--KLPPFLTSEA 341
               +G+ K AD WS+G  + EM TG+PPF      Q    ++   KV  ++P  +++EA
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255
Query: 342 HSLLKGVSFLTQLLHKDPSKR 362
                  +F+ +    DP KR
Sbjct: 256 K------AFILKCFEPDPDKR 270

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 21/275 (7%)
Query: 91  LEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRK 150
           +E E  A  E E  +K     +     +G GAF                      + + +
Sbjct: 10  VELEGLAACEGEYSQK-----YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQ 209
           D  I+   +  +  E  IL++V H  I+++   F+ +    L+++    G  LF  + R 
Sbjct: 65  DCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH 124
Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
               E  A +   ++VSAV +L    I+HRD+K ENI++  D  + L DFG A  ++   
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 270 RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
              + CGT EY APE+L+   +   + + WS+G+ LY ++  + PF      +L++ +  
Sbjct: 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC-----ELEETV-- 237
Query: 329 EKVKLPPFLTS-EAHSLLKGVSFLTQLLHKDPSKR 362
           E    PP+L S E  SL+ G      LL   P +R
Sbjct: 238 EAAIHPPYLVSKELMSLVSG------LLQPVPERR 266

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQAR--FYTAEIVSAV 228
           + H  IVQ   SF     + + ++ + GG L   L  + G  ++++    FYT +I+  +
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 229 SHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDE-SSRSNSMCGTTEYMAPEIL 286
            +LH   IVHRD+K +N+L+++  G + ++DFG +K +   +  + +  GT +YMAPEI+
Sbjct: 122 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 181
Query: 287 LS--KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKV--KLPPFLTSEA 341
               +G+ K AD WS+G  + EM TG+PPF      Q    ++   KV  ++P  +++EA
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 241
Query: 342 HSLLKGVSFLTQLLHKDPSKR 362
                  +F+ +    DP KR
Sbjct: 242 K------AFILKCFEPDPDKR 256

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHL--FFHLYRQGI-FRED 215
           E  I+ K+ HP +V  R       KL       L +++  GG L  + + +      +E 
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML---TDFGLAKEIDESSRSN 272
             R   ++I SA+ +LH+  I+HRDLKPENI++      ++    D G AKE+D+     
Sbjct: 123 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 182
Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
              GT +Y+APE+L  K +    D+WS G L +E +TG  PF
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHL--FFHLYRQGI-FRED 215
           E  I+ K+ HP +V  R       KL       L +++  GG L  + + +      +E 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML---TDFGLAKEIDESSRSN 272
             R   ++I SA+ +LH+  I+HRDLKPENI++      ++    D G AKE+D+     
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
              GT +Y+APE+L  K +    D+WS G L +E +TG  PF
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 85/152 (55%), Gaps = 2/152 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L ++ HP IV L     +   L L+ +F+           +   ++ Q + Y  ++
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           +  V+H H+  I+HRDLKP+N+L++SDG + L DFGLA+      RS +    T  Y AP
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           ++L+ SK ++   D WS+G +  EM+TG+P F
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 85/152 (55%), Gaps = 2/152 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L ++ HP IV L     +   L L+ +F+           +   ++ Q + Y  ++
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           +  V+H H+  I+HRDLKP+N+L++SDG + L DFGLA+      RS +    T  Y AP
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           ++L+ SK ++   D WS+G +  EM+TG+P F
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 8/184 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  +AE  +    +T P IV L  + +    + + ++ + GG L   +  QG  
Sbjct: 123 VKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCL 182
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG H  L DFG A  +      
Sbjct: 183 PEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 242
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            S+       GT  +MAPE++L +  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302
Query: 326 IINE 329
           I +E
Sbjct: 303 IASE 306

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +                  + A+KVM     +  +  + +K E ++L
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQ-----LAAIKVMD----VTGDEEEEIKQEINML 74
Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  ++      +L+L+++F   G +       +    +E+   + 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  +SHLH+  ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 280 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPF 314
           +MAPE++     N DA      D WS+GI   EM  G PP 
Sbjct: 195 WMAPEVIACD-ENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 225
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 279
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 280 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 308

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 197
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 251
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 252 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 280

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 211
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 265
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 266 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 294

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 183
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 237
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 238 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 266

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 264
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 265 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 293

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 211
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 265
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 266 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 294

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 264
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 265 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 293

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 264
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 265 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 293

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 198
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 252
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 253 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 281

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 183
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 237
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 238 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 266

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 225
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 279
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 280 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 308

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 11/228 (4%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           + A+K MR+    ++N    M  +  +L     P+IVQ   +F T + +++ ++ +    
Sbjct: 52  VIAVKQMRRSGNKEENKRILMDLDV-VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA 110
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFG 260
                  QG   E      T  IV A+ +L  K G++HRD+KP NIL+D  G + L DFG
Sbjct: 111 EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG 170
Query: 261 LAKEIDESSRSNSMCGTTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQPPFT 315
           ++  + +    +   G   YMAPE +         ++  AD WS+GI L E+ TGQ P+ 
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
Query: 316 HANRQ-KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +     ++  +++ E+   PP L           SF+   L KD  KR
Sbjct: 231 NCKTDFEVLTKVLQEE---PPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 183
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 237
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 238 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 266

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 123
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 182
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 236
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 237 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 265

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 217
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 271
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 272 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 300

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 178
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQ 232
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 233 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 261

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 63  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 122
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 123 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 181
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 182 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 235
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 236 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 264

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 178
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE  
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQ 232
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 233 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 261

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 23/229 (10%)
Query: 162 MKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDF-INGGHLFFHLYRQGIFREDQAR 218
           +K E  +L ++ H  ++QL      + + K+Y+++++ + G         +  F   QA 
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-----DESSRSNS 273
            Y  +++  + +LH  GIVH+D+KP N+L+ + G + ++  G+A+ +     D++ R++ 
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 274 MCGTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
             G+  +  PEI   L        D WS G+ LY + TG  PF   N  KL + I     
Sbjct: 173 --GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230
Query: 332 KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            +P         LLKG      +L  +P+KR       +  I+ H WFR
Sbjct: 231 AIPGDCGPPLSDLLKG------MLEYEPAKRF-----SIRQIRQHSWFR 268

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 51/241 (21%)
Query: 142 IYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           I A+K+M K+ I  I    V+ +K E  ++ K+ HP I +L   ++    + L+++  +G
Sbjct: 53  IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112
Query: 200 GHLF-------------------------------------FHLYRQG---IFREDQARF 219
           GHL                                       H +R+    + RE     
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--HVMLTDFGLAKEI-----DESSRSN 272
              +I SA+ +LH  GI HRD+KPEN L  ++    + L DFGL+KE       E     
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 273 SMCGTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           +  GT  ++APE+L   ++ +    D WS G+LL+ +L G  PF   N      +++N+K
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292
Query: 331 V 331
           +
Sbjct: 293 L 293

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 45/287 (15%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVMLL 56
Query: 170 TKVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RE 214
             + H ++V+       R +F       + +S L++ +++     L+  ++ + +   R+
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD 116
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------ 268
           +  R +  +I+ A+S++H  GI+HRDLKP NI +D   +V + DFGLAK +  S      
Sbjct: 117 EYWRLFR-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 269 -------SRSN--SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHAN 318
                  S  N  S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+   P  T   
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
           R  + +++ +  ++ PP        + K +  L  L+  DP+KR G+
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL--LIDHDPNKRPGA 278

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 197
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 251
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 252 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 280

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 8/184 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  +AE  +    +T P IV L  + +    + + ++ + GG L   +  QG  
Sbjct: 104 VKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCL 163
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG H  L DFG A  +      
Sbjct: 164 PEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 223
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
             +       GT  +MAPE++L +  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283
Query: 326 IINE 329
           I +E
Sbjct: 284 IASE 287

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 211
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSXECQ 265
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 266 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 294

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 198
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 252
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 253 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 281

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 211
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSXECQ 265
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 266 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 294

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 210
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSXECQ 264
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 265 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 293

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 225
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 279
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 280 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 308

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 234
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 274

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 112 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 171
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 172 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 230
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 284
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 285 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 313

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 87  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 146
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 147 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 205
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 206 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 259
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 260 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 288

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 97/184 (52%), Gaps = 12/184 (6%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H CG++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 198
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 252
Query: 343 SLLK 346
            L++
Sbjct: 253 HLIR 256

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 199
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 96/187 (51%), Gaps = 13/187 (6%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           ++ ++ E  +   + HP I+ LR        L L+++F  GG L   L  + I   D   
Sbjct: 50  IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILV 108
Query: 219 FYTAEIVSAVSHLHKCGIV---HRDLKPENILMD--------SDGHVMLTDFGLAKEIDE 267
            +  +I   +++LH   IV   HRDLK  NIL+         S+  + +TDFGLA+E   
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           +++  S  G   +MAPE++ +   +K +D WS G+LL+E+LTG+ PF   +   +   + 
Sbjct: 169 TTKM-SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 227
Query: 328 NEKVKLP 334
             K+ LP
Sbjct: 228 MNKLALP 234

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 90/160 (56%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+P
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 172
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 134/286 (46%), Gaps = 45/286 (15%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVXLLA 57
Query: 171 KVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RED 215
            + H ++V+       R +F       + +S L++  ++     L+  ++ + +   R++
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES------- 268
             R +  +I+ A+S++H  GI+HR+LKP NI +D   +V + DFGLAK +  S       
Sbjct: 118 YWRLFR-QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 269 ------SRSN--SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANR 319
                 S  N  S  GT  Y+A E+L   GH N+  D +S+GI+ +E +   P  T   R
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI--YPFSTGXER 234
Query: 320 QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
             + +++ +  ++ PP        + K +  L  L+  DP+KR G+
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKXKVEKKIIRL--LIDHDPNKRPGA 278

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 18/232 (7%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R  + + +     +  + D++ + +  P+IVQ   +       ++ ++ ++     
Sbjct: 50  MAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDK 109
Query: 204 FHLYRQGIFR----EDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTD 258
           F+ Y   +      E+     T   V A++HL +   I+HRD+KP NIL+D  G++ L D
Sbjct: 110 FYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCD 169
Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPF 314
           FG++ ++ +S       G   YMAPE +      +G++  +D WS+GI LYE+ TG+ P+
Sbjct: 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229
Query: 315 THANR--QKLQQRIINEKVKLPPFLTSEAHSLLKG--VSFLTQLLHKDPSKR 362
              N    +L Q +  +    PP L++          ++F+   L KD SKR
Sbjct: 230 PKWNSVFDQLTQVVKGD----PPQLSNSEEREFSPSFINFVNLCLTKDESKR 277

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 16/192 (8%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP +++L   F+T+    L+L+  +    LF ++  +G   E  +R +  ++V+A+ H H
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 233 KCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE-ILLSKG 290
             G+VHRD+K ENIL+D   G   L DFG    + +   ++   GT  Y  PE I   + 
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISRHQY 215
Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           H   A  WS+GILLY+M+ G  PF         Q I+  ++  P  ++ +  +L++    
Sbjct: 216 HALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSPDCCALIR---- 265
Query: 351 LTQLLHKDPSKR 362
             + L   PS R
Sbjct: 266 --RCLAPKPSSR 275

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG+++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG+++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 125/262 (47%), Gaps = 50/262 (19%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGL
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 262 AKEIDESSRSNS-----MCGTTEYM------APEILL-SKGHNKDADWWSVGILLYEMLT 309
           A+ IDES+  NS       G TEY+      APE++L S  +++  D WS G +L E+  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 310 GQP--------------------PFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLL--- 345
            +P                    P +  + + ++     E +K LP +  +    +    
Sbjct: 219 RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV 278
Query: 346 --KGVSFLTQLLHKDPSKRLGS 365
             KG+  L ++L  DP+KR+ +
Sbjct: 279 NPKGIDLLQRMLVFDPAKRITA 300

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 134/305 (43%), Gaps = 40/305 (13%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+      T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------------- 327
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI               
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 328 ----NEKVKLPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
               + K   P +   +   ++      G S L+Q+LH DP+KR+ +      A   H +
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHPF 289
Query: 379 FRSIN 383
           F+ + 
Sbjct: 290 FQDVT 294

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 101/191 (52%), Gaps = 21/191 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL---RYSFQTRSKLYLILDFIN 198
           ++A+KV    + ++   VD    E ++L K+ H  IV+L        TR K+ LI++F  
Sbjct: 36  LFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCP 92
Query: 199 GGHLFFHLYR-QGIFREDQARFYTA--EIVSAVSHLHKCGIVHRDLKPENIL--MDSDGH 253
            G L+  L      +   ++ F     ++V  ++HL + GIVHR++KP NI+  +  DG 
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152
Query: 254 VM--LTDFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKD----ADWWSVGIL 303
            +  LTDFG A+E+++  +  S+ GT EY+ P++    +L K H K      D WS+G+ 
Sbjct: 153 SVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 304 LYEMLTGQPPF 314
            Y   TG  PF
Sbjct: 213 FYHAATGSLPF 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +   RDIL   T           +    +Y++ D +     
Sbjct: 84  YCQRTLREIQILLRFRHENVIGIRDILRAST----------LEAMRDVYIVQDLMETD-- 131
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 132 LYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLA 191
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    E D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 192 RIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 35/287 (12%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+      T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 283 PEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------------- 327
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI               
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 328 ----NEKVKLPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGS 365
               + K   P +   +   ++      G S L+Q+LH DP+KR+ +
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 95/193 (49%), Gaps = 25/193 (12%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKA----ERDILTKVTHPFIVQLRYSFQTRSK------LY 191
           +Y  K+     ++    V   KA    E  I+ K+ H  IV+LRY F +  +      L 
Sbjct: 36  VYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95
Query: 192 LILDFINGGHLFFHLYRQG--IFREDQ------ARFYTAEIVSAVSHLHKCGIVHRDLKP 243
           L+LD++        +YR      R  Q       + Y  ++  +++++H  GI HRD+KP
Sbjct: 96  LVLDYVPAT-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 150
Query: 244 ENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVG 301
           +N+L+D D  V+ L DFG AK++     + S   +  Y APE++  +  +    D WS G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 302 ILLYEMLTGQPPF 314
            +L E+L GQP F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 118/250 (47%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  +S  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 271 HYDPNKRISA 280

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 34/263 (12%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK----AER 166
           + E+  VVG+GAF                  +   K   KD  IK+   +  +     E 
Sbjct: 10  EIEVEEVVGRGAFGV----------------VCKAKWRAKDVAIKQIESESERKAFIVEL 53
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAE 223
             L++V HP IV+L  +    + + L++++  GG L+  L+       +    A  +  +
Sbjct: 54  RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 111
Query: 224 IVSAVSHLHKC---GIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTE 279
               V++LH      ++HRDLKP N+L+ + G V+ + DFG A +I     +N   G+  
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAA 169
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           +MAPE+     +++  D +S GI+L+E++T + PF        +          PP + +
Sbjct: 170 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 229
Query: 340 EAHSLLKGVSFLTQLLHKDPSKR 362
               +    S +T+   KDPS+R
Sbjct: 230 LPKPI---ESLMTRCWSKDPSQR 249

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 32/268 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 92  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 151
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 356 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 383
           H DP+KR+ +      A   H +F+ + 
Sbjct: 272 HYDPNKRISA-----KAALAHPFFQDVT 294

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 50/262 (19%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGL
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 262 AKEIDESSRSNS-----MCGTTE------YMAPEILL-SKGHNKDADWWSVGILLYEMLT 309
           A+ IDES+  NS       G TE      Y APE++L S  +++  D WS G +L E+  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 310 GQP--------------------PFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLL--- 345
            +P                    P +  + + ++     E +K LP +  +    +    
Sbjct: 219 RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV 278
Query: 346 --KGVSFLTQLLHKDPSKRLGS 365
             KG+  L ++L  DP+KR+ +
Sbjct: 279 NPKGIDLLQRMLVFDPAKRITA 300

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 155
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 156 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 215
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 216 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 153
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 153
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 214 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 157
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 158 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 217
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 218 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 198
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 199 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 258
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 259 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + AV H H  G++HRD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  P
Sbjct: 120 LEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPP 178
Query: 284 E-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E  
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQ 232
Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
            L++    L       PS R        + I++H W + +
Sbjct: 233 HLIRWCLALR------PSDR-----PTFEEIQNHPWMQDV 261

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 124/268 (46%), Gaps = 32/268 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 37  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 95
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 96  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 216 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 275
Query: 356 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 383
           H DP+KR+ +      A   H +F+ + 
Sbjct: 276 HYDPNKRISA-----KAALAHPFFQDVT 298

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I+A +  R+  ++K    + +    D+ T  T         S +  S++YL+   +  G 
Sbjct: 69  IHARRTYRELRLLKHLKHENVIGLLDVFTPAT---------SIEDFSEVYLVTTLM--GA 117
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
              ++ +     ++  +F   +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGL
Sbjct: 118 DLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGL 177
Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A++ DE         T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F  ++  
Sbjct: 178 ARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 235
Query: 321 KLQQRIIN 328
              +RI+ 
Sbjct: 236 DQLKRIME 243

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 34/263 (12%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK----AER 166
           + E+  VVG+GAF                  +   K   KD  IK+   +  +     E 
Sbjct: 9   EIEVEEVVGRGAFGV----------------VCKAKWRAKDVAIKQIESESERKAFIVEL 52
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAE 223
             L++V HP IV+L  +    + + L++++  GG L+  L+       +    A  +  +
Sbjct: 53  RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 224 IVSAVSHLHKC---GIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTE 279
               V++LH      ++HRDLKP N+L+ + G V+ + DFG A +I     +N   G+  
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAA 168
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           +MAPE+     +++  D +S GI+L+E++T + PF        +          PP + +
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 228
Query: 340 EAHSLLKGVSFLTQLLHKDPSKR 362
               +    S +T+   KDPS+R
Sbjct: 229 LPKPI---ESLMTRCWSKDPSQR 248

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 147
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 148 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 207
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 208 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 124/268 (46%), Gaps = 32/268 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 37  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 95
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 96  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 216 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 275
Query: 356 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 383
           H DP+KR+ +      A   H +F+ + 
Sbjct: 276 HYDPNKRISA-----KAALAHPFFQDVT 298

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 127
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 128 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 187
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 188 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 131
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 191
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 34  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 92
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 93  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 152
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 153 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 213 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 272
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 273 HYDPNKRISA 282

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G + L DFG
Sbjct: 89  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 131
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 191
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 138
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 139 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 198
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 199 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 89/160 (55%), Gaps = 2/160 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L       E+     +  +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  +++L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YMAP
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAP 182
Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           E L    ++  +D WS+G+ L E+  G+ P    + ++L+
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELE 222

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 122/262 (46%), Gaps = 50/262 (19%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGL
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 262 AKEIDESSRSNS-----------MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLT 309
           A+ IDES+  NS              T  Y APE++L S  +++  D WS G +L E+  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 310 GQP--------------------PFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLL--- 345
            +P                    P +  + + ++     E +K LP +  +    +    
Sbjct: 219 RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV 278
Query: 346 --KGVSFLTQLLHKDPSKRLGS 365
             KG+  L ++L  DP+KR+ +
Sbjct: 279 NPKGIDLLQRMLVFDPAKRITA 300

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 132
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 133 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 192
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 193 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 124
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 125 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 184
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 185 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 21/191 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKA----ERDILTKVTHPFIVQLRYSFQTRSK------LY 191
           +Y  K+     ++    V   KA    E  I+ K+ H  IV+LRY F +  +      L 
Sbjct: 36  VYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95
Query: 192 LILDFINGGHLFFHLYRQGIFREDQ------ARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245
           L+LD++      + + R    R  Q       + Y  ++  +++++H  GI HRD+KP+N
Sbjct: 96  LVLDYV--PETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152
Query: 246 ILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGIL 303
           +L+D D  V+ L DFG AK++     + S   +  Y APE++  +  +    D WS G +
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 212
Query: 304 LYEMLTGQPPF 314
           L E+L GQP F
Sbjct: 213 LAELLLGQPIF 223

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 123
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 124 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 183
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 184 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 120
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 121 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 180
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 181 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRS 271
                + Y  ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 272 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 21/191 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL---RYSFQTRSKLYLILDFIN 198
           ++A+KV    + ++   VD    E ++L K+ H  IV+L        TR K+ LI++F  
Sbjct: 36  LFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCP 92
Query: 199 GGHLFFHLYR-QGIFREDQARFYTA--EIVSAVSHLHKCGIVHRDLKPENIL--MDSDGH 253
            G L+  L      +   ++ F     ++V  ++HL + GIVHR++KP NI+  +  DG 
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152
Query: 254 VM--LTDFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKD----ADWWSVGIL 303
            +  LTDFG A+E+++  +   + GT EY+ P++    +L K H K      D WS+G+ 
Sbjct: 153 SVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 304 LYEMLTGQPPF 314
            Y   TG  PF
Sbjct: 213 FYHAATGSLPF 223

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I+A +  R+  ++K    + +    D+ T  T         S +  S++YL+   +  G 
Sbjct: 69  IHARRTYRELRLLKHLKHENVIGLLDVFTPAT---------SIEDFSEVYLVTTLM--GA 117
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
              ++ +     ++  +F   +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGL
Sbjct: 118 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGL 177
Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A++ DE         T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F  ++  
Sbjct: 178 ARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 235
Query: 321 KLQQRIIN 328
              +RI+ 
Sbjct: 236 DQLKRIME 243

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 48  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 271 HYDPNKRISA 280

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 92  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 151
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 272 HYDPNKRISA 281

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 271 HYDPNKRISA 280

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 34  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 92
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 93  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 152
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 153 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 213 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 272
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 273 HYDPNKRISA 282

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 49  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 108
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 109 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 165
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 166 TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 123/268 (45%), Gaps = 32/268 (11%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 92  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 151
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 356 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 383
           H DP+KR+ +      A   H +F+ + 
Sbjct: 272 HYDPNKRISA-----KAALAHPFFQDVT 294

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           ++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R  +    T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--------------IN 328
           ++L+ SK ++   D WSVG +  EM+ G P F   +      RI              + 
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 329 EKVKLPPFLTSEA----HSLLK-----GVSFLTQLLHKDPSKRLGS 365
           E  K  P  T        S LK     G+  L+++L  DP++R+ +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           ++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R  +    T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--------------IN 328
           ++L+ SK ++   D WSVG +  EM+ G P F   +      RI              + 
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 329 EKVKLPPFLTSEA----HSLLK-----GVSFLTQLLHKDPSKRLGS 365
           E  K  P  T        S LK     G+  L+++L  DP++R+ +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 35/287 (12%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ + ++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+      T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 283 PEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------------- 327
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI               
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 328 ----NEKVKLPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGS 365
               + K   P +   +   ++      G S L+Q+LH DP+KR+ +
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I+A +  R+  ++K    + +    D+ T  T         S +  S++YL+   +  G 
Sbjct: 61  IHARRTYRELRLLKHLKHENVIGLLDVFTPAT---------SIEDFSEVYLVTTLM--GA 109
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
              ++ +     ++  +F   +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGL
Sbjct: 110 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 169
Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           A++ DE         T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F  ++  
Sbjct: 170 ARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 227
Query: 321 KLQQRIIN 328
              +RI+ 
Sbjct: 228 DQLKRIME 235

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 91  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+      T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 271 HYDPNKRISA 280

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 145 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 26/227 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+ +    T  Y A
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------------- 327
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI               
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 328 ----NEKVKLPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGS 365
               + K   P +   +   ++      G S L+Q+LH DP+KR+ +
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 26/227 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMA 282
           ++  ++  H   ++HRDLKP+N+L++++G + L DFGLA+      R+ +    T  Y A
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------------- 327
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI               
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 328 ----NEKVKLPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGS 365
               + K   P +   +   ++      G S L+Q+LH DP+KR+ +
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           ++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R  +    T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--------------IN 328
           ++L+ SK ++   D WSVG +  EM+ G P F   +      RI              + 
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 329 EKVKLPPFLTSEA----HSLLK-----GVSFLTQLLHKDPSKRLGS 365
           E  K  P  T        S LK     G+  L+++L  DP++R+ +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 145 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 156
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQ 209
           + H      E  +L  V H  I+ L   F  +  L      YL+++ ++          Q
Sbjct: 62  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC------Q 115
Query: 210 GIFRE---DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
            I  E   ++  +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+   
Sbjct: 116 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS 175
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
            +        T  Y APE++L  G+ ++ D WSVG ++ E++ G   F   +      ++
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 235
Query: 327 INE 329
           I +
Sbjct: 236 IEQ 238

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 46  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 105
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 106 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 162
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 163 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 104/191 (54%), Gaps = 8/191 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--DQARFYTA 222
           E  I+ ++ HP IV    +      L ++ ++++ G L+  L++ G   +  ++ R   A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 223 -EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTT 278
            ++   +++LH     IVHRDLK  N+L+D    V + DFGL++ +      S    GT 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTP 203
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF 336
           E+MAPE+L  +  N+ +D +S G++L+E+ T Q P+ + N  ++   +    +++++P  
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 337 LTSEAHSLLKG 347
           L  +  ++++G
Sbjct: 264 LNPQVAAIIEG 274

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 30/200 (15%)
Query: 156 KNHVDYMKAERDI--LTKVT-HPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQG 210
           +N  D  +  R+I  LT+++ H  IV L    +  +   +YL+ D++        + R  
Sbjct: 47  QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRAN 104
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK------- 263
           I      ++   +++  + +LH  G++HRD+KP NIL++++ HV + DFGL++       
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 264 -------EIDESSRS--------NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEM 307
                   I+E++ +             T  Y APEILL S  + K  D WS+G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 308 LTGQPPFTHANRQKLQQRII 327
           L G+P F  ++     +RII
Sbjct: 225 LCGKPIFPGSSTMNQLERII 244

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD--EMTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 244 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 288

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 105/191 (54%), Gaps = 8/191 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--DQARFYTA 222
           E  I+ ++ HP IV    +      L ++ ++++ G L+  L++ G   +  ++ R   A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 223 -EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESSRSNSMCGTT 278
            ++   +++LH     IVHR+LK  N+L+D    V + DFGL++ +      S S  GT 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 203
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF 336
           E+MAPE+L  +  N+ +D +S G++L+E+ T Q P+ + N  ++   +    +++++P  
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 337 LTSEAHSLLKG 347
           L  +  ++++G
Sbjct: 264 LNPQVAAIIEG 274

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD--EMTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 248 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 292

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 63/104 (60%), Gaps = 3/104 (2%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F E++ ++   +++  + ++H  G+VHRDLKP N+ ++ D  + + DFGLA+  D  +  
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEM 180
Query: 272 NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
                T  Y APE++LS  H N+  D WSVG ++ EMLTG+  F
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 68  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 63/104 (60%), Gaps = 3/104 (2%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F E++ ++   +++  + ++H  G+VHRDLKP N+ ++ D  + + DFGLA+  D  +  
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEM 198
Query: 272 NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
                T  Y APE++LS  H N+  D WSVG ++ EMLTG+  F
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 238 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 282

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 178
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 238
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 239 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 283

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 122 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 179
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 239
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 240 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 284

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 247 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 291

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 247 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 291

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 248 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 292

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 178
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 238
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 239 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 283

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTG 192
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ + ++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G + L DFG
Sbjct: 88  KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 261 LAKEIDESSRSNS-MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           LA+      R+ +    T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 319 RQKLQQRII------------------NEKVKLPPFLTSEAHSLL-----KGVSFLTQLL 355
                 RI                   + K   P +   +   ++      G S L+Q+L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 356 HKDPSKRLGS 365
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 244 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 288

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 193
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 254 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 298

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 193
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 254 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 298

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 247 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 291

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 123 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 180
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 240
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 241 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 285

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 92/178 (51%), Gaps = 15/178 (8%)
Query: 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           +  YL++ F+  G     L +     ED+ +F   +++  + ++H  GI+HRDLKP N+ 
Sbjct: 103 TDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160
Query: 248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYE 306
           ++ D  + + DFGLA++ D  S       T  Y APE++L+   + +  D WSVG ++ E
Sbjct: 161 VNEDCELKILDFGLARQAD--SEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 307 MLTGQPPFTHANRQKLQQRIINEKVKLPP------FLTSEAHSLLKGVSFLTQLLHKD 358
           M+TG+  F  ++    Q + I +    PP        + EA + +KG   L +L  KD
Sbjct: 219 MITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG---LPELEKKD 272

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 186
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++  
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 247 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 291

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 192
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 252
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 253 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 297

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 244 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 288

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 249 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTG 193
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 254 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 298

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 200
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 200
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 201
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--G 177
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 183
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--G 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 134 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 191
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 249

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 248 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 292

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 204
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 201
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 9/217 (4%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFY 220
           +K E  IL    H  I+ L  SF++  +L +I +FI+G  +F  +        E +   Y
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             ++  A+  LH   I H D++PENI+  +     + + +FG A+++        +    
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           EY APE+      +   D WS+G L+Y +L+G  PF     Q++ + I+N +        
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
            E    ++ + F+ +LL K+   R+ +     +A++H
Sbjct: 228 KEIS--IEAMDFVDRLLVKERKSRMTAS----EALQH 258

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 214 WSVGCILAEMLSNRPIF 230

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 52  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 112 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 168
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ 
Sbjct: 169 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTG 187
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--G 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 8/183 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 104 VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 163
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG    L DFG A  +      
Sbjct: 164 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 223
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            S+       GT  +MAPE+++ K  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283
Query: 326 IIN 328
           I +
Sbjct: 284 IAS 286

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMXG 204
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 264
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 265 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 309

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 8/183 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 88  VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 147
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG    L DFG A  +      
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            S+       GT  +MAPE+++ K  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267
Query: 326 IIN 328
           I +
Sbjct: 268 IAS 270

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 41  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ 
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 214

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 68/118 (57%), Gaps = 6/118 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXG 201
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 327
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 8/183 (4%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 102 VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 161
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS 271
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG    L DFG A  +      
Sbjct: 162 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 272 NSMC------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            S+       GT  +MAPE+++ K  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281
Query: 326 IIN 328
           I +
Sbjct: 282 IAS 284

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 242 ESLHDL------MCQCWRKDPEER 259

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 214 WSVGCILAEMLSNRPIF 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 92  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 149
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 150 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 209
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 210 WSVGCILAEMLSNRPIF 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 69  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 116
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 117 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 176
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 177 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 66  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 113
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 114 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 173
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 174 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 70  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 117
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 118 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 177
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 178 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 61  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 109 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 168
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 169 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 116 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 116 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 84  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 131
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 132 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 191
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 192 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 92  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 149
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 150 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 209
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 210 WSVGCILAEMLSNRPIF 226

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ 
Sbjct: 164 TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 220

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 72  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 119
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 120 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 179
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 180 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 64  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 111
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 112 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 171
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 172 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 2/150 (1%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +++HP I+ L  +F  +S + L+ DF+             +      + Y    
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS-MCGTTEYMAP 283
           +  + +LH+  I+HRDLKP N+L+D +G + L DFGLAK     +R+      T  Y AP
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAP 181
Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQP 312
           E+L  ++ +    D W+VG +L E+L   P
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 79/149 (53%), Gaps = 8/149 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S +  + +YL+   +  G    ++ +     +D  +F   +I+  + ++H   I+HRDLK
Sbjct: 95  SLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 152
Query: 243 PENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVG 301
           P N+ ++ D  + + DFGL +  D+         T  Y APEI+L+  H N+  D WSVG
Sbjct: 153 PSNLAVNEDSELKILDFGLCRHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 302 ILLYEMLTGQ---PPFTHANRQKLQQRII 327
            ++ E+LTG+   P   H ++ KL  R++
Sbjct: 211 CIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 116 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 176 RVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 69  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 116
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 117 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 176
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 177 RVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L  F         R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 242 ESLHDL------MCQCWRKDPEER 259

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ +++N G L   L  +     R  Q    +A
Sbjct: 60  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 238
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   K+P +R
Sbjct: 239 ESLHDL------MCQCWRKEPEER 256

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T  +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 68  KNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 242 ESLHDL------MCQCWRKDPEER 259

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 90/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D+GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ +++N G L   L  +     R  Q    +A
Sbjct: 60  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 238
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   K+P +R
Sbjct: 239 ESLHDL------MCQCWRKEPEER 256

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +    DI   +  P I Q++        +Y++ D +     
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDI---IRAPTIEQMK-------DVYIVQDLMETD-- 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA
Sbjct: 116 LYKLLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 263 K----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           +    + D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + + DFGLA+    S        T  Y APE++L  G+ ++ D WSVG ++ EM+ 
Sbjct: 164 TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVC 220

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKIRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 242 ESLHDL------MCQCWRKDPEER 259

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 119/252 (47%), Gaps = 44/252 (17%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR------QGIFREDQAR 218
           E  ++ ++ H  IV+L     T +KL L+ +F++     +   R      +G+   +  +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-ELNLVK 111
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGT 277
           ++  +++  ++  H+  I+HRDLKP+N+L++  G + L DFGLA+       + +S   T
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 278 TEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------NE 329
             Y AP++L+ S+ ++   D WS G +L EM+TG+P F   N ++ Q ++I       NE
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNE 230
Query: 330 KV-----KLPPF---------------LTSEAHSLLKG--VSFLTQLLHKDPSKRLGSGP 367
            +     KLP +               L       L G  + FL  LL  +P  RL +  
Sbjct: 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA-- 288
Query: 368 GGVDAIKHHKWF 379
                  HH WF
Sbjct: 289 ---KQALHHPWF 297

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +YL+   +  G   + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 114 TIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 171
Query: 243 PENILMDSDGHVMLTDFGLAK----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 297
           P N+L+++   + + DFGLA+    + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 172 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 231
Query: 298 WSVGILLYEMLTGQPPF 314
           WSVG +L EML+ +P F
Sbjct: 232 WSVGCILAEMLSNRPIF 248

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 6/165 (3%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+      
Sbjct: 153 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTG 210
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK 332
              T  Y APEI+L+  H N   D WSVG ++ E+LTG+  F   +     Q+I+     
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGT 270
Query: 333 LPPFLTSE--AHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
            P  + S   +H     ++ L Q+  ++ +   +G+ P  VD ++
Sbjct: 271 PPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLE 315

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQ 209
           + H      E  +L  V H  I+ L   F  +  L      YL+++ ++          Q
Sbjct: 64  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC------Q 117
Query: 210 GIFRE---DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
            I  E   ++  +   +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+   
Sbjct: 118 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 177
Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
            +        T  Y APE++L  G+  + D WSVG ++ E++ G
Sbjct: 178 TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 242 ESLHDL------MCQCWRKDPEER 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 54  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 232
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 233 ESLHDL------MCQCWRKDPEER 250

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 85/330 (25%), Positives = 143/330 (43%), Gaps = 56/330 (16%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRK--------------DTIIK 155
            D+ I R + QG F                   YA+K   K              D I  
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNK-------FYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI-NGGHLFFHLYRQGIFRE 214
           K+  D  K E  I+T + + + +          ++Y+I +++ N   L F  Y   +  +
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF-FVLDK 142
Query: 215 DQARFYTAEIVSAV--------SHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
           +   F   +++  +        S++H +  I HRD+KP NILMD +G V L+DFG ++ +
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQPPFT-HANRQKL 322
            +     S  GT E+M PE   ++     A  D WS+GI LY M     PF+   +  +L
Sbjct: 203 VDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 323 QQRIINEKVKLPP----FL-------TSEAHSLL--KGVSFLTQLLHKDPSKRLGSGPGG 369
              I  + ++ P     FL       ++ +++ L  + + FL   L K+P++R+ S    
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE--- 318
Query: 370 VDAIKHHKWFRSINWKTLE--AREMQPKFK 397
            DA+KH  W    N + L   ++E+  K K
Sbjct: 319 -DALKHE-WLADTNIEDLREFSKELYKKRK 346

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 242 ESLHDL------MCQCWRKDPEER 259

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 52  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 230
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 231 ESLHDL------MCQCWRKDPEER 248

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+    +     
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 249 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+    +     
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 249 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+    +     
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTG 188
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 249 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 166
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 123/277 (44%), Gaps = 38/277 (13%)
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ 209
           D ++KK  +  +K    +L ++ H  +V L    + + + YL+ +F++   L    L+  
Sbjct: 64  DKMVKKIAMREIK----LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN 119
Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
           G+  +   + Y  +I++ +   H   I+HRD+KPENIL+   G V L DFG A+ +    
Sbjct: 120 GLDYQVVQK-YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 270 RS-NSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPF------------- 314
              +    T  Y APE+L+    + K  D W++G L+ EM  G+P F             
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238
Query: 315 -THANRQKLQQRIINEK-----VKLPPFLTSE----AHSLLKGV--SFLTQLLHKDPSKR 362
               N     Q + N+      V+LP     E     +  L  V      + LH DP KR
Sbjct: 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKR 298
Query: 363 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
               P   + + HH +F+   +    ++E+Q K + D
Sbjct: 299 ----PFCAELL-HHDFFQMDGFAERFSQELQLKVQKD 330

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 106/238 (44%), Gaps = 32/238 (13%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L  + H  IV L     T   L L+ ++++     +      I      + +  ++
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL--AKEIDESSRSNSMCGTTEYMA 282
           +  +++ H+  ++HRDLKP+N+L++  G + L DFGL  AK I   +  N +  T  Y  
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168
Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------------- 327
           P+ILL S  ++   D W VG + YEM TG+P F  +  ++    I               
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 328 --NEKVKLPPFLTSEAHSLLK--------GVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
             NE+ K   +    A +LL         G   LT+LL  +   R+ +     DA+KH
Sbjct: 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAE----DAMKH 282

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 72  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 130
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 131 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 235

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/113 (39%), Positives = 59/113 (52%), Gaps = 1/113 (0%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+        + +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 231

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 242 ESLHDL------MCQCWRKDPEER 259

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 56  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    + G+ 
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 219

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 80  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S S+    + G+ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/113 (39%), Positives = 58/113 (51%), Gaps = 1/113 (0%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 188 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 239

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + +  FGLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 312 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 490
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   K+P +R
Sbjct: 491 ESLHDL------MCQCWRKEPEER 508

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL   NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 242 ESLHDL------MCQCWRKDPEER 259

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + DF LA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/113 (39%), Positives = 58/113 (51%), Gaps = 1/113 (0%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 231

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 123/268 (45%), Gaps = 54/268 (20%)
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LY 207
           D +IKK  +  ++    +L ++ HP +V L   F+ + +L+L+ ++ +  H   H    Y
Sbjct: 42  DPVIKKIALREIR----MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD--HTVLHELDRY 95
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID- 266
           ++G+  E   +  T + + AV+  HK   +HRD+KPENIL+     + L DFG A+ +  
Sbjct: 96  QRGV-PEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154
Query: 267 ESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF--------THA 317
            S   +    T  Y +PE+L+    +    D W++G +  E+L+G P +         + 
Sbjct: 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214
Query: 318 NRQKLQQRIINEK-----------VKLP------------PFLTSEAHSLLKGVSFLTQL 354
            R+ L   I   +           VK+P            P ++  A  LLKG       
Sbjct: 215 IRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGC------ 268
Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
           LH DP++RL       + + HH +F +I
Sbjct: 269 LHMDPTERLTC-----EQLLHHPYFENI 291

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 56  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 234
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   K+P +R
Sbjct: 235 ESLHDL------MCQCWRKEPEER 252

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 88/191 (46%), Gaps = 12/191 (6%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLH 232
           HP  V+L  +++    LYL  +   G  L  H    G    E Q   Y  + + A++HLH
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 292
             G+VH D+KP NI +   G   L DFGL  E+  +       G   YMAPE LL   + 
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQGSYG 233
Query: 293 KDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL 351
             AD +S+G+ + E+    + P      Q+L+Q        LPP  T+   S L+  S L
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSELR--SVL 285
Query: 352 TQLLHKDPSKR 362
             +L  DP  R
Sbjct: 286 VMMLEPDPKLR 296

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 230 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 288
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGL + I+++  +         ++
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 408
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   KDP +R
Sbjct: 409 ESLHDL------MCQCWRKDPEER 426

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D  + + D GLA+  D+      
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE--MTG 181
Query: 274 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRIINE 329
              T  Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++  
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR-LGSGPGGVDAIK 374
              +L   ++SE  S    +  LTQ+   + +   +G+ P  VD ++
Sbjct: 242 PGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 286

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYT 221
           + E  +L K  H  I+ L   + T+  L ++  +  G  L+ HL+ Q   F+  Q     
Sbjct: 80  RNEVAVLRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM---CGTT 278
            +    + +LH   I+HRD+K  NI +     V + DFGLA      S S  +    G+ 
Sbjct: 139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  + +N     +D +S GI+LYE++TG+ P++H N +
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR 243

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 45/113 (39%), Positives = 58/113 (51%), Gaps = 1/113 (0%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 231

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   K+P +R
Sbjct: 408 ESLHDL------MCQCWRKEPEER 425

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   K+P +R
Sbjct: 408 ESLHDL------MCQCWRKEPEER 425

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 90/189 (47%), Gaps = 32/189 (16%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 298
           KPEN+L  S   +  + LTDFG AKE            TT          + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKE------------TT---------GEKYDKSCDMW 182
Query: 299 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQL 354
           S+G+++Y +L G PPF      A    ++ RI   + + P    SE    +K    +  L
Sbjct: 183 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--MLIRNL 240
Query: 355 LHKDPSKRL 363
           L  +P++R+
Sbjct: 241 LKTEPTQRM 249

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 29/224 (12%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F++ R+ GQG F                    A+K + +D   +   +  M+     L  
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSV-----AIKKVIQDPRFRNRELQIMQD----LAV 75
Query: 172 VTHPFIVQLRYSFQT-----RSKLYL--ILDFINGGHLFFHLYRQGIFREDQA------R 218
           + HP IVQL+  F T     R  +YL  +++++       H   +  +R   A      +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT---LHRCCRNYYRRQVAPPPILIK 132
Query: 219 FYTAEIVSAVSHLH--KCGIVHRDLKPENILM-DSDGHVMLTDFGLAKEIDESSRSNSMC 275
            +  +++ ++  LH     + HRD+KP N+L+ ++DG + L DFG AK++  S  + +  
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 276 GTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHAN 318
            +  Y APE++    H   A D WSVG +  EM+ G+P F   N
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 352
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            APE L  K  +  +D WS GILL+E+ + G+ P+
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L  F         R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   K+P +R
Sbjct: 408 ESLHDL------MCQCWRKEPEER 425

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 108 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 165
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            APE L  K  +  +D WS GILL+E+ + G+ P+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 180
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            APE L  K  +  +D WS GILL+E+ + G+ P+
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 116 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 116 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 54  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 112
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 113 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 168
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 169 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 217

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 3/166 (1%)
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++  P +V +    +   +LY+    ING  L   L RQG     +A     +I SA+  
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES--SRSNSMCGTTEYMAPEILLS 288
            H  G  HRD+KPENIL+ +D    L DFG+A    +   ++  +  GT  Y APE    
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSE 209
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
                 AD +++  +LYE LTG PP+   ++  +    IN+ +  P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPY-QGDQLSVXGAHINQAIPRP 254

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           PE+LL   +    D WSVG +  EM   +P F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 79  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 137
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    + G+ 
Sbjct: 138 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 242

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 80  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SMCGTT 278
            +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    + G+ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 279 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           PE+LL   +    D WSVG +  EM   +P F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 41/187 (21%), Positives = 102/187 (54%), Gaps = 8/187 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 35  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 91  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMT 150
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR 319
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + + 
Sbjct: 151 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 210
Query: 320 QKLQQRI 326
            ++ + I
Sbjct: 211 SEVVEDI 217

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 81/155 (52%), Gaps = 6/155 (3%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           + ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKW 171
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            APE L     +  +D WS GILL+E+ + G+ P+
Sbjct: 172 TAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
           PE+LL   +    D WSVG +  EM   +P F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/187 (21%), Positives = 102/187 (54%), Gaps = 8/187 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 35  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 91  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 150
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR 319
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + + 
Sbjct: 151 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 210
Query: 320 QKLQQRI 326
            ++ + I
Sbjct: 211 SEVVEDI 217

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/187 (21%), Positives = 102/187 (54%), Gaps = 8/187 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 38  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 94  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 153
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR 319
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + + 
Sbjct: 154 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213
Query: 320 QKLQQRI 326
            ++ + I
Sbjct: 214 SEVVEDI 220

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   + ++ ++++ G L   L  +     R  Q     A
Sbjct: 53  EAQVMKKLRHEKLVQL-YAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 111
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 338
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 231
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
              H L      + Q   K+P +R
Sbjct: 232 ESLHDL------MCQCWRKEPEER 249

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/187 (21%), Positives = 102/187 (54%), Gaps = 8/187 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 33  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 89  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 148
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR 319
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + + 
Sbjct: 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208
Query: 320 QKLQQRI 326
            ++ + I
Sbjct: 209 SEVVEDI 215

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 18/197 (9%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEIVSAVS 229
           HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++ +A++
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALA 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILL 287
           +L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE + 
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 288 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLL 345
            +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL 
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL- 244
Query: 346 KGVSFLTQLLHKDPSKR 362
                +T+    DPS+R
Sbjct: 245 -----MTKCWAYDPSRR 256

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 20/231 (8%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R    +       +  + DI +  V  PF V    +      +++ ++ ++     
Sbjct: 79  MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--L 136
Query: 204 FHLYRQGIFR-----EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLT 257
              Y+Q I +     ED        IV A+ HLH K  ++HRD+KP N+L+++ G V + 
Sbjct: 137 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 196
Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEMLTGQPP 313
           DFG++  + +S       G   YMAPE     L  KG++  +D WS+GI + E+   + P
Sbjct: 197 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 256
Query: 314 FTHANR--QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +       Q+L+Q +     +LP    S        V F +Q L K+  +R
Sbjct: 257 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEF-----VDFTSQCLKKNSKER 302

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 16/169 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T  +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN---SM 274
           R    +    + +LH   I+HRDLK  NI +  D  V + DFGLA      S S+    +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 275 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 320
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+R++T  K N    +  E  ++  V  P++ +L       S + L+   +  G L 
Sbjct: 50  AIKVLRENTSPKANK--EILDEAYVMAGVGSPYVSRL-LGICLTSTVQLVTQLMPYGCLL 106
Query: 204 FHLYRQGIFREDQARF-------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            H+      RE++ R        +  +I   +S+L    +VHRDL   N+L+ S  HV +
Sbjct: 107 DHV------RENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKI 160
Query: 257 TDFGLAK--EIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQP 312
           TDFGLA+  +IDE+   ++      ++MA E +L +     +D WS G+ ++E++T G  
Sbjct: 161 TDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAK 220
Query: 313 PFTHANRQKLQQRI-INEKVKLPPFLTSEAHSLL 345
           P+     +++   +   E++  PP  T + + ++
Sbjct: 221 PYDGIPAREIPDLLEKGERLPQPPICTIDVYMIM 254

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 50/223 (22%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTI-IKKNHVD--YMKAERDILTKV 172
           +V+G G+F                  ++  K++  D + IKK   D  +   E  I+  V
Sbjct: 46  KVIGNGSFGV----------------VFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIV 89
Query: 173 THPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ---------- 216
            HP +V L+  F +         L L+L+++           + ++R  +          
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----------ETVYRASRHYAKLKQTMP 139
Query: 217 ---ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSN 272
               + Y  +++ +++++H  GI HRD+KP+N+L+D    V+ L DFG AK +     + 
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 273 SMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
           S   +  Y APE++  +  +  + D WS G ++ E++ GQP F
Sbjct: 200 SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/187 (21%), Positives = 102/187 (54%), Gaps = 8/187 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 36  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 92  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR 319
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + + 
Sbjct: 152 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211
Query: 320 QKLQQRI 326
            ++ + I
Sbjct: 212 SEVVEDI 218

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 108 GPGDFEIF--------RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           GPGD  +F        R +G+G F                  + A+K ++ D      H 
Sbjct: 21  GPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMV-AVKALKADA--GPQHR 77
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTR--SKLYLILDFINGGHLFFHLYRQGIFREDQA 217
              K E DIL  + H  I++ +   +    + L L+++++  G L  +L R  I    Q 
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA-QL 136
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
             +  +I   +++LH    +HRDL   N+L+D+D  V + DFGLAK + E      +   
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRED 196
Query: 278 TE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            +    + APE L        +D WS G+ LYE+LT
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSA 227
           + +  HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A
Sbjct: 68  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 126
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEI 285
           +++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE 
Sbjct: 127 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 186
Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 187 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 246
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +T+    DPS+R
Sbjct: 247 L------MTKCWAYDPSRR 259

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 75  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
               VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  + 
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGV 348
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL    
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL---- 249
Query: 349 SFLTQLLHKDPSKR 362
             +T+    DPS+R
Sbjct: 250 --MTKCWAYDPSRR 261

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSA 227
           + +  HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A
Sbjct: 67  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 125
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEI 285
           +++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE 
Sbjct: 126 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 185
Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 186 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 245
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +T+    DPS+R
Sbjct: 246 L------MTKCWAYDPSRR 258

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 98  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
               VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  + 
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGV 348
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL    
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL---- 272
Query: 349 SFLTQLLHKDPSKR 362
             +T+    DPS+R
Sbjct: 273 --MTKCWAYDPSRR 284

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
               VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  + 
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGV 348
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL    
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL---- 244
Query: 349 SFLTQLLHKDPSKR 362
             +T+    DPS+R
Sbjct: 245 --MTKCWAYDPSRR 256

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSA 227
           + +  HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A
Sbjct: 62  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEI 285
           +++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE 
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 343
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 344 LLKGVSFLTQLLHKDPSKR 362
           L      +T+    DPS+R
Sbjct: 241 L------MTKCWAYDPSRR 253

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/187 (21%), Positives = 102/187 (54%), Gaps = 8/187 (4%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++ ++ + + ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 55  AIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 110
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +  + ++DFG+ 
Sbjct: 111 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 170
Query: 263 KEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR 319
           + +  D+ + S       ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + + 
Sbjct: 171 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 230
Query: 320 QKLQQRI 326
            ++ + I
Sbjct: 231 SEVVEDI 237

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
               VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  + 
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGV 348
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL    
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL---- 244
Query: 349 SFLTQLLHKDPSKR 362
             +T+    DPS+R
Sbjct: 245 --MTKCWAYDPSRR 256

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+   +  G    ++MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 340
           PE +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP     
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 341 AHSLLKGVSFLTQLLHKDPSKR 362
            +SL      +T+    DPS+R
Sbjct: 621 LYSL------MTKCWAYDPSRR 636

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 20/231 (8%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R    +       +  + DI +  V  PF V    +      +++ ++ ++     
Sbjct: 35  MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--L 92
Query: 204 FHLYRQGIFR-----EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLT 257
              Y+Q I +     ED        IV A+ HLH K  ++HRD+KP N+L+++ G V + 
Sbjct: 93  DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 152
Query: 258 DFGLAKEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEMLTGQPP 313
           DFG++  + +    +   G   YMAPE     L  KG++  +D WS+GI + E+   + P
Sbjct: 153 DFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
Query: 314 FTHANR--QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +       Q+L+Q +     +LP    S        V F +Q L K+  +R
Sbjct: 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEF-----VDFTSQCLKKNSKER 258

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 32/213 (15%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S    + +Y++ +++       ++  QG   E+ AR +  +++  + ++H   ++HRDLK
Sbjct: 90  SLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLK 147
Query: 243 PENILMDSDGHVM-LTDFGLAKEIDE--SSRSNSMCG--TTEYMAPEILLS-KGHNKDAD 296
           P N+ ++++  V+ + DFGLA+ +D   S + +   G  T  Y +P +LLS   + K  D
Sbjct: 148 PANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAID 207
Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRII-----------NEKVKLPPFLT----SEA 341
            W+ G +  EMLTG+  F  A+  +  Q I+            E + + P       +E 
Sbjct: 208 MWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEP 267
Query: 342 H----SLLKGVS-----FLTQLLHKDPSKRLGS 365
           H     LL G+S     FL Q+L   P  RL +
Sbjct: 268 HKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 62/111 (55%), Gaps = 2/111 (1%)
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESSRSNSMCGT 277
            Y  ++  AV  +H  GI HRD+KP+N+L++S D  + L DFG AK++  S  S +   +
Sbjct: 145 IYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICS 204
Query: 278 TEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
             Y APE++L +  +    D WS+G +  E++ G+P F+         RII
Sbjct: 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRII 255

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 18/197 (9%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEIVSAVS 229
           HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++ +A++
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALA 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILL 287
           +L     VHRD+   N+L+ +   V L DFGL++ +++S+   +  G    ++MAPE + 
Sbjct: 126 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 288 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLL 345
            +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL 
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL- 244
Query: 346 KGVSFLTQLLHKDPSKR 362
                +T+    DPS+R
Sbjct: 245 -----MTKCWAYDPSRR 256

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            +   I   N +++ P     +   +LK        L +DP +R+
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCC------LKRDPKQRI 285

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            +   I   N +++ P     +   +LK        L +DP +R+
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCC------LKRDPKQRI 313

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 7/162 (4%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D +K  R  L K+ HP  +Q R  +      +L++++  G         +   +E +   
Sbjct: 100 DIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 158
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
            T   +  +++LH   ++HRD+K  NIL+   G V L DFG A  +   + +N   GT  
Sbjct: 159 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPY 215
Query: 280 YMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +MAPE++L+     ++   D WS+GI   E+   +PP  + N
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 108 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 166
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 226
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            +   I   N +++ P     +   +LK        L +DP +R+
Sbjct: 227 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCC------LKRDPKQRI 265

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 112 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 230
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            +   I   N +++ P     +   +LK        L +DP +R+
Sbjct: 231 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCC------LKRDPKQRI 269

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 109 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            +   I   N +++ P     +   +LK        L +DP +R+
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCC------LKRDPKQRI 266

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            +   I   N +++ P     +   +LK        L +DP +R+
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCC------LKRDPKQRI 313

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 7/162 (4%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D +K  R  L K+ HP  +Q R  +      +L++++  G         +   +E +   
Sbjct: 61  DIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
            T   +  +++LH   ++HRD+K  NIL+   G V L DFG A  +   + +N   GT  
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPY 176
Query: 280 YMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +MAPE++L+     ++   D WS+GI   E+   +PP  + N
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGLA+  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 323 QQRIINEKVKLPP 335
             + ++E  +LPP
Sbjct: 260 -IKAVDEGYRLPP 271

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 12/167 (7%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 98  YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 155
Query: 233 --KCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
             +  I+H DLKPENIL+ +     + + DFG + ++ +  R      +  Y +PE+LL 
Sbjct: 156 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSPEVLLG 213
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
             ++   D WS+G +L EM TG+P F+ AN      +I+ E + +PP
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPP 259

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 110/231 (47%), Gaps = 29/231 (12%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K ++  T+  ++ ++    E  I+ K+ H  +VQL Y+  +   +Y++ +++N G L 
Sbjct: 37  AIKTLKPGTMSPESFLE----EAQIMKKLKHDKLVQL-YAVVSEEPIYIVTEYMNKGSLL 91
Query: 204 FHLYRQGIFREDQARFY--------TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
             L      ++ + R           A++ + ++++ +   +HRDL+  NIL+ +     
Sbjct: 92  DFL------KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICK 145
Query: 256 LTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQP 312
           + DFGLA+ I+++  +         ++ APE  L       +D WS GILL E++T G+ 
Sbjct: 146 IADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 205
Query: 313 PFTHA-NRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P+    NR+ L+Q     ++  P       H L      +     KDP +R
Sbjct: 206 PYPGMNNREVLEQVERGYRMPCPQDCPISLHEL------MIHCWKKDPEER 250

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 43  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 98
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 99  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 157
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 158 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 165 ERDILTKVTHPFIVQLR-YSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARF--Y 220
           E  IL  +   FIV+ R  S+   R +L L+++++  G L   L R    R D +R   Y
Sbjct: 58  EIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLY 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTT 278
           +++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        G +
Sbjct: 117 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 279 E--YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII----- 327
              + APE L     ++ +D WS G++LYE+ T       P     R    +R +     
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCR 236
Query: 328 -------NEKVKLPPFLTSEAHSLLK 346
                   +++  PP   +E H L+K
Sbjct: 237 LLELLEEGQRLPAPPACPAEVHELMK 262

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
            +A+++L     VHRD+   N+L+ +   V L DFGL++ +++S+   +  G    ++MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 340
           PE +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP     
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 341 AHSLLKGVSFLTQLLHKDPSKR 362
            +SL      +T+    DPS+R
Sbjct: 621 LYSL------MTKCWAYDPSRR 636

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 12/167 (7%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 233 --KCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
             +  I+H DLKPENIL+ +     + + DFG + ++ +  R      +  Y +PE+LL 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSPEVLLG 232
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
             ++   D WS+G +L EM TG+P F+ AN      +I+ E + +PP
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPP 278

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 69/128 (53%), Gaps = 5/128 (3%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-S 250
           L+ ++IN    F  LY+  I  +   RFY  E++ A+ + H  GI+HRD+KP N+++D  
Sbjct: 117 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 251 DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
              + L D+GLA+    +   N    +  +  PE+L+  + ++   D WS+G +L  M+ 
Sbjct: 174 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 233
Query: 310 GQPPFTHA 317
            + PF H 
Sbjct: 234 RREPFFHG 241

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 69/128 (53%), Gaps = 5/128 (3%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-S 250
           L+ ++IN    F  LY+  I  +   RFY  E++ A+ + H  GI+HRD+KP N+++D  
Sbjct: 112 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 251 DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 309
              + L D+GLA+    +   N    +  +  PE+L+  + ++   D WS+G +L  M+ 
Sbjct: 169 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228
Query: 310 GQPPFTHA 317
            + PF H 
Sbjct: 229 RREPFFHG 236

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
           +E  I+ +  HP I++L         + ++ +F+  G L  F     G F   Q      
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGT- 277
            I S + +L +   VHRDL   NIL++S+    ++DFGL++ ++E+S     ++S+ G  
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 278 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
              + APE +  +     +D WS GI+++E+++ G+ P+   + Q +    I +  +LPP
Sbjct: 186 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN-AIEQDYRLPP 244

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 154
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 155 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 12/167 (7%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 233 --KCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
             +  I+H DLKPENIL+ +     + + DFG + ++ +  R      +  Y +PE+LL 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSPEVLLG 232
Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
             ++   D WS+G +L EM TG+P F+ AN      +I+ E + +PP
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPP 278

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THPFIVQLRYSFQTRSKLYLILDFI 197
           YA+KV+R    IKK +    K E DIL K+      +  IV+    F     + LI + +
Sbjct: 63  YAVKVVRN---IKK-YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118
Query: 198 NGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------ 249
            G  L+  + R     F  +  + Y  EI+ A+++L K  + H DLKPENIL+D      
Sbjct: 119 -GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177
Query: 250 --------SDGH-----------VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
                   +DG            + L DFG A    +S    S+  T +Y APE++L+ G
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG 235
Query: 291 HNKDADWWSVGILLYEMLTGQPPF-THANRQKL 322
            +  +D WS G +L E+ TG   F TH + + L
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 116/255 (45%), Gaps = 23/255 (9%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 321 KLQQRIINEKVKLPP 335
            +  + ++E  +LPP
Sbjct: 258 DV-IKAVDEGYRLPP 271

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 116/255 (45%), Gaps = 23/255 (9%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 321 KLQQRIINEKVKLPP 335
            +  + ++E  +LPP
Sbjct: 258 DV-IKAVDEGYRLPP 271

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 116/255 (45%), Gaps = 23/255 (9%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 26  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 82
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 83  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 135
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 136 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 195
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 196 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 255
Query: 321 KLQQRIINEKVKLPP 335
            +  + ++E  +LPP
Sbjct: 256 DV-IKAVDEGYRLPP 269

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 162 MKAERDILTKVTHPFIVQLR-YSFQ-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
            + E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R 
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRL 116
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMC 275
             Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        
Sbjct: 117 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 176
Query: 276 GTTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII-- 327
           G +   + APE L     ++ +D WS G++LYE+ T       P     R    +R +  
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPA 236
Query: 328 ----------NEKVKLPPFLTSEAHSLLK 346
                      +++  PP   +E H L+K
Sbjct: 237 LSRLLELLEEGQRLPAPPACPAEVHELMK 265

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 92/181 (50%), Gaps = 11/181 (6%)
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           +E  I+ +  HP I++L         + ++ +F+  G L  F  L   G F   Q     
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGML 122
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGT 277
             I S + +L +   VHRDL   NIL++S+    ++DFGL++ ++E+S     ++S+ G 
Sbjct: 123 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               + APE +  +     +D WS GI+++E+++ G+ P+   + Q +    I +  +LP
Sbjct: 183 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN-AIEQDYRLP 241
Query: 335 P 335
           P
Sbjct: 242 P 242

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 9/172 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGH 201
           A+K ++ D      H    K E DIL  + H  I++ +     Q    L L+++++  G 
Sbjct: 47  AVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L  +L R  I    Q   +  +I   +++LH    +HR+L   N+L+D+D  V + DFGL
Sbjct: 105 LRDYLPRHSIGLA-QLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGL 163
Query: 262 AKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           AK + E      +    +    + APE L        +D WS G+ LYE+LT
Sbjct: 164 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 323 QQRIINEKVKLPP 335
             + ++E  +LPP
Sbjct: 260 -IKAVDEGYRLPP 271

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 9/172 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGH 201
           A+K ++ D      H    K E DIL  + H  I++ +     Q    L L+++++  G 
Sbjct: 47  AVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           L  +L R  I    Q   +  +I   +++LH    +HR+L   N+L+D+D  V + DFGL
Sbjct: 105 LRDYLPRHSIGLA-QLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGL 163
Query: 262 AKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           AK + E      +    +    + APE L        +D WS G+ LYE+LT
Sbjct: 164 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 323 QQRIINEKVKLPP 335
             + ++E  +LPP
Sbjct: 260 -IKAVDEGYRLPP 271

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 162 MKAERDILTKVTHPFIVQLR-YSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
            + E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R 
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRL 117
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMC 275
             Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        
Sbjct: 118 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 177
Query: 276 GTTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII-- 327
           G +   + APE L     ++ +D WS G++LYE+ T       P     R    +R +  
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 237
Query: 328 ----------NEKVKLPPFLTSEAHSLLK 346
                      +++  PP   +E H L+K
Sbjct: 238 LCRLLELLEEGQRLPAPPACPAEVHELMK 266

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 75  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 127
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 128 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 187
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 188 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 247
Query: 323 QQRIINEKVKLPP 335
             + ++E  +LPP
Sbjct: 248 -IKAVDEGYRLPP 259

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 162 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 323 QQRIINEKVKLPP 335
             + ++E  +LPP
Sbjct: 260 -IKAVDEGYRLPP 271

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 24/165 (14%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---N 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  G   YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            +   I   N +++ P     +   +LK        L +DP +R+
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCC------LKRDPKQRI 313

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 165 ERDILTKVTHPFIVQLR-YSFQ-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--Y 220
           E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R   Y
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLY 132
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRSNSMCGTT 278
           +++I   + +L     VHRDL   NIL++S+ HV + DFGLAK   +D+        G +
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 279 E--YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII----- 327
              + APE L     ++ +D WS G++LYE+ T       P     R    +R +     
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 328 -------NEKVKLPPFLTSEAHSLLK 346
                   +++  PP   +E H L+K
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMK 278

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 58  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 110
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230
Query: 323 QQRIINEKVKLPP 335
             + ++E  +LPP
Sbjct: 231 -IKAVDEGYRLPP 242

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 43  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 98
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 99  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 157
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 158 LSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 154
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 155 LSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 158
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 159 LSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL +  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 323 QQRIINEKVKLPP 335
             + ++E  +LPP
Sbjct: 260 -IKAVDEGYRLPP 271

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+L+D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 110/212 (51%), Gaps = 16/212 (7%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+++ T  +K   + M  E  I+ ++ +P+IV+L    Q  + L L+++   GG L 
Sbjct: 41  AIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLH 97
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVS----HLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
             L  +   RE+      AE++  VS    +L +   VHRDL   N+L+ +  +  ++DF
Sbjct: 98  KFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 260 GLAKEI--DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           GL+K +  D+S  +    G    ++ APE +  +  +  +D WS G+ ++E L+ GQ P+
Sbjct: 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
Query: 315 THANRQKLQQRI-INEKVKLPPFLTSEAHSLL 345
                 ++   I   ++++ PP    E ++L+
Sbjct: 215 KKMKGPEVMAFIEQGKRMECPPECPPELYALM 246

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L+   HP +V L      R+++ LI  ++  G+L  HLY   +     +     EI    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 229 S----HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSMCGTTEYM 281
           +    +LH   I+HRD+K  NIL+D +    +TDFG++K   E+D++     + GT  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
            PE  +     + +D +S G++L+E+L  +        Q L + ++N
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV----QSLPREMVN 251

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SN 272
           + + Y   ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++         +
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKD 186
Query: 273 SMCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQK 321
           S  GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q 
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 322 LQQRII---NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            +   I   N +++ P     +   +LK        L +DP +R+
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCC------LKRDPKQRI 285

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 103 DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 161
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 162 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 55  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 110
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 111 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 169
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 170 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 46  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 102 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 158
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 159 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 110/212 (51%), Gaps = 16/212 (7%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+++ T  +K   + M  E  I+ ++ +P+IV+L    Q  + L L+++   GG L 
Sbjct: 367 AIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLH 423
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVS----HLHKCGIVHRDLKPENILMDSDGHVMLTDF 259
             L  +   RE+      AE++  VS    +L +   VHR+L   N+L+ +  +  ++DF
Sbjct: 424 KFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 260 GLAKEI--DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           GL+K +  D+S  +    G    ++ APE +  +  +  +D WS G+ ++E L+ GQ P+
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 315 THANRQKLQQRI-INEKVKLPPFLTSEAHSLL 345
                 ++   I   ++++ PP    E ++L+
Sbjct: 541 KKMKGPEVMAFIEQGKRMECPPECPPELYALM 572

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 158
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 159 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 43/255 (16%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HL 202
           A + +R+  I+K    D + A +DIL + T P+       F++   +Y++LD +    H 
Sbjct: 98  AKRTLRELKILKHFKHDNIIAIKDIL-RPTVPY-----GEFKS---VYVVLDLMESDLHQ 148
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
             H  +      +  R++  +++  + ++H   ++HRDLKP N+L++ +  + + DFG+A
Sbjct: 149 IIHSSQPLTL--EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 206
Query: 263 KEIDESSRS-----NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTH 316
           + +  S             T  Y APE++LS   + +  D WSVG +  EML  +  F  
Sbjct: 207 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 266
Query: 317 ANR-QKLQ--------------QRIINEKVK-----LPPFLTSEAHSLLKG-----VSFL 351
            N   +LQ              Q +  E+V+     LPP       ++  G     +S L
Sbjct: 267 KNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLL 326
Query: 352 TQLLHKDPSKRLGSG 366
            ++L  +PS R+ + 
Sbjct: 327 GRMLRFEPSARISAA 341

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 288 AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 343
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HR+L   N L+  +  V + DFG
Sbjct: 344 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 402
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 403 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 33/180 (18%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 270 RS-----NSMCGTTEYMAPEILLSKGH-------NKDADWWSVGILLYEMLT-GQPPFTH 316
            S     N+  GT+ + APE+L    +        +  D +S+G + Y +L+ G+ PF  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 317 ANRQKLQQRIINEKVKLPPFLTSEAHSLL-KGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
            ++   +  II     L         SL+ +    ++Q++  DP KR    P  +  ++H
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 296

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 115/255 (45%), Gaps = 23/255 (9%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ + +  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-- 263
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 264 EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
           E D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 321 KLQQRIINEKVKLPP 335
            +  + ++E  +LPP
Sbjct: 258 DV-IKAVDEGYRLPP 271

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 154
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 155 LSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 112/246 (45%), Gaps = 28/246 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 69
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 70  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 122
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSK 182
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242
Query: 335 PFLTSE 340
           P L SE
Sbjct: 243 PHLASE 248

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 249 AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+   +E  A    +   +I SA+ +L K   +HR+L   N L+  +  V + DFG
Sbjct: 305 DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 34/182 (18%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 191
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN--------------RQK 321
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +               + 
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251
Query: 322 LQQRIINEKVKLPP----------------FLTSEAHSLL--KGVSFLTQLLHKDPSKRL 363
           L   I    ++L P                F+ SE   L+  + + FL +LL  D   RL
Sbjct: 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311
Query: 364 GS 365
            +
Sbjct: 312 TA 313

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 34/182 (18%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN--------------RQK 321
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +               + 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 322 LQQRIINEKVKLPP----------------FLTSEAHSLL--KGVSFLTQLLHKDPSKRL 363
           L   I    ++L P                F+ SE   L+  + + FL +LL  D   RL
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 313
Query: 364 GS 365
            +
Sbjct: 314 TA 315

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 34/182 (18%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN--------------RQK 321
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +               + 
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 322 LQQRIINEKVKLPP----------------FLTSEAHSLL--KGVSFLTQLLHKDPSKRL 363
           L   I    ++L P                F+ SE   L+  + + FL +LL  D   RL
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 364 GS 365
            +
Sbjct: 313 TA 314

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 139 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 198
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 199 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 241

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 20/179 (11%)
Query: 150 KDTIIKKNHVDYMKAERDI--LTKVTHPFIVQ-------LRYSFQTRSK---------LY 191
           K  +IK+   +  KAER++  L K+ H  IV          Y  +T SK         L+
Sbjct: 37  KTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLF 96
Query: 192 LILDFINGGHLFFHLYRQGIFREDQ--ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           + ++F + G L   + ++   + D+  A     +I   V ++H   +++RDLKP NI + 
Sbjct: 97  IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156
Query: 250 SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
               V + DFGL   +    +     GT  YM+PE + S+ + K+ D +++G++L E+L
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 19/132 (14%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-------------S 269
           +I  AV  LH  G++HRDLKP NI    D  V + DFGL   +D+              +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIIN 328
           R     GT  YM+PE +    ++   D +S+G++L+E+L    PF T   R +    + N
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN 242
Query: 329 EKVKLPPFLTSE 340
             +K PP  T +
Sbjct: 243 --LKFPPLFTQK 252

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCG 276
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 117/269 (43%), Gaps = 28/269 (10%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F + R++G+G F                    A+K+++ D I   +  ++++ E   + +
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKV--AVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 172 VTHPFIVQLR-YSFQTRSKLYL-----ILDFINGG--HLFFHLYRQG-----IFREDQAR 218
             HP + +L   S ++R+K  L     IL F+  G  H F    R G     +  +   R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT- 277
           F   +I   + +L     +HRDL   N ++  D  V + DFGL+++I         C + 
Sbjct: 142 F-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKL 333
              +++A E L    +   +D W+ G+ ++E++T GQ P+      ++   +I   ++K 
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           PP    E + L      + Q    DP +R
Sbjct: 261 PPECMEEVYDL------MYQCWSADPKQR 283

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 29/176 (16%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 270 RS-----NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
                  N+  GT+ + APE+L     +   +  D +S+G + Y +L+ G+ PF   ++ 
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 258
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLL-KGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
             +  II     L         SL+ +    ++Q++  DP KR    P  +  ++H
Sbjct: 259 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 310

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 112/246 (45%), Gaps = 28/246 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 54
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 55  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 107
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSK 167
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 227
Query: 335 PFLTSE 340
           P L SE
Sbjct: 228 PHLASE 233

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 29/176 (16%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 270 RS-----NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 320
                  N+  GT+ + APE+L     +   +  D +S+G + Y +L+ G+ PF   ++ 
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 258
Query: 321 KLQQRIINEKVKLPPFLTSEAHSLL-KGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
             +  II     L         SL+ +    ++Q++  DP KR    P  +  ++H
Sbjct: 259 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 310

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ + +  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 323 QQRIINEKVKLPP 335
             + ++E  +LPP
Sbjct: 260 -IKAVDEGYRLPP 271

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 112/246 (45%), Gaps = 28/246 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 69
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 70  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 122
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 182
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242
Query: 335 PFLTSE 340
           P L SE
Sbjct: 243 PHLASE 248

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ + +  G L          R+
Sbjct: 58  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRK 110
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EI 265
             A+F   ++V       S + +L   G VHRDL   NIL++S+    ++DFGL++  E 
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 266 DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL 322
           D  +   +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q +
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230
Query: 323 QQRIINEKVKLPP 335
             + ++E  +LPP
Sbjct: 231 -IKAVDEGYRLPP 242

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 43/255 (16%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HL 202
           A + +R+  I+K    D + A +DIL + T P+       F++   +Y++LD +    H 
Sbjct: 97  AKRTLRELKILKHFKHDNIIAIKDIL-RPTVPY-----GEFKS---VYVVLDLMESDLHQ 147
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
             H  +      +  R++  +++  + ++H   ++HRDLKP N+L++ +  + + DFG+A
Sbjct: 148 IIHSSQPLTL--EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205
Query: 263 KEIDESSRS-----NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTH 316
           + +  S             T  Y APE++LS   + +  D WSVG +  EML  +  F  
Sbjct: 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265
Query: 317 ANR-QKLQ--------------QRIINEKVK-----LPPFLTSEAHSLLKG-----VSFL 351
            N   +LQ              Q +  E+V+     LPP       ++  G     +S L
Sbjct: 266 KNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLL 325
Query: 352 TQLLHKDPSKRLGSG 366
            ++L  +PS R+ + 
Sbjct: 326 GRMLRFEPSARISAA 340

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 94/194 (48%), Gaps = 24/194 (12%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 72  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 124
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE- 267
             RF   ++V       S + +L     VHRDL   NIL++S+    ++DFG+++ +++ 
Sbjct: 125 DGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 268 -----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
                ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q 
Sbjct: 185 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 242
Query: 322 LQQRIINEKVKLPP 335
           +  + I E  +LPP
Sbjct: 243 V-IKAIEEGYRLPP 255

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 112/246 (45%), Gaps = 28/246 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 61  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 113
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 114 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 173
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 174 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 233
Query: 335 PFLTSE 340
           P L SE
Sbjct: 234 PHLASE 239

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQ-----TRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           E  +L    HP I+ LR  F         KLYL+ + +    L   ++ Q I    Q  +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQ 137
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           ++   I+  +  LH+ G+VHRDL P NIL+  +  + + DF LA+E    +         
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 279 EYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF 314
            Y APE+++  KG  K  D WS G ++ EM   +  F
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 94/194 (48%), Gaps = 24/194 (12%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 57  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 109
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE- 267
             RF   ++V       S + +L     VHRDL   NIL++S+    ++DFG+++ +++ 
Sbjct: 110 DGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 169
Query: 268 -----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
                ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q 
Sbjct: 170 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 227
Query: 322 LQQRIINEKVKLPP 335
           +  + I E  +LPP
Sbjct: 228 V-IKAIEEGYRLPP 240

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQ-----TRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           E  +L    HP I+ LR  F         KLYL+ + +    L   ++ Q I    Q  +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQ 137
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           ++   I+  +  LH+ G+VHRDL P NIL+  +  + + DF LA+E    +         
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 279 EYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF 314
            Y APE+++  KG  K  D WS G ++ EM   +  F
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 94/194 (48%), Gaps = 24/194 (12%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 51  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 103
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE- 267
             RF   ++V       S + +L     VHRDL   NIL++S+    ++DFG+++ +++ 
Sbjct: 104 DGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 163
Query: 268 -----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
                ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q 
Sbjct: 164 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 221
Query: 322 LQQRIINEKVKLPP 335
           +  + I E  +LPP
Sbjct: 222 V-IKAIEEGYRLPP 234

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           +K   D++  E  I+ +  HP +V L         + ++++F+  G L   L +  G F 
Sbjct: 85  EKQRRDFL-CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT 143
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-- 271
             Q       I + + +L   G VHRDL   NIL++S+    ++DFGL++ I++   +  
Sbjct: 144 VIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVY 203
Query: 272 NSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN 328
            +  G     + APE +  +     +D WS GI+++E+++ G+ P+   + Q +  + I 
Sbjct: 204 TTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-IKAIE 262
Query: 329 EKVKLPPFLTSEA--HSLL 345
           E  +LP  +   A  H L+
Sbjct: 263 EGYRLPAPMDCPAGLHQLM 281

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 30/196 (15%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAER--DILTKVTHPFIVQL-RYSFQTRS---KLYLILDF 196
           YA+K      I+     D  +A+R  D+     HP I++L  Y  + R    + +L+L F
Sbjct: 57  YALK-----RILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111
Query: 197 INGGHLFFHLYR---QGIF-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
              G L+  + R   +G F  EDQ  +    I   +  +H  G  HRDLKP NIL+  +G
Sbjct: 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG 171
Query: 253 HVMLTDFGLAKEID---ESSR--------SNSMCGTTEYMAPEILLSKGH---NKDADWW 298
             +L D G   +     E SR        +   C T  Y APE+   + H   ++  D W
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC-TISYRAPELFSVQSHCVIDERTDVW 230
Query: 299 SVGILLYEMLTGQPPF 314
           S+G +LY M+ G+ P+
Sbjct: 231 SLGCVLYAMMFGEGPY 246

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 112/246 (45%), Gaps = 28/246 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 53
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 54  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 106
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 107 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 166
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 167 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 226
Query: 335 PFLTSE 340
           P L SE
Sbjct: 227 PHLASE 232

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
           E  IL + +HP IV+L      +  +Y++++ + GG     L  +G   R         +
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-----T 278
             + + +L     +HRDL   N L+     + ++DFG+++E  E+    +  G       
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVXAASGGLRQVPV 279
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP-PF 336
           ++ APE L    ++ ++D WS GILL+E  + G  P+ + + Q+ ++  + +  +LP P 
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPE 338
Query: 337 LTSEA 341
           L  +A
Sbjct: 339 LCPDA 343

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 7/160 (4%)
Query: 157 NHVDYMKAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           NH+  +K E +IL  + H  IV+ +   +    + + LI++F+  G L  +L + +    
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   Y  +I   + +L     VHRDL   N+L++S+  V + DFGL K I+      +
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 184
Query: 274 MCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +    +    + APE L+       +D WS G+ L+E+LT
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 112/246 (45%), Gaps = 28/246 (11%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 54
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T + 
Sbjct: 55  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 107
Query: 224 ------IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMC 275
                 +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 167
Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 227
Query: 335 PFLTSE 340
           P L SE
Sbjct: 228 PHLASE 233

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 49/86 (56%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +I   V ++H   ++HRDLKP NI +     V + DFGL   +    +     GT  YM+
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 283 PEILLSKGHNKDADWWSVGILLYEML 308
           PE + S+ + K+ D +++G++L E+L
Sbjct: 204 PEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
           E  IL + +HP IV+L      +  +Y++++ + GG     L  +G   R         +
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-----T 278
             + + +L     +HRDL   N L+     + ++DFG+++E  E+    +  G       
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPV 279
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP-PF 336
           ++ APE L    ++ ++D WS GILL+E  + G  P+ + + Q+ ++  + +  +LP P 
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPE 338
Query: 337 LTSEA 341
           L  +A
Sbjct: 339 LCPDA 343

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 33/180 (18%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HVMLTDFGLAKEIDESS 269
           +I S V+HLH   I+HRDLKP+NIL+ +                ++++DFGL K++D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 270 RS-----NSMCGTTEYMAPEILLSKGH-------NKDADWWSVGILLYEMLT-GQPPFTH 316
                  N+  GT+ + APE+L    +        +  D +S+G + Y +L+ G+ PF  
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 317 ANRQKLQQRIINEKVKLPPFLTSEAHSLL-KGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
            ++   +  II     L         SL+ +    ++Q++  DP KR    P  +  ++H
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 296

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 7/160 (4%)
Query: 157 NHVDYMKAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           NH+  +K E +IL  + H  IV+ +   +    + + LI++F+  G L  +L + +    
Sbjct: 53  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 112
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   Y  +I   + +L     VHRDL   N+L++S+  V + DFGL K I+      +
Sbjct: 113 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 172
Query: 274 MCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
           +    +    + APE L+       +D WS G+ L+E+LT
Sbjct: 173 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 83/166 (50%), Gaps = 28/166 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF----- 219
           E  ++  + HP +++         +L  I ++I GG L      +GI +   +++     
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL------RGIIKSMDSQYPWSQR 110
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK-EIDESS------- 269
             +  +I S +++LH   I+HRDL   N L+  + +V++ DFGLA+  +DE +       
Sbjct: 111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 270 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
                  +  ++ G   +MAPE++  + +++  D +S GI+L E++
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 2/153 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           +L ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEIL 286
           +   H   ++HRDLKP+N+L++ +G + L DFGLA+      R  S    T  Y  P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 287 L-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             +K ++   D WS G +  E+     P    N
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPLFPGN 206

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 111/245 (45%), Gaps = 28/245 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G F                    A+K++++ ++ +   ++    E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----EA 50
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE-- 223
            ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T +  
Sbjct: 51  KVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQLL 103
Query: 224 -----IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCG 276
                +  A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S     
Sbjct: 104 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
              +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        P
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 223
Query: 336 FLTSE 340
            L SE
Sbjct: 224 HLASE 228

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 11/167 (6%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L+   HP +V L      R+++ LI  ++  G+L  HLY   +     +     EI    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 229 S----HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSMCGTTEYM 281
           +    +LH   I+HRD+K  NIL+D +    +TDFG++K   E+ ++     + GT  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
            PE  +     + +D +S G++L+E+L  +        Q L + ++N
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV----QSLPREMVN 251

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/270 (21%), Positives = 121/270 (44%), Gaps = 25/270 (9%)
Query: 80  LSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXX 139
           ++  + + I     E+  E   E  ++I     +I +V+G G F                
Sbjct: 3   MTPGMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI 62
Query: 140 XXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
               A+K + K    +K   D++ +E  I+ +  HP ++ L       + + +I +F+  
Sbjct: 63  --FVAIKTL-KSGYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN 118
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDG 252
           G L          R++  +F   ++V       + + +L     VHRDL   NIL++S+ 
Sbjct: 119 GSL------DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL 172
Query: 253 HVMLTDFGLAKEIDESSR----SNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYE 306
              ++DFGL++ +++ +     ++++ G     + APE +  +     +D WS GI+++E
Sbjct: 173 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 232
Query: 307 MLT-GQPPFTHANRQKLQQRIINEKVKLPP 335
           +++ G+ P+     Q +    I +  +LPP
Sbjct: 233 VMSYGERPYWDMTNQDVINA-IEQDYRLPP 261

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 93/186 (50%), Gaps = 8/186 (4%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFR 213
           +K  VD++  E  I+ + +H  I++L         + +I +++  G L  F   + G F 
Sbjct: 87  EKQRVDFL-GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS 145
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSN 272
             Q       I + + +L     VHRDL   NIL++S+    ++DFGL++ + D+   + 
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 273 SMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN 328
           +  G      + APE +  +     +D WS GI+++E++T G+ P+   +  ++  + IN
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKAIN 264
Query: 329 EKVKLP 334
           +  +LP
Sbjct: 265 DGFRLP 270

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 47/238 (19%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  +EI  ++G G++                  +   K++R    + ++ +D  +  R+I
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRV----VAIKKILR----VFEDLIDCKRILREI 103
Query: 169 --LTKVTHPFIVQ-----LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF-REDQARFY 220
             L ++ H  +V+     +    +   +LY++L+  +    F  L+R  ++  E   +  
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTL 161
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS------- 273
              ++  V ++H  GI+HRDLKP N L++ D  V + DFGLA+ +D     NS       
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 274 ------------------MCG---TTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT 309
                             + G   T  Y APE ILL + + +  D WS+G +  E+L 
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 214 EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
           ED        IV A+ HLH K  ++HRD+KP N+L+++ G V   DFG++  + +    +
Sbjct: 135 EDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKD 194
Query: 273 SMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR--QKLQQRI 326
              G   Y APE     L  KG++  +D WS+GI   E+   + P+       Q+L+Q +
Sbjct: 195 IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVV 254
Query: 327 INEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
                +LP    S        V F +Q L K+  +R
Sbjct: 255 EEPSPQLPADKFSAEF-----VDFTSQCLKKNSKER 285

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM-------KA 164
           +E+ +V+G+G+F                    A+K++R +    +   + +       K 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHV-----ALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYT 221
           ++D    V H     +  +F  R+ + +  + ++     + L ++  F+       R + 
Sbjct: 154 DKDNTMNVIH-----MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFA 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSMCGTTE 279
             I+  +  LHK  I+H DLKPENIL+   G   + + DFG      E  R  +   +  
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRF 264
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           Y APE++L   +    D WS+G +L E+LTG P
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 112/227 (49%), Gaps = 17/227 (7%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL-DFINGGHL 202
           A+K + K    ++   D++ +E  I+ +  HP I++L     TR +L +I+ +++  G L
Sbjct: 81  AIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLE-GVVTRGRLAMIVTEYMENGSL 137
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             F     G F   Q       + + + +L   G VHRDL   N+L+DS+    ++DFGL
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 262 AKEI-DESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-T 315
           ++ + D+   + +  G      + APE +  +  +  +D WS G++++E+L  G+ P+  
Sbjct: 198 SRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
             NR  +    + E  +LP  +    H+L +    +    HKD ++R
Sbjct: 258 MTNRDVISS--VEEGYRLPAPMGC-PHALHQ---LMLDCWHKDRAQR 298

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 72
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 73  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM-------KA 164
           +E+ +V+G+G+F                    A+K++R +    +   + +       K 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHV-----ALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYT 221
           ++D    V H     +  +F  R+ + +  + ++     + L ++  F+       R + 
Sbjct: 154 DKDNTMNVIH-----MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFA 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSMCGTTE 279
             I+  +  LHK  I+H DLKPENIL+   G   + + DFG      E  R  +   +  
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRF 264
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           Y APE++L   +    D WS+G +L E+LTG P
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 112/227 (49%), Gaps = 17/227 (7%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL-DFINGGHL 202
           A+K + K    ++   D++ +E  I+ +  HP I++L     TR +L +I+ +++  G L
Sbjct: 81  AIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLE-GVVTRGRLAMIVTEYMENGSL 137
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             F     G F   Q       + + + +L   G VHRDL   N+L+DS+    ++DFGL
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 262 AKEI-DESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-T 315
           ++ + D+   + +  G      + APE +  +  +  +D WS G++++E+L  G+ P+  
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 316 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
             NR  +    + E  +LP  +    H+L +    +    HKD ++R
Sbjct: 258 MTNRDVISS--VEEGYRLPAPMGC-PHALHQ---LMLDCWHKDRAQR 298

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 93/188 (49%), Gaps = 22/188 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPF 314
            T G  P+
Sbjct: 253 FTLGGSPY 260

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y++ +++  G+L 
Sbjct: 61  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLL 116
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
            +L R+    E  A    +   +I SA+ +L K   +HRDL   N L+  +  V + DFG
Sbjct: 117 DYL-RECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFG 175
Query: 261 LAKEI--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           L++ +  D  +         ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 176 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 72
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 73  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 66
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 67  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 114/242 (47%), Gaps = 12/242 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + +  +V+G GAF                  + A+K++ + T  K N V++M  E  I+ 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV-AIKILNETTGPKAN-VEFMD-EALIMA 95
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
            + HP +V+L         + L+   +  G L  + H ++  I  +     +  +I   +
Sbjct: 96  SMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCVQIAKGM 153
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEYMAPEI 285
            +L +  +VHRDL   N+L+ S  HV +TDFGLA+ ++   +  +  G     ++MA E 
Sbjct: 154 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 286 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHS 343
           +  +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  T + + 
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 273
Query: 344 LL 345
           ++
Sbjct: 274 VM 275

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 66
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 67  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++F+ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEFLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 100 YGSLREYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 37/193 (19%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I   +++R+ TI+ +   DY+    D++          +        +LY++L+  +   
Sbjct: 67  IDCKRILREITILNRLKSDYIIRLYDLI----------IPDDLLKFDELYIVLEIADSD- 115
Query: 202 LFFHLYRQGIF-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
               L++  IF  E+  +     ++   + +H+ GI+HRDLKP N L++ D  V + DFG
Sbjct: 116 -LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174
Query: 261 LAKEIDESSRSNSMCGTTE-----------------------YMAPE-ILLSKGHNKDAD 296
           LA+ I+    +N +    E                       Y APE ILL + + K  D
Sbjct: 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234
Query: 297 WWSVGILLYEMLT 309
            WS G +  E+L 
Sbjct: 235 IWSTGCIFAELLN 247

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 91/176 (51%), Gaps = 10/176 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 43  AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 97
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGL
Sbjct: 98  DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 157
Query: 262 AKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           A+ I+++  +         ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 158 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDF-AGELEVLC 80
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +   
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
                 +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 9/234 (3%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE----YM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    +    + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 334
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 67
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 68  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 247 IDVYMIM 253

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 71  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 249
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 250 IDVYMIM 256

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 91/176 (51%), Gaps = 10/176 (5%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 216 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 270
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGL
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330
Query: 262 AKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           A+ I+++  +         ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDF-AGELEVLC 70
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +   +   
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
                 +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 115/238 (48%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 63  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 121
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 122 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 181
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 182 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 242 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 292

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 248 IDVYMIM 254

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 3/162 (1%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           +L ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEIL 286
           +   H   ++HRDLKP+N+L++ +G + L +FGLA+      R  S    T  Y  P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 287 L-SKGHNKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRI 326
             +K ++   D WS G +  E+   G+P F   +     +RI
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM-------KA 164
           +E+ +V+G+G F                    A+K++R +    +   + +       K 
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHV-----ALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYT 221
           ++D    V H     +  +F  R+ + +  + ++     + L ++  F+       R + 
Sbjct: 154 DKDNTMNVIH-----MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFA 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDESSRSNSMCGTTE 279
             I+  +  LHK  I+H DLKPENIL+   G   + + DFG      E  R      +  
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRF 264
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           Y APE++L   +    D WS+G +L E+LTG P
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 67
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 68  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 247 IDVYMIM 253

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 249 IDVYMIM 255

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 115/238 (48%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 61  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 119
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 120 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTE 179
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 180 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 240 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 290

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 116/248 (46%), Gaps = 12/248 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   + +  +V+G GAF                  + A+K++ + T  K N V++M  
Sbjct: 10  RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV-AIKILNETTGPKAN-VEFMD- 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  I+  + HP +V+L         + L+   +  G L  + H ++  I  +     +  
Sbjct: 67  EALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCV 124
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTE 279
           +I   + +L +  +VHRDL   N+L+ S  HV +TDFGLA+ ++   +  +  G     +
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFL 337
           +MA E +  +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC 244
Query: 338 TSEAHSLL 345
           T + + ++
Sbjct: 245 TIDVYMVM 252

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 115/238 (48%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 66  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 124
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 125 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 184
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 185 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 245 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 295

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 246 IDVYMIM 252

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 115/238 (48%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKEIDE-SSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++I+      N+  G    ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 303

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 93/188 (49%), Gaps = 22/188 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 120 MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 308 LT-GQPPF 314
            T G  P+
Sbjct: 299 FTLGGSPY 306

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 115/238 (48%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 303

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D  + R +G+GAF                  + A+K ++  T+  +   D+ + E ++LT
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQR-EAELLT 72
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQAR-------- 218
            + H  IV+          L ++ +++  G L   L   G    I  + Q R        
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 219 ----FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM 274
                  ++I S + +L     VHRDL   N L+ ++  V + DFG+++++  S+    +
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRV 191
Query: 275 CGTT----EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIIN 328
            G T     +M PE ++ +    ++D WS G++L+E+ T   QP F  +N + ++     
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 251
Query: 329 EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
             ++ P     E + ++ G         ++P +RL
Sbjct: 252 RVLERPRVCPKEVYDVMLGC------WQREPQQRL 280

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFR 213
           +K   D++  E  I+ +  HP I+ L         + ++ +++  G L   L +  G F 
Sbjct: 64  EKQRRDFL-GEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFT 122
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK--EIDESSRS 271
             Q       I + + +L   G VHRDL   NIL++S+    ++DFGL++  E D  +  
Sbjct: 123 VIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 182
Query: 272 NSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN 328
            +  G     + APE +  +     +D WS GI+++E+++ G+ P+     Q +  + + 
Sbjct: 183 TTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV-IKAVE 241
Query: 329 EKVKLP 334
           E  +LP
Sbjct: 242 EGYRLP 247

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 91/188 (48%), Gaps = 22/188 (11%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 -----------YRQGIFREDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                      Y      E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPF 314
            T G  P+
Sbjct: 253 FTLGGSPY 260

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 92/187 (49%), Gaps = 30/187 (16%)
Query: 162 MKAERDI--LTKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA 217
           M A R+I  L ++ HP ++ L+  F + +  K++L+ D+    H  +H+ +    R  +A
Sbjct: 63  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY--AEHDLWHIIK--FHRASKA 118
Query: 218 ------------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGL 261
                       +    +I+  + +LH   ++HRDLKP NIL+  +    G V + D G 
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 262 AKEIDESSRS----NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTH 316
           A+  +   +     + +  T  Y APE+LL   H  K  D W++G +  E+LT +P F H
Sbjct: 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-H 237
Query: 317 ANRQKLQ 323
             ++ ++
Sbjct: 238 CRQEDIK 244

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 115/238 (48%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 303

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 115/238 (48%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 303

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 111/248 (44%), Gaps = 10/248 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 339 SEAHSLLK 346
            + + +++
Sbjct: 249 IDVYMIMR 256

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 122/288 (42%), Gaps = 44/288 (15%)
Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKD 151
           E+E D + E   E      + E  +V+G GAF                    A+K++++ 
Sbjct: 33  EYEYDLKWEFPRE------NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 86
Query: 152 TIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQ 209
                +  + + +E  ++T++ +H  IV L  +      +YLI ++   G L  +L  ++
Sbjct: 87  A--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 210 GIFREDQARF----------------------YTAEIVSAVSHLHKCGIVHRDLKPENIL 247
             F ED+  +                      +  ++   +  L     VHRDL   N+L
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204
Query: 248 MDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           +     V + DFGLA++I   S    R N+     ++MAPE L    +   +D WS GIL
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARL-PVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 304 LYEMLT-GQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
           L+E+ + G  P+      AN  KL Q     K+  P + T E + +++
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGF--KMDQPFYATEEIYIIMQ 309

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 72  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 127
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 128 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 187 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 46  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 101
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 102 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 160
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 161 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 100 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 48  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 103
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 104 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 162
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 39  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 94
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 95  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 153
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 154 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 111/248 (44%), Gaps = 10/248 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 20  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 76
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 77  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 135
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 136 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 255
Query: 339 SEAHSLLK 346
            + + +++
Sbjct: 256 IDVYMIMR 263

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 45  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 100
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 101 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 159
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 160 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 40  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 95
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 96  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 154
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 155 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 97  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 47  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 102
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 103 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 161
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 162 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 59  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 114
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 115 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 173
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 9/194 (4%)
Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFH 205
           +D  + K+     K E + L  + HP IV+   S+++  K    + L+ +    G L  +
Sbjct: 60  QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTY 119
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFGLA 262
           L R  + +    R +  +I+  +  LH     I+HRDLK +NI +    G V + D GLA
Sbjct: 120 LKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 322
             +  +S + ++ GT E+ APE    K +++  D ++ G    E  T + P++       
Sbjct: 180 T-LKRASFAKAVIGTPEFXAPEXYEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQ 237
Query: 323 QQRIINEKVKLPPF 336
             R +   VK   F
Sbjct: 238 IYRRVTSGVKPASF 251

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 73/139 (52%), Gaps = 20/139 (14%)
Query: 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHR 239
           ++LYLI D+   G L+ +L    +  +   +   +  VS + HLH        K  I HR
Sbjct: 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFSTQGKPAIAHR 166
Query: 240 DLKPENILMDSDGHVMLTDFGLA-KEIDESSRS----NSMCGTTEYMAPEIL---LSKGH 291
           DLK +NIL+  +G   + D GLA K I +++      N+  GT  YM PE+L   L++ H
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNH 226
Query: 292 NKD---ADWWSVGILLYEM 307
            +    AD +S G++L+E+
Sbjct: 227 FQSYIMADMYSFGLILWEV 245

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 97  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 246 IDVYMIM 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 114/238 (47%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+ + + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 303

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-------- 274
           +I  AV  LH  G++HRDLKP NI    D  V + DFGL   +D+     ++        
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 275 -----CGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
                 GT  YM+PE +    ++   D +S+G++L+E+L
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 59  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 114
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 115 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 173
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 73  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 131
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 191
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 192 KHFESFKRADIYAMGLVFWEI 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 98  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 156
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 216
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 217 KHFESFKRADIYAMGLVFWEI 237

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 72  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 130
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 191 KHFESFKRADIYAMGLVFWEI 211

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 169
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 230 KHFESFKRADIYAMGLVFWEI 250

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 111/248 (44%), Gaps = 10/248 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLLK 346
            + + +++
Sbjct: 246 IDVYMIMR 253

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 75  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 133
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 193
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 194 KHFESFKRADIYAMGLVFWEI 214

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 13/163 (7%)
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
            Y++ I  ED    Y+ ++   +  L     +HRDL   NIL+  +  V + DFGLA++I
Sbjct: 191 FYKEPITMEDLIS-YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 266 DESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQP-PFTHANR 319
            ++    R        ++MAPE +  K ++  +D WS G+LL+E+  L G P P    + 
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE 309
Query: 320 QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
               +     +++ P + T E + +      +    H+DP +R
Sbjct: 310 DFCSRLREGMRMRAPEYSTPEIYQI------MLDCWHRDPKER 346

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 248 IDVYMIM 254

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 78  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 136
Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCGTTEYMAPEIL---LSK 289
           HRDLK +NIL+  +G   + D GLA   D ++ +     N   GT  YMAPE+L   ++ 
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 196
Query: 290 GH---NKDADWWSVGILLYEM 307
            H    K AD +++G++ +E+
Sbjct: 197 KHFESFKRADIYAMGLVFWEI 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 16  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 72
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 73  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 131
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 132 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 251
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 252 IDVYMIM 258

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 249 IDVYMIM 255

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 35  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 91
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 92  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 150
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 151 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 270
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 271 IDVYMIM 277

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 114/238 (47%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+ + + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 303

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 246 IDVYMIM 252

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 79/155 (50%), Gaps = 6/155 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE-DQARFYTAE 223
           E   + K++HP +V+          +Y++ ++I+ G L  +L   G   E  Q      +
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           +   ++ L     +HRDL   N L+D D  V ++DFG+ + + +    +S+ GT    ++
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFPVKW 171
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            APE+     ++  +D W+ GIL++E+ + G+ P+
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 249 IDVYMIM 255

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 17  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 73
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 74  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 253 IDVYMIM 259

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 111/248 (44%), Gaps = 10/248 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLLK 346
            + + +++
Sbjct: 248 IDVYMIMR 255

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L      R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 100 YGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDF-AGELEVLC 77
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
             Q   + A++   + +L +   +HR+L   NIL+  +    + DFGL++  +   +   
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
                 +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 251

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K + K    +K   D++ +E  I+ +  HP ++ L       + + +I +F+  G L 
Sbjct: 39  AIKTL-KSGYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL- 95
Query: 204 FHLYRQGIFREDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
                    R++  +F   ++V       + + +L     VHR L   NIL++S+    +
Sbjct: 96  -----DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKV 150
Query: 257 TDFGLAKEIDESSR----SNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT- 309
           +DFGL++ +++ +     ++++ G     + APE +  +     +D WS GI+++E+++ 
Sbjct: 151 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 210
Query: 310 GQPPFTHANRQKLQQRIINEKVKLPP 335
           G+ P+     Q +    I +  +LPP
Sbjct: 211 GERPYWDMTNQDVINA-IEQDYRLPP 235

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 115/238 (48%), Gaps = 31/238 (13%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +++  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEEDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 251 DGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 307
           +  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 308 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQR 303

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 7   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 63
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 64  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 122
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 123 IAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 242
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 243 IDVYMIM 249

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 7/151 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           E +IL  + H  IV+ +     Q    + L+++++  G L  +L R  +    Q   +  
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA-QLLLFAQ 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE--- 279
           +I   +++LH    +HR L   N+L+D+D  V + DFGLAK + E      +    +   
Sbjct: 120 QICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 179
Query: 280 -YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + APE L        +D WS G+ LYE+LT
Sbjct: 180 FWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 7/151 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           E +IL  + H  IV+ +     Q    + L+++++  G L  +L R  +    Q   +  
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA-QLLLFAQ 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE--- 279
           +I   +++LH    +HR L   N+L+D+D  V + DFGLAK + E      +    +   
Sbjct: 119 QICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 178
Query: 280 -YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            + APE L        +D WS G+ LYE+LT
Sbjct: 179 FWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 82/156 (52%), Gaps = 7/156 (4%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           E +++  + H  +V+L Y+  TR + +Y+I +++  G L  F      G     +   ++
Sbjct: 58  EANLMKTLQHDKLVRL-YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS 116
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TE 279
           A+I   ++++ +   +HRDL+  N+L+       + DFGLA+ I+++  +         +
Sbjct: 117 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK 176
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           + APE +        +D WS GILLYE++T G+ P+
Sbjct: 177 WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 61  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 119
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 120 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 219

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 87/217 (40%), Gaps = 63/217 (29%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGH------------------VML 256
           Q R    ++  AV  LH   + H DLKPENIL ++SD                    V +
Sbjct: 138 QVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRV 197
Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-T 315
            DFG A   D    S ++  T  Y APE++L  G ++  D WS+G +++E   G   F T
Sbjct: 198 VDFGSAT-FDHEHHS-TIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQT 255
Query: 316 HANRQKLQQ------------------------------------RIINEKVK-LPPFLT 338
           H NR+ L                                      R + E  K L  +LT
Sbjct: 256 HDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLT 315
Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           SEA    +    +  +L  +P+KRL  G    +A++H
Sbjct: 316 SEAEEHHQLFDLIESMLEYEPAKRLTLG----EALQH 348

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 118 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 60
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 61  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 240 IDVYMIM 246

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 62  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 120
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 121 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 220

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 63  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 121
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 122 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 221

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 55  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 113
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 114 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 173
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++  V +
Sbjct: 97  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 54  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 112
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 113 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 172
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 212

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 118 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 58  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 116
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 117 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 216

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 14/224 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 56  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 112
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S   V L DFGL+
Sbjct: 113 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 172
Query: 263 KEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 318
           + I++    +++      ++M+PE +  +     +D W   + ++E+L+   QP F   N
Sbjct: 173 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +  +      +++  P       ++L      +T+    DPS R
Sbjct: 233 KDVIGVLEKGDRLPKPDLCPPVLYTL------MTRCWDYDPSDR 270

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 29/194 (14%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---DSDGHV--MLTDFGLAKEIDES----SRSNS 273
           +  S ++HLH   IVHRDLKP NIL+   ++ G +  M++DFGL K++       SR + 
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 274 MCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE 329
           + GT  ++APE+L     +      D +S G + Y +++ G  PF  + ++  Q  I+  
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANILLG 243
Query: 330 KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA 389
              L   L  E H  +     + +++  DP KR    P     +K H +F S+       
Sbjct: 244 ACSL-DCLHPEKHEDVIARELIEKMIAMDPQKR----PSAKHVLK-HPFFWSL------- 290
Query: 390 REMQPKFKPDVSGK 403
            E Q +F  DVS +
Sbjct: 291 -EKQLQFFQDVSDR 303

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 248 IDVYMIM 254

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 130 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 189
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 190 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 238

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 149 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 208
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 209 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 257

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 129 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 237

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCG 276
           R+Y  E++ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    
Sbjct: 129 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 322
           +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 237

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 71  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 249
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 250 IDVYMIM 256

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 110/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+  GAF                  + A+K +R+ T  K N    +  
Sbjct: 17  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 73
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 74  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 253 IDVYMIM 259

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 14/224 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 44  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 100
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S   V L DFGL+
Sbjct: 101 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
Query: 263 KEI-DESSRSNSMCGT-TEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 318
           + I DE     S+     ++M+PE +  +     +D W   + ++E+L+   QP F   N
Sbjct: 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +  +      +++  P       ++L      +T+    DPS R
Sbjct: 221 KDVIGVLEKGDRLPKPDLCPPVLYTL------MTRCWDYDPSDR 258

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 110/248 (44%), Gaps = 10/248 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 339 SEAHSLLK 346
            + + +++
Sbjct: 248 IDVYMIMR 255

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 14/224 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 40  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 96
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S   V L DFGL+
Sbjct: 97  HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 156
Query: 263 KEI-DESSRSNSMCGT-TEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 318
           + I DE     S+     ++M+PE +  +     +D W   + ++E+L+   QP F   N
Sbjct: 157 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216
Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           +  +      +++  P       ++L      +T+    DPS R
Sbjct: 217 KDVIGVLEKGDRLPKPDLCPPVLYTL------MTRCWDYDPSDR 254

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 48  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 106
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +      
Sbjct: 107 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 206

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 185 QTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           + ++ +YL+ DF      G L   L +   F   + +     +++ + ++H+  I+HRD+
Sbjct: 95  RCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNKILHRDM 151
Query: 242 KPENILMDSDGHVMLTDFGLAKEI-----DESSRSNSMCGTTEYMAPEILLS-KGHNKDA 295
           K  N+L+  DG + L DFGLA+        + +R  +   T  Y  PE+LL  + +    
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 296 DWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           D W  G ++ EM T + P    N ++ Q  +I++
Sbjct: 212 DLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 174 HPFIVQL-------RYSFQTRSKLYLILDFINGGHLFFHLYR---QGIFREDQARFYTAE 223
           HP IVQ        +    T    +L+L  +  G L   L +   +G    D       +
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 224 IVSAVSHLH--KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE------SSRSNSMC 275
              AV H+H  K  I+HRDLK EN+L+ + G + L DFG A  I        S++  ++ 
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 276 -------GTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
                   T  Y  PEI+    +    +  D W++G +LY +   Q PF    +     R
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LR 260
Query: 326 IINEKVKLPPFLTSEA--HSLLKGVSFLTQLLHKDPSKRL 363
           I+N K  +PP  T     HSL++       +L  +P +RL
Sbjct: 261 IVNGKYSIPPHDTQYTVFHSLIRA------MLQVNPEERL 294

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 24/138 (17%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------------ 253
           FR D  R    +I  +V+ LH   + H DLKPENIL     +                  
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 254 -VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFG A   DE    +++  T  Y APE++L+ G ++  D WS+G +L E   G  
Sbjct: 175 DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
Query: 313 PF-THANRQKL--QQRII 327
            F TH +++ L   +RI+
Sbjct: 233 VFPTHDSKEHLAMMERIL 250

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 77/155 (49%), Gaps = 5/155 (3%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E +++  + H  +V+L         +Y+I +F+  G L  F      G     +   ++A
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEY 280
           +I   ++++ +   +HRDL+  N+L+       + DFGLA+ I+++  +         ++
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 176
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            APE +        ++ WS GILLYE++T G+ P+
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK--------LYLILDFIN---GGHLFFHLYRQGIFR 213
           E  IL  + H  +V L    +T++         +YL+ DF      G L   L +   F 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-----DES 268
             + +     +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+        + 
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 269 SRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           +R  +   T  Y  PE+LL  + +    D W  G ++ EM T + P    N ++ Q  +I
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242
Query: 328 NE 329
           ++
Sbjct: 243 SQ 244

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK--------LYLILDFIN---GGHLFFHLYRQGIFR 213
           E  IL  + H  +V L    +T++         +YL+ DF      G L   L +   F 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-----DES 268
             + +     +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+        + 
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 269 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           +R  +   T  Y  PE+LL  + +    D W  G ++ EM T + P    N ++ Q  +I
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242
Query: 328 NE 329
           ++
Sbjct: 243 SQ 244

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 42  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 97
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
            G L  +L +    R D  +   YT++I   + +L     +HR+L   NIL++++  V +
Sbjct: 98  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKI 156
Query: 257 TDFGLAKEIDESSRSNSMCGTTE----YMAPEILLSKGHNKDADWWSVGILLYEMLT 309
            DFGL K + +      +    E    + APE L     +  +D WS G++LYE+ T
Sbjct: 157 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK--------LYLILDFIN---GGHLFFHLYRQGIFR 213
           E  IL  + H  +V L    +T++         +YL+ DF      G L   L +   F 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 122
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-----DES 268
             + +     +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+        + 
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 269 SRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 327
           +R  +   T  Y  PE+LL  + +    D W  G ++ EM T + P    N ++ Q  +I
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 241
Query: 328 NE 329
           ++
Sbjct: 242 SQ 243

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 32/242 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 105 AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS
Sbjct: 283 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPS 335
Query: 361 KR 362
           +R
Sbjct: 336 QR 337

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 32/242 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 56  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 113
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 173
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 174 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 233
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS
Sbjct: 234 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPS 286
Query: 361 KR 362
           +R
Sbjct: 287 QR 288

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  +  M+ +R+ T  K N    +  
Sbjct: 44  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIME-LREATSPKANK--EILD 100
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 101 EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 159
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG---TTEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 160 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 279
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 280 IDVYMIM 286

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 57/90 (63%), Gaps = 4/90 (4%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMA 282
           + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ +++   + + GTT YMA
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           PE L  +   K +D +S G++L E++TG P
Sbjct: 204 PEALRGEITPK-SDIYSFGVVLLEIITGLP 232

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 32/242 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPS 294
Query: 361 KR 362
           +R
Sbjct: 295 QR 296

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 32/242 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 53  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 110
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 170
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 171 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 230
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS
Sbjct: 231 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPS 283
Query: 361 KR 362
           +R
Sbjct: 284 QR 285

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 264 PDYTTPEMYQT------MLDCWHGEPSQR 286

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 32/242 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPS 294
Query: 361 KR 362
           +R
Sbjct: 295 QR 296

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 32/242 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 57  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 114
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 115 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 174
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 175 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 234
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS
Sbjct: 235 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPS 287
Query: 361 KR 362
           +R
Sbjct: 288 QR 289

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+  GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 246 IDVYMIM 252

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 264 PDYTTPEMYQT------MLDCWHGEPSQR 286

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 474
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 475 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 273 PDYTTPEMYQT------MLDCWHGEPSQR 295

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 473
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 474 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 17  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 73
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 74  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 253 IDVYMIM 259

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+  GAF                  + A+K +R+ T  K N    +  
Sbjct: 17  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 73
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 74  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G     ++
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 253 IDVYMIM 259

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 273 PDYTTPEMYQT------MLDCWHGEPSQR 295

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 10/247 (4%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TEY 280
           I   +++L    +VHRDL   N+L+ +  HV +TDFG AK +    +     G     ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 338
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 339 SEAHSLL 345
            + + ++
Sbjct: 246 IDVYMIM 252

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 273 PDYTTPEMYQT------MLDCWHGEPSQR 295

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 94/238 (39%), Gaps = 49/238 (20%)
Query: 109 PGDFEIFRVVGQGAF---------XXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           P ++EI  ++G+G++                           I   +++R+ TI+ +   
Sbjct: 27  PDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 86
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           DY+    D++          +        +LY++L+  +       L++  IF  +Q  +
Sbjct: 87  DYIIRLHDLI----------IPEDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEQHVK 134
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES---------- 268
                ++     +H+ GI+HRDLKP N L++ D  V + DFGLA+ I+            
Sbjct: 135 TILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 269 ----------------SRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT 309
                            +  S   T  Y APE ILL + +    D WS G +  E+L 
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 56/90 (62%), Gaps = 4/90 (4%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMA 282
           + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ +++     + GTT YMA
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           PE L  +   K +D +S G++L E++TG P
Sbjct: 204 PEALRGEITPK-SDIYSFGVVLLEIITGLP 232

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 273 PDYTTPEMYQT------MLDCWHGEPSQR 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 256 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 315
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 316 PDYTTPEMYQT------MLDCWHGEPSQR 338

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 32/242 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPS 294
Query: 361 KR 362
           +R
Sbjct: 295 QR 296

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 32/242 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 49  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 107 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS
Sbjct: 227 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPS 279
Query: 361 KR 362
           +R
Sbjct: 280 QR 281

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 264 PDYTTPEMYQT------MLDCWHGEPSQR 286

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 49  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
               A+I   ++ + +   +HR+L+  NIL+       + DFGLA+ I+++  +      
Sbjct: 108 LDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 207

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 264 PDYTTPEMYQT------MLDCWHGEPSQR 286

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 154
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRDLK +NIL+  +G   + D GLA    +S+      +N   GT  YMA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 283 PEILLSK------GHNKDADWWSVGILLYEM 307
           PE+L            K  D W+ G++L+E+
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 318 PDYTTPEMYQT------MLDCWHGEPSQR 340

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 125
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRDLK +NIL+  +G   + D GLA    +S+      +N   GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 283 PEILLSK------GHNKDADWWSVGILLYEM 307
           PE+L            K  D W+ G++L+E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 269 PDYTTPEMYQT------MLDCWHGEPSQR 291

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 265 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 324
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 325 PDYTTPEMYQT------MLDCWHGEPSQR 347

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 263 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 322
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 323 PDYTTPEMYQT------MLDCWHGEPSQR 345

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 125
Query: 233 -----KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMA 282
                K  I HRDLK +NIL+  +G   + D GLA    +S+      +N   GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 283 PEILLSK------GHNKDADWWSVGILLYEM 307
           PE+L            K  D W+ G++L+E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 215 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 274
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 275 PDYTTPEMYQT------MLDCWHGEPSQR 297

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 51/84 (60%), Gaps = 2/84 (2%)
Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEID--ESSRSNSMCGTTEYMAPEILLSKGHNK 293
           I+HRD+K  NIL+D +   ++ DFGLAK +D  +     ++ GT  ++APE L +   ++
Sbjct: 163 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSE 222
Query: 294 DADWWSVGILLYEMLTGQPPFTHA 317
             D +  G++L E++TGQ  F  A
Sbjct: 223 KTDVFGYGVMLLELITGQRAFDLA 246

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 273 PDYTTPEMYQT------MLDCWHGEPSQR 295

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 309
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 310 PDYTTPEMYQT------MLDCWHGEPSQR 332

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/282 (20%), Positives = 120/282 (42%), Gaps = 49/282 (17%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
             D+      +++S        + +L +  +VHRDL   NIL+     + ++DFGL++++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 266 -DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
            +E S      G    ++MA E L    +   +D WS G+LL+E++T G  P+     ++
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 322 LQQRI-INEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           L   +    +++ P   + E + L      + Q   ++P KR
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRL------MLQCWKQEPDKR 296

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 119/242 (49%), Gaps = 32/242 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHLYRQ---GI------FREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L  +   G+          + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDGHVMLTDFGLAKE---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
           L+  D  + + DFGLA++   ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 304 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++         H  PS
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPS 294
Query: 361 KR 362
           +R
Sbjct: 295 QR 296

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 14/153 (9%)
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQGIFREDQARF 219
           R  L +V HP IVQ+ ++F   +        Y++++++ G  L     ++    E  A  
Sbjct: 130 RQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA-- 186
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           Y  EI+ A+S+LH  G+V+ DLKPENI++ ++  + L D G    I+       + GT  
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSRINS---FGYLYGTPG 242
Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           + APEI+ + G     D ++VG  L  +    P
Sbjct: 243 FQAPEIVRT-GPTVATDIYTVGRTLAALTLDLP 274

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 129
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 130 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCG 276
           Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I    +  R      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 333
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 268
Query: 334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           P + T E +        +    H +PS+R
Sbjct: 269 PDYTTPEMYQT------MLDCWHGEPSQR 291

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 55/90 (61%), Gaps = 4/90 (4%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMA 282
           + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ ++      + GTT YMA
Sbjct: 138 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           PE L  +   K +D +S G++L E++TG P
Sbjct: 198 PEALRGEITPK-SDIYSFGVVLLEIITGLP 226

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 56/210 (26%)
Query: 221 TAEIVSAVSHLHK-CGIVHRDLKPENILM---DSDGHVM---LTDFGLAKEIDESSRSNS 273
           + +++  + ++H+ CGI+H D+KPEN+LM   DS  +++   + D G A   DE   +NS
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNS 195
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG----QPPFTHANRQKLQQ--RII 327
           +  T EY +PE+LL       AD WS   L++E++TG    +P   H+  +      +II
Sbjct: 196 I-QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254
Query: 328 NEKVKLPPFLTS---------EAHSLLKGVS---------------------------FL 351
               +LP +L            +  LL+ +S                           FL
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
           + +L  DP KR  +G      + +H W + 
Sbjct: 315 SPMLQLDPRKRADAG-----GLVNHPWLKD 339

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 56/210 (26%)
Query: 221 TAEIVSAVSHLHK-CGIVHRDLKPENILM---DSDGHVM---LTDFGLAKEIDESSRSNS 273
           + +++  + ++H+ CGI+H D+KPEN+LM   DS  +++   + D G A   DE   +NS
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNS 195
Query: 274 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG----QPPFTHANRQKLQQ--RII 327
           +  T EY +PE+LL       AD WS   L++E++TG    +P   H+  +      +II
Sbjct: 196 I-QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254
Query: 328 NEKVKLPPFLTS---------EAHSLLKGVS---------------------------FL 351
               +LP +L            +  LL+ +S                           FL
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
           + +L  DP KR  +G      + +H W + 
Sbjct: 315 SPMLQLDPRKRADAG-----GLVNHPWLKD 339

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/282 (20%), Positives = 120/282 (42%), Gaps = 49/282 (17%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
             D+      +++S        + +L +  +VHRDL   NIL+     + ++DFGL++++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 266 -DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
            +E S      G    ++MA E L    +   +D WS G+LL+E++T G  P+     ++
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 322 LQQRI-INEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           L   +    +++ P   + E + L      + Q   ++P KR
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRL------MLQCWKQEPDKR 296

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 121
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 111
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 109
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
              ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +  DE+       G 
Sbjct: 110 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 278 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              ++ APE +     +  +D WS G+L++E  + GQ P+
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/282 (20%), Positives = 120/282 (42%), Gaps = 49/282 (17%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
             D+      +++S        + +L +  +VHRDL   NIL+     + ++DFGL++++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 266 -DESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 321
            +E S      G    ++MA E L    +   +D WS G+LL+E++T G  P+     ++
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 322 LQQRI-INEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           L   +    +++ P   + E + L      + Q   ++P KR
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRL------MLQCWKQEPDKR 296

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 87/177 (49%), Gaps = 22/177 (12%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 210 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 264
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGL
Sbjct: 265 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 324
Query: 262 AKEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           A+            G     ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 325 AR-----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 370

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 64/138 (46%), Gaps = 24/138 (17%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------------ 253
           FR D  R    +I  +V+ LH   + H DLKPENIL     +                  
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 254 -VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
            + + DFG A   DE    +++     Y APE++L+ G ++  D WS+G +L E   G  
Sbjct: 175 DIKVVDFGSATYDDE--HHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
Query: 313 PF-THANRQKL--QQRII 327
            F TH +++ L   +RI+
Sbjct: 233 VFPTHDSKEHLAMMERIL 250

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 55/90 (61%), Gaps = 4/90 (4%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMA 282
           + ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ ++    + + GTT Y A
Sbjct: 135 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           PE L  +   K +D +S G++L E++TG P
Sbjct: 195 PEALRGEITPK-SDIYSFGVVLLEIITGLP 223

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 50/84 (59%), Gaps = 2/84 (2%)
Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEID--ESSRSNSMCGTTEYMAPEILLSKGHNK 293
           I+HRD+K  NIL+D +   ++ DFGLAK +D  +     ++ G   ++APE L +   ++
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSE 214
Query: 294 DADWWSVGILLYEMLTGQPPFTHA 317
             D +  G++L E++TGQ  F  A
Sbjct: 215 KTDVFGYGVMLLELITGQRAFDLA 238

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSM 274
           +  ++   +  L     VHRDL   N ++D    V + DFGLA     KE D        
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 257
Query: 334 PP 335
            P
Sbjct: 258 QP 259

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSM 274
           +  ++   +  L     VHRDL   N ++D    V + DFGLA     KE D        
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 195
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 196 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 255
Query: 334 PP 335
            P
Sbjct: 256 QP 257

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
            A+I + + +L    +VH+DL   N+L+    +V ++D GL +E+  +     +  +   
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV 331
             +MAPE ++    + D+D WS G++L+E+ + G  P+   + Q + + I N +V
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 248

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
           +  ++   + +L     VHRDL   N ++D    V + DFGLA+++   E    ++  G 
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGA 196
Query: 278 ---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 197 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 256
Query: 334 PP 335
            P
Sbjct: 257 QP 258

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSM 274
           +  ++   +  L     VHRDL   N ++D    V + DFGLA     KE D        
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 257
Query: 334 PP 335
            P
Sbjct: 258 QP 259

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 35/198 (17%)
Query: 153 IIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           +I  +H   + AE   LT       ++ ++Y F+    + + + ++     F  +     
Sbjct: 57  LIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHES-FLDILNSLS 115
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAK------- 263
           F+E   R Y   +  A+  +H+ GIVHRD+KP N L +       L DFGLA+       
Sbjct: 116 FQE--VREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173
Query: 264 --------EIDESSRSNSMC--------------GTTEYMAPEILLSKGHNKDA-DWWSV 300
                   E  +   S + C              GT  + APE+L    +   A D WS 
Sbjct: 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233
Query: 301 GILLYEMLTGQPPFTHAN 318
           G++   +L+G+ PF  A+
Sbjct: 234 GVIFLSLLSGRYPFYKAS 251

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSM 274
           +  ++   +  L     VHRDL   N ++D    V + DFGLA     KE D        
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 316
Query: 334 PP 335
            P
Sbjct: 317 QP 318

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
            A+I + + +L    +VH+DL   N+L+    +V ++D GL +E+  +     +  +   
Sbjct: 151 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV 331
             +MAPE ++    + D+D WS G++L+E+ + G  P+   + Q + + I N +V
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 265

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSM 274
           +  ++   +  L     VHRDL   N ++D    V + DFGLA     KE D        
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGA 198
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 199 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 258
Query: 334 PP 335
            P
Sbjct: 259 QP 260

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSM 274
           +  ++   +  L     VHRDL   N ++D    V + DFGLA     KE D        
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 198
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 199 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 258
Query: 334 PP 335
            P
Sbjct: 259 QP 260

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA-----KEIDESSRSNSM 274
           +  ++   +  L     VHRDL   N ++D    V + DFGLA     KE D        
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 202
Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 203 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 262
Query: 334 PP 335
            P
Sbjct: 263 QP 264

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/252 (21%), Positives = 109/252 (43%), Gaps = 25/252 (9%)
Query: 118 VGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAF                  + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHI 105
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------IFRED---------QARFYTA 222
           V+          L ++ +++  G L   L   G         ED         Q     +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT---- 278
           ++ + + +L     VHRDL   N L+     V + DFG++++I  S+    + G T    
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLPI 224
Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPPF 336
            +M PE +L +    ++D WS G++L+E+ T   QP +  +N + +       +++ P  
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 284
Query: 337 LTSEAHSLLKGV 348
              E +++++G 
Sbjct: 285 CPPEVYAIMRGC 296

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
           +  ++   + +L     VHRDL   N ++D    V + DFGLA+++   E    ++  G 
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 189
Query: 278 ---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 190 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 249
Query: 334 PP 335
            P
Sbjct: 250 QP 251

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 6/122 (4%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGT 277
           +  ++   + +L     VHRDL   N ++D    V + DFGLA+++   E    ++  G 
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 195
Query: 278 ---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL 333
               ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++  +  L
Sbjct: 196 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 255
Query: 334 PP 335
            P
Sbjct: 256 QP 257
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	447
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	0.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	0.0
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	0.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	0.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	0.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	0.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	0.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-180
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-180
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-174
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-173
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-172
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-169
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-169
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-168
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-168
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-167
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-165
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-165
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-165
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-164
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-162
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-114
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-111
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-95
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-86
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-85
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-84
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-83
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-78
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-77
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-76
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-76
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-75
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-74
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-74
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-73
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-73
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-73
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-73
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-72
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-71
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-71
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-71
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-71
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-71
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-70
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-70
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-70
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-70
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-70
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-70
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-70
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-70
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-70
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-70
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-70
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-70
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-69
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-69
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-69
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-69
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-68
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-68
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-68
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-68
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-68
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-68
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-67
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-67
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-67
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-67
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-67
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-66
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-66
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-66
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-65
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-65
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-65
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-65
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-65
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-64
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-64
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-63
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-63
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-62
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-62
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-62
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-61
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-61
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-60
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-60
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-59
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-58
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-55
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-52
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-51
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-51
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-51
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-50
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-49
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-49
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-48
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-47
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-47
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-47
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-46
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-46
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-46
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-45
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-45
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-43
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-43
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-42
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-42
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-41
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-40
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-40
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-40
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-39
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-39
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-38
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-37
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-37
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-37
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-36
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-35
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-35
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-34
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-34
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-34
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-33
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-33
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-33
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-33
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-33
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-33
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-32
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-32
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-30
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-28
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-28
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-28
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-28
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-27
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-27
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-27
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-26
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-26
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-26
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-26
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-26
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-25
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-25
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-22
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-22
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-20
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-07
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-04

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  526 bits (1358), Expect = 0.0
 Identities = 160/326 (49%), Positives = 221/326 (67%), Gaps = 10/326 (3%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVD 160
               KI P  FE+ RV+G+G +GKVFQV+K      ++  I+AMKV++K  I++      
Sbjct: 9   RGPEKIRPECFELLRVLGKGGYGKVFQVRKVT--GANTGKIFAMKVLKKAMIVRNAKDTA 66

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTE 279
            AEI  A+ HLH+ GI++RDLKPENI+++  GHV LTDFGL KE I + + +++ CGT E
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           YMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ 246

Query: 340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
           EA  LLK       LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP 
Sbjct: 247 EARDLLKK------LLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPL 300

Query: 400 VSGKDCIANFDKCWTTMPADDSPAPT 425
           +  ++ ++ FD  +T     DSP  +
Sbjct: 301 LQSEEDVSQFDSKFTRQTPVDSPDDS 326

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  524 bits (1351), Expect = 0.0
 Identities = 154/381 (40%), Positives = 219/381 (57%), Gaps = 24/381 (6%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
           G S                       L   S     P DF   +V+G+G+FGKV   + K
Sbjct: 1   GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLY 191
                  +  YA+KV++K  I+KK    ++ +ER++L K V HPF+V L +SFQT  KLY
Sbjct: 61  -----AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
            +LD+INGG LF+HL R+  F E +ARFY AEI SA+ +LH   IV+RDLKPENIL+DS 
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175

Query: 252 GHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 310
           GH++LTDFGL KE I+ +S +++ CGT EY+APE+L  + +++  DWW +G +LYEML G
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

Query: 311 QPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGV 370
            PPF   N  ++   I+N+ ++L P +T+ A  LL+G      LL KD +KRLG+     
Sbjct: 236 LPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG------LLQKDRTKRLGA-KDDF 288

Query: 371 DAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP---- 426
             IK H +F  INW  L  +++ P F P+VSG + + +FD  +T  P  ++    P    
Sbjct: 289 MEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVL 348

Query: 427 ------TAGEHFKGYTYVAPN 441
                  A E F G++Y  P 
Sbjct: 349 VTASVKEAAEAFLGFSYAPPT 369

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  518 bits (1336), Expect = 0.0
 Identities = 152/330 (46%), Positives = 210/330 (63%), Gaps = 10/330 (3%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
            ++         E   K  P  FE+ +V+GQG+FGKVF VKK      D+  +YAMKV++
Sbjct: 4   SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKIS--GSDARQLYAMKVLK 61

Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ 209
           K T+  ++ V   K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++
Sbjct: 62  KATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE 120

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDES 268
            +F E+  +FY AE+  A+ HLH  GI++RDLKPENIL+D +GH+ LTDFGL+KE ID  
Sbjct: 121 VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
            ++ S CGT EYMAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+ 
Sbjct: 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

Query: 329 EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 388
            K+ +P FL+ EA SLL+       L  ++P+ RLG+GP GV+ IK H +F +I+W  L 
Sbjct: 241 AKLGMPQFLSPEAQSLLRM------LFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY 294

Query: 389 AREMQPKFKPDVSGKDCIANFDKCWTTMPA 418
            RE+ P FKP     +    FD  +T    
Sbjct: 295 RREIHPPFKPATGRPEDTFYFDPEFTAKTP 324

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  516 bits (1331), Expect = 0.0
 Identities = 127/345 (36%), Positives = 202/345 (58%), Gaps = 18/345 (5%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +  ++   DF    V+G+G+FGKV   ++K      +D +YA+K+++KD +I+ + V+  
Sbjct: 13  NRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECT 67

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ +L      PF+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY 
Sbjct: 68  MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI   +  L   GI++RDLK +N+++DS+GH+ + DFG+ KE I +   + + CGT +Y
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 187

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           +APEI+  + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ E
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 247

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 400
           A ++ KG      L+ K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP  
Sbjct: 248 AVAICKG------LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 301

Query: 401 SGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGYTYVAPN 441
            G++   NFD+ +T  P   +P             F+G+++V   
Sbjct: 302 CGRN-AENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSE 345

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  514 bits (1325), Expect = 0.0
 Identities = 132/346 (38%), Positives = 208/346 (60%), Gaps = 23/346 (6%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
           L G      LL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ + 
Sbjct: 236 LAG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289

Query: 405 CIANFDKCWTTMPADDSPAPTP-----------TAGEHFKGYTYVA 439
               FD  +T      +P                  E F+ + Y+A
Sbjct: 290 DTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  514 bits (1326), Expect = 0.0
 Identities = 130/357 (36%), Positives = 206/357 (57%), Gaps = 18/357 (5%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
             +    +   S  ++G  +FE  RV+G+G+FGKV   + K     ++  +YA+KV++KD
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVK-----ETGDLYAVKVLKKD 59

Query: 152 TIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
            I++ + V+    E+ IL+    HPF+ QL   FQT  +L+ +++F+NGG L FH+ +  
Sbjct: 60  VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR 119

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESS 269
            F E +ARFY AEI+SA+  LH  GI++RDLK +N+L+D +GH  L DFG+ KE I    
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
            + + CGT +Y+APEIL    +    DWW++G+LLYEML G  PF   N   L + I+N+
Sbjct: 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

Query: 330 KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLE 388
           +V  P +L  +A  +LK        + K+P+ RLGS   GG  AI  H +F+ I+W  L 
Sbjct: 240 EVVYPTWLHEDATGILKS------FMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLN 293

Query: 389 AREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGYTYVAPN 441
            R+++P F+P +  ++ ++NFD  +       +P           + F+ + YV+P 
Sbjct: 294 HRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSPE 350

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  508 bits (1310), Expect = 0.0
 Identities = 117/330 (35%), Positives = 198/330 (60%), Gaps = 15/330 (4%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K    DF+I R +G G+FG+V  ++ +      +   YAMKV++K+ +++   V++   E
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
           R +L+ VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+ 
Sbjct: 57  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEI 285
            A+ +LH   I++RDLKPENIL+D +GH+ +TDFG AK + +   + ++CGT +Y+APE+
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEV 174

Query: 286 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL 345
           + +K +NK  DWWS GIL+YEML G  PF  +N  K  ++I+N +++ PPF   +   LL
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234

Query: 346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKD 404
                   L+ +D S+RLG+   G + +K+H WF+ + W+ L +R ++  ++P +  G+ 
Sbjct: 235 SR------LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQG 288

Query: 405 CIANFDKCWTTMPADDSPAPTPTAGEHFKG 434
             + FDK +     +          + F+ 
Sbjct: 289 DTSQFDK-YPEEDINYGVQGEDPYADLFRD 317

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  508 bits (1309), Expect = e-180
 Identities = 131/394 (33%), Positives = 230/394 (58%), Gaps = 28/394 (7%)

Query: 65  HNRSHSFVGPSP-RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
           H+  H +  P+        ++   I+E +   +     ++   +G  DF++ RV+G+G++
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSY 65

Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY 182
            KV  V+ K      +D IYAM+V++K+ +     +D+++ E+ +  + + HPF+V L  
Sbjct: 66  AKVLLVRLK-----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120

Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
            FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI  A+++LH+ GI++RDLK
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 180

Query: 243 PENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVG 301
            +N+L+DS+GH+ LTD+G+ KE +     +++ CGT  Y+APEIL  + +    DWW++G
Sbjct: 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240

Query: 302 ILLYEMLTGQPPFTHA---------NRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLT 352
           +L++EM+ G+ PF                L Q I+ +++++P  L+ +A S+LK      
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS----- 295

Query: 353 QLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 411
             L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++SG+  + NFD 
Sbjct: 296 -FLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS 354

Query: 412 CWTTMPADDSPAPTP----TAGEHFKGYTYVAPN 441
            +T  P   +P             F+G+ Y+ P 
Sbjct: 355 QFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL 388

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  505 bits (1302), Expect = e-180
 Identities = 127/354 (35%), Positives = 216/354 (61%), Gaps = 27/354 (7%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +G  DF++ RV+G+G++ KV  V+ K      +D IYAMKV++K+ +     +D++
Sbjct: 2   AMDPLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMKVVKKELVNDDEDIDWV 56

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           + E+ +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI  A+++LH+ GI++RDLK +N+L+DS+GH+ LTD+G+ KE +     +++ CGT  Y
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---------NRQKLQQRIINEKV 331
           +APEIL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236

Query: 332 KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAR 390
           ++P  L+ +A S+LK        L+KDP +RLG  P  G   I+ H +FR+++W  +E +
Sbjct: 237 RIPRSLSVKAASVLKS------FLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQK 290

Query: 391 EMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP----TAGEHFKGYTYVAP 440
           ++ P FKP++SG+  + NFD  +T  P   +P             F+G+ Y+ P
Sbjct: 291 QVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINP 344

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  491 bits (1265), Expect = e-174
 Identities = 145/333 (43%), Positives = 212/333 (63%), Gaps = 18/333 (5%)

Query: 87  QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
           Q+  ++HE           K+G  +FE+ +V+G GA+GKVF V+K      D+  +YAMK
Sbjct: 31  QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKIS--GHDTGKLYAMK 88

Query: 147 VMRKDTII-KKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           V++K TI+ K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF 
Sbjct: 89  VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 148

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+KE
Sbjct: 149 HLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208

Query: 265 --IDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFT----H 316
              DE+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG  PFT     
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268

Query: 317 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH 376
            ++ ++ +RI+  +   P  +++ A  L++       LL KDP KRLG GP   D IK H
Sbjct: 269 NSQAEISRRILKSEPPYPQEMSALAKDLIQR------LLMKDPKKRLGCGPRDADEIKEH 322

Query: 377 KWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 409
            +F+ INW  L A+++   FKP +  +  ++NF
Sbjct: 323 LFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  489 bits (1260), Expect = e-173
 Identities = 125/363 (34%), Positives = 204/363 (56%), Gaps = 16/363 (4%)

Query: 72  VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
              + + +   S+   + + + +   + E  S+       F+  + +G G+FG+V  VK 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62

Query: 132 KGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191
           K     +S   YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY
Sbjct: 63  K-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
           ++++++ GG +F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177

Query: 252 GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           G++ +TDFG AK +    R+ ++CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G 
Sbjct: 178 GYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

Query: 312 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVD 371
           PPF      ++ ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN------LLQVDLTKRFGNLKNGVN 289

Query: 372 AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEH 431
            IK+HKWF + +W  +  R+++  F P   G    +NFD  +       S       G+ 
Sbjct: 290 DIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD-YEEEEIRVS--INEKCGKE 346

Query: 432 FKG 434
           F  
Sbjct: 347 FTE 349

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  497 bits (1281), Expect = e-172
 Identities = 134/420 (31%), Positives = 218/420 (51%), Gaps = 19/420 (4%)

Query: 29  SPDFDFTEVFGPLTPCRHNNQSPASTSA-SLGDPQVIHNRSHSFVGPSPRYALSSSLPLQ 87
           S  F  +E+            S       ++  P      +        R  +       
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318

Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
            ++  +         +  ++   DF    V+G+G+FGKV   ++K      +D +YA+K+
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKI 373

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           ++KD +I+ + V+    E+ +L      PF+ QL   FQT  +LY +++++NGG L +H+
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433

Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-I 265
            + G F+E  A FY AEI   +  L   GI++RDLK +N+++DS+GH+ + DFG+ KE I
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493

Query: 266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 325
            +   + + CGT +Y+APEI+  + + K  DWW+ G+LLYEML GQ PF   +  +L Q 
Sbjct: 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553

Query: 326 IINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 385
           I+   V  P  ++ EA ++ KG      L+ K P KRLG GP G   IK H +FR I+W+
Sbjct: 554 IMEHNVAYPKSMSKEAVAICKG------LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607

Query: 386 TLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGYTYVAPN 441
            LE +E+QP +KP  SG++   NFD+ +T  P   +P             F+G+++V   
Sbjct: 608 KLERKEIQPPYKPKASGRN-AENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSE 666

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  486 bits (1252), Expect = e-169
 Identities = 129/442 (29%), Positives = 204/442 (46%), Gaps = 35/442 (7%)

Query: 15  TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
              + LT    S + PD         +T C    +            ++ H   +  V P
Sbjct: 100 ACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHE--YLSVAP 157

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
              Y  S      +Q    E          + +    F  +RV+G+G FG+V   + +  
Sbjct: 158 FADYLDSIYFNRFLQWKWLER---------QPVTKNTFRQYRVLGKGGFGEVCACQVR-- 206

Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL 194
               +  +YA K + K  I K+        E+ IL KV   F+V L Y+++T+  L L+L
Sbjct: 207 ---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263

Query: 195 DFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
             +NGG L FH+Y  G   F E +A FY AEI   +  LH+  IV+RDLKPENIL+D  G
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 312
           H+ ++D GLA  + E        GT  YMAPE++ ++ +    DWW++G LLYEM+ GQ 
Sbjct: 324 HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

Query: 313 PFTHANRQ----KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPG 368
           PF    ++    ++++ +     +     + +A SL         LL KDP++RLG   G
Sbjct: 384 PFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ------LLCKDPAERLGCRGG 437

Query: 369 GVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC--IANFDKCWTTMPADDSPAPTP 426
               +K H  F+ +N+K L A  ++P FKPD     C  + + ++  T           P
Sbjct: 438 SAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKG----VELEP 493

Query: 427 TAGEHFKGYTYVA-PNPWLSSV 447
           T  + ++ +   + P PW + +
Sbjct: 494 TDQDFYQKFATGSVPIPWQNEM 515

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  477 bits (1230), Expect = e-169
 Identities = 121/345 (35%), Positives = 193/345 (55%), Gaps = 21/345 (6%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + K+   DF + +++G+G+FGKVF  + K      ++  +A+K ++KD ++  + V+  
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECT 64

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY 
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTEY 280
           AEI+  +  LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE +   +++N+ CGT +Y
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
           +APEILL + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  E
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 400
           A  LL        L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V
Sbjct: 245 AKDLLVK------LFVREPEKRLGVRG----DIRQHPLFREINWEELERKEIDPPFRPKV 294

Query: 401 SGKDCIANFDKCWTTMPADDSPAPTP----TAGEHFKGYTYVAPN 441
                 +NFDK +       S A            F+ ++++ P 
Sbjct: 295 KSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPG 339

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  478 bits (1231), Expect = e-168
 Identities = 119/357 (33%), Positives = 192/357 (53%), Gaps = 28/357 (7%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + ++   D+E+ +V+G+GAFG+V  V+ K      +  +YAMK++ K  +IK++   + 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             ERDI+     P++VQL Y+FQ    LY++++++ GG L   +       E  ARFYTA
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA 175

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEY 280
           E+V A+  +H  G +HRD+KP+N+L+D  GH+ L DFG   ++++    R ++  GT +Y
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235

Query: 281 MAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-- 334
           ++PE+L S+G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L   
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 295

Query: 335 --PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM 392
               ++ EA +L+         L  D   RLG    GV+ IK H +F++  W     R+ 
Sbjct: 296 DDNDISKEAKNLICA------FL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDT 346

Query: 393 QPKFKPDVSGKDCIANFDKCWTTMPADDS-PAPTPTAGEH--FKGYTYVAPNPWLSS 446
                PD+S     +NFD        +++ P P    G    F G+TY +   +LSS
Sbjct: 347 VAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSS 403

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  478 bits (1232), Expect = e-168
 Identities = 129/328 (39%), Positives = 201/328 (61%), Gaps = 13/328 (3%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
                E      A+ + ++   +FE  +++G+G FGKV  VK+K      +   YAMK++
Sbjct: 127 DNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK-----ATGRYYAMKIL 181

Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
           +K+ I+ K+ V +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R
Sbjct: 182 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR 241

Query: 209 QGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-ID 266
           + +F ED+ARFY AEIVSA+ +LH +  +V+RDLK EN+++D DGH+ +TDFGL KE I 
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301

Query: 267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
           + +   + CGT EY+APE+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I
Sbjct: 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

Query: 327 INEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT 386
           + E+++ P  L  EA SLL G      LL KDP +RLG G      I  H++F  I W+ 
Sbjct: 362 LMEEIRFPRTLGPEAKSLLSG------LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415

Query: 387 LEAREMQPKFKPDVSGKDCIANFDKCWT 414
           +  +++ P FKP V+ +     FD+ +T
Sbjct: 416 VYEKKLSPPFKPQVTSETDTRYFDEEFT 443

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  487 bits (1254), Expect = e-167
 Identities = 115/358 (32%), Positives = 181/358 (50%), Gaps = 29/358 (8%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           E    +   DF + R++G+G FG+V+  +K      D+  +YAMK + K  I  K     
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETL 235

Query: 162 MKAERDILTKV---THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
              ER +L+ V     PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   R
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           FY AEI+  + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT 
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTH 354

Query: 279 EYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLP 334
            YMAPE+L     ++  ADW+S+G +L+++L G  PF       + ++ +  +   V+LP
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414

Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 394
              + E  SLL+G      LL +D ++RLG    G   +K   +FRS++W+ +  ++  P
Sbjct: 415 DSFSPELRSLLEG------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

Query: 395 KFKPDVSGKDC-----IANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV 447
              P     +      I +FD+  T               E ++ +       W   V
Sbjct: 469 PLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDS-----DQELYRNFPLTISERWQQEV 521

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  469 bits (1209), Expect = e-165
 Identities = 102/327 (31%), Positives = 171/327 (52%), Gaps = 23/327 (7%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +    +    FEI R +G+G+FGKV  V+K      D+  +YAMK M K   +++N V  
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKN-----DTKKMYAMKYMNKQKCVERNEVRN 61

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           +  E  I+  + HPF+V L YSFQ    +++++D + GG L +HL +   F+E+  + + 
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYM 281
            E+V A+ +L    I+HRD+KP+NIL+D  GHV +TDF +A  +   ++  +M GT  YM
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 282 APEILLSK---GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPP 335
           APE+  S+   G++   DWWS+G+  YE+L G+ P+   +  + +++        V  P 
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241

Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK 395
             + E  SLLK       LL  +P +R       +  +++  +   INW  +  + + P 
Sbjct: 242 AWSQEMVSLLKK------LLEPNPDQRF----SQLSDVQNFPYMNDINWDAVFQKRLIPG 291

Query: 396 FKPDVSGKDCIANFDKCWTTMPADDSP 422
           F P+    +C   F+     M  +  P
Sbjct: 292 FIPNKGRLNCDPTFE--LEEMILESKP 316

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  465 bits (1199), Expect = e-165
 Identities = 112/299 (37%), Positives = 173/299 (57%), Gaps = 16/299 (5%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             RK  P DF+  +++G+G+F  V   ++       +   YA+K++ K  IIK+N V Y+
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYV 77

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTA
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI---DESSRSNSMCGTTE 279
           EIVSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +    + +R+NS  GT +
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           Y++PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 257

Query: 340 EAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
           +A  L++       LL  D +KRLG     G   +K H +F S+ W+ L  +   PK  
Sbjct: 258 KARDLVEK------LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT-PPKLT 309

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  469 bits (1208), Expect = e-165
 Identities = 121/370 (32%), Positives = 180/370 (48%), Gaps = 41/370 (11%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            E ++   DFEI +V+G+GAF +V  VK K      +  +YAMK+M K  ++K+  V   
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQVYAMKIMNKWDMLKRGEVSCF 108

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYT 221
           + ERD+L      +I QL ++FQ  + LYL++++  GG L   L + G     + ARFY 
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTE 279
           AEIV A+  +H+ G VHRD+KP+NIL+D  GH+ L DFG   ++  D + RS    GT +
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228

Query: 280 YMAPEILLSKG-------HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK 332
           Y++PEIL + G       +  + DWW++G+  YEM  GQ PF   +  +   +I++ K  
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288

Query: 333 LP-----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 387
           L        +  EA   ++        L   P  RLG   GG    + H +F  ++W  L
Sbjct: 289 LSLPLVDEGVPEEARDFIQR-------LLCPPETRLGR--GGAGDFRTHPFFFGLDWDGL 339

Query: 388 EAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAG----------EHFKGYTY 437
             R+  P F PD  G     NFD     + A  S      +             F GY+Y
Sbjct: 340 --RDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSY 397

Query: 438 VAPNPWLSSV 447
                  S V
Sbjct: 398 SCMALRDSEV 407

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  474 bits (1221), Expect = e-164
 Identities = 117/349 (33%), Positives = 183/349 (52%), Gaps = 23/349 (6%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           + +G   F  FRV+G+G FG+VF  + K      +  +YA K + K  + K+        
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMV 234

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFY 220
           E+ IL KV   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE-IDESSRSNSMCGTTE 279
           TA+IVS + HLH+  I++RDLKPEN+L+D DG+V ++D GLA E     +++    GT  
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPP 335
           +MAPE+LL + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P 
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD 414

Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK 395
             +  +    +       LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P 
Sbjct: 415 KFSPASKDFCEA------LLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

Query: 396 FKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAP-NPW 443
           F PD          D    +       A      E F+ +       PW
Sbjct: 469 FVPDSRTVYAKNIQDVGAFS--TVKGVAFEKADTEFFQEFASGTCPIPW 515

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  462 bits (1191), Expect = e-162
 Identities = 116/357 (32%), Positives = 187/357 (52%), Gaps = 34/357 (9%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + ++   DFEI +V+G+GAFG+V  VK K     ++D ++AMK++ K  ++K+      
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACF 121

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           + ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    E+ ARFY 
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTE 279
           AE+V A+  +H+   VHRD+KP+NILMD +GH+ L DFG   ++  D + +S+   GT +
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 280 YMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
           Y++PEIL +       +  + DWWS+G+ +YEML G+ PF   +  +   +I+N K +  
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301

Query: 335 -----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA 389
                  ++  A  L++        L      RLG    G++  K H +F  I+W  +  
Sbjct: 302 FPTQVTDVSENAKDLIRR-------LICSREHRLGQ--NGIEDFKKHPFFSGIDWDNI-- 350

Query: 390 REMQPKFKPDVSGKDCIANFDK---CWTTMPADDSPAPTPTAGEH--FKGYTYVAPN 441
           R  +  + P+VS     +NFD    C         P  T  +G H  F G+TY +  
Sbjct: 351 RNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSC 407

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  336 bits (865), Expect = e-114
 Identities = 93/305 (30%), Positives = 156/305 (51%), Gaps = 23/305 (7%)

Query: 99  LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
           L    +RK    DF+I R +G+G FG V+  ++K      +  I A+KV+ K  + K+  
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREK-----QNKFIMALKVLFKSQLEKEGV 57

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
              ++ E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++ 
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +  E+  A+ + H+  ++HRD+KPEN+LM   G + + DFG +     S R  +MCGT 
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMCGTL 176

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           +Y+ PE++  K H++  D W  G+L YE L G PPF   +  +  +RI+N  +K PPFL+
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 236

Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
             +  L+       +LL   P +RL      +  +  H W +        +R + P    
Sbjct: 237 DGSKDLIS------KLLRYHPPQRL-----PLKGVMEHPWVK------ANSRRVLPPVYQ 279

Query: 399 DVSGK 403
               K
Sbjct: 280 STQSK 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  327 bits (841), Expect = e-111
 Identities = 90/288 (31%), Positives = 152/288 (52%), Gaps = 17/288 (5%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G FG V+  ++K      S  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLR 57

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           + +A+S+ H   ++HRD+KPEN+L+ S G + + DFG +     SSR   +CGT +Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPP 176

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 391
           L+       +LL  +PS+R       +  +  H W  + + K    + 
Sbjct: 237 LIS------RLLKHNPSQRP-----MLREVLEHPWITANSSKPSNCQN 273

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  288 bits (740), Expect = 2e-95
 Identities = 82/338 (24%), Positives = 132/338 (39%), Gaps = 34/338 (10%)

Query: 46  HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
           H++   +       +         S     PR      +  + +  E       +     
Sbjct: 3   HHHHHSSGVDLGTENLYF-----QSMHQLQPR-----RVSFRGEASETLQSPGYDPSRPE 52

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
                 F+    +G G++G+VF+V+ K  +DG    +YA+K         K+    +  E
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSK--EDGR---LYAVKRSMSPFRGPKDRARKLA-E 106

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
                KV  HP  V+L  +++    LYL  +   G  L  H    G    E Q   Y  +
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRD 165

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
            + A++HLH  G+VH D+KP NI +   G   L DFGL  E+  +       G   YMAP
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQP-PFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E+ L   +   AD +S+G+ + E+      P      Q+L+Q  +    +    L+SE  
Sbjct: 226 EL-LQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL--PPEFTAGLSSELR 282

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
           S+L        +L  DP  R        +A+      R
Sbjct: 283 SVLV------MMLEPDPKLRA-----TAEALLALPVLR 309

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  281 bits (721), Expect = 5e-92
 Identities = 75/337 (22%), Positives = 133/337 (39%), Gaps = 54/337 (16%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----- 156
             E+     D+ I R + QG F K+   +K           YA+K   K  + KK     
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEKDN-------KFYALKKYEKSLLEKKRDFTK 75

Query: 157 ---------NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
                    +  D  K E  I+T + + + +          ++Y+I +++    +     
Sbjct: 76  SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135

Query: 208 RQGI--------FREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTD 258
              +              +     ++++ S++H +  I HRD+KP NILMD +G V L+D
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195

Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTH 316
           FG ++ + +        GT E+M PE   ++   +    D WS+GI LY M     PF+ 
Sbjct: 196 FGESEYMVDKKI-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

Query: 317 -ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS-------------FLTQLLHKDPSKR 362
             +  +L   I  + ++ P       + L    S             FL   L K+P++R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314

Query: 363 LGSGPGGVDAIKHHKWFRSINWKTLE--AREMQPKFK 397
           +       +    H+W    N + L   ++E+  K K
Sbjct: 315 I-----TSEDALKHEWLADTNIEDLREFSKELYKKRK 346

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  264 bits (676), Expect = 3e-86
 Identities = 75/273 (27%), Positives = 146/273 (53%), Gaps = 18/273 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DF++  ++G+G+F  V++ +        +    A+K++ K  + K   V  ++ E  I 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESI-----HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAV 228
            ++ HP I++L   F+  + +YL+L+  + G +  +L  R   F E++AR +  +I++ +
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILL 287
            +LH  GI+HRDL   N+L+  + ++ + DFGLA ++     +  ++CGT  Y++PEI  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
              H  ++D WS+G + Y +L G+PPF     +    +++    ++P FL+ EA  L+  
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH- 244

Query: 348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
                QLL ++P+ RL      + ++  H +  
Sbjct: 245 -----QLLRRNPADRL-----SLSSVLDHPFMS 267

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  262 bits (672), Expect = 8e-85
 Identities = 82/313 (26%), Positives = 152/313 (48%), Gaps = 20/313 (6%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP---GDFEIFRVVGQGAFGKVFQV 129
           GP+P     + +P              +   E  + P     +   R +G+G F K F++
Sbjct: 1   GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI 60

Query: 130 KKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
                 D D+  ++A K++ K  ++K +  + M  E  I   + H  +V     F+    
Sbjct: 61  S-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           ++++L+      L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175

Query: 250 SDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 308
            D  V + DFGLA +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L
Sbjct: 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235

Query: 309 TGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPG 368
            G+PPF  +  ++   RI   +  +P  +   A SL++      ++L  DP+ R      
Sbjct: 236 VGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ------KMLQTDPTARP----- 284

Query: 369 GVDAIKHHKWFRS 381
            ++ + + ++F S
Sbjct: 285 TINELLNDEFFTS 297

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  260 bits (667), Expect = 1e-84
 Identities = 79/297 (26%), Positives = 148/297 (49%), Gaps = 22/297 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +   R +G+G F K F++      D D+  ++A K++ K  ++K +  + M  E  I 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEIS-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  +V     F+    ++++L+      L     R+    E +AR+Y  +IV    
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEILLS 288
           +LH+  ++HRDLK  N+ ++ D  V + DFGLA +++ +  R   +CGT  Y+APE+L  
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 189

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           KGH+ + D WS+G ++Y +L G+PPF  +  ++   RI   +  +P  +   A SL++  
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ-- 247

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK----TLEAREMQPKFKPDVS 401
               ++L  DP+ R       ++ + + ++F S  +      +    + P+F    S
Sbjct: 248 ----KMLQTDPTARP-----TINELLNDEFFTS-GYIPARLPITCLTIPPRFSIAPS 294

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  256 bits (655), Expect = 9e-83
 Identities = 77/308 (25%), Positives = 140/308 (45%), Gaps = 50/308 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           DFE   V+GQGAFG+V + +         D   YA+K +R      +  +  + +E  +L
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNA------LDSRYYAIKKIRH----TEEKLSTILSEVMLL 56

Query: 170 TKVTHPFIVQLRYSFQ-------------TRSKLYLILDFINGGHLFFHLYRQGIF-RED 215
             + H ++V+   ++               +S L++ +++   G L+  ++ + +  + D
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---- 271
           +      +I+ A+S++H  GI+HRDLKP NI +D   +V + DFGLAK +  S       
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 272 -----------NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANR 319
                       S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+   P  T   R
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMER 234

Query: 320 QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
             + +++ +  ++ PP        + K    +  L+  DP+KR      G   + +  W 
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEK--KIIRLLIDHDPNKRP-----GARTLLNSGWL 287

Query: 380 RSINWKTL 387
              +   +
Sbjct: 288 PVKHQDEV 295

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  245 bits (627), Expect = 5e-78
 Identities = 87/320 (27%), Positives = 151/320 (47%), Gaps = 23/320 (7%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKV 147
               H +  +L  E+        +   + +G+G+FGK   VK         DG  Y +K 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKST------EDGRQYVIKE 56

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           +    +  K   +  + E  +L  + HP IVQ R SF+    LY+++D+  GG LF  + 
Sbjct: 57  INISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN 115

Query: 208 RQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
            Q   +F+EDQ   +  +I  A+ H+H   I+HRD+K +NI +  DG V L DFG+A+ +
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

Query: 266 DES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 324
           + +   + +  GT  Y++PEI  +K +N  +D W++G +LYE+ T +  F   + + L  
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

Query: 325 RIINEKVK-LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 383
           +II+     +    + +  SL+       QL  ++P  R       V++I    +     
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVS------QLFKRNPRDRP-----SVNSILEKGFIAKRI 284

Query: 384 WKTLEAREMQPKFKPDVSGK 403
            K L  + +  +F      K
Sbjct: 285 EKFLSPQLIAEEFCLKTFSK 304

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  241 bits (618), Expect = 5e-77
 Identities = 75/319 (23%), Positives = 124/319 (38%), Gaps = 56/319 (17%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             +      + +  ++GQGA   VF+ + K      +  ++A+KV    + ++   VD  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54

Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
             E ++L K+ H  IV+L       T     LI++F   G L+  L          E + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDFGLAKEIDESSRSNS 273
                ++V  ++HL + GIVHR++KP NI+     D      LTDFG A+E+++  +  S
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 274 MCGTTEYMAPEIL--------LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQK 321
           + GT EY+ P++           K +    D WS+G+  Y   TG  PF         ++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 322 LQQRIINEKVK---------------------LPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
           +  +II  K                       +   L+     LL     L  +L  D  
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT--PVLANILEADQE 292

Query: 361 KRLGSGPGGVDAIKHHKWF 379
           K       G D        
Sbjct: 293 KCW-----GFDQFFAETSD 306

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  242 bits (618), Expect = 4e-76
 Identities = 73/308 (23%), Positives = 121/308 (39%), Gaps = 59/308 (19%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             +      + +  ++GQGA   VF+ + K      +  ++A+KV    + ++   VD  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54

Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
             E ++L K+ H  IV+L       T     LI++F   G L+  L          E + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTDFGLAKEIDESSRSNS 273
                ++V  ++HL + GIVHR++KP NI+     D      LTDFG A+E+++  +  S
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 274 MCGTTEYMAPEIL--------LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQK 321
           + GT EY+ P++           K +    D WS+G+  Y   TG  PF         ++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 322 LQQRIINEKV-------------------------KLPPFLTSEAHSLLKGVSFLTQLLH 356
           +  +II  K                           L   L      +L        +L 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN------ILE 288

Query: 357 KDPSKRLG 364
            D  K  G
Sbjct: 289 ADQEKCWG 296

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  238 bits (610), Expect = 7e-76
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 39/294 (13%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +    + I + +G G   KVFQV  +         IYA+K +  +    +    Y   E
Sbjct: 24  SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 76

Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
              L K+      I++L     T   +Y++++      L   L ++      + + Y   
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 135

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEY 280
           ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +S  GT  Y
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194

Query: 281 MAPEILLSKG-----------HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN 328
           M PE +                +  +D WS+G +LY M  G+ PF    N+      II+
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254

Query: 329 --EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
              +++ P     +   +LK        L +DP +R+      +  +  H + +
Sbjct: 255 PNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRI-----SIPELLAHPYVQ 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  237 bits (606), Expect = 6e-75
 Identities = 72/294 (24%), Positives = 126/294 (42%), Gaps = 39/294 (13%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +    + I + +G G   KVFQV  +         IYA+K +  +    +    Y   E
Sbjct: 5   SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 57

Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
              L K+      I++L     T   +Y++++      L   L ++      + + Y   
Sbjct: 58  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 116

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEY 280
           ++ AV  +H+ GIVH DLKP N L+  DG + L DFG+A ++   + S   +S  GT  Y
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175

Query: 281 MAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN 328
           M PE +     +++           +D WS+G +LY M  G+ PF    N+      II+
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235

Query: 329 --EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
              +++ P     +   +LK        L +DP +R+      +  +  H + +
Sbjct: 236 PNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRI-----SIPELLAHPYVQ 278

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  236 bits (603), Expect = 3e-74
 Identities = 45/312 (14%), Positives = 116/312 (37%), Gaps = 45/312 (14%)

Query: 98  ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN 157
            ++ ++E ++G     +  ++G+GAF +V++  +  ++D  +   + +KV +     +  
Sbjct: 53  AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112

Query: 158 HVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-----YRQGIF 212
                    + L        ++   +   ++   L+ +  + G L   +       + + 
Sbjct: 113 I---GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-----------DSDGHVMLTDFGL 261
            +     +   ++  +  +H C I+H D+KP+N ++           D    + L D G 
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 262 AKEI---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           + ++    + +   + C T+ +   E+L +K  N   D++ V   +Y ML G        
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289

Query: 319 RQKLQQR--------------IINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLG 364
             + +                  +  + +P      +  LL+      Q L K   +   
Sbjct: 290 GGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR------QKLKKVFQQHYT 343

Query: 365 SGPGGVDAIKHH 376
           +    + A+++ 
Sbjct: 344 N---KIRALRNR 352

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  232 bits (593), Expect = 9e-74
 Identities = 83/277 (29%), Positives = 139/277 (50%), Gaps = 24/277 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +++   +G+GAF  V +   K      +   +A K++    +  ++    ++ E  I  K
Sbjct: 8   YDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKLSARDFQK-LEREARICRK 61

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A     +I+ ++++ 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 232 HKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           H  GIVHR+LKPEN+L+ S      V L DFGLA E+++S   +   GT  Y++PE+L  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 344
             ++K  D W+ G++LY +L G PPF   ++ +L  +I       P      +T EA SL
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241

Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
           +        +L  +P KR+ +      A+K   W  +
Sbjct: 242 ID------SMLTVNPKKRITA----DQALK-VPWICN 267

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  235 bits (600), Expect = 2e-73
 Identities = 80/345 (23%), Positives = 139/345 (40%), Gaps = 49/345 (14%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERK----------IGPGDFEI 114
           H+  H   G  PR +          E +H +  +L  + + K          +    + I
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
            + +G G   KVFQV  +         IYA+K +  +    +    Y   E   L K+  
Sbjct: 61  LKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQ 113

Query: 175 P--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
               I++L     T   +Y++++      L   L ++      + + Y   ++ AV  +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEILLSK 289
           + GIVH DLKP N L+  DG + L DFG+A ++   + S   +S  G   YM PE +   
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 290 G-----------HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN--EKVKLPP 335
                        +  +D WS+G +LY M  G+ PF    N+      II+   +++ P 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291

Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
               +   +LK        L +DP +R+      +  +  H + +
Sbjct: 292 IPEKDLQDVLK------CCLKRDPKQRI-----SIPELLAHPYVQ 325

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  237 bits (607), Expect = 2e-73
 Identities = 84/309 (27%), Positives = 152/309 (49%), Gaps = 29/309 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++  RV+G+G+FG+V   K K      +    A+KV+ K  + +K   + +  E  +L 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVKQKTDKESLLREVQLLK 81

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HP I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S +++
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           +HK  IVHRDLKPEN+L++S   D ++ + DFGL+   + S +     GT  Y+APE+ L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-L 200

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
              +++  D WS G++LY +L+G PPF  AN   + +++   K          ++  A  
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           L++      ++L   PS R+ +     DA+  H+W ++         ++        +  
Sbjct: 261 LIR------KMLTYVPSMRISA----RDALD-HEWIQTYT-----KEQISVDVPSLDNAI 304

Query: 404 DCIANFDKC 412
             I  F   
Sbjct: 305 LNIRQFQGT 313

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  237 bits (606), Expect = 3e-73
 Identities = 81/309 (26%), Positives = 152/309 (49%), Gaps = 26/309 (8%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
            H +        +       + I  ++G+G+FG+V + K +      +   YA+KV+ K 
Sbjct: 5   HHHSSGRENLYFQGTFA-ERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKA 58

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           +   K+    +  E ++L K+ HP I++L    +  S  Y++ +   GG LF  + ++  
Sbjct: 59  SAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDES 268
           F E  A     ++ S ++++HK  IVHRDLKPENIL++S   D  + + DFGL+    ++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 328
           ++     GT  Y+APE+ L   +++  D WS G++LY +L+G PPF   N   + +R+  
Sbjct: 178 TKMKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236

Query: 329 EKVKLP----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
            K          ++ +A  L++      ++L   PS R+ +       ++ H W +  + 
Sbjct: 237 GKYAFDLPQWRTISDDAKDLIR------KMLTFHPSLRITA----TQCLE-HPWIQKYSS 285

Query: 385 KTLEAREMQ 393
           +T    ++ 
Sbjct: 286 ETPTISDLP 294

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  233 bits (596), Expect = 4e-73
 Identities = 86/316 (27%), Positives = 144/316 (45%), Gaps = 33/316 (10%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
           GP            +  E       +             +++   +G+GAF  V +   K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDN---------YDVKEELGKGAFSVVRRCVHK 51

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                 +   +A K++    +  ++    ++ E  I  K+ HP IV+L  S Q  S  YL
Sbjct: 52  -----TTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYL 105

Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-- 250
           + D + GG LF  +  +  + E  A     +I+ ++++ H  GIVHR+LKPEN+L+ S  
Sbjct: 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165

Query: 251 -DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 309
               V L DFGLA E+++S   +   GT  Y++PE+L    ++K  D W+ G++LY +L 
Sbjct: 166 KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225

Query: 310 GQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGS 365
           G PPF   ++ +L  +I       P      +T EA SL+        +L  +P KR+ +
Sbjct: 226 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID------SMLTVNPKKRITA 279

Query: 366 GPGGVDAIKHHKWFRS 381
                 A+K   W  +
Sbjct: 280 ----DQALK-VPWICN 290

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  233 bits (597), Expect = 7e-72
 Identities = 80/290 (27%), Positives = 147/290 (50%), Gaps = 25/290 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++  + +G GA+G+V   + K      +    A+K++RK ++   ++   +  E  +L 
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVSTSSNSK-LLEEVAVLK 91

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F+ +   YL+++   GG LF  +  +  F E  A     +++S V++
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           LHK  IVHRDLKPEN+L++S   D  + + DFGL+   +   +     GT  Y+APE+ L
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-L 210

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
            K +++  D WS+G++L+ +L G PPF     Q++ +++   K          ++  A  
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 393
           L+K      Q+L  D  +R+ +      A++ H W + +  K     E+ 
Sbjct: 271 LIK------QMLQFDSQRRISAQ----QALE-HPWIKEMCSKKESGIELP 309

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  229 bits (585), Expect = 2e-71
 Identities = 56/386 (14%), Positives = 106/386 (27%), Gaps = 72/386 (18%)

Query: 46  HNNQSPASTSASLGDP-----QVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE 100
           H++ S    +     P     + + NR       +    + S+    +            
Sbjct: 4   HHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFR 63

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
            ESE    P       V+GQ       +   +  + G+    + + V         N + 
Sbjct: 64  VESELGERPRTLVRGTVLGQEDPYAYLEATDQ--ETGE---SFEVHVPYFTERPPSNAIK 118

Query: 161 YMKAER-------------------------DILTKVTHPFIVQLRYSFQTRSKLYLIL- 194
            MK E                          D++       ++++R   +    L     
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178

Query: 195 -------DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
                      G  L  H               T +++  ++ LH  G+VH  L+P +I+
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238

Query: 248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-----------HNKDAD 296
           +D  G V LT F                 +  +  PE+   +                 D
Sbjct: 239 LDQRGGVFLTGFEHLVRDGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLH 356
            W++G+++Y +     P T        + I      +P        +LL+G       L 
Sbjct: 296 AWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ----PVRALLEG------FLR 345

Query: 357 KDPSKRLGSGPGGVDAIKHHKWFRSI 382
                RL               +  +
Sbjct: 346 YPKEDRL-----LPLQAMETPEYEQL 366

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  226 bits (578), Expect = 3e-71
 Identities = 83/260 (31%), Positives = 144/260 (55%), Gaps = 22/260 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F    V+G GAF +VF VK++      +  ++A+K ++K    + + +   + E  +L 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQR-----LTGKLFALKCIKKSPAFRDSSL---ENEIAVLK 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           K+ H  IV L   +++ +  YL++  ++GG LF  +  +G++ E  A     +++SAV +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121

Query: 231 LHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           LH+ GIVHRDLKPEN+L    + +  +M+TDFGL+K ++++   ++ CGT  Y+APE+L 
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLA 180

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 343
            K ++K  D WS+G++ Y +L G PPF      KL ++I     +        ++  A  
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240

Query: 344 LLKGVSFLTQLLHKDPSKRL 363
            +        LL KDP++R 
Sbjct: 241 FIC------HLLEKDPNERY 254

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  226 bits (578), Expect = 4e-71
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 24/291 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDI 168
            +F I + +G+G F +V++           DG   A+K ++   ++          E D+
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACL------LDGVPVALKKVQIFDLMDAKARADCIKEIDL 85

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEI 224
           L ++ HP +++   SF   ++L ++L+  + G L   +        +  E     Y  ++
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAP 283
            SA+ H+H   ++HRD+KP N+ + + G V L D GL +    +++ ++S+ GT  YM+P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--ANRQKLQQRIINEKVK-LPPFLTSE 340
           E +   G+N  +D WS+G LLYEM   Q PF     N   L ++I       LP    SE
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 391
               L+    +   ++ DP KR    P         K   +    +LE   
Sbjct: 266 E---LR--QLVNMCINPDPEKR----PDVTYVYDVAKRMHACTASSLEHHH 307

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  225 bits (575), Expect = 4e-71
 Identities = 68/266 (25%), Positives = 135/266 (50%), Gaps = 27/266 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+E+   +G G++G+  ++++K      SDG I   K +   ++ +      + +E ++L
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRK------SDGKILVWKELDYGSMTEAE-KQMLVSEVNLL 59

Query: 170 TKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE 223
            ++ HP IV+       R+   LY+++++  GG L   + +         E+       +
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGT 277
           +  A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S + +  GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF 336
             YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K  ++P  
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239

Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKR 362
            + E + ++       ++L+     R
Sbjct: 240 YSDELNEIIT------RMLNLKDYHR 259

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  225 bits (576), Expect = 4e-71
 Identities = 79/276 (28%), Positives = 144/276 (52%), Gaps = 25/276 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + I  ++G+G+FG+V + K +      +   YA+KV+ K +   K+    +  E ++L K
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAKNKD-TSTILREVELLKK 77

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP I++L    +  S  Y++ +   GG LF  + ++  F E  A     ++ S ++++
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 232 HKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           HK  IVHRDLKPENIL++S   D  + + DFGL+    ++++     GT  Y+APE+ L 
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LR 196

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 344
             +++  D WS G++LY +L+G PPF   N   + +R+   K          ++ +A  L
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
           ++      ++L   PS R+ +       ++ H W +
Sbjct: 257 IR------KMLTFHPSLRITA----TQCLE-HPWIQ 281

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  224 bits (573), Expect = 1e-70
 Identities = 81/305 (26%), Positives = 146/305 (47%), Gaps = 42/305 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           +E+   +G G F  V + ++K      +   YA K ++K  +         + ++ E +I
Sbjct: 7   YEMGEELGSGQFAIVRKCRQK-----GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  +  +I+  V
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +LH   I H DLKPENI++      +  + L DFG+A +I+  +   ++ GT E++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAH 342
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    I           F      
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF------ 235

Query: 343 SLLKGVS-----FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
                 S     F+ +LL KDP +R+        +++ H W ++I  + +         +
Sbjct: 236 ---SNTSELAKDFIRRLLVKDPKRRMTI----AQSLE-HSWIKAIRRRNV---------R 278

Query: 398 PDVSG 402
            + SG
Sbjct: 279 GEDSG 283

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  224 bits (574), Expect = 1e-70
 Identities = 78/294 (26%), Positives = 136/294 (46%), Gaps = 33/294 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
           +E   ++G+G    V +   K      +   YA+K++        +  +  +        
Sbjct: 19  YEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 168 --ILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             IL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     +
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+APE
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193

Query: 285 IL------LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---- 334
           I+         G+ K+ D WS G+++Y +L G PPF H  +  + + I++   +      
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253

Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 388
              +     L+       + L   P KR        +    H +F+    + + 
Sbjct: 254 DDYSDTVKDLVS------RFLVVQPQKRY-----TAEEALAHPFFQQYVVEEVR 296

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  223 bits (571), Expect = 2e-70
 Identities = 79/277 (28%), Positives = 136/277 (49%), Gaps = 27/277 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + +   +G+G++G+V    +KG     +    A K + K        VD  K E +I+  
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKY---FVEDVDRFKQEIEIMKS 62

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A     +++SAV++ 
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122

Query: 232 HKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           HK  + HRDLKPEN L  +   D  + L DFGLA          +  GT  Y++P++ L 
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LE 181

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 344
             +  + D WS G+++Y +L G PPF+     ++  +I       P      ++ +A SL
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
           ++      +LL K P +R+ S          H+WF  
Sbjct: 242 IR------RLLTKSPKQRITS-----LQALEHEWFEK 267

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  225 bits (575), Expect = 2e-70
 Identities = 92/309 (29%), Positives = 163/309 (52%), Gaps = 32/309 (10%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG--VDDGDSDGIYAMKVMRKDTIIKKNH 158
           A+ +  IG   + + + +G+G F KV    K    +  G      A+K++ K    + N 
Sbjct: 8   ADEQPHIGN--YRLLKTIGKGNFAKV----KLARHILTGRE---VAIKIIDKT---QLNP 55

Query: 159 VDYMKAER--DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ 216
               K  R   I+  + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +
Sbjct: 56  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE 115

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
           AR    +IVSAV + H+  IVHRDLK EN+L+D+D ++ + DFG + E     + ++ CG
Sbjct: 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG 175

Query: 277 TTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
              Y APE+   K ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P 
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 235

Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK 395
           +++++  +LLK      + L  +P KR       ++ I   +W         E  E++P 
Sbjct: 236 YMSTDCENLLK------RFLVLNPIKRG-----TLEQIMKDRWIN----AGHEEDELKPF 280

Query: 396 FKPDVSGKD 404
            +P++   D
Sbjct: 281 VEPELDISD 289

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  223 bits (570), Expect = 2e-70
 Identities = 82/282 (29%), Positives = 142/282 (50%), Gaps = 19/282 (6%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           + +   KIG   + +   +G G FGKV    K G        + A+K++ +  I   + V
Sbjct: 3   KHDGRVKIGH--YVLGDTLGVGTFGKV----KIGEHQLTGHKV-AVKILNRQKIRSLDVV 55

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             +K E   L    HP I++L     T +  ++++++++GG LF ++ + G   E +AR 
Sbjct: 56  GKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +I+SAV + H+  +VHRDLKPEN+L+D+  +  + DFGL+  + +     + CG+  
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175

Query: 280 YMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           Y APE++  +     + D WS G++LY +L G  PF   +   L ++I      +P +L 
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
               +LL        +L  DP KR       +  I+ H+WF+
Sbjct: 236 RSVATLLM------HMLQVDPLKRA-----TIKDIREHEWFK 266

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  225 bits (576), Expect = 2e-70
 Identities = 90/326 (27%), Positives = 154/326 (47%), Gaps = 38/326 (11%)

Query: 46  HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
           H++   +       +       S +        +L     +     +  +D         
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSD--------- 53

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
                 FE+   +G+GA   V++ K+KG     +   YA+KV     + K      ++ E
Sbjct: 54  -----FFEVESELGRGATSIVYRCKQKG-----TQKPYALKV-----LKKTVDKKIVRTE 98

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L +++HP I++L+  F+T +++ L+L+ + GG LF  +  +G + E  A     +I+
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158

Query: 226 SAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
            AV++LH+ GIVHRDLKPEN+L      D  + + DFGL+K ++      ++CGT  Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP----PFL 337
           PEIL    +  + D WSVGI+ Y +L G  PF      Q + +RI+N +          +
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278

Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRL 363
           +  A  L++      +L+  DP KRL
Sbjct: 279 SLNAKDLVR------KLIVLDPKKRL 298

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  226 bits (577), Expect = 2e-70
 Identities = 81/281 (28%), Positives = 137/281 (48%), Gaps = 27/281 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++I   +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 14  YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L +V HP I+ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  +  +I+  V
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           ++LH   I H DLKPENI++        H+ L DFGLA EI++     ++ GT E++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    I               +  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
           A        F+ +LL K+  KRL       +A++ H W   
Sbjct: 249 A------KDFIRKLLVKETRKRLTI----QEALR-HPWITP 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  224 bits (573), Expect = 3e-70
 Identities = 80/284 (28%), Positives = 137/284 (48%), Gaps = 33/284 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++I   +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 14  YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L +V H  ++ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  +  +I+  V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           ++LH   I H DLKPENI++        H+ L DFGLA EI++     ++ GT E++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAH 342
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    I +         F      
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF------ 242

Query: 343 SLLKGVS-----FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
                 S     F+ +LL K+  KRL       +A++ H W   
Sbjct: 243 ---SHTSELAKDFIRKLLVKETRKRLTI----QEALR-HPWITP 278

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  224 bits (573), Expect = 3e-70
 Identities = 76/293 (25%), Positives = 142/293 (48%), Gaps = 27/293 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++    +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 13  YDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP ++ L   ++ ++ + LIL+ + GG LF  L  +    E++A  +  +I++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 229 SHLHKCGIVHRDLKPENILMDS----DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
            +LH   I H DLKPENI++         + + DFGLA +ID  +   ++ GT E++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 340
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    +     +         ++ 
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 393
           A        F+ +LL KDP KR+       D+++ H W +  + +   +R+  
Sbjct: 248 A------KDFIRRLLVKDPKKRMTI----QDSLQ-HPWIKPKDTQQALSRKAS 289

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  222 bits (568), Expect = 6e-70
 Identities = 80/279 (28%), Positives = 135/279 (48%), Gaps = 29/279 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G GAFG V  V+++      S     +K + KD    +  ++ ++AE ++L  
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDRS--QVPMEQIEAEIEVLKS 76

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQARFYTAEIVSA 227
           + HP I+++   F+    +Y++++   GG L         R     E        ++++A
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 228 VSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +++ H   +VH+DLKPENIL         + + DFGLA+       S +  GT  YMAPE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP---FLTSEA 341
           +   +      D WS G+++Y +LTG  PFT  + +++QQ+   ++         LT +A
Sbjct: 197 V-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255

Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
             LLK      Q+L KDP +R          + HH+WF+
Sbjct: 256 VDLLK------QMLTKDPERRP-----SAAQVLHHEWFK 283

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  227 bits (580), Expect = 8e-70
 Identities = 87/279 (31%), Positives = 138/279 (49%), Gaps = 25/279 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF  V +  K       +   YA  ++    +  ++H   ++ E  I  
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKLSARDHQK-LEREARICR 65

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEID-ESSRSNSMCGTTEYMAPEIL 286
            H+ G+VHR+LKPEN+L+ S      V L DFGLA E++ E        GT  Y++PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH 342
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
            L+       ++L  +PSKR+ +     +A+K H W   
Sbjct: 246 DLIN------KMLTINPSKRITA----AEALK-HPWISH 273

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  228 bits (584), Expect = 9e-70
 Identities = 82/288 (28%), Positives = 139/288 (48%), Gaps = 34/288 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------KNHVD 160
            +   R +G GA+G+V   K+K           A+KV++K    K          +   +
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            +  E  +L  + HP I++L   F+ +   YL+ +F  GG LF  +  +  F E  A   
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGT 277
             +I+S + +LHK  IVHRD+KPENIL+++     ++ + DFGL+    +  +     GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--- 334
             Y+APE+ L K +N+  D WS G+++Y +L G PPF   N Q + +++   K       
Sbjct: 212 AYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270

Query: 335 -PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
              ++ EA  L+K       +L  D +KR  +     +A+   +W + 
Sbjct: 271 WKNISDEAKELIK------LMLTYDYNKRCTAE----EALN-SRWIKK 307

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  223 bits (570), Expect = 1e-69
 Identities = 83/282 (29%), Positives = 142/282 (50%), Gaps = 38/282 (13%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           + +G+G+F    +   K      S+  +A+K      II K      + E   L     H
Sbjct: 17  KPLGEGSFSICRKCVHK-----KSNQAFAVK------IISKRMEANTQKEITALKLCEGH 65

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           P IV+L   F  +   +L+++ +NGG LF  + ++  F E +A +   ++VSAVSH+H  
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 235 GIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILLSKG 290
           G+VHRDLKPEN+L    + +  + + DFG A+     ++   + C T  Y APE+L   G
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQ-------KLQQRIINEKVKLP----PFLTS 339
           +++  D WS+G++LY ML+GQ PF   +R        ++ ++I              ++ 
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245

Query: 340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
           EA  L++G      LL  DP+KRL      +  +++++W + 
Sbjct: 246 EAKDLIQG------LLTVDPNKRL-----KMSGLRYNEWLQD 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  221 bits (564), Expect = 2e-69
 Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 51/291 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAER--D 167
           DF+   ++G G FG+VF+ K +       DG  Y +K ++ +           KAER   
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHR------IDGKTYVIKRVKYNN---------EKAEREVK 56

Query: 168 ILTKVTHPFIVQLRYSFQ----------------TRSKLYLILDFINGGHLFFHL--YRQ 209
            L K+ H  IV     +                     L++ ++F + G L   +   R 
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
               +  A     +I   V ++H   +++RDLKP NI +     V + DFGL   +    
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           +     GT  YM+PE + S+ + K+ D +++G++L E+L            K    +   
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF--ETSKFFTDLR-- 232

Query: 330 KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
              +      +  +LL+      +LL K P  R          I       
Sbjct: 233 DGIISDIFDKKEKTLLQ------KLLSKKPEDRP-----NTSEILRTLTVW 272

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  222 bits (568), Expect = 4e-69
 Identities = 71/283 (25%), Positives = 140/283 (49%), Gaps = 31/283 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DIL 169
           +E+  V+G+G F  V +   +     ++   +A+K++          +     +R   I 
Sbjct: 26  YELCEVIGKGPFSVVRRCINR-----ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A  Y  +I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 226 SAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESS-RSNSMCGTTEYM 281
            A+ + H   I+HRD+KP  +L+ S      V L  FG+A ++ ES   +    GT  +M
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFL 337
           APE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+       +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKMNPRQWSHI 259

Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
           +  A  L++      ++L  DP++R+       +A+  H W +
Sbjct: 260 SESAKDLVR------RMLMLDPAERITVY----EALN-HPWLK 291

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  222 bits (566), Expect = 6e-69
 Identities = 77/325 (23%), Positives = 130/325 (40%), Gaps = 71/325 (21%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DI 168
            + +   +GQG++G V    +       +  I A+K+M K+ I + N  D  + +    +
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIEN-----QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------------ 210
           + K+ HP I +L   ++    + L+++  +GGHL   L                      
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 211 ----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
                                 + RE        +I SA+ +LH  GI HRD+KPEN L 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201

Query: 249 DSDG--HVMLTDFGLAKEID-----ESSRSNSMCGTTEYMAPEIL--LSKGHNKDADWWS 299
            ++    + L DFGL+KE       E     +  GT  ++APE+L   ++ +    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 300 VGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGVSFLTQLL 355
            G+LL+ +L G  PF   N      +++N+K+         L+  A  LL        LL
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLS------NLL 315

Query: 356 HKDPSKRLGSGPGGVDAIKHHKWFR 380
           +++  +R             H W  
Sbjct: 316 NRNVDERF-----DAMRALQHPWIS 335

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  229 bits (586), Expect = 1e-68
 Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 42/304 (13%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G +E+   +G G FG V +   +     D+    A+K  R++   K  + +    E  I+
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQ-----DTGEQVAIKQCRQELSPK--NRERWCLEIQIM 66

Query: 170 TKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLY---RQGIFREDQARFY 220
            K+ HP +V  R       KL       L +++  GG L  +L         +E   R  
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRSNSMCGT 277
            ++I SA+ +LH+  I+HRDLKPENI++          + D G AKE+D+        GT
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
            +Y+APE+L  K +    D+WS G L +E +TG  PF    +       + EK      +
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 338 TSEAHSLLK------------------GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
             +    +K                     +L  +L     +R     G      +   F
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR-----GTDPQNPNVGCF 301

Query: 380 RSIN 383
           ++++
Sbjct: 302 QALD 305

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  219 bits (559), Expect = 4e-68
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 33/280 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + I   +G+G FG V +  +       S   Y  K ++     K      +K E  IL  
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKV----KGTDQVLVKKEISILNI 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
             H  I+ L  SF++  +L +I +FI+G  +F           E +   Y  ++  A+  
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 231 LHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           LH   I H D++PENI+  +     + + +FG A+++        +    EY APE+   
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLK 346
              +   D WS+G L+Y +L+G  PF     Q++ + I+N +       F         K
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---------K 228

Query: 347 GVS-----FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
            +S     F+ +LL K+   R+ +     +A++ H W + 
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTA----SEALQ-HPWLKQ 263

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  218 bits (558), Expect = 5e-68
 Identities = 83/287 (28%), Positives = 147/287 (51%), Gaps = 33/287 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---- 166
           ++ + + +G GA G+V    ++      +    A+K++ K      +  +   A      
Sbjct: 11  EYIMSKTLGSGACGEVKLAFER-----KTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 167 -DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y  +++
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 226 SAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
            AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E+S   ++CGT  Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 283 PEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP---- 334
           PE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K        
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
             ++ +A  L+K      +LL  DP  R        +    H W + 
Sbjct: 245 AEVSEKALDLVK------KLLVVDPKARF-----TTEEALRHPWLQD 280

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  221 bits (565), Expect = 6e-68
 Identities = 83/302 (27%), Positives = 149/302 (49%), Gaps = 37/302 (12%)

Query: 100 EAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
               ++ + P        + + +G GA G+V    ++      +    A++++ K     
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIRIISKRKFAI 175

Query: 156 KNHVDYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
            +  +   A       +IL K+ HP I++++  F      Y++L+ + GG LF  +    
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK 234

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDE 267
             +E   + Y  +++ AV +LH+ GI+HRDLKPEN+L+ S   D  + +TDFG +K + E
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

Query: 268 SSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQ 323
           +S   ++CGT  Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354

Query: 324 QRIINEKVKLP----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
            +I + K          ++ +A  L+K      +LL  DP  R        +    H W 
Sbjct: 355 DQITSGKYNFIPEVWAEVSEKALDLVK------KLLVVDPKARF-----TTEEALRHPWL 403

Query: 380 RS 381
           + 
Sbjct: 404 QD 405

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  217 bits (556), Expect = 7e-68
 Identities = 76/305 (24%), Positives = 140/305 (45%), Gaps = 31/305 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-MKAERDI 168
           G + +  ++G+G++GKV     K V D ++    A+K+++K  + +  + +  +K E  +
Sbjct: 5   GKYLMGDLLGEGSYGKV-----KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59

Query: 169 LTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGH--LFFHLYRQGIFREDQARFYTAEI 224
           L ++ H  ++QL      + + K+Y+++++   G   +   +  +  F   QA  Y  ++
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQL 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM---CGTTEYM 281
           +  + +LH  GIVH+D+KP N+L+ + G + ++  G+A+ +   +  ++     G+  + 
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 282 APEILL-SKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
            PEI            D WS G+ LY + TG  PF   N  KL + I      +P     
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238

Query: 340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
               LLKG      +L  +P+KR       +  I+ H WFR    K     E      P 
Sbjct: 239 PLSDLLKG------MLEYEPAKRF-----SIRQIRQHSWFR----KKHPPAEAPVPIPPS 283

Query: 400 VSGKD 404
              KD
Sbjct: 284 PDTKD 288

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  219 bits (559), Expect = 1e-67
 Identities = 87/359 (24%), Positives = 147/359 (40%), Gaps = 34/359 (9%)

Query: 26  SASSPDFDFT-EVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSL 84
            +S  D  F  E        RH          +            + +    +    +  
Sbjct: 7   HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK--LNDA 64

Query: 85  PLQIQELEHENDAELEAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
             +  E  +      E E        +F    +   V+G+G    V +   +      + 
Sbjct: 65  QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR-----ATG 119

Query: 141 GIYAMKVMRKDTIIKKNHV-----DYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL 194
             +A+K+M                +  + E  IL +V  HP I+ L  S+++ S ++L+ 
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179

Query: 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
           D +  G LF +L  +    E + R     ++ AVS LH   IVHRDLKPENIL+D +  +
Sbjct: 180 DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI 239

Query: 255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL------LSKGHNKDADWWSVGILLYEML 308
            L+DFG +  ++   +   +CGT  Y+APEIL         G+ K+ D W+ G++L+ +L
Sbjct: 240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299

Query: 309 TGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
            G PPF H  +  + + I+  + +         +S    L+       +LL  DP  RL
Sbjct: 300 AGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS------RLLQVDPEARL 352

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  217 bits (554), Expect = 2e-67
 Identities = 79/315 (25%), Positives = 135/315 (42%), Gaps = 32/315 (10%)

Query: 92  EHENDAELEAESERKIGPGDFEIF-----RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
            H +  +L  E+       +F  F     + +G+G F  V Q   K      +   YA K
Sbjct: 6   HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISK-----STGQEYAAK 60

Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            ++K    +    + +  E  +L      P ++ L   ++  S++ LIL++  GG +F  
Sbjct: 61  FLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119

Query: 206 LY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFG 260
                  +  E+       +I+  V +LH+  IVH DLKP+NIL+      G + + DFG
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179

Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           ++++I  +     + GT EY+APEIL         D W++GI+ Y +LT   PF   + Q
Sbjct: 180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239

Query: 321 KLQQRIINEKVKLP----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH 376
           +    I    V         ++  A        F+  LL K+P KR  +       +  H
Sbjct: 240 ETYLNISQVNVDYSEETFSSVSQLA------TDFIQSLLVKNPEKRPTA----EICLS-H 288

Query: 377 KWFRSINWKTLEARE 391
            W +  +++ L   E
Sbjct: 289 SWLQQWDFENLFHPE 303

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  216 bits (553), Expect = 5e-67
 Identities = 83/281 (29%), Positives = 148/281 (52%), Gaps = 20/281 (7%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
           A S+R IGP  + I   +G+G+FGKV    K          + A+K + +  + K +   
Sbjct: 2   AISKRHIGP--YIIRETLGEGSFGKV----KLATHYKTQQKV-ALKFISRQLLKKSDMHM 54

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            ++ E   L  + HP I++L     T + + +++++  GG LF ++  +    ED+ R +
Sbjct: 55  RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF 113

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +I+ A+ + H+  IVHRDLKPEN+L+D + +V + DFGL+  + + +   + CG+  Y
Sbjct: 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNY 173

Query: 281 MAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
            APE++  K +   + D WS GI+LY ML G+ PF       L +++ +    +P FL+ 
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP 233

Query: 340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            A SL++      +++  DP +R+      +  I+   WF 
Sbjct: 234 GAQSLIR------RMIVADPMQRI-----TIQEIRRDPWFN 263

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  216 bits (553), Expect = 5e-67
 Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 36/283 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +E+   +G G++    +   K      ++  +A+K      II K+  D    E +IL 
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHK-----ATNMEFAVK------IIDKSKRD-PTEEIEILL 70

Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           +   HP I+ L+  +     +Y++ + + GG L   + RQ  F E +A      I   V 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE 130

Query: 230 HLHKCGIVHRDLKPENILMDSDGH----VMLTDFGLAKEI-DESSRSNSMCGTTEYMAPE 284
           +LH  G+VHRDLKP NIL   +      + + DFG AK++  E+    + C T  ++APE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVKLP----PFL 337
           +L  +G++   D WS+G+LLY MLTG  PF +      +++  RI + K  L       +
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250

Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
           +  A  L+       ++LH DP +RL         +  H W  
Sbjct: 251 SDTAKDLVS------KMLHVDPHQRL-----TAALVLRHPWIV 282

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  217 bits (555), Expect = 7e-67
 Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 32/279 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++I   +G GAFG V +  +K      +  ++  K +     + K  V   K E  I+ +
Sbjct: 53  YDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYPLDKYTV---KNEISIMNQ 104

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSH 230
           + HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y  +    + H
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 164

Query: 231 LHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           +H+  IVH D+KPENI+ ++     V + DFGLA +++          T E+ APEI+  
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 224

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLK 346
           +      D W++G+L Y +L+G  PF   +  +  Q +     +     F          
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF---------S 275

Query: 347 GVS-----FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            VS     F+  LL K+P KRL       DA++ H W +
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTV----HDALE-HPWLK 309

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  213 bits (545), Expect = 1e-66
 Identities = 79/299 (26%), Positives = 148/299 (49%), Gaps = 31/299 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +    +++ + +G+GA+G+V    +  V+   ++   A+K++     +     + +
Sbjct: 2   AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           K E  I   + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTE 279
           ++++ V +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 280 YMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPPF- 336
           Y+APE+L  +  H +  D WS GI+L  ML G+ P+   ++  +       +K  L P+ 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 337 -LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 394
            + S   +LL       ++L ++PS R+      +  IK  +W+     K L+    +P
Sbjct: 233 KIDSAPLALLH------KILVENPSARI-----TIPDIKKDRWYN----KPLKKGAKRP 276

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  214 bits (546), Expect = 3e-66
 Identities = 81/337 (24%), Positives = 157/337 (46%), Gaps = 31/337 (9%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +    +++ + +G+GA+G+V    +  V+   ++   A+K++     +     + +
Sbjct: 2   AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           K E  I   + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTE 279
           ++++ V +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 280 YMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPPF- 336
           Y+APE+L  +  H +  D WS GI+L  ML G+ P+   ++  +       +K  L P+ 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 337 -LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK 395
            + S   +LL       ++L ++PS R+      +  IK  +W+     K L+    +P+
Sbjct: 233 KIDSAPLALLH------KILVENPSARI-----TIPDIKKDRWYN----KPLKKGAKRPR 277

Query: 396 FKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHF 432
                  +          + +      + + T G  +
Sbjct: 278 VTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGW 314

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  213 bits (544), Expect = 9e-66
 Identities = 73/298 (24%), Positives = 134/298 (44%), Gaps = 30/298 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--- 166
             +     +G GAFG V       VD   +  +  +K ++K+ +++   ++  K  +   
Sbjct: 24  QKYSTMSPLGSGAFGFV----WTAVDKEKNKEV-VVKFIKKEKVLEDCWIEDPKLGKVTL 78

Query: 167 --DILTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAE 223
              IL++V H  I+++   F+ +    L+++   +G  LF  + R     E  A +   +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +VSAV +L    I+HRD+K ENI++  D  + L DFG A  ++      + CGT EY AP
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198

Query: 284 EILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E+L+   +   + + WS+G+ LY ++  + PF         +  +   +  P  ++ E  
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL------EETVEAAIHPPYLVSKELM 252

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR-SINWKTLEAREMQPKFKPD 399
           SL+ G      LL   P +R       ++ +    W    +N       E+    KP+
Sbjct: 253 SLVSG------LLQPVPERRT-----TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPE 299

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  216 bits (553), Expect = 1e-65
 Identities = 82/282 (29%), Positives = 145/282 (51%), Gaps = 19/282 (6%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           + +   KIG   + +   +G G FGKV    K G  +     + A+K++ +  I   + V
Sbjct: 8   KHDGRVKIGH--YILGDTLGVGTFGKV----KVGKHELTGHKV-AVKILNRQKIRSLDVV 60

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E   L    HP I++L     T S +++++++++GG LF ++ + G   E ++R 
Sbjct: 61  GKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR 120

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +I+S V + H+  +VHRDLKPEN+L+D+  +  + DFGL+  + +     + CG+  
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 180

Query: 280 YMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 338
           Y APE++  + +   + D WS G++LY +L G  PF   +   L ++I +     P +L 
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240

Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
               SLLK       +L  DP KR       +  I+ H+WF+
Sbjct: 241 PSVISLLK------HMLQVDPMKRA-----TIKDIREHEWFK 271

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  213 bits (544), Expect = 2e-65
 Identities = 84/280 (30%), Positives = 138/280 (49%), Gaps = 29/280 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++  + +G G FG       + + D  +  + A+K + +   I +N    ++ E    
Sbjct: 20  DRYDFVKDIGSGNFGVA-----RLMRDKLTKELVAVKYIERGAAIDEN----VQREIINH 70

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +I+++ +GG L+  +   G F ED+ARF+  +++S VS
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130

Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H   I HRDLK EN L+D      + + DFG +K     S+  S  GT  Y+APE+LL
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190

Query: 288 SKGHN-KDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPP--FLTSE 340
            + ++ K AD WS G+ LY ML G  PF         +K  QRI++ K  +P    ++ E
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250

Query: 341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
              L+       ++   DP+ R+      +  IK H WF 
Sbjct: 251 CCHLIS------RIFVADPATRI-----SIPEIKTHSWFL 279

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  218 bits (558), Expect = 2e-65
 Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 32/282 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++I   +G GAFG V +V ++      +   +A K +       ++  + ++ E   ++ 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTP---HESDKETVRKEIQTMSV 210

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
           + HP +V L  +F+  +++ +I +F++GG LF           ED+A  Y  ++   + H
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 270

Query: 231 LHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS 288
           +H+   VH DLKPENI+  +     + L DFGL   +D         GT E+ APE+   
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 330

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLK 346
           K      D WSVG+L Y +L+G  PF   N  +  + + +    +    F          
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF---------S 381

Query: 347 GVS-----FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 383
           G+S     F+ +LL  DP+ R+        A++ H W    N
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTI----HQALE-HPWLTPGN 418

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  213 bits (543), Expect = 4e-65
 Identities = 64/263 (24%), Positives = 126/263 (47%), Gaps = 27/263 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
                 ++G G FG+V + ++       +    A K+++          + +K E  ++ 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTR---GMKDKEEVKNEISVMN 141

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
           ++ H  ++QL  +F++++ + L++++++GG LF  +  +     E     +  +I   + 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201

Query: 230 HLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           H+H+  I+H DLKPENIL  +     + + DFGLA+      +     GT E++APE++ 
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLL 345
               +   D WSVG++ Y +L+G  PF   N  +    I+  +  L    F         
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF--------- 312

Query: 346 KGVS-----FLTQLLHKDPSKRL 363
           + +S     F+++LL K+ S R+
Sbjct: 313 QDISEEAKEFISKLLIKEKSWRI 335

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  211 bits (538), Expect = 5e-65
 Identities = 88/343 (25%), Positives = 147/343 (42%), Gaps = 38/343 (11%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+  H   G  PR +  +            +  +L    E++     +++  ++G G FG
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCN-------DLHATKLAPGKEKEPLESQYQVGPLLGSGGFG 57

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM---KAERDILTKVTH--PFIVQ 179
            V+   +  V D       A+K + KD I     +        E  +L KV+     +++
Sbjct: 58  SVYSGIR--VSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112

Query: 180 LRYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVH 238
           L   F+      LIL+       LF  +  +G  +E+ AR +  +++ AV H H CG++H
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 172

Query: 239 RDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HNKDAD 296
           RD+K ENIL+D + G + L DFG    + ++  ++   GT  Y  PE +     H + A 
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-DGTRVYSPPEWIRYHRYHGRSAA 231

Query: 297 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLH 356
            WS+GILLY+M+ G  PF H       + II  +V     ++SE   L++        L 
Sbjct: 232 VWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQHLIR------WCLA 279

Query: 357 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
             PS R        + I++H W + +      A        P 
Sbjct: 280 LRPSDRP-----TFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 317

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  209 bits (533), Expect = 1e-64
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 50/310 (16%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
               ++    + +   +G+G++G V    K   ++ D+   YAMKV+ K  +I++     
Sbjct: 7   GDCVQLNQ--YTLKDEIGKGSYGVV----KLAYNENDNT-YYAMKVLSKKKLIRQAGFPR 59

Query: 162 MKAERD-----------------------ILTKVTHPFIVQLR--YSFQTRSKLYLILDF 196
               R                        IL K+ HP +V+L           LY++ + 
Sbjct: 60  RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119

Query: 197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML 256
           +N G +   +       EDQARFY  +++  + +LH   I+HRD+KP N+L+  DGH+ +
Sbjct: 120 VNQGPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKI 178

Query: 257 TDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHN---KDADWWSVGILLYEMLTGQP 312
            DFG++ E     +  ++  GT  +MAPE L         K  D W++G+ LY  + GQ 
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

Query: 313 PFTHANRQKLQQRIINEKVKLP--PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGV 370
           PF       L  +I ++ ++ P  P +  +   L+       ++L K+P  R+      V
Sbjct: 239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLIT------RMLDKNPESRI-----VV 287

Query: 371 DAIKHHKWFR 380
             IK H W  
Sbjct: 288 PEIKLHPWVT 297

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  211 bits (539), Expect = 3e-64
 Identities = 60/405 (14%), Positives = 105/405 (25%), Gaps = 71/405 (17%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
           + NR       +    + S+    +             ESE    P       V+GQ   
Sbjct: 32  LFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDP 91

Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER----------------- 166
               +       D ++   + + V         N +  MK E                  
Sbjct: 92  YAYLEAT-----DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146

Query: 167 --------DILTKVTHPFIVQLRYSFQTRSKLYLILDFIN--------GGHLFFHLYRQG 210
                   D++       ++++R   +    L     +          G  L  H     
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS- 269
                     T +++  ++ LH  G+VH  L+P +I++D  G V LT F        S+ 
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKD-----ADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
                     E  A  +L    H+        D W++G+ +Y +     P T        
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 324 QRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 383
           + I      +P        +LL+G       L      RL               +  + 
Sbjct: 327 EWIFRSCKNIPQ----PVRALLEG------FLRYPKEDRLLP-----LQAMETPEYEQL- 370

Query: 384 WKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTA 428
                 R       P                  P   +  P    
Sbjct: 371 ------RTELSAALPLYQTDGEPTREG----GAPPSGTSQPDEAG 405

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  206 bits (525), Expect = 3e-63
 Identities = 80/324 (24%), Positives = 142/324 (43%), Gaps = 37/324 (11%)

Query: 81  SSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
             + PLQ                +R+    ++ +  ++G+G FG VF   +  + D    
Sbjct: 2   MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHR--LTDRLQ- 58

Query: 141 GIYAMKVMRKDTIIKKNHVDYM---KAERDILTKV----THPFIVQLRYSFQTRSKLYLI 193
              A+KV+ ++ ++  + +        E  +L KV     HP +++L   F+T+    L+
Sbjct: 59  --VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116

Query: 194 LDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           L+  +    LF ++  +G   E  +R +  ++V+A+ H H  G+VHRD+K ENIL+D   
Sbjct: 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176

Query: 252 GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTG 310
           G   L DFG    + +   ++   GT  Y  PE +     H   A  WS+GILLY+M+ G
Sbjct: 177 GCAKLIDFGSGALLHDEPYTDF-DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

Query: 311 QPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGV 370
             PF         Q I+  ++  P  ++ +  +L++      + L   PS R       +
Sbjct: 236 DIPFER------DQEILEAELHFPAHVSPDCCALIR------RCLAPKPSSRP-----SL 278

Query: 371 DAIKHHKWFRSINWKTLEAREMQP 394
           + I    W +       E   + P
Sbjct: 279 EEILLDPWMQ----TPAEDVPLNP 298

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  205 bits (523), Expect = 6e-63
 Identities = 62/282 (21%), Positives = 108/282 (38%), Gaps = 38/282 (13%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            I    +   + +G+G F  V  V+            YA+K +      ++   +  + E
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGL-----HDGHFYALKRILCH---EQQDREEAQRE 76

Query: 166 RDILTKVTHPFIVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ----GIFREDQA 217
            D+     HP I++L            + +L+L F   G L+  + R         EDQ 
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM--- 274
            +    I   +  +H  G  HRDLKP NIL+  +G  +L D G   +       +     
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196

Query: 275 -------CGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQ 323
                    T  Y APE+   + H   ++  D WS+G +LY M+ G+ P+    ++    
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

Query: 324 QRIINEKVKLPPF--LTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +  ++ +P     +S    LL        ++  DP +R 
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLN------SMMTVDPHQRP 292

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  203 bits (518), Expect = 2e-62
 Identities = 73/305 (23%), Positives = 119/305 (39%), Gaps = 55/305 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAER--D 167
           DFE  + +G+G FG VF+ K K       D   YA+K +R    +    +   K  R   
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNK------VDDCNYAIKRIR----LPNRELAREKVMREVK 55

Query: 168 ILTKVTHPFIVQLRYSF------------QTRSKLYLILDFINGGHLFFHLYRQG---IF 212
            L K+ HP IV+   ++              +  LY+ +      +L   +  +      
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES---- 268
                     +I  AV  LH  G++HRDLKP NI    D  V + DFGL   +D+     
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 269 ---------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
                    +R     GT  YM+PE +    ++   D +S+G++L+E+L   P  T   R
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMER 233

Query: 320 QKLQQRIINEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
            +    + N K   L        + +++       +L   P +R    P     I  +  
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQ------DMLSPSPMER----P-EAINIIENAV 282

Query: 379 FRSIN 383
           F  ++
Sbjct: 283 FEDLD 287

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  206 bits (525), Expect = 3e-62
 Identities = 81/352 (23%), Positives = 155/352 (44%), Gaps = 47/352 (13%)

Query: 48  NQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKI 107
           + S   +            +  +   P P        P Q  +   ++  +++  +    
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61

Query: 108 GPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
              D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E 
Sbjct: 62  ---DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EV 105

Query: 167 DILTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARF 219
           ++  + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A  
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCG 276
               I  A+ +LH   I HRD+KPEN+L  S   +  + LTDFG AKE    +   + C 
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ----RIINEKVK 332
           T  Y+APE+L  + ++K  D WS+G+++Y +L G PPF   +   +      RI   + +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285

Query: 333 LP----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            P      ++ E   L++       LL  +P++R+      +    +H W  
Sbjct: 286 FPNPEWSEVSEEVKMLIR------NLLKTEPTQRM-----TITEFMNHPWIM 326

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  202 bits (515), Expect = 9e-62
 Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 55/300 (18%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
           V+G+GA  +V            +   YA+K++ K      +    +  E ++L +   H 
Sbjct: 20  VLGEGAHARVQTCINLI-----TSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHR 71

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            +++L   F+   + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  G
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 236 IVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSM--------CGTTEYMAPE 284
           I HRDLKPENIL    +    V + DF L   I  +   + +        CG+ EYMAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 285 IL-----LSKGHNKDADWWSVGILLYEMLTGQPPFTHANR---------------QKLQQ 324
           ++      +  ++K  D WS+G++LY +L+G PPF                      L +
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251

Query: 325 RIINEKVKLP----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            I   K + P      ++  A  L+       +LL +D  +RL         +  H W +
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLIS------KLLVRDAKQRL-----SAAQVLQHPWVQ 300

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  202 bits (516), Expect = 1e-61
 Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 43/282 (15%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
           V+G G  GKV +   +      +    A+K++      ++        E D   + +  P
Sbjct: 36  VLGLGVNGKVLECFHRR-----TGQKCALKLLYDSPKARQ--------EVDHHWQASGGP 82

Query: 176 FIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
            IV +   ++     +  L +I++ + GG LF  +  +G   F E +A     +I +A+ 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 230 HLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
            LH   I HRD+KPEN+L    + D  + LTDFG AKE  +++   + C T  Y+APE+L
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCYTPYYVAPEVL 201

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ----QRIINEKVKLP----PFLT 338
             + ++K  D WS+G+++Y +L G PPF     Q +     +RI   +   P      ++
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261

Query: 339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
            +A  L++       LL  DP++RL      +    +H W  
Sbjct: 262 EDAKQLIRL------LLKTDPTERL-----TITQFMNHPWIN 292

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  203 bits (518), Expect = 1e-61
 Identities = 46/324 (14%), Positives = 95/324 (29%), Gaps = 49/324 (15%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
           +AE   +S    G    ++   +  G    VF V+       +    +A+KV        
Sbjct: 48  NAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV-----ERLEDFALKVFTMGAENS 102

Query: 156 KNHVDYMKAERDILTKVTHPFIVQLR--------------------------YSFQTRSK 189
           ++ ++ +        ++      + R                                + 
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 190 LYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKP 243
             L++   +         L F    +G          TA+++   ++L   G+VH    P
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222

Query: 244 ENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVG 301
           +N+ +  DG +ML D     ++    R  +      Y   E L +         + W +G
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280

Query: 302 ILLYEMLTGQPPFTHAN--RQKLQQRIINEKVKLPPFLTSEAHSLLKGV-SFLTQLLHKD 358
           + +Y +     PF       +   +R                  L   V + + + L+ D
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340

Query: 359 PSKRLGSGPGGVDAIKHHKWFRSI 382
             +RL               F  +
Sbjct: 341 RRRRL-----LPLEAMETPEFLQL 359

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  198 bits (505), Expect = 1e-60
 Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 47/300 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F     +G G FG VF+  K+   DG    IYA+K  +K      +  + ++       
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKR--LDGC---IYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG----HLFFHLYRQGIFREDQARFYTAEIVS 226
              H  +V+   ++     + +  ++ NGG     +  +      F+E + +    ++  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVM-------------------LTDFGLAKEIDE 267
            + ++H   +VH D+KP NI +                          + D G    I  
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184

Query: 268 SSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
            S      G + ++A E+L  +  H   AD +++ + +      +P   + +       I
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240

Query: 327 INEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 385
              ++ ++P  L+ E   LLK       ++H DP +R    P    A+  H    S + K
Sbjct: 241 RQGRLPRIPQVLSQEFTELLK------VMIHPDPERR----P-SAMALVKHSVLLSASRK 289

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  202 bits (516), Expect = 1e-60
 Identities = 73/326 (22%), Positives = 128/326 (39%), Gaps = 50/326 (15%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           E D   E  S   +G   F    V+G GA G +     +G+ D       A+K       
Sbjct: 8   EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV---YRGMFDNRD---VAVK------R 55

Query: 154 IKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI- 211
           I      +   E  +L +   HP +++   + + R   Y+ ++      L  ++ ++   
Sbjct: 56  ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKEID 266
               +      +  S ++HLH   IVHRDLKP NIL+           M++DFGL K++ 
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 267 ESSRS----NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN 318
               S    + + GT  ++APE+L     +      D +S G + Y +++ G  PF  + 
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 319 RQKLQQRIINEKVKLP---PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
           +++    +    +            A  L++      +++  DP KR          +  
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIE------KMIAMDPQKRP-----SAKHVLK 283

Query: 376 HKWFRSINWKTLEAREMQPKFKPDVS 401
           H +F S         E Q +F  DVS
Sbjct: 284 HPFFWS--------LEKQLQFFQDVS 301

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  196 bits (499), Expect = 4e-59
 Identities = 71/321 (22%), Positives = 129/321 (40%), Gaps = 30/321 (9%)

Query: 52  ASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD 111
            S S S G    + + + ++   S +            E     +     + E +     
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETED-NEGVLLTEKLKPVDYEYREEVHW 59

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
                 VG+G+FG+V     +  D   +    A+K +R +    +        E      
Sbjct: 60  MTHQPRVGRGSFGEVH----RMKD-KQTGFQCAVKKVRLEVFRVE--------ELVACAG 106

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           ++ P IV L  + +    + + ++ + GG L   + + G   ED+A +Y  + +  + +L
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 166

Query: 232 HKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRS------NSMCGTTEYMAPE 284
           H   I+H D+K +N+L+ SDG    L DFG A  +            + + GT  +MAPE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEA 341
           +++ K  +   D WS   ++  ML G  P+T   R  L  +I +E     ++PP      
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286

Query: 342 HSLLKGVSFLTQLLHKDPSKR 362
                    + + L K+P  R
Sbjct: 287 A------QAIQEGLRKEPVHR 301

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  196 bits (500), Expect = 3e-58
 Identities = 76/331 (22%), Positives = 129/331 (38%), Gaps = 75/331 (22%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
               +++G G+ G V     +G   G      A+K       +  +  D    E  +LT+
Sbjct: 17  VVSEKILGYGSSGTV---VFQGSFQGRP---VAVK------RMLIDFCDIALMEIKLLTE 64

Query: 172 VT-HPFIVQLRYSFQTRSKLYLILDFINGGHLF-------FHLYRQGIFREDQARFYTAE 223
              HP +++   S  T   LY+ L+  N   L               + +E        +
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHVMLTDFGLAKEIDE--- 267
           I S V+HLH   I+HRDLKP+NIL+ +             +  ++++DFGL K++D    
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 268 --SSRSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFTHA 317
              +  N+  GT+ + APE+L         +   +  D +S+G + Y +L+ G+ PF   
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 318 NRQKLQQRIINEKVKLPPF-------LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGV 370
             +  +  II     L          L +EA  L+       Q++  DP KR        
Sbjct: 244 YSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLIS------QMIDHDPLKRP-----TA 290

Query: 371 DAIKHHKWFRSINWKTLEAREMQPKFKPDVS 401
             +  H  F          +  + +F   VS
Sbjct: 291 MKVLRHPLFWP--------KSKKLEFLLKVS 313

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  184 bits (470), Expect = 2e-55
 Identities = 76/278 (27%), Positives = 132/278 (47%), Gaps = 29/278 (10%)

Query: 100 EAESERKIGPGDFEIFR-----VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
           E + E  +   D+E        V+G+G +G V+     G D   +    A+K + +    
Sbjct: 7   EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVY----AGRD-LSNQVRIAIKEIPER--- 58

Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGI 211
              +   +  E  +   + H  IVQ   SF     + + ++ + GG    L    +    
Sbjct: 59  DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI-DESS 269
             E    FYT +I+  + +LH   IVHRD+K +N+L+++  G + ++DFG +K +   + 
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178

Query: 270 RSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRI 326
            + +  GT +YMAPEI+    +G+ K AD WS+G  + EM TG+PPF      Q    ++
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV 238

Query: 327 INEKV--KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
              KV  ++P  +++EA       +F+ +    DP KR
Sbjct: 239 GMFKVHPEIPESMSAEAK------AFILKCFEPDPDKR 270

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  177 bits (451), Expect = 2e-52
 Identities = 75/273 (27%), Positives = 137/273 (50%), Gaps = 15/273 (5%)

Query: 92  EHENDAELEAESERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
                + L      K  P + F     +G+G+FG+VF    KG+D+  +  + A+K++  
Sbjct: 3   HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKIIDL 57

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
           +    ++ ++ ++ E  +L++   P++ +   S+   +KL++I++++ GG     L   G
Sbjct: 58  EEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPG 114

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-S 269
              E Q      EI+  + +LH    +HRD+K  N+L+   G V L DFG+A ++ ++  
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           + N+  GT  +MAPE++    ++  AD WS+GI   E+  G+PP +  +  K+   I   
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234

Query: 330 KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
               PP L       LK   F+   L+K+PS R
Sbjct: 235 N---PPTLEGNYSKPLK--EFVEACLNKEPSFR 262

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  176 bits (448), Expect = 1e-51
 Identities = 73/289 (25%), Positives = 121/289 (41%), Gaps = 49/289 (16%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++G     + RV+ +G F  V++ +     D  S   YA+K +  +   ++     +  E
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQ-----DVGSGREYALKRLLSN---EEEKNRAIIQE 75

Query: 166 RDILTKVT-HPFIVQLRYSF-------QTRSKLYLILDFINGGHLFFHLYR---QGIFRE 214
              + K++ HP IVQ   +         T    +L+L  +  G L   L +   +G    
Sbjct: 76  VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135

Query: 215 DQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSN 272
           D       +   AV H+H+    I+HRDLK EN+L+ + G + L DFG A  I      +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

Query: 273 S-------------MCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTH 316
                            T  Y  PEI+    +    +  D W++G +LY +   Q PF  
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

Query: 317 ANRQKLQQRIINEKVKLPPFLT--SEAHSLLKGVSFLTQLLHKDPSKRL 363
                 + RI+N K  +PP  T  +  HSL++       +L  +P +RL
Sbjct: 256 GA----KLRIVNGKYSIPPHDTQYTVFHSLIR------AMLQVNPEERL 294

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  173 bits (440), Expect = 6e-51
 Identities = 67/272 (24%), Positives = 125/272 (45%), Gaps = 59/272 (21%)

Query: 111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E ++ 
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EVELH 64

Query: 170 TKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTA 222
            + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A     
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
            I  A+ +LH   I HRD+KPEN+L  S   +  + LTDFG AKE               
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------------- 170

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLP- 334
                    + ++K  D WS+G+++Y +L G PPF   +       ++ RI   + + P 
Sbjct: 171 -------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223

Query: 335 ---PFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
                ++ E   L++       LL  +P++R+
Sbjct: 224 PEWSEVSEEVKMLIR------NLLKTEPTQRM 249

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  172 bits (439), Expect = 6e-51
 Identities = 68/283 (24%), Positives = 128/283 (45%), Gaps = 19/283 (6%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           +  + ++  ELE ++      G F  F   +G+G+F  V+    KG+D   +    A   
Sbjct: 4   RNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVY----KGLDTETTV-EVAWCE 58

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF----QTRSKLYLILDFINGGHLF 203
           + +D  + K+     K E ++L  + HP IV+   S+    + +  + L+ + +  G L 
Sbjct: 59  L-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFG 260
            +L R  + +    R +  +I+  +  LH     I+HRDLK +NI +    G V + D G
Sbjct: 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177

Query: 261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 320
           LA     S    ++ GT E+MAPE +  + +++  D ++ G+ + EM T + P++     
Sbjct: 178 LATLKRASFAK-AVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235

Query: 321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
               R +   VK P      A   +K    +   + ++  +R 
Sbjct: 236 AQIYRRVTSGVK-PASFDKVAIPEVK--EIIEGCIRQNKDERY 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  172 bits (438), Expect = 3e-50
 Identities = 64/339 (18%), Positives = 112/339 (33%), Gaps = 80/339 (23%)

Query: 111 DFEIFRVVGQGAFGKVFQVK----------KK---------------------------- 132
           DFE  + +G+G FG VF+ K          K+                            
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 133 ------------GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
                            + D I+         +   + +D    +   +   +    V  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIF---REDQARFYTAEIVSAVSHLHKCGIV 237
                 +  LY+ +      +L   + R+                +I  AV  LH  G++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------RSNSMCGTTEYMAPE 284
           HRDLKP NI    D  V + DFGL   +D+                     GT  YM+PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHS 343
            +    ++   D +S+G++L+E+L      T   R ++   + N K   L      + H 
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHM 304

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
           +++       +L   P++R    P     I  +  F ++
Sbjct: 305 MVQ------DMLSPSPTER----P-EATDIIENAIFENL 332

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  170 bits (432), Expect = 2e-49
 Identities = 79/312 (25%), Positives = 152/312 (48%), Gaps = 39/312 (12%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD----FEIFRVVG 119
           +H+  H   G       + +L  Q   + HE   + +A     +  GD     + +  +G
Sbjct: 1   MHHHHHHSSGVDLG---TENLYFQSGVVTHE---QFKAALRMVVDQGDPRLLLDSYVKIG 54

Query: 120 QGAFGKVFQVKKKGVDDGDSDGIYAMKVM------RKDTIIKKNHVDYMKAERDILTKVT 173
           +G+ G V   ++K      S    A+K+M      R++ +           E  I+    
Sbjct: 55  EGSTGIVCLAREK-----HSGRQVAVKMMDLRKQQRRELLFN---------EVVIMRDYQ 100

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           H  +V++  S+    +L+++++F+ GG L   +  Q    E+Q       ++ A+++LH 
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLSKGHN 292
            G++HRD+K ++IL+  DG V L+DFG   +I  +  +  S+ GT  +MAPE++    + 
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 293 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH--SLLKGVSF 350
            + D WS+GI++ EM+ G+PP+   +  +  +R+ +     PP L +      +L+   F
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNSHKVSPVLR--DF 274

Query: 351 LTQLLHKDPSKR 362
           L ++L +DP +R
Sbjct: 275 LERMLVRDPQER 286

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  169 bits (430), Expect = 2e-49
 Identities = 77/281 (27%), Positives = 131/281 (46%), Gaps = 33/281 (11%)

Query: 95  NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM-- 148
           +D E+  +    +  GD    +  F  +GQGA G V+           +    A++ M  
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55

Query: 149 ----RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
               +K+ II          E  ++ +  +P IV    S+    +L+++++++ GG L  
Sbjct: 56  QQQPKKELIIN---------EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT- 105

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
            +  +    E Q      E + A+  LH   ++HRD+K +NIL+  DG V LTDFG   +
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165

Query: 265 I-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 323
           I  E S+ ++M GT  +MAPE++  K +    D WS+GI+  EM+ G+PP+ + N  +  
Sbjct: 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

Query: 324 QRIINEKVKLPPFLTSEAH--SLLKGVSFLTQLLHKDPSKR 362
             I        P L +     ++ +   FL + L  D  KR
Sbjct: 226 YLIATNG---TPELQNPEKLSAIFR--DFLNRCLEMDVEKR 261

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  166 bits (422), Expect = 5e-48
 Identities = 73/270 (27%), Positives = 123/270 (45%), Gaps = 20/270 (7%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
               +    D E    +G G  G+V++++ +      +  + A+K MR+     K     
Sbjct: 17  GQRYQAEINDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRS--GNKEENKR 69

Query: 162 MKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +  + D++ K    P+IVQ   +F T + +++ ++ +           QG   E      
Sbjct: 70  ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM 129

Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
           T  IV A+ +L  K G++HRD+KP NIL+D  G + L DFG++  + +    +   G   
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA 189

Query: 280 YMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFT--HANRQKLQQRIINEKVK 332
           YMAPE +         ++  AD WS+GI L E+ TGQ P+     + + L + ++ E+  
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK-VLQEE-- 246

Query: 333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            PP L           SF+   L KD  KR
Sbjct: 247 -PPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  164 bits (417), Expect = 3e-47
 Identities = 69/283 (24%), Positives = 136/283 (48%), Gaps = 15/283 (5%)

Query: 82  SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
           S   +Q++        +L+ +S  K     F++   +G+G++G V++   K     ++  
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHK-----ETGQ 55

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I A+K +  ++ +++     +  E  I+ +   P +V+   S+   + L++++++   G 
Sbjct: 56  IVAIKQVPVESDLQE-----IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110

Query: 202 LF-FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG 260
           +      R     ED+        +  + +LH    +HRD+K  NIL++++GH  L DFG
Sbjct: 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG 170

Query: 261 LAKEIDES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           +A ++ ++ ++ N++ GT  +MAPE++   G+N  AD WS+GI   EM  G+PP+   + 
Sbjct: 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230

Query: 320 QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            +    I       PP              F+ Q L K P +R
Sbjct: 231 MRAIFMIPTNP---PPTFRKPELWSDNFTDFVKQCLVKSPEQR 270

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  165 bits (419), Expect = 3e-47
 Identities = 66/255 (25%), Positives = 109/255 (42%), Gaps = 17/255 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+       D   +  + A+K M             +  E   L K
Sbjct: 56  FSDLREIGHGSFGAVY----FARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--- 288
           H   ++HRD+K  NIL+   G V L DFG A  +   + +NS  GT  +MAPE++L+   
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDE 227

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-LLKG 347
             ++   D WS+GI   E+   +PP  + N       I   +    P L S   S   + 
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPALQSGHWSEYFR- 283

Query: 348 VSFLTQLLHKDPSKR 362
            +F+   L K P  R
Sbjct: 284 -NFVDSCLQKIPQDR 297

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  163 bits (414), Expect = 6e-47
 Identities = 69/304 (22%), Positives = 140/304 (46%), Gaps = 29/304 (9%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+  H    P   Y + ++  L  Q     +  +++      I   D  I   +G G+FG
Sbjct: 3   HHHHHH---PMSDYDIPTTENLYFQGAM--DGDDMD------IPWCDLNIKEKIGAGSFG 51

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184
            V + +  G D        A+K++ +     +   ++++ E  I+ ++ HP IV    + 
Sbjct: 52  TVHRAEWHGSD-------VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHPNIVLFMGAV 103

Query: 185 QTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLHKCG--IVHR 239
                L ++ ++++ G L+  L++ G   +    +      ++   +++LH     IVHR
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163

Query: 240 DLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILLSKGHNKDADWW 298
           +LK  N+L+D    V + DFGL++    +  S  S  GT E+MAPE+L  +  N+ +D +
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223

Query: 299 SVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKD 358
           S G++L+E+ T Q P+ + N  ++   +  +  +L   +    +  +   + +      +
Sbjct: 224 SFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLNPQVA--AIIEGCWTNE 279

Query: 359 PSKR 362
           P KR
Sbjct: 280 PWKR 283

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  162 bits (411), Expect = 1e-46
 Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 32/288 (11%)

Query: 97  AELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK 156
           +E  +     I   D+E+  V+G GA   V                 A+K +  +    +
Sbjct: 2   SEDSSALPWSINRDDYELQEVIGSGATAVVQ----AAYCA-PKKEKVAIKRINLEKC--Q 54

Query: 157 NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQ---- 209
             +D +  E   +++  HP IV    SF  + +L+L++  ++GG    +  H+  +    
Sbjct: 55  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 114

Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
            G+  E        E++  + +LHK G +HRD+K  NIL+  DG V + DFG++  +   
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174

Query: 269 ------SRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 321
                     +  GT  +MAPE +   +G++  AD WS GI   E+ TG  P+      K
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234

Query: 322 LQQRIINEKVKLPPFLTSEAHSLLKGV-------SFLTQLLHKDPSKR 362
           +    +      PP L +                  ++  L KDP KR
Sbjct: 235 VLMLTLQND---PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  160 bits (407), Expect = 5e-46
 Identities = 76/258 (29%), Positives = 131/258 (50%), Gaps = 18/258 (6%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI   +G GAFGKV++ K K     ++  + A KV+       +  ++    E +IL  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNK-----ETGALAAAKVI---ETKSEEELEDYIVEIEILAT 72

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
             HP+IV+L  ++    KL+++++F  GG +    L       E Q +    +++ A++ 
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEYMAPEILLS- 288
           LH   I+HRDLK  N+LM  +G + L DFG++ +  ++  + +S  GT  +MAPE+++  
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 289 ----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
                 ++  AD WS+GI L EM   +PP    N  ++  +I       PP L + +   
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---PPTLLTPSKWS 249

Query: 345 LKGVSFLTQLLHKDPSKR 362
           ++   FL   L K+P  R
Sbjct: 250 VEFRDFLKIALDKNPETR 267

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  159 bits (404), Expect = 9e-46
 Identities = 63/267 (23%), Positives = 122/267 (45%), Gaps = 21/267 (7%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   D E    +G+GA+G V +++        S  I A+K +R    +       +  +
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHV-----PSGQIMAVKRIRAT--VNSQEQKRLLMD 55

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFF---HLYRQGIFREDQARFYT 221
            DI  +    PF V    +      +++ ++ ++     F    + +     ED      
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115

Query: 222 AEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             IV A+ HLH K  ++HRD+KP N+L+++ G V + DFG++  + +    +   G   Y
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPY 175

Query: 281 MAPEILLSKGHNKD----ADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPP 335
           MAPE +  + + K     +D WS+GI + E+   + P+ +     +  ++++ E     P
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---SP 232

Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKR 362
            L ++  S  + V F +Q L K+  +R
Sbjct: 233 QLPADKFS-AEFVDFTSQCLKKNSKER 258

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  159 bits (405), Expect = 2e-45
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 25/286 (8%)

Query: 91  LEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           +E     ++  E        D +    +G+GA+G V ++  K      S  I A+K +R 
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHK-----PSGQIMAVKRIRS 57

Query: 151 DTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF----H 205
              + +     +  + D++ +    P+IVQ   +       ++ ++ ++     F    +
Sbjct: 58  T--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVY 115

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
                +  E+     T   V A++HL     I+HRD+KP NIL+D  G++ L DFG++ +
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 265 IDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPFT--HAN 318
           + +S       G   YMAPE +      +G++  +D WS+GI LYE+ TG+ P+   ++ 
Sbjct: 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235

Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSL--LKGVSFLTQLLHKDPSKR 362
             +L Q ++      PP L++          ++F+   L KD SKR
Sbjct: 236 FDQLTQ-VVKGD---PPQLSNSEEREFSPSFINFVNLCLTKDESKR 277

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  158 bits (401), Expect = 5e-45
 Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 30/269 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +G+V+    KG     +  + A+KVM     +  +  + +K E ++L
Sbjct: 24  GIFELVELVGNGTYGQVY----KGRHV-KTGQLAAIKVMD----VTGDEEEEIKQEINML 74

Query: 170 TKV-THPFIVQLRYSF------QTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K   H  I     +F          +L+L+++F   G +       +    +E+   + 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTE 279
             EI+  +SHLH+  ++HRD+K +N+L+  +  V L DFG++ ++D +  R N+  GT  
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 280 YMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
           +MAPE++         ++  +D WS+GI   EM  G PP    +  +    I        
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---A 251

Query: 335 PFLTSEAHS-LLKGVSFLTQLLHKDPSKR 362
           P L S+  S   +  SF+   L K+ S+R
Sbjct: 252 PRLKSKKWSKKFQ--SFIESCLVKNHSQR 278

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  157 bits (398), Expect = 1e-44
 Identities = 71/268 (26%), Positives = 128/268 (47%), Gaps = 28/268 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           S   I   + E+  VVG+GAFG V + K +  D        A+K +  ++  K     ++
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD-------VAIKQIESESERK----AFI 49

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E   L++V HP IV+L  +    + + L++++  GG L+  L+         A    +
Sbjct: 50  V-ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 223 ---EIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMC 275
              +    V++LH      ++HRDLKP N+L+ + G V+ + DFG A +I       +  
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNK 164

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRIINEKVKLP 334
           G+  +MAPE+     +++  D +S GI+L+E++T + PF        +    ++   + P
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224

Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
             L       ++  S +T+   KDPS+R
Sbjct: 225 --LIKNLPKPIE--SLMTRCWSKDPSQR 248

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  158 bits (400), Expect = 2e-44
 Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 16/279 (5%)

Query: 87  QIQELEHENDAELEAESERKIG-------PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
           +++ELE +       E+              DFE    +G G  G VF+V  K      S
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP-----S 57

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
             + A K++  +  IK    + +  E  +L +   P+IV    +F +  ++ + ++ ++G
Sbjct: 58  GLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMLTD 258
           G L   L + G   E      +  ++  +++L  K  I+HRD+KP NIL++S G + L D
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
           FG++ ++   S +NS  GT  YM+PE L    ++  +D WS+G+ L EM  G+ P    +
Sbjct: 176 FGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234

Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHK 357
            ++L+     +             +  + ++        
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  153 bits (390), Expect = 1e-43
 Identities = 71/288 (24%), Positives = 122/288 (42%), Gaps = 37/288 (12%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
            H +    +A  + +I  G   + + +G G+FG V+    KG   GD     A+K++   
Sbjct: 6   HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVY----KGKWHGD----VAVKMLNVT 57

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
               +    + K E  +L K  H  I+     + T  +L ++  +  G  L+ HL+    
Sbjct: 58  APTPQQLQAF-KNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASET 115

Query: 212 -FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR 270
            F   +      +    + +LH   I+HRDLK  NI +  D  V + DFGLA E    S 
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175

Query: 271 SNSM---CGTTEYMAPEILLSKGHNKD---ADWWSVGILLYEMLTGQPPFTHAN------ 318
           S+      G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N      
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235

Query: 319 ----RQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
               R  L   +   +   P  +             + + L K   +R
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMK----------RLMAECLKKKRDER 273

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  156 bits (397), Expect = 5e-42
 Identities = 61/276 (22%), Positives = 108/276 (39%), Gaps = 45/276 (16%)

Query: 106 KIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
           ++ PGD     +E+   +  G  G ++      +D   +     +K +           +
Sbjct: 71  QLNPGDIVAGQYEVKGCIAHGGLGWIY----LALDRNVNGRPVVLKGLVHS-----GDAE 121

Query: 161 YMK---AERDILTKVTHPFIVQLRYSF------QTRSKLYLILDFINGGHLFFHLYRQGI 211
                 AER  L +V HP IVQ+ ++F            Y++++++ G  L     +   
Sbjct: 122 AQAMAMAERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQK 178

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
               +A  Y  EI+ A+S+LH  G+V+ DLKPENI++  +  + L D G    I+     
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRIN---SF 234

Query: 272 NSMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
             + GT  + APEI+  +     A D ++VG  L  +    P         L +      
Sbjct: 235 GYLYGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD--PV 290

Query: 331 VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSG 366
           +K                  L + +  DP +R  + 
Sbjct: 291 LKTYDSYG----------RLLRRAIDPDPRQRFTTA 316

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  149 bits (378), Expect = 8e-42
 Identities = 70/261 (26%), Positives = 116/261 (44%), Gaps = 14/261 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G + + R+VG+G  G V++ +     D   + I A+K+M +           M+ E    
Sbjct: 34  GPYRLRRLVGRGGMGDVYEAE-----DTVRERIVALKLMSETLSSDPVFRTRMQREARTA 88

Query: 170 TKVTHPFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
            ++  P +V + + F +   +LY+ +  ING  L   L RQG     +A     +I SA+
Sbjct: 89  GRLQEPHVVPI-HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEIL 286
              H  G  HRD+KPENIL+ +D    L DFG+A    +    +  +  GT  YMAPE  
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
                   AD +++  +LYE LTG PP+       +   I        P  ++    +  
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA----IPRPSTVRPGIPV 263

Query: 347 GV-SFLTQLLHKDPSKRLGSG 366
              + + + + K+P  R  + 
Sbjct: 264 AFDAVIARGMAKNPEDRYVTC 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  147 bits (373), Expect = 3e-41
 Identities = 59/288 (20%), Positives = 119/288 (41%), Gaps = 39/288 (13%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-------AMKVM 148
            +E        +   + E  + +G+G FG V +            G         A+K +
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHK------------GRLVKDKSVVAIKSL 52

Query: 149 RKDTIIKKNHVDYM----KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
                  +  +       + E  I++ + HP IV+L       +   ++++F+  G L+ 
Sbjct: 53  ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYH 110

Query: 205 HLYRQGIFREDQARFYTA-EIVSAVSHLHKCG--IVHRDLKPENILMDSDG-----HVML 256
            L  +    +   +     +I   + ++      IVHRDL+  NI + S          +
Sbjct: 111 RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

Query: 257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPF 314
            DFGL+++   S   + + G  ++MAPE + ++   + + AD +S  ++LY +LTG+ PF
Sbjct: 171 ADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

Query: 315 THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
              +  K++   +  +  L P +  +    L+  + +      DP KR
Sbjct: 229 DEYSYGKIKFINMIREEGLRPTIPEDCPPRLR--NVIELCWSGDPKKR 274

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  145 bits (368), Expect = 1e-40
 Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 25/268 (9%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAE 165
           I   +  +  ++G G FGKV++    G +        A+K  R D        ++ ++ E
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDE-------VAVKAARHDPDEDISQTIENVRQE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +   + HP I+ LR        L L+++F  GG L   L  + I   D    +  +I 
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNWAVQIA 115

Query: 226 SAVSHLHKCG---IVHRDLKPENILMDSDGH--------VMLTDFGLAKEIDESSRSNSM 274
             +++LH      I+HRDLK  NIL+             + +TDFGLA+E   +++  S 
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SA 174

Query: 275 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 334
            G   +MAPE++ +   +K +D WS G+LL+E+LTG+ PF   +   +   +   K+ LP
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234

Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
             + S           +    + DP  R
Sbjct: 235 --IPSTCPEPFA--KLMEDCWNPDPHSR 258

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  145 bits (367), Expect = 2e-40
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 11/210 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++I   +G G    V+  +     D   +   A+K +      K+  +   + E    
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAE-----DTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++++H  IV +    +     YL++++I G  L  ++   G    D A  +T +I+  + 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAPEILL 287
           H H   IVHRD+KP+NIL+DS+  + + DFG+AK + E+S  ++N + GT +Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--Q 183

Query: 288 SKGHNKDA--DWWSVGILLYEMLTGQPPFT 315
           +KG   D   D +S+GI+LYEML G+PPF 
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  147 bits (372), Expect = 3e-40
 Identities = 51/294 (17%), Positives = 105/294 (35%), Gaps = 23/294 (7%)

Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGA--FGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           H  +   +  S      G +E+  V+G+G      V   + K      +     ++ +  
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINL 62

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYR 208
           +       V +++ E  +     HP IV  R +F   ++L+++  F+  G        + 
Sbjct: 63  EAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121

Query: 209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
                E    +    ++ A+ ++H  G VHR +K  +IL+  DG V L+       +   
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181

Query: 269 -SRSNSMC-------GTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 318
             R   +            +++PE+L    +G++  +D +SVGI   E+  G  PF    
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241

Query: 319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDA 372
             ++    +N      P L   +    + ++        +              
Sbjct: 242 ATQMLLEKLNGT---VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRP 292

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  144 bits (366), Expect = 5e-40
 Identities = 57/272 (20%), Positives = 108/272 (39%), Gaps = 30/272 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     EI  ++G+G FG+V+     G   G+     A++++  +   +     + K E 
Sbjct: 30  IPFEQLEIGELIGKGRFGQVY----HGRWHGE----VAIRLIDIERDNEDQLKAF-KREV 80

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIV 225
               +  H  +V    +  +   L +I     G  L+  +    I    ++ R    EIV
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID---ESSRSNSM---CGTTE 279
             + +LH  GI+H+DLK +N+  D +G V++TDFGL           R + +    G   
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 280 YMAPEIL---------LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 330
           ++APEI+              +K +D +++G + YE+   + PF     + +  ++    
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--GT 257

Query: 331 VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
              P          +     L      +  +R
Sbjct: 258 GMKPNLSQIGMGKEIS--DILLFCWAFEQEER 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  141 bits (357), Expect = 4e-39
 Identities = 51/266 (19%), Positives = 106/266 (39%), Gaps = 27/266 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I          + +   G++++ + +G D         +KV++      +   D+ + E 
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGND-------IVVKVLKVRDWSTRKSRDFNE-EC 58

Query: 167 DILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED--QARFYTA 222
             L   +HP ++ +             LI  ++  G L+  L+    F  D  QA  +  
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 223 EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
           ++   ++ LH     I    L   ++++D D    ++   +        R         +
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAW 174

Query: 281 MAPEILLSKGHNKD---ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-PF 336
           +APE L  K  + +   AD WS  +LL+E++T + PF   +  ++  ++  E ++   P 
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234

Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKR 362
             S   S L     +   +++DP+KR
Sbjct: 235 GISPHVSKL-----MKICMNEDPAKR 255

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  141 bits (357), Expect = 8e-39
 Identities = 49/228 (21%), Positives = 98/228 (42%), Gaps = 24/228 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             R   P D     V+G+G FG+  +V  +      +  +  MK + +     +      
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRFD---EETQRTF 54

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYT 221
             E  ++  + HP +++         +L  I ++I GG L   +      +   Q   + 
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS------------ 269
            +I S +++LH   I+HRDL   N L+  + +V++ DFGLA+ + +              
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 270 ---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
              +  ++ G   +MAPE++  + +++  D +S GI+L E++      
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  140 bits (355), Expect = 1e-38
 Identities = 69/295 (23%), Positives = 118/295 (40%), Gaps = 57/295 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
           D  +   VG+G +G+V++   +G +        A+K      I           E ++  
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGEN-------VAVK------IFSSRDEKSWFRETELYN 55

Query: 169 LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
              + H  I+        S  + ++L+LI  +   G L+ +L    +      R     I
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSI 114

Query: 225 VSAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-----RS 271
            S ++HLH        K  I HRDLK +NIL+  +G   + D GLA    +S+      +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 272 NSMCGTTEYMAPEIL------LSKGHNKDADWWSVGILLYEMLTG----------QPPFT 315
           N   GT  YMAPE+L            K  D W+ G++L+E+             +PPF 
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 316 HANRQKLQQRIINEKV---KLPPFLTSEAHSLLKGVSFLTQLL----HKDPSKRL 363
                      + + V   +  P + +   S    ++ L +L+    +++PS RL
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFS-DPTLTSLAKLMKECWYQNPSARL 288

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  140 bits (356), Expect = 2e-38
 Identities = 60/216 (27%), Positives = 111/216 (51%), Gaps = 17/216 (7%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E+  ++G G   +V   +     D       A+KV+R D     +     + E    
Sbjct: 12  DRYELGEILGFGGMSEVHLAR-----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66

Query: 170 TKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + HP IV +              Y+++++++G  L   ++ +G     +A    A+  
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYM 281
            A++  H+ GI+HRD+KP NI++ +   V + DFG+A+ I +S     ++ ++ GT +Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 282 APEILLSKGHNKDA--DWWSVGILLYEMLTGQPPFT 315
           +PE   ++G + DA  D +S+G +LYE+LTG+PPFT
Sbjct: 187 SPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  139 bits (352), Expect = 8e-38
 Identities = 63/298 (21%), Positives = 118/298 (39%), Gaps = 55/298 (18%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
                 ++ + +G+G +G+V+  K +G          A+K      +           E 
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWRGEK-------VAVK------VFFTTEEASWFRET 80

Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +I     + H  I+           + ++LYLI D+   G L+ +L    +  +   +  
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKL- 139

Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-- 270
               VS + HLH        K  I HRDLK +NIL+  +G   + D GLA +    +   
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 271 ---SNSMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTG----------Q 311
               N+  GT  YM PE+L    +         AD +S G++L+E+             Q
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

Query: 312 PPF-----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL-TQLLHKDPSKRL 363
            P+     +  + + +++ +  +K++        +   L+ +  L T+    +P+ RL
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  138 bits (350), Expect = 2e-37
 Identities = 64/298 (21%), Positives = 122/298 (40%), Gaps = 55/298 (18%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
                  +   +G+G FG+V++ K +G +        A+K      I           E 
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKWRGEE-------VAVK------IFSSREERSWFREA 85

Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +I     + H  I+           T ++L+L+ D+   G LF +L R  +  E   +  
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL- 144

Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-- 270
                S ++HLH        K  I HRDLK +NIL+  +G   + D GLA   D ++   
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204

Query: 271 ---SNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTG----------Q 311
               N   GT  YMAPE+L            K AD +++G++ +E+             Q
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264

Query: 312 PPF-----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFL-TQLLHKDPSKRL 363
            P+     +  + +++++ +  +K++       ++   L+ ++ +  +  + + + RL
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  138 bits (349), Expect = 2e-37
 Identities = 57/318 (17%), Positives = 118/318 (37%), Gaps = 56/318 (17%)

Query: 88  IQELEHENDAELEAESER-KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
           +    H + + ++  +E         ++  V  +G FG V++ +             A+K
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-------VAVK 53

Query: 147 VMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGG 200
           +               + E ++  L  + H  I+Q     +        L+LI  F   G
Sbjct: 54  IF------PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107

Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH----------KCGIVHRDLKPENILMDS 250
            L   L    +   +        +   +++LH          K  I HRD+K +N+L+ +
Sbjct: 108 SLSDFLKANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166

Query: 251 DGHVMLTDFGLAKEIDESSRSNSM---CGTTEYMAPEIL-----LSKGHNKDADWWSVGI 302
           +    + DFGLA + +    +       GT  YMAPE+L       +      D +++G+
Sbjct: 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226

Query: 303 LLYEMLTG-----------QPPF-----THANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
           +L+E+ +              PF      H + + +Q+ ++++K +       + H+ + 
Sbjct: 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA 286

Query: 347 GVSFLTQL-LHKDPSKRL 363
            +    +     D   RL
Sbjct: 287 MLCETIEECWDHDAEARL 304

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  138 bits (348), Expect = 3e-37
 Identities = 62/317 (19%), Positives = 113/317 (35%), Gaps = 68/317 (21%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
            A SE  +   + ++  ++G+G +G V++        G  D    A+KV          +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYK--------GSLDERPVAVKVF------SFAN 48

Query: 159 VDYMKAERDI--LTKVTHPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
                 E++I  +  + H  I +      R +   R +  L++++   G L  +L     
Sbjct: 49  RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS 108

Query: 212 FREDQARFYTAEIVSAVSHLH---------KCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
                 R     +   +++LH         K  I HRDL   N+L+ +DG  +++DFGL+
Sbjct: 109 DWVSSCRL-AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 263 KEIDESSR---------SNSMCGTTEYMAPEIL-------LSKGHNKDADWWSVGILLYE 306
             +  +           + S  GT  YMAPE+L         +   K  D +++G++ +E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 307 MLTG-------------QPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSLLKGVSF 350
           +                Q  F            +   V   K  P            V  
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 351 LTQLL----HKDPSKRL 363
           L + +     +D   RL
Sbjct: 288 LKETIEDCWDQDAEARL 304

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  136 bits (345), Expect = 9e-37
 Identities = 77/322 (23%), Positives = 134/322 (41%), Gaps = 50/322 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E   +VG+G++G V + + K     D+  I A+K   +      + +    A R+I  
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNK-----DTGRIVAIKKFLES---DDDKMVKKIAMREIKL 77

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ H  +V L    + + + YL+ +F++   L               + Y  +I++ +
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMAP 283
              H   I+HRD+KPENIL+   G V L DFG A+ +  ++         E     Y AP
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVY--DDEVATRWYRAP 193

Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV----- 331
           E+L+    + K  D W++G L+ EM  G+P F   +       I+        +      
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 332 KLPPFLT------SEAHSLLK--------GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHK 377
           K P F         E   L +         +    + LH DP KR        + + HH 
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC----AELL-HHD 308

Query: 378 WFRSINWKTLEAREMQPKFKPD 399
           +F+   +    ++E+Q K + D
Sbjct: 309 FFQMDGFAERFSQELQLKVQKD 330

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  134 bits (339), Expect = 5e-36
 Identities = 73/319 (22%), Positives = 129/319 (40%), Gaps = 54/319 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G+G++G VF+ + +     D+  I A+K   +    + + V    A R+I  
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNR-----DTGQIVAIKKFLES---EDDPVIKKIALREIRM 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP +V L   F+ + +L+L+ ++ +   L      Q    E   +  T + + AV
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMAP 283
           +  HK   +HRD+KPENIL+     + L DFG A+ +   S         E     Y +P
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY----DDEVATRWYRSP 171

Query: 284 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII------NEKV--- 331
           E+L+    +    D W++G +  E+L+G P +    +  + Q   I         +    
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW--PGKSDVDQLYLIRKTLGDLIPRHQQV 229

Query: 332 --KLPPFLT------SEAHSLLK--------GVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
                 F         +   L           +  L   LH DP++RL         +  
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC----EQLLH- 284

Query: 376 HKWFRSINWKTLEAREMQP 394
           H +F +I      A+E   
Sbjct: 285 HPYFENIREIEDLAKEHDK 303

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  129 bits (328), Expect = 8e-35
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 89/324 (27%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +     +G+G +G V++ +            +A+K +R            ++ E +   
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIR------------LEKEDEGIP 44

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   IL ++ H  IV+L     T+ +L L+ + ++      L      +G      
Sbjct: 45  STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVT 101

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
           A+ +  ++++ +++ H   ++HRDLKP+N+L++ +G + + DFGLA+      R      
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---- 157

Query: 277 TTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII- 327
           T E     Y AP++L+ SK ++   D WSVG +  EM+ G P F      +  Q  RI  
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF--PGVSEADQLMRIFR 215

Query: 328 -----NEKV-----KLP------------------PFLTSEAHSLLKGVSFLTQLLHKDP 359
                N K      +LP                    L      LL       ++L  DP
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS------KMLKLDP 269

Query: 360 SKRLGSGPGGVDAIKHHKWFRSIN 383
           ++R+ +      A++ H +F+  N
Sbjct: 270 NQRITA----KQALE-HAYFKENN 288

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  130 bits (328), Expect = 2e-34
 Identities = 74/327 (22%), Positives = 127/327 (38%), Gaps = 60/327 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G+GA+GKVF    K  D  +     A+K +R  T   +  +  +   R++  
Sbjct: 12  QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQT--GEEGMP-LSTIREVAV 64

Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
              L    HP +V+L            +KL L+ + ++       +     +     +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--QDLTTYLDKVPEPGVPTETI 122

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
           +    +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV 331
             Y APE+LL   +    D WSVG +  EM   +P F  ++      +I+       E+ 
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242

Query: 332 -----KLP----------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGV 370
                 LP                  +      LL       + L  +P+KR+ +     
Sbjct: 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL------KCLTFNPAKRISA----Y 292

Query: 371 DAIKHHKWFRSINWKTLEAREMQPKFK 397
            A+  H +F+ +           P  +
Sbjct: 293 SALS-HPYFQDLERCKENLDSHLPPSQ 318

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  129 bits (326), Expect = 3e-34
 Identities = 81/319 (25%), Positives = 139/319 (43%), Gaps = 78/319 (24%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            ++    VG+G +G V++ K           I A+K +R            + AE +   
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIR------------LDAEDEGIP 63

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   +L ++ HP IV L     +   L L+ +F+       L  +   +   ++ Q
Sbjct: 64  STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN---KTGLQDSQ 120

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
            + Y  +++  V+H H+  I+HRDLKP+N+L++SDG + L DFGLA+      RS     
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY---- 176

Query: 277 TTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII- 327
           T E     Y AP++L+ SK ++   D WS+G +  EM+TG+P F         Q  +I  
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF--PGVTDDDQLPKIFS 234

Query: 328 -----NEKV-------------KLPPFLTSEAHSLLK-----GVSFLTQLLHKDPSKRLG 364
                N +                  F      S++      G+  L+ +L  DP+KR+ 
Sbjct: 235 ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294

Query: 365 SGPGGVDAIKHHKWFRSIN 383
           +     DA+  H +F+ ++
Sbjct: 295 A----RDAMN-HPYFKDLD 308

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  129 bits (326), Expect = 3e-34
 Identities = 72/335 (21%), Positives = 133/335 (39%), Gaps = 71/335 (21%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
            F+    +G G +  V++       +  +    A+K ++ D       T I+        
Sbjct: 6   QFKQLEKLGNGTYATVYKGL-----NKTTGVYVALKEVKLDSEEGTPSTAIR-------- 52

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHL--FFHLYRQGIFREDQAR 218
            E  ++ ++ H  IV+L     T +KL L+ +F++     ++              +  +
Sbjct: 53  -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
           ++  +++  ++  H+  I+HRDLKP+N+L++  G + L DFGLA+       +     ++
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF----SS 167

Query: 279 E-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII----- 327
           E     Y AP++L+ S+ ++   D WS G +L EM+TG+P F   N ++  + I      
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227

Query: 328 -NEKV-----KLP----------------PFLTSEAHSL-LKGVSFLTQLLHKDPSKRLG 364
            NE +     KLP                         L    + FL  LL  +P  RL 
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287

Query: 365 SGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
           +      A+  H WF         +          
Sbjct: 288 AK----QALH-HPWFAEYYHHA--SMGGSRSHHHH 315

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  127 bits (321), Expect = 1e-33
 Identities = 71/312 (22%), Positives = 113/312 (36%), Gaps = 58/312 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G GA+G V++ +     D  S    A+K +R            +   R++  
Sbjct: 10  RYEPVAEIGVGAYGTVYKAR-----DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
              L    HP +V+L             K+ L+ + ++       +           +  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--QDLRTYLDKAPPPGLPAETI 122

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT 277
           +    + +  +  LH   IVHRDLKPENIL+ S G V L DFGLA+          +  T
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV 331
             Y APE+LL   +    D WSVG +  EM   +P F   +      +I        E  
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242

Query: 332 -----KLP----------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGV 370
                 LP                P +      LL       ++L  +P KR+ +     
Sbjct: 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL------EMLTFNPHKRISA----F 292

Query: 371 DAIKHHKWFRSI 382
            A++ H +    
Sbjct: 293 RALQ-HSYLHKD 303

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  126 bits (318), Expect = 2e-33
 Identities = 68/317 (21%), Positives = 127/317 (40%), Gaps = 73/317 (23%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +E    +G+G +G VF+ K     + ++  I A+K +R            +  + +   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAK-----NRETHEIVALKRVR------------LDDDDEGVP 45

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   +L ++ H  IV+L     +  KL L+ +F +     +        G    + 
Sbjct: 46  SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEI 102

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
            + +  +++  +   H   ++HRDLKP+N+L++ +G + L +FGLA+      R      
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---- 158

Query: 277 TTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRII-- 327
           + E     Y  P++L  +K ++   D WS G +  E+     P    N    Q +RI   
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218

Query: 328 ----NEKV-----KLP---PFLTSEAHSLLK---------GVSFLTQLLHKDPSKRLGSG 366
                E+      KLP   P+    A + L          G   L  LL  +P +R+ + 
Sbjct: 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA- 277

Query: 367 PGGVDAIKHHKWFRSIN 383
               +A++ H +F    
Sbjct: 278 ---EEALQ-HPYFSDFC 290

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  129 bits (325), Expect = 3e-33
 Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 50/288 (17%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   +V+G G+FG V+Q K       DS  + A+K + +D         +   E  I+ K
Sbjct: 56  YTDTKVIGNGSFGVVYQAK-----LCDSGELVAIKKVLQDK-------RFKNRELQIMRK 103

Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFINGG-HLFFHLYRQG--IFREDQARFYTA 222
           + H  IV+LRY F +         L L+LD++    +     Y +          + Y  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYM 281
           ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     + S   +  Y 
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223

Query: 282 APEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ---------------- 324
           APE++  +  +    D WS G +L E+L GQP F       + Q                
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKVLGTPTREQI 281

Query: 325 RIINEKVKLPPFLTSEAHSLLK---------GVSFLTQLLHKDPSKRL 363
           R +N       F   +AH   K          ++  ++LL   P+ RL
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  125 bits (317), Expect = 6e-33
 Identities = 73/328 (22%), Positives = 131/328 (39%), Gaps = 70/328 (21%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
            +     +G+G +  V++ K K      +D + A+K +R +       T I+        
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSK-----LTDNLVALKEIRLEHEEGAPCTAIR-------- 49

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFY 220
            E  +L  + H  IV L     T   L L+ ++++     +L        I      + +
Sbjct: 50  -EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLF 105

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
             +++  +++ H+  ++HRDLKP+N+L++  G + L DFGLA+     +++       E 
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY----DNEV 161

Query: 280 ----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RIIN---- 328
               Y  P+ILL S  ++   D W VG + YEM TG+P F        +Q   I      
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF--PGSTVEEQLHFIFRILGT 219

Query: 329 ---------------EKVKLPPFLTSEAHSLLK-----GVSFLTQLLHKDPSKRLGSGPG 368
                          +    P +      S        G   LT+LL  +   R+ +   
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA--- 276

Query: 369 GVDAIKHHKWFRSINWKTLEAREMQPKF 396
             DA+K H +F S+  +  +  +    F
Sbjct: 277 -EDAMK-HPFFLSLGERIHKLPDTTSIF 302

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  125 bits (317), Expect = 7e-33
 Identities = 64/325 (19%), Positives = 120/325 (36%), Gaps = 87/325 (26%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +     +G+G +G+V++          ++   A+K +R            ++ E +   
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDT-----VTNETVAIKRIR------------LEHEEEGVP 77

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQAR 218
                   +L ++ H  I++L+       +L+LI ++    + L  ++ +         +
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMDKNPDVSMRVIK 135

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMLTDFGLAKEIDESSRSNS 273
            +  ++++ V+  H    +HRDLKP+N+L+          + + DFGLA+      R   
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF- 194

Query: 274 MCGTTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFT------------ 315
              T E     Y  PEILL S+ ++   D WS+  +  EML   P F             
Sbjct: 195 ---THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251

Query: 316 ------------------HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHK 357
                                +   + R    K  L   L  E   LL        +L  
Sbjct: 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLT------AMLEM 305

Query: 358 DPSKRLGSGPGGVDAIKHHKWFRSI 382
           DP KR+ +     +A++ H +F   
Sbjct: 306 DPVKRISA----KNALE-HPYFSHN 325

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  127 bits (320), Expect = 8e-33
 Identities = 76/324 (23%), Positives = 132/324 (40%), Gaps = 59/324 (18%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   +V+G G+FG VFQ K             A+K + +D         +   E  I+  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLV------ESDEVAIKKVLQDK-------RFKNRELQIMRI 88

Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFING---GHLFFHLYRQGIFREDQARFYTA 222
           V HP +V L+  F +         L L+L+++          +   +        + Y  
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYM 281
           +++ +++++H  GI HRD+KP+N+L+D    V+ L DFG AK +     + S   +  Y 
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208

Query: 282 APEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII----------- 327
           APE++  +  +  + D WS G ++ E++ GQP F       + Q   II           
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLF--PGESGIDQLVEIIKVLGTPSREQI 266

Query: 328 ---NEKVKLPPFLTSEAHSLLK---------GVSFLTQLLHKDPSKRLGSGPGGVDAIKH 375
              N       F     H   K          +  +++LL   PS R       ++A+ H
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR----LTAIEALCH 322

Query: 376 HKWF---RSINWKTLEAREMQPKF 396
             +F   R+   +    RE+ P F
Sbjct: 323 P-FFDELRTGEARMPNGRELPPLF 345

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  125 bits (317), Expect = 1e-32
 Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 76/317 (23%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
            +E    +G+G F  V++ + K     +++ I A+K   K   IK  H    K      A
Sbjct: 11  RYEKLDFLGEGQFATVYKARDK-----NTNQIVAIK---K---IKLGHRSEAKDGINRTA 59

Query: 165 ERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGI-FREDQARFY 220
            R+I  L +++HP I+ L  +F  +S + L+ DF+     L   +    +       + Y
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAY 117

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE- 279
               +  + +LH+  I+HRDLKP N+L+D +G + L DFGLAK     +R+     T + 
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY----THQV 173

Query: 280 ----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII----- 327
               Y APE+L  ++ +    D W+VG +L E+L   P         L Q  RI      
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL--PGDSDLDQLTRIFETLGT 231

Query: 328 -NEKV-----KLP-----------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLG 364
             E+       LP                      +   L++       L   +P  R+ 
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ------GLFLFNPCARIT 285

Query: 365 SGPGGVDAIKHHKWFRS 381
           +      A+K  K+F +
Sbjct: 286 A----TQALK-MKYFSN 297

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  124 bits (314), Expect = 3e-32
 Identities = 68/330 (20%), Positives = 121/330 (36%), Gaps = 89/330 (26%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +E    +GQG FG+VF+ +        +    A+K +             M+ E++   
Sbjct: 18  KYEKLAKIGQGTFGEVFKAR-----HRKTGQKVALKKVL------------MENEKEGFP 60

Query: 168 --------ILTKVTHPFIVQLR--------YSFQTRSKLYLILDFIN---GGHLFFHLYR 208
                   IL  + H  +V L            + +  +YL+ DF      G L      
Sbjct: 61  ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL---SNV 117

Query: 209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
              F   + +     +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+    +
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177

Query: 269 SRSNSMCGTTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFT------- 315
             S     T       Y  PE+LL  + +    D W  G ++ EM T  P          
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237

Query: 316 -----------------------HANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGVSFL 351
                                     + +L +    + K +L  ++          +  +
Sbjct: 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY-----ALDLI 292

Query: 352 TQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
            +LL  DP++R+ S     DA+  H +F S
Sbjct: 293 DKLLVLDPAQRIDS----DDALN-HDFFWS 317

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  118 bits (297), Expect = 7e-30
 Identities = 66/292 (22%), Positives = 122/292 (41%), Gaps = 49/292 (16%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F++ R+ GQG FG V   K     +  +    A+K + +D   +   +  M+     L  
Sbjct: 25  FQVERMAGQGTFGTVQLGK-----EKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAV 75

Query: 172 VTHPFIVQLRYSFQTRSK-------LYLILDFING---GHLFFHLYRQGIFREDQARFYT 221
           + HP IVQL+  F T  +       L ++++++          +  RQ        + + 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 222 AEIVSAVSHLHKC--GIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
            +++ ++  LH     + HRD+KP N+L++ +DG + L DFG AK++  S  + +   + 
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 279 EYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF--THANRQ------------KLQ 323
            Y APE++  ++ +    D WSVG +  EM+ G+P F   ++  Q            +  
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255

Query: 324 QRIINEKVKLPPFLTSEAHSLLK------------GVSFLTQLLHKDPSKRL 363
            R +N          S+                      L+ LL   P +R+
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  114 bits (288), Expect = 3e-28
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 47/246 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           +E+ +V+G+G+FG+V +       D       A+K++R       N   + +    E  I
Sbjct: 99  YEVLKVIGKGSFGQVVKAY-----DHKVHQHVALKMVR-------NEKRFHRQAAEEIRI 146

Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR---EDQAR 218
           L  +       T   ++ +  +F  R+ + +   F       + L ++  F+       R
Sbjct: 147 LEHLRKQDKDNTM-NVIHMLENFTFRNHICMT--FELLSMNLYELIKKNKFQGFSLPLVR 203

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEIDE------SSR 270
            +   I+  +  LHK  I+H DLKPENIL+   G   + + DFG +    +       SR
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263

Query: 271 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINE 329
                    Y APE++L   +    D WS+G +L E+LTG P         +L    + E
Sbjct: 264 F--------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL--ACMIE 313

Query: 330 KVKLPP 335
            + +P 
Sbjct: 314 LLGMPS 319

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  114 bits (286), Expect = 4e-28
 Identities = 75/327 (22%), Positives = 128/327 (39%), Gaps = 79/327 (24%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  D  YA+K +    I        M A R+I  L ++ HP
Sbjct: 29  VGRGTYGHVYKAKRK---DGKDDKDYALKQIEGTGIS-------MSACREIALLRELKHP 78

Query: 176 FIVQLR--YSFQTRSKLYLILDF--------INGGHLFFHLYRQGIFREDQARFYTAEIV 225
            ++ L+  +      K++L+ D+        I          +         +    +I+
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSD----GHVMLTDFGLAKEIDESSRSNSMCGTTE-- 279
             + +LH   ++HRDLKP NIL+  +    G V + D G A+  +   +  +        
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDPVVV 197

Query: 280 ---YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF-------THANRQKLQQ--RI 326
              Y APE+LL ++ + K  D W++G +  E+LT +P F         +N     Q  RI
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257

Query: 327 I------NEKV-----KLP------------PFLTSEAHSLLK---------GVSFLTQL 354
                   +K      K+P             +        ++             L +L
Sbjct: 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317

Query: 355 LHKDPSKRLGSGPGGVDAIKHHKWFRS 381
           L  DP KR+ S      A++   +F  
Sbjct: 318 LTMDPIKRITS----EQAMQ-DPYFLE 339

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  112 bits (283), Expect = 7e-28
 Identities = 59/301 (19%), Positives = 110/301 (36%), Gaps = 58/301 (19%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKDTIIKKNHVDY 161
              + + R +  G++G V           DS+G       ++      +   I  +    
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGV-------DSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYR-----Q 209
            +  R+I  L    HP I+ LR     +      KLYL+ + +        L +     +
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQR 128

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
            +      +++   I+  +  LH+ G+VHRDL P NIL+  +  + + DF LA+E    +
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 270 RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ-- 323
                     Y APE+++  KG  K  D WS G ++ EM   +  F   T  N+      
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248

Query: 324 ----------QRIINEKVK------LPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKR 362
                         +   +      L         +++          + ++L  +P +R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308

Query: 363 L 363
           +
Sbjct: 309 I 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  112 bits (282), Expect = 8e-28
 Identities = 69/306 (22%), Positives = 130/306 (42%), Gaps = 68/306 (22%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
             DF++  ++G+GA+G V            +  I A         IKK       +  ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSAT-----HKPTGEIVA---------IKKIEPFDKPLFALR 55

Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
             R+I  L    H  I+ +    +  S      +Y+I + +    H    +    +  +D
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDD 112

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
             +++  + + AV  LH   ++HRDLKP N+L++S+  + + DFGLA+ IDES+  NS  
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 276 GT-----TEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THAN-- 318
                   E++      APE++L+   +++  D WS G +L E+   +P F    + +  
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232

Query: 319 -----------RQKLQQRIINEKVK-----LPPFLTSEAHSLLKGVS-----FLTQLLHK 357
                           + I + + +     LP +  +    +   V+      L ++L  
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292

Query: 358 DPSKRL 363
           DP+KR+
Sbjct: 293 DPAKRI 298

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  111 bits (280), Expect = 9e-28
 Identities = 66/294 (22%), Positives = 121/294 (41%), Gaps = 55/294 (18%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
             D+++ R +G+G + +VF+       +  ++    +K+++         V   K +R+I
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAI-----NITNNEKVVVKILKP--------VKKKKIKREI 81

Query: 169 --LTKVT-HPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
             L  +   P I+ L    +        L+ + +N          Q    +   RFY  E
Sbjct: 82  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQ-TLTDYDIRFYMYE 138

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMA 282
           I+ A+ + H  GI+HRD+KP N+++D +   + L D+GLA+        N    +  +  
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 198

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRIIN------------ 328
           PE+L+  + ++   D WS+G +L  M+  + PF H +    Q  RI              
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258

Query: 329 -----------------EKVKLPPFLTSEAHSLL--KGVSFLTQLLHKDPSKRL 363
                             + +   F+ SE   L+  + + FL +LL  D   RL
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  110 bits (278), Expect = 2e-27
 Identities = 73/302 (24%), Positives = 123/302 (40%), Gaps = 60/302 (19%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + +G G  G VF        D D D   A+K   K  I+  +      A R+I
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAV-----DNDCDKRVAIK---K--IVLTDPQSVKHALREI 59

Query: 169 --LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLY--------RQGIFRE 214
             + ++ H  IV++      S    +     L  +N  ++              QG   E
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESSRSNS 273
           + AR +  +++  + ++H   ++HRDLKP N+ +++ D  + + DFGLA+ +D       
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 274 MCGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 326
               +E +      +P +LLS   + K  D W+ G +  EMLTG+  F  A+  + Q ++
Sbjct: 180 H--LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQL 236

Query: 327 INEKVKLPP-----FLTSEA---------------HSLLKGVS-----FLTQLLHKDPSK 361
           I E + +        L S                   LL G+S     FL Q+L   P  
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296

Query: 362 RL 363
           RL
Sbjct: 297 RL 298

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  111 bits (279), Expect = 3e-27
 Identities = 71/318 (22%), Positives = 123/318 (38%), Gaps = 78/318 (24%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + + + +G G+FG V +V      D +S   +A+K   K     +    Y   E DI+  
Sbjct: 9   YSLGKTLGTGSFGIVCEVF-----DIESGKRFALK---KVLQDPR----YKNRELDIMKV 56

Query: 172 VTHPFIVQLRYSFQTRSK--------------------------------------LYLI 193
           + H  I++L   F T                                         L +I
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 194 LDFINGG-HLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
           ++++    H     + +       +    Y  ++  AV  +H  GI HRD+KP+N+L++S
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 251 DGHVM-LTDFGLAKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEML 308
             + + L DFG AK++  S  S +   +  Y APE++L +  +    D WS+G +  E++
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 309 TGQPPF--THANRQ------------KLQQRIINEKVKLPPFLTSEAHSLLK-------- 346
            G+P F    +  Q            K Q   +N       F T +A    K        
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296

Query: 347 -GVSFLTQLLHKDPSKRL 363
             +  L Q+L  +P  R+
Sbjct: 297 LAIDLLEQILRYEPDLRI 314

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  110 bits (277), Expect = 3e-27
 Identities = 73/353 (20%), Positives = 124/353 (35%), Gaps = 102/353 (28%)

Query: 106 KIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
               GD     +EI   +G+GAFGKV +      D        A+K+++       N   
Sbjct: 5   ICQSGDVLSARYEIVDTLGEGAFGKVVECI----DHKAGGRHVAVKIVK-------NVDR 53

Query: 161 YMKA---ERDILTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-- 207
           Y +A   E  +L  +             VQ+   F+    + ++ +      L    Y  
Sbjct: 54  YCEAARSEIQVLEHLNTTDPNSTFR--CVQMLEWFEHHGHICIVFEL-----LGLSTYDF 106

Query: 208 -----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
                    FR D  R    +I  +V+ LH   + H DLKPENIL     +    +  + 
Sbjct: 107 IKENGFLP-FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165

Query: 263 KEIDESSRSN-------SMCGTTEYM----------APEILLSKGHNKDADWWSVGILLY 305
           ++       +       S     E+           APE++L+ G ++  D WS+G +L 
Sbjct: 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225

Query: 306 EMLTGQPPF-THANRQKL------------------------------------QQRIIN 328
           E   G   F TH +++ L                                      R ++
Sbjct: 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVS 285

Query: 329 EKVK-LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
              K L  F+ S+     +    + ++L  DP+KR+       +A+K H +F 
Sbjct: 286 RACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR----EALK-HPFFD 333

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  109 bits (275), Expect = 7e-27
 Identities = 69/348 (19%), Positives = 119/348 (34%), Gaps = 109/348 (31%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           +EI   +G+G FGKV +      D        A+K++R       N   Y +A   E ++
Sbjct: 21  YEIVGNLGEGTFGKVVECL----DHARGKSQVALKIIR-------NVGKYREAARLEINV 69

Query: 169 LTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLF----------FHLYRQG 210
           L K+             V +   F               GH+           F   ++ 
Sbjct: 70  LKKIKEKDKENKFL--CVLMSDWFNFH------------GHMCIAFELLGKNTFEFLKEN 115

Query: 211 IFR---EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
            F+       R    ++  A+  LH+  + H DLKPENIL  +     L +   + E   
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175

Query: 268 SSRSN-------SMCGTTEYM----------APEILLSKGHNKDADWWSVGILLYEMLTG 310
              ++       S     E+            PE++L  G  +  D WS+G +L+E   G
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

Query: 311 QPPF-THANRQKL------------------------------------QQRIINEKVK- 332
              F TH NR+ L                                      R + E  K 
Sbjct: 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP 295

Query: 333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
           L  ++  ++   ++    + ++L  DP++R+       +A+  H +F 
Sbjct: 296 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA----EALL-HPFFA 338

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  107 bits (268), Expect = 2e-26
 Identities = 34/256 (13%), Positives = 77/256 (30%), Gaps = 38/256 (14%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G + +    G     + +Q       D   D   A+  +    ++  + +    +    L
Sbjct: 31  GRYRLLIFHGGVPPLQFWQAL-----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           +++  P + ++     TR+   ++ ++I GG L   +          A      + +A  
Sbjct: 86  SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSP-SPVGAIRAMQSLAAAAD 143

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
             H+ G+      P  + +  DG V+L       + +                       
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD-------------------- 183

Query: 290 GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
                 D   +G  LY +L  + P       +     +R    +   P  +  +    + 
Sbjct: 184 ------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237

Query: 347 GVSFLTQLLHKDPSKR 362
            V    + +  D   R
Sbjct: 238 AV--AARSVQGDGGIR 251

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  110 bits (276), Expect = 2e-26
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 19/214 (8%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V         D   D   A+K   K +   +N     +A R++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAY-----DAVLDRNVAIK---KLSRPFQNQTHAKRAYREL 112

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             +  V H  I+ L        + +    +YL+++ +        + +  +   ++  + 
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL-DHERMSYL 169

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 314
            APE++L  G+ ++ D WSVG ++ EM+  +  F
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  108 bits (272), Expect = 2e-26
 Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 64/300 (21%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
              +     +G+GA+G V         D  +    A         IKK     +     +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAY-----DNLNKVRVA---------IKKISPFEHQTYCQR 71

Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
             R+I  L +  H  I+ +    +  +      +Y++ D +    +    L +      D
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY---KLLKTQHLSND 128

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMC 275
              ++  +I+  + ++H   ++HRDLKP N+L+++   + + DFGLA+  D         
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF- 187

Query: 276 GTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR--------- 319
             TEY+      APEI+L+ KG+ K  D WSVG +L EML+ +P F   +          
Sbjct: 188 -LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

Query: 320 ------QKLQQRIINEKVK-----LPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKRL 363
                 Q+    IIN K +     LP       + L           L ++L  +P KR+
Sbjct: 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  108 bits (271), Expect = 3e-26
 Identities = 70/337 (20%), Positives = 113/337 (33%), Gaps = 116/337 (34%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           + + R +G G F  V+  K     D  ++   AMK++R           Y +A   E  +
Sbjct: 21  YILVRKLGWGHFSTVWLAK-----DMVNNTHVAMKIVR-------GDKVYTEAAEDEIKL 68

Query: 169 LTKVT-----------HPFIVQLRYSFQTRSKLYLILDFINGGHL-------------FF 204
           L +V               I++L   F  +          NG H+               
Sbjct: 69  LQRVNDADNTKEDSMGANHILKLLDHFNHKGP--------NGVHVVMVFEVLGENLLALI 120

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD------SDGHVMLT 257
             Y          +  + +++  + ++H+ CGI+H D+KPEN+LM+      +   + + 
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180

Query: 258 DFGLAKEIDE------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 311
           D G A   DE       +R        EY +PE+LL       AD WS   L++E++TG 
Sbjct: 181 DLGNACWYDEHYTNSIQTR--------EYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

Query: 312 PPFT-------------------------------------HANRQKLQQRIINEKVK-- 332
             F                                        N + L + I   K    
Sbjct: 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292

Query: 333 ------LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
                    F   EA  +     FL+ +L  DP KR 
Sbjct: 293 EDVLTEKYKFSKDEAKEIS---DFLSPMLQLDPRKRA 326

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  108 bits (271), Expect = 3e-26
 Identities = 71/296 (23%), Positives = 130/296 (43%), Gaps = 60/296 (20%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + VG GA+G V         DG +    A+K   K     ++ +   +A R++
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIK---KLYRPFQSELFAKRAYREL 75

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARF 219
             L  + H  ++ L        +    +  YL++ F+         L +     ED+ +F
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG---KLMKHEKLGEDRIQF 132

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              +++  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA++ D     + M   T 
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEM---TG 184

Query: 280 YM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ------ 323
           Y+      APE++L+   + +  D WSVG ++ EM+TG+  F    H ++ K        
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244

Query: 324 ------QRIINEKVK-----LPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKRL 363
                 QR+ +++ K     LP     +  S+L   S      L ++L  D  +R+
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  106 bits (268), Expect = 6e-26
 Identities = 73/295 (24%), Positives = 124/295 (42%), Gaps = 59/295 (20%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  +     VG GA+G V         D  S    A+K   K +   ++ +   +A R++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAI-----DKRSGEKVAIK---KLSRPFQSEIFAKRAYREL 74

Query: 169 --LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             L  + H  ++ L   F   S        YL++ F+    L         F E++ ++ 
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL--QKIMGLKFSEEKIQYL 131

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +++  + ++H  G+VHRDLKP N+ ++ D  + + DFGLA+  D           T Y
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--------TGY 183

Query: 281 M------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ------- 323
           +      APE++LS   +N+  D WSVG ++ EMLTG+  F    + ++           
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243

Query: 324 -----QRIINEKVK-----LPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKRL 363
                Q++ ++  K     LP     +   L    S      L ++L  D  KRL
Sbjct: 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  106 bits (267), Expect = 1e-25
 Identities = 65/273 (23%), Positives = 119/273 (43%), Gaps = 60/273 (21%)

Query: 95  NDAELEAESERKIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
           ND   +   +  +  G+     +EI  ++G+G+FG+V +       D       A+K+++
Sbjct: 34  NDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY-----DRVEQEWVAIKIIK 88

Query: 150 KDTIIKKNHVDYMKA---ERDILTKVTHP------FIVQLRYSFQTRSKLYLILDFINGG 200
                  N   ++     E  +L  +         +IV L+  F  R+ L L+ +     
Sbjct: 89  -------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----- 136

Query: 201 HLFFHLY-------RQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDSD 251
            L ++LY        +G    +  R +  ++ +A+  L   +  I+H DLKPENIL+ + 
Sbjct: 137 MLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195

Query: 252 GH--VMLTDFGLAKEIDE------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
               + + DFG + ++ +       SR         Y +PE+LL   ++   D WS+G +
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRF--------YRSPEVLLGMPYDLAIDMWSLGCI 247

Query: 304 LYEMLTGQPPF-THANRQKLQQRIINEKVKLPP 335
           L EM TG+P F       ++    I E + +PP
Sbjct: 248 LVEMHTGEPLFSGANEVDQM--NKIVEVLGIPP 278

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  105 bits (265), Expect = 1e-25
 Identities = 64/267 (23%), Positives = 121/267 (45%), Gaps = 22/267 (8%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R +   +F+  +V+G GAFG V+    KG+   +G+   I  A+K +R+ T   K + + 
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           +  E  ++  V +P + +L       S + LI   +  G L  ++   +          +
Sbjct: 65  LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
             +I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G    
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPP 335
            ++MA E +L + +   +D WS G+ ++E++T G  P+      +        E++  PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKR 362
             T + + +      + +    D   R
Sbjct: 243 ICTIDVYMI------MRKCWMIDADSR 263

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  108 bits (272), Expect = 1e-25
 Identities = 68/302 (22%), Positives = 134/302 (44%), Gaps = 20/302 (6%)

Query: 68  SHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVF 127
           ++   G        S      + ++ E+   + +  + +I     E+ R +G+G FG V 
Sbjct: 348 NNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVH 407

Query: 128 QVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185
               +G+     +     A+K  +  T        +++ E   + +  HP IV+L     
Sbjct: 408 ----QGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQ-EALTMRQFDHPHIVKL-IGVI 460

Query: 186 TRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
           T + +++I++    G L   L  R+          Y  ++ +A+++L     VHRD+   
Sbjct: 461 TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 520

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGI 302
           N+L+ S+  V L DFGL++ +++S+   +  G    ++MAPE +  +     +D W  G+
Sbjct: 521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580

Query: 303 LLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPS 360
            ++E+L  G  PF    N   + +    E++ +PP      +SL      +T+    DPS
Sbjct: 581 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL------MTKCWAYDPS 634

Query: 361 KR 362
           +R
Sbjct: 635 RR 636

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  105 bits (265), Expect = 2e-25
 Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 55/299 (18%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V         D   +   A+K   K +   +N     +A R++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAY-----DAILERNVAIK---KLSRPFQNQTHAKRAYREL 75

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             +  V H  I+ L        S +    +Y++++ +        + +  +   ++  + 
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQMEL-DHERMSYL 132

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-------------- 326
            APE++L  G+ ++ D WSVG ++ EM+ G   F   +      ++              
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

Query: 327 INEKVK-----LP--------------PFLTSEAHSLLK---GVSFLTQLLHKDPSKRL 363
           +   V+      P               F     H+ LK       L+++L  D SKR+
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  105 bits (263), Expect = 4e-25
 Identities = 66/295 (22%), Positives = 125/295 (42%), Gaps = 58/295 (19%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  ++    VG GA+G V         D  +    A+K   K +   ++ +   +  R++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVK---KLSRPFQSIIHAKRTYREL 79

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             L  + H  ++ L        S +  + +YL+   +  G    ++ +     +D  +F 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +I+  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+        + M   T Y
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-----DEM---TGY 189

Query: 281 M------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR-------------- 319
           +      APEI+L+   +N+  D WSVG ++ E+LTG+  F   +               
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 320 -QKLQQRIINEKVK-----LPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKRL 363
             +L ++I +E  +     L         ++  G +      L ++L  D  KR+
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  104 bits (262), Expect = 4e-25
 Identities = 69/260 (26%), Positives = 103/260 (39%), Gaps = 77/260 (29%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           F + R +G G FG+V   +       D+   YA+KV+R       N   Y ++   E DI
Sbjct: 37  FLVIRKMGDGTFGRVLLCQ-----HIDNKKYYAVKVVR-------NIKKYTRSAKIEADI 84

Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-------RQGIFRE 214
           L K+        +  IV+    F     + LI +      L   LY         G F  
Sbjct: 85  LKKIQNDDINNNN--IVKYHGKFMYYDHMCLIFEP-----LGPSLYEIITRNNYNG-FHI 136

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT----------------- 257
           +  + Y  EI+ A+++L K  + H DLKPENIL+D                         
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 258 --------DFGLAKEIDE------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 303
                   DFG A    +      ++R         Y APE++L+ G +  +D WS G +
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQ--------YRAPEVILNLGWDVSSDMWSFGCV 248

Query: 304 LYEMLTGQPPF-THANRQKL 322
           L E+ TG   F TH + + L
Sbjct: 249 LAELYTGSLLFRTHEHMEHL 268

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  101 bits (255), Expect = 2e-24
 Identities = 45/232 (19%), Positives = 93/232 (40%), Gaps = 35/232 (15%)

Query: 101 AESERKIGPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
              E  +      +  + +G G FG V     KG           A+K+++ +       
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVK----KGYYQMKKVVKTVAVKILKNEANDPALK 62

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
            + +  E +++ ++ +P+IV++           L+++    G L  +L +    ++    
Sbjct: 63  DELLA-EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT 278
               ++   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +             
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------N 172

Query: 279 EY------------MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF 314
            Y             APE +    + K    +D WS G+L++E  + GQ P+
Sbjct: 173 YYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  101 bits (255), Expect = 2e-24
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 19/222 (8%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
              IG  D  +   +G G+FG V     +G  D  S      A+K ++ D + +   +D 
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVR----RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
              E + +  + H  +++L Y       + ++ +    G L   L   QG F       Y
Sbjct: 68  FIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             ++   + +L     +HRDL   N+L+ +   V + DFGL + + ++     M    + 
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 281 ----MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF 314
                APE L           +D W  G+ L+EM T GQ P+
Sbjct: 187 PFAWCAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPW 225

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 3e-24
 Identities = 57/244 (23%), Positives = 109/244 (44%), Gaps = 19/244 (7%)

Query: 77  RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD 136
            +        +    +    +  E     +      +  + +G+G FG V   +   + D
Sbjct: 8   HHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67

Query: 137 GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLI 193
              + + A+K ++  T  +++  D+ + E +IL  + H  IV+ +   YS   R+ L LI
Sbjct: 68  NTGEVV-AVKKLQHST--EEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLI 122

Query: 194 LDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           ++++  G L  +L + +      +   YT++I   + +L     +HRDL   NIL++++ 
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEY----MAPEILLSKGHNK---DADWWSVGILLY 305
            V + DFGL K + +      +    E      APE L     +K    +D WS G++LY
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLY 239

Query: 306 EMLT 309
           E+ T
Sbjct: 240 ELFT 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  100 bits (252), Expect = 3e-24
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 19/220 (8%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
                +      +  + +G+G FG V   +   + D   + + A+K ++  T  +++  D
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHST--EEHLRD 57

Query: 161 YMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQ 216
           + + E +IL  + H  IV+ +   YS   R+ L LI++++  G L  +L + +      +
Sbjct: 58  FER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIK 115

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
              YT++I   + +L     +HRDL   NIL++++  V + DFGL K + +      +  
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175

Query: 277 TTEY----MAPEILLSKGHNK---DADWWSVGILLYEMLT 309
             E      APE L     +K    +D WS G++LYE+ T
Sbjct: 176 PGESPIFWYAPESLT---ESKFSVASDVWSFGVVLYELFT 212

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (251), Expect = 4e-24
 Identities = 65/276 (23%), Positives = 119/276 (43%), Gaps = 40/276 (14%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
           + +I     E+ R +G+G FG V     +G+     +     A+K  +  T        +
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTS-DSVREKF 63

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           ++ E   + +  HP IV+L     T + +++I++    G L   L  R+          Y
Sbjct: 64  LQ-EALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             ++ +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S           Y
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----------TY 171

Query: 281 ------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRI 326
                       MAPE +  +     +D W  G+ ++E+L  G  PF    N   + +  
Sbjct: 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

Query: 327 INEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
             E++ +PP      +SL      +T+    DPS+R
Sbjct: 232 NGERLPMPPNCPPTLYSL------MTKCWAYDPSRR 261

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  101 bits (253), Expect = 5e-24
 Identities = 64/267 (23%), Positives = 121/267 (45%), Gaps = 22/267 (8%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R +   +F+  +V+G GAFG V+    KG+   +G+   I  A+K +R+ T   K + + 
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           +  E  ++  V +P + +L       S + LI   +  G L  ++   +          +
Sbjct: 65  LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
             +I   +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +     G    
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPP 335
            ++MA E +L + +   +D WS G+ ++E++T G  P+      +        E++  PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

Query: 336 FLTSEAHSLLKGVSFLTQLLHKDPSKR 362
             T + + +      + +    D   R
Sbjct: 243 ICTIDVYMI------MVKCWMIDADSR 263

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 58/265 (21%), Positives = 108/265 (40%), Gaps = 24/265 (9%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEA--ESERKIGPGDFEIFRVVGQG 121
           +H+  H   G    Y        Q     H  +    A     R+I      I +++G G
Sbjct: 1   MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60

Query: 122 AFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
             G+V      G            A+K ++     ++   D++  E  I+ +  HP I++
Sbjct: 61  DSGEVC----YGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLS-EASIMGQFDHPNIIR 114

Query: 180 LRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           L     TR +   ++ +++  G L   L    G F   Q       + + + +L   G V
Sbjct: 115 L-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173

Query: 238 HRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY----MAPEILLSKGHNK 293
           HRDL   N+L+DS+    ++DFGL++ +++   +       +      APE +       
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA---FRT 230

Query: 294 ---DADWWSVGILLYEMLT-GQPPF 314
               +D WS G++++E+L  G+ P+
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPY 255

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 15/218 (6%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R     +    +V+G G FG V     KGV   +G+S  I   +KV+   +  +++    
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVH----KGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAV 62

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
                  +  + H  IV+L       S L L+  ++  G L  H+   +G         +
Sbjct: 63  TD-HMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--- 277
             +I   + +L + G+VHR+L   N+L+ S   V + DFG+A  +    +          
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            ++MA E +    +   +D WS G+ ++E++T G  P+
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 23/218 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
             +  R +G+G FGKV         D  +DG     A+K ++ D    ++   + + E D
Sbjct: 32  YLKKIRDLGEGHFGKVS----LYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQ-EID 85

Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
           IL  + H  I++ +        + L L+++++  G L  +L R  I       F   +I 
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF-AQQIC 144

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY----M 281
             +++LH    +HRDL   N+L+D+D  V + DFGLAK + E      +    +      
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204

Query: 282 APEILLSKGHNK---DADWWSVGILLYEMLT-GQPPFT 315
           APE L      K    +D WS G+ LYE+LT      +
Sbjct: 205 APECLK---EYKFYYASDVWSFGVTLYELLTHCDSSQS 239

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 43/246 (17%)

Query: 93  HENDAELEAESERK-IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVM 148
           H + A+L A  +         +    +G+G FG V         D   D      A+K +
Sbjct: 5   HHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVE----LCRYDPLGDNTGALVAVKQL 60

Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFH 205
           +     ++   D+ + E  IL  +   FIV+ R   Y    +S L L+++++  G L   
Sbjct: 61  QHSGPDQQR--DFQR-EIQILKALHSDFIVKYRGVSYGPGRQS-LRLVMEYLPSGCLRDF 116

Query: 206 LYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
           L R +      +   Y+++I   + +L     VHRDL   NIL++S+ HV + DFGLAK 
Sbjct: 117 LQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176

Query: 265 IDESSRSNSMCGTTEY------------MAPEILLSKGHNK---DADWWSVGILLYEMLT 309
           +              Y             APE L     N     +D WS G++LYE+ T
Sbjct: 177 LPLDK--------DYYVVREPGQSPIFWYAPESLS---DNIFSRQSDVWSFGVVLYELFT 225

Query: 310 -GQPPF 314
                 
Sbjct: 226 YCDKSC 231

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 97.7 bits (244), Expect = 3e-23
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 34/235 (14%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKA 164
           I   D  + R++G+G FG+V+    +GV           A+K  +KD     N   +M  
Sbjct: 9   IAREDVVLNRILGEGFFGEVY----EGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMS- 62

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+  + HP IV+L          ++I++    G L  +L   +   +      Y+ +
Sbjct: 63  EAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--- 280
           I  A+++L     VHRD+   NIL+ S   V L DFGL++ I++           +Y   
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----------DYYKA 171

Query: 281 ---------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQ 324
                    M+PE +  +     +D W   + ++E+L+ G+ PF    N+  +  
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  100 bits (250), Expect = 4e-23
 Identities = 61/265 (23%), Positives = 117/265 (44%), Gaps = 36/265 (13%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++   S    G   R  L++  P    + +       E      I      +   +GQ
Sbjct: 143 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 194

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG+V+     G          A+K ++  T+  +    +++ E  ++ K+ H  +VQL
Sbjct: 195 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 244

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
            Y+  +   +Y++ ++++ G L   L      + +  ++          A+I S ++++ 
Sbjct: 245 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
           +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L   
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 291 HNKDADWWSVGILLYEMLT-GQPPF 314
               +D WS GILL E+ T G+ P+
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPY 382

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 96.9 bits (242), Expect = 6e-23
 Identities = 48/216 (22%), Positives = 108/216 (50%), Gaps = 22/216 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V        D        A+K +R+  + ++   D+++ E 
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE---DFIE-EA 54

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
           +++ K++HP +VQL Y        + L+ +F+  G L  +L  ++G+F  +       ++
Sbjct: 55  EVMMKLSHPKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
              +++L +  ++HRDL   N L+  +  + ++DFG+ + + +   ++S       ++ +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 173

Query: 283 PEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF 314
           PE+      ++    +D WS G+L++E+ + G+ P+
Sbjct: 174 PEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 57/230 (24%), Positives = 107/230 (46%), Gaps = 31/230 (13%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNH 158
           +   +I P      +V+G G FG+V+    KG+     G  +   A+K ++     +K  
Sbjct: 36  KFTTEIHPSCVTRQKVIGAGEFGEVY----KGMLKTSSGKKEVPVAIKTLKAGYT-EKQR 90

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
           VD++  E  I+ + +H  I++L     ++ K + +I +++  G L   L  + G F   Q
Sbjct: 91  VDFLG-EAGIMGQFSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG 276
                  I + + +L     VHRDL   NIL++S+    ++DFGL++ +++         
Sbjct: 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE------ 202

Query: 277 TTEY-----------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
              Y            APE +  +     +D WS GI+++E++T G+ P+
Sbjct: 203 -ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 22/212 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
             +  R +G+G FGKV         D + D      A+K ++ ++    +  D  K E +
Sbjct: 22  FLKRIRDLGEGHFGKVE----LCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKK-EIE 75

Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEI 224
           IL  + H  IV+ +   +    + + LI++F+  G L  +L + +      Q   Y  +I
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY---- 280
              + +L     VHRDL   N+L++S+  V + DFGL K I+      ++    +     
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 281 MAPEILLSKGHNK---DADWWSVGILLYEMLT 309
            APE L+    +K    +D WS G+ L+E+LT
Sbjct: 196 YAPECLM---QSKFYIASDVWSFGVTLHELLT 224

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 62/250 (24%), Positives = 120/250 (48%), Gaps = 15/250 (6%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           E+  +   E  +++   +  I +VVG G FG+V   + K     +     A+K ++    
Sbjct: 29  EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS--VAIKTLKVGYT 86

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGI 211
            +K   D++  E  I+ +  HP I++L     T+SK + ++ +++  G L   L      
Sbjct: 87  -EKQRRDFLG-EASIMGQFDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS 271
           F   Q       I S + +L   G VHRDL   NIL++S+    ++DFGL + +++   +
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203

Query: 272 NSMCGTTEY----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQR 325
                  +      +PE +  +     +D WS GI+L+E+++ G+ P+   +N+  ++  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA- 262

Query: 326 IINEKVKLPP 335
            ++E  +LPP
Sbjct: 263 -VDEGYRLPP 271

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 64/300 (21%), Positives = 115/300 (38%), Gaps = 55/300 (18%)

Query: 50  SPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP 109
           S  + +A   +    H  S S      R    SS P           +     S+ +I  
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTA---------SMPRPHSDWQIPD 53

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
             +EI  ++G G++G V +       D     + A+K   K   + ++ +D  +  R+I 
Sbjct: 54  -RYEIRHLIGTGSYGHVCEAY-----DKLEKRVVAIK---KILRVFEDLIDCKRILREIA 104

Query: 169 -LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
            L ++ H  +V++         +   +LY++L+                  E   +    
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLY 163

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT----- 277
            ++  V ++H  GI+HRDLKP N L++ D  V + DFGLA+ +D     NS         
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 278 -----------------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPP 313
                            T ++      APE++L  + + +  D WS+G +  E+L     
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 16/215 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G+G FG+VF     G    D+  + A+K  R+          +++ E 
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVF----SGRLRADNTLV-AVKSCRETLP-PDLKAKFLQ-EA 163

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
            IL + +HP IV+L     T+ + +Y++++ + GG     L       R         + 
Sbjct: 164 RILKQYSHPNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY---- 280
            + + +L     +HRDL   N L+     + ++DFG+++E  +     +  G  +     
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKW 281

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
            APE L    ++ ++D WS GILL+E  + G  P+
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 63/234 (26%), Positives = 110/234 (47%), Gaps = 38/234 (16%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +E+ + +G+GA+G V++       D  +  + A+K   K     +N  D  +  R+I
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSI-----DRRTGEVVAVK---KIFDAFQNSTDAQRTFREI 59

Query: 169 --LTK-VTHPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
             LT+   H  IV L    +  +   +YL+ D++        + R  I      ++   +
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQ 117

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT------ 277
           ++  + +LH  G++HRD+KP NIL++++ HV + DFGL++      R  +          
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 278 ----------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 314
                     T+Y+      APEILL S  + K  D WS+G +L E+L G+P F
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.4 bits (245), Expect = 3e-22
 Identities = 61/277 (22%), Positives = 122/277 (44%), Gaps = 36/277 (12%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++   S    G   R  L++  P    + +       E      I      +   +GQ
Sbjct: 226 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 277

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG+V+     G          A+K ++  T+  +    +++ E  ++ K+ H  +VQL
Sbjct: 278 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 327

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
            Y+  +   +Y++ ++++ G L   L      + +  ++          A+I S ++++ 
Sbjct: 328 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMAPEILLSKG 290
           +   VHRDL+  NIL+  +    + DFGLA+ I+++  +         ++ APE  L   
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 291 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 326
               +D WS GILL E+ T G+ P+     +++  ++
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAERDILTKVTH 174
            +G+G FG V+    KG  +       A+K +     I        +   E  ++ K  H
Sbjct: 38  KMGEGGFGVVY----KGYVNN---TTVAVKKLAAMVDITTEELKQQF-DQEIKVMAKCQH 89

Query: 175 PFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA------RFYTAE-IVS 226
             +V+L  +S        L+  ++  G L   L       +         R   A+   +
Sbjct: 90  ENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSC----LDGTPPLSWHMRCKIAQGAAN 144

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAP 283
            ++ LH+   +HRD+K  NIL+D      ++DFGLA+  ++ ++   ++ + GTT YMAP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204

Query: 284 EILLSKGH-NKDADWWSVGILLYEMLTGQPPF 314
           E L  +G     +D +S G++L E++TG P  
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLPAV 234

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 97.5 bits (243), Expect = 4e-22
 Identities = 49/219 (22%), Positives = 102/219 (46%), Gaps = 16/219 (7%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
            +   +I     ++ + +G G FG+V+                A+K M+  ++  +    
Sbjct: 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK------VAVKTMKPGSMSVE---A 229

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR 218
           ++  E +++  + H  +V+L ++  T+  +Y+I +F+  G L  F            +  
Sbjct: 230 FLA-EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCG 276
            ++A+I   ++ + +   +HRDL+  NIL+ +     + DFGLA+ I+++          
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347

Query: 277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
             ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.1 bits (237), Expect = 6e-22
 Identities = 51/235 (21%), Positives = 96/235 (40%), Gaps = 41/235 (17%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I    F + R++G+G FG V + + K  D        A+K+++ D I   +  ++++ E 
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK--VAVKMLKADIIASSDIEEFLR-EA 76

Query: 167 DILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF- 219
             + +  HP + +L        +        +IL F+  G L   L       E+     
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLP 135

Query: 220 ------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNS 273
                 +  +I   + +L     +HRDL   N ++  D  V + DFGL+++I        
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----- 190

Query: 274 MCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
                +Y             +A E L    +   +D W+ G+ ++E++T GQ P+
Sbjct: 191 -----DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 94.2 bits (235), Expect = 7e-22
 Identities = 52/223 (23%), Positives = 108/223 (48%), Gaps = 36/223 (16%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G  D       A+K++++ ++ +    ++++ E 
Sbjct: 21  IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSED---EFIE-EA 70

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
            ++  ++H  +VQL Y   T+ + +++I +++  G L  +L   +  F+  Q      ++
Sbjct: 71  KVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY---- 280
             A+ +L     +HRDL   N L++  G V ++DFGL++ + +           EY    
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----------DEYTSSV 179

Query: 281 --------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
                     PE+L+    +  +D W+ G+L++E+ + G+ P+
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 93.9 bits (234), Expect = 8e-22
 Identities = 49/241 (20%), Positives = 95/241 (39%), Gaps = 36/241 (14%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMK 163
           KI   D      +GQG F K+F+  ++ V D          +KV+ K      N+ +   
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFF 60

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
               +++K++H  +V   Y          L+ +F+  G L  +L + +            
Sbjct: 61  EAASMMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------VMLTDFGLAKEIDESSRSNS 273
            ++ +A+  L +  ++H ++  +NIL+  +          + L+D G++  +        
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----- 174

Query: 274 MCGTTEY-------MAPE-ILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQ 323
                +        + PE I   K  N   D WS G  L+E+ + G  P     +++KLQ
Sbjct: 175 -----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229

Query: 324 Q 324
            
Sbjct: 230 F 230

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 93.9 bits (234), Expect = 8e-22
 Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 37/227 (16%)

Query: 107 IGPGDFEIFRVV-GQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNHVDYMKA 164
           +   +  I  +  G G FG V     +GV       I  A+KV+++ T  K +  + M+ 
Sbjct: 6   LKRDNLLIADIELGCGNFGSVR----QGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMR- 59

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+ ++ +P+IV+L         L L+++   GG L   L  ++             +
Sbjct: 60  EAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--- 280
           +   + +L +   VHRDL   N+L+ +  +  ++DFGL+K +            + Y   
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--------SYYTAR 170

Query: 281 ---------MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF 314
                     APE +      K    +D WS G+ ++E L+ GQ P+
Sbjct: 171 SAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPY 214

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 49/216 (22%), Positives = 105/216 (48%), Gaps = 22/216 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   +  + + +G G FG V   K KG  D       A+K++++ ++ +    ++ + E 
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYD------VAVKMIKEGSMSED---EFFQ-EA 54

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
             + K++HP +V+  Y   ++   +Y++ ++I+ G L  +L          Q      ++
Sbjct: 55  QTMMKLSHPKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
              ++ L     +HRDL   N L+D D  V ++DFG+ + + +    +S+      ++ A
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA 173

Query: 283 PEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF 314
           PE+     + K    +D W+ GIL++E+ + G+ P+
Sbjct: 174 PEVFH---YFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 53/244 (21%), Positives = 105/244 (43%), Gaps = 40/244 (16%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P ++ I  ++G+G++G V+        D +++   A+K   K   + ++ +D  +  R+I
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAY-----DKNTEKNVAIK---KVNRMFEDLIDCKRILREI 76

Query: 169 --LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             L ++   +I++L             +LY++L+      L           E+  +   
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---- 277
             ++   + +H+ GI+HRDLKP N L++ D  V + DFGLA+ I+    +N +       
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 278 -------------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHA 317
                        T ++      APE++L  + + K  D WS G +  E+L       + 
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 318 NRQK 321
              +
Sbjct: 256 PTNR 259

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 53/260 (20%), Positives = 106/260 (40%), Gaps = 44/260 (16%)

Query: 80  LSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
           ++S  P      +     E E      +      + R +GQG+FG V++   KGV   + 
Sbjct: 1   MASVNPEYFSAADVYVPDEWE------VAREKITMSRELGQGSFGMVYEGVAKGVVKDEP 54

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFIN 198
           +   A+K + +     +  ++++  E  ++ +     +V+L     ++ +   +I++ + 
Sbjct: 55  ETRVAIKTVNEAAS-MRERIEFLN-EASVMKEFNCHHVVRL-LGVVSQGQPTLVIMELMT 111

Query: 199 GGHL--FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILM 248
            G L  +    R  +         +         EI   +++L+    VHRDL   N ++
Sbjct: 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171

Query: 249 DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY-------------MAPEILLSKGHNKDA 295
             D  V + DFG+ ++I E          T+Y             M+PE L        +
Sbjct: 172 AEDFTVKIGDFGMTRDIYE----------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221

Query: 296 DWWSVGILLYEMLT-GQPPF 314
           D WS G++L+E+ T  + P+
Sbjct: 222 DVWSFGVVLWEIATLAEQPY 241

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 48/213 (22%), Positives = 100/213 (46%), Gaps = 16/213 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +     ++   +G G FG+V+     G          A+K +++ ++       ++  E 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTK------VAVKSLKQGSMSPD---AFLA-EA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
           +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F           ++     A+I
Sbjct: 60  NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYMA 282
              ++ + +   +HRDL+  NIL+       + DFGLA+ I+++  +         ++ A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           PE +        +D WS GILL E++T G+ P+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 96.2 bits (239), Expect = 2e-21
 Identities = 62/315 (19%), Positives = 123/315 (39%), Gaps = 37/315 (11%)

Query: 15  TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
             LK+      ++++       +    +   H  +   + ++    P+     S     P
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
            P   + +S+         E   +        +   D E+    G G FG V     +GV
Sbjct: 308 MP---MDTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL----GCGNFGSVR----QGV 356

Query: 135 DDGDSDGIY-AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI 193
                  I  A+KV+++ T  K +  + M+ E  I+ ++ +P+IV+L         L L+
Sbjct: 357 YRMRKKQIDVAIKVLKQGTE-KADTEEMMR-EAQIMHQLDNPYIVRL-IGVCQAEALMLV 413

Query: 194 LDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           ++   GG L   L  ++             ++   + +L +   VHR+L   N+L+ +  
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473

Query: 253 HVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSV 300
           +  ++DFGL+K +            + Y             APE +  +  +  +D WS 
Sbjct: 474 YAKISDFGLSKALGADD--------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 525

Query: 301 GILLYEMLT-GQPPF 314
           G+ ++E L+ GQ P+
Sbjct: 526 GVTMWEALSYGQKPY 540

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 25/237 (10%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKV 147
           EL       +   S   +         V+G+G FG V+     G   D+       A+K 
Sbjct: 10  ELVQAVQHVVIGPSSLIV-----HFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKS 60

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FF 204
           +            ++  E  I+   +HP ++ L     ++     ++L ++  G L  F 
Sbjct: 61  L-NRITDIGEVSQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
                    +D   F   ++   + +L     VHRDL   N ++D    V + DFGLA++
Sbjct: 119 RNETHNPTVKDLIGF-GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177

Query: 265 IDESSRSNSMCGTTE------YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           + +     S+   T       +MA E L ++     +D WS G+LL+E++T G PP+
Sbjct: 178 MYDKE-YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 26/216 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   + ++ + +G+G FG V     +G          A+K ++ D   +     ++  E 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EA 65

Query: 167 DILTKVTHPFIVQLRYSFQTRSK--LYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
            ++T++ H  +VQL        K  LY++ +++  G L  +     + +   D    ++ 
Sbjct: 66  SVMTQLRHSNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT---TE 279
           ++  A+ +L     VHRDL   N+L+  D    ++DFGL KE   +             +
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVK 179

Query: 280 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           + APE L  K  +  +D WS GILL+E+ + G+ P+
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 16/214 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V+    +GV    S  + A+K +++DT+  +   +++K E 
Sbjct: 217 MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 267

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
            ++ ++ HP +VQL     TR    Y+I +F+  G+L  +     +         +   +
Sbjct: 268 AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--M 281
           I SA+ +L K   +HR+L   N L+  +  V + DFGL++ +   + +            
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 59/279 (21%), Positives = 107/279 (38%), Gaps = 20/279 (7%)

Query: 49  QSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIG 108
             P  +    G   +    +  +                  +L   N   ++A     IG
Sbjct: 26  LVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIG 85

Query: 109 PGDFEI--FRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           P    +    V+G+G FG V+     G   D+       A+K +            ++  
Sbjct: 86  PSSLIVHFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT- 139

Query: 165 ERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           E  I+   +HP ++ L     ++     ++L ++  G L  F          +D   F  
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-G 198

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT--- 278
            ++   +  L     VHRDL   N ++D    V + DFGLA+++ +    +    T    
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258

Query: 279 --EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
             ++MA E L ++     +D WS G+LL+E++T G PP+
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 91.9 bits (229), Expect = 7e-21
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 36/220 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYM------K 163
           +F+   ++G G FGKV+    KGV  DG        KV      +K+   +        +
Sbjct: 40  NFDHKFLIGHGVFGKVY----KGVLRDG-------AKVA-----LKRRTPESSQGIEEFE 83

Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARF 219
            E + L+   HP +V L  +  + R+++ LI  ++  G+L  HLY   +       + R 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 220 YTAEIVSA--VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK---EIDESSRSNSM 274
               I +A  + +LH   I+HRD+K  NIL+D +    +TDFG++K   E+D++  S  +
Sbjct: 143 EIC-IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201

Query: 275 CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPP 313
            GT  Y+ PE  +  G   + +D +S G++L+E+L  +  
Sbjct: 202 KGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSA 240

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 91.9 bits (229), Expect = 9e-21
 Identities = 63/235 (26%), Positives = 118/235 (50%), Gaps = 23/235 (9%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            +F    ++G+G FGKV+    KG   DG    + A+K + K+   +   + + + E ++
Sbjct: 30  DNFSNKNILGRGGFGKVY----KGRLADGT---LVAVKRL-KEERTQGGELQF-QTEVEM 80

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARFYTAEIV 225
           ++   H  +++LR    T ++  L+  ++  G +   L  +   +       R   A + 
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LG 139

Query: 226 SA--VSHLH-KCG--IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR--SNSMCGTT 278
           SA  +++LH  C   I+HRD+K  NIL+D +   ++ DFGLAK +D      + ++ GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 279 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK 332
            ++APE L + G  ++  D +  G++L E++TGQ  F  A        ++ + VK
Sbjct: 200 GHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 59/275 (21%), Positives = 95/275 (34%), Gaps = 53/275 (19%)

Query: 85  PLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYA 144
            + I   +   D + E               + +G GAFGKV +    G+   D+    A
Sbjct: 4   YVYIDPTQLPYDHKWE------FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA 57

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
           +K M K +         M  E  +L+ +  H  IV L     T      +I ++   G L
Sbjct: 58  VK-MLKPSAHLTEREALMS-ELKVLSYLGNHMNIVNL-LGACTIGGPTLVITEYCCYGDL 114

Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
                     F          ED               ++   ++ L     +HRDL   
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHN 292
           NIL+       + DFGLA++I   S          Y            MAPE + +  + 
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDS---------NYVVKGNARLPVKWMAPESIFNCVYT 225

Query: 293 KDADWWSVGILLYEMLT--GQP-PFTHANRQKLQQ 324
            ++D WS GI L+E+ +    P P    + +  + 
Sbjct: 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 55/214 (25%), Positives = 105/214 (49%), Gaps = 16/214 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V+    +GV    S  + A+K +++DT+  +   +++K E 
Sbjct: 10  MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 60

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
            ++ ++ HP +VQL     TR    Y+I +F+  G+L  +     +         +   +
Sbjct: 61  AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT--TEYM 281
           I SA+ +L K   +HRDL   N L+  +  V + DFGL++ +   + +         ++ 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 38/227 (16%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            + +++G+G FG V +   K  D        A+K M+ D   ++   +++  E   +   
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLK--VAVKTMKLDNSSQREIEEFLS-EAACMKDF 93

Query: 173 THPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
           +HP +++L       S Q   K  +IL F+  G L  +L                    +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKF 152

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
             +I   + +L     +HRDL   N ++  D  V + DFGL+K+I              Y
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---------YY 203

Query: 281 ------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
                       +A E L  + +   +D W+ G+ ++E+ T G  P+
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 56/260 (21%), Positives = 115/260 (44%), Gaps = 28/260 (10%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++ + +    G   R      +   +   +    +         +   + ++ + +G+
Sbjct: 150 MQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWA------LNMKELKLLQTIGK 203

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG V     +G          A+K ++ D   +     ++  E  ++T++ H  +VQL
Sbjct: 204 GEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EASVMTQLRHSNLVQL 251

Query: 181 RY--SFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCG 235
                 + +  LY++ +++  G L  +L    R  +  +   +F + ++  A+ +L    
Sbjct: 252 -LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYLEGNN 309

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDA 295
            VHRDL   N+L+  D    ++DFGL KE   +  +  +    ++ APE L  K  +  +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKS 367

Query: 296 DWWSVGILLYEMLT-GQPPF 314
           D WS GILL+E+ + G+ P+
Sbjct: 368 DVWSFGILLWEIYSFGRVPY 387

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 62/281 (22%), Positives = 113/281 (40%), Gaps = 49/281 (17%)

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
           SP     S L   I E    N           I   D  +   +G+GAFGKVF  +   +
Sbjct: 10  SPTEGKGSGLQGHIIE----NPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65

Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLI 193
                  + A+K +++ +  +    D+ + E ++LT + H  IV+  +   T  + L ++
Sbjct: 66  LPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHIVRF-FGVCTEGRPLLMV 121

Query: 194 LDFINGGHLFFHLYRQGIFREDQARFYT---------------AEIVSAVSHLHKCGIVH 238
            +++  G L   L   G   +  A                   +++ + + +L     VH
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181

Query: 239 RDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY-------------MAPEI 285
           RDL   N L+     V + DFG++++I            T+Y             M PE 
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYS----------TDYYRVGGRTMLPIRWMPPES 231

Query: 286 LLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQ 324
           +L +    ++D WS G++L+E+ T   QP +  +N + +  
Sbjct: 232 ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 63/299 (21%), Positives = 116/299 (38%), Gaps = 54/299 (18%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
               H+  H +  P+        +   + E E   D   E      +      + + +G+
Sbjct: 26  GYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWE------LPRDRLVLGKPLGE 79

Query: 121 GAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFI 177
           GAFG+V   +  G+D    + +   A+K M K    +K+  D +  E +++  +  H  I
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVK-MLKSDATEKDLSDLIS-EMEMMKMIGKHKNI 137

Query: 178 VQLRYSFQTRSK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARF 219
           + L     T+   LY+I+++ + G+L                   H   + +  +D    
Sbjct: 138 INL-LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE 279
              ++   + +L     +HRDL   N+L+  D  + + DFGLA++I              
Sbjct: 197 -AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---------Y 246

Query: 280 Y------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQ 324
           Y            MAPE L  + +   +D WS G+LL+E+ T  G P       +  + 
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 89.2 bits (222), Expect = 6e-20
 Identities = 62/280 (22%), Positives = 110/280 (39%), Gaps = 57/280 (20%)

Query: 82  SSLPL--QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
             LPL    + L ++   + E            ++ + +G+GAFG+V +    G+D   +
Sbjct: 4   DELPLDEHCERLPYDAS-KWE------FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTAT 56

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY--SFQTRSKLYLILDF 196
               A+K M K+      H   M  E  IL  +  H  +V L      +    L +I++F
Sbjct: 57  CRTVAVK-MLKEGATHSEHRALMS-ELKILIHIGHHLNVVNL-LGACTKPGGPLMVIVEF 113

Query: 197 INGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHR 239
              G+L                    LY+  +  E    + + ++   +  L     +HR
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHR 172

Query: 240 DLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILL 287
           DL   NIL+     V + DFGLA++I +           +Y            MAPE + 
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDP---------DYVRKGDARLPLKWMAPETIF 223

Query: 288 SKGHNKDADWWSVGILLYEMLT--GQP-PFTHANRQKLQQ 324
            + +   +D WS G+LL+E+ +    P P    + +  ++
Sbjct: 224 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 88.9 bits (221), Expect = 9e-20
 Identities = 63/289 (21%), Positives = 118/289 (40%), Gaps = 54/289 (18%)

Query: 72  VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
           +G S  +   S  P+     E+E   + + E  R        + + +G+GAFG+V   + 
Sbjct: 1   MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRD----KLTLGKPLGEGAFGQVVMAEA 56

Query: 132 KGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187
            G+D        A+ V   M KD   +K+  D +  E +++  +  H  I+ L     T+
Sbjct: 57  VGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNIINL-LGACTQ 112

Query: 188 SK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVS 229
              LY+I+++ + G+L                    +  + +  +D     T ++   + 
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC-TYQLARGME 171

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY--------- 280
           +L     +HRDL   N+L+  +  + + DFGLA++I+             Y         
Sbjct: 172 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---------YYKKTTNGRLP 222

Query: 281 ---MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQ 324
              MAPE L  + +   +D WS G+L++E+ T  G P       +  + 
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 61/283 (21%), Positives = 106/283 (37%), Gaps = 45/283 (15%)

Query: 75  SPRYALSSSLPLQIQ--ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
            P+Y +   +    +       +  +L    + +    + +  + +G GAFGKV +    
Sbjct: 9   KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 68

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-L 190
           G+   D+    A+K M K T         M  E  I++ +  H  IV L     T    +
Sbjct: 69  GLGKEDAVLKVAVK-MLKSTAHADEKEALMS-ELKIMSHLGQHENIVNL-LGACTHGGPV 125

Query: 191 YLILDFINGGHLFFHLYRQGIFREDQARFYT--------------AEIVSAVSHLHKCGI 236
            +I ++   G L   L R+    E    F                +++   ++ L     
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC 185

Query: 237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPE 284
           +HRD+   N+L+ +     + DFGLA++I   S          Y            MAPE
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---------NYIVKGNARLPVKWMAPE 236

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT--GQP-PFTHANRQKLQQ 324
            +    +   +D WS GILL+E+ +    P P    N +  + 
Sbjct: 237 SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 53/248 (21%), Positives = 105/248 (42%), Gaps = 41/248 (16%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
            +++   +  + R +G GAFG+V++ +  G+ +  S    A+K +  +   +++ +D++ 
Sbjct: 24  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLM 82

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT- 221
            E  I++K  H  IV+       +S   +++++ + GG L   L R+   R  Q      
Sbjct: 83  -EALIISKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAM 139

Query: 222 -------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESSRS 271
                   +I     +L +   +HRD+   N L+   G      + DFG+A++I      
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---- 195

Query: 272 NSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTH 316
                   Y             M PE  +        D WS G+LL+E+ +    P  + 
Sbjct: 196 ------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249

Query: 317 ANRQKLQQ 324
           +N++ L+ 
Sbjct: 250 SNQEVLEF 257

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 57/253 (22%), Positives = 108/253 (42%), Gaps = 46/253 (18%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
            + I   D  + R +G+GAFGKVF  +   +       + A+K ++  T       D+ +
Sbjct: 9   VQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQR 66

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------FFHLYRQGIFR 213
            E ++LT + H  IV+  Y        L ++ +++  G L            +   G  R
Sbjct: 67  -EAELLTNLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 214 EDQARFYT-------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
           + +            ++I S + +L     VHRDL   N L+ ++  V + DFG+++++ 
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184

Query: 267 ESSRSNSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQ 311
                      T+Y             M PE ++ +    ++D WS G++L+E+ T   Q
Sbjct: 185 S----------TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

Query: 312 PPFTHANRQKLQQ 324
           P F  +N + ++ 
Sbjct: 235 PWFQLSNTEVIEC 247

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 66/316 (20%), Positives = 122/316 (38%), Gaps = 63/316 (19%)

Query: 45  RHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESE 104
           +    + +S+S +   P V      S    +P  A  S       E E   D + E    
Sbjct: 29  QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS-------EYELPEDPKWE---- 77

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDY 161
                    + + +G+G FG+V   +  G+D        A+ V   M KD   +K+  D 
Sbjct: 78  --FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDL 133

Query: 162 MKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----------------- 202
           +  E +++  +  H  I+ L     T+   LY+I+++ + G+L                 
Sbjct: 134 VS-EMEMMKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA 262
              +  + +  +D     T ++   + +L     +HRDL   N+L+  +  + + DFGLA
Sbjct: 192 INRVPEEQMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250

Query: 263 KEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT- 309
           ++I+             Y            MAPE L  + +   +D WS G+L++E+ T 
Sbjct: 251 RDINNID---------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 301

Query: 310 -GQPPFTHANRQKLQQ 324
            G P       +  + 
Sbjct: 302 GGSPYPGIPVEELFKL 317

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 55/261 (21%), Positives = 105/261 (40%), Gaps = 23/261 (8%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
              RV+G+G FG V+  +             A+K + + T   +    +++ E  ++  +
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQ--CAIKSLSRITE-MQQVEAFLR-EGLLMRGL 79

Query: 173 THPFIVQLRY--SFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
            HP ++ L            +++L ++  G L  F    ++    +D   F   ++   +
Sbjct: 80  NHPNVLAL-IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARGM 137

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTE-----YMAP 283
            +L +   VHRDL   N ++D    V + DFGLA++I +    +            + A 
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEA 341
           E L +      +D WS G+LL+E+LT G PP+                ++  P +     
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257

Query: 342 HSLLKGVSFLTQLLHKDPSKR 362
           + +      + Q    DP+ R
Sbjct: 258 YQV------MQQCWEADPAVR 272

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 50/249 (20%), Positives = 100/249 (40%), Gaps = 43/249 (17%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I          +G+  FGKV++    G   G+     A+K ++          ++   E 
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRH-EA 63

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT---- 221
            +  ++ HP +V L     T+ + L +I  + + G L   L  +    +  +        
Sbjct: 64  MLRARLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 222 ------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS 269
                       A+I + + +L    +VH+DL   N+L+    +V ++D GL +E+  + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

Query: 270 RSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFT 315
                     Y            MAPE ++    + D+D WS G++L+E+ +   QP   
Sbjct: 183 ---------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233

Query: 316 HANRQKLQQ 324
           ++N+  ++ 
Sbjct: 234 YSNQDVVEM 242

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 54/258 (20%), Positives = 105/258 (40%), Gaps = 41/258 (15%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
                      +++   +  + R +G GAFG+V++ +  G+ +  S    A+K +  +  
Sbjct: 55  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVC 113

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIF 212
            +++ +D++  E  I++K  H  IV+       +S   +++L+ + GG L   L R+   
Sbjct: 114 SEQDELDFLM-EALIISKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFL-RETRP 170

Query: 213 REDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGL 261
           R  Q              +I     +L +   +HRD+   N L+   G      + DFG+
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230

Query: 262 AKEIDESSRSNSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEML 308
           A++I              Y             M PE  +        D WS G+LL+E+ 
Sbjct: 231 ARDIYR----------AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

Query: 309 T--GQPPFTHANRQKLQQ 324
           +    P  + +N++ L+ 
Sbjct: 281 SLGYMPYPSKSNQEVLEF 298

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 87.3 bits (216), Expect = 6e-19
 Identities = 62/317 (19%), Positives = 104/317 (32%), Gaps = 102/317 (32%)

Query: 85  PLQIQELEHENDAELEAESERKIG------PGD-----FEIFRVVGQGAFGKVFQVKKKG 133
           P Q +E+   +D E E  ++   G       GD     + + R +G G F  V+      
Sbjct: 1   PEQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSW--- 57

Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THP---FIVQLRYSFQ 185
             D       AMKV++      +++ +    E  +L  V       P    +VQL   F+
Sbjct: 58  --DIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111

Query: 186 TRSKLYLILDFINGGHL-------------FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
                       NG H+             +              +    +++  + +LH
Sbjct: 112 ISGV--------NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163

Query: 233 -KCGIVHRDLKPENILM------------------------------------------- 248
            KC I+H D+KPENIL+                                           
Sbjct: 164 TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVN 223

Query: 249 ------DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGI 302
                      V + D G A  + +    +    T +Y + E+L+  G+N  AD WS   
Sbjct: 224 PLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--TRQYRSLEVLIGSGYNTPADIWSTAC 281

Query: 303 LLYEMLTGQPPF-THAN 318
           + +E+ TG   F  H+ 
Sbjct: 282 MAFELATGDYLFEPHSG 298

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 65/275 (23%), Positives = 104/275 (37%), Gaps = 52/275 (18%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
           E  + +  E E + + +    + E  +V+G GAFGKV      G+         A+K M 
Sbjct: 25  EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-ML 83

Query: 150 KDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----- 202
           K+          M  E  ++T++ +H  IV L     T S  +YLI ++   G L     
Sbjct: 84  KEKADSSEREALMS-ELKMMTQLGSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLR 141

Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
                       +  ++ +  E+     T         ++   +  L     VHRDL   
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHN 292
           N+L+     V + DFGLA++I   S          Y            MAPE L    + 
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDS---------NYVVRGNARLPVKWMAPESLFEGIYT 252

Query: 293 KDADWWSVGILLYEMLT--GQP-PFTHANRQKLQQ 324
             +D WS GILL+E+ +    P P    +    + 
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 287

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 56/271 (20%), Positives = 105/271 (38%), Gaps = 53/271 (19%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
            +  ++  + + +    +  + + +G+G FGKV +     +         A+K M K+  
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK-MLKENA 65

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------- 202
                 D +  E ++L +V HP +++L Y   ++   L LI+++   G L          
Sbjct: 66  SPSELRDLLS-EFNVLKQVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123

Query: 203 ---------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
                            H   + +   D   F   +I   + +L +  +VHRDL   NIL
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISF-AWQISQGMQYLAEMKLVHRDLAARNIL 182

Query: 248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDA 295
           +     + ++DFGL++++ E            Y            MA E L    +   +
Sbjct: 183 VAEGRKMKISDFGLSRDVYEED---------SYVKRSQGRIPVKWMAIESLFDHIYTTQS 233

Query: 296 DWWSVGILLYEMLT--GQPPFTHANRQKLQQ 324
           D WS G+LL+E++T  G P       +    
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNL 264

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 59/287 (20%), Positives = 111/287 (38%), Gaps = 66/287 (22%)

Query: 74  PSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG 133
           P+P Y     L L  + L  E                + E  R +G+GAFG+VFQ +  G
Sbjct: 24  PNPMYQ-RMPLLLNPKLLSLE------------YPRNNIEYVRDIGEGAFGRVFQARAPG 70

Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYL 192
           +   +   + A+K M K+        D+ + E  ++ +  +P IV+L        K + L
Sbjct: 71  LLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMAEFDNPNIVKL-LGVCAVGKPMCL 127

Query: 193 ILDFINGGHL----------------FFHLYRQGIFREDQARFYT--------AEIVSAV 228
           + +++  G L                   L  +           +         ++ + +
Sbjct: 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY-------- 280
           ++L +   VHRDL   N L+  +  V + DFGL++ I             +Y        
Sbjct: 188 AYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS----------ADYYKADGNDA 237

Query: 281 -----MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ 320
                M PE +    +  ++D W+ G++L+E+ +   QP +  A+ +
Sbjct: 238 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 47/252 (18%), Positives = 99/252 (39%), Gaps = 32/252 (12%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G   +++ R +G+G+FG +F+       +  ++   A+K   + +      +   
Sbjct: 4   QNNVVG-VHYKVGRRIGEGSFGVIFEGT-----NLLNNQQVAIKFEPRRS--DAPQLRD- 54

Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
             E      +     I  + Y  Q      L++D +  +   L     R+  F       
Sbjct: 55  --EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAM 110

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKE-IDESSRS-- 271
              ++++ V  +H+  +V+RD+KP+N L+          + + DFG+ K   D  ++   
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170

Query: 272 -----NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP---FTHANRQKLQ 323
                 ++ GT  YM+    L +  ++  D  ++G +    L G  P      A  ++  
Sbjct: 171 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230

Query: 324 QRIINEKVKLPP 335
           +RI  +K   P 
Sbjct: 231 ERIGEKKQSTPL 242

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 80.1 bits (198), Expect = 7e-17
 Identities = 54/259 (20%), Positives = 103/259 (39%), Gaps = 46/259 (17%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G  +F + + +G G FG++   K     +  ++   A+K+        K+    +
Sbjct: 3   GVLMVG-PNFRVGKKIGCGNFGELRLGK-----NLYTNEYVAIKLEPM-----KSRAPQL 51

Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
             E     ++     I Q+ Y         ++L+ +  +   LF    R          F
Sbjct: 52  HLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR---------TF 102

Query: 220 --YTA-----EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGLAKE-ID 266
              T      +++S + ++H   +++RD+KPEN L+   G+     + + DF LAKE ID
Sbjct: 103 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162

Query: 267 ESSRS-------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP---FTH 316
             ++         S+ GT  YM+    L K  ++  D  ++G +    L G  P      
Sbjct: 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222

Query: 317 ANRQKLQQRIINEKVKLPP 335
              ++  Q+I + K   P 
Sbjct: 223 DTLKERYQKIGDTKRATPI 241

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.7 bits (197), Expect = 8e-17
 Identities = 53/249 (21%), Positives = 100/249 (40%), Gaps = 30/249 (12%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   + + R +G G+FG ++        D  +    A+K+    T  K   +    
Sbjct: 4   ELRVG-NRYRLGRKIGSGSFGDIYLGT-----DIAAGEEVAIKLECVKT--KHPQLHI-- 53

Query: 164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
            E  I   +     I  +R+         ++++ +  +   LF    R+  F        
Sbjct: 54  -ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLL 110

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKE-IDESSRS----- 271
             +++S + ++H    +HRD+KP+N LM        V + DFGLAK+  D  +       
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170

Query: 272 --NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP---FTHANRQKLQQRI 326
              ++ GT  Y +    L    ++  D  S+G +L     G  P      A +++  +RI
Sbjct: 171 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230

Query: 327 INEKVKLPP 335
             +K+  P 
Sbjct: 231 SEKKMSTPI 239

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 58/272 (21%), Positives = 107/272 (39%), Gaps = 54/272 (19%)

Query: 88  IQELEHENDAELEAESERK--IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-A 144
           +++  H +  +   +      +   D +   V+G+G FG+V     K     D   +  A
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVL----KARIKKDGLRMDAA 56

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
           +K   K+   K +H D+   E ++L K+  HP I+ L          LYL +++   G+L
Sbjct: 57  IK-RMKEYASKDDHRDFAG-ELEVLCKLGHHPNIINL-LGACEHRGYLYLAIEYAPHGNL 113

Query: 203 FFHLYRQGIFREDQARFYT----------------AEIVSAVSHLHKCGIVHRDLKPENI 246
              L +  +   D A                    A++   + +L +   +HRDL   NI
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 173

Query: 247 LMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY------------MAPEILLSKGHNKD 294
           L+  +    + DFGL++  +             Y            MA E L    +  +
Sbjct: 174 LVGENYVAKIADFGLSRGQE------------VYVKKTMGRLPVRWMAIESLNYSVYTTN 221

Query: 295 ADWWSVGILLYEMLT--GQPPFTHANRQKLQQ 324
           +D WS G+LL+E+++  G P       +  ++
Sbjct: 222 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 55/249 (22%), Positives = 102/249 (40%), Gaps = 30/249 (12%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   F + R +G G+FG+++        +  ++   A+K+    T  K   + Y  
Sbjct: 2   EPRVG-NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKT--KHPQLLY-- 51

Query: 164 AERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
            E  I   +     I  +R+         L++D +  +   LF    R+           
Sbjct: 52  -ESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLML 108

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKE-IDESSRS----- 271
             ++++ V  +H    +HRD+KP+N LM        V + DFGLAK+  D S+       
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168

Query: 272 --NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRI 326
              ++ GT  Y +    L    ++  D  S+G +L   L G  P+       +++  ++I
Sbjct: 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228

Query: 327 INEKVKLPP 335
             +KV    
Sbjct: 229 SEKKVATSI 237

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 46/259 (17%), Positives = 92/259 (35%), Gaps = 40/259 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDY 161
             +++   +GQG FG ++       +   SD    +KV   D           ++     
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 162 MKAERDILTKVTHPFIVQLRYS----FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
              +     K+ +  + +   S       +S  ++I+D   G  L      Q I+  +  
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL------QKIYEANAK 147

Query: 218 RF-------YTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAK----- 263
           RF        +  I+  + ++H+   VH D+K  N+L++  +   V L D+GLA      
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

Query: 264 ----EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 319
                     +     GT E+ + +       ++  D   +G  + + LTG  P+    +
Sbjct: 208 GVHKAYAADPKR-CHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266

Query: 320 QKLQQRI--INEKVKLPPF 336
                R   I  +  +   
Sbjct: 267 DPKYVRDSKIRYRENIASL 285

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 41/252 (16%), Positives = 86/252 (34%), Gaps = 26/252 (10%)

Query: 112 FEIFRVVGQGAFGKVF---QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD- 167
           +++     +   G ++          D G     +++K+  KD  +      + +A +  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 168 ------ILTKVTHPFIVQLRYSFQTRSKL-YLILDFINGGHL--FFHLYRQGIFREDQAR 218
                  L       I         + K  +L+L  + G  L     +  + +  E    
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVL 162

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKE-IDESS------ 269
                ++ A+  LH+   VH ++  ENI +D +    V L  +G A              
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-- 326
              +   G  E+++ ++    G ++ +D  S+G  + + L G  P+T+            
Sbjct: 223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQK 282

Query: 327 INEKVKLPPFLT 338
                K  PF+ 
Sbjct: 283 QKFVDKPGPFVG 294

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 44/300 (14%), Positives = 103/300 (34%), Gaps = 47/300 (15%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+ S   +G    Y  S   P              E +    +    + + + +G G FG
Sbjct: 6   HHSSGVDLGTENLYFQSMPFP--------------EGKVLDDMEGNQWVLGKKIGSGGFG 51

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDYMKAERDILTKVTHPF 176
            ++       +  + D  + +KV  ++           ++        +     ++ +  
Sbjct: 52  LIYLAFP--TNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109

Query: 177 IVQLRYS--FQTRSKLY--LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           I     S   + + + Y  ++++ + G  L     + G F++         ++  + ++H
Sbjct: 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH 168

Query: 233 KCGIVHRDLKPENILMD--SDGHVMLTDFGLAK---------EIDESSRSNSMCGTTEYM 281
           +   VH D+K  N+L+   +   V L D+GL+          +  E+ R     GT E+ 
Sbjct: 169 ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR-KGHNGTIEFT 227

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPP------FTHANRQKLQQRIINEKVKLPP 335
           + +       ++ +D   +G  +   L G+ P         A +      +      +  
Sbjct: 228 SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLK 287

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.4 bits (166), Expect = 8e-13
 Identities = 32/202 (15%), Positives = 59/202 (29%), Gaps = 55/202 (27%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
             +    +G+G FG+VFQ               A+K++  +     N   + K   +IL 
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIADH-------TPVAIKIIAIEGPDLVN-GSHQKTFEEILP 72

Query: 171 KVT---------------HP--------FIVQLRY----------------------SFQ 185
           ++                            VQ  Y                       F 
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPE 244
              +L+++L+F  GG       R  +     A+    ++ ++++         HRDL   
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191

Query: 245 NILMDSDGHVMLTDFGLAKEID 266
           N+L+       L      K   
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST 213

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 32/123 (26%), Positives = 54/123 (43%), Gaps = 23/123 (18%)

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
             LY+  +  E    + + ++   +  L     +HRDL   NIL+     V + DFGLA+
Sbjct: 183 EDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 264 EIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT-G 310
           +I +           +Y            MAPE +  + +   +D WS G+LL+E+ + G
Sbjct: 242 DIYKDP---------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 292

Query: 311 QPP 313
             P
Sbjct: 293 ASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 38/190 (20%), Positives = 69/190 (36%), Gaps = 16/190 (8%)

Query: 109 PGDFEIFR-------VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
              +E  R        +G+GAFG+V +    G+D   +    A+K M K+      H   
Sbjct: 14  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRAL 72

Query: 162 MKAERDILTKV-THPFIVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           M  E  IL  +  H  +V  L    +    L +I++F   G+L  +L      + ++   
Sbjct: 73  MS-ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVP 127

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGT-T 278
           Y  +           G +  DLK     + S      + F   K + +     +      
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187

Query: 279 EYMAPEILLS 288
           +++  E L+ 
Sbjct: 188 DFLTLEHLIC 197

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 4e-07
 Identities = 55/394 (13%), Positives = 113/394 (28%), Gaps = 107/394 (27%)

Query: 30  PDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQ 89
            ++ F      ++P +   + P+  +    +     +R ++      +Y +S        
Sbjct: 89  INYKFL-----MSPIKTEQRQPSMMTRMYIEQ---RDRLYNDNQVFAKYNVSR--LQPYL 138

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGK---VFQV-KKKGVDDGDSDGIYAM 145
           +L     A LE    + +         + G    GK      V     V       I+ +
Sbjct: 139 KLR---QALLELRPAKNVL--------IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187

Query: 146 KVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            +   ++         ++  + +L ++   +  +  +S   + +++ I   +    L   
Sbjct: 188 NLKNCNS-----PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKS 240

Query: 206 -LYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGL 261
             Y     +          A+  +A +    C           IL+ +    V  TDF  
Sbjct: 241 KPYENCLLVLLN----VQNAKAWNAFN--LSC----------KILLTTRFKQV--TDFLS 282

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP--------- 312
           A      S  +     T      +LL     +  D      L  E+LT  P         
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD------LPREVLTTNPRRLSIIAES 336

Query: 313 ---------PFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGVSFLTQLLHKD---P 359
                     + H N  KL   II   +  L P   +E   +   +S    +       P
Sbjct: 337 IRDGLATWDNWKHVNCDKL-TTIIESSLNVLEP---AEYRKMFDRLS----VFPPSAHIP 388

Query: 360 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 393
           +  L                 S+ W  +   ++ 
Sbjct: 389 TILL-----------------SLIWFDVIKSDVM 405

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 16/45 (35%), Positives = 23/45 (51%), Gaps = 2/45 (4%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE 267
           +I   V  LHK  ++H DL   N + D D  + + DFGL K  + 
Sbjct: 439 KIGEIVGKLHKNDVIHNDLTTSNFIFDKD--LYIIDFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	447
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.82
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.58
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.39
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.37
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.12
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.87
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.87
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.62
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.59
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.44
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.36
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.36
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.27
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.1
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.07
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.01
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.81
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.74
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.72
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.6
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.23
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.35

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.4e-72  Score=539.83  Aligned_cols=283  Identities=51%  Similarity=0.952  Sum_probs=251.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+++++||+|+||+||+|++...  ..+++.||||++++....... ...+.+|+.+|++++|||||+++++|++
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISG--SDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSS--TTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccC--CCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            4456899999999999999999997542  236889999999876543322 2357789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .+.+|||||||+||+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998754


Q ss_pred             C-CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          267 E-SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       267 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      . .....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|....+.+|..+++++++++
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  257 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  257 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            3 344567899999999999999999999999999999999999999999999999999999999999999999887766


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  398 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p  398 (447)
                      +.      ||++||++||++...+++|+++||||++++|+.+..++++|||+|
T Consensus       258 ~~------~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P  304 (304)
T 3ubd_A          258 RM------LFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP  304 (304)
T ss_dssp             HH------HTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred             HH------HcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence            65      999999999988766789999999999999999999999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-71  Score=581.01  Aligned_cols=330  Identities=32%  Similarity=0.634  Sum_probs=284.2

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHH---HHHHHhcCCCCceeee
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE---RDILTKVTHPFIVQLR  181 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E---~~il~~l~hpnIv~l~  181 (447)
                      ..+..++|+++++||+|+||+||+|+++.     +++.||||++.+..+........+.+|   +.+++.++|||||+++
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~-----tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~  258 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS  258 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence            35778899999999999999999999986     899999999998766555545555555   4555667899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      ++|++.+.+|||||||.||+|..+|.+.+.+++..+++|+.||+.||+|||++|||||||||+||||+.+|++||+|||+
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCccccccccc-CCCCCCccceeehhHhHHHHhhCCCCCCC---CCHHHHHHHHHhcccCCCCCC
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFL  337 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~pf~~---~~~~~~~~~i~~~~~~~p~~~  337 (447)
                      |+.+... ...+.|||+.|||||++. +..|+.++|||||||++|||++|++||.+   .+..++...+......+|..+
T Consensus       339 A~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~  417 (689)
T 3v5w_A          339 ACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF  417 (689)
T ss_dssp             CEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             eeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence            9987654 356789999999999997 46899999999999999999999999965   345667788888899999999


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCC
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP  417 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  417 (447)
                      ++++++++..      ||++||.+|+++...++++|++||||++++|+.+..+++.|||+|.+...++..+||-......
T Consensus       418 S~~a~dLI~~------lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~e  491 (689)
T 3v5w_A          418 SPELRSLLEG------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEE  491 (689)
T ss_dssp             CHHHHHHHHH------HTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC-------
T ss_pred             CHHHHHHHHH------HccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccCCcc
Confidence            9998877665      9999999999987678999999999999999999999999999999988887777774332222


Q ss_pred             CCCCCCCCCCCCCCccCeeeeCCCccccC
Q 013249          418 ADDSPAPTPTAGEHFKGYTYVAPNPWLSS  446 (447)
Q Consensus       418 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~  446 (447)
                      ..........+++.|++|+|..+..|++|
T Consensus       492 ~~~~~~~~~~d~~~f~~Fs~~~~~~~q~e  520 (689)
T 3v5w_A          492 DTKGIKLLDSDQELYRNFPLTISERWQQE  520 (689)
T ss_dssp             --CCCCCCHHHHTTTTTCCEECHHHHHHH
T ss_pred             ccCCCCCCchHHHHHhCCCccCccchhhh
Confidence            22222233457889999999999999876

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.9e-71  Score=532.88  Aligned_cols=271  Identities=39%  Similarity=0.747  Sum_probs=247.6

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+++|++++|||||+++++|++.+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~-----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            3579999999999999999999987     88999999999877666677788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|||||||+||+|.+++.+.+.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999987432


Q ss_pred             ---CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          269 ---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       269 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                         ....+.|||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|....+.+|..+++++++++
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  265 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV  265 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence               33567899999999999999999999999999999999999999999999999999999999999999999887766


Q ss_pred             hhhhHHhhhccCCCCCCCCCCC-CChhhhhcCCccCCCChhHHHhh
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAR  390 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~-~~~~~l~~h~~f~~~~~~~~~~~  390 (447)
                      +.      ||++||++|+++.. ....+|++||||++++|+.+..+
T Consensus       266 ~~------lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~  305 (311)
T 4aw0_A          266 EK------LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ  305 (311)
T ss_dssp             HH------HSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred             HH------HccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC
Confidence            55      99999999995421 12334799999999999999644

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.8e-65  Score=504.34  Aligned_cols=323  Identities=40%  Similarity=0.807  Sum_probs=288.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+++++||+|+||+||+|+++.     +++.||||++++...........+.+|+.+|+.++||||+++++++.+
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            345789999999999999999999886     788999999988765556667788899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc-
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~-  265 (447)
                      .+.+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. 
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999999999999999999998899999999999999999999999999999999999999999999999999999864 


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      .........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...+......+|..++.++.+++
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  236 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL  236 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            33334567899999999999999999999999999999999999999999999999999999999999999998887776


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT  425 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (447)
                      ..      ||++||.+||+++..++++|++||||.+++|+.+..+++.|||+|.+.+..++.+|+..|+..+...+++..
T Consensus       237 ~~------lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~  310 (337)
T 1o6l_A          237 AG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDR  310 (337)
T ss_dssp             HH------HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC------
T ss_pred             HH------HhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCcCCCcc
Confidence            65      999999999988777999999999999999999999999999999999999999999888776544333211


Q ss_pred             -------C----CCCCCccCeeeeCC
Q 013249          426 -------P----TAGEHFKGYTYVAP  440 (447)
Q Consensus       426 -------~----~~~~~f~~~~~~~~  440 (447)
                             .    ..+..|.||+|+++
T Consensus       311 ~~~~~~~~~~~~~~~~~f~~f~~~~~  336 (337)
T 1o6l_A          311 YDSLGLLELDQREEQEMFEDFDYIAD  336 (337)
T ss_dssp             --------------CCTTTTCCEECC
T ss_pred             cccccccccccccccccCCCceecCC
Confidence                   0    14688999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.5e-66  Score=516.04  Aligned_cols=327  Identities=39%  Similarity=0.816  Sum_probs=285.5

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      ..+..++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+.+|..+|+++ +||||++++++
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            34566799999999999999999999986     7889999999987665566666788999999887 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      |.+.+.+|+||||+.||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            99999999999999999999999998999999999999999999999999999999999999999999999999999998


Q ss_pred             c-ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCC---------CCHHHHHHHHHhcccCC
Q 013249          264 E-IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---------ANRQKLQQRIINEKVKL  333 (447)
Q Consensus       264 ~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~---------~~~~~~~~~i~~~~~~~  333 (447)
                      . ..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||..         .....+.+.+......+
T Consensus       202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~  281 (396)
T 4dc2_A          202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI  281 (396)
T ss_dssp             CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred             ecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence            6 3344456678999999999999999999999999999999999999999953         23455778888889999


Q ss_pred             CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCC-CChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccc
Q 013249          334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  412 (447)
Q Consensus       334 p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~-~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  412 (447)
                      |..++.++.++++.      ||++||.+||++.. .++++|++||||++++|+.+..+++.|||+|.+.+..++.+|+..
T Consensus       282 p~~~s~~~~~li~~------lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~  355 (396)
T 4dc2_A          282 PRSLSVKAASVLKS------FLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQ  355 (396)
T ss_dssp             CTTSCHHHHHHHHH------HTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHH
T ss_pred             CCcCCHHHHHHHHH------HhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChh
Confidence            99999888777665      99999999997632 257899999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCC----CCCCCCccCeeeeCCCc
Q 013249          413 WTTMPADDSPAPT----PTAGEHFKGYTYVAPNP  442 (447)
Q Consensus       413 ~~~~~~~~~~~~~----~~~~~~f~~~~~~~~~~  442 (447)
                      |+..+...++...    ..++..|.||+|+++..
T Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~  389 (396)
T 4dc2_A          356 FTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPLL  389 (396)
T ss_dssp             HHTSCCCCCCCCHHHHTTSCGGGGTTCCEECC--
T ss_pred             hccCCCccCCCcchhhccccccccCCcEeECccc
Confidence            9887665554321    23567899999999853

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.1e-66  Score=492.44  Aligned_cols=254  Identities=31%  Similarity=0.596  Sum_probs=217.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|++++|||||+++++|++.+.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTT-----TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTT-----TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            689999999999999999999876     789999999988766666667789999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||| +|+|.+++.+++.+++.+++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            99999999 67999999999999999999999999999999999999999999999999999999999999999877666


Q ss_pred             CCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  348 (447)
                      ...+.+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.+...+.+.|......+|..+++++++++.. 
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~-  245 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKR-  245 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH-
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence            6677899999999999998886 57999999999999999999999999999999999999999999999888776555 


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                           ||++||++||     +++|+++||||+
T Consensus       246 -----~L~~dP~~R~-----s~~eil~hpw~k  267 (275)
T 3hyh_A          246 -----MLIVNPLNRI-----SIHEIMQDDWFK  267 (275)
T ss_dssp             -----HSCSSGGGSC-----CHHHHHHCHHHH
T ss_pred             -----HccCChhHCc-----CHHHHHcCcccc
Confidence                 9999999999     899999999995

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-65  Score=507.37  Aligned_cols=323  Identities=40%  Similarity=0.799  Sum_probs=283.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  185 (447)
                      +..++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+.+|..+|+.+ +||||+++++++.
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKE-----TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcC-----CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            556799999999999999999999986     7889999999987666666777888999999988 6999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      +.+.+|+||||+.||+|..++.+.+.+++.+++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999999999999899999999999999999999999999999999999999999999999999999864


Q ss_pred             c-CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhh
Q 013249          266 D-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       266 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      . ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...|......+|..++.++.++
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  254 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI  254 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            3 333455678999999999999999999999999999999999999999999999999999999999999999888777


Q ss_pred             hhhhhHHhhhccCCCCCCCCC-CCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA  423 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~-~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  423 (447)
                      ++.      ||++||.+||++ ...++++|++||||++++|+.+..+++.|||+|.+.+..++.+|+..++..+...++.
T Consensus       255 i~~------lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~  328 (353)
T 3txo_A          255 LKS------FMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPI  328 (353)
T ss_dssp             HHH------HTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCC
T ss_pred             HHH------HhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcccccCCCcCCCc
Confidence            665      999999999965 2235599999999999999999999999999999999999999999888765544443


Q ss_pred             CCC----CCCCCccCeeeeCC
Q 013249          424 PTP----TAGEHFKGYTYVAP  440 (447)
Q Consensus       424 ~~~----~~~~~f~~~~~~~~  440 (447)
                      ...    ..+..|.||+|+++
T Consensus       329 ~~~~~~~~~~~~f~~f~~~~~  349 (353)
T 3txo_A          329 DEGHLPMINQDEFRNFEYVSP  349 (353)
T ss_dssp             CTTSGGGSCGGGGTTCCEECC
T ss_pred             cccccCcccccccCCceeeCc
Confidence            221    24678999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.2e-65  Score=506.67  Aligned_cols=329  Identities=39%  Similarity=0.785  Sum_probs=290.7

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      .+..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+..|..+|..+ +||||+++++++
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETT-----EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            3556799999999999999999999986     7889999999987655556677788999999988 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ++.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999986


Q ss_pred             cc-CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHh
Q 013249          265 ID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (447)
Q Consensus       265 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  343 (447)
                      .. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.|......+|..++.++.+
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  250 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  250 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            43 33345678999999999999999999999999999999999999999999999999999999999999999988877


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA  423 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  423 (447)
                      +++.      ||++||.+||+++..++++|++||||++++|+.+..++++|||+|.+.+. ++.+|+..++..+...++.
T Consensus       251 li~~------lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~  323 (353)
T 2i0e_A          251 ICKG------LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPP  323 (353)
T ss_dssp             HHHH------HTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCC
T ss_pred             HHHH------HhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCcccCCc
Confidence            7665      99999999999877789999999999999999999999999999999888 8999998877765544433


Q ss_pred             CCC----CCCCCccCeeeeCCCccccC
Q 013249          424 PTP----TAGEHFKGYTYVAPNPWLSS  446 (447)
Q Consensus       424 ~~~----~~~~~f~~~~~~~~~~~~~~  446 (447)
                      ...    .++..|.||+|+++..+..|
T Consensus       324 ~~~~~~~~~~~~f~~f~~~~~~~~~~~  350 (353)
T 2i0e_A          324 DQEVIRNIDQSEFEGFSFVNSEFLKPE  350 (353)
T ss_dssp             CHHHHHHSCTTTTCSCCEECTTCCCC-
T ss_pred             cccccccccccccCCCeeeCccccChh
Confidence            221    35688999999998765544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.4e-65  Score=496.08  Aligned_cols=253  Identities=26%  Similarity=0.470  Sum_probs=225.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      +.|+++++||+|+||+||+|+++.     +++.||||++.+....   ..+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  145 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE  145 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC-----CCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            469999999999999999999986     8899999999865432   23457889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      +|||||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... 
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            9999999999999998876 57999999999999999999999999999999999999999999999999999987543 


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCchhHHhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSLL  345 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li  345 (447)
                      ....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...|.....   ..+..++++++++ 
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl-  303 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF-  303 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH-
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH-
Confidence            345678999999999999999999999999999999999999999999999998888876532   2233466666655 


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                           |.+||++||++||     +++|+++||||...
T Consensus       304 -----i~~~L~~dP~~R~-----ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          304 -----LDRLLVRDPAQRA-----TAAELLKHPFLAKA  330 (346)
T ss_dssp             -----HHHHSCSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             -----HHHHcCCChhHCc-----CHHHHhcCHhhcCC
Confidence                 4559999999999     88999999999753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-64  Score=505.34  Aligned_cols=253  Identities=26%  Similarity=0.471  Sum_probs=226.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      +.|+++++||+|+||+||+|+++.     +++.||||++.+....   ..+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  222 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE  222 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECC-----CCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence            569999999999999999999986     8899999999865432   23457899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      +|||||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... 
T Consensus       223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999999999998865 57999999999999999999999999999999999999999999999999999987543 


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCchhHHhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSLL  345 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li  345 (447)
                      ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...|.....   ..+..++.++++++
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  381 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  381 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence            345678999999999999999999999999999999999999999999999999888877632   33446677776655


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .      +||++||++|+     +++|+++||||...
T Consensus       382 ~------~~L~~dP~~R~-----ta~ell~Hp~~~~~  407 (423)
T 4fie_A          382 D------RLLVRDPAQRA-----TAAELLKHPFLAKA  407 (423)
T ss_dssp             H------HHSCSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             H------HHcCCChhHCc-----CHHHHhcCHHhcCC
Confidence            5      59999999999     88999999999753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-65  Score=499.28  Aligned_cols=256  Identities=30%  Similarity=0.539  Sum_probs=224.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.... ....+.+.+|+.+|++++|||||+++++|++.+
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   96 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTE-----DGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENG   96 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETT-----TCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccceEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence            4689999999999999999999986     7899999999876543 445677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .+|||||||+||+|.+++..+  ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999999999999765  357999999999999999999999999999999999999999999999999999765


Q ss_pred             CCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhh
Q 013249          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSL  344 (447)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~l  344 (447)
                      ... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|..+.. .++..++.+++++
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence            432 23457899999999999999999999999999999999999999999999999999988765 3566778877766


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +..      ||++||++||     +++++++||||..
T Consensus       257 i~~------~L~~dP~~R~-----s~~e~l~hp~~~~  282 (350)
T 4b9d_A          257 VSQ------LFKRNPRDRP-----SVNSILEKGFIAK  282 (350)
T ss_dssp             HHH------HTCSSGGGSC-----CHHHHHTSHHHHT
T ss_pred             HHH------HccCChhHCc-----CHHHHhcCHHhhc
Confidence            554      9999999999     8999999999964

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.5e-64  Score=493.78  Aligned_cols=320  Identities=38%  Similarity=0.746  Sum_probs=257.4

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      .+..++|++.++||+|+||.||+|+++.     +++.||||++++.........+.+..|..+|+.+ +||||+++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~   87 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   87 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            4567899999999999999999999986     7899999999887655555667788899999877 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .+.+.+|+||||+.||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.
T Consensus        88 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           88 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999986


Q ss_pred             cc-CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHh
Q 013249          265 ID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (447)
Q Consensus       265 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  343 (447)
                      .. ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...|......+|..++.++.+
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  247 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD  247 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence            43 23345678999999999999999999999999999999999999999999999999999999998999989888877


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChh-hhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVD-AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP  422 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~-~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  422 (447)
                      ++..      ||+.||.+||     ++. +|++||||++++|+.+..+++.|||+|.+.+..+..+|+..++......++
T Consensus       248 li~~------lL~~dp~~R~-----~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~  316 (345)
T 1xjd_A          248 LLVK------LFVREPEKRL-----GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSF  316 (345)
T ss_dssp             HHHH------HSCSSGGGSB-----TTBSCGGGSGGGTTCCHHHHHTTCSCC----------------------------
T ss_pred             HHHH------HhcCCHhHcC-----CChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCCc
Confidence            7665      9999999999     455 999999999999999999999999999999999999999888776543333


Q ss_pred             CCC----CCCCCCccCeeeeCCC
Q 013249          423 APT----PTAGEHFKGYTYVAPN  441 (447)
Q Consensus       423 ~~~----~~~~~~f~~~~~~~~~  441 (447)
                      ...    ..++..|.||+|+++.
T Consensus       317 ~~~~~~~~~~~~~f~~f~~~~~~  339 (345)
T 1xjd_A          317 ADRALINSMDQNMFRNFSFMNPG  339 (345)
T ss_dssp             ----------CCTTTTCCC----
T ss_pred             ccccccccccccccCCCeeeChh
Confidence            221    2357889999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.9e-64  Score=500.53  Aligned_cols=322  Identities=46%  Similarity=0.854  Sum_probs=250.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHH-HHhcCCCCceeeeEEEEe
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~  186 (447)
                      ..++|+++++||+|+||.||+|+++.     +++.||||++.+...........+..|..+ ++.++||||++++++|.+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKA-----EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETT-----TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            34689999999999999999999986     788999999998766555556667778777 577899999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc-
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~-  265 (447)
                      .+.+|+||||+.||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.. 
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999999999999899999999999999999999999999999999999999999999999999999874 


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      .........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..|......++..++.++.+++
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence            33345567899999999999999999999999999999999999999999999999999999998899998988887776


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT  425 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (447)
                      +.      ||++||.+||++. ..++++++||||++++|+.+..+++.|||+|.+.+..++.+|+..|+.++...+....
T Consensus       271 ~~------lL~~dp~~R~~~~-~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~  343 (373)
T 2r5t_A          271 EG------LLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKA  343 (373)
T ss_dssp             HH------HTCSSGGGSTTTT-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC-----------------------
T ss_pred             HH------HcccCHHhCCCCC-CCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccccccccccCC
Confidence            65      9999999999874 4678999999999999999999999999999999999999999888876543322111


Q ss_pred             ----------CCCCCCccCeeeeCCC
Q 013249          426 ----------PTAGEHFKGYTYVAPN  441 (447)
Q Consensus       426 ----------~~~~~~f~~~~~~~~~  441 (447)
                                ...+..|.||+|+++.
T Consensus       344 ~~~~~~~~~~~~~~~~f~~f~~~~~~  369 (373)
T 2r5t_A          344 PDSVLVTASVKEAAEAFLGFSYAPPT  369 (373)
T ss_dssp             --------------------------
T ss_pred             ccccccccccccccccCCCCcccCch
Confidence                      1235679999999874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3e-63  Score=490.16  Aligned_cols=323  Identities=39%  Similarity=0.824  Sum_probs=284.2

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  185 (447)
                      +..++|++++.||+|+||.||+|+++.     +++.||||++.+.........+.+.+|+.+|+++ +||||+++++++.
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence            455789999999999999999999986     7899999999987666666777889999999988 8999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      +.+.+|+||||+.||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++..
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999864


Q ss_pred             -cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCC---------CCHHHHHHHHHhcccCCCC
Q 013249          266 -DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---------ANRQKLQQRIINEKVKLPP  335 (447)
Q Consensus       266 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~---------~~~~~~~~~i~~~~~~~p~  335 (447)
                       .........+||+.|+|||++.+..|+.++|||||||++|||++|+.||..         .....+.+.+......+|.
T Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  240 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  240 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred             cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence             333345677999999999999999999999999999999999999999965         3455677788888888998


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCC-CChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccC
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT  414 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~-~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  414 (447)
                      .++.++.++++.      ||++||.+||++.. .+++++++||||++++|+.+..+++.|||+|...+..++.+|+..++
T Consensus       241 ~~s~~~~~li~~------lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~  314 (345)
T 3a8x_A          241 SLSVKAASVLKS------FLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFT  314 (345)
T ss_dssp             TSCHHHHHHHHH------HTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHH
T ss_pred             CCCHHHHHHHHH------HhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccc
Confidence            888888776665      99999999997632 24689999999999999999999999999999999999999998877


Q ss_pred             CCCCCCCCCCC----CCCCCCccCeeeeCC
Q 013249          415 TMPADDSPAPT----PTAGEHFKGYTYVAP  440 (447)
Q Consensus       415 ~~~~~~~~~~~----~~~~~~f~~~~~~~~  440 (447)
                      ..+...++...    ...+..|.||+|+++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~  344 (345)
T 3a8x_A          315 NEPVQLTPDDDDIVRKIDQSEFEGFEYINP  344 (345)
T ss_dssp             TSCSSCCCCCHHHHTTSCGGGGTTCCEECC
T ss_pred             cCcccCCCccccccccccccccCCCEeeCC
Confidence            66543333221    235678999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-63  Score=532.46  Aligned_cols=331  Identities=39%  Similarity=0.781  Sum_probs=295.2

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      ..+..++|+++++||+|+||.||+|+++.     +++.||||++++.........+.+..|..+|..+ +||||++++++
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~  410 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC  410 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESS-----SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECC-----CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            34567899999999999999999999986     7889999999987655566667788899999987 69999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      |++.+.+||||||+.||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+
T Consensus       411 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             CBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence            99999999999999999999999998999999999999999999999999999999999999999999999999999998


Q ss_pred             cc-cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHH
Q 013249          264 EI-DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (447)
Q Consensus       264 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  342 (447)
                      .. .........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.|......+|..++.++.
T Consensus       491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  570 (674)
T 3pfq_A          491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV  570 (674)
T ss_dssp             ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHH
T ss_pred             ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence            64 33344567899999999999999999999999999999999999999999999999999999999999999999888


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP  422 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  422 (447)
                      ++++.      ||++||.+||++...++++|++||||++++|+.+..++++|||+|.+.+ .++.|||..|+..+...++
T Consensus       571 ~li~~------lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~  643 (674)
T 3pfq_A          571 AICKG------LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTP  643 (674)
T ss_dssp             HHHHH------HSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCC
T ss_pred             HHHHH------HccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCCccCC
Confidence            77665      9999999999876667899999999999999999999999999999988 8899999999887665554


Q ss_pred             CCC----CCCCCCccCeeeeCCCccccCC
Q 013249          423 APT----PTAGEHFKGYTYVAPNPWLSSV  447 (447)
Q Consensus       423 ~~~----~~~~~~f~~~~~~~~~~~~~~~  447 (447)
                      ...    ..++..|.||+|+++..++.++
T Consensus       644 ~~~~~~~~~~~~~f~~f~~~~~~~~~~~~  672 (674)
T 3pfq_A          644 PDQEVIRNIDQSEFEGFSFVNSEFLKPEV  672 (674)
T ss_dssp             CCHHHHTTCCGGGGTTCCEECSSCCCC--
T ss_pred             CchhhhhcccccccCCCcccChhhhchhh
Confidence            322    2356789999999998876653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.4e-63  Score=499.10  Aligned_cols=328  Identities=34%  Similarity=0.651  Sum_probs=278.9

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      ....+..++|+++++||+|+||+||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~  136 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY  136 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECC-----CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3456778899999999999999999999986     78899999998765544445556889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      +|.+...+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|
T Consensus       137 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          137 AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            99999999999999999999998875 56999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC--CCCccccCCcccccccccCCC----CCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCC
Q 013249          263 KEIDESS--RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP  334 (447)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~p  334 (447)
                      +......  ...+.+||+.|+|||++.+..    |+.++|||||||++|||++|+.||.+.+..+++.+|....  ..+|
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  295 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP  295 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC
Confidence            8765443  234678999999999998765    7899999999999999999999999999999999988753  4555


Q ss_pred             C--CCchhHHhhhhhhhHHhhhccCCCCC--CCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcc
Q 013249          335 P--FLTSEAHSLLKGVSFLTQLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  410 (447)
Q Consensus       335 ~--~~~~~~~~li~~~~~l~~~L~~dP~~--R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  410 (447)
                      .  .++.+++++++.      ||+.+|.+  |+     ++++|++||||++++|+.+..+++.|||+|.+.+..++.+|+
T Consensus       296 ~~~~~s~~~~~li~~------lL~~~~~rlgR~-----~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd  364 (410)
T 3v8s_A          296 DDNDISKEAKNLICA------FLTDREVRLGRN-----GVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD  364 (410)
T ss_dssp             TTCCCCHHHHHHHHH------HSSCGGGCTTSS-----CHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSC
T ss_pred             CcccccHHHHHHHHH------HccChhhhCCCC-----CHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcC
Confidence            4  577887776665      99988887  87     899999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCC---CCCCCCccCeeeeCCCccccCC
Q 013249          411 KCWTTMPADDSPAPT---PTAGEHFKGYTYVAPNPWLSSV  447 (447)
Q Consensus       411 ~~~~~~~~~~~~~~~---~~~~~~f~~~~~~~~~~~~~~~  447 (447)
                      ...+........+.+   ...+..|.||+|+++..|.+++
T Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~~  404 (410)
T 3v8s_A          365 DLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSA  404 (410)
T ss_dssp             CCCSCCSCCCCCCCCSSCCCTTGGGTTCCEECC-------
T ss_pred             CccccccccccCCCchhhcccccccccceEeCcccccccC
Confidence            876654332222211   1357789999999999888763

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-62  Score=478.78  Aligned_cols=315  Identities=37%  Similarity=0.758  Sum_probs=269.8

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+++++||+|+||+||+|+++.     +++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   77 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence            345689999999999999999999886     788999999988765555566778899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ...+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus        78 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           78 AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhh
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  346 (447)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......|......+|..++.++.++++
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  235 (318)
T 1fot_A          158 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS  235 (318)
T ss_dssp             S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             C--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            4  34567899999999999999999999999999999999999999999999999999999999999999988877766


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCC-CCccCCCcccccCCCCCCCCCCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS-GKDCIANFDKCWTTMPADDSPAPT  425 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~  425 (447)
                      .      ||+.||.+|+++...+++++++||||++++|+.+..++++|||+|.+. +..++.+|+.. .+..........
T Consensus       236 ~------lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~-~~~~~~~~~~~~  308 (318)
T 1fot_A          236 R------LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY-PEEDINYGVQGE  308 (318)
T ss_dssp             H------HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----------------CCCTTCCSC
T ss_pred             H------HhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcCCC-CccccccCccCC
Confidence            5      999999999988777899999999999999999999999999999987 47888999863 333222222223


Q ss_pred             CCCCCCccCe
Q 013249          426 PTAGEHFKGY  435 (447)
Q Consensus       426 ~~~~~~f~~~  435 (447)
                      ...+..|.||
T Consensus       309 ~~~~~~f~~f  318 (318)
T 1fot_A          309 DPYADLFRDF  318 (318)
T ss_dssp             CTTGGGSCCC
T ss_pred             chhhhhccCC
Confidence            3445678876

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.3e-62  Score=481.57  Aligned_cols=314  Identities=39%  Similarity=0.766  Sum_probs=282.6

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      ....++|++++.||+|+||.||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++||||+++++++.
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  111 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4566799999999999999999999886     78899999998876555566778889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      +...+|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++..
T Consensus       112 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceec
Confidence            99999999999999999999999889999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...|..+...+|..++.++.+++
T Consensus       192 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  269 (350)
T 1rdq_E          192 KG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             SS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred             cC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            54  2456789999999999999999999999999999999999999999999999999999999999999988887766


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT  425 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (447)
                      ..      ||+.||.+||++...++++|++||||.+++|..+..+++.|||+|...+..++.+|+ .++..+...+.  .
T Consensus       270 ~~------lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~-~~~~~~~~~~~--~  340 (350)
T 1rdq_E          270 RN------LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD-DYEEEEIRVSI--N  340 (350)
T ss_dssp             HH------HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC-CCCCCCCCCCS--S
T ss_pred             HH------HhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc-cccccccccCC--C
Confidence            65      999999999987666799999999999999999999999999999999999999998 45554432222  2


Q ss_pred             CCCCCCccCe
Q 013249          426 PTAGEHFKGY  435 (447)
Q Consensus       426 ~~~~~~f~~~  435 (447)
                      ...+..|.||
T Consensus       341 ~~~~~~f~~f  350 (350)
T 1rdq_E          341 EKCGKEFTEF  350 (350)
T ss_dssp             CCSTTTTTTC
T ss_pred             cchhhhcCCC
Confidence            2355678876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.8e-62  Score=468.13  Aligned_cols=253  Identities=23%  Similarity=0.431  Sum_probs=216.1

Q ss_pred             CCc-EEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013249          110 GDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (447)
Q Consensus       110 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (447)
                      ++| ++.++||+|+||+||+|+++.     +++.||+|++.+... .....+.+.+|+.+|++++|||||+++++|++  
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   98 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence            455 778899999999999999986     788999999987654 34456778999999999999999999999975  


Q ss_pred             --CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccC-CCCcEEEeecCC
Q 013249          187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMLTDFGL  261 (447)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~-~~~~~kL~DFG~  261 (447)
                        ...+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+||||+ .+|.+||+|||+
T Consensus        99 ~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl  178 (290)
T 3fpq_A           99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             TTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred             CCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence              3568999999999999999999999999999999999999999999998  99999999999997 489999999999


Q ss_pred             cccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC-CHHHHHHHHHhccc--CCCCCCc
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIINEKV--KLPPFLT  338 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~i~~~~~--~~p~~~~  338 (447)
                      |+.... ....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+. +...+...+..+..  .++...+
T Consensus       179 a~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (290)
T 3fpq_A          179 ATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  256 (290)
T ss_dssp             GGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             CEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence            986433 34567899999999999875 5999999999999999999999999764 44555566655432  2344555


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++++++      |.+||++||++||     +++++++||||+.
T Consensus       257 ~~~~~l------i~~~L~~dP~~R~-----s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          257 PEVKEI------IEGCIRQNKDERY-----SIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHH------HHHHSCSSGGGSC-----CHHHHHTSGGGC-
T ss_pred             HHHHHH------HHHHccCChhHCc-----CHHHHhcCccccC
Confidence            665554      5559999999999     8899999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-62  Score=479.19  Aligned_cols=243  Identities=27%  Similarity=0.414  Sum_probs=215.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .+.|++.++||+|+||+||+|+++.     +++.||||+++++..        ..+|+.+|+.++|||||+++++|.+.+
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~-----~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQ-----TGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hhheEeCcEeccCCCeEEEEEEECC-----CCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4579999999999999999999986     889999999986542        236999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-cEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~~kL~DFG~a~~~~~  267 (447)
                      .+|||||||+||+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+..
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            9999999999999999999999999999999999999999999999999999999999999988 699999999997654


Q ss_pred             CCC------CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCc
Q 013249          268 SSR------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLT  338 (447)
Q Consensus       268 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~  338 (447)
                      ...      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|.....   .+|+.++
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s  283 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA  283 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence            321      2346899999999999999999999999999999999999999998888888888887654   3567778


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +++.+++..      ||++||.+||     +++||++
T Consensus       284 ~~~~~li~~------~L~~dP~~R~-----sa~el~~  309 (336)
T 4g3f_A          284 PLTAQAIQE------GLRKEPVHRA-----SAMELRR  309 (336)
T ss_dssp             HHHHHHHHH------HTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHH------HccCCHhHCc-----CHHHHHH
Confidence            777766554      9999999999     7888754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.9e-61  Score=490.91  Aligned_cols=324  Identities=34%  Similarity=0.652  Sum_probs=272.5

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      ....+..++|+++++||+|+||+||+|+++.     +++.||+|++.+...........+.+|+.+|..++||||+++++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  141 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY  141 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcC-----CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            3456777899999999999999999999986     78899999998765544444556889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      +|.+.+.+|+|||||.||+|.+++.+ .+.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+
T Consensus       142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            99999999999999999999999987 57899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC--CCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc--ccC
Q 013249          262 AKEIDESSR--SNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVK  332 (447)
Q Consensus       262 a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~--~~~  332 (447)
                      |+.......  ....+||+.|+|||++.     ...|+.++|||||||++|||++|+.||.+.+..+.+.+|...  ...
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  301 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ  301 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence            987654332  34478999999999997     467899999999999999999999999999999999888764  355


Q ss_pred             CCCC---CchhHHhhhhhhhHHhhhccCCCCC--CCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCC
Q 013249          333 LPPF---LTSEAHSLLKGVSFLTQLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA  407 (447)
Q Consensus       333 ~p~~---~~~~~~~li~~~~~l~~~L~~dP~~--R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~  407 (447)
                      +|..   ++.+++++++.      ||+.+|++  |+     +++++++||||++++|+.+  ++++|||+|.+.+..++.
T Consensus       302 ~p~~~~~~s~~~~dLi~~------lL~~~~~r~~r~-----~~~eil~Hpff~~i~w~~l--~~~~~p~~P~~~~~~d~~  368 (437)
T 4aw2_A          302 FPTQVTDVSENAKDLIRR------LICSREHRLGQN-----GIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPTDTS  368 (437)
T ss_dssp             CCSSCCCSCHHHHHHHHT------TSSCGGGCTTTT-----TTHHHHTSGGGTTCCTTTG--GGSCCSCCCCCSSTTCCT
T ss_pred             CCcccccCCHHHHHHHHH------HhcccccccCCC-----CHHHHhCCCccCCCCHHHH--hhCCCCCCCcCCCccchh
Confidence            6654   67777766555      99998887  77     7899999999999999999  578999999999999999


Q ss_pred             CcccccCCCCCCCCCCC-----CCCCCCCccCeeeeCCCccc
Q 013249          408 NFDKCWTTMPADDSPAP-----TPTAGEHFKGYTYVAPNPWL  444 (447)
Q Consensus       408 ~~~~~~~~~~~~~~~~~-----~~~~~~~f~~~~~~~~~~~~  444 (447)
                      +|+..++.+....+.++     .......|.||+|.++....
T Consensus       369 ~fd~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~  410 (437)
T 4aw2_A          369 NFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVLS  410 (437)
T ss_dssp             TSCCC------------------CCTTGGGTTCCEESSCTTS
T ss_pred             hcCCcccccccccCCCCCccccccccCccccCCCcCCchhhc
Confidence            99987655543322221     12345679999999987543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-60  Score=480.22  Aligned_cols=323  Identities=36%  Similarity=0.660  Sum_probs=266.4

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      ....+..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|..++||||+++++
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~-----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  128 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ-----TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF  128 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            3456778899999999999999999999986     78999999998765555555566889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      +|++.+.+|+||||+.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+
T Consensus       129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence            999999999999999999999999875 4799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC--CCccccCCccccccccc-------CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--
Q 013249          262 AKEIDESSR--SNSMCGTTEYMAPEILL-------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--  330 (447)
Q Consensus       262 a~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--  330 (447)
                      ++.......  ....+||+.|+|||++.       ...|+.++|||||||++|||++|+.||.+.+..+++.+|....  
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  288 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH  288 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            987654332  34568999999999997       3568999999999999999999999999999999988887643  


Q ss_pred             cCCC---CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCC
Q 013249          331 VKLP---PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA  407 (447)
Q Consensus       331 ~~~p---~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~  407 (447)
                      ..+|   ..++.+++++++.      ||+ +|.+|++.  .++++|++||||++++|+.+.  +..|||+|.+.+..++.
T Consensus       289 ~~~p~~~~~~s~~~~dli~~------lL~-~p~~Rlgr--~~~~ei~~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~  357 (412)
T 2vd5_A          289 LSLPLVDEGVPEEARDFIQR------LLC-PPETRLGR--GGAGDFRTHPFFFGLDWDGLR--DSVPPFTPDFEGATDTC  357 (412)
T ss_dssp             CCCC----CCCHHHHHHHHT------TSS-CGGGCTTT--TTHHHHHTSGGGTTCCSTTST--TSCCSCCCC-----CCS
T ss_pred             cCCCccccCCCHHHHHHHHH------HcC-ChhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hcCCCCCCcCCCccccc
Confidence            4444   4677777776655      999 99999864  389999999999999999994  57899999999999999


Q ss_pred             CcccccCCCCCC-------CCC--C-CCCCCCCCccCeeeeCCC
Q 013249          408 NFDKCWTTMPAD-------DSP--A-PTPTAGEHFKGYTYVAPN  441 (447)
Q Consensus       408 ~~~~~~~~~~~~-------~~~--~-~~~~~~~~f~~~~~~~~~  441 (447)
                      ||+.........       .+.  . ........|.||+|+++.
T Consensus       358 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~  401 (412)
T 2vd5_A          358 NFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMA  401 (412)
T ss_dssp             SCC--CCCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSCCC
T ss_pred             ccCcccccccccccccCCCcccccCCCccccCCCCCCCcccCcc
Confidence            998643221110       010  0 011245679999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-60  Score=473.24  Aligned_cols=262  Identities=23%  Similarity=0.390  Sum_probs=220.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++++... .....+.+.+|+.+|+.++|||||++++++..   
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~-----t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRL-----TGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred             CCeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence            579999999999999999999986     889999999976542 33445678899999999999999999999764   


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                         .+.+|||||||. |+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence               367999999996 6799999988999999999999999999999999999999999999999999999999999998


Q ss_pred             cccC-----CCCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC--
Q 013249          264 EIDE-----SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP--  335 (447)
Q Consensus       264 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~--  335 (447)
                      .+..     .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....|.......+.  
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            7633     2234568999999999998875 5699999999999999999999999999999988888765433221  


Q ss_pred             ------------------CCchhHHhh-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          336 ------------------FLTSEAHSL-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       336 ------------------~~~~~~~~l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                                        ........+     -..+|||.+||++||++||     +++|+++||||+...
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI-----SAAAALRHPFLAKYH  352 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc-----CHHHHhcCHhhCcCC
Confidence                              111111111     1235677789999999999     899999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.1e-60  Score=481.58  Aligned_cols=300  Identities=42%  Similarity=0.822  Sum_probs=258.8

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|+++++||+|+||.||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++++.
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~  218 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ  218 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcC-----CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence            4556789999999999999999999886     78899999998776555566667888999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +.+.+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|+.
T Consensus       219 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             ETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             eCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999999999999998999999999999999999999998 9999999999999999999999999999986


Q ss_pred             cc-CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHh
Q 013249          265 ID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (447)
Q Consensus       265 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  343 (447)
                      .. ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...+......+|..++.++.+
T Consensus       299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  378 (446)
T 4ejn_A          299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS  378 (446)
T ss_dssp             TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence            43 33345567899999999999999999999999999999999999999999999999999999999999999888877


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  416 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  416 (447)
                      ++..      ||++||.+||++...+++++++||||.+++|+.+..+++.|||+|.+....+..+|++.||..
T Consensus       379 li~~------~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~~~  445 (446)
T 4ejn_A          379 LLSG------LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQ  445 (446)
T ss_dssp             HHHH------HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-------
T ss_pred             HHHH------HcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchhhhcC
Confidence            6655      999999999988777999999999999999999999999999999999999999999988764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9e-60  Score=489.15  Aligned_cols=324  Identities=36%  Similarity=0.685  Sum_probs=278.4

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|+++++||+|+||.||+|+++.     +++.||||++.+.........+.+.+|+.+|++++||||++++++|
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKA-----TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            44677899999999999999999999986     7899999999887665556667888999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecC
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                      .+...+|+||||++||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence            9999999999999999999999764    369999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC----CHHHHHHHHHhcccCCCC
Q 013249          261 LAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPP  335 (447)
Q Consensus       261 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~----~~~~~~~~i~~~~~~~p~  335 (447)
                      +++.+..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.    ...++.+.+......+|.
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~  414 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD  414 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc
Confidence            9988754433 34569999999999999999999999999999999999999999765    457788888888888998


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCC-----CccCCCcc
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG-----KDCIANFD  410 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~  410 (447)
                      .++.++.++++.      ||++||.+||++...++++|++||||++++|..+..+++.|||+|....     ..+..+|+
T Consensus       415 ~~s~~~~~li~~------lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~  488 (543)
T 3c4z_A          415 KFSPASKDFCEA------LLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFS  488 (543)
T ss_dssp             TSCHHHHHHHHH------HSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC
T ss_pred             ccCHHHHHHHHH------hccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccccccCCchhhhhcc
Confidence            899888777665      9999999999886667899999999999999999999999999998753     22334443


Q ss_pred             cccCCCCCCCCCCCCCCCCCCccCeeeeC-CCccccC
Q 013249          411 KCWTTMPADDSPAPTPTAGEHFKGYTYVA-PNPWLSS  446 (447)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~f~~~~~~~-~~~~~~~  446 (447)
                      ..    .   .....+.+...|.+|++.+ +.+|+.|
T Consensus       489 ~~----~---~~~~~~~~~~~f~~f~~~~~~~~~~~~  518 (543)
T 3c4z_A          489 TV----K---GVAFEKADTEFFQEFASGTCPIPWQEE  518 (543)
T ss_dssp             ----------CCCCCHHHHHHHHHHCCEECHHHHHHH
T ss_pred             cc----C---CCCCCcchhhHhhcCCCCCCChhHHHh
Confidence            21    1   1112234678899999977 4479876

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.6e-60  Score=457.73  Aligned_cols=257  Identities=28%  Similarity=0.474  Sum_probs=199.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      ++|++++.||+|+||+||+|+++.     +++.||||+++...  .....+.+.+|+.+|++++|||||+++++|.+.+ 
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   77 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT   77 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETT-----TCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred             hhCEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence            379999999999999999999986     78999999997643  3444567889999999999999999999997544 


Q ss_pred             -----------EEEEEEeccCCCChHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcE
Q 013249          189 -----------KLYLILDFINGGHLFFHLYRQGIF---REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (447)
Q Consensus       189 -----------~~~lv~E~~~gg~L~~~l~~~~~~---~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~  254 (447)
                                 ++|+|||||.||+|.+++...+.+   .+..++.|+.||+.||+|||++|||||||||+||||+.+|++
T Consensus        78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence                       479999999999999999877653   456789999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC-------------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH-
Q 013249          255 MLTDFGLAKEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-  320 (447)
Q Consensus       255 kL~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-  320 (447)
                      ||+|||+|+.+....             ...+.+||+.|||||++.+..|+.++|||||||++|||++   ||...... 
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~  234 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV  234 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence            999999998765432             1234689999999999999999999999999999999996   78643221 


Q ss_pred             HHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          321 KLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       321 ~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      .....+.  ...+|+..+..   .-...+||.+||++||++||     +++++++||||++++|..
T Consensus       235 ~~~~~~~--~~~~p~~~~~~---~~~~~~li~~~L~~dP~~Rp-----s~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          235 RTLTDVR--NLKFPPLFTQK---YPCEYVMVQDMLSPSPMERP-----EAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHH--TTCCCHHHHHH---CHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGCCC----
T ss_pred             HHHHHHh--cCCCCCCCccc---CHHHHHHHHHHcCCChhHCc-----CHHHHhcCHhhCCCCCCC
Confidence            2222222  23344322111   11234678889999999999     889999999999999843

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.4e-59  Score=454.66  Aligned_cols=304  Identities=51%  Similarity=0.933  Sum_probs=246.2

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      +..++|+++++||+|+||.||+|++...  ..+++.||+|++++..... ......+.+|+.+|+.++||||+++++++.
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTG--ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSS--TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEecc--CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            4556899999999999999999997531  1278899999998754322 234456788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      ..+.+|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++..
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999864


Q ss_pred             cC-CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhh
Q 013249          266 DE-SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       266 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      .. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..++.++.++
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  251 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDL  251 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            32 23345678999999999999999999999999999999999999999999999999999999889998888888776


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA  418 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  418 (447)
                      +..      ||..||.+||++...+++++++||||++++|+.+..+++.|||+|......+..+|+..++....
T Consensus       252 i~~------~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~  319 (327)
T 3a62_A          252 LKK------LLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTP  319 (327)
T ss_dssp             HHH------HSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC-------------------
T ss_pred             HHH------HHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhcchhhhcccc
Confidence            665      99999999998877789999999999999999999999999999999999999999987766443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.1e-60  Score=455.68  Aligned_cols=259  Identities=22%  Similarity=0.413  Sum_probs=222.6

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|.+.++||+|+||+||+|+++......++..||||+++..   .....+.+.+|+++|++++|||||+++++|.
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3555689999999999999999999876555557889999999754   3445567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ-------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  252 (447)
                      +.+.+|||||||+||+|.++|...             ..+++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999864             3699999999999999999999999999999999999999999


Q ss_pred             cEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHh
Q 013249          253 HVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN  328 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~  328 (447)
                      ++||+|||+|+.......   ....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987643322   234579999999999999999999999999999999998 9999999999999988887


Q ss_pred             cc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          329 EK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       329 ~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      +. ...|..++.++.+++..      ||+.||++||     ++++|  |+|++
T Consensus       246 ~~~~~~p~~~~~~~~~li~~------cl~~dP~~RP-----s~~~i--~~~L~  285 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLG------CWQREPHMRK-----NIKGI--HTLLQ  285 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHH------HTCSSGGGSC-----CHHHH--HHHHH
T ss_pred             CCCCCCCccchHHHHHHHHH------HcCCChhHCc-----CHHHH--HHHHH
Confidence            65 46677888887766554      9999999999     78898  45664

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.2e-58  Score=460.90  Aligned_cols=290  Identities=34%  Similarity=0.695  Sum_probs=261.9

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|+++++||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+|+.++|||||+++++|.
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   85 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKND-----TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ   85 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4556789999999999999999999886     78999999998876666667778899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      +.+.+|+||||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.+
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            99999999999999999999999889999999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCC---CCHHHHHHHHHhcccCCCCCCch
Q 013249          266 DESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTS  339 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~---~~~~~~~~~i~~~~~~~p~~~~~  339 (447)
                      .........+||+.|+|||++.+   ..|+.++|||||||++|||++|+.||..   ....++...+......+|..++.
T Consensus       166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~  245 (384)
T 4fr4_A          166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ  245 (384)
T ss_dssp             CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence            77666778899999999999974   4689999999999999999999999964   45566777777888888988888


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  410 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  410 (447)
                      ++.++++.      ||+.||.+||+    +++++++||||++++|+.+..+++.|||+|.....++...|+
T Consensus       246 ~~~~li~~------lL~~dP~~R~s----~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~~~~~~~~~~  306 (384)
T 4fr4_A          246 EMVSLLKK------LLEPNPDQRFS----QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFE  306 (384)
T ss_dssp             HHHHHHHH------HSCSSGGGSCC----SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCCSSCCCCCCC
T ss_pred             HHHHHHHH------HhcCCHhHhcc----cHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCCCCCCCCccC
Confidence            88777665      99999999994    389999999999999999999999999999887665555554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.9e-59  Score=454.28  Aligned_cols=257  Identities=22%  Similarity=0.398  Sum_probs=217.4

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|.+.++||+|+||+||+|++++.....+++.||||+++..   .....+.+.+|+++|++++|||||+++++|.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3555689999999999999999999886555557889999999753   3445567999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~  250 (447)
                      +.+.+|||||||+||+|.+++...               +++++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999999754               35899999999999999999999999999999999999999


Q ss_pred             CCcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHH
Q 013249          251 DGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  326 (447)
Q Consensus       251 ~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i  326 (447)
                      ++++||+|||+|+.+....   .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998764332   2345689999999999999999999999999999999999 99999999999888888


Q ss_pred             Hhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          327 INE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       327 ~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ..+ ....|..+++++.+++..      ||+.||++||     ++++|+++
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~------cl~~dP~~RP-----s~~ei~~~  313 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRG------CWQREPQQRH-----SIKDVHAR  313 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHH------HCCSSTTTSC-----CHHHHHHH
T ss_pred             HcCCCCCCcccccHHHHHHHHH------HcCcChhHCc-----CHHHHHHH
Confidence            775 456788888887766554      9999999999     78999763

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.3e-59  Score=486.37  Aligned_cols=324  Identities=36%  Similarity=0.672  Sum_probs=275.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|+++++||+|+||.||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++++
T Consensus       179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  253 (576)
T 2acx_A          179 QPVTKNTFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY  253 (576)
T ss_dssp             SCCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCccccceEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence            34677899999999999999999999986     7899999999887665555667788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      .+.+.+|+||||+.||+|.+++...+.  +++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++
T Consensus       254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccc
Confidence            999999999999999999999987644  999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC----CHHHHHHHHHhcccCCCCCCc
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLT  338 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~----~~~~~~~~i~~~~~~~p~~~~  338 (447)
                      +...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.    ....+...+......+|..++
T Consensus       334 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s  413 (576)
T 2acx_A          334 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS  413 (576)
T ss_dssp             EECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             eecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCC
Confidence            9876655556679999999999999999999999999999999999999999765    456677778877788888888


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCC-----ccCCCccccc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK-----DCIANFDKCW  413 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~~  413 (447)
                      .++.++++.      ||++||.+||++...+++++++||||++++|+.+..+++.|||+|.....     .+..+|+.  
T Consensus       414 ~~~~dLI~~------lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~~~~~~~~~d~~~f~~--  485 (576)
T 2acx_A          414 PQARSLCSQ------LLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFST--  485 (576)
T ss_dssp             HHHHHHHHH------HTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCCCC-------------
T ss_pred             HHHHHHHHH------hccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCccccccCCcccHhhccc--
Confidence            888777665      99999999998876689999999999999999999999999999987542     22333321  


Q ss_pred             CCCCCCCCCCCCCCCCCCccCeeeeC-CCccccC
Q 013249          414 TTMPADDSPAPTPTAGEHFKGYTYVA-PNPWLSS  446 (447)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~f~~~~~~~-~~~~~~~  446 (447)
                        ..   .....+.+...|.+|...+ +.+|+.|
T Consensus       486 --~~---~~~~~~~~~~~f~~f~~~~~~~~~~~e  514 (576)
T 2acx_A          486 --VK---GVELEPTDQDFYQKFATGSVPIPWQNE  514 (576)
T ss_dssp             -----------CHHHHHHHHHHCCEECHHHHHHH
T ss_pred             --cC---CCCCCccHHHHHhhhccCCCCcccchh
Confidence              11   1122334677788888854 4578754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.6e-58  Score=452.95  Aligned_cols=253  Identities=24%  Similarity=0.457  Sum_probs=206.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (447)
                      ++|+++++||+|+||+||+|+++..  ..+++.||||.+.+..     ....+.+|+++|+.+ +|||||+++++|++.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQ--VGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBT--TSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CcEEEEEEEecccCcEEEEEEEccc--CCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            5799999999999999999987631  1267899999986542     234577899999998 6999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC-CcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~~kL~DFG~a~~~~~  267 (447)
                      ++|+|||||+||+|.+++   +.+++.+++.++.||+.||+|||++|||||||||+||||+.+ +++||+|||+|+....
T Consensus        94 ~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999999999988   459999999999999999999999999999999999999876 8999999999986432


Q ss_pred             CC-----------------------------CCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCC-C
Q 013249          268 SS-----------------------------RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFT-H  316 (447)
Q Consensus       268 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~-~  316 (447)
                      ..                             ...+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||. +
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            21                             12356899999999999875 58999999999999999999999995 4


Q ss_pred             CCHHHHHHHHHhcc-------------------cCCC-----------------------------------CCCchhHH
Q 013249          317 ANRQKLQQRIINEK-------------------VKLP-----------------------------------PFLTSEAH  342 (447)
Q Consensus       317 ~~~~~~~~~i~~~~-------------------~~~p-----------------------------------~~~~~~~~  342 (447)
                      .+..+....|....                   ..+|                                   ..++++  
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~--  328 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE--  328 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH--
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH--
Confidence            44545444443210                   0011                                   112333  


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                          ++|||.+||++||++|+     +++|+++||||++++
T Consensus       329 ----a~DLl~~lL~~dP~~R~-----ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          329 ----AYDLLDKLLDLNPASRI-----TAEEALLHPFFKDMS  360 (361)
T ss_dssp             ----HHHHHHHHTCSCTTTSC-----CHHHHHTSGGGTTC-
T ss_pred             ----HHHHHHHHCcCChhHCc-----CHHHHhcCcccCCCC
Confidence                34677779999999999     899999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.2e-58  Score=481.78  Aligned_cols=259  Identities=27%  Similarity=0.520  Sum_probs=233.6

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++++.||+|+||+||+|+++.     +++.||+|++.+..   ....+.+.+|+.+|+.++|||||+++++|++.+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~-----tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  227 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN  227 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            3589999999999999999999986     88999999997653   233466889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC--CcEEEeecCCcccc
Q 013249          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEI  265 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~--~~~kL~DFG~a~~~  265 (447)
                      .+|||||||+||+|++++.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            99999999999999999864 4689999999999999999999999999999999999999854  89999999999998


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhH
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  341 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  341 (447)
                      .........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++..|......++.    .++.++
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            7766667789999999999999999999999999999999999999999999999999999988776653    456666


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      +++      |.+||++||.+||     +++|+++||||+..+|..
T Consensus       388 ~dl------i~~~L~~dp~~R~-----t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          388 KDF------IRKLLLADPNTRM-----TIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHH------HHTTSCSSGGGSC-----CHHHHHHSTTTSCCCCTT
T ss_pred             HHH------HHHHccCChhHCc-----CHHHHhcCcCcCCCCCCC
Confidence            555      5559999999999     889999999999887754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-58  Score=446.87  Aligned_cols=258  Identities=22%  Similarity=0.355  Sum_probs=219.9

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++++++++||+|+||+||+|++++..+..+++.||||+++...  .....+.+.+|+.+|++++|||||++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            35566899999999999999999998765555578899999997543  3344567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~  249 (447)
                      +.+.+|||||||++|+|.++|..+                ..+++.++..|+.||+.||+|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999753                3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEeecCCcccccCC---CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHH
Q 013249          250 SDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQR  325 (447)
Q Consensus       250 ~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~  325 (447)
                      +++++||+|||+|+.+...   ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999999876432   23445789999999999999999999999999999999998 9999999999999888


Q ss_pred             HHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          326 IINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       326 i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +..+. ...|..++.++.+++.      +||+.||++||     ++++|+++
T Consensus       260 i~~~~~~~~p~~~~~~~~~li~------~C~~~dP~~RP-----s~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLPCPDDCPAWVYALMI------ECWNEFPSRRP-----RFKDIHSR  300 (308)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHcCCCCCCcccchHHHHHHHH------HHcCCChhHCc-----CHHHHHHH
Confidence            87764 3567777777766655      59999999999     78888764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-57  Score=438.77  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=206.1

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      .+.+..+++++.++||+|+||+||+|++++        .||||+++... ......+.+.+|+.+|++++|||||+++++
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            466788899999999999999999998542        48999987543 234556789999999999999999999998


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      +.+ +.+|||||||+||+|.+++... +.+++.++..|+.||+.||+|||+++||||||||+||||++++++||+|||+|
T Consensus       101 ~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          101 MTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             ECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             EEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence            754 5689999999999999999765 67999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC---CCCCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC----
Q 013249          263 KEIDES---SRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----  332 (447)
Q Consensus       263 ~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~----  332 (447)
                      +.....   ......+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+.......+......    
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            876432   23456789999999999964   35899999999999999999999999887655544444443332    


Q ss_pred             --CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          333 --LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       333 --~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                        .+..++.++.++      +.+||+.||++||     ++++|+++
T Consensus       260 ~~~~~~~~~~l~~l------i~~cl~~dP~~RP-----s~~ei~~~  294 (307)
T 3omv_A          260 SKLYKNCPKAMKRL------VADCVKKVKEERP-----LFPQILSS  294 (307)
T ss_dssp             TTSCTTSCHHHHHH------HHHHTCSSSTTSC-----CHHHHHHH
T ss_pred             ccccccchHHHHHH------HHHHcCCCHhHCc-----CHHHHHHH
Confidence              233455555554      5559999999999     77887653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.4e-57  Score=445.90  Aligned_cols=260  Identities=23%  Similarity=0.426  Sum_probs=222.6

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRY  182 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~  182 (447)
                      .+.+..++|+++++||+|+||+||+|++++.....+++.||||.+....  .....+.+.+|+.+|+++.| ||||++++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            4567788999999999999999999999987766677899999997653  23445678899999999965 89999999


Q ss_pred             EEEe-CCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          183 SFQT-RSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       183 ~~~~-~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                      +|.+ ++.+|||||||++|+|.++|+..                ..+++.++..|+.||+.||+|||+++||||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            9976 46799999999999999999763                348999999999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCH-H
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR-Q  320 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~-~  320 (447)
                      |||++++.+||+|||+|+.+.....   ....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+. .
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999997644322   345689999999999999999999999999999999998 9999988654 4


Q ss_pred             HHHHHHHhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          321 KLQQRIINE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       321 ~~~~~i~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .+...+..+ ....|..+++++.+++.      +||+.||++||     ++++|++|
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~------~c~~~dP~~RP-----t~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTML------DCWHGEPSQRP-----TFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHH------HHcCcChhHCc-----CHHHHHHH
Confidence            444445443 45677888888776655      49999999999     88999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.6e-55  Score=427.53  Aligned_cols=259  Identities=31%  Similarity=0.606  Sum_probs=238.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++++.||+|+||.||+|+++.     +++.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   86 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHIL-----TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE   86 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            34689999999999999999999876     788999999987653 344566788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      +.+|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999998776


Q ss_pred             CCCCCccccCCcccccccccCCCCC-CccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  346 (447)
                      .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..++...+..+...+|...+.++.++++
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  246 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK  246 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            6666778999999999999988775 789999999999999999999999999999999999999999998888877665


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      .      ||+.||.+||     +++++++||||+...
T Consensus       247 ~------~L~~dP~~R~-----t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          247 R------FLVLNPIKRG-----TLEQIMKDRWINAGH  272 (328)
T ss_dssp             H------HCCSSTTTSC-----CHHHHTTCTTTTTTC
T ss_pred             H------HCCCChhHCc-----CHHHHhcCHhhcCCC
Confidence            5      9999999999     899999999998654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.9e-54  Score=427.35  Aligned_cols=265  Identities=30%  Similarity=0.518  Sum_probs=237.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||+|++.+......   ...+.+.+|+.+|+.++||||++++++|.+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             hceEEeeEEeeCcCEEEEEEEECC-----CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            479999999999999999999986     788999999987543221   234678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC----cEEEeecCCc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~~kL~DFG~a  262 (447)
                      ...+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999999998888999999999999999999999999999999999999998877    7999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----CCCc
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  338 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~  338 (447)
                      +...........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++...|......++    ..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence            987766566678899999999999999999999999999999999999999999999999999988877665    3455


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhh
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR  390 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~  390 (447)
                      .+++++      |.+||.+||.+||     +++++++||||.+++|.....+
T Consensus       247 ~~~~~l------i~~~L~~dP~~R~-----t~~e~l~hp~~~~~~~~~~~~~  287 (361)
T 2yab_A          247 ELAKDF------IRKLLVKETRKRL-----TIQEALRHPWITPVDTQQAMVR  287 (361)
T ss_dssp             HHHHHH------HHHHSCSSTTTSC-----CHHHHHTSTTTSCSSHHHHHHH
T ss_pred             HHHHHH------HHHHCCCChhHCc-----CHHHHhcCcCcCCCchhhhhhc
Confidence            555554      5559999999999     8899999999999999876543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-54  Score=429.60  Aligned_cols=295  Identities=47%  Similarity=0.875  Sum_probs=248.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-chhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      +..++|+++++||+|+||.||+|++...  ..+++.||||++++.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEccc--CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            4456899999999999999999998531  127889999999764321 122234466799999999 699999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .....+|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999986


Q ss_pred             ccCC--CCCCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCC----CHHHHHHHHHhcccCCCCC
Q 013249          265 IDES--SRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPF  336 (447)
Q Consensus       265 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~----~~~~~~~~i~~~~~~~p~~  336 (447)
                      +...  ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||...    ....+...+......+|..
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  288 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence            5322  22345689999999999986  45789999999999999999999999643    4456666777777778888


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF  409 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  409 (447)
                      ++..+.+++.      +||..||.+||++...+++++++|+||..++|..+..+++.+||.|.+.+..+..+|
T Consensus       289 ~~~~~~~li~------~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~  355 (355)
T 1vzo_A          289 MSALAKDLIQ------RLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF  355 (355)
T ss_dssp             SCHHHHHHHH------HHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred             cCHHHHHHHH------HHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCccccccccccC
Confidence            8777766655      599999999998877799999999999999999999999999999998877776665

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-53  Score=419.75  Aligned_cols=256  Identities=30%  Similarity=0.565  Sum_probs=229.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++++.+.+
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYK-----TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            4689999999999999999999876     78899999998765444444567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+ +|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999999999 7899999988899999999999999999999999999999999999999999999999999999987666


Q ss_pred             CCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  347 (447)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.....+...+......+|..++.++.++++.
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  241 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR  241 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            66677899999999999998876 68999999999999999999999877666655556666667788888887766555


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                            ||+.||.+||     +++++++||||+.
T Consensus       242 ------~L~~dP~~Rp-----t~~eil~hp~~~~  264 (336)
T 3h4j_B          242 ------MIVADPMQRI-----TIQEIRRDPWFNV  264 (336)
T ss_dssp             ------TSCSSGGGSC-----CHHHHTTCHHHHT
T ss_pred             ------HcCCChhHCc-----CHHHHHhChhhcc
Confidence                  9999999999     8999999999974

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-52  Score=405.95  Aligned_cols=265  Identities=28%  Similarity=0.509  Sum_probs=234.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      +|++.+.||+|+||.||+|+++.     +++.||+|++.+.....   ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ceEeceEEeeCCCeEEEEEEECC-----CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            69999999999999999999886     78899999998654321   12356788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC----cEEEeecCCcc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLAK  263 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~~kL~DFG~a~  263 (447)
                      ..+|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            99999999999999999998888999999999999999999999999999999999999999887    89999999999


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----CCCch
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTS  339 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~  339 (447)
                      ...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    ...+.
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  246 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence            87655555667899999999999999999999999999999999999999999988888888877666554    23455


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhh
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE  391 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~  391 (447)
                      ++.+      ||.+||+.||.+||     +++++++||||...+|.....+.
T Consensus       247 ~~~~------li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~~~~~~~  287 (326)
T 2y0a_A          247 LAKD------FIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSRK  287 (326)
T ss_dssp             HHHH------HHHHHSCSSGGGSC-----CHHHHHHSTTTSCCSHHHHHHHH
T ss_pred             HHHH------HHHHHccCChhhCC-----CHHHHhcCCCccCCcchhhhhhh
Confidence            5444      55669999999999     89999999999999987765443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.7e-52  Score=412.82  Aligned_cols=255  Identities=32%  Similarity=0.581  Sum_probs=228.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            369999999999999999999886     788999999987653 33455678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC---cEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~~kL~DFG~a~~~~  266 (447)
                      +|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999999998888999999999999999999999999999999999999998654   59999999999877


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC----CchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF----LTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~----~~~~~~  342 (447)
                      ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+..+...+|..    ++.++.
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            6655667889999999999999999999999999999999999999999999999999998887776642    455554


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +      ||.+||+.||.+||     +++++++||||.+
T Consensus       263 ~------li~~~L~~dP~~R~-----t~~e~l~hp~~~~  290 (362)
T 2bdw_A          263 S------LIDSMLTVNPKKRI-----TADQALKVPWICN  290 (362)
T ss_dssp             H------HHHHHSCSSGGGSC-----CHHHHTTSHHHHT
T ss_pred             H------HHHHHcCCChhhCc-----CHHHHhcCcccCC
Confidence            4      55569999999999     8899999999974

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-51  Score=419.35  Aligned_cols=255  Identities=32%  Similarity=0.590  Sum_probs=226.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||.||+|.++.     +++.||+|++.+... .....+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~-----~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETT-----TTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECC-----CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            379999999999999999999886     889999999987653 33445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC---CCCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~---~~~~~kL~DFG~a~~~~  266 (447)
                      +|+||||+.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999999999999999999999999999999999999999999999999999998   56889999999998765


Q ss_pred             CCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhH
Q 013249          267 ESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  341 (447)
Q Consensus       267 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  341 (447)
                      ... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++...+..+...++.    .++.++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            433 235678999999999999999999999999999999999999999999999999999988877664    456665


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      .++      |.+||+.||.+||     +++++++||||..
T Consensus       245 ~~l------i~~~L~~dP~~Rp-----ta~e~L~hp~~~~  273 (444)
T 3soa_A          245 KDL------INKMLTINPSKRI-----TAAEALKHPWISH  273 (444)
T ss_dssp             HHH------HHHHSCSSTTTSC-----CHHHHHHSCTTHH
T ss_pred             HHH------HHHHcCCChhHCC-----CHHHHhcCccccC
Confidence            555      5559999999999     8899999999964

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-52  Score=405.86  Aligned_cols=247  Identities=25%  Similarity=0.344  Sum_probs=190.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      .+|.+.++||+|+||+||+|++       +++.||||++.....    .......|+..+.+++|||||++++++.+.+ 
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-------~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-------TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-------CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            3689999999999999999987       457899999975431    1122345666677899999999999998653 


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCcccCCCCcEEEe
Q 013249          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~iiHrDikp~NILl~~~~~~kL~  257 (447)
                         .+|||||||+||+|.+++... .++++.+..++.|++.||.|||++        +||||||||+||||+.++++||+
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence               689999999999999999764 689999999999999999999987        99999999999999999999999


Q ss_pred             ecCCcccccCCCC-----CCccccCCcccccccccCC------CCCCccceeehhHhHHHHhhCCCCCCC----------
Q 013249          258 DFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTGQPPFTH----------  316 (447)
Q Consensus       258 DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~ell~G~~pf~~----------  316 (447)
                      |||+|+.......     ....+||+.|||||++.+.      .|+.++|||||||++|||++|..||..          
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            9999987654322     2346899999999999764      367799999999999999999776532          


Q ss_pred             -----CCHHHHHHHHHhccc--CCCCCCc-hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          317 -----ANRQKLQQRIINEKV--KLPPFLT-SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       317 -----~~~~~~~~~i~~~~~--~~p~~~~-~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                           .....+...+.....  .+|.... .+..  -...+|+.+||+.||++||     ++++|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~--~~l~~li~~cl~~dP~~RP-----t~~ei~~  290 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL--RVMAKIMRECWYANGAARL-----TALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHH--HHHHHHHHTTCCSSGGGSC-----CHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHH--HHHHHHHHHHcccCHhHCc-----CHHHHHH
Confidence                 122344444444332  2232211 1111  1224678889999999999     7888876

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-52  Score=428.07  Aligned_cols=260  Identities=30%  Similarity=0.582  Sum_probs=238.1

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|.+++.||+|+||.||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++||||+++++++.
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~   86 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHEL-----TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS   86 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETT-----TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3455789999999999999999999886     78899999998766545556678899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      +.+.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      .........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++..+....|..++.++.++
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L  246 (476)
T 2y94_A          167 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL  246 (476)
T ss_dssp             CTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             cccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence            76666667899999999999998766 68999999999999999999999999988999999998888888888887766


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++.      ||+.||.+||     +++++++||||+.
T Consensus       247 i~~------~L~~dP~~Rp-----t~~eil~hp~~~~  272 (476)
T 2y94_A          247 LKH------MLQVDPMKRA-----TIKDIREHEWFKQ  272 (476)
T ss_dssp             HHH------HTCSSTTTSC-----CHHHHHTCHHHHT
T ss_pred             HHH------HcCCCchhCc-----CHHHHHhCHHhhh
Confidence            555      9999999999     8999999999974

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.5e-53  Score=416.27  Aligned_cols=279  Identities=29%  Similarity=0.533  Sum_probs=236.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (447)
                      ++|++.+.||+|+||.||+|+++.     +++.||||++.+....       ..+|+++|.++ +||||+++++++.+..
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKA-----TNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            369999999999999999999986     7889999999865421       34688888887 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-C---CcEEEeecCCccc
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-D---GHVMLTDFGLAKE  264 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~---~~~kL~DFG~a~~  264 (447)
                      .+|+||||+.||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||+.. +   +.+||+|||+++.
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999999999999899999999999999999999999999999999999999843 3   3599999999987


Q ss_pred             ccCC-CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCC---CCHHHHHHHHHhcccCCCC----C
Q 013249          265 IDES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPP----F  336 (447)
Q Consensus       265 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~---~~~~~~~~~i~~~~~~~p~----~  336 (447)
                      .... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+   .+..++...+..+...++.    .
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            6443 334567899999999999988899999999999999999999999975   4667788888887776653    4


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCccccc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW  413 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  413 (447)
                      ++.++.++      |.+||..||++||     +++++++||||.  +|+.+...++.+++.|.........+|....
T Consensus       250 ~s~~~~~l------i~~~L~~dP~~R~-----t~~~il~hp~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  313 (342)
T 2qr7_A          250 VSDTAKDL------VSKMLHVDPHQRL-----TAALVLRHPWIV--HWDQLPQYQLNRQDAPHLVKGAMAATYSALN  313 (342)
T ss_dssp             SCHHHHHH------HHHHTCSSTTTSC-----CHHHHTTSHHHH--TGGGSCCSCCCCCCCHHHHHHHHHHHHHHHT
T ss_pred             CCHHHHHH------HHHHCCCChhHCc-----CHHHHhcCCeec--CccccccccCCCccchhhhhhHHHHHHhhhc
Confidence            56666555      4559999999999     889999999994  6888888888888887544333334454443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.9e-52  Score=401.89  Aligned_cols=258  Identities=29%  Similarity=0.497  Sum_probs=213.3

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||+||+|+++      +++.||+|++.... ........+.+|+.+|++++||||+++++++.+..
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET------TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC------CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            468999999999999999999975      57899999997653 23444567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99999999985 777777665 4599999999999999999999999999999999999999999999999999987653


Q ss_pred             C-CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----------
Q 013249          268 S-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----------  335 (447)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----------  335 (447)
                      . ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......++          
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            3 23345678999999999976 56899999999999999999999999887776666665542221111          


Q ss_pred             --------------------CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          336 --------------------FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       336 --------------------~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                                          .++.+      .++||.+||++||++||     +++++++||||++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQE------GIDLLSNMLCFDPNKRI-----SARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHH------HHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTSCTT
T ss_pred             hhhhcccccccCCcHHHhCcccCHH------HHHHHHHHcCCChhHCC-----CHHHHhcCcccccCCcc
Confidence                                11222      24677789999999999     89999999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-52  Score=404.73  Aligned_cols=254  Identities=26%  Similarity=0.459  Sum_probs=226.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|++....    .....+.+|+.+|+.++||||+++++++.+.+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   74 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             hhceEeeeEEecCCCeEEEEEEECC-----CCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence            4689999999999999999999886     78899999987532    23456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC--CCcEEEeecCCcccc
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEI  265 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~--~~~~kL~DFG~a~~~  265 (447)
                      .+|+||||++||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            999999999999999999765 47999999999999999999999999999999999999987  789999999999987


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhH
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  341 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  341 (447)
                      .........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+......++.    .++.++
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            6655556678999999999999988999999999999999999999999999999999999888776653    455555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .++      |.+||..||.+||     +++++++||||...
T Consensus       235 ~~l------i~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  264 (321)
T 1tki_A          235 MDF------VDRLLVKERKSRM-----TASEALQHPWLKQK  264 (321)
T ss_dssp             HHH------HHTTSCSSGGGSC-----CHHHHHHSHHHHSC
T ss_pred             HHH------HHHHcCCChhHCc-----CHHHHhcChhhccC
Confidence            554      5559999999999     88999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.8e-51  Score=396.13  Aligned_cols=254  Identities=27%  Similarity=0.467  Sum_probs=220.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.....   ...+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT-----TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC-----CCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence            4579999999999999999999875     788999999976542   23456789999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+.||+|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999999999998765 6899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCchhHHhh
Q 013249          269 S-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSL  344 (447)
Q Consensus       269 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~l  344 (447)
                      . .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.....   ..|..++..+.++
T Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (297)
T 3fxz_A          170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (297)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred             ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence            3 34457899999999999999999999999999999999999999998887776666554432   2344555555554


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                            |.+||+.||++||     +++++++||||+..
T Consensus       250 ------i~~~l~~dp~~Rp-----s~~ell~h~~~~~~  276 (297)
T 3fxz_A          250 ------LNRCLEMDVEKRG-----SAKELLQHQFLKIA  276 (297)
T ss_dssp             ------HHHHSCSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             ------HHHHccCChhHCc-----CHHHHhhChhhccc
Confidence                  5569999999999     89999999999854

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.8e-51  Score=398.57  Aligned_cols=266  Identities=30%  Similarity=0.517  Sum_probs=235.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|++.+......   ...+.+.+|+.+|+.++||||+++++++.+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccEEEeeEeeecCCEEEEEEEECC-----CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            369999999999999999999886     788999999986543221   135678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC----cEEEeecCCc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~~kL~DFG~a  262 (447)
                      ...+|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999999999999888899999999999999999999999999999999999999888    7999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----CCCc
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  338 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~  338 (447)
                      +............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    ...+
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence            987665555667899999999999999999999999999999999999999999988888888887766554    3445


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhh
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE  391 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~  391 (447)
                      .++.+      ||.+||..||++||     +++++++||||.+++|.....+.
T Consensus       247 ~~~~~------li~~~l~~dp~~Rp-----s~~e~l~hp~~~~~~~~~~~~~~  288 (321)
T 2a2a_A          247 ELAKD------FIRKLLVKETRKRL-----TIQEALRHPWITPVDNQQAMVRR  288 (321)
T ss_dssp             HHHHH------HHHTTSCSSTTTSC-----CHHHHHHSTTTSCSSHHHHHHHH
T ss_pred             HHHHH------HHHHHcCCChhhCc-----CHHHHhcCccccCCCcccccccc
Confidence            55544      45569999999999     88999999999999998876543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-51  Score=412.52  Aligned_cols=262  Identities=21%  Similarity=0.385  Sum_probs=216.7

Q ss_pred             CCCCcEEEeeEeec--CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          108 GPGDFEIFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       108 ~~~~y~~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      ..++|+++++||+|  +||.||+|+++.     +++.||||++..... .....+.+.+|+.+|+.++|||||++++++.
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcC-----CCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            44689999999999  999999999986     788999999987643 3456677889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +.+.+|+||||+++|+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||.+.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            999999999999999999999876  679999999999999999999999999999999999999999999999999886


Q ss_pred             cccCC--------CCCCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-
Q 013249          264 EIDES--------SRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-  332 (447)
Q Consensus       264 ~~~~~--------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-  332 (447)
                      .....        ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.......+..+... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            54221        12233579999999999987  67999999999999999999999999876655444433322111 


Q ss_pred             ---------------------------------------------CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCC
Q 013249          333 ---------------------------------------------LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGP  367 (447)
Q Consensus       333 ---------------------------------------------~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~  367 (447)
                                                                   ++..++.++      .+||.+||+.||++||    
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~------~~li~~~L~~dP~~Rp----  326 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF------HHFVEQCLQRNPDARP----  326 (389)
T ss_dssp             -------------------------------------------------CCHHH------HHHHHHHTCSCTTTSC----
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHH------HHHHHHHhhcCcccCC----
Confidence                                                         122233333      3466679999999999    


Q ss_pred             CChhhhhcCCccCCCChhH
Q 013249          368 GGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       368 ~~~~~l~~h~~f~~~~~~~  386 (447)
                       +++++++||||+.+.|..
T Consensus       327 -ta~ell~hp~f~~~~~~~  344 (389)
T 3gni_B          327 -SASTLLNHSFFKQIKRRA  344 (389)
T ss_dssp             -CHHHHTTSGGGGGC---C
T ss_pred             -CHHHHhcCHHHHHHhhcc
Confidence             889999999999887654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-51  Score=406.04  Aligned_cols=258  Identities=28%  Similarity=0.553  Sum_probs=220.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc--hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ++|++.+.||+|+||+||+|+++.     +++.||||++.......  ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRE-----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cceEEeeEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            369999999999999999999886     78899999997654322  12356788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc---EEEeecC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFG  260 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---~kL~DFG  260 (447)
                      +.+|+||||++|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999998877643    35899999999999999999999999999999999999987655   9999999


Q ss_pred             CcccccCCCC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----C
Q 013249          261 LAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----P  335 (447)
Q Consensus       261 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----~  335 (447)
                      +++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. ...+...+......++    .
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence            9988755432 44578999999999999999999999999999999999999999875 4566677776665554    2


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      .++.++.++      |.+||+.||++||     +++++++||||+..++
T Consensus       258 ~~s~~~~~l------i~~~L~~dP~~R~-----s~~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          258 HISESAKDL------VRRMLMLDPAERI-----TVYEALNHPWLKERDR  295 (351)
T ss_dssp             TSCHHHHHH------HHHHTCSSTTTSC-----CHHHHHTSHHHHTHHH
T ss_pred             cCCHHHHHH------HHHHCCCChhHCc-----CHHHHhcChhhcCCcc
Confidence            455555554      5569999999999     8899999999987543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.4e-51  Score=392.08  Aligned_cols=256  Identities=23%  Similarity=0.427  Sum_probs=213.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++..... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC-----CCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            589999999999999999999986     788999999986542 34455678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      +|+||||+.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9999999987544444444678999999999999999999999999999999999999999999999999999876533 


Q ss_pred             CCCCccccCCcccccccccCCC-CCCccceeehhHhHHHHhhCCCC-CCCCCHHHHHHHHHhcccCCC------------
Q 013249          269 SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPP-FTHANRQKLQQRIINEKVKLP------------  334 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~p-f~~~~~~~~~~~i~~~~~~~p------------  334 (447)
                      ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+.......+            
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2344568999999999998765 89999999999999999987777 566677776666654322111            


Q ss_pred             -----------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 -----------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 -----------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                       +.++.++      .+||.+||+.||++||     +++++++||||+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATG------RDLLQNLLKCNPVQRI-----SAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHH------HHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTC
T ss_pred             ccccccccCCcchhhcccccChHH------HHHHHHHhccChhhCC-----CHHHHhcCcccccC
Confidence                             1123333      3567779999999999     89999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.3e-51  Score=392.38  Aligned_cols=259  Identities=34%  Similarity=0.688  Sum_probs=234.4

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQ-----NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcC-----CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            3455789999999999999999999876     78899999998765444445567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      +.+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      ... .....+|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......+|..++.++.+++
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  243 (284)
T 2vgo_A          165 PSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI  243 (284)
T ss_dssp             SSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred             ccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence            442 3345689999999999999999999999999999999999999999999888888888888888888888877665


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ..      ||..||.+||     +++++++||||+.
T Consensus       244 ~~------~l~~~p~~Rp-----s~~~ll~h~~~~~  268 (284)
T 2vgo_A          244 SK------LLRYHPPQRL-----PLKGVMEHPWVKA  268 (284)
T ss_dssp             HH------HSCSSGGGSC-----CHHHHHTCHHHHH
T ss_pred             HH------HhhcCHhhCC-----CHHHHhhCHHHHh
Confidence            55      9999999999     8999999999964

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.4e-51  Score=392.27  Aligned_cols=259  Identities=34%  Similarity=0.631  Sum_probs=232.2

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.+.||+|+||.||+|+++.     +++.||||++.+...........+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEcc-----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            4566799999999999999999999886     78899999998766555555677889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      +.+..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           80 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      ... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......+|...+.++.+++
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (279)
T 3fdn_A          160 PSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI  238 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             Ccc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence            433 2345689999999999999999999999999999999999999999999999999998888888888888887665


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ..      ||+.||.+||     +++++++||||.+
T Consensus       239 ~~------~l~~~p~~Rp-----s~~e~l~h~~~~~  263 (279)
T 3fdn_A          239 SR------LLKHNPSQRP-----MLREVLEHPWITA  263 (279)
T ss_dssp             HH------HCCSSGGGSC-----CHHHHHHCHHHHH
T ss_pred             HH------HhccChhhCC-----CHHHHhhCccccC
Confidence            55      9999999999     8999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-50  Score=387.68  Aligned_cols=262  Identities=31%  Similarity=0.562  Sum_probs=233.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|++..... .....+.+.+|+.++++++||||+++++++...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEES   78 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcC-----CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence            4689999999999999999999886     788999999987653 3445567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc---EEEeecCCcccc
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEI  265 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---~kL~DFG~a~~~  265 (447)
                      ..|+||||+.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999999999999998899999999999999999999999999999999999999987665   999999999887


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhH
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  341 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  341 (447)
                      ..........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+......++.    .++.++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            7666666678999999999999999999999999999999999999999999999988888887776654    445555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHH
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  387 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~  387 (447)
                      .+      ||.+||+.||++||     +++++++||||.+..+...
T Consensus       239 ~~------li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          239 KS------LIDSMLTVNPKKRI-----TADQALKVPWICNRERVAS  273 (284)
T ss_dssp             HH------HHHHHSCSSTTTSC-----CHHHHTTSHHHHSCCCGGG
T ss_pred             HH------HHHHHcccChhhCC-----CHHHHhcCccccCChhHHh
Confidence            54      45559999999999     8999999999988765443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-51  Score=420.18  Aligned_cols=272  Identities=25%  Similarity=0.415  Sum_probs=206.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++..  
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKL-----EKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC-------CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECC-----CCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            4689999999999999999999886     78899999997643 334455678899999999999999999999943  


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                         ...+|+||||+ +++|..++.....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          126 VEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             TTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence               35799999998 56899999888889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC----------------------------CCCccccCCcccccccc-cCCCCCCccceeehhHhHHHHhh-----
Q 013249          264 EIDESS----------------------------RSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLT-----  309 (447)
Q Consensus       264 ~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ell~-----  309 (447)
                      ......                            .....+||+.|+|||++ .+..|+.++|||||||++|||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            764221                            23456789999999986 45679999999999999999998     


Q ss_pred             ------CCCCCCCCCH--------------------HHHHHHHHhccc--------------------CCC---------
Q 013249          310 ------GQPPFTHANR--------------------QKLQQRIINEKV--------------------KLP---------  334 (447)
Q Consensus       310 ------G~~pf~~~~~--------------------~~~~~~i~~~~~--------------------~~p---------  334 (447)
                            |+++|.+.+.                    .+....|.....                    .++         
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  7777766441                    122222221100                    011         


Q ss_pred             --CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCC
Q 013249          335 --PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  398 (447)
Q Consensus       335 --~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p  398 (447)
                        +..+.++      ++||.+||++||++||     +++++++||||+++.|..++.....+.+.|
T Consensus       365 ~~~~~s~~~------~dLl~~mL~~dP~~R~-----t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~  419 (458)
T 3rp9_A          365 RFPASSADA------IHLLKRMLVFNPNKRI-----TINECLAHPFFKEVRIAEVETNATEKVRLP  419 (458)
T ss_dssp             GSTTSCHHH------HHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTCCGGGCCCCSSCCCCS
T ss_pred             HCCCCCHHH------HHHHHHHhccCccccC-----CHHHHhcCHhhhhcCCCccCCCCCCCCCCC
Confidence              1123333      4667779999999999     899999999999999998876555554444

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=393.17  Aligned_cols=269  Identities=26%  Similarity=0.407  Sum_probs=214.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.... ......+.+.+|+.++++++||||+++++++...+.
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRD-----TGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR   76 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCC-----CCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence            689999999999999999999876     78899999987653 234445668899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      +|+||||+.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999999999999888888999999999999999999999999999999999999999999999999999876532 


Q ss_pred             CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC---------------
Q 013249          269 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---------------  332 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~---------------  332 (447)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......               
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            23345689999999999976 66899999999999999999999999988877766655432111               


Q ss_pred             ----CC------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCC
Q 013249          333 ----LP------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK  395 (447)
Q Consensus       333 ----~p------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~  395 (447)
                          .+            +.++.++      .+||.+||+.||.+||     +++++++||||+++.+.....+..+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~  304 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPA------LGLLKGCLHMDPTERL-----TCEQLLHHPYFENIREIEDLAKEHDKP  304 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHH------HHHHHHHCCSSTTTSC-----CHHHHHTSGGGTTCC------------
T ss_pred             ccCcCCCccccchhhhhcccccHHH------HHHHHHHccCChhhcC-----CHHHHhcChHHHhccCHHHHHHhhccH
Confidence                11            1223333      3567779999999999     899999999999998877655555443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.7e-51  Score=404.35  Aligned_cols=253  Identities=32%  Similarity=0.585  Sum_probs=207.9

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++.+.....    +.+.+|+.+++.++||||+++++++.+.
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKL-----TKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETT-----TCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            34689999999999999999999986     78899999997653322    3577899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc--EEEeecCCcccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTDFGLAKEI  265 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--~kL~DFG~a~~~  265 (447)
                      +.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.  +||+|||+++..
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999999999999999999998889999999999999999999999999999999999999987765  999999999865


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCc-cceeehhHhHHHHhhCCCCCCCCC----HHHHHHHHHhcccCCCC--CCc
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKD-ADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPP--FLT  338 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~pf~~~~----~~~~~~~i~~~~~~~p~--~~~  338 (447)
                      .........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+    .....+.+......+|.  .++
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence            55445566789999999999998888655 899999999999999999997643    34555666666666655  356


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      .++.++      |.+||+.||++||     +++++++||||.
T Consensus       249 ~~~~~l------i~~~L~~dP~~Rp-----s~~ell~hp~f~  279 (361)
T 3uc3_A          249 PECCHL------ISRIFVADPATRI-----SIPEIKTHSWFL  279 (361)
T ss_dssp             HHHHHH------HHHHSCSCTTTSC-----CHHHHHTSHHHH
T ss_pred             HHHHHH------HHHHccCChhHCc-----CHHHHHhCcchh
Confidence            666555      5559999999999     899999999994

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-51  Score=409.00  Aligned_cols=269  Identities=26%  Similarity=0.465  Sum_probs=210.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (447)
                      ++|+++++||+|+||.||+|.++.     +++.||||++.+.. ........+.+|+.+|+.+. ||||+++++++...+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRR-----TGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETT-----TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             CceEEEEEeeeCCCeEEEEEEECC-----CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            589999999999999999999886     78899999987543 23444566778999999997 999999999997544


Q ss_pred             --EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          189 --KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       189 --~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                        .+|+|||||. ++|..++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+.
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence              7999999997 588888866 579999999999999999999999999999999999999999999999999998653


Q ss_pred             C----------------------CCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHH
Q 013249          267 E----------------------SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ  323 (447)
Q Consensus       267 ~----------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~  323 (447)
                      .                      .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            2                      112344689999999999987 67899999999999999999999999999888887


Q ss_pred             HHHHhcccCCCC------------------------------------------------CCchhHHhhhhhhhHHhhhc
Q 013249          324 QRIINEKVKLPP------------------------------------------------FLTSEAHSLLKGVSFLTQLL  355 (447)
Q Consensus       324 ~~i~~~~~~~p~------------------------------------------------~~~~~~~~li~~~~~l~~~L  355 (447)
                      ..|... ...|.                                                ..+.+      .++||.+||
T Consensus       241 ~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~dll~~~L  313 (388)
T 3oz6_A          241 ERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE------ALDLLDKLL  313 (388)
T ss_dssp             HHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHH------HHHHHHHHC
T ss_pred             HHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHH------HHHHHHHhh
Confidence            777632 22221                                                12222      346777799


Q ss_pred             cCCCCCCCCCCCCChhhhhcCCccCCC---ChhHHHhhhcCCCCCC
Q 013249          356 HKDPSKRLGSGPGGVDAIKHHKWFRSI---NWKTLEAREMQPKFKP  398 (447)
Q Consensus       356 ~~dP~~R~~~~~~~~~~l~~h~~f~~~---~~~~~~~~~~~~~~~p  398 (447)
                      +.||++||     +++++++||||+..   +|.....+.+.+||.+
T Consensus       314 ~~dP~~R~-----t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~  354 (388)
T 3oz6_A          314 QFNPNKRI-----SANDALKHPFVSIFHNPNEEPNCDHIITIPIND  354 (388)
T ss_dssp             CSSGGGSC-----CHHHHTTSTTTTTTCCGGGCCCCSSCCCCC---
T ss_pred             ccCcccCC-----CHHHHhCCHHHHHhcCCccCCCCCCCCCCCccc
Confidence            99999999     89999999998754   3433333444445444

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-50  Score=405.60  Aligned_cols=256  Identities=28%  Similarity=0.519  Sum_probs=225.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||.||+|.++.     +++.||+|++....   ......+.+|+.+|+.++||||+++++++.+...
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCEEEEEEEECC-----CCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            579999999999999999999886     78899999997643   2233468899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC--CCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~--~~~~kL~DFG~a~~~~  266 (447)
                      +|+||||+.||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            999999999999999987654 7999999999999999999999999999999999999974  5789999999999876


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  342 (447)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......++.    .++.++.
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            655555678999999999999999999999999999999999999999999988888888877665543    3455555


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      ++      |.+||+.||.+||     +++++++||||++..+
T Consensus       283 ~l------i~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~  313 (387)
T 1kob_A          283 DF------IKNLLQKEPRKRL-----TVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HH------HHTTSCSSGGGSC-----CHHHHHTSTTTSSCCT
T ss_pred             HH------HHHHcCCChhHCc-----CHHHHhhCccccCCcc
Confidence            54      5559999999999     8999999999987543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-50  Score=386.25  Aligned_cols=261  Identities=30%  Similarity=0.574  Sum_probs=225.2

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++.+.||+|+||.||+|+++.     +++.||||++...........+.+.+|+.+++.++||||+++++++
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQL-----TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECC-----CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            34556799999999999999999999875     7889999999876544555667789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ...+.+|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           81 STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             ecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHh
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  343 (447)
                      ..........+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.......+......+|..++.++.+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  240 (276)
T 2h6d_A          161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT  240 (276)
T ss_dssp             CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence            765555556789999999999988765 6899999999999999999999999988888888888887788888877766


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++.      +||+.||.+||     +++++++||||+.
T Consensus       241 li~------~~l~~~p~~Rp-----s~~~~l~h~~~~~  267 (276)
T 2h6d_A          241 LLM------HMLQVDPLKRA-----TIKDIREHEWFKQ  267 (276)
T ss_dssp             HHH------HHTCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             HHH------HHccCChhhCC-----CHHHHHhChhhcc
Confidence            655      49999999999     8999999999964

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.8e-51  Score=399.54  Aligned_cols=265  Identities=22%  Similarity=0.366  Sum_probs=211.5

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++..... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTV-----TNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECC-----CCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            3579999999999999999999876     788999999976532 3334456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc-----CCCCcEEEeecCCcc
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-----DSDGHVMLTDFGLAK  263 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl-----~~~~~~kL~DFG~a~  263 (447)
                      .+|+||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||     +.++.+||+|||+++
T Consensus       107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99999999975 999999999899999999999999999999999999999999999999     455669999999998


Q ss_pred             cccCC-CCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-------
Q 013249          264 EIDES-SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-------  334 (447)
Q Consensus       264 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p-------  334 (447)
                      ..... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.......+       
T Consensus       186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            76532 233456789999999999874 589999999999999999999999999888877777665321111       


Q ss_pred             -----------CCCchhHHhhh------hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          335 -----------PFLTSEAHSLL------KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       335 -----------~~~~~~~~~li------~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                                 ..........+      ...+||.+||+.||++||     +++++++||||++++|+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI-----SAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCC-----CHHHHhCCcccCCCCCC
Confidence                       11111111111      124677889999999999     89999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.1e-50  Score=395.33  Aligned_cols=258  Identities=29%  Similarity=0.565  Sum_probs=234.5

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|.+.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            3579999999999999999999876     78899999998776555666778899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999876432


Q ss_pred             -CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhh
Q 013249          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  347 (447)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+|..++.++.++++.
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  274 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  274 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence             2344567999999999999999999999999999999999999999999888888888888888888888877666554


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                            ||+.||++||     +++++++|+||.+.
T Consensus       275 ------~l~~dp~~Rp-----s~~ell~~~~~~~~  298 (335)
T 2owb_A          275 ------MLQTDPTARP-----TINELLNDEFFTSG  298 (335)
T ss_dssp             ------HTCSSGGGSC-----CGGGGGGSHHHHTS
T ss_pred             ------HccCChhHCc-----CHHHHhcCccccCC
Confidence                  9999999999     88999999999754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.6e-50  Score=386.35  Aligned_cols=258  Identities=29%  Similarity=0.565  Sum_probs=233.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|.+.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC-----CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            4589999999999999999999876     78899999998766555666778899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999876432


Q ss_pred             -CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhh
Q 013249          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  347 (447)
                       .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+......+|..++.++.+++..
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  248 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  248 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence             2344567999999999999999999999999999999999999999999888888888888888888888877666554


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                            ||+.||++||     +++++++||||.+.
T Consensus       249 ------~l~~~p~~Rp-----s~~~ll~~~~~~~~  272 (294)
T 2rku_A          249 ------MLQTDPTARP-----TINELLNDEFFTSG  272 (294)
T ss_dssp             ------HTCSSGGGSC-----CGGGGGGSHHHHTS
T ss_pred             ------HcccChhhCc-----CHHHHhhChheecC
Confidence                  9999999999     88999999999753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=399.64  Aligned_cols=255  Identities=34%  Similarity=0.589  Sum_probs=205.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++....     ..+.+.+|+.+|++++||||+++++++.+.+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKG-----TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECC-----CCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            3579999999999999999999986     78899999997642     2345778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEEeecCCcccc
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEI  265 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL~DFG~a~~~  265 (447)
                      .+|+||||+.|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999999999988888999999999999999999999999999999999999975   889999999999887


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCC----CCCchh
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP----PFLTSE  340 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~~~~p----~~~~~~  340 (447)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+......++    ..++.+
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence            6555556678999999999999999999999999999999999999999765544 46666776655443    234555


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      +.+      ||.+||+.||++||     +++++++||||.+..+
T Consensus       282 ~~~------li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          282 AKD------LVRKLIVLDPKKRL-----TTFQALQHPWVTGKAA  314 (349)
T ss_dssp             HHH------HHHTTSCSSGGGSC-----CHHHHHHSTTTTSTTC
T ss_pred             HHH------HHHHHccCChhhCc-----CHHHHhcCcccCCCcc
Confidence            554      45569999999999     8899999999987653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-50  Score=414.45  Aligned_cols=259  Identities=25%  Similarity=0.420  Sum_probs=210.5

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence            4689999999999999999999886     78899999998653 3445566788999999999999999999999654 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                           ..+|+||||+.++ |...+.  ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus       135 ~~~~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             ccccCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence                 4689999999765 656553  35899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCc
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLT  338 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~  338 (447)
                      +...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....|.......++    ...
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            9877665667789999999999999999999999999999999999999999999888877777653211100    000


Q ss_pred             hhH------------------------------Hh--hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          339 SEA------------------------------HS--LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       339 ~~~------------------------------~~--li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ...                              ..  .-..++||.+||++||++||     +++++++||||+.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTGG
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCC-----CHHHHhcChhhhh
Confidence            000                              00  11246788889999999999     8999999999984

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-50  Score=394.81  Aligned_cols=260  Identities=26%  Similarity=0.446  Sum_probs=204.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++++.||+|+||.||+|+++.     +++.||+|++....  .....+.+.+|+.+|++++||||+++++++.+.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKT-----TGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTEN   76 (317)
T ss_dssp             ---------------CEEEEEECSS-----SCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred             ccceeEeeEECCCCCEEEEEEEECC-----CCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence            3589999999999999999999875     78899999997653  2233356778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          189 KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      .+|+||||+. |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus        77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            9999999998 5898888754      35899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC------
Q 013249          263 KEIDES-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP------  334 (447)
Q Consensus       263 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p------  334 (447)
                      +..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.......+      
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            876533 23345689999999999986 4689999999999999999999999999988887777654321111      


Q ss_pred             ----------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          335 ----------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       335 ----------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                                                  ..++.+      ..+||.+||+.||++||     +++++++||||.+..|..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------l~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGN------LMDFLHGLLQLNPDMRL-----SAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHH------HHHHHHHHSCSSGGGSC-----CHHHHTTSGGGGGGCC--
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHH------HHHHHHHHCCCCcccCC-----CHHHHhCChhhhcccchh
Confidence                                        012222      34677779999999999     889999999998876654


Q ss_pred             H
Q 013249          387 L  387 (447)
Q Consensus       387 ~  387 (447)
                      .
T Consensus       305 ~  305 (317)
T 2pmi_A          305 S  305 (317)
T ss_dssp             -
T ss_pred             h
Confidence            3

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.5e-50  Score=383.64  Aligned_cols=252  Identities=31%  Similarity=0.581  Sum_probs=226.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||+|+||.||+|.++.     ++..+|+|++.+...   ...+.+.+|+.++++++||||+++++++.+...
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCC-----CCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            369999999999999999999886     788999999976532   234668899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc---CCCCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~~kL~DFG~a~~~~  266 (447)
                      +|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999999988899999999999999999999999999999999999999   788999999999998877


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  342 (447)
                      .........||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..+....+......+|.    .++.++.
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            66666677899999999998765 899999999999999999999999999999988888888777664    4566655


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++      |.+||+.||.+||     ++.++++||||++
T Consensus       240 ~l------i~~~l~~dp~~R~-----s~~~~l~h~~~~~  267 (277)
T 3f3z_A          240 SL------IRRLLTKSPKQRI-----TSLQALEHEWFEK  267 (277)
T ss_dssp             HH------HHHHTCSSTTTSC-----CHHHHTTSHHHHH
T ss_pred             HH------HHHHccCChhhCc-----CHHHHhcCHHHhc
Confidence            55      5559999999999     8899999999964

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.4e-50  Score=407.90  Aligned_cols=263  Identities=26%  Similarity=0.467  Sum_probs=211.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|+++++||+|+||.||+|+++.     +++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++... 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKN-----TEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            4689999999999999999999886     78899999997643 3344556788999999999999999999999776 


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                          ..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence                57999999996 5999999888889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC-----------------------CCCccccCCcccccccc-cCCCCCCccceeehhHhHHHHhh----------
Q 013249          264 EIDESS-----------------------RSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLT----------  309 (447)
Q Consensus       264 ~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ell~----------  309 (447)
                      ......                       .....+||+.|+|||++ ....|+.++|||||||++|||++          
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            764322                       23567899999999986 45679999999999999999998          


Q ss_pred             -CCCCCCCCC-----------------HHHHHHHHHhcc------------------------cCCC-------CCCchh
Q 013249          310 -GQPPFTHAN-----------------RQKLQQRIINEK------------------------VKLP-------PFLTSE  340 (447)
Q Consensus       310 -G~~pf~~~~-----------------~~~~~~~i~~~~------------------------~~~p-------~~~~~~  340 (447)
                       |.++|.+.+                 ..+....|....                        ...+       +.++.+
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence             444554433                 112222222110                        0000       123444


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHh
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  389 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~  389 (447)
                      +      ++||.+||++||.+||     +++++++||||+++.|...+.
T Consensus       338 ~------~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~~~~~~e~  375 (432)
T 3n9x_A          338 G------INLLESMLKFNPNKRI-----TIDQALDHPYLKDVRKKKLEN  375 (432)
T ss_dssp             H------HHHHHHHSCSSTTTSC-----CHHHHHTCGGGTTTCCTTTC-
T ss_pred             H------HHHHHHHhcCCcccCC-----CHHHHhcChhhhhccCcccCc
Confidence            3      4566679999999999     899999999999999987664

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.6e-51  Score=420.44  Aligned_cols=258  Identities=30%  Similarity=0.553  Sum_probs=231.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.++||+|+||.||+|+++.     +++.||||++.+.........+.+.+|+.+|++++||||+++++++.+.+.
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CceEEeeEEecCCCEEEEEEEECC-----CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            369999999999999999999886     788999999987665555566788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc---CCCCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~~kL~DFG~a~~~~  266 (447)
                      +|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999999999998999999999999999999999999999999999999999   567899999999999877


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  342 (447)
                      ........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+..+...++.    .++.++.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence            6665667789999999999976 6999999999999999999999999999999999999888766542    3455555


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      +      ||.+||++||.+||     +++++++||||+...+
T Consensus       260 ~------li~~~L~~dp~~R~-----s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          260 D------LIRKMLTYVPSMRI-----SARDALDHEWIQTYTK  290 (484)
T ss_dssp             H------HHHHHTCSSGGGSC-----CHHHHHTSHHHHHHTC
T ss_pred             H------HHHHHCCCChhHCc-----CHHHHhhChhhccccc
Confidence            4      55569999999999     8999999999986544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-50  Score=387.06  Aligned_cols=254  Identities=24%  Similarity=0.437  Sum_probs=210.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||.||+|+++      +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC------CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            58999999999999999999874      678899999976542 23334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9999999976 888888764 67999999999999999999999999999999999999999999999999999876432


Q ss_pred             -CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-------------
Q 013249          269 -SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-------------  333 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~-------------  333 (447)
                       ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.......             
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence             22345678999999999976 458999999999999999999999999988877776665421110             


Q ss_pred             ----------------CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          334 ----------------PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       334 ----------------p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                      ...++.++      .+||.+||+.||++||     +++++++||||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~  287 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESG------IDLLSKMLKLDPNQRI-----TAKQALEHAYFKEN  287 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHH------HHHHHHHTCSSTTTSC-----CHHHHHTSGGGGC-
T ss_pred             cccccccccCccHHHHhhhcCHHH------HHHHHHHcCCCcccCC-----CHHHHhcCcchhhc
Confidence                            01123333      3567779999999999     88999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-50  Score=388.76  Aligned_cols=259  Identities=27%  Similarity=0.388  Sum_probs=213.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc--hhHHHHHHHHHHHHHhc---CCCCceeee
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKV---THPFIVQLR  181 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l---~hpnIv~l~  181 (447)
                      +..++|+++++||+|+||+||+|+++.     +++.||||++.......  ......+.+|+.+++.+   +||||++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTT-----TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            345789999999999999999999875     78899999997543211  11123455677777766   499999999


Q ss_pred             EEEEeCC-----EEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcE
Q 013249          182 YSFQTRS-----KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (447)
Q Consensus       182 ~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~  254 (447)
                      +++....     .+++||||+. ++|.+++.....  +++.+++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred             eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence            9998765     6899999996 599999987654  9999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC
Q 013249          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP  334 (447)
Q Consensus       255 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p  334 (447)
                      ||+|||+++...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus       160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999999987766666778899999999999999999999999999999999999999999988888877765322111


Q ss_pred             ---------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 ---------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 ---------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                                 +.++.++      .+||.+||++||++||     +++++++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~R~-----t~~e~l~h~~~~~~  303 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESG------AQLLLEMLTFNPHKRI-----SAFRALQHSYLHKD  303 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHH------HHHHHHHTCSSTTTSC-----CHHHHHTSTTC---
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHH------HHHHHHHhcCCCccCC-----CHHHHhcCccccCC
Confidence                                       1122222      4567779999999999     88999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=388.78  Aligned_cols=256  Identities=31%  Similarity=0.587  Sum_probs=215.2

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-----------------------hhHHHHHHH
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------------------KNHVDYMKA  164 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~~~  164 (447)
                      ..++|++.+.||+|+||.||+|+++.     +++.||||++.+.....                       ....+.+.+
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNEN-----DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ   85 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETT-----TTEEEEEEEEECC-------------------------------CHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence            34689999999999999999999876     78899999997654221                       122356889


Q ss_pred             HHHHHHhcCCCCceeeeEEEEe--CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013249          165 ERDILTKVTHPFIVQLRYSFQT--RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK  242 (447)
Q Consensus       165 E~~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDik  242 (447)
                      |+.+|++++||||+++++++.+  ...+|+||||+++++|.+++ ..+.+++.+++.++.||+.||.|||++||+|||||
T Consensus        86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  164 (298)
T 2zv2_A           86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK  164 (298)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            9999999999999999999987  67899999999999997754 34679999999999999999999999999999999


Q ss_pred             CCCcccCCCCcEEEeecCCcccccCCC-CCCccccCCcccccccccCCC---CCCccceeehhHhHHHHhhCCCCCCCCC
Q 013249          243 PENILMDSDGHVMLTDFGLAKEIDESS-RSNSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN  318 (447)
Q Consensus       243 p~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell~G~~pf~~~~  318 (447)
                      |+|||++.++.+||+|||+++...... .....+||+.|+|||++.+..   ++.++|||||||++|+|++|+.||...+
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999999998765432 234568999999999998765   3778999999999999999999999988


Q ss_pred             HHHHHHHHHhcccCCCC--CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          319 RQKLQQRIINEKVKLPP--FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       319 ~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      ...+...+......+|.  .++.++.++      |.+||+.||++||     +++++++||||+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l------i~~~l~~dp~~R~-----s~~e~l~hp~~~  297 (298)
T 2zv2_A          245 IMCLHSKIKSQALEFPDQPDIAEDLKDL------ITRMLDKNPESRI-----VVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHHHCCCCCCSSSCCCHHHHHH------HHHHTCSCTTTSC-----CHHHHTTCHHHH
T ss_pred             HHHHHHHHhcccCCCCCccccCHHHHHH------HHHHhhcChhhCC-----CHHHHhcCcccc
Confidence            88888888777666553  456666555      5559999999999     889999999995

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-50  Score=406.75  Aligned_cols=248  Identities=31%  Similarity=0.574  Sum_probs=204.2

Q ss_pred             CCcEEE-eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHH-hcCCCCceeeeEEEEe-
Q 013249          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQT-  186 (447)
Q Consensus       110 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~-  186 (447)
                      ++|.+. ++||+|+||+||+|+++.     +++.||||++...        ..+.+|+.++. ..+||||++++++|.. 
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECC-----CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            478887 789999999999999886     7889999998643        23567888874 5589999999999876 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEEee
Q 013249          187 ---RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTD  258 (447)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL~D  258 (447)
                         ...+|+|||||.||+|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+||||+.   ++.+||+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence               567999999999999999998754  5999999999999999999999999999999999999997   78999999


Q ss_pred             cCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH----HHHHHHHhcccCCC
Q 013249          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQRIINEKVKLP  334 (447)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~----~~~~~i~~~~~~~p  334 (447)
                      ||+++...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..    .+...+..+...++
T Consensus       208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            99999876555556788999999999999999999999999999999999999999765432    24556666666665


Q ss_pred             C----CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 P----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 ~----~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      .    .++.++.++      |.+||+.||.+||     +++++++||||..
T Consensus       288 ~~~~~~~s~~~~~l------i~~~L~~dP~~Rp-----t~~eil~hp~~~~  327 (400)
T 1nxk_A          288 NPEWSEVSEEVKML------IRNLLKTEPTQRM-----TITEFMNHPWIMQ  327 (400)
T ss_dssp             TTTTTTSCHHHHHH------HHTTSCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             CcccccCCHHHHHH------HHHHCCCChhHCc-----CHHHHhcCccccC
Confidence            3    456666555      5559999999999     8999999999964

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-50  Score=385.18  Aligned_cols=258  Identities=29%  Similarity=0.593  Sum_probs=201.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++.+.........+.+.+|+.++++++||||+++++++.+.+
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIH-----TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             cccceeeeeecCCCceEEEEEEEcc-----CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            3579999999999999999999875     78899999998765444555677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999999999875 6799999999999999999999999999999999999999999999999999987643


Q ss_pred             C-CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhh
Q 013249          268 S-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  346 (447)
                      . ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......|..++.++.+++.
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  244 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH  244 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHH
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHH
Confidence            2 223456799999999999999999999999999999999999999987766666666655566677777777766555


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                            +||+.||++||     +++++++||||...
T Consensus       245 ------~~l~~dp~~Rp-----s~~~~l~h~~~~~~  269 (278)
T 3cok_A          245 ------QLLRRNPADRL-----SLSSVLDHPFMSRN  269 (278)
T ss_dssp             ------HHSCSSGGGSC-----CHHHHTTSTTTC--
T ss_pred             ------HHcccCHhhCC-----CHHHHhcCccccCC
Confidence                  59999999999     89999999999754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-50  Score=395.71  Aligned_cols=256  Identities=28%  Similarity=0.492  Sum_probs=213.3

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||.||+|+++.     +++.||||++.....  ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   78 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhceeeeEEecCCCEEEEEEEECC-----CCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            4689999999999999999999886     788999999975432  223356789999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      ..|+||||++||+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999865322


Q ss_pred             ---CCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHH-HHHHHHhcccCCC--CCCchhH
Q 013249          269 ---SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQK-LQQRIINEKVKLP--PFLTSEA  341 (447)
Q Consensus       269 ---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~-~~~~i~~~~~~~p--~~~~~~~  341 (447)
                         ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+... ....+.......+  ..++.++
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  238 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence               22346789999999999988765 778999999999999999999997655432 2223333222222  2345555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .      +||.+||+.||++||     +++++++||||+..
T Consensus       239 ~------~li~~~L~~dP~~R~-----t~~eil~h~~~~~~  268 (323)
T 3tki_A          239 L------ALLHKILVENPSARI-----TIPDIKKDRWYNKP  268 (323)
T ss_dssp             H------HHHHHHSCSSTTTSC-----CHHHHTTCTTTTCC
T ss_pred             H------HHHHHHccCChhhCc-----CHHHHhhChhhccc
Confidence            4      456669999999999     89999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.7e-50  Score=401.73  Aligned_cols=258  Identities=26%  Similarity=0.494  Sum_probs=221.3

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (447)
                      |...++||+|+||.||+|+++.     +++.||+|+++....   ...+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  162 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV  162 (373)
T ss_dssp             EEEEEECC-----CEEEEEETT-----TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             eecceEEecCcCEEEEEEEEcC-----CCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3446789999999999999876     788999999986532   33456889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc--CCCCcEEEeecCCcccccCC
Q 013249          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM--DSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl--~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++.....
T Consensus       163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            999999999999988765 469999999999999999999999999999999999999  67789999999999987766


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHHhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHSL  344 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l  344 (447)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......++.    .++.++.+ 
T Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  321 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE-  321 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHH-
T ss_pred             cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHH-
Confidence            6666678999999999999999999999999999999999999999999999888888887665543    34555555 


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHH
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  388 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~  388 (447)
                           ||.+||+.||.+||     +++++++||||.+..|....
T Consensus       322 -----li~~~L~~dp~~Rp-----s~~e~l~hp~~~~~~~~~~~  355 (373)
T 2x4f_A          322 -----FISKLLIKEKSWRI-----SASEALKHPWLSDHKLHSRL  355 (373)
T ss_dssp             -----HHHTTSCSSGGGSC-----CHHHHHHSHHHHCHHHHHHH
T ss_pred             -----HHHHHcCCChhhCC-----CHHHHhcCcCcCCCchhhhh
Confidence                 45569999999999     89999999999988765543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.9e-50  Score=414.33  Aligned_cols=256  Identities=31%  Similarity=0.552  Sum_probs=225.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch----------hHHHHHHHHHHHHHhcCCCCcee
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----------NHVDYMKAERDILTKVTHPFIVQ  179 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~  179 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+......          ...+.+.+|+.+|++++||||++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             cceEEEeEecccCCeEEEEEEECC-----CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            579999999999999999999886     788999999987543221          34567889999999999999999


Q ss_pred             eeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC---cEEE
Q 013249          180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVML  256 (447)
Q Consensus       180 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~~kL  256 (447)
                      +++++.+...+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            9999999999999999999999999999889999999999999999999999999999999999999998876   6999


Q ss_pred             eecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--
Q 013249          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--  334 (447)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p--  334 (447)
                      +|||+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+..+...++  
T Consensus       191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             EECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            99999998776666667889999999999874 589999999999999999999999999999999999998877665  


Q ss_pred             --CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 --PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 --~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                        ..++.++.+++      .+||++||.+||     +++++++||||+..
T Consensus       270 ~~~~~s~~~~~li------~~~L~~dp~~R~-----t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          270 DWKNISDEAKELI------KLMLTYDYNKRC-----TAEEALNSRWIKKY  308 (504)
T ss_dssp             HHTTSCHHHHHHH------HHHTCSSTTTSC-----CHHHHHTSHHHHHT
T ss_pred             ccCCCCHHHHHHH------HHHcCCChhHCC-----CHHHHhcCHhhhhc
Confidence              45666665554      559999999999     89999999999754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.9e-50  Score=414.40  Aligned_cols=255  Identities=30%  Similarity=0.580  Sum_probs=224.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|+++++||+|+||+||+|+++.     +++.||||++.+.... ......+.+|+.+|++++||||+++++++.+...+
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETT-----TCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            69999999999999999999886     7889999999875432 33456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC---CCCcEEEeecCCcccccC
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~---~~~~~kL~DFG~a~~~~~  267 (447)
                      |+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999999999889999999999999999999999999999999999999995   566899999999998776


Q ss_pred             CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHHh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHS  343 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~  343 (447)
                      .......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+..+...++.    .++.++.+
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            666667789999999999976 4999999999999999999999999999999999998887765542    34555554


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                            ||.+||+.||.+||     +++++++||||+...
T Consensus       256 ------li~~~L~~dp~~R~-----t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 ------LIRKMLTFHPSLRI-----TATQCLEHPWIQKYS  284 (486)
T ss_dssp             ------HHHHHTCSSTTTSC-----CHHHHHHCHHHHHTC
T ss_pred             ------HHHHHcCCChhhCc-----CHHHHhcCHhhccCc
Confidence                  55569999999999     889999999998653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-49  Score=382.38  Aligned_cols=264  Identities=30%  Similarity=0.539  Sum_probs=228.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh------cchhHHHHHHHHHHHHHhcC-CCCceeee
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI------IKKNHVDYMKAERDILTKVT-HPFIVQLR  181 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~il~~l~-hpnIv~l~  181 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++.....      ......+.+.+|+.+|+++. ||||++++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhccceeeeecCCCceEEEEEEEcC-----cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            4689999999999999999999986     788999999975431      11233466789999999995 99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      +++.....+|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            99999999999999999999999999888999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCccccccccc------CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILL------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP  335 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~  335 (447)
                      +.............||+.|+|||++.      ...++.++||||||+++|+|++|..||...+.......+......++.
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            98876655566778999999999985      456889999999999999999999999999888888888877666543


Q ss_pred             ----CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHH
Q 013249          336 ----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  388 (447)
Q Consensus       336 ----~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~  388 (447)
                          .++.++.      +||.+||+.||.+||     +++++++||||++..++.+.
T Consensus       251 ~~~~~~~~~l~------~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          251 PEWDDYSDTVK------DLVSRFLVVQPQKRY-----TAEEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             TTGGGSCHHHH------HHHHHHCCSSGGGSC-----CHHHHTTSGGGCTTC-----
T ss_pred             ccccccCHHHH------HHHHHHccCCcccCC-----CHHHHHhChHhhhccchhhc
Confidence                2344444      456669999999999     88999999999998887664

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-49  Score=396.89  Aligned_cols=276  Identities=25%  Similarity=0.423  Sum_probs=214.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++++.||+|+||.||+|+++.     +++.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC-----CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            3589999999999999999999876     78899999997643 23445567889999999999999999999997654


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                            .+|+||||+.+ +|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence                  89999999975 6877775  45899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---------
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---------  333 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~---------  333 (447)
                      +...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......         
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            88765545556789999999999999999999999999999999999999999988887777765432111         


Q ss_pred             ----------CCCCchh-----------------HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          334 ----------PPFLTSE-----------------AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       334 ----------p~~~~~~-----------------~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                                |......                 ....-...+||.+||+.||.+||     +++++++||||+.  |..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~--~~~  327 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI-----SVDEALQHPYINV--WYD  327 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHHSHHHHT--TCC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCC-----CHHHHhCCcchhh--hcC
Confidence                      0000000                 00011245788889999999999     8999999999974  434


Q ss_pred             HHhhhcCCCCCCCC
Q 013249          387 LEAREMQPKFKPDV  400 (447)
Q Consensus       387 ~~~~~~~~~~~p~~  400 (447)
                      .......+|+.|..
T Consensus       328 ~~~~~~~~~~~~~~  341 (371)
T 2xrw_A          328 PSEAEAPPPKIPDK  341 (371)
T ss_dssp             HHHHTCCCCCCCTT
T ss_pred             ccccCCCCCCCCCh
Confidence            44445556666654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-49  Score=381.97  Aligned_cols=252  Identities=31%  Similarity=0.552  Sum_probs=213.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|.+.++||+|+||.||+|+++.     ++..+|+|++....  .....+.+.+|+.+|++++||||+++++++.+...+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             heeecceeccCCCeEEEEEEEcc-----CCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            69999999999999999999876     78899999998754  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc---CCCCcEEEeecCCcc
Q 013249          191 YLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~~kL~DFG~a~  263 (447)
                      |+||||+++|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            999999999999988854    3679999999999999999999999999999999999999   456889999999998


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC---Cchh
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---LTSE  340 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~---~~~~  340 (447)
                      ...........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+......++..   .+++
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             C----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             ecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence            876655566778999999999986 568999999999999999999999999998888887777665554432   4555


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +.+      ||.+||+.||++||     +++++++||||+.
T Consensus       255 ~~~------li~~~L~~dP~~Rp-----s~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVD------LLKQMLTKDPERRP-----SAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHH------HHHHHTCSCTTTSC-----CHHHHHTSGGGGC
T ss_pred             HHH------HHHHHccCChhhCc-----CHHHHhcCHHhhc
Confidence            544      55569999999999     8999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5e-50  Score=392.59  Aligned_cols=266  Identities=28%  Similarity=0.480  Sum_probs=222.9

Q ss_pred             CcEEE-eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013249          111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (447)
                      .|.+. ++||+|+||.||+|+++.     +++.||+|++.+... .......+.+|+.+++.+. ||||+++++++.+.+
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKS-----TGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             EEeeccceeCCCCCeEEEEEEECC-----CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            57777 899999999999999886     788999999987543 2334556889999999995 699999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEEeecCCcc
Q 013249          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAK  263 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL~DFG~a~  263 (447)
                      .+|+||||+.||+|.+++...  +.+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            999999999999999988543  67999999999999999999999999999999999999988   7899999999999


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCch
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTS  339 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~  339 (447)
                      ...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......++.    .++.
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             EC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence            876655556678999999999999999999999999999999999999999999988888888776655543    3444


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ  393 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~  393 (447)
                      ++.+      ||.+||+.||.+||     +++++++||||++.+|+.+......
T Consensus       263 ~~~~------li~~~L~~dP~~Rp-----t~~~ll~h~~~~~~~~~~~~~~~~~  305 (327)
T 3lm5_A          263 LATD------FIQSLLVKNPEKRP-----TAEICLSHSWLQQWDFENLFHPEET  305 (327)
T ss_dssp             HHHH------HHHHHSCSSGGGSC-----CHHHHTTCGGGCCCCTTCC------
T ss_pred             HHHH------HHHHHcCCChhhCc-----CHHHHhCCHhhcccccccccCccCC
Confidence            5444      55669999999999     8999999999999999877544433

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-49  Score=394.72  Aligned_cols=258  Identities=30%  Similarity=0.462  Sum_probs=217.6

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----CCCceee
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQL  180 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l  180 (447)
                      .+..++|+++++||+|+||+||+|+++.     +++.||||++...    ....+.+..|+.+++.+.     ||||+++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHID-----NKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECC-----CCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3445789999999999999999999876     7889999999743    233445678999999996     9999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC--------
Q 013249          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--------  250 (447)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~--------  250 (447)
                      ++++...+.+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||||+.        
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence            99999999999999999 999999998764  5999999999999999999999999999999999999975        


Q ss_pred             -----------------CCcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCC
Q 013249          251 -----------------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  313 (447)
Q Consensus       251 -----------------~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~p  313 (447)
                                       ++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence                             78999999999987544  23456899999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCchhH----------------------------Hhh------------hhhhhHHhh
Q 013249          314 FTHANRQKLQQRIINEKVKLPPFLTSEA----------------------------HSL------------LKGVSFLTQ  353 (447)
Q Consensus       314 f~~~~~~~~~~~i~~~~~~~p~~~~~~~----------------------------~~l------------i~~~~~l~~  353 (447)
                      |...+..+....+......+|.....+.                            ..+            -...+||.+
T Consensus       259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            9998888777776654443332110000                            000            012378889


Q ss_pred             hccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          354 LLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       354 ~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      ||+.||++||     +++++++||||+
T Consensus       339 ~L~~dP~~Rp-----ta~elL~hp~f~  360 (360)
T 3llt_A          339 ILQIDPTLRP-----SPAELLKHKFLE  360 (360)
T ss_dssp             HCCSSGGGSC-----CHHHHTTSGGGC
T ss_pred             HhcCChhhCC-----CHHHHhcCcccC
Confidence            9999999999     899999999995

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.8e-50  Score=383.14  Aligned_cols=261  Identities=30%  Similarity=0.561  Sum_probs=223.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|++........   ...+.+.+|+.++++++||||+++++++.+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG-----TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC-----CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence            369999999999999999999886     788999999987543221   235678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC----cEEEeecCCc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~~kL~DFG~a  262 (447)
                      ...+|+||||+.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999999998888999999999999999999999999999999999999998877    8999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----CCCc
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  338 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~  338 (447)
                      .............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......++    ...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence            887655555567899999999999999999999999999999999999999999988888888776655544    2344


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      .++.+      ||.+||..||++||     +++++++||||+.+.+..
T Consensus       240 ~~~~~------li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          240 ELAKD------FIRRLLVKDPKRRM-----TIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             HHHHH------HHHTTSCSSGGGSC-----CHHHHHHCHHHHHHHHCC
T ss_pred             HHHHH------HHHHHccCCHhHCc-----CHHHHHhCHHHHHHHHHh
Confidence            44444      55569999999999     889999999998765543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.9e-50  Score=390.62  Aligned_cols=250  Identities=31%  Similarity=0.607  Sum_probs=196.4

Q ss_pred             CcEEE---eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe
Q 013249          111 DFEIF---RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (447)
Q Consensus       111 ~y~~~---~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  186 (447)
                      +|++.   ++||+|+||.||+|+++.     +++.||||++.+..      ...+.+|+.+++.+. ||||+++++++.+
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~   77 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKK-----SNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHD   77 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETT-----TCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ccccccCCCccccCCCeEEEEEEECC-----CCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            46654   789999999999999986     78899999997542      245678999999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC---cEEEeecCCcc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGLAK  263 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~~kL~DFG~a~  263 (447)
                      ...+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            999999999999999999999999999999999999999999999999999999999999997766   89999999998


Q ss_pred             cccCC-CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC-------HHHHHHHHHhcccCCCC
Q 013249          264 EIDES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-------RQKLQQRIINEKVKLPP  335 (447)
Q Consensus       264 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-------~~~~~~~i~~~~~~~p~  335 (447)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+       ..++...+..+...++.
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            75433 23456689999999999999999999999999999999999999997643       35667777776665543


Q ss_pred             ----CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          336 ----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       336 ----~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                          .++.++.+      ||.+||+.||.+||     +++++++||||++.
T Consensus       238 ~~~~~~s~~~~~------li~~~L~~dP~~Rp-----t~~ell~h~w~~~~  277 (325)
T 3kn6_A          238 EAWKNVSQEAKD------LIQGLLTVDPNKRL-----KMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHTSCHHHHH------HHHHHHCCCTTTCC-----CTTTSTTCGGGCTT
T ss_pred             ccccCCCHHHHH------HHHHHCCCChhHCC-----CHHHHhcChhhccC
Confidence                34555555      45569999999999     78999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-49  Score=387.33  Aligned_cols=257  Identities=29%  Similarity=0.543  Sum_probs=210.9

Q ss_pred             CCcEEE-eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013249          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (447)
                      +.|++. ++||+|+||.||+|+++.     +++.||||++.+..   ....+.+.+|+.+|+++ +||||+++++++.+.
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLI-----TSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSS-----SCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             eeEEecCceecCCceEEEEEEEEcC-----CCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            579985 789999999999999775     78899999997643   23345688999999985 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc---EEEeecCCccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKE  264 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---~kL~DFG~a~~  264 (447)
                      +.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999999999998889999999999999999999999999999999999999998776   99999999886


Q ss_pred             ccCCC--------CCCccccCCcccccccccC-----CCCCCccceeehhHhHHHHhhCCCCCCCCC-------------
Q 013249          265 IDESS--------RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHAN-------------  318 (447)
Q Consensus       265 ~~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~pf~~~~-------------  318 (447)
                      .....        .....+||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+..             
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            53211        1234569999999999975     558899999999999999999999997654             


Q ss_pred             --HHHHHHHHHhcccCCCC----CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          319 --RQKLQQRIINEKVKLPP----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       319 --~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                        ...+...+......+|.    .++.++.+      ||.+||+.||.+||     +++++++||||++..+.
T Consensus       244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~------li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKD------LISKLLVRDAKQRL-----SAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHH------HHHHHSCSSTTTSC-----CHHHHHHSTTCC-----
T ss_pred             hHHHHHHHHHhccCcccCchhcccCCHHHHH------HHHHHhhCChhhCC-----CHHHHhcChhhcCCCCc
Confidence              24456677777666653    34555554      55569999999999     88999999999987654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.1e-49  Score=392.04  Aligned_cols=255  Identities=31%  Similarity=0.572  Sum_probs=223.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-----cchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      ++|++.+.||+|+||.||+|+++.     +++.||||++.....     ......+.+.+|+.+++++ +||||++++++
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRA-----TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhcccceEEecCCCEEEEEEEECC-----CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            369999999999999999999875     788999999976431     1123345688999999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +...+..|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            99999999999999999999999988899999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCcccccccccC------CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC---
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---  334 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p---  334 (447)
                      .+.........+||+.|+|||++.+      ..++.++|||||||++|+|++|+.||...+.......+......++   
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            8776666667889999999999863      3588999999999999999999999999888888888877765543   


Q ss_pred             -CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          335 -PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       335 -~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                       ...+.++.+      ||.+||+.||++||     +++++++||||+
T Consensus       329 ~~~~~~~~~~------li~~~L~~dP~~Rp-----s~~ell~hp~f~  364 (365)
T 2y7j_A          329 WDDRSSTVKD------LISRLLQVDPEARL-----TAEQALQHPFFE  364 (365)
T ss_dssp             HSSSCHHHHH------HHHHHSCSSTTTSC-----CHHHHHHSGGGC
T ss_pred             cccCCHHHHH------HHHHHcCCChhHCc-----CHHHHhcCcccC
Confidence             234444444      55669999999999     889999999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.6e-49  Score=410.66  Aligned_cols=254  Identities=30%  Similarity=0.571  Sum_probs=221.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +|+++++||+|+||+||+|+++.     ++..||||++.+.... ......+.+|+.+|+.++||||++++++|.+...+
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETT-----TCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECC-----CCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            69999999999999999999986     7889999999876432 22345688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC---CcEEEeecCCcccccC
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEIDE  267 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~~kL~DFG~a~~~~~  267 (447)
                      |+|||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||+++....
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999999999988999999999999999999999999999999999999999764   5599999999998776


Q ss_pred             CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHHh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHS  343 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~  343 (447)
                      .......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..++...+......++.    .++.++.+
T Consensus       192 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          192 QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence            66666788999999999986 46999999999999999999999999999999999999888776653    35555555


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +      |.+||+.||.+||     +++++++||||+..
T Consensus       271 l------i~~~L~~dp~~R~-----s~~e~l~hp~~~~~  298 (494)
T 3lij_A          271 L------IKQMLQFDSQRRI-----SAQQALEHPWIKEM  298 (494)
T ss_dssp             H------HHHHTCSSTTTSC-----CHHHHHTCHHHHHH
T ss_pred             H------HHHHCCCChhhCc-----cHHHHhcCcccccC
Confidence            4      5559999999999     88999999999764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-49  Score=394.73  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=211.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (447)
                      ++|++++.||+|+||.||+|.++.     +++.||||++.... ......+.+.+|+.+|+.++||||+++++++...  
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             ceEEEeEEeeecCCeEEEEEEECC-----CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            589999999999999999999876     78899999996543 2344556788999999999999999999999865  


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                          ..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence                3579999999 8899988876 679999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--------  334 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p--------  334 (447)
                      ....  .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....|.......+        
T Consensus       177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            7654  2445689999999999987 7799999999999999999999999999888877777664322211        


Q ss_pred             -----------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          335 -----------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       335 -----------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                                             ...+.++      ++||.+||+.||.+||     +++++++||||+.+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ll~~mL~~dP~~R~-----t~~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLA------VNLLEKMLVLDAEQRV-----TAGEALAHPYFESLHDTE  318 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHH------HHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTC---
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHH------HHHHHHHccCChhHCC-----CHHHHhcChHHHhhcCCc
Confidence                                   1223333      4667779999999999     899999999999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=397.18  Aligned_cols=258  Identities=27%  Similarity=0.511  Sum_probs=222.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch-----hHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||||++.+......     ...+.+.+|+.+|++++||||+++++++
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKE-----KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETT-----TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cceEEEeEEEecCCEEEEEEEECC-----CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            379999999999999999999886     788999999987643221     1333467799999999999999999999


Q ss_pred             EeCCEEEEEEeccCCC-ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .+.+.+++||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999998776 999999988899999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHH
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  342 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  342 (447)
                      ...........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....      .........|..++.++.
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~  252 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELM  252 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHH
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHH
Confidence            8776666667889999999999998776 788999999999999999999997632      223344455666777776


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC------CChhHHHh
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS------INWKTLEA  389 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~------~~~~~~~~  389 (447)
                      +++..      ||+.||++||     +++++++||||+.      .+|+.+..
T Consensus       253 ~li~~------~L~~dP~~Rp-----s~~ell~hp~~~~~~~~~~~~~~~~~~  294 (335)
T 3dls_A          253 SLVSG------LLQPVPERRT-----TLEKLVTDPWVTQPVNLADYTWEEVFR  294 (335)
T ss_dssp             HHHHH------HTCSSGGGSC-----CHHHHHHCTTTTCCCCGGGCCHHHHC-
T ss_pred             HHHHH------HccCChhhCc-----CHHHHhcCccccCCccccccCHHHHhh
Confidence            66554      9999999999     8999999999965      45665543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6e-50  Score=405.31  Aligned_cols=264  Identities=30%  Similarity=0.583  Sum_probs=211.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-----hhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ++|.+.+.||+|+||.||+|.++.     +++.||||++.+.....     ......+.+|+.+|++++||||+++++++
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECC-----CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            589999999999999999999886     78899999998754321     12223477899999999999999999997


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC---cEEEeecCC
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMLTDFGL  261 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~~kL~DFG~  261 (447)
                      . ...+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+
T Consensus       210 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          210 D-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             E-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             e-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            5 456899999999999999998888999999999999999999999999999999999999997544   599999999


Q ss_pred             cccccCCCCCCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCCCCH-HHHHHHHHhcccCCC---
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKLP---  334 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~~~~p---  334 (447)
                      ++...........+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||..... ..+...+......++   
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            998776666667889999999999864   5678899999999999999999999976433 234455555554443   


Q ss_pred             -CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhh
Q 013249          335 -PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR  390 (447)
Q Consensus       335 -~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~  390 (447)
                       ..++.++.+      ||.+||+.||++||     +++++++||||++.+|.....+
T Consensus       369 ~~~~~~~~~~------li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~~~~~~~~  414 (419)
T 3i6u_A          369 WAEVSEKALD------LVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRKFQD  414 (419)
T ss_dssp             HTTSCHHHHH------HHHHHSCSSTTTSC-----CHHHHHHSGGGCCHHHHHHHHH
T ss_pred             hcccCHHHHH------HHHHHccCChhHCc-----CHHHHhCCcccCChhHHHHHHH
Confidence             234555444      55669999999999     8899999999999888776543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.2e-50  Score=393.59  Aligned_cols=258  Identities=29%  Similarity=0.510  Sum_probs=218.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc--chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      +|++.+.||+|+||.||+|+++.     +++.||+|++.+....  .....+.+.+|+.+|++++||||+++++++.+.+
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQ-----TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             heeecceeeecCCeEEEEEEECC-----CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            69999999999999999999876     7889999999876432  2455677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH----------------------------------------cCCCCHHHHHHHHHHHHHHH
Q 013249          189 KLYLILDFINGGHLFFHLYR----------------------------------------QGIFREDQARFYTAEIVSAV  228 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~aL  228 (447)
                      .+|+||||++||+|.+++..                                        ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            99999999999999998842                                        11246788999999999999


Q ss_pred             HHHHHCCceeccCCCCCcccCCCC--cEEEeecCCcccccCCC-----CCCccccCCcccccccccC--CCCCCccceee
Q 013249          229 SHLHKCGIVHRDLKPENILMDSDG--HVMLTDFGLAKEIDESS-----RSNSMCGTTEYMAPEILLS--KGHNKDADWWS  299 (447)
Q Consensus       229 ~~LH~~~iiHrDikp~NILl~~~~--~~kL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS  299 (447)
                      .|||++||+||||||+||||+.++  .+||+|||+++.+....     ......||+.|+|||++.+  ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998777  89999999998753321     2345679999999999975  67899999999


Q ss_pred             hhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC----CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          300 VGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF----LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       300 lGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~----~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      |||++|||++|+.||.+.+..+....+......++..    ++.++.+      ||.+||+.||.+||     +++++++
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------li~~~l~~~p~~Rp-----s~~~~l~  330 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARD------LLSNLLNRNVDERF-----DAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHH------HHHHHSCSCTTTSC-----CHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHH------HHHHHcCCChhHCC-----CHHHHhc
Confidence            9999999999999999999988888888876655432    4455544      55569999999999     8899999


Q ss_pred             CCccCCCCh
Q 013249          376 HKWFRSINW  384 (447)
Q Consensus       376 h~~f~~~~~  384 (447)
                      ||||+++.|
T Consensus       331 hp~~~~~~~  339 (345)
T 3hko_A          331 HPWISQFSD  339 (345)
T ss_dssp             SHHHHTTSS
T ss_pred             ChhhccChH
Confidence            999988764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-49  Score=390.41  Aligned_cols=268  Identities=27%  Similarity=0.431  Sum_probs=222.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||.||+|+++.     +++.||||++.... ......+.+.+|+.++++++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKD-----TGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETT-----TCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhheeeeEEeecCCEEEEEEEECC-----CCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            4589999999999999999999876     78899999987653 23444566789999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999999999888887888999999999999999999999999999999999999999999999999999876432


Q ss_pred             -CCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC--------------
Q 013249          269 -SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--------------  332 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~--------------  332 (447)
                       ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......              
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence             233456799999999999875 7899999999999999999999999988877766655432111              


Q ss_pred             -----CC------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcC
Q 013249          333 -----LP------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ  393 (447)
Q Consensus       333 -----~p------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~  393 (447)
                           ++            +.++.++      .+||.+||+.||.+||     +++++++||||+...+.....++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l------~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~  324 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVV------IDLAKKCLHIDPDKRP-----FCAELLHHDFFQMDGFAERFSQELQ  324 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHH------HHHHHHHTCSSGGGSC-----CGGGGGGSHHHHGGGHHHHHHHHHH
T ss_pred             cccccCccccccchhhhcccchhHHH------HHHHHHHhccCcccCC-----CHHHHhcCchhccCChhhhhhHHHh
Confidence                 11            1223333      3566679999999999     8899999999998888877665554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-49  Score=392.39  Aligned_cols=265  Identities=25%  Similarity=0.380  Sum_probs=217.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (447)
                      ++|+++++||+|+||.||+|+++.     +++.||||++..... .......+.+|+.+|+.++||||+++++++..   
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETT-----TCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             cceeEEEEEecCCCcEEEEEEECC-----CCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            589999999999999999999876     788999999876543 22333456789999999999999999999987   


Q ss_pred             -----CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecC
Q 013249          187 -----RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                           .+.+|+||||+.+ +|...+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence                 4579999999976 666666544 679999999999999999999999999999999999999999999999999


Q ss_pred             CcccccC-----CCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC
Q 013249          261 LAKEIDE-----SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP  334 (447)
Q Consensus       261 ~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p  334 (447)
                      +++.+..     .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987642     222345678999999999976 5689999999999999999999999999988888777766544443


Q ss_pred             CCCchhHHh--------------------------hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          335 PFLTSEAHS--------------------------LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       335 ~~~~~~~~~--------------------------li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      .........                          --...+||.+||+.||++||     +++++++||||.+..+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----DSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGSSSCCC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCC-----CHHHHhCCCCcCCCCCcc
Confidence            322111110                          01134788889999999999     889999999998755443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-48  Score=382.14  Aligned_cols=253  Identities=25%  Similarity=0.473  Sum_probs=218.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|+..+.||+|+||.||+|+++.     +++.||||++....   ....+.+.+|+.++++++||||+++++++...+.+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~-----~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKH-----SGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhhccEEeccCCCeEEEEEEECC-----CCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            38888999999999999999876     78899999997643   23345688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      |+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       118 ~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence            999999999999998754 579999999999999999999999999999999999999999999999999998765432 


Q ss_pred             CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---CCCCchhHHhhhh
Q 013249          270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---PPFLTSEAHSLLK  346 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~---p~~~~~~~~~li~  346 (447)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.......   +..++.++.+   
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---  273 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRD---  273 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHH---
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHH---
Confidence            3456789999999999999999999999999999999999999999888887777776553221   1234444444   


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                         ||.+||+.||++||     +++++++||||....
T Consensus       274 ---li~~~l~~dp~~Rp-----s~~ell~hp~~~~~~  302 (321)
T 2c30_A          274 ---FLERMLVRDPQERA-----TAQELLDHPFLLQTG  302 (321)
T ss_dssp             ---HHHHHSCSSTTTSC-----CHHHHHTSGGGGGCC
T ss_pred             ---HHHHHccCChhhCc-----CHHHHhcChhhccCC
Confidence               55669999999999     899999999997654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-49  Score=385.03  Aligned_cols=250  Identities=28%  Similarity=0.403  Sum_probs=200.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh-cCCCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~  188 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++...........+ ...|+..+.+ .+||||+++++++.+.+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~-~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKE-----DGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TSCEEEEEEESSSCCSHHHHHH-HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeheeccCCCeEEEEEEECC-----CCeEEEEEEecccccChHHHHH-HHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            369999999999999999999886     7889999998764333333333 3445555544 48999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999999 66888887665 4699999999999999999999999999999999999999999999999999988766


Q ss_pred             CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc--CCCCCCchhHHhhh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--KLPPFLTSEAHSLL  345 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li  345 (447)
                      ........||+.|+|||++.+ .++.++|||||||++|||++|..||....   ....+.....  .++..++.++.++ 
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~l-  284 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSV-  284 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHH-
T ss_pred             CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHH-
Confidence            655666789999999999886 69999999999999999999977765432   2223332221  1233455555554 


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                           |.+||+.||++||     +++++++||||+.
T Consensus       285 -----i~~~L~~dP~~Rp-----t~~ell~hp~~~~  310 (311)
T 3p1a_A          285 -----LVMMLEPDPKLRA-----TAEALLALPVLRQ  310 (311)
T ss_dssp             -----HHHHSCSSTTTSC-----CHHHHHTSGGGSC
T ss_pred             -----HHHHcCCChhhCc-----CHHHHHhCccccC
Confidence                 5559999999999     8999999999974

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-50  Score=390.61  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=208.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||.||+|+++.     +++.||||++.....  ......+.+|+.+|+.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL-----TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC-----CCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence            589999999999999999999886     788999999975432  1111234569999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||+.| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           75 LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             EEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             EEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9999999975 888888765 45999999999999999999999999999999999999999999999999999865432


Q ss_pred             -CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-----------
Q 013249          269 -SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP-----------  335 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~-----------  335 (447)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......+.           
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             22345678999999999986 56899999999999999999999999999888877777653221111           


Q ss_pred             -------------------CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          336 -------------------FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       336 -------------------~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                                         .++.++      .+||.+||+.||++||     +++++++||||.++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDG------ADLLTKLLQFEGRNRI-----SAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHH------HHHHHHHSCSSGGGSC-----CHHHHTTSGGGGGGCS
T ss_pred             hcccccccccchhhhhhcCCCCHHH------HHHHHHHcCcCcccCC-----CHHHHhcChhhhhccc
Confidence                               112222      4677789999999999     8999999999987653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8e-49  Score=379.62  Aligned_cols=253  Identities=34%  Similarity=0.655  Sum_probs=221.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+...
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRL-----TGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccceeeeeccCCCCceEEEEEECC-----CCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            369999999999999999999876     788999999986432   223457899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc---CCCCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~~kL~DFG~a~~~~  266 (447)
                      +|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999999999999888899999999999999999999999999999999999999   788999999999997654


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  342 (447)
                      .. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...+...+......++.    .++.++.
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            32 234457999999999999999999999999999999999999999999988888888887665543    3455554


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +      ||.+||..||.+||     +++++++||||.+.
T Consensus       240 ~------li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~  268 (304)
T 2jam_A          240 D------FICHLLEKDPNERY-----TCEKALSHPWIDGN  268 (304)
T ss_dssp             H------HHHHHHCSSTTTSC-----CHHHHHTSHHHHSS
T ss_pred             H------HHHHHcCCChhHCc-----CHHHHhcCccccCC
Confidence            4      55569999999999     88999999999753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-49  Score=395.02  Aligned_cols=252  Identities=29%  Similarity=0.450  Sum_probs=210.3

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (447)
                      ..++|+++++||+|+||+||+|+++.     +++.||||++......       ..+|+.+|+.++||||++++++|.. 
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIE-----SGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETT-----TCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeec
Confidence            45689999999999999999999876     7899999998754321       2369999999999999999999844 


Q ss_pred             -------------------------------------CCEEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHH
Q 013249          187 -------------------------------------RSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIV  225 (447)
Q Consensus       187 -------------------------------------~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~  225 (447)
                                                           ...+++||||+.+ +|.+.+.    ..+.+++..++.++.||+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 3458999999985 6665554    457899999999999999


Q ss_pred             HHHHHHHHCCceeccCCCCCcccC-CCCcEEEeecCCcccccCCCCCCccccCCcccccccccCC-CCCCccceeehhHh
Q 013249          226 SAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGIL  303 (447)
Q Consensus       226 ~aL~~LH~~~iiHrDikp~NILl~-~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvi  303 (447)
                      .||.|||++||+||||||+|||++ .++.+||+|||+++.+.........+||+.|+|||++.+. .++.++|||||||+
T Consensus       152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            999999999999999999999997 6899999999999987666666677899999999998875 48999999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHhcc-----------------cC------------CCCCCchhHHhhhhhhhHHhhh
Q 013249          304 LYEMLTGQPPFTHANRQKLQQRIINEK-----------------VK------------LPPFLTSEAHSLLKGVSFLTQL  354 (447)
Q Consensus       304 l~ell~G~~pf~~~~~~~~~~~i~~~~-----------------~~------------~p~~~~~~~~~li~~~~~l~~~  354 (447)
                      +|||++|+.||.+.+..+....+....                 ..            +|...+.++      .+||.+|
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~  305 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA------IDLLEQI  305 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH------HHHHHHH
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH------HHHHHHH
Confidence            999999999999988887777765421                 11            222334444      4566679


Q ss_pred             ccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          355 LHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       355 L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      |+.||.+||     +++++++||||+.+.
T Consensus       306 L~~dP~~R~-----t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          306 LRYEPDLRI-----NPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CCSSGGGSC-----CHHHHHTSGGGHHHH
T ss_pred             ccCChhhCC-----CHHHHhcCHHHHHHH
Confidence            999999999     889999999998654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.7e-50  Score=389.23  Aligned_cols=257  Identities=25%  Similarity=0.432  Sum_probs=215.6

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++.............+.+|+.++++++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLR-----DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECC-----CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            4589999999999999999999876     78899999998765555666678899999999999999999999987643


Q ss_pred             ----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       189 ----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                          ..|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence                4599999999999999999889999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC----CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----CC
Q 013249          265 IDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PF  336 (447)
Q Consensus       265 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----~~  336 (447)
                      +....    .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+    ..
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            64332    23346799999999999999999999999999999999999999999888887777666544332    33


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++.++.++      |.+||+.||.+||     +..+++.|+|++.
T Consensus       246 ~~~~l~~l------i~~~l~~dP~~R~-----~~~~~l~~~l~~~  279 (311)
T 3ork_A          246 LSADLDAV------VLKALAKNPENRY-----QTAAEMRADLVRV  279 (311)
T ss_dssp             CCHHHHHH------HHHHTCSSGGGSC-----SSHHHHHHHHHHH
T ss_pred             CCHHHHHH------HHHHHhcCHhhCh-----hhHHHHHHHHHHH
Confidence            55555555      5559999999999     6789999999853

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.5e-49  Score=384.97  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=204.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||||++....  .....+.+.+|+.+|++++||||++++++|.+.. 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETT-----TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hcCceeeEecCCCCeEEEEEEEcC-----CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            379999999999999999999886     78899999997643  3345567899999999999999999999986543 


Q ss_pred             --------------------------------------------------------EEEEEEeccCCCChHHHHHHcCC-
Q 013249          189 --------------------------------------------------------KLYLILDFINGGHLFFHLYRQGI-  211 (447)
Q Consensus       189 --------------------------------------------------------~~~lv~E~~~gg~L~~~l~~~~~-  211 (447)
                                                                              .+|+||||++|++|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    38999999999999999987643 


Q ss_pred             --CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-------------CCCcccc
Q 013249          212 --FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-------------RSNSMCG  276 (447)
Q Consensus       212 --~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-------------~~~~~~g  276 (447)
                        ..+..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......             .....+|
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence              5666789999999999999999999999999999999999999999999998765432             2344679


Q ss_pred             CCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhcc
Q 013249          277 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLH  356 (447)
Q Consensus       277 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~  356 (447)
                      |+.|+|||++.+..++.++|||||||++|||++|..|+..  .......+...  .+|......   .-...+||.+||+
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~---~~~~~~li~~~l~  311 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFPLLFTQK---YPQEHMMVQDMLS  311 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCHHHHHH---CHHHHHHHHHHHC
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCcccccC---ChhHHHHHHHHcc
Confidence            9999999999999999999999999999999998777522  12222222222  222211111   1122457778999


Q ss_pred             CCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          357 KDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       357 ~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .||++||     +++++++||||+++
T Consensus       312 ~~p~~Rp-----s~~~~l~~~~f~~~  332 (332)
T 3qd2_B          312 PSPTERP-----EATDIIENAIFENL  332 (332)
T ss_dssp             SSGGGSC-----CHHHHHHSTTCCCC
T ss_pred             CCCCcCC-----CHHHHhhchhhhcC
Confidence            9999999     88999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-48  Score=381.78  Aligned_cols=252  Identities=26%  Similarity=0.466  Sum_probs=209.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT-  186 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-  186 (447)
                      .++|+++++||+|+||.||+|+++.     +++.||||++....      .+.+.+|+.+|++++ ||||+++++++.+ 
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CCceEEEEEecccCCeEEEEEEECC-----CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            4589999999999999999999876     78899999987432      245789999999997 9999999999988 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-cEEEeecCCccc
Q 013249          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKE  264 (447)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~~kL~DFG~a~~  264 (447)
                       ....++||||+.+++|..++.   .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence             678999999999999988874   489999999999999999999999999999999999999777 899999999998


Q ss_pred             ccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCC-CHHHHHHHHH-------------hc
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRII-------------NE  329 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~i~-------------~~  329 (447)
                      ..........+||..|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+.             ..
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            766666667789999999999987 67899999999999999999999999543 3333222221             11


Q ss_pred             ccCCCC------------------------CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          330 KVKLPP------------------------FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       330 ~~~~p~------------------------~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      ...+++                        .++.++      .+||.+||+.||.+||     +++++++||||+++.|+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA------LDFLDKLLRYDHQSRL-----TAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHH------HHHHHTTSCSSGGGSC-----CHHHHHTSGGGTTCC--
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHH------HHHHHHHhcCCcccCC-----CHHHHhcCccHhhhccC
Confidence            111111                        133443      3566679999999999     89999999999998875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-48  Score=377.36  Aligned_cols=247  Identities=27%  Similarity=0.451  Sum_probs=209.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++++.||+|+||.||+|+++.     +++.||+|++...........+.+.+|+.++++++||||+++++++.+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTI-----LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETT-----TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECC-----CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            345689999999999999999999876     788999999976655556667789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-----CCCCCch
Q 013249          267 ESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----LPPFLTS  339 (447)
Q Consensus       267 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-----~p~~~~~  339 (447)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..............     .+..++.
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence            432  233467999999999999999999999999999999999999999998877766655544322     2344555


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLG  364 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~  364 (447)
                      .+.++      |.+||.+||.+||+
T Consensus       243 ~l~~l------i~~~l~~dp~~R~~  261 (294)
T 4eqm_A          243 SLSNV------ILRATEKDKANRYK  261 (294)
T ss_dssp             HHHHH------HHHHSCSSGGGSCS
T ss_pred             HHHHH------HHHHhcCCHhHccc
Confidence            55554      55599999999993

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.6e-49  Score=392.27  Aligned_cols=266  Identities=28%  Similarity=0.475  Sum_probs=222.8

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      ....+..++|+++++||+|+||.||+|+++.     +++.||+|++....  .....+.+.+|+.+|+.++||||+++++
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~   98 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYG   98 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECC-----CCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeE
Confidence            3445677899999999999999999999886     78899999997652  3445567889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEEeecCC
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      ++...+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A           99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCC
Confidence            9999999999999999999999999888999999999999999999999986 999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHH---------------
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI---------------  326 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i---------------  326 (447)
                      +...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+               
T Consensus       179 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          179 SGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             CHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             Ccccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            9765432 234568999999999999999999999999999999999999999877765543322               


Q ss_pred             ---------------------------Hhccc-CCC-CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCC
Q 013249          327 ---------------------------INEKV-KLP-PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHK  377 (447)
Q Consensus       327 ---------------------------~~~~~-~~p-~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~  377 (447)
                                                 ..... ..+ ..++.++.      +||.+||+.||.+||     +++++++||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~li~~~L~~dP~~Rp-----t~~ell~hp  326 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ------DFVNKCLIKNPAERA-----DLKQLMVHA  326 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHH------HHHHHHHCSSTTTSC-----CHHHHHTSH
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHH------HHHHHHhhcChhhCC-----CHHHHhhCh
Confidence                                       11111 111 12333433      556679999999999     899999999


Q ss_pred             ccCCCChhHH
Q 013249          378 WFRSINWKTL  387 (447)
Q Consensus       378 ~f~~~~~~~~  387 (447)
                      ||++.+|..+
T Consensus       327 ~~~~~~~~~~  336 (360)
T 3eqc_A          327 FIKRSDAEEV  336 (360)
T ss_dssp             HHHHHHHSCC
T ss_pred             HhhcchHhhh
Confidence            9998766654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-48  Score=384.93  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=217.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|++++.||+|+||.||+|+++.     +++.||||++...........+.+.+|+.+|++++||||+++++++...+..
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             heeeeeEEccCCCEEEEEEEEcc-----CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence            59999999999999999999875     7889999999865444455567788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          191 YLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      |+||||+. |+|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            99999997 56777765 457899999999999999999999999999999999999999999999999999987643  


Q ss_pred             CCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--CCCCchhHHhh
Q 013249          270 RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSL  344 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~l  344 (447)
                       ....+||+.|+|||++.   ...++.++|||||||++|||++|+.||...+.......+.......  +..++..+.++
T Consensus       207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  285 (348)
T 1u5q_A          207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF  285 (348)
T ss_dssp             -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred             -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence             34568999999999985   5678999999999999999999999999888777766666554321  23455555554


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                            |.+||+.||++||     +++++++||||....
T Consensus       286 ------i~~~l~~dP~~Rp-----s~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          286 ------VDSCLQKIPQDRP-----TSEVLLKHRFVLRER  313 (348)
T ss_dssp             ------HHHHTCSSGGGSC-----CHHHHTTCHHHHSCC
T ss_pred             ------HHHHcccChhhCc-----CHHHHhhChhhhccC
Confidence                  5559999999999     889999999997644

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-48  Score=375.45  Aligned_cols=257  Identities=30%  Similarity=0.577  Sum_probs=225.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||||++..... .....+.+.+|+.++++++||||+++++++.....
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcC-----CCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            379999999999999999999876     788999999976543 23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC---CcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~~kL~DFG~a~~~~  266 (447)
                      +|+||||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888899999999999999999999999999999999999999764   479999999998876


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----CCCchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  342 (447)
                      .........||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..++...+..+...++    ..++.++.
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             CCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            65555566799999999998765 89999999999999999999999999998888888887765543    24455555


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      +      ||.+||..||.+||     +++++++||||+...+
T Consensus       255 ~------li~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~  285 (287)
T 2wei_A          255 D------LIRKMLTFHPSLRI-----TATQCLEHPWIQKYSS  285 (287)
T ss_dssp             H------HHHHHTCSSGGGSC-----CHHHHHHSHHHHHHCC
T ss_pred             H------HHHHHcccChhhCc-----CHHHHhcCHHHhcccc
Confidence            4      45569999999999     8899999999986654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.6e-48  Score=385.02  Aligned_cols=268  Identities=25%  Similarity=0.426  Sum_probs=217.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (447)
                      ++|+++++||+|+||.||+|+++.     +++.||||++....  .....+.+.+|+.+|++++||||+++++++...  
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNL-----NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccEEEEEEeecCCCeEEEEEEECC-----CCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            589999999999999999999876     78899999997532  344456788999999999999999999999764  


Q ss_pred             ---CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                         ..+|+||||+.| +|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       100 ~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          100 EQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence               479999999974 89888865 5699999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC----CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC------
Q 013249          265 IDESS----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL------  333 (447)
Q Consensus       265 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~------  333 (447)
                      .....    .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......      
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            64322    2345689999999998764 558999999999999999999999999887777666665321111      


Q ss_pred             --------------C-----------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHH
Q 013249          334 --------------P-----------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  388 (447)
Q Consensus       334 --------------p-----------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~  388 (447)
                                    +           +..+.++      .+||.+||+.||++||     +++++++||||+.. |....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~R~-----t~~e~l~hp~~~~~-~~~~~  325 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKA------LDLLDKMLTFNPHKRI-----EVEQALAHPYLEQY-YDPSD  325 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHH------HHHHHHHTCSSTTTSC-----CHHHHHTSGGGTTT-CCGGG
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHH------HHHHHHHcCCChhhCC-----CHHHHhcCcchhhc-cCccc
Confidence                          1           1233333      4567779999999999     89999999999875 33333


Q ss_pred             hhhcCCCCCC
Q 013249          389 AREMQPKFKP  398 (447)
Q Consensus       389 ~~~~~~~~~p  398 (447)
                      .....+||.+
T Consensus       326 ~~~~~~~~~~  335 (364)
T 3qyz_A          326 EPIAEAPFKF  335 (364)
T ss_dssp             SCCCSSCCCC
T ss_pred             ccCCCCcCCc
Confidence            3333334443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.7e-49  Score=388.20  Aligned_cols=264  Identities=28%  Similarity=0.513  Sum_probs=227.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchh--------------HHHHHHHHHHHHHhc
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--------------HVDYMKAERDILTKV  172 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~--------------~~~~~~~E~~il~~l  172 (447)
                      +..++|++.+.||+|+||.||+|++       +++.||||++.........              ..+.+.+|+.+++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            3456899999999999999999987       5688999999876433221              126788999999999


Q ss_pred             CCCCceeeeEEEEeCCEEEEEEeccCCCChHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCC
Q 013249          173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH------LYR--QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKP  243 (447)
Q Consensus       173 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------l~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp  243 (447)
                      +||||+++++++.+.+.+|+||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||
T Consensus       101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p  180 (348)
T 2pml_X          101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP  180 (348)
T ss_dssp             CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred             CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence            999999999999999999999999999999888      655  5779999999999999999999999 9999999999


Q ss_pred             CCcccCCCCcEEEeecCCcccccCCCCCCccccCCcccccccccCC-CCCC-ccceeehhHhHHHHhhCCCCCCCCCH-H
Q 013249          244 ENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNK-DADWWSVGILLYEMLTGQPPFTHANR-Q  320 (447)
Q Consensus       244 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~ell~G~~pf~~~~~-~  320 (447)
                      +|||++.++.+||+|||++...... ......||..|+|||++.+. .++. ++|||||||++|||++|+.||...+. .
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             HhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9999999999999999999876543 34556899999999999877 6666 89999999999999999999988766 7


Q ss_pred             HHHHHHHhcccCCC-------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          321 KLQQRIINEKVKLP-------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       321 ~~~~~i~~~~~~~p-------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++...+......+|                   ..++.++.+      ||.+||+.||.+||     +++++++||||.+
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~------li~~~L~~dP~~Rp-----s~~e~l~hp~f~~  328 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID------FLKLFLRKNPAERI-----TSEDALKHEWLAD  328 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHH------HHHHHCCSSGGGSC-----CHHHHHTSGGGTT
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHH------HHHHHccCChhhCC-----CHHHHhcCccccC
Confidence            77788877776666                   345555544      45569999999999     8899999999999


Q ss_pred             CChhHHHh
Q 013249          382 INWKTLEA  389 (447)
Q Consensus       382 ~~~~~~~~  389 (447)
                      .+|..+..
T Consensus       329 ~~~~~~~~  336 (348)
T 2pml_X          329 TNIEDLRE  336 (348)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHHH
Confidence            99988753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-48  Score=395.39  Aligned_cols=252  Identities=30%  Similarity=0.491  Sum_probs=207.9

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR---  187 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---  187 (447)
                      +|+++++||+|+||.||+|+++.     +++.||||++.....       ...+|+++|+.++|||||+++++|...   
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             eEEeeeEEeeCCCEEEEEEEECC-----CCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence            69999999999999999999986     788999999875431       133699999999999999999998542   


Q ss_pred             ---CEEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC-CcEEEeec
Q 013249          188 ---SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDF  259 (447)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~~kL~DF  259 (447)
                         ..+++||||+.+ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+||
T Consensus       123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence               247899999986 5555443    34679999999999999999999999999999999999999965 57899999


Q ss_pred             CCcccccCCCCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc---------
Q 013249          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---------  329 (447)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~---------  329 (447)
                      |+++.+.........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+...         
T Consensus       202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999987665556677899999999999764 7999999999999999999999999998877766665542         


Q ss_pred             --------ccCCC------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          330 --------KVKLP------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       330 --------~~~~p------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                              ...+|            ...+.++      ++||.+||++||.+||     +++++++||||+.+.+..
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~------~~Li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA------IALCSRLLEYTPTARL-----TPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHH------HHHHHHHSCSSGGGSC-----CHHHHHTSGGGGGGGCTT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHH------HHHHHHhccCChhHCC-----CHHHHhCCHhhccccccc
Confidence                    11222            2233333      4566779999999999     889999999998765543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=384.04  Aligned_cols=255  Identities=27%  Similarity=0.484  Sum_probs=209.8

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC--CCceeeeEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSF  184 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~  184 (447)
                      +..++|++++.||+|+||.||+|.+.      +++.||||++..... .....+.+.+|+.+|+.++|  |||+++++++
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   78 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   78 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence            45668999999999999999999864      578899999986542 34455778899999999976  9999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .....+|+|||+ .+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.
T Consensus        79 ~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           79 ITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             ECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             eeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            999999999995 5789999999999999999999999999999999999999999999999997 67899999999987


Q ss_pred             ccCCCC---CCccccCCcccccccccC-----------CCCCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHHHHHhc
Q 013249          265 IDESSR---SNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINE  329 (447)
Q Consensus       265 ~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~  329 (447)
                      ......   ....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.... .......+...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  236 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  236 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence            644322   345689999999999865           678899999999999999999999997643 33333444332


Q ss_pred             --ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          330 --KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       330 --~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                        ...+|...+.++.++      |.+||+.||.+||     +++++++||||+.
T Consensus       237 ~~~~~~~~~~~~~l~~l------i~~~L~~dp~~Rp-----t~~e~l~hp~~~~  279 (343)
T 3dbq_A          237 NHEIEFPDIPEKDLQDV------LKCCLKRDPKQRI-----SIPELLAHPYVQI  279 (343)
T ss_dssp             TSCCCCCCCSCHHHHHH------HHHHTCSSTTTSC-----CHHHHHTSHHHHS
T ss_pred             CcccCCcccCCHHHHHH------HHHHcCCChhHCC-----CHHHHHhCccccc
Confidence              334566666666555      4459999999999     8999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-48  Score=392.13  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=208.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      .+|++.++||+|+||+||+|+++.     ++ .+|+|++......       ..+|+.+|+.++||||++++++|...+ 
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~-----~~-~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVE-----SD-EVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT-----TE-EEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECC-----CC-eEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            479999999999999999999874     44 4888887654321       236999999999999999999996543 


Q ss_pred             -----EEEEEEeccCCCChHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC-CCCcEEEeec
Q 013249          189 -----KLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDF  259 (447)
Q Consensus       189 -----~~~lv~E~~~gg~L~~~l---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~~kL~DF  259 (447)
                           .+|+||||+.++.+....   .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus       107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence                 389999999876443322   2356899999999999999999999999999999999999999 7999999999


Q ss_pred             CCcccccCCCCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--------
Q 013249          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------  330 (447)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--------  330 (447)
                      |+++...........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+....        
T Consensus       187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999987666666677899999999999764 58999999999999999999999999988877776665421        


Q ss_pred             ---------cCC------------CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHH
Q 013249          331 ---------VKL------------PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  387 (447)
Q Consensus       331 ---------~~~------------p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~  387 (447)
                               ..+            +...+.++      .+||.+||++||.+||     +++++++||||+.+.|...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDA------IDLISRLLEYTPSARL-----TAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHH------HHHHHHHCCSSGGGSC-----CHHHHHTSGGGSTTTSSCC
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHH------HHHHHHHhCCChhhCC-----CHHHHhcChhhhhhccccc
Confidence                     111            12234444      4556669999999999     8899999999999877543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=379.55  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=213.9

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.++||+|+||+||+|+++.     +++.||||++.....  ....+.+.+|+.+|++++||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECC-----CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence            44689999999999999999999986     788999999976542  23355678899999999999999999999875


Q ss_pred             C--EEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc----CCCCcEEEee
Q 013249          188 S--KLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTD  258 (447)
Q Consensus       188 ~--~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~~kL~D  258 (447)
                      .  .+|+||||++|++|.+++.....   +++.+++.++.||+.||.|||++||+||||||+||||    +.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            5  88999999999999999986543   9999999999999999999999999999999999999    8888999999


Q ss_pred             cCCcccccCCCCCCccccCCccccccccc--------CCCCCCccceeehhHhHHHHhhCCCCCCCC----CHHHHHHHH
Q 013249          259 FGLAKEIDESSRSNSMCGTTEYMAPEILL--------SKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRI  326 (447)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~ell~G~~pf~~~----~~~~~~~~i  326 (447)
                      ||+++...........+||+.|+|||++.        +..++.++|||||||++|||++|+.||...    ...++...+
T Consensus       160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            99999877666666778999999999986        567899999999999999999999999642    234455555


Q ss_pred             Hhccc-------------------CCC--CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCc
Q 013249          327 INEKV-------------------KLP--PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW  378 (447)
Q Consensus       327 ~~~~~-------------------~~p--~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~  378 (447)
                      ..+..                   .++  ..++......+  .+||.+||+.||++||     +++++++||=
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~ll~~~L~~dP~~R~-----s~~ell~h~~  305 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL--TPVLANILEADQEKCW-----GFDQFFAETS  305 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHH--HHHHHHHSCCCTTTSC-----CHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHh--HHHHHHhccCChhhhc-----cHHHhhhccH
Confidence            54432                   111  12333333332  4678889999999999     8899999863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.6e-48  Score=370.10  Aligned_cols=255  Identities=22%  Similarity=0.397  Sum_probs=213.7

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (447)
                      ....|++.+.||+|+||.||+|.+..     ++..||+|++..... .....+.+.+|+.+|+.++||||+++++++.. 
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   97 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecC-----CceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence            34458999999999999999999876     788999999986553 34456778899999999999999999999875 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccC-CCCcEEEeecC
Q 013249          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMLTDFG  260 (447)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~-~~~~~kL~DFG  260 (447)
                         ...+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             cCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence               4569999999999999999998889999999999999999999999999  99999999999997 78999999999


Q ss_pred             CcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHHHHHhccc--CCCCCC
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINEKV--KLPPFL  337 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~~~--~~p~~~  337 (447)
                      ++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .......+.....  .++...
T Consensus       178 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (290)
T 1t4h_A          178 LATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA  255 (290)
T ss_dssp             GGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred             Cccccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence            99765432 3445679999999998875 58999999999999999999999998744 4444444443321  223334


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++++.+      ||.+||+.||.+||     +++++++||||++
T Consensus       256 ~~~l~~------li~~~l~~dp~~Rp-----s~~ell~h~~f~~  288 (290)
T 1t4h_A          256 IPEVKE------IIEGCIRQNKDERY-----SIKDLLNHAFFQE  288 (290)
T ss_dssp             CHHHHH------HHHHHSCSSGGGSC-----CHHHHHTSGGGC-
T ss_pred             CHHHHH------HHHHHccCChhhCC-----CHHHHhhCccccc
Confidence            455544      55569999999999     8999999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=377.07  Aligned_cols=258  Identities=28%  Similarity=0.493  Sum_probs=221.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhcCCCCceeeeEEEE--
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQ--  185 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--  185 (447)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|++.+..... ....+.+.+|+.+++.++||||+++++++.  
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSE-----TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTT-----TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred             ccceeEeeEEecCCCeEEEEEEECC-----CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            3689999999999999999999875     78899999998754322 344567889999999999999999999984  


Q ss_pred             eCCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +...+|+||||+.++ |.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            456899999999887 6677665  3579999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC---CCCCccccCCcccccccccCCCC--CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCc
Q 013249          264 EIDES---SRSNSMCGTTEYMAPEILLSKGH--NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT  338 (447)
Q Consensus       264 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~  338 (447)
                      .....   .......||+.|+|||++.+...  +.++|||||||++|+|++|+.||.+.+..+....+......++..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  237 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCG  237 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccC
Confidence            76432   22335679999999999986543  77999999999999999999999999999999999888888888888


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      .++.+++..      ||..||.+||     +++++++||||+...
T Consensus       238 ~~l~~li~~------~l~~dp~~Rp-----s~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          238 PPLSDLLKG------MLEYEPAKRF-----SIRQIRQHSWFRKKH  271 (305)
T ss_dssp             HHHHHHHHH------HTCSSTTTSC-----CHHHHHHSHHHHSCC
T ss_pred             HHHHHHHHH------HccCChhhCC-----CHHHHhcCcccccCC
Confidence            887766555      9999999999     889999999998654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.5e-49  Score=383.53  Aligned_cols=261  Identities=31%  Similarity=0.609  Sum_probs=213.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ++|++.+.||+|+||.||+|+++.     +++.||||++.+....     .......+.+|+.+|++++||||+++++++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hceeEeeEEecCCCEEEEEEEEcC-----CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            369999999999999999999886     7889999999765321     122334578899999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc---EEEeecCC
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGL  261 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---~kL~DFG~  261 (447)
                      .... +|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            7765 8999999999999999988889999999999999999999999999999999999999987664   99999999


Q ss_pred             cccccCCCCCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCC---
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP---  334 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~~~~p---  334 (447)
                      ++...........+||+.|+|||++.   ...++.++|||||||++|+|++|..||...... .+...+..+...+.   
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            98876543344567999999999974   567899999999999999999999999764432 34445555544332   


Q ss_pred             -CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHH
Q 013249          335 -PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  387 (447)
Q Consensus       335 -~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~  387 (447)
                       ..++.++.      +||.+||..||++||     +++++++||||.+.+|...
T Consensus       244 ~~~~~~~~~------~li~~~l~~dP~~Rp-----s~~~~l~h~~~~~~~~~~~  286 (322)
T 2ycf_A          244 WAEVSEKAL------DLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRK  286 (322)
T ss_dssp             HTTSCHHHH------HHHHHHSCSSTTTSC-----CHHHHHTSGGGCCHHHHHH
T ss_pred             hhhcCHHHH------HHHHHHcccCHhhCC-----CHHHHhhCcCcCCHHHHHH
Confidence             23444444      456669999999999     8899999999998877654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.2e-48  Score=376.94  Aligned_cols=252  Identities=26%  Similarity=0.444  Sum_probs=210.4

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++.+.||+|+||+||+|++       .++.||||++..... .....+.+.+|+.+|++++||||+++++++
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-------HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-------TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-------CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            446667999999999999999999986       456799999976543 344556788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccCCCCcEEEeec
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                      .+...+|+||||+.+|+|.+++...+.   +++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999999999987653   999999999999999999999999  999999999999999999999999


Q ss_pred             CCcccccCCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHh--cccCCCCC
Q 013249          260 GLAKEIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPF  336 (447)
Q Consensus       260 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~--~~~~~p~~  336 (447)
                      |+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..  ....+|..
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN  263 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            9998654332 23456899999999999999999999999999999999999999999888887776643  34456777


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.++.++++.      ||+.||.+||     +++++++
T Consensus       264 ~~~~l~~li~~------~l~~dP~~Rp-----s~~~ll~  291 (309)
T 3p86_A          264 LNPQVAAIIEG------CWTNEPWKRP-----SFATIMD  291 (309)
T ss_dssp             SCHHHHHHHHH------HTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHHH------HccCChhhCc-----CHHHHHH
Confidence            88877666554      9999999999     7888886

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-48  Score=384.78  Aligned_cols=260  Identities=24%  Similarity=0.397  Sum_probs=211.3

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc--hhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      .++|++++.||+|+||.||+|+++.     +++.||||++.......  ....+.+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            4589999999999999999999875     78899999997543221  1122457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+.+|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999999986 788887655 46899999999999999999999999999999999999999999999999999876


Q ss_pred             cCC-CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC---------
Q 013249          266 DES-SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---------  334 (447)
Q Consensus       266 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p---------  334 (447)
                      ... ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+.......+         
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            433 23445789999999999976 4589999999999999999999999999988888777765322111         


Q ss_pred             -------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          335 -------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       335 -------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                                         ...+.++      .+||.+||+.||.+||     +++++++||||.+..+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~Rp-----t~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDL------LDLIQGLFLFNPCARI-----TATQALKMKYFSNRPGP  301 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHH------HHHHHHHHCSSTTTSC-----CHHHHHTSGGGTSSSCC
T ss_pred             CcccccccccCCCChHHhhccCCHHH------HHHHHHHhccChhhCC-----CHHHHhcChhhhcCCCC
Confidence                               1112223      4567779999999999     88999999999876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.9e-48  Score=391.84  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=212.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc------CCCCceeeeE
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV------THPFIVQLRY  182 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~  182 (447)
                      ..+|+++++||+|+||.||+|+++.     +++.||||++....    ...+.+.+|+.+++.+      +|+||+++++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHK-----VHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETT-----TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECC-----CCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            4579999999999999999999886     78899999997542    3334567788888877      5779999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc--EEEee
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMLTD  258 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--~kL~D  258 (447)
                      ++.....+|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||||+.++.  +||+|
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence            9999999999999996 68999888764  4999999999999999999999999999999999999999987  99999


Q ss_pred             cCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC--
Q 013249          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--  336 (447)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~--  336 (447)
                      ||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......+..  
T Consensus       246 FG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          246 FGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            999976543  3445689999999999999999999999999999999999999999988887776665421111000  


Q ss_pred             ---------------------------------------------CchhHHhhh------hhhhHHhhhccCCCCCCCCC
Q 013249          337 ---------------------------------------------LTSEAHSLL------KGVSFLTQLLHKDPSKRLGS  365 (447)
Q Consensus       337 ---------------------------------------------~~~~~~~li------~~~~~l~~~L~~dP~~R~~~  365 (447)
                                                                   ...+....+      ..++||.+||++||++||  
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp--  401 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM--  401 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC--
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC--
Confidence                                                         000000111      124788889999999999  


Q ss_pred             CCCChhhhhcCCccCCC
Q 013249          366 GPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       366 ~~~~~~~l~~h~~f~~~  382 (447)
                         +++++++||||+..
T Consensus       402 ---ta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          402 ---TPGQALRHPWLRRR  415 (429)
T ss_dssp             ---CHHHHHTSTTTC--
T ss_pred             ---CHHHHhCChhhccC
Confidence               89999999999753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.2e-48  Score=373.31  Aligned_cols=258  Identities=24%  Similarity=0.405  Sum_probs=198.4

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++++.||+|+||.||+|+++.     +++.||||++..... .....+.+.++..+++.++||||+++++++.
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~   76 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVP-----SGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALF   76 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecC-----CCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence            3556789999999999999999999876     788999999976532 2333444555666688889999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEEeecC
Q 013249          186 TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                      +.+..|+||||++| +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus        77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence            99999999999975 77666543    46899999999999999999999998 99999999999999999999999999


Q ss_pred             CcccccCCCCCCccccCCcccccccc----cCCCCCCccceeehhHhHHHHhhCCCCCCC-CCHHHHHHHHHh-cccCCC
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN-EKVKLP  334 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~ell~G~~pf~~-~~~~~~~~~i~~-~~~~~p  334 (447)
                      +++............||+.|+|||++    .+..++.++|||||||++|+|++|+.||.. .........+.. .....+
T Consensus       156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (290)
T 3fme_A          156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP  235 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC
T ss_pred             CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc
Confidence            99887665555566899999999996    566789999999999999999999999975 333333333333 333333


Q ss_pred             -CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 -PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 -~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                       ..++.++.++      |.+||+.||++||     +++++++||||+.
T Consensus       236 ~~~~~~~~~~l------i~~~l~~~p~~Rp-----t~~e~l~hp~f~~  272 (290)
T 3fme_A          236 ADKFSAEFVDF------TSQCLKKNSKERP-----TYPELMQHPFFTL  272 (290)
T ss_dssp             TTTSCHHHHHH------HHHHTCSSGGGSC-----CHHHHTTSHHHHH
T ss_pred             cccCCHHHHHH------HHHHhhcChhhCc-----CHHHHHhCccccc
Confidence             2456666555      5559999999999     8999999999964

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-48  Score=387.25  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=197.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (447)
                      ++|++++.||+|+||.||+|.++.     +++.||||++.... ......+.+.+|+.+|+.++||||+++++++...  
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETT-----TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CceEEeeEEeecCCeEEEEEEECC-----CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            589999999999999999999876     78899999997543 2344556788999999999999999999999754  


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                          ..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence                5689999999 7899888865 679999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-----CCC
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-----PFL  337 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p-----~~~  337 (447)
                      .....  ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....|.......+     ...
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          181 HTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             ccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            76542  345689999999999987 6789999999999999999999999999888877776654321110     000


Q ss_pred             chhHHh---------------h-----hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          338 TSEAHS---------------L-----LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       338 ~~~~~~---------------l-----i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      +.....               .     -...+||.+||+.||.+||     +++++++||||.....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~-----t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQYHD  320 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc-----CHHHHhcChhhhhccC
Confidence            000000               0     1135677789999999999     8999999999987643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-48  Score=386.81  Aligned_cols=259  Identities=22%  Similarity=0.399  Sum_probs=220.7

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  181 (447)
                      +.+..++|++.+.||+|+||.||+|++.+...  ...+..||||+++...  .....+.+.+|+.+|+.+ +||||++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            34556789999999999999999999865332  2356789999997652  345567789999999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                      +++.+.+.+|+||||+.||+|.+++....                .+++.++..++.||+.||.|||++||+||||||+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            99999999999999999999999998753                47899999999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~  321 (447)
                      |||+.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999998764432   2334567889999999999999999999999999999999 999999888888


Q ss_pred             HHHHHHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          322 LQQRIINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       322 ~~~~i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +...+..+. ...|..++.++.+++.      +||+.||.+||     ++++++++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~------~~l~~dP~~Rp-----t~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRP-----TFKQLVED  358 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHH------HHcCCChhhCc-----CHHHHHHH
Confidence            777776553 3456667777666555      59999999999     78898864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.6e-48  Score=388.63  Aligned_cols=255  Identities=27%  Similarity=0.469  Sum_probs=211.7

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC--CCCceeeeEEEE
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSFQ  185 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~  185 (447)
                      ...+|+++++||+|+||.||+|.++      .++.||||++..... .....+.+.+|+.+|+++.  ||||+++++++.
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~  126 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI  126 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcC------CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence            3456999999999999999999864      478899999987543 3455677899999999996  599999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      ..+.+|+||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            9999999999 56889999999989999999999999999999999999999999999999995 589999999999876


Q ss_pred             cCCC---CCCccccCCcccccccccC-----------CCCCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHHHHHhcc
Q 013249          266 DESS---RSNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINEK  330 (447)
Q Consensus       266 ~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~~  330 (447)
                      ....   .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.... .......+....
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~  284 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  284 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence            4432   2345689999999999875           368899999999999999999999997653 334445555433


Q ss_pred             --cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          331 --VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       331 --~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                        ..+|...+.++.++      |.+||+.||.+||     +++++++||||...
T Consensus       285 ~~~~~~~~~~~~~~~l------i~~~L~~dP~~Rp-----s~~ell~hp~~~~~  327 (390)
T 2zmd_A          285 HEIEFPDIPEKDLQDV------LKCCLKRDPKQRI-----SIPELLAHPYVQIQ  327 (390)
T ss_dssp             SCCCCCCCSCHHHHHH------HHHHTCSSTTTSC-----CHHHHHTSHHHHSC
T ss_pred             ccCCCCccchHHHHHH------HHHHcccChhhCC-----CHHHHhhCcCcccc
Confidence              34566666666555      4559999999999     88999999999754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.3e-48  Score=369.41  Aligned_cols=255  Identities=28%  Similarity=0.502  Sum_probs=215.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|++.+.||+|+||.||+|+++.     +++.||||++.....  ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeecCCCcEEEEEEECC-----CCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            379999999999999999999876     788999999976532  3345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC-
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~-  268 (447)
                      .|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999999999987778999999999999999999999999999999999999999999999999999865432 


Q ss_pred             --CCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCC--CCCchhHH
Q 013249          269 --SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP--PFLTSEAH  342 (447)
Q Consensus       269 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~~~~p--~~~~~~~~  342 (447)
                        ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.. .....+.......+  ..++.++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence              22345679999999999987765 77899999999999999999999765543 22333333322222  23455554


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      +      ||.+||..||.+||     +++++++||||++.
T Consensus       240 ~------li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  268 (276)
T 2yex_A          240 A------LLHKILVENPSARI-----TIPDIKKDRWYNKP  268 (276)
T ss_dssp             H------HHHHHSCSSTTTSC-----CHHHHTTCTTTTCC
T ss_pred             H------HHHHHCCCCchhCC-----CHHHHhcCccccCh
Confidence            4      55669999999999     89999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-48  Score=382.10  Aligned_cols=255  Identities=19%  Similarity=0.316  Sum_probs=206.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+++++||+|+||.||+|+++.... .....+|+|.+....  .......+.+|+.+++.++||||+++++++. 
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGE-SIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTC-SCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCc-eEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            456789999999999999999999876211 012237777765432  1222234668999999999999999999886 


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+..++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            45689999999999999999875 57999999999999999999999999999999999999999999999999999976


Q ss_pred             cCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchh
Q 013249          266 DESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  340 (447)
Q Consensus       266 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~  340 (447)
                      ....   ......||..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+... ....|...+.+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID  245 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence            4432   2334568889999999999999999999999999999999 99999988877777777655 34455566666


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.++      |.+||..||.+||     +++++++|
T Consensus       246 ~~~l------i~~~l~~dp~~Rp-----s~~el~~~  270 (325)
T 3kex_A          246 VYMV------MVKCWMIDENIRP-----TFKELANE  270 (325)
T ss_dssp             TTHH------HHHHTCSCTTTSC-----CHHHHHHH
T ss_pred             HHHH------HHHHcCCChhhCc-----CHHHHHHH
Confidence            5554      5559999999999     77887654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.2e-50  Score=400.85  Aligned_cols=251  Identities=17%  Similarity=0.199  Sum_probs=204.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHH---HHHHhcCCCCceeee----
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---DILTKVTHPFIVQLR----  181 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~----  181 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++.+.........+.+.+|+   .+|++++|||||+++    
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C-----CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             CceEEEcceeecCCCEEEEEEEECC-----CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            5689999999999999999999865     7889999999876555566677899999   455566899999998    


Q ss_pred             ---EEEEeCC-----------------EEEEEEeccCCCChHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHHC
Q 013249          182 ---YSFQTRS-----------------KLYLILDFINGGHLFFHLYRQGIFRE-------DQARFYTAEIVSAVSHLHKC  234 (447)
Q Consensus       182 ---~~~~~~~-----------------~~~lv~E~~~gg~L~~~l~~~~~~~~-------~~~~~i~~qi~~aL~~LH~~  234 (447)
                         +++.+.+                 ..|+||||+ +|+|.+++...+.+++       ..+..|+.||+.||+|||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence               7776553                 289999999 6799999987665665       78888999999999999999


Q ss_pred             CceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccccCCcccccccccCC-----------CCCCccceeehhHh
Q 013249          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-----------GHNKDADWWSVGIL  303 (447)
Q Consensus       235 ~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvi  303 (447)
                      ||+||||||+||||+.++.+||+|||+++....  .....+| +.|+|||++.+.           .++.++|||||||+
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999999986443  3445678 999999999987           89999999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          304 LYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       304 l~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      +|||++|+.||.+.+.......+.    ..+..++.++.+++.      +||+.||.+||     +++++++||||+.+.
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~------~~L~~dp~~Rp-----t~~e~l~hp~f~~~~  367 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLE------GFLRYPKEDRL-----LPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHH------HHTCSSGGGCC-----CHHHHHTSHHHHHHH
T ss_pred             HHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHH------HHcCCCchhCC-----CHHHHhhChHHHHHH
Confidence            999999999997765443332222    233556666666554      59999999999     889999999998653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.3e-48  Score=374.48  Aligned_cols=261  Identities=30%  Similarity=0.499  Sum_probs=217.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++++.||+|+||.||+|+++.     +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKE-----TGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETT-----TCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             ccceeecceeccCCCeEEEEEEEcC-----CCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            3579999999999999999999876     78899999987542   334567888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      .+|+||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999999998876 46799999999999999999999999999999999999999999999999998764321


Q ss_pred             -CCCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC---CCCCCc
Q 013249          268 -SSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLT  338 (447)
Q Consensus       268 -~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~---~p~~~~  338 (447)
                       ........||+.|+|||++.     +..++.++|||||||++|+|++|..||...+.......+......   .+..++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS  249 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence             11233457999999999983     667899999999999999999999999988887777766655432   233445


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHH
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  388 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~  388 (447)
                      .++.+      ||.+||..||.+||     +++++++||||.++.|....
T Consensus       250 ~~l~~------li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  288 (302)
T 2j7t_A          250 VEFRD------FLKIALDKNPETRP-----SAAQLLEHPFVSSITSNKAL  288 (302)
T ss_dssp             HHHHH------HHHHHSCSCTTTSC-----CHHHHTTSTTTTTCCCCHHH
T ss_pred             HHHHH------HHHHHcccChhhCC-----CHHHHhcChHHhhhccchhH
Confidence            55544      45569999999999     88999999999999887644

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.8e-48  Score=376.79  Aligned_cols=260  Identities=26%  Similarity=0.395  Sum_probs=215.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEE-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ-  185 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~-  185 (447)
                      ++|++++.||+|+||.||+|++..    .+++.||||++...... ......+.+|+.+++.+   +||||+++++++. 
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             hceeeeeeecccccEEEEEEEecC----CCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            589999999999999999999852    16788999999764321 11122355677777666   8999999999987 


Q ss_pred             ----eCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          186 ----TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       186 ----~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                          ....+++||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence                5568999999997 59999998754  4999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-----C--
Q 013249          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----K--  332 (447)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-----~--  332 (447)
                      |+++............||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....     .  
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            999876654445567899999999999999999999999999999999999999999888877777664211     0  


Q ss_pred             --------------------CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          333 --------------------LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       333 --------------------~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                                          ++..++.++      .+||.+||..||.+||     +++++++||||+++++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELG------KDLLLKCLTFNPAKRI-----SAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHH------HHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTCCCCC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHH------HHHHHHHcCCCcccCC-----CHHHHhcCccccccchhh
Confidence                                112233333      3566779999999999     889999999999887643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.9e-48  Score=382.89  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=211.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|.+.+.||+|+||.||+|+++.     +++.||||++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS  115 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccEEEEeEEecCCCeEEEEEEECC-----CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence            589999999999999999999886     78899999997643 234455678899999999999999999999987765


Q ss_pred             E------EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          190 L------YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       190 ~------~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .      |+||||+. ++|...+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       116 ~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             STTCCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             cccceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            4      99999997 5787776  3459999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---------
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---------  333 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~---------  333 (447)
                      ....  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......         
T Consensus       193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          193 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             cccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            7644  2345689999999999987 788999999999999999999999999988877777665422111         


Q ss_pred             ----------------------CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          334 ----------------------PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       334 ----------------------p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                                            ++..+.++      .+||.+||+.||++||     +++++++||||+.+....
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~  334 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQA------ADLLEKMLELDVDKRL-----TAAQALTHPFFEPFRDPE  334 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHH------HHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHH------HHHHHHHCCCChhhcC-----CHHHHhcCcccccCCCcc
Confidence                                  11223333      4566779999999999     889999999999776544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.2e-48  Score=378.48  Aligned_cols=273  Identities=23%  Similarity=0.348  Sum_probs=201.6

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++.+.||+|+||.||+|+++...  .....||||++..... .....+.+.+|+.++++++||||+++++++
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQED--GSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccC--CcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            4466779999999999999999999877521  1223799999976543 334466788999999999999999999999


Q ss_pred             EeCCEE------EEEEeccCCCChHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC
Q 013249          185 QTRSKL------YLILDFINGGHLFFHLYRQG------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       185 ~~~~~~------~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  252 (447)
                      ......      |+||||+.+|+|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            877655      99999999999999986543      599999999999999999999999999999999999999999


Q ss_pred             cEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHh
Q 013249          253 HVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN  328 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~  328 (447)
                      .+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            999999999987644322   223456788999999999999999999999999999999 9999998888887777766


Q ss_pred             cc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCC-------hhhhhcCCccCCCChhHHHhhh
Q 013249          329 EK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGG-------VDAIKHHKWFRSINWKTLEARE  391 (447)
Q Consensus       329 ~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~-------~~~l~~h~~f~~~~~~~~~~~~  391 (447)
                      .. ...+..++.++.+++.      +||+.||.+||     +       +++++.|+|+.+..+..+....
T Consensus       255 ~~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~~l~~~l~~~l~~~~~~~~~~~pl~~~~  314 (323)
T 3qup_A          255 GNRLKQPPECMEEVYDLMY------QCWSADPKQRP-----SFTCLRMELENILGHLSVLSTSQDPLYINI  314 (323)
T ss_dssp             TCCCCCCTTCCHHHHHHHH------HTTCSSGGGSC-----CHHHHHHHHHHHHHC---------------
T ss_pred             CCCCCCCCccCHHHHHHHH------HHccCChhhCc-----CHHHHHHHHHHHHHHhhhcCCCCCCCCCCC
Confidence            53 4556677777666555      59999999999     6       7889999999887766665433

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.5e-48  Score=379.84  Aligned_cols=272  Identities=22%  Similarity=0.383  Sum_probs=217.1

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC------ceeee
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF------IVQLR  181 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l~  181 (447)
                      ..++|++.+.||+|+||.||+|+++..    .++.||+|+++..    ....+.+.+|+.+++.++|++      ++.++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHAR----GKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCC----CceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            346899999999999999999998751    3368999999753    233456778999999987655      89999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc-----------
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-----------  248 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl-----------  248 (447)
                      +++...+.+|+||||+ +++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+||||           
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence            9999999999999999 667777776653  69999999999999999999999999999999999999           


Q ss_pred             --------CCCCcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH
Q 013249          249 --------DSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ  320 (447)
Q Consensus       249 --------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~  320 (447)
                              +.++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                    5678999999999987544  234568999999999999999999999999999999999999999988877


Q ss_pred             HHHHHHHhcccCCCCCC--------------------chhHH------------------hhhhhhhHHhhhccCCCCCC
Q 013249          321 KLQQRIINEKVKLPPFL--------------------TSEAH------------------SLLKGVSFLTQLLHKDPSKR  362 (447)
Q Consensus       321 ~~~~~i~~~~~~~p~~~--------------------~~~~~------------------~li~~~~~l~~~L~~dP~~R  362 (447)
                      +....+......+|...                    .....                  ......+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            66655544332222110                    00000                  00123478888999999999


Q ss_pred             CCCCCCChhhhhcCCccCCCChhHHHhhhcCCC
Q 013249          363 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK  395 (447)
Q Consensus       363 ~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~  395 (447)
                      |     +++++++||||.+++|+....+..+.|
T Consensus       326 p-----t~~e~l~hp~f~~~~~~~~~~~~~~~p  353 (355)
T 2eu9_A          326 I-----TLAEALLHPFFAGLTPEERSFHTSRNP  353 (355)
T ss_dssp             C-----CHHHHTTSGGGGGCCHHHHC-------
T ss_pred             c-----CHHHHhcChhhcCCChhhccccccCCC
Confidence            9     889999999999999987765554443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-47  Score=367.04  Aligned_cols=250  Identities=22%  Similarity=0.358  Sum_probs=208.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||||++...... ......+.+|+.++..+ +||||+++++++.+.+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRL-----DGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             chhhhhhhhcCCCceEEEEEEEcC-----CCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            379999999999999999999876     7889999999865432 23345677899999999 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC-------------
Q 013249          189 KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-------------  251 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-------------  251 (447)
                      .+|+||||++|++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.+             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999999999765    679999999999999999999999999999999999999854             


Q ss_pred             ------CcEEEeecCCcccccCCCCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHH
Q 013249          252 ------GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ  324 (447)
Q Consensus       252 ------~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~  324 (447)
                            ..+||+|||++......   ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++.....   ..
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~  238 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WH  238 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HH
T ss_pred             cccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HH
Confidence                  47999999999876543   234699999999999875 566899999999999999999988755422   33


Q ss_pred             HHHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          325 RIINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       325 ~i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .+.... ..+|..++.++.+++..      ||+.||.+||     +++++++||||.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~------~l~~dp~~Rp-----s~~~ll~h~~~~~~  286 (289)
T 1x8b_A          239 EIRQGRLPRIPQVLSQEFTELLKV------MIHPDPERRP-----SAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHTTCCCCCSSCCCHHHHHHHHH------HTCSSGGGSC-----CHHHHHTCTTC---
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHH------HhCCCcccCC-----CHHHHhhChHhhhh
Confidence            343333 34566777777666555      9999999999     88999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=371.39  Aligned_cols=263  Identities=25%  Similarity=0.465  Sum_probs=218.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ...++|++++.||+|+||.||+|.++.     +++.||||++....     ..+.+.+|+.+++.++||||+++++++..
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   95 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKE-----TGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFK   95 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETT-----TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECC-----CCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence            345689999999999999999999875     78899999997642     23457889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+.+|+||||+.+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A           96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            999999999999999999987 4568999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCchhH
Q 013249          266 DESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEA  341 (447)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~  341 (447)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....   ..+..++.++
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  255 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF  255 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence            5432 23456799999999999999999999999999999999999999998877666555544322   1233445555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhh
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR  390 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~  390 (447)
                      .+      ||.+||..||.+||     +++++++||||.+..+......
T Consensus       256 ~~------li~~~l~~dp~~Rp-----t~~~ll~~~~~~~~~~~~~~~~  293 (314)
T 3com_A          256 TD------FVKQCLVKSPEQRA-----TATQLLQHPFVRSAKGVSILRD  293 (314)
T ss_dssp             HH------HHHHHTCSCTTTSC-----CHHHHTTSHHHHTCCCGGGGHH
T ss_pred             HH------HHHHHccCChhhCc-----CHHHHHhCHHHhcCCcchHHHH
Confidence            54      45569999999999     8999999999998877665443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.8e-48  Score=381.49  Aligned_cols=259  Identities=24%  Similarity=0.398  Sum_probs=205.2

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--------cchhHHHHHHHHHHHHHhcCCCCce
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--------IKKNHVDYMKAERDILTKVTHPFIV  178 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv  178 (447)
                      ...++|++.+.||+|+||.||+|.+.      .++.||||++.....        ......+.+.+|+.+|++++||||+
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDS------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECT------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HhccceEEeEEeccCCCEEEEEEECC------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            34578999999999999999999864      578899999865422        1223346788999999999999999


Q ss_pred             eeeEEEEe-----CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC
Q 013249          179 QLRYSFQT-----RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       179 ~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  252 (447)
                      ++++++..     ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  171 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN  171 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence            99999954     347999999997 5777777654 4799999999999999999999999999999999999999999


Q ss_pred             cEEEeecCCcccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc
Q 013249          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV  331 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~  331 (447)
                      .+||+|||+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (362)
T 3pg1_A          172 DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG  251 (362)
T ss_dssp             CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            999999999987665555666789999999999987 6789999999999999999999999999888777776654211


Q ss_pred             CC--------------------------------CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 KL--------------------------------PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ~~--------------------------------p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ..                                ++..+..+      .+||.+||+.||.+||     +++++++||||
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~Rp-----t~~ell~hp~f  320 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVA------LDLIAKMLEFNPQRRI-----STEQALRHPYF  320 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHH------HHHHHHHTCSSGGGSC-----CHHHHHTSGGG
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHH------HHHHHHHhcCChhhCC-----CHHHHHcCchh
Confidence            10                                11122222      4567779999999999     88999999999


Q ss_pred             CCCC
Q 013249          380 RSIN  383 (447)
Q Consensus       380 ~~~~  383 (447)
                      +++.
T Consensus       321 ~~~~  324 (362)
T 3pg1_A          321 ESLF  324 (362)
T ss_dssp             TTTC
T ss_pred             hhcc
Confidence            8763

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=387.33  Aligned_cols=263  Identities=20%  Similarity=0.332  Sum_probs=221.5

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|+++++||+|+||+||+|++++..+..+++.||||++....  .......+.+|+.++++++||||+++++++.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            35567899999999999999999997765444578899999996532  3344456788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC---cEE
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVM  255 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~~k  255 (447)
                      +....|+||||+.||+|.+++...+       .+++.+++.++.||+.||.|||++||+||||||+||||+.+|   .+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999998653       489999999999999999999999999999999999999655   599


Q ss_pred             EeecCCcccccC---CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-
Q 013249          256 LTDFGLAKEIDE---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-  330 (447)
Q Consensus       256 L~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-  330 (447)
                      |+|||+++....   ........||+.|+|||++.+..++.++|||||||++|||++ |..||...+..++...+.... 
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999986522   223345678999999999999999999999999999999998 999999999988888877654 


Q ss_pred             cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          331 VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       331 ~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ...+..++.++.+++.      +||+.||.+||     ++++|++|.++-.
T Consensus       305 ~~~~~~~~~~l~~li~------~~l~~dP~~Rp-----s~~eil~~l~~~~  344 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMT------QCWQHQPEDRP-----NFAIILERIEYCT  344 (367)
T ss_dssp             CCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHH------HHcCCCHhHCc-----CHHHHHHHHHHHh
Confidence            3455667777665554      59999999999     8899999877643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-47  Score=375.74  Aligned_cols=261  Identities=25%  Similarity=0.441  Sum_probs=214.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC------Cceee
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP------FIVQL  180 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp------nIv~l  180 (447)
                      +..++|++.+.||+|+||.||+|.+..    .+++.||||++...    ....+.+.+|+.+++.++|+      +|+++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHK----AGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecC----CCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            345689999999999999999998843    26789999999753    23445678899999988765      49999


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC--------
Q 013249          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--------  250 (447)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~--------  250 (447)
                      ++++...+.+|+||||+ +++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.        
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 889999998775  6899999999999999999999999999999999999987        


Q ss_pred             -----------CCcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH
Q 013249          251 -----------DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR  319 (447)
Q Consensus       251 -----------~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~  319 (447)
                                 ++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             CccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                       67899999999987544  23456899999999999999999999999999999999999999998887


Q ss_pred             HHHHHHHHhcccCCCCCC--------------------chhH------------------HhhhhhhhHHhhhccCCCCC
Q 013249          320 QKLQQRIINEKVKLPPFL--------------------TSEA------------------HSLLKGVSFLTQLLHKDPSK  361 (447)
Q Consensus       320 ~~~~~~i~~~~~~~p~~~--------------------~~~~------------------~~li~~~~~l~~~L~~dP~~  361 (447)
                      .+....+......+|...                    ....                  ...-...+||.+||+.||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            776655544332222110                    0000                  00011247888899999999


Q ss_pred             CCCCCCCChhhhhcCCccCCCC
Q 013249          362 RLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       362 R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      ||     +++++++||||+.+.
T Consensus       320 Rp-----t~~ell~hp~f~~~~  336 (339)
T 1z57_A          320 RI-----TLREALKHPFFDLLK  336 (339)
T ss_dssp             SC-----CHHHHTTSGGGGGGG
T ss_pred             cc-----CHHHHhcCHHHHHHh
Confidence            99     899999999998653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-48  Score=376.93  Aligned_cols=266  Identities=26%  Similarity=0.446  Sum_probs=195.0

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++.+.||+|+||.||+|+++.     +++.||||++.....  ....+.+.+|+.++++++||||+++++++
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAP-----KKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC------------------CCCCCCCTTBCCEEEEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECC-----CCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            44667899999999999999999998765     778999999875432  23445678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEE
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYR--------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL  256 (447)
                      ...+.+|+||||++|++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence            999999999999999999999874        456999999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCC------CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 013249          257 TDFGLAKEIDESS------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE  329 (447)
Q Consensus       257 ~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~  329 (447)
                      +|||++.......      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+...........
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  242 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN  242 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence            9999987654321      2234579999999999976 56899999999999999999999999887766555444433


Q ss_pred             ccC----------CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHH
Q 013249          330 KVK----------LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  388 (447)
Q Consensus       330 ~~~----------~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~  388 (447)
                      ...          ....++.++.      +||.+||+.||.+||     +++++++||||.+..+..+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~------~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  300 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFR------KMISLCLQKDPEKRP-----TAAELLRHKFFQKAKNKEFL  300 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHH------HHHHHHCCSSGGGSC-----CHHHHHTSTTC---------
T ss_pred             CCCccccccccchhhhhhhHHHH------HHHHHHccCChhhCc-----CHHHHhhChhhhcCCCCccc
Confidence            221          1123344444      456669999999999     88999999999988766554

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.9e-47  Score=380.03  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=213.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CC-----CceeeeE
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP-----FIVQLRY  182 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp-----nIv~l~~  182 (447)
                      .++|++.++||+|+||+||+|+++.     +++.||||+++..    ......+..|+.+++.++ |+     +|+++++
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRV-----EQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcC-----CCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            5689999999999999999999876     7889999999753    233456778899988885 44     4999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCcccC--CCCcEEE
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMD--SDGHVML  256 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~iiHrDikp~NILl~--~~~~~kL  256 (447)
                      ++...+.+|+||||+. ++|.+++...  +.+++..++.++.||+.||.|||  ++||+||||||+||||+  .++.+||
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            9999999999999996 5999999876  46999999999999999999999  57999999999999994  5788999


Q ss_pred             eecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 013249          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF  336 (447)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~  336 (447)
                      +|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......|..
T Consensus       203 ~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          203 VDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             EeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99999987754  3445789999999999999999999999999999999999999999998888777776532211100


Q ss_pred             -----------------------------------CchhHHh-----------------------hhhhhhHHhhhccCC
Q 013249          337 -----------------------------------LTSEAHS-----------------------LLKGVSFLTQLLHKD  358 (447)
Q Consensus       337 -----------------------------------~~~~~~~-----------------------li~~~~~l~~~L~~d  358 (447)
                                                         ....+..                       ....++||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                                               0000000                       013357899999999


Q ss_pred             CCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          359 PSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       359 P~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      |++||     +++++++||||+...+
T Consensus       361 P~~Rp-----ta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          361 PKTRI-----QPYYALQHSFFKKTAD  381 (382)
T ss_dssp             TTTSC-----CHHHHTTSGGGCC---
T ss_pred             hhhCC-----CHHHHhcCcccccCCC
Confidence            99999     8999999999987544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.5e-48  Score=369.26  Aligned_cols=256  Identities=25%  Similarity=0.509  Sum_probs=220.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (447)
                      .++|++++.||+|+||.||+|+++.     +++.||+|++..... .....+.+.+|+.++++++||||+++++++..  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECC-----CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            3589999999999999999999886     788999999986543 34456678899999999999999999998854  


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCcccCCCCcEEEe
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~-----iiHrDikp~NILl~~~~~~kL~  257 (447)
                      ...+|+||||++|++|.+++...    ..+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            67899999999999999998754    34999999999999999999999999     9999999999999999999999


Q ss_pred             ecCCcccccCCCC-CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCC
Q 013249          258 DFGLAKEIDESSR-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPP  335 (447)
Q Consensus       258 DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~  335 (447)
                      |||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..++...+..+.. .+|.
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY  238 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence            9999987654322 2345789999999999998999999999999999999999999999888888888877655 4566


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      .++.++.+++.      +||+.||.+||     ++++|++|+|+..
T Consensus       239 ~~~~~l~~li~------~~l~~~p~~Rp-----s~~~ll~~~~~~~  273 (279)
T 2w5a_A          239 RYSDELNEIIT------RMLNLKDYHRP-----SVEEILENPLILE  273 (279)
T ss_dssp             TSCHHHHHHHH------HHTCSSGGGSC-----CHHHHHTSTTCCG
T ss_pred             ccCHHHHHHHH------HHcCCCcccCC-----CHHHHHhChhhhh
Confidence            67777766655      49999999999     8999999999964

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.6e-48  Score=386.74  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=205.6

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC--------CCCcee
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--------HPFIVQ  179 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--------hpnIv~  179 (447)
                      ..++|+++++||+|+||+||+|+++.     +++.||||++...    ....+.+.+|+.+|+.++        |+||++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQ-----GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecC-----CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            35789999999999999999999876     7889999999753    234456788999999985        788999


Q ss_pred             eeEEEE----eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCC
Q 013249          180 LRYSFQ----TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDG  252 (447)
Q Consensus       180 l~~~~~----~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~  252 (447)
                      +++++.    ....+|+||||+ +++|.+.+...  +.+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            999998    556899999999 56666666554  5699999999999999999999998 999999999999999776


Q ss_pred             -------------------------------------------------cEEEeecCCcccccCCCCCCccccCCccccc
Q 013249          253 -------------------------------------------------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP  283 (447)
Q Consensus       253 -------------------------------------------------~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aP  283 (447)
                                                                       .+||+|||+++.....  ....+||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP  262 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence                                                             7999999999876543  3456899999999


Q ss_pred             ccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC------HHHHHHHHHhcccCCCCC---------------------
Q 013249          284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN------RQKLQQRIINEKVKLPPF---------------------  336 (447)
Q Consensus       284 E~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~------~~~~~~~i~~~~~~~p~~---------------------  336 (447)
                      |++.+..++.++|||||||++|||++|+.||...+      .......+.......|..                     
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            99999999999999999999999999999997644      223333332211111100                     


Q ss_pred             -----------------CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          337 -----------------LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       337 -----------------~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                                       .....  .-...+||.+||+.||++||     +++++++||||++
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~  397 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEE--AAGFTDFLLPMLELIPEKRA-----TAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHH--HHHHHHHHGGGGCSSGGGSC-----CHHHHHTSGGGGC
T ss_pred             cccCCcchhHhhhhhcccchhh--HHHHHHHHHHHhccChhhcC-----CHHHHhhCccccC
Confidence                             00110  11234678889999999999     8999999999964

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4e-47  Score=367.41  Aligned_cols=253  Identities=26%  Similarity=0.499  Sum_probs=221.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      +.|++++.||+|+||.||+|+++.     +++.||||++.....  ....+.+.+|+.+++.++||||+++++++.....
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECC-----CCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            369999999999999999999876     788999999976542  3445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +|+||||+.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999999998854 679999999999999999999999999999999999999999999999999998765432


Q ss_pred             -CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCCCchhHHhhhhh
Q 013249          270 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLKG  347 (447)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~  347 (447)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++..++.++.+++. 
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~-  252 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE-  252 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH-
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH-
Confidence             23456799999999999999999999999999999999999999998888777766655432 345566766666555 


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                           +||..||.+||     +++++++||||..
T Consensus       253 -----~~l~~dp~~Rp-----s~~~ll~~~~~~~  276 (303)
T 3a7i_A          253 -----ACLNKEPSFRP-----TAKELLKHKFILR  276 (303)
T ss_dssp             -----HHCCSSGGGSC-----CHHHHTTCHHHHH
T ss_pred             -----HHcCCChhhCc-----CHHHHhhChhhhc
Confidence                 59999999999     8999999999964

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-47  Score=370.48  Aligned_cols=262  Identities=26%  Similarity=0.460  Sum_probs=214.1

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  185 (447)
                      ...++|++++.||+|+||.||+|++..     +++.||||++....    ...+.+.+|+.+++++ +||||+++++++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECC-----CCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            345689999999999999999999876     78899999997543    2234678899999999 7999999999998


Q ss_pred             e------CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEe
Q 013249          186 T------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       186 ~------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~  257 (447)
                      .      ...+|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence            7      56899999999999999999865  579999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCC-CCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc
Q 013249          258 DFGLAKEIDESS-RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV  331 (447)
Q Consensus       258 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~  331 (447)
                      |||++....... ......||+.|+|||++.     +..++.++|||||||++|+|++|..||...+.......+.....
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  251 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA  251 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence            999998764322 234567999999999997     56689999999999999999999999998887776666655432


Q ss_pred             C--CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHH
Q 013249          332 K--LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  388 (447)
Q Consensus       332 ~--~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~  388 (447)
                      .  .+..++.++.++      |.+||..||.+||     +++++++||||++..+....
T Consensus       252 ~~~~~~~~~~~l~~l------i~~~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~~~  299 (326)
T 2x7f_A          252 PRLKSKKWSKKFQSF------IESCLVKNHSQRP-----ATEQLMKHPFIRDQPNERQV  299 (326)
T ss_dssp             CCCSCSCSCHHHHHH------HHHHCCSSGGGSC-----CHHHHHTSHHHHCCTTHHHH
T ss_pred             ccCCccccCHHHHHH------HHHHhccChhhCC-----CHHHHhhChHHhhCccccce
Confidence            2  123455665555      5559999999999     88999999999988776543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5e-49  Score=392.17  Aligned_cols=259  Identities=15%  Similarity=0.213  Sum_probs=196.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc--CCCCceeee------
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV--THPFIVQLR------  181 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~------  181 (447)
                      .+|++.++||+|+||.||+|+++.     +++.||||++...........+.+.+|+.+++.+  +||||++++      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p  136 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE-----RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP  136 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC-----CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence            359999999999999999999876     7889999999986654556667788885555444  699988755      


Q ss_pred             -EEEEeC-----------------CEEEEEEeccCCCChHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHHCCc
Q 013249          182 -YSFQTR-----------------SKLYLILDFINGGHLFFHLYRQ-GIFREDQA------RFYTAEIVSAVSHLHKCGI  236 (447)
Q Consensus       182 -~~~~~~-----------------~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~------~~i~~qi~~aL~~LH~~~i  236 (447)
                       +++...                 ..+|+||||+. |+|.+++... ..+.+...      ..++.||+.||.|||++||
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence             555433                 34899999998 8999999864 33444444      5777999999999999999


Q ss_pred             eeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCC
Q 013249          237 VHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF  314 (447)
Q Consensus       237 iHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf  314 (447)
                      +||||||+||||+.+|.+||+|||+++.....  .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999876432  224567799999999987  78999999999999999999999999


Q ss_pred             CCCCHHHH--HHH-----HHhcccCCC--CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          315 THANRQKL--QQR-----IINEKVKLP--PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       315 ~~~~~~~~--~~~-----i~~~~~~~p--~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      ........  ...     .......++  ..++.++.++      |.+||+.||++||     +++++++||||+++.|.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------i~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL------IGRFLNFDRRRRL-----LPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHH------HHHHTCSSTTTCC-----CHHHHTTSHHHHHHHHH
T ss_pred             CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHH------HHHHcCCChhhCC-----CHHHHhcCHHHHHHHHH
Confidence            76533210  000     001112222  3455665555      5559999999999     88999999999998876


Q ss_pred             HH
Q 013249          386 TL  387 (447)
Q Consensus       386 ~~  387 (447)
                      .-
T Consensus       363 ~~  364 (371)
T 3q60_A          363 IS  364 (371)
T ss_dssp             HH
T ss_pred             Hh
Confidence            54

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=374.32  Aligned_cols=255  Identities=22%  Similarity=0.355  Sum_probs=216.4

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.++||+|+||.||+|+++...  ..+..||||++....  .....+.+.+|+.+|++++||||+++++++.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPG--QRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTT--SCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCC--CCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            455678999999999999999999987532  245679999997542  3445567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +.+.+|+||||++||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999999999755 6799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      ......    .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..++...+... ....+..++
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            644321    223346778999999998999999999999999999999 99999999888888877765 344566677


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++.+++.      +||..||.+||     ++++|++
T Consensus       281 ~~l~~li~------~~l~~dp~~Rp-----s~~eil~  306 (325)
T 3kul_A          281 HALHQLML------DCWHKDRAQRP-----RFSQIVS  306 (325)
T ss_dssp             HHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHH------HHccCChhhCc-----CHHHHHH
Confidence            77766655      49999999999     7888886

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-47  Score=376.06  Aligned_cols=258  Identities=21%  Similarity=0.362  Sum_probs=222.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++++.||+|+||.||+|++++.....+++.||||+++...  .....+.+.+|+.++++++||||+++++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            456667999999999999999999999865444467899999997653  344556789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (447)
                      .+.+.+|+||||+++|+|.+++...                        ..+++.+++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999874                        5689999999999999999999999999999


Q ss_pred             CCCCCcccCCCCcEEEeecCCcccccCC---CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCC
Q 013249          241 LKPENILMDSDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH  316 (447)
Q Consensus       241 ikp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~  316 (447)
                      |||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            9999999999999999999999875432   12334568899999999999899999999999999999999 9999999


Q ss_pred             CCHHHHHHHHHhccc-CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          317 ANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       317 ~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+..++...+..+.. .+|..++.++.+++.      +||..||.+||     +++++++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~------~~l~~~p~~Rp-----s~~~~~~  328 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMR------LCWSKLPADRP-----SFCSIHR  328 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHH------HHcccCcccCC-----CHHHHHH
Confidence            988888888776654 456677777666655      49999999999     7888876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.4e-48  Score=381.28  Aligned_cols=260  Identities=23%  Similarity=0.420  Sum_probs=217.3

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (447)
                      .+.+..++|++.+.||+|+||.||+|++.+..+..+++.||||++....  .....+.+.+|+.+|+++ +||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            3456678999999999999999999998765555678999999997643  334456788999999999 7899999999


Q ss_pred             EEEeCC-EEEEEEeccCCCChHHHHHHcCC--------------------------------------------------
Q 013249          183 SFQTRS-KLYLILDFINGGHLFFHLYRQGI--------------------------------------------------  211 (447)
Q Consensus       183 ~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~--------------------------------------------------  211 (447)
                      ++...+ .+|+||||+.||+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998755 49999999999999999986543                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC---CCC
Q 013249          212 ----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSN  272 (447)
Q Consensus       212 ----------------~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~---~~~  272 (447)
                                      +++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......   ...
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                            8999999999999999999999999999999999999999999999999998764332   233


Q ss_pred             ccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHH-HHHHhc-ccCCCCCCchhHHhhhhhhh
Q 013249          273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQ-QRIINE-KVKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       273 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~-~~i~~~-~~~~p~~~~~~~~~li~~~~  349 (447)
                      ...||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.. ..+... ....|...+.++.+++.   
T Consensus       254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---  330 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML---  330 (359)
T ss_dssp             -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH---
T ss_pred             ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH---
Confidence            4578999999999999999999999999999999998 99999876544333 333332 34566677777766655   


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                         +||+.||.+||     +++++++|
T Consensus       331 ---~~l~~dP~~Rp-----s~~ell~~  349 (359)
T 3vhe_A          331 ---DCWHGEPSQRP-----TFSELVEH  349 (359)
T ss_dssp             ---HHTCSSGGGSC-----CHHHHHHH
T ss_pred             ---HHccCChhhCC-----CHHHHHHH
Confidence               49999999999     78999876

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.3e-47  Score=375.70  Aligned_cols=258  Identities=26%  Similarity=0.432  Sum_probs=212.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++....  .......+.+|+.+|+.++||||+++++++... 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKP-----TGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECC-----CCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            4689999999999999999999876     78899999996432  344455678899999999999999999988754 


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                          ..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence                67999999997 589888876 579999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC-----------CCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc
Q 013249          264 EIDESSR-----------SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV  331 (447)
Q Consensus       264 ~~~~~~~-----------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~  331 (447)
                      .......           ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            7643211           223578999999998764 6789999999999999999999999998887766555543211


Q ss_pred             CCC--------------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 KLP--------------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ~~p--------------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      ..+                                +.++.++      .+||.+||+.||++||     +++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~li~~~L~~dP~~Rp-----t~~ell~hp~~  309 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKG------IDLLQRMLVFDPAKRI-----TAKEALEHPYL  309 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH------HHHHHHHSCSSGGGSC-----CHHHHHTSGGG
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHH------HHHHHHhcCcCcccCC-----CHHHHhcCccc
Confidence            100                                1223333      3567779999999999     88999999999


Q ss_pred             CCCChhH
Q 013249          380 RSINWKT  386 (447)
Q Consensus       380 ~~~~~~~  386 (447)
                      +...+..
T Consensus       310 ~~~~~~~  316 (353)
T 2b9h_A          310 QTYHDPN  316 (353)
T ss_dssp             TTTCCTT
T ss_pred             cccCCcc
Confidence            9876543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.8e-48  Score=376.75  Aligned_cols=270  Identities=29%  Similarity=0.475  Sum_probs=224.8

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhcC--CCCceee
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVT--HPFIVQL  180 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~--hpnIv~l  180 (447)
                      ....++|++.++||+|+||.||+|+++.     +++.||||++........   ...+.+.+|+.++++++  |+||+++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETT-----TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            3456789999999999999999999876     788999999987643221   11234667999999996  5999999


Q ss_pred             eEEEEeCCEEEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC-CCCcEEEee
Q 013249          181 RYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTD  258 (447)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~~kL~D  258 (447)
                      ++++...+.+++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999999999986 89999999889999999999999999999999999999999999999999 789999999


Q ss_pred             cCCcccccCCCCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 013249          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL  337 (447)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~  337 (447)
                      ||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...      ..+......++..+
T Consensus       194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~  266 (320)
T 3a99_A          194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRV  266 (320)
T ss_dssp             CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCC
T ss_pred             Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhhcccccccccC
Confidence            9999876543 3345679999999999987665 68899999999999999999999753      23445566677778


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCC
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  398 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p  398 (447)
                      +.++.+++..      ||+.||++||     ++++|++||||+++.+...........+.|
T Consensus       267 ~~~~~~li~~------~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~~~~~~~~~~~~p  316 (320)
T 3a99_A          267 SSECQHLIRW------CLALRPSDRP-----TFEEIQNHPWMQDVLLPQETAEIHLHSLSP  316 (320)
T ss_dssp             CHHHHHHHHH------HTCSSGGGSC-----CHHHHHTSGGGSSCCCHHHHHHHHTC----
T ss_pred             CHHHHHHHHH------HccCChhhCc-----CHHHHhcCHhhcCccCccccccccccccCC
Confidence            8877766554      9999999999     899999999999987766554444444433

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-47  Score=367.56  Aligned_cols=263  Identities=28%  Similarity=0.525  Sum_probs=212.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (447)
                      ++|++++.||+|+||.||+|+++.     +++.||||++...    ....+.+.+|+.++++++||||+++++++.+   
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNAL-----DSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             ccchhhheeccCCcEEEEEEEEcC-----CCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            379999999999999999999876     7889999999653    3345678899999999999999999998865   


Q ss_pred             ----------CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEE
Q 013249          187 ----------RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       187 ----------~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~k  255 (447)
                                ...+|+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence                      457899999999999999998654 578999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCC---------------CCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCC-CC
Q 013249          256 LTDFGLAKEIDES---------------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTH-AN  318 (447)
Q Consensus       256 L~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~-~~  318 (447)
                      |+|||+++.....               .......||+.|+|||++.+. .++.++|||||||++|+|++   ||.. .+
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            9999999875421               123356799999999999865 68999999999999999998   5543 33


Q ss_pred             HHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhh
Q 013249          319 RQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE  391 (447)
Q Consensus       319 ~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~  391 (447)
                      .......+......+|..........  ..+||.+||+.||.+||     +++++++||||....++....+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~~~~  299 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFPPDFDDNKMKV--EKKIIRLLIDHDPNKRP-----GARTLLNSGWLPVKHQDEVIKEA  299 (303)
T ss_dssp             HHHHHHHHHSTTCCCCTTCCTTTSHH--HHHHHHHHTCSSGGGSC-----CHHHHHHSSCSCCCCHHHHHHHH
T ss_pred             HHHHHHhccccccccCccccccchHH--HHHHHHHHHhcCcccCc-----CHHHHhCCCCcCCCChHHHHHHH
Confidence            44555666655556665544332111  13466679999999999     89999999999998888776544

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-47  Score=373.26  Aligned_cols=244  Identities=21%  Similarity=0.297  Sum_probs=205.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++......     +.+.+|+.+++.+ +||||+++++++...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLY-----TNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETT-----TTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             cCCeEEEEEeeccCCceEEEEEECC-----CCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            4689999999999999999999876     7899999998754321     2477899999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc-----EEEeecCC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDFGL  261 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~-----~kL~DFG~  261 (447)
                      ...|+||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             CccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            9999999999 99999999874 68999999999999999999999999999999999999999887     99999999


Q ss_pred             cccccCCCC--------CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCC---CCHHHHHHHHHhcc
Q 013249          262 AKEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEK  330 (447)
Q Consensus       262 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~---~~~~~~~~~i~~~~  330 (447)
                      ++.+.....        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+   .+..+....+....
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            987643322        2467899999999999999999999999999999999999999987   34455556665544


Q ss_pred             cCCCC-----CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          331 VKLPP-----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       331 ~~~p~-----~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ...+.     ..+ ++      .+||.+||..||.+||     ++++|++
T Consensus       237 ~~~~~~~~~~~~p-~~------~~li~~~l~~~p~~RP-----~~~~l~~  274 (330)
T 2izr_A          237 RATPIEVLCENFP-EM------ATYLRYVRRLDFFEKP-----DYDYLRK  274 (330)
T ss_dssp             HHSCHHHHTTTCH-HH------HHHHHHHHHCCTTCCC-----CHHHHHH
T ss_pred             ccCCHHHHhccCh-HH------HHHHHHHHhCCCCCCC-----CHHHHHH
Confidence            43332     122 33      4456669999999999     6677655

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-47  Score=379.53  Aligned_cols=254  Identities=27%  Similarity=0.395  Sum_probs=199.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      ++|++.++||+|+||.||+|+++.     +++.||||++.......    ....+|+..++.++||||++++++|...+ 
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKS-----TGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             TTEEEC----------CEEEEETT-----TCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             cceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            589999999999999999999886     78899999986643222    23556788889999999999999997643 


Q ss_pred             ------EEEEEEeccCCCChHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCcccCC-CCcEE
Q 013249          189 ------KLYLILDFINGGHLFFHL----YRQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDS-DGHVM  255 (447)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~iiHrDikp~NILl~~-~~~~k  255 (447)
                            .+|+||||+.++ |...+    .....+++..++.++.||+.||.|||  ++||+||||||+||||+. ++.+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  389999999875 43333    34567999999999999999999999  999999999999999997 89999


Q ss_pred             EeecCCcccccCCCCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC
Q 013249          256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP  334 (447)
Q Consensus       256 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p  334 (447)
                      |+|||+++...........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.......+
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            9999999987766666677899999999999765 489999999999999999999999999888877777664321110


Q ss_pred             --------------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 --------------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 --------------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                                      ...+.+      ..+||.+||+.||.+||     +++++++||||+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~  321 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKE------AYDLLSALLQYLPEERM-----KPYEALCHPYFDEL  321 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHH------HHHHHHHHTCSSGGGSC-----CHHHHTTSGGGGGG
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHH------HHHHHHHHhccCccccC-----CHHHHhcCcccccc
Confidence                                            001222      34677779999999999     88999999999876


Q ss_pred             Ch
Q 013249          383 NW  384 (447)
Q Consensus       383 ~~  384 (447)
                      .+
T Consensus       322 ~~  323 (360)
T 3e3p_A          322 HD  323 (360)
T ss_dssp             GC
T ss_pred             CC
Confidence            43

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-47  Score=362.41  Aligned_cols=251  Identities=20%  Similarity=0.402  Sum_probs=217.0

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.+.||+|+||.||+|++.      .++.||+|++......    .+.+.+|+.++++++||||+++++++
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~   74 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVC   74 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec------CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4566779999999999999999999986      4567999999865422    24578999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .+.+.+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           75 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence            9999999999999999999999754 568999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCch
Q 013249          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~  339 (447)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... ....|...+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T 4hcu_A          155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  234 (269)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence            654321  2234567888999999998999999999999999999999 99999999988888887765 3344556677


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ++.+++.      +||+.||++||     +++++++|
T Consensus       235 ~~~~li~------~~l~~~p~~Rp-----s~~~ll~~  260 (269)
T 4hcu_A          235 HVYQIMN------HCWRERPEDRP-----AFSRLLRQ  260 (269)
T ss_dssp             HHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHH------HHccCCcccCc-----CHHHHHHH
Confidence            6666555      59999999999     78999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=378.84  Aligned_cols=258  Identities=22%  Similarity=0.407  Sum_probs=222.1

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (447)
                      .+..++|++.++||+|+||.||+|++.+...  ...+..||||++....  .....+.+.+|+++++++ +||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            4556789999999999999999999875432  1345679999997652  344556788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCc
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NI  246 (447)
                      ++...+.+|+||||+.+|+|.+++....                .+++.+++.++.||+.||.|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998754                489999999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHH
Q 013249          247 LMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  322 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~  322 (447)
                      ||+.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998764432   2334567889999999999999999999999999999999 9999999988888


Q ss_pred             HHHHHhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          323 QQRIINE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       323 ~~~i~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ...+... ....+..++.++.+++.      +||+.||++||     ++++++++
T Consensus       303 ~~~~~~~~~~~~~~~~~~~l~~li~------~~l~~dP~~Rp-----s~~ell~~  346 (382)
T 3tt0_A          303 FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQRP-----TFKQLVED  346 (382)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHH------HHcCCChhhCc-----CHHHHHHH
Confidence            8877765 34456677777766655      49999999999     88999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=386.91  Aligned_cols=262  Identities=27%  Similarity=0.407  Sum_probs=192.3

Q ss_pred             CcEE-EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013249          111 DFEI-FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (447)
Q Consensus       111 ~y~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  187 (447)
                      .|++ .++||+|+||+||+|+++..   .+++.||||++......     ..+.+|+.+|++++||||+++++++..  .
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDG---KDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSS---SCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccC---CCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            4666 45899999999999998742   25788999999754321     346789999999999999999999954  6


Q ss_pred             CEEEEEEeccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc----CCCCcE
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHV  254 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~~  254 (447)
                      ..+|+||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||||    +.++.+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            789999999965 777776532         249999999999999999999999999999999999999    778999


Q ss_pred             EEeecCCcccccCC----CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHH---------
Q 013249          255 MLTDFGLAKEIDES----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------  320 (447)
Q Consensus       255 kL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---------  320 (447)
                      ||+|||+++.+...    ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..         
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            99999999876432    22345789999999999987 45899999999999999999999999765542         


Q ss_pred             HHHHHHHhcccCCCCCCchhHHh--------------------------------hhhhhhHHhhhccCCCCCCCCCCCC
Q 013249          321 KLQQRIINEKVKLPPFLTSEAHS--------------------------------LLKGVSFLTQLLHKDPSKRLGSGPG  368 (447)
Q Consensus       321 ~~~~~i~~~~~~~p~~~~~~~~~--------------------------------li~~~~~l~~~L~~dP~~R~~~~~~  368 (447)
                      +....|.......+.........                                .-...+||.+||++||.+||     
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~-----  326 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI-----  326 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC-----
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC-----
Confidence            33444433211111100000000                                11234788889999999999     


Q ss_pred             ChhhhhcCCccCCCChhH
Q 013249          369 GVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       369 ~~~~l~~h~~f~~~~~~~  386 (447)
                      +++++++||||.+..+..
T Consensus       327 ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          327 TSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             CHHHHHTSGGGTSSSCCC
T ss_pred             CHHHHhcChhhccCCCCc
Confidence            899999999998765543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=374.97  Aligned_cols=254  Identities=28%  Similarity=0.414  Sum_probs=209.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|.+.+.||+|+||.||+|+++.     +++.||||++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ceEEEeeeEecCCCeEEEEEEECC-----CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            589999999999999999999876     78899999997643 234455678899999999999999999999987653


Q ss_pred             ------EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          190 ------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       190 ------~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                            +|+||||+. ++|..++.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             cccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence                  599999997 58877663  359999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC----------
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----------  332 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~----------  332 (447)
                      .....  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......          
T Consensus       175 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          175 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            75432  345678999999999987 67899999999999999999999999988877766665432110          


Q ss_pred             ---------------------CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          333 ---------------------LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       333 ---------------------~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                                           .+...+.++.      +||.+||+.||++||     +++++++||||+.+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~li~~~L~~dp~~Rp-----t~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAA------DLLEKMLELDVDKRL-----TAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHH------HHHHHHSCSCTTTSC-----CHHHHHTSGGGTTTCCG
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHH------HHHHHHcCCCcccCC-----CHHHHhcCcchhhccCc
Confidence                                 1123344444      456669999999999     88999999999876543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=368.71  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=207.6

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE---
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ---  185 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~---  185 (447)
                      .++|++++.||+|+||.||+|+++.     +++.||||++...   .....+.+.+|+.++++++||||+++++++.   
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDND-----CDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG   81 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETT-----TTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred             CCceeEEEEeccCCCeEEEEEEECC-----CCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence            4689999999999999999999876     7889999998754   3445567889999999999999999999873   


Q ss_pred             -----------eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC-CCCc
Q 013249          186 -----------TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGH  253 (447)
Q Consensus       186 -----------~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~  253 (447)
                                 ....+|+||||+. |+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence                       4468999999997 58988885 46799999999999999999999999999999999999997 5679


Q ss_pred             EEEeecCCcccccCC----CCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHh
Q 013249          254 VMLTDFGLAKEIDES----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN  328 (447)
Q Consensus       254 ~kL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~  328 (447)
                      +||+|||+++.....    .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999876432    22344568999999999875 6789999999999999999999999999888777766654


Q ss_pred             cccCC------------------------------CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCc
Q 013249          329 EKVKL------------------------------PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW  378 (447)
Q Consensus       329 ~~~~~------------------------------p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~  378 (447)
                      .....                              ++.++.++.      +||.+||+.||.+||     +++++++|||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~li~~~L~~dP~~Rp-----t~~ell~hp~  308 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV------DFLEQILTFSPMDRL-----TAEEALSHPY  308 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHH------HHHHTTSCSSGGGSC-----CHHHHHTSHH
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHH------HHHHHHcCCCccccC-----CHHHHhCCcc
Confidence            32111                              122344444      456669999999999     8999999999


Q ss_pred             cCCCChhH
Q 013249          379 FRSINWKT  386 (447)
Q Consensus       379 f~~~~~~~  386 (447)
                      |+..+|..
T Consensus       309 ~~~~~~p~  316 (320)
T 2i6l_A          309 MSIYSFPM  316 (320)
T ss_dssp             HHTTCC--
T ss_pred             cccccCcc
Confidence            99877654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=368.13  Aligned_cols=248  Identities=22%  Similarity=0.377  Sum_probs=208.0

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.++||+|+||+||+|.++.     +++.||+|++...   .....+.+.+|+.+|++++||||+++++++.+
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   78 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK   78 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECC-----CCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence            445689999999999999999999886     7889999988543   34556778899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+.+|+||||+.||+|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            9999999999999999999987 467999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCC---------------CccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHH-----HHHH
Q 013249          266 DESSRS---------------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK-----LQQR  325 (447)
Q Consensus       266 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~-----~~~~  325 (447)
                      ......               ...+||+.|+|||++.+..++.++|||||||++|||++|..||.......     ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  238 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG  238 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence            432221               25679999999999999999999999999999999999999986432110     0011


Q ss_pred             HHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          326 IINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       326 i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..  ....|..++.++.+++.      +||+.||++||     +++++++
T Consensus       239 ~~--~~~~~~~~~~~l~~li~------~~l~~dP~~Rp-----s~~~l~~  275 (310)
T 3s95_A          239 FL--DRYCPPNCPPSFFPITV------RCCDLDPEKRP-----SFVKLEH  275 (310)
T ss_dssp             HH--HHTCCTTCCTTHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             cc--cccCCCCCCHHHHHHHH------HHccCChhhCc-----CHHHHHH
Confidence            11  11245666666665554      59999999999     7888886

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.8e-47  Score=369.74  Aligned_cols=260  Identities=22%  Similarity=0.372  Sum_probs=221.9

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      .+.+..++|++.+.||+|+||.||+|.+.......+++.||||++....  .....+.+.+|+.+|+.++||||++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            3455667899999999999999999998654433467899999997543  34556778899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGI------------------------FREDQARFYTAEIVSAVSHLHKCGIVHR  239 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~aL~~LH~~~iiHr  239 (447)
                      +.+.+.+|+||||+.|++|.+++.....                        +++.+++.++.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            9999999999999999999999987543                        8999999999999999999999999999


Q ss_pred             cCCCCCcccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCC
Q 013249          240 DLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT  315 (447)
Q Consensus       240 Dikp~NILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~  315 (447)
                      ||||+|||++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987643321   234467889999999999889999999999999999999 999999


Q ss_pred             CCCHHHHHHHHHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          316 HANRQKLQQRIINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       316 ~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.+...+...+.... ...+..++.++.+++.      +||..||.+||     ++++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~------~~l~~dp~~Rp-----s~~~l~~~  305 (314)
T 2ivs_A          255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLML------QCWKQEPDKRP-----VFADISKD  305 (314)
T ss_dssp             TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHH------HHccCChhhCc-----CHHHHHHH
Confidence            888877777766553 3456667777666555      49999999999     78998874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-47  Score=373.77  Aligned_cols=258  Identities=20%  Similarity=0.316  Sum_probs=218.8

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.+.||+|+||.||+|++++.....+++.||||++....  .......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            45556899999999999999999988743333367889999997543  2334556889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEE
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~k  255 (447)
                      +.+..|+||||+.+|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            999999999999999999998753          4579999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc
Q 013249          256 LTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV  331 (447)
Q Consensus       256 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~  331 (447)
                      |+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  258 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence            99999998654322   1233467889999999999899999999999999999999 9999999888888877766543


Q ss_pred             -CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          332 -KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       332 -~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                       ..+..++.++.+++.      +||..||.+||     +++++++|
T Consensus       259 ~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~e~l~~  293 (322)
T 1p4o_A          259 LDKPDNCPDMLFELMR------MCWQYNPKMRP-----SFLEIISS  293 (322)
T ss_dssp             CCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHH------HHcCCCcccCc-----CHHHHHHH
Confidence             455666776666554      59999999999     78888876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-46  Score=357.69  Aligned_cols=250  Identities=21%  Similarity=0.358  Sum_probs=215.0

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++++.||+|+||.||+|+++      ++..||+|++......    .+.+.+|+.++++++||||+++++++.
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~   73 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK------GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCS   73 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             EechhheeeeeeeccCCCceEEEEEec------CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            455678999999999999999999876      4567999999765432    245788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +...+|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             cCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            9999999999999999999998764 599999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCchh
Q 013249          265 IDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~  340 (447)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+..... ..|...+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT  233 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHH
Confidence            644322  223456778999999999899999999999999999999 9999999888888777776543 335556666


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.+++      .+||+.||.+||     +++++++|
T Consensus       234 l~~li------~~~l~~~p~~Rp-----s~~~ll~~  258 (268)
T 3sxs_A          234 IYQIM------YSCWHELPEKRP-----TFQQLLSS  258 (268)
T ss_dssp             HHHHH------HHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHH------HHHcCCChhhCc-----CHHHHHHH
Confidence            65554      459999999999     88999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-46  Score=374.82  Aligned_cols=256  Identities=25%  Similarity=0.438  Sum_probs=204.4

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----------CCC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPF  176 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpn  176 (447)
                      ..++|++.+.||+|+||+||+|+++.     +++.||||++....    ...+.+.+|+.+++++.           |||
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecC-----CCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            45689999999999999999999876     78899999997543    23456778999998886           899


Q ss_pred             ceeeeEEEEeCC----EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccC
Q 013249          177 IVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMD  249 (447)
Q Consensus       177 Iv~l~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~  249 (447)
                      |+++++++...+    .+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+||||+
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME  166 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence            999999998654    899999999 88999999864  4599999999999999999999998 999999999999994


Q ss_pred             ------CCCcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC-----
Q 013249          250 ------SDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-----  318 (447)
Q Consensus       250 ------~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-----  318 (447)
                            ..+.+||+|||+++.....  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+     
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence                  4458999999999876543  345689999999999999999999999999999999999999997654     


Q ss_pred             -HHHHHHHHHhcccCCCCC--------------------------------------CchhHHhhhhhhhHHhhhccCCC
Q 013249          319 -RQKLQQRIINEKVKLPPF--------------------------------------LTSEAHSLLKGVSFLTQLLHKDP  359 (447)
Q Consensus       319 -~~~~~~~i~~~~~~~p~~--------------------------------------~~~~~~~li~~~~~l~~~L~~dP  359 (447)
                       .......+......+|..                                      ++...  .-...+||.+||+.||
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE--AKEISDFLSPMLQLDP  322 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHH--HHHHHHHHGGGGCSST
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcch--HHHHHHHHHHHhccCc
Confidence             222233332211111110                                      00111  0122467788999999


Q ss_pred             CCCCCCCCCChhhhhcCCccCCC
Q 013249          360 SKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       360 ~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .+||     +++++++||||++.
T Consensus       323 ~~Rp-----t~~ell~hp~f~~~  340 (373)
T 1q8y_A          323 RKRA-----DAGGLVNHPWLKDT  340 (373)
T ss_dssp             TTCB-----CHHHHHTCGGGTTC
T ss_pred             cccC-----CHHHHhhChhhhcc
Confidence            9999     89999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.6e-47  Score=362.08  Aligned_cols=251  Identities=21%  Similarity=0.384  Sum_probs=213.4

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++++.||+|+||.||+|+++      ++..||+|++......    .+.+.+|+.++++++||||+++++++
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~   88 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVC   88 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEET------TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEc------CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            3455678999999999999999999876      5667999999865422    24578899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .+...+|+||||+.+++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR  168 (283)
T ss_dssp             CSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred             ecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccc
Confidence            999999999999999999999976 4679999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCch
Q 013249          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~  339 (447)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+..... ..|...+.
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (283)
T 3gen_A          169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE  248 (283)
T ss_dssp             GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCH
Confidence            654321  1233456788999999998899999999999999999998 9999999988888888776643 34556666


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ++.+++.      +||+.||.+||     +++++++|
T Consensus       249 ~l~~li~------~~l~~~p~~Rp-----s~~~ll~~  274 (283)
T 3gen_A          249 KVYTIMY------SCWHEKADERP-----TFKILLSN  274 (283)
T ss_dssp             HHHHHHH------HTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHH------HHccCChhHCc-----CHHHHHHH
Confidence            6665554      59999999999     88999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-47  Score=372.10  Aligned_cols=260  Identities=24%  Similarity=0.388  Sum_probs=215.6

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (447)
                      .+.+..++|++.+.||+|+||.||+|++.+.....++..||||++....  .....+.+.+|+.+|+++ +||||+++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3456678999999999999999999998654444467889999997543  233446788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQG-----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHR  239 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHr  239 (447)
                      ++...+.+|+||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+||
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  196 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  196 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999999999999999999999998653                       37999999999999999999999999999


Q ss_pred             cCCCCCcccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCC
Q 013249          240 DLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT  315 (447)
Q Consensus       240 Dikp~NILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~  315 (447)
                      ||||+||||+.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987644322   234567889999999999999999999999999999998 999998


Q ss_pred             CCCHHHHHHHHHhcc--cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          316 HANRQKLQQRIINEK--VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       316 ~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.........+....  ...|...+.++.+++.      +||..||.+||     +++++++|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~~l~~~  328 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ------SCWAFDSRKRP-----SFPNLTSF  328 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH------HHcCCCchhCc-----CHHHHHHH
Confidence            776554444444433  3345666777666555      59999999999     78999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.6e-47  Score=361.60  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=205.5

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++.+.||+|+||.||+|+++...  ..+..||+|++....  .....+.+.+|+.++++++||||+++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCC--CCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            3455678999999999999999999987522  246679999987542  344556788999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      . .+.+|+||||+.+++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence            4 567899999999999999998664 69999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCch
Q 013249          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~  339 (447)
                      .......  .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... ..++..++.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  244 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            7654322  233456789999999998999999999999999999996 999999888877777776543 456667777


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ++.+++.      +||..||.+||     ++++++++
T Consensus       245 ~l~~li~------~~l~~~p~~Rp-----s~~~l~~~  270 (281)
T 1mp8_A          245 TLYSLMT------KCWAYDPSRRP-----RFTELKAQ  270 (281)
T ss_dssp             HHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHH------HHccCChhhCc-----CHHHHHHH
Confidence            7766555      59999999999     78888863

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-46  Score=364.85  Aligned_cols=259  Identities=23%  Similarity=0.370  Sum_probs=217.6

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      +.+..++|++.+.||+|+||.||+|++.+..+..+++.||||++....  .....+.+.+|+.+|+++ +||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            446667899999999999999999998655445578899999997653  233456788999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                      +...+..|+||||+++|+|.+++....                  .+++.+++.++.||+.||.|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999999998754                  48999999999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~  321 (447)
                      ||++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987654332   234557889999999999999999999999999999999 999998776544


Q ss_pred             HHHHHHhccc--CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          322 LQQRIINEKV--KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       322 ~~~~i~~~~~--~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ....+.....  ..+...+.++.+++.      +||..||.+||     ++++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~ell~~  301 (313)
T 1t46_A          256 KFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRP-----TFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHhccCCCCCCcccCCHHHHHHHH------HHcCCCchhCc-----CHHHHHHH
Confidence            4444443332  234556666665554      59999999999     78888864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.9e-46  Score=361.22  Aligned_cols=252  Identities=27%  Similarity=0.423  Sum_probs=204.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++...........+.+.+|+.++++++||||+++++++...+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTV-----RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcC-----CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            4689999999999999999999876     78899999998765555556678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999876443


Q ss_pred             C--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCchhHHh
Q 013249          269 S--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHS  343 (447)
Q Consensus       269 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~  343 (447)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...+...+.....   ..+..++.++.+
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence            2  23356799999999999999999999999999999999999999988776654444433221   234456666655


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++      .+||..||++||+    +++++++
T Consensus       268 li------~~~l~~dP~~Rp~----s~~~l~~  289 (309)
T 2h34_A          268 VI------ARGMAKNPEDRYV----TCGDLSA  289 (309)
T ss_dssp             HH------HHHTCSSGGGSCS----SHHHHHH
T ss_pred             HH------HHhccCCHHHHHH----hHHHHHH
Confidence            54      4599999999994    4667665

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.9e-47  Score=379.42  Aligned_cols=253  Identities=22%  Similarity=0.409  Sum_probs=216.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.+.||+|+||.||+|+++.     +++.||||+++...  .....+.+.+|+.+|++++||||+++++++
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRA-----DNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEec-----CCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34566789999999999999999999986     78899999987542  234445678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      ...+.+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            99999999999999999999998654 69999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          264 EIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       264 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      .......   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+ ....|..++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP  341 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            6543211   112235778999999998889999999999999999998 99999998888777766654 345566677


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++.+++.      +||+.||++||     ++++|++
T Consensus       342 ~~l~~li~------~cl~~dP~~Rp-----s~~~i~~  367 (377)
T 3cbl_A          342 DAVFRLME------QCWAYEPGQRP-----SFSTIYQ  367 (377)
T ss_dssp             HHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHH------HHcCCCchhCc-----CHHHHHH
Confidence            77666555      59999999999     7888875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.9e-46  Score=355.19  Aligned_cols=250  Identities=28%  Similarity=0.463  Sum_probs=201.8

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      +..++|++.++||+|+||.||+|++       .++.||||++....... ....+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW-------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL   76 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE-------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE-------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            4567999999999999999999987       35679999987653322 334567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCcccCC--------CCcE
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDS--------DGHV  254 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iiHrDikp~NILl~~--------~~~~  254 (447)
                      +.+..|+||||++|++|.+++. .+.+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           77 KEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             CC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             cCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence            9999999999999999988874 568999999999999999999999999   999999999999986        7789


Q ss_pred             EEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc--C
Q 013249          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--K  332 (447)
Q Consensus       255 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~--~  332 (447)
                      ||+|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.....  .
T Consensus       156 kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (271)
T 3dtc_A          156 KITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP  234 (271)
T ss_dssp             EECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred             EEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence            999999998765433 3356799999999999999999999999999999999999999999888877777666543  3


Q ss_pred             CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       333 ~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .+..++.++.+++.      +||+.||.+||     +++++++|
T Consensus       235 ~~~~~~~~~~~li~------~~l~~~p~~Rp-----s~~e~l~~  267 (271)
T 3dtc_A          235 IPSTCPEPFAKLME------DCWNPDPHSRP-----SFTNILDQ  267 (271)
T ss_dssp             CCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCcccCHHHHHHHH------HHhcCCcccCc-----CHHHHHHH
Confidence            45566766666555      59999999999     78998864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=360.20  Aligned_cols=255  Identities=26%  Similarity=0.447  Sum_probs=208.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|....+||+|+||.||+|+++.     +++.||||++....   ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLS-----NQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETT-----TCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECC-----CCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            345556699999999999999876     78899999987642   3344668899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-CCcEEEeecCCcccc
Q 013249          190 LYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLAKEI  265 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~~kL~DFG~a~~~  265 (447)
                      +++||||+++++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            999999999999999998752   4679999999999999999999999999999999999987 899999999999876


Q ss_pred             cCCC-CCCccccCCcccccccccCC--CCCCccceeehhHhHHHHhhCCCCCCCCCHHH-HHHH--HHhcccCCCCCCch
Q 013249          266 DESS-RSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQK-LQQR--IINEKVKLPPFLTS  339 (447)
Q Consensus       266 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~-~~~~--i~~~~~~~p~~~~~  339 (447)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+... ....  .......++..++.
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence            4322 23456799999999999764  38899999999999999999999997543322 1111  22233456667777


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      ++.+++.      +||+.||++||     +++++++||||+...
T Consensus       254 ~~~~li~------~~l~~dp~~Rp-----s~~~ll~~~~~~~~~  286 (295)
T 2clq_A          254 EAKAFIL------KCFEPDPDKRA-----CANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHH------HTTCSSTTTSC-----CHHHHHTSGGGCC--
T ss_pred             HHHHHHH------HHccCChhhCC-----CHHHHhcChhhhhcc
Confidence            7766555      59999999999     889999999998643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-46  Score=361.57  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=209.7

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      .+..++|++.+.||+|+||+||+|+++...+  ...+..||+|++....   ....+.+.+|+.++++++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            3556789999999999999999999875221  0012569999987543   3445678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc--------E
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------V  254 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--------~  254 (447)
                      +.+.+..|+||||+.||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987754 999999999999999999999999999999999999998887        9


Q ss_pred             EEeecCCcccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhC-CCCCCCCCHHHHHHHHHhcccC
Q 013249          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEKVK  332 (447)
Q Consensus       255 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~~~~~~  332 (447)
                      ||+|||++.....   .....||+.|+|||++.+ ..++.++|||||||++|||++| .+||...+.... ..+......
T Consensus       161 kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~  236 (289)
T 4fvq_A          161 KLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDRHQ  236 (289)
T ss_dssp             EECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCC
T ss_pred             eeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhccCC
Confidence            9999999876533   234568999999999987 7799999999999999999995 555555554443 444455666


Q ss_pred             CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       333 ~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +|...+.++.+++.      +||+.||.+||     +++++++|
T Consensus       237 ~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~~ll~~  269 (289)
T 4fvq_A          237 LPAPKAAELANLIN------NCMDYEPDHRP-----SFRAIIRD  269 (289)
T ss_dssp             CCCCSSCTTHHHHH------HHSCSSGGGSC-----CHHHHHHH
T ss_pred             CCCCCCHHHHHHHH------HHcCCChhHCc-----CHHHHHHH
Confidence            77777776666555      59999999999     88999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=362.50  Aligned_cols=258  Identities=28%  Similarity=0.454  Sum_probs=195.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++++.||+|+||.||+|+++.     +++.||||++..... .....+.+..+..+++.++||||+++++++..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETT-----TCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhhccccccceeeecCCeeEEEEEEec-----CCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            345689999999999999999999876     788999999976542 23333445556667888999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .+.+|+||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999999 5555555443 57899999999999999999999995 999999999999999999999999999987


Q ss_pred             ccCCCCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCC-CCHHHHHHHHHhcccC-CC--C
Q 013249          265 IDESSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVK-LP--P  335 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~-~~~~~~~~~i~~~~~~-~p--~  335 (447)
                      ...........||+.|+|||++.     ...++.++|||||||++|+|++|+.||.. .+..+....+...... ++  .
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred             ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence            76555555678999999999995     45688999999999999999999999976 4455556666555432 22  2


Q ss_pred             CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          336 FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       336 ~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      .++.++.+++      .+||+.||.+||     +++++++||||++.
T Consensus       255 ~~~~~l~~li------~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  290 (318)
T 2dyl_A          255 GFSGDFQSFV------KDCLTKDHRKRP-----KYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCCHHHHHHH------HHHTCSCTTTSC-----CHHHHTTSHHHHHH
T ss_pred             CCCHHHHHHH------HHHccCChhHCc-----CHHHHhhCHHHHhc
Confidence            3566665554      459999999999     89999999999754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-46  Score=367.79  Aligned_cols=252  Identities=24%  Similarity=0.398  Sum_probs=211.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcE--EEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      +..++|++.+.||+|+||.||+|+++.     ++..  +|+|.+....  .....+.+.+|+.+|+++ +||||++++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEcc-----CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence            345689999999999999999999875     5554  4999887532  334455688999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NIL  247 (447)
                      +.+.+.+|+||||+++++|.+++...+                .+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl  174 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  174 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence            999999999999999999999998654                6999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHH
Q 013249          248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  326 (447)
Q Consensus       248 l~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i  326 (447)
                      ++.++.+||+|||+++............+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+
T Consensus       175 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          175 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             EcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            99999999999999986544333445567889999999998889999999999999999998 99999999888887777


Q ss_pred             Hhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          327 INE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       327 ~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ... ....+..++.++.+++.      +||..||.+||     ++++++++
T Consensus       255 ~~~~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~ell~~  294 (327)
T 1fvr_A          255 PQGYRLEKPLNCDDEVYDLMR------QCWREKPYERP-----SFAQILVS  294 (327)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHH------HHccCChhhCc-----CHHHHHHH
Confidence            655 23455566666665554      59999999999     88999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-45  Score=354.84  Aligned_cols=247  Identities=19%  Similarity=0.271  Sum_probs=207.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  185 (447)
                      +..++|++.+.||+|+||.||+|+++.     +++.||||++.....     .+.+.+|+.+++.+ +|+||+++++++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            445689999999999999999999875     788999999875432     12467899999999 7999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc-----EEEeec
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMLTDF  259 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~-----~kL~DF  259 (447)
                      .....|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+||
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999999999999 999999998754 5999999999999999999999999999999999999988776     999999


Q ss_pred             CCcccccCCCC--------CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC---CHHHHHHHHHh
Q 013249          260 GLAKEIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIIN  328 (447)
Q Consensus       260 G~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~---~~~~~~~~i~~  328 (447)
                      |+++.......        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +.......+..
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            99987654322        34567999999999999999999999999999999999999999763   44455555544


Q ss_pred             cccCC-----CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          329 EKVKL-----PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       329 ~~~~~-----p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .....     ...++.++.+++      .+||..||++||     ++++|++
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li------~~~l~~dp~~RP-----~~~~l~~  276 (298)
T 1csn_A          236 KKQSTPLRELCAGFPEEFYKYM------HYARNLAFDATP-----DYDYLQG  276 (298)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHH------HHHHHCCTTCCC-----CHHHHHH
T ss_pred             hccCccHHHHHhhCcHHHHHHH------HHHhcCCcccCC-----CHHHHHH
Confidence            33222     234566665554      459999999999     7788865

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.5e-46  Score=366.13  Aligned_cols=259  Identities=22%  Similarity=0.396  Sum_probs=219.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  181 (447)
                      +.+..++|++.+.||+|+||.||+|++.+...  ..++..||||++....  .....+.+.+|+.+++++ +||||++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            44566799999999999999999999865332  2357789999997643  344566788999999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                      +++...+.+|+||||+.+|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            99999999999999999999999998654                38999999999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~  321 (447)
                      ||++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            9999999999999999987654321   234457889999999998889999999999999999999 999999988888


Q ss_pred             HHHHHHhcc-cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          322 LQQRIINEK-VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       322 ~~~~i~~~~-~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +...+.... ...+..++.++.+++.      +||..||.+||     ++++++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~ell~~  312 (334)
T 2pvf_A          268 LFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRP-----TFKQLVED  312 (334)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHH------HHccCChhhCc-----CHHHHHHH
Confidence            877776653 3456667776666554      59999999999     78999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.7e-47  Score=369.89  Aligned_cols=263  Identities=25%  Similarity=0.430  Sum_probs=189.5

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHH-HHHhcCCCCceeeeE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRY  182 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~  182 (447)
                      .+.+..++|++++.||+|+||.||+|.++.     +++.||||++....  .......+..|+. +++.++||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~   88 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-----SGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYG   88 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETT-----TTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcC-----CCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence            355677899999999999999999999876     78899999997643  2223334445555 777889999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCcccCCCCcEEE
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVML  256 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~~kL  256 (447)
                      ++...+.+|+||||+.+ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence            99999999999999986 77776653     56799999999999999999999999 9999999999999999999999


Q ss_pred             eecCCcccccCCCCCCccccCCcccccccc----cCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH-HHHHHHHhcc-
Q 013249          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEK-  330 (447)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~-  330 (447)
                      +|||+++............||+.|+|||++    .+..++.++|||||||++|+|++|+.||...+.. +....+..+. 
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (327)
T 3aln_A          168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP  247 (327)
T ss_dssp             CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred             ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence            999999887655445556899999999999    4567899999999999999999999999765322 2221222111 


Q ss_pred             cCCC----CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          331 VKLP----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       331 ~~~p----~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      ..++    ..++.++.+      ||.+||+.||.+||     +++++++||||...++.
T Consensus       248 ~~~~~~~~~~~~~~l~~------li~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          248 PQLSNSEEREFSPSFIN------FVNLCLTKDESKRP-----KYKELLKHPFILMYEER  295 (327)
T ss_dssp             CCCCCCSSCCCCHHHHH------HHHHHTCSSGGGSC-----CHHHHTTSHHHHHHHHS
T ss_pred             CCCCCcccccCCHHHHH------HHHHHhhCChhhCc-----CHHHHHhChHHHHhHhh
Confidence            1122    234555544      45569999999999     88999999999865544

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=365.76  Aligned_cols=252  Identities=29%  Similarity=0.519  Sum_probs=207.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---hHHHHHHHHHHHHHhc----CCCCceeee
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKV----THPFIVQLR  181 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l----~hpnIv~l~  181 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++........   .....+.+|+.+++++    +||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLT-----DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTT-----TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEcc-----CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            4689999999999999999998875     788999999976543221   1223355799999998    899999999


Q ss_pred             EEEEeCCEEEEEEec-cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC-CCCcEEEeec
Q 013249          182 YSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMLTDF  259 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~-~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~~kL~DF  259 (447)
                      +++...+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            999999999999999 78999999999888999999999999999999999999999999999999999 8899999999


Q ss_pred             CCcccccCCCCCCccccCCcccccccccCCCCC-CccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCc
Q 013249          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT  338 (447)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~  338 (447)
                      |+++..... ......||..|+|||++.+..+. .++|||||||++|+|++|+.||...      ..+......++..++
T Consensus       185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~  257 (312)
T 2iwi_A          185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVS  257 (312)
T ss_dssp             SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSC
T ss_pred             chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCC
Confidence            999876553 34456799999999999876664 5899999999999999999999753      234556667777788


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      .++.+++.      +||+.||++||     +++++++||||+...
T Consensus       258 ~~~~~li~------~~l~~~p~~Rp-----s~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          258 PDCCALIR------RCLAPKPSSRP-----SLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHHHH------HHTCSSTTTSC-----CHHHHHHSTTTCC--
T ss_pred             HHHHHHHH------HHccCChhhCc-----CHHHHhcChhhcCch
Confidence            77766655      59999999999     899999999998653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-46  Score=372.66  Aligned_cols=257  Identities=17%  Similarity=0.197  Sum_probs=198.3

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHH--------HHHHHHHHHHHhcCCCCce
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--------DYMKAERDILTKVTHPFIV  178 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~--------~~~~~E~~il~~l~hpnIv  178 (447)
                      +..++|++.++||+|+||.||+|.++.......++.||||++...........        ..+..|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            44568999999999999999999987644434568899999876432111111        1233455667778899999


Q ss_pred             eeeEEEEeC----CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC--CC
Q 013249          179 QLRYSFQTR----SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SD  251 (447)
Q Consensus       179 ~l~~~~~~~----~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~--~~  251 (447)
                      ++++++...    ..+|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5689999999 99999999876 6799999999999999999999999999999999999999  88


Q ss_pred             CcEEEeecCCcccccCCC--------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH-HH
Q 013249          252 GHVMLTDFGLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KL  322 (447)
Q Consensus       252 ~~~kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~  322 (447)
                      +.+||+|||+++.+....        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999998754321        123456999999999999999999999999999999999999999753222 11


Q ss_pred             HHHHHhc-ccC--------C-CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          323 QQRIINE-KVK--------L-PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       323 ~~~i~~~-~~~--------~-p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ....... ...        + +...+.++.++      +.+||..||.+||     ++++|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------i~~cl~~~p~~RP-----~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKY------METVKLLDYTEKP-----LYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHH------HHHHHTCCTTCCC-----CHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHH------HHHHhcCCCCCCC-----CHHHHHH
Confidence            1111110 000        1 13445555555      5559999999999     6777764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-46  Score=366.06  Aligned_cols=255  Identities=22%  Similarity=0.341  Sum_probs=206.3

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+++++||+|+||+||+|+++..... ....||+|.+....  .....+.+.+|+.++++++||||+++++++.+
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEK-VKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCce-EEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            3456899999999999999999998752110 12236788776432  23445678899999999999999999999987


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .. .++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            65 78999999999999999874 67999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchh
Q 013249          266 DESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  340 (447)
Q Consensus       266 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  340 (447)
                      .....   .....||..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+.... ...+...+.+
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            54332   223456889999999999999999999999999999999 999999888777766665543 3445566666


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.++      +.+||+.||.+||     ++++++++
T Consensus       248 ~~~l------i~~~l~~~p~~Rp-----s~~ell~~  272 (327)
T 3poz_A          248 VYMI------MVKCWMIDADSRP-----KFRELIIE  272 (327)
T ss_dssp             HHHH------HHHHTCSCGGGSC-----CHHHHHHH
T ss_pred             HHHH------HHHHcCCChhhCC-----CHHHHHHH
Confidence            6555      5559999999999     78998875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2e-46  Score=368.47  Aligned_cols=248  Identities=31%  Similarity=0.563  Sum_probs=178.2

Q ss_pred             CCcEEEe-eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013249          110 GDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (447)
Q Consensus       110 ~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (447)
                      ++|++.+ +||+|+||.||+|+++.     +++.||||++.....       ........++.+.||||+++++++..  
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRR-----TGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECC-----CCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            4899965 69999999999999986     788999999875321       12223344677799999999999976  


Q ss_pred             --CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEEeec
Q 013249          187 --RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDF  259 (447)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL~DF  259 (447)
                        ...+|+||||++||+|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              456899999999999999998764  6999999999999999999999999999999999999976   455999999


Q ss_pred             CCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHH----HHHHHhcccCCC-
Q 013249          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL----QQRIINEKVKLP-  334 (447)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~----~~~i~~~~~~~p-  334 (447)
                      |+++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........    ...+......++ 
T Consensus       176 g~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          176 GFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             TTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             ccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            999876543 33456889999999999888899999999999999999999999976654433    223333333333 


Q ss_pred             ---CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 ---PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 ---~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                         ..++.++.++      |.+||+.||.+||     +++++++||||+.
T Consensus       255 ~~~~~~~~~~~~l------i~~~L~~dP~~Rp-----t~~ell~hp~~~~  293 (336)
T 3fhr_A          255 PEWSEVSEDAKQL------IRLLLKTDPTERL-----TITQFMNHPWINQ  293 (336)
T ss_dssp             TTSTTCCHHHHHH------HHHHSCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             hhhccCCHHHHHH------HHHHCCCChhHCc-----CHHHHhcCccccc
Confidence               2455555554      5559999999999     8999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.3e-46  Score=364.33  Aligned_cols=258  Identities=21%  Similarity=0.374  Sum_probs=216.6

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      ..+..++|++.+.||+|+||.||+|.+...........||+|++....  .....+.+.+|+.+|+.+ +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            456678999999999999999999999875544456789999997643  334456788999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQ--------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~  249 (447)
                      +...+.+|+||||+++|+|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999998753              3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHH
Q 013249          250 SDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQR  325 (447)
Q Consensus       250 ~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~  325 (447)
                      .++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            999999999999987644322   234557889999999999999999999999999999998 9999987665554444


Q ss_pred             HHhccc--CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          326 IINEKV--KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       326 i~~~~~--~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.....  ..|...+.++.+++      .+||+.||.+||     +++++++
T Consensus       279 ~~~~~~~~~~~~~~~~~l~~li------~~~l~~~p~~Rp-----s~~~l~~  319 (333)
T 2i1m_A          279 LVKDGYQMAQPAFAPKNIYSIM------QACWALEPTHRP-----TFQQICS  319 (333)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHH------HHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHH------HHHhccChhhCc-----CHHHHHH
Confidence            444332  34555666665554      459999999999     7899886

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.8e-46  Score=351.64  Aligned_cols=251  Identities=20%  Similarity=0.389  Sum_probs=215.7

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.+.||+|+||.||+|++.      +++.||+|++......    .+.+.+|+.+++.++||||+++++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~   72 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVC   72 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec------CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456678999999999999999999986      4568999999865422    24688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .+.+.+|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccc
Confidence            9999999999999999999999875 568999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCch
Q 013249          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~  339 (447)
                      ......  ......|+..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.... ...|...+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  232 (267)
T 3t9t_A          153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  232 (267)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcH
Confidence            653321  1234467889999999998899999999999999999999 999999988888888777653 334555666


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ++.+++      .+||+.||.+||     ++++++++
T Consensus       233 ~l~~li------~~~l~~~p~~Rp-----s~~~ll~~  258 (267)
T 3t9t_A          233 HVYQIM------NHCWRERPEDRP-----AFSRLLRQ  258 (267)
T ss_dssp             HHHHHH------HHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHH------HHHccCChhhCc-----CHHHHHHH
Confidence            665554      459999999999     78888864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=382.37  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=198.5

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (447)
                      .++..+|++.++||+|+||+|+.....      +++.||||++......      .+.+|+.+|+.+ +|||||++++++
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~------~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~   87 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRGMF------DNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTE   87 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEEES------SSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             EEccEEEecCCeeecCcCEEEEEEEEe------CCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEE
Confidence            355567999999999999997643322      6788999999764321      245799999999 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-----CCcEEEee
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMLTD  258 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-----~~~~kL~D  258 (447)
                      .+...+|+|||||. |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+||||+.     ...+||+|
T Consensus        88 ~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           88 KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             ecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            99999999999996 59999987654 4666678899999999999999999999999999999953     23588999


Q ss_pred             cCCcccccCC----CCCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc
Q 013249          259 FGLAKEIDES----SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK  330 (447)
Q Consensus       259 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~  330 (447)
                      ||+++.....    ......+||+.|+|||++.   ...++.++|||||||++|||++ |..||...........  ...
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--~~~  244 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--LGA  244 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--TTC
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--hcc
Confidence            9999876533    2234568999999999998   4567889999999999999999 9999976554443322  222


Q ss_pred             cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          331 VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       331 ~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      ...+... .....-....+||.+||+.||.+||     +++++++||||.+++|.
T Consensus       245 ~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~evl~hp~f~~~~~~  293 (432)
T 3p23_A          245 CSLDCLH-PEKHEDVIARELIEKMIAMDPQKRP-----SAKHVLKHPFFWSLEKQ  293 (432)
T ss_dssp             CCCTTSC-TTCHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHTSTTTCCHHHH
T ss_pred             CCccccC-ccccccHHHHHHHHHHHhCCHhhCC-----CHHHHHhCccccChHHH
Confidence            2221111 1111111234677889999999999     88999999999998884

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3e-46  Score=362.84  Aligned_cols=259  Identities=23%  Similarity=0.420  Sum_probs=216.5

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      +.+..++|++.+.||+|+||.||+|++.+..+..+++.||||++....  .....+.+.+|+.+++++ +||||++++++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            445667999999999999999999998765555578999999997653  334456788999999999 79999999999


Q ss_pred             EEeCC-EEEEEEeccCCCChHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCc
Q 013249          184 FQTRS-KLYLILDFINGGHLFFHLYRQGI----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (447)
Q Consensus       184 ~~~~~-~~~lv~E~~~gg~L~~~l~~~~~----------------~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NI  246 (447)
                      +...+ .+|+||||+.|++|.+++.....                +++..++.++.||+.||.|||++||+||||||+||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            87754 59999999999999999987654                89999999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHH-H
Q 013249          247 LMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ-K  321 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~-~  321 (447)
                      |++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... .
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            999999999999999987644322   234567889999999999999999999999999999998 99999876533 3


Q ss_pred             HHHHHHhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          322 LQQRIINE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       322 ~~~~i~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ....+... ....+...+.++.+++.      +||..||.+||     +++++++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRMRAPDYTTPEMYQTML------DCWHGEPSQRP-----TFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHhccCccCCCCCCCCHHHHHHHH------HHcCCChhhCc-----CHHHHHHH
Confidence            33444333 34456667777666555      49999999999     88999886

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.8e-46  Score=378.56  Aligned_cols=248  Identities=25%  Similarity=0.426  Sum_probs=212.7

Q ss_pred             hhcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013249          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      ..+.+..++|++.+.||+|+||.||++.++       ++.||||+++...     ..+.+.+|+.+|++++||||+++++
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~  253 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLG  253 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec-------CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEE
Confidence            445677889999999999999999999874       4589999997643     2356889999999999999999999


Q ss_pred             EEEeCC-EEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeec
Q 013249          183 SFQTRS-KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       183 ~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                      ++.... .+|+||||+.+|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       254 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             EEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeC
Confidence            987665 79999999999999999987654  799999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCC
Q 013249          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (447)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (447)
                      |+++.....  .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|..+
T Consensus       334 G~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~  411 (450)
T 1k9a_A          334 GLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC  411 (450)
T ss_dssp             TTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred             CCccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence            999865432  223467899999999999999999999999999999998 99999988777777777654 34567777


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.++.+++..      ||..||.+||     ++++|++
T Consensus       412 ~~~l~~li~~------cl~~dp~~Rp-----t~~~l~~  438 (450)
T 1k9a_A          412 PPAVYDVMKN------CWHLDAATRP-----TFLQLRE  438 (450)
T ss_dssp             CHHHHHHHHH------HTCSSGGGSC-----CHHHHHH
T ss_pred             CHHHHHHHHH------HcCCChhHCc-----CHHHHHH
Confidence            8777766555      9999999999     7788875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=360.44  Aligned_cols=258  Identities=22%  Similarity=0.350  Sum_probs=211.6

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++.+.||+|+||.||+|.++.... ..+..||||++....  .......+.+|+.+++.++||||+++++++
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCC-CccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34667899999999999999999999875221 134569999997543  334455688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      ...+.+|+||||+++++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999999999865 679999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCC
Q 013249          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (447)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (447)
                      .......    .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... ....+..+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  275 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC  275 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence            7643221    223346788999999999999999999999999999999 99999988888888777665 33445566


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.++.+++.      +||+.||.+||     ++++++++
T Consensus       276 ~~~l~~li~------~~l~~~p~~Rp-----s~~~l~~~  303 (333)
T 1mqb_A          276 PSAIYQLMM------QCWQQERARRP-----KFADIVSI  303 (333)
T ss_dssp             BHHHHHHHH------HHTCSSTTTSC-----CHHHHHHH
T ss_pred             CHHHHHHHH------HHcCCChhhCc-----CHHHHHHH
Confidence            666665554      59999999999     78888863

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-45  Score=359.19  Aligned_cols=256  Identities=27%  Similarity=0.477  Sum_probs=208.2

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC--CCCceeeeEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSF  184 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~  184 (447)
                      +..++|++++.||+|+||.||+|+++      +++.||||++..... .....+.+.+|+.++++++  ||||+++++++
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC------CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            44568999999999999999999864      577899999976542 3445677889999999997  59999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .....+|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~  175 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  175 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence            99999999999 55889999999989999999999999999999999999999999999999996 48999999999987


Q ss_pred             ccCCCC---CCccccCCcccccccccC-----------CCCCCccceeehhHhHHHHhhCCCCCCCCC-HHHHHHHHHhc
Q 013249          265 IDESSR---SNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINE  329 (447)
Q Consensus       265 ~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~  329 (447)
                      ......   ....+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.... .......+...
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  255 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence            644322   235579999999999976           468889999999999999999999997653 33333334332


Q ss_pred             --ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          330 --KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       330 --~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                        ...++...+.++.+++      .+||..||.+||     +++++++||||+..
T Consensus       256 ~~~~~~~~~~~~~l~~li------~~~l~~dp~~Rp-----s~~ell~h~~~~~~  299 (313)
T 3cek_A          256 NHEIEFPDIPEKDLQDVL------KCCLKRDPKQRI-----SIPELLAHPYVQIQ  299 (313)
T ss_dssp             TSCCCCCCCSCHHHHHHH------HHHTCSSTTTSC-----CHHHHHTSHHHHCC
T ss_pred             ccccCCcccchHHHHHHH------HHHccCCcccCc-----CHHHHhcCccccCC
Confidence              2345556666665554      459999999999     88999999999753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-45  Score=354.34  Aligned_cols=255  Identities=19%  Similarity=0.299  Sum_probs=214.0

Q ss_pred             cCcCCCCcEEEe-eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          105 RKIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      ..+..++|++.+ .||+|+||.||+|.++..   ..++.||||++.... ......+.+.+|+.+++.++||||++++++
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCC---CceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345566899998 999999999999976431   267889999997653 234446678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      + ..+.+|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            9 566789999999999999999998889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCC
Q 013249          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFL  337 (447)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~  337 (447)
                      .......    .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..++...+.... ..+|..+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC  245 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            7644322    122346788999999998889999999999999999999 999999988888777776553 4456677


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.++.+++..      ||..||.+||     +++++++
T Consensus       246 ~~~l~~li~~------~l~~dp~~Rp-----s~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNL------CWTYDVENRP-----GFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHH------HTCSSTTTSC-----CHHHHHH
T ss_pred             CHHHHHHHHH------HcCCChhhCc-----CHHHHHH
Confidence            7777666554      9999999999     7788875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.1e-46  Score=371.53  Aligned_cols=255  Identities=22%  Similarity=0.356  Sum_probs=204.1

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.+.||+|+||.||+|+++...  ..+..||||+++...  .....+.+.+|+.+|++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPS--KKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTT--SCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCC--CCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            345568999999999999999999876321  257789999997642  3445567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +...+|+||||++||+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            9999999999999999999998764 699999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCc
Q 013249          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLT  338 (447)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~  338 (447)
                      ......    .....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+.... ...+..++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  276 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP  276 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence            643321    112345778999999999999999999999999999998 999999988888877776553 33445566


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++.++      |.+||+.||.+||     +++++++
T Consensus       277 ~~l~~l------i~~cl~~dp~~RP-----s~~~i~~  302 (373)
T 2qol_A          277 AALYQL------MLDCWQKDRNNRP-----KFEQIVS  302 (373)
T ss_dssp             HHHHHH------HHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHH------HHHHhCcChhhCc-----CHHHHHH
Confidence            666555      4559999999999     7788876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.5e-46  Score=357.06  Aligned_cols=251  Identities=23%  Similarity=0.373  Sum_probs=217.4

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.+.||+|+||.||+|.++.     ++..||+|++...    ....+.+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   78 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVC   78 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGG-----GTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecC-----CCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            44566789999999999999999999986     7889999999754    23456688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      .+...+|+||||+.|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999999999874  45999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      ........  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+... ....|..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  238 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCC
Confidence            87654322  233457889999999999999999999999999999999 99999988877777766654 344566677


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++.+++.      +||..||.+||     +++++++
T Consensus       239 ~~l~~li~------~~l~~dp~~Rp-----s~~~~~~  264 (288)
T 3kfa_A          239 EKVYELMR------ACWQWNPSDRP-----SFAEIHQ  264 (288)
T ss_dssp             HHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHH------HHhCCChhhCc-----CHHHHHH
Confidence            77766655      49999999999     7888876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1e-45  Score=350.77  Aligned_cols=248  Identities=20%  Similarity=0.322  Sum_probs=212.5

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++.+.||+|+||.||+|+++       ++.||||++..... .....+.+.+|+.++++++||||+++++++
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQ-------GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGAC   76 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEEC-------CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence            3456678999999999999999999973       56799999987543 344456788999999999999999999999


Q ss_pred             EeC--CEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccCCCCcEEEee
Q 013249          185 QTR--SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMLTD  258 (447)
Q Consensus       185 ~~~--~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~~kL~D  258 (447)
                      .+.  ..+++||||+++|+|.+++....  .+++.+++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             CTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             ccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEe
Confidence            877  78999999999999999998765  4899999999999999999999999  99999999999999999999999


Q ss_pred             cCCcccccCCCCCCccccCCcccccccccCCCCCC---ccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCC
Q 013249          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKL  333 (447)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~--~~~  333 (447)
                      ||++....    .....||+.|+|||++.+..++.   ++|||||||++|||++|+.||...+.......+....  ..+
T Consensus       157 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (271)
T 3kmu_A          157 ADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI  232 (271)
T ss_dssp             GGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred             ccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC
Confidence            99876532    23457899999999998766554   7999999999999999999999988888777766553  345


Q ss_pred             CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          334 PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       334 p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      |..++.++.+++..      ||+.||++||     +++++++
T Consensus       233 ~~~~~~~~~~li~~------~l~~~p~~Rp-----s~~~il~  263 (271)
T 3kmu_A          233 PPGISPHVSKLMKI------CMNEDPAKRP-----KFDMIVP  263 (271)
T ss_dssp             CTTCCHHHHHHHHH------HTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCCHHHHHHHHH------HcCCChhhCc-----CHHHHHH
Confidence            66777777666554      9999999999     7888875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.2e-46  Score=364.41  Aligned_cols=261  Identities=20%  Similarity=0.328  Sum_probs=213.8

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++++.||+|+||.||+|++.+..+..+++.||||++....  .......+.+|+.++++++||||+++++++..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            4456899999999999999999996544334478899999996432  33445568889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEE
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVML  256 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL  256 (447)
                      ....|+||||++|++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998763       4899999999999999999999999999999999999984   446999


Q ss_pred             eecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-c
Q 013249          257 TDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-V  331 (447)
Q Consensus       257 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~  331 (447)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..++...+.... .
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999998653322   2334568999999999998899999999999999999998 999999988888877776653 3


Q ss_pred             CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          332 KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       332 ~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      ..+..++.++.+++.      +||..||.+||     +++++++|.|+-
T Consensus       265 ~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~~ll~~l~~~  302 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMT------QCWQHQPEDRP-----NFAIILERIEYC  302 (327)
T ss_dssp             CCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHH------HHhcCChhhCc-----CHHHHHHHHHHH
Confidence            455566766665554      59999999999     889999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.7e-46  Score=357.89  Aligned_cols=255  Identities=22%  Similarity=0.354  Sum_probs=204.7

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|+++++||+|+||+||+|+++.... .+++.||||++...   .....+.+.+|+.+|++++||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCS-SCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccC-CCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3556789999999999999999998653222 37889999998754   3445567889999999999999999999986


Q ss_pred             e--CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          186 T--RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       186 ~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      .  ...+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  456999999999999999998764 5999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC----CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH----------------HH
Q 013249          263 KEIDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----------------KL  322 (447)
Q Consensus       263 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~----------------~~  322 (447)
                      +......    ......++..|+|||++.+..++.++|||||||++|||++|..||......                ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            8764432    123345778899999999999999999999999999999999998643221                11


Q ss_pred             HHHHHh-cccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          323 QQRIIN-EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       323 ~~~i~~-~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ...+.. .....|..++.++.+++.      +||..||++||     +++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~el~~  284 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRP-----SFRDLAL  284 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHH------HHSCSSGGGSC-----CHHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHH------HHcCCChhhCC-----CHHHHHH
Confidence            112221 233456667777766655      49999999999     7888875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=354.44  Aligned_cols=254  Identities=22%  Similarity=0.331  Sum_probs=215.4

Q ss_pred             CcCCCCcEEEe-eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          106 KIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      .+..++|.+.+ .||+|+||.||+|.++..   .++..||||+++...  .....+.+.+|+.++++++||||+++++++
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   79 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC   79 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccC---CCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence            34556888887 999999999999987532   156789999997642  345567788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                       ..+.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           80 -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             -cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence             456699999999999999998654 569999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCC
Q 013249          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFL  337 (447)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~  337 (447)
                      .......    .....||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+.... ..+|..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  238 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC  238 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCc
Confidence            7643322    223456889999999998889999999999999999998 999999888888777776653 4566777


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +.++.+++..      ||..||.+||     +++++++|
T Consensus       239 ~~~l~~li~~------~l~~~p~~Rp-----s~~~l~~~  266 (287)
T 1u59_A          239 PPELYALMSD------CWIYKWEDRP-----DFLTVEQR  266 (287)
T ss_dssp             CHHHHHHHHH------TTCSSGGGSC-----CHHHHHHH
T ss_pred             CHHHHHHHHH------HcCCChhhCc-----CHHHHHHH
Confidence            7777766555      9999999999     88999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=374.43  Aligned_cols=254  Identities=30%  Similarity=0.478  Sum_probs=208.7

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.++||+|+||+||+|+++.     +++.||||++.....  ....+.+.+|+.+|++++||||+++++++...
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   79 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECC-----CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence            34689999999999999999999986     788999999976542  23345677899999999999999999999875


Q ss_pred             C--EEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc----CCCCcEEEee
Q 013249          188 S--KLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMLTD  258 (447)
Q Consensus       188 ~--~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~~kL~D  258 (447)
                      .  ..|+||||++||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence            5  7899999999999999997643   39999999999999999999999999999999999999    7888899999


Q ss_pred             cCCcccccCCCCCCccccCCcccccccccC--------CCCCCccceeehhHhHHHHhhCCCCCCC----CCHHHHHHHH
Q 013249          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLS--------KGHNKDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRI  326 (447)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ell~G~~pf~~----~~~~~~~~~i  326 (447)
                      ||+++...........+||+.|+|||++.+        ..++.++|||||||++|||++|+.||..    ....+....+
T Consensus       160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            999998766555567789999999999875        5678899999999999999999999963    2334555555


Q ss_pred             HhcccC-------------------CC--CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          327 INEKVK-------------------LP--PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       327 ~~~~~~-------------------~p--~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..+...                   +|  ..++......+  .+||.+||+.||++|+     +++++++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l--~~ll~~~L~~dP~~R~-----s~~e~l~  302 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL--TPVLANILEADQEKCW-----GFDQFFA  302 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHH--HHHHHHHSCCCTTTSC-----CHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhc--hHHHHHhhccChhhhc-----cHHHHHH
Confidence            544321                   11  12223333332  3678889999999999     7787754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.6e-45  Score=352.26  Aligned_cols=256  Identities=23%  Similarity=0.369  Sum_probs=211.9

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++.+.||+|+||.||+|++....  .++..||+|++.+..  .....+.+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   82 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGII   82 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            3455678999999999999999999876422  245679999997653  334556788999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .++ ..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        83 ~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           83 EEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             cCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence            754 568999999999999999765 459999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCch
Q 013249          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~  339 (447)
                      .......  .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... ....+..++.
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP  241 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCH
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCH
Confidence            7644321  234567889999999998899999999999999999998 99999877776666666554 3345566777


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .+.+++.      +||..||.+||     ++++++++
T Consensus       242 ~l~~li~------~~l~~~p~~Rp-----s~~ell~~  267 (281)
T 3cc6_A          242 VLYTLMT------RCWDYDPSDRP-----RFTELVCS  267 (281)
T ss_dssp             HHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHH------HHccCCchhCc-----CHHHHHHH
Confidence            7666555      59999999999     78998874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-45  Score=358.52  Aligned_cols=258  Identities=21%  Similarity=0.340  Sum_probs=206.7

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|.+.+.||+|+||.||+|++....  .++..||+|++..... .....+.+.+|+.++++++||||+++++++
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQED--GTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTT--SCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccC--CceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3456678999999999999999999876522  2567899999976542 344556788999999999999999999999


Q ss_pred             EeCC-----EEEEEEeccCCCChHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc
Q 013249          185 QTRS-----KLYLILDFINGGHLFFHLYR------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (447)
Q Consensus       185 ~~~~-----~~~lv~E~~~gg~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~  253 (447)
                      ....     ..|+||||+.+++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            8755     35999999999999999853      356999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 013249          254 VMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE  329 (447)
Q Consensus       254 ~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~  329 (447)
                      +||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+...+...+...
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  265 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG  265 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence            9999999998764322   1233457889999999999999999999999999999999 99999988887777777665


Q ss_pred             -ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       330 -~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                       ....+..++.++.+++.      +||..||.+||     ++++++++
T Consensus       266 ~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~~l~~~  302 (313)
T 3brb_A          266 HRLKQPEDCLDELYEIMY------SCWRTDPLDRP-----TFSVLRLQ  302 (313)
T ss_dssp             CCCCCBTTCCHHHHHHHH------HTTCSSGGGSC-----CHHHHHHH
T ss_pred             CCCCCCccccHHHHHHHH------HHcCCChhhCc-----CHHHHHHH
Confidence             34456666766665554      59999999999     78898864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.6e-46  Score=363.03  Aligned_cols=251  Identities=21%  Similarity=0.318  Sum_probs=198.2

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|+++++||+|+||+||+|+++       ++.||||++....    ........|+.+|++++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL-------NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET-------TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             ccchhhchhhheecccCceEEEEEEEC-------CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            355678999999999999999999863       5789999997542    22334556899999999999999999998


Q ss_pred             eCC----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCCcccCCC
Q 013249          186 TRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC----------GIVHRDLKPENILMDSD  251 (447)
Q Consensus       186 ~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------~iiHrDikp~NILl~~~  251 (447)
                      ...    .+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++          ||+||||||+|||++.+
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence            743    58999999999999999976 4599999999999999999999999          99999999999999999


Q ss_pred             CcEEEeecCCcccccCCCC---CCccccCCcccccccccCC-----CCCCccceeehhHhHHHHhhCCCCCCCCC-----
Q 013249          252 GHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHAN-----  318 (447)
Q Consensus       252 ~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~ell~G~~pf~~~~-----  318 (447)
                      +.+||+|||+++.......   ....+||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+..     
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            9999999999987644322   3346899999999999873     45678899999999999999999996532     


Q ss_pred             -----------HHHHHHHHHhcccCCCCCCchh---HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          319 -----------RQKLQQRIINEKVKLPPFLTSE---AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       319 -----------~~~~~~~i~~~~~~~p~~~~~~---~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                                 ...+...+..... .| .....   ....-...+||.+||+.||++||     +++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  311 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKK-RP-VLRDYWQKHAGMAMLCETIEECWDHDAEARL-----SAGCVGE  311 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCC-CC-CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccC-CC-CccccccccchHHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence                       2223333322221 11 11111   01111235678889999999999     7888875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-45  Score=377.26  Aligned_cols=250  Identities=22%  Similarity=0.390  Sum_probs=213.4

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      .+.+..++|++.++||+|+||.||+|.++      .+..||||+++...    ...+.+.+|+.+|++++||||++++++
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~  251 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAV  251 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEET------TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEEC------CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            34566778999999999999999999986      45679999997643    234678899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      +. ...+|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus       252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence            86 56789999999999999999754  3689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCC
Q 013249          262 AKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (447)
Q Consensus       262 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (447)
                      ++......  ......+|..|+|||++....++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|..+
T Consensus       331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~  410 (454)
T 1qcf_A          331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC  410 (454)
T ss_dssp             GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTS
T ss_pred             ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            98764321  1223456789999999998899999999999999999999 99999999888888777655 33445667


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.++.+++.      +||..||++||     ++++|++
T Consensus       411 ~~~l~~li~------~cl~~dp~~RP-----t~~~i~~  437 (454)
T 1qcf_A          411 PEELYNIMM------RCWKNRPEERP-----TFEYIQS  437 (454)
T ss_dssp             CHHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             CHHHHHHHH------HHccCChhHCc-----CHHHHHH
Confidence            777666555      59999999999     7788875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.4e-45  Score=374.35  Aligned_cols=268  Identities=21%  Similarity=0.307  Sum_probs=212.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~  187 (447)
                      .++|+++++||+|+||.||+|+++.     +++.||||++......     ..+..|+.+++.+.| ++|..+..++...
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~   75 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG   75 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETT-----TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECC-----CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence            4689999999999999999999876     7889999998754322     236789999999987 5566666667788


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc---CCCCcEEEeecCCcc
Q 013249          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~~kL~DFG~a~  263 (447)
                      ...||||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+||||   +.++.+||+|||+++
T Consensus        76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            8999999999 9999999985 4679999999999999999999999999999999999999   688999999999998


Q ss_pred             cccCCCC--------CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC---HHHHHHHHHhcccC
Q 013249          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVK  332 (447)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~---~~~~~~~i~~~~~~  332 (447)
                      .+.....        ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+..   ....+..+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            7654322        226789999999999999999999999999999999999999997643   33444444433221


Q ss_pred             -----CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhh----------cCCccCCCChhHHHhhhcCCCCC
Q 013249          333 -----LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIK----------HHKWFRSINWKTLEAREMQPKFK  397 (447)
Q Consensus       333 -----~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~----------~h~~f~~~~~~~~~~~~~~~~~~  397 (447)
                           ++..++.++.++      |.+||..||++||     ++++|+          .++|+..++|..+..++.+.+..
T Consensus       235 ~~~~~l~~~~p~~l~~l------i~~cl~~dP~~RP-----s~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~  303 (483)
T 3sv0_A          235 TSIEALCRGYPTEFASY------FHYCRSLRFDDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASA  303 (483)
T ss_dssp             SCHHHHHTTSCHHHHHH------HHHHHTCCTTCCC-----CHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC--------
T ss_pred             ccHHHHhcCCcHHHHHH------HHHHhcCChhhCc-----CHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCC
Confidence                 224455565555      5559999999999     556553          37899999999998777766655


Q ss_pred             C
Q 013249          398 P  398 (447)
Q Consensus       398 p  398 (447)
                      |
T Consensus       304 p  304 (483)
T 3sv0_A          304 P  304 (483)
T ss_dssp             -
T ss_pred             C
Confidence            5

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.9e-45  Score=350.46  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=205.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhH----HHHHHHHHHHHHhcCCCCceeeeE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH----VDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      +..++|++.+.||+|+||.||+|+++.     +++.||+|++..........    .+.+.+|+.++++++||||+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVK-----DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG   90 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETT-----TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhhccceehhccccCCceeEEEEEEcC-----CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence            456789999999999999999999876     78899999987644322211    257889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccCCCCc-----E
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH-----V  254 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~-----~  254 (447)
                      ++.+..  ++||||+.+|+|.+.+... ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.     +
T Consensus        91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           91 LMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             EETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             eecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence            997766  6999999999998888655 47999999999999999999999999  999999999999988876     9


Q ss_pred             EEeecCCcccccCCCCCCccccCCccccccccc--CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHH--HHHHHhc-
Q 013249          255 MLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL--QQRIINE-  329 (447)
Q Consensus       255 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~--~~~i~~~-  329 (447)
                      ||+|||+++....  ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||...+....  ...+... 
T Consensus       169 kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          169 KVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             EECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             EeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence            9999999986543  344568999999999994  45678899999999999999999999976543332  3333333 


Q ss_pred             -ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          330 -KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       330 -~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                       ...++..++.++.+++.      +||+.||.+||     +++++++
T Consensus       247 ~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~~ll~  282 (287)
T 4f0f_A          247 LRPTIPEDCPPRLRNVIE------LCWSGDPKKRP-----HFSYIVK  282 (287)
T ss_dssp             CCCCCCTTSCHHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHH------HHhcCChhhCc-----CHHHHHH
Confidence             23455667777666655      49999999999     7888875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.7e-46  Score=382.53  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=216.3

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.++||+|+||.||+|+++.     ++..||||+++....    ..+.+.+|+.+|++++||||+++++++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~  285 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC  285 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGG-----GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcC-----CCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34556789999999999999999999985     678999999976432    345688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      .....+|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus       286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence            9999999999999999999999864  45899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      +.......  .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+... ....|..++
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  445 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  445 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            87644322  223456789999999998899999999999999999999 99999988877777666554 334566777


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++.+++.      +||+.||.+||     ++++|++
T Consensus       446 ~~l~~li~------~cl~~dP~~RP-----s~~el~~  471 (495)
T 1opk_A          446 EKVYELMR------ACWQWNPSDRP-----SFAEIHQ  471 (495)
T ss_dssp             HHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHH------HHcCcChhHCc-----CHHHHHH
Confidence            77766655      49999999999     7788875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=359.43  Aligned_cols=250  Identities=22%  Similarity=0.354  Sum_probs=204.5

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcE----EEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI----YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (447)
                      +..++|+++++||+|+||.||+|+++.     +++.    ||+|.+....  .....+.+.+|+.+++.++||||+++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~   84 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIP-----EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLG   84 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC-----TTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcC-----CCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence            456789999999999999999999876     3443    5666665432  2344567889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      ++.... .++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             EEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            998765 88999999999999999874 5799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCC
Q 013249          262 AKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPF  336 (447)
Q Consensus       262 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~  336 (447)
                      ++.......   .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+.... ...+..
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  243 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI  243 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            987643322   223456889999999999999999999999999999999 999999888877777666543 345566


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+.++.+++      .+||..||.+||     +++++++
T Consensus       244 ~~~~l~~li------~~~l~~dp~~Rp-----s~~ell~  271 (327)
T 3lzb_A          244 CTIDVYMIM------RKCWMIDADSRP-----KFRELII  271 (327)
T ss_dssp             BCHHHHHHH------HHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHH------HHHcCCChhHCc-----CHHHHHH
Confidence            677666554      459999999999     7899886

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6e-45  Score=353.26  Aligned_cols=251  Identities=27%  Similarity=0.455  Sum_probs=199.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|.++.     +++.||||++...........+.+.+|+.++++++||||+++++++...+
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLL-----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETT-----TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ccceEEEEeecCCCCceEEEEEEcC-----CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3579999999999999999999875     78899999998655445566677889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .+|+||||+.+++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            99999999999999998864    45699999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC--CHHHHHHHHHhcccC-C-CCCCch
Q 013249          265 IDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA--NRQKLQQRIINEKVK-L-PPFLTS  339 (447)
Q Consensus       265 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~--~~~~~~~~i~~~~~~-~-p~~~~~  339 (447)
                      ..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.  +...+...+...... . +..++.
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            64432 234567999999999999999999999999999999999999999654  344455555444322 1 134556


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.++      |.+||..||.+||     +++++++
T Consensus       266 ~l~~l------i~~~l~~dp~~Rp-----s~~~il~  290 (310)
T 2wqm_A          266 ELRQL------VNMCINPDPEKRP-----DVTYVYD  290 (310)
T ss_dssp             HHHHH------HHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHH------HHHHcCCChhhCC-----CHHHHHH
Confidence            65555      5559999999999     7888886

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.4e-45  Score=349.56  Aligned_cols=245  Identities=19%  Similarity=0.280  Sum_probs=198.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE-EeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~  187 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++......     ..+.+|+.+++.++|++++..+..+ ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcC-----CCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence            3589999999999999999999876     7889999987654322     2367899999999988777666555 677


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc---CCCCcEEEeecCCcc
Q 013249          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~~kL~DFG~a~  263 (447)
                      ...++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            8899999999 9999999975 4679999999999999999999999999999999999999   788999999999998


Q ss_pred             cccCCCC--------CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCH---HHHHHHHHhcccC
Q 013249          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR---QKLQQRIINEKVK  332 (447)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~---~~~~~~i~~~~~~  332 (447)
                      .......        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.   ......+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            7654322        2356899999999999999999999999999999999999999976432   2233333333333


Q ss_pred             CC-----CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          333 LP-----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       333 ~p-----~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+     ..++.++.+++.      +||+.||++||     +++++++
T Consensus       237 ~~~~~~~~~~~~~l~~li~------~~l~~~p~~Rp-----t~~~l~~  273 (296)
T 4hgt_A          237 TPIEVLCKGYPSEFATYLN------FCRSLRFDDKP-----DYSYLRQ  273 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHH------HHHTSCTTCCC-----CHHHHHH
T ss_pred             chhhhhhccCCHHHHHHHH------HHHhcCCCCCC-----CHHHHHH
Confidence            33     455666665554      59999999999     7788775

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.1e-45  Score=348.93  Aligned_cols=250  Identities=22%  Similarity=0.378  Sum_probs=212.1

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      ++.+..++|++++.||+|+||.||+|+++      .++.||||++.....    ..+.+.+|+.+|+.++||||++++++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAV   76 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc------CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            35566779999999999999999999875      456799999976432    23568899999999999999999998


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      +.. +.+|+||||+.+++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL  155 (279)
T ss_dssp             ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence            864 56899999999999999986543  699999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCC
Q 013249          262 AKEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFL  337 (447)
Q Consensus       262 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~  337 (447)
                      +........  .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.... ...+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (279)
T 1qpc_A          156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC  235 (279)
T ss_dssp             CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccc
Confidence            987654322  233457889999999998889999999999999999999 999999988888777776552 3345566


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.++.+++.      +||..||++||     +++++++
T Consensus       236 ~~~l~~li~------~~l~~~p~~Rp-----s~~~l~~  262 (279)
T 1qpc_A          236 PEELYQLMR------LCWKERPEDRP-----TFDYLRS  262 (279)
T ss_dssp             CHHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             cHHHHHHHH------HHhccChhhCC-----CHHHHHH
Confidence            666666555      59999999999     7788876

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-45  Score=353.89  Aligned_cols=255  Identities=22%  Similarity=0.372  Sum_probs=204.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.+.||+|+||.||+|++....  ..+..||||+++..........+.+.+|+.++++++||||+++++++..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            34568999999999999999999875421  1334699999987654455667788999999999999999999999987


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .. .++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 89999999999999998764 57999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccC--CCCCCc
Q 013249          266 DESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK--LPPFLT  338 (447)
Q Consensus       266 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~--~p~~~~  338 (447)
                      .....    .....+|..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+......  .+..++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            44322    234467889999999998889999999999999999999 99999999988888887765433  344566


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++.+++.      +||..||.+||     +++++++
T Consensus       252 ~~l~~li~------~~l~~~p~~Rp-----s~~~l~~  277 (291)
T 1u46_A          252 QDIYNVMV------QCWAHKPEDRP-----TFVALRD  277 (291)
T ss_dssp             HHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHH------HHccCCcccCc-----CHHHHHH
Confidence            66665554      59999999999     7889886

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.5e-45  Score=350.90  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=195.0

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      ...+..++|++.++||+|+||.||+|+++        ..+|+|+++... ......+.+.+|+.+|++++||||++++++
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESS--------SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEc--------CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            34577789999999999999999999753        349999997654 244556778999999999999999999985


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      + ....+++||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence            4 566789999999999999998644 56999999999999999999999999999999999999999999999999999


Q ss_pred             ccccC---CCCCCccccCCccccccccc---CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHH-HHHHHHhcccCC--
Q 013249          263 KEIDE---SSRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK-LQQRIINEKVKL--  333 (447)
Q Consensus       263 ~~~~~---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~-~~~~i~~~~~~~--  333 (447)
                      +....   ........||+.|+|||++.   +..++.++|||||||++|+|++|+.||...+..+ +...+.......  
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence            86543   22234567999999999997   5668889999999999999999999998755444 444444333221  


Q ss_pred             ---CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          334 ---PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       334 ---p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                         +..++.++.+      ||.+||..||.+||     +++++++
T Consensus       248 ~~~~~~~~~~l~~------li~~~l~~~p~~Rp-----s~~ell~  281 (289)
T 3og7_A          248 SKVRSNCPKRMKR------LMAECLKKKRDERP-----SFPRILA  281 (289)
T ss_dssp             TSSCTTSCHHHHH------HHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             hhccccCCHHHHH------HHHHHccCChhhCC-----CHHHHHH
Confidence               2234455544      45569999999999     7788875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=362.95  Aligned_cols=255  Identities=17%  Similarity=0.193  Sum_probs=198.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchh--------HHHHHHHHHHHHHhcCCCCce
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--------HVDYMKAERDILTKVTHPFIV  178 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv  178 (447)
                      +..++|++.+.||+|+||.||+|+++...  .++..+|||++.........        ....+.+|+.+++.++||||+
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKP--EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSC--GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCC--CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            34568999999999999999999987532  26778999998764321111        112355788899999999999


Q ss_pred             eeeEEEEe----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC--
Q 013249          179 QLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--  252 (447)
Q Consensus       179 ~l~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~--  252 (447)
                      ++++++..    ...+|+||||+ |++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||||+.++  
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            99999988    78899999999 999999998888999999999999999999999999999999999999998887  


Q ss_pred             cEEEeecCCcccccCCC--------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCC--CCHHHH
Q 013249          253 HVMLTDFGLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--ANRQKL  322 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~--~~~~~~  322 (447)
                      .+||+|||+++.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||..  .+....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            99999999998763321        12456799999999999999999999999999999999999999965  333333


Q ss_pred             HHHHHhcccCCCC---------CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          323 QQRIINEKVKLPP---------FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       323 ~~~i~~~~~~~p~---------~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ..........+|.         .++.++.++      |.+||..||++||     ++++|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l------i~~~l~~dp~~Rp-----s~~~l~~  321 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQF------LVCAHSLAYDEKP-----NYQALKK  321 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHH------HHHHHTCCTTCCC-----CHHHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHH------HHHHhhcCcccCC-----CHHHHHH
Confidence            3322222222332         445555554      5559999999999     7888875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.2e-45  Score=349.12  Aligned_cols=243  Identities=24%  Similarity=0.414  Sum_probs=207.8

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----  186 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  186 (447)
                      +|++++.||+|+||.||+|+++.     +++.||+|++....       +.+.+|+.++++++||||+++++++..    
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRI-----DGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETT-----TCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             ccceeeeeccCCceEEEEEEEcC-----CCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            69999999999999999999875     78899999997542       135689999999999999999999865    


Q ss_pred             ------------CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC
Q 013249          187 ------------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       187 ------------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  252 (447)
                                  ...+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence                        45689999999999999999765  6799999999999999999999999999999999999999999


Q ss_pred             cEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 013249          253 HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK  332 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~  332 (447)
                      .+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||...  ......+...  .
T Consensus       160 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~  235 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--I  235 (284)
T ss_dssp             EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--C
T ss_pred             CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--c
Confidence            99999999999876655556678999999999999999999999999999999999999988432  2233333322  3


Q ss_pred             CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       333 ~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      ++..++.++.+++      .+||..||.+||     +++++++|.|.-
T Consensus       236 ~~~~~~~~~~~li------~~~l~~dp~~Rp-----s~~e~l~~l~~~  272 (284)
T 2a19_B          236 ISDIFDKKEKTLL------QKLLSKKPEDRP-----NTSEILRTLTVW  272 (284)
T ss_dssp             CCTTSCHHHHHHH------HHHTCSSGGGSC-----CHHHHHHHHHHH
T ss_pred             ccccCCHHHHHHH------HHHccCChhhCc-----CHHHHHHHHHHH
Confidence            4556666666554      459999999999     889999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-44  Score=347.48  Aligned_cols=245  Identities=19%  Similarity=0.284  Sum_probs=202.5

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE-EeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~  187 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++......     +.+.+|+.+++.++|++++..+..+ ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcC-----CCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence            3689999999999999999999876     7889999998754321     2477899999999988766665555 667


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCccc---CCCCcEEEeecCCcc
Q 013249          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~~kL~DFG~a~  263 (447)
                      ...|+||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            8899999999 9999999974 4679999999999999999999999999999999999999   488999999999998


Q ss_pred             cccCCCC--------CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC---HHHHHHHHHhcccC
Q 013249          264 EIDESSR--------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVK  332 (447)
Q Consensus       264 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~---~~~~~~~i~~~~~~  332 (447)
                      .......        .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+   .......+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            7654322        245689999999999999999999999999999999999999997632   22344444444333


Q ss_pred             CC-----CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          333 LP-----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       333 ~p-----~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+     ..++.++.+++.      +||+.||.+||     +++++++
T Consensus       237 ~~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~~l~~  273 (296)
T 3uzp_A          237 TPIEVLCKGYPSEFATYLN------FCRSLRFDDKP-----DYSYLRQ  273 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHH------HHHTSCTTCCC-----CHHHHHH
T ss_pred             CchHHHHhhCCHHHHHHHH------HHHhcCcCcCC-----CHHHHHH
Confidence            33     556666666555      59999999999     7788875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6e-45  Score=356.19  Aligned_cols=255  Identities=25%  Similarity=0.406  Sum_probs=209.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE-
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  185 (447)
                      +..++|++++.||+|+||.||+|+++.... .+++.||||++...   .....+.+.+|+.+|++++||||+++++++. 
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   95 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYG   95 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSS-SCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCC-CcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence            455689999999999999999999653222 37889999999764   2344567889999999999999999999987 


Q ss_pred             -eCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          186 -TRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       186 -~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                       +...+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence             45679999999999999999976 4569999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC----CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH---------------HHHH
Q 013249          264 EIDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------------KLQQ  324 (447)
Q Consensus       264 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---------------~~~~  324 (447)
                      ......    ......||..|+|||++.+..++.++|||||||++|+|++|..||......               .+..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            764432    223456888999999999988999999999999999999999999654322               1222


Q ss_pred             HHHhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          325 RIINE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       325 ~i~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .+... ....+..++.++.+++.      +||+.||++||     ++++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~------~~l~~dP~~Rp-----s~~ell~~  297 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRP-----SFSALGPQ  297 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HhhcccCCCCCCcccHHHHHHHH------HHcCCChhhCc-----CHHHHHHH
Confidence            22222 23445667777666555      49999999999     78888653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.9e-45  Score=372.25  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=208.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.++||+|+||.||+|.+++      +..||||+++....    ..+.+.+|+.+|++++||||+++++++
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC------CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45666789999999999999999999863      45699999986432    234688999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      .+ +.+|+||||+.+|+|.+++...  ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence            76 6789999999999999999643  56999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      +.......  .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|..++
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  407 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  407 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            87643321  223457789999999998899999999999999999999 99999999888888777655 334566677


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++.+++.      +||+.||++||     ++++|++
T Consensus       408 ~~l~~li~------~cl~~dP~~Rp-----t~~~l~~  433 (452)
T 1fmk_A          408 ESLHDLMC------QCWRKEPEERP-----TFEYLQA  433 (452)
T ss_dssp             HHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHH------HHccCChhhCc-----CHHHHHH
Confidence            77666555      59999999999     7888876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.5e-45  Score=349.37  Aligned_cols=246  Identities=24%  Similarity=0.425  Sum_probs=203.0

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.+.||+|+||.||++++       .++.||||++....     ..+.+.+|+.++++++||||+++++++
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDY-------RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI   83 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE-------TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEE-------cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            445667999999999999999999986       35689999987542     345688999999999999999999997


Q ss_pred             EeC-CEEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          185 QTR-SKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       185 ~~~-~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      ... +.+|+||||+++++|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence            554 579999999999999999976643  89999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCch
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~  339 (447)
                      +......  .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+... ....+..++.
T Consensus       164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (278)
T 1byg_A          164 TKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  241 (278)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred             ccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCH
Confidence            9865442  233467899999999999999999999999999999998 99999988877777766554 3445666777


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.++++      +||..||.+||     +++++++
T Consensus       242 ~l~~li~------~~l~~~p~~Rp-----s~~~l~~  266 (278)
T 1byg_A          242 AVYEVMK------NCWHLDAAMRP-----SFLQLRE  266 (278)
T ss_dssp             HHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHH------HHhcCChhhCC-----CHHHHHH
Confidence            7766655      49999999999     7788875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-44  Score=349.06  Aligned_cols=251  Identities=20%  Similarity=0.326  Sum_probs=206.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE-EeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~  188 (447)
                      .+|++.++||+|+||.||+|++....  .....+|+|.+...  ......+.+.+|+.++++++||||+++++++ ...+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            46999999999999999999876421  14456899988753  2345567788999999999999999999986 4566


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      ..|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            889999999999999999764 5689999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccC-CCCCCchh
Q 013249          268 SS-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK-LPPFLTSE  340 (447)
Q Consensus       268 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~-~p~~~~~~  340 (447)
                      ..     ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+...... .|..++.+
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  260 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence            21     2334567889999999999999999999999999999999 77888877777766666665443 35566776


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.+++.      +||..||++||     +++++++
T Consensus       261 l~~li~------~~l~~~p~~Rp-----s~~ell~  284 (298)
T 3f66_A          261 LYEVML------KCWHPKAEMRP-----SFSELVS  284 (298)
T ss_dssp             HHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHH------HHcCCChhhCc-----CHHHHHH
Confidence            665554      59999999999     7888876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-44  Score=345.80  Aligned_cols=250  Identities=22%  Similarity=0.351  Sum_probs=208.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|.+.++||+|+||.||+|++....  ..+..+|+|++...  ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCC--Cceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            4777899999999999999986522  24457999998753  2345567788999999999999999999999876655


Q ss_pred             -EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          191 -YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       191 -~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                       ++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             999999999999999976 356899999999999999999999999999999999999999999999999999865322


Q ss_pred             -----CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhH
Q 013249          269 -----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEA  341 (447)
Q Consensus       269 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~  341 (447)
                           .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..++...+.... ...+..++.++
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence                 22344578899999999999999999999999999999999 566677777776666666543 34556677766


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+++.      +||..||.+||     +++++++
T Consensus       258 ~~li~------~~l~~~p~~Rp-----s~~~ll~  280 (298)
T 3pls_A          258 YQVMQ------QCWEADPAVRP-----TFRVLVG  280 (298)
T ss_dssp             HHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHH------HHccCChhhCc-----CHHHHHH
Confidence            66555      59999999999     7888886

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-45  Score=360.66  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=204.5

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++.+.||+|+||.||+|+++      +++.||||++....   ....+.+.+|+.+++.++||||+++++++...
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            4568999999999999999999854      57889999887542   34456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +.+|+||||+++|+|.+++....    .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999999886543    58999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC---CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHH------H-HHHhccc--
Q 013249          264 EIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ------Q-RIINEKV--  331 (447)
Q Consensus       264 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~------~-~i~~~~~--  331 (447)
                      .....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      . .......  
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            65322   2234456899999999999889999999999999999999999999754322111      1 1111110  


Q ss_pred             ----CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          332 ----KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       332 ----~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                          ..+.....+..  -...+++.+||+.||++||     +++++++|
T Consensus       268 ~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rp-----s~~ell~~  309 (321)
T 2qkw_B          268 IVDPNLADKIRPESL--RKFGDTAVKCLALSSEDRP-----SMGDVLWK  309 (321)
T ss_dssp             SSSSSCTTCSCHHHH--HHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hcChhhccccCHHHH--HHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence                11111222211  1234678889999999999     88999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-44  Score=382.99  Aligned_cols=249  Identities=20%  Similarity=0.319  Sum_probs=209.3

Q ss_pred             CcEEE-eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       111 ~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      .+.+. ++||+|+||.||+|.++..   ..++.||||+++... ......+.+.+|+.+|++++|||||++++++.. +.
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  443 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES  443 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECS---SCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             hccccCCEeccCCCEEEEEEEEcCC---CcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence            34443 4899999999999976531   256889999997653 334456778999999999999999999999865 45


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            89999999999999999998899999999999999999999999999999999999999999999999999998764332


Q ss_pred             C----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhHHh
Q 013249          270 R----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHS  343 (447)
Q Consensus       270 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~  343 (447)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+. ...|..++.++.+
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  603 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD  603 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1    223456789999999999999999999999999999998 999999999888888877653 4567777877776


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++..      ||..||++||     ++++|++
T Consensus       604 li~~------cl~~dP~~RP-----s~~~l~~  624 (635)
T 4fl3_A          604 LMNL------CWTYDVENRP-----GFAAVEL  624 (635)
T ss_dssp             HHHH------HTCSSTTTSC-----CHHHHHH
T ss_pred             HHHH------HcCCCHhHCc-----CHHHHHH
Confidence            6555      9999999999     7788765

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9e-45  Score=352.96  Aligned_cols=250  Identities=24%  Similarity=0.426  Sum_probs=199.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.+.||+|+||.||+|+++.     +++.||||++...   .....+.+.+|+.+++.++||||+++++++..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLH-----DGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecC-----CCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            455689999999999999999999876     7889999998653   23455678899999999999999999999873


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEee
Q 013249          187 ----RSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD  258 (447)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~D  258 (447)
                          ...+|+||||+.+|+|.+++..    ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence                3479999999999999999876    46799999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCC----------CCccccCCcccccccccCCC---CCCccceeehhHhHHHHhhCCCCCCCCCH--HHHH
Q 013249          259 FGLAKEIDESSR----------SNSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHANR--QKLQ  323 (447)
Q Consensus       259 FG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell~G~~pf~~~~~--~~~~  323 (447)
                      ||++........          .....||+.|+|||++.+..   ++.++|||||||++|+|++|+.||.....  ....
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  257 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA  257 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence            999876432111          12345799999999997654   68999999999999999999999953110  1111


Q ss_pred             HHHHhcccCC--CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          324 QRIINEKVKL--PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       324 ~~i~~~~~~~--p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ..+ .....+  +..++.++.++      |.+||+.||.+||     ++++++++
T Consensus       258 ~~~-~~~~~~~~~~~~~~~l~~l------i~~~l~~dp~~Rp-----s~~~ll~~  300 (317)
T 2buj_A          258 LAV-QNQLSIPQSPRHSSALWQL------LNSMMTVDPHQRP-----HIPLLLSQ  300 (317)
T ss_dssp             HHH-HCC--CCCCTTSCHHHHHH------HHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHh-hccCCCCccccCCHHHHHH------HHHHhhcChhhCC-----CHHHHHHH
Confidence            222 222223  33556666555      4559999999999     88999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=364.19  Aligned_cols=250  Identities=16%  Similarity=0.318  Sum_probs=197.4

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeee
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLR  181 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~  181 (447)
                      ..+..++|.+.++||+|+||+||+|.++...+..+++.||||++....      ...+..|+.+++.++   |+||++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            345667899999999999999999965433333478899999987542      234667888888887   89999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC------
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS------  250 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~------  250 (447)
                      +++...+..|+||||++||+|.+++..     .+.+++..++.++.||+.||+|||++|||||||||+||||+.      
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence            999999999999999999999999974     457999999999999999999999999999999999999998      


Q ss_pred             -----CCcEEEeecCCccccc---CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHH
Q 013249          251 -----DGHVMLTDFGLAKEID---ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL  322 (447)
Q Consensus       251 -----~~~~kL~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~  322 (447)
                           ++.+||+|||+|+.+.   ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... 
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-  292 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-  292 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence                 8999999999997653   2233456789999999999999999999999999999999999999995432210 


Q ss_pred             HHHHHhcccCCCC-CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          323 QQRIINEKVKLPP-FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       323 ~~~i~~~~~~~p~-~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                          ......++. ..+....      +++.+||+.+|.+|+.    +++++.+
T Consensus       293 ----~~~~~~~~~~~~~~~~~------~~~~~~l~~~p~~r~~----~~~~l~~  332 (365)
T 3e7e_A          293 ----CKPEGLFRRLPHLDMWN------EFFHVMLNIPDCHHLP----SLDLLRQ  332 (365)
T ss_dssp             ----EEECSCCTTCSSHHHHH------HHHHHHHCCCCTTCCC----CHHHHHH
T ss_pred             ----eeechhccccCcHHHHH------HHHHHHcCCCCCCcch----HHHHHHH
Confidence                000111111 1233333      4566699999999973    4555543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-44  Score=366.51  Aligned_cols=251  Identities=27%  Similarity=0.409  Sum_probs=192.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (447)
                      +.|.+.++||+|+||+||.+...      +++.||||++....      .+.+.+|+.+|+++ +||||+++++++.+..
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~------~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF------QGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES------SSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             heeeccCeEeeCCCeEEEEEEEE------CCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            35677889999999999875432      68899999987542      23567899999876 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCC-------HHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC----------
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFR-------EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------  251 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~-------~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~----------  251 (447)
                      .+|+|||||. |+|.+++...+...       +..++.++.||+.||+|||++||+||||||+||||+.+          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999996 59999998764332       33457899999999999999999999999999999654          


Q ss_pred             ---CcEEEeecCCcccccCCCC-----CCccccCCcccccccccC-------CCCCCccceeehhHhHHHHhh-CCCCCC
Q 013249          252 ---GHVMLTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFT  315 (447)
Q Consensus       252 ---~~~kL~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~-G~~pf~  315 (447)
                         +.+||+|||+++.......     ....+||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               4899999999997654321     234689999999999976       668999999999999999999 999997


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC---chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          316 HANRQKLQQRIINEKVKLPPFL---TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       316 ~~~~~~~~~~i~~~~~~~p~~~---~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      ......  ..+......++...   ....  .....+||.+||+.||.+||     ++.++++||||...
T Consensus       242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rp-----s~~eil~hp~f~~~  302 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLDEMKCLHDRSL--IAEATDLISQMIDHDPLKRP-----TAMKVLRHPLFWPK  302 (434)
T ss_dssp             STTTHH--HHHHHTCCCCCCCTTCCCHHH--HHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSCH
T ss_pred             CchhhH--HHHhcCCCCcccccccccccc--hHHHHHHHHHHhhCChhhCC-----CHHHHHhCCccCCc
Confidence            654433  34444444433221   1111  11234677789999999999     88999999999754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.2e-44  Score=350.97  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=204.4

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RS  188 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~  188 (447)
                      .|+++++||+|+||+||++.++.... .+++.||||++....  .....+.+.+|+.+|++++||||+++++++.+  ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCC-CCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            34999999999999999998764332 378899999998652  34456678899999999999999999999987  46


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            899999999999999998664 5899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH---------------HHHHHHHh-
Q 013249          269 SR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------------KLQQRIIN-  328 (447)
Q Consensus       269 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---------------~~~~~i~~-  328 (447)
                      ..    .....||..|+|||++.+..++.++|||||||++|+|++|..||......               .+...+.. 
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            22    23456888999999999988999999999999999999999999653221               11111111 


Q ss_pred             cccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          329 EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       329 ~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .....+..++.++.++++      +||+.||.+||     +++++++
T Consensus       268 ~~~~~~~~~~~~l~~li~------~~l~~dP~~Rp-----s~~ell~  303 (318)
T 3lxp_A          268 ERLPRPDKCPAEVYHLMK------NCWETEASFRP-----TFENLIP  303 (318)
T ss_dssp             CCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             cCCCCCccccHHHHHHHH------HHcCCCcccCc-----CHHHHHH
Confidence            123445666777666555      49999999999     7888885

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.9e-44  Score=348.08  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=204.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      ...|++++.||+|+||.||+|++.... ..+++.||||++....  .....+.+.+|+.+|+.++||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTS-SSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEcccc-CccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            346999999999999999999964322 2378899999997653  334456788999999999999999999999876 


Q ss_pred             -CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          188 -SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       188 -~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                       ..+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence             679999999999999999954 467999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCC----CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC--------------C-HHHHHHHH
Q 013249          266 DESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA--------------N-RQKLQQRI  326 (447)
Q Consensus       266 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~--------------~-~~~~~~~i  326 (447)
                      ....    ......||..|+|||++.+..++.++|||||||++|+|++|..|+...              . ...+...+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            5433    233456888999999999999999999999999999999999886422              1 11222222


Q ss_pred             Hh-cccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          327 IN-EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       327 ~~-~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .. .....+..++.++.+++.      +||..||.+||     +++++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~------~~l~~dp~~Rp-----s~~~ll~  295 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLMR------KCWEFQPSNRT-----SFQNLIE  295 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHH------HTTCSSGGGSC-----CHHHHHH
T ss_pred             hccCCCCCCCCCCHHHHHHHH------HHcCCCCCCCC-----CHHHHHH
Confidence            22 233456667777766655      49999999999     7888875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=353.02  Aligned_cols=246  Identities=27%  Similarity=0.452  Sum_probs=183.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  185 (447)
                      +...+|++.++||+|+||.||+|+++.     +++.||||++....   ....+.+.+|+.+++++. ||||+++++++.
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVG-----SGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECC-----CCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            344589999999999999999999886     78899999986542   344556889999999996 999999999994


Q ss_pred             --------eCCEEEEEEeccCCCChHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccCCCC
Q 013249          186 --------TRSKLYLILDFINGGHLFFHLYR---QGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDG  252 (447)
Q Consensus       186 --------~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~  252 (447)
                              ....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+||||+.++
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence                    3456899999996 688888765   467999999999999999999999999  99999999999999999


Q ss_pred             cEEEeecCCcccccCCCC-------------CCccccCCcccccccc---cCCCCCCccceeehhHhHHHHhhCCCCCCC
Q 013249          253 HVMLTDFGLAKEIDESSR-------------SNSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLTGQPPFTH  316 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~ell~G~~pf~~  316 (447)
                      .+||+|||+++.......             ....+||+.|+|||++   .+..++.++|||||||++|+|++|+.||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            999999999987654322             1245699999999998   566788999999999999999999999976


Q ss_pred             CCHHHHHHHHHhcccCC--CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          317 ANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       317 ~~~~~~~~~i~~~~~~~--p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .....+.    ......  +...+..+.+      ||.+||+.||.+||     +++++++|
T Consensus       256 ~~~~~~~----~~~~~~~~~~~~~~~~~~------li~~~l~~~p~~Rp-----s~~e~l~~  302 (337)
T 3ll6_A          256 GAKLRIV----NGKYSIPPHDTQYTVFHS------LIRAMLQVNPEERL-----SIAEVVHQ  302 (337)
T ss_dssp             --------------CCCCTTCCSSGGGHH------HHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred             hhHHHhh----cCcccCCcccccchHHHH------HHHHHccCChhhCc-----CHHHHHHH
Confidence            5544332    222222  2334444444      56669999999999     88999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=377.06  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=211.2

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.++||+|+||.||+|.+++      +..||||+++....    ..+.+.+|+.+|++++||||+++++++.
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~  332 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS  332 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT------TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC------CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3555679999999999999999999863      45699999986532    2346889999999999999999999987


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      + ..+||||||+.+|+|.+++...  ..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus       333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            6 6789999999999999999743  569999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCch
Q 013249          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~  339 (447)
                      ......  ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....++...+..+ ....|..++.
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  491 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE  491 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            764321  1223456789999999998899999999999999999999 99999998888888777655 3345666777


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.+++.      +||+.||++||     ++++|++
T Consensus       492 ~l~~li~------~cl~~dP~~RP-----t~~~l~~  516 (535)
T 2h8h_A          492 SLHDLMC------QCWRKEPEERP-----TFEYLQA  516 (535)
T ss_dssp             HHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHH------HHcCCChhHCc-----CHHHHHH
Confidence            7666554      59999999999     7788876

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=380.24  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=210.8

Q ss_pred             CcCCCCcEEEe-eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          106 KIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       106 ~~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      .+..+++.+.+ .||+|+||.||+|.++...   .+..||||+++...  .....+.+.+|+.+|++++|||||++++++
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~  405 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC  405 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSS---CEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCC---CcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence            34556777777 8999999999999886422   45679999997652  334556788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .. +.+|+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus       406 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          406 QA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             ES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             cc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            76 5699999999999999998754 569999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCC
Q 013249          264 EIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFL  337 (447)
Q Consensus       264 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~  337 (447)
                      .+.....    .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+. ..+|..+
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~  564 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC  564 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTC
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence            7643221    122345689999999999999999999999999999998 999999988888888777653 4567777


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +.++.+++..      ||..||.+||     ++++|++
T Consensus       565 ~~~l~~li~~------cl~~dP~~RP-----s~~~l~~  591 (613)
T 2ozo_A          565 PPELYALMSD------CWIYKWEDRP-----DFLTVEQ  591 (613)
T ss_dssp             CHHHHHHHHH------TTCSSTTTSC-----CHHHHHH
T ss_pred             CHHHHHHHHH------HcCCChhHCc-----CHHHHHH
Confidence            8877766555      9999999999     7777764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-45  Score=363.01  Aligned_cols=251  Identities=20%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE-eCCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~  189 (447)
                      .|++.++||+|+||.||+|++....  ..+..||+|.++..  ......+.+.+|+.++++++||||+++++++. ..+.
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            5889999999999999999876411  13456899998653  23455677889999999999999999999875 4568


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .|+||||+.+|+|.+++... ..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            89999999999999999765 45899999999999999999999999999999999999999999999999999865432


Q ss_pred             C-----CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCchhH
Q 013249          269 S-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSEA  341 (447)
Q Consensus       269 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~  341 (447)
                      .     ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...+..++...+..+.. ..|..++.++
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            2     1233467889999999999999999999999999999999 7889987776666666665543 3456677766


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .+++.      +||..||++||     ++++++++
T Consensus       326 ~~li~------~cl~~dp~~RP-----s~~ell~~  349 (373)
T 3c1x_A          326 YEVML------KCWHPKAEMRP-----SFSELVSR  349 (373)
T ss_dssp             HHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHH------HHcCCChhhCc-----CHHHHHHH
Confidence            66554      59999999999     78898863

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=356.36  Aligned_cols=247  Identities=16%  Similarity=0.239  Sum_probs=198.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCC---CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCcee------
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ------  179 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~------  179 (447)
                      .++|++.+.||+|+||.||+|+++.+...   ..++.||||++...        +.+.+|+.++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            46899999999999999999998753211   03678999998754        24678999999999999987      


Q ss_pred             ---------eeEEEEe-CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcc
Q 013249          180 ---------LRYSFQT-RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (447)
Q Consensus       180 ---------l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NIL  247 (447)
                               +++++.. ...+|+||||+ +++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5677766 78899999999 99999999886  78999999999999999999999999999999999999


Q ss_pred             cCCCC--cEEEeecCCcccccCCC--------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC
Q 013249          248 MDSDG--HVMLTDFGLAKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA  317 (447)
Q Consensus       248 l~~~~--~~kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~  317 (447)
                      ++.++  .+||+|||+++.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  99999999998754321        123458999999999999999999999999999999999999999765


Q ss_pred             --CHHHHHHHHH---hcccCCCC------CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          318 --NRQKLQQRII---NEKVKLPP------FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       318 --~~~~~~~~i~---~~~~~~p~------~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                        +...+...+.   .....++.      .++.++.++      |.+||..||++||     ++++|++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l------i~~~l~~dp~~Rp-----s~~~l~~  329 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKY------LKVVMALTYEEKP-----PYAMLRN  329 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHH------HHHHHTCCTTCCC-----CHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHH------HHHHHhCChhhCC-----CHHHHHH
Confidence              3333333322   12122211      235555555      5559999999999     7888876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.7e-44  Score=345.00  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=192.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh--cCCCCceeeeEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSF  184 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~  184 (447)
                      +..++|++++.||+|+||+||+|++       +++.||||++....      ...+..|.+++..  ++||||+++++++
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-------QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-------TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-------CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            3456899999999999999999986       46789999986542      2335567777776  7899999999987


Q ss_pred             Ee----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCcccCCCC
Q 013249          185 QT----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       185 ~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~iiHrDikp~NILl~~~~  252 (447)
                      ..    ...+|+||||+++|+|.+++. ...+++..+..++.||+.||.|||        ++||+||||||+|||++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence            54    356899999999999999994 457999999999999999999999        99999999999999999999


Q ss_pred             cEEEeecCCcccccCCCC-----CCccccCCcccccccccCC------CCCCccceeehhHhHHHHhhC----------C
Q 013249          253 HVMLTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTG----------Q  311 (447)
Q Consensus       253 ~~kL~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~ell~G----------~  311 (447)
                      .+||+|||+++.......     ....+||+.|+|||++.+.      .++.++|||||||++|||++|          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            999999999987544322     2345899999999999876      455789999999999999999          8


Q ss_pred             CCCCCCC----HHHHHHHHHhcccCCCCCCchhH--HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          312 PPFTHAN----RQKLQQRIINEKVKLPPFLTSEA--HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       312 ~pf~~~~----~~~~~~~i~~~~~~~p~~~~~~~--~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .||....    .......+.......+.......  ...-...+||.+||+.||++||     +++++++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~i~~  295 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL-----TALRIKK  295 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC-----CHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC-----CHHHHHH
Confidence            8985421    12222222222222221111000  0111234677889999999999     7888875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=348.51  Aligned_cols=242  Identities=29%  Similarity=0.464  Sum_probs=194.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.+.||+|+||.||+|+++       ++.||||++...     ...+.+.+|+.+|++++||||+++++++.+
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   72 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR-------AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN   72 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET-------TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC-------CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            45568999999999999999999874       467999998643     234568899999999999999999998874


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCCcccCCCCc-EEEeec
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHK---CGIVHRDLKPENILMDSDGH-VMLTDF  259 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~iiHrDikp~NILl~~~~~-~kL~DF  259 (447)
                        ..|+||||++||+|.+++...+   .+++..+..++.||+.||.|||+   +||+||||||+|||++.++. +||+||
T Consensus        73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence              4799999999999999998765   37899999999999999999999   89999999999999998886 799999


Q ss_pred             CCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCC--HHHHHHHHHhc-ccCCCCC
Q 013249          260 GLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRIINE-KVKLPPF  336 (447)
Q Consensus       260 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~--~~~~~~~i~~~-~~~~p~~  336 (447)
                      |++......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||....  ...+...+... ....+..
T Consensus       151 g~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (307)
T 2eva_A          151 GTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN  228 (307)
T ss_dssp             CC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTT
T ss_pred             ccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccc
Confidence            999865432  234579999999999999999999999999999999999999997543  23333333332 3334556


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.++.++      |.+||+.||.+||     +++++++
T Consensus       229 ~~~~l~~l------i~~~l~~dp~~Rp-----s~~ell~  256 (307)
T 2eva_A          229 LPKPIESL------MTRCWSKDPSQRP-----SMEEIVK  256 (307)
T ss_dssp             CCHHHHHH------HHHHTCSSGGGSC-----CHHHHHH
T ss_pred             cCHHHHHH------HHHHhcCChhhCc-----CHHHHHH
Confidence            66666555      4559999999999     7888886

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.5e-45  Score=356.65  Aligned_cols=257  Identities=21%  Similarity=0.333  Sum_probs=202.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++.+.||+|+||.||+|+++      +++.||||++.......  ....+.+|+.+++.++||||+++++++..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   98 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMT   98 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred             HHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEec
Confidence            45678999999999999999999743      57889999997654221  12257889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCcccCCCCcEEEeec
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVMLTDF  259 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~iiHrDikp~NILl~~~~~~kL~DF  259 (447)
                      ....++||||+.+|+|.+++....    .+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df  178 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF  178 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence            999999999999999999998653    499999999999999999999999   9999999999999999999999999


Q ss_pred             CCcccccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC----CHHHHHHHHHhccc--
Q 013249          260 GLAKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKV--  331 (447)
Q Consensus       260 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~----~~~~~~~~i~~~~~--  331 (447)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...    ..............  
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            9998764322  234456999999999999888999999999999999999999999521    10001111111100  


Q ss_pred             -C--------CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCc
Q 013249          332 -K--------LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW  378 (447)
Q Consensus       332 -~--------~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~  378 (447)
                       .        .......+.  .-...+++.+||+.||.+||     +++++++|-.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~Rp-----s~~ell~~L~  307 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEE--VEQLIQVALLCTQSSPMERP-----KMSEVVRMLE  307 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHH--HHHHHHHHHHHTCSCGGGSC-----CHHHHHHHHH
T ss_pred             hhhhhhcChhhccccCHHH--HHHHHHHHHHHhCcCCccCC-----CHHHHHHHhc
Confidence             0        111111111  11235678889999999999     8899998744

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-43  Score=342.64  Aligned_cols=227  Identities=29%  Similarity=0.573  Sum_probs=184.5

Q ss_pred             CCcEEE-eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHH-HhcCCCCceeeeEEEEe-
Q 013249          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQT-  186 (447)
Q Consensus       110 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~-  186 (447)
                      ++|.+. ++||+|+||.||+|.++.     +++.||||++...        ..+.+|+.++ +.++||||+++++++.. 
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcC-----CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            478887 789999999999999876     7889999998643        2356788887 56689999999999987 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEEee
Q 013249          187 ---RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTD  258 (447)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL~D  258 (447)
                         ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               678999999999999999998764  6999999999999999999999999999999999999998   78999999


Q ss_pred             cCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHH----HhcccCCC
Q 013249          259 FGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI----INEKVKLP  334 (447)
Q Consensus       259 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i----~~~~~~~p  334 (447)
                      ||++....                     +..++.++|||||||++|||++|+.||...+.......+    ......++
T Consensus       164 fg~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          164 FGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             CTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             cccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            99986543                     244778999999999999999999999776544332111    11122222


Q ss_pred             ----CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 ----PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 ----~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                          ..++.++.+      ||.+||+.||.+||     +++++++||||.+
T Consensus       223 ~~~~~~~~~~~~~------li~~~l~~dP~~Rp-----s~~e~l~hp~~~~  262 (299)
T 3m2w_A          223 NPEWSEVSEEVKM------LIRNLLKTEPTQRM-----TITEFMNHPWIMQ  262 (299)
T ss_dssp             HHHHTTSCHHHHH------HHHHHTCSSTTTSC-----CHHHHHTSHHHHT
T ss_pred             chhcccCCHHHHH------HHHHHcccChhhCC-----CHHHHhcChhhcc
Confidence                234555544      55569999999999     8899999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.8e-45  Score=384.63  Aligned_cols=273  Identities=26%  Similarity=0.391  Sum_probs=215.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (447)
                      .++|++.++||+|+||.||+|.++.     +++.||||++....  .....+.+.+|+.+|++++||||+++++++..  
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~-----tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQD-----TGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTT-----TTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            3689999999999999999998765     78899999987642  34455678899999999999999999998765  


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCc---EEE
Q 013249          187 ----RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VML  256 (447)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---~kL  256 (447)
                          .+..|+||||++||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence                677899999999999999998754   5899999999999999999999999999999999999997765   999


Q ss_pred             eecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHH---------HH-
Q 013249          257 TDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ---------RI-  326 (447)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~---------~i-  326 (447)
                      +|||++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+........         .+ 
T Consensus       166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            99999998776666667889999999999999999999999999999999999999997653322110         00 


Q ss_pred             ----HhcccCC------CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCC
Q 013249          327 ----INEKVKL------PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF  396 (447)
Q Consensus       327 ----~~~~~~~------p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~  396 (447)
                          ..+...+      |..++......  ..+||.+||..||++||     +++++++||||..  ++.+..+++-..|
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~--L~dLI~~mL~~DP~kRP-----Ta~elL~hp~F~~--l~~iL~~kil~~f  316 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGK--LERWLQCMLMWHQRQRG-----TDPQNPNVGCFQA--LDSILSLKLLSVM  316 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHH--HHHHHHHHSCSSCC--------CCTTCCCCTTHHH--HHHHHCCCEEECC
T ss_pred             hhhhhccccccccccCCchhhchhhhHH--HHHHHHHHccCCHhhCc-----CHHHHhcCHHHHH--HHHHHhccccccc
Confidence                0111111      12222222221  24577789999999999     7799999999985  5666666655555


Q ss_pred             C
Q 013249          397 K  397 (447)
Q Consensus       397 ~  397 (447)
                      .
T Consensus       317 ~  317 (676)
T 3qa8_A          317 N  317 (676)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-43  Score=376.28  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=214.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++.+.||+|+||.||+|.++....  .+..||+|++....  .....+.+.+|+.+|++++||||+++++++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPEN--PAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSS--CCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCC--ccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34556789999999999999999999875322  46789999987542  344556788999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      . .+.+|+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            5 456899999999999999998654 68999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCch
Q 013249          264 EIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~  339 (447)
                      .......  .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+. ..+|..++.
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  619 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  619 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence            7644322  223457789999999999999999999999999999997 999999998888888777653 456777777


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ++.+++.      +||..||.+||     ++++|++
T Consensus       620 ~l~~li~------~~l~~dP~~RP-----s~~el~~  644 (656)
T 2j0j_A          620 TLYSLMT------KCWAYDPSRRP-----RFTELKA  644 (656)
T ss_dssp             HHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHH------HHcCCChhHCc-----CHHHHHH
Confidence            7766555      59999999999     7888876

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.9e-44  Score=348.78  Aligned_cols=252  Identities=20%  Similarity=0.355  Sum_probs=188.5

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHH--HHhcCCCCceeeeE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRY  182 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i--l~~l~hpnIv~l~~  182 (447)
                      ..+..++|+++++||+|+||.||+|++       +++.||||++.....      ..+..|..+  +..++||||+++++
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~   74 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL-------DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIV   74 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE-------TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE-------CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhhee
Confidence            346678999999999999999999976       567899999975421      223334444  45689999999998


Q ss_pred             EEEe-----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCccc
Q 013249          183 SFQT-----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENILM  248 (447)
Q Consensus       183 ~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------~iiHrDikp~NILl  248 (447)
                      .+..     ...+|+||||+++|+|.+++.... .++..+..++.||+.||.|||++         ||+||||||+||||
T Consensus        75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill  153 (336)
T 3g2f_A           75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV  153 (336)
T ss_dssp             EEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred             cccccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence            6643     336899999999999999997654 58999999999999999999999         99999999999999


Q ss_pred             CCCCcEEEeecCCcccccCC---------CCCCccccCCcccccccccC-------CCCCCccceeehhHhHHHHhhCCC
Q 013249          249 DSDGHVMLTDFGLAKEIDES---------SRSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLTGQP  312 (447)
Q Consensus       249 ~~~~~~kL~DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~G~~  312 (447)
                      +.++.+||+|||+++.+...         ......+||+.|+|||++.+       ..++.++|||||||++|||++|..
T Consensus       154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            99999999999999876432         12235579999999999987       456678999999999999999977


Q ss_pred             CCCCC-C-----------------HHHHHHHHHhc--ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhh
Q 013249          313 PFTHA-N-----------------RQKLQQRIINE--KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDA  372 (447)
Q Consensus       313 pf~~~-~-----------------~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~  372 (447)
                      ||... .                 .......+...  ...+|..........-...+||.+||+.||++||     ++++
T Consensus       234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~e  308 (336)
T 3g2f_A          234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL-----TAQX  308 (336)
T ss_dssp             GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC-----CHHH
T ss_pred             cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCc-----chHH
Confidence            66321 1                 11111111111  2233333322111111234667779999999999     7888


Q ss_pred             hhc
Q 013249          373 IKH  375 (447)
Q Consensus       373 l~~  375 (447)
                      +++
T Consensus       309 ~l~  311 (336)
T 3g2f_A          309 AEE  311 (336)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            854

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.5e-44  Score=344.18  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=198.6

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-cchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      |...+.||+|+||.||+|.+       .++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV-------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES-------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccCCccccCCCeEEEEEEE-------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce
Confidence            44558999999999999974       467899999875432 2344567789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          191 YLILDFINGGHLFFHLYR---QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      |+||||+++++|.+++..   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            999999999999999874   34699999999999999999999999999999999999999999999999999987644


Q ss_pred             CCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHH----HHHHHHhcccCCC------
Q 013249          268 SSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK----LQQRIINEKVKLP------  334 (447)
Q Consensus       268 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~----~~~~i~~~~~~~p------  334 (447)
                      ...   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.......    +...+......++      
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK  264 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred             ccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence            222   334679999999999875 48899999999999999999999997654322    2222222111100      


Q ss_pred             -CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          335 -PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       335 -~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                       ........  -...+++.+||+.||.+||     ++++++++
T Consensus       265 ~~~~~~~~~--~~l~~li~~cl~~~p~~Rp-----s~~~l~~~  300 (307)
T 2nru_A          265 MNDADSTSV--EAMYSVASQCLHEKKNKRP-----DIKKVQQL  300 (307)
T ss_dssp             CSCCCHHHH--HHHHHHHHHHTCSSTTTSC-----CHHHHHHH
T ss_pred             ccccchHHH--HHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence             01111111  1224578889999999999     78888863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-43  Score=341.80  Aligned_cols=246  Identities=26%  Similarity=0.409  Sum_probs=190.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc--CCCCceeeeEEEEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV--THPFIVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~~~~~  187 (447)
                      ++|+++++||+|+||.||+|++       .++.||||++....      ......|.+++..+  +||||+++++++...
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKW-------RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE-------TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cceEEEeEeecCCCeEEEEEEE-------CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            4799999999999999999987       36789999986532      12234455555544  899999999999887


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCcccCCCCcEE
Q 013249          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~iiHrDikp~NILl~~~~~~k  255 (447)
                          ..+|+||||+++|+|.+++... .+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+|
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence                7899999999999999999664 689999999999999999999998        999999999999999999999


Q ss_pred             EeecCCcccccCCCC-----CCccccCCcccccccccCCCCCCc------cceeehhHhHHHHhhC----------CCCC
Q 013249          256 LTDFGLAKEIDESSR-----SNSMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTG----------QPPF  314 (447)
Q Consensus       256 L~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~ell~G----------~~pf  314 (447)
                      |+|||+++.+.....     ....+||+.|+|||++.+..++..      +|||||||++|||++|          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            999999987643322     235689999999999988777665      9999999999999999          7777


Q ss_pred             CCC-----CHHHHHHHHHhccc--CCCCCCch-hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          315 THA-----NRQKLQQRIINEKV--KLPPFLTS-EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       315 ~~~-----~~~~~~~~i~~~~~--~~p~~~~~-~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ...     ........+.....  .+|..... +..  -...+||.+||+.||.+||     +++++++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rp-----s~~ell~~  325 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL--RQMGKLMTECWAHNPASRL-----TALRVKKT  325 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHH--HHHHHHHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHH--HHHHHHHHHhhhhChhhCC-----CHHHHHHH
Confidence            542     22222222222211  12221111 111  1224678889999999999     78999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=349.06  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=205.7

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      .+.+..++|++.+.||+|+||.||+|++++        .+|+|++..... .....+.+.+|+.++++++||||++++++
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   97 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGA   97 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            355677899999999999999999998753        399999876432 22233456789999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      +.+...+++||||+.|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus        98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B           98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             EECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             EecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence            999999999999999999999997654 699999999999999999999999999999999999998 689999999998


Q ss_pred             ccccC------CCCCCccccCCcccccccccC---------CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHH
Q 013249          263 KEIDE------SSRSNSMCGTTEYMAPEILLS---------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII  327 (447)
Q Consensus       263 ~~~~~------~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~  327 (447)
                      +....      ........||+.|+|||++.+         ..++.++|||||||++|||++|+.||...+.......+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            76431      122334568999999999975         357889999999999999999999999988888877776


Q ss_pred             hcccCCC--CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          328 NEKVKLP--PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       328 ~~~~~~p--~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .......  ..++.++.++      |.+||..||.+||     +++++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~l------i~~~l~~~p~~Rp-----t~~~l~~  295 (319)
T 2y4i_B          257 TGMKPNLSQIGMGKEISDI------LLFCWAFEQEERP-----TFTKLMD  295 (319)
T ss_dssp             TTCCCCCCCSSCCTTHHHH------HHHHHCSSTTTSC-----CHHHHHH
T ss_pred             cCCCCCCCcCCCCHHHHHH------HHHHhcCChhhCc-----CHHHHHH
Confidence            6543221  2355555555      5559999999999     7888886

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=345.05  Aligned_cols=255  Identities=22%  Similarity=0.351  Sum_probs=206.1

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++++.||+|+||.||+|++..... .+++.||||++...   .....+.+.+|+.+|++++||||+++++++.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSS-SCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccC-CCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            3455689999999999999999998643222 37889999998763   3445567889999999999999999999987


Q ss_pred             eCC--EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          186 TRS--KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       186 ~~~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      ..+  .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            644  789999999999999999876 46999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH----------------HH
Q 013249          263 KEIDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----------------KL  322 (447)
Q Consensus       263 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~----------------~~  322 (447)
                      +.......    .....++..|+|||++.+..++.++|||||||++|||++|..||......                .+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87654322    23345778899999999888999999999999999999999998642111                11


Q ss_pred             HHHHHh-cccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          323 QQRIIN-EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       323 ~~~i~~-~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ...+.. .....+..++.++.+++.      +||..||++||     +++++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~------~cl~~dP~~Rp-----s~~el~~  315 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRP-----SFRDLAL  315 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHH------HHSCSSGGGSC-----CHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHH------HHcCCChhhCc-----CHHHHHH
Confidence            112221 123445666776666555      59999999999     7888875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.2e-45  Score=358.13  Aligned_cols=248  Identities=15%  Similarity=0.233  Sum_probs=189.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcC---------C
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVT---------H  174 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~---------h  174 (447)
                      .++|+++++||+|+||+||+|++       +++.||||++.+....     .....+.+.+|+.+|+.++         |
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h   91 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT   91 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred             cccchheeeecccCceEEEEEEe-------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence            34799999999999999999987       4588999999875421     2334467889999999886         6


Q ss_pred             CCceeeeEEE-----------------Ee-------------CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHH
Q 013249          175 PFIVQLRYSF-----------------QT-------------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI  224 (447)
Q Consensus       175 pnIv~l~~~~-----------------~~-------------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi  224 (447)
                      ||||++.+++                 .+             .+.+|+||||+.+|++.+.+.+ +.+++.+++.++.||
T Consensus        92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQL  170 (336)
T ss_dssp             CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHH
T ss_pred             CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHH
Confidence            6666666554                 32             6789999999999977666643 678999999999999


Q ss_pred             HHHHHHHH-HCCceeccCCCCCcccCCCC--------------------cEEEeecCCcccccCCCCCCccccCCccccc
Q 013249          225 VSAVSHLH-KCGIVHRDLKPENILMDSDG--------------------HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP  283 (447)
Q Consensus       225 ~~aL~~LH-~~~iiHrDikp~NILl~~~~--------------------~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aP  283 (447)
                      +.||.||| ++||+||||||+||||+.++                    .+||+|||+|+.....    ..+||+.|+||
T Consensus       171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP  246 (336)
T 2vuw_A          171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred             HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence            99999999 99999999999999999887                    8999999999976542    45899999999


Q ss_pred             ccccCCCCCCccceeehhHh-HHHHhhCCCCCCCCCH-HHHHHHHHhcccCCCCCC-chhHHh-hhhhhhHHhhhccCCC
Q 013249          284 EILLSKGHNKDADWWSVGIL-LYEMLTGQPPFTHANR-QKLQQRIINEKVKLPPFL-TSEAHS-LLKGVSFLTQLLHKDP  359 (447)
Q Consensus       284 E~~~~~~~~~~~DvwSlGvi-l~ell~G~~pf~~~~~-~~~~~~i~~~~~~~p~~~-~~~~~~-li~~~~~l~~~L~~dP  359 (447)
                      |++.+.. +.++||||||++ .++++.|..||..... ......+.... .++... ...... .-...+||.+||++| 
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~L~~d-  323 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM-TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-  323 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC-CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh-ccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence            9998776 889999998777 8889999999954211 12223333221 111111 111111 112356788899976 


Q ss_pred             CCCCCCCCCChhhhh-cCCccC
Q 013249          360 SKRLGSGPGGVDAIK-HHKWFR  380 (447)
Q Consensus       360 ~~R~~~~~~~~~~l~-~h~~f~  380 (447)
                               ++++++ +||||+
T Consensus       324 ---------sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 ---------SATDLLCQHSLFK  336 (336)
T ss_dssp             ---------SHHHHHHHCGGGC
T ss_pred             ---------CHHHHHhcCCCcC
Confidence                     589999 999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-42  Score=341.62  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=197.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh--cCCCCceeeeEEEEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~  187 (447)
                      ++|++.+.||+|+||.||+|++       +++.||||++....      ...+.+|.++++.  ++||||+++++++...
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE-------TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ccEEEEeeecCCCCcEEEEEEE-------cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3799999999999999999986       46789999986532      2446678899887  7899999999999887


Q ss_pred             C----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCcccCCCCcEE
Q 013249          188 S----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       188 ~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~iiHrDikp~NILl~~~~~~k  255 (447)
                      .    .+|+||||+.+|+|.+++.+ ..+++.+++.++.||+.||.|||        ++||+||||||+||||+.++.+|
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence            6    89999999999999999976 46899999999999999999999        89999999999999999999999


Q ss_pred             EeecCCcccccCCC-----CCCccccCCcccccccccCCC------CCCccceeehhHhHHHHhhC----------CCCC
Q 013249          256 LTDFGLAKEIDESS-----RSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTG----------QPPF  314 (447)
Q Consensus       256 L~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~ell~G----------~~pf  314 (447)
                      |+|||+++......     ......||+.|+|||++.+..      ++.++|||||||++|||++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999998765433     234567999999999998752      33689999999999999999          7898


Q ss_pred             CCC-----CHHHHHHHHHhcccC--CCCCC-chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          315 THA-----NRQKLQQRIINEKVK--LPPFL-TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       315 ~~~-----~~~~~~~~i~~~~~~--~p~~~-~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ...     ....+...+......  +|... +.+...  ...++|.+||+.||++||     +++++++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~li~~cl~~dp~~Rp-----s~~~i~~~  330 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR--VMAKIMRECWYANGAARL-----TALRIKKT  330 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHH--HHHHHHHHHCCSSGGGSC-----CHHHHHHH
T ss_pred             cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHH--HHHHHHHHHhccChhhCC-----CHHHHHHH
Confidence            654     234444444333221  22211 111111  224578889999999999     78999875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3e-44  Score=362.79  Aligned_cols=251  Identities=18%  Similarity=0.155  Sum_probs=194.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCcee--------
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQ--------  179 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~--------  179 (447)
                      ..+|.+.++||+|+||+||+|+++.     +++.||||++...........+.+.+|+.+++.+.| +|+..        
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             ceeEEEecccccCCCEEEEEEEecC-----CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            3468899999999999999999886     788999999885443344445678899999999977 32111        


Q ss_pred             -eeE------------EEEe-----CCEEEEEEeccCCCChHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013249          180 -LRY------------SFQT-----RSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYTAEIVSAVSHLHKC  234 (447)
Q Consensus       180 -l~~------------~~~~-----~~~~~lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~  234 (447)
                       ..+            ++..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||.|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence             111            1111     22467888876 6789888742       23477889999999999999999999


Q ss_pred             CceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccccCCcccccccc----------cCCCCCCccceeehhHhH
Q 013249          235 GIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL----------LSKGHNKDADWWSVGILL  304 (447)
Q Consensus       235 ~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvil  304 (447)
                      |||||||||+||||+.++.+||+|||+++.....  ....+| +.|+|||++          .+..++.++|||||||++
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999999876543  455678 999999999          556688899999999999


Q ss_pred             HHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          305 YEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       305 ~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      |||++|+.||...+..+....+...    ...++.++.++      |.+||+.||++||     ++.++++||||+.+.
T Consensus       308 ~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~l------i~~~l~~dP~~Rp-----t~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSEWIFRS----CKNIPQPVRAL------LEGFLRYPKEDRL-----LPLQAMETPEYEQLR  371 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSGGGGSS----CCCCCHHHHHH------HHHHTCSSGGGSC-----CHHHHTTSHHHHHHH
T ss_pred             HHHHHCCCCCCCcchhhhHHHHHhh----cccCCHHHHHH------HHHHccCChhhCc-----CHHHHHhCHHHHHHH
Confidence            9999999999876654443333322    23455666555      4559999999999     889999999998764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-41  Score=364.30  Aligned_cols=242  Identities=23%  Similarity=0.338  Sum_probs=195.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.++||+|+||.||+|.++.    .+++.||||++....  .......+.+|+.+|++++||||+++++++...+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRN----VNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGG----GTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcC----CCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            4689999999999999999999864    146889999987532  3445567889999999999999999999998765


Q ss_pred             E-----EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          189 K-----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       189 ~-----~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      .     .||||||++|++|.+++..  .+++.+++.++.||+.||.|||++|||||||||+||||+.+ .+||+|||+++
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence            5     7999999999999887754  79999999999999999999999999999999999999885 89999999998


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHh
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  343 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  343 (447)
                      .....   ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+...           ...+... .....
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~-----------~~~~~~~-~~~~~  293 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV-----------DGLPEDD-PVLKT  293 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC-----------SSCCTTC-HHHHH
T ss_pred             hcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc-----------ccccccc-ccccc
Confidence            76543   456799999999998765 48899999999999999999999865211           0111111 11111


Q ss_pred             hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       344 li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      .-...+||.+||++||.+||     +..+.+.|+|+.
T Consensus       294 ~~~l~~li~~~l~~dP~~R~-----~~~~~l~~~l~~  325 (681)
T 2pzi_A          294 YDSYGRLLRRAIDPDPRQRF-----TTAEEMSAQLTG  325 (681)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----SSHHHHHHHHHH
T ss_pred             CHHHHHHHhhhccCChhhCC-----CHHHHHHHHHHH
Confidence            11234678889999999999     557778888874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.9e-41  Score=323.37  Aligned_cols=222  Identities=15%  Similarity=0.185  Sum_probs=181.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++...........+.+.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTA-----LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETT-----TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecC-----CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence            4689999999999999999999875     78899999998765555566678889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+||||++|++|.+++.. + ....++..++.||+.||+|||++||+||||||+||||+.+|.+||+++|        
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             cEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999999999854 3 4666789999999999999999999999999999999999999998554        


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHH---HHHhcccC----CCCCCchhH
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ---RIINEKVK----LPPFLTSEA  341 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~---~i~~~~~~----~p~~~~~~~  341 (447)
                                 |++       .++.++|||||||++|||++|+.||.+.+......   ++......    ++..++.++
T Consensus       175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                       333       37889999999999999999999998765422110   11111111    123455555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++      |.+||++||++| +     ++++++
T Consensus       237 ~~l------i~~~l~~dP~~R-s-----~~el~~  258 (286)
T 3uqc_A          237 SAV------AARSVQGDGGIR-S-----ASTLLN  258 (286)
T ss_dssp             HHH------HHHHHCTTSSCC-C-----HHHHHH
T ss_pred             HHH------HHHHcccCCccC-C-----HHHHHH
Confidence            554      556999999999 4     577765

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.7e-36  Score=315.71  Aligned_cols=189  Identities=15%  Similarity=0.130  Sum_probs=138.5

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-------chhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------KKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (447)
                      ..++.|++|.+..++..-     .++.||||++.+....       .+...+.+.+|+++|+++ .|+||++++++++++
T Consensus       240 ~~~~~~~~~~h~~~rr~~-----fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~  314 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYF-----FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA  314 (569)
T ss_dssp             CC-C--------CCEEEE-----ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS
T ss_pred             hccccCCccccccccccc-----ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC
Confidence            345677777777666553     6788999999865321       234456789999999999 699999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      +.+||||||++|++|.++|.+.+++++.   .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus       315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999999999999998875   4789999999999999999999999999999999999999999987654


Q ss_pred             C-CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCC
Q 013249          268 S-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  313 (447)
Q Consensus       268 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~p  313 (447)
                      . ....+.+||+.|||||++.+. +..++|+||+|+++++|.+|..+
T Consensus       392 ~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            3 334567899999999999765 66789999999999998776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=6.5e-31  Score=273.44  Aligned_cols=185  Identities=19%  Similarity=0.164  Sum_probs=148.1

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc-----chhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      ..++||+|+||.||+|..       .++.+++|........     .....+.+.+|+++|++++||||+++..++...+
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  412 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD  412 (540)
T ss_dssp             --------CCEEEEEEEC-------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred             CCCEEeeCCCEEEEEEEE-------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence            356899999999999953       4567899986543322     1223456889999999999999997666666777


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      ..|+||||++|++|.+++..        +..++.||+.||+|||++||+||||||+|||++.  ++||+|||+++.....
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            88999999999999998865        6789999999999999999999999999999998  9999999999987543


Q ss_pred             CC--------CCccccCCcccccccccC--CCCCCccceeehhHhHHHHhhCCCCCC
Q 013249          269 SR--------SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFT  315 (447)
Q Consensus       269 ~~--------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~  315 (447)
                      ..        ....+||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            21        135789999999999987  678888999999999888888777763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=3.3e-27  Score=225.74  Aligned_cols=148  Identities=21%  Similarity=0.230  Sum_probs=119.0

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcch---------------hHHHHHHHHHHHHHhcCCC
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---------------NHVDYMKAERDILTKVTHP  175 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---------------~~~~~~~~E~~il~~l~hp  175 (447)
                      .|.+.+.||+|+||.||+|++ .     +++.||||+++.......               .....+.+|+.+|++++  
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~-----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-E-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-T-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEecCEeccCCCceEEEEEe-C-----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            466779999999999999998 4     788999999975322111               13456889999999999  


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEE
Q 013249          176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM  255 (447)
Q Consensus       176 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~k  255 (447)
                      | +++++++.. +..|+||||++|++|.+ +      .......++.||+.||.|||++||+||||||+|||++ +|.+|
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence            5 666666544 45699999999999977 3      1234567999999999999999999999999999999 99999


Q ss_pred             EeecCCcccccCCCCCCccccCCcccccccccC
Q 013249          256 LTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS  288 (447)
Q Consensus       256 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  288 (447)
                      |+|||+|+.            +..|+|||++.+
T Consensus       233 l~DFG~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          233 IIDFPQSVE------------VGEEGWREILER  253 (282)
T ss_dssp             ECCCTTCEE------------TTSTTHHHHHHH
T ss_pred             EEECCCCeE------------CCCCCHHHHHHH
Confidence            999999864            345789998853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1.3e-22  Score=191.30  Aligned_cols=141  Identities=21%  Similarity=0.178  Sum_probs=108.2

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcE--EEEEEeechhhcc---------------------hhHHHHHHHHHH
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIK---------------------KNHVDYMKAERD  167 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~--~avK~~~~~~~~~---------------------~~~~~~~~~E~~  167 (447)
                      -|++.+.||+|+||.||+|.++.     +++.  ||||+++......                     ......+.+|+.
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~-----~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVF-----DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEE-----TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcC-----CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            37899999999999999999853     6778  9999975432110                     111236788999


Q ss_pred             HHHhcCCCCc--eeeeEEEEeCCEEEEEEeccCC-C----ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCceec
Q 013249          168 ILTKVTHPFI--VQLRYSFQTRSKLYLILDFING-G----HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHR  239 (447)
Q Consensus       168 il~~l~hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHr  239 (447)
                      +|+++.|++|  ..+++.    ...+|||||+.+ |    .|.+....   .++..+..++.||+.||.||| ++||+||
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            9999988764  333332    246899999942 3    56555322   235678899999999999999 9999999


Q ss_pred             cCCCCCcccCCCCcEEEeecCCcccc
Q 013249          240 DLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       240 Dikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      ||||+|||++.  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=4.3e-19  Score=174.79  Aligned_cols=140  Identities=12%  Similarity=0.160  Sum_probs=101.1

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc------------ch---hH----HHHHHHHHHHHHhc
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------------KK---NH----VDYMKAERDILTKV  172 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~------------~~---~~----~~~~~~E~~il~~l  172 (447)
                      |++.+.||.|+||.||+|.+.      +|+.||||+++.....            ..   ..    .-...+|...|.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECC------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999864      6889999997643211            00   00    01224567777777


Q ss_pred             CCCCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC
Q 013249          173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (447)
Q Consensus       173 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  252 (447)
                      .+.++... ..+.... .+|||||++|+.|..+.      ..+.+..++.||+.+|.|||++|||||||||.||||+++|
T Consensus       171 ~~~gv~vp-~p~~~~~-~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          171 YEEGFPVP-EPIAQSR-HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             HHTTCSCC-CEEEEET-TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred             HhcCCCCC-eeeeccC-ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence            55443222 2222222 37999999998885432      2234567889999999999999999999999999998877


Q ss_pred             ----------cEEEeecCCcccc
Q 013249          253 ----------HVMLTDFGLAKEI  265 (447)
Q Consensus       253 ----------~~kL~DFG~a~~~  265 (447)
                                .+.|+||+-+...
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence                      3899999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=5.2e-13  Score=125.37  Aligned_cols=140  Identities=11%  Similarity=0.061  Sum_probs=110.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (447)
                      +.|++...+|.|+.+.||++..       .++.+++|+........   ...+.+|..+|+.+. +..+.++++++...+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~-------~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~   83 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC-------SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             ccceeEeeccCCCCCeEEEEEC-------CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence            3699999999999999999863       35689999987532111   124778999999885 567778999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-----------------------------------  233 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-----------------------------------  233 (447)
                      ..|+||||++|.+|...+     .+......++.+++.+|..||+                                   
T Consensus        84 ~~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             ceEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            999999999999986652     1223345788899999999998                                   


Q ss_pred             ------------------------CCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          234 ------------------------CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       234 ------------------------~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                                              ..++|+|++|.|||+++++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                    4589999999999998765667999987643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=3.5e-12  Score=119.05  Aligned_cols=135  Identities=13%  Similarity=0.133  Sum_probs=98.8

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC--ceeeeEEEEeC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTR  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~  187 (447)
                      .+|.+..+.+.|..+.||++...      +++.+++|+.....      ...+..|..+++.+.+.+  +.+++++....
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             CCCceEecccCCCCceEEEEecC------CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            35666555556667999998642      45679999976431      124678999999886544  45688888888


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--------------------------------  235 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--------------------------------  235 (447)
                      +..|+||||++|.+|.  .   ....   ...++.+++..|..||+..                                
T Consensus        88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            8899999999998883  1   1112   2356677777778887643                                


Q ss_pred             --------------------------ceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          236 --------------------------IVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       236 --------------------------iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                                                ++|+|++|.|||+++++.+.|+|||.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                      99999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=2.1e-11  Score=119.83  Aligned_cols=142  Identities=13%  Similarity=0.256  Sum_probs=105.8

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEee--chhhcchhHHHHHHHHHHHHHhcCC--CCceeeeEEEEeC
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTR  187 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~  187 (447)
                      ...++.|+.|.++.||++..       .++.+++|+..  .....  .....+.+|..+|+.+..  ..+.+++.++.+.
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~-------~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVT-------PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEEC-------SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             CceEEEcCCcccceEEEEEE-------CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            44577899999999999874       34578888876  33211  112357789999999974  4577888887766


Q ss_pred             ---CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------
Q 013249          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-------------------------------  233 (447)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-------------------------------  233 (447)
                         +..|+||||++|..+.+.  ....++..+...++.+++..|..||.                               
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL  188 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence               458999999999877431  12346788889999999999999997                               


Q ss_pred             ---------------------------CCceeccCCCCCcccCCCCc--EEEeecCCccc
Q 013249          234 ---------------------------CGIVHRDLKPENILMDSDGH--VMLTDFGLAKE  264 (447)
Q Consensus       234 ---------------------------~~iiHrDikp~NILl~~~~~--~kL~DFG~a~~  264 (447)
                                                 ..++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                       35899999999999997753  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=6.3e-11  Score=113.72  Aligned_cols=180  Identities=17%  Similarity=0.246  Sum_probs=120.2

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCC--ceeeeEEEEeCC---
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPF--IVQLRYSFQTRS---  188 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpn--Iv~l~~~~~~~~---  188 (447)
                      ++.++.|....||++.          +.+++|+....     .....+.+|..+|+.+. +..  +.+++.......   
T Consensus        25 i~~~~~G~~n~v~~v~----------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~   89 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQ   89 (304)
T ss_dssp             CCEEEECSSEEEEEST----------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCS
T ss_pred             eEecCCCCcceEEEEC----------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCC
Confidence            3458999999999752          34889986532     23456889999998884 332  233433333322   


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-----------------------------------  233 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-----------------------------------  233 (447)
                      ..|+|||+++|..|.....  ..++..+...++.+++..|..||+                                   
T Consensus        90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            3588999999988865433  346778888888999998888886                                   


Q ss_pred             -----------------------CCceeccCCCCCcccCC--CCcEEEeecCCcccccCCCCCCccccCCcc---ccccc
Q 013249          234 -----------------------CGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEY---MAPEI  285 (447)
Q Consensus       234 -----------------------~~iiHrDikp~NILl~~--~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y---~aPE~  285 (447)
                                             ..++|+|++|.|||+++  ++.+.|+||+.+........   ......+   ..|+.
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~  244 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEF  244 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHH
Confidence                                   13699999999999998  45688999998875432110   0001111   22222


Q ss_pred             ccC--CCCC------------CccceeehhHhHHHHhhCCCCC
Q 013249          286 LLS--KGHN------------KDADWWSVGILLYEMLTGQPPF  314 (447)
Q Consensus       286 ~~~--~~~~------------~~~DvwSlGvil~ell~G~~pf  314 (447)
                      ...  ..|.            .-.+.|++|.++|.+.+|..+|
T Consensus       245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            110  0111            1258899999999999998876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=6.3e-07  Score=85.82  Aligned_cols=134  Identities=17%  Similarity=0.237  Sum_probs=92.3

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC---CceeeeEEEE-eCCEE
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP---FIVQLRYSFQ-TRSKL  190 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~-~~~~~  190 (447)
                      ++.++.|....||++          ++.+++|+-..     ......+.+|..+|+.+.+.   .+.+.+.+.. ..+..
T Consensus        24 v~~l~~G~~n~v~~v----------g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~   88 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----------NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP   88 (306)
T ss_dssp             EEEEEECSSEEEEEE----------TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE
T ss_pred             eeecCCCcceeEEEE----------CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce
Confidence            456889999999986          13488888532     22345688999999999752   2445555553 34567


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC------------------------------------  234 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~------------------------------------  234 (447)
                      |+|||+++|..|.....  ..++..+...++.++...|..||+.                                    
T Consensus        89 ~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           89 FVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            89999999988865321  2345555555555555555555532                                    


Q ss_pred             ------------------------CceeccCCCCCcccCC---CCc-EEEeecCCcccc
Q 013249          235 ------------------------GIVHRDLKPENILMDS---DGH-VMLTDFGLAKEI  265 (447)
Q Consensus       235 ------------------------~iiHrDikp~NILl~~---~~~-~kL~DFG~a~~~  265 (447)
                                              .++|+|+++.|||++.   ++. +.|+||+.+...
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                    3599999999999987   455 489999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.58  E-value=7.9e-07  Score=83.19  Aligned_cols=133  Identities=17%  Similarity=0.169  Sum_probs=92.6

Q ss_pred             eEeecCCe-EEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeCCEEEEEE
Q 013249          117 VVGQGAFG-KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLIL  194 (447)
Q Consensus       117 ~lG~G~fg-~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lv~  194 (447)
                      .+..|..| .||+.....     .+..++||+-...      ....+.+|..+|+.+.. --+-+++.++.+.+..|+||
T Consensus        31 ~~~~G~S~~~v~rl~~~~-----~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm   99 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKP-----NAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT   99 (272)
T ss_dssp             EEECSSSSCEEEEEECCT-----TCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             EccCCCcCCeEEEEEecC-----CCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence            34445554 689876543     4567899986543      23457789999988852 22556788888899999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 013249          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC----------------------------------------  234 (447)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------------------------------------  234 (447)
                      |+++|.++.+.....    ......++.++...|.-||..                                        
T Consensus       100 e~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          100 TAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             ECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             EeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            999998876655432    122334555555555555531                                        


Q ss_pred             ------------------CceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          235 ------------------GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       235 ------------------~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                                        .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              168999999999999877777999997754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.37  E-value=7.4e-07  Score=88.49  Aligned_cols=80  Identities=16%  Similarity=0.255  Sum_probs=49.6

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-cc---hhHHHHHHHHHHHHHhcCC--CCce-eeeEEEEe
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IK---KNHVDYMKAERDILTKVTH--PFIV-QLRYSFQT  186 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~-~~---~~~~~~~~~E~~il~~l~h--pnIv-~l~~~~~~  186 (447)
                      ..+.||.|.++.||++....     .++.++||....... ..   ....+.+..|.++|+.+..  +..+ +++.+  +
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~-----~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEEECCCCceEEEEEEEECC-----CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            46789999999999996542     456799998653211 00   0122346678889887742  4444 44433  3


Q ss_pred             CCEEEEEEeccCCC
Q 013249          187 RSKLYLILDFINGG  200 (447)
Q Consensus       187 ~~~~~lv~E~~~gg  200 (447)
                      ....++|||++.|.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            44568999999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=8.3e-06  Score=78.68  Aligned_cols=136  Identities=15%  Similarity=0.180  Sum_probs=78.3

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----CCCceeee-E--EEE
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQLR-Y--SFQ  185 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~-~--~~~  185 (447)
                      -++.|+.|..+.||++...       +..+++|+....    .   ..+..|..+++.+.     .|.++... +  +..
T Consensus        36 ~~~~l~gG~~n~~~~v~~~-------~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~  101 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTD-------SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK  101 (346)
T ss_dssp             EEEECC----CEEEEEEET-------TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE
T ss_pred             EeeeccccccCcEEEEEeC-------CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE
Confidence            3456677788999998753       235899998752    1   12334555554442     34444311 0  123


Q ss_pred             eCCEEEEEEeccCCCChH--------------HHHHHc-CCC-------------CHH--------H-------------
Q 013249          186 TRSKLYLILDFINGGHLF--------------FHLYRQ-GIF-------------RED--------Q-------------  216 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~--------------~~l~~~-~~~-------------~~~--------~-------------  216 (447)
                      ..+..++||||++|..+.              ..++.. ..+             .+.        .             
T Consensus       102 ~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  181 (346)
T 2q83_A          102 HGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKE  181 (346)
T ss_dssp             ETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred             ECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccC
Confidence            567889999999986431              112211 101             111        0             


Q ss_pred             ----------HHHHHHHHHHHHHHHHH-------------CCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          217 ----------ARFYTAEIVSAVSHLHK-------------CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       217 ----------~~~i~~qi~~aL~~LH~-------------~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                                +..+..++..++++|+.             ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          182 DPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                      11122233445666652             579999999999999888899999999765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.12  E-value=4.8e-06  Score=81.18  Aligned_cols=91  Identities=11%  Similarity=0.135  Sum_probs=54.7

Q ss_pred             cEEEeeE-eecCCeEEEEEEEcCCCCCC-CCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-C--CCceeeeEEEEe
Q 013249          112 FEIFRVV-GQGAFGKVFQVKKKGVDDGD-SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H--PFIVQLRYSFQT  186 (447)
Q Consensus       112 y~~~~~l-G~G~fg~V~~~~~~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~  186 (447)
                      ....+.| +.|....+|++......++. .++.+++|+..............+.+|..+|+.+. +  -.+.+++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3446778 88999999988653000000 15578899865432000000123667888888774 2  245567776655


Q ss_pred             C---CEEEEEEeccCCCCh
Q 013249          187 R---SKLYLILDFINGGHL  202 (447)
Q Consensus       187 ~---~~~~lv~E~~~gg~L  202 (447)
                      .   +..|+||||++|..+
T Consensus       102 ~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             STTTSSCEEEEECCCCBCC
T ss_pred             CCccCCceEEEEecCCCCh
Confidence            4   356899999988654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.87  E-value=0.00011  Score=70.24  Aligned_cols=78  Identities=12%  Similarity=0.143  Sum_probs=59.8

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC---CCCceeeeEEEEeCC
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRS  188 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~  188 (447)
                      ..-.+.|+.|....+|++..       .++.++||+....      ....+..|...|+.+.   ...+.+++.+....+
T Consensus        38 i~~~~~l~gG~~n~~y~v~~-------~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g  104 (312)
T 3jr1_A           38 IKHKEKLYSGEMNEIWLIND-------EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG  104 (312)
T ss_dssp             CCEEEEECCSSSSEEEEEES-------SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS
T ss_pred             eeeeEEeCCccceeeeEEEE-------CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC
Confidence            34567899999999999863       3567889987542      2456788999888874   256777888888888


Q ss_pred             EEEEEEeccCCCCh
Q 013249          189 KLYLILDFINGGHL  202 (447)
Q Consensus       189 ~~~lv~E~~~gg~L  202 (447)
                      ..|+||||++|..+
T Consensus       105 ~~~lvme~l~G~~~  118 (312)
T 3jr1_A          105 HSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEEEECCCCCCC
T ss_pred             ceEEEEEeccCCCC
Confidence            99999999998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.87  E-value=5.1e-05  Score=75.81  Aligned_cols=77  Identities=9%  Similarity=0.089  Sum_probs=46.0

Q ss_pred             HCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCcccc--CCcccccccccCCCCC---CccceeehhHhHHHH
Q 013249          233 KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCG--TTEYMAPEILLSKGHN---KDADWWSVGILLYEM  307 (447)
Q Consensus       233 ~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~---~~~DvwSlGvil~el  307 (447)
                      ...++|+|+++.|||++.++ ++|+||+.+..............  ...|++|+......-.   ...++..+...+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            45799999999999998877 99999998875322111101111  1346666655421111   123344666777776


Q ss_pred             hhC
Q 013249          308 LTG  310 (447)
Q Consensus       308 l~G  310 (447)
                      +.+
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.62  E-value=9.5e-05  Score=70.75  Aligned_cols=142  Identities=17%  Similarity=0.243  Sum_probs=80.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----CCCceeee-E-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQLR-Y-  182 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~-~-  182 (447)
                      ++..-++.|+.|....+|++...       +..+++|+.....  ..   +.+..|..+++.+.     -|.++... + 
T Consensus        22 ~~~~~~~~i~~G~~n~~~~v~~~-------~g~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~   89 (322)
T 2ppq_A           22 GSLTSYKGIAEGVENSNFLLHTT-------KDPLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGE   89 (322)
T ss_dssp             CCEEEEEEECC---EEEEEEEES-------SCCEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCC
T ss_pred             CcceEeeccCCCcccceEEEEeC-------CccEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCC
Confidence            44556778888999999998753       2358899887521  11   23556777776663     23333211 0 


Q ss_pred             -EEEeCCEEEEEEeccCCCChH--------------HHHHHc-CCC--------CHHHHHH---------------HHHH
Q 013249          183 -SFQTRSKLYLILDFINGGHLF--------------FHLYRQ-GIF--------REDQARF---------------YTAE  223 (447)
Q Consensus       183 -~~~~~~~~~lv~E~~~gg~L~--------------~~l~~~-~~~--------~~~~~~~---------------i~~q  223 (447)
                       +....+..++||+|++|..+.              ..++.. ..+        .......               +...
T Consensus        90 ~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~  169 (322)
T 2ppq_A           90 LLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREE  169 (322)
T ss_dssp             SCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHH
T ss_pred             EEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHH
Confidence             122346789999999986431              112211 011        1000000               0112


Q ss_pred             HHHHHHHHHH-------CCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          224 IVSAVSHLHK-------CGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       224 i~~aL~~LH~-------~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      +...++.|..       .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3445555653       369999999999999887666899998765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.59  E-value=0.0002  Score=67.98  Aligned_cols=132  Identities=14%  Similarity=0.079  Sum_probs=72.8

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc-eeeeEEEEeCCEEEEE
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYLI  193 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv  193 (447)
                      ++.|+.|....+|++  .         .+++|+.......   . ....+|..+++.+....+ .++++.  +.+.-++|
T Consensus        23 i~~l~gG~tN~~~~~--~---------~~vlR~~~~~~~~---~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v   85 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA--G---------DLCLRIPGKGTEE---Y-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMV   85 (301)
T ss_dssp             CEEEESCSSEEEEEE--T---------TEEEEEECC-------C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEE
T ss_pred             eeEcCCcccccccee--e---------eEEEECCCCCccc---e-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEE
Confidence            678889999999998  2         3888887643110   0 112457777777643222 344443  33334789


Q ss_pred             Eecc-CCCChHHH------------------HHHcCC-C----C-HHHHHHHHHH--------------HHHHHHHHH--
Q 013249          194 LDFI-NGGHLFFH------------------LYRQGI-F----R-EDQARFYTAE--------------IVSAVSHLH--  232 (447)
Q Consensus       194 ~E~~-~gg~L~~~------------------l~~~~~-~----~-~~~~~~i~~q--------------i~~aL~~LH--  232 (447)
                      +||+ +|..|...                  ++.... +    . ...+..+...              +...+..|.  
T Consensus        86 ~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  165 (301)
T 3dxq_A           86 TRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSA  165 (301)
T ss_dssp             EECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHH
T ss_pred             EeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHH
Confidence            9999 66544211                  111110 1    1 1111111111              111111111  


Q ss_pred             --H----CCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          233 --K----CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       233 --~----~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                        .    ..++|+|+.+.||| ..++.+.|+||..+..
T Consensus       166 l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          166 LAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              1    13899999999999 5667889999987754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.44  E-value=0.0011  Score=62.21  Aligned_cols=80  Identities=11%  Similarity=0.057  Sum_probs=54.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC---CceeeeEEEEe
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP---FIVQLRYSFQT  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~  186 (447)
                      .+..-++.+|.|..+.||++...      +|+.|+||+......   .....+..|...|+.+.--   -+.+++.+  +
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~------DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA------DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET------TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC------CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--c
Confidence            35677889999999999999864      577899998654321   1123477899999988421   23344433  2


Q ss_pred             CCEEEEEEeccCCCCh
Q 013249          187 RSKLYLILDFINGGHL  202 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L  202 (447)
                      .  -++||||++++..
T Consensus        84 ~--~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 D--RTLAMEWVDERPP   97 (288)
T ss_dssp             T--TEEEEECCCCCCC
T ss_pred             C--ceEEEEeecccCC
Confidence            2  3789999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.36  E-value=0.00038  Score=66.95  Aligned_cols=31  Identities=35%  Similarity=0.438  Sum_probs=27.1

Q ss_pred             CCceeccCCCCCcccCCC----CcEEEeecCCccc
Q 013249          234 CGIVHRDLKPENILMDSD----GHVMLTDFGLAKE  264 (447)
Q Consensus       234 ~~iiHrDikp~NILl~~~----~~~kL~DFG~a~~  264 (447)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999875    6899999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.36  E-value=0.00057  Score=65.39  Aligned_cols=75  Identities=9%  Similarity=0.184  Sum_probs=46.0

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC--CceeeeEE-----EEeCC
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYS-----FQTRS  188 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~-----~~~~~  188 (447)
                      ..|+ |....||++...      .++.+++|+......    ....+..|..+++.+...  .+.+++..     ....+
T Consensus        32 ~~l~-g~~n~~y~v~~~------~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g  100 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE------DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG  100 (328)
T ss_dssp             EEEC-CSSSEEEEECCT------TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred             Eeec-CcccceEEEEcC------CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence            3566 888899987532      345699999864321    123456688887776421  13333332     23356


Q ss_pred             EEEEEEeccCCCC
Q 013249          189 KLYLILDFINGGH  201 (447)
Q Consensus       189 ~~~lv~E~~~gg~  201 (447)
                      ..++||++++|..
T Consensus       101 ~~~~l~~~i~G~~  113 (328)
T 1zyl_A          101 FYFAVFPSVGGRQ  113 (328)
T ss_dssp             EEEEEEECCCCEE
T ss_pred             EEEEEEEecCCCC
Confidence            7789999998854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.27  E-value=0.00047  Score=69.02  Aligned_cols=79  Identities=14%  Similarity=0.113  Sum_probs=49.1

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc-eeeeEEEEeCCEE
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKL  190 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~  190 (447)
                      -++.|+.|....||++.......  ...++.+++|+.....  .   .+.+..|..+++.+...++ .++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            45678889999999997642100  0124679999874311  1   1234478888888753333 456665542    


Q ss_pred             EEEEeccCCCC
Q 013249          191 YLILDFINGGH  201 (447)
Q Consensus       191 ~lv~E~~~gg~  201 (447)
                      .+||||++|..
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            28999998743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.10  E-value=0.002  Score=62.16  Aligned_cols=31  Identities=16%  Similarity=0.371  Sum_probs=27.5

Q ss_pred             CCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          234 CGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       234 ~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999888899999987764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.07  E-value=0.00093  Score=65.24  Aligned_cols=80  Identities=14%  Similarity=0.138  Sum_probs=43.7

Q ss_pred             EEeeEeecCCeEEEEEEEcCCC---CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCCE
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVD---DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSK  189 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~  189 (447)
                      .+..|+.|....+|++...+..   ....++.+++|+.....   . .......|..+++.+.... +.++++.+  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---D-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---G-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---c-ceecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            3567788888999998753200   00012578899875431   1 1111356888888775333 33555544  22 


Q ss_pred             EEEEEeccCCCC
Q 013249          190 LYLILDFINGGH  201 (447)
Q Consensus       190 ~~lv~E~~~gg~  201 (447)
                       ++||||++|..
T Consensus       110 -~~v~e~i~G~~  120 (369)
T 3c5i_A          110 -GRIEEWLYGDP  120 (369)
T ss_dssp             -EEEEECCCSEE
T ss_pred             -cEEEEEecCCc
Confidence             68999998854

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.01  E-value=0.00093  Score=65.61  Aligned_cols=146  Identities=17%  Similarity=0.162  Sum_probs=83.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCC--CCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVD--DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  186 (447)
                      +++++ +.|..|....+|++......  ....++.|++|+....    ......+.+|..+++.+. +.-..++++.+.+
T Consensus        51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~  125 (379)
T 3feg_A           51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE  125 (379)
T ss_dssp             GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred             CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence            44443 45666888889998753200  0113467999986331    112334568999988875 3223456655543


Q ss_pred             CCEEEEEEeccCCCChH--------------HH---HHHcC-----CC--CHHHHHHHHHHHHH----------------
Q 013249          187 RSKLYLILDFINGGHLF--------------FH---LYRQG-----IF--REDQARFYTAEIVS----------------  226 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~--------------~~---l~~~~-----~~--~~~~~~~i~~qi~~----------------  226 (447)
                          .+||||++|..|.              ..   ++...     ..  -+.++..+..++..                
T Consensus       126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence                2999999986542              11   11111     11  23556666654422                


Q ss_pred             ---HHHHHH----H----CCceeccCCCCCcccCCC----CcEEEeecCCccc
Q 013249          227 ---AVSHLH----K----CGIVHRDLKPENILMDSD----GHVMLTDFGLAKE  264 (447)
Q Consensus       227 ---aL~~LH----~----~~iiHrDikp~NILl~~~----~~~kL~DFG~a~~  264 (447)
                         .+..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               233332    2    248999999999999876    7899999987753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.81  E-value=0.0032  Score=56.22  Aligned_cols=96  Identities=20%  Similarity=0.129  Sum_probs=64.3

Q ss_pred             ChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCcccccCCCCCCccccCC
Q 013249          201 HLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTT  278 (447)
Q Consensus       201 ~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~  278 (447)
                      +|.+.|... .+++|++++.++.|.+.+|.-+-. +.-..+=+.|..|+|..+|.|-+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            788888754 689999999999999999877622 2222344456889999999988764 1110           1233


Q ss_pred             cccccccccCCCCCCccceeehhHhHHHHhh
Q 013249          279 EYMAPEILLSKGHNKDADWWSVGILLYEMLT  309 (447)
Q Consensus       279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ell~  309 (447)
                      .+.|||... ...+.+.-|||||+++|.-+-
T Consensus       102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          102 PPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             CCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence            567888863 345677889999999999886

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.72  E-value=0.018  Score=57.85  Aligned_cols=76  Identities=18%  Similarity=0.303  Sum_probs=47.6

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCc-eeeeEEEEeCCEEEE
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYL  192 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~l  192 (447)
                      -++.|+.|-...+|++....     .++.+++|+.....   ...++ ...|..+|+.+...++ .++++.+.  +  .+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~---~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~  178 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKT---DEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GR  178 (458)
T ss_dssp             EEEEECC--CEEEEEEEETT-----TTEEEEEEEECC-C---CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred             EEEEcCCCeEeEEEEEEECC-----CCceEEEEECCCCh---hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence            45678889999999998642     24678899875421   11111 2578999998875444 45666653  2  24


Q ss_pred             EEeccCCCCh
Q 013249          193 ILDFINGGHL  202 (447)
Q Consensus       193 v~E~~~gg~L  202 (447)
                      ||||++|..|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999987543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.60  E-value=0.025  Score=56.21  Aligned_cols=81  Identities=16%  Similarity=0.150  Sum_probs=47.5

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEE
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  190 (447)
                      -++.|..|....+|++.......  ...++.|++|+.....   ...+ ...+|..+++.+. +.-..++++.+  .+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFY-DSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhc-CHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            45567778889999998642100  0015779999864421   1111 1346888888774 22234455433  22  


Q ss_pred             EEEEeccCCCCh
Q 013249          191 YLILDFINGGHL  202 (447)
Q Consensus       191 ~lv~E~~~gg~L  202 (447)
                      ++||||++|..|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            689999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.23  E-value=0.28  Score=48.17  Aligned_cols=29  Identities=31%  Similarity=0.518  Sum_probs=24.8

Q ss_pred             ceeccCCCCCccc------CCCCcEEEeecCCccc
Q 013249          236 IVHRDLKPENILM------DSDGHVMLTDFGLAKE  264 (447)
Q Consensus       236 iiHrDikp~NILl------~~~~~~kL~DFG~a~~  264 (447)
                      ++|+|+.+.|||+      ++++.++++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999987754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.35  E-value=2.8  Score=37.22  Aligned_cols=113  Identities=15%  Similarity=0.139  Sum_probs=75.6

Q ss_pred             CCCCceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHHCCceeccCCCCCcccCCC
Q 013249          173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS-HLHKCGIVHRDLKPENILMDSD  251 (447)
Q Consensus       173 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~-~LH~~~iiHrDikp~NILl~~~  251 (447)
                      .||++ . ...-.+++.+.+.++.-+++.=+..+   ..++....++++.+|+.... ++  ..-+|--|.|+||+++.+
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57887 3 34457788888888877555444444   34678888888888776554 33  456788899999999999


Q ss_pred             CcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCcccee-ehhHhHHHHhhCCCCC
Q 013249          252 GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW-SVGILLYEMLTGQPPF  314 (447)
Q Consensus       252 ~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw-SlGvil~ell~G~~pf  314 (447)
                      +.++|.-.|+-..                ++|.-+.      ..|.| .+=|++..++.++..|
T Consensus       121 ~~p~i~hRGi~~~----------------lpP~e~~------ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          121 LEPFFLHVGVKES----------------LPPDEWD------DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CCEEESCCEETTT----------------BSSCSCC------HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CcEEEEEcCCccc----------------CCCCCCC------HHHHHHHHHHHHHHHHcCCCCH
Confidence            9999987775322                2232211      11222 3557788888887776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	447
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-99
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-97
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-94
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-93
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-91
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-89
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-86
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-83
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-79
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-79
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-78
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-77
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-76
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-75
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-75
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-75
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-74
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-74
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-72
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-71
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-70
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-67
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-65
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-64
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-63
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-63
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-61
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-60
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-59
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-58
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-58
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-58
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-55
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-55
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-55
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-54
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-54
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-53
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-52
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-51
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-49
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-39
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  299 bits (767), Expect = e-99
 Identities = 130/346 (37%), Positives = 206/346 (59%), Gaps = 23/346 (6%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPE 284
           SA+ +LH   +V+RD+K EN+++D DGH+ +TDFGL KE   + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 404
           L        LL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ + 
Sbjct: 236 LA------GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289

Query: 405 CIANFDKCWTTMPADDSP-----------APTPTAGEHFKGYTYVA 439
               FD  +T      +P                  E F+ + Y+A
Sbjct: 290 DTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  293 bits (751), Expect = 1e-97
 Identities = 119/333 (35%), Positives = 188/333 (56%), Gaps = 21/333 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + +++G+G+FGKVF  + K      ++  +A+K ++KD ++  + V+    E+ +L+
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 57

Query: 171 KV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI+  + 
Sbjct: 58  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI-DESSRSNSMCGTTEYMAPEILLS 288
            LH  GIV+RDLK +NIL+D DGH+ + DFG+ KE     +++N+ CGT +Y+APEILL 
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
           + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  EA  LL   
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV-- 235

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN 408
               +L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V      +N
Sbjct: 236 ----KLFVREPEKRLGV----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSN 287

Query: 409 FDKCWTTMPADDSPAPTPTAG----EHFKGYTY 437
           FDK +       S A            F+ +++
Sbjct: 288 FDKEFLNEKPRLSFADRALINSMDQNMFRNFSF 320

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  284 bits (727), Expect = 6e-94
 Identities = 116/326 (35%), Positives = 199/326 (61%), Gaps = 15/326 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+I R +G G+FG+V  ++ +      +   YAMKV++K+ +++   V++   ER +L+
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+  A+ +
Sbjct: 60  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
           LH   I++RDLKPENIL+D +GH+ +TDFG AK + +   + ++CGT +Y+APE++ +K 
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKP 177

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           +NK  DWWS GIL+YEML G  PF  +N  K  ++I+N +++ PPF   +   LL     
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS---- 233

Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANF 409
             +L+ +D S+RLG+   G + +K+H WF+ + W+ L +R ++  ++P +  G+   + F
Sbjct: 234 --RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQF 291

Query: 410 DKCWTTMPADDSPAPTPTAGEHFKGY 435
           DK +     +          + F+ +
Sbjct: 292 DK-YPEEDINYGVQGEDPYADLFRDF 316

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  282 bits (723), Expect = 1e-93
 Identities = 111/291 (38%), Positives = 171/291 (58%), Gaps = 15/291 (5%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F  V   ++       +   YA+K++ K  IIK+N V Y+  
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTR 57

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYM 281
           VSA+ +LH  GI+HRDLKPENIL++ D H+ +TDFG AK +   S   R+NS  GT +Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237

Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSG-PGGVDAIKHHKWFRSINWKTLEARE 391
             L++      +LL  D +KRLG     G   +K H +F S+ W+ L  + 
Sbjct: 238 RDLVE------KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  278 bits (711), Expect = 7e-91
 Identities = 113/349 (32%), Positives = 180/349 (51%), Gaps = 29/349 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 171 KVT---HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           + H+H   +V+RDLKP NIL+D  GHV ++D GLA +  +  + ++  GT  YMAPE+L 
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQ 178

Query: 288 S-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPPFLTSEAHS 343
               ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  S
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 403
           LL+       LL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P     
Sbjct: 239 LLE------GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEV 292

Query: 404 DC-----IANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV 447
           +      I +FD+  T               E ++ +       W   V
Sbjct: 293 NAADAFDIGSFDEEDTKGIKLLDSDQ-----ELYRNFPLTISERWQQEV 336

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  272 bits (697), Expect = 4e-89
 Identities = 125/354 (35%), Positives = 202/354 (57%), Gaps = 16/354 (4%)

Query: 82  SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
            S+   + + + +   + E  S+       F+  + +G G+FG+V  VK K     +S  
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK-----ESGN 67

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
            YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG 
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL 261
           +F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G++ +TDFG 
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 321
           AK +    R+ ++CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G PPF      +
Sbjct: 188 AKRVK--GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

Query: 322 LQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
           + ++I++ KV+ P   +S+   LL+       LL  D +KR G+   GV+ IK+HKWF +
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

Query: 382 INWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGY 435
            +W  +  R+++  F P   G    +NFD  +       S       G+ F  +
Sbjct: 300 TDWIAIYQRKVEAPFIPKFKGPGDTSNFDD-YEEEEIRVS--INEKCGKEFTEF 350

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  263 bits (673), Expect = 1e-86
 Identities = 88/271 (32%), Positives = 147/271 (54%), Gaps = 17/271 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G FG V+  ++K      S  I A+KV+ K  + K      ++ E +I +
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKG 290
            H   ++HRD+KPEN+L+ S G + + DFG +     SSR  ++CGT +Y+ PE++  + 
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 180

Query: 291 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVSF 350
           H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L+     
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS---- 236

Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
             +LL  +PS+R       +  +  H W  +
Sbjct: 237 --RLLKHNPSQRP-----MLREVLEHPWITA 260

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (658), Expect = 1e-83
 Identities = 146/325 (44%), Positives = 208/325 (64%), Gaps = 12/325 (3%)

Query: 87  QIQELEHE-NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAM 145
           Q+  ++HE   A L   +E+ +G  +FE+ +V+G GA+GKVF V+K  +   D+  +YAM
Sbjct: 1   QLLTVKHELRTANLTGHAEK-VGIENFELLKVLGTGAYGKVFLVRK--ISGHDTGKLYAM 57

Query: 146 KVMRKDTIIKK-NHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           KV++K TI++K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 58  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK 263
            HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GHV+LTDFGL+K
Sbjct: 118 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177

Query: 264 EID--ESSRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANR 319
           E    E+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG  PFT    
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237

Query: 320 QKLQQRIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF 379
           +  Q  I    +K  P    E  +L K    + +LL KDP KRLG GP   D IK H +F
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAK--DLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

Query: 380 RSINWKTLEAREMQPKFKPDVSGKD 404
           + INW  L A+++   FKP +  + 
Sbjct: 296 QKINWDDLAAKKVPAPFKPVIRDEL 320

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (631), Expect = 1e-79
 Identities = 74/317 (23%), Positives = 140/317 (44%), Gaps = 52/317 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G VF+V  K      S  + A K++  +  IK    + +  E  +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  ++  +++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 231 LH-KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSK 289
           L  K  I+HRD+KP NIL++S G + L DFG++ ++ +S  +NS  GT  YM+PE L   
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT 178

Query: 290 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ------------------------- 324
            ++  +D WS+G+ L EM  G+ P    + ++L+                          
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 325 -------------RIINEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVD 371
                         +++  V  PP         L+   F+ + L K+P++R       + 
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLK 293

Query: 372 AIKHHKWFRSINWKTLE 388
            +  H + +  + + ++
Sbjct: 294 QLMVHAFIKRSDAEEVD 310

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  247 bits (632), Expect = 3e-79
 Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 18/291 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++I   +G GAFG V +V ++      +   +A K +       ++  + ++ E   ++
Sbjct: 27  HYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTP---HESDKETVRKEIQTMS 78

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y  ++   + 
Sbjct: 79  VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           H+H+   VH DLKPENI+  +     + L DFGL   +D         GT E+ APE+  
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K      D WSVG+L Y +L+G  PF   N  +  + + +    +     S      K 
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK- 257

Query: 348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 398
             F+ +LL  DP+ R+      +     H W    N    +++    ++  
Sbjct: 258 -DFIRKLLLADPNTRM-----TIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  243 bits (622), Expect = 9e-78
 Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 19/291 (6%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++I   +G GAFG V +  +K      +  ++  K +     + K  V   K E  I+
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYPLDKYTV---KNEISIM 80

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAV 228
            ++ HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y  +    +
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140

Query: 229 SHLHKCGIVHRDLKPENILMDS--DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
            H+H+  IVH D+KPENI+ ++     V + DFGLA +++          T E+ APEI+
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 287 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK 346
             +      D W++G+L Y +L+G  PF   +  +  Q +     +      S      K
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 397
              F+  LL K+P KRL      V     H W +  +   L +R    ++ 
Sbjct: 261 --DFIKNLLQKEPRKRL-----TVHDALEHPWLKG-DHSNLTSRIPSSRYN 303

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 2e-77
 Identities = 83/305 (27%), Positives = 143/305 (46%), Gaps = 32/305 (10%)

Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            R + P D +EI   +G GAFGKV++ + K     ++  + A KV+       +  ++  
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKAQNK-----ETSVLAAAKVIDTK---SEEELEDY 56

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
             E DIL    HP IV+L  +F   + L+++++F  GG +   +   +    E Q +   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES-SRSNSMCGTTEY 280
            + + A+++LH   I+HRDLK  NIL   DG + L DFG++ +   +  R +S  GT  +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 281 MAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VK 332
           MAPE+++      + ++  AD WS+GI L EM   +PP    N  ++  +I   +   + 
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236

Query: 333 LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM 392
            P   +S     LK      + L K+   R          +  H +    + K +  RE+
Sbjct: 237 QPSRWSSNFKDFLK------KCLEKNVDARW-----TTSQLLQHPFVTVDSNKPI--REL 283

Query: 393 QPKFK 397
             + K
Sbjct: 284 IAEAK 288

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (609), Expect = 1e-76
 Identities = 79/295 (26%), Positives = 143/295 (48%), Gaps = 20/295 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---HVDYMKAERD 167
            ++    +G G F  V + ++K      +   YA K ++K            + ++ E  
Sbjct: 11  YYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           IL ++ HP ++ L   ++ ++ + LIL+ + GG LF  L  +    E++A  +  +I++ 
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 228 VSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           V +LH   I H DLKPENI++         + + DFGLA +ID  +   ++ GT E++AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

Query: 284 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           EI+  +    +AD WS+G++ Y +L+G  PF    +Q+    +     +      S   +
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245

Query: 344 LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW-KTLEAREMQPKFK 397
           L K   F+ +LL KDP KR+      +     H W +  +  + L +    P+F+
Sbjct: 246 LAK--DFIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  236 bits (604), Expect = 1e-75
 Identities = 91/295 (30%), Positives = 147/295 (49%), Gaps = 18/295 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++   V+G GAF +V   + K      +  + A+K + K  +  +     M+ E  +L 
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDK-----RTQKLVAIKCIAKKAL--EGKEGSMENEIAVLH 62

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A     +++ AV +
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 231 LHKCGIVHRDLKPENIL---MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
           LH  GIVHRDLKPEN+L   +D D  +M++DFGL+K  D  S  ++ CGT  Y+APE+L 
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
            K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +       +     K 
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK- 241

Query: 348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR-EMQPKFKPDVS 401
             F+  L+ KDP KR        +    H W              +  + K + +
Sbjct: 242 -DFIRHLMEKDPEKRF-----TCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFA 290

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  235 bits (600), Expect = 2e-75
 Identities = 80/283 (28%), Positives = 138/283 (48%), Gaps = 25/283 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
           ++E   ++G+G    V +   K      +   YA+K++        +  +  +       
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 58

Query: 165 ERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV  HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 59  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           ++  +  LHK  IVHRDLKPENIL+D D ++ LTDFG + ++D   +   +CGT  Y+AP
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 284 EILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 337
           EI+         G+ K+ D WS G+++Y +L G PPF H  +  + + I++   +     
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238

Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
             +    +K    +++ L   P KR        +    H +F+
Sbjct: 239 WDDYSDTVK--DLVSRFLVVQPQKRY-----TAEEALAHPFFQ 274

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (596), Expect = 5e-75
 Identities = 75/278 (26%), Positives = 136/278 (48%), Gaps = 25/278 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            D+++ + +G+GA+G+V     +      ++   A+K++     +     + +K E  I 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRAVDC--PENIKKEICIN 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  ++++ V 
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEIL 286
           +LH  GI HRD+KPEN+L+D   ++ ++DFGLA     ++R    N MCGT  Y+APE+L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 287 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---LTSEAH 342
             +  H +  D WS GI+L  ML G+ P+   +    +     EK         + S   
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

Query: 343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
           +LL       ++L ++PS R+      +  IK  +W+ 
Sbjct: 238 ALLH------KILVENPSARI-----TIPDIKKDRWYN 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 2e-74
 Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 28/294 (9%)

Query: 95  NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           +D E+  +    +  GD    +  F  +GQGA G V+           +    A++ M  
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
               KK  +     E  ++ +  +P IV    S+    +L+++++++ GG L   +    
Sbjct: 56  QQQPKKELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESS 269
              E Q      E + A+  LH   ++HRD+K +NIL+  DG V LTDFG   +I  E S
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 270 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 329
           + ++M GT  +MAPE++  K +    D WS+GI+  EM+ G+PP+ + N  +    I   
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 330 ---KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
              +++ P  L++     L       + L  D  KR          +  H++ +
Sbjct: 232 GTPELQNPEKLSAIFRDFLN------RCLDMDVEKRG-----SAKELLQHQFLK 274

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  232 bits (594), Expect = 4e-74
 Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 20/272 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +        +  + A+K M             +  E   L K
Sbjct: 17  FSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLS--- 288
           H   ++HRD+K  NIL+   G V L DFG A  +     +NS  GT  +MAPE++L+   
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDE 188

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV 348
             ++   D WS+GI   E+   +PP  + N       I     + P   +       +  
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEYFR-- 244

Query: 349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
           +F+   L K P  R        + +  H++  
Sbjct: 245 NFVDSCLQKIPQDRP-----TSEVLLKHRFVL 271

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 6e-72
 Identities = 67/281 (23%), Positives = 138/281 (49%), Gaps = 30/281 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+   +G G++G+  ++++K         I   K +   ++ +      + +E ++L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSMTEAE-KQMLVSEVNLLR 58

Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEI 224
           ++ HP IV+       +T + LY+++++  GG L   + +    +    E+       ++
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 225 VSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTDFGLAKEID-ESSRSNSMCGTT 278
             A+   H+       ++HRDLKP N+ +D   +V L DFGLA+ ++ ++S + +  GT 
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFL 337
            YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K  ++P   
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238

Query: 338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
           + E + ++       ++L+     R       V+ I  +  
Sbjct: 239 SDELNEIIT------RMLNLKDYHRP-----SVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (578), Expect = 1e-71
 Identities = 70/302 (23%), Positives = 123/302 (40%), Gaps = 27/302 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            + I   +G+G FG V +  +       S   Y  K ++     K      +K E  IL 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKV----KGTDQVLVKKEISILN 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVS 229
              H  I+ L  SF++  +L +I +FI+G  +F  +        E +   Y  ++  A+ 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 230 HLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILL 287
            LH   I H D++PENI+  +     + + +FG A+++        +    EY APE+  
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 288 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 347
               +   D WS+G L+Y +L+G  PF     Q++ + I+N +         E       
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM- 235

Query: 348 VSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR----SINWKTLEA----REMQPKFKPD 399
             F+ +LL K+   R+            H W +     ++ K +      R      K D
Sbjct: 236 -DFVDRLLVKERKSRM-----TASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKD 289

Query: 400 VS 401
           ++
Sbjct: 290 LN 291

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 1e-70
 Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 17/263 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I  G   + + +G G+FG V++ K  G          A+K++       +  +   K E 
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQ-QLQAFKNEV 55

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
            +L K  H  I+     + T  +L ++  +  G  L+ HL+  +  F   +      +  
Sbjct: 56  GVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMA 282
             + +LH   I+HRDLK  NI +  D  V + DFGLA      S   +   + G+  +MA
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 283 PEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 339
           PE++  +  N     +D ++ GI+LYE++TGQ P+++ N +     ++      P     
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 340 EAHSLLKGVSFLTQLLHKDPSKR 362
            ++        + + L K   +R
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDER 257

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 1e-69
 Identities = 59/276 (21%), Positives = 123/276 (44%), Gaps = 23/276 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
            +    +G+G+F  V++         ++    A   ++   + K +     K E ++L  
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKG 64

Query: 172 VTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           + HP IV+   S+++  K    + L+ + +  G L  +L R  + +    R +  +I+  
Sbjct: 65  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124

Query: 228 VSHLHKCG--IVHRDLKPENILMDS-DGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  LH     I+HRDLK +NI +    G V + D GLA  +  +S + ++ GT E+MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPE 183

Query: 285 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 344
           +   + +++  D ++ G+ + EM T + P++         R +   VK   F       +
Sbjct: 184 MY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
                 +   + ++  +R       +  + +H +F+
Sbjct: 243 ---KEIIEGCIRQNKDERY-----SIKDLLNHAFFQ 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  213 bits (542), Expect = 8e-67
 Identities = 63/264 (23%), Positives = 127/264 (48%), Gaps = 15/264 (5%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E+  ++G G   +V   +             A+KV+R D     +     + E    
Sbjct: 7   DRYELGEILGFGGMSEVHLARDL-----RLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61

Query: 170 TKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + HP IV +  + +  +      Y+++++++G  L   ++ +G     +A    A+  
Sbjct: 62  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES----SRSNSMCGTTEYM 281
            A++  H+ GI+HRD+KP NI++ +   V + DFG+A+ I +S    +++ ++ GT +Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           +PE       +  +D +S+G +LYE+LTG+PPFT  +   +  + + E    P       
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 342 HSLLKGVSFLTQLLHKDPSKRLGS 365
            + L   + + + L K+P  R  +
Sbjct: 242 SADLD--AVVLKALAKNPENRYQT 263

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 4e-66
 Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 31/281 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK---AER 166
             +++  ++G G FG V+   +        +   A+K + KD I     +        E 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 58

Query: 167 DILTKVT--HPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAE 223
            +L KV+     +++L   F+      LIL+       LF  +  +G  +E+ AR +  +
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           ++ AV H H CG++HRD+K ENIL+D + G + L DFG    + + +      GT  Y  
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSP 177

Query: 283 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 341
           PE +   + H + A  WS+GILLY+M+ G  PF H         II  +V     ++SE 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231

Query: 342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 382
             L++        L   PS R        + I++H W + +
Sbjct: 232 QHLIR------WCLALRPSDRP-----TFEEIQNHPWMQDV 261

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 4e-65
 Identities = 63/261 (24%), Positives = 119/261 (45%), Gaps = 25/261 (9%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   + ++ + +G+G FG V     +G          A+K ++ D   +        AE 
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA-----FLAEA 51

Query: 167 DILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAE 223
            ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    ++ +
Sbjct: 52  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAP 283
           +  A+ +L     VHRDL   N+L+  D    ++DFGL KE   SS  ++     ++ AP
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAP 169

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPPFLTSEA 341
           E L  K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P       
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229

Query: 342 HSLLKGVSFLTQLLHKDPSKR 362
           + ++K         H D + R
Sbjct: 230 YEVMK------NCWHLDAAMR 244

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 6e-64
 Identities = 77/286 (26%), Positives = 139/286 (48%), Gaps = 35/286 (12%)

Query: 110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E ++
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDCPKARR--------EVEL 57

Query: 169 LTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
             + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A    
Sbjct: 58  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKEIDESSRSNSMCGTT 278
             I  A+ +LH   I HRD+KPEN+L  S   +  + LTDFG AKE    +   + C T 
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177

Query: 279 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLP 334
            Y+APE+L  + ++K  D WS+G+++Y +L G PPF   +       ++ RI   + + P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 335 PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
               SE    +K    +  LL  +P++R+      +    +H W  
Sbjct: 238 NPEWSEVSEEVK--MLIRNLLKTEPTQRM-----TITEFMNHPWIM 276

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 7e-64
 Identities = 57/264 (21%), Positives = 108/264 (40%), Gaps = 17/264 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+FG V + +             A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L   QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS----RSNSMCGTTEYM 281
             + +L     +HRDL   N+L+ +   V + DFGL + + ++               + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLT 338
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +L  P    
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 339 SEAHSLLKGVSFLTQLLHKDPSKR 362
            + ++++       Q     P  R
Sbjct: 242 QDIYNVMV------QCWAHKPEDR 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 1e-63
 Identities = 51/275 (18%), Positives = 112/275 (40%), Gaps = 19/275 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G G FG V +   +           A+K+++ +        D + AE +++ ++ +P
Sbjct: 13  KELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNP 68

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           +IV++           L+++    G L  +L +    ++        ++   + +L +  
Sbjct: 69  YIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 236 IVHRDLKPENILMDSDGHVMLTDFGLAKEIDES----SRSNSMCGTTEYMAPEILLSKGH 291
            VHRDL   N+L+ +  +  ++DFGL+K +                 ++ APE +     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 292 NKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGVS 349
           +  +D WS G+L++E  + GQ P+      ++   +   E++  P     E + L+    
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN--- 244

Query: 350 FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 384
                   D   R G     V+    + ++  +N 
Sbjct: 245 ---LCWTYDVENRPGF--AAVELRLRNYYYDVVNE 274

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 2e-63
 Identities = 66/304 (21%), Positives = 122/304 (40%), Gaps = 38/304 (12%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
            E  + +  E E + + +    + E  +V+G GAFGKV      G+         A+K++
Sbjct: 16  NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 75

Query: 149 RKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++      +  + + +E  ++T++  H  IV L  +      +YLI ++   G L  +L 
Sbjct: 76  KEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 208 RQ-----------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
            +                        +   +    +  ++   +  L     VHRDL   
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193

Query: 245 NILMDSDGHVMLTDFGLAKEIDESSRS---NSMCGTTEYMAPEILLSKGHNKDADWWSVG 301
           N+L+     V + DFGLA++I   S      +     ++MAPE L    +   +D WS G
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253

Query: 302 ILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGVSFLTQLLHKD 358
           ILL+E+ + G  P+          ++I    K+  P + T E + +++           D
Sbjct: 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ------SCWAFD 307

Query: 359 PSKR 362
             KR
Sbjct: 308 SRKR 311

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 6e-63
 Identities = 58/260 (22%), Positives = 116/260 (44%), Gaps = 19/260 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G          A+K++++ ++ +         E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMSEDE----FIEEA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
            ++  ++H  +VQL      +  +++I +++  G L  +L   +  F+  Q      ++ 
Sbjct: 51  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAP 283
            A+ +L     +HRDL   N L++  G V ++DFGL++ +  DE + S        +  P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        P L SE  
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-- 228

Query: 343 SLLKGVSFLTQLLHKDPSKR 362
              K  + +    H+   +R
Sbjct: 229 ---KVYTIMYSCWHEKADER 245

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-62
 Identities = 69/308 (22%), Positives = 121/308 (39%), Gaps = 36/308 (11%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA--ERDILT 170
           E    +G+G F  V++ + K     +++ I A+K ++     +        A  E  +L 
Sbjct: 1   EKLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +++HP I+ L  +F  +S + L+ DF+             +      + Y    +  + +
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILLS- 288
           LH+  I+HRDLKP N+L+D +G + L DFGLAK     +R+ +    T  Y APE+L   
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 289 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----------------EKV 331
           + +    D W+VG +L E+L   P     +      RI                   + V
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 332 KLPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT 386
               F     H +           +  L   +P  R+             K+F +    T
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNRPGPT 290

Query: 387 LEAREMQP 394
              +  +P
Sbjct: 291 PGCQLPRP 298

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  200 bits (509), Expect = 1e-61
 Identities = 59/266 (22%), Positives = 111/266 (41%), Gaps = 17/266 (6%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           ++I     +I +V+G G FG+V     K    G  +   A+K ++      +       +
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLK--LPGKREIFVAIKTLKSGYT--EKQRRDFLS 76

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAE 223
           E  I+ +  HP ++ L       + + +I +F+  G L  F     G F   Q       
Sbjct: 77  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS------RSNSMCGT 277
           I + + +L     VHRDL   NIL++S+    ++DFGL++ +++ +       +      
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 278 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPF 336
             + APE +  +     +D WS GI+++E+++ G+ P+     Q +   I  +    PP 
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 337 LTSEAHSLLKGVSFLTQLLHKDPSKR 362
               A         +     KD + R
Sbjct: 257 DCPSA-----LHQLMLDCWQKDRNHR 277

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 6e-61
 Identities = 64/312 (20%), Positives = 118/312 (37%), Gaps = 51/312 (16%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E    +GQG FG+VF+ + +      +    A+K +  +   +   +  ++ E  IL
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENEKEGFPITALR-EIKIL 63

Query: 170 TKVTHPFIVQLRYSFQTRS--------KLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             + H  +V L    +T++         +YL+ DF               F   + +   
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-----NSMCG 276
             +++ + ++H+  I+HRD+K  N+L+  DG + L DFGLA+    +  S      +   
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 277 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           T  Y  PE+LL  + +    D W  G ++ EM T  P       Q     I      + P
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 336 FLTSEAHSLLK--------------------------GVSFLTQLLHKDPSKRLGSGPGG 369
            +     +                              +  + +LL  DP++R+      
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----D 298

Query: 370 VDAIKHHKWFRS 381
            D   +H +F S
Sbjct: 299 SDDALNHDFFWS 310

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 4e-60
 Identities = 58/260 (22%), Positives = 112/260 (43%), Gaps = 23/260 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            D E+    G G FG V Q   +           A+KV+++ T  +K   + M  E  I+
Sbjct: 13  ADIEL----GCGNFGSVRQGVYRMRKKQI---DVAIKVLKQGT--EKADTEEMMREAQIM 63

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAV 228
            ++ +P+IV+L    Q    L L+++   GG L   L  +              ++   +
Sbjct: 64  HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES----SRSNSMCGTTEYMAPE 284
            +L +   VHRDL   N+L+ +  +  ++DFGL+K +       +  ++     ++ APE
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 285 ILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPPFLTSEAH 342
            +  +  +  +D WS G+ ++E L+ GQ P+      ++   I   ++++ PP    E +
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242

Query: 343 SLLKGVSFLTQLLHKDPSKR 362
           +L+                R
Sbjct: 243 ALMS------DCWIYKWEDR 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 5e-60
 Identities = 51/260 (19%), Positives = 118/260 (45%), Gaps = 19/260 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V            +    A+K +R+  + +++       E 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMSEED----FIEEA 51

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIV 225
           +++ K++HP +VQL      ++ + L+ +F+  G L  +   ++G+F  +       ++ 
Sbjct: 52  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMAP 283
             +++L +  ++HRDL   N L+  +  + ++DFG+ + +  D+ + S       ++ +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           E+     ++  +D WS G+L++E+ + G+ P+ + +  ++ + I        P L S   
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST-- 229

Query: 343 SLLKGVSFLTQLLHKDPSKR 362
                   +     + P  R
Sbjct: 230 ---HVYQIMNHCWKERPEDR 246

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 7e-60
 Identities = 70/304 (23%), Positives = 121/304 (39%), Gaps = 38/304 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDI 168
            +E    +G+GA+GKVF    K  D  +     A+K +R  T  +   +  ++  A    
Sbjct: 8   QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 169 LTKVTHPFIVQLRYSFQT-----RSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
           L    HP +V+L            +KL L+ + ++     +     +     +  +    
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  +  LH   +VHRDLKP+NIL+ S G + L DFGLA+         S+  T  Y A
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE+LL   +    D WSVG +  EM   +P F  ++      +I++              
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 343 SLLK---------------------GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS 381
           +L +                     G   L + L  +P+KR+        +   H +F+ 
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQD 298

Query: 382 INWK 385
           +   
Sbjct: 299 LERC 302

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 2e-59
 Identities = 65/262 (24%), Positives = 117/262 (44%), Gaps = 23/262 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I      +   +GQG FG+V+     G          A+K ++  T+  +        E 
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMSPEA----FLQEA 63

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
            ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A+I
Sbjct: 64  QVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMA 282
            S ++++ +   VHRDL+  NIL+  +    + DFGLA+ I  +E +         ++ A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 340
           PE  L       +D WS GILL E+ T G+ P+     +++  ++    ++  PP     
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242

Query: 341 AHSLLKGVSFLTQLLHKDPSKR 362
            H L+       Q   K+P +R
Sbjct: 243 LHDLMC------QCWRKEPEER 258

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  193 bits (491), Expect = 5e-59
 Identities = 51/281 (18%), Positives = 115/281 (40%), Gaps = 37/281 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + E  R +G+GAFG+VFQ +  G+   +   + A+K+++++     +     + E  ++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------- 210
           +  +P IV+L         + L+ +++  G L   L                        
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 211 ----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID 266
                    +      ++ + +++L +   VHRDL   N L+  +  V + DFGL++ I 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 267 ESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ-PPFTHANRQKL 322
            +       +      +M PE +    +  ++D W+ G++L+E+ +    P+     +++
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 323 QQRIINEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
              + +  +   P     E ++L++          K P+ R
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMR------LCWSKLPADR 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-58
 Identities = 63/261 (24%), Positives = 119/261 (45%), Gaps = 16/261 (6%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     E+ R +G+G FG V     +G+     +   A+ +         +  +    E 
Sbjct: 4   IQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
             + +  HP IV+L     T + +++I++    G L   L  R+          Y  ++ 
Sbjct: 60  LTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMAP 283
           +A+++L     VHRD+   N+L+ S+  V L DFGL++ +++S+  +++      ++MAP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 284 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEA 341
           E +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238

Query: 342 HSLLKGVSFLTQLLHKDPSKR 362
           +SL+       +    DPS+R
Sbjct: 239 YSLMT------KCWAYDPSRR 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-58
 Identities = 62/302 (20%), Positives = 123/302 (40%), Gaps = 18/302 (5%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAFG V++      +        A+K +R+ T  K N    +  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKAN--KEILD 60

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  ++  V +P + +L     T +   +      G  L +    +          +  +I
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYM 281
              +++L    +VHRDL   N+L+ +  HV +TDFGLAK +    +   +       ++M
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 282 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTS 339
           A E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T 
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 240

Query: 340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
           + + ++       +    D   R    P   + I           + L  +  +    P 
Sbjct: 241 DVYMIMV------KCWMIDADSR----PKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290

Query: 400 VS 401
            +
Sbjct: 291 PT 292

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-58
 Identities = 75/312 (24%), Positives = 128/312 (41%), Gaps = 51/312 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +   +V+G G+FG V+Q K       DS  + A+K + +D   K         E  I+ 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKRFKNR-------ELQIMR 68

Query: 171 KVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLY---RQGIFREDQARFYT 221
           K+ H  IV+LRY F +  +      L L+LD++         +    +        + Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-LTDFGLAKEIDESSRSNSMCGTTEY 280
            ++  +++++H  GI HRD+KP+N+L+D D  V+ L DFG AK++     + S   +  Y
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188

Query: 281 MAP-EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN----------- 328
            AP  I  +  +    D WS G +L E+L GQP F   +       II            
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 329 ------EKVKLPPFLTSEAHSLLK------GVSFLTQLLHKDPSKRLGSGPGGVDAIKHH 376
                  + K P         + +       ++  ++LL   P+ RL            H
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAH 303

Query: 377 KWFRSINWKTLE 388
            +F  +    ++
Sbjct: 304 SFFDELRDPNVK 315

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  191 bits (485), Expect = 2e-58
 Identities = 63/295 (21%), Positives = 122/295 (41%), Gaps = 37/295 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +     +G+G +G V++ +            +A+K +R +    +        E  IL 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILK 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++++ +++
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS-NSMCGTTEYMAPEILLSK 289
            H   ++HRDLKP+N+L++ +G + + DFGLA+      R       T  Y AP++L+  
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 290 G-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN------------------EK 330
             ++   D WSVG +  EM+ G P F   +      RI                      
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 331 VKLPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
                +      S LKG+       L+++L  DP++R+            H +F+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFK 285

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-58
 Identities = 55/262 (20%), Positives = 114/262 (43%), Gaps = 23/262 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +     ++   +G G FG+V+     G          A+K +++ ++          AE 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGSMSPDA----FLAEA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR--EDQARFYTAEI 224
           +++ ++ H  +V+L Y+  T+  +Y+I +++  G L   L      +   ++     A+I
Sbjct: 60  NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS--RSNSMCGTTEYMA 282
              ++ + +   +HRDL+  NIL+       + DFGLA+ I+++            ++ A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 340
           PE +        +D WS GILL E++T G+ P+      ++ Q +    ++  P     E
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238

Query: 341 AHSLLKGVSFLTQLLHKDPSKR 362
            + L++          + P  R
Sbjct: 239 LYQLMR------LCWKERPEDR 254

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-58
 Identities = 60/295 (20%), Positives = 119/295 (40%), Gaps = 33/295 (11%)

Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT 152
           + +  +L  + + +         + +G GAFGKV +    G+   D+    A+K+++   
Sbjct: 6   YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65

Query: 153 IIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--- 208
            +     + + +E  +L+ +  H  IV L  +        +I ++   G L   L R   
Sbjct: 66  HLT--EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 209 ---------------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
                          +     +    ++ ++   ++ L     +HRDL   NIL+     
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183

Query: 254 VMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT- 309
             + DFGLA++I   S      +     ++MAPE + +  +  ++D WS GI L+E+ + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243

Query: 310 GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
           G  P+          ++I E  ++  P    +E + ++K           DP KR
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKR 292

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 4e-58
 Identities = 58/276 (21%), Positives = 114/276 (41%), Gaps = 30/276 (10%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +   D +   V+G+G FG+V + + K              + R      K+       E
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGE 60

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--------------- 209
            ++L K+  HP I+ L  + + R  LYL +++   G+L   L +                
Sbjct: 61  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES 268
                  Q   + A++   + +L +   +HRDL   NIL+  +    + DFGL++  +  
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII 327
            +         +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++ 
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240

Query: 328 -NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
              +++ P     E + L++      Q   + P +R
Sbjct: 241 QGYRLEKPLNCDDEVYDLMR------QCWREKPYER 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-57
 Identities = 74/299 (24%), Positives = 133/299 (44%), Gaps = 37/299 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+    +G+G +G V++ + K      +  + A+K +R DT  +      ++ E  +L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFIN-GGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++ HP IV+L     T +KLYL+ +F++     F              + Y  +++  ++
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-SNSMCGTTEYMAPEILLS 288
             H   ++HRDLKP+N+L++++G + L DFGLA+      R       T  Y APEILL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 289 KGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------------------NE 329
             +     D WS+G +  EM+T +  F   +      RI                   + 
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 330 KVKLPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 383
           K   P +   +   ++  +       L+Q+LH DP+KR+        A   H +F+ + 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-----SAKAALAHPFFQDVT 290

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (476), Expect = 6e-57
 Identities = 57/262 (21%), Positives = 115/262 (43%), Gaps = 21/262 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V++   K           A+K +++DT+  +        E 
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTMEVEE----FLKEA 64

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
            ++ ++ HP +VQL          Y+I +F+  G+L  +L              +   +I
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI--DESSRSNSMCGTTEYMA 282
            SA+ +L K   +HRDL   N L+  +  V + DFGL++ +  D  +         ++ A
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE 340
           PE L     +  +D W+ G+LL+E+ T G  P+   +  ++ + +  + +++ P     +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244

Query: 341 AHSLLKGVSFLTQLLHKDPSKR 362
            + L++           +PS R
Sbjct: 245 VYELMR------ACWQWNPSDR 260

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 3e-55
 Identities = 54/262 (20%), Positives = 109/262 (41%), Gaps = 12/262 (4%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P      +V+G G FG+V++   K    G  +   A+K ++      +        E
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKT-SSGKKEVPVAIKTLKAG--YTEKQRVDFLGE 59

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEI 224
             I+ + +H  I++L         + +I +++  G    F   + G F   Q       I
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----SNSMCGTTEY 280
            + + +L     VHRDL   NIL++S+    ++DFGL++ +++       ++       +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 281 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 340
            APE +  +     +D WS GI+++E++T               + IN+  +LP    + 
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP----TP 235

Query: 341 AHSLLKGVSFLTQLLHKDPSKR 362
                     + Q   ++ ++R
Sbjct: 236 MDCPSAIYQLMMQCWQQERARR 257

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 5e-55
 Identities = 69/310 (22%), Positives = 119/310 (38%), Gaps = 43/310 (13%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + VG GA+G V         DG +    A+K + +     +        E  +
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIKKLYRP-FQSELFAKRAYRELRL 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFREDQARFYTAEI 224
           L  + H  ++ L   F     L    DF       G     L +     ED+ +F   ++
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  + ++H  GI+HRDLKP N+ ++ D  + + DFGLA++ D  S       T  Y APE
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPE 188

Query: 285 ILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           ++L+   + +  D WSVG ++ EM+TG+  F  ++     + I+      P        S
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248

Query: 344 LLK-------------------------GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
                                        V+ L ++L  D  +R+            H +
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPY 303

Query: 379 FRSINWKTLE 388
           F S++    E
Sbjct: 304 FESLHDTEDE 313

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  183 bits (465), Expect = 7e-55
 Identities = 67/311 (21%), Positives = 122/311 (39%), Gaps = 56/311 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ R +G+G + +VF+          ++    +K      I+K      +K E  IL 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVK------ILKPVKKKKIKREIKILE 84

Query: 171 KV-THPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            +   P I+ L    +        L+ + +N               +   RFY  EI+ A
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 141

Query: 228 VSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEIL 286
           + + H  GI+HRD+KP N+++D +   + L D+GLA+        N    +  +  PE+L
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201

Query: 287 LS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------------------ 327
           +  + ++   D WS+G +L  M+  + PF H +    Q   I                  
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 328 ------------NEKVKLPPFLTSEAHSLL--KGVSFLTQLLHKDPSKRLGSGPGGVDAI 373
                       + + +   F+ SE   L+  + + FL +LL  D   RL          
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREA 316

Query: 374 KHHKWFRSINW 384
             H +F ++  
Sbjct: 317 MEHPYFYTVVK 327

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 2e-54
 Identities = 66/326 (20%), Positives = 120/326 (36%), Gaps = 46/326 (14%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +     +G+GA+G V            +    A+K +       + +      E  IL +
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDN-----VNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62

Query: 172 VTHPFIVQLRYSFQTRS---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             H  I+ +    +  +      + L     G   + L +      D   ++  +I+  +
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRS----NSMCGTTEYMAPE 284
            ++H   ++HRDLKP N+L+++   + + DFGLA+  D              T  Y APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 285 ILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           I+L+  G+ K  D WSVG +L EML+ +P F   +       I+           +   +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 344 LL-------------------------KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
           L                          K +  L ++L  +P KR+      V+    H +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPY 297

Query: 379 FRSINWKTLEAREMQPKFKPDVSGKD 404
                +   +    +  FK D+   D
Sbjct: 298 LEQY-YDPSDEPIAEAPFKFDMELDD 322

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 4e-54
 Identities = 62/296 (20%), Positives = 113/296 (38%), Gaps = 37/296 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +E    +G+G +G VF+ K +     ++  I A+K +R D    +        E  +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  +  
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSM-CGTTEYMAPEILLSK 289
            H   ++HRDLKP+N+L++ +G + L +FGLA+      R  S    T  Y  P++L   
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 290 G-HNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK- 346
             ++   D WS G +  E+    +P F   +     +RI                 L   
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 347 ----------------------GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR 380
                                 G   L  LL  +P +R+       +    H +F 
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFS 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 9e-54
 Identities = 60/289 (20%), Positives = 128/289 (44%), Gaps = 32/289 (11%)

Query: 98  ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIK 155
           EL  +   ++      + + +G+GAFG+V   +  G+D    +     A+K+++ D    
Sbjct: 1   ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-- 58

Query: 156 KNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---- 210
           +  +  + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L  +     
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 211 ------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTD 258
                                   ++   + +L     +HRDL   N+L+  D  + + D
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 259 FGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 314
           FGLA++I       ++ +     ++MAPE L  + +   +D WS G+LL+E+ T G  P+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

Query: 315 THANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
                ++L + +    ++  P   T+E + +++         H  PS+R
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQR 281

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (455), Expect = 1e-53
 Identities = 51/309 (16%), Positives = 104/309 (33%), Gaps = 40/309 (12%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   + + R +G G+FG ++           +    A+K+        K     + 
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECV-----KTKHPQLH 50

Query: 164 AERDILTKVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
            E  I   +     I  +R+         ++++ +         +    F          
Sbjct: 51  IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLAD 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMLTDFGLAKEIDESS--------RS 271
           +++S + ++H    +HRD+KP+N LM        V + DFGLAK+  ++          +
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170

Query: 272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 331
            ++ GT  Y +    L    ++  D  S+G +L     G  P+        +Q+      
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230

Query: 332 KLPPFLTSEAHSLLKGVS-----FLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS----- 381
           K           L KG       +L          +       +  +  + + R      
Sbjct: 231 KKMSTPIEV---LCKGYPSEFATYLNFCRSLRFDDKPDY--SYLRQLFRNLFHRQGFSYD 285

Query: 382 --INWKTLE 388
              +W  L+
Sbjct: 286 YVFDWNMLK 294

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 6e-53
 Identities = 68/333 (20%), Positives = 121/333 (36%), Gaps = 58/333 (17%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V             D   A+K + +     + H      E  +
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRP-FQNQTHAKRAYRELVL 69

Query: 169 LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           +  V H  I+ L   F  +        +YL+++ ++                ++  +   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLY 126

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMA 282
           +++  + HLH  GI+HRDLKP NI++ SD  + + DFGLA+    S        T  Y A
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 283 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 342
           PE++L  G+ ++ D WSVG ++ EM+  +  F   +      ++I +     P    +  
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 343 SLLK------------------------------------GVSFLTQLLHKDPSKRLGSG 366
             ++                                        L+++L  DP+KR+   
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI--- 303

Query: 367 PGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 399
              VD    H +     W      E  P    D
Sbjct: 304 --SVDDALQHPYIN--VWYDPAEVEAPPPQIYD 332

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 7e-53
 Identities = 57/309 (18%), Positives = 121/309 (39%), Gaps = 32/309 (10%)

Query: 95  NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
           + A++    E ++      + R +GQG+FG V++   KGV   + +   A+K + +   +
Sbjct: 5   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 64

Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR- 213
           +         E  ++ +     +V+L           +I++ +  G L  +L        
Sbjct: 65  R--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122

Query: 214 ---------EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE 264
                      +      EI   +++L+    VHRDL   N ++  D  V + DFG+ ++
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182

Query: 265 IDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQ 320
           I E+    +         +M+PE L        +D WS G++L+E+ T  + P+   + +
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242

Query: 321 KLQQRIINEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH---- 375
           ++ + ++   +   P         L++           +P  R    P  ++ I      
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMR----PSFLEIISSIKEE 292

Query: 376 -HKWFRSIN 383
               FR ++
Sbjct: 293 MEPGFREVS 301

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-52
 Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 21/284 (7%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIF--RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           +L   N   ++A     IGP    +    V+G+G FG V+      +D+       A+K 
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVY--HGTLLDNDGKKIHCAVKS 62

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHLF-FH 205
           + + T      V     E  I+   +HP ++ L     ++     ++L ++  G L  F 
Sbjct: 63  LNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
                         +  ++   +  L     VHRDL   N ++D    V + DFGLA+++
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 266 DESS-----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR 319
            +                ++MA E L ++     +D WS G+LL+E++T G PP+   N 
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240

Query: 320 QKLQQRII-NEKVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
             +   ++   ++  P +     + ++       +  H     R
Sbjct: 241 FDITVYLLQGRRLLQPEYCPDPLYEVML------KCWHPKAEMR 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 60/283 (21%), Positives = 118/283 (41%), Gaps = 30/283 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           S+ +      ++ + +G+GAFG+V +    G+D   +    A+K++++       H   M
Sbjct: 6   SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALM 64

Query: 163 KAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG----------- 210
              + ++    H  +V L     +    L +I++F   G+L  +L  +            
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 211 -----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI 265
                    +    Y+ ++   +  L     +HRDL   NIL+     V + DFGLA++I
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184

Query: 266 DESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQK 321
            +     R        ++MAPE +  + +   +D WS G+LL+E+ +    P+      +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244

Query: 322 LQQRIINEKVKL--PPFLTSEAHSLLKGVSFLTQLLHKDPSKR 362
              R + E  ++  P + T E +  +          H +PS+R
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTML------DCWHGEPSQR 281

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  173 bits (438), Expect = 2e-51
 Identities = 43/272 (15%), Positives = 94/272 (34%), Gaps = 32/272 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +++ R +G+G+FG +F+          ++   A+K   +     ++    ++ E    
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPR-----RSDAPQLRDEYRTY 54

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             +     I  + Y  Q      L++D +              F          ++++ V
Sbjct: 55  KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 229 SHLHKCGIVHRDLKPENILMDS-----DGHVMLTDFGLAKEIDESS--------RSNSMC 275
             +H+  +V+RD+KP+N L+          + + DFG+ K   +             ++ 
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 276 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 335
           GT  YM+    L +  ++  D  ++G +    L G  P+        +Q+      K   
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234

Query: 336 FLTSEAHSLLKGVS-----FLTQLLHKDPSKR 362
               E   L  G       ++    +      
Sbjct: 235 TPLRE---LCAGFPEEFYKYMHYARNLAFDAT 263

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-50
 Identities = 68/326 (20%), Positives = 118/326 (36%), Gaps = 45/326 (13%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  ++    VG GA+G V            +    A+K + +       H      E  +
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           L  + H  ++ L   F     L     + L     G    ++ +     +D  +F   +I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPE 284
           +  + ++H   I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y APE
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPE 188

Query: 285 ILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 343
           I+L+  H N+  D WSVG ++ E+LTG+  F   +     + I+         L  +  S
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248

Query: 344 LLK-------------------------GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKW 378
                                        V  L ++L  D  KR+            H +
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAY 303

Query: 379 FRSINWKTLEAREMQPKFKPDVSGKD 404
           F    +   +   +   +      +D
Sbjct: 304 FA--QYHDPDDEPVADPYDQSFESRD 327

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 6e-49
 Identities = 62/293 (21%), Positives = 120/293 (40%), Gaps = 51/293 (17%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
               +   +G+G FG+V++ K +G          A+K+       ++    + +AE    
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGE-------EVAVKIFSS----REERSWFREAEIYQT 51

Query: 170 TKVTHPFIVQLRYSFQ----TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + H  I+    +      T ++L+L+ D+   G LF +L R  +  E   +       
Sbjct: 52  VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTA 110

Query: 226 SAVSHLH--------KCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-----RSN 272
           S ++HLH        K  I HRDLK +NIL+  +G   + D GLA   D ++       N
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170

Query: 273 SMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTGQPPF------------ 314
              GT  YMAPE+L    + K       AD +++G++ +E+                   
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 315 ---THANRQKLQQRIINEKVKLP-PFLTSEAHSLLKGVSFLTQLLHKDPSKRL 363
              +  + +++++ +  +K++   P       +L      + +  + + + RL
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  141 bits (356), Expect = 7e-39
 Identities = 66/359 (18%), Positives = 122/359 (33%), Gaps = 73/359 (20%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
             + + R +G G F  V+  K        ++   AMK++R D +  +   D +K  + + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67

Query: 169 ------LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-----LFFHLYRQGIFREDQA 217
                    +    I++L   F  +    + +  +              Y          
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 218 RFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVM----LTDFGLAKEIDESSRSN 272
           +  + +++  + ++H +CGI+H D+KPEN+LM+          +    L           
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 273 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF------------------ 314
           +   T EY +PE+LL       AD WS   L++E++TG   F                  
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 315 -------------------THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGVS-----F 350
                              T  N + L + I   K      + +E +   K  +     F
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 351 LTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 409
           L+ +L  DP KR          + +H W +     TL   E++   +        I  +
Sbjct: 308 LSPMLQLDPRKRA-----DAGGLVNHPWLK----DTLGMEEIRVPDRELYGSGSDIPGW 357

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 1e-18
 Identities = 31/211 (14%), Positives = 69/211 (32%), Gaps = 45/211 (21%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-------------- 161
           +++G+G    VF    +        G   +K  +      K   +               
Sbjct: 6   KLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 162 -MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             + E   L K+    + ++           ++++ I+   L+         R +     
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEV 108

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEY 280
              I+  V+  +  GIVH DL   N+L+  +  + + DF  + E+ E           E 
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG-------WREI 160

Query: 281 MAPEIL-----LSKGHNKDADWWSVGILLYE 306
           +  ++       S+ +  + D  S    + +
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	447
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.09
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.03
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.29
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.79
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.72

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-72  Score=549.07  Aligned_cols=323  Identities=40%  Similarity=0.800  Sum_probs=290.2

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+.+|+.+|++++|||||+++++|++
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            456799999999999999999999986     889999999998776666677888999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .+.+|+|||||+||+|..++.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999764


Q ss_pred             C-CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhh
Q 013249          267 E-SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  345 (447)
Q Consensus       267 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  345 (447)
                      . .......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++.+.+....+.+|..+++++++++
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  236 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL  236 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence            3 344567899999999999999999999999999999999999999999999999999999999999999999887766


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCC-
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP-  424 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  424 (447)
                      +.      ||++||.+|+++...+++++++||||++++|+.+..+++.|||+|.+....++.+|++.++......++.. 
T Consensus       237 ~~------~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~~~~~~~~~~~~  310 (337)
T d1o6la_         237 AG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDR  310 (337)
T ss_dssp             HH------HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC------
T ss_pred             Hh------hccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchhhhccCCCCCCcc
Confidence            65      99999999998776789999999999999999999999999999999988899999987665543322211 


Q ss_pred             ----------CCCCCCCccCeeeeCC
Q 013249          425 ----------TPTAGEHFKGYTYVAP  440 (447)
Q Consensus       425 ----------~~~~~~~f~~~~~~~~  440 (447)
                                ....++.|.+|+|++.
T Consensus       311 ~~~~~~~~~~~~~~~~~f~~f~~v~d  336 (337)
T d1o6la_         311 YDSLGLLELDQREEQEMFEDFDYIAD  336 (337)
T ss_dssp             --------------CCTTTTCCEECC
T ss_pred             ccccccccccchhhhhccCCCEeeCC
Confidence                      1245788999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-68  Score=519.38  Aligned_cols=313  Identities=37%  Similarity=0.760  Sum_probs=271.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+.+|+.+|+.++|||||++++++.+.+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            4689999999999999999999986     78999999998876666666788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+|||||.||+|..++.....+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.... 
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-  156 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  156 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999998755 


Q ss_pred             CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhhh
Q 013249          269 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGV  348 (447)
Q Consensus       269 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  348 (447)
                       ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|......+|+.++.++++++.. 
T Consensus       157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~-  234 (316)
T d1fota_         157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR-  234 (316)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH-
T ss_pred             -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence             345679999999999999999999999999999999999999999999999999999999999999999988777665 


Q ss_pred             hHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCC-CccCCCcccccCCCCCCCCCCCCCC
Q 013249          349 SFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG-KDCIANFDKCWTTMPADDSPAPTPT  427 (447)
Q Consensus       349 ~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  427 (447)
                           ||++||.+|+++...++++|++||||++++|+.+..+.+++||+|.+.. ..++++|++ +.+...........+
T Consensus       235 -----~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~~~f~~-~~~~~~~~~~~~~~~  308 (316)
T d1fota_         235 -----LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK-YPEEDINYGVQGEDP  308 (316)
T ss_dssp             -----HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----------------CCCTTCCSCCT
T ss_pred             -----HhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchhhhcCC-CccccccCCCCCCCc
Confidence                 9999999999887779999999999999999999999999999997644 457778875 333333333333445


Q ss_pred             CCCCccCe
Q 013249          428 AGEHFKGY  435 (447)
Q Consensus       428 ~~~~f~~~  435 (447)
                      ..+.|.+|
T Consensus       309 ~~~~~~~f  316 (316)
T d1fota_         309 YADLFRDF  316 (316)
T ss_dssp             TGGGSCCC
T ss_pred             hhhhcCCC
Confidence            67788877

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-68  Score=521.78  Aligned_cols=293  Identities=41%  Similarity=0.805  Sum_probs=272.4

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ...++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++|||||++++++.+
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~-----~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~  112 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence            345789999999999999999999986     788999999988766666667788999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      ...+|+||||+.||+|..++.+.+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus       113 ~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhh
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  346 (447)
                      .  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+...+..+|......+|..+++++.++++
T Consensus       193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  270 (350)
T d1rdqe_         193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred             c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence            4  34567899999999999999999999999999999999999999999999999999999999999999998877766


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccc
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  412 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  412 (447)
                      .      ||++||.+|+.....++++|++||||++++|..+..++++|||+|......+.++|+..
T Consensus       271 ~------~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~~~~  330 (350)
T d1rdqe_         271 N------LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDY  330 (350)
T ss_dssp             H------HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCCC
T ss_pred             H------HhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhcCCC
Confidence            5      99999999987666689999999999999999999999999999999999999999754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-68  Score=517.69  Aligned_cols=312  Identities=38%  Similarity=0.748  Sum_probs=255.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHH-hcCCCCceeeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~  188 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+..|..++. .++|||||++++++.+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~-----t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC-----CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence            689999999999999999999986     88999999998876555555666677777765 689999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC-
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE-  267 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~-  267 (447)
                      .+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... 
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999987643 


Q ss_pred             CCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhhh
Q 013249          268 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  347 (447)
Q Consensus       268 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  347 (447)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|..+.+.+|..+++++.++++.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  236 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK  236 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            33345578999999999999999999999999999999999999999999999999999999999999999988776655


Q ss_pred             hhHHhhhccCCCCCCCCCCCCChh-hhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCC---
Q 013249          348 VSFLTQLLHKDPSKRLGSGPGGVD-AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA---  423 (447)
Q Consensus       348 ~~~l~~~L~~dP~~R~~~~~~~~~-~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  423 (447)
                            ||++||.+||     +++ ++++||||++++|+.+..+++.||++|.+....++.+|+..+.......+..   
T Consensus       237 ------~L~~dP~~R~-----s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~  305 (320)
T d1xjda_         237 ------LFVREPEKRL-----GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRA  305 (320)
T ss_dssp             ------HSCSSGGGSB-----TTBSCGGGSGGGTTCCHHHHHTTCSCC--------------------------------
T ss_pred             ------hcccCCCCCc-----CHHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhhhCCccCCCCccc
Confidence                  9999999999     554 8999999999999999999999999999998888999987765433222221   


Q ss_pred             -CCCCCCCCccCeee
Q 013249          424 -PTPTAGEHFKGYTY  437 (447)
Q Consensus       424 -~~~~~~~~f~~~~~  437 (447)
                       ....+++.|+||+|
T Consensus       306 ~~~~~~~~~f~~f~~  320 (320)
T d1xjda_         306 LINSMDQNMFRNFSF  320 (320)
T ss_dssp             ------CCTTTTCCC
T ss_pred             ccCchhhcccCcCcC
Confidence             22346889999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-66  Score=514.84  Aligned_cols=327  Identities=33%  Similarity=0.637  Sum_probs=262.6

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHH---HHHHHhcCCCCceeeeEEE
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE---RDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E---~~il~~l~hpnIv~l~~~~  184 (447)
                      ..++|+++++||+|+||.||+|+++.     +++.||||++.+...........+.+|   +.+++.++|||||+++++|
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~-----t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~   76 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF   76 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECC-----CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence            45799999999999999999999986     789999999987655444434444444   6667777899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .+.+.+|+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus        77 ~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          77 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCC---HHHHHHHHHhcccCCCCCCchh
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLPPFLTSE  340 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~---~~~~~~~i~~~~~~~p~~~~~~  340 (447)
                      +... .....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||.+.+   ...+...+......+|..++++
T Consensus       157 ~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         157 FSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             CSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             cCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence            7654 3456789999999999974 678999999999999999999999997654   3344445555666777888888


Q ss_pred             HHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCccCCCcccccCCCCCCC
Q 013249          341 AHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD  420 (447)
Q Consensus       341 ~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  420 (447)
                      +.+++..      ||++||++||++....+++|++||||++++|..+..++++|||+|.....+....|+..........
T Consensus       236 ~~~li~~------~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d~~~~~~~~~~  309 (364)
T d1omwa3         236 LRSLLEG------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTK  309 (364)
T ss_dssp             HHHHHHH------HTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC-------------------
T ss_pred             HHHHHHH------HcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCCcCCccccccCChhhcc
Confidence            8776655      9999999999876566899999999999999999999999999998776665555543211111111


Q ss_pred             CCCCCCCCCCCccCeeeeCCCccccC
Q 013249          421 SPAPTPTAGEHFKGYTYVAPNPWLSS  446 (447)
Q Consensus       421 ~~~~~~~~~~~f~~~~~~~~~~~~~~  446 (447)
                      .......+++.|++|++..+..++++
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (364)
T d1omwa3         310 GIKLLDSDQELYRNFPLTISERWQQE  335 (364)
T ss_dssp             -CCCCSSSSGGGTTCCEECHHHHHHH
T ss_pred             CCCCCChHHHHHhcCCccCchHHHHH
Confidence            22223356778999998877666543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-66  Score=496.85  Aligned_cols=278  Identities=39%  Similarity=0.732  Sum_probs=245.6

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+++|++++|||||+++++|.+.
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   80 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD   80 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence            44689999999999999999999986     7889999999887666666778899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDE  267 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~  267 (447)
                      +.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+||||+++|.+||+|||+|+.+..
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998653


Q ss_pred             C---CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhh
Q 013249          268 S---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  344 (447)
Q Consensus       268 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  344 (447)
                      .   ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.++|....+.+|..++++++++
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  240 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL  240 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            2   2344678999999999999999999999999999999999999999999999999999999999999999888776


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCC-CChhhhhcCCccCCCChhHHHhhhcCCCCCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKP  398 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~-~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p  398 (447)
                      ++.      ||++||++||++.. .....|++||||++++|+.+..+  .||-.|
T Consensus       241 i~~------~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~--~pP~l~  287 (288)
T d1uu3a_         241 VEK------LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ--TPPKLT  287 (288)
T ss_dssp             HHT------TSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS--CCCCCC
T ss_pred             HHH------HccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC--CCCCCC
Confidence            655      99999999994321 12223689999999999999643  455444

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-64  Score=477.88  Aligned_cols=258  Identities=34%  Similarity=0.633  Sum_probs=238.9

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++++.||+|+||+||+|+++.     +++.||+|++.+.........+.+.+|+.+|++++|||||++++++.+
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   77 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD   77 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECC-----CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence            345789999999999999999999986     788999999988766666667788999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      .+.+|+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus        78 ~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          78 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             CCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhHHhhhh
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  346 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  346 (447)
                      .. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+......+|..+++++++++.
T Consensus       158 ~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  236 (263)
T d2j4za1         158 SS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS  236 (263)
T ss_dssp             CC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             CC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            43 34567899999999999999999999999999999999999999999999999999999999999999988877665


Q ss_pred             hhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          347 GVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       347 ~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      .      ||++||++||     +++|+++||||.+
T Consensus       237 ~------~L~~dp~~R~-----t~~eil~hp~~~~  260 (263)
T d2j4za1         237 R------LLKHNPSQRP-----MLREVLEHPWITA  260 (263)
T ss_dssp             H------HTCSSGGGSC-----CHHHHHTCHHHHH
T ss_pred             H------HccCCHhHCc-----CHHHHHcCcCcCC
Confidence            5      9999999999     8999999999963

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=465.57  Aligned_cols=268  Identities=27%  Similarity=0.489  Sum_probs=231.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+.....   ....+.+.+|+.+|++++|||||+++++|.+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cCEEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            469999999999999999999986     88999999998754322   2245678999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC----cEEEeecCCc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMLTDFGLA  262 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~~kL~DFG~a  262 (447)
                      .+.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+|
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999999999989999999999999999999999999999999999999998877    5999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----CCCc
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  338 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~  338 (447)
                      +...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....|......++    ..++
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence            988766667778999999999999999999999999999999999999999999999999999988876655    3456


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcC
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ  393 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~  393 (447)
                      .++.++      |.+||++||++||     +++++++||||+..+|.........
T Consensus       245 ~~~~~l------i~~~L~~dP~~R~-----s~~eil~hp~~~~~~~~~~l~~~~~  288 (293)
T d1jksa_         245 ALAKDF------IRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSSAWS  288 (293)
T ss_dssp             HHHHHH------HHTTSCSSGGGSC-----CHHHHHHSTTTCC------------
T ss_pred             HHHHHH------HHHHccCChhHCc-----CHHHHhcCcccCCCChhHhhccCCC
Confidence            665555      5559999999999     8999999999999999876544443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-62  Score=463.32  Aligned_cols=254  Identities=28%  Similarity=0.505  Sum_probs=214.1

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+...  .+..+.+.+|+.+|++++|||||++++++.+.+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~   76 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN   76 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CcceEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence            4689999999999999999999986     789999999986542  233456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+|||||+||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.+...
T Consensus        77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999976432


Q ss_pred             ---CCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHH-HHHHhcccCCC--CCCchhH
Q 013249          269 ---SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRIINEKVKLP--PFLTSEA  341 (447)
Q Consensus       269 ---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~-~~i~~~~~~~p--~~~~~~~  341 (447)
                         ......+||+.|||||++.+..+ +.++|||||||++|||++|+.||...+..... ..+.......+  ..++.++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  236 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  236 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence               23456789999999999988776 57899999999999999999999765543333 33333222222  2455555


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      .+      ||.+||++||++||     +++|+++||||+
T Consensus       237 ~~------li~~~L~~dP~~R~-----t~~eil~hpwf~  264 (271)
T d1nvra_         237 LA------LLHKILVENPSARI-----TIPDIKKDRWYN  264 (271)
T ss_dssp             HH------HHHHHSCSSTTTSC-----CHHHHTTCTTTT
T ss_pred             HH------HHHHHcCCChhHCc-----CHHHHhcCHhhC
Confidence            54      45569999999999     899999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-61  Score=462.15  Aligned_cols=253  Identities=27%  Similarity=0.474  Sum_probs=223.2

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+...   ...+.+.+|+.+|++++|||||+++++|.+.+
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTT-----TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccccEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            3579999999999999999999876     788999999986542   23456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      .+|+|||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            99999999999999988765 57999999999999999999999999999999999999999999999999999987543


Q ss_pred             -CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc---cCCCCCCchhHHhh
Q 013249          269 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHSL  344 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~l  344 (447)
                       ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+....   ...|..++.+++++
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  249 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence             34556789999999999999999999999999999999999999999988877777666543   23445567776665


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +.      +||++||++||     +++|+++||||+.
T Consensus       250 i~------~~L~~dP~~R~-----s~~eil~Hp~~~~  275 (293)
T d1yhwa1         250 LN------RCLDMDVEKRG-----SAKELLQHQFLKI  275 (293)
T ss_dssp             HH------HHTCSSTTTSC-----CHHHHTTCGGGGG
T ss_pred             HH------HHccCChhHCc-----CHHHHhcCHhhCC
Confidence            54      59999999999     8999999999974

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-61  Score=466.81  Aligned_cols=254  Identities=35%  Similarity=0.644  Sum_probs=210.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      +.|+++++||+|+||+||+|+++.     +++.||||++.+....  .....+.+|+.+|++++|||||++++++.+++.
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKR-----TQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETT-----TCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            469999999999999999999986     7889999999876532  233567899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC---CCCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~---~~~~~kL~DFG~a~~~~  266 (447)
                      +|+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+|+...
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999999999999999999999999999999999999999999999999999994   57899999999999877


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  342 (447)
                      ......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+......++.    .+++++.
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            666667789999999999999999999999999999999999999999999999999999988766553    4566665


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ++      |.+||++||++||     +++|+++||||.+
T Consensus       242 ~l------i~~~L~~dP~~R~-----s~~eil~hp~~~~  269 (307)
T d1a06a_         242 DF------IRHLMEKDPEKRF-----TCEQALQHPWIAG  269 (307)
T ss_dssp             HH------HHHHSCSSGGGSC-----CHHHHHHSTTTTS
T ss_pred             HH------HHHHccCCHhHCc-----CHHHHhcCHhhCC
Confidence            55      5559999999999     8899999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-60  Score=467.11  Aligned_cols=258  Identities=28%  Similarity=0.529  Sum_probs=231.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||.||+|+++.     +++.||||++.+..   ....+.+.+|+.+|++++|||||+++++|.+.+.
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~-----~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            489999999999999999999986     78999999997653   2334678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC--CCCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~--~~~~~kL~DFG~a~~~~  266 (447)
                      +|+|||||+||+|.+++.+ .+.+++.+++.|+.||+.||+|||++|||||||||+||||+  .++.+||+|||+|+.+.
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999999999999854 46799999999999999999999999999999999999995  46889999999999887


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  342 (447)
                      ........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...|......++.    .++.+++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            766667789999999999999999999999999999999999999999999999999999888776654    3555555


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhH
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  386 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~  386 (447)
                      +      ||.+||++||++||     +++|+++||||...+|..
T Consensus       258 ~------li~~~L~~dP~~R~-----t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         258 D------FIRKLLLADPNTRM-----TIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             H------HHHHHCCSSGGGSC-----CHHHHHHSTTTSCTTCCS
T ss_pred             H------HHHHHccCChhHCc-----CHHHHhcCcccCCCCCCC
Confidence            4      45569999999999     899999999999877643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-60  Score=457.12  Aligned_cols=255  Identities=29%  Similarity=0.497  Sum_probs=222.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      +.|++++.||+|+||+||+|+++.     +++.||||++.+..   ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~   83 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE-----TSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN   83 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC-----CCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence            368999999999999999999986     78899999997643   3334568899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+|||||+||+|.+++.+ .+.+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999999999998765 467999999999999999999999999999999999999999999999999999865332


Q ss_pred             -CCCCccccCCccccccccc-----CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc---CCCCCCch
Q 013249          269 -SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTS  339 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~  339 (447)
                       ......+||+.|+|||++.     +..|+.++|||||||++|||++|+.||.+.+..++..++.....   ..|..++.
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence             2234678999999999984     45689999999999999999999999999888888888887653   23445666


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  383 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~  383 (447)
                      ++.++      |.+||++||++||     +++|+++||||+.-.
T Consensus       244 ~~~~l------i~~~L~~dp~~R~-----t~~ell~hp~~~~~~  276 (288)
T d2jfla1         244 NFKDF------LKKCLEKNVDARW-----TTSQLLQHPFVTVDS  276 (288)
T ss_dssp             HHHHH------HHHHSCSSTTTSC-----CHHHHTTSGGGCCCC
T ss_pred             HHHHH------HHHHccCChhHCc-----CHHHHhcCcccCCCC
Confidence            66655      4559999999999     889999999997533

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=471.68  Aligned_cols=262  Identities=28%  Similarity=0.472  Sum_probs=219.0

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|+++++||+|+||+||+|+++.     +++.||+|++++..  .....+.+.+|+.+|++++|||||+++++|.+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   75 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   75 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETT-----TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            445789999999999999999999986     88999999997653  34445678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+++|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.+
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            99999999999999999999999999999999999999999999997 59999999999999999999999999999976


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHH------------------
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------------------  327 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~------------------  327 (447)
                      ... ...+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+......                  
T Consensus       156 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         156 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             HHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             CCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            543 3456799999999999999999999999999999999999999997655432211100                  


Q ss_pred             ------------------------hcc-cCCCC-CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          328 ------------------------NEK-VKLPP-FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       328 ------------------------~~~-~~~p~-~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                                              ... ..++. ..+.+      .+|||.+||++||.+||     +++|+++||||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~------~~dli~~~L~~dP~~R~-----ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE------FQDFVNKCLIKNPAERA-----DLKQLMVHAFIKR  303 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHH------HHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHH------HHHHHHHHcCCChhHCc-----CHHHHhhCHhhCc
Confidence                                    000 00000 12223      34667779999999999     8999999999987


Q ss_pred             CChhHH
Q 013249          382 INWKTL  387 (447)
Q Consensus       382 ~~~~~~  387 (447)
                      .+|+.+
T Consensus       304 ~~~~~~  309 (322)
T d1s9ja_         304 SDAEEV  309 (322)
T ss_dssp             HHHSCC
T ss_pred             CCcccc
Confidence            776543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=452.48  Aligned_cols=253  Identities=26%  Similarity=0.513  Sum_probs=214.4

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  187 (447)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+... .+...+.+.+|+++|++++|||||++++++.+  .
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            589999999999999999999986     788999999987654 34456778999999999999999999999865  4


Q ss_pred             CEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCcccCCCCcEEEee
Q 013249          188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMLTD  258 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-----iiHrDikp~NILl~~~~~~kL~D  258 (447)
                      +.+|+|||||+||+|.+++.+    ++.+++..++.++.||+.||+|||++|     ||||||||+||||+.+|.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            568999999999999998864    467999999999999999999999876     99999999999999999999999


Q ss_pred             cCCcccccCCC-CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhccc-CCCCC
Q 013249          259 FGLAKEIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF  336 (447)
Q Consensus       259 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~-~~p~~  336 (447)
                      ||+|+.+.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|..+.. .+|..
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  237 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  237 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            99999875433 34567899999999999999999999999999999999999999999999999999887765 45677


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      +++++.++++.      ||+.||++||     +++||++|||.
T Consensus       238 ~s~~l~~li~~------~L~~dp~~Rp-----s~~ell~hp~i  269 (269)
T d2java1         238 YSDELNEIITR------MLNLKDYHRP-----SVEEILENPLI  269 (269)
T ss_dssp             SCHHHHHHHHH------HTCSSGGGSC-----CHHHHHTSTTC
T ss_pred             cCHHHHHHHHH------HcCCChhHCc-----CHHHHHhCCcC
Confidence            88887766554      9999999999     89999999995

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.6e-60  Score=464.32  Aligned_cols=254  Identities=28%  Similarity=0.516  Sum_probs=228.9

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+...   ...+.+.+|+.+|++++|||||+++++|.+++.
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            479999999999999999999986     789999999976532   234567899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccC--CCCcEEEeecCCccccc
Q 013249          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMLTDFGLAKEID  266 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~--~~~~~kL~DFG~a~~~~  266 (447)
                      +|+|||||+||+|.+++... .++++.+++.|+.||+.||.|||++|||||||||+||||+  .++.+||+|||+|+.+.
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            99999999999999887655 4699999999999999999999999999999999999998  67899999999999987


Q ss_pred             CCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhHH
Q 013249          267 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  342 (447)
Q Consensus       267 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  342 (447)
                      ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...|......++.    .++.++.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            766667789999999999999999999999999999999999999999999999999999988776654    4566666


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                      ++      |.+||++||.+||     +++|+++||||++.
T Consensus       261 ~l------i~~~L~~dp~~R~-----s~~eil~Hp~~~~~  289 (352)
T d1koba_         261 DF------IKNLLQKEPRKRL-----TVHDALEHPWLKGD  289 (352)
T ss_dssp             HH------HHTTSCSSGGGSC-----CHHHHHTSTTTSSC
T ss_pred             HH------HHHHccCChhHCc-----CHHHHhcCHhhCCC
Confidence            55      4559999999999     88999999999863

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-60  Score=455.87  Aligned_cols=252  Identities=24%  Similarity=0.387  Sum_probs=224.5

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      .|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECC-----CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence            49999999999999999999986     7889999999877655566677899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR  270 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~  270 (447)
                      |+|||||.||+|..++..++.+++.+++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....   
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            99999999999988888888999999999999999999999999999999999999999999999999999987544   


Q ss_pred             CCccccCCcccccccccC---CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--CCCCchhHHhhh
Q 013249          271 SNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLL  345 (447)
Q Consensus       271 ~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~li  345 (447)
                      ....+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+.+..+....+.......  +..+++++.+++
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li  247 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            345689999999999964   458999999999999999999999999988888887777665432  234666666555


Q ss_pred             hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          346 KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       346 ~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                            .+||++||++||     +++++++||||..
T Consensus       248 ------~~~L~~dP~~Rp-----t~~ell~Hp~~~~  272 (309)
T d1u5ra_         248 ------DSCLQKIPQDRP-----TSEVLLKHRFVLR  272 (309)
T ss_dssp             ------HHHTCSSGGGSC-----CHHHHTTCHHHHS
T ss_pred             ------HHHCcCChhHCc-----CHHHHHhCHHhcC
Confidence                  459999999999     8899999999964

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-59  Score=457.23  Aligned_cols=290  Identities=47%  Similarity=0.873  Sum_probs=247.7

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc-hhHHHHHHHHHHHHHhcCC-CCceeeeEEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTH-PFIVQLRYSF  184 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~h-pnIv~l~~~~  184 (447)
                      ++.++|+++++||+|+||+||+|++...  ..+++.||||++++..... ....+.+.+|+.+|++++| |||+++++++
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~   98 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   98 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECcc--CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence            4557899999999999999999987542  2378899999997654322 2334567789999999976 8999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      .+...+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             ccC--CCCCCccccCCcccccccccCC--CCCCccceeehhHhHHHHhhCCCCCCCCCHH----HHHHHHHhcccCCCCC
Q 013249          265 IDE--SSRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQRIINEKVKLPPF  336 (447)
Q Consensus       265 ~~~--~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~pf~~~~~~----~~~~~i~~~~~~~p~~  336 (447)
                      +..  ........|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.+.+..    .+..........+|..
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            643  2234567899999999999764  4688999999999999999999999765433    3444455556677778


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCCCCc
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD  404 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~~~~  404 (447)
                      ++.++.++++.      ||++||++||++...+++|+++||||++++|+.+..+++++||+|.+.+..
T Consensus       259 ~s~~~~~li~~------~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~  320 (322)
T d1vzoa_         259 MSALAKDLIQR------LLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDEL  320 (322)
T ss_dssp             SCHHHHHHHHH------HTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-C
T ss_pred             CCHHHHHHHHH------HcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCC
Confidence            88888776655      999999999988767899999999999999999999999999999887654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.7e-59  Score=443.22  Aligned_cols=257  Identities=31%  Similarity=0.560  Sum_probs=229.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc------hhHHHHHHHHHHHHHhcC-CCCceeee
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------KNHVDYMKAERDILTKVT-HPFIVQLR  181 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~E~~il~~l~-hpnIv~l~  181 (447)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.+.....      +...+.+.+|+.+|++++ |||||+++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             cccCEEceEEecCcCeEEEEEEECC-----CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            3689999999999999999999876     78999999998754322      233456889999999997 99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      ++|.+++.+|||||||+||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccccccccC------CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP  335 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~  335 (447)
                      ++.+.........+||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+.+.....+.+..+...++.
T Consensus       157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            998877666677899999999999863      35688999999999999999999999999999999999988766554


Q ss_pred             ----CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          336 ----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       336 ----~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                          .++++++++      |.+||++||++||     +++++++||||+.
T Consensus       237 ~~~~~~s~~~~~l------i~~~L~~~p~~R~-----s~~eil~h~~~~~  275 (277)
T d1phka_         237 PEWDDYSDTVKDL------VSRFLVVQPQKRY-----TAEEALAHPFFQQ  275 (277)
T ss_dssp             TTGGGSCHHHHHH------HHHHCCSSGGGSC-----CHHHHTTSGGGCT
T ss_pred             cccccCCHHHHHH------HHHHccCChhHCc-----CHHHHHcCHHHHH
Confidence                456666555      5559999999999     8899999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-59  Score=440.82  Aligned_cols=250  Identities=23%  Similarity=0.421  Sum_probs=213.6

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----C
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----R  187 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~  187 (447)
                      |++.++||+|+||+||+|+++.     +++.||+|++..... .....+.+.+|+++|++++|||||+++++|.+    .
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~-----~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             EEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            4777899999999999999986     788999999987654 34456678999999999999999999999975    4


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCcccC-CCCcEEEeecCCccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMLTDFGLAKE  264 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDikp~NILl~-~~~~~kL~DFG~a~~  264 (447)
                      ..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+||||+ +++.+||+|||+|+.
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            568999999999999999999899999999999999999999999998  99999999999996 589999999999986


Q ss_pred             ccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC-CHHHHHHHHHhccc--CCCCCCchhH
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIINEKV--KLPPFLTSEA  341 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~i~~~~~--~~p~~~~~~~  341 (447)
                      ... ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+. +...+...+..+..  .++...++++
T Consensus       165 ~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (270)
T d1t4ha_         165 KRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  242 (270)
T ss_dssp             CCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             ccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence            443 34456789999999999875 5999999999999999999999999765 45555666655432  2334455665


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFR  380 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~  380 (447)
                      +++      |.+||++||++||     +++|+++||||+
T Consensus       243 ~~l------i~~~l~~dp~~R~-----s~~ell~Hp~fk  270 (270)
T d1t4ha_         243 KEI------IEGCIRQNKDERY-----SIKDLLNHAFFQ  270 (270)
T ss_dssp             HHH------HHHHSCSSGGGSC-----CHHHHHTSGGGC
T ss_pred             HHH------HHHHccCCHhHCc-----CHHHHhCCcccC
Confidence            554      5569999999999     899999999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-59  Score=450.79  Aligned_cols=253  Identities=26%  Similarity=0.469  Sum_probs=227.7

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|++++.||+|+||+||+|+++.     +++.||||++++...    ....+.+|+++|+.++|||||+++++|++.+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~-----~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   74 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            3689999999999999999999986     788999999986532    2345789999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCC--CcEEEeecCCcccc
Q 013249          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMLTDFGLAKEI  265 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~--~~~kL~DFG~a~~~  265 (447)
                      .+|+|||||+||+|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++..
T Consensus        75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999999999999999998665 79999999999999999999999999999999999999854  48999999999987


Q ss_pred             cCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----CCchhH
Q 013249          266 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  341 (447)
Q Consensus       266 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  341 (447)
                      .........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++...|......++.    .++.++
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            7666666778999999999999999999999999999999999999999999999999999988877664    466666


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      +++      |.+||++||++||     +++|+++||||+.
T Consensus       235 ~~l------i~~~L~~dp~~R~-----s~~eil~hp~~~~  263 (321)
T d1tkia_         235 MDF------VDRLLVKERKSRM-----TASEALQHPWLKQ  263 (321)
T ss_dssp             HHH------HHTTSCSSGGGSC-----CHHHHHHSHHHHS
T ss_pred             HHH------HHHHccCChhHCc-----CHHHHhcCHhhcc
Confidence            555      5559999999999     8999999999964

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=438.07  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=211.8

Q ss_pred             EEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcc--hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 013249          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (447)
Q Consensus       113 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (447)
                      +.+++||+|+||+||+|+++.     +++.||||+++......  ....+.+.+|+.+|++++|||||++++++.+++++
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             CcceEeccCcCeEEEEEEECC-----CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence            357899999999999999876     78999999997654322  12234688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC-
Q 013249          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS-  269 (447)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~-  269 (447)
                      |+||||+.|+++..+....+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        76 ~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9999999998887777667789999999999999999999999999999999999999999999999999998765433 


Q ss_pred             CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------------
Q 013249          270 RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--------------  334 (447)
Q Consensus       270 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p--------------  334 (447)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+...+|.......+              
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            3456789999999999875 5689999999999999999999999999998888887765321110              


Q ss_pred             --------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 --------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 --------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                    ...+.+      .++||.+||++||++||     +++|+++||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~------~~dll~~~L~~dP~~R~-----sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDD------LLDLIQGLFLFNPCARI-----TATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHH------HHHHHHHHHCSSTTTSC-----CHHHHHTSGGGTSS
T ss_pred             hhccCCCCChHHhcccCCHH------HHHHHHHHccCChhhCc-----CHHHHhCCHhhCCC
Confidence                          012222      34677789999999999     89999999999763

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=433.06  Aligned_cols=252  Identities=30%  Similarity=0.512  Sum_probs=219.6

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchh---HHHHHHHHHHHHHhcC--CCCceeeeEEE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---HVDYMKAERDILTKVT--HPFIVQLRYSF  184 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~E~~il~~l~--hpnIv~l~~~~  184 (447)
                      ++|++.++||+|+||+||+|+++.     +++.||||++.+.......   ....+.+|+.+|++++  |||||+++++|
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~   78 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF   78 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence            589999999999999999999986     7899999999876543221   1233568999999997  89999999999


Q ss_pred             EeCCEEEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-CCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~~kL~DFG~a  262 (447)
                      .+.+.+|+||||+.+ +++.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence            999999999999976 588888888899999999999999999999999999999999999999985 479999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCCCC-CCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCchhH
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA  341 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  341 (447)
                      +..... ...+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.      ..+......++..++.++
T Consensus       159 ~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~  231 (273)
T d1xwsa_         159 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSEC  231 (273)
T ss_dssp             EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHH
T ss_pred             eecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHH
Confidence            876543 3456789999999999987665 67799999999999999999999763      356677788899999888


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                      +++++.      ||++||++||     +++|+++||||+++..
T Consensus       232 ~~li~~------~L~~dp~~R~-----s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         232 QHLIRW------CLALRPSDRP-----TFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             HHHHHH------HTCSSGGGSC-----CHHHHHTSGGGSSCCC
T ss_pred             HHHHHH------HccCCHhHCc-----CHHHHhcCHhhCCCCC
Confidence            776655      9999999999     8999999999998653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-57  Score=432.93  Aligned_cols=262  Identities=28%  Similarity=0.458  Sum_probs=213.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||+++.... .+...+.+.+|+++|++++|||||+++++|.+.+.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            689999999999999999999986     788999999976542 23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCC
Q 013249          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDES  268 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~  268 (447)
                      +|+||||+.++.+...... .+.+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus        76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            9999999976544433333 356999999999999999999999999999999999999999999999999999876543


Q ss_pred             -CCCCccccCCcccccccccCCC-CCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC------------
Q 013249          269 -SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP------------  334 (447)
Q Consensus       269 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p------------  334 (447)
                       ......+||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+...++........            
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             3345568999999999988765 47899999999999999999999999888887777654322111            


Q ss_pred             ------CCCchhHHhhh-----hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 ------PFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 ------~~~~~~~~~li-----~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                            ...........     ...+||.+||++||++||     +++||++||||+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----t~~ell~H~ff~~~  289 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-----SAKAALAHPFFQDV  289 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGTTC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc-----CHHHHhCCHhhccC
Confidence                  11111111111     134678889999999999     89999999999876

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=442.71  Aligned_cols=249  Identities=29%  Similarity=0.549  Sum_probs=209.4

Q ss_pred             CCCcEEEe-eEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHh-cCCCCceeeeEEEEe
Q 013249          109 PGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQT  186 (447)
Q Consensus       109 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~  186 (447)
                      .++|++++ +||+|+||+||+|+++.     +++.||||++++.        ..+.+|+.++.+ .+|||||+++++|++
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~   76 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   76 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECC-----CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            45899885 59999999999999986     7889999999753        236679988755 489999999999976


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEEe
Q 013249          187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLT  257 (447)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL~  257 (447)
                          +..+|+|||||+||+|.+++.+.  ..+++.+++.|+.||+.||+|||++||+||||||+|||++.   ++.+||+
T Consensus        77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence                46799999999999999999875  36999999999999999999999999999999999999985   5679999


Q ss_pred             ecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHH----HHhcccCC
Q 013249          258 DFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR----IINEKVKL  333 (447)
Q Consensus       258 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~----i~~~~~~~  333 (447)
                      |||+|+...........+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+.......    +......+
T Consensus       157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~  236 (335)
T d2ozaa1         157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  236 (335)
T ss_dssp             CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred             ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            99999988776667788999999999999999999999999999999999999999977654443333    33344445


Q ss_pred             CC----CCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          334 PP----FLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       334 p~----~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      |.    .+++++.      +||.+||++||++||     +++++++||||..
T Consensus       237 ~~~~~~~~s~~~~------~li~~~L~~dP~~R~-----s~~eil~hp~~~~  277 (335)
T d2ozaa1         237 PNPEWSEVSEEVK------MLIRNLLKTEPTQRM-----TITEFMNHPWIMQ  277 (335)
T ss_dssp             CTTHHHHSCHHHH------HHHHHHSCSSTTTSC-----CHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHH------HHHHHHccCChhHCc-----CHHHHHcCHHhhC
Confidence            43    2444444      456669999999999     8899999999953

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=432.58  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=214.5

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc---CCCCceeeeEEEEe
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQT  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~  186 (447)
                      ++|+++++||+|+||+||+|+++.    .+++.||||+++..... ......+.+|+.+|+.+   +||||++++++|..
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~----~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEEC----CCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence            589999999999999999999864    14678999999765432 22222355677777665   79999999999863


Q ss_pred             -----CCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecC
Q 013249          187 -----RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                           ...+|++|||+.++.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence                 3579999999998877554443 3569999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC--------
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--------  332 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~--------  332 (447)
                      +++...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....|......        
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            998876655667789999999999999999999999999999999999999999999988888777643111        


Q ss_pred             -------------------CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCCh
Q 013249          333 -------------------LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  384 (447)
Q Consensus       333 -------------------~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~  384 (447)
                                         ++..++.++      .+||.+||++||++||     +++|+++||||+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~------~dli~~mL~~dP~~R~-----sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELG------KDLLLKCLTFNPAKRI-----SAYSALSHPYFQDLER  301 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHH------HHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTCCC
T ss_pred             cccchhhhhccccccchhhccccCCHHH------HHHHHHHCcCChhHCc-----CHHHHhcChhhcCchh
Confidence                               112233333      4567779999999999     8899999999998864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8e-56  Score=421.57  Aligned_cols=254  Identities=25%  Similarity=0.437  Sum_probs=214.3

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      ++|++.+.||+|+||+||+|+++.     +++.||||++++....+....+.+.+|+++|+.++|||||++++++...+ 
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLR-----LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            579999999999999999999986     78999999998876656666778999999999999999999999998653 


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                         .+|+||||++|++|..++...+.+++.+++.++.||+.||+|||++|||||||||+||||+.++.++|+|||.++..
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence               48999999999999999999999999999999999999999999999999999999999999999999999998765


Q ss_pred             cCC----CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----CCC
Q 013249          266 DES----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFL  337 (447)
Q Consensus       266 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~  337 (447)
                      ...    ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++..++.......+    ..+
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence            332    234457899999999999999999999999999999999999999999999888888887765443    345


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                      +.++.++      |.+||++||++||+    ++++++ |+|.
T Consensus       242 s~~l~~l------i~~~L~~dp~~R~~----sa~~l~-~~l~  272 (277)
T d1o6ya_         242 SADLDAV------VLKALAKNPENRYQ----TAAEMR-ADLV  272 (277)
T ss_dssp             CHHHHHH------HHHHTCSSGGGSCS----SHHHHH-HHHH
T ss_pred             CHHHHHH------HHHHccCCHhHCHh----HHHHHH-HHHH
Confidence            6666555      45599999999994    456655 4443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-56  Score=432.82  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=217.6

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      +.+..++|+++++||+|+||+||+|++++..+......||+|.+....  .......+.+|+.+|+++ +|||||+++++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence            456678999999999999999999999875544445679999987543  233445688899999998 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQ-----------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (447)
                      +.+.+.+|+|||||+||+|.+++..+                       ..+++..++.|+.||+.||+|||++||||||
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD  189 (325)
T d1rjba_         110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  189 (325)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            99999999999999999999999754                       2489999999999999999999999999999


Q ss_pred             CCCCCcccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCC
Q 013249          241 LKPENILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH  316 (447)
Q Consensus       241 ikp~NILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~  316 (447)
                      |||+|||++.++++||+|||+|+.......   ..+.+||+.|||||++.+..|+.++|||||||++|||++ |+.||.+
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654332   235678999999999999999999999999999999998 9999988


Q ss_pred             CCHHHHHHHHHhcc--cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          317 ANRQKLQQRIINEK--VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       317 ~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .+......++....  +..|..+++++.+++..      ||+.||++||     ++++|++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~------cl~~dP~~RP-----t~~ei~~~  320 (325)
T d1rjba_         270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS------CWAFDSRKRP-----SFPNLTSF  320 (325)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH------HTCSSGGGSC-----CHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH------HcCCChhHCc-----CHHHHHHH
Confidence            76665555665553  34567788877766554      9999999999     88999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-56  Score=424.40  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=215.9

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.++||+|+||+||+|+++.     +++.||||+++++..    ..+.+.+|+++|++++|||||+++++|
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGG-----GTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECC-----CCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            44666789999999999999999999986     788999999976432    345688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      .+.+.+|+|||||++|+|..++.+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence            9999999999999999999999765  57899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCC-CCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          263 KEIDESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP-PFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       263 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~-pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      +.......  .....||+.|+|||++.+..|+.++|||||||++|||++|.. ||.+.+...+.+.+..+ ...+|..++
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  242 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  242 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccch
Confidence            97654332  233458999999999999999999999999999999999655 55666777666666544 345677788


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++.+++..      ||+.||++||     ++++|++
T Consensus       243 ~~l~~li~~------cl~~dP~~Rp-----s~~ei~~  268 (287)
T d1opja_         243 EKVYELMRA------CWQWNPSDRP-----SFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHH------HTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHH------HcCCCHhHCc-----CHHHHHH
Confidence            877666554      9999999999     7889865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-56  Score=421.83  Aligned_cols=251  Identities=20%  Similarity=0.335  Sum_probs=212.0

Q ss_pred             eeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 013249          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (447)
Q Consensus       116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (447)
                      ++||+|+||+||+|.++..   .+++.||||+++... .+....+.+.+|+.+|++++|||||++++++.++ ..|||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccC---CcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence            4799999999999987642   256789999997654 3345567789999999999999999999999754 5789999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC----C
Q 013249          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR----S  271 (447)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~----~  271 (447)
                      ||++|+|.+++.+...+++.++..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.....    .
T Consensus        88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999987644322    2


Q ss_pred             CccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHHhhhhhhh
Q 013249          272 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGVS  349 (447)
Q Consensus       272 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~~  349 (447)
                      ....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ...+|..++.++.+++..  
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~--  245 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL--  245 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH--
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH--
Confidence            34578999999999999999999999999999999998 99999999988888888765 456777888887766554  


Q ss_pred             HHhhhccCCCCCCCCCCCCChhhh---hcCCccCCC
Q 013249          350 FLTQLLHKDPSKRLGSGPGGVDAI---KHHKWFRSI  382 (447)
Q Consensus       350 ~l~~~L~~dP~~R~~~~~~~~~~l---~~h~~f~~~  382 (447)
                          ||+.||++||     ++++|   ++|+|++-+
T Consensus       246 ----cl~~dp~~RP-----s~~~i~~~L~~~~~~~~  272 (277)
T d1xbba_         246 ----CWTYDVENRP-----GFAAVELRLRNYYYDVV  272 (277)
T ss_dssp             ----HTCSSTTTSC-----CHHHHHHHHHHHHHHHH
T ss_pred             ----HcCCCHhHCc-----CHHHHHHHhhCHHhhcC
Confidence                9999999999     66776   567666433

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-55  Score=420.97  Aligned_cols=254  Identities=24%  Similarity=0.432  Sum_probs=214.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||+||+|+++      +++.||||++..... .....+.+.+|+.+|++++|||||+++++|...+.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC------CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            68999999999999999999985      678999999977543 34445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      .|++|||+.++.+..+....+.+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|.......
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            99999999988887777777899999999999999999999999999999999999999999999999999998765432


Q ss_pred             -CCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--------------
Q 013249          270 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--------------  333 (447)
Q Consensus       270 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~--------------  333 (447)
                       ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...++.......              
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence             2445679999999999976 456899999999999999999999999988888777765432211              


Q ss_pred             ---------------CCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          334 ---------------PPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       334 ---------------p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                                     +..++.++      .|||.+||++||++||     +++|+++||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~------~dli~~~L~~dP~~R~-----s~~ell~Hp~f~~  286 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESG------IDLLSKMLKLDPNQRI-----TAKQALEHAYFKE  286 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHH------HHHHHHHTCSSTTTSC-----CHHHHHTSGGGGC
T ss_pred             ccccccccCcchhhhcccCCHHH------HHHHHHHccCChhHCc-----CHHHHhcCcccCc
Confidence                           11222222      4677789999999999     8899999999963

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=416.21  Aligned_cols=249  Identities=20%  Similarity=0.399  Sum_probs=207.3

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++++.||+|+||+||+|+++      +++.||||++++....    .+.+.+|++++++++|||||++++++..
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~   71 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLE   71 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET------TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC------CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceecc
Confidence            45679999999999999999999986      4567999999764322    2458899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                      .+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus        72 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence            99999999999999999998765 56899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhH
Q 013249          266 DESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEA  341 (447)
Q Consensus       266 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~  341 (447)
                      .....  .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..++...+..+. ...|...+.++
T Consensus       152 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l  231 (263)
T d1sm2a_         152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV  231 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             cCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence            54332  234678999999999999999999999999999999999 688888888888888887653 34566677776


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .+++.      +||+.||++||     ++++|++|
T Consensus       232 ~~li~------~cl~~~p~~Rp-----s~~~il~~  255 (263)
T d1sm2a_         232 YQIMN------HCWKERPEDRP-----AFSRLLRQ  255 (263)
T ss_dssp             HHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHH------HHccCCHhHCc-----CHHHHHHH
Confidence            66554      59999999999     88999886

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=419.61  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=205.6

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.++||+|+||+||+|+++        ..||||+++.... .....+.+.+|+.+|++++|||||++++++
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~   73 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS   73 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS--------SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC--------CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence            5577889999999999999999999743        3599999976543 345667899999999999999999999986


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      . .+.+|+|||||+||+|.+++... +.+++.++..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+
T Consensus        74 ~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          74 T-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             C-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             e-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence            5 45689999999999999999765 569999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC---CCCCccccCCcccccccccCC---CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-----
Q 013249          264 EIDES---SRSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----  332 (447)
Q Consensus       264 ~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-----  332 (447)
                      .....   ......+||+.|||||++.+.   .|+.++|||||||++|||++|+.||.+.+.......+......     
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~  232 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS  232 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence            76432   233457899999999999753   4889999999999999999999999887655444444333222     


Q ss_pred             -CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          333 -LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       333 -~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                       .+..+++++.++      |.+||..||++||     ++++|+++
T Consensus       233 ~~~~~~~~~l~~l------i~~cl~~dp~~RP-----t~~~il~~  266 (276)
T d1uwha_         233 KVRSNCPKAMKRL------MAECLKKKRDERP-----LFPQILAS  266 (276)
T ss_dssp             GSCTTCCHHHHHH------HHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hccccchHHHHHH------HHHHcCCCHhHCc-----CHHHHHHH
Confidence             334556666555      5559999999999     88999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-55  Score=421.13  Aligned_cols=256  Identities=23%  Similarity=0.356  Sum_probs=208.8

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+..++|++.++||+|+||+||+|+++...  .....||||.+....  .....+.+.+|+.+|++++|||||++++++.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~   97 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPG--KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVT   97 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCC--CEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            456678999999999999999999987522  133468999886543  3445567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +.+.+|+|||||+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.
T Consensus        98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_          98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence            999999999999999999988774 5799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC------CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCC
Q 013249          265 IDESSR------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPF  336 (447)
Q Consensus       265 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~  336 (447)
                      +.....      .....||+.|||||++.+..|+.++|||||||++|||++ |+.||.+.+..++...+..+. ...|..
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  257 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD  257 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            654322      122457899999999999999999999999999999998 899999999988888887653 455666


Q ss_pred             CchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          337 LTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       337 ~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ++.++.+++.      +||+.||++||     ++++|+++
T Consensus       258 ~~~~l~~li~------~cl~~~P~~RP-----s~~ei~~~  286 (299)
T d1jpaa_         258 CPSALHQLML------DCWQKDRNHRP-----KFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHH------HHTCSSTTTSC-----CHHHHHHH
T ss_pred             chHHHHHHHH------HHcCCCHhHCc-----CHHHHHHH
Confidence            7777766555      59999999999     77888763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=419.08  Aligned_cols=256  Identities=22%  Similarity=0.387  Sum_probs=217.8

Q ss_pred             hcCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 013249          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (447)
Q Consensus       104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (447)
                      .+.+..++|+++++||+|+||+||+|+++      +++.||||+++....    ..+.+.+|+.+|++++|||||+++++
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~   76 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAV   76 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEEC------CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEee
Confidence            35566779999999999999999999976      567899999976432    23568899999999999999999998


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      +.+ +.+|+||||+++|+|.+++...  ..+++.++..|+.||+.||.|||++||+||||||+||||++++.+||+|||+
T Consensus        77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence            754 5679999999999999876543  3699999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCC
Q 013249          262 AKEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  337 (447)
Q Consensus       262 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~  337 (447)
                      |+.+....  ......||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..++.+.+..+ ....|..+
T Consensus       156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~  235 (272)
T d1qpca_         156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC  235 (272)
T ss_dssp             CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccC
Confidence            99875432  2345678999999999998899999999999999999999 56677778888888877765 34556777


Q ss_pred             chhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc--CCccCC
Q 013249          338 TSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH--HKWFRS  381 (447)
Q Consensus       338 ~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~--h~~f~~  381 (447)
                      +.++.+++.      +||+.||++||     ++++|++  |+||..
T Consensus       236 ~~~l~~li~------~cl~~~P~~Rp-----t~~ei~~~L~~~fts  270 (272)
T d1qpca_         236 PEELYQLMR------LCWKERPEDRP-----TFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CHHHHHHHH------HHTCSSGGGSC-----CHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHH------HHcCCCHhHCc-----CHHHHHHHhhhhhhc
Confidence            777766555      59999999999     8899988  788753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-55  Score=417.89  Aligned_cols=256  Identities=22%  Similarity=0.346  Sum_probs=216.8

Q ss_pred             cCCCCcEEEee-EeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          107 IGPGDFEIFRV-VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       107 ~~~~~y~~~~~-lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      +..++|.+.+. ||+|+||+||+|.++...   ++..||||++++..  .....+.+.+|+++|++++|||||++++++.
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~   79 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   79 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCC---CcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence            34467888885 999999999999886522   45579999997643  3455677899999999999999999999987


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      ++ .+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus        80 ~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          80 AE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             SS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             cC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence            54 589999999999999987654 6799999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          265 IDESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       265 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      +.....    ....+||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...|..+ ...+|+.++
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  238 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  238 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence            654322    234578999999999999999999999999999999998 99999998888888888765 356778888


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhh---hcCCcc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAI---KHHKWF  379 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l---~~h~~f  379 (447)
                      .++.+++..      ||..||++||     ++.+|   ++|.|+
T Consensus       239 ~~l~~li~~------cl~~~p~~RP-----s~~~i~~~L~~~~~  271 (285)
T d1u59a_         239 PELYALMSD------CWIYKWEDRP-----DFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHHH------TTCSSGGGSC-----CHHHHHHHHHHHHH
T ss_pred             HHHHHHHHH------HcCCCHhHCc-----CHHHHHHHHHHHHH
Confidence            887766555      9999999999     55555   667766

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-55  Score=411.22  Aligned_cols=248  Identities=21%  Similarity=0.390  Sum_probs=218.1

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|+++++||+|+||+||+|+++      +++.||||++++....    .+.+.+|+.++++++|||||++++++.+.
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~   71 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   71 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET------TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC------CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence            4679999999999999999999986      5678999999875432    24588999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                      +.+|+||||+.+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence            9999999999999999887654 679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC--CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCchhHH
Q 013249          267 ESSR--SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  342 (447)
Q Consensus       267 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~  342 (447)
                      ....  .....||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+..++...+..+ ....|...+.++.
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  231 (258)
T d1k2pa_         152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY  231 (258)
T ss_dssp             SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHH
Confidence            4322  334678999999999999999999999999999999998 89999999999998888875 3345666776666


Q ss_pred             hhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          343 SLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       343 ~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ++++      +||+.||++||     ++++|++|
T Consensus       232 ~li~------~cl~~dP~~RP-----t~~eil~~  254 (258)
T d1k2pa_         232 TIMY------SCWHEKADERP-----TFKILLSN  254 (258)
T ss_dssp             HHHH------HTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHH------HHccCCHhHCc-----CHHHHHHH
Confidence            5554      59999999999     88999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=418.74  Aligned_cols=262  Identities=25%  Similarity=0.372  Sum_probs=214.0

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+... .......+.+|+.+|++++||||+++++++..  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            3689999999999999999999986     789999999976543 33445667899999999999999999999865  


Q ss_pred             ------CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecC
Q 013249          187 ------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFG  260 (447)
Q Consensus       187 ------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG  260 (447)
                            ...+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence                  34689999999888776666666789999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCC-----CCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC
Q 013249          261 LAKEIDES-----SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP  334 (447)
Q Consensus       261 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p  334 (447)
                      +++.+...     ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+......++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99865422     223456899999999999865 689999999999999999999999999888887777765443332


Q ss_pred             CCCc-------------------hhHHh-------hhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 PFLT-------------------SEAHS-------LLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 ~~~~-------------------~~~~~-------li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                      ....                   .....       ....+|||.+||++||++||     +++|+++||||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~-----sa~elL~Hpff~~  310 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----DSDDALNHDFFWS  310 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGSS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc-----CHHHHHcChhhcc
Confidence            2110                   00111       11235788999999999999     8999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=422.62  Aligned_cols=249  Identities=30%  Similarity=0.486  Sum_probs=208.6

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----  186 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  186 (447)
                      +|+.+++||+|+||+||+|+++.     +++.||||++.++..       ...+|+++|++++||||++++++|..    
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~   88 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK   88 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC-----CCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence            69999999999999999999986     789999999976532       12469999999999999999999854    


Q ss_pred             --CCEEEEEEeccCCCChHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-cEEEeecC
Q 013249          187 --RSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFG  260 (447)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~---l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~~kL~DFG  260 (447)
                        ..++|+|||||.++.+...   ......+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||
T Consensus        89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence              3468999999987643333   23456799999999999999999999999999999999999999775 89999999


Q ss_pred             CcccccCCCCCCccccCCcccccccccC-CCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcc---------
Q 013249          261 LAKEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------  330 (447)
Q Consensus       261 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~---------  330 (447)
                      +++.+.......+.+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||...+..+....+....         
T Consensus       169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            9998876666777899999999999875 578999999999999999999999999888887777665321         


Q ss_pred             --------cCCC------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          331 --------VKLP------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       331 --------~~~p------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                              ..++            ...++++      ++||.+||++||++||     +++|+++||||+.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~------~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA------IALCSRLLEYTPTARL-----TPLEACAHSFFDEL  309 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHH------HHHHHHHSCSSGGGSC-----CHHHHHTSGGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHH------HHHHHHHccCChhHCc-----CHHHHhcCHhhccc
Confidence                    1111            1223333      4567779999999999     88999999999755

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-54  Score=421.30  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=209.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++++.. ......+.+.+|+.+|+.++|||||+++++|...+
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            4689999999999999999999986     78999999998654 34455677889999999999999999999997654


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                            ++|+||||+ +.+|...+ +.+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence                  579999999 56676655 4568999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-------
Q 013249          263 KEIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-------  334 (447)
Q Consensus       263 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p-------  334 (447)
                      +....  .....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+.......|       
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         169 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             eccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            87655  34567899999999998864 568999999999999999999999998887776665544322111       


Q ss_pred             ------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          335 ------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       335 ------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                                              ...++++      ++||.+||++||++||     +++|+++||||+.+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~------~dli~~mL~~dP~~R~-----ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLA------VNLLEKMLVLDAEQRV-----TAGEALAHPYFESLHDT  310 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHH------HHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTC--
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHH------HHHHHHHCcCChhHCc-----CHHHHhcChhhCcCCCc
Confidence                                    1223333      4677779999999999     89999999999987643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=410.23  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=211.6

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++.+.||+|+||+||+|+++.      ++.||||+++....    ..+.+.+|+.+|++++|||||++++++
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~------~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~   81 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV   81 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECC------CCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEE
Confidence            44566789999999999999999999863      45699999976542    235688999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLA  262 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a  262 (447)
                      .+ +.+|+||||+.+|+|..++..  .+.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus        82 ~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          82 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             ec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchh
Confidence            55 568999999999999888754  357999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          263 KEIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       263 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      +......  ......||+.|+|||++....++.++|||||||++|||++ |.+||.+.+..++...+..+ ....+..++
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccC
Confidence            8764332  2334679999999999999999999999999999999999 56666777888788777655 345677788


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc--CCccCC
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH--HKWFRS  381 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~--h~~f~~  381 (447)
                      .++.+++.      +||+.||++||     ++++|++  |+||.+
T Consensus       241 ~~l~~li~------~cl~~dP~~Rp-----s~~~i~~~L~~~~~~  274 (285)
T d1fmka3         241 ESLHDLMC------QCWRKEPEERP-----TFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHHH------HHTCSSGGGSC-----CHHHHHHHHHTTTSC
T ss_pred             HHHHHHHH------HHcccCHhHCc-----CHHHHHHHHhhhhcC
Confidence            77766655      59999999999     8899987  888864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.1e-54  Score=418.96  Aligned_cols=252  Identities=25%  Similarity=0.447  Sum_probs=208.8

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEe-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT-  186 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-  186 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++++..      .+.+.+|+.+|+.+. ||||++++++|.. 
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            3579999999999999999999986     88999999987532      345788999999995 9999999999985 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCC-cEEEeecCCccc
Q 013249          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMLTDFGLAKE  264 (447)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~~kL~DFG~a~~  264 (447)
                       ...+|+|||||.+++|....   +.+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence             45799999999999987653   5799999999999999999999999999999999999998655 699999999998


Q ss_pred             ccCCCCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCH-HHHHHHHHhc-------------
Q 013249          265 IDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINE-------------  329 (447)
Q Consensus       265 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~-------------  329 (447)
                      ..........+||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+...             
T Consensus       180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            8776667778899999999998865 579999999999999999999999965443 2222222110             


Q ss_pred             ccCCC------------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCCChh
Q 013249          330 KVKLP------------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  385 (447)
Q Consensus       330 ~~~~p------------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~~~~  385 (447)
                      .....                        ..++++      .+|||.+||++||++||     +++|+++||||+++.|+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~------~~dli~~mL~~dP~~R~-----ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE------ALDFLDKLLRYDHQSRL-----TAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHH------HHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTSCCC
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHH------HHHHHHHHccCChhHCc-----CHHHHhcCcccCCCCCC
Confidence            00000                        012222      35677889999999999     89999999999999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=410.37  Aligned_cols=256  Identities=24%  Similarity=0.381  Sum_probs=209.4

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|+++++||+|+||.||+|+++...  ..+..||||.++..  ......+.+.+|+.+|++++|||||++++++
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~   77 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI   77 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCC--ceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456678999999999999999999987532  24567889888643  2345566788999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      . .+.+|+||||+.+|+|..++... +.+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+
T Consensus        78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence            6 46789999999999999887654 579999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC--CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCch
Q 013249          264 EIDESS--RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTS  339 (447)
Q Consensus       264 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~  339 (447)
                      .+....  ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++...+..+. ..+|+.++.
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  236 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  236 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            764332  2345678999999999999999999999999999999998 999999999888888887764 467778888


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ++.+++..      ||..||++||     ++++|++|
T Consensus       237 ~~~~li~~------cl~~dp~~Rp-----s~~ei~~~  262 (273)
T d1mp8a_         237 TLYSLMTK------CWAYDPSRRP-----RFTELKAQ  262 (273)
T ss_dssp             HHHHHHHH------HTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHH------HcCCCHhHCc-----CHHHHHHH
Confidence            87776555      9999999999     88999876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-53  Score=405.50  Aligned_cols=255  Identities=24%  Similarity=0.437  Sum_probs=218.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||+++... ........+.+|+.+|+.++||||+++++++.+...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC-----CCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            589999999999999999999986     88999999997654 345567788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCC
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESS  269 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~  269 (447)
                      +++|||++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+......
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999999875543


Q ss_pred             C-CCccccCCcccccccccCCC-CCCccceeehhHhHHHHhhCCCCC-CCCCHHHHHHHHHhcccCCC------------
Q 013249          270 R-SNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLP------------  334 (447)
Q Consensus       270 ~-~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~pf-~~~~~~~~~~~i~~~~~~~p------------  334 (447)
                      . .....+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+...++.......+            
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            3 33456788999999988665 689999999999999999999885 56666666666554222111            


Q ss_pred             -----------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCC
Q 013249          335 -----------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRS  381 (447)
Q Consensus       335 -----------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~  381 (447)
                                       ...+.+      ..+||.+||++||.+||     +++|+++||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~------~~dll~~mL~~dP~~R~-----sa~e~L~Hp~f~~  288 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNAT------GRDLLQNLLKCNPVQRI-----SAEEALQHPYFSD  288 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHH------HHHHHHHHSCSSGGGSC-----CHHHHTTSGGGSS
T ss_pred             ccccccccccchhhhccccCCHH------HHHHHHHHccCChhHCc-----CHHHHhcChhhcC
Confidence                             112222      24677789999999999     8899999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=403.14  Aligned_cols=256  Identities=22%  Similarity=0.356  Sum_probs=208.2

Q ss_pred             CcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 013249          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (447)
Q Consensus       106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (447)
                      .+.++.|++.++||+|+||.||+|.++.... .....||||++....  .......+.+|+.+|++++|||||++++++.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            3566789999999999999999999875321 233579999997543  3344556889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +.+.+++|||||.++++.+.+... +.+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999999998887765 6799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC----CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCc
Q 013249          265 IDESS----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  338 (447)
Q Consensus       265 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  338 (447)
                      +....    ......||+.|||||++.+..++.++|||||||++|||++ |.+||...+..++...+..+ ....|..++
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  239 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence            64332    2234568999999999999999999999999999999999 45666777777777777654 334566677


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .++.+++      .+||+.||++||     ++++|++
T Consensus       240 ~~l~~li------~~cl~~~p~~RP-----t~~eil~  265 (283)
T d1mqba_         240 SAIYQLM------MQCWQQERARRP-----KFADIVS  265 (283)
T ss_dssp             HHHHHHH------HHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHH------HHHCcCCHhHCc-----CHHHHHH
Confidence            7666555      459999999999     7888876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=418.82  Aligned_cols=259  Identities=25%  Similarity=0.404  Sum_probs=204.1

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+... .......+.+|+.+|++++|||||+++++|..   
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~-----t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT-----TTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC-----CCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            579999999999999999999986     789999999987643 45556678899999999999999999999964   


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                         ..++|+|||||.++.+ ..+  ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++
T Consensus        91 ~~~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TTTCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cccCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence               4689999999976544 444  4579999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC---------
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---------  334 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p---------  334 (447)
                      ...........+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+......++.......+         
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            87776667778899999999999999999999999999999999999999998888777766653221100         


Q ss_pred             ----------CCC----------------ch-hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 ----------PFL----------------TS-EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 ----------~~~----------------~~-~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                ...                .. .....-..++||.+||++||++||     +++|+++||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTGGG
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc-----CHHHHhcCcccCCC
Confidence                      000                00 000011236789999999999999     89999999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-53  Score=407.31  Aligned_cols=258  Identities=20%  Similarity=0.347  Sum_probs=222.2

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      ..+..++|++++.||+|+||+||+|++++..+..+++.||||+++...  .....+.+.+|+.+|++++||||+++++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            445567899999999999999999999876666678899999997643  344566789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQG------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (447)
                      ...+..++||||+.+|+|.+++....                        .+++.++..|+.||+.||+|||+++|||||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence            99999999999999999999997542                        388999999999999999999999999999


Q ss_pred             CCCCCcccCCCCcEEEeecCCcccccCC---CCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhC-CCCCCC
Q 013249          241 LKPENILMDSDGHVMLTDFGLAKEIDES---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTH  316 (447)
Q Consensus       241 ikp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~  316 (447)
                      |||+||||+.++.+||+|||+|+.....   ....+.+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            9999999999999999999999865332   223456789999999999999999999999999999999998 478999


Q ss_pred             CCHHHHHHHHHhccc-CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          317 ANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       317 ~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      .+..++...+..+.. ..|..++.++.+++      .+||+.||++||     ++++|++
T Consensus       246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li------~~cl~~~P~~RP-----t~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILACPENCPLELYNLM------RLCWSKLPADRP-----SFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHH------HHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHH------HHHcCCChhHCc-----CHHHHHH
Confidence            999999888887654 35667777766654      459999999999     7888864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=409.73  Aligned_cols=259  Identities=23%  Similarity=0.412  Sum_probs=206.2

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      +.+..++|+++++||+|+||.||+|+++......+++.||||+++...  .....+.+.+|..++.++ +|+||+.++++
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            456667999999999999999999999887666677899999997543  233345566777777766 68999999998


Q ss_pred             EEeC-CEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCc
Q 013249          184 FQTR-SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (447)
Q Consensus       184 ~~~~-~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NI  246 (447)
                      +... ..+++|||||++|+|.+++...                ..+++.+++.++.||+.||+|||++|||||||||+||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI  165 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  165 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence            8654 5689999999999999999754                2489999999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhC-CCCCCCCCHHHH
Q 013249          247 LMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKL  322 (447)
Q Consensus       247 Ll~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~  322 (447)
                      ||+.++++||+|||+|+......   .....+||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+..+.
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998754332   23456899999999999999999999999999999999986 578877654443


Q ss_pred             H-HHHHhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          323 Q-QRIINE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       323 ~-~~i~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      . ..+..+ ....|..+++++.+++.      +||+.||++||     ++++|++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~------~cl~~dP~~Rp-----t~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGTRMRAPDYTTPEMYQTML------DCWHGEPSQRP-----TFSELVEH  290 (299)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHH------HHcCCChhHCc-----CHHHHHHH
Confidence            3 333332 44566777877766655      59999999999     88999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=411.44  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=206.2

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+..  .....+.+.+|+.+|+.++||||+++++++.... 
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNV-----NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETT-----TCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCeEEEEEEeeccCeEEEEEEECC-----CCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            479999999999999999999876     78899999997643  3445567889999999999999999999997643 


Q ss_pred             ----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       189 ----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                          .+|++ +|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus        81 ~~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          81 EQMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             TTCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence                35555 55668999999865 4799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCC----CCCCccccCCccccccccc-CCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccC-------
Q 013249          265 IDES----SRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-------  332 (447)
Q Consensus       265 ~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~-------  332 (447)
                      ....    ......+||+.|+|||++. +..++.++||||+||++|||++|+.||.+.+..+....+......       
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            5332    2245578999999999985 456789999999999999999999999988776665554432111       


Q ss_pred             -------------CCCCCchhHHhhh-----hhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          333 -------------LPPFLTSEAHSLL-----KGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       333 -------------~p~~~~~~~~~li-----~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                   .+.........+.     +.++||.+||++||++||     +++++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----ta~e~L~hpf~~~~  301 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPYLEQY  301 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTT
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc-----CHHHHhcCHhhccC
Confidence                         1111110011110     235677789999999999     89999999999754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=404.13  Aligned_cols=254  Identities=22%  Similarity=0.373  Sum_probs=206.3

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (447)
                      +..++|++++.||+|+||.||+|+++....  ....||||++.+.........+.+.+|+.+|++++|||||++++++.+
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~--~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSG--KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTS--CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCC--cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            455689999999999999999999865221  345799999987766566667789999999999999999999999976


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccc
Q 013249          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEI  265 (447)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~  265 (447)
                       ..+++||||+++|+|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence             4678999999999999877654 57999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcccC--CCCCCc
Q 013249          266 DESSR----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK--LPPFLT  338 (447)
Q Consensus       266 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~~~--~p~~~~  338 (447)
                      .....    .....|+..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+......  .+..++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  241 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence            54332    234568889999999999999999999999999999998 89999999999999888877543  455677


Q ss_pred             hhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhh
Q 013249          339 SEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIK  374 (447)
Q Consensus       339 ~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~  374 (447)
                      .++.+++.      +||..||++||     ++++|+
T Consensus       242 ~~l~~li~------~cl~~dp~~RP-----t~~ei~  266 (273)
T d1u46a_         242 QDIYNVMV------QCWAHKPEDRP-----TFVALR  266 (273)
T ss_dssp             HHHHHHHH------HHTCSSGGGSC-----CHHHHH
T ss_pred             HHHHHHHH------HHcCCChhHCc-----CHHHHH
Confidence            77666555      59999999999     778876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-53  Score=408.58  Aligned_cols=254  Identities=22%  Similarity=0.336  Sum_probs=210.4

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (447)
                      ..++|+++++||+|+||+||+|+++..+. .....||+|.++...  .....+.+.+|+.+|++++|||||++++++.++
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCC-EEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            34689999999999999999999876221 112358888876542  344556789999999999999999999999875


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCccccc
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEID  266 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~  266 (447)
                       ..+++|||+.+|+|.+.+... ..+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence             567888999999998887765 579999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCchhH
Q 013249          267 ESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEA  341 (447)
Q Consensus       267 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~  341 (447)
                      ....   .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..++...+..+. ...|..++.++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence            4332   234568999999999999999999999999999999998 899999888888877776654 45677777777


Q ss_pred             HhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          342 HSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       342 ~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      .+++.      +||..||.+||     ++++|++|
T Consensus       243 ~~li~------~cl~~dP~~RP-----s~~eil~~  266 (317)
T d1xkka_         243 YMIMV------KCWMIDADSRP-----KFRELIIE  266 (317)
T ss_dssp             HHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHH------HhCCCChhhCc-----CHHHHHHH
Confidence            66655      49999999999     88999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=409.08  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=214.6

Q ss_pred             cCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCc--EEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      +..++|++.++||+|+||+||+|+++.     ++.  .||||.+....  .....+.+.+|+++|+++ +|||||+++++
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~   79 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGA   79 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECC-----CCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEE
Confidence            556799999999999999999999986     444  46777765432  334456788999999998 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcc
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NIL  247 (447)
                      +.+.+.+|+||||++||+|.+++++.                ..+++.++..++.||+.||.|||+++|+||||||+|||
T Consensus        80 ~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL  159 (309)
T d1fvra_          80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  159 (309)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence            99999999999999999999999754                56999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhC-CCCCCCCCHHHHHHHH
Q 013249          248 MDSDGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRI  326 (447)
Q Consensus       248 l~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i  326 (447)
                      ++.++.+||+|||+|+............||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..++...+
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             EcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999999876655555567899999999999999999999999999999999996 5689999999988887


Q ss_pred             Hhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          327 INE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       327 ~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ..+ .+..|..+++++.+++.      +||+.||++||     ++++|++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~------~cl~~dP~~RP-----s~~eil~~  279 (309)
T d1fvra_         240 PQGYRLEKPLNCDDEVYDLMR------QCWREKPYERP-----SFAQILVS  279 (309)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HhcCCCCCCccCCHHHHHHHH------HHcCCChhHCc-----CHHHHHHH
Confidence            764 45566777777776655      49999999999     88999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=412.77  Aligned_cols=254  Identities=25%  Similarity=0.374  Sum_probs=210.4

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+++|++++|||||++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT-----TTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            3689999999999999999999886     78999999998654 2344556788999999999999999999999643 


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                          ...++||+|+.||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++.
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             ccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence                344666777789999998854 579999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCccccCCcccccccccCC-CCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------
Q 013249          264 EIDESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--------  334 (447)
Q Consensus       264 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~~~~p--------  334 (447)
                      ....  ...+..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.......+        
T Consensus       170 ~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            6544  34557899999999997765 468999999999999999999999999988888777765433221        


Q ss_pred             -----------------------CCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCccCCC
Q 013249          335 -----------------------PFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  382 (447)
Q Consensus       335 -----------------------~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f~~~  382 (447)
                                             ...++++      ++||.+||++||.+||     +++|+++||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~------~dli~~mL~~dP~~R~-----ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLA------VDLLEKMLVLDSDKRI-----TAAQALAHAYFAQY  307 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHH------HHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTT
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHH------HHHHHHHCcCChhhCc-----CHHHHhcCHhhCCC
Confidence                                   1122332      4677779999999999     89999999999854

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=397.90  Aligned_cols=247  Identities=24%  Similarity=0.439  Sum_probs=206.7

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|+++++||+|+||.||+|+++       +..||||+++++.     ..+.+.+|+++|++++|||||++++++
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~   69 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI   69 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC-------CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4567789999999999999999999974       4579999997543     335688999999999999999999998


Q ss_pred             Ee-CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCC
Q 013249          185 QT-RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGL  261 (447)
Q Consensus       185 ~~-~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~  261 (447)
                      .+ .+.+|+||||+++|+|.+++..++  .+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+
T Consensus        70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence            54 566899999999999999997653  589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCch
Q 013249          262 AKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  339 (447)
Q Consensus       262 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~  339 (447)
                      ++.....  .....+|..|+|||++.+..++.++|||||||++|||++ |++||...+..++...+..+ ...+|...++
T Consensus       150 s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (262)
T d1byga_         150 TKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  227 (262)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred             ceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            9876543  344578999999999999999999999999999999998 89999998888888888764 4567777888


Q ss_pred             hHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          340 EAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       340 ~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      ++.++++      +||+.||.+||     ++++|+++
T Consensus       228 ~~~~li~------~cl~~dP~~Rp-----s~~~l~~~  253 (262)
T d1byga_         228 AVYEVMK------NCWHLDAAMRP-----SFLQLREQ  253 (262)
T ss_dssp             HHHHHHH------HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHH------HHcccCHhHCc-----CHHHHHHH
Confidence            7776655      49999999999     78888763

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=399.94  Aligned_cols=258  Identities=22%  Similarity=0.407  Sum_probs=215.8

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeee
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  181 (447)
                      +.+..++|+++++||+|+||.||+|+.+++.+.  ..+..||||+++++.  .......+.+|..++.++ +|||||+++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            556778999999999999999999998765432  234579999997653  334456677888888888 799999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                      ++|.+++.+|+|||||++|+|.+++..+.                .+++.+++.++.||+.||+|||+++||||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            99999999999999999999999997553                48999999999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCC---CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESS---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~  321 (447)
                      ||++.++.+||+|||+++......   .....+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+...
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            999999999999999999765433   2345679999999999999999999999999999999998 799999999888


Q ss_pred             HHHHHHhc-ccCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          322 LQQRIINE-KVKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       322 ~~~~i~~~-~~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      +...+..+ .+..|..++.++.+++.      +||++||++||     ++++|++
T Consensus       246 ~~~~i~~~~~~~~p~~~~~~l~~li~------~cl~~dP~~Rp-----s~~eil~  289 (299)
T d1fgka_         246 LFKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQRP-----TFKQLVE  289 (299)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHH------HHccCCHhHCc-----CHHHHHH
Confidence            88777654 34567777877766555      59999999999     7899886

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=402.50  Aligned_cols=258  Identities=20%  Similarity=0.302  Sum_probs=222.2

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (447)
                      +.+..++|++++.||+|+||+||+|.++++.+...+..||||++++..  .......+.+|+.++++++|||||++++++
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            567778999999999999999999998765444456789999997643  334456788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcE
Q 013249          185 QTRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV  254 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~  254 (447)
                      .....+++||||+.+|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+||||+.++++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence            9999999999999999999988643          246889999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhC-CCCCCCCCHHHHHHHHHhcc
Q 013249          255 MLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEK  330 (447)
Q Consensus       255 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~~~~  330 (447)
                      ||+|||+|+.+.....   ....+||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...+..+.
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence            9999999987644322   3345789999999999999999999999999999999997 68899999999888887654


Q ss_pred             c-CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          331 V-KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       331 ~-~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      . ..|..++..+.+++.      +||+.||++||     ++++|++
T Consensus       253 ~~~~p~~~~~~l~~li~------~cl~~~P~~RP-----s~~~il~  287 (308)
T d1p4oa_         253 LLDKPDNCPDMLFELMR------MCWQYNPKMRP-----SFLEIIS  287 (308)
T ss_dssp             CCCCCTTCCHHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCcccchHHHHHHHH------HHcCCChhHCc-----CHHHHHH
Confidence            3 456677777666655      49999999999     7888886

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=398.22  Aligned_cols=258  Identities=23%  Similarity=0.376  Sum_probs=219.1

Q ss_pred             cCcCCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhc-CCCCceeeeEE
Q 013249          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (447)
Q Consensus       105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (447)
                      +.+..++|++.++||+|+||.||+|++++..+..+++.||||++++..  .......+.+|+.+++++ +|||||+++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            456667999999999999999999999876666688999999997653  344456788999999999 69999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 013249          184 FQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (447)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~N  245 (447)
                      +.+...+|+|||||++|+|.+++.+..                  .+++..+..++.||+.||+|||++|||||||||+|
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            999999999999999999999997653                  58999999999999999999999999999999999


Q ss_pred             cccCCCCcEEEeecCCcccccCCCC---CCccccCCcccccccccCCCCCCccceeehhHhHHHHhh-CCCCCCCCCHHH
Q 013249          246 ILMDSDGHVMLTDFGLAKEIDESSR---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  321 (447)
Q Consensus       246 ILl~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~  321 (447)
                      ||++.++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999997654322   234678999999999999999999999999999999998 777787766655


Q ss_pred             HHHHHHhcc--cCCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          322 LQQRIINEK--VKLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       322 ~~~~i~~~~--~~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                      ...++....  ...|...+.++.+++.      +||+.||++||     ++++|++
T Consensus       256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~------~cl~~dP~~RP-----s~~~il~  300 (311)
T d1t46a_         256 KFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRP-----TFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHH------HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHhcCCCCCCcccccHHHHHHHH------HHcCCChhHCc-----CHHHHHH
Confidence            555555443  3345566666665554      59999999999     7888885

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=382.30  Aligned_cols=248  Identities=20%  Similarity=0.303  Sum_probs=201.2

Q ss_pred             EEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-CCEEEE
Q 013249          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSKLYL  192 (447)
Q Consensus       114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l  192 (447)
                      +.++||+|+||+||+|++....  .+...||||++++.  ......+.+.+|+++|++++|||||++++++.. ++.+++
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~--~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC------CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCC--CEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            3678999999999999987521  13346899998753  345556789999999999999999999999865 568999


Q ss_pred             EEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEEeecCCcccccCCCC-
Q 013249          193 ILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMLTDFGLAKEIDESSR-  270 (447)
Q Consensus       193 v~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL~DFG~a~~~~~~~~-  270 (447)
                      |||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||||++++.+||+|||+++....... 
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999999988755 4578889999999999999999999999999999999999999999999999987643322 


Q ss_pred             ----CCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCC-CCCHHHHHHHHHhc-ccCCCCCCchhHHhh
Q 013249          271 ----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINE-KVKLPPFLTSEAHSL  344 (447)
Q Consensus       271 ----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~-~~~~~~~~~~i~~~-~~~~p~~~~~~~~~l  344 (447)
                          .....||..|+|||++.+..++.++|||||||++|||++|..||. ..+..++...+..+ ....|...++++.++
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l  266 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  266 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence                223568999999999999999999999999999999999777664 34444555665554 334566677776665


Q ss_pred             hhhhhHHhhhccCCCCCCCCCCCCChhhhhcC
Q 013249          345 LKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHH  376 (447)
Q Consensus       345 i~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h  376 (447)
                      +      .+||+.||++||     +++||++|
T Consensus       267 i------~~cl~~dP~~RP-----s~~ei~~~  287 (311)
T d1r0pa_         267 M------LKCWHPKAEMRP-----SFSELVSR  287 (311)
T ss_dssp             H------HHHTCSSGGGSC-----CHHHHHHH
T ss_pred             H------HHHcCCCHhHCc-----CHHHHHHH
Confidence            5      459999999999     88999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-49  Score=381.86  Aligned_cols=251  Identities=18%  Similarity=0.262  Sum_probs=194.0

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCce-eeeEEEEeCC
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRS  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~  188 (447)
                      ++|++++.||+|+||+||+|+++.     +++.||||++......     +.+..|+++++.++|+|++ .+.+++.+.+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~   76 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   76 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECC-----CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence            479999999999999999999876     7889999998764321     2367899999999876654 5556667888


Q ss_pred             EEEEEEeccCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC---CCcEEEeecCCccc
Q 013249          189 KLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMLTDFGLAKE  264 (447)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~~kL~DFG~a~~  264 (447)
                      ..++||||+. ++|...+. ..+.+++..+..++.|++.||+|||++|||||||||+|||++.   +..+||+|||+|+.
T Consensus        77 ~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          77 YNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            9999999995 45555554 4568999999999999999999999999999999999998754   55799999999998


Q ss_pred             ccCCC--------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHHHHHHHHH---hccc--
Q 013249          265 IDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII---NEKV--  331 (447)
Q Consensus       265 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~---~~~~--  331 (447)
                      +....        .....+||+.|||||++.+..++.++|||||||++|||++|+.||...........+.   ....  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            65432        2345689999999999999999999999999999999999999997765444333221   1111  


Q ss_pred             ---CCCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhcCCcc
Q 013249          332 ---KLPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKHHKWF  379 (447)
Q Consensus       332 ---~~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~h~~f  379 (447)
                         .++..++.++.+++      .+||..||++||++.  .+.++++|+|.
T Consensus       236 ~~~~~~~~~p~~~~~li------~~cl~~~p~~RP~~~--~i~~~l~~~~~  278 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYL------NFCRSLRFDDKPDYS--YLRQLFRNLFH  278 (299)
T ss_dssp             CHHHHTTTSCHHHHHHH------HHHHHSCTTCCCCHH--HHHHHHHHHHH
T ss_pred             ChhHhccCCCHHHHHHH------HHHccCChhHCcCHH--HHHHHHHHHHH
Confidence               12345566665554      459999999999431  23455667654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-47  Score=366.91  Aligned_cols=244  Identities=19%  Similarity=0.276  Sum_probs=200.6

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeC
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTR  187 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~  187 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||++......     ..+.+|+++++.+.| +||+.+++++...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   73 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG   73 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             CCceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence            4689999999999999999999886     7889999998654321     236778999999975 8999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCC-----CCcEEEeecCC
Q 013249          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMLTDFGL  261 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~-----~~~~kL~DFG~  261 (447)
                      ...|+||||+ +++|.+++... ..+++..+..++.|++.||+|||++|||||||||+||||+.     ++.+||+|||+
T Consensus        74 ~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          74 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             CccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence            9999999999 78998888765 47999999999999999999999999999999999999974     57899999999


Q ss_pred             cccccCCC--------CCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCC---CHHHHHHHHHhcc
Q 013249          262 AKEIDESS--------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEK  330 (447)
Q Consensus       262 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~---~~~~~~~~i~~~~  330 (447)
                      |+.+....        .....+||+.|||||++.+..++.++|||||||++|||++|+.||.+.   +.......+....
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            98764321        234568999999999999999999999999999999999999999754   3334444444332


Q ss_pred             cC-----CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhh
Q 013249          331 VK-----LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIK  374 (447)
Q Consensus       331 ~~-----~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~  374 (447)
                      ..     ++..+++++..++.      .|+..+|++||     +.+.+.
T Consensus       233 ~~~~~~~l~~~~p~~l~~ii~------~~~~~~~~~rP-----~y~~l~  270 (293)
T d1csna_         233 QSTPLRELCAGFPEEFYKYMH------YARNLAFDATP-----DYDYLQ  270 (293)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHH------HHHHCCTTCCC-----CHHHHH
T ss_pred             CCCChHHhcCCCCHHHHHHHH------HHhcCCcccCc-----CHHHHH
Confidence            22     22445666655554      59999999999     555554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=373.63  Aligned_cols=248  Identities=24%  Similarity=0.342  Sum_probs=189.7

Q ss_pred             CCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 013249          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (447)
Q Consensus       110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (447)
                      .+|.+.++||+|+||.||+|++       +++.||||+++....    .......|+..+..++|||||++++++.+.+ 
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-------~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~   71 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-------TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-------CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence            3689999999999999999986       467899999865421    1122334555566789999999999997653 


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCCcccCCCCcEEEe
Q 013249          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK--------CGIVHRDLKPENILMDSDGHVMLT  257 (447)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~--------~~iiHrDikp~NILl~~~~~~kL~  257 (447)
                         .+|+|||||++|+|.+++.+. .+++.++..++.|++.||.|||.        +|||||||||+||||+.++++||+
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             cceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence               689999999999999999775 68999999999999999999996        599999999999999999999999


Q ss_pred             ecCCcccccCCC-----CCCccccCCcccccccccCCC------CCCccceeehhHhHHHHhhCCCCCCC----------
Q 013249          258 DFGLAKEIDESS-----RSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTGQPPFTH----------  316 (447)
Q Consensus       258 DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~ell~G~~pf~~----------  316 (447)
                      |||+++......     .....+||+.|+|||++.+..      ++.++|||||||+||||++|..||..          
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            999998764432     234568999999999987643      56789999999999999999887732          


Q ss_pred             -----CCHHHHHHHHHhcccC--CCCCCchhHHhhhhhhhHHhhhccCCCCCCCCCCCCChhhhhc
Q 013249          317 -----ANRQKLQQRIINEKVK--LPPFLTSEAHSLLKGVSFLTQLLHKDPSKRLGSGPGGVDAIKH  375 (447)
Q Consensus       317 -----~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~~~l~~~L~~dP~~R~~~~~~~~~~l~~  375 (447)
                           .....+...+.....+  +|.... .....-...+++.+||+.||++||     +++||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ei~~  290 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARL-----TALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSC-----CHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCcccC-ChHHHHHHHHHHHHHcccCHhHCc-----CHHHHHH
Confidence                 1233333333333321  221111 001111234678889999999999     7888876

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-46  Score=369.55  Aligned_cols=273  Identities=24%  Similarity=0.376  Sum_probs=200.9

Q ss_pred             CCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----------CCCc
Q 013249          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPFI  177 (447)
Q Consensus       109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpnI  177 (447)
                      .++|+++++||+|+||+||+|+++.     +++.||||+++++..    ..+.+.+|+.+|+.++           |+||
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~-----~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            3569999999999999999999886     889999999986532    2345678888888775           5789


Q ss_pred             eeeeEEEEe--CCEEEEEEeccCCCChHHHH-H--HcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCcccCCC
Q 013249          178 VQLRYSFQT--RSKLYLILDFINGGHLFFHL-Y--RQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSD  251 (447)
Q Consensus       178 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l-~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~  251 (447)
                      +++++++..  ....+++|+++.++...... .  ....+++..++.++.||+.||+|||+ +||+||||||+||||+.+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999988864  45677777776655433322 2  33579999999999999999999998 899999999999999876


Q ss_pred             Cc------EEEeecCCcccccCCCCCCccccCCcccccccccCCCCCCccceeehhHhHHHHhhCCCCCCCCCHH-----
Q 013249          252 GH------VMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----  320 (447)
Q Consensus       252 ~~------~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-----  320 (447)
                      +.      +||+|||.+.....  .....+||+.|+|||++.+..|+.++||||+||++++|++|+.||...+..     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence            53      99999999987654  345678999999999999999999999999999999999999999654321     


Q ss_pred             -HHHHHHHhccc------------------------CCCCCCchhH------------HhhhhhhhHHhhhccCCCCCCC
Q 013249          321 -KLQQRIINEKV------------------------KLPPFLTSEA------------HSLLKGVSFLTQLLHKDPSKRL  363 (447)
Q Consensus       321 -~~~~~i~~~~~------------------------~~p~~~~~~~------------~~li~~~~~l~~~L~~dP~~R~  363 (447)
                       +....+.....                        ..........            ...-..+|||.+||++||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             11111111000                        0000000000            0011235788899999999999


Q ss_pred             CCCCCChhhhhcCCccCCCChhHHHhhhcCCCCCCCCC
Q 013249          364 GSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS  401 (447)
Q Consensus       364 ~~~~~~~~~l~~h~~f~~~~~~~~~~~~~~~~~~p~~~  401 (447)
                           +++|+++||||+++.    ....++.|..+...
T Consensus       321 -----ta~e~L~Hp~f~~~~----~~~~~~~p~~~~~~  349 (362)
T d1q8ya_         321 -----DAGGLVNHPWLKDTL----GMEEIRVPDRELYG  349 (362)
T ss_dssp             -----CHHHHHTCGGGTTCT----TCTTCCCTTSCTTC
T ss_pred             -----CHHHHhcCcccCCCC----CcccCCCCCcccCC
Confidence                 899999999998553    23345555555443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=3.8e-27  Score=210.11  Aligned_cols=167  Identities=19%  Similarity=0.229  Sum_probs=123.6

Q ss_pred             cEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhc---------------chhHHHHHHHHHHHHHhcCCCC
Q 013249          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---------------KKNHVDYMKAERDILTKVTHPF  176 (447)
Q Consensus       112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~---------------~~~~~~~~~~E~~il~~l~hpn  176 (447)
                      +.+.++||+|+||+||+|++.      +++.||||+++.....               ..........|...+.++.|.+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             chhCCEeeeCcceEEEEEECC------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            468899999999999999875      6788999987642110               0111234556888999999999


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCcccCCCCcEEE
Q 013249          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVML  256 (447)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~~kL  256 (447)
                      ++..+++..    .+++|||++++.+.       .+++..+..++.|++.+|.|||++||+||||||+|||+++++ ++|
T Consensus        76 v~~~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~l  143 (191)
T d1zara2          76 VPKVYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWI  143 (191)
T ss_dssp             SCCEEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEE
T ss_pred             cceEEEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEE
Confidence            998876532    27999999887552       255667788999999999999999999999999999998654 899


Q ss_pred             eecCCcccccCCCCCCccccCCccccc------ccccCCCCCCccceeehhHhH
Q 013249          257 TDFGLAKEIDESSRSNSMCGTTEYMAP------EILLSKGHNKDADWWSVGILL  304 (447)
Q Consensus       257 ~DFG~a~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwSlGvil  304 (447)
                      +|||+|+.......       ..|...      +.+ .+.|+.++|+||+.--+
T Consensus       144 iDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGW-------REILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTH-------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCc-------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            99999977543211       112211      111 35688999999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=3.6e-07  Score=82.84  Aligned_cols=139  Identities=12%  Similarity=0.063  Sum_probs=90.9

Q ss_pred             CcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCE
Q 013249          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (447)
Q Consensus       111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (447)
                      .|++.+..+-++.+.||++..       .++.++||.........   ...+.+|..+|+.+. +--+-+++.+...++.
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~-------~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC-------SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             ceEEEEcCCCCCCCcEEEEEe-------CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            677777765555679998752       45668888876543211   223567888888774 3234567778888899


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 013249          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK------------------------------------  233 (447)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~------------------------------------  233 (447)
                      .|+||++++|..+......     ......++.++...|..||+                                    
T Consensus        85 ~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             eEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            9999999999877443211     11112223333333333332                                    


Q ss_pred             -----------------C------CceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          234 -----------------C------GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       234 -----------------~------~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                                       .      .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                             1      268999999999999876677999987753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.09  E-value=5.2e-06  Score=79.97  Aligned_cols=81  Identities=16%  Similarity=0.301  Sum_probs=48.4

Q ss_pred             EeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechh-hcc---hhHHHHHHHHHHHHHhcC-C-C-CceeeeEEEEeC
Q 013249          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-IIK---KNHVDYMKAERDILTKVT-H-P-FIVQLRYSFQTR  187 (447)
Q Consensus       115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~-~~~---~~~~~~~~~E~~il~~l~-h-p-nIv~l~~~~~~~  187 (447)
                      .+.||.|....||++....     +++.++||.-.... ...   ....++...|..+|+.+. + | .+.+++.+  +.
T Consensus        31 ~~eig~G~~N~vfrV~~~~-----~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred             EEEeCCCceEeEEEEEeCC-----CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence            5678999999999997543     56788998643211 000   112334566888887663 2 3 34445433  44


Q ss_pred             CEEEEEEeccCCCCh
Q 013249          188 SKLYLILDFINGGHL  202 (447)
Q Consensus       188 ~~~~lv~E~~~gg~L  202 (447)
                      ...++|||++.+..+
T Consensus       104 ~~~~lvmE~L~~~~~  118 (392)
T d2pula1         104 EMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTEEEECCCTTSEE
T ss_pred             CCCEEEEeccCCccc
Confidence            456789999977543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.03  E-value=6.5e-06  Score=73.82  Aligned_cols=136  Identities=14%  Similarity=0.135  Sum_probs=81.0

Q ss_pred             eEeecCC-eEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC--CceeeeEEEEeCCEEEEE
Q 013249          117 VVGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQTRSKLYLI  193 (447)
Q Consensus       117 ~lG~G~f-g~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~~~~~lv  193 (447)
                      .+..|.. +.||++...      .+..+++|.......      ..+..|..+|+.+...  -+.+++.+..+.+..++|
T Consensus        17 ~~~~G~s~~~v~r~~~~------~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             ECSCTTSSCEEEEEECT------TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             EcCCcccCCeEEEEEeC------CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            3444543 688988743      456688897654321      2366788888777432  255677777888889999


Q ss_pred             EeccCCCChHH--------------HHHHcC-------CCC--HHHHH-----HHH---------------HHHHHHHHH
Q 013249          194 LDFINGGHLFF--------------HLYRQG-------IFR--EDQAR-----FYT---------------AEIVSAVSH  230 (447)
Q Consensus       194 ~E~~~gg~L~~--------------~l~~~~-------~~~--~~~~~-----~i~---------------~qi~~aL~~  230 (447)
                      |++++|.++..              .+.+-.       .+.  .....     .+.               ......+..
T Consensus        85 ~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          85 LGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             EECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             EEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            99998865521              111100       000  00000     000               001222333


Q ss_pred             HHHC-------CceeccCCCCCcccCCCCcEEEeecCCccc
Q 013249          231 LHKC-------GIVHRDLKPENILMDSDGHVMLTDFGLAKE  264 (447)
Q Consensus       231 LH~~-------~iiHrDikp~NILl~~~~~~kL~DFG~a~~  264 (447)
                      +...       .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            3332       279999999999999876678999987653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.29  E-value=0.00032  Score=65.14  Aligned_cols=69  Identities=12%  Similarity=0.245  Sum_probs=44.0

Q ss_pred             CeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcCCC-----Cceee--eEEEEeCCEEEEEEe
Q 013249          123 FGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP-----FIVQL--RYSFQTRSKLYLILD  195 (447)
Q Consensus       123 fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-----nIv~l--~~~~~~~~~~~lv~E  195 (447)
                      --.||++...      +|+.|++|+.+....    ..+.+..|..++..|...     ..+..  -..+...+..+.+++
T Consensus        35 EN~vy~v~~~------dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~  104 (325)
T d1zyla1          35 ENRVYQFQDE------DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  104 (325)
T ss_dssp             SSEEEEECCT------TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             cceeEEEEcC------CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence            4689998754      577899999875432    224467788888776421     11111  122345678899999


Q ss_pred             ccCCCC
Q 013249          196 FINGGH  201 (447)
Q Consensus       196 ~~~gg~  201 (447)
                      ++.|..
T Consensus       105 ~~~G~~  110 (325)
T d1zyla1         105 SVGGRQ  110 (325)
T ss_dssp             CCCCEE
T ss_pred             ecCCcC
Confidence            998743

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.79  E-value=0.0015  Score=59.91  Aligned_cols=144  Identities=15%  Similarity=0.205  Sum_probs=76.7

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-----CCCceee--
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQL--  180 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l--  180 (447)
                      +.++..-.+.|..|---+.|++...       +..|++|+.....  ...   .+..|..++..+.     .|..+..  
T Consensus        16 ~lg~~~~~~~i~~G~~N~ny~v~t~-------~g~yVLri~~~~~--~~~---~l~~~~~~l~~L~~~g~pvp~pi~~~~   83 (316)
T d2ppqa1          16 DVGSLTSYKGIAEGVENSNFLLHTT-------KDPLILTLYEKRV--EKN---DLPFFLGLMQHLAAKGLSCPLPLPRKD   83 (316)
T ss_dssp             CCCCEEEEEEECC---EEEEEEEES-------SCCEEEEEECC-----CC---HHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred             CCCCceEeecCCCCcccCeEEEEEC-------CCcEEEEEcCCCC--CHH---HHHHHHHHHHhhhhccccccccceecC
Confidence            4456666777878888899998753       3459999986532  222   3445666666663     2322221  


Q ss_pred             -eEEEEeCCEEEEEEeccCCCChH--------------HHHHHcC---------CCCHH------------------HHH
Q 013249          181 -RYSFQTRSKLYLILDFINGGHLF--------------FHLYRQG---------IFRED------------------QAR  218 (447)
Q Consensus       181 -~~~~~~~~~~~lv~E~~~gg~L~--------------~~l~~~~---------~~~~~------------------~~~  218 (447)
                       .....-.+....++.++.|....              ..++...         .....                  ...
T Consensus        84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (316)
T d2ppqa1          84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR  163 (316)
T ss_dssp             CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred             CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence             01122345666777776664321              0111000         00110                  111


Q ss_pred             HHHHHHHHHHHHHH----HCCceeccCCCCCcccCCCCcEEEeecCCcc
Q 013249          219 FYTAEIVSAVSHLH----KCGIVHRDLKPENILMDSDGHVMLTDFGLAK  263 (447)
Q Consensus       219 ~i~~qi~~aL~~LH----~~~iiHrDikp~NILl~~~~~~kL~DFG~a~  263 (447)
                      ..+..+...+.-.+    ..|+||+|+.++|||++.+...-|.||+.|.
T Consensus       164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            12222222222222    2479999999999999988777899999775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.72  E-value=0.0024  Score=60.58  Aligned_cols=85  Identities=15%  Similarity=0.130  Sum_probs=52.5

Q ss_pred             CCCCcEEEeeEeecCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhcchhHHHHHHHHHHHHHhcC-CCCceeeeEEE
Q 013249          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSF  184 (447)
Q Consensus       108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~  184 (447)
                      ..+++++ +.|+.|---.+|++.......  ....+.|.+++.-..    ... ....+|..+++.+. +.-..++++++
T Consensus        41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~  114 (395)
T d1nw1a_          41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-SHLVAESVIFTLLSERHLGPKLYGIF  114 (395)
T ss_dssp             CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred             CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chh-hHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence            3345554 578888899999998753211  113456777776421    112 23557888988885 43334666666


Q ss_pred             EeCCEEEEEEeccCCCCh
Q 013249          185 QTRSKLYLILDFINGGHL  202 (447)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L  202 (447)
                      .+    .+||||++|..|
T Consensus       115 ~~----g~I~efi~g~~l  128 (395)
T d1nw1a_         115 SG----GRLEEYIPSRPL  128 (395)
T ss_dssp             TT----EEEECCCCEEEC
T ss_pred             CC----ceEEEEeccccC
Confidence            43    589999987544